Citrus Sinensis ID: 005590
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 689 | 2.2.26 [Sep-21-2011] | |||||||
| Q9P6P3 | 534 | Serine/threonine-protein | yes | no | 0.442 | 0.571 | 0.388 | 5e-55 | |
| Q9V3D5 | 722 | Dual specificity tyrosine | yes | no | 0.457 | 0.436 | 0.389 | 1e-54 | |
| Q09690 | 1087 | Dual specificity protein | no | no | 0.457 | 0.289 | 0.379 | 1e-54 | |
| Q54BC9 | 915 | Probable serine/threonine | yes | no | 0.438 | 0.330 | 0.387 | 4e-54 | |
| Q8BI55 | 632 | Dual specificity tyrosine | yes | no | 0.448 | 0.488 | 0.384 | 7e-54 | |
| Q09815 | 836 | Serine/threonine-protein | no | no | 0.455 | 0.375 | 0.365 | 3e-53 | |
| Q9NR20 | 520 | Dual specificity tyrosine | yes | no | 0.447 | 0.592 | 0.382 | 2e-52 | |
| A8WJR8 | 815 | Dual specificity tyrosine | N/A | no | 0.470 | 0.397 | 0.36 | 2e-51 | |
| P83102 | 828 | Putative dual specificity | no | no | 0.441 | 0.367 | 0.380 | 5e-51 | |
| P14680 | 807 | Dual specificity protein | yes | no | 0.464 | 0.396 | 0.351 | 1e-50 |
| >sp|Q9P6P3|PPK15_SCHPO Serine/threonine-protein kinase ppk15 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=ppk15 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 216 bits (550), Expect = 5e-55, Method: Compositional matrix adjust.
Identities = 134/345 (38%), Positives = 188/345 (54%), Gaps = 40/345 (11%)
Query: 374 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKL 433
+L T +Y + + LG F +V + QDL T V +K+IKN F++Q + E+ +L+L
Sbjct: 121 LLGTDEGRKYLILDTLGHGTFGQVARCQDLKTQQIVAIKVIKNKPAFYNQCVMEVSILEL 180
Query: 434 VN-KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 492
+N K DP D+ H++RLYD F H HL +V ELL NLYE K NQ G L ++
Sbjct: 181 LNNKYDPEDKRHLIRLYDQFMHKNHLCLVFELLSINLYELIKQNQFRG----LHLSLVRS 236
Query: 493 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 552
Q L L IIHCDLKPENIL++ +K+ID GS+C + + Y+QSR
Sbjct: 237 FATQLLSCTSLLKQARIIHCDLKPENILLQDLSSPIVKVIDFGSACHERQTVYTYIQSRF 296
Query: 553 YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 612
YR+PEVI+GL Y+ ID+WSLGCILAEL+ G LFP ++ L RI+ MLG ML
Sbjct: 297 YRSPEVILGLHYNCGIDMWSLGCILAELFLGLPLFPGNSEYNQLCRIVDMLGNPPTWMLE 356
Query: 613 QGQEIYKYFT-------KEYDLYYI------NEETNQ----------LEYII-------- 641
G+ KY+ K Y+L I N +T Q L+ I+
Sbjct: 357 MGKNSKKYYNSGFVNGRKTYELKSIEQFSIENNKTEQPGKQYFGEKTLDAIVLNYPRRKT 416
Query: 642 -PEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685
P+ + EH + FIDF++ LE+NP +R T +A +HP++
Sbjct: 417 TPKLTPEEHEERLC---FIDFIKQFLELNPLKRWTPDQAKNHPFI 458
|
Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9V3D5|DYRK2_DROME Dual specificity tyrosine-phosphorylation-regulated kinase 2 OS=Drosophila melanogaster GN=smi35A PE=1 SV=1 | Back alignment and function description |
|---|
Score = 215 bits (547), Expect = 1e-54, Method: Compositional matrix adjust.
Identities = 125/321 (38%), Positives = 180/321 (56%), Gaps = 6/321 (1%)
Query: 366 EENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL 425
++N + II + IA RY + E +G +F +V +A D T V +KII+N K F +Q++
Sbjct: 181 DDNGNYKIIEHDHIAFRYEILEVIGKGSFGQVIRALDHKTNTHVAIKIIRNKKRFLNQAV 240
Query: 426 DEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF 485
E+ +L + + D H+++ + DY Y +HL I EL+ NLYE K N +G F
Sbjct: 241 VELNILDELREKDADGSHNVIHMLDYTYFRKHLCITFELMSLNLYELIKKNNYNG----F 296
Query: 486 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 545
++ ++ ++ L L+ IIHCDLKPENIL+K IK+ID GSSC+ +
Sbjct: 297 SMSLIRRFCNSIVKCLRLLYKENIIHCDLKPENILLKQRGSSSIKVIDFGSSCYVDRKIY 356
Query: 546 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 605
Y+QSR YR+PEVI+GL Y ID+WSLGCILAEL+TG LFP + V LA I+ +LG
Sbjct: 357 TYIQSRFYRSPEVILGLQYGTAIDMWSLGCILAELYTGFPLFPGENEVEQLACIMEVLG- 415
Query: 606 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTL 665
+ ++L+ + F D T + P SL H L D +FIDF++
Sbjct: 416 LPPKVLISVARRRRLFFDSRDAPRCITNTKGRKR-SPGSKSLAHILHCQDRYFIDFLQRC 474
Query: 666 LEINPQRRPTAREALDHPWLQ 686
LE +P R T EA H +LQ
Sbjct: 475 LEWDPAERMTPDEAAHHEFLQ 495
|
In vitro; can phosphorylate exogenous substrates on Ser and Thr residues. May have a physiological role in development being involved in cellular growth and differentiation. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q09690|POM1_SCHPO Dual specificity protein kinase pom1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=pom1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 214 bits (546), Expect = 1e-54, Method: Compositional matrix adjust.
Identities = 123/324 (37%), Positives = 186/324 (57%), Gaps = 9/324 (2%)
Query: 364 GFE-ENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD 422
GF+ E D ++L IA RY V ++LG +F +V + D TG V LKII+N K F
Sbjct: 679 GFDDERGDYKVVLGDHIAYRYEVVDFLGKGSFGQVLRCIDYETGKLVALKIIRNKKRFHM 738
Query: 423 QSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE 482
Q+L E K+L+ + + DP DE+ +++ D+FY +HL + ELL NLYE K N G
Sbjct: 739 QALVETKILQKIREWDPLDEYCMVQYTDHFYFRDHLCVATELLGKNLYELIKSNGFKG-- 796
Query: 483 AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 542
+ ++ ITRQ ++ L L+ +IHCDLKPENIL+ + ++K+ID GSSCF+ +
Sbjct: 797 --LPIVVIKSITRQLIQCLTLLNEKHVIHCDLKPENILLCHPFKSQVKVIDFGSSCFEGE 854
Query: 543 NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 602
+ Y+QSR YR+PEVI+G+ Y ID+WSLGCI+AE++TG LFP + LA I+ +
Sbjct: 855 CVYTYIQSRFYRSPEVILGMGYGTPIDVWSLGCIIAEMYTGFPLFPGENEQEQLACIMEI 914
Query: 603 LGPIDLEMLMQGQEIYKYF-TKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDF 661
GP D ++ + +F + +++ + P SL LQ D F+ F
Sbjct: 915 FGPPDHSLIDKCSRKKVFFDSSGKPRPFVSSKGVSRR---PFSKSLHQVLQCKDVSFLSF 971
Query: 662 VRTLLEINPQRRPTAREALDHPWL 685
+ L+ +P R T ++A H +L
Sbjct: 972 ISDCLKWDPDERMTPQQAAQHDFL 995
|
Involved in localization of polarized growth and cytokinesis. May interact with both the actin and microtubule cytoskeleton. Requires tea1 for localization to the cell ends but not to the cell center. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q54BC9|DYRK2_DICDI Probable serine/threonine-protein kinase dyrk2 OS=Dictyostelium discoideum GN=dyrk2 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 213 bits (542), Expect = 4e-54, Method: Compositional matrix adjust.
Identities = 119/307 (38%), Positives = 170/307 (55%), Gaps = 5/307 (1%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 438
IA R+ + LG +F +V + D TG V LKI++N K F +Q+L EIK+L+ + ND
Sbjct: 601 IAYRFEIVSILGQGSFCQVVKGYDYKTGEMVALKILRNQKRFHNQALTEIKILEYLKTND 660
Query: 439 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
P I+ L +YFY HL + ELL NLY+F K N G + L ++ Q L
Sbjct: 661 PNSTASIVHLNNYFYFRNHLILTFELLSMNLYDFLKVNHFQG----YNLNLVRRFGAQIL 716
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEV 558
+L +L IIH DLKPENIL+KS + IK+ID GSSCF+ + + Y+QSR YR+PEV
Sbjct: 717 TSLRFLSKRNIIHADLKPENILLKSPTKSGIKLIDFGSSCFENEQIFTYIQSRFYRSPEV 776
Query: 559 IIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 618
I+G YD+ ID+WSLGCIL E++TG LFP LA I+ +LG ++
Sbjct: 777 ILGTKYDKSIDIWSLGCILVEIFTGVPLFPGSDEPEQLACIMEVLGAPPKSVIDNSTRKD 836
Query: 619 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTARE 678
+F + + T Y I + S + ++ D F +F+ L+ P +R TA +
Sbjct: 837 IFFEDDGTPKPVKNSTTGELYTIGTK-SFKDSIRSGDEDFDNFILDCLKWEPSQRITAEQ 895
Query: 679 ALDHPWL 685
L H W+
Sbjct: 896 GLKHDWI 902
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q8BI55|DYRK4_MOUSE Dual specificity tyrosine-phosphorylation-regulated kinase 4 OS=Mus musculus GN=Dyrk4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 212 bits (540), Expect = 7e-54, Method: Compositional matrix adjust.
Identities = 121/315 (38%), Positives = 172/315 (54%), Gaps = 6/315 (1%)
Query: 374 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKL 433
+L+ IA RY V E +G +F +V + D V LKII+N K F Q+L E+K+L+
Sbjct: 210 VLHDHIAYRYEVLEMIGKGSFGQVAKCLDHKNNELVALKIIRNKKRFHHQALVELKILEA 269
Query: 434 VNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI 493
+ + D + H+++ + D+FY HL I ELL NLYE K N G F L ++
Sbjct: 270 LRRKDKDNNHNVVHMKDFFYFRNHLCITFELLGINLYELMKNNSFHG----FNLSIVRRF 325
Query: 494 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY 553
T L+ L L+ IIHCDLKPENI++ + +K+ID GSSC++ + Y+QSR Y
Sbjct: 326 TFSILKCLHMLYVEKIIHCDLKPENIVLYQRGQVTVKVIDFGSSCYEHQKVYTYIQSRFY 385
Query: 554 RAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613
R+PEVI+G PY+ ID+WSLGCI+AEL+TG LFP + V LA I+ +LG
Sbjct: 386 RSPEVILGHPYNMAIDMWSLGCIMAELYTGYPLFPGENEVEQLACIMEVLGLPPAHFTQT 445
Query: 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 673
+F + IN Y P+ L ++ D+ F+DF+R L P R
Sbjct: 446 ASRRQVFFDSKGLPKNINNNRGGKRY--PDSKDLTMVVKTYDSSFLDFLRRCLVWEPSLR 503
Query: 674 PTAREALDHPWLQHP 688
T +AL H W+ P
Sbjct: 504 MTPEQALKHAWIHEP 518
|
Possible non-essential role in spermiogenesis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q09815|PPK5_SCHPO Serine/threonine-protein kinase ppk5 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=ppk5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 210 bits (535), Expect = 3e-53, Method: Compositional matrix adjust.
Identities = 117/320 (36%), Positives = 178/320 (55%), Gaps = 6/320 (1%)
Query: 366 EENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL 425
++N D I + RY + + +G +F +V + D G V +K+IKN + F Q+L
Sbjct: 501 DDNGDYKAIQGDHLLYRYEIIDTVGKGSFGQVLKCIDHKRGQVVAIKVIKNRQKFHGQTL 560
Query: 426 DEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF 485
E+ +LK + + DPAD+++++R +F HL IV ELL +NL++ + N G
Sbjct: 561 VEVGILKRLCEADPADKNNVIRYLSHFDFRGHLCIVTELLGSNLFDVIRENNYKG----L 616
Query: 486 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 545
L ++ Q L+AL L IIHCDLKPEN+L+ + IK+ID GSSCF + +
Sbjct: 617 PLIVVKSFALQGLQALRLLQGQNIIHCDLKPENLLLSHPLKARIKLIDFGSSCFYNEKVY 676
Query: 546 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 605
Y+QSR YRAPE+I+GL Y ++ID+WS GCILAEL+TG LFP L I+ +LGP
Sbjct: 677 TYLQSRFYRAPEIILGLEYGKEIDIWSFGCILAELFTGVPLFPGGNETEQLGYIMEVLGP 736
Query: 606 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTL 665
+ ++ YF E + I + N+L ++P + L A F+DF+
Sbjct: 737 PPMALIRNSTRSKAYFDSEGKPHPITDSHNRL--LVPSTRTFSQLLNTKQASFLDFLSKC 794
Query: 666 LEINPQRRPTAREALDHPWL 685
L+ +P+ R T AL H ++
Sbjct: 795 LKWDPKDRITVDSALQHEFI 814
|
Has a role in meiosis. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9NR20|DYRK4_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 4 OS=Homo sapiens GN=DYRK4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 207 bits (528), Expect = 2e-52, Method: Compositional matrix adjust.
Identities = 120/314 (38%), Positives = 170/314 (54%), Gaps = 6/314 (1%)
Query: 374 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKL 433
+L+ IA RY V E +G +F +V + D V LKII+N K F Q+L E+K+L+
Sbjct: 95 VLHDHIAYRYEVLETIGKGSFGQVAKCLDHKNNELVALKIIRNKKRFHQQALMELKILEA 154
Query: 434 VNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI 493
+ K D + ++++ + D+FY H I ELL NLYE K N G F+L ++
Sbjct: 155 LRKKDKDNTYNVVHMKDFFYFRNHFCITFELLGINLYELMKNNNFQG----FSLSIVRRF 210
Query: 494 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY 553
T L+ L+ L IIHCDLKPENI++ + +K+ID GSSC++ + Y+QSR Y
Sbjct: 211 TLSVLKCLQMLSVEKIIHCDLKPENIVLYQKGQASVKVIDFGSSCYEHQKVYTYIQSRFY 270
Query: 554 RAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613
R+PEVI+G PYD ID+WSLGCI AEL+TG LFP + V LA I+ +LG +
Sbjct: 271 RSPEVILGHPYDVAIDMWSLGCITAELYTGYPLFPGENEVEQLACIMEVLGLPPAGFIQT 330
Query: 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 673
+F + I + Y P+ L L+ D F+DF+R L P R
Sbjct: 331 ASRRQTFFDSKGFPKNITNNRGKKRY--PDSKDLTMVLKTYDTSFLDFLRRCLVWEPSLR 388
Query: 674 PTAREALDHPWLQH 687
T +AL H W+
Sbjct: 389 MTPDQALKHAWIHQ 402
|
Possible non-essential role in spermiogenesis. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|A8WJR8|MBK2_CAEBR Dual specificity tyrosine-phosphorylation-regulated kinase mbk-2 OS=Caenorhabditis briggsae GN=mbk-2 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 204 bits (519), Expect = 2e-51, Method: Compositional matrix adjust.
Identities = 126/350 (36%), Positives = 183/350 (52%), Gaps = 26/350 (7%)
Query: 356 IIHRKNRTGFE-ENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII 414
+I N G++ EN ++++ IA RY V + +G +F +V +A D V LK++
Sbjct: 432 VIGGANNGGYDDENGSYQLVVHDHIAYRYEVLKVIGKGSFGQVIKAFDHKYQQYVALKLV 491
Query: 415 KNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQK 474
+N+K F Q+ +EI++L + + D H+I+ + DYF H I ELL NLYE K
Sbjct: 492 RNEKRFHRQADEEIRILDHLRRQDSDGTHNIIHMLDYFNFRNHKCITFELLSINLYELIK 551
Query: 475 FNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 534
N+ G F+L ++ L L+ L +IHCDLKPEN+L+K R IK+ID
Sbjct: 552 RNKFQG----FSLMLVRKFAYSMLLCLDLLQKNRLIHCDLKPENVLLKQQGRSGIKVIDF 607
Query: 535 GSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP----ND 590
GSSCF + Y+QSR YRAPEVI+G Y ID+WSLGCILAEL TG L P ND
Sbjct: 608 GSSCFDDQRIYTYIQSRFYRAPEVILGTKYGMPIDMWSLGCILAELLTGYPLLPGEDEND 667
Query: 591 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYII--------- 641
+ +I+ ++GM P LE + + +K Y Y ++
Sbjct: 668 QLALII-ELLGMPPPKSLETAKRARTFIT--SKGYPRYCTATSMPDGSVVLAGARSKRGK 724
Query: 642 ----PEESSLEHHLQ-FSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686
PE S L+ D F+DF++ L+ +P+ R T +AL H WL+
Sbjct: 725 MRGPPESRSWSTALKNMGDELFVDFLKRCLDWDPETRMTPAQALKHKWLR 774
|
Required for oocyte-to-zygote transition in which it phosphorylates oocyte proteins, including mei-1, oma-1, oma-2, mex-5, and mex-6, modifying their activity and/or stability following meiosis. Functions in both spindle positioning and in the posterior localization of cytoplasmic determinants, including pie-1, pos-1, and pgl-1, in early embryos. Caenorhabditis briggsae (taxid: 6238) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P83102|DYRK3_DROME Putative dual specificity tyrosine-phosphorylation-regulated kinase 3 homolog OS=Drosophila melanogaster GN=Dyrk3 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 203 bits (516), Expect = 5e-51, Method: Compositional matrix adjust.
Identities = 123/323 (38%), Positives = 180/323 (55%), Gaps = 19/323 (5%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 438
+A RY + + +G +F +V +A D T V LKI++N+K F Q+ +EI++L + ++D
Sbjct: 272 VAYRYEMLKIIGKGSFGQVIKAYDHKTHEHVALKIVRNEKRFHRQAQEEIRILHHLRRHD 331
Query: 439 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
+ +I+ ++DYF H I ELL NLYE K N G F+L ++ L
Sbjct: 332 KYNTMNIIHMFDYFTFRNHTCITFELLSINLYELIKKNGFKG----FSLQLVRKFAHSLL 387
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEV 558
+ L+ L+ IIHCD+KPEN+L+K R IK+ID GSSCF+ + Y+QSR YRAPEV
Sbjct: 388 QCLDALYKNDIIHCDMKPENVLLKQQGRSGIKVIDFGSSCFENQRIYTYIQSRFYRAPEV 447
Query: 559 IIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 618
I+G Y + ID+WSLGCILAEL +G LFP + LA II +LG + +L +
Sbjct: 448 ILGGKYGRAIDMWSLGCILAELLSGHALFPGENESDQLACIIEVLGMPNKNILASSKRSK 507
Query: 619 KYFT-KEYDLY-YINEETNQLEYII------------PEESSLEHHLQ-FSDAFFIDFVR 663
+F+ K Y Y + ++ + +I P SL L D F++F+R
Sbjct: 508 SFFSPKGYPRYCTVRTMSDGMVVLIGGQSRRGKQRGPPCSKSLSKALDGCKDPLFLNFIR 567
Query: 664 TLLEINPQRRPTAREALDHPWLQ 686
LE + +R T EAL HPWL+
Sbjct: 568 GCLEWDADKRLTPSEALKHPWLR 590
|
Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P14680|YAK1_YEAST Dual specificity protein kinase YAK1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=YAK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 201 bits (511), Expect = 1e-50, Method: Compositional matrix adjust.
Identities = 130/370 (35%), Positives = 196/370 (52%), Gaps = 50/370 (13%)
Query: 360 KNRTGFEE-NKDLPIILNTVIA----GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII 414
K GF+ N D + +N V+ +Y V + LG F +V + Q+L T + +K++
Sbjct: 341 KCNNGFDNINSDYILYVNDVLGVEQNRKYLVLDILGQGTFGQVVKCQNLLTKEILAVKVV 400
Query: 415 KNDKDFFDQSLDEIKLLKLVN-KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQ 473
K+ ++ QS+ E K+L+L+N K DP ++HH LR+YD F H HL +V ELL NLYE
Sbjct: 401 KSRTEYLTQSITEAKILELLNQKIDPTNKHHFLRMYDSFVHKNHLCLVFELLSNNLYELL 460
Query: 474 KFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 533
K N+ G ++ ++ T Q L++L L +IHCDLKPENIL+ + + E+KIID
Sbjct: 461 KQNKFHG----LSIQLIRTFTTQILDSLCVLKESKLIHCDLKPENILLCAPDKPELKIID 516
Query: 534 LGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVV 593
GSSC + + Y+QSR YRAPE+I+G+PY ID+WSLGCI+AEL+ G +FP +
Sbjct: 517 FGSSCEEARTVYTYIQSRFYRAPEIILGIPYSTSIDMWSLGCIVAELFLGIPIFPGASEY 576
Query: 594 MILARIIGMLGPIDLEMLMQGQEIYKYF-----------TKEYDLYYINEETNQLEYIIP 642
L RII LG M+ G+ K+ T+++ + I E EY I
Sbjct: 577 NQLTRIIDTLGYPPSWMIDMGKNSGKFMKKLAPEESSSSTQKHRMKTIEEFCR--EYNIV 634
Query: 643 EESSLEH-----------------HLQFSDAF----------FIDFVRTLLEINPQRRPT 675
E+ S ++ +Q S I F+ +L +NP R T
Sbjct: 635 EKPSKQYFKWRKLPDIIRNYRYPKSIQNSQELIDQEMQNRECLIHFLGGVLNLNPLERWT 694
Query: 676 AREALDHPWL 685
++A+ HP++
Sbjct: 695 PQQAMLHPFI 704
|
Negative regulator of the cell cycle acting downstream of the cAMP-dependent protein kinase. Part of a glucose-sensing system involved in growth control in response to glucose availability. Phosphorylates POP2. Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 689 | ||||||
| 224101151 | 725 | predicted protein [Populus trichocarpa] | 0.943 | 0.896 | 0.615 | 0.0 | |
| 297736602 | 728 | unnamed protein product [Vitis vinifera] | 0.976 | 0.924 | 0.624 | 0.0 | |
| 356551440 | 710 | PREDICTED: dual specificity tyrosine-pho | 0.959 | 0.930 | 0.591 | 0.0 | |
| 255585370 | 609 | ATP binding protein, putative [Ricinus c | 0.554 | 0.627 | 0.825 | 0.0 | |
| 359486399 | 596 | PREDICTED: probable serine/threonine-pro | 0.544 | 0.629 | 0.813 | 0.0 | |
| 224109312 | 591 | predicted protein [Populus trichocarpa] | 0.506 | 0.590 | 0.842 | 1e-179 | |
| 356501164 | 593 | PREDICTED: probable serine/threonine-pro | 0.526 | 0.612 | 0.816 | 1e-177 | |
| 357125722 | 715 | PREDICTED: dual specificity protein kina | 0.960 | 0.925 | 0.499 | 1e-174 | |
| 226506060 | 725 | ATP binding protein [Zea mays] gi|195616 | 0.973 | 0.925 | 0.495 | 1e-174 | |
| 449441300 | 575 | PREDICTED: dual specificity protein kina | 0.494 | 0.593 | 0.812 | 1e-174 |
| >gi|224101151|ref|XP_002312161.1| predicted protein [Populus trichocarpa] gi|222851981|gb|EEE89528.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 861 bits (2225), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 458/744 (61%), Positives = 533/744 (71%), Gaps = 94/744 (12%)
Query: 8 DVETVIEFLRKNGFKEAESALKEDMMEKIRDLGSFDYEKFLFPVLPPVKIPASLRQTEVD 67
DVE V++FLRKNG ++AE ALKEDM+E+ +LGSFD+EKFLF VLPPV++PAS+R +V+
Sbjct: 14 DVEAVLDFLRKNGLRDAELALKEDMIERSNELGSFDFEKFLF-VLPPVRVPASVRPLDVE 72
Query: 68 EGGADRSSRSSSASSSDDDEFVSLASSTS--DLCSSEFTNPYGLRSTSHGNSEASSESLS 125
EGG SS+ S DDEFVSL SSTS ++ SSEF+NPYGL STS NSE SS+ LS
Sbjct: 73 EGGGAVERLRSSSGSPSDDEFVSLGSSTSASEVYSSEFSNPYGLHSTSQANSETSSDRLS 132
Query: 126 QFDTARDY---DLQNDFYWHDEKDEGYFMTPSYGGSDFFGCPSEDKFIMTSEADRLFENP 182
QF TARDY D+QND YW+DEK+EG+FM+P + G D+FGCPSEDKF+MTSE + FEN
Sbjct: 133 QFGTARDYPDFDMQNDSYWYDEKEEGHFMSPCFNGPDYFGCPSEDKFVMTSETGKQFENS 192
Query: 183 LAVYDQSEG----------------LHSETNQPEAGGI--------KEKL-----KDCAA 213
L +YD+SEG + S N+ EA + K +L +D ++
Sbjct: 193 LGLYDKSEGETQGNIDYLDKQCLYNVTSVNNKNEAQSMNYHHDFDKKNQLEGDIDRDGSS 252
Query: 214 YGCSEPLCKCCAGEGKINNDYGYLSSKEADLIDLQHNVVGDSSTDCDLAPHPGTEKSSSY 273
++ + G+I+ D Y SSK DL D Q V G+S TD D P
Sbjct: 253 AHNAKFFTETGGIYGRISVDCIYTSSKGPDLGDFQLKV-GESPTDYDTVP---------- 301
Query: 274 SSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDTRDGE-VNGALHEGKADAEEH 332
+H + + ID+ + DG VNG HE A
Sbjct: 302 --------------------VHMENKNANYYENGIDDFEVGDGGGVNGEAHELAAAIGGE 341
Query: 333 GVATPDLLMFDNLEEECEIFHLRIIHRKNR---------------------------TGF 365
V +LLM+ N E+E E+F+LR+IHRKNR TGF
Sbjct: 342 DVNANELLMYYNQEDEYEVFNLRVIHRKNRSCGHGIDPADSTLFSWRSDACAMQVKWTGF 401
Query: 366 EENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL 425
EENKDLPI+LNTVIAGRYYVTEYLGSAAFSKV QA DLHTG+DVCLKIIKNDKDFFDQSL
Sbjct: 402 EENKDLPIVLNTVIAGRYYVTEYLGSAAFSKVIQAHDLHTGIDVCLKIIKNDKDFFDQSL 461
Query: 426 DEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF 485
DEIKLLK+VNK DPADE HILRLYDYFYH EHLFIVCELL+ANLYEFQKFNQESGGEAYF
Sbjct: 462 DEIKLLKIVNKLDPADERHILRLYDYFYHQEHLFIVCELLKANLYEFQKFNQESGGEAYF 521
Query: 486 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 545
TL RLQVITRQCLEALEYLH LGIIHCDLKPEN+LIKSY++CEIK+IDLGSSCF++DNLC
Sbjct: 522 TLSRLQVITRQCLEALEYLHDLGIIHCDLKPENVLIKSYRKCEIKVIDLGSSCFKSDNLC 581
Query: 546 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 605
LYVQSRSYRAPEVI+GLPYDQKIDLWSLGCILAEL +GEVLFPNDAVVMIL R+IGMLGP
Sbjct: 582 LYVQSRSYRAPEVILGLPYDQKIDLWSLGCILAELCSGEVLFPNDAVVMILTRMIGMLGP 641
Query: 606 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTL 665
+D EML GQE +KYFT+EYDLY++NEETNQ+EY+IPEESSLEHHLQ SD FIDFVR L
Sbjct: 642 LDPEMLETGQETHKYFTEEYDLYHLNEETNQVEYLIPEESSLEHHLQVSDVGFIDFVRDL 701
Query: 666 LEINPQRRPTAREALDHPWLQHPY 689
LE+NP RRPTAREAL+HPWL H Y
Sbjct: 702 LELNPLRRPTAREALEHPWLSHSY 725
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297736602|emb|CBI25473.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 850 bits (2197), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 456/730 (62%), Positives = 534/730 (73%), Gaps = 57/730 (7%)
Query: 4 VSSSDVETVIEFLRKNGFKEAESALKEDMMEKIRDLGSFDYEKFLFPVLPPV---KIPAS 60
++ SDV+ V+EFLRK G E+ESAL++D+ E+ + SFD+E F+FP++PP +IPAS
Sbjct: 1 MAVSDVDAVLEFLRKYGLSESESALRQDVSER-GGVASFDFESFVFPMVPPPPPVRIPAS 59
Query: 61 LRQTEVDEGGADRSSRSSSASSSDDDEFVSLASSTSDLCSSEFTNPYGLRSTSHGNSEAS 120
R+ E G D SS S D+FVSL SS +D SSEFTNPYG+ S + NS AS
Sbjct: 60 SRRMEEAVGDTDSSSVCS-------DDFVSLGSSATDAYSSEFTNPYGVHSATQANSTAS 112
Query: 121 SESLSQFDTARDY---DLQNDFYWHDEKDEGYFMTPSYGGSDFFGCPSEDKFIMTSEADR 177
S+SL +F TARDY D+QND YW+DEKD+ YF T +GGS+ FGCPSEDKF+MT E D+
Sbjct: 113 SDSLCEFGTARDYSDFDMQNDLYWYDEKDDDYFNTSCFGGSESFGCPSEDKFVMTLEKDK 172
Query: 178 LFENPLAVYDQSEGLHS---------------------------------ETNQPEAGGI 204
E+ L + +SEG + E QP+ G
Sbjct: 173 QSESQLTLIHKSEGYPTLPTTNYLEKPCVFNLTSMDGVNDIPVTDYYHLGEHFQPD-GAR 231
Query: 205 KEKLKDCAAYGCSEPLCKCCAG----EGKINNDYGYLSSKEADLIDLQHNVVGDSSTDCD 260
+ + CA Y CS PLCKCCAG G DY ++ E DL Q VVG TDCD
Sbjct: 232 EGDHESCAVYSCSVPLCKCCAGAEGFRGGDPVDYSQMNFAETDLDGSQLKVVGKIPTDCD 291
Query: 261 LAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDTRDGEVNG 320
A KS YS KR S+ D I FK +SDLH + E + DGEV G
Sbjct: 292 SASEYKINKSFDYSI-KRSSANDLIGEFKSTSDLHIENTEPN---GNYGYEVGDDGEVAG 347
Query: 321 ALHEGKADAEEHGVATPD-LLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVI 379
+E +A+ ++ AT D LLM++N E+E E+F+LRIIHRKNRTGFEENKDLPI+LNTV+
Sbjct: 348 ECYEPEANVDDQEGATADELLMYENQEDEYEVFNLRIIHRKNRTGFEENKDLPIVLNTVL 407
Query: 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 439
AGRYY+TEYLGSAAFSKV QA DL TG+DVCLKIIKNDKDFFDQSLDEIKLLK VNK+DP
Sbjct: 408 AGRYYITEYLGSAAFSKVVQAHDLQTGMDVCLKIIKNDKDFFDQSLDEIKLLKYVNKHDP 467
Query: 440 ADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 499
ADE HILRLYDYFYH EHLFIVCELLRANLYEFQKFNQESGGE YFTL RLQVITRQCLE
Sbjct: 468 ADERHILRLYDYFYHQEHLFIVCELLRANLYEFQKFNQESGGETYFTLKRLQVITRQCLE 527
Query: 500 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVI 559
ALEYLH LGIIHCDLKPENILIKSY+RC+IK+IDLGSSCF+TDNL LYVQSRSYRAPEVI
Sbjct: 528 ALEYLHDLGIIHCDLKPENILIKSYRRCDIKVIDLGSSCFRTDNLSLYVQSRSYRAPEVI 587
Query: 560 IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYK 619
+GLPYDQ+ID+WSLGCILAEL +GEVLFPND +V +L R+IGMLGPIDLEML++GQE YK
Sbjct: 588 LGLPYDQRIDIWSLGCILAELCSGEVLFPNDELVTLLVRMIGMLGPIDLEMLVRGQETYK 647
Query: 620 YFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA 679
YFTKEYDLY+INEETN++EY+IPEESSLE HLQ SD F++F+R LLEINPQRRPTA+EA
Sbjct: 648 YFTKEYDLYHINEETNEMEYLIPEESSLEDHLQISDVGFLNFLRDLLEINPQRRPTAKEA 707
Query: 680 LDHPWLQHPY 689
LDHPWL H Y
Sbjct: 708 LDHPWLSHSY 717
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356551440|ref|XP_003544083.1| PREDICTED: dual specificity tyrosine-phosphorylation-regulated kinase 4-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 775 bits (2001), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 432/730 (59%), Positives = 510/730 (69%), Gaps = 69/730 (9%)
Query: 6 SSDVETVIEFLRKNGFKEAESALKEDMMEKIRDLGSFDYEKFLFPVLPPVKIPASLRQTE 65
S+ VE V+EFLRKNG EAESAL++D++E DLG+FDYEKF FP++PP +
Sbjct: 4 SNGVEAVLEFLRKNGLSEAESALRQDIIEN-NDLGNFDYEKFFFPMVPPPPPVRVRSFSR 62
Query: 66 VDEGGADRSSRSSSASSSDDDEFVSLASSTSDLCSSEFTNPYGLRSTSH--GNSEASSES 123
+ E AD + S S DEFVS+ S TS + SSEF NPYG+RS+S +S +SSE
Sbjct: 63 LSELSAD-----GNCSKSSSDEFVSIGSPTSRVSSSEFINPYGIRSSSQTQNDSASSSER 117
Query: 124 LSQFDTARDY---DLQNDFYWHDEKDEGYFMTPSYGGSDFFGCPSEDKFIMTSEADRLFE 180
LSQF TARDY ++QN+ YW++EKD+ YFMTPS+ G DFF C SEDKF+MT+E + +
Sbjct: 118 LSQFGTARDYHDFEMQNEPYWYNEKDDDYFMTPSFEGPDFFACQSEDKFVMTAETENQHD 177
Query: 181 NPL-AVYDQSEGL---------------------------------HSETNQPEAGGIKE 206
N L VY+ E L H + N G ++
Sbjct: 178 NSLDLVYNSEEFLLKGNGNGGFMDKACLYNHSSVRDGNATYSKEYCHVDNNNLFEGELEG 237
Query: 207 KL-KDCAAYGCSEPLCKCCAGEGKINND---YGYLSSKEADLIDLQHNVVGDSSTDCDLA 262
K K A C P CK G G + D +GY + KE I L+ + + +L
Sbjct: 238 KAEKHTVACSCEVPFCKSSPG-GSCSLDPTNFGYPNLKE---IHLKFGDINSFDSTSELT 293
Query: 263 PHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDTRDGEVNGAL 322
+ + + SSK + G DL K +KDL P +D RDG G L
Sbjct: 294 VNQSFDYYTKNDSSKE---------YNGPYDLTIKVNQKDL-PNGLDTYKARDG---GEL 340
Query: 323 HEGKADAE---EHGVATPDLLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVI 379
E D E + T D L+ EEE E+F LRIIHRKNRTGFEENK+LPI+LNTV+
Sbjct: 341 AEECQDPEITADGEDTTDDELLKYTQEEEYEVFDLRIIHRKNRTGFEENKELPIVLNTVL 400
Query: 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 439
AGRYYVTEYLGSAAFS+V QA DL TG+DVCLKIIKNDKDFFDQSLDEIKLLKLVNK+DP
Sbjct: 401 AGRYYVTEYLGSAAFSRVVQAHDLQTGIDVCLKIIKNDKDFFDQSLDEIKLLKLVNKHDP 460
Query: 440 ADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 499
AD HH LRLYDYFYH EHLFIV ELL+ANLYEFQKF QESGGE YFTL RLQ+ITRQCLE
Sbjct: 461 ADLHHFLRLYDYFYHQEHLFIVTELLQANLYEFQKFKQESGGEEYFTLNRLQLITRQCLE 520
Query: 500 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVI 559
AL+YLHSLGI+HCDLKPENILIKSY+RCEIK+IDLGSSCFQTDNLCLYVQSRSYRAPEV+
Sbjct: 521 ALQYLHSLGIVHCDLKPENILIKSYRRCEIKVIDLGSSCFQTDNLCLYVQSRSYRAPEVM 580
Query: 560 IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYK 619
+GL YD+KID+WSLGCILAEL +GEVLFPNDAVVMILAR+IGM G ID+EML++GQE +K
Sbjct: 581 LGLQYDEKIDIWSLGCILAELCSGEVLFPNDAVVMILARMIGMFGSIDMEMLVKGQETHK 640
Query: 620 YFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA 679
YFTKEYD+YY+NEET+QLEYIIPEESSLE HLQ +D FIDFVR LL INP+RRPTAR+A
Sbjct: 641 YFTKEYDIYYVNEETDQLEYIIPEESSLEQHLQVTDTTFIDFVRYLLSINPKRRPTARQA 700
Query: 680 LDHPWLQHPY 689
L HPWL + Y
Sbjct: 701 LRHPWLSYVY 710
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255585370|ref|XP_002533381.1| ATP binding protein, putative [Ricinus communis] gi|223526774|gb|EEF28999.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 658 bits (1697), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 317/384 (82%), Positives = 344/384 (89%), Gaps = 2/384 (0%)
Query: 308 IDNSDTRDGEVNGALHEGKADAEEHG--VATPDLLMFDNLEEECEIFHLRIIHRKNRTGF 365
+ +S + GE N E +A EE V T DLLM D E+E E+F LRIIHRKNRTGF
Sbjct: 221 MKSSKDKIGEANEEADELRATEEEEDGEVNTNDLLMLDAQEDEYEVFDLRIIHRKNRTGF 280
Query: 366 EENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL 425
EENKDLPI+LNTVIAGRYYVTEYLGSAAFSKV QA DL+TG+DVCLKIIKNDKDFFDQSL
Sbjct: 281 EENKDLPIVLNTVIAGRYYVTEYLGSAAFSKVVQAHDLYTGIDVCLKIIKNDKDFFDQSL 340
Query: 426 DEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF 485
DEIKLLKLVNK+DPADE HI+RLYDYFYH EHLFIVCELLRANLYEFQKFNQESGGE YF
Sbjct: 341 DEIKLLKLVNKHDPADERHIIRLYDYFYHQEHLFIVCELLRANLYEFQKFNQESGGEPYF 400
Query: 486 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 545
TL RLQVITRQCLEALEYLH LGIIHCDLKPENILIKSY+RCEIK+IDLGSSCFQ+DNLC
Sbjct: 401 TLSRLQVITRQCLEALEYLHHLGIIHCDLKPENILIKSYRRCEIKVIDLGSSCFQSDNLC 460
Query: 546 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 605
LYVQSRSYRAPEVI+GLPYDQKIDLWSLGCILAEL +GEVLFPNDAVVMILAR+IGMLGP
Sbjct: 461 LYVQSRSYRAPEVILGLPYDQKIDLWSLGCILAELCSGEVLFPNDAVVMILARVIGMLGP 520
Query: 606 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTL 665
IDLEML++GQE +KYFT EYDLYY+NEE NQ+EYIIPEESSLEHHLQ SD FIDFV++L
Sbjct: 521 IDLEMLVRGQETHKYFTTEYDLYYVNEEKNQIEYIIPEESSLEHHLQTSDVEFIDFVKSL 580
Query: 666 LEINPQRRPTAREALDHPWLQHPY 689
LE+NP RRPTAREAL+HPWL + Y
Sbjct: 581 LEVNPVRRPTAREALEHPWLLYSY 604
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359486399|ref|XP_002272072.2| PREDICTED: probable serine/threonine-protein kinase dyrk2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 648 bits (1671), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 306/376 (81%), Positives = 342/376 (90%), Gaps = 1/376 (0%)
Query: 315 DGEVNGALHEGKADAEEHGVATPD-LLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPI 373
DGEV G +E +A+ ++ AT D LLM++N E+E E+F+LRIIHRKNRTGFEENKDLPI
Sbjct: 210 DGEVAGECYEPEANVDDQEGATADELLMYENQEDEYEVFNLRIIHRKNRTGFEENKDLPI 269
Query: 374 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKL 433
+LNTV+AGRYY+TEYLGSAAFSKV QA DL TG+DVCLKIIKNDKDFFDQSLDEIKLLK
Sbjct: 270 VLNTVLAGRYYITEYLGSAAFSKVVQAHDLQTGMDVCLKIIKNDKDFFDQSLDEIKLLKY 329
Query: 434 VNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI 493
VNK+DPADE HILRLYDYFYH EHLFIVCELLRANLYEFQKFNQESGGE YFTL RLQVI
Sbjct: 330 VNKHDPADERHILRLYDYFYHQEHLFIVCELLRANLYEFQKFNQESGGETYFTLKRLQVI 389
Query: 494 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY 553
TRQCLEALEYLH LGIIHCDLKPENILIKSY+RC+IK+IDLGSSCF+TDNL LYVQSRSY
Sbjct: 390 TRQCLEALEYLHDLGIIHCDLKPENILIKSYRRCDIKVIDLGSSCFRTDNLSLYVQSRSY 449
Query: 554 RAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613
RAPEVI+GLPYDQ+ID+WSLGCILAEL +GEVLFPND +V +L R+IGMLGPIDLEML++
Sbjct: 450 RAPEVILGLPYDQRIDIWSLGCILAELCSGEVLFPNDELVTLLVRMIGMLGPIDLEMLVR 509
Query: 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 673
GQE YKYFTKEYDLY+INEETN++EY+IPEESSLE HLQ SD F++F+R LLEINPQRR
Sbjct: 510 GQETYKYFTKEYDLYHINEETNEMEYLIPEESSLEDHLQISDVGFLNFLRDLLEINPQRR 569
Query: 674 PTAREALDHPWLQHPY 689
PTA+EALDHPWL H Y
Sbjct: 570 PTAKEALDHPWLSHSY 585
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224109312|ref|XP_002315156.1| predicted protein [Populus trichocarpa] gi|222864196|gb|EEF01327.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 634 bits (1636), Expect = e-179, Method: Compositional matrix adjust.
Identities = 300/356 (84%), Positives = 329/356 (92%)
Query: 334 VATPDLLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAA 393
V +LLM+ N E+E E+F+LR+IHRKNRTGFEENKDLPI+LNTVIAGRYYVTEYLGSAA
Sbjct: 236 VNAAELLMYYNQEDEYEVFNLRVIHRKNRTGFEENKDLPIVLNTVIAGRYYVTEYLGSAA 295
Query: 394 FSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 453
FSKV QA DLHTG+DVCLKIIKNDKDFFDQSLDEIKLLK+VNK+DPADE HILRLYDYFY
Sbjct: 296 FSKVIQAHDLHTGIDVCLKIIKNDKDFFDQSLDEIKLLKIVNKHDPADERHILRLYDYFY 355
Query: 454 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCD 513
H EHLFIVCELL+ANLYEFQKF+QES G+AYFTL RLQVITRQCLEALEYLH LGIIHCD
Sbjct: 356 HQEHLFIVCELLKANLYEFQKFSQESDGKAYFTLSRLQVITRQCLEALEYLHHLGIIHCD 415
Query: 514 LKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSL 573
LKPENILIKSY+RCEIK+IDLGSSCF++DNLCLYVQSRSYRAPEVI+GLPYDQKIDLWSL
Sbjct: 416 LKPENILIKSYRRCEIKVIDLGSSCFKSDNLCLYVQSRSYRAPEVILGLPYDQKIDLWSL 475
Query: 574 GCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEE 633
GCILAEL +GEVLFPNDAVVMILAR+IGMLGPI EML+ GQE +KYFT+EYDLYY NEE
Sbjct: 476 GCILAELCSGEVLFPNDAVVMILARMIGMLGPIHSEMLVMGQETHKYFTEEYDLYYSNEE 535
Query: 634 TNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHPY 689
TNQ+EY+IPEESSLEHHLQ SD FIDF+R LLE+NP RR TA+EAL+HPWL H Y
Sbjct: 536 TNQIEYLIPEESSLEHHLQISDVGFIDFMRNLLELNPLRRLTAKEALEHPWLSHSY 591
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356501164|ref|XP_003519398.1| PREDICTED: probable serine/threonine-protein kinase dyrk2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 627 bits (1618), Expect = e-177, Method: Compositional matrix adjust.
Identities = 299/366 (81%), Positives = 331/366 (90%), Gaps = 3/366 (0%)
Query: 324 EGKADAEEHGVATPDLLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVIAGRY 383
E AD E+ T D L+ EEE E+F LRIIHRKNRTGFEENK+LPI+LNTV+AGRY
Sbjct: 231 EITADGED---TTDDELLKYTQEEEYEVFDLRIIHRKNRTGFEENKELPIVLNTVLAGRY 287
Query: 384 YVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEH 443
YVTEYLGSAAFS+V QA DL TG+D CLKIIKNDKDFFDQSLDEIKLLKLVNK+DPAD+H
Sbjct: 288 YVTEYLGSAAFSRVVQAHDLQTGIDFCLKIIKNDKDFFDQSLDEIKLLKLVNKHDPADKH 347
Query: 444 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 503
HILRLYDYFYH EHLFIV ELLRANLYEFQKFNQESGGEAYFTL RLQ+ITRQCLEAL+Y
Sbjct: 348 HILRLYDYFYHQEHLFIVTELLRANLYEFQKFNQESGGEAYFTLNRLQLITRQCLEALQY 407
Query: 504 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLP 563
LHSLGI+HCDLKPENILIKSY+RCEIK+IDLGSSCFQTDNLCLYVQSRSYRAPEV++GL
Sbjct: 408 LHSLGIVHCDLKPENILIKSYRRCEIKVIDLGSSCFQTDNLCLYVQSRSYRAPEVMLGLQ 467
Query: 564 YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTK 623
YD+KIDLWSLGCILAEL +GEVLFPNDAVVMILAR+IGMLG ID+EML++GQE +KYFTK
Sbjct: 468 YDEKIDLWSLGCILAELCSGEVLFPNDAVVMILARMIGMLGSIDMEMLVKGQETHKYFTK 527
Query: 624 EYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHP 683
EYD+YY+NEET+QLEYIIPEESSLE HLQ +D FIDFVR LL INP+RRP+AR+AL HP
Sbjct: 528 EYDIYYVNEETDQLEYIIPEESSLEQHLQVTDTMFIDFVRYLLSINPKRRPSARQALRHP 587
Query: 684 WLQHPY 689
WL + Y
Sbjct: 588 WLSYVY 593
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357125722|ref|XP_003564539.1| PREDICTED: dual specificity protein kinase YAK1-like isoform 2 [Brachypodium distachyon] | Back alignment and taxonomy information |
|---|
Score = 619 bits (1595), Expect = e-174, Method: Compositional matrix adjust.
Identities = 369/739 (49%), Positives = 452/739 (61%), Gaps = 77/739 (10%)
Query: 4 VSSSDVETVIEFLRKNGFKEAESALKEDMMEKIRDLGSFDYEKFLFPVLPPVKIPASLRQ 63
+++ ++ V+ FL ++GF SAL++D++++ D G D L P LPP+++PAS
Sbjct: 1 MAAPGLDEVMAFLTEHGFASTASALRDDVLDRSAD-GESDSTATLGPQLPPLRLPASASG 59
Query: 64 TEVDEGGADRSSRSSSASSSDDDEFVSLASSTSDLCSSEFTNPYGLRSTSHGNSEASSES 123
+ + S+S+S S A + S NPYG+ S H S+ SS
Sbjct: 60 GAGGGVALEAPASPGSSSNSA----SSSAFVSMSSSPSGLLNPYGVWSPPHSQSDGSSSE 115
Query: 124 LSQFDTARDYDLQNDFY---WHDEKDEGYFMTPSYGGSDFFGCPSEDKFIMTSEADRLFE 180
+ +F TAR YD + F+ W + D + P G D EDKF+ R
Sbjct: 116 M-EFGTARQYDTTDLFFQEGWLYD-DHLFHSKPDDDGRD----KEEDKFVHGGSG-RTEM 168
Query: 181 NPLAVYDQSEGLHSETNQPEAGGIKEKLKDCA-AYGCSEPLCKCCAGEGK---------- 229
L D H+ N E CA Y CS PLC CC GE K
Sbjct: 169 LVLNADDDRRHEHAGNNSCEG---------CAEVYTCSSPLCGCCGGELKNEEGLQVVSN 219
Query: 230 -----------INNDYGYLSSKEADLIDLQHNVVGDSSTDCDLAPHPGT-----EKSSSY 273
+++ L DL L+ +V DS +CDL PG E +
Sbjct: 220 SSSVVYGRYKVMDDQTEILDECGLDLFQLKQSV--DSVLECDLPRDPGQGDEHLELNVVE 277
Query: 274 SSSKRGSSIDWI---------------EGFKGSSDLHFKGAEKDLMPAEIDNSDTRD--- 315
+ SS D + SSD + L P ++ D D
Sbjct: 278 KELQMLSSFDRFIPHVTDNIKLHDSTENNLESSSDKEYLKESYSLHPFP-ESGDPDDPYE 336
Query: 316 ----GEVNGALHEGKA-DAEEHGVATPDLLMFDNLEEECEIFHLRIIHRKNRTGFEENKD 370
G +N + A AE+ + + L N + E E+F LRI+HRKNRTGFEENKD
Sbjct: 337 FGDIGPLNTGVKSSTALIAEKEDMESNIDLALSNFQREYEVFELRIVHRKNRTGFEENKD 396
Query: 371 LPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKL 430
PI+LN+VIAGRYYVTEYLGSAAFSKV QA DL TG+DVCLKIIKNDKDFFDQSLDEIKL
Sbjct: 397 FPIVLNSVIAGRYYVTEYLGSAAFSKVVQAHDLQTGIDVCLKIIKNDKDFFDQSLDEIKL 456
Query: 431 LKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRL 490
LK VNK DP+DEHH+LRLYDYFYH EHLFIV ELLRANLYEFQK+NQE GGE YFTL R+
Sbjct: 457 LKFVNKYDPSDEHHVLRLYDYFYHQEHLFIVTELLRANLYEFQKYNQEFGGEVYFTLPRI 516
Query: 491 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQS 550
QVI RQCLEAL YLH L I+HCDLKPENILIKSY+RCEIK+IDLGSSCF TDNLCLYVQS
Sbjct: 517 QVIARQCLEALVYLHHLRIVHCDLKPENILIKSYRRCEIKVIDLGSSCFLTDNLCLYVQS 576
Query: 551 RSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 610
RSYRAPEVI+GLPYDQ+ID+WSLGCILAEL TGEVLFPN+ + M+LAR+IG++GPID+EM
Sbjct: 577 RSYRAPEVILGLPYDQRIDIWSLGCILAELCTGEVLFPNEPLPMMLARMIGIIGPIDMEM 636
Query: 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINP 670
L GQE +KYFT +YDL+ NEET+QLEY+IPE+SSL HLQ DA F+DF+ LL+INP
Sbjct: 637 LALGQEAHKYFTDDYDLFTKNEETDQLEYLIPEKSSLRRHLQCHDAEFVDFLSYLLQINP 696
Query: 671 QRRPTAREALDHPWLQHPY 689
++RPTA EAL H WL Y
Sbjct: 697 RKRPTASEALKHHWLSSEY 715
|
Source: Brachypodium distachyon Species: Brachypodium distachyon Genus: Brachypodium Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|226506060|ref|NP_001148168.1| ATP binding protein [Zea mays] gi|195616354|gb|ACG30007.1| ATP binding protein [Zea mays] gi|414879861|tpg|DAA56992.1| TPA: putative protein kinase superfamily protein [Zea mays] | Back alignment and taxonomy information |
|---|
Score = 618 bits (1593), Expect = e-174, Method: Compositional matrix adjust.
Identities = 367/740 (49%), Positives = 455/740 (61%), Gaps = 69/740 (9%)
Query: 4 VSSSDVETVIEFLRKNGFKEAESALKEDMMEKIRDLGSFDYEKFLFPVLPPVKIPASLRQ 63
+++ ++ V+ FL +GF A SAL++D++E+ G ++ L P LPP+++PAS
Sbjct: 1 MAAPGLDKVMAFLTDHGFAGAASALRDDVLERTA-AGDESHDAALDPHLPPLRMPASAGG 59
Query: 64 TEVDEGGADRSSRSSSASSSDDDE------FVSLASSTSDLCSSEFTNPYGLRSTSHGNS 117
G + + AS FVSL S+ S L NPYGL S H S
Sbjct: 60 AGAGAGAGAGAGTPTPASPGSSSGSASSSAFVSLRSTPSGL-----LNPYGLWSPRHSQS 114
Query: 118 EASSESLSQFDTARDYDLQNDFYWHDEKDEGYFMTPSYGGSDFFGCPSEDKFIMTSEADR 177
+ASS + +F TAR YD + F+ D + + PS + EDKF++ +
Sbjct: 115 DASSSEM-EFGTARQYDTTDLFFQEDWLYDDHLF-PSKLDDEDDEGKEEDKFVLDAH--- 169
Query: 178 LFENPLAVYDQSEGLHSETNQPEAGGIKEKLKDCA-AYGCSEPLCKCCAGEGKINN-DYG 235
+ V G GG ++ + CA Y CS PLC CC G K + D
Sbjct: 170 --DGSEQVEIGKLGAGHNHRHEHIGG--DRCEGCAEVYICSSPLCGCCGGGLKNDGLDVA 225
Query: 236 YLSSKEA----DLIDLQHNVVGDSSTD-------------CDLAPHPG----------TE 268
SS ++D Q ++ D + D C + PG E
Sbjct: 226 RSSSSTVYGRYKIMDDQTEILDDCAQDAFQLKQSRDIMFECGMTRDPGRGYDDSGLSVVE 285
Query: 269 KS----SSYSSSKRGSSIDWIEG--FKGSSDLHFKGAEKDLMP-----------AEIDNS 311
K SS+ + + D+ E GS D + K + P ++D +
Sbjct: 286 KELQILSSFDTVVNHGTYDFTENGELNGSCDKNLKSSIHKEYPKGHRIQPFPESGDLDEA 345
Query: 312 D--TRDGEVNGALHEGKADAEEHGVATPDLLMFDNLEEECEIFHLRIIHRKNRTGFEENK 369
D G +N + A E T L + E E+F LRIIHRKNRTGFEENK
Sbjct: 346 DEFRHVGSLNTDVQHSTALKAEEDAETNIDLALSDFHREYEVFELRIIHRKNRTGFEENK 405
Query: 370 DLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIK 429
D PI+LN+V+AGRYY+TEYLGSAAFSKV QA DL TG+DVCLKIIKNDKDFFDQSLDEIK
Sbjct: 406 DFPIVLNSVVAGRYYITEYLGSAAFSKVVQAHDLRTGMDVCLKIIKNDKDFFDQSLDEIK 465
Query: 430 LLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGR 489
LLK VNK DP DEHH+LRLYDYFYH EHLFIV ELLRANLYEFQK+NQESGGE YFTL R
Sbjct: 466 LLKFVNKYDPLDEHHVLRLYDYFYHQEHLFIVTELLRANLYEFQKYNQESGGEVYFTLPR 525
Query: 490 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ 549
+QVI RQCLEAL YLH L IIHCDLKPENILIKSY RCEIK+IDLGSSCF TDNLCLYVQ
Sbjct: 526 IQVIARQCLEALVYLHRLRIIHCDLKPENILIKSYSRCEIKVIDLGSSCFLTDNLCLYVQ 585
Query: 550 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 609
SRSYRAPEVI+GLPYDQ+ID+WSLGCIL+EL+TGEVLFPN+ V ++LA++IG+ GPID+E
Sbjct: 586 SRSYRAPEVILGLPYDQRIDIWSLGCILSELYTGEVLFPNEPVSVMLAQMIGITGPIDME 645
Query: 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 669
ML GQE KYFT +YDL+ NEET+QLEY+IPE+SSL H+Q D+ F+DF+ LL+IN
Sbjct: 646 MLELGQETQKYFTDDYDLFTENEETDQLEYLIPEKSSLRQHIQCPDSEFVDFLSYLLQIN 705
Query: 670 PQRRPTAREALDHPWLQHPY 689
P++RPTA EAL HPWL Y
Sbjct: 706 PRKRPTADEALQHPWLSFSY 725
|
Source: Zea mays Species: Zea mays Genus: Zea Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449441300|ref|XP_004138420.1| PREDICTED: dual specificity protein kinase pom1-like [Cucumis sativus] gi|449533074|ref|XP_004173502.1| PREDICTED: dual specificity protein kinase pom1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 617 bits (1592), Expect = e-174, Method: Compositional matrix adjust.
Identities = 290/357 (81%), Positives = 326/357 (91%)
Query: 333 GVATPDLLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSA 392
A +L M+ ++E E+F LRIIHRKNRTGFEE+KDLPI+LNTV+AGRYYVTEYLGSA
Sbjct: 218 AAADDELPMYYTNDDEFEVFDLRIIHRKNRTGFEESKDLPIVLNTVLAGRYYVTEYLGSA 277
Query: 393 AFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 452
AFS+V +A DLH GVDVCLKIIKNDK+FFDQSLDEIKLLKLVNK+DPAD+ HILRLYDYF
Sbjct: 278 AFSRVVRAHDLHMGVDVCLKIIKNDKEFFDQSLDEIKLLKLVNKHDPADQCHILRLYDYF 337
Query: 453 YHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHC 512
YH EHLFIVCELLRANLYEFQKFNQESGG+AYFT RLQVITRQCLEALE+LH LGIIHC
Sbjct: 338 YHQEHLFIVCELLRANLYEFQKFNQESGGDAYFTFRRLQVITRQCLEALEFLHHLGIIHC 397
Query: 513 DLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWS 572
DLKPENILIKSY+RCEIK+IDLGSSCFQ+DNLCLYVQSRSYRAPEV++GLPY+ KIDLWS
Sbjct: 398 DLKPENILIKSYKRCEIKVIDLGSSCFQSDNLCLYVQSRSYRAPEVMLGLPYNPKIDLWS 457
Query: 573 LGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINE 632
LGCILAELW+GEVLFPN+AVVMILAR+IG+ GPIDLEML++GQE +KYFTKEYDL+YINE
Sbjct: 458 LGCILAELWSGEVLFPNNAVVMILARMIGLFGPIDLEMLLKGQETHKYFTKEYDLFYINE 517
Query: 633 ETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHPY 689
ET+Q+E+IIPEESSLE HLQ D FIDF+ +LLEINP+RRPTA+EAL HPWL Y
Sbjct: 518 ETDQMEFIIPEESSLEDHLQVFDLGFIDFLTSLLEINPERRPTAKEALAHPWLSQSY 574
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 689 | ||||||
| TAIR|locus:2047741 | 570 | AT2G40120 [Arabidopsis thalian | 0.516 | 0.624 | 0.794 | 5.2e-186 | |
| TAIR|locus:2206855 | 1152 | AT1G73450 [Arabidopsis thalian | 0.570 | 0.341 | 0.641 | 6.3e-146 | |
| TAIR|locus:2206840 | 1169 | AT1G73460 [Arabidopsis thalian | 0.574 | 0.338 | 0.639 | 5.6e-145 | |
| TAIR|locus:2089774 | 1138 | AT3G17750 [Arabidopsis thalian | 0.499 | 0.302 | 0.709 | 1.4e-142 | |
| POMBASE|SPAC823.03 | 534 | ppk15 "serine/threonine protei | 0.441 | 0.569 | 0.395 | 1.1e-56 | |
| RGD|1306800 | 633 | Dyrk4 "dual-specificity tyrosi | 0.474 | 0.516 | 0.374 | 3.8e-56 | |
| UNIPROTKB|D4A0W8 | 597 | Dyrk4 "Protein Dyrk4" [Rattus | 0.474 | 0.547 | 0.374 | 3.8e-56 | |
| MGI|MGI:1330292 | 632 | Dyrk4 "dual-specificity tyrosi | 0.474 | 0.517 | 0.380 | 4.8e-56 | |
| ASPGD|ASPL0000065013 | 885 | AN7104 [Emericella nidulans (t | 0.451 | 0.351 | 0.391 | 9.8e-56 | |
| UNIPROTKB|F5H6L9 | 545 | DYRK4 "Dual-specificity tyrosi | 0.462 | 0.585 | 0.374 | 1.6e-55 |
| TAIR|locus:2047741 AT2G40120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1522 (540.8 bits), Expect = 5.2e-186, Sum P(2) = 5.2e-186
Identities = 283/356 (79%), Positives = 320/356 (89%)
Query: 330 EEHGVATPDLLMFDNLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYL 389
++ V ++ + +E+E E+F+LRIIH KNRTGFEENKDLPI++NTVI GRYY+TEY+
Sbjct: 208 DQLNVTDEEVDVVHEVEDEYEVFNLRIIHWKNRTGFEENKDLPIVINTVIGGRYYITEYI 267
Query: 390 GSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLY 449
GSAAFSKV QAQDLH GVDVCLKIIKNDKDFFDQSLDEIKLLK VNK+DPADEHHILRLY
Sbjct: 268 GSAAFSKVVQAQDLHNGVDVCLKIIKNDKDFFDQSLDEIKLLKHVNKHDPADEHHILRLY 327
Query: 450 DYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGI 509
DYFYH EHLFIVCELLRANLYEFQKFNQESGGE YF L RLQVITRQCL+AL +LH LGI
Sbjct: 328 DYFYHQEHLFIVCELLRANLYEFQKFNQESGGEPYFNLSRLQVITRQCLDALVFLHGLGI 387
Query: 510 IHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKID 569
IHCDLKPENILIKSY+RC +KIIDLGSSCF++DNLCLYVQSRSYRAPEVI+GLPYD+KID
Sbjct: 388 IHCDLKPENILIKSYKRCAVKIIDLGSSCFRSDNLCLYVQSRSYRAPEVILGLPYDEKID 447
Query: 570 LWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYY 629
LWSLGCILAEL +GEVLFPN+AV MILARI+ +LGPI+ EML +GQE +KYFTKEYDLY+
Sbjct: 448 LWSLGCILAELCSGEVLFPNEAVAMILARIVAVLGPIETEMLEKGQETHKYFTKEYDLYH 507
Query: 630 INEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685
+NEE+N++EYII EESSLE LQ SD F+DFVRTLL+INP RRPTA EAL+HPWL
Sbjct: 508 LNEESNEIEYIITEESSLEEQLQVSDELFLDFVRTLLDINPLRRPTALEALNHPWL 563
|
|
| TAIR|locus:2206855 AT1G73450 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1349 (479.9 bits), Expect = 6.3e-146, Sum P(3) = 6.3e-146
Identities = 256/399 (64%), Positives = 311/399 (77%)
Query: 291 SSDLHFKGAEKDLMPAEIDNSDTRDGEVNGALHEGKADAEEHGVATPDLLMFDNLEEECE 350
SS ++ E+ E D+S+ DG H D EE + EEE E
Sbjct: 755 SSLSNYARGERKHAEKENDSSEREDG------HATALDDEEAVAVQEQVRQIKAQEEEFE 808
Query: 351 IFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVC 410
F L+I+HRKNRTGFEE K+ ++LN+VIAGRY+VTEYLGSAAFSK QA DL TG+DVC
Sbjct: 809 TFDLKIVHRKNRTGFEEEKNFNVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLQTGMDVC 868
Query: 411 LKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLY 470
+KIIKN+KDFFDQSLDEIKLLK VNK+DPAD++H+LRLYDYFY+ EHL IVCELL+ANLY
Sbjct: 869 IKIIKNNKDFFDQSLDEIKLLKYVNKHDPADKYHLLRLYDYFYYREHLLIVCELLKANLY 928
Query: 471 EFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 530
EF KFN+ESGGE YFT+ RLQ IT QCLE+L++LH LG+IHCDLKPENIL+KSY RCEIK
Sbjct: 929 EFHKFNRESGGEVYFTMPRLQSITIQCLESLQFLHGLGLIHCDLKPENILVKSYSRCEIK 988
Query: 531 IIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 590
+IDLGSSCF+TD+LC YVQSRSYRAPEVI+GLPYD+KID+WSLGCILAEL TG VLF ND
Sbjct: 989 VIDLGSSCFETDHLCSYVQSRSYRAPEVILGLPYDKKIDVWSLGCILAELCTGNVLFQND 1048
Query: 591 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHH 650
+ +LAR++G++G D EML +G++ +KYFTK LY N+E+N+LEY+IP+ +SL H
Sbjct: 1049 SPASLLARVMGIVGSFDNEMLTKGRDSHKYFTKNRMLYERNQESNRLEYLIPKRTSLRHR 1108
Query: 651 LQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHPY 689
L D F DFV LLEINP++RP+A EAL HPWL +PY
Sbjct: 1109 LPMGDQGFTDFVAHLLEINPKKRPSAAEALKHPWLSYPY 1147
|
|
| TAIR|locus:2206840 AT1G73460 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1341 (477.1 bits), Expect = 5.6e-145, Sum P(3) = 5.6e-145
Identities = 255/399 (63%), Positives = 312/399 (78%)
Query: 291 SSDLHFKGAEKDLMPAEIDNSDTRDGEVNGALHEGKADAEEHGVATPDLLMFDNLEEECE 350
SS ++ E+ E D +D+ + E + A D EE + EEE E
Sbjct: 769 SSLSNYACEERKHADKEDDRNDSSEIEDDNAT---ALDDEEAVAVQEQVRQIKAQEEEFE 825
Query: 351 IFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVC 410
F L+I+HRKNRTGFEE K+ ++LN+VIAGRY+VTEYLGSAAFSK QA DL TG+DVC
Sbjct: 826 TFDLKIVHRKNRTGFEEEKNFNVVLNSVIAGRYHVTEYLGSAAFSKAIQAHDLQTGMDVC 885
Query: 411 LKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLY 470
+KIIKN+KDFFDQSLDEIKLLK VNK+DPAD++H+LRLYDYFY+ EHL IVCELL+ANLY
Sbjct: 886 IKIIKNNKDFFDQSLDEIKLLKYVNKHDPADKYHLLRLYDYFYYREHLLIVCELLKANLY 945
Query: 471 EFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 530
EF KFN+ESGGE YFT+ RLQ IT QCLE+L++LH LG+IHCDLKPENIL+KSY RCEIK
Sbjct: 946 EFHKFNRESGGEVYFTMPRLQSITIQCLESLQFLHGLGLIHCDLKPENILVKSYSRCEIK 1005
Query: 531 IIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 590
+IDLGSSCF+TD+LC YVQSRSYRAPEVI+GLPYD+KID+WSLGCILAEL TG VLF ND
Sbjct: 1006 VIDLGSSCFETDHLCSYVQSRSYRAPEVILGLPYDKKIDVWSLGCILAELCTGNVLFQND 1065
Query: 591 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHH 650
+ +LAR++G++G D EML +G++ +KYFTK LY N+E+N+LEY+IP+ +SL H
Sbjct: 1066 SPASLLARVMGIVGSFDNEMLTKGRDSHKYFTKNRMLYERNQESNRLEYLIPKRTSLRHR 1125
Query: 651 LQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHPY 689
L D F DFV LLEINP++RP+A EAL HPWL +PY
Sbjct: 1126 LPMGDQGFTDFVAHLLEINPKKRPSAAEALKHPWLSYPY 1164
|
|
| TAIR|locus:2089774 AT3G17750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1334 (474.7 bits), Expect = 1.4e-142, Sum P(2) = 1.4e-142
Identities = 244/344 (70%), Positives = 296/344 (86%)
Query: 346 EEECEIFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHT 405
E++ E F+L+I+HRKNRTGFEE+K+ ++LN+VIAGRY+VTE+LGSAAFSK QA DLHT
Sbjct: 790 EQDFETFNLKIVHRKNRTGFEEDKNFHVVLNSVIAGRYHVTEHLGSAAFSKAIQAHDLHT 849
Query: 406 GVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELL 465
G+DVC+KIIKN+KDFFDQSLDEIKLLK VN++DPAD++H+LRLYDYFY EHL IVCELL
Sbjct: 850 GIDVCVKIIKNNKDFFDQSLDEIKLLKYVNQHDPADKYHLLRLYDYFYFREHLLIVCELL 909
Query: 466 RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 525
+ANLYEFQKFN+ESGGE YFT+ RLQ IT QCLEAL +LH LG+IHCDLKPENILIKSY
Sbjct: 910 KANLYEFQKFNRESGGEVYFTMPRLQSITIQCLEALNFLHGLGLIHCDLKPENILIKSYS 969
Query: 526 RCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 585
RCEIK+IDLGSSCF+TD+LC YVQSRSYRAPEVI+GLPYD+KID+WSLGCILAEL TG V
Sbjct: 970 RCEIKVIDLGSSCFETDHLCSYVQSRSYRAPEVILGLPYDKKIDIWSLGCILAELCTGNV 1029
Query: 586 LFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEES 645
LF ND+ +LAR+IG++G ID EML +G++ KYFTK + LY N+E+N LEY+IP++S
Sbjct: 1030 LFQNDSPATLLARVIGIIGSIDQEMLAKGRDTCKYFTKNHLLYERNQESNNLEYLIPKKS 1089
Query: 646 SLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHPY 689
SL L D FIDFV LL+++P++RP+A EAL HPWL +PY
Sbjct: 1090 SLRRRLPMGDQGFIDFVAYLLQVDPKKRPSAFEALKHPWLTYPY 1133
|
|
| POMBASE|SPAC823.03 ppk15 "serine/threonine protein kinase Ppk15 (predicted)" [Schizosaccharomyces pombe (taxid:4896)] | Back alignment and assigned GO terms |
|---|
Score = 525 (189.9 bits), Expect = 1.1e-56, Sum P(2) = 1.1e-56
Identities = 128/324 (39%), Positives = 186/324 (57%)
Query: 364 GFEE-NKDLPIILNTVIA---GR-YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK 418
GF+ N D + +N ++ GR Y + + LG F +V + QDL T V +K+IKN
Sbjct: 106 GFDNVNHDYVLYVNDLLGTDEGRKYLILDTLGHGTFGQVARCQDLKTQQIVAIKVIKNKP 165
Query: 419 DFFDQSLDEIKLLKLVN-KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQ 477
F++Q + E+ +L+L+N K DP D+ H++RLYD F H HL +V ELL NLYE K NQ
Sbjct: 166 AFYNQCVMEVSILELLNNKYDPEDKRHLIRLYDQFMHKNHLCLVFELLSINLYELIKQNQ 225
Query: 478 ESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537
G L ++ Q L L IIHCDLKPENIL++ +K+ID GS+
Sbjct: 226 FRG----LHLSLVRSFATQLLSCTSLLKQARIIHCDLKPENILLQDLSSPIVKVIDFGSA 281
Query: 538 CFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILA 597
C + + Y+QSR YR+PEVI+GL Y+ ID+WSLGCILAEL+ G LFP ++ L
Sbjct: 282 CHERQTVYTYIQSRFYRSPEVILGLHYNCGIDMWSLGCILAELFLGLPLFPGNSEYNQLC 341
Query: 598 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYIN-EETNQLEYIIPEESSLEHHL--QFS 654
RI+ MLG ML G+ KY Y+ ++N +T +L+ I E+ S+E++ Q
Sbjct: 342 RIVDMLGNPPTWMLEMGKNSKKY----YNSGFVNGRKTYELKSI--EQFSIENNKTEQPG 395
Query: 655 DAFFIDFVRTLLEIN-PQRRPTAR 677
+F + + +N P+R+ T +
Sbjct: 396 KQYFGEKTLDAIVLNYPRRKTTPK 419
|
|
| RGD|1306800 Dyrk4 "dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 543 (196.2 bits), Expect = 3.8e-56, Sum P(2) = 3.8e-56
Identities = 127/339 (37%), Positives = 191/339 (56%)
Query: 354 LRIIHRK-NRTGFEENKDLPI-ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCL 411
L ++ K ++T F++ + +L+ IA RY V + +G +F +V + D V L
Sbjct: 189 LNVVPEKFSKTSFDDEHGSYVKVLHDHIAYRYEVLDMIGKGSFGQVAKCLDHKNNELVAL 248
Query: 412 KIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYE 471
KII+N K F Q+L E+K+L+ + + D + H+++ + D+FY HL I ELL NLYE
Sbjct: 249 KIIRNKKRFHHQALVELKILEALRRKDKDNTHNVVHMKDFFYFRNHLCITFELLGINLYE 308
Query: 472 FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 531
K N G F+L ++ T L+ L+ L+ IIHCDLKPENI++ + +K+
Sbjct: 309 LMKNNSFQG----FSLSIVRRFTLSVLKCLQMLYVEKIIHCDLKPENIVLYHRGQVTVKV 364
Query: 532 IDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA 591
ID GSSC++ + Y+QSR YR+PEVI+G PY+ ID+WSLGCI+AEL+TG LFP +
Sbjct: 365 IDFGSSCYEHQKVYTYIQSRFYRSPEVILGHPYNMAIDMWSLGCIMAELYTGYPLFPGEN 424
Query: 592 VVMILARIIGMLG--PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEH 649
V LA I+ +LG P L ++I+ + +K N N+ E P L
Sbjct: 425 EVEQLACIMEVLGLPPTHLIQTATRRQIF-FDSKGLPKNITN---NRGEKRYPNSKDLPM 480
Query: 650 HLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688
++ D+ F+DF+R L P R T +AL H W+ P
Sbjct: 481 VVKTYDSSFLDFLRRCLVWEPSLRMTPDQALKHAWIHEP 519
|
|
| UNIPROTKB|D4A0W8 Dyrk4 "Protein Dyrk4" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 543 (196.2 bits), Expect = 3.8e-56, Sum P(2) = 3.8e-56
Identities = 127/339 (37%), Positives = 191/339 (56%)
Query: 354 LRIIHRK-NRTGFEENKDLPI-ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCL 411
L ++ K ++T F++ + +L+ IA RY V + +G +F +V + D V L
Sbjct: 153 LNVVPEKFSKTSFDDEHGSYVKVLHDHIAYRYEVLDMIGKGSFGQVAKCLDHKNNELVAL 212
Query: 412 KIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYE 471
KII+N K F Q+L E+K+L+ + + D + H+++ + D+FY HL I ELL NLYE
Sbjct: 213 KIIRNKKRFHHQALVELKILEALRRKDKDNTHNVVHMKDFFYFRNHLCITFELLGINLYE 272
Query: 472 FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 531
K N G F+L ++ T L+ L+ L+ IIHCDLKPENI++ + +K+
Sbjct: 273 LMKNNSFQG----FSLSIVRRFTLSVLKCLQMLYVEKIIHCDLKPENIVLYHRGQVTVKV 328
Query: 532 IDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA 591
ID GSSC++ + Y+QSR YR+PEVI+G PY+ ID+WSLGCI+AEL+TG LFP +
Sbjct: 329 IDFGSSCYEHQKVYTYIQSRFYRSPEVILGHPYNMAIDMWSLGCIMAELYTGYPLFPGEN 388
Query: 592 VVMILARIIGMLG--PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEH 649
V LA I+ +LG P L ++I+ + +K N N+ E P L
Sbjct: 389 EVEQLACIMEVLGLPPTHLIQTATRRQIF-FDSKGLPKNITN---NRGEKRYPNSKDLPM 444
Query: 650 HLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688
++ D+ F+DF+R L P R T +AL H W+ P
Sbjct: 445 VVKTYDSSFLDFLRRCLVWEPSLRMTPDQALKHAWIHEP 483
|
|
| MGI|MGI:1330292 Dyrk4 "dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 546 (197.3 bits), Expect = 4.8e-56, Sum P(2) = 4.8e-56
Identities = 129/339 (38%), Positives = 186/339 (54%)
Query: 354 LRIIHRK-NRTGFE-ENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCL 411
L ++ K ++T F+ E+ +L+ IA RY V E +G +F +V + D V L
Sbjct: 188 LNVVPEKFSKTSFDDEHGSYMKVLHDHIAYRYEVLEMIGKGSFGQVAKCLDHKNNELVAL 247
Query: 412 KIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYE 471
KII+N K F Q+L E+K+L+ + + D + H+++ + D+FY HL I ELL NLYE
Sbjct: 248 KIIRNKKRFHHQALVELKILEALRRKDKDNNHNVVHMKDFFYFRNHLCITFELLGINLYE 307
Query: 472 FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI-- 529
K N G F L ++ T L+ L L+ IIHCDLKPENI++ YQR ++
Sbjct: 308 LMKNNSFHG----FNLSIVRRFTFSILKCLHMLYVEKIIHCDLKPENIVL--YQRGQVTV 361
Query: 530 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 589
K+ID GSSC++ + Y+QSR YR+PEVI+G PY+ ID+WSLGCI+AEL+TG LFP
Sbjct: 362 KVIDFGSSCYEHQKVYTYIQSRFYRSPEVILGHPYNMAIDMWSLGCIMAELYTGYPLFPG 421
Query: 590 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEH 649
+ V LA I+ +LG +F + IN Y P+ L
Sbjct: 422 ENEVEQLACIMEVLGLPPAHFTQTASRRQVFFDSKGLPKNINNNRGGKRY--PDSKDLTM 479
Query: 650 HLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688
++ D+ F+DF+R L P R T +AL H W+ P
Sbjct: 480 VVKTYDSSFLDFLRRCLVWEPSLRMTPEQALKHAWIHEP 518
|
|
| ASPGD|ASPL0000065013 AN7104 [Emericella nidulans (taxid:162425)] | Back alignment and assigned GO terms |
|---|
Score = 533 (192.7 bits), Expect = 9.8e-56, Sum P(2) = 9.8e-56
Identities = 130/332 (39%), Positives = 192/332 (57%)
Query: 360 KNRTGFE-ENKDLPIILNTVI----AG---RYYVTEYLGSAAFSKVFQAQDLHTGVDVCL 411
KN G++ E+ D + +N ++ AG RY + + LG F +V + Q+L T V +
Sbjct: 311 KN-DGYDNEDSDYILYVNDILGSEEAGHKNRYLILDVLGQGTFGQVVKCQNLKTQEVVAV 369
Query: 412 KIIKNDKDFFDQSLDEIKLLKLVNKN-DPADEHHILRLYDYFYHLEHLFIVCELLRANLY 470
K+IKN +F+QS+ E+ +L L+N D D+HH+LRL D F H +HL +V ELL NLY
Sbjct: 370 KVIKNKTAYFNQSMMEVSVLDLLNSRYDKNDDHHLLRLKDTFIHRQHLCLVFELLSVNLY 429
Query: 471 EFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 530
E K NQ G TL R V +Q L AL L+ +IHCDLKPENIL+K+ + IK
Sbjct: 430 ELIKQNQFRGLST--TLVR--VFAQQLLNALSLLNKAHLIHCDLKPENILLKNLESPIIK 485
Query: 531 IIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 590
+ID GS+C + + Y+QSR YR+PEV++GLPY ID+WSLGCI+ EL+ G LFP
Sbjct: 486 VIDFGSACDERQTVYTYIQSRFYRSPEVLLGLPYSSAIDMWSLGCIVVELFLGLPLFPGS 545
Query: 591 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHH 650
+ + RI+ MLG ML G++ ++F K D + ++ +L+ + E+ S EH+
Sbjct: 546 SEYNQVCRIVEMLGLPPTWMLEMGKQSGEFFEKTQDEF--GRKSYRLKSL--EQYSREHN 601
Query: 651 L--QFSDAFF-IDFVRTLLEINPQRRPTAREA 679
Q S +F + ++ P R ++A
Sbjct: 602 TKEQPSKKYFQASTLEEIIRSYPMPRKNMKQA 633
|
|
| UNIPROTKB|F5H6L9 DYRK4 "Dual-specificity tyrosine-phosphorylation-regulated kinase 4" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 531 (192.0 bits), Expect = 1.6e-55, Sum P(2) = 1.6e-55
Identities = 122/326 (37%), Positives = 177/326 (54%)
Query: 361 NRTGFEENKDLPI-ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD 419
++T F++ + +L+ IA RY V E +G +F +V + D V LKII+N K
Sbjct: 196 SKTSFDDEHGFYLKVLHDHIAYRYEVLETIGKGSFGQVAKCLDHKNNELVALKIIRNKKR 255
Query: 420 FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQES 479
F Q+L E+K+L+ + K D + ++++ + D+FY H I ELL NLYE K N
Sbjct: 256 FHQQALMELKILEALRKKDKDNTYNVVHMKDFFYFRNHFCITFELLGINLYELMKNNNFQ 315
Query: 480 GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539
G F+L ++ T L+ L+ L IIHCDLKPENI++ + +K+ID GSSC+
Sbjct: 316 G----FSLSIVRRFTLSVLKCLQMLSVEKIIHCDLKPENIVLYQKGQASVKVIDFGSSCY 371
Query: 540 QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 599
+ + Y+QSR YR+PEVI+G PYD ID+WSLGCI AEL+TG LFP + V LA I
Sbjct: 372 EHQKVYTYIQSRFYRSPEVILGHPYDVAIDMWSLGCITAELYTGYPLFPGENEVEQLACI 431
Query: 600 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFI 659
+ +LG + +F + I + Y P+ L L+ D F+
Sbjct: 432 MEVLGLPPAGFIQTASRRQTFFDSKGFPKNITNNRGKKRY--PDSKDLTMVLKTYDTSFL 489
Query: 660 DFVRTLLEINPQRRPTAREALDHPWL 685
DF+R L P R T +AL H W+
Sbjct: 490 DFLRRCLVWEPSLRMTPDQALKHAWI 515
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| estExt_fgenesh4_pg.C_LG_VIII0583 | hypothetical protein (726 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 689 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-68 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-56 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-51 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-50 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-49 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-46 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-45 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-44 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-42 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-41 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-40 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-39 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-38 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-38 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-38 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-35 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-35 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-35 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-35 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-35 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-35 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-33 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-33 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-33 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-31 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-30 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-30 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-30 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-30 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-29 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-29 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-28 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-28 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-28 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-28 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-28 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-28 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-27 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-27 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-27 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-27 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-26 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-25 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-25 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-25 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-25 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-25 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-25 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-25 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-24 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-23 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-23 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-23 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-23 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-22 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-20 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-20 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-19 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-18 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-18 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-18 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-17 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-16 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-16 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-15 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-14 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-13 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-12 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-12 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-10 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-10 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-10 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-09 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-09 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-08 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 5e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-08 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-08 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-07 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-06 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-06 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-06 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 4e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-06 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-06 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-06 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-05 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-05 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-05 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-05 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-05 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-05 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-05 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-04 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-04 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-04 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-04 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-04 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-04 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 0.001 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 0.001 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 0.001 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 0.002 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 223 bits (572), Expect = 2e-68
Identities = 99/309 (32%), Positives = 141/309 (45%), Gaps = 61/309 (19%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPA 440
Y + E LG +F KV+ A+D TG V +K+IK K ++ L EIK+LK +
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLK----- 55
Query: 441 DEH-HILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
H +I+RLYD F + L++V E +L++ K + + RQ L
Sbjct: 56 --HPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG------RLSEDEARFYLRQIL 107
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSYRAP 556
ALEYLHS GI+H DLKPENIL+ +K+ D G + L +V + Y AP
Sbjct: 108 SALEYLHSKGIVHRDLKPENILLDE--DGHVKLADFGLARQLDPGEKLTTFVGTPEYMAP 165
Query: 557 EVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 616
EV++G Y + +D+WSLG IL EL TG+ FP D ++ L + IG
Sbjct: 166 EVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGK-------------- 211
Query: 617 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 676
P+ S D +R LL +P++R TA
Sbjct: 212 -------------------------PKPPFPPPEWDISPE-AKDLIRKLLVKDPEKRLTA 245
Query: 677 REALDHPWL 685
EAL HP+
Sbjct: 246 EEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 4e-56
Identities = 93/306 (30%), Positives = 136/306 (44%), Gaps = 61/306 (19%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKNDPADEH-H 444
LGS +F V++A+ TG V +KI+K + EI++L+ ++ H +
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLS-------HPN 59
Query: 445 ILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 503
I+RL D F +HL++V E +L+++ + + I Q L LEY
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG------PLSEDEAKKIALQILRGLEY 113
Query: 504 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---LCLYVQSRSYRAPEVII 560
LHS GIIH DLKPENIL+ + +KI D G + + L +V + Y APEV++
Sbjct: 114 LHSNGIIHRDLKPENILLD--ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLL 171
Query: 561 -GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYK 619
G Y K+D+WSLG IL EL TG+ F + ++ L I +LGP
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGP-------------- 217
Query: 620 YFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA 679
E EE D ++ L +P +RPTA E
Sbjct: 218 ----------PLEFDEPKWSSGSEE-------------AKDLIKKCLNKDPSKRPTAEEI 254
Query: 680 LDHPWL 685
L HPW
Sbjct: 255 LQHPWF 260
|
Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 3e-51
Identities = 94/315 (29%), Positives = 142/315 (45%), Gaps = 45/315 (14%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDP 439
Y E LG + V++A+D TG V LK I+ D + +L EI LLK +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK---- 56
Query: 440 ADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
H +I++L D + L++V E +L ++ + ++ I Q L
Sbjct: 57 ---HPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGP-----LSPNLIKSIMYQLL 108
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQ------TDNLCLYVQSR 551
L Y HS I+H DLKP+NILI +K+ D G + F T V +
Sbjct: 109 RGLAYCHSHRILHRDLKPQNILINR--DGVLKLADFGLARAFGIPLRTYTHE----VVTL 162
Query: 552 SYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 610
YRAPE+++G Y +D+WS+GCI AE+ TG+ LFP D+ + L +I +LG E
Sbjct: 163 WYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEES 222
Query: 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINP 670
G + + + LE L D ID + +L+ NP
Sbjct: 223 WP-GVTKLPDYKPTFPKF--------------PPKDLEKVLPRLDPEGIDLLSKMLQYNP 267
Query: 671 QRRPTAREALDHPWL 685
+R +A+EAL HP+
Sbjct: 268 AKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 2e-50
Identities = 96/314 (30%), Positives = 148/314 (47%), Gaps = 42/314 (13%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVN-KND 438
Y +G + V++A+D TG V +K IK + +L EIKLLK +N N
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPN- 59
Query: 439 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
I++L D F H L++V E + +LY+ K Q ++ Q L
Sbjct: 60 ------IIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG-----LPESLIKSYLYQLL 108
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS-CFQTDNLCL--YVQSRSYRA 555
+ L + HS GI+H DLKPEN+LI +K+ D G + F + YV +R YRA
Sbjct: 109 QGLAFCHSHGILHRDLKPENLLIN--TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRA 166
Query: 556 PEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG-PIDLEMLMQ 613
PE+++G Y +D+WS+GCI AEL + LFP + + L +I LG P
Sbjct: 167 PELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPD------- 219
Query: 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFF--IDFVRTLLEINPQ 671
E++ FT Y + P+++ + F +A +D + +L +P
Sbjct: 220 -PEVWPKFTSLARNYKFS---------FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPH 269
Query: 672 RRPTAREALDHPWL 685
+R TA +AL HP+
Sbjct: 270 KRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 2e-49
Identities = 108/330 (32%), Positives = 151/330 (45%), Gaps = 60/330 (18%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLVN 435
RY + + +GS A+ V A D TG V +K I N FD +D EIKLL+ +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN---VFDDLIDAKRILREIKLLRHLR 57
Query: 436 KNDPADEH-HILRLYDYFYH-----LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGR 489
H +I+ L D ++IV EL+ +L++ K Q T
Sbjct: 58 -------HENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQP------LTDDH 104
Query: 490 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------SSCFQTDN 543
+Q Q L L+YLHS +IH DLKP NIL+ S C++KI D G +
Sbjct: 105 IQYFLYQILRGLKYLHSANVIHRDLKPSNILVNS--NCDLKICDFGLARGVDPDEDEKGF 162
Query: 544 LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFP-NDAVVMILARIIG 601
L YV +R YRAPE+++ Y + ID+WS+GCI AEL T + LFP D + L I+
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-LNLIVE 221
Query: 602 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINE----ETNQLEYIIPEESSLEHHLQFSDAF 657
+LG E L K+ T E Y+ L + P S
Sbjct: 222 VLGTPSEEDL-------KFITSEKARNYLKSLPKKPKKPLSKLFPGASPE---------- 264
Query: 658 FIDFVRTLLEINPQRRPTAREALDHPWLQH 687
ID + +L +P++R TA EAL HP+L
Sbjct: 265 AIDLLEKMLVFDPKKRITADEALAHPYLAQ 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 3e-46
Identities = 91/315 (28%), Positives = 158/315 (50%), Gaps = 44/315 (13%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ--SLDEIKLLKLVNKNDPA 440
Y V + LG F V+ A++ TG V +K +K +++ +L E+K L+ +N++
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHP-- 58
Query: 441 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 500
+I++L + F + L+ V E + NLY+ K + F+ ++ I Q L+
Sbjct: 59 ---NIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGK----PFSESVIRSIIYQILQG 111
Query: 501 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------SSCFQTDNLCLYVQSRSYR 554
L ++H G H DLKPEN+L+ + +KI D G S TD YV +R YR
Sbjct: 112 LAHIHKHGFFHRDLKPENLLVSGPEV--VKIADFGLAREIRSRPPYTD----YVSTRWYR 165
Query: 555 APEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFP-NDAVVMILARIIGMLGPIDLEMLM 612
APE+++ Y +D+W+LGCI+AEL+T LFP + + + +I +LG +
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY-KICSVLGTPTKQDWP 224
Query: 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPE--ESSLEHHLQFSDAFFIDFVRTLLEINP 670
+G ++ ++L + P+ +SL + + ID ++ +L +P
Sbjct: 225 EGYKL----------------ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDP 268
Query: 671 QRRPTAREALDHPWL 685
++RPTA +AL HP+
Sbjct: 269 KKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 4e-45
Identities = 95/317 (29%), Positives = 149/317 (47%), Gaps = 45/317 (14%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII----KNDKDFFDQSLDEIKLLKLVNKN 437
RY + +G A VF+A+D TG V LK + +Q+L EIK L+
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGG-IPNQALREIKALQAC--- 56
Query: 438 DPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 496
+H ++++L D F H +V E + ++L E + + +++ R
Sbjct: 57 ----QHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERP-----LPEAQVKSYMRM 107
Query: 497 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLY---VQSRS 552
L+ + Y+H+ GI+H DLKP N+LI + +KI D G + F + LY V +R
Sbjct: 108 LLKGVAYMHANGIMHRDLKPANLLISA--DGVLKIADFGLARLFSEEEPRLYSHQVATRW 165
Query: 553 YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 611
YRAPE++ G YD +DLW++GCI AEL G LFP + + LA + LG
Sbjct: 166 YRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLG------- 218
Query: 612 MQGQEIYKYFTKEYD---LYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEI 668
+E + T D + + + LE I P+ S +D ++ LL
Sbjct: 219 TPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEA----------LDLLKGLLVY 268
Query: 669 NPQRRPTAREALDHPWL 685
+P +R +A EAL HP+
Sbjct: 269 DPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 2e-44
Identities = 76/199 (38%), Positives = 104/199 (52%), Gaps = 19/199 (9%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 446
LG F V+ A+D TG V +KIIK + ++ L EI++LK +N +I+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH------PNIV 54
Query: 447 RLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH 505
+LY F HL++V E +L + K N+ + + I Q LE LEYLH
Sbjct: 55 KLYGVFEDENHLYLVMEYCEGGSLKDLLKENEG-----KLSEDEILRILLQILEGLEYLH 109
Query: 506 SLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQSRSYRAPEVIIGL 562
S GIIH DLKPENIL+ S +K+ D G S L V + +Y APEV++G
Sbjct: 110 SNGIIHRDLKPENILLDSDNGK-VKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGK 168
Query: 563 P-YDQKIDLWSLGCILAEL 580
Y +K D+WSLG IL EL
Sbjct: 169 GYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 8e-42
Identities = 89/316 (28%), Positives = 146/316 (46%), Gaps = 39/316 (12%)
Query: 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKN 437
+Y V +G A+ V + ++ TG V +K K +D+D +L E+K+L+ +
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL--- 57
Query: 438 DPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 496
H +I+ L + F L++V E + L E + + ++ Q
Sbjct: 58 ----RHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDA-----VRSYIWQ 108
Query: 497 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG----SSCFQTDNLCLYVQSRS 552
L+A+ Y HS IIH D+KPENIL+ +K+ D G L YV +R
Sbjct: 109 LLQAIAYCHSHNIIHRDIKPENILVSESG--VLKLCDFGFARALRARPASPLTDYVATRW 166
Query: 553 YRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 611
YRAPE+++G Y + +D+W++GCI+AEL GE LFP D+ + L I LGP+
Sbjct: 167 YRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQ 226
Query: 612 MQGQEIYKYFTKEYDLYYINEETNQLEYI-IPEESSLEH-HLQFSDAFFIDFVRTLLEIN 669
+L+ N + + + SLE + + +DF++ L ++
Sbjct: 227 --------------ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMD 272
Query: 670 PQRRPTAREALDHPWL 685
P+ R T E L HP+
Sbjct: 273 PKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 5e-41
Identities = 86/302 (28%), Positives = 136/302 (45%), Gaps = 58/302 (19%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPADEHHI 445
E +G F +V++A+ TG +V +K+IK K+ ++ ++EI++LK +I
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCK------HPNI 59
Query: 446 LRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 504
++ Y + + L+IV E +L + K ++ T ++ + ++ L+ LEYL
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT-----LTESQIAYVCKELLKGLEYL 114
Query: 505 HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSYRAPEVIIGL 562
HS GIIH D+K NIL+ S E+K+ID G S +D V + + APEVI G
Sbjct: 115 HSNGIIHRDIKAANILLTS--DGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGK 172
Query: 563 PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFT 622
PYD K D+WSLG EL G+ + P +
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPYSEL--------------PPMKALFKIATN------ 212
Query: 623 KEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682
PE+ S E F DF++ L+ NP++RPTA + L H
Sbjct: 213 ------------GPPGLRNPEKWSDE---------FKDFLKKCLQKNPEKRPTAEQLLKH 251
Query: 683 PW 684
P+
Sbjct: 252 PF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 3e-40
Identities = 106/327 (32%), Positives = 162/327 (49%), Gaps = 64/327 (19%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD-----QSLDEIKLLKLVNK 436
RY +GS A+ +V A D TG V +K K + F ++ E++LLK +
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK--KLSRPFQSAIHAKRTYRELRLLKHM-- 71
Query: 437 NDPADEHHILRLYDYFYHLEHL------FIVCELLRANLY---EFQKFNQESGGEAYFTL 487
D +++ L D F L ++V L+ A+L + QK + +
Sbjct: 72 ----DHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDD--------- 118
Query: 488 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 547
+Q + Q L L+Y+HS GIIH DLKP NI + CE+KI+D G + D + Y
Sbjct: 119 -HIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE--DCELKILDFGLARHTDDEMTGY 175
Query: 548 VQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 606
V +R YRAPE+++ + Y+Q +D+WS+GCI+AEL TG+ LFP + L RI+ ++G
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTP 235
Query: 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQ--FSDAF------F 658
D E L+Q I+ E+ + YI SL + F + F
Sbjct: 236 DEE-LLQK---------------ISSESAR-NYI----QSLPQMPKKDFKEVFSGANPLA 274
Query: 659 IDFVRTLLEINPQRRPTAREALDHPWL 685
ID + +L ++P +R TA EAL HP+L
Sbjct: 275 IDLLEKMLVLDPDKRITAAEALAHPYL 301
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 89/323 (27%), Positives = 148/323 (45%), Gaps = 58/323 (17%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFD-QSLDEIKLLKLVNKNDP 439
Y +G + +V++A++ TG V LK I+ N+K+ F ++ EIKLL+ +
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR---- 56
Query: 440 ADEH-HILRLYDYFYHLEHLFIVCELLRANLY---EFQKFNQESG----GEAYFTLGRLQ 491
H +I+RL + IV + ++Y E+ + +G E FT +++
Sbjct: 57 ---HPNIVRLKE---------IVTSKGKGSIYMVFEYMDHDL-TGLLDSPEVKFTESQIK 103
Query: 492 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 551
+Q LE L+YLHS GI+H D+K NILI + +K+ D G + T +R
Sbjct: 104 CYMKQLLEGLQYLHSNGILHRDIKGSNILINN--DGVLKLADFGLARPYTKRNSADYTNR 161
Query: 552 S----YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 606
YR PE+++G Y ++D+WS+GCILAEL+ G+ +F + L +I + G
Sbjct: 162 VITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP 221
Query: 607 DLE-----MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDF 661
E + E K K Y + E D +D
Sbjct: 222 TDENWPGVSKLPWFENLK-PKKPY-----------------KRRLREFFKHLIDPSALDL 263
Query: 662 VRTLLEINPQRRPTAREALDHPW 684
+ LL ++P++R +A +AL H +
Sbjct: 264 LDKLLTLDPKKRISADQALQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 6e-39
Identities = 95/312 (30%), Positives = 153/312 (49%), Gaps = 41/312 (13%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ--SLDEIKLLKLVNKNDPA 440
Y + +G FS+V +AQ TG +K +K +Q +L EI+ L+ ++
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLS----- 55
Query: 441 DEHHILRLYDYFYHLEH--LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
+ILRL + + + L +V EL+ NLYE K G + R++ Q L
Sbjct: 56 PHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIK-----GRKRPLPEKRVKSYMYQLL 110
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC--FQTDNLCLYVQSRSYRAP 556
++L+++H GI H D+KPENILIK +K+ D GS + Y+ +R YRAP
Sbjct: 111 KSLDHMHRNGIFHRDIKPENILIKDD---ILKLADFGSCRGIYSKPPYTEYISTRWYRAP 167
Query: 557 EVII--GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614
E ++ G Y K+D+W++GC+ E+ + LFP + +A+I +LG D E+L
Sbjct: 168 ECLLTDGY-YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVL--- 223
Query: 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEE--SSLEHHLQFSDAFFIDFVRTLLEINPQR 672
K F K + + Y P + + L L + A +D ++ LL +P
Sbjct: 224 ----KKFRK----------SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDE 269
Query: 673 RPTAREALDHPW 684
R TA++AL HP+
Sbjct: 270 RITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 93/316 (29%), Positives = 131/316 (41%), Gaps = 78/316 (24%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLK--IIKNDKDFFDQSLD-EIKLLK-LVNKNDPADE 442
E LG +F V+ A D TG + +K + D + ++L+ EI++L L + N
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN----- 60
Query: 443 HHILRLYDYFYHLE--HLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVITR 495
I+R Y E L I E L + L +F K E ++ TR
Sbjct: 61 --IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP-EP---------VIRKYTR 108
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR- 554
Q LE L YLHS GI+H D+K NIL+ S +K+ D G + + ++ + S R
Sbjct: 109 QILEGLAYLHSNGIVHRDIKGANILVDS--DGVVKLADFGCA-KRLGDIETGEGTGSVRG 165
Query: 555 -----APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 609
APEVI G Y + D+WSLGC + E+ TG+ + M
Sbjct: 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA------------- 212
Query: 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 669
LY I E IPE S E DF+R L +
Sbjct: 213 -----------------LYKIGSSGEPPE--IPEHLSEE---------AKDFLRKCLRRD 244
Query: 670 PQRRPTAREALDHPWL 685
P++RPTA E L HP+L
Sbjct: 245 PKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 104/335 (31%), Positives = 160/335 (47%), Gaps = 60/335 (17%)
Query: 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ-----SLDEIKLLK 432
+ RY + +GS A V A D TG +V +K K + F + + E+ L+K
Sbjct: 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIK--KLSRPFQNVTHAKRAYRELVLMK 70
Query: 433 LVN-KNDPADEHHILRLYDYFY------HLEHLFIVCELLRANLYEFQKFNQESGGEAYF 485
LVN KN I+ L + F + +++V EL+ ANL Q + E
Sbjct: 71 LVNHKN-------IIGLLNVFTPQKSLEEFQDVYLVMELMDANLC--QVIQMDLDHE--- 118
Query: 486 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------SSCF 539
R+ + Q L +++LHS GIIH DLKP NI++KS C +KI+D G +S
Sbjct: 119 ---RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTSFM 173
Query: 540 QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 599
T YV +R YRAPEVI+G+ Y + +D+WS+GCI+ E+ G VLFP + +I
Sbjct: 174 MTP----YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKI 229
Query: 600 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEY---------IIPEESSLEHH 650
I LG E + + Q + Y+ Y + P +S +
Sbjct: 230 IEQLGTPSDEFMSRLQPTVR--------NYVENRPKYAGYSFEELFPDVLFPPDSESHNK 281
Query: 651 LQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685
L+ S A D + +L I+P++R + +AL HP++
Sbjct: 282 LKASQAR--DLLSKMLVIDPEKRISVDDALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 5e-38
Identities = 89/316 (28%), Positives = 148/316 (46%), Gaps = 42/316 (13%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQS-LDEIKLLKLVNKNDP 439
Y +G A+ V++A+DL+TG V LK ++ ++ S L EI LLK +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLE---- 56
Query: 440 ADEH-HILRLYD--YFYHLEH---LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI 493
+ EH +I+RL D + + L +V E + +L + + G ++ +
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPE----TIKDL 112
Query: 494 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS---CFQTDNLCLYVQS 550
RQ L +++LHS I+H DLKP+NIL+ S + +KI D G + F+ L V +
Sbjct: 113 MRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ--VKIADFGLARIYSFEM-ALTSVVVT 169
Query: 551 RSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG-PIDLE 609
YRAPEV++ Y +D+WS+GCI AEL+ LF + L +I ++G P + E
Sbjct: 170 LWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229
Query: 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 669
+ + + + + + +PE D ++ +L N
Sbjct: 230 W---PRNV--SLPRS---SFPSYTPRSFKSFVPEICEEGL----------DLLKKMLTFN 271
Query: 670 PQRRPTAREALDHPWL 685
P +R +A EAL HP+
Sbjct: 272 PHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 101/329 (30%), Positives = 150/329 (45%), Gaps = 51/329 (15%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN-DKDFFDQ-SLDEIKLLKLVNK 436
+ RY Y+G A+ V A TGV V +K I + F Q +L EIK+L+
Sbjct: 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKH 62
Query: 437 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEA-YFTLGRLQVITR 495
+ I+R + ++IV EL+ +LY+ K S YF
Sbjct: 63 ENIIGILDIIRPPSFES-FNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLY-------- 113
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDN---LCLYVQ 549
Q L L+Y+HS ++H DLKP N+L+ + C++KI D G + + D+ L YV
Sbjct: 114 QILRGLKYIHSANVLHRDLKPSNLLLNT--NCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 550 SRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 608
+R YRAPE+++ Y + ID+WS+GCILAE+ + LFP + L I+G+LG
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQ 231
Query: 609 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHH--LQFSDAF------FID 660
E DL I YI SL + ++ F +D
Sbjct: 232 E----------------DLNCIISL-RARNYIK----SLPFKPKVPWNKLFPNADPKALD 270
Query: 661 FVRTLLEINPQRRPTAREALDHPWLQHPY 689
+ +L NP +R T EAL HP+L+ Y
Sbjct: 271 LLDKMLTFNPHKRITVEEALAHPYLE-QY 298
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 100/342 (29%), Positives = 155/342 (45%), Gaps = 81/342 (23%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 432
I +Y + + LG A+ V++A D T V LK I D F + D EI L+
Sbjct: 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIF---DAFRNATDAQRTFREIMFLQ 61
Query: 433 LVNKNDPADEHHILRLYD----------Y--FYHLE---HLFIVCELLRAN-LYEFQKFN 476
+ + +I++L + Y F ++E H I RAN L + K
Sbjct: 62 ELGDHP-----NIVKLLNVIKAENDKDIYLVFEYMETDLHAVI-----RANILEDVHK-- 109
Query: 477 QESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG- 535
+ I Q L+AL+Y+HS +IH DLKP NIL+ S C +K+ D G
Sbjct: 110 --------------RYIMYQLLKALKYIHSGNVIHRDLKPSNILLNS--DCRVKLADFGL 153
Query: 536 SSCFQTDNLCL-------YVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLF 587
+ YV +R YRAPE+++G Y + +D+WS+GCIL E+ G+ LF
Sbjct: 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213
Query: 588 PNDAVVMILARIIGMLGPI---DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEE 644
P + + L +II ++GP D+E ++ L+ ++P+
Sbjct: 214 PGTSTLNQLEKIIEVIGPPSAEDIES-IKSPFAATMLDSLPSRPRKP-----LDELLPKA 267
Query: 645 SSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686
S DA +D ++ LL NP +R TA EAL+HP++
Sbjct: 268 S--------DDA--LDLLKKLLVFNPNKRLTAEEALEHPYVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 91/327 (27%), Positives = 149/327 (45%), Gaps = 56/327 (17%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD------QSLDEIKLLKLVN 435
RY E +GS A+ V A D +G V +K I + FD ++L E+K+L+
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHA---FDVPTLAKRTLRELKILRHFK 62
Query: 436 KNDPADEHHILRLYDYFY----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQ 491
++ I+ + D + +++V +L+ ++L+ +Q T ++
Sbjct: 63 HDN------IIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQP------LTEEHIR 110
Query: 492 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-------SSCFQTDNL 544
Q L L+Y+HS +IH DLKP N+L+ + CE++I D G S +
Sbjct: 111 YFLYQLLRGLKYIHSANVIHRDLKPSNLLVN--EDCELRIGDFGMARGLSSSPTEHKYFM 168
Query: 545 CLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 603
YV +R YRAPE+++ LP Y ID+WS+GCI AE+ LFP V L I+ +L
Sbjct: 169 TEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVL 228
Query: 604 GPIDLEML--MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAF--FI 659
G E+L + + KY +P + + F A +
Sbjct: 229 GSPSEEVLNRIGSDRVRKYIQN-----------------LPRKQPVPWSKIFPKASPEAL 271
Query: 660 DFVRTLLEINPQRRPTAREALDHPWLQ 686
D + +L+ +P+ R T +AL HP+L
Sbjct: 272 DLLSQMLQFDPEERITVEQALQHPFLA 298
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 107/325 (32%), Positives = 157/325 (48%), Gaps = 40/325 (12%)
Query: 374 ILNTV--IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEI 428
I TV I RY + +G AF V A+D TG +V +K I ++ E+
Sbjct: 1 IFGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYREL 60
Query: 429 KLLK-LVNKNDPADEHHILRLYDYFYH-LEHLFIVCELLRANLYEFQKFNQESGGEAYFT 486
KLLK L ++N I+ L D F LE ++ V ELL +L+ + E F
Sbjct: 61 KLLKHLRHEN-------IISLSDIFISPLEDIYFVTELLGTDLH---RLLTSRPLEKQF- 109
Query: 487 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL 546
+Q Q L L+Y+HS G++H DLKP NILI + C++KI D G + Q +
Sbjct: 110 ---IQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN--ENCDLKICDFGLARIQDPQMTG 164
Query: 547 YVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG- 604
YV +R YRAPE+++ YD ++D+WS GCI AE+ G+ LFP V + I +LG
Sbjct: 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGT 224
Query: 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 664
P D ++ E L ++ + E + +D ID +
Sbjct: 225 PPD--------DVINTICSENTLRFVQSLPKR------EPVPFSEKFKNADPSAIDLLEK 270
Query: 665 LLEINPQRRPTAREALDHPWLQHPY 689
+L +PQ+R +A EAL HP+L PY
Sbjct: 271 MLVFDPQKRISAAEALAHPYLA-PY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 102/320 (31%), Positives = 150/320 (46%), Gaps = 53/320 (16%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-----NDKDFFDQS-LDEIKLLKLVN 435
RY + LG ++ V++A+D TG V +K IK KD + + L EIKLL+ +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 436 KNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVIT 494
H +I+ L D F H ++ +V E + +L + K T ++
Sbjct: 61 -------HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDK-----SIVLTPADIKSYM 108
Query: 495 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC-FQTDNLCLYVQ--SR 551
L LEYLHS I+H DLKP N+LI S +K+ D G + F + N + Q +R
Sbjct: 109 LMTLRGLEYLHSNWILHRDLKPNNLLIAS--DGVLKLADFGLARSFGSPNRKMTHQVVTR 166
Query: 552 SYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG-PI--- 606
YRAPE++ G Y +D+WS+GCI AEL P D+ + L +I LG P
Sbjct: 167 WYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEEN 226
Query: 607 --DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 664
+ L E +K F L+ I P S DA +D ++
Sbjct: 227 WPGVTSLPDYVE-FKPFPP-----------TPLKQIFPAAS--------DDA--LDLLQR 264
Query: 665 LLEINPQRRPTAREALDHPW 684
LL +NP +R TAR+AL+HP+
Sbjct: 265 LLTLNPNKRITARQALEHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 100/325 (30%), Positives = 153/325 (47%), Gaps = 51/325 (15%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLVN 435
RY + E +G ++ V A D HTG V +K I D F+ D EIKLL+L+
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN---DVFEHVSDATRILREIKLLRLLR 57
Query: 436 KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 495
D + HI+ L + +++V EL+ ++L++ K N + E + Q
Sbjct: 58 HPDIVEIKHIM-LPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHH------QFFLY 110
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG----------SSCFQTDNLC 545
Q L AL+Y+H+ + H DLKP+NIL + C++KI D G ++ F TD
Sbjct: 111 QLLRALKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVAFNDTPTAIFWTD--- 165
Query: 546 LYVQSRSYRAPEVIIGL--PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 603
YV +R YRAPE+ Y ID+WS+GCI AE+ TG+ LFP VV L I +L
Sbjct: 166 -YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLL 224
Query: 604 GPIDLEML--MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDF 661
G E + ++ ++ +Y + + P +D +
Sbjct: 225 GTPSPETISRVRNEKARRYL-------------SSMRKKQP--VPFSQKFPNADPLALRL 269
Query: 662 VRTLLEINPQRRPTAREALDHPWLQ 686
+ LL +P+ RPTA EAL P+ +
Sbjct: 270 LERLLAFDPKDRPTAEEALADPYFK 294
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 8e-34
Identities = 105/319 (32%), Positives = 162/319 (50%), Gaps = 37/319 (11%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS-----LDEIKLLKLVNK 436
RY + +GS A V A D G++V +K K + F +Q+ E+ LLK VN
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVK--KLSRPFQNQTHAKRAYRELVLLKCVNH 79
Query: 437 NDPADEHHILRLYDYFY------HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRL 490
+ I+ L + F + +++V EL+ ANL Q + E E R+
Sbjct: 80 KN------IISLLNVFTPQKSLEEFQDVYLVMELMDANL--CQVIHMELDHE------RM 125
Query: 491 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YV 548
+ Q L +++LHS GIIH DLKP NI++KS C +KI+D G + N + YV
Sbjct: 126 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTACTNFMMTPYV 183
Query: 549 QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 608
+R YRAPEVI+G+ Y + +D+WS+GCI+ EL G V+F + ++I LG
Sbjct: 184 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA 243
Query: 609 EMLMQGQEIYKYFTKEYDLYY-INEETNQLEYIIPEESSLEH-HLQFSDAFFIDFVRTLL 666
E + + Q + + + Y I+ E ++I P ES E L+ S A D + +L
Sbjct: 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSES--ERDKLKTSQAR--DLLSKML 299
Query: 667 EINPQRRPTAREALDHPWL 685
I+P +R + EAL HP++
Sbjct: 300 VIDPDKRISVDEALRHPYI 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 1e-33
Identities = 79/321 (24%), Positives = 126/321 (39%), Gaps = 58/321 (18%)
Query: 385 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKNDPA 440
+ LG +F +V+ A+D V LK++ + ++ L EI++L +N
Sbjct: 4 ILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLN----- 55
Query: 441 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 500
+I++LYD+F L++V E + + ++ G + + I Q L A
Sbjct: 56 HPPNIVKLYDFFQDEGSLYLVMEYVDGG--SLEDLLKKIGRKGPLSESEALFILAQILSA 113
Query: 501 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---------LCLYVQSR 551
LEYLHS GIIH D+KPENIL+ +K+ID G + D V +
Sbjct: 114 LEYLHSKGIIHRDIKPENILL-DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 552 SYRAPEVIIGL---PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 608
Y APEV++GL D+WSLG L EL TG F +
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSAT------------ 220
Query: 609 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEI 668
+ K + + + +I + D ++ LL
Sbjct: 221 ------SQTLKIILELPTPSLASPLSPSNPELISKA-------------ASDLLKKLLAK 261
Query: 669 NPQRRPTAREALDHPWLQHPY 689
+P+ R ++ L H L H
Sbjct: 262 DPKNRLSSSSDLSHDLLAHLK 282
|
Length = 384 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 82/313 (26%), Positives = 134/313 (42%), Gaps = 68/313 (21%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK-LVNKNDPAD 441
Y E +G A +V++A D TG +V +K ++ K + ++EI ++K + N
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPN---- 76
Query: 442 EHHILRLYDYFYHLEHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 500
I+ YD + + L++V E + L + N ++ + R+ L+
Sbjct: 77 ---IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN-----FVRMNEPQIAYVCREVLQG 128
Query: 501 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-------Y 553
LEYLHS +IH D+K +NIL+ +K+ D G F L R+ +
Sbjct: 129 LEYLHSQNVIHRDIKSDNILLSK--DGSVKLADFG---FAA-QLTKEKSKRNSVVGTPYW 182
Query: 554 RAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613
APEVI Y K+D+WSLG I+ EM +
Sbjct: 183 MAPEVIKRKDYGPKVDIWSLG--------------------IMCI----------EM-AE 211
Query: 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 673
G+ Y L+ I T + IP L++ ++S F DF+ L +P++R
Sbjct: 212 GEPPYLREPPLRALFLI---TTKG---IPP---LKNPEKWSPE-FKDFLNKCLVKDPEKR 261
Query: 674 PTAREALDHPWLQ 686
P+A E L HP+L+
Sbjct: 262 PSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 3e-33
Identities = 92/314 (29%), Positives = 149/314 (47%), Gaps = 52/314 (16%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLK-LVNKNDPADEH 443
E LG ++ V++ ++ TG V LK I D + S + EI L+K L ++N
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHEN------ 59
Query: 444 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 503
I+RL+D + L +V E + +L ++ + G ++ T Q L+ + +
Sbjct: 60 -IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGA---LDPNTVKSFTYQLLKGIAF 115
Query: 504 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--------SSCFQTDNLCLYVQSRSYRA 555
H ++H DLKP+N+LI +R E+K+ D G + F + + L+ YRA
Sbjct: 116 CHENRVLHRDLKPQNLLIN--KRGELKLADFGLARAFGIPVNTFSNEVVTLW-----YRA 168
Query: 556 PEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFP----NDAVVMILARIIGMLGPIDLEM 610
P+V++G Y ID+WS+GCI+AE+ TG LFP D ++ I RI+G P +
Sbjct: 169 PDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIF-RIMGT--PTESTW 225
Query: 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINP 670
Q EY + L+ + P +D ID + LL++NP
Sbjct: 226 PGISQ------LPEYKPTFPRYPPQDLQQLFPH----------ADPLGIDLLHRLLQLNP 269
Query: 671 QRRPTAREALDHPW 684
+ R +A +AL HPW
Sbjct: 270 ELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 4e-32
Identities = 98/321 (30%), Positives = 154/321 (47%), Gaps = 43/321 (13%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHT--GVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNK 436
RY + + LG A+ V A++ T V +K I N K ++L E+KLL+
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 437 NDPADEHHILRLYD----YFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 492
+ +I LYD + + L++ EL+ A+L++ + Q +A+F Q
Sbjct: 61 HK-----NITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLT-DAHF-----QS 109
Query: 493 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN-------LC 545
Q L L+Y+HS ++H DLKP N+L+ + CE+KI D G + ++N +
Sbjct: 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNA--DCELKICDFGLARGFSENPGENAGFMT 167
Query: 546 LYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 604
YV +R YRAPE+++ Y + ID+WS+GCILAEL + +F V L +I+ +LG
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG 227
Query: 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 664
D E L I + Y N E I P + L +D +
Sbjct: 228 TPDEETL---SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLA----------LDLLEK 274
Query: 665 LLEINPQRRPTAREALDHPWL 685
LL +P +R + EAL+HP+L
Sbjct: 275 LLAFDPTKRISVEEALEHPYL 295
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 82/311 (26%), Positives = 138/311 (44%), Gaps = 64/311 (20%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 437
+Y + + +G +F KV+ + G LK I ++K+ + +L+E+K+LK +N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKER-EDALNEVKILKKLN-- 57
Query: 438 DPADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR 495
H +I++ Y+ F L IV E +L + K Q+ G+ F ++
Sbjct: 58 -----HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIK-KQKKEGK-PFPEEQILDWFV 110
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF--QTDNLCL-YVQSRS 552
Q AL+YLHS I+H D+KP+NI + S +K+ D G S T +L V +
Sbjct: 111 QLCLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDFGISKVLSSTVDLAKTVVGTPY 168
Query: 553 YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 612
Y +PE+ PY+ K D+WSLGC+L EL T + F + ++ + +I+
Sbjct: 169 YLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL------------ 216
Query: 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 672
+Y IP Q+S + V +LL+ +P+
Sbjct: 217 ---------KGQYPP-------------IPS--------QYSS-ELRNLVSSLLQKDPEE 245
Query: 673 RPTAREALDHP 683
RP+ + L P
Sbjct: 246 RPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 86/319 (26%), Positives = 155/319 (48%), Gaps = 45/319 (14%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKNDP 439
Y E +G + KV++A+D +TG V LK + +++ +L EI LL++++++
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESI- 61
Query: 440 ADEHHILRLYDYFYHLEH---------LFIVCELLRANLYEFQKFNQESGGEAYFTLGRL 490
+I+RL D +EH L++V E L ++L +F N G +
Sbjct: 62 ----YIVRLLD----VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPA-KTI 112
Query: 491 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY--- 547
+ Q L+ + + H G++H DLKP+N+L+ + +KI DLG + + Y
Sbjct: 113 KSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL-LKIADLGLGRAFSIPVKSYTHE 171
Query: 548 VQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 606
+ + YRAPEV++G Y +D+WS+GCI AE+ + LFP D+ + L I +LG
Sbjct: 172 IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG-- 229
Query: 607 DLEMLMQGQEIYKYFTKEYDLY-YINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTL 665
++++ +K D + + + L +P L +D ++ +
Sbjct: 230 -----TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVP---DLSPEG-------LDLLQKM 274
Query: 666 LEINPQRRPTAREALDHPW 684
L +P +R +A+ AL HP+
Sbjct: 275 LRYDPAKRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 88/310 (28%), Positives = 129/310 (41%), Gaps = 68/310 (21%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 446
LG + V++ + TG LK I D++F Q L E+K L+ + +++
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRS------CESPYVV 62
Query: 447 RLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 501
+ Y FY + IV E L L + K E L I RQ L+ L
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIP-----EPV-----LAYIARQILKGL 112
Query: 502 EYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF--QTDNLCL-YVQSRSYRAPE 557
+YLH+ IIH D+KP N+LI S E+KI D G S T + C +V + +Y +PE
Sbjct: 113 DYLHTKRHIIHRDIKPSNLLINSKG--EVKIADFGISKVLENTLDQCNTFVGTVTYMSPE 170
Query: 558 VIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 617
I G Y D+WSLG L E G+ FP G +L
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGK--FPFLPP--------GQPSFFEL--------- 211
Query: 618 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 677
+ I + SL +FS F DF+ L+ +P++RP+A
Sbjct: 212 ---------MQAICDG---------PPPSLPAE-EFSPE-FRDFISACLQKDPKKRPSAA 251
Query: 678 EALDHPWLQH 687
E L HP+++
Sbjct: 252 ELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 96/321 (29%), Positives = 161/321 (50%), Gaps = 52/321 (16%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL-------DEIKLLKLV 434
RY +GS A+ V A D V +K K + F QSL E++LLK +
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVK--KLSRPF--QSLIHARRTYRELRLLKHM 71
Query: 435 NKNDPADEHHILRLYDYFY------HLEHLFIVCELLRA---NLYEFQKFNQESGGEAYF 485
+++ L D F + +++V L+ A N+ + QK + E
Sbjct: 72 K------HENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDE------- 118
Query: 486 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 545
+Q + Q L L+Y+HS GIIH DLKP N+ + + CE++I+D G + D +
Sbjct: 119 ---HVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN--EDCELRILDFGLARQADDEMT 173
Query: 546 LYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 604
YV +R YRAPE+++ + Y+Q +D+WS+GCI+AEL G+ LFP + + L RI+ ++G
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVG 233
Query: 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 664
E+L + + E+ YI L + +P++ L+ + ++ ID +
Sbjct: 234 TPSPEVLKK-------ISSEHARKYI----QSLPH-MPQQ-DLKKIFRGANPLAIDLLEK 280
Query: 665 LLEINPQRRPTAREALDHPWL 685
+L ++ +R +A EAL HP+
Sbjct: 281 MLVLDSDKRISASEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 90/302 (29%), Positives = 147/302 (48%), Gaps = 44/302 (14%)
Query: 397 VFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIK-LLKLVNKNDPADEHHILRLYDYF 452
V++A+D TG V LK +K +K+ F SL EI LLKL + N I+ + +
Sbjct: 21 VYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPN-------IVTVKEVV 73
Query: 453 Y--HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGII 510
+L+ +++V E + +L + ++ F ++ + Q L + +LH I+
Sbjct: 74 VGSNLDKIYMVMEYVEHDLKSLMETMKQP-----FLQSEVKCLMLQLLSGVAHLHDNWIL 128
Query: 511 HCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ---SRSYRAPEVIIGLP-YDQ 566
H DLK N+L+ + R +KI D G + L Y Q + YRAPE+++G Y
Sbjct: 129 HRDLKTSNLLLNN--RGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYST 186
Query: 567 KIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG-PIDLEMLMQGQEIYKYFTKEY 625
ID+WS+GCI AEL T + LFP + + L +I +LG P + +I+ F++
Sbjct: 187 AIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTE--------KIWPGFSE-- 236
Query: 626 DLYYINEETNQLEYIIPEESSLEHH---LQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682
L ++T + + L L SD F D + LL +P +R +A +AL H
Sbjct: 237 -LPGAKKKT----FTKYPYNQLRKKFPALSLSDNGF-DLLNRLLTYDPAKRISAEDALKH 290
Query: 683 PW 684
P+
Sbjct: 291 PY 292
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 7e-30
Identities = 91/331 (27%), Positives = 153/331 (46%), Gaps = 64/331 (19%)
Query: 385 VTEY-----LGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFD-QSLDEIKLLKLVNK 436
VTE+ +G + V++A+D +G V LK ++ N++D SL EI LL +
Sbjct: 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-- 63
Query: 437 NDPADEHH--ILRLYDYFY--HLEHLFIV---CELLRANLYEFQKFNQESGGEAYFTLGR 489
H I+ L + HL+ +F+V CE A+L + F+ +
Sbjct: 64 ------RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMP--------TPFSESQ 109
Query: 490 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ 549
++ + Q L L+YLH IIH DLK N+L+ + +KI D G L +
Sbjct: 110 VKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT--DKGCLKIADFG----LARTYGLPAK 163
Query: 550 SRS-------YRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 601
+ YRAPE+++G Y ID+W++GCILAEL + L P + + L II
Sbjct: 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQ 223
Query: 602 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEE--SSLEHHLQFSDAFFI 659
+LG + I+ F+ DL + ++ +P++ ++L+H + +
Sbjct: 224 LLG-------TPNESIWPGFS---DLPLVG------KFTLPKQPYNNLKHKFPWLSEAGL 267
Query: 660 DFVRTLLEINPQRRPTAREALDHPWLQ-HPY 689
+ LL +P++R TA EAL+ + + P
Sbjct: 268 RLLNFLLMYDPKKRATAEEALESSYFKEKPL 298
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 91/316 (28%), Positives = 149/316 (47%), Gaps = 42/316 (13%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF-----FDQSLDEIKLLKLVNK 436
RY +GS A+ V A D TG+ V +K K + F ++ E++LLK +
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRELRLLKHMKH 75
Query: 437 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 496
+ + +++V L+ A+L K + T +Q + Q
Sbjct: 76 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-------LTDDHVQFLIYQ 128
Query: 497 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAP 556
L L+Y+HS IIH DLKP N+ + + CE+KI+D G + D + YV +R YRAP
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAVN--EDCELKILDFGLARHTDDEMTGYVATRWYRAP 186
Query: 557 EVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615
E+++ + Y+Q +D+WS+GCI+AEL TG LFP + L I+ ++G G
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG-------TPGA 239
Query: 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFF------IDFVRTLLEIN 669
E+ K + E YI T +P+ + F++ F +D + +L ++
Sbjct: 240 ELLKKISSESARNYIQSLTQ-----MPK-------MNFANVFIGANPLAVDLLEKMLVLD 287
Query: 670 PQRRPTAREALDHPWL 685
+R TA +AL H +
Sbjct: 288 SDKRITAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 6e-29
Identities = 89/317 (28%), Positives = 149/317 (47%), Gaps = 42/317 (13%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKND 438
RY + +GS A+ V A D TG V +K + + F ++ E++LLK + +
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHEN 75
Query: 439 PADEHHILRLYDYFYHLEHL------FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 492
++ L D F L ++V + +L + K E E R+Q
Sbjct: 76 ------VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK--HEKLSED-----RIQF 122
Query: 493 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 552
+ Q L+ L+Y+H+ GIIH DLKP N+ + + CE+KI+D G + + YV +R
Sbjct: 123 LVYQMLKGLKYIHAAGIIHRDLKPGNLAVN--EDCELKILDFGLARQTDSEMTGYVVTRW 180
Query: 553 YRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG--PIDLE 609
YRAPEVI+ + Y Q +D+WS+GCI+AE+ TG+ LF + L I+ + G +
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240
Query: 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 669
+Q ++ Y K ++P + L ++ + +L ++
Sbjct: 241 QKLQSEDAKNYVKKLPRF-----RKKDFRSLLPNANPLA----------VNVLEKMLVLD 285
Query: 670 PQRRPTAREALDHPWLQ 686
+ R TA EAL HP+ +
Sbjct: 286 AESRITAAEALAHPYFE 302
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 82/319 (25%), Positives = 125/319 (39%), Gaps = 89/319 (27%)
Query: 393 AFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRL 448
A+ +VF A+ TG +K+IK K+ DQ L E +L ++++L
Sbjct: 5 AYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSP------YVVKL 58
Query: 449 YDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRL-----QVITRQCLEA 500
Y F ++L++V E L GG+ L G L ++ + + A
Sbjct: 59 YYSFQGKKNLYLVMEYLP-------------GGDLASLLENVGSLDEDVARIYIAEIVLA 105
Query: 501 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-------- 552
LEYLHS GIIH DLKP+NILI S +K+ D G S + +
Sbjct: 106 LEYLHSNGIIHRDLKPDNILIDSNG--HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVG 163
Query: 553 ---YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 609
Y APEVI+G + + +D WSLGCIL E G F + I I+
Sbjct: 164 TPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL--------- 214
Query: 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 669
+ + E +++ ID + LL +
Sbjct: 215 ------------NGKIEWPEDVEVSDEA---------------------IDLISKLLVPD 241
Query: 670 PQRRPTAR---EALDHPWL 685
P++R A+ E +HP+
Sbjct: 242 PEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 95/318 (29%), Positives = 145/318 (45%), Gaps = 55/318 (17%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLVNKNDPADE 442
+G A+ V A++ T V +K I N FD +D EIKLL+ ++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIAN---AFDNRIDAKRTLREIKLLRHLDHENVIAI 69
Query: 443 HHILR--LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 500
I+ + F ++IV EL+ +L++ + +Q + Q Q L
Sbjct: 70 KDIMPPPHREAF---NDVYIVYELMDTDLHQIIRSSQT------LSDDHCQYFLYQLLRG 120
Query: 501 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPE 557
L+Y+HS ++H DLKP N+L+ + C++KI D G ++ + D + YV +R YRAPE
Sbjct: 121 LKYIHSANVLHRDLKPSNLLLNA--NCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPE 178
Query: 558 VIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 616
+++ Y ID+WS+GCI AEL + LFP V L I +LG
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPS--------- 229
Query: 617 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEH--HLQFSDAF------FIDFVRTLLEI 668
E DL +I E YI SL + F+ F ID + +L
Sbjct: 230 -------EEDLGFIRNE-KARRYI----RSLPYTPRQSFARLFPHANPLAIDLLEKMLVF 277
Query: 669 NPQRRPTAREALDHPWLQ 686
+P +R T EAL HP+L
Sbjct: 278 DPSKRITVEEALAHPYLA 295
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 86/319 (26%), Positives = 131/319 (41%), Gaps = 82/319 (25%)
Query: 388 YLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKNDPADEH- 443
+G F KV+ A +L TG + +K I+ ND + DE+K+L+L+ H
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK-------HP 59
Query: 444 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGR------LQVITRQC 497
++++ Y H E ++I F ++ E GR ++V T Q
Sbjct: 60 NLVKYYGVEVHREKVYI-----------FMEYCSGGTLEELLEHGRILDEHVIRVYTLQL 108
Query: 498 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ-------S 550
LE L YLHS GI+H D+KP NI + IK+ D G + +N + +
Sbjct: 109 LEGLAYLHSHGIVHRDIKPANIFLDH--NGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGT 166
Query: 551 RSYRAPEVIIGLPYDQK---IDLWSLGCILAELWTGEVLFPN-DAVVMILARIIGMLGPI 606
+Y APEVI G D+WSLGC++ E+ TG+ + D I+ + P
Sbjct: 167 PAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP- 225
Query: 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLL 666
IP+ LQ S DF+ L
Sbjct: 226 ---------------------------------PIPD------SLQLSPE-GKDFLDRCL 245
Query: 667 EINPQRRPTAREALDHPWL 685
E +P++RPTA E L HP++
Sbjct: 246 ESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 81/316 (25%), Positives = 126/316 (39%), Gaps = 87/316 (27%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG +F KV + TG +K++K + + +L E +L +N H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN--------H 52
Query: 445 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRLQVIT 494
I++L+ F E L++V E GGE F+ R +
Sbjct: 53 PFIVKLHYAFQTEEKLYLVLEYA-------------PGGELFSHLSKEGRFSEERARFYA 99
Query: 495 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC--FQTDNLCL-YVQSR 551
+ + ALEYLHSLGII+ DLKPENIL+ IK+ D G + + + +
Sbjct: 100 AEIVLALEYLHSLGIIYRDLKPENILLD--ADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157
Query: 552 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 611
Y APEV++G Y + +D WSLG +L E+ TG+ F + I +I+
Sbjct: 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL----------- 206
Query: 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQ 671
+ L + PE S E D + LL+ +P
Sbjct: 207 ----------------------KDPLRF--PEFLSPE---------ARDLISGLLQKDPT 233
Query: 672 RRPTAREALD---HPW 684
+R + A + HP+
Sbjct: 234 KRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 88/317 (27%), Positives = 150/317 (47%), Gaps = 43/317 (13%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKND 438
RY + +GS A+ V A D TG V +K + + F ++ E+ LLK +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ--- 72
Query: 439 PADEHHILRLYDYF------YHLEHLFIVCELLRANLYEFQ--KFNQESGGEAYFTLGRL 490
+++ L D F + ++V ++ +L + +++ ++
Sbjct: 73 ---HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSED----------KV 119
Query: 491 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQS 550
Q + Q L L+Y+HS GIIH DLKP N+ + + CE+KI+D G + + YV +
Sbjct: 120 QYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN--EDCELKILDFGLARHADAEMTGYVVT 177
Query: 551 RSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 609
R YRAPEVI+ + Y+Q +D+WS+GCI+AE+ TG+ LF + L +I+ + G E
Sbjct: 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE 237
Query: 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 669
+ Q++ K Y + P+ S +D + +LE++
Sbjct: 238 FV---QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQA----------VDLLEKMLELD 284
Query: 670 PQRRPTAREALDHPWLQ 686
+R TA EAL+HP+
Sbjct: 285 VDKRLTATEALEHPYFD 301
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 4e-28
Identities = 99/319 (31%), Positives = 152/319 (47%), Gaps = 52/319 (16%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ-----SLDEIKLLK-LVN 435
+Y E +G + VF+A++ T V LK ++ D D D+ +L EI LLK L +
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKH 58
Query: 436 KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 495
KN I+RLYD + + L +V E +L +K+ G+ + ++
Sbjct: 59 KN-------IVRLYDVLHSDKKLTLVFEYCDQDL---KKYFDSCNGDIDPEI--VKSFMF 106
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--------CFQTDNLCLY 547
Q L+ L + HS ++H DLKP+N+LI + E+K+ D G + C+ + + L+
Sbjct: 107 QLLKGLAFCHSHNVLHRDLKPQNLLIN--KNGELKLADFGLARAFGIPVRCYSAEVVTLW 164
Query: 548 VQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGP 605
YR P+V+ G Y ID+WS GCI AEL G LFP + V L RI +LG
Sbjct: 165 -----YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 219
Query: 606 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTL 665
E ++ Y K Y +Y T L ++P+ +S D ++ L
Sbjct: 220 PTEESWPGVSKLPDY--KPYPMY---PATTSLVNVVPKLNSTGR----------DLLQNL 264
Query: 666 LEINPQRRPTAREALDHPW 684
L NP +R +A EAL HP+
Sbjct: 265 LVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 99/314 (31%), Positives = 157/314 (50%), Gaps = 27/314 (8%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS-----LDEIKLLKLVNK 436
RY + +GS A V A D +V +K K + F +Q+ E+ L+K VN
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 437 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 496
+ ++ + ++IV EL+ ANL Q E E R+ + Q
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL--CQVIQMELDHE------RMSYLLYQ 134
Query: 497 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSYR 554
L +++LHS GIIH DLKP NI++KS C +KI+D G + + + YV +R YR
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 192
Query: 555 APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614
APEVI+G+ Y + +D+WS+GCI+ E+ G VLFP + ++I LG E + +
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252
Query: 615 QEIYKYFTKEYDLY--YINEETNQLEYIIPEESSLEHH-LQFSDAFFIDFVRTLLEINPQ 671
Q + + + Y Y E+ + + P +S EH+ L+ S A D + +L I+
Sbjct: 253 QPTVRTYVENRPKYAGYSFEKLFP-DVLFPADS--EHNKLKASQAR--DLLSKMLVIDAS 307
Query: 672 RRPTAREALDHPWL 685
+R + EAL HP++
Sbjct: 308 KRISVDEALQHPYI 321
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 3e-27
Identities = 95/313 (30%), Positives = 156/313 (49%), Gaps = 25/313 (7%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS-----LDEIKLLKLVNK 436
RY + +GS A V A D +V +K K + F +Q+ E+ L+K VN
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 437 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 496
+ ++ + +++V EL+ ANL Q E E R+ + Q
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANL--CQVIQMELDHE------RMSYLLYQ 127
Query: 497 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSYR 554
L +++LHS GIIH DLKP NI++KS C +KI+D G + + + YV +R YR
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYR 185
Query: 555 APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614
APEVI+G+ Y + +D+WS+GCI+ E+ ++LFP + ++I LG E + +
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 615 QEIYKYFTKEYDLYY-INEETNQLEYIIPEESSLEHH-LQFSDAFFIDFVRTLLEINPQR 672
Q + + + Y + + + P +S EH+ L+ S A D + +L I+P +
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADS--EHNKLKASQAR--DLLSKMLVIDPAK 301
Query: 673 RPTAREALDHPWL 685
R + EAL HP++
Sbjct: 302 RISVDEALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 86/344 (25%), Positives = 139/344 (40%), Gaps = 81/344 (23%)
Query: 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLK--IIKNDKDFFD-QSLDEIKLLKLVN-K 436
Y + LG F +V++A+ + TG V LK ++ N+KD F +L EIK+LK +
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHP 67
Query: 437 N---------DPADEHHILR--LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF 485
N + D+ R +Y +++H +L + L E
Sbjct: 68 NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-----DL--SGLLENPSVK--------L 112
Query: 486 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---------- 535
T +++ Q LE + YLH I+H D+K NILI + + +KI D G
Sbjct: 113 TESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDN--QGILKIADFGLARPYDGPPP 170
Query: 536 ----SSCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPND 590
T V +R YR PE+++G Y +D+W +GC+ AE++T +
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ-- 228
Query: 591 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIP-------- 642
G D++ Q I+K EET +P
Sbjct: 229 -------------GKSDID---QLHLIFKL------CGTPTEETWPGWRSLPGCEGVHSF 266
Query: 643 --EESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 684
+LE +D + LL ++P +R TA +AL+HP+
Sbjct: 267 TNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 85/316 (26%), Positives = 137/316 (43%), Gaps = 49/316 (15%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD------QSLDEIKLLKLVNKNDPADE 442
+G AF V+ D G V LK + N F + E+K+L ++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPN---VFQNLVSCKRVFRELKMLCFFKHDNVLSA 64
Query: 443 HHILR--LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 500
IL+ D F E +++V EL++++L++ Q + ++V Q L
Sbjct: 65 LDILQPPHIDPF---EEIYVVTELMQSDLHKIIVSPQP------LSSDHVKVFLYQILRG 115
Query: 501 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--------SSCFQTDNLCLYVQSRS 552
L+YLHS GI+H D+KP N+L+ S C +KI D G S T V ++
Sbjct: 116 LKYLHSAGILHRDIKPGNLLVNS--NCVLKICDFGLARVEEPDESKHMTQE----VVTQY 169
Query: 553 YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE-M 610
YRAPE+++G Y +D+WS+GCI AEL +LF + + L I +LG LE M
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM 229
Query: 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINP 670
+ + + + P L + + + +L +P
Sbjct: 230 RSACEGARAHIL-------------RGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDP 276
Query: 671 QRRPTAREALDHPWLQ 686
+R +A +AL HP+L
Sbjct: 277 DKRISAADALAHPYLD 292
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 89/309 (28%), Positives = 145/309 (46%), Gaps = 40/309 (12%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ-----SLDEIKLLKLVNKNDPAD 441
E +G + V++A+D TG V LK I+ + + D+ ++ EI LLK +N P
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETE--DEGVPSTAIREISLLKELN--HP-- 58
Query: 442 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 501
+I+RL D + L++V E L +L K +S ++ Q L+ +
Sbjct: 59 --NIVRLLDVVHSENKLYLVFEFLDLDL----KKYMDSSPLTGLDPPLIKSYLYQLLQGI 112
Query: 502 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLY---VQSRSYRAPE 557
Y HS ++H DLKP+N+LI +K+ D G + F + Y V + YRAPE
Sbjct: 113 AYCHSHRVLHRDLKPQNLLIDREG--ALKLADFGLARAFGVP-VRTYTHEVVTLWYRAPE 169
Query: 558 VIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 616
+++G Y +D+WS+GCI AE+ LFP D+ + L RI LG D E + G
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPD-EDVWPGVT 228
Query: 617 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 676
+Y + L ++P +L+ +D + +L +P +R +A
Sbjct: 229 SL----PDYKPTFPKWARQDLSKVVP---NLDED-------GLDLLSKMLVYDPAKRISA 274
Query: 677 REALDHPWL 685
+ AL HP+
Sbjct: 275 KAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 87/342 (25%), Positives = 149/342 (43%), Gaps = 64/342 (18%)
Query: 379 IAGRY-YVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---------DKDFFDQ----- 423
I+ RY +LG + KV +A D TG V +K +K D+
Sbjct: 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHF 65
Query: 424 -SLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE 482
+L E+K++ + +I+ L D + + + +V +++ ++L + +++
Sbjct: 66 TTLRELKIMNEIK------HENIMGLVDVYVEGDFINLVMDIMASDLKKV--VDRK---- 113
Query: 483 AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQT 541
T +++ I Q L L LH +H DL P NI I S C KI D G + +
Sbjct: 114 IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC--KIADFGLARRYGY 171
Query: 542 DNLC------LYVQSRS----------YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGE 584
+Q R YRAPE+++G Y +D+WS+GCI AEL TG+
Sbjct: 172 PPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
Query: 585 VLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEE 644
LFP + + L RI +LG + + Q +++ Y E+ +
Sbjct: 232 PLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYT----------------EFTPRKP 275
Query: 645 SSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686
L+ + ID +++LL++NP R +A+EAL H + +
Sbjct: 276 KDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 1e-26
Identities = 85/339 (25%), Positives = 126/339 (37%), Gaps = 102/339 (30%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA------ 440
+ +G +FS V A++ T + +KI LD+ +L+K K
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKI-----------LDKRQLIKE-KKVKYVKIEKEV 54
Query: 441 ---DEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 495
H I++LY F E+L+ V E A E ++ ++ G +
Sbjct: 55 LTRLNGHPGIIKLYYTFQDEENLYFVLEY--APNGELLQYIRKYGS---LDEKCTRFYAA 109
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---------- 545
+ L ALEYLHS GIIH DLKPENIL+ IKI D G++ N
Sbjct: 110 EILLALEYLHSKGIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSPESNKGDATN 167
Query: 546 -----LYVQSRS--------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLF--PND 590
+ R Y +PE++ P + DLW+LGCI+ ++ TG+ F N+
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227
Query: 591 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHH 650
+ Q+I +LEY P
Sbjct: 228 YLTF--------------------QKI-----------------LKLEYSFPP------- 243
Query: 651 LQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHPY 689
DA D + LL ++PQ R E D HP+
Sbjct: 244 NFPPDA--KDLIEKLLVLDPQDRLGVNEGYD-ELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 89/303 (29%), Positives = 130/303 (42%), Gaps = 55/303 (18%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHIL 446
LG+ V + TG + +K I+ + + Q L E+ +L N P +I+
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILH--KCNSP----YIV 62
Query: 447 RLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH 505
Y FY+ + I E + +L + K Q E LG+ I L+ L YLH
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPE--RILGK---IAVAVLKGLTYLH 117
Query: 506 S-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL-YVQSRSYRAPEVIIGLP 563
IIH D+KP NIL+ S R +IK+ D G S ++L +V + SY APE I G
Sbjct: 118 EKHKIIHRDVKPSNILVNS--RGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGND 175
Query: 564 YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTK 623
Y K D+WSLG L EL TG +P + G +L
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPYPPEN--------DPPDGIFEL--------------- 212
Query: 624 EYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHP 683
L+YI+ E +FS F DFV L +P+ RP+ +E L+HP
Sbjct: 213 -------------LQYIVNEPPPRLPSGKFS-PDFQDFVNLCLIKDPRERPSYKELLEHP 258
Query: 684 WLQ 686
+++
Sbjct: 259 FIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 83/311 (26%), Positives = 153/311 (49%), Gaps = 36/311 (11%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKND 438
++ V +G A+ V + + T V +K K+ +++ + +L E+K+L+ + + +
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 439 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
I+ L + F L++V E + N+ E + +G +++ Q +
Sbjct: 62 ------IVELKEAFRRRGKLYLVFEYVEKNMLELLE-EMPNGVPP----EKVRSYIYQLI 110
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD----NLCLYVQSRSYR 554
+A+ + H I+H D+KPEN+LI +K+ D G + ++ N YV +R YR
Sbjct: 111 KAIHWCHKNDIVHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSNANYTEYVATRWYR 168
Query: 555 APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614
+PE+++G PY + +D+WS+GCIL EL G+ LFP ++ + L I +LGP+ E +
Sbjct: 169 SPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM--- 225
Query: 615 QEIYKYFTKEYDLYYINEETNQLEY-IIPEESSLE-HHLQFSDAFFIDFVRTLLEINPQR 672
L+Y N + L + + SLE +L +D ++ LL++NP
Sbjct: 226 -----------KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTD 274
Query: 673 RPTAREALDHP 683
R + L+HP
Sbjct: 275 RYLTEQCLNHP 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 82/315 (26%), Positives = 123/315 (39%), Gaps = 72/315 (22%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKLVNKND 438
Y + + +G AF V++ +L TG V +K I K ++ + EI LLK +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK--- 57
Query: 439 PADEHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVI 493
+I++ + L+I+ E LR + +F F ES Y
Sbjct: 58 ---HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFP-ESLVAVYV-------- 105
Query: 494 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---LCLYVQS 550
Q L+ L YLH G+IH D+K NIL +K+ D G + D V +
Sbjct: 106 -YQVLQGLAYLHEQGVIHRDIKAANILTTKDG--VVKLADFGVATKLNDVSKDDASVVGT 162
Query: 551 RSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 610
+ APEVI D+WSLGC + EL TG + + L P
Sbjct: 163 PYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD-------------LNP----- 204
Query: 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINP 670
M L+ I ++ +PE S E DF+ + +P
Sbjct: 205 -MAA------------LFRIVQDD---HPPLPEGISPE---------LKDFLMQCFQKDP 239
Query: 671 QRRPTAREALDHPWL 685
RPTA++ L HPW+
Sbjct: 240 NLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 90/342 (26%), Positives = 150/342 (43%), Gaps = 46/342 (13%)
Query: 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKN 437
V R+ + LG F KV +A D +KI++N + + EI+ ++ V +
Sbjct: 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQA 185
Query: 438 DPADEHHILRLYDYFYHLE-HLFIVCELLRANLYEF----QKFNQESGGEAYFTLGRLQV 492
DPAD ++++ YF + H+ IV L ++ F+ + F G
Sbjct: 186 DPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTG---- 241
Query: 493 ITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQR--------------CEIKIIDLGSS 537
AL+Y H+ L ++H DLKPENIL+++ C ++I DLG
Sbjct: 242 ------VALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC 295
Query: 538 CFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLF---PNDAVVM 594
C + + V +R YR+PEV++GL + D+WS+GCI+ EL+TG++L+ N +
Sbjct: 296 CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355
Query: 595 ILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFS 654
++ + +G L P + +E + L + L I E
Sbjct: 356 LMEKTLGRL-PSEWAGRCGTEEARLLYNSAGQLRPCT-DPKHLARIARARPVRE---VIR 410
Query: 655 DAFFIDFVRTLLEINPQRRPTAREALDHPWL--------QHP 688
D D + LL + Q+R AR+ HP++ QHP
Sbjct: 411 DDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPECRQHP 452
|
Length = 467 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 82/309 (26%), Positives = 131/309 (42%), Gaps = 67/309 (21%)
Query: 385 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHH 444
+ E LG ++ V++A TG V +K++ ++D + EI +LK D +
Sbjct: 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEII-KEISILK------QCDSPY 59
Query: 445 ILRLYDYFYHLEHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 503
I++ Y ++ L+IV E A + + K ++ E + I Q L+ LEY
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEE-----EIAAILYQTLKGLEY 114
Query: 504 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPEVII 560
LHS IH D+K NIL+ + + K+ D G S TD + + + + APEVI
Sbjct: 115 LHSNKKIHRDIKAGNILLN--EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQ 172
Query: 561 GLPYDQKIDLWSLGCILAELWTGEV----LFPNDAVVMILARIIGMLGPIDLEMLMQGQE 616
+ Y+ K D+WSLG E+ G+ + P A+ MI
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI--------------------- 211
Query: 617 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 676
N+ L PE+ S E F DFV+ L +P+ RP+A
Sbjct: 212 -------------PNKPPPTLS--DPEKWSPE---------FNDFVKKCLVKDPEERPSA 247
Query: 677 REALDHPWL 685
+ L HP++
Sbjct: 248 IQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 88/307 (28%), Positives = 143/307 (46%), Gaps = 38/307 (12%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEH 443
E +G + V++A++ TG V LK I+ D + ++ EI LLK +N +
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN----- 60
Query: 444 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 503
I++L D + L++V E L +L +F + SG L ++ Q L+ L +
Sbjct: 61 -IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSG----IPLPLIKSYLFQLLQGLAF 115
Query: 504 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYRAPEVII 560
HS ++H DLKP+N+LI + IK+ D G + + Y V + YRAPE+++
Sbjct: 116 CHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 173
Query: 561 GLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYK 619
G Y +D+WSLGCI AE+ T LFP D+ + L RI LG D + ++
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-------EVVWP 226
Query: 620 YFT--KEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 677
T +Y + ++P D D + +L +P +R +A+
Sbjct: 227 GVTSLPDYKPSFPKWARQDFSKVVPP----------LDEDGRDLLSQMLHYDPNKRISAK 276
Query: 678 EALDHPW 684
AL HP+
Sbjct: 277 AALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 67/202 (33%), Positives = 104/202 (51%), Gaps = 31/202 (15%)
Query: 493 ITRQCLEALEYLHSLGIIHCDLKPENILI-KSYQRCEIKIIDLGSSCFQT---DNLCLYV 548
I Q L+A+ + H IH D+KPENILI K Q IK+ D G + T D+ YV
Sbjct: 105 IIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ---IKLCDFGFARILTGPGDDYTDYV 161
Query: 549 QSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 607
+R YRAPE+++G Y +D+W++GC+ AEL TG+ L+P + V L I LG
Sbjct: 162 ATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG--- 218
Query: 608 LEMLMQGQEIYKYFTKEYDLYYINEETNQL--EYIIPEESSLEH-HLQFSDAFF--IDFV 662
+++ + Q+I+ TNQ IPE + E +F + + F+
Sbjct: 219 -DLIPRHQQIF--------------STNQFFKGLSIPEPETREPLESKFPNISSPALSFL 263
Query: 663 RTLLEINPQRRPTAREALDHPW 684
+ L+++P R + E L+HP+
Sbjct: 264 KGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 89/322 (27%), Positives = 148/322 (45%), Gaps = 57/322 (17%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKLVNKND 438
+Y +G ++ V + + TG V +K ++DK ++ EI++LK +
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL---- 57
Query: 439 PADEHH--ILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITR 495
H ++ L + F + L++V E + L + +K+ +G R++
Sbjct: 58 ----RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY--PNG----LDESRVRKYLF 107
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF-------QTDNLCLYV 548
Q L +E+ HS IIH D+KPENIL+ Q +K+ D G + TD YV
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVS--QSGVVKLCDFGFARTLAAPGEVYTD----YV 161
Query: 549 QSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 607
+R YRAPE+++G Y + +D+W++GC++ E+ TGE LFP D+ + L II LG
Sbjct: 162 ATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLG--- 218
Query: 608 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYI-----IPEESSLEHHLQFSDAFFIDFV 662
++ + QEI F K N L + E LE +D
Sbjct: 219 -NLIPRHQEI---FQK-----------NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLA 263
Query: 663 RTLLEINPQRRPTAREALDHPW 684
+ L I+P RP++ + L H +
Sbjct: 264 KQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 86/308 (27%), Positives = 143/308 (46%), Gaps = 64/308 (20%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKII--KNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 446
LG AF KV++A++ TG K+I K++++ D + EI++L + +I+
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV-EIEILA------TCNHPYIV 72
Query: 447 RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS 506
+L FY L+I+ E + + G T ++QVI RQ LEAL+YLHS
Sbjct: 73 KLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVICRQMLEALQYLHS 128
Query: 507 LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPEVII--- 560
+ IIH DLK N+L+ +IK+ D G S L ++ + + APEV++
Sbjct: 129 MKIIHRDLKAGNVLLT--LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 561 --GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 618
PYD K D+WSLG L E+ ++ P+ + + R++ + + L Q
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM--AQIEPPHHELNPM--RVLLKIAKSEPPTLSQ----- 237
Query: 619 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTARE 678
P + S+E F DF++T L+ +P+ RP+A +
Sbjct: 238 -----------------------PSKWSME---------FRDFLKTALDKHPETRPSAAQ 265
Query: 679 ALDHPWLQ 686
L+HP++
Sbjct: 266 LLEHPFVS 273
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 91/338 (26%), Positives = 151/338 (44%), Gaps = 70/338 (20%)
Query: 388 YLGSAAFSKVFQA--QDLHTGVDVCLKIIKNDKDFFD---QS-LDEIKLLK-LVNKNDPA 440
+G + +V++A ++ G + +K K DK+ + QS EI LL+ L ++N
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHEN--- 63
Query: 441 DEHHILRLYDYFYHLEH----LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 496
++ L + F LEH ++++ + +L++ KF++++ ++ + Q
Sbjct: 64 ----VVSLVEVF--LEHADKSVYLLFDYAEHDLWQIIKFHRQAKR-VSIPPSMVKSLLWQ 116
Query: 497 CLEALEYLHSLGIIHCDLKPENILIKS--YQRCEIKIIDLG-SSCFQTDNLCLY-----V 548
L + YLHS ++H DLKP NIL+ +R +KI DLG + F L V
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 549 QSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFP-----NDAVVMI----LAR 598
+ YRAPE+++G Y + ID+W++GCI AEL T E +F L R
Sbjct: 177 VTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236
Query: 599 IIGMLGPIDLEM------------LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESS 646
I +LG + LM+ + Y + + E +
Sbjct: 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWM--------EKHKKPD-- 286
Query: 647 LEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 684
S F D +R LLE +P +R TA EAL+HP+
Sbjct: 287 -------SQGF--DLLRKLLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 85/319 (26%), Positives = 148/319 (46%), Gaps = 47/319 (14%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKND 438
+Y E +G + V++A+D T + LK I+ D+ ++ EI LLK
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLK------ 56
Query: 439 PADEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 496
+ H I+RL D + + L++V E L +L K + +S + ++ Q
Sbjct: 57 --EMQHGNIVRLQDVVHSEKRLYLVFEYLDLDL----KKHMDSSPDFAKNPRLIKTYLYQ 110
Query: 497 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--------CFQTDNLCLYV 548
L + Y HS ++H DLKP+N+LI + +K+ D G + F + + L+
Sbjct: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDR-RTNALKLADFGLARAFGIPVRTFTHEVVTLW- 168
Query: 549 QSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 607
YRAPE+++G Y +D+WS+GCI AE+ + LFP D+ + L +I +LG +
Sbjct: 169 ----YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPN 224
Query: 608 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLE 667
E + +Y + L ++P +LE +D + +L
Sbjct: 225 EETWPGVTSL-----PDYKSAFPKWPPKDLATVVP---TLEPA-------GVDLLSKMLR 269
Query: 668 INPQRRPTAREALDHPWLQ 686
++P +R TAR AL+H + +
Sbjct: 270 LDPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 81/331 (24%), Positives = 136/331 (41%), Gaps = 52/331 (15%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLK-IIKNDKDFFDQSLDEIKLLKLVNKN 437
+ RY LG + VF A D V +K I+ D +L EIK+++ +
Sbjct: 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL--- 59
Query: 438 DPADEHHILRLYDYF--------------YHLEHLFIVCELLRANLYEFQKFNQESGGEA 483
D +I+++Y+ L ++IV E + +L Q E
Sbjct: 60 ---DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANV--LEQGPLSEE 114
Query: 484 YFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---- 539
+ L Q L L+Y+HS ++H DLKP N+ I + +KI D G +
Sbjct: 115 HARL-----FMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLV-LKIGDFGLARIVDPH 168
Query: 540 --QTDNLCLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVLFPNDAVVMI 595
L + ++ YR+P +++ P Y + ID+W+ GCI AE+ TG+ LF +
Sbjct: 169 YSHKGYLSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ 227
Query: 596 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSD 655
+ I+ + + E + + F + E L ++P +
Sbjct: 228 MQLILESVPVVREEDRNELLNVIPSFVRNDG----GEPRRPLRDLLPG---VNPEA---- 276
Query: 656 AFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686
+DF+ +L NP R TA EAL HP++
Sbjct: 277 ---LDFLEQILTFNPMDRLTAEEALMHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 83/307 (27%), Positives = 147/307 (47%), Gaps = 35/307 (11%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLK-LVNKNDPADE 442
E +G + V++ ++ TG V +K I+ ++ ++ EI LLK L + N
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN----- 60
Query: 443 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 502
I+ L D L+++ E L +L +K+ Y ++ Q L+ +
Sbjct: 61 --IVCLQDVLMQESRLYLIFEFLSMDL---KKYLDSLPKGQYMDAELVKSYLYQILQGIL 115
Query: 503 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYRAPEVI 559
+ HS ++H DLKP+N+LI + + IK+ D G + + +Y V + YRAPEV+
Sbjct: 116 FCHSRRVLHRDLKPQNLLIDN--KGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVL 173
Query: 560 IGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 618
+G P Y +D+WS+G I AE+ T + LF D+ + L RI +LG ++++
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPT-------EDVW 226
Query: 619 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTARE 678
T D Y N ++ SL ++ D +D + +L +P +R +A++
Sbjct: 227 PGVTSLPD--YKNTFPKW------KKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKK 278
Query: 679 ALDHPWL 685
AL+HP+
Sbjct: 279 ALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 5e-23
Identities = 92/340 (27%), Positives = 155/340 (45%), Gaps = 39/340 (11%)
Query: 358 HRKNRTGFEEN-KDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN 416
H N E+ K + +N Y + +G+ +F V++A + T V +K +
Sbjct: 42 HNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ 101
Query: 417 DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY------HLEHLF--IVCELLRAN 468
D + ++ L +K L +N I+ L DY+Y + +++F +V E +
Sbjct: 102 DPQYKNRELLIMKNLNHIN---------IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQT 152
Query: 469 LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 528
++++ K + L +L + Q AL Y+HS I H DLKP+N+LI
Sbjct: 153 VHKYMKHYARNNHALPLFLVKL--YSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHT- 209
Query: 529 IKIIDLGSS--CFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEV 585
+K+ D GS+ Y+ SR YRAPE+++G Y IDLWSLGCI+AE+ G
Sbjct: 210 LKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYP 269
Query: 586 LFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEES 645
+F + V L RII +LG + L + Y D+ + + + L+ + P+ +
Sbjct: 270 IFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYA------DIKFPDVKPKDLKKVFPKGT 323
Query: 646 SLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685
+ I+F+ L+ P +R EAL P+
Sbjct: 324 PDDA---------INFISQFLKYEPLKRLNPIEALADPFF 354
|
Length = 440 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 6e-23
Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK-----LVNK 436
+ + E +G +F +V++A D T V +K+I +++ DEI+ ++ L
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID-----LEEAEDEIEDIQQEIQFLSQC 56
Query: 437 NDPADEHHILRLYDYFYHLEHLFIVCELLR----ANLYEFQKFNQESGGEAYFTLGRLQV 492
P +I + Y F L+I+ E +L + K ++ +
Sbjct: 57 RSP----YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETY----------IAF 102
Query: 493 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQ 549
I R+ L LEYLH G IH D+K NIL+ ++K+ D G S T + +V
Sbjct: 103 ILREVLLGLEYLHEEGKIHRDIKAANILLSEEG--DVKLADFGVSGQLTSTMSKRNTFVG 160
Query: 550 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 584
+ + APEVI YD+K D+WSLG EL GE
Sbjct: 161 TPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 8e-23
Identities = 82/322 (25%), Positives = 149/322 (46%), Gaps = 38/322 (11%)
Query: 381 GRYYVTEY-----LGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFD-QSLDEIKLLK 432
G+ V ++ +G + +V++A+D TG V LK ++ N+K+ F ++ EIK+L+
Sbjct: 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILR 61
Query: 433 LVNKNDPADEHHIL----RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLG 488
+N + + I+ D+ ++V E + +L ESG +F+
Sbjct: 62 QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL----ESG-LVHFSED 116
Query: 489 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLY 547
++ +Q LE L Y H +H D+K NIL+ + + +IK+ D G + + ++ Y
Sbjct: 117 HIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNN--KGQIKLADFGLARLYNSEESRPY 174
Query: 548 ---VQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 603
V + YR PE+++G Y ID+WS GCIL EL+T + +F + + L I +
Sbjct: 175 TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC 234
Query: 604 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVR 663
G + ++ + T + Y + +I +D +
Sbjct: 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPA--------------LDLLD 280
Query: 664 TLLEINPQRRPTAREALDHPWL 685
+L ++P +R TA EAL+ PWL
Sbjct: 281 HMLTLDPSKRCTAEEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 79/326 (24%), Positives = 142/326 (43%), Gaps = 60/326 (18%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 441
+Y +G A+ V++A+D H+G V LK ++ + L ++ + L+ + + D
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 442 EHHILRLYDYFYHLEHLFIVCELLRAN-----LYEFQKFNQESGGEAYFT--------LG 488
+I+RL D VC R + F+ +Q+ Y
Sbjct: 61 HPNIVRLMD----------VCATSRTDRETKVTLVFEHVDQDL--RTYLDKVPPPGLPAE 108
Query: 489 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL-- 546
++ + RQ L L++LH+ I+H DLKPENIL+ S ++K+ D G + + + L
Sbjct: 109 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS--GGQVKLADFGLARIYSCQMALTP 166
Query: 547 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG-- 604
V + YRAPEV++ Y +D+WS+GCI AE++ + LF ++ L +I ++G
Sbjct: 167 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 226
Query: 605 -----PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFI 659
P D+ + + ++ ++PE +
Sbjct: 227 PEDDWPRDVTLPRGA--------------FSPRGPRPVQSVVPE----------IEESGA 262
Query: 660 DFVRTLLEINPQRRPTAREALDHPWL 685
+ +L NP +R +A AL HP+
Sbjct: 263 QLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 84/312 (26%), Positives = 138/312 (44%), Gaps = 38/312 (12%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKII--KNDKDFFD-QSLDEIKLLKLVNKNDPADEHHI 445
+G F +VF+A+ T V LK + +N+K+ F +L EIK+L+L+ + + I
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 446 LR----LYDYFYHLEHL-FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 500
R Y+ + +L F CE A L + FTL ++ + + L
Sbjct: 80 CRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK--------FTLSEIKKVMKMLLNG 131
Query: 501 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG----SSCFQTDNLCLY---VQSRSY 553
L Y+H I+H D+K NILI + +K+ D G S + Y V + Y
Sbjct: 132 LYYIHRNKILHRDMKAANILIT--KDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWY 189
Query: 554 RAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 612
R PE+++G Y ID+W GCI+AE+WT + + L I + G I
Sbjct: 190 RPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT----- 244
Query: 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 672
E++ K +L+ E + + E L+ + D +D + LL ++P +
Sbjct: 245 --PEVWPGVDK-LELFKKMELPQGQKRKVKER--LKPY--VKDPHALDLIDKLLVLDPAK 297
Query: 673 RPTAREALDHPW 684
R A AL+H +
Sbjct: 298 RIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 4e-22
Identities = 74/319 (23%), Positives = 128/319 (40%), Gaps = 81/319 (25%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK------NDKDFFDQSL-DEIKLLKLVNKNDP 439
+ LG+ AFS +QA+D+ TG + +K + ++++ ++L EI+L+ +N
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN---- 61
Query: 440 ADEHHILRLYDYFYHLEHLFIVCELLRAN-----LYEFQKFNQESGGEAYFTLGRLQVIT 494
HI+R+ H + E + L ++ F +E+ Y T
Sbjct: 62 --HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAF-KEAVIINY---------T 109
Query: 495 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC-------LY 547
Q L L YLH IIH D+K N+LI S + ++I D G++
Sbjct: 110 EQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGTGAGEFQGQL 168
Query: 548 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV---VMILARIIGMLG 604
+ + ++ APEV+ G Y + D+WS+GC++ E+ T + + + + ++ +I
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT 228
Query: 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 664
IPE L L+ D
Sbjct: 229 APS---------------------------------IPE--HLSPGLR-------DVTLR 246
Query: 665 LLEINPQRRPTAREALDHP 683
LE+ P+ RP +RE L HP
Sbjct: 247 CLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 7e-22
Identities = 65/216 (30%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 437
+ V + LG ++ V++ + L LK + + K+ D +++EI++L VN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERED-AVNEIRILASVN-- 57
Query: 438 DPADEHHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITR- 495
+I+ + F L IV E +L + ++ L Q I R
Sbjct: 58 ----HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKR-----KLIPEQEIWRI 108
Query: 496 --QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ--SR 551
Q L L+ LH I+H DLK NIL+ +KI DLG S N+ Q +
Sbjct: 109 FIQLLRGLQALHEQKILHRDLKSANILL--VANDLVKIGDLGISKVLKKNM-AKTQIGTP 165
Query: 552 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLF 587
Y APEV G PY K D+WSLGC+L E+ T F
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 7e-22
Identities = 86/320 (26%), Positives = 134/320 (41%), Gaps = 88/320 (27%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPADEHHILR 447
LG AF KV++AQ TG+ KII+ ++ + + EI +L +I+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILS------ECKHPNIVG 66
Query: 448 LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG---------EAYFTLGRLQVITRQCL 498
LY+ +++ L+I+ E GG E T +++ + RQ L
Sbjct: 67 LYEAYFYENKLWILIEFC-------------DGGALDSIMLELERGLTEPQIRYVCRQML 113
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------ 552
EAL +LHS +IH DLK NIL+ ++K+ D G S L Q R
Sbjct: 114 EALNFLHSHKVIHRDLKAGNILLT--LDGDVKLADFGVSAKNKSTL----QKRDTFIGTP 167
Query: 553 -YRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 606
+ APEV+ PYD K D+WSLG L EL E P+ + + R++
Sbjct: 168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP--PHHELNPM--RVL------ 217
Query: 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLL 666
L+ + E +L+ ++S +F DF+++ L
Sbjct: 218 ------------------------------LKILKSEPPTLDQPSKWSSSFN-DFLKSCL 246
Query: 667 EINPQRRPTAREALDHPWLQ 686
+P RPTA E L HP++
Sbjct: 247 VKDPDDRPTAAELLKHPFVS 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 80/325 (24%), Positives = 131/325 (40%), Gaps = 90/325 (27%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPA 440
Y + + +GS + V++A+D+ TG V +K+IK D F+ EI +LK +
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPN-- 61
Query: 441 DEHHILRLYDYFYHLEHLFIVCE------------LLRANLYEFQKFNQESGGEAYFTLG 488
I+ + + + L+IV E + R L E Q AY
Sbjct: 62 ----IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQI--------AY---- 105
Query: 489 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC--- 545
+ R+ L+ L YLH G IH D+K NIL+ ++K+ D G S T +
Sbjct: 106 ----VCRETLKGLAYLHETGKIHRDIKGANILLTE--DGDVKLADFGVSAQLTATIAKRK 159
Query: 546 LYVQSRSYRAPEVI---IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 602
++ + + APEV YD K D+W+LG EL E+ P
Sbjct: 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL--AELQPPM------------- 204
Query: 603 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQ----FSDAFF 658
+DL+ + + ++I + + L+ +S F
Sbjct: 205 ----------------------FDLHPM-----RALFLISKSNFPPPKLKDKEKWSPVF- 236
Query: 659 IDFVRTLLEINPQRRPTAREALDHP 683
DF++ L +P++RPTA + L HP
Sbjct: 237 HDFIKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 88/327 (26%), Positives = 130/327 (39%), Gaps = 91/327 (27%)
Query: 387 EYLGSAAFSKVFQAQDLHTG-------VDVCLKIIKND----KDFFDQSLDEIKLLKLVN 435
E +G + +V+ A ++ TG V++ I KD EI+ LK
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLK--- 63
Query: 436 KNDPADEHHILRLYDYFYHLEHLFIV----CELLRANLYEFQKF-NQESGGEAYFTLGRL 490
L+HL IV E L F ++ S G T GR
Sbjct: 64 ------------------DLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRF 105
Query: 491 Q-----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 545
+ T Q LE L YLHS GI+H DLK +N+L+ + C KI D G S ++D++
Sbjct: 106 EEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGIC--KISDFGIS-KKSDDIY 162
Query: 546 LYVQSRSYR------APEVI--IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILA 597
Q+ S + APEVI Y K+D+WSLGC++ E++ G + ++ +
Sbjct: 163 DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI---- 218
Query: 598 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAF 657
++K K + IP + S + S
Sbjct: 219 -----------------AAMFKLGNK------------RSAPPIPPDVS----MNLSPV- 244
Query: 658 FIDFVRTLLEINPQRRPTAREALDHPW 684
+DF+ INP RPTARE L HP+
Sbjct: 245 ALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 79/317 (24%), Positives = 121/317 (38%), Gaps = 70/317 (22%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPA 440
Y + E +G A + V+ A L V +K I +K D+ E++ + N
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCN----- 57
Query: 441 DEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
H ++++ Y F + L++V L +L + K + GG + + ++ L
Sbjct: 58 --HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA---TVLKEVL 112
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------ 552
+ LEYLHS G IH D+K NIL+ +KI D G S D + R
Sbjct: 113 KGLEYLHSNGQIHRDIKAGNILLGEDG--SVKIADFGVSASLADGGDRTRKVRKTFVGTP 170
Query: 553 -YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEV----LFPNDAVVMILARIIGMLGPI 606
+ APEV+ + YD K D+WS G EL TG P +++ L P
Sbjct: 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN-----DPP 225
Query: 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLL 666
LE YK ++K F + L
Sbjct: 226 SLET----GADYKKYSKS---------------------------------FRKMISLCL 248
Query: 667 EINPQRRPTAREALDHP 683
+ +P +RPTA E L H
Sbjct: 249 QKDPSKRPTAEELLKHK 265
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 4e-21
Identities = 66/236 (27%), Positives = 105/236 (44%), Gaps = 55/236 (23%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHH 444
LG+ +F +V + +G LKI+ K + L+E ++L+ + H
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR--------H 60
Query: 445 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL----GRL-----QVI 493
++ LY F +L++V E + GGE F+ GR +
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYV-------------PGGE-LFSHLRKSGRFPEPVARFY 106
Query: 494 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS- 552
Q + ALEYLHSL I++ DLKPEN+L+ S IKI D G V+ R+
Sbjct: 107 AAQVVLALEYLHSLDIVYRDLKPENLLLDSDG--YIKITDFG--------FAKRVKGRTY 156
Query: 553 -------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 601
Y APE+I+ Y + +D W+LG ++ E+ G F +D + I +I+
Sbjct: 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE 212
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 5e-21
Identities = 63/242 (26%), Positives = 99/242 (40%), Gaps = 51/242 (21%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDE-IKLLKLVNKNDPADEHHILR 447
LG F +V + LK +K + E I K + + + I++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRH-IVETGQQEHIFSEKEILEE--CNHPFIVK 57
Query: 448 LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRL-----QVITRQCLE 499
LY F ++++++ E GGE + L G + +
Sbjct: 58 LYRTFKDKKYIYMLMEYCL-------------GGELWTILRDRGLFDEYTARFYIACVVL 104
Query: 500 ALEYLHSLGIIHCDLKPENILIKS--YQRCEIKIIDLGSSCFQTDNLCLYVQSRS----- 552
A EYLH+ GII+ DLKPEN+L+ S Y +K++D G + ++S
Sbjct: 105 AFEYLHNRGIIYRDLKPENLLLDSNGY----VKLVDFGFA--------KKLKSGQKTWTF 152
Query: 553 -----YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV--VMILARIIGMLGP 605
Y APE+I+ YD +D WSLG +L EL TG F D + I I+ G
Sbjct: 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK 212
Query: 606 ID 607
++
Sbjct: 213 LE 214
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 6e-20
Identities = 83/315 (26%), Positives = 127/315 (40%), Gaps = 83/315 (26%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD-----QSLD-EIKLLKLVNKNDPADE 442
LG AF +V+ D+ TG ++ +K + D D + +L+ EI+LLK +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHE----- 64
Query: 443 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG------EAYFTLGR--LQVIT 494
R+ Y+ C L F ++ GG +AY L + T
Sbjct: 65 ----RIVQYYG--------CLRDDETLSIFMEYM--PGGSVKDQLKAYGALTETVTRKYT 110
Query: 495 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS------CFQTDNLCLYV 548
RQ LE +EYLHS I+H D+K NIL S +K+ D G+S C +
Sbjct: 111 RQILEGVEYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRLQTICSSGTGMKSVT 168
Query: 549 QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 608
+ + +PEVI G Y +K D+WS+GC + E+ T + P A +
Sbjct: 169 GTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK---PPWA---------------EF 210
Query: 609 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEI 668
E + I+K T+ +P S DA +F+R
Sbjct: 211 EAM---AAIFKIATQP------------TNPQLPSHVS-------PDA--RNFLRRTFVE 246
Query: 669 NPQRRPTAREALDHP 683
N ++RP+A E L H
Sbjct: 247 NAKKRPSAEELLRHF 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 9e-20
Identities = 66/201 (32%), Positives = 99/201 (49%), Gaps = 21/201 (10%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKN-DKDFFDQSLDEIKLLKLVNKNDPADEHHILR 447
LG AF KV++AQ+ TGV K+I ++ + + EI +L D +I++
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILA------SCDHPNIVK 66
Query: 448 LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL 507
L D FY+ +L+I+ E + E T +++V+ +Q LEAL YLH
Sbjct: 67 LLDAFYYENNLWILIEFCAGGAVDAVMLELERP----LTEPQIRVVCKQTLEALNYLHEN 122
Query: 508 GIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPEVII---- 560
IIH DLK NIL +IK+ D G S T + ++ + + APEV++
Sbjct: 123 KIIHRDLKAGNILFT--LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 561 -GLPYDQKIDLWSLGCILAEL 580
PYD K D+WSLG L E+
Sbjct: 181 KDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 82/318 (25%), Positives = 141/318 (44%), Gaps = 45/318 (14%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVD-VCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA 440
+Y +G A+ KVF+A+DL G V LK ++ L I+ + ++ +
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 441 DEHHILRLYDYFYHLEHLFIVCELLRAN-----LYEFQKFNQ------ESGGEAYFTLGR 489
+ +++RL+D VC + R + F+ +Q + E
Sbjct: 62 EHPNVVRLFD----------VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 111
Query: 490 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS---CFQTDNLCL 546
++ + Q L L++LHS ++H DLKP+NIL+ S +IK+ D G + FQ L
Sbjct: 112 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQIKLADFGLARIYSFQM-ALTS 168
Query: 547 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 606
V + YRAPEV++ Y +DLWS+GCI AE++ + LF + V L +I+ ++G
Sbjct: 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 228
Query: 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLL 666
E + + + + ++ +E + + L L L
Sbjct: 229 GEEDWPRDVALPRQ-------AFHSKSAQPIEKFVTDIDELGKDLLLK----------CL 271
Query: 667 EINPQRRPTAREALDHPW 684
NP +R +A AL HP+
Sbjct: 272 TFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 60/191 (31%), Positives = 90/191 (47%), Gaps = 35/191 (18%)
Query: 498 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC-LYVQSRSYRAP 556
L+ L YLHS IIH D+KP NIL+ + ++K+ D G S ++L + + Y AP
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLTR--KGQVKLCDFGVSGELVNSLAGTFTGTSFYMAP 172
Query: 557 EVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 616
E I G PY D+WSLG L E+ FP + LGPI+L
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEG--------EPPLGPIELLS------ 218
Query: 617 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 676
Y +N +L + + +++S+ F DF++ LE +P RRPT
Sbjct: 219 -----------YIVNMPNPEL------KDEPGNGIKWSEE-FKDFIKQCLEKDPTRRPTP 260
Query: 677 REALDHPWLQH 687
+ L+HPW++
Sbjct: 261 WDMLEHPWIKA 271
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 6e-19
Identities = 68/224 (30%), Positives = 101/224 (45%), Gaps = 49/224 (21%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPA 440
Y E +G A+ V++ + + TG V LKII D D S E+ LL + ++ P
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 441 DEHHILRLYDYFYHLEHLFIVCE---------LLRANLYEFQKFNQESGGEAYFTLGRLQ 491
+ I + Y + L+I+ E L++A E Y +
Sbjct: 63 N---ITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIA----------EKY-----IS 104
Query: 492 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 551
VI R+ L AL+Y+H +G+IH D+K NIL+ + +K+ D G + L Q+
Sbjct: 105 VIIREVLVALKYIHKVGVIHRDIKAANILVTNTGN--VKLCDFGVA-------ALLNQNS 155
Query: 552 SYR----------APEVII-GLPYDQKIDLWSLGCILAELWTGE 584
S R APEVI G YD K D+WSLG + E+ TG
Sbjct: 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGN 199
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 58/228 (25%), Positives = 97/228 (42%), Gaps = 31/228 (13%)
Query: 387 EYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPA 440
+ LG AF +V++ + V+V +K +K D L E ++++ ++
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLD----- 59
Query: 441 DEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
H ++++L E L+IV E + +L + + N+ +L L Q
Sbjct: 60 --HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-----LSLSDLLSFALQIA 112
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS----YR 554
+EYL S IH DL N L+ +KI D G S D Y + R R
Sbjct: 113 RGMEYLESKNFIHRDLAARNCLVGE--NLVVKISDFGLSRDLYD--DDYYRKRGGKLPIR 168
Query: 555 --APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARI 599
APE + + K D+WS G +L E++T GE +P + +L +
Sbjct: 169 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYL 216
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 5e-18
Identities = 58/227 (25%), Positives = 95/227 (41%), Gaps = 28/227 (12%)
Query: 387 EYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPA 440
+ LG AF +V++ V+V +K +K D L E ++++ ++
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLD----- 59
Query: 441 DEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
H +I++L E L IV E + +L ++ + N+ +L L Q
Sbjct: 60 --HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE----LSLSDLLSFALQIA 113
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS---YR- 554
+EYL S IH DL N L+ +KI D G S D+ Y R
Sbjct: 114 RGMEYLESKNFIHRDLAARNCLVGE--NLVVKISDFGLSRDLYDDD-YYKVKGGKLPIRW 170
Query: 555 -APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARI 599
APE + + K D+WS G +L E++T GE +P + +L +
Sbjct: 171 MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYL 217
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 83/309 (26%), Positives = 137/309 (44%), Gaps = 33/309 (10%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPA 440
Y + LG ++ VF+ + T V LK I+ +++ ++ E+ LLK + +
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHAN-- 64
Query: 441 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 500
I+ L+D + L +V E L ++L +++ G ++ +++ Q L
Sbjct: 65 ----IVTLHDIIHTERCLTLVFEYLDSDL---KQYLDNCGN--LMSMHNVKIFMFQLLRG 115
Query: 501 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPE 557
L Y H I+H DLKP+N+LI ++ E+K+ D G + T V + YR P+
Sbjct: 116 LSYCHKRKILHRDLKPQNLLIN--EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPD 173
Query: 558 VIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 616
V++G Y ID+W +GCIL E+ TG +FP V L I +LG +E
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLG-------TPTEE 226
Query: 617 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 676
+ T NEE + L +H D ID + +LL + R +A
Sbjct: 227 TWPGITS-------NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISA 279
Query: 677 REALDHPWL 685
AL H +
Sbjct: 280 EAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 82/312 (26%), Positives = 139/312 (44%), Gaps = 37/312 (11%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPA 440
Y + LG ++ V++ + T V LK I+ +++ ++ E+ LLK
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLK-------- 59
Query: 441 DEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
D H I+ L+D + + L +V E L +L +++ + G + +++ Q L
Sbjct: 60 DLKHANIVTLHDIIHTEKSLTLVFEYLDKDL---KQYLDDCGN--SINMHNVKLFLFQLL 114
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRA 555
L Y H ++H DLKP+N+LI +R E+K+ D G + T V + YR
Sbjct: 115 RGLNYCHRRKVLHRDLKPQNLLIN--ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRP 172
Query: 556 PEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614
P++++G Y +ID+W +GCI E+ TG LFP V L I +LG
Sbjct: 173 PDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILG-------TPT 225
Query: 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP 674
+E + NEE Y L +H D+ + + LL+ ++R
Sbjct: 226 EETWPGILS-------NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRI 278
Query: 675 TAREALDHPWLQ 686
+A EA+ HP+
Sbjct: 279 SAEEAMKHPYFH 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 7e-18
Identities = 79/320 (24%), Positives = 130/320 (40%), Gaps = 81/320 (25%)
Query: 382 RYYVTEY--LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL-DEIKLLKLVNKND 438
R Y+ + +G + V A D TG V +K + K + L +E+ +++
Sbjct: 18 RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMR------ 71
Query: 439 PADEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEA--YFTLGRLQ--- 491
D H I+ +Y + + L++V E L GG T R+
Sbjct: 72 --DYQHPNIVEMYSSYLVGDELWVVMEFL-------------EGGALTDIVTHTRMNEEQ 116
Query: 492 --VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---- 545
+ L+AL +LH+ G+IH D+K ++IL+ S R +K+ D G C Q
Sbjct: 117 IATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR--VKLSDFG-FCAQVSKEVPRRK 173
Query: 546 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 605
V + + APEVI LPY ++D+WSLG ++ E+ GE + N+ + + RI L P
Sbjct: 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPP 233
Query: 606 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTL 665
L++ + S F+ +
Sbjct: 234 ----------------------------------------KLKNLHKVS-PRLRSFLDRM 252
Query: 666 LEINPQRRPTAREALDHPWL 685
L +P +R TA E L+HP+L
Sbjct: 253 LVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 22/210 (10%)
Query: 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNK 436
G + + + +G FS V++A L G V LK ++ D L EI LLK
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLK---- 57
Query: 437 NDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR 495
D ++++ F L IV EL A +L K ++ + +
Sbjct: 58 --QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKR----LIPERTIWKY 111
Query: 496 --QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQS 550
Q ALE++HS I+H D+KP N+ I + +K+ DLG F +T V +
Sbjct: 112 FVQLCSALEHMHSKRIMHRDIKPANVFITA--TGVVKLGDLGLGRFFSSKTTAAHSLVGT 169
Query: 551 RSYRAPEVIIGLPYDQKIDLWSLGCILAEL 580
Y +PE I Y+ K D+WSLGC+L E+
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 35/224 (15%)
Query: 393 AFSKVFQAQDLHTGVDVCLKII-KNDKDFFDQSLDEIKLLKLVNKN--DPADEHHILRLY 449
AF V+ A+ TG +K++ K+D + +++ +K + ++ +LY
Sbjct: 8 AFGSVYLAKKRSTGDYFAIKVLKKSDMI----AKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 450 DYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ--------CLEAL 501
F ++L++V E L +GG+ + L + + +
Sbjct: 64 YSFQSKDYLYLVMEYL-------------NGGDCASLIKTLGGLPEDWAKQYIAEVVLGV 110
Query: 502 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG 561
E LH GIIH D+KPEN+LI Q +K+ D G S +N +V + Y APE I+G
Sbjct: 111 EDLHQRGIIHRDIKPENLLID--QTGHLKLTDFGLSRNGLENK-KFVGTPDYLAPETILG 167
Query: 562 LPYDQKIDLWSLGCILAELWTGEVLF----PNDAVVMILARIIG 601
+ D+ D WSLGC++ E G F P+ IL+R I
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN 211
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 75/316 (23%), Positives = 126/316 (39%), Gaps = 72/316 (22%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS----LDEIKLLKLVNKND 438
+ + +G AF KV Q T +K + K S L+E ++L+ +N
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP- 60
Query: 439 PADEHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVI 493
++ L+ F E++++V +L LR +L + KF++E +++
Sbjct: 61 -----FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE----------QVKFW 105
Query: 494 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSR 551
+ + ALEYLHS GIIH D+KP+NIL+ ++ + I D + T + +
Sbjct: 106 ICEIVLALEYLHSKGIIHRDIKPDNILLD--EQGHVHITDFNIATKVTPDTLTTSTSGTP 163
Query: 552 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 611
Y APEV+ Y +D WSLG E G+ + + +
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR---------------- 207
Query: 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQ 671
D +ET + Y P S E ID + LLE +PQ
Sbjct: 208 --------------DQIRAKQETADVLY--PATWSTE---------AIDAINKLLERDPQ 242
Query: 672 RR--PTAREALDHPWL 685
+R ++ +HP+
Sbjct: 243 KRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (200), Expect = 6e-17
Identities = 62/257 (24%), Positives = 98/257 (38%), Gaps = 57/257 (22%)
Query: 389 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKND 438
LG AF +V++ T V +K +K ++F L+E ++K +
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEF----LEEASIMKKL---- 58
Query: 439 PADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQC 497
+I+RL E L+IV E + +L +F + + E TL L + Q
Sbjct: 59 --SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-----LTLKDLLQMALQI 111
Query: 498 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY---- 553
+ +EYL S +H DL N L+ KI D G L + Y
Sbjct: 112 AKGMEYLESKNFVHRDLAARNCLVTENLVV--KISDFG--------LSRDIYEDDYYRKR 161
Query: 554 ---------RAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIG-- 601
APE + + K D+WS G +L E++T GE +P + +L +
Sbjct: 162 GGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGY 221
Query: 602 -----MLGPIDLEMLMQ 613
P +L LM
Sbjct: 222 RLPRPENCPDELYELML 238
|
Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 8e-17
Identities = 80/315 (25%), Positives = 125/315 (39%), Gaps = 78/315 (24%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLK---IIKNDKDFFD---QSLDEIKLL-KLVNKNDP 439
E LGS +F V++ +L G +K + + + + Q EI LL KL + N
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN-- 63
Query: 440 ADEHHILRLYDYFYHLEHLFIVCELLR----ANLYEFQKFNQESGGEAYFTLGRLQVITR 495
I++ ++L+I EL+ A L +K+ F +++ TR
Sbjct: 64 -----IVQYLGTEREEDNLYIFLELVPGGSLAKLL--KKYGS-------FPEPVIRLYTR 109
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSY 553
Q L LEYLH +H D+K NIL+ + +K+ D G + + + S +
Sbjct: 110 QILLGLEYLHDRNTVHRDIKGANILVDT--NGVVKLADFGMAKQVVEFSFAKSFKGSPYW 167
Query: 554 RAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI--IGMLGPIDLEM 610
APEVI Y D+WSLGC + E+ TG+ + V + +I L P
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPP----- 222
Query: 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINP 670
IP+ S E DF+ L+ +P
Sbjct: 223 ------------------------------IPDHLSDEAK---------DFILKCLQRDP 243
Query: 671 QRRPTAREALDHPWL 685
RPTA E L+HP++
Sbjct: 244 SLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 8e-17
Identities = 66/205 (32%), Positives = 93/205 (45%), Gaps = 19/205 (9%)
Query: 487 LGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 545
LG+ I+ L L YL I+H D+KP NIL+ S R EIK+ D G S D++
Sbjct: 101 LGK---ISIAVLRGLTYLREKHKIMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMA 155
Query: 546 -LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP-NDAVVMILARIIGML 603
+V +RSY +PE + G Y + D+WSLG L E+ G P DA + M
Sbjct: 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-----KELEAMF 210
Query: 604 GPID--LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDF 661
G E + + + I E L+YI+ E FSD F DF
Sbjct: 211 GRPVSEGEAKESHRPVSGHPPDSPRPMAIFE---LLDYIVNEPPPKLPSGAFSDE-FQDF 266
Query: 662 VRTLLEINPQRRPTAREALDHPWLQ 686
V L+ NP+ R +E HP+++
Sbjct: 267 VDKCLKKNPKERADLKELTKHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 9e-17
Identities = 65/201 (32%), Positives = 87/201 (43%), Gaps = 56/201 (27%)
Query: 495 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR 554
RQ L+ L YLH+ GIIH D+K NIL+ + + IKI D G S N L ++ R
Sbjct: 113 RQILKGLNYLHNRGIIHRDIKGANILVDN--KGGIKISDFGISKKLEANS-LSTKTNGAR 169
Query: 555 ----------APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 604
APEV+ Y +K D+WSLGC++ E+ TG+ FP+
Sbjct: 170 PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD--------------- 214
Query: 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 664
Q Q I+K + E IP S E IDF+
Sbjct: 215 ------CTQLQAIFKIGE------NASPE-------IPSNISSEA---------IDFLEK 246
Query: 665 LLEINPQRRPTAREALDHPWL 685
EI+ +RPTA E L HP+L
Sbjct: 247 TFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 9e-17
Identities = 81/318 (25%), Positives = 137/318 (43%), Gaps = 77/318 (24%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPA 440
+Y E +G A V+ A D+ TG +V +K + + + ++EI +++ NK+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMR-ENKHP-- 76
Query: 441 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG-------EAYFTLGRLQVI 493
+I+ D + + L++V E L +GG E G++ +
Sbjct: 77 ---NIVNYLDSYLVGDELWVVMEYL-------------AGGSLTDVVTETCMDEGQIAAV 120
Query: 494 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ----TDNLCLYVQ 549
R+CL+ALE+LHS +IH D+K +NIL+ +K+ D G C Q V
Sbjct: 121 CRECLQALEFLHSNQVIHRDIKSDNILLG--MDGSVKLTDFG-FCAQITPEQSKRSTMVG 177
Query: 550 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 609
+ + APEV+ Y K+D+WSLG + E+ GE P
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE---PP-------------------- 214
Query: 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLE-HHLQFSDAFFIDFVRTLLEI 668
Y+NE + Y+I + E + + A F DF+ LE+
Sbjct: 215 -------------------YLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEM 255
Query: 669 NPQRRPTAREALDHPWLQ 686
+ ++R +A+E L HP+L+
Sbjct: 256 DVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 77/302 (25%), Positives = 127/302 (42%), Gaps = 55/302 (18%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHH 444
E LG V++A L T + +K+I D + Q + E+++L D +
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILY------KCDSPY 60
Query: 445 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 504
I+ Y F+ + I E + + + E LGR+ V ++ L YL
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEH------VLGRIAVAV---VKGLTYL 111
Query: 505 HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC-LYVQSRSYRAPEVIIGLP 563
SL I+H D+KP N+L+ + R ++K+ D G S +++ YV + +Y APE I G
Sbjct: 112 WSLKILHRDVKPSNMLVNT--RGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQ 169
Query: 564 YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTK 623
Y D+WSLG EL G +P + + G L P+ L
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPYPQ------IQKNQGSLMPLQL--------------- 208
Query: 624 EYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHP 683
L+ I+ E+ + QFS+ F+ F+ + P+ RP +DHP
Sbjct: 209 -------------LQCIVDEDPPVLPVGQFSEK-FVHFITQCMRKQPKERPAPENLMDHP 254
Query: 684 WL 685
++
Sbjct: 255 FI 256
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 81/312 (25%), Positives = 141/312 (45%), Gaps = 37/312 (11%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPA 440
Y E LG ++ VF+ + T V LK I+ +++ ++ E+ LLK
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLK-------- 59
Query: 441 DEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
D H I+ L+D + + L +V E L +L +++ + G ++ +++ Q L
Sbjct: 60 DLKHANIVTLHDIVHTDKSLTLVFEYLDKDL---KQYMDDCG--NIMSMHNVKIFLYQIL 114
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRA 555
L Y H ++H DLKP+N+LI +R E+K+ D G + T V + YR
Sbjct: 115 RGLAYCHRRKVLHRDLKPQNLLIN--ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRP 172
Query: 556 PEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614
P+V++G Y +ID+W +GCI E+ +G LFP V L I +LG
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLG-------TPT 225
Query: 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP 674
+E + + N+E + + L +H D I+ + L+ ++R
Sbjct: 226 EETWPGISS-------NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRI 278
Query: 675 TAREALDHPWLQ 686
+A EA+ H + +
Sbjct: 279 SAEEAMKHAYFR 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 5e-16
Identities = 80/321 (24%), Positives = 141/321 (43%), Gaps = 48/321 (14%)
Query: 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKN 437
A Y E LG +++ V++ + G V LK+I+ ++ ++ E LLK +
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63
Query: 438 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 497
+ I+ L+D + E L +V E + +L ++ ++ GG +++ Q
Sbjct: 64 N------IVLLHDIIHTKETLTLVFEYVHTDLCQY--MDKHPGG---LHPENVKLFLFQL 112
Query: 498 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--------SSCFQTDNLCLYVQ 549
L L Y+H I+H DLKP+N+LI E+K+ D G S + + + L+
Sbjct: 113 LRGLSYIHQRYILHRDLKPQNLLISDTG--ELKLADFGLARAKSVPSHTYSNEVVTLW-- 168
Query: 550 SRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVM-ILARIIGMLGPID 607
YR P+V++G Y +D+W +GCI E+ G FP + L RI +LG +
Sbjct: 169 ---YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPN 225
Query: 608 LEMLMQGQEIYKYFTKEYDLYY---INEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 664
+ + + + + LY + + N+L Y+ E D
Sbjct: 226 EDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAE---------------DLASK 270
Query: 665 LLEINPQRRPTAREALDHPWL 685
LL+ P+ R +A+ AL H +
Sbjct: 271 LLQCFPKNRLSAQAALSHEYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 82/311 (26%), Positives = 131/311 (42%), Gaps = 63/311 (20%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ-SLDEIKLLK-LVNKNDP 439
+Y E +G A VF A D+ TG +V +K I K + ++EI ++K L N N
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPN-- 77
Query: 440 ADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 499
I+ D F + LF+V E L + E ++ + R+CL+
Sbjct: 78 -----IVNFLDSFLVGDELFVVMEYLAGGSL------TDVVTETCMDEAQIAAVCRECLQ 126
Query: 500 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ----TDNLCLYVQSRSYRA 555
ALE+LH+ +IH D+K +N+L+ +K+ D G C Q V + + A
Sbjct: 127 ALEFLHANQVIHRDIKSDNVLLG--MDGSVKLTDFG-FCAQITPEQSKRSTMVGTPYWMA 183
Query: 556 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615
PEV+ Y K+D+WSLG + E+ GE + N+ + L
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------------------- 224
Query: 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 675
Y+ E PE+ S F DF+ LE++ ++R +
Sbjct: 225 -------------YLIATNGTPELQNPEKLS---------PIFRDFLNRCLEMDVEKRGS 262
Query: 676 AREALDHPWLQ 686
A+E L HP+L+
Sbjct: 263 AKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 79/310 (25%), Positives = 130/310 (41%), Gaps = 61/310 (19%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 441
+Y E +G A V+ A D+ TG +V +K + + + + L+ NKN
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNP--- 76
Query: 442 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 501
+I+ D + + L++V E L + E G++ + R+CL+AL
Sbjct: 77 --NIVNYLDSYLVGDELWVVMEYLAGGSL------TDVVTETCMDEGQIAAVCRECLQAL 128
Query: 502 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ----TDNLCLYVQSRSYRAPE 557
++LHS +IH D+K +NIL+ +K+ D G C Q V + + APE
Sbjct: 129 DFLHSNQVIHRDIKSDNILLG--MDGSVKLTDFG-FCAQITPEQSKRSTMVGTPYWMAPE 185
Query: 558 VIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 617
V+ Y K+D+WSLG + E+ GE P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGE---PP---------------------------- 214
Query: 618 YKYFTKEYDLYYINEETNQLEYIIPEESSLE-HHLQFSDAFFIDFVRTLLEINPQRRPTA 676
Y+NE + Y+I + E + + A F DF+ LE++ RR +A
Sbjct: 215 -----------YLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSA 263
Query: 677 REALDHPWLQ 686
+E L HP+L+
Sbjct: 264 KELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 76/257 (29%), Positives = 109/257 (42%), Gaps = 66/257 (25%)
Query: 444 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 503
+I++ Y YF +FI EL+ L + K Q G LG++ V ++AL Y
Sbjct: 75 YIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQ--GPIPEDILGKMTVAI---VKALHY 129
Query: 504 L---HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-----YRA 555
L H G+IH D+KP NIL+ + +K+ D G S D+ ++RS Y A
Sbjct: 130 LKEKH--GVIHRDVKPSNILLDA--SGNVKLCDFGISGRLVDSK---AKTRSAGCAAYMA 182
Query: 556 PEVIIGLP----YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 611
PE I YD + D+WSLG L EL TG+ + N + E+L
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT--------------EFEVL 228
Query: 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEES-SLEHHLQFSDAFFIDFVRTLLEINP 670
TK I+ EE SL + FS F FV L +
Sbjct: 229 ----------TK----------------ILQEEPPSLPPNEGFS-PDFCSFVDLCLTKDH 261
Query: 671 QRRPTAREALDHPWLQH 687
++RP RE L HP+++
Sbjct: 262 RKRPKYRELLQHPFIRR 278
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD----EIKLLKLVNKNDPADEHH 444
LG +F KVF A+ T +K +K D D ++ E ++L L A EH
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL------AWEHP 56
Query: 445 IL-RLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 501
L LY F E+LF V E L ++ Q ++ F L R + + L
Sbjct: 57 FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK-------FDLPRATFYAAEIICGL 109
Query: 502 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPEV 558
++LHS GI++ DLK +NIL+ IKI D G + C + + Y APE+
Sbjct: 110 QFLHSKGIVYRDLKLDNILLD--TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEI 167
Query: 559 IIGLPYDQKIDLWSLGCILAELWTGEVLF 587
++G Y+ +D WS G +L E+ G+ F
Sbjct: 168 LLGQKYNTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 70/254 (27%), Positives = 102/254 (40%), Gaps = 61/254 (24%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK-----LVNKNDPADEH 443
+G AF +V+ +D TG +K+++ D + ++I ++ L + + P
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRK-SDMIKR--NQIAHVRAERDILADADSP---- 61
Query: 444 HILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
I++LY F EHL++V E L L F +E A F I L
Sbjct: 62 WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE---TARF------YIAELVL 112
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--------------CFQTDNL 544
AL+ +H LG IH D+KP+NILI + IK+ D G
Sbjct: 113 -ALDSVHKLGFIHRDIKPDNILIDA--DGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 545 CLYVQSR------------------SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVL 586
V R Y APEV+ G PY + D WSLG IL E+ G
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
Query: 587 FPNDAVVMILARII 600
F +D + +II
Sbjct: 230 FYSDTLQETYNKII 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 25/221 (11%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVD-VCLKII----------KNDKD-FFDQSLDEIKL 430
Y V E+LGS AF V++ + + G + + LK I K ++D + E+ +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 431 LK--LVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTL 487
+K L + N I+R Y F + L+IV +L+ A L E +E FT
Sbjct: 62 IKEQLRHPN-------IVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQR--FTE 112
Query: 488 GRLQVITRQCLEALEYLH-SLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL 546
R+ I Q + AL YLH I+H DL P NI++ + I L L
Sbjct: 113 ERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS 172
Query: 547 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLF 587
V + Y PE++ PY +K D+W+ GCIL ++ T + F
Sbjct: 173 VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 85/310 (27%), Positives = 133/310 (42%), Gaps = 74/310 (23%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIK-LLKLVNKNDPADEHHI 445
E +G +F +V++ D T V +KII +++ DEI+ + + + D +I
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDSPYI 64
Query: 446 LRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL--GRLQ-----VITRQCL 498
R Y + L+I+ E L GG A L G L+ I R+ L
Sbjct: 65 TRYYGSYLKGTKLWIIMEYL-------------GGGSALDLLKPGPLEETYIATILREIL 111
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRSYRA 555
+ L+YLHS IH D+K N+L+ ++ ++K+ D G + TD +V + + A
Sbjct: 112 KGLDYLHSERKIHRDIKAANVLLS--EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 169
Query: 556 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615
PEVI YD K D+WSLG EL GE PN
Sbjct: 170 PEVIKQSAYDFKADIWSLGITAIELAKGEP--PNS------------------------- 202
Query: 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 675
DL+ + ++ ++IP+ S Q+S F +FV L +P+ RPT
Sbjct: 203 ----------DLHPM-----RVLFLIPKNSPPTLEGQYSKP-FKEFVEACLNKDPRFRPT 246
Query: 676 AREALDHPWL 685
A+E L H ++
Sbjct: 247 AKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 2e-15
Identities = 53/227 (23%), Positives = 90/227 (39%), Gaps = 41/227 (18%)
Query: 387 EYLGSAAFSKVFQA---QDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPAD 441
+ LG AF +V++ +V +K +K D ++ L E +++K +
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG------ 54
Query: 442 EH-HILRLYDYFYHLEHLFIVCELL-RANLYEF---QKFNQESGGEAYFTLGRLQVITRQ 496
H +++RL E L++V E + +L ++ + S ++ +L L Q
Sbjct: 55 -HPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113
Query: 497 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR-- 554
+ +EYL S +H DL N L+ KI D G L V Y
Sbjct: 114 IAKGMEYLASKKFVHRDLAARNCLVGEDLVV--KISDFG--------LSRDVYDDDYYRK 163
Query: 555 -----------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589
APE + + K D+WS G +L E++T G +P
Sbjct: 164 KTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG 210
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 63/205 (30%), Positives = 91/205 (44%), Gaps = 29/205 (14%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK------LVNKNDPADE 442
+G + +VF A+ TG V LK +K K L+E++ + K++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMK--KSLL-FKLNEVRHVLTERDILTTTKSE---- 61
Query: 443 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESG----GEAYFTLGRLQVITRQCL 498
+++L F E+L++ E + +F+ G A F + +
Sbjct: 62 -WLVKLLYAFQDDEYLYLAMEYVPGG--DFRTLLNNLGVLSEDHARFYMAEM-------F 111
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEV 558
EA++ LH LG IH DLKPEN LI IK+ D G S V S Y APEV
Sbjct: 112 EAVDALHELGYIHRDLKPENFLID--ASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEV 169
Query: 559 IIGLPYDQKIDLWSLGCILAELWTG 583
+ G YD +D WSLGC+L E G
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 60/234 (25%), Positives = 97/234 (41%), Gaps = 52/234 (22%)
Query: 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 439
G + + E +G + KV++A+ TG V +KI+ +D ++ +E +L+
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILR-----KY 59
Query: 440 ADEHHILRLYDYFYHLEH------LFIVCELLRA----NLYEFQKFNQESGGE---AYFT 486
++ +I Y F L++V EL +L + + + E AY
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY-- 117
Query: 487 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL 546
I R+ L L YLH +IH D+K +NIL+ E+K++D G +
Sbjct: 118 ------ILRETLRGLAYLHENKVIHRDIKGQNILLTK--NAEVKLVDFG--------VSA 161
Query: 547 YVQSRSYR-----------APEVII-----GLPYDQKIDLWSLGCILAELWTGE 584
+ S R APEVI YD + D+WSLG EL G+
Sbjct: 162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 9e-15
Identities = 67/243 (27%), Positives = 110/243 (45%), Gaps = 22/243 (9%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKND 438
+Y +G AF V + V +K I + KD + +E ++LKL++ +
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 439 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
I+ Y+ F + L IV E ++ Q+ L Q L
Sbjct: 61 ------IIEYYENFLEDKALMIVMEYAPGGTLA--EYIQKRCNSLLDEDTILHFFV-QIL 111
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY--VQSRSYRAP 556
AL ++H+ I+H DLK +NIL+ ++ +KI D G S + Y V + Y +P
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHKMV-VKIGDFGISKILSSKSKAYTVVGTPCYISP 170
Query: 557 EVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII-GMLGPI------DLE 609
E+ G PY+QK D+W+LGC+L EL + + F + ++ +I+ G PI DL
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLR 230
Query: 610 MLM 612
L+
Sbjct: 231 QLI 233
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 12/204 (5%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 441
+Y V +G +F + Q +++ +K I+ K + + L P
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHP-- 58
Query: 442 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 501
+I+ + F HL+IV E QK + G + + LQ + CL +
Sbjct: 59 --NIVAFKESFEADGHLYIVMEYCDGGDL-MQKIKLQRG-KLFPEDTILQWFVQMCL-GV 113
Query: 502 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL---CLYVQSRSYRAPEV 558
+++H ++H D+K +NI + Q ++K+ D GS+ T C YV + Y PE+
Sbjct: 114 QHIHEKRVLHRDIKSKNIFLT--QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI 171
Query: 559 IIGLPYDQKIDLWSLGCILAELWT 582
+PY+ K D+WSLGCIL EL T
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 81/316 (25%), Positives = 139/316 (43%), Gaps = 38/316 (12%)
Query: 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII--KNDKDFFDQSLDEIKLLK-LVNK 436
A Y E LG +++ V++ G V LK+I K ++ ++ E LLK L +
Sbjct: 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 437 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 496
N I+ L+D + E L V E + +L ++ Q GG + + ++ Q
Sbjct: 64 N-------IVLLHDIIHTKETLTFVFEYMHTDLAQY--MIQHPGGLHPYNV---RLFMFQ 111
Query: 497 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSY 553
L L Y+H I+H DLKP+N+LI E+K+ D G + + V + Y
Sbjct: 112 LLRGLAYIHGQHILHRDLKPQNLLISYLG--ELKLADFGLARAKSIPSQTYSSEVVTLWY 169
Query: 554 RAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVM-ILARIIGMLGPIDLEML 611
R P+V++G Y +D+W GCI E+ G+ FP + V L +I +LG
Sbjct: 170 RPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLG------- 222
Query: 612 MQGQEIYKYFTK--EYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 669
+ ++ + +K Y + Q ++ + S + D +L +
Sbjct: 223 VPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAE-------DLASQMLMMF 275
Query: 670 PQRRPTAREALDHPWL 685
P+ R +A++AL HP+
Sbjct: 276 PKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 82/314 (26%), Positives = 139/314 (44%), Gaps = 48/314 (15%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLK-LVNKNDPAD 441
+ LG +++ V++ + TG V LK I+ + + F ++ E LLK L + N
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPF--TAIREASLLKDLKHAN---- 64
Query: 442 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 501
I+ L+D + + L +V E L +L Q + GG ++ +++ Q L L
Sbjct: 65 ---IVTLHDIIHTKKTLTLVFEYLDTDLK--QYMDDCGGG---LSMHNVRLFLFQLLRGL 116
Query: 502 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--------SSCFQTDNLCLYVQSRSY 553
Y H ++H DLKP+N+LI +R E+K+ D G S + + + L+ Y
Sbjct: 117 AYCHQRRVLHRDLKPQNLLIS--ERGELKLADFGLARAKSVPSKTYSNEVVTLW-----Y 169
Query: 554 RAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFP-NDAVVMILARIIGMLGPIDLEML 611
R P+V++G Y +D+W +GCI E+ TG LFP + V L +I +LG E
Sbjct: 170 RPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETW 229
Query: 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQ 671
++ + Y L P + H + L+ P+
Sbjct: 230 PGVSSNPEFKPYSFPFY----PPRPLINHAPRLDRIPHG--------EELALKFLQYEPK 277
Query: 672 RRPTAREALDHPWL 685
+R +A EA+ HP+
Sbjct: 278 KRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 67/236 (28%), Positives = 111/236 (47%), Gaps = 32/236 (13%)
Query: 382 RYYVTEYL--GSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 439
R Y+ ++ G + V A + HTG V +K + D Q E+ ++V D
Sbjct: 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKM----DLRKQQRRELLFNEVVIMRD- 75
Query: 440 ADEHH--ILRLYDYFYHLEHLFIVCELLRA----NLYEFQKFNQESGGEAYFTLGRLQVI 493
HH ++ +Y+ + + L++V E L ++ + N+E ++ +
Sbjct: 76 --YHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----------QIATV 123
Query: 494 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC----LYVQ 549
L AL YLH+ G+IH D+K ++IL+ S R IK+ D G C Q V
Sbjct: 124 CLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR--IKLSDFGF-CAQVSKEVPKRKSLVG 180
Query: 550 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 605
+ + APEVI LPY ++D+WSLG ++ E+ GE + N+ + + RI L P
Sbjct: 181 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP 236
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 66/209 (31%), Positives = 95/209 (45%), Gaps = 19/209 (9%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD----EIKLLKLVNKNDPADEHH 444
LG +F KV A+ G +K +K D D ++ E ++L L +N P H
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWEN-PFLTH- 60
Query: 445 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 504
LY F EHLF V E L F Q+ G F L R + + L++L
Sbjct: 61 ---LYCTFQTKEHLFFVMEFLNGGDLMFHI--QDKG---RFDLYRATFYAAEIVCGLQFL 112
Query: 505 HSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPEVIIG 561
HS GII+ DLK +N+++ IKI D G + F + + + Y APE++ G
Sbjct: 113 HSKGIIYRDLKLDNVMLDRDGH--IKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG 170
Query: 562 LPYDQKIDLWSLGCILAELWTGEVLFPND 590
L Y +D WS G +L E+ G+ F D
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 31/215 (14%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG +F KV A+ T +K++K D D + ++ E ++L L K H
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK------HP 56
Query: 445 IL-RLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 501
L +L+ F + LF V E + ++ Q+ + A F + + L
Sbjct: 57 FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVL-------GL 109
Query: 502 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------YRA 555
++LH GII+ DLK +N+L+ S IKI D G + + V + + Y A
Sbjct: 110 QFLHERGIIYRDLKLDNVLLDS--EGHIKIADFGMC---KEGILGGVTTSTFCGTPDYIA 164
Query: 556 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 590
PE++ PY +D W+LG +L E+ G+ F D
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 5e-14
Identities = 63/207 (30%), Positives = 93/207 (44%), Gaps = 30/207 (14%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKN----DKDFFDQSLDEIKLLKLVNKNDPADEHH 444
+G +F KV Q + T LK I+ + +L E +L VN P
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN--CP----F 54
Query: 445 ILRLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 502
I+ L F E L++V + + Q+ E F L R + T + L ALE
Sbjct: 55 IVPLKFSFQSPEKLYLVLAFINGGELFHHLQR-------EGRFDLSRARFYTAELLCALE 107
Query: 503 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------SSCFQTDNLCLYVQSRSYRAP 556
LH +I+ DLKPENIL+ YQ I + D G +T+ C + Y AP
Sbjct: 108 NLHKFNVIYRDLKPENILL-DYQG-HIALCDFGLCKLNMKDDDKTNTFC---GTPEYLAP 162
Query: 557 EVIIGLPYDQKIDLWSLGCILAELWTG 583
E+++G Y + +D W+LG +L E+ TG
Sbjct: 163 ELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 6e-14
Identities = 76/309 (24%), Positives = 129/309 (41%), Gaps = 59/309 (19%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 441
+Y E +G A V+ A D+ TG +V ++ + + + + L+ NKN
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP--- 77
Query: 442 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 501
+I+ D + + L++V E L + E G++ + R+CL+AL
Sbjct: 78 --NIVNYLDSYLVGDELWVVMEYLAGGSL------TDVVTETCMDEGQIAAVCRECLQAL 129
Query: 502 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ----TDNLCLYVQSRSYRAPE 557
E+LHS +IH D+K +NIL+ +K+ D G C Q V + + APE
Sbjct: 130 EFLHSNQVIHRDIKSDNILLG--MDGSVKLTDFG-FCAQITPEQSKRSTMVGTPYWMAPE 186
Query: 558 VIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 617
V+ Y K+D+WSLG + E+ GE + N+ + L
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--------------------- 225
Query: 618 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 677
Y+ E PE+ S A F DF+ L+++ ++R +A+
Sbjct: 226 -----------YLIATNGTPELQNPEKLS---------AIFRDFLNRCLDMDVEKRGSAK 265
Query: 678 EALDHPWLQ 686
E L H +L+
Sbjct: 266 ELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 389 LGSAAFSKVFQAQDLHTG-VDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG F +V Q TG + C K+ K + +L+E K+L+ V+
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS------RF 54
Query: 445 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 504
I+ L F + L +V L+ ++ +N GE F R Q + LE+L
Sbjct: 55 IVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNV---GEPGFPEARAIFYAAQIICGLEHL 111
Query: 505 HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSYRAPEVIIGL 562
H I++ DLKPEN+L+ + +I DLG + + + Y APEV+ G
Sbjct: 112 HQRRIVYRDLKPENVLLDDHGNV--RISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGE 169
Query: 563 PYDQKIDLWSLGCILAELWTGEVLF 587
YD +D ++LGC L E+ G F
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 84/318 (26%), Positives = 125/318 (39%), Gaps = 86/318 (27%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL-DEIKLLK-LVNKNDPADEHHIL 446
LG + V+ A+DL T V + +K I + Q L +EI L L ++N I+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN-------IV 68
Query: 447 RLYDYFYHLEHLFIVCE---------LLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 497
+ I E LLR+ K+ E + T+Q
Sbjct: 69 QYLGSDSENGFFKIFMEQVPGGSLSALLRS------KWGPLKDNEQ-----TIIFYTKQI 117
Query: 498 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--------CFQTDNLCLYVQ 549
LE L+YLH I+H D+K +N+L+ +Y +KI D G+S C +T +
Sbjct: 118 LEGLKYLHDNQIVHRDIKGDNVLVNTYSGV-VKISDFGTSKRLAGINPCTET-----FTG 171
Query: 550 SRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 607
+ Y APEVI P Y D+WSLGC + E+ TG+ F LG
Sbjct: 172 TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE-------------LGEPQ 218
Query: 608 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLE 667
M G ++ I+ E IPE S E +F+ E
Sbjct: 219 AAMFKVG------------MFKIHPE-------IPESLSAEAK---------NFILRCFE 250
Query: 668 INPQRRPTAREALDHPWL 685
+P +R +A + L P+L
Sbjct: 251 PDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 64/242 (26%), Positives = 118/242 (48%), Gaps = 36/242 (14%)
Query: 468 NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI--KSYQ 525
++ +F + ++ + G ++ + Q L+ + YLH+ ++H DLKP NIL+ + +
Sbjct: 88 HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPE 147
Query: 526 RCEIKIIDLG-SSCFQTD-----NLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILA 578
R +KI D+G + F + +L V + YRAPE+++G Y + ID+W++GCI A
Sbjct: 148 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA 207
Query: 579 ELWTGEVLF---------PNDAVVMILARIIGMLG-PI-----DLEMLMQGQEIYKYFTK 623
EL T E +F N L RI ++G P D++ + + + K F +
Sbjct: 208 ELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRR 267
Query: 624 EYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHP 683
Y N + ++Y +E H D+ ++ LL ++P +R T+ +A+ P
Sbjct: 268 N---TYTN--CSLIKY-------MEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 315
Query: 684 WL 685
+
Sbjct: 316 YF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 23/208 (11%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD----EIKLLKLVNKNDPADEHH 444
LG +F KV A+ T +KI+K D D ++ E ++L L P
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLAL-----PGKPPF 62
Query: 445 ILRLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 502
+ +L+ F ++ L+ V E + +Y Q+ + A F + + L
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAI-------GLF 115
Query: 503 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPEVI 559
+LHS GII+ DLK +N+++ + IKI D G + F + + Y APE+I
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDA--EGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII 173
Query: 560 IGLPYDQKIDLWSLGCILAELWTGEVLF 587
PY + +D W+ G +L E+ G+ F
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 28/210 (13%)
Query: 496 QCLEALEYLHSLGIIHCDLKPENILI--KSYQRCEIKIIDLG-SSCFQTD-----NLCLY 547
Q L+ + YLH+ ++H DLKP NIL+ + +R +KI D+G + F + +L
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 548 VQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLF---------PNDAVVMILA 597
V + YRAPE+++G Y + ID+W++GCI AEL T E +F N L
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLD 235
Query: 598 RIIGMLG-PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQL-EYIIPEESSLEHHLQFSD 655
RI ++G P D + +++ +Y T + D + L +Y +E H D
Sbjct: 236 RIFSVMGFPADKDW-EDIRKMPEYPTLQKDFRRTTYANSSLIKY-------MEKHKVKPD 287
Query: 656 AFFIDFVRTLLEINPQRRPTAREALDHPWL 685
+ ++ LL ++P +R T+ +AL P+
Sbjct: 288 SKVFLLLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 64/210 (30%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG +F KV A+ T +K +K D D + ++ E ++L L A EH
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLAL------AWEHP 56
Query: 445 IL-RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 503
L L+ F EHLF V E L F Q SG F R + + + L++
Sbjct: 57 FLTHLFCTFQTKEHLFFVMEYLNGGDLMFHI--QSSG---RFDEARARFYAAEIICGLQF 111
Query: 504 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ------TDNLCLYVQSRSYRAPE 557
LH GII+ DLK +N+L+ IKI D G C + Y APE
Sbjct: 112 LHKKGIIYRDLKLDNVLLDKDGH--IKIADFGMCKENMNGEGKASTFC---GTPDYIAPE 166
Query: 558 VIIGLPYDQKIDLWSLGCILAELWTGEVLF 587
++ G Y++ +D WS G +L E+ G+ F
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 64/204 (31%), Positives = 88/204 (43%), Gaps = 50/204 (24%)
Query: 490 LQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYV 548
L I ++ALEYLHS L +IH D+KP N+LI + ++K+ D G S + D++ +
Sbjct: 105 LGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLIN--RNGQVKLCDFGISGYLVDSVAKTI 162
Query: 549 Q--SRSYRAPEVIIG----LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 602
+ Y APE I YD K D+WSLG + EL TG FP D+
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR--FPYDS----------- 209
Query: 603 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFV 662
+ L Q + E + QL P E FS F DFV
Sbjct: 210 -WKTPFQQLKQ---------------VVEEPSPQL----PAEK-------FS-PEFQDFV 241
Query: 663 RTLLEINPQRRPTAREALDHPWLQ 686
L+ N + RP E L HP+ +
Sbjct: 242 NKCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 57/175 (32%), Positives = 87/175 (49%), Gaps = 22/175 (12%)
Query: 440 ADEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 497
A+ +H I++L+ F L+++ + LR F + S E FT ++ +
Sbjct: 53 AEVNHPFIVKLHYAFQTEGKLYLILDFLRGG----DLFTRLSK-EVMFTEEDVKFYLAEL 107
Query: 498 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN------LCLYVQSR 551
AL++LHSLGII+ DLKPENIL+ + IK+ D G S D+ C V+
Sbjct: 108 ALALDHLHSLGIIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYSFCGTVE-- 163
Query: 552 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP----NDAVVMILARIIGM 602
Y APEV+ + Q D WS G ++ E+ TG + F + + MIL +GM
Sbjct: 164 -YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGM 217
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 31/209 (14%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIK-LLKLVNKNDPADEHHI 445
E +G +F +VF+ D T V +KII +++ DEI+ + + + D ++
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 446 LRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL-------GRLQVITRQCL 498
+ Y + L+I+ E L GG A L ++ I R+ L
Sbjct: 65 TKYYGSYLKDTKLWIIMEYL-------------GGGSALDLLEPGPLDETQIATILREIL 111
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRSYRA 555
+ L+YLHS IH D+K N+L+ + E+K+ D G + TD +V + + A
Sbjct: 112 KGLDYLHSEKKIHRDIKAANVLLSEHG--EVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 169
Query: 556 PEVIIGLPYDQKIDLWSLGCILAELWTGE 584
PEVI YD K D+WSLG EL GE
Sbjct: 170 PEVIKQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 6e-13
Identities = 60/230 (26%), Positives = 98/230 (42%), Gaps = 23/230 (10%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA- 440
RY + + LG +F V+ +D + LK++K + + E+ + V N A
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLK------EIPVGELNPNETVQANQEAQ 54
Query: 441 -----DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 495
D I++ + F + I+ E + + + G+ TL QV
Sbjct: 55 LLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGK---TLSENQVCEW 111
Query: 496 --QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQS 550
Q L + Y+H I+H DLK +NI +K+ +KI D G S D + +
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL---LKIGDFGVSRLLMGSCDLATTFTGT 168
Query: 551 RSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 600
Y +PE + YD K D+WSLGCIL E+ F + ++ RI+
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 9e-13
Identities = 67/226 (29%), Positives = 96/226 (42%), Gaps = 33/226 (14%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 446
E LG+ +F +V A+ TG +K +K EI +K V H+
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKR---------EILKMKQVQ--------HVA 66
Query: 447 RLYDYFYHLEHLFIV---CELLRAN-LYEFQKFNQESGGEAYFTL---GRL--QVITRQC 497
+ L H FIV C N +Y +F GGE + L GR V
Sbjct: 67 QEKSILMELSHPFIVNMMCSFQDENRVYFLLEF--VVGGELFTHLRKAGRFPNDVAKFYH 124
Query: 498 LE---ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR 554
E A EYLHS II+ DLKPEN+L+ + +K+ D G + D + Y
Sbjct: 125 AELVLAFEYLHSKDIIYRDLKPENLLLD--NKGHVKVTDFGFAKKVPDRTFTLCGTPEYL 182
Query: 555 APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 600
APEVI + + +D W++G +L E G F +D I +I+
Sbjct: 183 APEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL 228
|
Length = 329 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 64/234 (27%), Positives = 109/234 (46%), Gaps = 24/234 (10%)
Query: 383 YYVTEYLGSAAFSKVFQA---QDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 439
+ + +G +F VF+ D + + K ++ ++++DE ++L +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL----- 56
Query: 440 ADEHHILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQV--ITRQ 496
D +I+R Y+ F L IV E +L++ K + L QV Q
Sbjct: 57 -DSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR------PLPEDQVWRFFIQ 109
Query: 497 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSY 553
L L +LHS I+H D+K N+ + +Y +KI DLG + +DN V + Y
Sbjct: 110 ILLGLAHLHSKKILHRDIKSLNLFLDAYD--NVKIGDLGVAKLLSDNTNFANTIVGTPYY 167
Query: 554 RAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLF-PNDAVVMILARIIGMLGPI 606
+PE+ PY++K D+W+LG +L E TG+ F N+ +IL I G+ P+
Sbjct: 168 LSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV 221
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 38/107 (35%), Positives = 55/107 (51%), Gaps = 23/107 (21%)
Query: 487 LGRLQV--ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL 544
LG QV + RQ L A++Y+H GIIH D+K EN+L+ + +I + D G++CF
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE--DICLGDFGAACFARG-- 312
Query: 545 CLYVQSRS------------YRAPEVIIGLPYDQKIDLWSLGCILAE 579
S S APEV+ G PY +D+WS G ++ E
Sbjct: 313 -----SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 70/268 (26%), Positives = 107/268 (39%), Gaps = 59/268 (22%)
Query: 422 DQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESG 480
+L+EI +L L+ + I+ Y++F L I E LY K ++ G
Sbjct: 44 RDALNEIVILSLLQHPN------IIAYYNHFMDDNTLLIEMEYANGGTLY--DKIVRQKG 95
Query: 481 GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 540
F + Q + A+ Y+H GI+H D+K NI + + IK+ D G S
Sbjct: 96 --QLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT--KAGLIKLGDFGISKIL 151
Query: 541 TDNLCL---YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILA 597
+ V + Y +PE+ G+ Y+ K D+W+LGC+L EL T L
Sbjct: 152 GSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT-------------LK 198
Query: 598 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAF 657
R P++L + K Y + S E
Sbjct: 199 RTFDATNPLNL--------VVKIVQGNYT-------------PVVSVYSSE--------- 228
Query: 658 FIDFVRTLLEINPQRRPTAREALDHPWL 685
I V +LL+ +P++RPTA E LD P L
Sbjct: 229 LISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 79/313 (25%), Positives = 133/313 (42%), Gaps = 80/313 (25%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIK-LLKLVNKNDPADEHHI 445
E +G +F +VF+ D T V +KII +++ DEI+ + + + D ++
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 446 LRLYDYFYHLEHLFIVCE---------LLRANLY-EFQKFNQESGGEAYFTLGRLQVITR 495
+ Y + L+I+ E LLRA + EFQ + + +
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQ----------------IATMLK 108
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRS 552
+ L+ L+YLHS IH D+K N+L+ ++ ++K+ D G + TD +V +
Sbjct: 109 EILKGLDYLHSEKKIHRDIKAANVLLS--EQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 166
Query: 553 YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 612
+ APEVI YD K D+WSLG EL GE PN
Sbjct: 167 WMAPEVIQQSAYDSKADIWSLGITAIELAKGEP--PNS---------------------- 202
Query: 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 672
D++ + ++ ++IP+ + +FS F +F+ L +P
Sbjct: 203 -------------DMHPM-----RVLFLIPKNNPPTLTGEFSKP-FKEFIDACLNKDPSF 243
Query: 673 RPTAREALDHPWL 685
RPTA+E L H ++
Sbjct: 244 RPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 60/228 (26%), Positives = 109/228 (47%), Gaps = 28/228 (12%)
Query: 382 RYYVTEY--LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 439
R + Y +G + V A++ H+G V +K++ D Q E+ ++V D
Sbjct: 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMM----DLRKQQRRELLFNEVVIMRD- 74
Query: 440 ADEHHILRLYDYFYHLEHLFIVCELLRA----NLYEFQKFNQESGGEAYFTLGRLQVITR 495
+++ +Y + E L+++ E L+ ++ + N+E ++ +
Sbjct: 75 YQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEE----------QIATVCE 124
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC----LYVQSR 551
L+AL YLHS G+IH D+K ++IL+ R +K+ D G C Q V +
Sbjct: 125 SVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGF-CAQISKDVPKRKSLVGTP 181
Query: 552 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 599
+ APEVI PY ++D+WSLG ++ E+ GE + +D+ V + R+
Sbjct: 182 YWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL 229
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 56/202 (27%), Positives = 83/202 (41%), Gaps = 54/202 (26%)
Query: 493 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 552
I L+ L YLHS IH D+K NIL+ + +K+ D GS+ +V +
Sbjct: 120 ICHGALQGLAYLHSHERIHRDIKAGNILLT--EPGTVKLADFGSASL-VSPANSFVGTPY 176
Query: 553 YRAPEVIIGL---PYDQKIDLWSLG--CI-LAELWTGEVLFPNDAVVMILARIIGMLGPI 606
+ APEVI+ + YD K+D+WSLG CI LAE LF +A+
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAE--RKPPLFNMNAMSA------------ 222
Query: 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLL 666
LY+I + N + + S F +FV + L
Sbjct: 223 --------------------LYHIAQ--NDSPTLSSNDWSDY---------FRNFVDSCL 251
Query: 667 EINPQRRPTAREALDHPWLQHP 688
+ PQ RP++ E L H ++
Sbjct: 252 QKIPQDRPSSEELLKHRFVLRE 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 13/205 (6%)
Query: 389 LGSAAFSKVFQAQDLHTG-VDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG F +V Q +TG + C K+ K K +L E ++L+ VN
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN------SPF 54
Query: 445 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 504
I+ L F HL +V L+ ++ +N GE + R+ + Q + +L
Sbjct: 55 IVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNV---GERGLEMERVIHYSAQITCGILHL 111
Query: 505 HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPY 564
HS+ I++ D+KPEN+L+ C + + L + + Y APE++ PY
Sbjct: 112 HSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPY 171
Query: 565 DQKIDLWSLGCILAELWTGEVLFPN 589
+D +++GC + E+ G F +
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 42/221 (19%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLL-KLVNKN 437
Y V E +G +F V + + G + K I +K+ Q + E+ +L +L + N
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-QQLVSEVNILRELKHPN 60
Query: 438 DPADEHHILRLYDYFYHLEH--LFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRL 490
I+R YD + L+IV E L + + +K + Y +
Sbjct: 61 -------IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERK------YIEEEFI 107
Query: 491 QVITRQCLEALEYLHSLG-----IIHCDLKPENILIKSYQRCEI------KIIDLGSSCF 539
I Q L AL H+ ++H DLKP NI + + ++ KI+ SS
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA 167
Query: 540 QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAEL 580
+T YV + Y +PE + + YD+K D+WSLGC++ EL
Sbjct: 168 KT-----YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 42/116 (36%), Positives = 59/116 (50%), Gaps = 13/116 (11%)
Query: 479 SGGEAYFTLG--------RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 530
+GGE +F L R + + AL YLHS+ I++ DLKPENIL+ S + +
Sbjct: 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDS--QGHVV 136
Query: 531 IIDLG---SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 583
+ D G Q+D + + Y APEVI PYD +D W LG +L E+ G
Sbjct: 137 LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 42/119 (35%), Positives = 62/119 (52%), Gaps = 16/119 (13%)
Query: 479 SGGE--------AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 530
+GGE +FT ++V + + AL++LH LGII+ D+K ENIL+ S +
Sbjct: 88 NGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDS--EGHVV 145
Query: 531 IIDLG-SSCFQTDNL---CLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTG 583
+ D G S F + + + Y APEVI G +D+ +D WSLG + EL TG
Sbjct: 146 LTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 78/311 (25%), Positives = 120/311 (38%), Gaps = 69/311 (22%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKII--KNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 446
+GS A V++ TG LK+I ++ Q EI++L+ VN P ++
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNH--PN----VV 135
Query: 447 RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS 506
+ +D F H + ++ E + E E L + RQ L + YLH
Sbjct: 136 KCHDMFDHNGEIQVLLEFMDGGSLEGTHIADE---------QFLADVARQILSGIAYLHR 186
Query: 507 LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF--QTDNLC-LYVQSRSYRAPEVI---- 559
I+H D+KP N+LI S + +KI D G S QT + C V + +Y +PE I
Sbjct: 187 RHIVHRDIKPSNLLINSAKN--VKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDL 244
Query: 560 -IGLPYDQKI-DLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 617
G YD D+WSLG + E + G F +G G D LM
Sbjct: 245 NHGA-YDGYAGDIWSLGVSILEFYLGRFPFG-----------VGRQG--DWASLMCA--- 287
Query: 618 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 677
+ P E+ +F F+ L+ P +R +A
Sbjct: 288 -------------------ICMSQPPEAPATASREFR-----HFISCCLQREPAKRWSAM 323
Query: 678 EALDHPWLQHP 688
+ L HP++
Sbjct: 324 QLLQHPFILRA 334
|
Length = 353 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 8e-12
Identities = 56/199 (28%), Positives = 84/199 (42%), Gaps = 40/199 (20%)
Query: 493 ITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC-LYVQS 550
I +E L YL++ I+H D+KP NIL+ S R +IK+ D G S +++ +V +
Sbjct: 108 IAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS--RGQIKLCDFGVSGELINSIADTFVGT 165
Query: 551 RSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLF--PNDAVVMILARIIGMLGPIDL 608
+Y +PE I G Y K D+WSLG + EL G+ F N G P+ +
Sbjct: 166 STYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD-------GQDDPMGI 218
Query: 609 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEI 668
L+Q + E +L P E DFV L
Sbjct: 219 LDLLQ--------------QIVQEPPPRL----PSSDFPED--------LRDFVDACLLK 252
Query: 669 NPQRRPTAREALD-HPWLQ 686
+P RPT ++ P++Q
Sbjct: 253 DPTERPTPQQLCAMPPFIQ 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 8e-12
Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 29/209 (13%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLVNKNDPADE 442
LG AF +V+ D+ TG ++ K ++ D + + S + EI+LLK +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 443 HHILRLYDYFYHLEH-LFIVCELLRANLYEFQKFNQESGGEAY--FTLGRLQVITRQCLE 499
+ LR E L I E + + Q +AY T + TRQ LE
Sbjct: 70 YGCLR-----DRAEKTLTIFMEYMPGGSVKDQL-------KAYGALTESVTRKYTRQILE 117
Query: 500 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS------CFQTDNLCLYVQSRSY 553
+ YLHS I+H D+K NIL S +K+ D G+S C + + +
Sbjct: 118 GMSYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 554 RAPEVIIGLPYDQKIDLWSLGCILAELWT 582
+PEVI G Y +K D+WSLGC + E+ T
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 42/122 (34%), Positives = 57/122 (46%), Gaps = 26/122 (21%)
Query: 500 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC--------------------- 538
ALEYLH+ GI+H DLKP+N+LI S IK+ D G S
Sbjct: 113 ALEYLHNYGIVHRDLKPDNLLITSMG--HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 539 FQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILAR 598
F +C + Y APEVI+ Y + +D W++G IL E G V F D + +
Sbjct: 171 FLDKQVC---GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 227
Query: 599 II 600
+I
Sbjct: 228 VI 229
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 77/309 (24%), Positives = 126/309 (40%), Gaps = 63/309 (20%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPAD 441
Y + + +GS + V++A++LHTG +KIIK + D F EI ++K
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVK------ECK 64
Query: 442 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV--ITRQCLE 499
+I+ + + E L+I E Q +G L LQ+ + R+ L+
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGG--SLQDIYHVTG-----PLSELQIAYVCRETLQ 117
Query: 500 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRSYRAP 556
L YLHS G +H D+K NIL+ ++K+ D G + T + ++ + + AP
Sbjct: 118 GLAYLHSKGKMHRDIKGANILLTDNG--DVKLADFGVAAKITATIAKRKSFIGTPYWMAP 175
Query: 557 EVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613
EV Y+Q D+W++G EL E+ P + L P+ LM
Sbjct: 176 EVAAVEKNGGYNQLCDIWAVGITAIEL--AELQPP-----------MFDLHPMRALFLMS 222
Query: 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 673
+ L+ ++S F +FV+ L NP++R
Sbjct: 223 KSNF-------------------------QPPKLKDKTKWSSTFH-NFVKISLTKNPKKR 256
Query: 674 PTAREALDH 682
PTA L H
Sbjct: 257 PTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 65/219 (29%), Positives = 101/219 (46%), Gaps = 50/219 (22%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD---EHHI 445
LG + KVFQ + + TG D K F + L + +++ N+ D A E +I
Sbjct: 4 LGKGGYGKVFQVRKV-TGAD-------TGKIFAMKVLKKATIVR--NQKDTAHTKAERNI 53
Query: 446 LRLYDYFYHLEHLFIVCELLRANLYEFQK-------FNQESGGEAYFTLGRLQVITR--- 495
L ++H FIV +L+ Y FQ SGGE + L R +
Sbjct: 54 LE------AVKHPFIV-DLI----YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTA 102
Query: 496 -----QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQ---TDNL 544
+ ALE+LH GII+ DLKPENIL+ + +K+ D G S + T
Sbjct: 103 CFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG--HVKLTDFGLCKESIHEGTVTHTF 160
Query: 545 CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 583
C ++ Y APE+++ + + +D WSLG ++ ++ TG
Sbjct: 161 CGTIE---YMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 25/209 (11%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG +F KV A+ +G +K++K D D + ++ E ++L L A H
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSL------ARNHP 56
Query: 445 IL-RLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 501
L +LY F + LF V E + ++ QK + F R + + AL
Sbjct: 57 FLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR-------FDEARARFYAAEITSAL 109
Query: 502 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPEV 558
+LH GII+ DLK +N+L+ C K+ D G N + + Y APE+
Sbjct: 110 MFLHDKGIIYRDLKLDNVLLDHEGHC--KLADFGMCKEGIFNGKTTSTFCGTPDYIAPEI 167
Query: 559 IIGLPYDQKIDLWSLGCILAELWTGEVLF 587
+ + Y +D W++G +L E+ G F
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 77/316 (24%), Positives = 123/316 (38%), Gaps = 70/316 (22%)
Query: 385 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN--DKDFFDQSLDEIKLLKLVNKNDPADE 442
V + LG + V++ TGV + +K I+ D+ F+Q + E+ +L A
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILH------KAVS 58
Query: 443 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 502
+I+ Y F+ +++ E + A K L+ IT ++ L+
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAG--SLDKLYAGGVATEGIPEDVLRRITYAVVKGLK 116
Query: 503 YL-HSLGIIHCDLKPENILIKSYQRCEIKIIDLG------SSCFQTDNLCLYVQSRSYRA 555
+L IIH D+KP N+L+ ++K+ D G +S +T+ C +SY A
Sbjct: 117 FLKEEHNIIHRDVKPTNVLVNG--NGQVKLCDFGVSGNLVASLAKTNIGC-----QSYMA 169
Query: 556 PEVIIG------LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 609
PE I Y + D+WSLG + E+ G +P + I A+ L
Sbjct: 170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ---------LS 220
Query: 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 669
++ G +P S DA DFV L
Sbjct: 221 AIVDGDPPT----------------------LPSGYS-------DDA--QDFVAKCLNKI 249
Query: 670 PQRRPTAREALDHPWL 685
P RRPT + L+HPWL
Sbjct: 250 PNRRPTYAQLLEHPWL 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 39/214 (18%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK-LVNKNDPAD 441
LG AF +V+ D TG ++ +K ++ D + + S + EI+LLK L+++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHE----- 64
Query: 442 EHHILRLYDYFYHLEH-----LFIVCELLRANLYEFQKFNQESGGEAYFTLGR--LQVIT 494
R+ Y+ L L I E + + Q ++Y L + T
Sbjct: 65 -----RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-------KSYGALTENVTRKYT 112
Query: 495 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS------CFQTDNLCLYV 548
RQ LE + YLHS I+H D+K NIL S +K+ D G+S C +
Sbjct: 113 RQILEGVSYLHSNMIVHRDIKGANILRDSVG--NVKLGDFGASKRLQTICLSGTGMKSVT 170
Query: 549 QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT 582
+ + +PEVI G Y +K D+WS+GC + E+ T
Sbjct: 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 49/217 (22%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK---LVNKNDPADEHHI 445
+G +F KV A+ K D F+ +K+L+ ++ K + + HI
Sbjct: 3 IGKGSFGKVLLAKH------------KADGKFY-----AVKVLQKKAILKKKE---QKHI 42
Query: 446 LRLYDYFY-HLEHLFIVCELLRANLYEFQK-------FNQESGGEAYFTLGR----LQVI 493
+ + +++H F+V L Y FQ + +GGE +F L R +
Sbjct: 43 MAERNVLLKNVKHPFLVG--LH---YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPR 97
Query: 494 TR----QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCL 546
R + AL YLHSL II+ DLKPENIL+ S + + + D G +
Sbjct: 98 ARFYAAEIASALGYLHSLNIIYRDLKPENILLDS--QGHVVLTDFGLCKEGIEHSKTTST 155
Query: 547 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 583
+ + Y APEV+ PYD+ +D W LG +L E+ G
Sbjct: 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 32/213 (15%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKND 438
+ + + +G FS+V++A L GV V LK ++ D + EI LLK +N +
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 439 PADEHHILRLYDYFYHLEHLFIVCELLRAN-----LYEFQKFNQ---ESGGEAYFTLGRL 490
+++ Y F L IV EL A + F+K + E YF
Sbjct: 64 ------VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV---- 113
Query: 491 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLY 547
Q ALE++HS ++H D+KP N+ I + +K+ DLG F +T
Sbjct: 114 -----QLCSALEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSSKTTAAHSL 166
Query: 548 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAEL 580
V + Y +PE I Y+ K D+WSLGC+L E+
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 43/214 (20%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD-QSLDEIKLLKLVNKNDPADEHHILR 447
+G +F KV A+ K+D F+ + L + +LK +N E ++L
Sbjct: 3 IGKGSFGKVLLAKR------------KSDGSFYAVKVLQKKTILKKKEQNHIMAERNVL- 49
Query: 448 LYDYFYHLEHLFIVCELLRANLYEFQK-------FNQESGGEAYFTLGRLQVITR----- 495
+L+H F+V L Y FQ + +GGE +F L R +
Sbjct: 50 ----LKNLKHPFLVG--LH---YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF 100
Query: 496 ---QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQ 549
+ A+ YLHSL II+ DLKPENIL+ S + + + D G + +
Sbjct: 101 YAAEVASAIGYLHSLNIIYRDLKPENILLDS--QGHVVLTDFGLCKEGVEPEETTSTFCG 158
Query: 550 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 583
+ Y APEV+ PYD+ +D W LG +L E+ G
Sbjct: 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 9e-11
Identities = 74/302 (24%), Positives = 128/302 (42%), Gaps = 65/302 (21%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKII----KNDKDFFDQSLDEIKLLKLVNKNDPADEHH 444
+G +F V+ A+D+ T V +K + K + + + E+K L+ + + +
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE--- 89
Query: 445 ILRLYDYFYHLEHL-FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 503
Y Y EH ++V E + + + +++ E + IT L+ L Y
Sbjct: 90 ----YKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV-----EIAAITHGALQGLAY 140
Query: 504 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL- 562
LHS +IH D+K NIL+ + ++K+ D GS+ + +V + + APEVI+ +
Sbjct: 141 LHSHNMIHRDIKAGNILLT--EPGQVKLADFGSASIASPANS-FVGTPYWMAPEVILAMD 197
Query: 563 --PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKY 620
YD K+D+WSLG EL
Sbjct: 198 EGQYDGKVDVWSLGITCIEL---------------------------------------- 217
Query: 621 FTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 680
++ L+ +N + L +I ES ++SD +F +FV + L+ PQ RPT+ E L
Sbjct: 218 AERKPPLFNMN-AMSALYHIAQNESPTLQSNEWSD-YFRNFVDSCLQKIPQDRPTSEELL 275
Query: 681 DH 682
H
Sbjct: 276 KH 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 9e-11
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 31/215 (14%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG +F KV A+ T +K++K D D D ++ E ++L L K+
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHP-----F 57
Query: 445 ILRLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 502
+ L+ F + LF V E + +++ Q+ + F R + + AL
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK-------FDEPRSRFYAAEVTLALM 110
Query: 503 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ-------TDNLCLYVQSRSYRA 555
+LH G+I+ DLK +NIL+ + C K+ D G C + T C + Y A
Sbjct: 111 FLHRHGVIYRDLKLDNILLDAEGHC--KLADFGM-CKEGILNGVTTTTFC---GTPDYIA 164
Query: 556 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 590
PE++ L Y +D W+LG ++ E+ G+ F D
Sbjct: 165 PEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 37/101 (36%), Positives = 54/101 (53%), Gaps = 2/101 (1%)
Query: 500 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVI 559
ALEYLHS I++ DLKPENIL+ IK+ D G + D + Y APEVI
Sbjct: 113 ALEYLHSKEIVYRDLKPENILLDK--EGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVI 170
Query: 560 IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 600
+++ +D W+LG ++ E+ G F +D I +I+
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL 211
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 23/208 (11%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-EIKLLKLVNKNDPADEHHILR 447
LGS F +V++ + V V +KI+K+D Q E++ LK + H++
Sbjct: 14 LGSGYFGEVWEGLWKNR-VRVAIKILKSDDLLKQQDFQKEVQALKRLR------HKHLIS 66
Query: 448 LYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS 506
L+ E ++I+ EL+ +L F + S + L + Q E + YL
Sbjct: 67 LFAVCSVGEPVYIITELMEKGSLLAFLR----SPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 507 LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-----YRAPEVIIG 561
IH DL NIL+ C K+ D G + +++ Y+ S + APE
Sbjct: 123 QNSIHRDLAARNILVGEDLVC--KVADFGLARLIKEDV--YLSSDKKIPYKWTAPEAASH 178
Query: 562 LPYDQKIDLWSLGCILAELWT-GEVLFP 588
+ K D+WS G +L E++T G+V +P
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLVNKNDPADE 442
LG AF +V+ D TG ++ +K + D D + S + EI+LLK + +
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 443 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGR--LQVITRQCLEA 500
+ LR + + L I E + + Q +AY L + TRQ L+
Sbjct: 70 YGCLRDPEE----KKLSIFVEYMPGGSIKDQL-------KAYGALTENVTRRYTRQILQG 118
Query: 501 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS------CFQTDNLCLYVQSRSYR 554
+ YLHS I+H D+K NIL S +K+ D G+S C + + +
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176
Query: 555 APEVIIGLPYDQKIDLWSLGCILAELWT 582
+PEVI G Y +K D+WS+ C + E+ T
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 66/268 (24%), Positives = 108/268 (40%), Gaps = 33/268 (12%)
Query: 428 IKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL 487
I+ + L N N P+ ++R+ D +V ++LY + + S +
Sbjct: 106 IEAMLLQNVNHPS----VIRMKDTLVSGAITCMVLPHYSSDLYTY--LTKRSRP---LPI 156
Query: 488 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 547
+ +I +Q LE L YLH+ IIH D+K ENI I ++ I DLG++ F
Sbjct: 157 DQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD--QVCIGDLGAAQFPVVAPAFL 214
Query: 548 --VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAE-------LWTGEVLFPNDAVV---MI 595
+ APEV+ Y+ K D+WS G +L E ++ P + V
Sbjct: 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSH 274
Query: 596 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSD 655
L +II L + E + + + Y E Y P + + D
Sbjct: 275 LLKIISTLK-VHPEEFPRDPG--SRLVRGFIEYASLERQPYTRY--PCFQRVNLPI---D 326
Query: 656 AFFIDFVRTLLEINPQRRPTAREALDHP 683
F+ V +L + RP+A E L++P
Sbjct: 327 GEFL--VHKMLTFDAAMRPSAEEILNYP 352
|
Length = 357 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 62/258 (24%), Positives = 104/258 (40%), Gaps = 70/258 (27%)
Query: 441 DEHH--ILRLYDYFYHLEHLFIVCELLRA----NLYEFQKFNQESGGEAYFTLGRLQVIT 494
D H ++ +Y+ + + L++V E L ++ + N+E ++ +
Sbjct: 73 DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----------QIAAVC 122
Query: 495 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-- 552
L+AL LH+ G+IH D+K ++IL+ R +K+ D G C Q V R
Sbjct: 123 LAVLKALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGF-CAQVSK---EVPRRKSL 176
Query: 553 -----YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 607
+ APE+I LPY ++D+WSLG ++ E+ GE + N+ + + I L P
Sbjct: 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-- 234
Query: 608 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLE 667
+ L + P F+ LL
Sbjct: 235 -------------------------KLKNLHKVSP--------------SLKGFLDRLLV 255
Query: 668 INPQRRPTAREALDHPWL 685
+P +R TA E L HP+L
Sbjct: 256 RDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 29/211 (13%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG +F KV A+ T +KI+K D D + ++ E ++L L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLAL-----SGKPPF 62
Query: 445 ILRLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 502
+ +L+ F ++ L+ V E + +Y+ Q+ + A F + + L
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI-------GLF 115
Query: 503 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------YRAP 556
+LHS GII+ DLK +N+++ S IKI D G +N+ V +++ Y AP
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDS--EGHIKIADFGMC---KENMWDGVTTKTFCGTPDYIAP 170
Query: 557 EVIIGLPYDQKIDLWSLGCILAELWTGEVLF 587
E+I PY + +D W+ G +L E+ G+ F
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 37/109 (33%), Positives = 54/109 (49%), Gaps = 15/109 (13%)
Query: 493 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 552
I R L A++YLH IIH D+K ENI I ++ + D G++CF D ++
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFIN--HPGDVCLGDFGAACFPVD----INANKY 240
Query: 553 Y--------RAPEVIIGLPYDQKIDLWSLGCILAELWTGE-VLFPNDAV 592
Y APE++ PY +D+WS G +L E+ T LF D +
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGL 289
|
Length = 391 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 13/116 (11%)
Query: 479 SGGEAYFTLGR----LQVITR----QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 530
+GGE ++ L R L+ R + AL YLHSL I++ DLKPENIL+ S + I
Sbjct: 79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS--QGHIV 136
Query: 531 IIDLG---SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 583
+ D G + + + Y APEV+ PYD+ +D W LG +L E+ G
Sbjct: 137 LTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 25/209 (11%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG +F KV A+ T +KI+K D D + ++ E ++L L +K
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDK-----PPF 62
Query: 445 ILRLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 502
+ +L+ F ++ L+ V E + +Y Q+ + +A F + V L
Sbjct: 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV-------GLF 115
Query: 503 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT--DNLCL--YVQSRSYRAPEV 558
+LH GII+ DLK +N+++ S IKI D G C + D + + + Y APE+
Sbjct: 116 FLHRRGIIYRDLKLDNVMLDS--EGHIKIADFGM-CKEHMVDGVTTRTFCGTPDYIAPEI 172
Query: 559 IIGLPYDQKIDLWSLGCILAELWTGEVLF 587
I PY + +D W+ G +L E+ G+ F
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 32/213 (15%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKND 438
+ + + +G FS+V++A L V LK ++ D + EI LLK +N +
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 439 PADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR-- 495
+++ D F L IV EL A +L + K YF + + R
Sbjct: 64 ------VIKYLDSFIEDNELNIVLELADAGDLSQMIK---------YFKKQKRLIPERTV 108
Query: 496 -----QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLY 547
Q A+E++HS ++H D+KP N+ I + +K+ DLG F +T
Sbjct: 109 WKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSSKTTAAHSL 166
Query: 548 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAEL 580
V + Y +PE I Y+ K D+WSLGC+L E+
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (149), Expect = 3e-10
Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 32/187 (17%)
Query: 412 KIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR-ANLY 470
KIIK K+F + E + +L+ N + ++LY L+ ++ + ++ +L+
Sbjct: 47 KIIKA-KNF---NAIEPMVHQLMKDNP-----NFIKLYYSVTTLKGHVLIMDYIKDGDLF 97
Query: 471 EFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 530
+ K + ++ I RQ +EAL LH IIH D+K EN+L + I
Sbjct: 98 DLLKKEG------KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRA-KDRIY 150
Query: 531 IIDLGSSCFQTDNLCLYVQSRS-------YRAPEVIIGLPYDQKIDLWSLGCILAELWTG 583
+ D G LC + + S Y +PE I G YD D W++G + EL TG
Sbjct: 151 LCDYG--------LCKIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTG 202
Query: 584 EVLFPND 590
+ F D
Sbjct: 203 KHPFKED 209
|
Length = 267 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 5/103 (4%)
Query: 487 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC- 545
LG++ + + L L H I+H D+KP NIL+ S R EIK+ D G S D++
Sbjct: 105 LGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMAN 160
Query: 546 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP 588
+V +RSY +PE + G Y + D+WS+G L EL G P
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP 203
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 51/201 (25%), Positives = 83/201 (41%), Gaps = 52/201 (25%)
Query: 494 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS---CFQTDNLCLYVQS 550
T+Q L+ + YLH+ ++H D+K N+++ IK+ID G + + +
Sbjct: 108 TKQILDGVAYLHNNCVVHRDIKGNNVMLMP--NGIIKLIDFGCARRLAWVGLHGTHSNML 165
Query: 551 RSYR------APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 604
+S APEVI Y +K D+WS+GC + E+ TG+ + + R+ M
Sbjct: 166 KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS------MDRLAAM-- 217
Query: 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 664
+YI ++P L FS A IDFV +
Sbjct: 218 -----------------------FYIGAHRG----LMP---RLPDS--FSAA-AIDFVTS 244
Query: 665 LLEINPQRRPTAREALDHPWL 685
L + RP+A + L H +L
Sbjct: 245 CLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 40/218 (18%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG F KV ++ TG +KI++ + KD ++ E ++L+ H
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ-------NTRHP 55
Query: 445 ILRLYDY-FYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR-------- 495
L Y F + L V E AN GGE +F L R +V T
Sbjct: 56 FLTALKYAFQTHDRLCFVMEY--AN-----------GGELFFHLSRERVFTEERARFYGA 102
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ--TDNLCL--YVQSR 551
+ + ALEYLHS +++ D+K EN+++ + IKI D G C + +D + + +
Sbjct: 103 EIVSALEYLHSRDVVYRDIKLENLMLD--KDGHIKITDFG-LCKEGISDGATMKTFCGTP 159
Query: 552 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 589
Y APEV+ Y + +D W LG ++ E+ G + F N
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 60/220 (27%), Positives = 91/220 (41%), Gaps = 44/220 (20%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG F KV ++ TG +KI+K + KD +L E ++L+ H
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-------HP 55
Query: 445 ILRLYDYFYHLEH-LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR-------- 495
L Y + L V E +GGE +F L R +V +
Sbjct: 56 FLTALKYSFQTHDRLCFVMEYA-------------NGGELFFHLSRERVFSEDRARFYGA 102
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------SSCFQTDNLCLYVQ 549
+ + AL YLHS +++ DLK EN+++ + IKI D G S C
Sbjct: 103 EIVSALGYLHSCDVVYRDLKLENLMLD--KDGHIKITDFGLCKEGISDGATMKTFC---G 157
Query: 550 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 589
+ Y APEV+ Y + +D W LG ++ E+ G + F N
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 61/241 (25%), Positives = 106/241 (43%), Gaps = 17/241 (7%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 441
RY + + +G +F K++ A+ +K I K + K + L+ K +
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 442 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 501
I+ + F LFIV E ++ N++ G F+ ++ Q L
Sbjct: 61 ---IVTFFASFQENGRLFIVMEYCDGGDL-MKRINRQRG--VLFSEDQILSWFVQISLGL 114
Query: 502 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYRAPEV 558
+++H I+H D+K +NI + K+ D G + D++ L V + Y +PE+
Sbjct: 115 KHIHDRKILHRDIKSQNIFLSKNGMVA-KLGDFGIARQLNDSMELAYTCVGTPYYLSPEI 173
Query: 559 IIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII-GMLGPI------DLEML 611
PY+ K D+WSLGC+L EL T + F + + ++ +I G PI DL L
Sbjct: 174 CQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSL 233
Query: 612 M 612
+
Sbjct: 234 I 234
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 36/216 (16%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG F KV ++ +G +KI+K + KD +L E ++LK N P
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLK--NTRHP----F 56
Query: 445 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR--------Q 496
+ L F + L V E + +GGE +F L R +V + +
Sbjct: 57 LTSLKYSFQTKDRLCFVMEYV-------------NGGELFFHLSRERVFSEDRTRFYGAE 103
Query: 497 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSY 553
+ AL+YLHS I++ DLK EN+++ + IKI D G + + + Y
Sbjct: 104 IVSALDYLHSGKIVYRDLKLENLMLD--KDGHIKITDFGLCKEGITDAATMKTFCGTPEY 161
Query: 554 RAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 589
APEV+ Y + +D W LG ++ E+ G + F N
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 30/221 (13%)
Query: 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 439
AG + + E +G+ + +V++ + + TG +K++ +D ++ EI +LK +
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYS---- 70
Query: 440 ADEHH--ILRLYDYFY------HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQ 491
HH I Y F H + L++V E A + + G A +
Sbjct: 71 ---HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAG--SVTDLVKNTKGNA-LKEDWIA 124
Query: 492 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC----LY 547
I R+ L L +LH+ +IH D+K +N+L+ + E+K++D G S Q D +
Sbjct: 125 YICREILRGLAHLHAHKVIHRDIKGQNVLLT--ENAEVKLVDFGVSA-QLDRTVGRRNTF 181
Query: 548 VQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTG 583
+ + + APEVI YD + D+WSLG E+ G
Sbjct: 182 IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 13/203 (6%)
Query: 389 LGSAAFSKVFQAQDLHTG-VDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG F +V Q TG + C ++ K + +L+E ++L+ VN
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN------SQF 61
Query: 445 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 504
++ L + + L +V ++ +F +N + G F R + L LE L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG---FEEERALFYAAEILCGLEDL 118
Query: 505 HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPY 564
H ++ DLKPENIL+ Y I + L + +++ V + Y APEV+ Y
Sbjct: 119 HRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY 178
Query: 565 DQKIDLWSLGCILAELWTGEVLF 587
D W LGC++ E+ G+ F
Sbjct: 179 TLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 9e-10
Identities = 72/311 (23%), Positives = 130/311 (41%), Gaps = 63/311 (20%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPAD 441
+ + + +GS + V++A++++TG +K+IK + + F EI ++K
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMK------DCK 64
Query: 442 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV--ITRQCLE 499
+I+ + + + L+I E Q +G L Q+ ++R+ L+
Sbjct: 65 HSNIVAYFGSYLRRDKLWICMEFCGGG--SLQDIYHVTG-----PLSESQIAYVSRETLQ 117
Query: 500 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRSYRAP 556
L YLHS G +H D+K NIL+ +K+ D G S T + ++ + + AP
Sbjct: 118 GLYYLHSKGKMHRDIKGANILLTD--NGHVKLADFGVSAQITATIAKRKSFIGTPYWMAP 175
Query: 557 EVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613
EV Y+Q D+W++G EL E+ P + L P+ LM
Sbjct: 176 EVAAVERKGGYNQLCDIWAVGITAIEL--AELQPP-----------MFDLHPMRALFLMT 222
Query: 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 673
+ L+ +++S++F FV+ L NP++R
Sbjct: 223 KSNF-------------------------QPPKLKDKMKWSNSFH-HFVKMALTKNPKKR 256
Query: 674 PTAREALDHPW 684
PTA + L HP+
Sbjct: 257 PTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 62/236 (26%), Positives = 98/236 (41%), Gaps = 39/236 (16%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG+ F +V+ T V +K +K + + F L E +++K + +
Sbjct: 14 LGAGQFGEVWMGTWNGT-TKVAVKTLKPGTMSPEAF----LQEAQIMKKLRHD------K 62
Query: 445 ILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 503
+++LY E ++IV E + +L +F K SG L +L + Q E + Y
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLK----SGEGKKLRLPQLVDMAAQIAEGMAY 118
Query: 504 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSR---SYRAPEVI 559
L S IH DL NIL+ C KI D G + + D ++ + APE
Sbjct: 119 LESRNYIHRDLAARNILVGENLVC--KIADFGLARLIEDDEYTAREGAKFPIKWTAPEAA 176
Query: 560 IGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614
+ K D+WS G +L E+ T G V +P GM LE + +G
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVPYP------------GMTNREVLEQVERG 220
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 51/153 (33%), Positives = 77/153 (50%), Gaps = 15/153 (9%)
Query: 445 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF---TLGRLQVITRQCLEAL 501
I++ Y + +I EL+ +L +F K+ E ++ LG++ V T ++AL
Sbjct: 65 IVKFYGALFREGDCWICMELMDISLDKFYKYVYEVL-KSVIPEEILGKIAVAT---VKAL 120
Query: 502 EYL-HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQS--RSYRAPEV 558
YL L IIH D+KP NIL+ + IK+ D G S D++ + R Y APE
Sbjct: 121 NYLKEELKIIHRDVKPSNILLD--RNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPER 178
Query: 559 I---IGLPYDQKIDLWSLGCILAELWTGEVLFP 588
I YD + D+WSLG L E+ TG+ +P
Sbjct: 179 IDPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 38/103 (36%), Positives = 56/103 (54%), Gaps = 5/103 (4%)
Query: 487 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC- 545
LG++ + + L L H I+H D+KP NIL+ S R EIK+ D G S D++
Sbjct: 105 LGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMAN 160
Query: 546 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP 588
+V +RSY +PE + G Y + D+WS+G L E+ G P
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP 203
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 74/307 (24%), Positives = 124/307 (40%), Gaps = 67/307 (21%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKII----KNDKDFFDQSLDEIKLL-KLVNKNDPADEH 443
+G +F V+ A+D+ V +K + K + + + E++ L KL + N
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 444 HILRLYDYFYHLEH-LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 502
LR + + +E+ L +LL + Q+ + +T L+ L
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV-------------EIAAVTHGALQGLA 129
Query: 503 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL 562
YLHS +IH D+K NIL+ + +K+ D GS+ +V + + APEVI+ +
Sbjct: 130 YLHSHNMIHRDVKAGNILLS--EPGLVKLGDFGSASIMAPANX-FVGTPYWMAPEVILAM 186
Query: 563 ---PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYK 619
YD K+D+WSLG EL E P
Sbjct: 187 DEGQYDGKVDVWSLGITCIEL--AERKPP------------------------------- 213
Query: 620 YFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA 679
L+ +N + L +I ES +S+ +F +FV + L+ PQ RPT+
Sbjct: 214 -------LFNMN-AMSALYHIAQNESPALQSGHWSE-YFRNFVDSCLQKIPQDRPTSEVL 264
Query: 680 LDHPWLQ 686
L H ++
Sbjct: 265 LKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 39/116 (33%), Positives = 55/116 (47%), Gaps = 4/116 (3%)
Query: 474 KFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 533
KF+ + G F R + LE LH I++ DLKPENIL+ Y I+I D
Sbjct: 88 KFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG--HIRISD 145
Query: 534 LGSSCFQTDNLCL--YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLF 587
LG + + + V + Y APEV+ Y D W LGC++ E+ G+ F
Sbjct: 146 LGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 45/146 (30%), Positives = 70/146 (47%), Gaps = 24/146 (16%)
Query: 459 FIVCELLRANLYEFQKFNQES-------GGEAYFTLGRLQVITRQCLE--------ALEY 503
FIVC Y F ++ S GG+ ++ L + V + + LE+
Sbjct: 58 FIVCMS-----YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEH 112
Query: 504 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC-FQTDNLCLYVQSRSYRAPEVII-G 561
+H+ +++ DLKP NIL+ + ++I DLG +C F V + Y APEV+ G
Sbjct: 113 MHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 170
Query: 562 LPYDQKIDLWSLGCILAELWTGEVLF 587
+ YD D +SLGC+L +L G F
Sbjct: 171 VAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 2e-09
Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 42/227 (18%)
Query: 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 439
AG + + E +G+ + +V++ + + TG +K++ D ++ EI +LK +
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS---- 60
Query: 440 ADEHH--ILRLYDYFYHL------EHLFIVCELLRA----NLYEFQKFNQESGGEAYFTL 487
HH I Y F + L++V E A +L + K N TL
Sbjct: 61 ---HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN---------TL 108
Query: 488 GR--LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 545
+ I R+ L L +LH +IH D+K +N+L+ + E+K++D G S Q D
Sbjct: 109 KEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT--ENAEVKLVDFGVSA-QLDRTV 165
Query: 546 ----LYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTG 583
++ + + APEVI YD K DLWSLG E+ G
Sbjct: 166 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 389 LGSAAFSKVFQAQDLHTG-VDVCLKI----IKNDKDFFDQSLDEIKLLKLVNKNDPADEH 443
LG F +V Q TG + C K+ IK K +L+E ++L+ VN
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE-SMALNEKQILEKVN------SR 60
Query: 444 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 503
++ L + + L +V L+ +F ++ GEA F GR + LE
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM---GEAGFEEGRAVFYAAEICCGLED 117
Query: 504 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSYRAPEVIIG 561
LH I++ DLKPENIL+ + I+I DLG + + + V + Y APEV+
Sbjct: 118 LHQERIVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 175
Query: 562 LPYDQKIDLWSLGCILAELWTGEVLF 587
Y D W+LGC+L E+ G+ F
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-09
Identities = 58/213 (27%), Positives = 87/213 (40%), Gaps = 48/213 (22%)
Query: 431 LKLVNKNDPADEH------------------HILRLYDYFYHLEH-LFIVCEL-----LR 466
+KL+ + P +EH +I+ L D LF V E LR
Sbjct: 8 IKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLR 67
Query: 467 ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI-KSYQ 525
L G GRL + Q L+AL H+ GI+H DLKP+NI++ ++
Sbjct: 68 EVL-------AADGALPAGETGRLML---QVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117
Query: 526 RCEIKIID-----LGSSCFQTDNLCL-----YVQSRSYRAPEVIIGLPYDQKIDLWSLGC 575
R K++D L D L + + +Y APE + G P DL++ G
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 576 ILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 608
I E TG+ + +V IL + L P+D+
Sbjct: 178 IFLECLTGQRVVQGASVAEILYQ---QLSPVDV 207
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 42/130 (32%), Positives = 67/130 (51%), Gaps = 22/130 (16%)
Query: 479 SGGEAY--------FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 530
+GGE + F +Q+ + + + ALE+LH LGII+ D+K ENIL+ S +
Sbjct: 88 NGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDS--NGHVV 145
Query: 531 IIDLG-SSCFQTD------NLCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELW 581
+ D G S F D + C ++ Y AP+++ G +D+ +D WS+G ++ EL
Sbjct: 146 LTDFGLSKEFHEDEVERAYSFCGTIE---YMAPDIVRGGDGGHDKAVDWWSMGVLMYELL 202
Query: 582 TGEVLFPNDA 591
TG F D
Sbjct: 203 TGASPFTVDG 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 44/219 (20%)
Query: 389 LGSAAFSKVFQAQDLHTG-----VDVCLKIIK----NDKDFFDQSLDEIKLL-KLVNKND 438
LGS F V H G +DV +K+I+ ++ DF + E K++ KL + N
Sbjct: 12 LGSGQFGVV------HLGKWRGKIDVAIKMIREGAMSEDDFIE----EAKVMMKLSHPN- 60
Query: 439 PADEHHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQC 497
+++LY +FIV E + L + + + G + L + + C
Sbjct: 61 ------LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL----LDMCSDVC 110
Query: 498 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR--- 554
EA+EYL S G IH DL N L+ +K+ D G + + D+ Y S+ +
Sbjct: 111 -EAMEYLESNGFIHRDLAARNCLVGE--DNVVKVSDFGLARYVLDDQ--YTSSQGTKFPV 165
Query: 555 ---APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589
PEV + K D+WS G ++ E+++ G++ +
Sbjct: 166 KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 74/280 (26%), Positives = 99/280 (35%), Gaps = 96/280 (34%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 448
LG +VF + TG LK++ DK + + + +K V E IL
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVL--DK----KEMIKRNKVKRV-----LTEQEILAT 57
Query: 449 YDYFYHLEHLFIVCELLRANLY-EFQK-----FNQE--SGGEAYFTLGRLQVITRQCLE- 499
D H F+ LY FQ + GGE + L Q +CL
Sbjct: 58 LD------HPFLP------TLYASFQTETYLCLVMDYCPGGELFRLL---QRQPGKCLSE 102
Query: 500 ------------ALEYLHSLGIIHCDLKPENILIK------------SYQ-----RCEIK 530
ALEYLH LGI++ DLKPENIL+ S Q K
Sbjct: 103 EVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSK 162
Query: 531 IIDLGSSCFQTDNLCLYV-------QSRS------YRAPEVIIGLPYDQKIDLWSLGCIL 577
+ GS +++ +S S Y APEVI G + +D W+LG +L
Sbjct: 163 ALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILL 222
Query: 578 AELWTG-------------------EVLFPNDAVVMILAR 598
E+ G EV FP V AR
Sbjct: 223 YEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSAR 262
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 36/112 (32%), Positives = 50/112 (44%), Gaps = 12/112 (10%)
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN----LCLYVQSRSYR 554
A+ +H +G +H D+KPEN+LI IK+ D GS+ T N L V + Y
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTG--HIKLADFGSAARLTANKMVNSKLPVGTPDYI 170
Query: 555 APEVIIGL------PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 600
APEV+ + Y + D WSLG I E+ G F I+
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM 222
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 30/210 (14%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEH 443
E +G F V Q + +TG V +K IK D + F +++ + KL +KN
Sbjct: 12 EIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEET---AVMTKLHHKN------ 60
Query: 444 HILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 502
++RL H L+IV EL+ + NL F + + G A ++ +L + E +E
Sbjct: 61 -LVRLLGVILH-NGLYIVMELMSKGNLVNFLR----TRGRALVSVIQLLQFSLDVAEGME 114
Query: 503 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT---DNLCLYVQSRSYRAPEVI 559
YL S ++H DL NIL+ + K+ D G + + DN L V+ + APE +
Sbjct: 115 YLESKKLVHRDLAARNILVS--EDGVAKVSDFGLARVGSMGVDNSKLPVK---WTAPEAL 169
Query: 560 IGLPYDQKIDLWSLGCILAELWT-GEVLFP 588
+ K D+WS G +L E+++ G +P
Sbjct: 170 KHKKFSSKSDVWSYGVLLWEVFSYGRAPYP 199
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 19/206 (9%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL-R 447
+G +++KV + T +K+IK + D+ +D ++ K V + A H L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFET--ASNHPFLVG 60
Query: 448 LYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH 505
L+ F LF V E + ++ Q+ + A F + + AL +LH
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISL-------ALNFLH 113
Query: 506 SLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT----DNLCLYVQSRSYRAPEVIIG 561
GII+ DLK +N+L+ + IK+ D G C + D + + +Y APE++ G
Sbjct: 114 ERGIIYRDLKLDNVLLDA--EGHIKLTDYGM-CKEGIRPGDTTSTFCGTPNYIAPEILRG 170
Query: 562 LPYDQKIDLWSLGCILAELWTGEVLF 587
Y +D W+LG ++ E+ G F
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 8e-09
Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 50/194 (25%)
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQSRS 552
Q AL+YLH I+H DLK +N+ + IK+ DLG + Q D + +
Sbjct: 110 QIAMALQYLHEKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDMASTLIGTPY 167
Query: 553 YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII-GMLGPIDLEML 611
Y +PE+ PY+ K D+W+LGC + E+ T + F + ++ RII G L P+
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPM----- 222
Query: 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQ 671
K+Y PE + + T+L P+
Sbjct: 223 ----------PKDYS---------------PE--------------LGELIATMLSKRPE 243
Query: 672 RRPTAREALDHPWL 685
+RP+ + L P++
Sbjct: 244 KRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 23/200 (11%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKII----KNDKDFFDQSLDEIKLLKLVNKNDPADEHH 444
+G +F V+ A + HT V +K + K + + + E+K L+ + + +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE--- 85
Query: 445 ILRLYDYFYHLEHL-FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 503
Y Y EH ++V E + + + +++ E + IT L+ L Y
Sbjct: 86 ----YKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEV-----EIAAITHGALQGLAY 136
Query: 504 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL- 562
LHS +IH D+K NIL+ + ++K+ D GS+ + +V + + APEVI+ +
Sbjct: 137 LHSHNMIHRDIKAGNILLT--EPGQVKLADFGSASKSSPANS-FVGTPYWMAPEVILAMD 193
Query: 563 --PYDQKIDLWSLGCILAEL 580
YD K+D+WSLG EL
Sbjct: 194 EGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 56/226 (24%), Positives = 90/226 (39%), Gaps = 52/226 (23%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG F KV A+ TG +K +K +D + + E ++ + N E H
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANS-----ERH 61
Query: 445 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG-------EAYFTLGRLQVITR 495
++ L+ F +H+ V E +GG F+ R
Sbjct: 62 PFLVNLFACFQTEDHVCFVMEYA-------------AGGDLMMHIHTDVFSEPRAVFYAA 108
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRS 552
+ L+YLH I++ DLK +N+L+ + +KI D G LC + R+
Sbjct: 109 CVVLGLQYLHENKIVYRDLKLDNLLLDT--EGFVKIADFG--------LCKEGMGFGDRT 158
Query: 553 --------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 590
+ APEV+ Y + +D W LG ++ E+ GE FP D
Sbjct: 159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 32/213 (15%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ----SLDEIKLLKLVNKNDPADEHH 444
+G F +V+ + TG +K + + Q +L+E +L LV+ D
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP---F 58
Query: 445 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE----- 499
I+ + F+ + L + +L+ +GG+ ++ L + V + + +
Sbjct: 59 IVCMTYAFHTPDKLCFILDLM-------------NGGDLHYHLSQHGVFSEKEMRFYATE 105
Query: 500 ---ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC-FQTDNLCLYVQSRSYRA 555
LE++H+ +++ DLKP NIL+ + ++I DLG +C F V + Y A
Sbjct: 106 IILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKPHASVGTHGYMA 163
Query: 556 PEVI-IGLPYDQKIDLWSLGCILAELWTGEVLF 587
PEV+ G YD D +SLGC+L +L G F
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 51/204 (25%), Positives = 92/204 (45%), Gaps = 15/204 (7%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 448
+G +++KV + T +K++K + D+ +D ++ K V + ++ ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ-ASNHPFLVGL 61
Query: 449 YDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS 506
+ F LF V E + ++ Q+ + A F + + AL YLH
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL-------ALNYLHE 114
Query: 507 LGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPEVIIGLP 563
GII+ DLK +N+L+ S IK+ D G D + + +Y APE++ G
Sbjct: 115 RGIIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 564 YDQKIDLWSLGCILAELWTGEVLF 587
Y +D W+LG ++ E+ G F
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 40/141 (28%), Positives = 73/141 (51%), Gaps = 16/141 (11%)
Query: 494 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY-----V 548
T + + AL+ +HS+G IH D+KP+N+L+ +K+ D G +C + D + V
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--HLKLADFG-TCMKMDANGMVRCDTAV 204
Query: 549 QSRSYRAPEVIIGL----PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII---- 600
+ Y +PEV+ Y ++ D WS+G L E+ G+ F D++V ++I+
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN 264
Query: 601 GMLGPIDLEMLMQGQEIYKYF 621
+ P D+E+ Q +++ F
Sbjct: 265 SLTFPDDIEISKQAKDLICAF 285
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 35/116 (30%), Positives = 64/116 (55%), Gaps = 12/116 (10%)
Query: 494 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY-----V 548
T + + AL+ +HS+G+IH D+KP+N+L+ + +K+ D G +C + D + V
Sbjct: 148 TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG--HLKLADFG-TCMKMDETGMVRCDTAV 204
Query: 549 QSRSYRAPEVIIGLP----YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 600
+ Y +PEV+ Y ++ D WS+G L E+ G+ F D++V ++I+
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 42/125 (33%), Positives = 65/125 (52%), Gaps = 21/125 (16%)
Query: 479 SGGEA--------YFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 530
SGGE F+ ++ + + + ALE+LH LGI++ D+K ENIL+ S +
Sbjct: 88 SGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDS--EGHVV 145
Query: 531 IIDLG-SSCF------QTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWT 582
+ D G S F +T + C ++ Y APE+I G + + +D WSLG ++ EL T
Sbjct: 146 LTDFGLSKEFLSEEKERTYSFCGTIE---YMAPEIIRGKGGHGKAVDWWSLGILIFELLT 202
Query: 583 GEVLF 587
G F
Sbjct: 203 GASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-08
Identities = 24/48 (50%), Positives = 32/48 (66%), Gaps = 1/48 (2%)
Query: 490 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537
+Q I RQ L AL+ LHS GI+H D+KP+NI+ KIIDLG++
Sbjct: 257 IQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSG-SFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 492 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL----CL- 546
I R+ LEAL YLH GIIH D+K ENI + + + D G++C + C
Sbjct: 189 TIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLG--DFGAACKLDAHPDTPQCYG 246
Query: 547 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAEL 580
+ + +PE++ PY K D+WS G +L E+
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 23/214 (10%)
Query: 385 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHH 444
+ E +G + KVF+ + G +KI+ D ++ E +LK + +D +
Sbjct: 22 IIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKAL-----SDHPN 76
Query: 445 ILRLYDYFYHLE-----HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
+++ Y +Y + L++V EL ++ + K + G + + I + L
Sbjct: 77 VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI--IAYILHEAL 134
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRSYRA 555
L++LH IH D+K NIL+ + +K++D G S T V + + A
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTT--EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 192
Query: 556 PEVI-----IGLPYDQKIDLWSLGCILAELWTGE 584
PEVI + YD + D+WSLG EL G+
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGD 226
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 59/224 (26%), Positives = 94/224 (41%), Gaps = 51/224 (22%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG F KV ++ TG +KI+K + KD +L E ++L+ N P
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ--NSRHP----- 55
Query: 445 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQ-------ESGGEAYFTLGRLQVITR-- 495
L A Y FQ ++ +GGE +F L R +V +
Sbjct: 56 -------------------FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR 96
Query: 496 ------QCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLC 545
+ + AL+YLHS +++ DLK EN+++ + IKI D G +
Sbjct: 97 ARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD--KDGHIKITDFGLCKEGIKDGATMK 154
Query: 546 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 589
+ + Y APEV+ Y + +D W LG ++ E+ G + F N
Sbjct: 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 8e-08
Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 24/208 (11%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLL-KLVNKNDPADEHHI 445
+G F V + G V +K +K+D L E ++ L + N +
Sbjct: 12 ATIGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPN-------L 62
Query: 446 LRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 504
++L L+IV E + + +L ++ + S G A TL + E +EYL
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLR----SRGRAVITLAQQLGFALDVCEGMEYL 118
Query: 505 HSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPEVIIG 561
+H DL N+L+ + K+ D G + D+ L V+ + APE +
Sbjct: 119 EEKNFVHRDLAARNVLVS--EDLVAKVSDFGLAKEASQGQDSGKLPVK---WTAPEALRE 173
Query: 562 LPYDQKIDLWSLGCILAELWT-GEVLFP 588
+ K D+WS G +L E+++ G V +P
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYP 201
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 9e-08
Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 22/219 (10%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 448
LG+ F +V+ + V +K +K L+E L+K + + ++RL
Sbjct: 14 LGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHD------KLVRL 66
Query: 449 YDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL 507
Y E ++I+ E + + +L +F K + GG+ L +L + Q E + Y+
Sbjct: 67 YAVVTKEEPIYIITEYMAKGSLLDFLK--SDEGGK--VLLPKLIDFSAQIAEGMAYIERK 122
Query: 508 GIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY----RAPEVIIGLP 563
IH DL+ N+L+ C KI D G + DN + + APE I
Sbjct: 123 NYIHRDLRAANVLVSESLMC--KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 180
Query: 564 YDQKIDLWSLGCILAELWT-GEVLFP---NDAVVMILAR 598
+ K D+WS G +L E+ T G++ +P N V+ L R
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR 219
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 9e-08
Identities = 60/225 (26%), Positives = 91/225 (40%), Gaps = 49/225 (21%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD------- 441
LG AF KVF A+ C ++ D+ L +K LK +++ D
Sbjct: 13 LGEGAFGKVFLAE--------CHNLLPEQ----DKMLVAVKALKEASESARQDFQREAEL 60
Query: 442 -----EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAY------------ 484
HI+R Y L +V E +R + +F + G +A
Sbjct: 61 LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHG--DLNRFLRSHGPDAKILAGGEDVAPGQ 118
Query: 485 FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTD 542
TLG++ I Q + YL SL +H DL N L+ Q +KI D G S + TD
Sbjct: 119 LTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG--QGLVVKIGDFGMSRDIYSTD 176
Query: 543 NLCLYVQSRS-----YRAPEVIIGLPYDQKIDLWSLGCILAELWT 582
V R+ + PE I+ + + D+WS G +L E++T
Sbjct: 177 Y--YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 9e-08
Identities = 62/261 (23%), Positives = 99/261 (37%), Gaps = 79/261 (30%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK--LVNKNDPA 440
++ + +G AF +V Q TG +K + + F L +K + L + P
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP- 61
Query: 441 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV----ITR- 495
++ LY F ++L+++ E L GG+ L + +TR
Sbjct: 62 ---WVVSLYYSFQDAQYLYLIMEFL-------------PGGDLMTMLIKYDTFSEDVTRF 105
Query: 496 ---QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC-------------- 538
+C+ A+E +H LG IH D+KP+NILI + IK+ D G S
Sbjct: 106 YMAECVLAIEAVHKLGFIHRDIKPDNILID--RGGHIKLSDFGLSTGFHKQHDSAYYQKL 163
Query: 539 FQ---------------TDNLCLYVQSRS---------------------YRAPEVIIGL 562
Q D++ L + S+ Y APE+ +
Sbjct: 164 LQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ 223
Query: 563 PYDQKIDLWSLGCILAELWTG 583
Y Q+ D WSLG I+ E G
Sbjct: 224 GYGQECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 52/214 (24%), Positives = 85/214 (39%), Gaps = 42/214 (19%)
Query: 493 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC-------FQTDNLC 545
I + L AL+Y+HS G IH +K +IL+ + + + L S Q
Sbjct: 106 ILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK--VVLSGLRYSVSMIKHGKRQRVVHD 163
Query: 546 LYVQSRS---YRAPEV----IIGLPYDQKIDLWSLGCILAELWTGEVLFPN-DAVVMILA 597
S + +PEV + G Y++K D++S+G EL G V F + A M+L
Sbjct: 164 FPKSSVKNLPWLSPEVLQQNLQG--YNEKSDIYSVGITACELANGHVPFKDMPATQMLLE 221
Query: 598 RIIG-MLGPID-----LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHL 651
++ G + +D L Q N+ P +
Sbjct: 222 KVRGTVPCLLDKSTYPLYEDSMSQSRSS----------NEHPNNRDSVDHPYTRT----- 266
Query: 652 QFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685
FS+ F FV L+ +P+ RP+A + L+H +
Sbjct: 267 -FSEHFH-QFVELCLQRDPESRPSASQLLNHSFF 298
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 23/219 (10%)
Query: 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 439
+ + E +G + KV++ + G +KI+ D ++ E +L+ + N P
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSL-PNHP 79
Query: 440 ADEHHILRLYDYFYHLEH-----LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVI 493
++++ Y FY + L++V EL ++ E K G + I
Sbjct: 80 ----NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR--LDEAMISYI 133
Query: 494 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQS 550
L L++LH+ IIH D+K NIL+ + +K++D G S T V +
Sbjct: 134 LYGALLGLQHLHNNRIIHRDVKGNNILLTT--EGGVKLVDFGVSAQLTSTRLRRNTSVGT 191
Query: 551 RSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGE 584
+ APEVI YD + D+WSLG EL G+
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGD 230
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 57/221 (25%), Positives = 100/221 (45%), Gaps = 36/221 (16%)
Query: 389 LGSAAFSKVFQAQDL-------HTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKND 438
LG F +V A+ L V V +K++K+D KD D + E++++K++ K+
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDL-VSEMEMMKMIGKHK 81
Query: 439 PADEHHILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGR-------- 489
+I+ L L+++ E + NL E+ + + G E + + R
Sbjct: 82 -----NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTF 136
Query: 490 --LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 547
L T Q +EYL S IH DL N+L+ + +KI D G + +N+ Y
Sbjct: 137 KDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT--ENNVMKIADFGLA-RDVNNIDYY 193
Query: 548 VQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 582
++ + R APE + Y + D+WS G ++ E++T
Sbjct: 194 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 40/151 (26%), Positives = 63/151 (41%), Gaps = 23/151 (15%)
Query: 444 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE---- 499
+++ L+ Y + +F+V + GG+ + + + I +C++
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQ-------------HAEGGKLWSHISKFLNIPEECVKRWAA 92
Query: 500 ----ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRA 555
AL+ LH GI+ DL P NIL+ R I++ D+ Y A
Sbjct: 93 EMVVALDALHREGIVCRDLNPNNILLD--DRGHIQLTYFSRWSEVEDSCDGEAVENMYCA 150
Query: 556 PEVIIGLPYDQKIDLWSLGCILAELWTGEVL 586
PEV + D WSLG IL EL TG+ L
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTGKTL 181
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 49/202 (24%), Positives = 90/202 (44%), Gaps = 11/202 (5%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 448
+G +++KV + +K++K + D+ +D ++ K V + ++ ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPF-LVGL 61
Query: 449 YDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG 508
+ F LF+V E + F Q E + ++ C+ AL +LH G
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEI----CI-ALNFLHERG 116
Query: 509 IIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYRAPEVIIGLPYD 565
II+ DLK +N+L+ IK+ D G D + + +Y APE++ G Y
Sbjct: 117 IIYRDLKLDNVLLD--ADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174
Query: 566 QKIDLWSLGCILAELWTGEVLF 587
+D W+LG ++ E+ G F
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 20/201 (9%)
Query: 389 LGSAAFSKVFQAQDLHTG-VDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG F +V Q TG + C K+ K + ++ ++ E ++L V+
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH------SRF 54
Query: 445 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFN--QESGGEAYFTLGRLQVITRQCLEALE 502
I+ L F L +V ++ + +N +E+ G F R T Q + LE
Sbjct: 55 IVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG---FPEPRACFYTAQIISGLE 111
Query: 503 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPEVI 559
+LH II+ DLKPEN+L+ + ++I DLG + D Y + + APE++
Sbjct: 112 HLHQRRIIYRDLKPENVLLDN--DGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELL 169
Query: 560 IGLPYDQKIDLWSLGCILAEL 580
G YD +D ++LG L E+
Sbjct: 170 QGEEYDFSVDYFALGVTLYEM 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 55/224 (24%), Positives = 90/224 (40%), Gaps = 37/224 (16%)
Query: 389 LGSAAFSKVFQAQDLHTG-----VDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKNDPA 440
LG F KV +A V +K++K + + D L E LLK VN
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDL-LSEFNLLKQVN----- 61
Query: 441 DEHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKF---------NQESG-----G 481
H+++LY L ++ E LR+ L E +K N+ S
Sbjct: 62 -HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 482 EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 541
E T+G L Q ++YL + ++H DL N+L+ ++ +I L ++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 542 DNLCLYVQSR---SYRAPEVIIGLPYDQKIDLWSLGCILAELWT 582
D+ + R + A E + Y + D+WS G +L E+ T
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLK---IIKNDKDFFDQSLDEIKLLKLVNKND 438
+Y + +G +F K + G +K I K ++S E+ +L N
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLS--NMKH 58
Query: 439 PADEHHILRLYDYFYHLEHLFIV---CELLRANLYEFQKFNQESGGEAYFTLGR-LQVIT 494
P +I++ + F +L+IV CE +LY +K N + G F + L
Sbjct: 59 P----NIVQYQESFEENGNLYIVMDYCE--GGDLY--KKINAQRG--VLFPEDQILDWFV 108
Query: 495 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-----SSCFQTDNLCLYVQ 549
+ CL AL+++H I+H D+K +NI + + IK+ D G +S + C +
Sbjct: 109 QICL-ALKHVHDRKILHRDIKSQNIFLT--KDGTIKLGDFGIARVLNSTVELARTC--IG 163
Query: 550 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT 582
+ Y +PE+ PY+ K D+W+LGC+L E+ T
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 498 LEALEYLHSLGIIHCDLKPENILIK-------SYQRCEIKIIDLGSSCFQTDNLCLY-VQ 549
L+AL+Y+H +G +H +K +ILI S R + +I+ G + Y V+
Sbjct: 111 LKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVK 170
Query: 550 SRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVLFPN-DAVVMILARIIGMLGPI 606
+ +PEV+ YD K D++S+G EL G V F + A M+L ++ G + +
Sbjct: 171 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 230
Query: 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYII--PEESSLEHHLQFSDAFFIDFVRT 664
+ +E+ ++ + E T E SS ++ FS F FV
Sbjct: 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFH-HFVEQ 289
Query: 665 LLEINPQRRPTAREALDHPWLQH 687
L+ NP RP+A L+H + +
Sbjct: 290 CLQRNPDARPSASTLLNHSFFKQ 312
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 4e-07
Identities = 47/185 (25%), Positives = 84/185 (45%), Gaps = 17/185 (9%)
Query: 412 KIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYE 471
K +K Q +EI L +N + ILR Y + + +LY
Sbjct: 198 KRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKY------DFDLYS 251
Query: 472 FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 531
F +++ + L + + I +Q L A+EY+H +IH D+K ENI + C+ KI
Sbjct: 252 FM-YDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN----CDGKI 306
Query: 532 I--DLGSSC-FQTDNLCL---YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 585
+ D G++ F+ + +V + + +PE++ G Y + D+WS G IL ++ + +
Sbjct: 307 VLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366
Query: 586 LFPND 590
D
Sbjct: 367 CPIGD 371
|
Length = 501 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 49/199 (24%), Positives = 76/199 (38%), Gaps = 63/199 (31%)
Query: 440 ADEHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVIT 494
AD +++LY F ++L+ V + + + L F ++ L R +
Sbjct: 58 ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEED--------LARFYIAE 109
Query: 495 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------------------- 535
C A+E +H +G IH D+KP+NILI + IK+ D G
Sbjct: 110 LTC--AIESVHKMGFIHRDIKPDNILID--RDGHIKLTDFGLCTGFRWTHDSKYYQKGDH 165
Query: 536 ---------------SSC---------FQTDNLCL---YVQSRSYRAPEVIIGLPYDQKI 568
C + CL V + +Y APEV++ Y Q
Sbjct: 166 HRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 225
Query: 569 DLWSLGCILAELWTGEVLF 587
D WS+G IL E+ G+ F
Sbjct: 226 DWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 40/117 (34%), Positives = 60/117 (51%), Gaps = 14/117 (11%)
Query: 479 SGGEAY--------FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 530
SGGE + F+ R + + + ALE+LH I++ DLKPENIL+ + I
Sbjct: 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDA--TGHIA 136
Query: 531 IIDLG-SSCFQTDNLC--LYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTG 583
+ D G S TDN + + Y APEV++ Y + +D WSLG ++ E+ G
Sbjct: 137 LCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 53/207 (25%), Positives = 82/207 (39%), Gaps = 23/207 (11%)
Query: 387 EYLGSAAFSKVFQA---QDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEH 443
+ LG +F V + + V +K +K+DK +D+ LK D
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDK--LSDIMDD--FLKEAAIMHSLDHE 56
Query: 444 HILRLYDYFYHLEH-LFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 501
+++RLY L H L +V EL +L + + + +F + L Q +
Sbjct: 57 NLIRLYGVV--LTHPLMMVTELAPLGSLLDRLRKDAL----GHFLISTLCDYAVQIANGM 110
Query: 502 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------A 555
YL S IH DL NIL+ S ++KI D G N YV + A
Sbjct: 111 RYLESKRFIHRDLAARNILLAS--DDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCA 168
Query: 556 PEVIIGLPYDQKIDLWSLGCILAELWT 582
PE + + D+W G L E++T
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 7e-07
Identities = 65/242 (26%), Positives = 105/242 (43%), Gaps = 50/242 (20%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADE 442
Y V + +G+ F +VF + T C K I + ++ +L+ VN
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL---KEREKSQLVIEVNVMRELKH 71
Query: 443 HHILRLYDYFYHL--EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV-----ITR 495
+I+R D F + + L+I+ E A + + Q+ Y G+++ ITR
Sbjct: 72 KNIVRYIDRFLNKANQKLYILMEFCDAG--DLSRNIQK----CYKMFGKIEEHAIVDITR 125
Query: 496 QCLEALEYLHSLG-------IIHCDLKPENILIKS---------------YQRCEIKIID 533
Q L AL Y H+L ++H DLKP+NI + + R KI D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185
Query: 534 LGSSCFQTDNLCLYVQSRS------YRAPEVII--GLPYDQKIDLWSLGCILAELWTGEV 585
G S N+ + + S Y +PE+++ YD K D+W+LGCI+ EL +G+
Sbjct: 186 FGLS----KNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241
Query: 586 LF 587
F
Sbjct: 242 PF 243
|
Length = 1021 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 22/207 (10%)
Query: 389 LGSAAFSKVFQAQ-DLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILR 447
LG+ F +V+ A + HT V V K +K + L E ++K +H L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAV--KTMKPGSMSVEAFLAEANVMK-------TLQHDKLV 64
Query: 448 LYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS 506
E ++I+ E + + +L +F K + G + L +L + Q E + ++
Sbjct: 65 KLHAVVTKEPIYIITEFMAKGSLLDFLK--SDEGSKQ--PLPKLIDFSAQIAEGMAFIEQ 120
Query: 507 LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY----RAPEVIIGL 562
IH DL+ NIL+ + C KI D G + DN + + APE I
Sbjct: 121 RNYIHRDLRAANILVSASLVC--KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 178
Query: 563 PYDQKIDLWSLGCILAELWT-GEVLFP 588
+ K D+WS G +L E+ T G + +P
Sbjct: 179 SFTIKSDVWSFGILLMEIVTYGRIPYP 205
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 9e-07
Identities = 52/194 (26%), Positives = 91/194 (46%), Gaps = 25/194 (12%)
Query: 412 KIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE-LLRANLY 470
KIIK + D E K+L +N + LY F +L++V E ++ +
Sbjct: 68 KIIKQKQ--VDHVFSERKILNYIN------HPFCVNLYGSFKDESYLYLVLEFVIGGEFF 119
Query: 471 EFQKFNQESGGE-AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 529
F + N+ + F ++ +I EYL SL I++ DLKPEN+L+ + I
Sbjct: 120 TFLRRNKRFPNDVGCFYAAQIVLI-------FEYLQSLNIVYRDLKPENLLLD--KDGFI 170
Query: 530 KIIDLGSSCF---QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVL 586
K+ D G + +T LC + Y APE+++ + + + D W+LG + E+ G
Sbjct: 171 KMTDFGFAKVVDTRTYTLC---GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
Query: 587 FPNDAVVMILARII 600
F + ++I +I+
Sbjct: 228 FYANEPLLIYQKIL 241
|
Length = 340 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 43/139 (30%), Positives = 64/139 (46%), Gaps = 12/139 (8%)
Query: 456 EHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDL 514
E ++IV E + + +L +F K G Y L +L + Q + + Y+ + IH DL
Sbjct: 73 EPIYIVTEFMGKGSLLDFLK----EGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDL 128
Query: 515 KPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY----RAPEVIIGLPYDQKIDL 570
+ NIL+ C KI D G + DN Q + APE + + K D+
Sbjct: 129 RAANILVGDNLVC--KIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 571 WSLGCILAELWT-GEVLFP 588
WS G +L EL T G V +P
Sbjct: 187 WSFGILLTELVTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 59/255 (23%), Positives = 94/255 (36%), Gaps = 71/255 (27%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 448
LG AF +V A + T +K ++ + +K + + AD +++L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAE--ADNEWVVKL 66
Query: 449 YDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE--------A 500
Y F ++L+ V + + GG+ L R++V A
Sbjct: 67 YYSFQDKDNLYFVMDYI-------------PGGDMMSLLIRMEVFPEVLARFYIAELTLA 113
Query: 501 LEYLHSLGIIHCDLKPENILI-----------------------KSYQ------------ 525
+E +H +G IH D+KP+NILI K YQ
Sbjct: 114 IESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP 173
Query: 526 ----------RCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPEVIIGLPYDQKIDLWS 572
RC ++ L + CL V + +Y APEV++ Y Q D WS
Sbjct: 174 SDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233
Query: 573 LGCILAELWTGEVLF 587
+G IL E+ G+ F
Sbjct: 234 VGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 28/215 (13%)
Query: 387 EYLGSAAFSKVF----QAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADE 442
E +G F +VF +A + V C + + D + L E ++LK + +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP--PDLKAKFLQEARILKQYSHPN---- 54
Query: 443 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 502
I+RL + ++IV EL++ +F F + G + L + +E
Sbjct: 55 --IVRLIGVCTQKQPIYIVMELVQGG--DFLTFLRTEG--PRLKVKELIQMVENAAAGME 108
Query: 503 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR-------A 555
YL S IH DL N L+ ++ +KI D G S + D + Y + + A
Sbjct: 109 YLESKHCIHRDLAARNCLVT--EKNVLKISDFGMSREEEDGV--YASTGGMKQIPVKWTA 164
Query: 556 PEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589
PE + Y + D+WS G +L E ++ G V + N
Sbjct: 165 PEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN 199
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 49/214 (22%), Positives = 90/214 (42%), Gaps = 42/214 (19%)
Query: 389 LGSAAFSKVFQAQDLHTG----VDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADE 442
LGS AF V++ + G + V +K+++ + + LDE ++ V D
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV------DH 68
Query: 443 HHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVIT--RQCLE 499
H++RL + ++ +L+ L ++ + +++ +G ++ Q +
Sbjct: 69 PHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKD-------NIGSQYLLNWCVQIAK 120
Query: 500 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR----- 554
+ YL ++H DL N+L+K+ Q +KI D G + L V + Y
Sbjct: 121 GMSYLEEKRLVHRDLAARNVLVKTPQ--HVKITDFGLAKL------LDVDEKEYHAEGGK 172
Query: 555 ------APEVIIGLPYDQKIDLWSLGCILAELWT 582
A E I+ Y K D+WS G + EL T
Sbjct: 173 VPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 60/257 (23%), Positives = 96/257 (37%), Gaps = 75/257 (29%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 448
LG AF +V A+ + T +K ++ + +K + + AD ++RL
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAE--ADNEWVVRL 66
Query: 449 YDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE--------A 500
Y F ++L+ V + + GG+ L R+ + A
Sbjct: 67 YYSFQDKDNLYFVMDYI-------------PGGDMMSLLIRMGIFPEDLARFYIAELTCA 113
Query: 501 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------------------------- 535
+E +H +G IH D+KP+NILI + IK+ D G
Sbjct: 114 VESVHKMGFIHRDIKPDNILID--RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSM 171
Query: 536 ---------SSCFQTDNL-------------CL---YVQSRSYRAPEVIIGLPYDQKIDL 570
++C D L CL V + +Y APEV++ Y Q D
Sbjct: 172 DFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 231
Query: 571 WSLGCILAELWTGEVLF 587
WS+G IL E+ G+ F
Sbjct: 232 WSVGVILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 34/89 (38%), Positives = 47/89 (52%), Gaps = 4/89 (4%)
Query: 501 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF--QTDNLCLYVQSRSYRAPEV 558
LE L I++ DLKPENIL+ R I+I DLG + + + + V + Y APEV
Sbjct: 115 LEDLQRERIVYRDLKPENILLDD--RGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEV 172
Query: 559 IIGLPYDQKIDLWSLGCILAELWTGEVLF 587
I Y D W LGC++ E+ G+ F
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 56/238 (23%), Positives = 106/238 (44%), Gaps = 36/238 (15%)
Query: 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII-------KNDKDFFDQSLDEIKLLK 432
A Y V + +G AF +V + T +K++ ++D FF + D +
Sbjct: 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF-- 99
Query: 433 LVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQ 491
A+ +++L+ F +L++V E + +L A F
Sbjct: 100 -------ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF------ 146
Query: 492 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---- 547
T + + AL+ +HS+G IH D+KP+N+L+ + +K+ D G +C + + +
Sbjct: 147 -YTAEVVLALDAIHSMGFIHRDVKPDNMLLD--KSGHLKLADFG-TCMKMNKEGMVRCDT 202
Query: 548 -VQSRSYRAPEVIIGLP----YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 600
V + Y +PEV+ Y ++ D WS+G L E+ G+ F D++V ++I+
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 34/103 (33%), Positives = 57/103 (55%), Gaps = 23/103 (22%)
Query: 501 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF----QTDNLCLYVQSRS---- 552
+EY+HS G++H DLKP+NIL+ + E+ I+D G++ F + D L + V R+
Sbjct: 126 IEYVHSKGVLHRDLKPDNILLGLFG--EVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 553 -------------YRAPEVIIGLPYDQKIDLWSLGCILAELWT 582
Y APE ++G+P + D+++LG IL ++ T
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 36/220 (16%)
Query: 389 LGSAAFSKVFQAQ----DLHTGVDVC----LKIIKNDKDFFDQSLDEIKLLKLVNKNDPA 440
LG AF +V +A+ D LK +KD D + E++++K++ K+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDL-VSEMEMMKMIGKHK-- 76
Query: 441 DEHHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYF----------TLGR 489
+I+ L L++V E NL +F + + G A T
Sbjct: 77 ---NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 490 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ 549
L Q +E+L S IH DL N+L+ + +KI D G + + + Y +
Sbjct: 134 LVSFAYQVARGMEFLASKKCIHRDLAARNVLVT--EDHVMKIADFGLA--RDIHHIDYYR 189
Query: 550 SRS-------YRAPEVIIGLPYDQKIDLWSLGCILAELWT 582
+ + APE + Y + D+WS G +L E++T
Sbjct: 190 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 448
LG+ F +V+ + V +K +K + L+E +++K + ++D +++L
Sbjct: 14 LGNGQFGEVWMGT-WNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHD-----KLVQL 66
Query: 449 YDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL 507
Y E ++IV E + + +L +F K G L L + Q + Y+ +
Sbjct: 67 YAVVSE-EPIYIVTEYMSKGSLLDFLK----DGEGRALKLPNLVDMAAQVAAGMAYIERM 121
Query: 508 GIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY----RAPEVIIGLP 563
IH DL+ NIL+ C KI D G + DN Q + APE +
Sbjct: 122 NYIHRDLRSANILVGDGLVC--KIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 564 YDQKIDLWSLGCILAELWT-GEVLFP 588
+ K D+WS G +L EL T G V +P
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 36/92 (39%), Positives = 49/92 (53%), Gaps = 7/92 (7%)
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR---- 551
Q + AL+ +HS ++H DLK NI + IK+ D G S +D++ L V S
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDSVSLDVASSFCGT 234
Query: 552 -SYRAPEVIIGLPYDQKIDLWSLGCILAELWT 582
Y APE+ Y +K D+WSLG IL EL T
Sbjct: 235 PYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 29/91 (31%), Positives = 37/91 (40%), Gaps = 12/91 (13%)
Query: 495 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR 554
QCL AL LH L + L+K GS F+T +
Sbjct: 24 LQCLGALRELHRQAKSGNILLTWDGLLKLD----------GSVAFKTPEQSR--PDPYFM 71
Query: 555 APEVIIGLPYDQKIDLWSLGCILAELWTGEV 585
APEVI G Y +K D++SLG L E E+
Sbjct: 72 APEVIQGQSYTEKADIYSLGITLYEALDYEL 102
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 30/129 (23%), Positives = 53/129 (41%), Gaps = 43/129 (33%)
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLY------- 547
+ + A++ +H LG IH D+KP+N+L+ + + IK+ D G + + + +
Sbjct: 109 ETILAIDSIHKLGYIHRDIKPDNLLLDA--KGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166
Query: 548 ---------------------------------VQSRSYRAPEVIIGLPYDQKIDLWSLG 574
V + Y APEV + Y+++ D WSLG
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226
Query: 575 CILAELWTG 583
I+ E+ G
Sbjct: 227 VIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 52/200 (26%), Positives = 79/200 (39%), Gaps = 64/200 (32%)
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS--- 552
Q L A+ ++HS +IH D+K NIL+ C ++ LG F +Y + S
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILL-----CSNGLVKLGDFGFSK----MYAATVSDDV 201
Query: 553 ---------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 603
Y APE+ PY +K D++SLG +L EL T + P D
Sbjct: 202 GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT--LKRPFDGE----------- 248
Query: 604 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVR 663
++E +M K YD +P S E + V
Sbjct: 249 ---NMEEVMH-----KTLAGRYD-------------PLPPSISPEMQ---------EIVT 278
Query: 664 TLLEINPQRRPTAREALDHP 683
LL +P+RRP++ + L+ P
Sbjct: 279 ALLSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 50/203 (24%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 389 LGSAAFSKVFQA--QDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 446
LGS F V + + + V +KI+KND + D +L + +LL+ N D +I+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN--DPALKD-ELLREANVMQQLDNPYIV 59
Query: 447 RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS 506
R+ E +V EL A L KF Q++ + T + + Q ++YL
Sbjct: 60 RMIG-ICEAESWMLVMEL--AELGPLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEE 113
Query: 507 LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-------YRAPEVI 559
+H DL N+L+ + +I L + +N Y ++++ + APE +
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN---YYKAKTHGKWPVKWYAPECM 170
Query: 560 IGLPYDQKIDLWSLGCILAELWT 582
+ K D+WS G ++ E ++
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 66/273 (24%), Positives = 116/273 (42%), Gaps = 49/273 (17%)
Query: 389 LGSAAFSKVFQAQDL-------HTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKND 438
LG F +V A+ + + V V +K++K+D KD D + E++++K++ K+
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDL-VSEMEMMKMIGKHK 78
Query: 439 PADEHHILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYF----------TL 487
+I+ L L+++ E + NL E+ + + G + F T
Sbjct: 79 -----NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF 133
Query: 488 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 547
L Q +EYL S IH DL N+L+ + +KI D G + N+ Y
Sbjct: 134 KDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT--EDNVMKIADFGLA-RDVHNIDYY 190
Query: 548 VQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARII 600
++ + R APE + Y + D+WS G +L E++T G +P V +
Sbjct: 191 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL----- 245
Query: 601 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEE 633
++L +G + K ++LY I E
Sbjct: 246 -------FKLLKEGHRMDKPANCTHELYMIMRE 271
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 61/238 (25%), Positives = 103/238 (43%), Gaps = 43/238 (18%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG+ F +V++ +T V +K +K + KDF L E +++K + H
Sbjct: 14 LGAGQFGEVWEGLWNNT-TPVAVKTLKPGTMDPKDF----LAEAQIMKKL--------RH 60
Query: 445 --ILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 501
+++LY E ++IV EL++ +L E+ Q G A L +L + Q +
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYL---QGGAGRA-LKLPQLIDMAAQVASGM 116
Query: 502 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSR---SYRAPE 557
YL + IH DL N+L+ C K+ D G + + D ++ + APE
Sbjct: 117 AYLEAQNYIHRDLAARNVLVGENNIC--KVADFGLARVIKEDIYEAREGAKFPIKWTAPE 174
Query: 558 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614
+ + K D+WS G +L E+ T G + +P GM L+ + QG
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGRMPYP------------GMTNAEVLQQVDQG 220
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 9e-06
Identities = 45/182 (24%), Positives = 80/182 (43%), Gaps = 22/182 (12%)
Query: 408 DVCLKIIKNDKDFFDQSLDEIK-LLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR 466
DV +K+IK D+ ++E K ++KL ++ +++LY ++IV E +
Sbjct: 30 DVAIKMIKEGSMSEDEFIEEAKVMMKLSHEK-------LVQLYGVCTKQRPIYIVTEYMS 82
Query: 467 ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 526
N F +L + + E + YL S IH DL N L+ Q
Sbjct: 83 NGCL----LNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD-QG 137
Query: 527 CEIKIIDLGSSCFQTDNLCLYVQSRS------YRAPEVIIGLPYDQKIDLWSLGCILAEL 580
C +K+ D G S + D+ Y S + PEV++ + K D+W+ G ++ E+
Sbjct: 138 C-VKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEV 194
Query: 581 WT 582
++
Sbjct: 195 YS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 53/217 (24%), Positives = 92/217 (42%), Gaps = 33/217 (15%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS---LDEIKLLKLVNKNDPADEH 443
E +G F V++ L +V +K ++ D L E ++LK + P
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRST-LPPDLKRKFLQEAEILK--QYDHP---- 52
Query: 444 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA--- 500
+I++L + ++IV EL+ F ++ T+ +L + L+A
Sbjct: 53 NIVKLIGVCVQKQPIYIVMELVPGG--SLLTFLRKKKNR--LTVKKL---LQMSLDAAAG 105
Query: 501 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------ 554
+EYL S IH DL N L+ + +KI D G S + + +Y S +
Sbjct: 106 MEYLESKNCIHRDLAARNCLVG--ENNVLKISDFGMS--REEEGGIYTVSDGLKQIPIKW 161
Query: 555 -APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589
APE + Y + D+WS G +L E ++ G+ +P
Sbjct: 162 TAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG 198
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 42/139 (30%), Positives = 64/139 (46%), Gaps = 12/139 (8%)
Query: 456 EHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDL 514
E ++IV E + + +L +F K E G Y L +L + Q + Y+ + +H DL
Sbjct: 73 EPIYIVTEYMSKGSLLDFLK--GEMG--KYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 128
Query: 515 KPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY----RAPEVIIGLPYDQKIDL 570
+ NIL+ C K+ D G + DN Q + APE + + K D+
Sbjct: 129 RAANILVGENLVC--KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 571 WSLGCILAELWT-GEVLFP 588
WS G +L EL T G V +P
Sbjct: 187 WSFGILLTELTTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 38/146 (26%), Positives = 63/146 (43%), Gaps = 12/146 (8%)
Query: 443 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 502
H+I+RL + I+ E + K+ ++ GE F+ +L + R ++
Sbjct: 66 HNIIRLEGVVTKFKPAMIITEYMENG--ALDKYLRDHDGE--FSSYQLVGMLRGIAAGMK 121
Query: 503 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSRS-----YRAP 556
YL + +H DL NIL+ S C K+ D G S + D Y S + AP
Sbjct: 122 YLSDMNYVHRDLAARNILVNSNLEC--KVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 557 EVIIGLPYDQKIDLWSLGCILAELWT 582
E I + D+WS G ++ E+ +
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 34/220 (15%)
Query: 389 LGSAAFSKVFQAQDLHTGVD---------VCLKIIKN---DKDFFDQSLDEIKLLKLVNK 436
LG F +V +A+ G+D V +K++K+ DKD D + E++L+KL+ K
Sbjct: 20 LGEGCFGQVVRAEAY--GIDKSRPDQTVTVAVKMLKDNATDKDLADL-ISEMELMKLIGK 76
Query: 437 NDPADEHHILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGR------ 489
+ +I+ L L+++ E + NL EF + + G + F + +
Sbjct: 77 HK-----NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 490 ----LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 545
L Q +EYL S IH DL N+L+ +I L D
Sbjct: 132 SFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191
Query: 546 LYVQSR---SYRAPEVIIGLPYDQKIDLWSLGCILAELWT 582
R + APE + Y + D+WS G ++ E++T
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 20/48 (41%), Positives = 32/48 (66%), Gaps = 2/48 (4%)
Query: 490 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537
++ + RQ L L LH +GI+H D+KPEN+L+ ++KIID G++
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV--DGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 34/220 (15%)
Query: 389 LGSAAFSKVFQAQDLHTGVD---------VCLKIIKND---KDFFDQSLDEIKLLKLVNK 436
LG F +V A+ + G+D V +K++K+D KD D + E++++K++ K
Sbjct: 26 LGEGCFGQVVMAEAI--GLDKEKPNRVTKVAVKMLKSDATEKDLSDL-ISEMEMMKMIGK 82
Query: 437 NDPADEHHILRLYDYFYHLEHLFIVCELL-RANLYEFQK----------FNQESGGEAYF 485
+ +I+ L L+++ E + NL E+ + +N E
Sbjct: 83 HK-----NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQL 137
Query: 486 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 545
+ L Q +EYL S IH DL N+L+ +I L D
Sbjct: 138 SFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197
Query: 546 LYVQSR---SYRAPEVIIGLPYDQKIDLWSLGCILAELWT 582
R + APE + Y + D+WS G +L E++T
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 41/152 (26%), Positives = 69/152 (45%), Gaps = 16/152 (10%)
Query: 441 DEHHILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 499
D +I+RL + I+ E + +L +F + N + FT+G+L + R
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN-----DGKFTVGQLVGMLRGIAS 117
Query: 500 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------Y 553
++YL + +H DL NIL+ S C K+ D G S D+ Y ++ +
Sbjct: 118 GMKYLSEMNYVHRDLAARNILVNSNLVC--KVSDFGLSRRLEDSEATY-TTKGGKIPIRW 174
Query: 554 RAPEVIIGLPYDQKIDLWSLGCILAELWT-GE 584
APE I + D+WS G ++ E+ + GE
Sbjct: 175 TAPEAIAYRKFTSASDVWSFGIVMWEVMSYGE 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 23/211 (10%)
Query: 389 LGSAAFSKVFQAQ--DLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 446
LG AF KVF A+ +L D L +K KD D + + + N HI+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTN--LQHEHIV 70
Query: 447 RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF----------TLGRLQVITRQ 496
+ Y + L +V E ++ + KF + G +A T ++ I +Q
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHG--DLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 497 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQSR--- 551
+ YL S +H DL N L+ + +KI D G S + TD + +
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVG--ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 552 SYRAPEVIIGLPYDQKIDLWSLGCILAELWT 582
+ PE I+ + + D+WSLG +L E++T
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 28/209 (13%)
Query: 389 LGSAAFSKVFQA----QDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPADE 442
LG F KV +TG V +K + + + +S EI++L+ + D
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL------DH 65
Query: 443 HHILRL--YDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 499
+I++ L ++ E L +L ++ + +++ L RL + + Q +
Sbjct: 66 ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQIN-----LKRLLLFSSQICK 120
Query: 500 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF-QTDNLCLYVQSRS-----Y 553
++YL S IH DL NIL++S +KI D G + D YV+ +
Sbjct: 121 GMDYLGSQRYIHRDLAARNILVESEDL--VKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178
Query: 554 RAPEVIIGLPYDQKIDLWSLGCILAELWT 582
APE + + D+WS G L EL+T
Sbjct: 179 YAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 34/128 (26%), Positives = 56/128 (43%), Gaps = 23/128 (17%)
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR------S 552
E +EYL IH DL N L+ S +K+ D G + + D+ Y S
Sbjct: 111 EGMEYLERNSFIHRDLAARNCLVSS--TGVVKVSDFGMTRYVLDDE--YTSSSGAKFPVK 166
Query: 553 YRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEML 611
+ PEV Y K D+WS G ++ E++T G++ F + + +EM+
Sbjct: 167 WSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV------------VEMI 214
Query: 612 MQGQEIYK 619
+G +Y+
Sbjct: 215 SRGFRLYR 222
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 45/159 (28%), Positives = 70/159 (44%), Gaps = 15/159 (9%)
Query: 456 EHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDL 514
E ++I+ E + +L +F K G + T+ +L + Q E + ++ IH DL
Sbjct: 73 EPIYIITEYMENGSLVDFLK--TPEGIK--LTINKLIDMAAQIAEGMAFIERKNYIHRDL 128
Query: 515 KPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY----RAPEVIIGLPYDQKIDL 570
+ NIL+ C KI D G + DN + + APE I + K D+
Sbjct: 129 RAANILVSETLCC--KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 571 WSLGCILAELWT-GEVLFP---NDAVVMILARIIGMLGP 605
WS G +L E+ T G + +P N V+ L R M P
Sbjct: 187 WSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRP 225
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 32/111 (28%), Positives = 58/111 (52%), Gaps = 13/111 (11%)
Query: 500 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ--TDNLC---LYVQSRSYR 554
A++ +H LG +H D+KP+N+L+ + I++ D G SC + D + V + Y
Sbjct: 114 AIDSVHQLGYVHRDIKPDNVLLD--KNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYI 170
Query: 555 APEVIIGLP-----YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 600
+PE++ + Y + D WSLG + E+ GE F +++V +I+
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 8e-05
Identities = 32/111 (28%), Positives = 56/111 (50%), Gaps = 13/111 (11%)
Query: 500 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ-----TDNLCLYVQSRSYR 554
A++ +H L +H D+KP+NIL+ I++ D G SC + T + V + Y
Sbjct: 114 AIDSVHQLHYVHRDIKPDNILMD--MNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYI 170
Query: 555 APEVIIGLP-----YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 600
+PE++ + Y + D WSLG + E+ GE F +++V +I+
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 53/243 (21%), Positives = 97/243 (39%), Gaps = 67/243 (27%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK--LVNKNDPADEHHIL 446
+G AF +V Q TG +KI++ + + I+ + LV AD ++
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE----ADSLWVV 64
Query: 447 RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE------- 499
+++ F +L+++ E L GG+ L + +T + +
Sbjct: 65 KMFYSFQDKLNLYLIMEFL-------------PGGDMMTLLMKKDTLTEEETQFYIAETV 111
Query: 500 -ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---------------------SS 537
A++ +H LG IH D+KP+N+L+ S + +K+ D G S
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLLDS--KGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 538 CFQTDNLCLYVQSRSYR-----------------APEVIIGLPYDQKIDLWSLGCILAEL 580
F N+ ++ +++ APEV + Y++ D WSLG I+ E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 581 WTG 583
G
Sbjct: 230 LIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 21/38 (55%), Positives = 26/38 (68%), Gaps = 2/38 (5%)
Query: 500 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537
AL+YLH GIIH DLKP+N+LI + IK+ D G S
Sbjct: 116 ALDYLHRHGIIHRDLKPDNMLISN--EGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 30/92 (32%), Positives = 43/92 (46%), Gaps = 7/92 (7%)
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID--LGSSCFQTDNLCLY-VQSRS 552
Q + YLH G+IH D+ N +I + +KI D L F D CL ++R
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQ--VKITDNALSRDLFPMDYHCLGDNENRP 182
Query: 553 YR--APEVIIGLPYDQKIDLWSLGCILAELWT 582
+ A E ++ Y D+WS G +L EL T
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 31/111 (27%), Positives = 55/111 (49%), Gaps = 13/111 (11%)
Query: 500 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ-----TDNLCLYVQSRSYR 554
A+ +H L +H D+KP+N+L+ I++ D G SC + T + V + Y
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLD--MNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYI 170
Query: 555 APEVIIGL-----PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 600
+PE++ + Y + D WSLG + E+ GE F +++V +I+
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 49/220 (22%), Positives = 88/220 (40%), Gaps = 43/220 (19%)
Query: 389 LGSAAFSKVFQ--AQDL---HTGVDVCLKIIKNDKDFFD--QSLDEIKLLKLVNKNDPAD 441
LG +F V++ A+ + V +K + + + + L+E ++K N
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNC----- 68
Query: 442 EHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 496
HH++RL + +V EL L++ L + + + G TL + + +
Sbjct: 69 -HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 497 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQSRSYR 554
+ + YL + +H DL N ++ KI D G + ++TD Y YR
Sbjct: 128 IADGMAYLAAKKFVHRDLAARNCMVAEDLTV--KIGDFGMTRDIYETD----Y-----YR 176
Query: 555 ------------APEVIIGLPYDQKIDLWSLGCILAELWT 582
APE + + K D+WS G +L E+ T
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 54/237 (22%), Positives = 95/237 (40%), Gaps = 55/237 (23%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLK--LVNKNDPADEHHIL 446
+G AF +V Q TG +KI++ + + I+ + LV AD ++
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE----ADGAWVV 64
Query: 447 RLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 504
+++ F +L+++ E L + K + S F + + + A++ +
Sbjct: 65 KMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-------ETVLAIDAI 117
Query: 505 HSLGIIHCDLKPENILIKSYQRCEIKIIDLG---------------------SSCFQTDN 543
H LG IH D+KP+N+L+ + + +K+ D G S F N
Sbjct: 118 HQLGFIHRDIKPDNLLLDA--KGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 544 L---------------CLY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 583
+ Y V + Y APEV + Y++ D WSLG I+ E+ G
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 31/155 (20%), Positives = 57/155 (36%), Gaps = 26/155 (16%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 448
L ++V+ D LKI + + D+ E+ +L+L+ + + ++
Sbjct: 6 LKGGLTNRVYLLGT--KDEDYVLKINPSREKGADR-EREVAILQLLARKGL----PVPKV 58
Query: 449 YDYFYHLEHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL 507
+++ E + L E + +E I Q E L LH L
Sbjct: 59 LASGESDGWSYLLMEWIEGETLDEVSEEEKED-------------IAEQLAELLAKLHQL 105
Query: 508 ---GIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539
+ H DL P NIL+ + + IID + +
Sbjct: 106 PLLVLCHGDLHPGNILVDDGK--ILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 30/105 (28%), Positives = 47/105 (44%), Gaps = 8/105 (7%)
Query: 482 EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQ 540
+ FT+ +L + R ++YL +G +H DL NIL+ S C K+ D G S +
Sbjct: 100 DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVC--KVSDFGLSRVLE 157
Query: 541 TDNLCLYVQSRS-----YRAPEVIIGLPYDQKIDLWSLGCILAEL 580
D Y + APE I + D+WS G ++ E+
Sbjct: 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 35/221 (15%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVD-VCLKIIKNDKDF--------FDQS---LDEIK----- 429
E LG AF K+++ G+D L IK KD F Q + E+
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 430 -LLKLVNKNDPADEHHILRLYDYFYHLE-HLFIVCELLRANLYEFQKFNQESGG-EAYFT 486
LL +V + P + L++Y + H F++ +R+ + + E G ++
Sbjct: 71 CLLGVVTQEQP-----VCMLFEYLNQGDLHEFLI---MRSPHSDVGCSSDEDGTVKSSLD 122
Query: 487 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL 546
G I Q +EYL S +H DL NILI ++ +KI DLG S
Sbjct: 123 HGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG--EQLHVKISDLGLSREIYSADYY 180
Query: 547 YVQSRS-----YRAPEVIIGLPYDQKIDLWSLGCILAELWT 582
VQ +S + PE I+ + D+WS G +L E+++
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 20/43 (46%), Positives = 25/43 (58%), Gaps = 2/43 (4%)
Query: 493 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535
I + L LEY+H GI H D+KPENI++ R IID G
Sbjct: 131 IMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG--YIIDYG 171
|
Length = 294 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 30/95 (31%), Positives = 45/95 (47%), Gaps = 13/95 (13%)
Query: 497 CL---EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS- 552
CL E + YL S +IH DL N L+ Q +K+ D G + F D+ Y S
Sbjct: 106 CLDVCEGMAYLESSNVIHRDLAARNCLVGENQ--VVKVSDFGMTRFVLDDQ--YTSSTGT 161
Query: 553 -----YRAPEVIIGLPYDQKIDLWSLGCILAELWT 582
+ +PEV Y K D+WS G ++ E+++
Sbjct: 162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 32/110 (29%), Positives = 48/110 (43%), Gaps = 13/110 (11%)
Query: 481 GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--SSC 538
+ TL L + Q +E+L S IH DL NIL+ +KI D G
Sbjct: 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDI 223
Query: 539 FQTDNLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 582
++ + YV+ R APE I Y + D+WS G +L E+++
Sbjct: 224 YKDPD---YVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 52/225 (23%), Positives = 80/225 (35%), Gaps = 49/225 (21%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA-------- 440
LG AF KVF + C + + D+ L +K LK ND
Sbjct: 13 LGEGAFGKVFLGE--------CYHLEPEN----DKELVAVKTLKETASNDARKDFEREAE 60
Query: 441 -----DEHHILRLYDYFYHLEHLFIVCE---------LLRANLYEFQKFNQESGGEAYFT 486
+I++ Y + +V E LR++ + T
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 487 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNL 544
L +L I Q + YL S +H DL N L+ +KI D G S + TD
Sbjct: 121 LSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY--DLVVKIGDFGMSRDVYTTD-- 176
Query: 545 CLYVQSRSYR-------APEVIIGLPYDQKIDLWSLGCILAELWT 582
Y + + PE I+ + + D+WS G +L E++T
Sbjct: 177 --YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 7e-04
Identities = 37/121 (30%), Positives = 57/121 (47%), Gaps = 18/121 (14%)
Query: 493 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLY-VQ 549
I Q +EYL S +H DL N L+ + +KI D G S + D Y VQ
Sbjct: 129 IAIQIAAGMEYLSSHHFVHRDLAARNCLV--GEGLTVKISDFGLSRDIYSAD---YYRVQ 183
Query: 550 SRS-----YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVL----FPNDAVV-MILARI 599
S+S + PE I+ + + D+WS G +L E+++ + F N V+ MI +R
Sbjct: 184 SKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ 243
Query: 600 I 600
+
Sbjct: 244 L 244
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 59/229 (25%), Positives = 92/229 (40%), Gaps = 47/229 (20%)
Query: 381 GRYYVTEYLGSAAFS-KVFQAQDLHTGVD-VCLKIIKND------KDFFDQSLDEIKLLK 432
G ++ E G FS K F D V +K+++ D +DF L E+K+L
Sbjct: 19 GEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDF----LKEVKILS 74
Query: 433 LVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 492
++ DP +I RL L ++ E + + +F Q+ E +
Sbjct: 75 RLS--DP----NIARLLGVCTVDPPLCMIMEYM--ENGDLNQFLQKHVAETSGLACNSKS 126
Query: 493 ITRQCL--------EALEYLHSLGIIHCDLKPENILI-KSYQRCEIKIIDLGSSCFQTDN 543
++ L + YL SL +H DL N L+ K+Y IKI D G S N
Sbjct: 127 LSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYT---IKIADFGMS----RN 179
Query: 544 L--CLYVQSRSYRAP--------EVIIGLPYDQKIDLWSLGCILAELWT 582
L Y + + RAP E ++ + K D+W+ G L E+ T
Sbjct: 180 LYSSDYYRVQG-RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 9e-04
Identities = 39/149 (26%), Positives = 68/149 (45%), Gaps = 18/149 (12%)
Query: 458 LFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 516
L+IV E + + +L ++ + S G + L + EA+EYL + +H DL
Sbjct: 75 LYIVTEYMAKGSLVDYLR----SRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAA 130
Query: 517 ENILIKSYQRCEIKIIDLG-----SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLW 571
N+L+ K+ D G SS T L + + APE + + K D+W
Sbjct: 131 RNVLVSEDNVA--KVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKFSTKSDVW 183
Query: 572 SLGCILAELWT-GEVLFPNDAVVMILARI 599
S G +L E+++ G V +P + ++ R+
Sbjct: 184 SFGILLWEIYSFGRVPYPRIPLKDVVPRV 212
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 51/215 (23%), Positives = 86/215 (40%), Gaps = 28/215 (13%)
Query: 388 YLGSAAFSKVFQAQDLHTGVD------VCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 441
+LGS AF +V++ V +K ++ K DQ ++ + LK + +
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR--KGATDQ--EKKEFLKEAHLMSNFN 57
Query: 442 EHHILRLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLE 499
+I++L E +I+ EL+ L + E G TL L I +
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 500 ALEYLHSLGIIHCDLKPENILI--KSYQRCEI-KIIDLG--SSCFQTDNLCLYVQSRSYR 554
YL + IH DL N L+ K Y + KI D G +++D Y +
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSD----YYRKEGEG 173
Query: 555 -------APEVIIGLPYDQKIDLWSLGCILAELWT 582
APE ++ + + D+WS G ++ E+ T
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 30/100 (30%), Positives = 46/100 (46%), Gaps = 8/100 (8%)
Query: 489 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYV 548
+L + Q + +EYL S +H DL NIL++S R +KI D G + + Y
Sbjct: 109 KLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR--VKIGDFGLTKVLPQDKEYYK 166
Query: 549 QSRS------YRAPEVIIGLPYDQKIDLWSLGCILAELWT 582
+ APE + + D+WS G +L EL+T
Sbjct: 167 VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 34/121 (28%), Positives = 55/121 (45%), Gaps = 13/121 (10%)
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSRS-- 552
Q + ++YL S +H DL N+L++S + +KI D G + +TD V+
Sbjct: 117 QICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIETDKEYYTVKDDLDS 174
Query: 553 ---YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 609
+ APE +I + D+WS G L EL T D+ + + M+GP +
Sbjct: 175 PVFWYAPECLIQSKFYIASDVWSFGVTLYELLT-----YCDSESSPMTLFLKMIGPTHGQ 229
Query: 610 M 610
M
Sbjct: 230 M 230
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 45/203 (22%), Positives = 79/203 (38%), Gaps = 25/203 (12%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHH--IL 446
LG + +V++ + V +K +K D ++ L E ++K + H ++
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK--------EIKHPNLV 65
Query: 447 RLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH 505
+L +I+ E + NL ++ + A L + Q A+EYL
Sbjct: 66 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL----YMATQISSAMEYLE 121
Query: 506 SLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR------SYRAPEVI 559
IH DL N L+ +K+ D G S T + Y + APE +
Sbjct: 122 KKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPESL 177
Query: 560 IGLPYDQKIDLWSLGCILAELWT 582
+ K D+W+ G +L E+ T
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 7/95 (7%)
Query: 493 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--SSCFQTDNLCLYVQS 550
I Q +E+L S ++H DL N+L+ + + +KI DLG + D L S
Sbjct: 129 IVTQIAAGMEFLSSHHVVHKDLATRNVLV--FDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 551 R---SYRAPEVIIGLPYDQKIDLWSLGCILAELWT 582
+ +PE I+ + D+WS G +L E+++
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 689 | |||
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.98 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.98 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.98 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.96 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| cd08677 | 118 | C2A_Synaptotagmin-13 C2 domain. Synaptotagmin is a | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| cd08692 | 135 | C2B_Tac2-N C2 domain second repeat found in Tac2-N | 99.82 | |
| cd08407 | 138 | C2B_Synaptotagmin-13 C2 domain second repeat prese | 99.82 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| cd08680 | 124 | C2_Kibra C2 domain found in Human protein Kibra. K | 99.81 | |
| cd08406 | 136 | C2B_Synaptotagmin-12 C2 domain second repeat prese | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.76 | |
| cd04028 | 146 | C2B_RIM1alpha C2 domain second repeat contained in | 99.76 | |
| cd08392 | 128 | C2A_SLP-3 C2 domain first repeat present in Synapt | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.75 | |
| cd08381 | 122 | C2B_PI3K_class_II C2 domain second repeat present | 99.75 | |
| cd08685 | 119 | C2_RGS-like C2 domain of the Regulator Of G-Protei | 99.74 | |
| cd08393 | 125 | C2A_SLP-1_2 C2 domain first repeat present in Syna | 99.74 | |
| cd08408 | 138 | C2B_Synaptotagmin-14_16 C2 domain second repeat pr | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| cd04029 | 125 | C2A_SLP-4_5 C2 domain first repeat present in Syna | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| cd08395 | 120 | C2C_Munc13 C2 domain third repeat in Munc13 (mamma | 99.69 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.69 | |
| cd08409 | 137 | C2B_Synaptotagmin-15 C2 domain second repeat prese | 99.67 | |
| cd08410 | 135 | C2B_Synaptotagmin-17 C2 domain second repeat prese | 99.65 | |
| cd08384 | 133 | C2B_Rabphilin_Doc2 C2 domain second repeat present | 99.64 | |
| KOG1028 | 421 | consensus Ca2+-dependent phospholipid-binding prot | 99.64 | |
| cd08404 | 136 | C2B_Synaptotagmin-4 C2 domain second repeat presen | 99.63 | |
| cd04020 | 162 | C2B_SLP_1-2-3-4 C2 domain second repeat present in | 99.62 | |
| cd08389 | 124 | C2A_Synaptotagmin-14_16 C2A domain first repeat pr | 99.61 | |
| cd08521 | 123 | C2A_SLP C2 domain first repeat present in Synaptot | 99.61 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.61 | |
| cd08403 | 134 | C2B_Synaptotagmin-3-5-6-9-10 C2 domain second repe | 99.61 | |
| cd08402 | 136 | C2B_Synaptotagmin-1 C2 domain second repeat presen | 99.61 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.6 | |
| cd08388 | 128 | C2A_Synaptotagmin-4-11 C2A domain first repeat pre | 99.6 | |
| cd04030 | 127 | C2C_KIAA1228 C2 domain third repeat present in unc | 99.6 | |
| cd08387 | 124 | C2A_Synaptotagmin-8 C2A domain first repeat presen | 99.6 | |
| cd04010 | 148 | C2B_RasA3 C2 domain second repeat present in RAS p | 99.59 | |
| cd04031 | 125 | C2A_RIM1alpha C2 domain first repeat contained in | 99.59 | |
| cd08405 | 136 | C2B_Synaptotagmin-7 C2 domain second repeat presen | 99.59 | |
| cd08385 | 124 | C2A_Synaptotagmin-1-5-6-9-10 C2A domain first repe | 99.58 | |
| KOG1028 | 421 | consensus Ca2+-dependent phospholipid-binding prot | 99.58 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.57 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.56 | |
| cd04041 | 111 | C2A_fungal C2 domain first repeat; fungal group. C | 99.56 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.55 | |
| cd04039 | 108 | C2_PSD C2 domain present in Phosphatidylserine dec | 99.53 | |
| cd08682 | 126 | C2_Rab11-FIP_classI C2 domain found in Rab11-famil | 99.52 | |
| cd08386 | 125 | C2A_Synaptotagmin-7 C2A domain first repeat presen | 99.52 | |
| cd04009 | 133 | C2B_Munc13-like C2 domain second repeat in Munc13 | 99.52 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.51 | |
| cd08688 | 110 | C2_KIAA0528-like C2 domain found in the Human KIAA | 99.51 | |
| cd08401 | 121 | C2A_RasA2_RasA3 C2 domain first repeat present in | 99.5 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.49 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.49 | |
| cd08390 | 123 | C2A_Synaptotagmin-15-17 C2A domain first repeat pr | 99.47 | |
| cd04032 | 127 | C2_Perforin C2 domain of Perforin. Perforin contai | 99.47 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.45 | |
| cd08376 | 116 | C2B_MCTP_PRT C2 domain second repeat found in Mult | 99.45 | |
| cd04018 | 151 | C2C_Ferlin C2 domain third repeat in Ferlin. Ferli | 99.45 | |
| cd08690 | 155 | C2_Freud-1 C2 domain found in 5' repressor element | 99.45 | |
| cd04036 | 119 | C2_cPLA2 C2 domain present in cytosolic PhosphoLip | 99.44 | |
| cd04016 | 121 | C2_Tollip C2 domain present in Toll-interacting pr | 99.44 | |
| cd04025 | 123 | C2B_RasA1_RasA4 C2 domain second repeat present in | 99.43 | |
| cd00276 | 134 | C2B_Synaptotagmin C2 domain second repeat present | 99.43 | |
| cd04035 | 123 | C2A_Rabphilin_Doc2 C2 domain first repeat present | 99.43 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.43 | |
| cd04042 | 121 | C2A_MCTP_PRT C2 domain first repeat found in Multi | 99.43 | |
| cd08686 | 118 | C2_ABR C2 domain in the Active BCR (Breakpoint clu | 99.42 | |
| cd04022 | 127 | C2A_MCTP_PRT_plant C2 domain first repeat found in | 99.42 | |
| cd08379 | 126 | C2D_MCTP_PRT_plant C2 domain fourth repeat found i | 99.41 | |
| cd08375 | 136 | C2_Intersectin C2 domain present in Intersectin. A | 99.4 | |
| cd04026 | 131 | C2_PKC_alpha_gamma C2 domain in Protein Kinase C ( | 99.39 | |
| cd08676 | 153 | C2A_Munc13-like C2 domain first repeat in Munc13 ( | 99.39 | |
| KOG1030 | 168 | consensus Predicted Ca2+-dependent phospholipid-bi | 99.39 | |
| cd08374 | 133 | C2F_Ferlin C2 domain sixth repeat in Ferlin. Ferli | 99.39 | |
| cd04019 | 150 | C2C_MCTP_PRT_plant C2 domain third repeat found in | 99.39 | |
| cd04033 | 133 | C2_NEDD4_NEDD4L C2 domain present in the Human neu | 99.38 | |
| cd04024 | 128 | C2A_Synaptotagmin-like C2 domain first repeat pres | 99.37 | |
| cd04037 | 124 | C2E_Ferlin C2 domain fifth repeat in Ferlin. Ferli | 99.36 | |
| cd04043 | 126 | C2_Munc13_fungal C2 domain in Munc13 (mammalian un | 99.35 | |
| cd04054 | 121 | C2A_Rasal1_RasA4 C2 domain first repeat present in | 99.34 | |
| cd04011 | 111 | C2B_Ferlin C2 domain second repeat in Ferlin. Ferl | 99.34 | |
| cd08681 | 118 | C2_fungal_Inn1p-like C2 domain found in fungal Ing | 99.34 | |
| cd04017 | 135 | C2D_Ferlin C2 domain fourth repeat in Ferlin. Ferl | 99.33 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-70 Score=567.68 Aligned_cols=410 Identities=23% Similarity=0.322 Sum_probs=336.1
Q ss_pred CCCCCCcccCCCCc--------ccccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCccccc
Q 005590 216 CSEPLCKCCAGEGK--------INNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIE 286 (689)
Q Consensus 216 ~~~~~c~~~~~~~~--------~~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne 286 (689)
+.+++||++|+|+| +..+.|+|.|+|| ||.|||.||.||||||+.|+||++.+.|+||+++|+||||+|||
T Consensus 155 nVPslCG~DhtE~RGrl~l~~~~~~~~l~v~i~ea~NLiPMDpNGlSDPYvk~kliPD~~~~sKqKTkTik~~LNP~wNE 234 (683)
T KOG0696|consen 155 NVPSLCGTDHTERRGRLYLEAHIKRDVLTVTIKEAKNLIPMDPNGLSDPYVKLKLIPDPKNESKQKTKTIKATLNPVWNE 234 (683)
T ss_pred cCCcccCCcchhhcceEEEEEEecCceEEEEehhhccccccCCCCCCCcceeEEeccCCcchhhhhhhhhhhhcCccccc
Confidence 47899999999877 4889999999999 99999999999999999999999999999999999999999999
Q ss_pred ccccccccccCccccccccccccCCCCCCCcccccccccccccccccCCCccchhchhhhhhhheee-eeeee-------
Q 005590 287 GFKGSSDLHFKGAEKDLMPAEIDNSDTRDGEVNGALHEGKADAEEHGVATPDLLMFDNLEEECEIFH-LRIIH------- 358 (689)
Q Consensus 287 ~f~~~~~~~~~~~~~~L~~~V~D~d~~~~~d~~G~v~~~~~~~~~e~~~~~~~l~~~~l~ee~~~~~-lr~i~------- 358 (689)
+|+|+ +...+.++.|.+.||||||.++|||+|.++++++++.++++.+ |++.|.+++.++. +....
T Consensus 235 tftf~--Lkp~DkdrRlsiEvWDWDrTsRNDFMGslSFgisEl~K~p~~G----WyKlLsqeEGEyyNvp~~~~~~e~~~ 308 (683)
T KOG0696|consen 235 TFTFK--LKPSDKDRRLSIEVWDWDRTSRNDFMGSLSFGISELQKAPVDG----WYKLLSQEEGEYYNVPVPDEDSEDNE 308 (683)
T ss_pred eeEEe--cccccccceeEEEEecccccccccccceecccHHHHhhcchhh----HHHHhhhhcCceeccCCCCchhhHHH
Confidence 99999 9999999999999999999999999999999999999999999 7777777665442 22111
Q ss_pred ------ccccCCc---CC------CCC--cce-eeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--
Q 005590 359 ------RKNRTGF---EE------NKD--LPI-ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-- 418 (689)
Q Consensus 359 ------~~~~~~~---~~------~~~--~pi-~~~~~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~-- 418 (689)
++.+.+. .+ ... ... ....+-..+|..+.+||+|+||+|.+|..+.+.+.+|||+++++.
T Consensus 309 ~lr~k~~~~~~~~~~s~p~~~~~~~~~~~~~~~~~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDVii 388 (683)
T KOG0696|consen 309 ELRQKFERARIGPGSSKPEKKTMPTDSKFHNSSKRDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVII 388 (683)
T ss_pred HHHHHHhhcccCCCcCCCCCCCCCCcccCCCCCcccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceee
Confidence 1111111 00 000 000 011233467999999999999999999999999999999998764
Q ss_pred --hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHH
Q 005590 419 --DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 496 (689)
Q Consensus 419 --~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~Q 496 (689)
+..+..+.|.++|.... ..|++++++.+|+..+.+|+||||+.|+-+-+....-. .+.+..+..++..
T Consensus 389 QdDDvectm~EKrvLAL~~-----kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~G-----kFKEp~AvFYAaE 458 (683)
T KOG0696|consen 389 QDDDVECTMVEKRVLALPG-----KPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-----KFKEPVAVFYAAE 458 (683)
T ss_pred ecCcccceehhhhheecCC-----CCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhc-----ccCCchhhhhhHH
Confidence 23344555666665444 34799999999999999999999999753333322211 1788889999999
Q ss_pred HHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccc---cCCccccccCccccChhhhcCCCCCchhhHHHH
Q 005590 497 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ---TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSL 573 (689)
Q Consensus 497 Il~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~---~~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSL 573 (689)
|+-||-+||++|||+||||.+|||++. .|+|||+|||++... .....+++|||.|+|||++..++|+.++|+||+
T Consensus 459 iaigLFFLh~kgIiYRDLKLDNvmLd~--eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~ 536 (683)
T KOG0696|consen 459 IAIGLFFLHSKGIIYRDLKLDNVMLDS--EGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF 536 (683)
T ss_pred HHHHhhhhhcCCeeeeeccccceEecc--CCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHH
Confidence 999999999999999999999999995 899999999998642 334556899999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccC
Q 005590 574 GCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQF 653 (689)
Q Consensus 574 Gvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~ 653 (689)
||+||||+.|++||.+.+..++.+.|+.-- ...|. .
T Consensus 537 GVLLyEmlaGQpPFdGeDE~elF~aI~ehn-----------------------------------vsyPK---------s 572 (683)
T KOG0696|consen 537 GVLLYEMLAGQPPFDGEDEDELFQAIMEHN-----------------------------------VSYPK---------S 572 (683)
T ss_pred HHHHHHHHcCCCCCCCCCHHHHHHHHHHcc-----------------------------------CcCcc---------c
Confidence 999999999999999999999999886221 11221 2
Q ss_pred CcHHHHHHHHHhcccCCCCCcCH-----HHHHcCCCCCC
Q 005590 654 SDAFFIDFVRTLLEINPQRRPTA-----REALDHPWLQH 687 (689)
Q Consensus 654 ~~~~l~dLI~~mL~~dP~kRpTa-----~ElL~hpwf~~ 687 (689)
.+.+++++...+|...|.+|... +++-.||||+.
T Consensus 573 lSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 573 LSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred ccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 34568899999999999999863 67889999975
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-56 Score=487.21 Aligned_cols=320 Identities=49% Similarity=0.768 Sum_probs=288.6
Q ss_pred CcCCCCCcceeeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCC
Q 005590 364 GFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEH 443 (689)
Q Consensus 364 ~~~~~~~~pi~~~~~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~ 443 (689)
....++.+.++.++.+..||.|++.||+|+||+|.+|.|..|++.||||++++.+....+...|+++|..|+.....+..
T Consensus 169 ~~~~~~dY~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~ 248 (586)
T KOG0667|consen 169 FDDEDGDYQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKY 248 (586)
T ss_pred CCCCCCceeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCe
Confidence 45567788999999999999999999999999999999999999999999999999999999999999999976667778
Q ss_pred ceeEEEEEEEeCCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec
Q 005590 444 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 523 (689)
Q Consensus 444 ~Iv~l~~~f~~~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~ 523 (689)
|+|+++++|...+|+|||+|.++.+|+++++.++..+ +++..++.|+.||+.||.+||+.||||+||||+||||..
T Consensus 249 n~Vrm~d~F~fr~HlciVfELL~~NLYellK~n~f~G----lsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~ 324 (586)
T KOG0667|consen 249 NIVRMLDYFYFRNHLCIVFELLSTNLYELLKNNKFRG----LSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKD 324 (586)
T ss_pred eEEEeeeccccccceeeeehhhhhhHHHHHHhcCCCC----CCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeecc
Confidence 9999999999999999999999999999999887765 999999999999999999999999999999999999988
Q ss_pred cCCCeEEEEecCCcccccCCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhc
Q 005590 524 YQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 603 (689)
Q Consensus 524 ~~~~~vkL~DFGls~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~ 603 (689)
.....|||||||+|++.....+.+++++.|+|||+++|.+|+.++||||||||+.||++|.+.|++.+..++++.|++++
T Consensus 325 ~~r~~vKVIDFGSSc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~l 404 (586)
T KOG0667|consen 325 PKRSRIKVIDFGSSCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVL 404 (586)
T ss_pred CCcCceeEEecccccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHh
Confidence 77889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcHHHHhhhhhhhhhhhccccchhhhhccc-----------------cccccCC-ccchhhhhcc-CCcHHHHHHHHH
Q 005590 604 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETN-----------------QLEYIIP-EESSLEHHLQ-FSDAFFIDFVRT 664 (689)
Q Consensus 604 g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~p-~~~~l~~~~~-~~~~~l~dLI~~ 664 (689)
|.+|..++..+....++|+......+...+.. ......| ....+...+. ..+..|.|||.+
T Consensus 405 G~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~ 484 (586)
T KOG0667|consen 405 GLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKR 484 (586)
T ss_pred CCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHH
Confidence 99999999999999999987322222111111 2444455 4555555554 456789999999
Q ss_pred hcccCCCCCcCHHHHHcCCCCCC
Q 005590 665 LLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 665 mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
||.+||.+|+|+.|+|+||||+.
T Consensus 485 ~L~~dP~~R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 485 CLEWDPAERITPAQALNHPFLTG 507 (586)
T ss_pred HhccCchhcCCHHHHhcCccccc
Confidence 99999999999999999999983
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=414.85 Aligned_cols=259 Identities=31% Similarity=0.516 Sum_probs=212.6
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh--------hhHhHHHHHHHHHHhcccCCCCCCceeEE
Q 005590 377 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--------FFDQSLDEIKLLKLVNKNDPADEHHILRL 448 (689)
Q Consensus 377 ~~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~--------~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l 448 (689)
..+++.|.+.+.||+|+||.|-+|.++.+|+.||||++.+.+. ......+|++||++|+ ||+||++
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~------HP~IV~~ 241 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS------HPNIVRI 241 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC------CCCEEEE
Confidence 3467889999999999999999999999999999999986432 2234568999999886 6899999
Q ss_pred EEEEEeCCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecc-CC
Q 005590 449 YDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QR 526 (689)
Q Consensus 449 ~~~f~~~~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~-~~ 526 (689)
+++|...+..|+||||++| .|.+.+..+.. +.+..-+.+++||+.||.|||++||+||||||+|||+..+ ++
T Consensus 242 ~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~------l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~ 315 (475)
T KOG0615|consen 242 KDFFEVPDSSYMVLEYVEGGELFDKVVANKY------LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAED 315 (475)
T ss_pred eeeeecCCceEEEEEEecCccHHHHHHhccc------cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcc
Confidence 9999999999999999995 68887765443 7788889999999999999999999999999999999864 56
Q ss_pred CeEEEEecCCcccccC--CccccccCccccChhhhcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCChHHH-HHHHHH
Q 005590 527 CEIKIIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGLP---YDQKIDLWSLGCILAELWTGEVLFPNDAVVM-ILARII 600 (689)
Q Consensus 527 ~~vkL~DFGls~~~~~--~~~~~~gt~~Y~APE~l~~~~---~s~~~DIwSLGvil~eLltG~~PF~~~~~~~-~l~~i~ 600 (689)
+.+||+|||+|+..+. -..+.||||.|.|||++.+.. +..++|||||||+||-+|+|.+||....... +..+|.
T Consensus 316 ~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~ 395 (475)
T KOG0615|consen 316 CLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQIL 395 (475)
T ss_pred eEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHh
Confidence 8999999999998854 345689999999999998765 3348899999999999999999997653333 333332
Q ss_pred hhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHH
Q 005590 601 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 680 (689)
Q Consensus 601 ~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL 680 (689)
+ ..|.+.. .. ....+++.++||..||..||++|||++|+|
T Consensus 396 ~-----------------------------------G~y~f~p--~~---w~~Iseea~dlI~~mL~VdP~~R~s~~eaL 435 (475)
T KOG0615|consen 396 K-----------------------------------GRYAFGP--LQ---WDRISEEALDLINWMLVVDPENRPSADEAL 435 (475)
T ss_pred c-----------------------------------CcccccC--hh---hhhhhHHHHHHHHHhhEeCcccCcCHHHHh
Confidence 1 1111110 01 112356789999999999999999999999
Q ss_pred cCCCCCC
Q 005590 681 DHPWLQH 687 (689)
Q Consensus 681 ~hpwf~~ 687 (689)
+||||+.
T Consensus 436 ~hpW~~~ 442 (475)
T KOG0615|consen 436 NHPWFKD 442 (475)
T ss_pred cChhhhc
Confidence 9999983
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-50 Score=422.63 Aligned_cols=283 Identities=32% Similarity=0.530 Sum_probs=241.8
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hh-hHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC
Q 005590 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DF-FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 378 ~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~-~~-~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
.+.+||.++++||.|.||.||+|+.+.+|+.||||.+++.- .+ .-.-+||++.|++++ .||||+++.+++.+.
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln-----~hpniikL~Evi~d~ 81 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN-----PHPNIIKLKEVIRDN 81 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcC-----CCCcchhhHHHhhcc
Confidence 34589999999999999999999999999999999987642 11 234457888888776 378999999999988
Q ss_pred C-eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEec
Q 005590 456 E-HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 534 (689)
Q Consensus 456 ~-~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DF 534 (689)
+ ++|+|||||+.+|+++++.+. ..|++..++.|++||++||+|+|++|+.||||||+||||.. ...|||+||
T Consensus 82 ~~~L~fVfE~Md~NLYqLmK~R~-----r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~--~~~iKiaDF 154 (538)
T KOG0661|consen 82 DRILYFVFEFMDCNLYQLMKDRN-----RLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG--NDVIKIADF 154 (538)
T ss_pred CceEeeeHHhhhhhHHHHHhhcC-----CcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc--cceeEeccc
Confidence 8 999999999999999998653 34999999999999999999999999999999999999985 678999999
Q ss_pred CCccccc--CCccccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 005590 535 GSSCFQT--DNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 611 (689)
Q Consensus 535 Gls~~~~--~~~~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~ 611 (689)
|+|+... ++.+.++.|+||+|||+++. .-|+.++||||+|||++|+.+-++.|++.++.+.+.+|..++|.+..+.|
T Consensus 155 GLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 155 GLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred ccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence 9998754 45566899999999999875 45899999999999999999999999999999999999999999999988
Q ss_pred hhhhhhhhhhhccccchhhhhccccccccCCc--cchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCCC
Q 005590 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPE--ESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~~ 688 (689)
..+..+.. .+.+.+|. ...+.........++.+||.+||.|||.+||||.|+|+|||||.+
T Consensus 235 ~eg~~La~----------------~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 235 PEGYNLAS----------------AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred hhHHHHHH----------------HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 88755543 22233332 223334444456789999999999999999999999999999965
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=423.37 Aligned_cols=251 Identities=32% Similarity=0.544 Sum_probs=224.2
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeec----chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN----DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~----~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
.+|...+.||+|||++||.+++..+|+.||+|++.+ .....+...+|++|.+.|+ |||||+++++|++.+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~------HpnIV~f~~~FEDs~ 91 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK------HPNIVQFYHFFEDSN 91 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC------CCcEEeeeeEeecCC
Confidence 689999999999999999999999999999999987 3455678888999998885 789999999999999
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
+.|||+|+|. ++|..+++.. +.++|.+++.+++||+.||.|||+.+|+|||||..|++++. +.+|||+|||
T Consensus 92 nVYivLELC~~~sL~el~Krr------k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~--~~~VKIgDFG 163 (592)
T KOG0575|consen 92 NVYIVLELCHRGSLMELLKRR------KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNE--NMNVKIGDFG 163 (592)
T ss_pred ceEEEEEecCCccHHHHHHhc------CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecC--cCcEEecccc
Confidence 9999999998 5666666522 23999999999999999999999999999999999999994 8899999999
Q ss_pred Cccccc---CCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 005590 536 SSCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 612 (689)
Q Consensus 536 ls~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~ 612 (689)
+|.... +...+.||||.|.|||++....++..+||||+|||||-||.|++||+..+..+.+.+|.
T Consensus 164 LAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik------------ 231 (592)
T KOG0575|consen 164 LATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK------------ 231 (592)
T ss_pred eeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH------------
Confidence 998876 45677899999999999999999999999999999999999999999999999998884
Q ss_pred hhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCCCC
Q 005590 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHPY 689 (689)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~~~ 689 (689)
..+|.+|.. .+.++++||++||+.||.+|||++++|.|+||.+.|
T Consensus 232 -----------------------~~~Y~~P~~---------ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~ 276 (592)
T KOG0575|consen 232 -----------------------LNEYSMPSH---------LSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGF 276 (592)
T ss_pred -----------------------hcCcccccc---------cCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence 335666653 235688999999999999999999999999996654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-48 Score=388.58 Aligned_cols=279 Identities=27% Similarity=0.447 Sum_probs=234.7
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
++|+.+.++|+|+||.||+++++.||+.||||.+... +......++|+++|+.++ |+|+|.++.+|.....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLk------H~NLVnLiEVFrrkrk 75 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLK------HENLVNLIEVFRRKRK 75 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcc------cchHHHHHHHHHhcce
Confidence 5788999999999999999999999999999998754 334567789999999886 6799999999999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 458 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 458 l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
+++|+|||+.++++.+...... ++...++.+++|++.|+.|+|++++|||||||+||||+ ..+.+||||||+|
T Consensus 76 lhLVFE~~dhTvL~eLe~~p~G-----~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit--~~gvvKLCDFGFA 148 (396)
T KOG0593|consen 76 LHLVFEYCDHTVLHELERYPNG-----VPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT--QNGVVKLCDFGFA 148 (396)
T ss_pred eEEEeeecchHHHHHHHhccCC-----CCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe--cCCcEEeccchhh
Confidence 9999999999988777655432 88999999999999999999999999999999999999 4899999999999
Q ss_pred cccc---CCccccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 005590 538 CFQT---DNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 538 ~~~~---~~~~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
+... +..+.++.|+||+|||.+.+ .+|+.++||||+||++.||++|++.|++.+..+++-.|++.+|++.+.-..
T Consensus 149 R~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~- 227 (396)
T KOG0593|consen 149 RTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQS- 227 (396)
T ss_pred HhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHH-
Confidence 8765 34455789999999999998 689999999999999999999999999999999999999999987764321
Q ss_pred hhhhhhhhhccccchhhhhccccccccCC-ccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCC
Q 005590 614 GQEIYKYFTKEYDLYYINEETNQLEYIIP-EESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686 (689)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p-~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~ 686 (689)
.|. -+....++...-| ....++..+.....-+.||+.+||..||.+|++-+|+|.||+|+
T Consensus 228 ------iF~-------~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 228 ------IFS-------SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred ------Hhc-------cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 111 1111222322222 23344444555556789999999999999999999999999995
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=378.15 Aligned_cols=278 Identities=32% Similarity=0.504 Sum_probs=240.5
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
.||..+++||+|.||.||+|+|..+|+.||||.++..+ .......+|++.|++++ |+||+.++++|-+.+.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~------h~nIi~LiD~F~~~~~ 75 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELK------HPNIIELIDVFPHKSN 75 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHcc------CcchhhhhhhccCCCc
Confidence 57899999999999999999999999999999998643 22457889999999996 6799999999999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 458 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 458 l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
+.||+||++.+|...++... ..++...++.++.++++||+|||.+.|+||||||.|+||++ +|.+||+|||++
T Consensus 76 l~lVfEfm~tdLe~vIkd~~-----i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~--~g~lKiADFGLA 148 (318)
T KOG0659|consen 76 LSLVFEFMPTDLEVVIKDKN-----IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISS--DGQLKIADFGLA 148 (318)
T ss_pred eEEEEEeccccHHHHhcccc-----cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcC--CCcEEeecccch
Confidence 99999999999998887544 34999999999999999999999999999999999999995 899999999999
Q ss_pred ccccCCcc---ccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 005590 538 CFQTDNLC---LYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 538 ~~~~~~~~---~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
+....... ..+-|++|+|||.+.|. .|+..+||||+|||+.||+-|.+-|++.+..+++..|.+.+|.+.++.|+.
T Consensus 149 r~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~ 228 (318)
T KOG0659|consen 149 RFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPE 228 (318)
T ss_pred hccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcc
Confidence 98765432 23679999999999985 599999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
...+.+|.+-. .+|. ..+...+...+.+..||+.+||..||.+|+|+.|+|+|+||+.
T Consensus 229 ~~~lpdY~~~~---------------~~P~-~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 229 MTSLPDYVKIQ---------------QFPK-PPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred ccccccHHHHh---------------cCCC-CccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 88777665411 1111 1112233334566799999999999999999999999999984
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=394.17 Aligned_cols=253 Identities=31% Similarity=0.471 Sum_probs=214.3
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEee--cchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~--~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
...+.+.++.||+|+.|+||+++|+.|++.+|+|++. .+.....++.+|+++++..+ +|+||.+|+.|.+..
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~------spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQ------SPYIVGFYGAFYSNG 150 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC------CCCeeeEeEEEEeCC
Confidence 3456788889999999999999999999999999994 35667789999999999884 679999999999999
Q ss_pred -eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEeccCCCeEEEEe
Q 005590 457 -HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIID 533 (689)
Q Consensus 457 -~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~-~gIvHrDLKp~NILl~~~~~~~vkL~D 533 (689)
.++|+||||++ +|..+++..+ .+++..+..|++++++||.|||+ .+||||||||+||||++ .|+|||+|
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~~g------~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNs--kGeVKicD 222 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKRVG------RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNS--KGEVKICD 222 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeecc--CCCEEecc
Confidence 59999999996 5555555332 28999999999999999999996 89999999999999996 99999999
Q ss_pred cCCcccccCC-ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----hHHHHHHHHHhhcCCCc
Q 005590 534 LGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND-----AVVMILARIIGMLGPID 607 (689)
Q Consensus 534 FGls~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~-----~~~~~l~~i~~~~g~~~ 607 (689)
||.+...... ..+++||..|||||.+.+..|+.++||||||+.++|+.+|+.||... +..+++..|... ++|
T Consensus 223 FGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~--ppP 300 (364)
T KOG0581|consen 223 FGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE--PPP 300 (364)
T ss_pred ccccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC--CCC
Confidence 9999876554 46789999999999999999999999999999999999999999764 444555444311 111
Q ss_pred HHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 608 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 608 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
.+|.. ..+++|++||..||+.||.+|||+.|+++|||+++
T Consensus 301 --------------------------------~lP~~--------~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~ 340 (364)
T KOG0581|consen 301 --------------------------------RLPEG--------EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK 340 (364)
T ss_pred --------------------------------CCCcc--------cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence 11111 24578999999999999999999999999999975
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=399.87 Aligned_cols=281 Identities=29% Similarity=0.475 Sum_probs=240.5
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005590 377 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 453 (689)
Q Consensus 377 ~~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~ 453 (689)
..-.+.|+.+++||+|.||.||+|++..+|+.||+|.++.+ ..+.....+||.||++|. ||||++|.+...
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~------HpNIikL~eivt 186 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLD------HPNIIKLEEIVT 186 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcC------CCcccceeeEEE
Confidence 33456799999999999999999999999999999999865 345667889999999985 689999999998
Q ss_pred eC--CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEE
Q 005590 454 HL--EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 531 (689)
Q Consensus 454 ~~--~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL 531 (689)
.. ..+|+|+|||+.+|.-++.... ..|++.+++.+++||+.||.|||.+||+|||||.+||||+ .+|.+||
T Consensus 187 ~~~~~siYlVFeYMdhDL~GLl~~p~-----vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLid--n~G~LKi 259 (560)
T KOG0600|consen 187 SKLSGSIYLVFEYMDHDLSGLLSSPG-----VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILID--NNGVLKI 259 (560)
T ss_pred ecCCceEEEEEecccchhhhhhcCCC-----cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEc--CCCCEEe
Confidence 77 6899999999999888776433 3399999999999999999999999999999999999999 4899999
Q ss_pred EecCCcccccCC----ccccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 005590 532 IDLGSSCFQTDN----LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 606 (689)
Q Consensus 532 ~DFGls~~~~~~----~~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~ 606 (689)
+|||+|+++... .+..+-|+||+|||.++|. .|+.++|+||+||||.||++|++.|++.+..+++..|.+..|.+
T Consensus 260 aDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP 339 (560)
T KOG0600|consen 260 ADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSP 339 (560)
T ss_pred ccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCC
Confidence 999999976543 4456789999999999986 59999999999999999999999999999999999999999999
Q ss_pred cHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 607 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
.++.|. ...+.. ........+....+.+.+...++..++|+..||..||.+|.||.++|+|+||
T Consensus 340 ~e~~W~-~~kLP~--------------~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 340 TEDYWP-VSKLPH--------------ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF 403 (560)
T ss_pred Chhccc-cccCCc--------------ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence 988876 222211 1122223333445555677778889999999999999999999999999999
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-46 Score=382.62 Aligned_cols=280 Identities=35% Similarity=0.586 Sum_probs=236.3
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeec---chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe-
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH- 454 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~---~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~- 454 (689)
+..+|..++.||+|+||.|+.|.++.+|+.||||.+.. ......+..+|+++|+.++ |+||+.+++++..
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~------HeNIi~l~di~~p~ 93 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLR------HENIIGLLDIFRPP 93 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhc------CCCcceEEeecccc
Confidence 34667778999999999999999999999999998862 3455678889999999886 6799999999975
Q ss_pred ----CCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEE
Q 005590 455 ----LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 530 (689)
Q Consensus 455 ----~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vk 530 (689)
-+.+|+|+|+|+.+|...++..+. ++...++.+++||++||+|+|+.+|+||||||.|+|++. +|.+|
T Consensus 94 ~~~~f~DvYiV~elMetDL~~iik~~~~------L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~--~c~lK 165 (359)
T KOG0660|consen 94 SRDKFNDVYLVFELMETDLHQIIKSQQD------LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNA--DCDLK 165 (359)
T ss_pred cccccceeEEehhHHhhHHHHHHHcCcc------ccHHHHHHHHHHHHHhcchhhcccccccccchhheeecc--CCCEE
Confidence 246999999999999988875543 889999999999999999999999999999999999995 89999
Q ss_pred EEecCCccccc-----CCccccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 005590 531 IIDLGSSCFQT-----DNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 604 (689)
Q Consensus 531 L~DFGls~~~~-----~~~~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g 604 (689)
|+|||+|+... ...+.++.|.+|+|||++.. ..|+.++||||+||||.||++|++.|++.+..+++..|+..+|
T Consensus 166 I~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lG 245 (359)
T KOG0660|consen 166 ICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLG 245 (359)
T ss_pred eccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcC
Confidence 99999999873 23456788999999999865 5699999999999999999999999999999999999999999
Q ss_pred CCcHHHHhhhh--hhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 605 PIDLEMLMQGQ--EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 605 ~~~~e~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
.++.+.+.... ....|+... ...| ...+...+...++.+++||.+||..||.+|+|++|+|+|
T Consensus 246 tP~~e~l~~i~s~~ar~yi~sl--------------p~~p-~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 246 TPSEEDLQKIRSEKARPYIKSL--------------PQIP-KQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred CCCHHHHHHhccHHHHHHHHhC--------------CCCC-CCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 99888776543 222232211 1111 123344555667889999999999999999999999999
Q ss_pred CCCCC
Q 005590 683 PWLQH 687 (689)
Q Consensus 683 pwf~~ 687 (689)
|||..
T Consensus 311 PYl~~ 315 (359)
T KOG0660|consen 311 PYLAP 315 (359)
T ss_pred hhhhh
Confidence 99974
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=378.90 Aligned_cols=282 Identities=26% Similarity=0.413 Sum_probs=235.9
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE--
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY-- 453 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~-- 453 (689)
-.+.|+.++.|++|.||.||+|+|+.|++.||+|.++.++ .+.-..++|+.+|..++ ||||+.+-.+..
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~------H~NIV~vkEVVvG~ 147 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKAR------HPNIVEVKEVVVGS 147 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcC------CCCeeeeEEEEecc
Confidence 3467999999999999999999999999999999998754 24456789999998875 679999998877
Q ss_pred eCCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEe
Q 005590 454 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 533 (689)
Q Consensus 454 ~~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~D 533 (689)
+.+.+|+|||||+.+|..++..-. ..|...+++.++.|++.||+|||...|+||||||+|+|+. ..|.+||+|
T Consensus 148 ~~d~iy~VMe~~EhDLksl~d~m~-----q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~--~~G~lKiaD 220 (419)
T KOG0663|consen 148 NMDKIYIVMEYVEHDLKSLMETMK-----QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS--HKGILKIAD 220 (419)
T ss_pred ccceeeeeHHHHHhhHHHHHHhcc-----CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec--cCCcEEecc
Confidence 446799999999999999887544 2399999999999999999999999999999999999999 489999999
Q ss_pred cCCcccccCC---ccccccCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHH
Q 005590 534 LGSSCFQTDN---LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 609 (689)
Q Consensus 534 FGls~~~~~~---~~~~~gt~~Y~APE~l~~~~-~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e 609 (689)
||+|+.++.+ .+..+-|.+|+|||.+++.+ |+.++|+||+|||+.||+++++.|++.+..+++.+|...+|.+.+.
T Consensus 221 FGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~ 300 (419)
T KOG0663|consen 221 FGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEA 300 (419)
T ss_pred cchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccc
Confidence 9999998877 44467799999999999865 9999999999999999999999999999999999999999999988
Q ss_pred HHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCC--cHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFS--DAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~--~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
.|+.-......- .....-....++...+... ++...+|++++|.+||.+|+||.|+|+|+||..
T Consensus 301 iwpg~~~lp~~k--------------~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 301 IWPGYSELPAVK--------------KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred cCCCccccchhh--------------ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 887644332110 0000111112222222222 366789999999999999999999999999986
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=382.96 Aligned_cols=251 Identities=29% Similarity=0.483 Sum_probs=216.6
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
.++|+++++||+|+||+|++++.+.+++.+|+|++++.. ...+...+|..||..+ .||+|++++..|++.
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v------~hPFiv~l~ysFQt~ 97 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI------KHPFIVKLIYSFQTE 97 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC------CCCcEeeeEEecccC
Confidence 578999999999999999999999999999999998743 3456777888888875 478999999999999
Q ss_pred CeEEEEEEccccc-hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEec
Q 005590 456 EHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 534 (689)
Q Consensus 456 ~~l~lVmEy~~g~-L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DF 534 (689)
+++|+|+||+.|+ |.-.+.... .|++..++.++..|+.||.|||++|||||||||+|||++ ..|+|+|+||
T Consensus 98 ~kLylVld~~~GGeLf~hL~~eg------~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd--~~GHi~LtDF 169 (357)
T KOG0598|consen 98 EKLYLVLDYLNGGELFYHLQREG------RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLD--EQGHIKLTDF 169 (357)
T ss_pred CeEEEEEeccCCccHHHHHHhcC------CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeec--CCCcEEEecc
Confidence 9999999999974 544443222 299999999999999999999999999999999999999 5999999999
Q ss_pred CCcccc---cCCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 005590 535 GSSCFQ---TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 611 (689)
Q Consensus 535 Gls~~~---~~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~ 611 (689)
|+++.. ++...++|||+.|||||++.+.+|+.++|+||||+++|+|++|.+||.+.+...+..+|.+...+.+
T Consensus 170 gL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~---- 245 (357)
T KOG0598|consen 170 GLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLP---- 245 (357)
T ss_pred ccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCC----
Confidence 999753 3345568999999999999999999999999999999999999999999999888888863321111
Q ss_pred hhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCc----CHHHHHcCCCCCC
Q 005590 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP----TAREALDHPWLQH 687 (689)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRp----Ta~ElL~hpwf~~ 687 (689)
....+.++++||+++|..||++|. .+.++-+||||..
T Consensus 246 ---------------------------------------p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 246 ---------------------------------------PGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred ---------------------------------------CccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCccccc
Confidence 112356789999999999999996 7999999999975
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=389.82 Aligned_cols=250 Identities=30% Similarity=0.489 Sum_probs=221.3
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
.+|...+.||.|+|++|++|+++.+++.||||++.+.- .-.+...+|..+|..|. .||.|++|+..|++..
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~-----~hPgivkLy~TFQD~~ 147 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLS-----GHPGIVKLYFTFQDEE 147 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhh-----CCCCeEEEEEEeeccc
Confidence 67999999999999999999999999999999987532 22356677888898886 5899999999999999
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
.+|+|+||+. |+|+++++..+. |.+..++.++.||+.||+|||++|||||||||+|||++. +++++|+|||
T Consensus 148 sLYFvLe~A~nGdll~~i~K~Gs------fde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~--dmhikITDFG 219 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKYGS------FDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDK--DGHIKITDFG 219 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHhCc------chHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcC--CCcEEEeecc
Confidence 9999999998 689999886643 899999999999999999999999999999999999994 9999999999
Q ss_pred CcccccCC----------------ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHH
Q 005590 536 SSCFQTDN----------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 599 (689)
Q Consensus 536 ls~~~~~~----------------~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i 599 (689)
.|..+.+. .+.++||..|.+||++.....+..+|||+||||||+|+.|.+||.+.++..++++|
T Consensus 220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI 299 (604)
T KOG0592|consen 220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI 299 (604)
T ss_pred ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH
Confidence 98754321 24589999999999999999999999999999999999999999999999999998
Q ss_pred HhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHH
Q 005590 600 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA 679 (689)
Q Consensus 600 ~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~El 679 (689)
+ .+.+.+|+.. ++.+++||+++|..||++|+|++||
T Consensus 300 ~-----------------------------------~l~y~fp~~f---------p~~a~dLv~KLLv~dp~~Rlt~~qI 335 (604)
T KOG0592|consen 300 Q-----------------------------------ALDYEFPEGF---------PEDARDLIKKLLVRDPSDRLTSQQI 335 (604)
T ss_pred H-----------------------------------HhcccCCCCC---------CHHHHHHHHHHHccCccccccHHHH
Confidence 7 3455555432 3568899999999999999999999
Q ss_pred HcCCCCCC
Q 005590 680 LDHPWLQH 687 (689)
Q Consensus 680 L~hpwf~~ 687 (689)
-+||||..
T Consensus 336 k~HpFF~~ 343 (604)
T KOG0592|consen 336 KAHPFFEG 343 (604)
T ss_pred hhCccccc
Confidence 99999975
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=378.69 Aligned_cols=314 Identities=35% Similarity=0.602 Sum_probs=259.4
Q ss_pred CCcceeeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEE
Q 005590 369 KDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 448 (689)
Q Consensus 369 ~~~pi~~~~~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l 448 (689)
+.+-...++.+.+||.|+.+||+|.||+|..+.|..++..|||||++.-....+..+-|+++|++++...+..---++++
T Consensus 77 GH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m 156 (415)
T KOG0671|consen 77 GHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQM 156 (415)
T ss_pred ceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence 44556788999999999999999999999999999999999999998766667788899999999988776666678899
Q ss_pred EEEEEeCCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecc----
Q 005590 449 YDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY---- 524 (689)
Q Consensus 449 ~~~f~~~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~---- 524 (689)
.++|...+|.|||+|.++-++++++..+.... ++...++.|++||+++++|||+.+++|.||||+|||+.+.
T Consensus 157 ~~wFdyrghiCivfellG~S~~dFlk~N~y~~----fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 157 RDWFDYRGHICIVFELLGLSTFDFLKENNYIP----FPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred ehhhhccCceEEEEeccChhHHHHhccCCccc----cchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEE
Confidence 99999999999999999989999998766543 9999999999999999999999999999999999998531
Q ss_pred --------------CCCeEEEEecCCcccccCCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 005590 525 --------------QRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 590 (689)
Q Consensus 525 --------------~~~~vkL~DFGls~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~ 590 (689)
....|+|+|||.|.+........+.|..|+|||++++.+|+.+.||||+||||+|+.+|...|+..
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 134689999999999888888889999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhcc-ccccccCCccchhhhhccC---CcHHHHHHHHHhc
Q 005590 591 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEET-NQLEYIIPEESSLEHHLQF---SDAFFIDFVRTLL 666 (689)
Q Consensus 591 ~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~p~~~~l~~~~~~---~~~~l~dLI~~mL 666 (689)
...+.++.|..++||+|..|..+.. ..++|... ...+...-. .+..+.......+...... ....+.|||++||
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~-~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTR-KEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhh-hHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 8999999999999999999988764 33344322 111111100 1111221111112111111 2246899999999
Q ss_pred ccCCCCCcCHHHHHcCCCCCCC
Q 005590 667 EINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 667 ~~dP~kRpTa~ElL~hpwf~~~ 688 (689)
..||.+|+|+.|+|.||||...
T Consensus 391 ~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 391 EFDPARRITLREALSHPFFARL 412 (415)
T ss_pred ccCccccccHHHHhcCHHhhcC
Confidence 9999999999999999999763
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=395.94 Aligned_cols=299 Identities=29% Similarity=0.493 Sum_probs=235.3
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC-CeE
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL-EHL 458 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~-~~l 458 (689)
.++|+++++||+|+||+||+|++..+++.||||+++...........|+.+++.+++.+...|.+|++++++|... .+.
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 5789999999999999999999999999999999976544455667899999999888777888999999998865 589
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEeccC------------
Q 005590 459 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQ------------ 525 (689)
Q Consensus 459 ~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~-~gIvHrDLKp~NILl~~~~------------ 525 (689)
++|||+++++|++++.... .+++..++.|+.||+.||.|||+ .|||||||||+|||++..+
T Consensus 208 ~iv~~~~g~~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 208 CIVMPKYGPCLLDWIMKHG------PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred EEEEeccCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 9999999888888776432 28899999999999999999998 5999999999999998532
Q ss_pred --CCeEEEEecCCcccccCCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhc
Q 005590 526 --RCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 603 (689)
Q Consensus 526 --~~~vkL~DFGls~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~ 603 (689)
.+.+||+|||.+..........+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+.+..+...+
T Consensus 282 ~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 361 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTL 361 (467)
T ss_pred CCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Confidence 235999999998766555666789999999999999999999999999999999999999999998889999999999
Q ss_pred CCCcHHHHhhhh--hhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 604 GPIDLEMLMQGQ--EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 604 g~~~~e~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
|.+|.++..... ....++........... ...+.. +........ ...++.+.+||.+||++||.+|||++|+|+
T Consensus 362 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~--~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 362 GRLPSEWAGRCGTEEARLLYNSAGQLRPCTD-PKHLAR-IARARPVRE--VIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred CCCCHHHHhhccchhHHHHhhhcccccccCC-HHHHHh-hhcccchhh--hhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 999987765321 11112211110000000 000000 000000000 112466889999999999999999999999
Q ss_pred CCCCCCC
Q 005590 682 HPWLQHP 688 (689)
Q Consensus 682 hpwf~~~ 688 (689)
||||++-
T Consensus 438 Hp~~~~~ 444 (467)
T PTZ00284 438 HPYVLKY 444 (467)
T ss_pred Ccccccc
Confidence 9999874
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=360.43 Aligned_cols=249 Identities=27% Similarity=0.499 Sum_probs=221.5
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|++++.||.|+||+|.+++++.+|..+|+|++.+.+ .+.+...+|..+|+.+. ||+++++++.|.+..
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~------~PFlv~l~~t~~d~~ 117 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS------HPFLVKLYGTFKDNS 117 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc------CceeEEEEEeeccCC
Confidence 68999999999999999999999999999999998753 34566777888888774 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
++|+||||++| .|..+++..++ |++..++.++.||+.||+|||+++|++|||||+||||++ +|.+||+|||
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~r------F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~--~G~iKitDFG 189 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSGR------FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQ--NGHIKITDFG 189 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcCC------CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeecc--CCcEEEEecc
Confidence 99999999996 57777775544 999999999999999999999999999999999999995 9999999999
Q ss_pred CcccccCCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 005590 536 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615 (689)
Q Consensus 536 ls~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~ 615 (689)
+|........+.||||.|+|||++...+|..++|+|||||++|||+.|.+||.+.+...+..+|...
T Consensus 190 FAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~------------- 256 (355)
T KOG0616|consen 190 FAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG------------- 256 (355)
T ss_pred ceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC-------------
Confidence 9999988888899999999999999999999999999999999999999999999998888888632
Q ss_pred hhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCC-----cCHHHHHcCCCCCC
Q 005590 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR-----PTAREALDHPWLQH 687 (689)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kR-----pTa~ElL~hpwf~~ 687 (689)
...+|. ..+..+++||.++|+.|-.+| ....++-.||||..
T Consensus 257 ----------------------~v~fP~---------~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 257 ----------------------KVKFPS---------YFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred ----------------------cccCCc---------ccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence 223332 234668999999999999999 35778999999975
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=371.46 Aligned_cols=277 Identities=32% Similarity=0.534 Sum_probs=229.7
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC----
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE---- 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~---- 456 (689)
-.|.-.+++|+|+||.||+|+...+++.||||..-.++. ---+|+++|+.+ +||||+++..+|....
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l------~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKL------DHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhc------CCcCeeeEEEEEEecCCCch
Confidence 358889999999999999999999999999999887764 334789999855 6889999999997432
Q ss_pred -eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 -HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 -~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
++.+|||||+.+|.+.++..... +..++...++.+.+||++||.|||+.||+||||||.|+|++. ++|.+||+|||
T Consensus 95 ~~lnlVleymP~tL~~~~r~~~~~--~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~-~tg~LKicDFG 171 (364)
T KOG0658|consen 95 VYLNLVLEYMPETLYRVIRHYTRA--NQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDP-DTGVLKICDFG 171 (364)
T ss_pred hHHHHHHHhchHHHHHHHHHHhhc--CCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcC-CCCeEEeccCC
Confidence 56789999999999998864222 223888899999999999999999999999999999999997 68999999999
Q ss_pred Cccccc--CCccccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 005590 536 SSCFQT--DNLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 612 (689)
Q Consensus 536 ls~~~~--~~~~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~ 612 (689)
+|+... .+...+.-|+.|+|||.+.+. .|+.++||||.||++.||+-|++.|++.+..+++..|++++|.++.+.+.
T Consensus 172 SAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 172 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred cceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 998754 334557789999999999986 59999999999999999999999999999999999999999999988876
Q ss_pred hhhhhhhhhhccccchhhhhccccccccCCccch--h-hhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESS--L-EHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~--l-~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
.....+. ....|.... . .-.....++++.+|+.++|+++|.+|.++.|+|.||||+.
T Consensus 252 ~mn~~y~------------------~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFde 311 (364)
T KOG0658|consen 252 SMNPNYT------------------EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDE 311 (364)
T ss_pred hcCcccc------------------cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHH
Confidence 5543221 111111000 0 1123345788999999999999999999999999999974
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=387.40 Aligned_cols=317 Identities=33% Similarity=0.587 Sum_probs=273.2
Q ss_pred CCCcceeeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeE
Q 005590 368 NKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILR 447 (689)
Q Consensus 368 ~~~~pi~~~~~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~ 447 (689)
.+++.+.+++++.+||.|....|+|-||+|..|.|...|..|||||+++...-...-++|++||++|+...+-+-.|+++
T Consensus 419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 56788999999999999999999999999999999999999999999998877788899999999999988888889999
Q ss_pred EEEEEEeCCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCC
Q 005590 448 LYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC 527 (689)
Q Consensus 448 l~~~f~~~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~ 527 (689)
++..|.+.+|+|+|+|-+.-+|.++++..+... -|.+..++.++.|+.-||..|-.+||+|.||||+||||+. ...
T Consensus 499 l~r~F~hknHLClVFE~LslNLRevLKKyG~nv---GL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE-~k~ 574 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNV---GLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNE-SKN 574 (752)
T ss_pred HHHHhhhcceeEEEehhhhchHHHHHHHhCccc---ceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEecc-Ccc
Confidence 999999999999999999999999988665433 3889999999999999999999999999999999999986 566
Q ss_pred eEEEEecCCcccccCC-ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 005590 528 EIKIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 606 (689)
Q Consensus 528 ~vkL~DFGls~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~ 606 (689)
.+||||||.|...+++ .+.+.-+..|+|||+++|.+|+...|+||+||+||||.||+..|++.+...++..++.+.|++
T Consensus 575 iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~ 654 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF 654 (752)
T ss_pred eeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence 8999999999887665 455677889999999999999999999999999999999999999999999999999999999
Q ss_pred cHHHHhhhhhhhhhhhccccchhhhhcc-------ccccccCCc---------cchhhhhccCCcHHHHHHHHHhcccCC
Q 005590 607 DLEMLMQGQEIYKYFTKEYDLYYINEET-------NQLEYIIPE---------ESSLEHHLQFSDAFFIDFVRTLLEINP 670 (689)
Q Consensus 607 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~p~---------~~~l~~~~~~~~~~l~dLI~~mL~~dP 670 (689)
|..|+.+++...+.|+....+++..... ..+...-|. ...++......-..|++||.+||..||
T Consensus 655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP 734 (752)
T KOG0670|consen 655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP 734 (752)
T ss_pred cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence 9999999999988888877666532211 111111221 111111111112468999999999999
Q ss_pred CCCcCHHHHHcCCCCCCC
Q 005590 671 QRRPTAREALDHPWLQHP 688 (689)
Q Consensus 671 ~kRpTa~ElL~hpwf~~~ 688 (689)
++|+|..++|+||||+.+
T Consensus 735 ~KRit~nqAL~HpFi~~k 752 (752)
T KOG0670|consen 735 EKRITVNQALKHPFITEK 752 (752)
T ss_pred hhcCCHHHHhcCCcccCC
Confidence 999999999999999863
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=380.89 Aligned_cols=255 Identities=32% Similarity=0.509 Sum_probs=219.9
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----h--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005590 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----K--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 451 (689)
Q Consensus 378 ~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~----~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~ 451 (689)
...++|.+.+.||+|+||+|++|++..+++.||+|++.+. . .....+.+|+.+++.+++ ||||++++++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~-----HpnI~~l~ev 88 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRS-----HPNIIRLLEV 88 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhcc-----CCCEeEEEEE
Confidence 4568999999999999999999999999999999987664 1 234566689989988863 6799999999
Q ss_pred EEeCCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEE
Q 005590 452 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 530 (689)
Q Consensus 452 f~~~~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vk 530 (689)
+....++++||||+.| .|++++.... .+.+..++.+++||+.|++|||++||+||||||+|||++.+. +.+|
T Consensus 89 ~~t~~~~~ivmEy~~gGdL~~~i~~~g------~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~-~~~K 161 (370)
T KOG0583|consen 89 FATPTKIYIVMEYCSGGDLFDYIVNKG------RLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE-GNLK 161 (370)
T ss_pred EecCCeEEEEEEecCCccHHHHHHHcC------CCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC-CCEE
Confidence 9999999999999995 8998887532 288999999999999999999999999999999999999632 8999
Q ss_pred EEecCCcccc---cCCccccccCccccChhhhcCCC-CC-chhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 005590 531 IIDLGSSCFQ---TDNLCLYVQSRSYRAPEVIIGLP-YD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 605 (689)
Q Consensus 531 L~DFGls~~~---~~~~~~~~gt~~Y~APE~l~~~~-~s-~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~ 605 (689)
|+|||++... .....+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||...+...+...|.
T Consensus 162 l~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~----- 236 (370)
T KOG0583|consen 162 LSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIR----- 236 (370)
T ss_pred EeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHh-----
Confidence 9999999876 34567789999999999999988 87 78999999999999999999999877777776653
Q ss_pred CcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 606 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 606 ~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
...+.+|.... ++++++||++||..||.+|+|+.+++.||||
T Consensus 237 ------------------------------~~~~~~p~~~~--------S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~ 278 (370)
T KOG0583|consen 237 ------------------------------KGEFKIPSYLL--------SPEARSLIEKMLVPDPSTRITLLEILEHPWF 278 (370)
T ss_pred ------------------------------cCCccCCCCcC--------CHHHHHHHHHHcCCCcccCCCHHHHhhChhh
Confidence 22334444321 4668899999999999999999999999999
Q ss_pred CC
Q 005590 686 QH 687 (689)
Q Consensus 686 ~~ 687 (689)
+.
T Consensus 279 ~~ 280 (370)
T KOG0583|consen 279 QK 280 (370)
T ss_pred cc
Confidence 96
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=371.47 Aligned_cols=319 Identities=35% Similarity=0.615 Sum_probs=272.5
Q ss_pred cccCCcCCCCCcceeeCceec-CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccC
Q 005590 360 KNRTGFEENKDLPIILNTVIA-GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 438 (689)
Q Consensus 360 ~~~~~~~~~~~~pi~~~~~l~-~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~ 438 (689)
+....|..++++|+.++++++ +||.+.++||-|.|++||+|.|....+.||+|+.+......+..+.||++|+.++...
T Consensus 56 E~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~D 135 (590)
T KOG1290|consen 56 EDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGD 135 (590)
T ss_pred cChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcC
Confidence 345677889999999999999 9999999999999999999999999999999999988777889999999999998865
Q ss_pred --CCCCCceeEEEEEEEeC----CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCcee
Q 005590 439 --PADEHHILRLYDYFYHL----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIH 511 (689)
Q Consensus 439 --~~~h~~Iv~l~~~f~~~----~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~-~gIvH 511 (689)
.....+||++++.|... .|+|+|+|+++.+|+.++......+ ++...++.|++||+.||.|||. +||||
T Consensus 136 p~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrG----lpl~~VK~I~~qvL~GLdYLH~ecgIIH 211 (590)
T KOG1290|consen 136 PNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRG----LPLSCVKEICRQVLTGLDYLHRECGIIH 211 (590)
T ss_pred CCCCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCC----CcHHHHHHHHHHHHHHHHHHHHhcCccc
Confidence 44566999999999854 5999999999999999999887765 9999999999999999999996 59999
Q ss_pred ccCCCCcEEEec--------------------------------------------------------------------
Q 005590 512 CDLKPENILIKS-------------------------------------------------------------------- 523 (689)
Q Consensus 512 rDLKp~NILl~~-------------------------------------------------------------------- 523 (689)
-||||+|||+..
T Consensus 212 TDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~ 291 (590)
T KOG1290|consen 212 TDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGL 291 (590)
T ss_pred cCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccc
Confidence 999999999840
Q ss_pred ----------------------------------------------c---------------------------------
Q 005590 524 ----------------------------------------------Y--------------------------------- 524 (689)
Q Consensus 524 ----------------------------------------------~--------------------------------- 524 (689)
.
T Consensus 292 ~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~ 371 (590)
T KOG1290|consen 292 EGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSP 371 (590)
T ss_pred ccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCc
Confidence 0
Q ss_pred -----------------CCCeEEEEecCCcccccCCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 005590 525 -----------------QRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLF 587 (689)
Q Consensus 525 -----------------~~~~vkL~DFGls~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF 587 (689)
.+..|||+|||.|++.....+.-.+|+.|+|||++.+.+|+..+||||++|++|||+||..+|
T Consensus 372 ~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLF 451 (590)
T KOG1290|consen 372 GTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLF 451 (590)
T ss_pred cccccccccCCCCCCCccceeEEEeeccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceee
Confidence 001478999999999888888888999999999999999999999999999999999999999
Q ss_pred CC------ChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCc---HHH
Q 005590 588 PN------DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSD---AFF 658 (689)
Q Consensus 588 ~~------~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~---~~l 658 (689)
.. ...++.++.|+..+|.+|......+....+||++......... +.++ |-...+.+-+.+.. .+|
T Consensus 452 ePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~----LK~W-pL~~VL~eKY~~s~e~A~~f 526 (590)
T KOG1290|consen 452 EPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRR----LKPW-PLYEVLIEKYEWSEEDAQQF 526 (590)
T ss_pred cCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccc----cCCC-cHHHHHHHHhCCCHHHHHHH
Confidence 53 4667899999999999999999999999999988766543322 1111 11122233333332 468
Q ss_pred HHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 659 IDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 659 ~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
.+||.-||+.+|++||||.++|+||||..
T Consensus 527 sdFL~PmLef~PeKR~tA~~cl~hPwLn~ 555 (590)
T KOG1290|consen 527 SDFLSPMLEFDPEKRPTAAQCLKHPWLNP 555 (590)
T ss_pred HHHHHHHHhcCccccccHHHHhcCccccC
Confidence 99999999999999999999999999973
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=365.28 Aligned_cols=276 Identities=29% Similarity=0.440 Sum_probs=224.8
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
++|++.++||.|+||+||+|++..+++.||+|+++... .......+|+.+++.++ |+||+++++++...+..
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~ 78 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLK------HANIVTLHDIIHTERCL 78 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCC------CCCEeeEEEEEcCCCeE
Confidence 57999999999999999999999999999999987532 22345668888888774 78999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcc
Q 005590 459 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 459 ~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 538 (689)
++||||+.++|.+++..... .+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++.
T Consensus 79 ~lv~e~~~~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~--~~~~kl~DfG~~~ 151 (288)
T cd07871 79 TLVFEYLDSDLKQYLDNCGN-----LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINE--KGELKLADFGLAR 151 (288)
T ss_pred EEEEeCCCcCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC--CCCEEECcCccee
Confidence 99999999988887754322 2788899999999999999999999999999999999984 7889999999986
Q ss_pred cccCC---ccccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 539 FQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 539 ~~~~~---~~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
..... .....+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.++.+.|...
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 152 AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGI 231 (288)
T ss_pred eccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcc
Confidence 54322 223567899999999876 56899999999999999999999999999999999999999998888877654
Q ss_pred hhhhhhhhccccchhhhhccccccccCCc--cchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPE--ESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
.....+.. ..+|. ...........+.++++||++||++||.+|||++|+|+||||
T Consensus 232 ~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 232 TSNEEFRS----------------YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccchhhhc----------------cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 32221111 00110 011112223346778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=365.81 Aligned_cols=284 Identities=32% Similarity=0.490 Sum_probs=236.4
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC-
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE- 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~---~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~- 456 (689)
..|..+++||+|+||+||+|+++.+|+.||+|.++.+.. ......+|+-+|+.+++.+ ||+++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~-----~iv~L~dv~~~~~~ 85 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHAN-----HIVRLHDVIHTSNN 85 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCc-----ceEEEEeeeeeccc
Confidence 457777889999999999999999999999999987543 4567789999999998653 2999999999877
Q ss_pred -----eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEE
Q 005590 457 -----HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 531 (689)
Q Consensus 457 -----~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL 531 (689)
.+++|+||++-+|..++....... ..++...++.+++||+.||.|||+.||+||||||.||||++ .|.+||
T Consensus 86 ~~~~~~l~lvfe~~d~DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~--~G~lKl 161 (323)
T KOG0594|consen 86 HRGIGKLYLVFEFLDRDLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISS--SGVLKL 161 (323)
T ss_pred ccccceEEEEEEeecccHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECC--CCcEee
Confidence 899999999999999988765432 22667899999999999999999999999999999999995 899999
Q ss_pred EecCCcccccC---CccccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCc
Q 005590 532 IDLGSSCFQTD---NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 607 (689)
Q Consensus 532 ~DFGls~~~~~---~~~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~ 607 (689)
+|||+|+...- ..+..+.|.+|+|||++.+. .|+..+||||+|||+.||+++++.|++.+..+++.+|...+|.+.
T Consensus 162 aDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 162 ADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPN 241 (323)
T ss_pred eccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCC
Confidence 99999986552 23456889999999999987 699999999999999999999999999999999999999999999
Q ss_pred HHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 608 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 608 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
++.|+......+|-.. +. ..+....+.......++...+++.+||+.+|.+|+||..+|+||||+.
T Consensus 242 e~~Wp~v~~~~~~k~~----f~----------~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~ 307 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAP----FP----------KWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSE 307 (323)
T ss_pred ccCCCCcccccccccc----Cc----------CCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcc
Confidence 9888775544332110 00 001112223333334467889999999999999999999999999985
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=386.95 Aligned_cols=253 Identities=27% Similarity=0.467 Sum_probs=220.7
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005590 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 453 (689)
Q Consensus 378 ~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~----~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~ 453 (689)
+--++|+++++||+|+||+|+++..+.+++.+|||+++++ .+..+..+.|.+|+...+ .||++++++.+|+
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~-----~HPFL~~L~~~fQ 439 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELAN-----RHPFLVNLFSCFQ 439 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhc-----cCCeEeecccccc
Confidence 3347899999999999999999999999999999999985 355678888999998886 5999999999999
Q ss_pred eCCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEe
Q 005590 454 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 533 (689)
Q Consensus 454 ~~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~D 533 (689)
+.+|+|+||||+.|+. ++...+ ...|++.+++.++..|+.||+|||++||||||||.+|||++. .|++||+|
T Consensus 440 T~~~l~fvmey~~Ggd--m~~~~~----~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~--eGh~kiAD 511 (694)
T KOG0694|consen 440 TKEHLFFVMEYVAGGD--LMHHIH----TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDT--EGHVKIAD 511 (694)
T ss_pred cCCeEEEEEEecCCCc--EEEEEe----cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcc--cCcEEecc
Confidence 9999999999999865 222111 123999999999999999999999999999999999999995 89999999
Q ss_pred cCCccc---ccCCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 005590 534 LGSSCF---QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 610 (689)
Q Consensus 534 FGls~~---~~~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~ 610 (689)
||+++. .+....++||||.|+|||++.+..|+.++|+|||||+|||||.|+.||++++..++...|+..
T Consensus 512 FGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d-------- 583 (694)
T KOG0694|consen 512 FGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND-------- 583 (694)
T ss_pred cccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--------
Confidence 999875 345667899999999999999999999999999999999999999999999999999888611
Q ss_pred HhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCH-----HHHHcCCCC
Q 005590 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA-----REALDHPWL 685 (689)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa-----~ElL~hpwf 685 (689)
+...| .+++.+++++|+++|..||++|.-+ .++.+||||
T Consensus 584 ---------------------------~~~yP---------~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFF 627 (694)
T KOG0694|consen 584 ---------------------------EVRYP---------RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFF 627 (694)
T ss_pred ---------------------------CCCCC---------CcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCcc
Confidence 12223 2345678899999999999999985 778899999
Q ss_pred CC
Q 005590 686 QH 687 (689)
Q Consensus 686 ~~ 687 (689)
+.
T Consensus 628 r~ 629 (694)
T KOG0694|consen 628 RS 629 (694)
T ss_pred cc
Confidence 85
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=363.92 Aligned_cols=255 Identities=30% Similarity=0.489 Sum_probs=213.7
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
.++|.+.+.||+|+||+||+|+++.++..||||.+.+. +...+....|+.+|+.++ |||||+++++....+
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~------H~nIV~l~d~~~~~~ 82 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELK------HPNIVRLLDCIEDDD 82 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcC------CcceeeEEEEEecCC
Confidence 47899999999999999999999999999999998764 345667789999999996 789999999999999
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecc-CC---CeEEE
Q 005590 457 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QR---CEIKI 531 (689)
Q Consensus 457 ~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~-~~---~~vkL 531 (689)
.+|+|||||. |+|..++..... +++..++.++.||+.||++||+++||||||||+||||+.. .. ..+||
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~~------l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKI 156 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRGR------LPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKI 156 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEe
Confidence 9999999999 578888775542 8999999999999999999999999999999999999863 22 57999
Q ss_pred EecCCcccccCC--ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHH
Q 005590 532 IDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 609 (689)
Q Consensus 532 ~DFGls~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e 609 (689)
+|||+|+..... ..+.||++-|||||++..+.|+.|+|+||+|+|+|+|++|+.||...+..+++..+.+.-.
T Consensus 157 ADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~----- 231 (429)
T KOG0595|consen 157 ADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE----- 231 (429)
T ss_pred cccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc-----
Confidence 999999987653 4568999999999999999999999999999999999999999999998888876531111
Q ss_pred HHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
+...++... .....+|+...|+.+|..|.+..+-+.|+++..
T Consensus 232 ---------------------------~~~~~~~~~---------s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 232 ---------------------------IVPVLPAEL---------SNPLRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred ---------------------------ccCchhhhc---------cCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 111111111 122447888888888888888888888887754
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=375.28 Aligned_cols=253 Identities=29% Similarity=0.463 Sum_probs=211.4
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
.++|.+++.||+|+||.||+|+.+.||..+|+|++++.. ........|-.+|... +.+.||++|..|++.
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~------ds~~vVKLyYsFQD~ 213 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV------DSPWVVKLYYSFQDK 213 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc------CCCcEEEEEEEecCC
Confidence 478999999999999999999999999999999998753 3455666677777664 357999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEec
Q 005590 456 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 534 (689)
Q Consensus 456 ~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DF 534 (689)
+++||||||++| ++..++.... .|++..++.++.+++.|+..||+.|+|||||||+|+||+. .|+|||+||
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~------~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~--~GHiKLSDF 285 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKD------TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDA--KGHIKLSDF 285 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcC------cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecC--CCCEeeccc
Confidence 999999999996 5666655333 2999999999999999999999999999999999999994 999999999
Q ss_pred CCccccc------------------------C-C-------------------------ccccccCccccChhhhcCCCC
Q 005590 535 GSSCFQT------------------------D-N-------------------------LCLYVQSRSYRAPEVIIGLPY 564 (689)
Q Consensus 535 Gls~~~~------------------------~-~-------------------------~~~~~gt~~Y~APE~l~~~~~ 564 (689)
|++.-.. + . ....+|||.|+|||++.+.+|
T Consensus 286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY 365 (550)
T KOG0605|consen 286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY 365 (550)
T ss_pred cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC
Confidence 9862100 0 0 001489999999999999999
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCcc
Q 005590 565 DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEE 644 (689)
Q Consensus 565 s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 644 (689)
+...|+||||||+||||.|.+||.++++.+...+|+ .|.. ...+|..
T Consensus 366 ~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~------------nwr~---------------------~l~fP~~ 412 (550)
T KOG0605|consen 366 GKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIV------------NWRE---------------------TLKFPEE 412 (550)
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------------HHhh---------------------hccCCCc
Confidence 999999999999999999999999999999999986 1111 1223322
Q ss_pred chhhhhccCCcHHHHHHHHHhcccCCCCCcC---HHHHHcCCCCCC
Q 005590 645 SSLEHHLQFSDAFFIDFVRTLLEINPQRRPT---AREALDHPWLQH 687 (689)
Q Consensus 645 ~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT---a~ElL~hpwf~~ 687 (689)
... ..+++|||.+||. ||.+|.- ++|+-+||||+.
T Consensus 413 ~~~-------s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 413 VDL-------SDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred Ccc-------cHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 222 2668999999999 9999996 999999999986
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=382.55 Aligned_cols=249 Identities=31% Similarity=0.520 Sum_probs=219.4
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~----~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
+-|++.+.||.|+-|.|.+|++..||+.+|||++.+. ......+.+|+-||+.+. ||||+++|++++...
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~------HpnVl~LydVwe~~~ 85 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE------HPNVLRLYDVWENKQ 85 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhc------CCCeeeeeeeeccCc
Confidence 5699999999999999999999999999999999875 234567889999999986 679999999999999
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
++|+|.||+. |.|++++...+. +++.++..++.||+.|+.|+|..+|+||||||+|+|++. .+.|||+|||
T Consensus 86 ~lylvlEyv~gGELFdylv~kG~------l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~--~~nIKIADFG 157 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKGP------LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDV--KNNIKIADFG 157 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhc--ccCEeeeccc
Confidence 9999999998 568888875543 899999999999999999999999999999999999995 5559999999
Q ss_pred CcccccC--CccccccCccccChhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 005590 536 SSCFQTD--NLCLYVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 612 (689)
Q Consensus 536 ls~~~~~--~~~~~~gt~~Y~APE~l~~~~~s-~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~ 612 (689)
+|..... -..+.||+|.|.|||++.|.+|+ .++||||.|||||.||+|.+||.+++...++.++.
T Consensus 158 MAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~------------ 225 (786)
T KOG0588|consen 158 MASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQ------------ 225 (786)
T ss_pred eeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHH------------
Confidence 9977544 35668999999999999999987 78999999999999999999999999888888774
Q ss_pred hhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
...+.+|. ..+.++++||++||+.||.+|+|.+|+++|||+++
T Consensus 226 -----------------------~G~f~MPs---------~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g 268 (786)
T KOG0588|consen 226 -----------------------RGVFEMPS---------NISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSG 268 (786)
T ss_pred -----------------------cCcccCCC---------cCCHHHHHHHHHHhccCccccccHHHHhhCchhhc
Confidence 22333442 34567899999999999999999999999999975
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=358.59 Aligned_cols=276 Identities=28% Similarity=0.501 Sum_probs=222.2
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
++|++.+.||+|+||+||++++..+++.||+|++.... .......+|+.+++.++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~ 74 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK------QENIVELKEAFRRRGK 74 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCC------CccccchhhhEecCCE
Confidence 47999999999999999999999999999999987542 23455677888887774 6799999999999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 458 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 458 l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
.++||||+.+++++.+.... ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||++
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~--~~~~kl~Dfg~~ 147 (287)
T cd07848 75 LYLVFEYVEKNMLELLEEMP-----NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISH--NDVLKLCDFGFA 147 (287)
T ss_pred EEEEEecCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCcEEEeeccCc
Confidence 99999999988777654322 23889999999999999999999999999999999999984 788999999998
Q ss_pred ccccCC----ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 005590 538 CFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 538 ~~~~~~----~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
...... .....+++.|+|||++.+..++.++|+|||||++|+|++|++||++.+..+.+..+....++++.+.+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07848 148 RNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKL 227 (287)
T ss_pred ccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHh
Confidence 765332 2235689999999999998999999999999999999999999999888888888888888888766543
Q ss_pred hhhhhhhhhccccchhhhhccccccccCCcc----chhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEE----SSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~----~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
......+. . ...|.. ..........+..+++||++||+.||++|||++|+|+||||
T Consensus 228 ~~~~~~~~--------------~--~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 228 FYSNPRFH--------------G--LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred hhccchhc--------------c--cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 21110000 0 000100 00111122346779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=360.69 Aligned_cols=281 Identities=26% Similarity=0.406 Sum_probs=218.2
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
.++|++.+.||+|+||+||+|++..+++.||+|++.... .......+|+.+++.++ |+||+++++++.....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~ 77 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLK------HANIVLLHDIIHTKET 77 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCC------CCCcCeEEEEEecCCe
Confidence 368999999999999999999999999999999987532 22335667888888774 7899999999999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 458 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 458 l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
.++||||+.+++.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++
T Consensus 78 ~~lv~e~~~~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~ 150 (303)
T cd07869 78 LTLVFEYVHTDLCQYMDKHP-----GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISD--TGELKLADFGLA 150 (303)
T ss_pred EEEEEECCCcCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEECCCCcc
Confidence 99999999999888776432 12788899999999999999999999999999999999984 788999999998
Q ss_pred ccccCC---ccccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC-hHHHHHHHHHhhcCCCcHHHHh
Q 005590 538 CFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPND-AVVMILARIIGMLGPIDLEMLM 612 (689)
Q Consensus 538 ~~~~~~---~~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~-~~~~~l~~i~~~~g~~~~e~~~ 612 (689)
...... .....+++.|+|||++.+. .++.++|||||||++|+|++|..||.+. +..+.+..+...++.+....|.
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 151 RAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWP 230 (303)
T ss_pred eeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhcc
Confidence 654322 2335678999999998764 5889999999999999999999999864 4556677777777776665554
Q ss_pred hhhhhhhhhhccccchhhhhccccccccCCccchhhhhc--cCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHL--QFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~--~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
.......+.... .....|. .+.... ......+.+||++||+.||++|||+.|+|+||||++
T Consensus 231 ~~~~~~~~~~~~------------~~~~~~~--~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~ 293 (303)
T cd07869 231 GVHSLPHFKPER------------FTLYSPK--NLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293 (303)
T ss_pred chhhcccccccc------------ccccCCc--cHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence 433221111000 0000010 000000 012356889999999999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=354.77 Aligned_cols=279 Identities=28% Similarity=0.449 Sum_probs=219.1
Q ss_pred CcEEEEEEeccCCCCceEEEEECC-CCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLH-TGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-- 454 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~-tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~-- 454 (689)
++|++.+.||+|+||+||+|++.. +++.||+|+++... .......+|+.+++.+.. ..||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~hpniv~~~~~~~~~~ 77 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET---FEHPNVVRLFDVCTVSR 77 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcc---cCCCCcceEEEEEeccc
Confidence 479999999999999999999854 57889999987532 223355678888777753 468999999999862
Q ss_pred ---CCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEE
Q 005590 455 ---LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 531 (689)
Q Consensus 455 ---~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL 531 (689)
...+++||||+.++|.+++..... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||
T Consensus 78 ~~~~~~~~lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~--~~~~kl 151 (290)
T cd07862 78 TDRETKLTLVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQIKL 151 (290)
T ss_pred CCCCCcEEEEEccCCCCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcC--CCCEEE
Confidence 356899999999998888764322 23889999999999999999999999999999999999984 788999
Q ss_pred EecCCcccccCC--ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHH
Q 005590 532 IDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 609 (689)
Q Consensus 532 ~DFGls~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e 609 (689)
+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|.+||.+....+.+..+....+.+..+
T Consensus 152 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 152 ADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231 (290)
T ss_pred ccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 999998765432 234568999999999999899999999999999999999999999998888888888877766555
Q ss_pred HHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
.+......... .+.. .+ ...+.......+..+++||.+||+.||++|||+.|+|+||||
T Consensus 232 ~~~~~~~~~~~---------------~~~~-~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 232 DWPRDVALPRQ---------------AFHS-KS-AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hchhhhcccch---------------hccC-CC-CCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 44332211100 0000 00 011111222346778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=365.89 Aligned_cols=298 Identities=31% Similarity=0.509 Sum_probs=227.2
Q ss_pred CcceeeCc---eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCC
Q 005590 370 DLPIILNT---VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEH 443 (689)
Q Consensus 370 ~~pi~~~~---~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~ 443 (689)
.+++..++ .+.++|++.+.||+|+||.||++++..+|+.||+|++... ........+|+.+++.+ .||
T Consensus 7 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~ 80 (359)
T cd07876 7 FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV------NHK 80 (359)
T ss_pred cceecccchhhhhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC------CCC
Confidence 34444443 4568999999999999999999999999999999998643 22345566788777766 478
Q ss_pred ceeEEEEEEEeCC------eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 005590 444 HILRLYDYFYHLE------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPE 517 (689)
Q Consensus 444 ~Iv~l~~~f~~~~------~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~ 517 (689)
||+++++++.... ..++||||+++++...+.. .+++..+..++.||+.||.|||+.||+||||||+
T Consensus 81 niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~ 152 (359)
T cd07876 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 152 (359)
T ss_pred CEeeeeeeeccCCCccccceeEEEEeCCCcCHHHHHhc--------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence 9999999987543 5799999999988776531 1788899999999999999999999999999999
Q ss_pred cEEEeccCCCeEEEEecCCcccccCC--ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHH
Q 005590 518 NILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI 595 (689)
Q Consensus 518 NILl~~~~~~~vkL~DFGls~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~ 595 (689)
|||++. ++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....
T Consensus 153 NIl~~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~ 230 (359)
T cd07876 153 NIVVKS--DCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ 230 (359)
T ss_pred HEEECC--CCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999985 788999999998754332 2335789999999999999999999999999999999999999999888888
Q ss_pred HHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccc--hhhhhccCCcHHHHHHHHHhcccCCCCC
Q 005590 596 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEES--SLEHHLQFSDAFFIDFVRTLLEINPQRR 673 (689)
Q Consensus 596 l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~--~l~~~~~~~~~~l~dLI~~mL~~dP~kR 673 (689)
+..+...++.++.+.+.........+......... ......++... .........+..+++||.+||+.||++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 306 (359)
T cd07876 231 WNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPG----ISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKR 306 (359)
T ss_pred HHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCC----cchhhhccccccccccccccccchhHHHHHHHHhccCcccC
Confidence 88888888887776655433222211111000000 00011111100 0011112335678999999999999999
Q ss_pred cCHHHHHcCCCCCC
Q 005590 674 PTAREALDHPWLQH 687 (689)
Q Consensus 674 pTa~ElL~hpwf~~ 687 (689)
||+.|+|+||||+.
T Consensus 307 ~t~~e~l~hp~~~~ 320 (359)
T cd07876 307 ISVDEALRHPYITV 320 (359)
T ss_pred CCHHHHhcCchhhh
Confidence 99999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=360.76 Aligned_cols=277 Identities=33% Similarity=0.565 Sum_probs=220.4
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC---
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--- 455 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~--- 455 (689)
+|++.++||+|+||.||+|++..+++.||||++... ......+.+|+++++.++ ||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~~~~~~ 74 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLR------HPDIVEIKHIMLPPSRR 74 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCC------CCCEeeecceEeccCCC
Confidence 699999999999999999999999999999998642 223345678888888774 78999999988643
Q ss_pred --CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEe
Q 005590 456 --EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 533 (689)
Q Consensus 456 --~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~D 533 (689)
..+++||||++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|
T Consensus 75 ~~~~~~lv~e~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~--~~~~kL~D 146 (338)
T cd07859 75 EFKDIYVVFELMESDLHQVIKAND------DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANA--DCKLKICD 146 (338)
T ss_pred CCceEEEEEecCCCCHHHHHHhcc------cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC--CCcEEEcc
Confidence 3589999999988888775432 2889999999999999999999999999999999999984 78899999
Q ss_pred cCCcccccCC------ccccccCccccChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 005590 534 LGSSCFQTDN------LCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 605 (689)
Q Consensus 534 FGls~~~~~~------~~~~~gt~~Y~APE~l~~--~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~ 605 (689)
||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+...++.
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~ 226 (338)
T cd07859 147 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGT 226 (338)
T ss_pred CccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence 9998753221 123578999999999876 57899999999999999999999999998888888888888888
Q ss_pred CcHHHHhhhhhh--hhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCC
Q 005590 606 IDLEMLMQGQEI--YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHP 683 (689)
Q Consensus 606 ~~~e~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hp 683 (689)
++...+...... ..++. .+....+ ..........++.+.+||.+||+.||++|||+.|+|+||
T Consensus 227 ~~~~~~~~i~~~~~~~~~~-------------~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp 291 (338)
T cd07859 227 PSPETISRVRNEKARRYLS-------------SMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADP 291 (338)
T ss_pred CCHHHHHHhhhhhHHHHHH-------------hhcccCC--CchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCc
Confidence 877765543221 11111 0111111 112222233457789999999999999999999999999
Q ss_pred CCCC
Q 005590 684 WLQH 687 (689)
Q Consensus 684 wf~~ 687 (689)
||+.
T Consensus 292 ~f~~ 295 (338)
T cd07859 292 YFKG 295 (338)
T ss_pred hhhh
Confidence 9975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=347.18 Aligned_cols=259 Identities=30% Similarity=0.453 Sum_probs=219.2
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005590 377 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 453 (689)
Q Consensus 377 ~~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~ 453 (689)
..+.+.|.+.+.||+|.|+.|+++.+..+|+.+|+|++... ....+.+.+|++|.+.|+ ||||+++.+.+.
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~Lq------HP~IvrL~~ti~ 80 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ------HPNIVRLHDSIQ 80 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcC------CCcEeehhhhhc
Confidence 45678899999999999999999999999999999998643 234577889999998886 789999999999
Q ss_pred eCCeEEEEEEccccc-hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCC-CeEEE
Q 005590 454 HLEHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKI 531 (689)
Q Consensus 454 ~~~~l~lVmEy~~g~-L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~-~~vkL 531 (689)
.....|+|+|++.|+ |..-+-.. ..+++..+...++||++||.|+|.+||||||+||+|+|+-+..+ .-+||
T Consensus 81 ~~~~~ylvFe~m~G~dl~~eIV~R------~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL 154 (355)
T KOG0033|consen 81 EESFHYLVFDLVTGGELFEDIVAR------EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKL 154 (355)
T ss_pred ccceeEEEEecccchHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceee
Confidence 999999999999975 44333322 34889999999999999999999999999999999999975433 46999
Q ss_pred EecCCcccccCCc--cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHH
Q 005590 532 IDLGSSCFQTDNL--CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 609 (689)
Q Consensus 532 ~DFGls~~~~~~~--~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e 609 (689)
+|||++...++.. ..++|||.|||||++...+|+..+|||+.|||||-||.|.+||.+.+...++.+|++..-..|
T Consensus 155 ~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~-- 232 (355)
T KOG0033|consen 155 ADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYP-- 232 (355)
T ss_pred cccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCC--
Confidence 9999998877543 347899999999999999999999999999999999999999999988898888863322111
Q ss_pred HHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
.|.+. ..+++.++||++||..||.+|+|+.|+|+|||+.+
T Consensus 233 -------------------------------~~~w~-------~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 233 -------------------------------SPEWD-------TVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred -------------------------------CcccC-------cCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 12222 23567899999999999999999999999999975
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=375.36 Aligned_cols=282 Identities=30% Similarity=0.482 Sum_probs=220.5
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC---
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--- 455 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~--- 455 (689)
...+|++.++||+|+||+||+|.+..+++.||||++..+.. ...+|+.+++.++ |+||++++++|...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~------h~niv~l~~~~~~~~~~ 134 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---YKNRELLIMKNLN------HINIIFLKDYYYTECFK 134 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHhcC------CCCCcceeeeEeecccc
Confidence 45689999999999999999999999999999998876532 3346888888774 78999999987532
Q ss_pred -----CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEE
Q 005590 456 -----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 530 (689)
Q Consensus 456 -----~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vk 530 (689)
..+++||||+.+++.+++...... ...+++..++.++.||+.||.|||+.||+||||||+||||+. ..+.+|
T Consensus 135 ~~~~~~~l~lvmE~~~~~l~~~~~~~~~~--~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~-~~~~vk 211 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIPQTVHKYMKHYARN--NHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP-NTHTLK 211 (440)
T ss_pred cCCCceEEEEEEecCCccHHHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC-CCCcee
Confidence 257899999999988877643322 233889999999999999999999999999999999999984 345799
Q ss_pred EEecCCcccccC--CccccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCc
Q 005590 531 IIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 607 (689)
Q Consensus 531 L~DFGls~~~~~--~~~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~ 607 (689)
|+|||+++.... ......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+.+++..+|.++
T Consensus 212 L~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 212 LCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291 (440)
T ss_pred eeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999999976532 23345789999999998764 689999999999999999999999999988899999999998877
Q ss_pred HHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 608 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 608 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
.+.+.........+. +.......+...+|. ..+.++++||.+||++||.+|||+.|+|+||||+.
T Consensus 292 ~~~~~~~~~~~~~~~------~~~~~~~~l~~~~p~---------~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 292 EDQLKEMNPNYADIK------FPDVKPKDLKKVFPK---------GTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred HHHHHHhchhhhccc------CCccCchhHHHHhcc---------CCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 666543221110000 000000111111221 23467899999999999999999999999999964
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=354.26 Aligned_cols=280 Identities=27% Similarity=0.409 Sum_probs=225.9
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
++|++.++||+|+||+||+|++..+++.||+|+++... .......+|+.+++.++ |+||+++++++...++.
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~ 79 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLK------HANIVTLHDIVHTDKSL 79 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCC------CCCcceEEEEEeeCCeE
Confidence 67999999999999999999999999999999987542 22235667888887774 68999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcc
Q 005590 459 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 459 ~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 538 (689)
++||||+.+++.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++.
T Consensus 80 ~lv~e~~~~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~ 152 (309)
T cd07872 80 TLVFEYLDKDLKQYMDDCG-----NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINE--RGELKLADFGLAR 152 (309)
T ss_pred EEEEeCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEECccccce
Confidence 9999999998887765432 22788899999999999999999999999999999999984 7889999999987
Q ss_pred cccCC---ccccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 539 FQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 539 ~~~~~---~~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
..... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.++.+.|...
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07872 153 AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGI 232 (309)
T ss_pred ecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhh
Confidence 54322 223467899999999875 45889999999999999999999999999999999999999998888877654
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
.....+...... ..............+.++++||.+||+.||.+|||+.|+|+||||+.
T Consensus 233 ~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 233 SSNDEFKNYNFP--------------KYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred cchhhhhhhhcC--------------ccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 433222111000 00000111122335677899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=361.73 Aligned_cols=289 Identities=30% Similarity=0.515 Sum_probs=223.0
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
+.++|++.+.||+|+||.||++.+..+++.||+|++... ........+|+.+++.++ |+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~ 88 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN------HKNIISLLNVFTPQ 88 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhC------CCchhceeeeeecc
Confidence 468999999999999999999999999999999998753 223456667888887774 78999999998644
Q ss_pred ------CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeE
Q 005590 456 ------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 529 (689)
Q Consensus 456 ------~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~v 529 (689)
...++||||+.+++...+.. .++...++.++.||+.||.|||+.||+||||||+|||++. ++.+
T Consensus 89 ~~~~~~~~~~lv~e~~~~~l~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~--~~~~ 158 (355)
T cd07874 89 KSLEEFQDVYLVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTL 158 (355)
T ss_pred ccccccceeEEEhhhhcccHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECC--CCCE
Confidence 35799999999988776542 1788899999999999999999999999999999999984 7889
Q ss_pred EEEecCCcccccCC--ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCc
Q 005590 530 KIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 607 (689)
Q Consensus 530 kL~DFGls~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~ 607 (689)
||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..++..++.+.
T Consensus 159 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (355)
T cd07874 159 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238 (355)
T ss_pred EEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99999999765443 2345789999999999999999999999999999999999999999888888888888888776
Q ss_pred HHHHhhhhhhhhhhhccccchhhhhccccccccCCccc--hhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 608 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEES--SLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 608 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~--~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
.+.+.........+......... ..+...++... .........+..+++||.+||+.||++|||+.|+|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~ 314 (355)
T cd07874 239 PEFMKKLQPTVRNYVENRPKYAG----LTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI 314 (355)
T ss_pred HHHHHhhcHHHHHHHhcCCcccc----ccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcch
Confidence 66655544332211111100000 00000001000 0001111234678999999999999999999999999999
Q ss_pred CC
Q 005590 686 QH 687 (689)
Q Consensus 686 ~~ 687 (689)
+.
T Consensus 315 ~~ 316 (355)
T cd07874 315 NV 316 (355)
T ss_pred hc
Confidence 74
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=353.90 Aligned_cols=249 Identities=26% Similarity=0.389 Sum_probs=209.3
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++ ||||+++++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~~~~~~ 74 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS------HPFIIRLFWTEHDQR 74 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC------CCcHhhhHhhhccCC
Confidence 47999999999999999999999999999999987532 22345667888887774 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
+.++||||+.+ +|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~--~~~~kl~Dfg 146 (291)
T cd05612 75 FLYMLMEYVPGGELFSYLRNSG------RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDK--EGHIKLTDFG 146 (291)
T ss_pred eEEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC--CCCEEEEecC
Confidence 99999999985 6777765432 2888999999999999999999999999999999999984 7889999999
Q ss_pred CcccccCCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 005590 536 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615 (689)
Q Consensus 536 ls~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~ 615 (689)
++...........|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 147 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~------------ 214 (291)
T cd05612 147 FAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK------------ 214 (291)
T ss_pred cchhccCCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------
Confidence 99876665556689999999999999999999999999999999999999998877666555543110
Q ss_pred hhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcC-----HHHHHcCCCCCC
Q 005590 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPWLQH 687 (689)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT-----a~ElL~hpwf~~ 687 (689)
..+|. ..+..+++||++||+.||.+|++ ++++++||||+.
T Consensus 215 -----------------------~~~~~---------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 215 -----------------------LEFPR---------HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred -----------------------cCCCc---------cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 01111 12456889999999999999995 999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=367.52 Aligned_cols=279 Identities=23% Similarity=0.323 Sum_probs=216.5
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEE
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 459 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~ 459 (689)
..+|++++.||+|+||.||+|++..+++.||+|.... ....+|+++++.++ ||||++++++|......+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~------HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAIN------HPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCC------CCCCCCEeEEEEECCeeE
Confidence 4689999999999999999999999999999997643 34678999998885 789999999999999999
Q ss_pred EEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccc
Q 005590 460 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539 (689)
Q Consensus 460 lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 539 (689)
+|||++.++|..++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++..
T Consensus 160 lv~e~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~--~~~vkL~DFG~a~~ 231 (391)
T PHA03212 160 LILPRYKTDLYCYLAAKR------NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINH--PGDVCLGDFGAACF 231 (391)
T ss_pred EEEecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcC--CCCEEEEeCCcccc
Confidence 999999988887765432 2788999999999999999999999999999999999984 78899999999865
Q ss_pred ccC----CccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------hHHHHHHHHHhhcCCCcH
Q 005590 540 QTD----NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND-------AVVMILARIIGMLGPIDL 608 (689)
Q Consensus 540 ~~~----~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~-------~~~~~l~~i~~~~g~~~~ 608 (689)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||-.. .....+..++...|+.|.
T Consensus 232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~ 311 (391)
T PHA03212 232 PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPN 311 (391)
T ss_pred cccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChh
Confidence 332 223357999999999999999999999999999999999999877432 344567777777787665
Q ss_pred HHHhhhhh-hhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 609 EMLMQGQE-IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 609 e~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
+....... ....+... . ......|.....+......+.++.+||.+||++||.+||||.|+|+||||+.
T Consensus 312 ~~~~~~~~~~~~~~~~~---------~-~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 312 EFPIDAQANLDEIYIGL---------A-KKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred hcCcchhHHHHHHHHHH---------H-hccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 54322111 11111000 0 0000011111111112223457889999999999999999999999999986
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=360.52 Aligned_cols=290 Identities=31% Similarity=0.513 Sum_probs=223.5
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
+.++|++.+.||+|+||.||++.+..+++.||||++... ........+|+.+++.++ |+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~ii~~~~~~~~~ 95 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN------HKNIIGLLNVFTPQ 95 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcC------CCCccccceeeccc
Confidence 458999999999999999999999999999999998753 223345667777777664 78999999988643
Q ss_pred ------CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeE
Q 005590 456 ------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 529 (689)
Q Consensus 456 ------~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~v 529 (689)
...++||||+.+++.+.+.. .++...+..++.||+.||.|||+.||+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~~~~lv~e~~~~~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~ 165 (364)
T cd07875 96 KSLEEFQDVYIVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTL 165 (364)
T ss_pred ccccccCeEEEEEeCCCCCHHHHHHh--------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECC--CCcE
Confidence 35799999999988776642 1778889999999999999999999999999999999985 7889
Q ss_pred EEEecCCcccccCC--ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCc
Q 005590 530 KIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 607 (689)
Q Consensus 530 kL~DFGls~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~ 607 (689)
||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+.
T Consensus 166 kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (364)
T cd07875 166 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245 (364)
T ss_pred EEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99999999765443 2335789999999999999999999999999999999999999999998899999988888877
Q ss_pred HHHHhhhhhhhhhhhccccchhhhhccc-cccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCC
Q 005590 608 LEMLMQGQEIYKYFTKEYDLYYINEETN-QLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686 (689)
Q Consensus 608 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~ 686 (689)
.+.+........................ ......+.. .......+..+++||.+||+.||.+|||+.|+|+||||+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~ 322 (364)
T cd07875 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPAD---SEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322 (364)
T ss_pred HHHHHhhhHHHHHHHhhCCCcCCCChHhhCcccccccc---ccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 6665554433222111111000000000 000001110 011112345789999999999999999999999999997
Q ss_pred C
Q 005590 687 H 687 (689)
Q Consensus 687 ~ 687 (689)
.
T Consensus 323 ~ 323 (364)
T cd07875 323 V 323 (364)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=347.26 Aligned_cols=278 Identities=27% Similarity=0.418 Sum_probs=218.5
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe----
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH---- 454 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~---- 454 (689)
+|++.+.||+|+||+||+|++..+++.||+|+++... .......+|+.+++.+.. .+|+||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~h~ni~~~~~~~~~~~~~ 77 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEA---FDHPNIVRLMDVCATSRTD 77 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhh---cCCCCeeeeeeeeccccCC
Confidence 5899999999999999999999999999999987532 122345678888887754 358999999999864
Q ss_pred -CCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEe
Q 005590 455 -LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 533 (689)
Q Consensus 455 -~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~D 533 (689)
....++||||+.+++.+++..... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|
T Consensus 78 ~~~~~~lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~--~~~~kl~d 151 (288)
T cd07863 78 RETKVTLVFEHVDQDLRTYLDKVPP----PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS--GGQVKLAD 151 (288)
T ss_pred CCceEEEEEcccccCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC--CCCEEECc
Confidence 346899999999988887754322 22889999999999999999999999999999999999984 78899999
Q ss_pred cCCcccccCC--ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 005590 534 LGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 611 (689)
Q Consensus 534 FGls~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~ 611 (689)
||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|.+||.+......+.++...++.+....|
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 152 FGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred cCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence 9998765432 23356789999999999989999999999999999999999999988888888888877776555444
Q ss_pred hhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
......... ...... ...........+..+.+||.+||+.||++|||+.|+++||||
T Consensus 232 ~~~~~~~~~---------------~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 232 PRDVTLPRG---------------AFSPRG--PRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccc---------------ccCCCC--CCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 321111000 000000 001111122345678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=361.94 Aligned_cols=261 Identities=33% Similarity=0.500 Sum_probs=224.1
Q ss_pred eCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005590 375 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYD 450 (689)
Q Consensus 375 ~~~~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~ 450 (689)
....+...|.+.+.||+|.||.||+++++.+|+.+|+|++.+... ......+|+.+|+.+.. ||||+++++
T Consensus 29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~-----hpniv~l~~ 103 (382)
T KOG0032|consen 29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSG-----HPNIVQLKD 103 (382)
T ss_pred ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccC-----CCCEEEEEE
Confidence 344566789999999999999999999999999999999987543 34678899999999974 789999999
Q ss_pred EEEeCCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCC--C
Q 005590 451 YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR--C 527 (689)
Q Consensus 451 ~f~~~~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~--~ 527 (689)
+|.+...+++|||++.| .|++.+... .+++..+..++.||+.|+.|||+.||+||||||+|+|+..... +
T Consensus 104 ~~e~~~~~~lvmEL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~ 176 (382)
T KOG0032|consen 104 AFEDPDSVYLVMELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSG 176 (382)
T ss_pred EEEcCCeEEEEEEecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCC
Confidence 99999999999999995 677777654 1999999999999999999999999999999999999976443 5
Q ss_pred eEEEEecCCcccccC--CccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 005590 528 EIKIIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 605 (689)
Q Consensus 528 ~vkL~DFGls~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~ 605 (689)
.+|++|||++..... .....+||+.|+|||++.+.+|+..+||||+|+++|.|++|.+||.+.+.......|...-..
T Consensus 177 ~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~ 256 (382)
T KOG0032|consen 177 RIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFD 256 (382)
T ss_pred cEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCC
Confidence 899999999988766 456689999999999999999999999999999999999999999998887777766532221
Q ss_pred CcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 606 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 606 ~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
++. +.+ ...+..+++||++||..||.+|+|+.++|+|||+
T Consensus 257 f~~---------------------------------~~w-------~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi 296 (382)
T KOG0032|consen 257 FTS---------------------------------EPW-------DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWI 296 (382)
T ss_pred CCC---------------------------------CCc-------cccCHHHHHHHHHhcccCcccCCCHHHHhcCccc
Confidence 111 111 1234568899999999999999999999999999
Q ss_pred CC
Q 005590 686 QH 687 (689)
Q Consensus 686 ~~ 687 (689)
+.
T Consensus 297 ~~ 298 (382)
T KOG0032|consen 297 KS 298 (382)
T ss_pred cC
Confidence 86
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=358.65 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=210.5
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
.++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+|+.+++.++ ||||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~iv~~~~~~~~~ 90 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS------HPFIVNMMCSFQDE 90 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC------CCCCCcEEEEEEcC
Confidence 368999999999999999999999999999999997542 23345677888888774 78999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEec
Q 005590 456 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 534 (689)
Q Consensus 456 ~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DF 534 (689)
+..++||||+.+ +|.+.+.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+||
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~--~~~~kl~Df 162 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLRKAG------RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDN--KGHVKVTDF 162 (329)
T ss_pred CEEEEEEcCCCCChHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECC--CCCEEEeec
Confidence 999999999985 6776665322 2788999999999999999999999999999999999984 788999999
Q ss_pred CCcccccCCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 535 GSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 535 Gls~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
|++...........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 163 g~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~------------ 230 (329)
T PTZ00263 163 GFAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG------------ 230 (329)
T ss_pred cCceEcCCCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------------
Confidence 99987766666678999999999999999999999999999999999999999887665555444311
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcC-----HHHHHcCCCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPWLQH 687 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT-----a~ElL~hpwf~~ 687 (689)
...+|. ..+..+++||.+||+.||.+|++ ++++++||||++
T Consensus 231 -----------------------~~~~p~---------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 231 -----------------------RLKFPN---------WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred -----------------------CcCCCC---------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 011111 13456889999999999999997 799999999975
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=350.28 Aligned_cols=265 Identities=28% Similarity=0.416 Sum_probs=215.9
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC
Q 005590 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 378 ~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
.-.+.|++.+.||.|..++||+|+...+++.||||++..++ ...+.+.+|+..+..+ +||||++++..|...
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~------~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI------DHPNIVTYHCSFVVD 96 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc------CCCCcceEEEEEEec
Confidence 44578999999999999999999999999999999998754 2346677777777766 478999999999999
Q ss_pred CeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEec
Q 005590 456 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 534 (689)
Q Consensus 456 ~~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DF 534 (689)
..+++||+||. |+++++++.....+ +.+..+..|++++++||.|||.+|.||||||+.||||+. +|.|||+||
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~G----l~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~--dG~VkLadF 170 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDG----LEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDS--DGTVKLADF 170 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHcccc----ccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcC--CCcEEEcCc
Confidence 99999999999 67888888765544 999999999999999999999999999999999999995 899999999
Q ss_pred CCcccccC-------CccccccCccccChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 005590 535 GSSCFQTD-------NLCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 605 (689)
Q Consensus 535 Gls~~~~~-------~~~~~~gt~~Y~APE~l~~--~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~ 605 (689)
|.+....+ ...+++||++|||||++.. .+|+.|+||||||++..||.+|..||....+.+++..-.. +.
T Consensus 171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--n~ 248 (516)
T KOG0582|consen 171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--ND 248 (516)
T ss_pred eeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--CC
Confidence 97644321 1255789999999999754 4699999999999999999999999988777766544332 22
Q ss_pred CcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 606 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 606 ~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
+|... ..+... ...+..+..|+.+|..||+.||++||||+++|+|+||
T Consensus 249 pp~~~-t~~~~~-------------------------------d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FF 296 (516)
T KOG0582|consen 249 PPTLL-TSGLDK-------------------------------DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFF 296 (516)
T ss_pred CCCcc-cccCCh-------------------------------HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHH
Confidence 22111 111000 0112223468999999999999999999999999999
Q ss_pred CCC
Q 005590 686 QHP 688 (689)
Q Consensus 686 ~~~ 688 (689)
++.
T Consensus 297 k~~ 299 (516)
T KOG0582|consen 297 KKA 299 (516)
T ss_pred hhc
Confidence 863
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=367.21 Aligned_cols=250 Identities=28% Similarity=0.485 Sum_probs=218.8
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
++|.+.+.||+|.||.||+|+.+.+.+.||+|.+.+.. .....+.+|++|++.++ ||||+.+++.|+...+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lk------Hpniv~m~esfEt~~~ 75 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLK------HPNIVEMLESFETSAH 75 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcC------CcchhhHHHhhcccce
Confidence 57888999999999999999999999999999987642 33456788999999886 6799999999999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 458 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 458 l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
+++|.||+.|+|..++..... ++++.++.|++|++.||.|||+.+|+|||+||.|||+. ..+.+|++|||+|
T Consensus 76 ~~vVte~a~g~L~~il~~d~~------lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~--~~~~~KlcdFg~A 147 (808)
T KOG0597|consen 76 LWVVTEYAVGDLFTILEQDGK------LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE--KGGTLKLCDFGLA 147 (808)
T ss_pred EEEEehhhhhhHHHHHHhccC------CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec--CCCceeechhhhh
Confidence 999999999999988876554 99999999999999999999999999999999999999 4889999999999
Q ss_pred ccccCC---ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 538 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 538 ~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
+-.+.. .+...|||.|||||++.+++|+..+|+||||||+||+++|++||-..+..++...|..--.++|.
T Consensus 148 r~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~------ 221 (808)
T KOG0597|consen 148 RAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS------ 221 (808)
T ss_pred hhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc------
Confidence 876654 34468999999999999999999999999999999999999999988888777776522111110
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~~ 688 (689)
..+..|++||..+|..||.+|+|=.+++.|||.++.
T Consensus 222 --------------------------------------~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 222 --------------------------------------TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred --------------------------------------cccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 234679999999999999999999999999998653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=367.46 Aligned_cols=251 Identities=27% Similarity=0.455 Sum_probs=211.7
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh-hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 459 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~-~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~ 459 (689)
.+|...++||+|+.|.||.|....+++.||||.+..... ..+-+.+|+.+|+.++ |+|||++++.|...+.++
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~------H~NiVnfl~Sylv~deLW 346 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLH------HPNIVNFLDSYLVGDELW 346 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhcc------chHHHHHHHHhcccceeE
Confidence 568888999999999999999999999999999876543 3356778999999886 679999999999999999
Q ss_pred EEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcc
Q 005590 460 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 460 lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 538 (689)
+|||||+| +|.+.+.... +++.++..|+++++.||+|||.+||+|||||.+|||++. +|.+||+|||++.
T Consensus 347 VVMEym~ggsLTDvVt~~~-------~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~--~g~vKltDFGFca 417 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKTR-------MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTM--DGSVKLTDFGFCA 417 (550)
T ss_pred EEEeecCCCchhhhhhccc-------ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEecc--CCcEEEeeeeeee
Confidence 99999996 5666665433 889999999999999999999999999999999999995 7789999999987
Q ss_pred cccC---CccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 005590 539 FQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615 (689)
Q Consensus 539 ~~~~---~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~ 615 (689)
.... ...+.+|||.|||||++....|+.++||||||++++||+-|++||-+.++..-+..|. .-|.+.
T Consensus 418 qi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa-~ng~P~-------- 488 (550)
T KOG0578|consen 418 QISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPK-------- 488 (550)
T ss_pred ccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh-hcCCCC--------
Confidence 6543 3566899999999999999999999999999999999999999998765554444432 111111
Q ss_pred hhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
.. .....+++|++||.+||+.||.+|++|.|||+||||+.
T Consensus 489 -----------------------lk---------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 489 -----------------------LK---------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred -----------------------cC---------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 11 11234578999999999999999999999999999964
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=361.01 Aligned_cols=279 Identities=28% Similarity=0.468 Sum_probs=221.1
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC--
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE-- 456 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~-- 456 (689)
+|++.+.||+|+||+||++.+..+|+.||||++... ........+|+++++.++ |+||+++++++....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~ 74 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFK------HDNVLSALDILQPPHID 74 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCC------CCCcCCHhheecCCCcc
Confidence 478899999999999999999999999999998642 223356677888887764 679999999998776
Q ss_pred ---eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEe
Q 005590 457 ---HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 533 (689)
Q Consensus 457 ---~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~D 533 (689)
+.++||||+.++|.+.+.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|
T Consensus 75 ~~~~~~lv~e~~~~~l~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~--~~~~kL~D 146 (372)
T cd07853 75 PFEEIYVVTELMQSDLHKIIVSPQ------PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNS--NCVLKICD 146 (372)
T ss_pred ccceEEEEeeccccCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECC--CCCEEecc
Confidence 899999999988877765322 3889999999999999999999999999999999999984 78899999
Q ss_pred cCCcccccCC----ccccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcH
Q 005590 534 LGSSCFQTDN----LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 608 (689)
Q Consensus 534 FGls~~~~~~----~~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~ 608 (689)
||++...... .....+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...+|.++.
T Consensus 147 fg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~ 226 (372)
T cd07853 147 FGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226 (372)
T ss_pred ccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 9998764322 2234678899999999874 4789999999999999999999999999999999999999998777
Q ss_pred HHHhhhhh-hhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 609 EMLMQGQE-IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 609 e~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
+.+..... ...++... ....|............++++.+||.+||+.||++|||+.|+|+||||+.
T Consensus 227 ~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 227 EAMRSACEGARAHILRG-------------PHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred HHHHHhhHHHHHHHHhC-------------CCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 66544322 11111100 00011111111111233577899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=352.91 Aligned_cols=255 Identities=27% Similarity=0.405 Sum_probs=210.6
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---------------hhhHhHHHHHHHHHHhcccCCCCC
Q 005590 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---------------DFFDQSLDEIKLLKLVNKNDPADE 442 (689)
Q Consensus 378 ~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---------------~~~~~~~~Ei~iL~~l~~~~~~~h 442 (689)
..-++|++++.||+|.||+|.+|++..+++.||||++.+.+ ...++..+|+.||++++ |
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~------H 167 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH------H 167 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC------C
Confidence 34578999999999999999999999999999999997532 12357788999999886 6
Q ss_pred CceeEEEEEEEeC--CeEEEEEEccccchHHHHhhhhccCCCcc-cCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 005590 443 HHILRLYDYFYHL--EHLFIVCELLRANLYEFQKFNQESGGEAY-FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENI 519 (689)
Q Consensus 443 ~~Iv~l~~~f~~~--~~l~lVmEy~~g~L~~l~~~~~~~~~~~~-ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NI 519 (689)
+|||+|+.+..+. +.+|||+|||..+-... ...... +++.+++.+++.++.||.|||.+|||||||||+|+
T Consensus 168 ~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w------~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNL 241 (576)
T KOG0585|consen 168 PNVVKLIEVLDDPESDKLYLVLEYCSKGEVKW------CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNL 241 (576)
T ss_pred cCeeEEEEeecCcccCceEEEEEeccCCcccc------CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhhe
Confidence 7999999998865 58999999998543222 222233 89999999999999999999999999999999999
Q ss_pred EEeccCCCeEEEEecCCccccc--------CCccccccCccccChhhhcCCC----CCchhhHHHHHHHHHHHHhCCCCC
Q 005590 520 LIKSYQRCEIKIIDLGSSCFQT--------DNLCLYVQSRSYRAPEVIIGLP----YDQKIDLWSLGCILAELWTGEVLF 587 (689)
Q Consensus 520 Ll~~~~~~~vkL~DFGls~~~~--------~~~~~~~gt~~Y~APE~l~~~~----~s~~~DIwSLGvil~eLltG~~PF 587 (689)
||+. +|+|||+|||.+.... +.....+|||.|+|||.+.+.. .+.+.|||||||+||.|+.|+.||
T Consensus 242 Ll~~--~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF 319 (576)
T KOG0585|consen 242 LLSS--DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF 319 (576)
T ss_pred EEcC--CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence 9995 7999999999887541 1234478999999999998732 457899999999999999999999
Q ss_pred CCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcc
Q 005590 588 PNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLE 667 (689)
Q Consensus 588 ~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~ 667 (689)
-++...++..+|+...- .+|... ...+.++|||.+||+
T Consensus 320 ~~~~~~~l~~KIvn~pL-----------------------------------~fP~~p-------e~~e~~kDli~~lL~ 357 (576)
T KOG0585|consen 320 FDDFELELFDKIVNDPL-----------------------------------EFPENP-------EINEDLKDLIKRLLE 357 (576)
T ss_pred ccchHHHHHHHHhcCcc-----------------------------------cCCCcc-------cccHHHHHHHHHHhh
Confidence 99999998888863211 222221 123568899999999
Q ss_pred cCCCCCcCHHHHHcCCCCCCC
Q 005590 668 INPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 668 ~dP~kRpTa~ElL~hpwf~~~ 688 (689)
+||++|+++.++-.|||..+.
T Consensus 358 KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 358 KDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred cChhheeehhhheecceeccC
Confidence 999999999999999998764
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=354.94 Aligned_cols=279 Identities=32% Similarity=0.578 Sum_probs=222.2
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
+.++|++++.||+|+||+||+|.+..+++.||+|++.... .......+|+++++.++ |+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~ 86 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMK------HENVIGLLDVFTPA 86 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcC------CCchhhhhhhhccc
Confidence 3578999999999999999999999999999999987532 22345667888888774 67999999988643
Q ss_pred ------CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeE
Q 005590 456 ------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 529 (689)
Q Consensus 456 ------~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~v 529 (689)
...+++|++++++|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~l~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~--~~~~ 157 (343)
T cd07878 87 TSIENFNEVYLVTNLMGADLNNIVKCQ-------KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNE--DCEL 157 (343)
T ss_pred ccccccCcEEEEeecCCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECC--CCCE
Confidence 457999999988887766421 2889999999999999999999999999999999999984 7889
Q ss_pred EEEecCCcccccCCccccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcH
Q 005590 530 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 608 (689)
Q Consensus 530 kL~DFGls~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~ 608 (689)
||+|||++...........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+....+.++.
T Consensus 158 kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07878 158 RILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237 (343)
T ss_pred EEcCCccceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999999877666666789999999999987 46889999999999999999999999998888888888888777766
Q ss_pred HHHhhhhhh--hhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCC
Q 005590 609 EMLMQGQEI--YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686 (689)
Q Consensus 609 e~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~ 686 (689)
+.+...... ..+.. .+ ...+. ..+.......++.+.+||.+||+.||.+|||+.|+|+||||.
T Consensus 238 ~~~~~~~~~~~~~~~~-------------~~-~~~~~-~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~ 302 (343)
T cd07878 238 EVLKKISSEHARKYIQ-------------SL-PHMPQ-QDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFS 302 (343)
T ss_pred HHHHhcchhhHHHHhh-------------cc-ccccc-hhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence 554432211 01100 00 00111 111222233456788999999999999999999999999997
Q ss_pred C
Q 005590 687 H 687 (689)
Q Consensus 687 ~ 687 (689)
.
T Consensus 303 ~ 303 (343)
T cd07878 303 Q 303 (343)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=354.21 Aligned_cols=254 Identities=25% Similarity=0.424 Sum_probs=210.4
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCC-cEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005590 376 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTG-VDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 450 (689)
Q Consensus 376 ~~~l~~rY~i~~~LG~G~fG~Vyla~d~~tg-~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~ 450 (689)
..+..++|++.+.||+|+||.||+|++..++ ..||+|++.... .....+.+|+.+++.++ ||||+++++
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~Iv~~~~ 98 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN------HPFCVNLYG 98 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC------CCCCcceEE
Confidence 4445578999999999999999999876554 689999987532 23345667888887774 789999999
Q ss_pred EEEeCCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeE
Q 005590 451 YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 529 (689)
Q Consensus 451 ~f~~~~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~v 529 (689)
++...+..++||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+
T Consensus 99 ~~~~~~~~~lv~Ey~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~--~~~i 170 (340)
T PTZ00426 99 SFKDESYLYLVLEFVIGGEFFTFLRRNK------RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDK--DGFI 170 (340)
T ss_pred EEEeCCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC--CCCE
Confidence 99999999999999974 6777765432 2889999999999999999999999999999999999984 7899
Q ss_pred EEEecCCcccccCCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHH
Q 005590 530 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 609 (689)
Q Consensus 530 kL~DFGls~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e 609 (689)
||+|||++...........||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+.......+....
T Consensus 171 kL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~------ 244 (340)
T PTZ00426 171 KMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI------ 244 (340)
T ss_pred EEecCCCCeecCCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC------
Confidence 99999999876655556789999999999999889999999999999999999999998877666555543111
Q ss_pred HHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCc-----CHHHHHcCCC
Q 005590 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPW 684 (689)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRp-----Ta~ElL~hpw 684 (689)
..+|. ..+..+.+||++||+.||.+|+ |++++++|||
T Consensus 245 -----------------------------~~~p~---------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~ 286 (340)
T PTZ00426 245 -----------------------------IYFPK---------FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW 286 (340)
T ss_pred -----------------------------CCCCC---------CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCC
Confidence 01111 1235678999999999999995 8999999999
Q ss_pred CCC
Q 005590 685 LQH 687 (689)
Q Consensus 685 f~~ 687 (689)
|++
T Consensus 287 f~~ 289 (340)
T PTZ00426 287 FGN 289 (340)
T ss_pred cCC
Confidence 985
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=352.28 Aligned_cols=257 Identities=25% Similarity=0.346 Sum_probs=210.4
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|++++.||+|+||.||+|++..+++.||||+++... .....+.+|+.++..++ |+||+++++++...+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~------h~~iv~~~~~~~~~~ 74 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK------SEWLVKLLYAFQDDE 74 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC------CCCCccEEEEEEcCC
Confidence 47999999999999999999999999999999997642 22345666777777664 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
+.++||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~kL~Dfg 146 (333)
T cd05600 75 YLYLAMEYVPGGDFRTLLNNLG------VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDA--SGHIKLTDFG 146 (333)
T ss_pred EEEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC--CCCEEEEeCc
Confidence 99999999975 6777765322 2889999999999999999999999999999999999984 7889999999
Q ss_pred CcccccCCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 005590 536 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615 (689)
Q Consensus 536 ls~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~ 615 (689)
++...........||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+......
T Consensus 147 ~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---------- 216 (333)
T cd05600 147 LSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET---------- 216 (333)
T ss_pred CCcccccccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc----------
Confidence 9987665555678999999999999999999999999999999999999999887776665554311000
Q ss_pred hhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
...|... ......+.++.+||.+||..+|.+||++.++++||||..
T Consensus 217 -----------------------~~~~~~~---~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 217 -----------------------LQRPVYD---DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred -----------------------ccCCCCC---ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 0000000 000123467889999999999999999999999999986
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=340.76 Aligned_cols=244 Identities=27% Similarity=0.401 Sum_probs=204.3
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeec---chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEE-EEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYD-YFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~---~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~-~f~~~~ 456 (689)
..|+|+++||+|.||+||++++..+|..+|.|.+.- +.........|+.+|+.|+ ||||+++++ .|...+
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~------HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLN------HPNIVQYYAHSFIEDN 92 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcC------CchHHHHHHHhhhccc
Confidence 579999999999999999999999999999998874 3344567788999999886 679999998 555555
Q ss_pred e-EEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH--CC--ceeccCCCCcEEEeccCCCeEE
Q 005590 457 H-LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS--LG--IIHCDLKPENILIKSYQRCEIK 530 (689)
Q Consensus 457 ~-l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~--~g--IvHrDLKp~NILl~~~~~~~vk 530 (689)
. ++||||||+ |+|...++..+. ....+++..++.++.|++.||..+|+ .+ |+||||||.||+|+ .+|.||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~--qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~--~~gvvK 168 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKK--QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT--ANGVVK 168 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHh--ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc--CCCcee
Confidence 4 999999999 577777765543 34559999999999999999999999 45 99999999999999 589999
Q ss_pred EEecCCcccccCCc---cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCc
Q 005590 531 IIDLGSSCFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 607 (689)
Q Consensus 531 L~DFGls~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~ 607 (689)
|+|||++++..... ..++|||.||+||.+.+.+|+.++|||||||++|||+.-++||.+.+-.++..+|...--|
T Consensus 169 LGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~-- 246 (375)
T KOG0591|consen 169 LGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYP-- 246 (375)
T ss_pred eccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCC--
Confidence 99999999876543 3479999999999999999999999999999999999999999999888887777522100
Q ss_pred HHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCH
Q 005590 608 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 676 (689)
Q Consensus 608 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa 676 (689)
.+|. . ..+..+..||..|+..||+.||+.
T Consensus 247 --------------------------------~~p~-----~---~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 247 --------------------------------PLPD-----E---HYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred --------------------------------CCcH-----H---HhhhHHHHHHHHHccCCcccCCCc
Confidence 0110 1 123457799999999999999985
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=346.43 Aligned_cols=286 Identities=26% Similarity=0.395 Sum_probs=210.8
Q ss_pred EEeccCCCCceEEEEEC--CCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--CCeEEEEE
Q 005590 387 EYLGSAAFSKVFQAQDL--HTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--LEHLFIVC 462 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~--~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~--~~~l~lVm 462 (689)
++||+|+||+||+|+++ .+++.+|+|++..... .....+|+.+++.++ ||||+++++++.. ..+.++||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELK------HPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcC------CCCCcceeeeEecCCCcEEEEEE
Confidence 57999999999999965 4678999999875432 345678999998874 7899999999864 45789999
Q ss_pred EccccchHHHHhhhhcc---CCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec--cCCCeEEEEecCCc
Q 005590 463 ELLRANLYEFQKFNQES---GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS--YQRCEIKIIDLGSS 537 (689)
Q Consensus 463 Ey~~g~L~~l~~~~~~~---~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~--~~~~~vkL~DFGls 537 (689)
||+.+++.+++...... .....+++..++.++.||+.||.|||+.||+||||||+|||+.. ...+.+||+|||++
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 80 DYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 99999988887644321 12234889999999999999999999999999999999999953 24678999999999
Q ss_pred ccccCC------ccccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChH---------HHHHHHHHh
Q 005590 538 CFQTDN------LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAV---------VMILARIIG 601 (689)
Q Consensus 538 ~~~~~~------~~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~---------~~~l~~i~~ 601 (689)
...... .....+|+.|+|||++.+. .++.++||||+||++|+|++|++||..... ...+.++..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 765432 2235779999999999874 589999999999999999999999965332 356677888
Q ss_pred hcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 602 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 602 ~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
.+|.++...|................. .......+............+..+.+||++||++||.+|||++|+|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFR------RNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhh------ccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 888777666654332211100000000 00000000000111112233567889999999999999999999999
Q ss_pred CCCC
Q 005590 682 HPWL 685 (689)
Q Consensus 682 hpwf 685 (689)
||||
T Consensus 314 hp~f 317 (317)
T cd07868 314 DPYF 317 (317)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=351.75 Aligned_cols=243 Identities=26% Similarity=0.397 Sum_probs=199.5
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEE
Q 005590 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 462 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVm 462 (689)
+.||+|+||+||+|++..+|+.||||+++... .......+|+.+++.+ .||||+++++++...+.+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l------~hp~i~~~~~~~~~~~~~~lv~ 74 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT------RHPFLTALKYSFQTHDRLCFVM 74 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC------CCCCCCCEEEEEEcCCEEEEEE
Confidence 36899999999999999999999999998642 2234556677777666 4789999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccccc
Q 005590 463 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 541 (689)
Q Consensus 463 Ey~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~ 541 (689)
||+.+ +|.+.+.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++....
T Consensus 75 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~--~~~~kl~DfG~a~~~~ 146 (323)
T cd05571 75 EYANGGELFFHLSRER------VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDK--DGHIKITDFGLCKEGI 146 (323)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECC--CCCEEEeeCCCCcccc
Confidence 99985 5666554322 3889999999999999999999999999999999999984 7889999999986532
Q ss_pred ---CCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhh
Q 005590 542 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 618 (689)
Q Consensus 542 ---~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~ 618 (689)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~---------------- 210 (323)
T cd05571 147 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME---------------- 210 (323)
T ss_pred cCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC----------------
Confidence 2233467999999999999999999999999999999999999999877665555443210
Q ss_pred hhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCc-----CHHHHHcCCCCCC
Q 005590 619 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQH 687 (689)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRp-----Ta~ElL~hpwf~~ 687 (689)
...+|. ..+..+.+||++||+.||++|| ++.++++||||+.
T Consensus 211 -------------------~~~~p~---------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 211 -------------------EIRFPR---------TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred -------------------CCCCCC---------CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 001111 2346688999999999999999 8999999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=341.00 Aligned_cols=278 Identities=27% Similarity=0.431 Sum_probs=221.2
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
++|++.+.||.|+||.||+|.+..+++.||+|.++... .......+|+.+++.++ |+||+++++++...+..
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~nI~~~~~~~~~~~~~ 79 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK------HANIVTLHDIIHTEKSL 79 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcC------CCCcceEEEEEecCCeE
Confidence 67999999999999999999999999999999987532 22345667888888774 78999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcc
Q 005590 459 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 459 ~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 538 (689)
++||||+.++|.+++..... .+++..++.++.||+.||.|||+.||+|+||||+||+++. ++.++|+|||++.
T Consensus 80 ~lv~e~~~~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~--~~~~kl~dfg~~~ 152 (301)
T cd07873 80 TLVFEYLDKDLKQYLDDCGN-----SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINE--RGELKLADFGLAR 152 (301)
T ss_pred EEEEeccccCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECC--CCcEEECcCcchh
Confidence 99999999988877654321 2788999999999999999999999999999999999984 7789999999986
Q ss_pred cccCC---ccccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 539 FQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 539 ~~~~~---~~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
..... .....+++.|+|||++.+. .++.++|||||||++|+|++|++||...+..+.+..+...++.+....|...
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 153 AKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 232 (301)
T ss_pred ccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhh
Confidence 54322 2234568899999998764 4788999999999999999999999998888888888888887776665442
Q ss_pred hhhhhhhhccccchhhhhccccccccCCc--cchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPE--ESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
.....+.. ...|. ...+.......+..+++||.+||+.||.+|||+.|+|+||||+.
T Consensus 233 ~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 233 LSNEEFKS----------------YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred hccccccc----------------cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 21111000 00111 00011122234567899999999999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=348.46 Aligned_cols=253 Identities=29% Similarity=0.425 Sum_probs=203.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC--e
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE--H 457 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~--~ 457 (689)
.+|...+.||+|+||.||++.+..+|+..|||.+.... ...+.+.+|+++|..++ ||+||++++...... .
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~------~p~IV~~~G~~~~~~~~~ 90 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLN------HPNIVQYYGSSSSRENDE 90 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCC------CCCEEeeCCccccccCee
Confidence 56888899999999999999999999999999987642 12456889999999986 679999999865554 6
Q ss_pred EEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 458 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 458 l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
++|.|||+. |+|.+++...+. .+++..++.+++||++||.|||++||+||||||+|||++.. ++.+||+|||+
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~-----~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~-~~~~KlaDFG~ 164 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGG-----KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPS-NGDVKLADFGL 164 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCC-CCeEEeccCcc
Confidence 999999998 578888775543 29999999999999999999999999999999999999941 58999999998
Q ss_pred cccccC------CccccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC-hHHHHHHHHHhhcCCCcH
Q 005590 537 SCFQTD------NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPND-AVVMILARIIGMLGPIDL 608 (689)
Q Consensus 537 s~~~~~------~~~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~-~~~~~l~~i~~~~g~~~~ 608 (689)
+..... ......||+.|||||++.+. ....++|||||||++.||+||++||... ...+.+..+.
T Consensus 165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig-------- 236 (313)
T KOG0198|consen 165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIG-------- 236 (313)
T ss_pred ccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHh--------
Confidence 876552 13347899999999999963 3345999999999999999999999763 2222221111
Q ss_pred HHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 609 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 609 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
.......+|. ..+.++++||++||..||++||||+++|+|||+++
T Consensus 237 -------------------------~~~~~P~ip~---------~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 237 -------------------------REDSLPEIPD---------SLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred -------------------------ccCCCCCCCc---------ccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 0000112222 24567899999999999999999999999999975
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=350.13 Aligned_cols=256 Identities=29% Similarity=0.490 Sum_probs=225.7
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005590 376 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 452 (689)
Q Consensus 376 ~~~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f 452 (689)
+..|++-|.+.+.||+|.|+.|-+|++..+|+.||||++.+.+ .....+..|++.|+.++ |||||++|.+.
T Consensus 13 DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQ------HpNiVRLYEVi 86 (864)
T KOG4717|consen 13 DGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQ------HPNIVRLYEVI 86 (864)
T ss_pred ccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhc------CcCeeeeeehh
Confidence 4567788999999999999999999999999999999997653 34567788999998886 67999999999
Q ss_pred EeCCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEE
Q 005590 453 YHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 531 (689)
Q Consensus 453 ~~~~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL 531 (689)
.....+|+|+|+=++ +|++++..+... +.+..+++++.||+.|+.|+|+..+|||||||+||.+.. .-|-|||
T Consensus 87 DTQTKlyLiLELGD~GDl~DyImKHe~G-----l~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE-KlGlVKL 160 (864)
T KOG4717|consen 87 DTQTKLYLILELGDGGDLFDYIMKHEEG-----LNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE-KLGLVKL 160 (864)
T ss_pred cccceEEEEEEecCCchHHHHHHhhhcc-----ccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee-ecCceEe
Confidence 999999999999874 899999866543 899999999999999999999999999999999998874 5789999
Q ss_pred EecCCcccc--cCCccccccCccccChhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcH
Q 005590 532 IDLGSSCFQ--TDNLCLYVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 608 (689)
Q Consensus 532 ~DFGls~~~--~~~~~~~~gt~~Y~APE~l~~~~~s-~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~ 608 (689)
+|||++-.+ +....+.||+..|-|||+++|..|+ +++||||||||||.|.+|++||+..+..+.+..|+.+
T Consensus 161 TDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC------ 234 (864)
T KOG4717|consen 161 TDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC------ 234 (864)
T ss_pred eeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc------
Confidence 999998543 4567789999999999999999988 5799999999999999999999999999999988733
Q ss_pred HHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 609 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 609 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
.|.+|.. .+.++++||..||+.||.+|.+++|+..|+|+|.
T Consensus 235 -----------------------------KYtvPsh---------vS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~ 275 (864)
T KOG4717|consen 235 -----------------------------KYTVPSH---------VSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQA 275 (864)
T ss_pred -----------------------------cccCchh---------hhHHHHHHHHHHHhcCchhhccHHHHhccccccC
Confidence 3445543 2367899999999999999999999999999985
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=351.81 Aligned_cols=252 Identities=22% Similarity=0.352 Sum_probs=203.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|++++.||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.+ +|++|+++++.+.+..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~------~~~~iv~~~~~~~~~~ 74 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA------DSLWVVKMFYSFQDKL 74 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC------CCCCcceEEEEEecCC
Confidence 47999999999999999999999999999999997532 2234556677777766 4789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
.+++||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~--~~~vkL~DFG 146 (363)
T cd05628 75 NLYLIMEFLPGGDMMTLLMKKD------TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDS--KGHVKLSDFG 146 (363)
T ss_pred eEEEEEcCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC--CCCEEEeecc
Confidence 99999999985 6777665322 3889999999999999999999999999999999999984 7889999999
Q ss_pred CcccccCC--------------------------------------ccccccCccccChhhhcCCCCCchhhHHHHHHHH
Q 005590 536 SSCFQTDN--------------------------------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 577 (689)
Q Consensus 536 ls~~~~~~--------------------------------------~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil 577 (689)
++...... ....+||+.|+|||++.+..++.++|||||||++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 226 (363)
T cd05628 147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (363)
T ss_pred CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence 98643211 1234789999999999999999999999999999
Q ss_pred HHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHH
Q 005590 578 AELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAF 657 (689)
Q Consensus 578 ~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~ 657 (689)
|+|++|..||.+.+..+...++..... ...+|... ..++.
T Consensus 227 ~ell~G~~Pf~~~~~~~~~~~i~~~~~---------------------------------~~~~p~~~-------~~s~~ 266 (363)
T cd05628 227 YEMLIGYPPFCSETPQETYKKVMNWKE---------------------------------TLIFPPEV-------PISEK 266 (363)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCcC---------------------------------cccCCCcC-------CCCHH
Confidence 999999999998777776666542110 11122211 12456
Q ss_pred HHHHHHHhcccCCC---CCcCHHHHHcCCCCCC
Q 005590 658 FIDFVRTLLEINPQ---RRPTAREALDHPWLQH 687 (689)
Q Consensus 658 l~dLI~~mL~~dP~---kRpTa~ElL~hpwf~~ 687 (689)
+++||.+|+. +|. .||+++|+++||||++
T Consensus 267 ~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 267 AKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred HHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence 8899999875 444 4689999999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=349.28 Aligned_cols=299 Identities=31% Similarity=0.529 Sum_probs=229.5
Q ss_pred CcceeeCc---eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCC
Q 005590 370 DLPIILNT---VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEH 443 (689)
Q Consensus 370 ~~pi~~~~---~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~ 443 (689)
++|+..+. .+.++|++.+.||+|+||.||+|.+..+++.||+|++... ........+|+.+++.++ |+
T Consensus 2 ~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~ 75 (353)
T cd07850 2 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVN------HK 75 (353)
T ss_pred ceeecccchhhhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcC------CC
Confidence 35566655 4578999999999999999999999999999999998642 223345667888877764 78
Q ss_pred ceeEEEEEEEeC------CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 005590 444 HILRLYDYFYHL------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPE 517 (689)
Q Consensus 444 ~Iv~l~~~f~~~------~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~ 517 (689)
||++++++|... .+.++||||+.+++.+.+... ++...+..++.||+.||.|||+.||+||||||+
T Consensus 76 ~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~--------l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~ 147 (353)
T cd07850 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD--------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 147 (353)
T ss_pred CCcceeeeeccCCCccccCcEEEEEeccCCCHHHHHhhc--------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHH
Confidence 999999998644 357999999999888766421 778899999999999999999999999999999
Q ss_pred cEEEeccCCCeEEEEecCCcccccCCc--cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHH
Q 005590 518 NILIKSYQRCEIKIIDLGSSCFQTDNL--CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI 595 (689)
Q Consensus 518 NILl~~~~~~~vkL~DFGls~~~~~~~--~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~ 595 (689)
||+++. ++.+||+|||++....... ....+++.|+|||++.+..++.++|+|||||++|+|++|+.||...+....
T Consensus 148 Nil~~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~ 225 (353)
T cd07850 148 NIVVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ 225 (353)
T ss_pred HEEECC--CCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 999985 7789999999997654432 234678899999999999999999999999999999999999999888888
Q ss_pred HHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccc---hhhhhccCCcHHHHHHHHHhcccCCCC
Q 005590 596 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEES---SLEHHLQFSDAFFIDFVRTLLEINPQR 672 (689)
Q Consensus 596 l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~---~l~~~~~~~~~~l~dLI~~mL~~dP~k 672 (689)
...+...++.++.++..........+......... ..+...++... .........+..+++||.+||+.||++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 301 (353)
T cd07850 226 WNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAG----YSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEK 301 (353)
T ss_pred HHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCC----cchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhh
Confidence 88999899988877665544332222111110000 00011111100 000001123456889999999999999
Q ss_pred CcCHHHHHcCCCCCCC
Q 005590 673 RPTAREALDHPWLQHP 688 (689)
Q Consensus 673 RpTa~ElL~hpwf~~~ 688 (689)
|||+.|+|+||||+..
T Consensus 302 R~t~~eiL~~~~~~~~ 317 (353)
T cd07850 302 RISVDDALQHPYINVW 317 (353)
T ss_pred CcCHHHHhcChhHhhc
Confidence 9999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=331.45 Aligned_cols=253 Identities=30% Similarity=0.489 Sum_probs=212.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---------hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---------KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 451 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---------~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~ 451 (689)
..|.-.+.||.|..++|.++.++.+|..+|+|++... ....+...+|+.||+++. +||+|+++.++
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~-----GHP~II~l~D~ 91 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVM-----GHPYIIDLQDV 91 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhc-----CCCcEEEeeee
Confidence 4566777899999999999999999999999998642 123455667899999986 68999999999
Q ss_pred EEeCCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEE
Q 005590 452 FYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 530 (689)
Q Consensus 452 f~~~~~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vk 530 (689)
|+....+++|+|.|. |.|.+++...- .+++++.+.|++|++.|+.|||.++|+||||||+|||++ ++..||
T Consensus 92 yes~sF~FlVFdl~prGELFDyLts~V------tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILld--dn~~i~ 163 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLTSKV------TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLD--DNMNIK 163 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhhhhe------eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeec--cccceE
Confidence 999999999999998 78999886443 399999999999999999999999999999999999999 478899
Q ss_pred EEecCCcccccCC--ccccccCccccChhhhc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhh
Q 005590 531 IIDLGSSCFQTDN--LCLYVQSRSYRAPEVII------GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 602 (689)
Q Consensus 531 L~DFGls~~~~~~--~~~~~gt~~Y~APE~l~------~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~ 602 (689)
|+|||+++..... ....||||+|.|||.+. ..+|+..+|+|++|||||.|+.|.+||......-++..|+..
T Consensus 164 isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG 243 (411)
T KOG0599|consen 164 ISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG 243 (411)
T ss_pred EeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc
Confidence 9999999987654 55689999999999985 235999999999999999999999999876666666665522
Q ss_pred cCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 603 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 603 ~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
+.+..-|++... +...+|||++||+.||++|+|++|+|+|
T Consensus 244 ---------------------------------kyqF~speWadi-------s~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 244 ---------------------------------KYQFRSPEWADI-------SATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ---------------------------------ccccCCcchhhc-------cccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 122223333332 3446899999999999999999999999
Q ss_pred CCCC
Q 005590 683 PWLQ 686 (689)
Q Consensus 683 pwf~ 686 (689)
|||+
T Consensus 284 pff~ 287 (411)
T KOG0599|consen 284 PFFI 287 (411)
T ss_pred hHHH
Confidence 9994
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=345.92 Aligned_cols=249 Identities=26% Similarity=0.414 Sum_probs=204.3
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 383 Y~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
|++++.||+|+||.||+|.+..+++.||||+++... .....+.+|++++..++ ...||||+++++++...++.
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~---~l~hp~i~~~~~~~~~~~~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN---SERHPFLVNLFACFQTEDHV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc---ccCCCChhceeeEEEcCCEE
Confidence 688999999999999999999999999999997542 23345666777666554 34699999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
|+||||+.+ +|...+.. ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++
T Consensus 78 ~lv~E~~~~~~L~~~~~~-------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~--~~~~kL~Dfg~~ 148 (324)
T cd05589 78 CFVMEYAAGGDLMMHIHT-------DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDT--EGFVKIADFGLC 148 (324)
T ss_pred EEEEcCCCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC--CCcEEeCcccCC
Confidence 999999986 45444321 13899999999999999999999999999999999999985 788999999987
Q ss_pred cccc---CCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 538 CFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 538 ~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
.... ......+|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~----------- 217 (324)
T cd05589 149 KEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE----------- 217 (324)
T ss_pred ccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 6432 22334678999999999999999999999999999999999999998877666655543110
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCc-----CHHHHHcCCCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQH 687 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRp-----Ta~ElL~hpwf~~ 687 (689)
...|. ..+..+.+||++||+.||.+|| ++.++++||||++
T Consensus 218 ------------------------~~~p~---------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 218 ------------------------VRYPR---------FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred ------------------------CCCCC---------CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 01111 1245678999999999999999 7999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=352.47 Aligned_cols=252 Identities=24% Similarity=0.385 Sum_probs=205.1
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|++++.||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.++ |+||++++++|...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~------h~~iv~~~~~~~~~~ 74 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD------NPWVVKLYYSFQDEN 74 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC------CCCCcceEEEEEcCC
Confidence 47999999999999999999999999999999997542 23345667888888774 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
++++||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.++|+|||
T Consensus 75 ~~~lv~E~~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~--~~~~kl~Dfg 146 (364)
T cd05599 75 YLYLIMEYLPGGDMMTLLMKKD------TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDA--KGHIKLSDFG 146 (364)
T ss_pred eEEEEECCCCCcHHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC--CCCEEEeecc
Confidence 99999999975 6766665322 2899999999999999999999999999999999999984 7889999999
Q ss_pred CcccccCC-----------------------------------------ccccccCccccChhhhcCCCCCchhhHHHHH
Q 005590 536 SSCFQTDN-----------------------------------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLG 574 (689)
Q Consensus 536 ls~~~~~~-----------------------------------------~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLG 574 (689)
++...... ....+||+.|+|||++.+..++.++||||||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 226 (364)
T cd05599 147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226 (364)
T ss_pred cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecch
Confidence 87543211 0124689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCC
Q 005590 575 CILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFS 654 (689)
Q Consensus 575 vil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~ 654 (689)
|++|+|++|..||.+.+..+....+..... ...+|... ..
T Consensus 227 ~il~el~~G~~Pf~~~~~~~~~~~i~~~~~---------------------------------~~~~~~~~-------~~ 266 (364)
T cd05599 227 VIMYEMLVGYPPFCSDNPQETYRKIINWKE---------------------------------TLQFPDEV-------PL 266 (364)
T ss_pred hHHHHhhcCCCCCCCCCHHHHHHHHHcCCC---------------------------------ccCCCCCC-------CC
Confidence 999999999999988776665554431100 01111111 23
Q ss_pred cHHHHHHHHHhcccCCCCCcC---HHHHHcCCCCCC
Q 005590 655 DAFFIDFVRTLLEINPQRRPT---AREALDHPWLQH 687 (689)
Q Consensus 655 ~~~l~dLI~~mL~~dP~kRpT---a~ElL~hpwf~~ 687 (689)
++.+++||++||. +|.+|++ +.|+++||||..
T Consensus 267 s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 267 SPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred CHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 4678899999997 9999998 999999999975
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=340.09 Aligned_cols=253 Identities=25% Similarity=0.287 Sum_probs=200.6
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 383 Y~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
|++.+.||+|+||+||++.+..+|+.||+|++.... .......+|+.+++.++ |++|+++++++...+..
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~------~~~iv~~~~~~~~~~~~ 75 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN------SRFVVSLAYAYETKDAL 75 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC------CCcEEEEEEEEccCCeE
Confidence 788999999999999999999999999999987532 12234567888887774 67999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
++||||+.+ +|...+.... ...+++..+..++.||+.||.|||+.||+||||||+|||++. ++.++|+|||++
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~--~~~~kl~Dfg~~ 149 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMG----NPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDD--RGHIRISDLGLA 149 (285)
T ss_pred EEEEEecCCCcHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECC--CCCEEEeeCCCc
Confidence 999999985 5555543221 123889999999999999999999999999999999999984 778999999998
Q ss_pred ccccCC--ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 005590 538 CFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615 (689)
Q Consensus 538 ~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~ 615 (689)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...+.
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~----------- 218 (285)
T cd05631 150 VQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK----------- 218 (285)
T ss_pred EEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh-----------
Confidence 765332 2345789999999999999999999999999999999999999986543222221110000
Q ss_pred hhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcC-----HHHHHcCCCCCC
Q 005590 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPWLQH 687 (689)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT-----a~ElL~hpwf~~ 687 (689)
.....++ ...+..+.+||++||+.||.+||+ ++++++||||+.
T Consensus 219 --------------------~~~~~~~---------~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 219 --------------------EDQEEYS---------EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred --------------------cccccCC---------ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 0000111 123466889999999999999997 999999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=344.50 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=204.5
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
+|++++.||+|+||.||+|++..+++.||||++..+. ........|.+++..+.+ |++|+++++++...+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-----~~~i~~~~~~~~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK-----PPFLTQLHSCFQTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCC-----CCceeeeEEEEEcCCE
Confidence 5899999999999999999999999999999997642 233456677777776653 4579999999999999
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 458 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 458 l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
+++||||+.+ +|..++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~--~~~~kL~Dfg~ 147 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVG------KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDA--EGHIKIADFGM 147 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcC--CCCEEEeecCc
Confidence 9999999985 6666654322 2788999999999999999999999999999999999985 78899999998
Q ss_pred ccccc---CCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 005590 537 SCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 537 s~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
+.... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~--------- 218 (324)
T cd05587 148 CKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV--------- 218 (324)
T ss_pred ceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 86421 223345789999999999999999999999999999999999999988776666655532111
Q ss_pred hhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCH-----HHHHcCCCCCC
Q 005590 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA-----REALDHPWLQH 687 (689)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa-----~ElL~hpwf~~ 687 (689)
.+|. ..+..+++||++||..||.+|+++ +++++||||+.
T Consensus 219 --------------------------~~~~---------~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 219 --------------------------SYPK---------SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred --------------------------CCCC---------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 1111 134568899999999999999986 89999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=336.38 Aligned_cols=276 Identities=31% Similarity=0.435 Sum_probs=218.8
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
+|++.+.||+|+||.||+|++..+|+.+|+|+++... .......+|+.+++.++ |+||+++++++.+....
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~------h~~i~~~~~~~~~~~~~ 74 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK------HKNIVRLYDVLHSDKKL 74 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcC------CCCeeeHHHHhccCCce
Confidence 6899999999999999999999999999999987532 22345667888888774 67999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcc
Q 005590 459 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 459 ~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 538 (689)
++|+||+.+++.+++.... ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.++|+|||++.
T Consensus 75 ~lv~e~~~~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~--~~~~~l~dfg~~~ 147 (284)
T cd07839 75 TLVFEYCDQDLKKYFDSCN-----GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINK--NGELKLADFGLAR 147 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcC--CCcEEECccchhh
Confidence 9999999998887765332 23899999999999999999999999999999999999985 7789999999987
Q ss_pred cccCC---ccccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCC-CCCChHHHHHHHHHhhcCCCcHHHHhh
Q 005590 539 FQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVL-FPNDAVVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 539 ~~~~~---~~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~P-F~~~~~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
..... .....+++.|+|||++.+. .++.++|||||||++|+|++|..| |.+.+..+.+..+...++..+...+..
T Consensus 148 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07839 148 AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPG 227 (284)
T ss_pred ccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHH
Confidence 54332 2234568899999998775 478999999999999999998877 567777788888888888777666554
Q ss_pred hhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
......+. .....+............+..+++||++||+.||.+|||+.++++||||
T Consensus 228 ~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 228 VSKLPDYK---------------PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred hhhccccc---------------ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 33221110 0001111111122223345778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=331.67 Aligned_cols=278 Identities=27% Similarity=0.435 Sum_probs=219.6
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
+|++.+.||+|++|.||+|++..+++.||+|++.... .......+|+.+++.+. |+||+++++++......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~ 74 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ------HPNIVCLQDVLMQESRL 74 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcC------CCCEeeeEEEEeeCCeE
Confidence 4899999999999999999999999999999986532 22356677888888774 78999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcc
Q 005590 459 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 459 ~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 538 (689)
++||||+.+++.+++..... ...+++..++.++.||+.||.|||+.||+|+||||+||+++. ++.++|+|||++.
T Consensus 75 ~~v~e~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~--~~~~~l~dfg~~~ 149 (285)
T cd07861 75 YLIFEFLSMDLKKYLDSLPK---GQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDN--KGVIKLADFGLAR 149 (285)
T ss_pred EEEEecCCCCHHHHHhcCCC---CCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcC--CCcEEECccccee
Confidence 99999999888877654321 234889999999999999999999999999999999999984 7889999999986
Q ss_pred cccCCc---cccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 539 FQTDNL---CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 539 ~~~~~~---~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
...... ....+++.|+|||++.+. .++.++|+|||||++|+|++|++||.+......+..+...++......|...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
T cd07861 150 AFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV 229 (285)
T ss_pred ecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcc
Confidence 543321 223568899999998754 5789999999999999999999999988887777777777777666666544
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
.....+.... ... ............+.++++||++||+.||++|||+.++++||||
T Consensus 230 ~~~~~~~~~~-------------~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 230 TSLPDYKNTF-------------PKW--KKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhhHHHHhhc-------------ccc--CcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 4332221100 000 0001111122356778999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=341.42 Aligned_cols=254 Identities=27% Similarity=0.386 Sum_probs=211.3
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
-..|++++.||+|.-|+||+++...++..+|+|++.++.. ...+...|.+||..+ +||+++.+|..|+..
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l------DHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL------DHPFLPTLYASFETD 149 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc------CCCccchhhheeecc
Confidence 3678999999999999999999999999999999987532 234555677777766 689999999999999
Q ss_pred CeEEEEEEccccc-hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEec
Q 005590 456 EHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 534 (689)
Q Consensus 456 ~~l~lVmEy~~g~-L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DF 534 (689)
...|+|||||.|+ |..+.+ . +....|++..++.++..++.||+|||.+|||+|||||+||||. ++|+|.|+||
T Consensus 150 ~~~cl~meyCpGGdL~~Lrq-k---Qp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvr--edGHIMLsDF 223 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQ-K---QPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVR--EDGHIMLSDF 223 (459)
T ss_pred ceeEEEEecCCCccHHHHHh-h---CCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEe--cCCcEEeeec
Confidence 9999999999964 554433 2 3345599999999999999999999999999999999999999 5999999999
Q ss_pred CCcccc-----------------------------------cCC------------------------ccccccCccccC
Q 005590 535 GSSCFQ-----------------------------------TDN------------------------LCLYVQSRSYRA 555 (689)
Q Consensus 535 Gls~~~-----------------------------------~~~------------------------~~~~~gt~~Y~A 555 (689)
.++... ... ...++||-.|.|
T Consensus 224 DLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlA 303 (459)
T KOG0610|consen 224 DLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLA 303 (459)
T ss_pred cccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccc
Confidence 975210 000 012577888999
Q ss_pred hhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccc
Q 005590 556 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETN 635 (689)
Q Consensus 556 PE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (689)
||++.|...+.++|+|+|||++||||.|..||.+.+..+.+.+|+..-.
T Consensus 304 PEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l------------------------------- 352 (459)
T KOG0610|consen 304 PEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPL------------------------------- 352 (459)
T ss_pred ceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCC-------------------------------
Confidence 9999999999999999999999999999999999999999988863222
Q ss_pred cccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcC----HHHHHcCCCCCC
Q 005590 636 QLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT----AREALDHPWLQH 687 (689)
Q Consensus 636 ~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT----a~ElL~hpwf~~ 687 (689)
.+|... .....++|||+++|.+||++|+. |.|+=+||||++
T Consensus 353 ----~Fp~~~-------~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~g 397 (459)
T KOG0610|consen 353 ----KFPEEP-------EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEG 397 (459)
T ss_pred ----cCCCCC-------cchhHHHHHHHHHhccChhhhhccccchHHhhcCccccC
Confidence 223222 12345889999999999999999 999999999986
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=344.25 Aligned_cols=291 Identities=24% Similarity=0.278 Sum_probs=210.9
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
..++|++++.||+|+||.||++++..++..+|+|++... ......+.+|+++++.++ |+||+++++++...+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~ 76 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN------SPYIVGFYGAFYSDG 76 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC------CCCCCeEEEEEEECC
Confidence 357899999999999999999999999999999998764 233456778888888774 689999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEeccCCCeEEEEec
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDL 534 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~-gIvHrDLKp~NILl~~~~~~~vkL~DF 534 (689)
..++||||+.+ +|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.++|+||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~--~~~~kl~Df 148 (331)
T cd06649 77 EISICMEHMDGGSLDQVLKEAK------RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNS--RGEIKLCDF 148 (331)
T ss_pred EEEEEeecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcC--CCcEEEccC
Confidence 99999999985 6777665332 288999999999999999999986 6999999999999984 788999999
Q ss_pred CCcccccCC-ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 005590 535 GSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 535 Gls~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
|++...... .....+++.|+|||++.+..++.++|||||||++|+|++|+.||......++...+..............
T Consensus 149 g~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (331)
T cd06649 149 GVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHS 228 (331)
T ss_pred cccccccccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccc
Confidence 998755332 3345789999999999999999999999999999999999999987766554332211100000000000
Q ss_pred hhhh----hhhhhcc----ccchhhhhcc-ccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCC
Q 005590 614 GQEI----YKYFTKE----YDLYYINEET-NQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 684 (689)
Q Consensus 614 ~~~~----~~~~~~~----~~~~~~~~~~-~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpw 684 (689)
.... ....... .......... .......|... ....+.++++||.+||++||++|||+.|+|+|||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLP-----NGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCC-----CccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 0000 0000000 0000000000 00000011100 1124567999999999999999999999999999
Q ss_pred CCCC
Q 005590 685 LQHP 688 (689)
Q Consensus 685 f~~~ 688 (689)
|+..
T Consensus 304 ~~~~ 307 (331)
T cd06649 304 IKRS 307 (331)
T ss_pred Hhhc
Confidence 9753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=349.57 Aligned_cols=252 Identities=29% Similarity=0.441 Sum_probs=207.6
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|++.+.||+|+||+||+|++..+++.||||+++... .....+.+|+.++..++ |+||+++++++...+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~ 74 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD------SPWIVKLYYSFQDEE 74 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC------CCCccchhhheecCC
Confidence 47999999999999999999999999999999997542 23345667777777765 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
+.++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||||+. ++.+||+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~--~~~~kL~Dfg 146 (350)
T cd05573 75 HLYLVMEYMPGGDLMNLLIRK------DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDA--DGHIKLADFG 146 (350)
T ss_pred eEEEEEcCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC--CCCEEeecCC
Confidence 99999999974 777776543 22889999999999999999999999999999999999984 7889999999
Q ss_pred CcccccCCc--------------------------------cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhC
Q 005590 536 SSCFQTDNL--------------------------------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 583 (689)
Q Consensus 536 ls~~~~~~~--------------------------------~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG 583 (689)
++....... ....||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g 226 (350)
T cd05573 147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226 (350)
T ss_pred CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccC
Confidence 987644322 235789999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHH
Q 005590 584 EVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVR 663 (689)
Q Consensus 584 ~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~ 663 (689)
+.||..........++..... ...+|... ..++.+.+||.
T Consensus 227 ~~Pf~~~~~~~~~~~i~~~~~---------------------------------~~~~p~~~-------~~~~~~~~li~ 266 (350)
T cd05573 227 FPPFYSDTLQETYNKIINWKE---------------------------------SLRFPPDP-------PVSPEAIDLIC 266 (350)
T ss_pred CCCCCCCCHHHHHHHHhccCC---------------------------------cccCCCCC-------CCCHHHHHHHH
Confidence 999988776665555432100 01111111 13467889999
Q ss_pred HhcccCCCCCcC-HHHHHcCCCCCC
Q 005590 664 TLLEINPQRRPT-AREALDHPWLQH 687 (689)
Q Consensus 664 ~mL~~dP~kRpT-a~ElL~hpwf~~ 687 (689)
+||. ||.+|++ +.++|+||||+.
T Consensus 267 ~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 267 RLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 9997 9999999 999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=352.22 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=201.2
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
.|++++.||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.++ |+||+++++++.+.++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~------h~~iv~l~~~~~~~~~ 75 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD------NEWVVKLYYSFQDKDN 75 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC------CCCeeeeEEEEecCCE
Confidence 6899999999999999999999999999999997532 23445677888887764 7899999999999999
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 458 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 458 l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
+++||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||||+. ++.+||+|||+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~--~~~~kL~DFGl 147 (381)
T cd05626 76 LYFVMDYIPGGDMMSLLIRME------VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDL--DGHIKLTDFGL 147 (381)
T ss_pred EEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECC--CCCEEEeeCcC
Confidence 9999999975 6777665322 2888999999999999999999999999999999999984 78899999998
Q ss_pred cccccC--------------------------------------------------CccccccCccccChhhhcCCCCCc
Q 005590 537 SCFQTD--------------------------------------------------NLCLYVQSRSYRAPEVIIGLPYDQ 566 (689)
Q Consensus 537 s~~~~~--------------------------------------------------~~~~~~gt~~Y~APE~l~~~~~s~ 566 (689)
+..... .....+||+.|+|||++.+..++.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (381)
T cd05626 148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ 227 (381)
T ss_pred CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence 643210 011347899999999999999999
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccch
Q 005590 567 KIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESS 646 (689)
Q Consensus 567 ~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 646 (689)
++|||||||++|+|++|..||...+..+....+..... ...+|..
T Consensus 228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---------------------------------~~~~~~~-- 272 (381)
T cd05626 228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWEN---------------------------------TLHIPPQ-- 272 (381)
T ss_pred ccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccc---------------------------------ccCCCCC--
Confidence 99999999999999999999987766554444431100 0111111
Q ss_pred hhhhccCCcHHHHHHHHHhccc--CCCCCcCHHHHHcCCCCCC
Q 005590 647 LEHHLQFSDAFFIDFVRTLLEI--NPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 647 l~~~~~~~~~~l~dLI~~mL~~--dP~kRpTa~ElL~hpwf~~ 687 (689)
...++++++||.+||.. +|..|+++.++++||||+.
T Consensus 273 -----~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 273 -----VKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred -----CCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 11346788999996654 4555999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=321.56 Aligned_cols=256 Identities=27% Similarity=0.417 Sum_probs=215.3
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEE
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 459 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~ 459 (689)
-++|.|.+.||+|-||.||+|+.+.++-.||+|++.+.. ......+-++.+.+.....+.||||+++|++|.+....|
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq--i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ--ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH--HHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 478999999999999999999999999999999998653 222223333444444445567899999999999999999
Q ss_pred EEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcc
Q 005590 460 IVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 460 lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 538 (689)
+++||.. |.++..+..... ..+.+.....+++|++.||.|+|..++|||||||+|+|++. .+.+||+|||.+.
T Consensus 99 LilEya~~gel~k~L~~~~~----~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~--~~~lkiAdfGwsV 172 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRM----KRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGS--AGELKIADFGWSV 172 (281)
T ss_pred EEEEecCCchHHHHHHhccc----ccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCC--CCCeeccCCCcee
Confidence 9999998 567776653322 33889999999999999999999999999999999999996 8889999999987
Q ss_pred ccc-CCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhh
Q 005590 539 FQT-DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 617 (689)
Q Consensus 539 ~~~-~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~ 617 (689)
... ....+.|||..|.|||++.+..++..+|+|++|++.||++.|.+||...+..+.+.+|.++
T Consensus 173 ~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~--------------- 237 (281)
T KOG0580|consen 173 HAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV--------------- 237 (281)
T ss_pred ecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc---------------
Confidence 653 4456789999999999999999999999999999999999999999988888888888633
Q ss_pred hhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 618 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
+..+|. ..+..+.|||.+||..+|.+|.+..|++.|||+..
T Consensus 238 --------------------~~~~p~---------~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 238 --------------------DLKFPS---------TISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred --------------------cccCCc---------ccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 233331 23456789999999999999999999999999864
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=342.13 Aligned_cols=241 Identities=29% Similarity=0.457 Sum_probs=198.1
Q ss_pred eccCCCCceEEEEECCCCcEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEEEc
Q 005590 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 464 (689)
Q Consensus 389 LG~G~fG~Vyla~d~~tg~~vAvKii~~~----~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmEy 464 (689)
||+|+||+||+|++..+++.||+|++... ........+|+.+++.+ +||||+++++++...+..++||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~~~lv~e~ 74 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV------NCPFIVPLKFSFQSPEKLYLVLAF 74 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC------CCCcEeceeeEEecCCeEEEEEcC
Confidence 79999999999999999999999998753 22334566777777766 478999999999999999999999
Q ss_pred ccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccC-
Q 005590 465 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD- 542 (689)
Q Consensus 465 ~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~- 542 (689)
+.+ +|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++. ++.++|+|||++.....
T Consensus 75 ~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~--~~~~kl~Dfg~~~~~~~~ 146 (312)
T cd05585 75 INGGELFHHLQREG------RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDY--QGHIALCDFGLCKLNMKD 146 (312)
T ss_pred CCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECC--CCcEEEEECcccccCccC
Confidence 985 6666665322 2889999999999999999999999999999999999984 78899999999875322
Q ss_pred --CccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhh
Q 005590 543 --NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKY 620 (689)
Q Consensus 543 --~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~ 620 (689)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 147 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~------------------ 208 (312)
T cd05585 147 DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE------------------ 208 (312)
T ss_pred CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC------------------
Confidence 223457899999999999999999999999999999999999999887666555444311
Q ss_pred hhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCc---CHHHHHcCCCCCC
Q 005590 621 FTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP---TAREALDHPWLQH 687 (689)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRp---Ta~ElL~hpwf~~ 687 (689)
...+|. ..+..+++||.+||+.||.+|| ++.|+|+||||.+
T Consensus 209 -----------------~~~~~~---------~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 209 -----------------PLRFPD---------GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ 252 (312)
T ss_pred -----------------CCCCCC---------cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCC
Confidence 001111 2345688999999999999997 5899999999985
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=352.52 Aligned_cols=252 Identities=27% Similarity=0.403 Sum_probs=201.7
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|+++++||+|+||+||++++..+++.||||++.+.. .....+.+|+++++.+ +||||++++++|....
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l------~hp~iv~~~~~~~~~~ 74 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES------DSPWVVSLYYSFQDAQ 74 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC------CCCCcceEEEEEEcCC
Confidence 47999999999999999999999999999999987542 2234566677777765 4789999999999999
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
+.|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~--~~~~kl~DfG 146 (377)
T cd05629 75 YLYLIMEFLPGGDLMTMLIKYD------TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDR--GGHIKLSDFG 146 (377)
T ss_pred eeEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC--CCCEEEeecc
Confidence 9999999997 46777665322 2889999999999999999999999999999999999984 7889999999
Q ss_pred CcccccCC--------------------------------------------------ccccccCccccChhhhcCCCCC
Q 005590 536 SSCFQTDN--------------------------------------------------LCLYVQSRSYRAPEVIIGLPYD 565 (689)
Q Consensus 536 ls~~~~~~--------------------------------------------------~~~~~gt~~Y~APE~l~~~~~s 565 (689)
+++..... ....+||+.|+|||++.+..++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 226 (377)
T cd05629 147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC
Confidence 88532110 0024689999999999999999
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccc
Q 005590 566 QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEES 645 (689)
Q Consensus 566 ~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 645 (689)
.++|||||||++|+|++|..||.+.+..+.+..+..... ...+|..
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------------------------~~~~p~~- 272 (377)
T cd05629 227 QECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRE---------------------------------TLYFPDD- 272 (377)
T ss_pred CceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCC---------------------------------ccCCCCC-
Confidence 999999999999999999999988776665555431100 0011111
Q ss_pred hhhhhccCCcHHHHHHHHHhcccCCCCC---cCHHHHHcCCCCCC
Q 005590 646 SLEHHLQFSDAFFIDFVRTLLEINPQRR---PTAREALDHPWLQH 687 (689)
Q Consensus 646 ~l~~~~~~~~~~l~dLI~~mL~~dP~kR---pTa~ElL~hpwf~~ 687 (689)
...+.++.+||++||. +|.+| +|+.|+++||||+.
T Consensus 273 ------~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 273 ------IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred ------CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 1134668899999998 67765 59999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=343.33 Aligned_cols=244 Identities=25% Similarity=0.434 Sum_probs=199.7
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEE
Q 005590 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 462 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVm 462 (689)
+.||+|+||+||+|+++.+++.||||++..+. ........|..++..+. .||||+++++++...+.+++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----~h~~iv~~~~~~~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-----NHPFLTQLYCCFQTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcc-----CCCchhceeeEEEcCCEEEEEE
Confidence 36899999999999999999999999997542 22345556666666543 4889999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccccc
Q 005590 463 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 541 (689)
Q Consensus 463 Ey~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~ 541 (689)
||+.+ +|...+.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++....
T Consensus 76 Ey~~~g~L~~~i~~~~------~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~--~~~~kL~DfG~~~~~~ 147 (320)
T cd05590 76 EFVNGGDLMFHIQKSR------RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDH--EGHCKLADFGMCKEGI 147 (320)
T ss_pred cCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECC--CCcEEEeeCCCCeecC
Confidence 99985 6665554322 2889999999999999999999999999999999999985 7889999999976532
Q ss_pred ---CCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhh
Q 005590 542 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 618 (689)
Q Consensus 542 ---~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~ 618 (689)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++..+....
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~--------------- 212 (320)
T cd05590 148 FNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE--------------- 212 (320)
T ss_pred cCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC---------------
Confidence 22334578999999999999999999999999999999999999999887766665553110
Q ss_pred hhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCH------HHHHcCCCCCC
Q 005590 619 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA------REALDHPWLQH 687 (689)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa------~ElL~hpwf~~ 687 (689)
..+|. ..+..+++||++||+.||.+|+++ +++++||||+.
T Consensus 213 --------------------~~~~~---------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 213 --------------------VVYPT---------WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred --------------------CCCCC---------CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 01111 124568899999999999999998 99999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=351.48 Aligned_cols=252 Identities=25% Similarity=0.359 Sum_probs=202.4
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
.+|+++++||+|+||+||+|++..+++.||+|++.... .....+.+|+.+++.++ |+||+++++.|...+
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~------h~~iv~~~~~~~~~~ 74 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD------NEWVVRLYYSFQDKD 74 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC------CCcCCeEEEEEEeCC
Confidence 36999999999999999999999999999999997542 23445667888887764 689999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
++++||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~--~g~~kL~DFG 146 (382)
T cd05625 75 NLYFVMDYIPGGDMMSLLIRMG------IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDR--DGHIKLTDFG 146 (382)
T ss_pred EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC--CCCEEEeECC
Confidence 99999999985 6766664322 2788999999999999999999999999999999999984 7889999999
Q ss_pred CcccccC--------------------------------------------------CccccccCccccChhhhcCCCCC
Q 005590 536 SSCFQTD--------------------------------------------------NLCLYVQSRSYRAPEVIIGLPYD 565 (689)
Q Consensus 536 ls~~~~~--------------------------------------------------~~~~~~gt~~Y~APE~l~~~~~s 565 (689)
++..... .....+||+.|+|||++.+..++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 226 (382)
T cd05625 147 LCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT 226 (382)
T ss_pred CCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC
Confidence 8642110 00124689999999999999999
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccc
Q 005590 566 QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEES 645 (689)
Q Consensus 566 ~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 645 (689)
.++|||||||++|+|++|++||.+.+..+....+.... ....+|..
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---------------------------------~~~~~p~~- 272 (382)
T cd05625 227 QLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQ---------------------------------TSLHIPPQ- 272 (382)
T ss_pred CeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccC---------------------------------CCcCCCCc-
Confidence 99999999999999999999998876655544443110 01111211
Q ss_pred hhhhhccCCcHHHHHHHHHhcccCCCCCcC---HHHHHcCCCCCC
Q 005590 646 SLEHHLQFSDAFFIDFVRTLLEINPQRRPT---AREALDHPWLQH 687 (689)
Q Consensus 646 ~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT---a~ElL~hpwf~~ 687 (689)
...++++++||.+|+ .+|.+|++ ++|+++||||+.
T Consensus 273 ------~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 273 ------AKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred ------ccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 123466889999986 59999998 999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=337.18 Aligned_cols=285 Identities=26% Similarity=0.425 Sum_probs=209.2
Q ss_pred EEeccCCCCceEEEEECC--CCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--CCeEEEEE
Q 005590 387 EYLGSAAFSKVFQAQDLH--TGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--LEHLFIVC 462 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~--tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~--~~~l~lVm 462 (689)
.+||+|+||+||+|++.. ++..||+|.+.... ......+|+.+++.++ ||||+++++++.. ....++||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELK------HPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCC------CCCeeeEEEEEeccCCCeEEEEE
Confidence 579999999999999653 66889999987543 2245678888888774 6799999999864 46789999
Q ss_pred EccccchHHHHhhhhcc---CCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec--cCCCeEEEEecCCc
Q 005590 463 ELLRANLYEFQKFNQES---GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS--YQRCEIKIIDLGSS 537 (689)
Q Consensus 463 Ey~~g~L~~l~~~~~~~---~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~--~~~~~vkL~DFGls 537 (689)
||+.+++.+++...... .....+++..++.++.||+.||.|||+.||+||||||+|||+.. ..++.+||+|||++
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 80 DYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 99999988887643321 12234888999999999999999999999999999999999953 24678999999999
Q ss_pred ccccCC------ccccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChH---------HHHHHHHHh
Q 005590 538 CFQTDN------LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAV---------VMILARIIG 601 (689)
Q Consensus 538 ~~~~~~------~~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~---------~~~l~~i~~ 601 (689)
+..... .....+|+.|+|||++.+. .++.++|||||||++|+|++|++||..... ...+.++..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 765432 1234678999999999774 588999999999999999999999975332 345667777
Q ss_pred hcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCcc-chhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHH
Q 005590 602 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEE-SSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 680 (689)
Q Consensus 602 ~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~-~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL 680 (689)
.++.+..+.|........+........ ...+..+.. ..........+..+.+||.+||+.||.+|||+.|+|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l 312 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFR-------RTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQAL 312 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhc-------ccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHh
Confidence 788777766655433322111000000 000000000 000111112345688999999999999999999999
Q ss_pred cCCCC
Q 005590 681 DHPWL 685 (689)
Q Consensus 681 ~hpwf 685 (689)
+||||
T Consensus 313 ~hp~f 317 (317)
T cd07867 313 QDPYF 317 (317)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=344.61 Aligned_cols=244 Identities=26% Similarity=0.390 Sum_probs=198.2
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEE
Q 005590 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 462 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVm 462 (689)
+.||+|+||.||++++..+++.||+|++.... .......+|+++++.+ .||||+++++++...++.++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~~~~~~~~~~~lv~ 74 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT------RHPFLTSLKYSFQTKDRLCFVM 74 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC------CCCCCcceEEEEEcCCEEEEEE
Confidence 36899999999999999999999999997542 2334556677777665 4789999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccccc
Q 005590 463 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 541 (689)
Q Consensus 463 Ey~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~ 541 (689)
||+.+ +|...+... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++....
T Consensus 75 Ey~~~g~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~--~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 75 EYVNGGELFFHLSRE------RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDK--DGHIKITDFGLCKEGI 146 (328)
T ss_pred eCCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECC--CCcEEEecCcCCccCC
Confidence 99985 565554322 13889999999999999999999999999999999999984 7889999999987532
Q ss_pred C---CccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhh
Q 005590 542 D---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 618 (689)
Q Consensus 542 ~---~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~ 618 (689)
. .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~---------------- 210 (328)
T cd05593 147 TDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME---------------- 210 (328)
T ss_pred CcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC----------------
Confidence 2 223457899999999999989999999999999999999999999876655544433210
Q ss_pred hhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCc-----CHHHHHcCCCCCCC
Q 005590 619 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQHP 688 (689)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRp-----Ta~ElL~hpwf~~~ 688 (689)
...+|. ..+..+.+||++||+.||++|+ ++.|+++||||...
T Consensus 211 -------------------~~~~p~---------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 211 -------------------DIKFPR---------TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred -------------------CccCCC---------CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 011111 1345688999999999999997 89999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.03 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=203.3
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
+|++.+.||+|+||+||+|++..+++.||||++.+... .......|..++..+. .|++|+++++++...+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----~~~~i~~~~~~~~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG-----KPPFLTQLHSCFQTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc-----CCCeEeeEEEEEecCCE
Confidence 48899999999999999999999999999999986431 2233455666655543 46899999999999999
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 458 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 458 l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
+++||||+.+ +|.+.+.... .+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~--~~~~kL~DfG~ 147 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVG------RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS--EGHIKIADFGM 147 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECC--CCcEEEccCCC
Confidence 9999999985 6666654322 2889999999999999999999999999999999999985 78899999999
Q ss_pred ccccc---CCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 005590 537 SCFQT---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 537 s~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
+.... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~--------- 218 (323)
T cd05616 148 CKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV--------- 218 (323)
T ss_pred ceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------
Confidence 86532 223345789999999999999999999999999999999999999998877766665542111
Q ss_pred hhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcC-----HHHHHcCCCCCC
Q 005590 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPWLQH 687 (689)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT-----a~ElL~hpwf~~ 687 (689)
.+|. ..+..+.+||.+||+.||++|++ ..++++||||+.
T Consensus 219 --------------------------~~p~---------~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 219 --------------------------AYPK---------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred --------------------------CCCC---------cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 1111 12456889999999999999998 489999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=340.02 Aligned_cols=253 Identities=31% Similarity=0.515 Sum_probs=218.6
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005590 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 453 (689)
Q Consensus 378 ~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~ 453 (689)
-+..||++.+.||+|.||+|-+|.+...|+.||||.+++++ ...-.+.+|++||..|+ ||||+++|.+|.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN------HPhII~IyEVFE 123 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN------HPHIIQIYEVFE 123 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcC------CCceeehhhhhc
Confidence 45679999999999999999999999999999999998754 33345667888888775 789999999999
Q ss_pred eCCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEE
Q 005590 454 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 532 (689)
Q Consensus 454 ~~~~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~ 532 (689)
..+.+.|||||.. |.|++++...+. +++.+++.+++||+.|+.|+|+++++|||||.+|||++ +++.+||+
T Consensus 124 NkdKIvivMEYaS~GeLYDYiSer~~------LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD--~N~NiKIA 195 (668)
T KOG0611|consen 124 NKDKIVIVMEYASGGELYDYISERGS------LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLD--QNNNIKIA 195 (668)
T ss_pred CCceEEEEEEecCCccHHHHHHHhcc------ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeec--CCCCeeee
Confidence 9999999999998 579999987654 99999999999999999999999999999999999999 58899999
Q ss_pred ecCCcccccCC--ccccccCccccChhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHH
Q 005590 533 DLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 609 (689)
Q Consensus 533 DFGls~~~~~~--~~~~~gt~~Y~APE~l~~~~~s-~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e 609 (689)
|||++-.+.+. ..++||+|-|.+||++.+.+|. ..+|.|||||+||-|..|..||.+.+...+..+|..
T Consensus 196 DFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~-------- 267 (668)
T KOG0611|consen 196 DFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISR-------- 267 (668)
T ss_pred ccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhc--------
Confidence 99999877654 4568999999999999999876 689999999999999999999999988887777641
Q ss_pred HHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCCCC
Q 005590 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHPY 689 (689)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~~~ 689 (689)
..|.-|..+ ..+.-||+.||-.||++|.|+.++..|=|++=.|
T Consensus 268 ---------------------------GaYrEP~~P----------SdA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy 310 (668)
T KOG0611|consen 268 ---------------------------GAYREPETP----------SDASGLIRWMLMVNPERRATIEDIASHWWVNWGY 310 (668)
T ss_pred ---------------------------ccccCCCCC----------chHHHHHHHHHhcCcccchhHHHHhhhheeeccc
Confidence 112222221 2345799999999999999999999999987544
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=331.46 Aligned_cols=292 Identities=29% Similarity=0.440 Sum_probs=233.9
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCc----EEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGV----DVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 453 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~----~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~ 453 (689)
..|++++.||+|.||.||+|..+.++. .+|||.++.++ .......+|+.++++++ |+||+.+..+|.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~------h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELK------HPNVISLVKVFL 97 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhc------CCcchhHHHHHh
Confidence 468999999999999999996544433 68999998653 23456779999999996 578999999998
Q ss_pred e-CCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecc--CCCeEE
Q 005590 454 H-LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY--QRCEIK 530 (689)
Q Consensus 454 ~-~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~--~~~~vk 530 (689)
. ...+++++||.+.+|+..++++..... ..++...++.|+.||+.|+.|||++-|+||||||.||||..+ +.|.||
T Consensus 98 ~~d~~v~l~fdYAEhDL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAEHDLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ccCceEEEEehhhhhhHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeE
Confidence 7 788999999999999999998887666 579999999999999999999999999999999999999742 459999
Q ss_pred EEecCCcccccCCccc------cccCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCC---------hHHH
Q 005590 531 IIDLGSSCFQTDNLCL------YVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPND---------AVVM 594 (689)
Q Consensus 531 L~DFGls~~~~~~~~~------~~gt~~Y~APE~l~~~~-~s~~~DIwSLGvil~eLltG~~PF~~~---------~~~~ 594 (689)
|+|||+++....+... .+-|.+|+|||.++|.. |+.++|+|++|||+.||++-++.|.+. -..+
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 9999999987765443 45689999999999865 999999999999999999999999653 3347
Q ss_pred HHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCC-ccchhhhhccCCcHHHHHHHHHhcccCCCCC
Q 005590 595 ILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIP-EESSLEHHLQFSDAFFIDFVRTLLEINPQRR 673 (689)
Q Consensus 595 ~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p-~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kR 673 (689)
++.+|..++|.+..+.|+.-..+.++-..-.++.. .+..+ .....-+..+..++...+|+.+||+.||.+|
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~--------~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kR 328 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRR--------HYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKR 328 (438)
T ss_pred HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHH--------hhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhh
Confidence 89999999999999988876665444221111000 00000 0111122233345557899999999999999
Q ss_pred cCHHHHHcCCCCCC
Q 005590 674 PTAREALDHPWLQH 687 (689)
Q Consensus 674 pTa~ElL~hpwf~~ 687 (689)
+|++++|+|+||..
T Consensus 329 Ita~qAleh~yF~~ 342 (438)
T KOG0666|consen 329 ITAEQALEHPYFTE 342 (438)
T ss_pred ccHHHHhccccccc
Confidence 99999999999975
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.95 Aligned_cols=244 Identities=29% Similarity=0.431 Sum_probs=197.0
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEE
Q 005590 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 462 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVm 462 (689)
+.||+|+||.||+|++..+|+.||+|+++... ........|..++..+ .+|++|+++++++...++.++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~~i~~~~~~~~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA-----WENPFLTHLYCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhc-----cCCCCccCeeEEEEeCCEEEEEE
Confidence 36999999999999999999999999998642 2233445566665543 25789999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccc-
Q 005590 463 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ- 540 (689)
Q Consensus 463 Ey~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~- 540 (689)
||+.+ +|..++... ..+++..+..++.||+.||.|||+.||+||||||+|||++. ++.++|+|||++...
T Consensus 76 E~~~~g~L~~~i~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~--~~~~kl~Dfg~~~~~~ 147 (316)
T cd05620 76 EFLNGGDLMFHIQDK------GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDR--DGHIKIADFGMCKENV 147 (316)
T ss_pred CCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC--CCCEEeCccCCCeecc
Confidence 99985 566655432 12889999999999999999999999999999999999984 778999999998642
Q ss_pred --cCCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhh
Q 005590 541 --TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 618 (689)
Q Consensus 541 --~~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~ 618 (689)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~---------------- 211 (316)
T cd05620 148 FGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD---------------- 211 (316)
T ss_pred cCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----------------
Confidence 22233467899999999999999999999999999999999999999887766555444211
Q ss_pred hhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCH-HHHHcCCCCCC
Q 005590 619 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA-REALDHPWLQH 687 (689)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa-~ElL~hpwf~~ 687 (689)
...+|. ..+..+++||++||+.||++|+++ +++++||||+.
T Consensus 212 -------------------~~~~~~---------~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 212 -------------------TPHYPR---------WITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKT 253 (316)
T ss_pred -------------------CCCCCC---------CCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCC
Confidence 011111 134568899999999999999998 58889999976
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.33 Aligned_cols=244 Identities=25% Similarity=0.395 Sum_probs=200.1
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEE
Q 005590 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 462 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVm 462 (689)
+.||+|+||.||+|++..+++.||+|++..+. ........|.+++..+. .||+|++++++|...+..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-----~hp~i~~~~~~~~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-----KHPFLTALHCCFQTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhcc-----CCCCccceeeEEEcCCeEEEEE
Confidence 36899999999999999999999999997642 22344556777766553 4889999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccccc
Q 005590 463 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 541 (689)
Q Consensus 463 Ey~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~ 541 (689)
||+.+ +|...+.... .+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++....
T Consensus 76 E~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~--~~~~kL~Dfg~~~~~~ 147 (321)
T cd05591 76 EYVNGGDLMFQIQRSR------KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDA--EGHCKLADFGMCKEGI 147 (321)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC--CCCEEEeecccceecc
Confidence 99985 5665554322 2888999999999999999999999999999999999984 7889999999986532
Q ss_pred C---CccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhh
Q 005590 542 D---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 618 (689)
Q Consensus 542 ~---~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~ 618 (689)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.+..+...
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~---------------- 211 (321)
T cd05591 148 LNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD---------------- 211 (321)
T ss_pred cCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC----------------
Confidence 2 233457899999999999999999999999999999999999999988777666555311
Q ss_pred hhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCc-------CHHHHHcCCCCCC
Q 005590 619 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-------TAREALDHPWLQH 687 (689)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRp-------Ta~ElL~hpwf~~ 687 (689)
...+|. ..+.++.+||.+||+.||++|+ ++.++++||||+.
T Consensus 212 -------------------~~~~p~---------~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 212 -------------------DVLYPV---------WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred -------------------CCCCCC---------CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 001111 1245688999999999999999 9999999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=351.06 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=202.7
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|++++.||+|+||.||+|++..+++.||||++.... .....+.+|+.+++.+. |+||+++++.|...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~------h~~iv~~~~~~~~~~ 74 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD------NEWVVKLYYSFQDKD 74 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC------CCCcceEEEEEEcCC
Confidence 47999999999999999999999999999999987532 22345667888888774 679999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
++++||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~--~~~ikL~DFG 146 (376)
T cd05598 75 NLYFVMDYIPGGDMMSLLIRLG------IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR--DGHIKLTDFG 146 (376)
T ss_pred EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECC--CCCEEEEeCC
Confidence 99999999974 6777765432 2788999999999999999999999999999999999984 7889999999
Q ss_pred CcccccC----------------------------------------------CccccccCccccChhhhcCCCCCchhh
Q 005590 536 SSCFQTD----------------------------------------------NLCLYVQSRSYRAPEVIIGLPYDQKID 569 (689)
Q Consensus 536 ls~~~~~----------------------------------------------~~~~~~gt~~Y~APE~l~~~~~s~~~D 569 (689)
++..... .....+||+.|+|||++.+..++.++|
T Consensus 147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 226 (376)
T cd05598 147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226 (376)
T ss_pred CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee
Confidence 8642110 011247899999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhh
Q 005590 570 LWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEH 649 (689)
Q Consensus 570 IwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~ 649 (689)
||||||++|+|++|+.||.+....+....+.... ....+|..
T Consensus 227 iwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~---------------------------------~~~~~~~~----- 268 (376)
T cd05598 227 WWSVGVILYEMLVGQPPFLADTPAETQLKVINWE---------------------------------TTLHIPSQ----- 268 (376)
T ss_pred eeeccceeeehhhCCCCCCCCCHHHHHHHHhccC---------------------------------ccccCCCC-----
Confidence 9999999999999999998876655544432100 00111111
Q ss_pred hccCCcHHHHHHHHHhcccCCCCCc---CHHHHHcCCCCCC
Q 005590 650 HLQFSDAFFIDFVRTLLEINPQRRP---TAREALDHPWLQH 687 (689)
Q Consensus 650 ~~~~~~~~l~dLI~~mL~~dP~kRp---Ta~ElL~hpwf~~ 687 (689)
...+..+.+||.+|+ .+|.+|+ |+.|+++||||+.
T Consensus 269 --~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 269 --AKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred --CCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 113456789999977 5999999 9999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=305.91 Aligned_cols=278 Identities=31% Similarity=0.470 Sum_probs=234.0
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
+|.-.++||+|.||+|++|++..+++.||+|.++.+. ......++|+.++++++| .||++++++......+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkh------knivrl~dvlhsdkkl 76 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH------KNIVRLHDVLHSDKKL 76 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhh------cceeehhhhhccCcee
Confidence 4666788999999999999999999999999998753 234678899999999974 5899999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcc
Q 005590 459 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 459 ~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 538 (689)
-+|+|||..+|..+...... .+..+.++.++.|+++||.++|+.++.||||||.|+||+. +|++||+|||+++
T Consensus 77 tlvfe~cdqdlkkyfdslng-----~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~--ngelkladfglar 149 (292)
T KOG0662|consen 77 TLVFEFCDQDLKKYFDSLNG-----DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINR--NGELKLADFGLAR 149 (292)
T ss_pred EEeHHHhhHHHHHHHHhcCC-----cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEecc--CCcEEecccchhh
Confidence 99999999999888765432 2888999999999999999999999999999999999995 8999999999998
Q ss_pred cccCCc-c--ccccCccccChhhhcCCC-CCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 005590 539 FQTDNL-C--LYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 539 ~~~~~~-~--~~~gt~~Y~APE~l~~~~-~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
-.+-+. + ..+-|.+|++|.++.+.. |+...|+||.|||+.|+.. |++.|++.+..+++.+|...+|.+.++.|+.
T Consensus 150 afgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps 229 (292)
T KOG0662|consen 150 AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPS 229 (292)
T ss_pred hcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCc
Confidence 766543 2 246699999999999865 8999999999999999987 8999999999999999999999999888877
Q ss_pred hhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
...+.+|.. + ...|...++.+........-+||++++|.-+|.+|++|+++|+||||..
T Consensus 230 ~t~lpdyk~-----y----------p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 230 MTKLPDYKP-----Y----------PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred cccCCCCcc-----c----------CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 655544321 1 1223333333333333344679999999999999999999999999975
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=341.44 Aligned_cols=243 Identities=25% Similarity=0.396 Sum_probs=198.0
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEE
Q 005590 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 462 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVm 462 (689)
+.||+|+||.||++++..+|+.||+|+++... .......+|+++++.+ .||||+++++.|...+..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~i~~~~~~~~~~~~~~lv~ 74 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT------RHPFLTALKYAFQTHDRLCFVM 74 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC------CCCCCcceeeEEecCCEEEEEE
Confidence 36899999999999999999999999997642 2234455677777766 4789999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccccc
Q 005590 463 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 541 (689)
Q Consensus 463 Ey~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~ 541 (689)
||+.+ +|...+.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++....
T Consensus 75 E~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~kL~Dfg~~~~~~ 146 (323)
T cd05595 75 EYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK--DGHIKITDFGLCKEGI 146 (323)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcC--CCCEEecccHHhcccc
Confidence 99985 5655543221 3889999999999999999999999999999999999984 7889999999876532
Q ss_pred C---CccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhh
Q 005590 542 D---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 618 (689)
Q Consensus 542 ~---~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~ 618 (689)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...
T Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~---------------- 210 (323)
T cd05595 147 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME---------------- 210 (323)
T ss_pred CCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC----------------
Confidence 2 223357899999999999999999999999999999999999999877665554443210
Q ss_pred hhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCc-----CHHHHHcCCCCCC
Q 005590 619 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQH 687 (689)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRp-----Ta~ElL~hpwf~~ 687 (689)
...+|. ..++.+.+||.+||+.||++|+ ++.++++||||.+
T Consensus 211 -------------------~~~~p~---------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 211 -------------------EIRFPR---------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred -------------------CCCCCC---------CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence 001111 1346688999999999999998 9999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=344.76 Aligned_cols=277 Identities=25% Similarity=0.290 Sum_probs=205.1
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 460 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~l 460 (689)
.+|++++.||+|+||.||+|++..+++.||+|+.... ....|+.+++.++ |+||+++++++......++
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVN------HPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCC------CCCCcChhheEEeCCeeEE
Confidence 4799999999999999999999999999999986543 2346888887764 7899999999999999999
Q ss_pred EEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccc
Q 005590 461 VCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 540 (689)
Q Consensus 461 VmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~ 540 (689)
||||+.++|.+++.... ..+++..++.|+.||+.||.|||+.||+||||||+|||++. .+.+||+|||++...
T Consensus 135 v~e~~~~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~--~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 135 VLPHYSSDLYTYLTKRS-----RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIND--VDQVCIGDLGAAQFP 207 (357)
T ss_pred EEEccCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEEecCcccccc
Confidence 99999999888875432 23889999999999999999999999999999999999984 778999999998754
Q ss_pred cC--CccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCC-CCCCCC---------hHHHHHHHHHhhcCCCcH
Q 005590 541 TD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE-VLFPND---------AVVMILARIIGMLGPIDL 608 (689)
Q Consensus 541 ~~--~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~-~PF~~~---------~~~~~l~~i~~~~g~~~~ 608 (689)
.. ......||+.|+|||++.+..++.++|||||||++|+|+++. .+|... .....+..++..++..+.
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 287 (357)
T PHA03209 208 VVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287 (357)
T ss_pred ccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence 32 223457899999999999999999999999999999999854 444431 112334444444444333
Q ss_pred HHHhhh-hhh-hhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCC
Q 005590 609 EMLMQG-QEI-YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686 (689)
Q Consensus 609 e~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~ 686 (689)
+..... ... ..++.. .. ....|............+..+.+||.+||+.||.+||||.|||+||||+
T Consensus 288 ~~~~~~~~~~~~~~~~~-------~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~ 355 (357)
T PHA03209 288 EFPRDPGSRLVRGFIEY-------AS-----LERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFA 355 (357)
T ss_pred hcCCCCccHHHHHHHhh-------cc-----cCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhc
Confidence 221100 000 001000 00 0000000000001112345677899999999999999999999999998
Q ss_pred C
Q 005590 687 H 687 (689)
Q Consensus 687 ~ 687 (689)
+
T Consensus 356 ~ 356 (357)
T PHA03209 356 Q 356 (357)
T ss_pred c
Confidence 6
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=334.16 Aligned_cols=281 Identities=27% Similarity=0.413 Sum_probs=221.3
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC-
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL- 455 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~---~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~- 455 (689)
.++|++.+.||+|+||.||+|++..+|+.||+|+++.... ......+|+.+++.++ |+||+++++++...
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~ 79 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLR------HPNIVELKEVVVGKH 79 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCC------CCCCcceEEEEecCC
Confidence 3689999999999999999999999999999999875321 1234557888888774 67999999998755
Q ss_pred -CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEec
Q 005590 456 -EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 534 (689)
Q Consensus 456 -~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DF 534 (689)
+..++||||+.++|.+++.... ..+++..+..++.||+.||.|||+.|++||||||+||+++. ++.++|+||
T Consensus 80 ~~~~~lv~e~~~~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~--~~~~kL~df 152 (309)
T cd07845 80 LDSIFLVMEYCEQDLASLLDNMP-----TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTD--KGCLKIADF 152 (309)
T ss_pred CCeEEEEEecCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC--CCCEEECcc
Confidence 5689999999998888776432 23889999999999999999999999999999999999984 788999999
Q ss_pred CCcccccCC---ccccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 005590 535 GSSCFQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 610 (689)
Q Consensus 535 Gls~~~~~~---~~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~ 610 (689)
|.+...... .....+++.|+|||++.+ ..++.++|+|||||++|+|++|++||.+.+..+.+..+...++.++..+
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07845 153 GLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESI 232 (309)
T ss_pred ceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 998765432 222345778999999876 4588999999999999999999999999999999999988888777666
Q ss_pred HhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
|.........- ...........+.......++.+.+||++||++||++|||+.++|+||||++
T Consensus 233 ~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 233 WPGFSDLPLVG--------------KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred chhhhcccccc--------------cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 55432221100 0000000001112222334677899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=341.20 Aligned_cols=293 Identities=25% Similarity=0.346 Sum_probs=210.6
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC
Q 005590 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 378 ~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
+..++|++.++||+|+||.||++.+..++..+|+|++... ......+.+|+++++.++ |+||++++++|...
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~ 75 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN------SPYIVGFYGAFYSD 75 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC------CCcccceeEEEEEC
Confidence 3457899999999999999999999999999999998754 233456778888888774 68999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEeccCCCeEEEEe
Q 005590 456 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIID 533 (689)
Q Consensus 456 ~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~-gIvHrDLKp~NILl~~~~~~~vkL~D 533 (689)
++.++||||+.+ +|.+++.... .+++..+..++.||+.||.|||+. +|+|+||||+|||++. ++.+||+|
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~--~~~~kL~D 147 (333)
T cd06650 76 GEISICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS--RGEIKLCD 147 (333)
T ss_pred CEEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcC--CCCEEEee
Confidence 999999999975 7777765432 278889999999999999999985 7999999999999984 77899999
Q ss_pred cCCcccccCC-ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhc-CCCcHHHH
Q 005590 534 LGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML-GPIDLEML 611 (689)
Q Consensus 534 FGls~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~-g~~~~e~~ 611 (689)
||++...... .....+++.|+|||++.+..++.++|+|||||++|+|++|+.||...........+.... +.......
T Consensus 148 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (333)
T cd06650 148 FGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227 (333)
T ss_pred CCcchhhhhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccccc
Confidence 9998754332 234578999999999999889999999999999999999999998765544332221111 00000000
Q ss_pred h-h----hhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCC
Q 005590 612 M-Q----GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686 (689)
Q Consensus 612 ~-~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~ 686 (689)
. . +.....+.......... ........... .........+.++++||.+||+.||++|||+.|+++||||+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~ 303 (333)
T cd06650 228 SPRPRPPGRPLSSYGPDSRPPMAI---FELLDYIVNEP-PPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIK 303 (333)
T ss_pred CcccCCccchhhhhcccccccccH---HHHHHHHhcCC-CccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHh
Confidence 0 0 00000000000000000 00000000000 00000112356789999999999999999999999999997
Q ss_pred CC
Q 005590 687 HP 688 (689)
Q Consensus 687 ~~ 688 (689)
..
T Consensus 304 ~~ 305 (333)
T cd06650 304 RS 305 (333)
T ss_pred cC
Confidence 64
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=347.34 Aligned_cols=253 Identities=22% Similarity=0.366 Sum_probs=203.4
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
.++|++.+.||+|+||.||++++..+++.+|+|++.+.. .....+.+|+.+++.+ .||||+++++++...
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~------~hp~iv~~~~~~~~~ 115 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA------NSPWVVQLFCAFQDD 115 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC------CCCCEeeEEEEEEcC
Confidence 478999999999999999999999999999999987532 1223455677777655 478999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEec
Q 005590 456 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 534 (689)
Q Consensus 456 ~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DF 534 (689)
.++++||||+.+ +|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-------~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~--~~~~kL~DF 186 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY-------DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDK--HGHLKLADF 186 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECC--CCCEEEEec
Confidence 999999999974 677766432 2788899999999999999999999999999999999984 788999999
Q ss_pred CCcccccCC----ccccccCccccChhhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 005590 535 GSSCFQTDN----LCLYVQSRSYRAPEVIIGLP----YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 606 (689)
Q Consensus 535 Gls~~~~~~----~~~~~gt~~Y~APE~l~~~~----~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~ 606 (689)
|++...... ....+||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.+....+.+++....
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~-- 264 (370)
T cd05621 187 GTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN-- 264 (370)
T ss_pred ccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc--
Confidence 998765432 13457999999999997643 78899999999999999999999988776666555542111
Q ss_pred cHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCC--CcCHHHHHcCCC
Q 005590 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR--RPTAREALDHPW 684 (689)
Q Consensus 607 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~k--RpTa~ElL~hpw 684 (689)
...+|... ..+..+++||.+||+.++.+ |+|+.|+++|||
T Consensus 265 -------------------------------~~~~p~~~-------~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 265 -------------------------------SLNFPEDV-------EISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred -------------------------------ccCCCCcc-------cCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence 11112111 12456889999999866654 899999999999
Q ss_pred CCC
Q 005590 685 LQH 687 (689)
Q Consensus 685 f~~ 687 (689)
|+.
T Consensus 307 ~~~ 309 (370)
T cd05621 307 FKN 309 (370)
T ss_pred cCC
Confidence 975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=339.75 Aligned_cols=249 Identities=25% Similarity=0.416 Sum_probs=197.5
Q ss_pred cEEEEEEeccCCCCceEEEEEC---CCCcEEEEEEeecch-----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 453 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~---~tg~~vAvKii~~~~-----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~ 453 (689)
+|++.+.||+|+||+||++++. .+++.||+|++.+.. ........|+.+++.++ .|++|+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~~i~~~~~~~~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR-----QSPFLVTLHYAFQ 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhcc-----CCCCcccEEEEEe
Confidence 4899999999999999999863 478999999987532 22345667888888775 3689999999999
Q ss_pred eCCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEE
Q 005590 454 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 532 (689)
Q Consensus 454 ~~~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~ 532 (689)
..+.+++||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~--~~~~kl~ 147 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQRD------NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDS--EGHVVLT 147 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECC--CCCEEEe
Confidence 99999999999985 6766664322 2889999999999999999999999999999999999985 7889999
Q ss_pred ecCCcccccC----CccccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChH----HHHHHHHHhhc
Q 005590 533 DLGSSCFQTD----NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAV----VMILARIIGML 603 (689)
Q Consensus 533 DFGls~~~~~----~~~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~----~~~l~~i~~~~ 603 (689)
|||++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ......+..
T Consensus 148 DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-- 225 (332)
T cd05614 148 DFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-- 225 (332)
T ss_pred eCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc--
Confidence 9999875422 12235789999999999875 478899999999999999999999964321 111111110
Q ss_pred CCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCc-----CHHH
Q 005590 604 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TARE 678 (689)
Q Consensus 604 g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRp-----Ta~E 678 (689)
....+|. ..+..+.+||.+||+.||++|| ++++
T Consensus 226 ---------------------------------~~~~~~~---------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~ 263 (332)
T cd05614 226 ---------------------------------CDPPFPS---------FIGPEAQDLLHKLLRKDPKKRLGAGPQGASE 263 (332)
T ss_pred ---------------------------------CCCCCCC---------CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHH
Confidence 0011111 1345688999999999999999 8999
Q ss_pred HHcCCCCCC
Q 005590 679 ALDHPWLQH 687 (689)
Q Consensus 679 lL~hpwf~~ 687 (689)
+++||||+.
T Consensus 264 ~l~h~~~~~ 272 (332)
T cd05614 264 IKEHPFFKG 272 (332)
T ss_pred HHcCCCcCC
Confidence 999999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=323.38 Aligned_cols=252 Identities=35% Similarity=0.562 Sum_probs=202.7
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhH---hHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEE
Q 005590 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD---QSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 459 (689)
Q Consensus 383 Y~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~---~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~ 459 (689)
|++.+.||+|+||+||++++..+++.||+|++........ ...+|+.+++.++ |+||+++++++......+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~------~~~i~~~~~~~~~~~~~~ 74 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLR------HPNIVQILDVFQDDNYLY 74 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHT------BTTBCHEEEEEEESSEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccc------cccccccccccccccccc
Confidence 8999999999999999999999999999999987643322 2345888888884 679999999999999999
Q ss_pred EEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcc
Q 005590 460 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 460 lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 538 (689)
+||||+.+ +|.+++.... .+++..+..++.||+.||.+||+.||+|+||||+||+++ .++.++|+|||.+.
T Consensus 75 ~v~~~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~--~~~~~~l~Dfg~~~ 146 (260)
T PF00069_consen 75 IVMEYCPGGSLQDYLQKNK------PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLD--ENGEVKLIDFGSSV 146 (260)
T ss_dssp EEEEEETTEBHHHHHHHHS------SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEES--TTSEEEESSGTTTE
T ss_pred ccccccccccccccccccc------ccccccccccccccccccccccccccccccccccccccc--cccccccccccccc
Confidence 99999997 7887776222 288999999999999999999999999999999999999 48889999999987
Q ss_pred cc---cCCccccccCccccChhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 539 FQ---TDNLCLYVQSRSYRAPEVII-GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 539 ~~---~~~~~~~~gt~~Y~APE~l~-~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
.. ........++..|+|||++. +..++.++|+||||+++|+|++|..||...........+...........
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 222 (260)
T PF00069_consen 147 KLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS---- 222 (260)
T ss_dssp ESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc----
Confidence 52 22334467899999999998 78899999999999999999999999987733333333221111000000
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
.. ........+.+||.+||+.||++|||+.++++||||
T Consensus 223 --------------------------~~-------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 223 --------------------------SQ-------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp --------------------------TT-------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred --------------------------cc-------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 00 000011568899999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=346.37 Aligned_cols=253 Identities=23% Similarity=0.346 Sum_probs=204.9
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
.++|++.+.||+|+||.||++++..+++.||+|++.... .....+.+|+.+++.+ .||||+++++++...
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~------~h~~iv~~~~~~~~~ 115 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA------NSEWIVQLHYAFQDD 115 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC------CCCCcceEEEEEecC
Confidence 468999999999999999999999999999999997532 2223455677777766 478999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEec
Q 005590 456 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 534 (689)
Q Consensus 456 ~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DF 534 (689)
.+.++||||+.+ +|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~--~~~~kL~Df 186 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNY-------DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK--SGHLKLADF 186 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcC--CCCEEEEec
Confidence 999999999975 676665421 2788899999999999999999999999999999999984 789999999
Q ss_pred CCcccccCC----ccccccCccccChhhhcCC----CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 005590 535 GSSCFQTDN----LCLYVQSRSYRAPEVIIGL----PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 606 (689)
Q Consensus 535 Gls~~~~~~----~~~~~gt~~Y~APE~l~~~----~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~ 606 (689)
|++...... ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 187 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-- 264 (370)
T cd05596 187 GTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN-- 264 (370)
T ss_pred cceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC--
Confidence 998765432 2245789999999998754 378899999999999999999999988776665555531100
Q ss_pred cHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCC--CcCHHHHHcCCC
Q 005590 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR--RPTAREALDHPW 684 (689)
Q Consensus 607 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~k--RpTa~ElL~hpw 684 (689)
...+|... ..+.++++||++||+.+|.+ |+|++|+++|||
T Consensus 265 -------------------------------~~~~~~~~-------~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~ 306 (370)
T cd05596 265 -------------------------------SLTFPDDI-------EISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF 306 (370)
T ss_pred -------------------------------cCCCCCcC-------CCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence 01112111 13467899999999999998 999999999999
Q ss_pred CCC
Q 005590 685 LQH 687 (689)
Q Consensus 685 f~~ 687 (689)
|+.
T Consensus 307 ~~~ 309 (370)
T cd05596 307 FKN 309 (370)
T ss_pred cCC
Confidence 975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.32 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=203.9
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|.+.+.||+|+||+||++++..+|+.||+|+++.... ....+.+|+.+++.+ .|++|+++++++...+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~------~~~~i~~~~~~~~~~~ 74 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS------NSPWIPQLQYAFQDKD 74 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC------CCCCCcceeeEEecCC
Confidence 479999999999999999999999999999999986432 334455666666654 4789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
+.++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~--~~~~kL~Dfg 147 (330)
T cd05601 75 NLYLVMEYQPGGDLLSLLNRYE-----DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDR--TGHIKLADFG 147 (330)
T ss_pred eEEEEECCCCCCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECC--CCCEEeccCC
Confidence 99999999974 6777765432 13889999999999999999999999999999999999984 7889999999
Q ss_pred CcccccCCc----cccccCccccChhhhc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 005590 536 SSCFQTDNL----CLYVQSRSYRAPEVII------GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 605 (689)
Q Consensus 536 ls~~~~~~~----~~~~gt~~Y~APE~l~------~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~ 605 (689)
++....... ....+|+.|+|||++. ...++.++|||||||++|+|++|..||...+....+..+.....
T Consensus 148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~- 226 (330)
T cd05601 148 SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR- 226 (330)
T ss_pred CCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC-
Confidence 987654322 2246899999999987 45678999999999999999999999987766655555431100
Q ss_pred CcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 606 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 606 ~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
...+|.. ...+..+.+||++||+ +|.+|||+.++++||||
T Consensus 227 --------------------------------~~~~~~~-------~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~ 266 (330)
T cd05601 227 --------------------------------FLKFPED-------PKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFF 266 (330)
T ss_pred --------------------------------ccCCCCC-------CCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCc
Confidence 0011111 1134668899999998 99999999999999999
Q ss_pred CC
Q 005590 686 QH 687 (689)
Q Consensus 686 ~~ 687 (689)
+.
T Consensus 267 ~~ 268 (330)
T cd05601 267 SK 268 (330)
T ss_pred CC
Confidence 85
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=326.18 Aligned_cols=278 Identities=31% Similarity=0.512 Sum_probs=222.1
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
+|++.+.||.|++|.||+|.+..+|+.||+|++.... .....+.+|+.+++.++ |+||+++++++......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~~~ 74 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQ------HPYVVKLLDVFPHGSGF 74 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCC------CCCCcceeeEEecCCee
Confidence 5899999999999999999999999999999987542 23456777888887774 78999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcc
Q 005590 459 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 459 ~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 538 (689)
++||||+.++|.+++.... ..+++..++.++.||+.||.|||+.|++|+||||+||+++. ++.++|+|||.+.
T Consensus 75 ~~v~e~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~--~~~~~l~dfg~~~ 147 (286)
T cd07832 75 VLVMEYMPSDLSEVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISA--DGVLKIADFGLAR 147 (286)
T ss_pred EEEecccCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcC--CCcEEEeeeeecc
Confidence 9999999778888775433 23889999999999999999999999999999999999985 7889999999887
Q ss_pred cccCC----ccccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 005590 539 FQTDN----LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 539 ~~~~~----~~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
..... .....++..|+|||.+.+. .++.++|||||||++|+|++|.+||.+......+..+...++.+....+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07832 148 LFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPG 227 (286)
T ss_pred cccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhh
Confidence 65432 2335678899999998754 468999999999999999999999998888888888888888777666654
Q ss_pred hhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCC
Q 005590 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686 (689)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~ 686 (689)
......+-. ..........+.......+..+.+||.+||+.||++|||++++|+||||.
T Consensus 228 ~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 228 LTSLPDYNK--------------ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred ccCcchhhc--------------ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 333322110 00000001111222223457789999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=347.16 Aligned_cols=283 Identities=24% Similarity=0.346 Sum_probs=215.0
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEEC--CCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005590 376 NTVIAGRYYVTEYLGSAAFSKVFQAQDL--HTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 453 (689)
Q Consensus 376 ~~~l~~rY~i~~~LG~G~fG~Vyla~d~--~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~ 453 (689)
..++..+|.+++.||.|+||.||++... .+++.||+|.+.... ...+|+++++.++ |+||+++++++.
T Consensus 87 ~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~----~~~~E~~il~~l~------h~~iv~~~~~~~ 156 (392)
T PHA03207 87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----TPGREIDILKTIS------HRAIINLIHAYR 156 (392)
T ss_pred chhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc----cHHHHHHHHHhcC------CCCccceeeeEe
Confidence 3455678999999999999999999753 456889999887543 3457899998875 689999999999
Q ss_pred eCCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEe
Q 005590 454 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 533 (689)
Q Consensus 454 ~~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~D 533 (689)
.....++|||++.++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.++|+|
T Consensus 157 ~~~~~~lv~e~~~~~l~~~l~~~------~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~--~~~~~l~D 228 (392)
T PHA03207 157 WKSTVCMVMPKYKCDLFTYVDRS------GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDE--PENAVLGD 228 (392)
T ss_pred eCCEEEEEehhcCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcC--CCCEEEcc
Confidence 99999999999999888877322 23899999999999999999999999999999999999984 78899999
Q ss_pred cCCcccccCC-----ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---hHHHHHHHHHhhcCC
Q 005590 534 LGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND---AVVMILARIIGMLGP 605 (689)
Q Consensus 534 FGls~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~---~~~~~l~~i~~~~g~ 605 (689)
||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+. .....+..+.+.++.
T Consensus 229 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~ 308 (392)
T PHA03207 229 FGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQV 308 (392)
T ss_pred CccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhcc
Confidence 9998764432 12357899999999999999999999999999999999999999654 234556666666665
Q ss_pred CcHHHHhhhh-hhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCC
Q 005590 606 IDLEMLMQGQ-EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 684 (689)
Q Consensus 606 ~~~e~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpw 684 (689)
.+.+...... ...+.+.... ......+.+|.. + .....+..+.+||++||+.||++|||+.|+|.|||
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~--~--~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~ 377 (392)
T PHA03207 309 HPLEFPQNGSTNLCKHFKQYA-------IVLRPPYTIPPV--I--RKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL 377 (392)
T ss_pred CccccCCccchhHHHHHHhhc-------ccccCCccccch--h--hccCcchhHHHHHHHHhccChhhCCCHHHHhhCch
Confidence 5443221110 0111111000 000000111111 0 01123456889999999999999999999999999
Q ss_pred CCC
Q 005590 685 LQH 687 (689)
Q Consensus 685 f~~ 687 (689)
|++
T Consensus 378 f~~ 380 (392)
T PHA03207 378 FTK 380 (392)
T ss_pred hhc
Confidence 985
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=341.46 Aligned_cols=244 Identities=25% Similarity=0.388 Sum_probs=196.6
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEE
Q 005590 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 462 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVm 462 (689)
+.||+|+||+||++++..+|+.||+|++.... ........|+++++.+ .|+||+++++++...+.+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~------~hp~i~~~~~~~~~~~~~~lv~ 74 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS------RHPFLTALKYSFQTHDRLCFVM 74 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC------CCCCCCceEEEEEcCCEEEEEE
Confidence 36899999999999999999999999997642 2233445566666554 4789999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEeccCCCeEEEEecCCcccc
Q 005590 463 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 540 (689)
Q Consensus 463 Ey~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~-~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~ 540 (689)
||+.+ +|...+... ..+++..++.++.||+.||.|||+ .||+||||||+|||++. ++.+||+|||++...
T Consensus 75 E~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~--~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 75 EYANGGELFFHLSRE------RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK--DGHIKITDFGLCKEG 146 (325)
T ss_pred eCCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECC--CCCEEEecCCCCeec
Confidence 99986 555544322 138899999999999999999997 79999999999999984 788999999998643
Q ss_pred c---CCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhh
Q 005590 541 T---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 617 (689)
Q Consensus 541 ~---~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~ 617 (689)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~--------------- 211 (325)
T cd05594 147 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--------------- 211 (325)
T ss_pred CCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC---------------
Confidence 2 2223457899999999999999999999999999999999999999877655544443210
Q ss_pred hhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCc-----CHHHHHcCCCCCCC
Q 005590 618 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQHP 688 (689)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRp-----Ta~ElL~hpwf~~~ 688 (689)
...+|. ..++.+.+||++||+.||++|+ ++.++++||||.+.
T Consensus 212 --------------------~~~~p~---------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 212 --------------------EIRFPR---------TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred --------------------CCCCCC---------CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 011111 1346688999999999999997 99999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=337.31 Aligned_cols=244 Identities=26% Similarity=0.415 Sum_probs=196.1
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEE
Q 005590 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 462 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVm 462 (689)
+.||+|+||+||+|++..+++.||+|+++.+.. .......|..++..+ ..||||+++++++....+.++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~hp~i~~~~~~~~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-----WEHPFLTHLFCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhc-----cCCCCccceeeEEEcCCEEEEEE
Confidence 368999999999999999999999999986431 223334455554433 35899999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccccc
Q 005590 463 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 541 (689)
Q Consensus 463 Ey~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~ 541 (689)
||+.+ +|..++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++....
T Consensus 76 e~~~gg~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~--~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 76 EYLNGGDLMFHIQSSG------RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK--DGHIKIADFGMCKENM 147 (316)
T ss_pred cCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECC--CCCEEEccCcCCeECC
Confidence 99975 5665554322 2889999999999999999999999999999999999984 7889999999987532
Q ss_pred C---CccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhh
Q 005590 542 D---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 618 (689)
Q Consensus 542 ~---~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~ 618 (689)
. .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-------------- 213 (316)
T cd05592 148 NGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRP-------------- 213 (316)
T ss_pred CCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence 2 22345789999999999999999999999999999999999999988776665555431110
Q ss_pred hhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCH-HHHHcCCCCCC
Q 005590 619 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA-REALDHPWLQH 687 (689)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa-~ElL~hpwf~~ 687 (689)
.+|. ..+..+.+||.+||+.||++||++ .++++||||..
T Consensus 214 ---------------------~~~~---------~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 214 ---------------------HFPR---------WISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred ---------------------CCCC---------CCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCC
Confidence 1111 124567899999999999999986 58889999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=337.07 Aligned_cols=244 Identities=26% Similarity=0.421 Sum_probs=199.4
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEE
Q 005590 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 462 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVm 462 (689)
+.||+|+||+||+|++..+++.||||++++.. ........|.++++.+. .|+||+++++++...+++++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-----~h~~i~~~~~~~~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-----KHPFLTQLHSCFQTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhcc-----CCCCccceeeEEEcCCEEEEEE
Confidence 36899999999999999999999999998642 23345566777776664 4889999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccccc
Q 005590 463 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 541 (689)
Q Consensus 463 Ey~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~ 541 (689)
||+.+ +|...+.... .+++..+..++.||+.||.|||+.||+||||||+|||++. ++.++|+|||++....
T Consensus 76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~~ 147 (318)
T cd05570 76 EYVNGGDLMFHIQRSG------RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDS--EGHIKIADFGMCKEGI 147 (318)
T ss_pred cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECC--CCcEEecccCCCeecC
Confidence 99985 5655544321 2889999999999999999999999999999999999985 7889999999886421
Q ss_pred ---CCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhh
Q 005590 542 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 618 (689)
Q Consensus 542 ---~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~ 618 (689)
......++++.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+.......+...
T Consensus 148 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~---------------- 211 (318)
T cd05570 148 LGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED---------------- 211 (318)
T ss_pred cCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC----------------
Confidence 2223457899999999999999999999999999999999999999887665555444210
Q ss_pred hhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCH-----HHHHcCCCCCC
Q 005590 619 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA-----REALDHPWLQH 687 (689)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa-----~ElL~hpwf~~ 687 (689)
...+|. ..+..+.+||++||+.||.+|||+ .++++||||+.
T Consensus 212 -------------------~~~~~~---------~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 212 -------------------EVRYPR---------WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred -------------------CCCCCC---------cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 001111 134568899999999999999999 99999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=336.13 Aligned_cols=244 Identities=28% Similarity=0.447 Sum_probs=196.9
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEE
Q 005590 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 462 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVm 462 (689)
+.||+|+||+||+|++..+++.||||+++... ........|..++..+ ..||||+++++++...+++++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~hp~iv~~~~~~~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-----WEHPFLTHLYCTFQTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhc-----cCCCcCcceEEEEEeCCEEEEEE
Confidence 36899999999999999999999999998642 2223444555555543 35899999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccccc
Q 005590 463 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 541 (689)
Q Consensus 463 Ey~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~ 541 (689)
||+.+ +|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++....
T Consensus 76 ey~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~--~~~~kl~Dfg~~~~~~ 147 (316)
T cd05619 76 EYLNGGDLMFHIQSCH------KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDT--DGHIKIADFGMCKENM 147 (316)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECC--CCCEEEccCCcceECC
Confidence 99985 6766665322 2788999999999999999999999999999999999985 7789999999986432
Q ss_pred ---CCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhh
Q 005590 542 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 618 (689)
Q Consensus 542 ---~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~ 618 (689)
.......||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+....+...
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~---------------- 211 (316)
T cd05619 148 LGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD---------------- 211 (316)
T ss_pred CCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----------------
Confidence 2233457899999999999999999999999999999999999999877665555443210
Q ss_pred hhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHH-HHHcCCCCCC
Q 005590 619 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR-EALDHPWLQH 687 (689)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~-ElL~hpwf~~ 687 (689)
...+|. ..+..+.+||.+||+.||++||++. ++++||||+.
T Consensus 212 -------------------~~~~~~---------~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05619 212 -------------------NPCYPR---------WLTREAKDILVKLFVREPERRLGVKGDIRQHPFFRE 253 (316)
T ss_pred -------------------CCCCCc---------cCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCC
Confidence 001111 1235678999999999999999996 8999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=343.73 Aligned_cols=252 Identities=21% Similarity=0.362 Sum_probs=203.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|++++.||+|+||+||++++..+++.||||+++... .....+.+|+.++..+ +|++|+++++.+...+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~iv~~~~~~~~~~ 74 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA------DGAWVVKMFYSFQDKR 74 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC------CCCCEeeEEEEEEcCC
Confidence 46899999999999999999999999999999997532 2334556677777665 4789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
++++||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||||+. ++.++|+|||
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~--~~~vkL~DfG 146 (360)
T cd05627 75 NLYLIMEFLPGGDMMTLLMKKD------TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDA--KGHVKLSDFG 146 (360)
T ss_pred EEEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC--CCCEEEeecc
Confidence 99999999985 6777665322 2889999999999999999999999999999999999984 7889999999
Q ss_pred CcccccCC--------------------------------------ccccccCccccChhhhcCCCCCchhhHHHHHHHH
Q 005590 536 SSCFQTDN--------------------------------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 577 (689)
Q Consensus 536 ls~~~~~~--------------------------------------~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil 577 (689)
++...... ....+||+.|+|||++.+..++.++|||||||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil 226 (360)
T cd05627 147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (360)
T ss_pred CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence 87543210 1134789999999999999999999999999999
Q ss_pred HHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHH
Q 005590 578 AELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAF 657 (689)
Q Consensus 578 ~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~ 657 (689)
|+|++|..||.+.+.......+.... ....+|... ..+..
T Consensus 227 yel~tG~~Pf~~~~~~~~~~~i~~~~---------------------------------~~~~~p~~~-------~~s~~ 266 (360)
T cd05627 227 YEMLIGYPPFCSETPQETYRKVMNWK---------------------------------ETLVFPPEV-------PISEK 266 (360)
T ss_pred eecccCCCCCCCCCHHHHHHHHHcCC---------------------------------CceecCCCC-------CCCHH
Confidence 99999999998877766655543110 011122111 13456
Q ss_pred HHHHHHHhcccCCCCCc---CHHHHHcCCCCCC
Q 005590 658 FIDFVRTLLEINPQRRP---TAREALDHPWLQH 687 (689)
Q Consensus 658 l~dLI~~mL~~dP~kRp---Ta~ElL~hpwf~~ 687 (689)
+++||.+|+ .||.+|+ ++.|+++||||++
T Consensus 267 ~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 267 AKDLILRFC-TDSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred HHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCC
Confidence 889999987 4999998 4899999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=326.08 Aligned_cols=278 Identities=27% Similarity=0.423 Sum_probs=215.6
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
++|++.+.||+|++|.||++++..+++.||+|.+..... ......+|+.+++.++ |+||+++++++...++.
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~ 78 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK------HANIVTLHDIIHTKKTL 78 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCC------CcceeeEEEEEecCCeE
Confidence 689999999999999999999998999999999875421 2234567888888775 67999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcc
Q 005590 459 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 459 ~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 538 (689)
++||||+.++|.+++..... .+++..++.++.||+.||.|||+.||+||||||+||+++. ++.++|+|||++.
T Consensus 79 ~lv~e~~~~~L~~~~~~~~~-----~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~--~~~~kl~dfg~~~ 151 (291)
T cd07844 79 TLVFEYLDTDLKQYMDDCGG-----GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISE--RGELKLADFGLAR 151 (291)
T ss_pred EEEEecCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcC--CCCEEECcccccc
Confidence 99999999988877653321 3789999999999999999999999999999999999985 7789999999986
Q ss_pred cccCC---ccccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCh-HHHHHHHHHhhcCCCcHHHHhh
Q 005590 539 FQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDA-VVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 539 ~~~~~---~~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG~~PF~~~~-~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
..... .....++..|+|||++.+ ..++.++|+||+||++|+|++|..||.... ..+.+..+...++.+..+.+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07844 152 AKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPG 231 (291)
T ss_pred ccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhh
Confidence 54321 222346788999999876 458899999999999999999999997654 5566677777777766666554
Q ss_pred hhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCc--HHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSD--AFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~--~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
......+...... ......+........ ..+.++|.+||+.+|++|||+.|+|+||||
T Consensus 232 ~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 232 VSSNPEFKPYSFP--------------FYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hhhcccccccccc--------------ccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 4332221111000 000001111111122 567899999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=326.17 Aligned_cols=283 Identities=29% Similarity=0.460 Sum_probs=219.3
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~---~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
++|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+|+.+++.+.+ |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~-----~~~i~~~~~~~~~~~~ 75 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSE-----SIYIVRLLDVEHVEEK 75 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccC-----CCCccceeeeEeecCC
Confidence 479999999999999999999999999999999875422 23466788988888853 5799999999987665
Q ss_pred -----EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEE
Q 005590 458 -----LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 532 (689)
Q Consensus 458 -----l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~ 532 (689)
.++||||+.+++.+++...... ....+++..++.++.||+.||.|||+.||+||||||+||+++. .++.++|+
T Consensus 76 ~~~~~~~lv~e~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~-~~~~~kl~ 153 (295)
T cd07837 76 NGKPSLYLVFEYLDSDLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK-QKGLLKIA 153 (295)
T ss_pred CCCceEEEEeeccCcCHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEec-CCCeEEEe
Confidence 8999999999988887644322 1234899999999999999999999999999999999999984 36789999
Q ss_pred ecCCcccccCCc---cccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcH
Q 005590 533 DLGSSCFQTDNL---CLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 608 (689)
Q Consensus 533 DFGls~~~~~~~---~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~ 608 (689)
|||++....... ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+....+.++...++.++.
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (295)
T cd07837 154 DLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE 233 (295)
T ss_pred ecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 999987543321 22356788999999865 45789999999999999999999999988777777777777666655
Q ss_pred HHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCC
Q 005590 609 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686 (689)
Q Consensus 609 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~ 686 (689)
..+........+..- ....+ ..........+..+.+||.+||..||.+|||+.|+|.||||+
T Consensus 234 ~~~~~~~~~~~~~~~--------------~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 234 QVWPGVSKLRDWHEF--------------PQWKP--QDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhCcchhhccchhhc--------------Ccccc--hhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 554433222211100 00000 001111123456789999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=334.93 Aligned_cols=249 Identities=24% Similarity=0.369 Sum_probs=202.9
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
+|++.+.||+|+||+||+|+++.+|+.||+|++..+. ........|..++..+. .|++|+++++++...+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----~~~~i~~~~~~~~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD-----KPPFLTQLHSCFQTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc-----CCCchhheeeEEecCCE
Confidence 4788999999999999999999999999999998642 22344556777766554 35689999999999999
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 458 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 458 l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
+++||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~--~~~ikL~Dfg~ 147 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVG------KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS--EGHIKIADFGM 147 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC--CCCEEEecccc
Confidence 9999999985 6666554322 2889999999999999999999999999999999999985 78899999999
Q ss_pred cccccC---CccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 005590 537 SCFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 537 s~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
+..... ......||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+....
T Consensus 148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~---------- 217 (323)
T cd05615 148 CKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN---------- 217 (323)
T ss_pred ccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence 865322 2234568999999999999999999999999999999999999998877666655553111
Q ss_pred hhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcC-----HHHHHcCCCCCC
Q 005590 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPWLQH 687 (689)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT-----a~ElL~hpwf~~ 687 (689)
..+|. ..+..+.+||.+||+.||.+|++ ..++++||||+.
T Consensus 218 -------------------------~~~p~---------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 218 -------------------------VSYPK---------SLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred -------------------------CCCCc---------cCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCC
Confidence 01111 12356789999999999999997 589999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=337.21 Aligned_cols=253 Identities=21% Similarity=0.340 Sum_probs=194.6
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEE
Q 005590 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 462 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVm 462 (689)
+.||+|+||+||++++..+++.||+|+++... .....+.+|..+++.+. +||||++++++|.....+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~-----~hp~Iv~~~~~~~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS-----NHPFLVGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc-----CCCCCCceEEEEEcCCEEEEEE
Confidence 36899999999999999999999999998642 22345667777777664 4789999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccc-
Q 005590 463 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ- 540 (689)
Q Consensus 463 Ey~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~- 540 (689)
||+.+ +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 76 e~~~~g~L~~~~~~~------~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~--~~~~kL~Dfg~~~~~~ 147 (329)
T cd05588 76 EFVSGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA--EGHIKLTDYGMCKEGI 147 (329)
T ss_pred eCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC--CCCEEECcCccccccc
Confidence 99986 565555432 12899999999999999999999999999999999999985 788999999998642
Q ss_pred --cCCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhh
Q 005590 541 --TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 618 (689)
Q Consensus 541 --~~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~ 618 (689)
.......+||+.|+|||++.+..++.++|+|||||++|+|++|+.||......... .....+. ..
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~-------~~~~~~~------~~ 214 (329)
T cd05588 148 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP-------DQNTEDY------LF 214 (329)
T ss_pred cCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccc-------cccchHH------HH
Confidence 22334467899999999999999999999999999999999999999632110000 0000000 00
Q ss_pred hhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcC------HHHHHcCCCCCC
Q 005590 619 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT------AREALDHPWLQH 687 (689)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT------a~ElL~hpwf~~ 687 (689)
+.. ......+|. ..+..+.+||++||+.||.+|+| +.++++||||..
T Consensus 215 ~~~-------------~~~~~~~p~---------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 215 QVI-------------LEKQIRIPR---------SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHH-------------HcCCCCCCC---------CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 000 000111221 23456889999999999999997 799999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.58 Aligned_cols=279 Identities=32% Similarity=0.465 Sum_probs=219.6
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh------hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD------FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~------~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
+|++.+.||.|++|.||+|.+..+++.||+|.++.... ....+..|+.+++.++ |+||+++++++...
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~------h~~i~~~~~~~~~~ 74 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK------HPNIIGLLDVFGHK 74 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC------CCCChhhhheeecC
Confidence 58899999999999999999999999999999976432 1234456777777664 78999999999999
Q ss_pred CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 456 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 456 ~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
+..++||||+.++|.+++.... ..+++..+..++.||++||.|||+.||+|+||||+||+++. ++.++|+|||
T Consensus 75 ~~~~lv~e~~~~~L~~~i~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~--~~~~~l~dfg 147 (298)
T cd07841 75 SNINLVFEFMETDLEKVIKDKS-----IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIAS--DGVLKLADFG 147 (298)
T ss_pred CEEEEEEcccCCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcC--CCCEEEccce
Confidence 9999999999778888775432 13889999999999999999999999999999999999995 7889999999
Q ss_pred CcccccCC---ccccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 005590 536 SSCFQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 611 (689)
Q Consensus 536 ls~~~~~~---~~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~ 611 (689)
++...... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+....+.+.++...++.+...++
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (298)
T cd07841 148 LARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENW 227 (298)
T ss_pred eeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhh
Confidence 98765432 223356788999999865 45789999999999999999999999888877778888777777666665
Q ss_pred hhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCCCC
Q 005590 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHPY 689 (689)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~~~ 689 (689)
........+... ...............+..+++||.+||++||++|||+.|+|+||||++.+
T Consensus 228 ~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 228 PGVTSLPDYVEF----------------KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred hhcccccccccc----------------cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 543332221110 00001111112223356789999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=330.27 Aligned_cols=287 Identities=29% Similarity=0.491 Sum_probs=216.9
Q ss_pred cEEEEEEeccCCCCceEEEEECC--CCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLH--TGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~--tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
+|++.++||+|+||.||+|++.. +++.||+|++.... .......+|+.+++.++ ||||+++++++...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~ 74 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK------HENVVSLVEVFLEH 74 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC------CCCccceEEEEeCC
Confidence 58999999999999999999988 89999999998632 23356677888888774 68999999999988
Q ss_pred --CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec--cCCCeEEE
Q 005590 456 --EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS--YQRCEIKI 531 (689)
Q Consensus 456 --~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~--~~~~~vkL 531 (689)
..+++||||+++++.+++....... ...+++..++.++.||+.||.|||+.+|+||||||+||+++. ..++.+||
T Consensus 75 ~~~~~~lv~e~~~~~l~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl 153 (316)
T cd07842 75 ADKSVYLLFDYAEHDLWQIIKFHRQAK-RVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKI 153 (316)
T ss_pred CCceEEEEEeCCCcCHHHHHHhhccCC-CcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEE
Confidence 8899999999998888776443322 234899999999999999999999999999999999999984 12688999
Q ss_pred EecCCcccccCCcc------ccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChH---------HHH
Q 005590 532 IDLGSSCFQTDNLC------LYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAV---------VMI 595 (689)
Q Consensus 532 ~DFGls~~~~~~~~------~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~---------~~~ 595 (689)
+|||++........ ...+++.|+|||++.+. .++.++|+|||||++|+|++|++||.+... ...
T Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 233 (316)
T cd07842 154 GDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ 233 (316)
T ss_pred CCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence 99999876543222 24668889999998764 588999999999999999999999975433 235
Q ss_pred HHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhh---ccCCcHHHHHHHHHhcccCCCC
Q 005590 596 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHH---LQFSDAFFIDFVRTLLEINPQR 672 (689)
Q Consensus 596 l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~---~~~~~~~l~dLI~~mL~~dP~k 672 (689)
+..+...++.++...+........+.... .. ......+. ..+... ....+..+.++|.+||+.||++
T Consensus 234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-------~~--~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~ 303 (316)
T cd07842 234 LERIFEVLGTPTEKDWPDIKKMPEYDTLM-------KD--FKTKTYPS-NSLAKWMEKHKKPDSQGFDLLRKLLEYDPTK 303 (316)
T ss_pred HHHHHHHhCCCchhHHHHHhhcccchhhh-------hh--ccCCCCCC-ccHHHHHHhccCCCHHHHHHHHHHhcCCccc
Confidence 66677777776666554333322211100 00 00001110 111111 1134567899999999999999
Q ss_pred CcCHHHHHcCCCC
Q 005590 673 RPTAREALDHPWL 685 (689)
Q Consensus 673 RpTa~ElL~hpwf 685 (689)
|||+.|+++||||
T Consensus 304 Rps~~eil~~~~f 316 (316)
T cd07842 304 RITAEEALEHPYF 316 (316)
T ss_pred CcCHHHHhcCCCC
Confidence 9999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=324.82 Aligned_cols=277 Identities=30% Similarity=0.464 Sum_probs=218.5
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
+|++++.||.|++|.||+|++..+|+.||||.+..+. .....+.+|+++++.++ |+||+++++++...+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~ 74 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN------HPNIVKLLDVIHTENKL 74 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcC------CCCCcchhhhcccCCcE
Confidence 4889999999999999999999999999999887542 12245677888888774 68999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcc
Q 005590 459 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 459 ~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 538 (689)
++||||+.++|.+++..... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++. ++.++|+|||++.
T Consensus 75 ~~v~e~~~~~l~~~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~--~~~~~l~dfg~~~ 148 (284)
T cd07860 75 YLVFEFLHQDLKKFMDASPL----SGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLAR 148 (284)
T ss_pred EEEeeccccCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEEeeccchh
Confidence 99999998888777654321 23889999999999999999999999999999999999985 7789999999986
Q ss_pred cccCCc---cccccCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 539 FQTDNL---CLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 539 ~~~~~~---~~~~gt~~Y~APE~l~~~~-~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
...... ....+++.|+|||++.+.. ++.++|+|||||++|+|+||+.||...+....+.++....+.++...+...
T Consensus 149 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07860 149 AFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 228 (284)
T ss_pred hcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhh
Confidence 543321 2235678899999987654 688999999999999999999999998888888888888887776665543
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
.....+... ..... ...........++.+++||.+||+.||++|||+.++|+||||
T Consensus 229 ~~~~~~~~~-------------~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 229 TSLPDYKPS-------------FPKWA--RQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hHHHHHHhh-------------ccccc--ccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 332211110 00000 000111112345678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=323.64 Aligned_cols=279 Identities=26% Similarity=0.388 Sum_probs=215.2
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
++|++.+.||+|+||.||+|.+..+|+.||+|++.... .......+|+.+++.+. |+||+++++++......
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~------h~ni~~~~~~~~~~~~~ 78 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK------HANIVLLHDIIHTKETL 78 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcC------CCCEeEEEEEEecCCeE
Confidence 68999999999999999999999999999999987542 22235567888888774 67999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcc
Q 005590 459 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 459 ~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 538 (689)
++||||+.+++++.+.... ..+++..++.++.||+.||.|||+.||+|+||||+||+++. ++.++|+|||++.
T Consensus 79 ~lv~e~~~~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~--~~~~~l~Dfg~~~ 151 (291)
T cd07870 79 TFVFEYMHTDLAQYMIQHP-----GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISY--LGELKLADFGLAR 151 (291)
T ss_pred EEEEecccCCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcC--CCcEEEecccccc
Confidence 9999999988877664322 12678889999999999999999999999999999999984 7889999999886
Q ss_pred cccCC---ccccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC-hHHHHHHHHHhhcCCCcHHHHhh
Q 005590 539 FQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPND-AVVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 539 ~~~~~---~~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~-~~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
..... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||... ...+.+.++...++.++..++..
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07870 152 AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG 231 (291)
T ss_pred ccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhh
Confidence 53322 2234568899999998764 5788999999999999999999999764 44567777777788777666655
Q ss_pred hhhhhhhhhccccchhhhhccccccccCCccc-hhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEES-SLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~-~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
......+...... ...+... ...... .....+.+||.+||..||++|||+.|++.||||
T Consensus 232 ~~~~~~~~~~~~~------------~~~~~~~~~~~~~~-~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 232 VSKLPNYKPEWFL------------PCKPQQLRVVWKRL-SRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhhcccccchhcc------------ccCCcchhhhcccc-CCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 4433322111000 0000000 000000 114568899999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=321.43 Aligned_cols=273 Identities=33% Similarity=0.513 Sum_probs=213.8
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC--CeE
Q 005590 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--EHL 458 (689)
Q Consensus 383 Y~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~--~~l 458 (689)
|++.+.||+|+||.||++++..+++.+|+|+++.... ......+|+.+++.+. +|+||+++++++.+. +.+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLS-----PHPNILRLIEVLFDRKTGRL 75 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcC-----CCCCccceEEEEecCCCCcE
Confidence 6789999999999999999999999999999875421 1223345666666553 478999999999987 899
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcc
Q 005590 459 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 459 ~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 538 (689)
++||||+.+++++.+.... ..+++..++.++.||+.||.|||+.|++||||+|+||+++. +.+||+|||++.
T Consensus 76 ~lv~e~~~~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~---~~~kl~dfg~~~ 147 (282)
T cd07831 76 ALVFELMDMNLYELIKGRK-----RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD---DILKLADFGSCR 147 (282)
T ss_pred EEEEecCCccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC---CCeEEEeccccc
Confidence 9999999998888765432 23889999999999999999999999999999999999984 889999999987
Q ss_pred cccCC--ccccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 005590 539 FQTDN--LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615 (689)
Q Consensus 539 ~~~~~--~~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~ 615 (689)
..... .....+++.|+|||.+.. ..++.++|+|||||++|+|++|..||.+.+..+.+..+...++.++..+.....
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 148 GIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred ccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhc
Confidence 65332 233467889999998754 457889999999999999999999999988888888888888877766522110
Q ss_pred hhhhhhhccccchhhhhccccccccCCc--cchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 616 EIYKYFTKEYDLYYINEETNQLEYIIPE--ESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
.. ......+|. ...........+..+++||.+||+.||++|||+.++++||||
T Consensus 228 ~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 228 KS-----------------RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cc-----------------ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 00 000111111 011111222346779999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=334.96 Aligned_cols=243 Identities=27% Similarity=0.421 Sum_probs=197.4
Q ss_pred EEeccCCCCceEEEEEC---CCCcEEEEEEeecch-----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 387 EYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~---~tg~~vAvKii~~~~-----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
+.||+|+||.||++++. .+++.||+|+++... .......+|+.+++.++ ||||++++++|...+..
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~------hp~iv~~~~~~~~~~~~ 75 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK------HPFIVDLIYAFQTGGKL 75 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC------CCchhceeeEEecCCeE
Confidence 67999999999999863 478899999997532 12234567888887764 78999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
++||||+.+ +|.+.+.... .+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~~ 147 (323)
T cd05584 76 YLILEYLSGGELFMHLEREG------IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDA--QGHVKLTDFGLC 147 (323)
T ss_pred EEEEeCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC--CCCEEEeeCcCC
Confidence 999999985 6666654322 2788899999999999999999999999999999999984 788999999998
Q ss_pred ccccC---CccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 538 CFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 538 ~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+....+..+....
T Consensus 148 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~----------- 216 (323)
T cd05584 148 KESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK----------- 216 (323)
T ss_pred eecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 64322 2233578999999999999889999999999999999999999998876665555443110
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCc-----CHHHHHcCCCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQH 687 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRp-----Ta~ElL~hpwf~~ 687 (689)
..+|. ..+..+.+||++||+.||++|| ++.++++||||..
T Consensus 217 ------------------------~~~~~---------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 217 ------------------------LNLPP---------YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred ------------------------CCCCC---------CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence 11111 1245688999999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=333.42 Aligned_cols=255 Identities=22% Similarity=0.336 Sum_probs=200.5
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|++.+.||+|+||+||++++..+++.||+|++.+.. .....+.+|+.+++.+ .|+||++++++|...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~~~~~~~ 74 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG------DRRWITNLHYAFQDEN 74 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC------CCCCCCceEEEEecCC
Confidence 47999999999999999999999999999999997532 2233455666666654 4789999999999999
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
++++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~--~~~~kl~Dfg 147 (331)
T cd05597 75 NLYLVMDYYVGGDLLTLLSKFE-----DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDK--NGHIRLADFG 147 (331)
T ss_pred eEEEEEecCCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECC--CCCEEEEECC
Confidence 9999999997 47777765322 12889999999999999999999999999999999999984 7889999999
Q ss_pred CcccccCCc----cccccCccccChhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 005590 536 SSCFQTDNL----CLYVQSRSYRAPEVIIG-----LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 606 (689)
Q Consensus 536 ls~~~~~~~----~~~~gt~~Y~APE~l~~-----~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~ 606 (689)
++....... ....||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 148 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~-- 225 (331)
T cd05597 148 SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-- 225 (331)
T ss_pred ceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--
Confidence 986543321 22468999999999973 4578899999999999999999999988766665555431100
Q ss_pred cHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCC--CcCHHHHHcCCC
Q 005590 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR--RPTAREALDHPW 684 (689)
Q Consensus 607 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~k--RpTa~ElL~hpw 684 (689)
...+|.. ....+..+++||++||..++++ |+++.++++|||
T Consensus 226 -------------------------------~~~~~~~------~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~ 268 (331)
T cd05597 226 -------------------------------HFQFPPD------VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268 (331)
T ss_pred -------------------------------cccCCCc------cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence 0011110 0113466889999999765544 889999999999
Q ss_pred CCC
Q 005590 685 LQH 687 (689)
Q Consensus 685 f~~ 687 (689)
|..
T Consensus 269 ~~~ 271 (331)
T cd05597 269 FEG 271 (331)
T ss_pred CCC
Confidence 975
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=326.38 Aligned_cols=280 Identities=26% Similarity=0.431 Sum_probs=215.8
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC-
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE- 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~- 456 (689)
++|++.+.||+|+||.||+|++..+++.||||++.... .......+|+.+++.++ ||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLK------HENVVNLIEICRTKAT 85 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCC------CCCccceEEEEecccc
Confidence 67999999999999999999999999999999986532 12234456788877774 679999999887543
Q ss_pred -------eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeE
Q 005590 457 -------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 529 (689)
Q Consensus 457 -------~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~v 529 (689)
..++||||+.+++.+++.... ..+++..++.++.||+.||.|||+.|++|+||||+||+++. ++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~--~~~~ 158 (310)
T cd07865 86 PYNRYKGSFYLVFEFCEHDLAGLLSNKN-----VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITK--DGIL 158 (310)
T ss_pred cccCCCceEEEEEcCCCcCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECC--CCcE
Confidence 469999999988877765322 23899999999999999999999999999999999999984 7889
Q ss_pred EEEecCCcccccCCc-------cccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHh
Q 005590 530 KIIDLGSSCFQTDNL-------CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 601 (689)
Q Consensus 530 kL~DFGls~~~~~~~-------~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~ 601 (689)
||+|||++....... ....++..|+|||.+.+. .++.++|+||||+++|+|++|.+||.+.+....+..+..
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~ 238 (310)
T cd07865 159 KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQ 238 (310)
T ss_pred EECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999986543221 124567889999998764 478899999999999999999999999888888888888
Q ss_pred hcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 602 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 602 ~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
..+.++.+++........+-.-.. . .......+. .+ .....+..+.+||.+||..||.+|||++|+|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~----~----~~~~~~~~~--~l--~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 239 LCGSITPEVWPGVDKLELFKKMEL----P----QGQKRKVKE--RL--KPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HhCCCChhhcccccchhhhhhccC----C----CccchhhHH--hc--ccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 888888877665533221110000 0 000000000 00 00112456789999999999999999999999
Q ss_pred CCCC
Q 005590 682 HPWL 685 (689)
Q Consensus 682 hpwf 685 (689)
||||
T Consensus 307 h~~f 310 (310)
T cd07865 307 HDFF 310 (310)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=326.05 Aligned_cols=254 Identities=24% Similarity=0.286 Sum_probs=202.1
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
.|++.++||+|+||+||++.+..+++.||+|++.... .......+|+.+++.++ |++|+++++++...++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~ 74 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN------SRFVVSLAYAYETKDA 74 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC------CCCEeeeeeeecCCCe
Confidence 4889999999999999999999999999999987532 11234567888887774 6799999999999999
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 458 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 458 l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
+++||||+.+ +|.+.+.... ...+++..+..++.||+.||.|||+.||+||||||+||+++. ++.++|+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~--~~~~~l~Dfg~ 148 (285)
T cd05605 75 LCLVLTLMNGGDLKFHIYNMG----NPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDD--YGHIRISDLGL 148 (285)
T ss_pred EEEEEeccCCCcHHHHHHhcC----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECC--CCCEEEeeCCC
Confidence 9999999985 5655543221 123889999999999999999999999999999999999984 78899999999
Q ss_pred cccccCC--ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 537 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 537 s~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
+...... .....+++.|+|||++.+..++.++|+||+||++|+|++|+.||.+.........+...+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~--------- 219 (285)
T cd05605 149 AVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE--------- 219 (285)
T ss_pred ceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh---------
Confidence 8765332 22357899999999999989999999999999999999999999876543333222111000
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCc-----CHHHHHcCCCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQH 687 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRp-----Ta~ElL~hpwf~~ 687 (689)
....++ ...+..+.+||.+||+.||.+|| +++++++||||..
T Consensus 220 ----------------------~~~~~~---------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 220 ----------------------DQEEYS---------EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred ----------------------cccccC---------cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 000011 11345688999999999999999 9999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=347.90 Aligned_cols=280 Identities=24% Similarity=0.308 Sum_probs=205.6
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
...+|.+.+.||+|+||.||++.+..+++.||||.... ....+|+++++.++ |+||+++++++...+..
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~------HpnIv~l~~~~~~~~~~ 235 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLS------HPAVLALLDVRVVGGLT 235 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCC------CCCCCcEEEEEEECCEE
Confidence 35689999999999999999999999999999996432 34568999998875 68999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcc
Q 005590 459 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 459 ~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 538 (689)
++|||++.++|.+++..... .+++..++.|+.||+.||.|||+.||+||||||+||||+. ++.+||+|||+++
T Consensus 236 ~lv~e~~~~~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~--~~~vkL~DFGla~ 308 (461)
T PHA03211 236 CLVLPKYRSDLYTYLGARLR-----PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNG--PEDICLGDFGAAC 308 (461)
T ss_pred EEEEEccCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECC--CCCEEEcccCCce
Confidence 99999999998887754321 3899999999999999999999999999999999999984 7789999999987
Q ss_pred cccCC-----ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC-CCC------hHHHHHHHHHhhcCCC
Q 005590 539 FQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLF-PND------AVVMILARIIGMLGPI 606 (689)
Q Consensus 539 ~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF-~~~------~~~~~l~~i~~~~g~~ 606 (689)
..... .....||+.|+|||++.+..++.++|||||||++|||++|..|+ ... .....+.+++...+..
T Consensus 309 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~ 388 (461)
T PHA03211 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVH 388 (461)
T ss_pred ecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccc
Confidence 64332 12356899999999999999999999999999999999987654 221 1112233333322211
Q ss_pred cHHHHhh-hhhhhhhhhccccchhhhhccccccccCCc-cchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCC
Q 005590 607 DLEMLMQ-GQEIYKYFTKEYDLYYINEETNQLEYIIPE-ESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 684 (689)
Q Consensus 607 ~~e~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~-~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpw 684 (689)
..+.-.. .......+. ... .....+. ....+..+...+..+.+||.+||+.||.+|||+.|||+|||
T Consensus 389 ~~~~~~~~~~~l~~~~~--------~~~---~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~ 457 (461)
T PHA03211 389 VDEFPQHAGSRLVSQYR--------HRA---ARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPL 457 (461)
T ss_pred cccCCCCcchHHHHHHH--------hhh---hcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcc
Confidence 1100000 000000000 000 0000110 00011112234567889999999999999999999999999
Q ss_pred CCC
Q 005590 685 LQH 687 (689)
Q Consensus 685 f~~ 687 (689)
|+.
T Consensus 458 f~~ 460 (461)
T PHA03211 458 FQS 460 (461)
T ss_pred cCC
Confidence 986
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=319.55 Aligned_cols=276 Identities=29% Similarity=0.467 Sum_probs=212.2
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
++|++.+.||+|++|.||+|.+..+|+.||+|++.... .....+.+|+.+++.++ |+||+++++++.....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~------h~~i~~~~~~~~~~~~ 74 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK------HPNLVNLIEVFRRKRK 74 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCC------CCCEeeeeeEEeeCCE
Confidence 47999999999999999999999999999999986532 12345667888888774 6799999999999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 458 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 458 l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
.++||||+++++++.+.... ..+++..++.++.||+.||.|||+.||+|+||||+||+++. ++.++|+|||++
T Consensus 75 ~~~v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~--~~~~~l~dfg~~ 147 (286)
T cd07847 75 LHLVFEYCDHTVLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITK--QGQIKLCDFGFA 147 (286)
T ss_pred EEEEEeccCccHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcC--CCcEEECccccc
Confidence 99999999987666554322 12889999999999999999999999999999999999984 778999999998
Q ss_pred ccccCCc---cccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 005590 538 CFQTDNL---CLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 538 ~~~~~~~---~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
....... ....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+....+.+..+...++.........
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07847 148 RILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227 (286)
T ss_pred eecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 7654332 23457889999999876 4578999999999999999999999998877777766665555443321111
Q ss_pred hhhhhhhhhccccchhhhhccccccccCCc---cchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPE---ESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~---~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
.. ...+... ...|. ...........+..+.+||.+||+.+|++|||+.|++.||||
T Consensus 228 ~~-~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 228 FS-TNQFFKG---------------LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cc-ccccccc---------------ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 00 0000000 00111 001111222345778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=322.90 Aligned_cols=281 Identities=28% Similarity=0.451 Sum_probs=219.4
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
++|++.+.||.|++|.||++++..+|+.||+|.+.... .....+.+|+.+++.++ |+||+++++++....+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~ 75 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ------HGNIVRLQDVVHSEKR 75 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhcc------CCCEeeEEEEEecCCe
Confidence 57999999999999999999999999999999986532 22345667888888774 6799999999999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 458 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 458 l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
.++||||+++++.+.+..... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++. .++.+||+|||++
T Consensus 76 ~~lv~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~-~~~~~kl~dfg~~ 150 (294)
T PLN00009 76 LYLVFEYLDLDLKKHMDSSPD----FAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR-RTNALKLADFGLA 150 (294)
T ss_pred EEEEEecccccHHHHHHhCCC----CCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC-CCCEEEEcccccc
Confidence 999999999888777653321 22678888999999999999999999999999999999984 3467999999998
Q ss_pred ccccCC---ccccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 005590 538 CFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 538 ~~~~~~---~~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
...... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|.+||......+.+.++...++.+....|..
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 151 RAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230 (294)
T ss_pred cccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 654322 2234568899999998764 578999999999999999999999998888777777777777766666554
Q ss_pred hhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
......+... .. ..+. ..........++++.+||.+||+.+|++||++.++|+||||+.
T Consensus 231 ~~~~~~~~~~-------------~~-~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 231 VTSLPDYKSA-------------FP-KWPP-KDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred cccchhhhhh-------------cc-cCCC-CCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 3332222110 00 0000 0111112234567899999999999999999999999999975
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=334.68 Aligned_cols=253 Identities=21% Similarity=0.328 Sum_probs=192.7
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEE
Q 005590 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 462 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVm 462 (689)
+.||+|+||+||+|++..+++.||+|++++.. .......+|+.++..+. .||||+++++++...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~-----~hp~iv~~~~~~~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-----NHPFLVGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcC-----CCCcCCceeeEEEeCCEEEEEE
Confidence 36899999999999999999999999998632 22344556776666553 4789999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccccc
Q 005590 463 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 541 (689)
Q Consensus 463 Ey~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~ 541 (689)
||+.+ +|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 76 E~~~~~~L~~~~~~~------~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~--~~~~kL~DfG~~~~~~ 147 (329)
T cd05618 76 EYVNGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGL 147 (329)
T ss_pred eCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECC--CCCEEEeeCCcccccc
Confidence 99986 555544322 23889999999999999999999999999999999999985 7889999999986532
Q ss_pred ---CCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhh
Q 005590 542 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 618 (689)
Q Consensus 542 ---~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~ 618 (689)
.......||+.|+|||++.+..++.++|+|||||++|+|++|..||........ +. ........
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-----------~~--~~~~~~~~ 214 (329)
T cd05618 148 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN-----------PD--QNTEDYLF 214 (329)
T ss_pred CCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCC-----------cc--cccHHHHH
Confidence 223346789999999999999999999999999999999999999952110000 00 00000000
Q ss_pred hhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcC------HHHHHcCCCCCC
Q 005590 619 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT------AREALDHPWLQH 687 (689)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT------a~ElL~hpwf~~ 687 (689)
+.. ......+|. ..+..+.+||++||+.||++||| +.++++||||+.
T Consensus 215 ~~i-------------~~~~~~~p~---------~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 215 QVI-------------LEKQIRIPR---------SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HHH-------------hcCCCCCCC---------CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 000 000111222 23456889999999999999998 589999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=334.35 Aligned_cols=244 Identities=24% Similarity=0.363 Sum_probs=193.7
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEE
Q 005590 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 462 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVm 462 (689)
+.||+|+||+||+|++..+|+.||+|++..... .......|..++. ....||||+++++.+...+..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~-----~~l~hp~iv~~~~~~~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLL-----KNVKHPFLVGLHYSFQTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHH-----hhCCCCCCCCeeEEEEeCCEEEEEE
Confidence 368999999999999999999999999975421 1122333333221 1235899999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccccc
Q 005590 463 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 541 (689)
Q Consensus 463 Ey~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~ 541 (689)
||+.+ +|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 76 e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~--~~~~kl~Dfg~~~~~~ 147 (323)
T cd05575 76 DYVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDS--QGHVVLTDFGLCKEGI 147 (323)
T ss_pred cCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECC--CCcEEEeccCCCcccc
Confidence 99986 5666554322 3889999999999999999999999999999999999984 7889999999986532
Q ss_pred ---CCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhh
Q 005590 542 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 618 (689)
Q Consensus 542 ---~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~ 618 (689)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--------------- 212 (323)
T cd05575 148 EHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP--------------- 212 (323)
T ss_pred cCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC---------------
Confidence 22334578999999999999999999999999999999999999998876666555443100
Q ss_pred hhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCH----HHHHcCCCCCC
Q 005590 619 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA----REALDHPWLQH 687 (689)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa----~ElL~hpwf~~ 687 (689)
..++ ...+..+.+||++||+.||.+||++ .++++||||..
T Consensus 213 --------------------~~~~---------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 213 --------------------LRLK---------PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred --------------------CCCC---------CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence 0011 0124568899999999999999998 69999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=340.18 Aligned_cols=254 Identities=22% Similarity=0.342 Sum_probs=202.8
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
..++|++.+.||+|+||.||++++..+++.+|+|++.... .....+.+|+.+++.+ .||||+++++++..
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~------~hp~iv~~~~~~~~ 114 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA------NSPWVVQLFYAFQD 114 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC------CCCCCCeEEEEEEc
Confidence 3478999999999999999999999999999999987522 1223455667776655 47899999999999
Q ss_pred CCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEe
Q 005590 455 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 533 (689)
Q Consensus 455 ~~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~D 533 (689)
..++++||||+.+ +|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~--~~~ikL~D 185 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK--SGHLKLAD 185 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECC--CCCEEEEe
Confidence 9999999999975 677666422 2788899999999999999999999999999999999984 78899999
Q ss_pred cCCcccccCC----ccccccCccccChhhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 005590 534 LGSSCFQTDN----LCLYVQSRSYRAPEVIIGLP----YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 605 (689)
Q Consensus 534 FGls~~~~~~----~~~~~gt~~Y~APE~l~~~~----~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~ 605 (689)
||++...... ....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+......++......
T Consensus 186 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 265 (371)
T cd05622 186 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 265 (371)
T ss_pred CCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc
Confidence 9998765432 22457999999999997643 788999999999999999999999987776666555421110
Q ss_pred CcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCC--CcCHHHHHcCC
Q 005590 606 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR--RPTAREALDHP 683 (689)
Q Consensus 606 ~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~k--RpTa~ElL~hp 683 (689)
..+|.. ...+..+++||.+||..++.+ |+++.|+++||
T Consensus 266 ---------------------------------~~~~~~-------~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 266 ---------------------------------LTFPDD-------NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ---------------------------------ccCCCc-------CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111211 123466889999999854443 78999999999
Q ss_pred CCCC
Q 005590 684 WLQH 687 (689)
Q Consensus 684 wf~~ 687 (689)
||++
T Consensus 306 ~~~~ 309 (371)
T cd05622 306 FFKN 309 (371)
T ss_pred ccCC
Confidence 9975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=339.01 Aligned_cols=251 Identities=25% Similarity=0.325 Sum_probs=195.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
.+|+++++||+|+||.||++++..+++.||||++... ......+.+|+++++.++ |+||+++++++...+.+
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVN------HPNVVKCHDMFDHNGEI 147 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCC------CCCcceeeeEeccCCeE
Confidence 5688889999999999999999999999999998653 233456778888888764 78999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcc
Q 005590 459 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 459 ~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 538 (689)
++||||+.++.+.. .....+..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++.
T Consensus 148 ~lv~e~~~~~~L~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~--~~~~kL~DfG~~~ 216 (353)
T PLN00034 148 QVLLEFMDGGSLEG---------THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINS--AKNVKIADFGVSR 216 (353)
T ss_pred EEEEecCCCCcccc---------cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC--CCCEEEcccccce
Confidence 99999998653221 112567778899999999999999999999999999999984 7889999999987
Q ss_pred cccCC---ccccccCccccChhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 005590 539 FQTDN---LCLYVQSRSYRAPEVIIG-----LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 610 (689)
Q Consensus 539 ~~~~~---~~~~~gt~~Y~APE~l~~-----~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~ 610 (689)
..... .....||..|+|||++.. ...+.++|||||||++|+|++|+.||......+....+....
T Consensus 217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~------- 289 (353)
T PLN00034 217 ILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC------- 289 (353)
T ss_pred ecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-------
Confidence 65432 234578999999998743 234568999999999999999999997432211111110000
Q ss_pred HhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCCC
Q 005590 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~~ 688 (689)
.......+ ...+.++++||.+||+.||++|||+.|+|+||||.+.
T Consensus 290 ------------------------~~~~~~~~---------~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 290 ------------------------MSQPPEAP---------ATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred ------------------------ccCCCCCC---------CccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 00000001 1234678999999999999999999999999999864
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=324.61 Aligned_cols=249 Identities=24% Similarity=0.298 Sum_probs=194.0
Q ss_pred eccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEEEc
Q 005590 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 464 (689)
Q Consensus 389 LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmEy 464 (689)
||+|+||+||++++..+++.||+|++..... ....+..|+++++.++ |++|+++++++....+.++||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~------~~~i~~~~~~~~~~~~~~lv~e~ 74 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH------SRFIVSLAYAFQTKTDLCLVMTI 74 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC------CCcEeeeeEEEcCCCeEEEEEeC
Confidence 6999999999999999999999999875421 2244567888887774 67999999999999999999999
Q ss_pred ccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccCC
Q 005590 465 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 543 (689)
Q Consensus 465 ~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~ 543 (689)
+.+ +|...+.... .....+++..+..++.||+.||.|||+.||+||||||+||+++. ++.++|+|||++......
T Consensus 75 ~~~g~L~~~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 75 MNGGDLRYHIYNVD--EENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDN--DGNVRISDLGLAVELKDG 150 (280)
T ss_pred CCCCCHHHHHHhcc--ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEEeeCccceecCCC
Confidence 986 5555443221 12234899999999999999999999999999999999999984 788999999998654332
Q ss_pred ---ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhh
Q 005590 544 ---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKY 620 (689)
Q Consensus 544 ---~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~ 620 (689)
.....+|+.|+|||++.+..++.++|+|||||++|+|++|+.||...........+...+.
T Consensus 151 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~---------------- 214 (280)
T cd05608 151 QSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL---------------- 214 (280)
T ss_pred CccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc----------------
Confidence 2235789999999999999999999999999999999999999975432211111110000
Q ss_pred hhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCc-----CHHHHHcCCCCCC
Q 005590 621 FTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQH 687 (689)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRp-----Ta~ElL~hpwf~~ 687 (689)
.....+| ...+..+.+||.+||+.||++|| |++++++||||+.
T Consensus 215 ---------------~~~~~~~---------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 215 ---------------NDSVTYP---------DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred ---------------ccCCCCc---------ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 0000011 11345688999999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.59 Aligned_cols=248 Identities=30% Similarity=0.460 Sum_probs=208.1
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
..|+.++.||+|.||.||+|.+..+++.||+|++..+ ......+.+|+.+|..++. +||.++|+.|..+..+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~------~~it~yygsyl~g~~L 86 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDS------PNITEYYGSYLKGTKL 86 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCc------chHHhhhhheeecccH
Confidence 4588889999999999999999999999999999865 3445677888999888864 6899999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
+++||||.| ++.++++.... +.+..+..++++++.||.|||..+.+|||||+.|||+.. .|.+||+|||.+
T Consensus 87 wiiMey~~gGsv~~lL~~~~~------~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~--~g~vkl~DfgVa 158 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKSGNI------LDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSE--SGDVKLADFGVA 158 (467)
T ss_pred HHHHHHhcCcchhhhhccCCC------CccceeeeehHHHHHHhhhhhhcceecccccccceeEec--cCcEEEEeccee
Confidence 999999995 67777664432 477888899999999999999999999999999999995 589999999998
Q ss_pred ccccCC---ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 538 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 538 ~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
...... ..+++|||.|||||++.+..|+.++||||||++.+||++|.+||....+..+
T Consensus 159 ~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv------------------- 219 (467)
T KOG0201|consen 159 GQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV------------------- 219 (467)
T ss_pred eeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE-------------------
Confidence 776542 3568999999999999998999999999999999999999999975443211
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccc--hhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEES--SLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~--~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
-+.||... .+.. ..++.|++||..||+.||+.||+|.+||+|+|++.
T Consensus 220 -----------------------lflIpk~~PP~L~~---~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 220 -----------------------LFLIPKSAPPRLDG---DFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred -----------------------EEeccCCCCCcccc---ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 12222211 1111 33566999999999999999999999999999875
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=330.99 Aligned_cols=280 Identities=33% Similarity=0.583 Sum_probs=217.1
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC-
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL- 455 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~- 455 (689)
+.++|++.+.||+|+||.||+|++..+|+.||+|++... ........+|+.+++.++ |+||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~ 76 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFK------HENIIGILDIIRPPS 76 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCC------CCCcCchhheeeccc
Confidence 457899999999999999999999999999999998642 223455677888888775 67999999887644
Q ss_pred ----CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEE
Q 005590 456 ----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 531 (689)
Q Consensus 456 ----~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL 531 (689)
.+.++||||+.+++...+... .+++..++.++.||+.||.|||+.||+||||||+||+++. ++.++|
T Consensus 77 ~~~~~~~~lv~e~~~~~l~~~~~~~-------~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~--~~~~kl 147 (336)
T cd07849 77 FESFNDVYIVQELMETDLYKLIKTQ-------HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--NCDLKI 147 (336)
T ss_pred ccccceEEEEehhcccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC--CCCEEE
Confidence 368999999998887665421 2889999999999999999999999999999999999984 788999
Q ss_pred EecCCcccccCC------ccccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 005590 532 IDLGSSCFQTDN------LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 604 (689)
Q Consensus 532 ~DFGls~~~~~~------~~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g 604 (689)
+|||++...... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+....+..+...++
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~ 227 (336)
T cd07849 148 CDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLG 227 (336)
T ss_pred CcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 999998654322 122467889999998765 4689999999999999999999999998888888888888888
Q ss_pred CCcHHHHhhhhhhh--hhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 605 PIDLEMLMQGQEIY--KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 605 ~~~~e~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
.++.+.+....... .++. ... ..............+.++.+||++||+.+|++|||+.|+++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~-------------~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 228 TPSQEDLNCIISLRARNYIK-------------SLP--FKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CCCHHHHHHhhchhhhhHHh-------------hcC--cCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 76665543221110 0000 000 000000111112235668999999999999999999999999
Q ss_pred CCCCCC
Q 005590 683 PWLQHP 688 (689)
Q Consensus 683 pwf~~~ 688 (689)
|||..-
T Consensus 293 p~~~~~ 298 (336)
T cd07849 293 PYLEQY 298 (336)
T ss_pred cccccc
Confidence 999753
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=323.05 Aligned_cols=280 Identities=29% Similarity=0.427 Sum_probs=220.4
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC--
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL-- 455 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~-- 455 (689)
++|++.+.||.|+||.||+|++..+++.+|+|.++... .......+|+.+++.++ ||||+++++++...
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------h~ni~~~~~~~~~~~~ 78 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ------HPNIVTVKEVVVGSNL 78 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcC------CCCEEEEEEEEEecCC
Confidence 57999999999999999999999999999999987542 22234567888887774 78999999999877
Q ss_pred CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 456 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 456 ~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
...++||||+.++|.+++..... .+++..++.++.||+.||.|||+.|++|+||||+||+++. ++.++|+|||
T Consensus 79 ~~~~lv~e~~~~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~--~~~~~l~d~g 151 (293)
T cd07843 79 DKIYMVMEYVEHDLKSLMETMKQ-----PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNN--RGILKICDFG 151 (293)
T ss_pred CcEEEEehhcCcCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECC--CCcEEEeecC
Confidence 89999999999888887764332 3899999999999999999999999999999999999985 7889999999
Q ss_pred CcccccCC---ccccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 005590 536 SSCFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 611 (689)
Q Consensus 536 ls~~~~~~---~~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~ 611 (689)
++...... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||......+.+.++....+.+....|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (293)
T cd07843 152 LAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231 (293)
T ss_pred ceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHH
Confidence 98765443 2234568889999998764 4689999999999999999999999998888888888888887777766
Q ss_pred hhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
.....+.......... .....+...++.. ..+..+.+||++||+.||++|||+.|+|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~--------~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 232 PGFSELPGAKKKTFTK----YPYNQLRKKFPAL--------SLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred HHhhccchhccccccc----ccchhhhcccccc--------CCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 5544332211100000 0000111111110 035668899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.10 Aligned_cols=276 Identities=30% Similarity=0.498 Sum_probs=217.1
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 459 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~ 459 (689)
+|++.+.||.|++|+||+|++..+|+.||||+++... .......+|+.+++.++ |+||+++++++...+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELK------HENIVRLHDVIHTENKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhc------CCCEeeeeeeEeeCCcEE
Confidence 5899999999999999999999999999999987642 22356667888888774 679999999999999999
Q ss_pred EEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccc
Q 005590 460 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539 (689)
Q Consensus 460 lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 539 (689)
+||||+.+++.+++..... ...+++..+..++.||+.||.|||+.|++|+||||+||+++. ++.++|+|||++..
T Consensus 75 lv~e~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~--~~~~~l~d~g~~~~ 149 (284)
T cd07836 75 LVFEYMDKDLKKYMDTHGV---RGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINK--RGELKLADFGLARA 149 (284)
T ss_pred EEEecCCccHHHHHHhcCC---CCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECC--CCcEEEeecchhhh
Confidence 9999999988887754331 234899999999999999999999999999999999999984 78899999999865
Q ss_pred ccCC---ccccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 005590 540 QTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615 (689)
Q Consensus 540 ~~~~---~~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~ 615 (689)
.... .....++..|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+..+...++......+....+....
T Consensus 150 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 150 FGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred hcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence 4332 1224568889999998764 57899999999999999999999999888888887777666665555544332
Q ss_pred hhhhhhhccccchhhhhccccccccCCcc--chhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 616 EIYKYFTKEYDLYYINEETNQLEYIIPEE--SSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~--~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
....+. ..+|.. ..........+..++++|.+||+.||.+||++.++++||||
T Consensus 230 ~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 230 QLPEYK-----------------PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cCchhc-----------------ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 111111 001110 00011111234668899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=330.52 Aligned_cols=280 Identities=30% Similarity=0.444 Sum_probs=220.4
Q ss_pred eecCcEEEE-EEeccCCCCceEEEEECCCCcEEEEEEeecchhhh---------------HhHHHHHHHHHHhcccCCCC
Q 005590 378 VIAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFF---------------DQSLDEIKLLKLVNKNDPAD 441 (689)
Q Consensus 378 ~l~~rY~i~-~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~---------------~~~~~Ei~iL~~l~~~~~~~ 441 (689)
.+.+||.++ +.||.|+||+||+|++..+++.||||++....... ..+.+|+.+++.++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------ 78 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK------ 78 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC------
Confidence 456788754 67999999999999999999999999986532211 13567888877774
Q ss_pred CCceeEEEEEEEeCCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 005590 442 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI 521 (689)
Q Consensus 442 h~~Iv~l~~~f~~~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl 521 (689)
|+||+++++++...+..++||||+.++|.+++.... .+++..+..++.||+.||.|||+.||+|+||+|+||++
T Consensus 79 h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill 152 (335)
T PTZ00024 79 HENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKI------RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI 152 (335)
T ss_pred CcceeeeeEEEecCCcEEEEEeccccCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE
Confidence 689999999999999999999999998888775322 28899999999999999999999999999999999999
Q ss_pred eccCCCeEEEEecCCcccccC-----------------CccccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhC
Q 005590 522 KSYQRCEIKIIDLGSSCFQTD-----------------NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTG 583 (689)
Q Consensus 522 ~~~~~~~vkL~DFGls~~~~~-----------------~~~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG 583 (689)
+. ++.++|+|||.+..... ......+++.|+|||.+.+. .++.++|+|||||++|+|++|
T Consensus 153 ~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg 230 (335)
T PTZ00024 153 NS--KGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230 (335)
T ss_pred CC--CCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhC
Confidence 84 77899999998865441 11123457789999998764 478999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHH
Q 005590 584 EVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVR 663 (689)
Q Consensus 584 ~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~ 663 (689)
.+||.+.+..+.+..+...++.++...|........+.. ..... ...........+..+.+||.
T Consensus 231 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~--~~~~~~~~~~~~~~~~~li~ 294 (335)
T PTZ00024 231 KPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTE--------------FTPRK--PKDLKTIFPNASDDAIDLLQ 294 (335)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccc--------------cCcCC--cccHHHhCcCCChHHHHHHH
Confidence 999999988888888888888777666554432211100 00000 11111222334567899999
Q ss_pred HhcccCCCCCcCHHHHHcCCCCCC
Q 005590 664 TLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 664 ~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
+||+.+|++|||++|+|.||||+.
T Consensus 295 ~~l~~~P~~R~s~~~~l~~~~~~~ 318 (335)
T PTZ00024 295 SLLKLNPLERISAKEALKHEYFKS 318 (335)
T ss_pred HHcCCCchhccCHHHHhcCcccCC
Confidence 999999999999999999999985
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=333.71 Aligned_cols=243 Identities=28% Similarity=0.411 Sum_probs=197.9
Q ss_pred EEeccCCCCceEEEEE---CCCCcEEEEEEeecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEE
Q 005590 387 EYLGSAAFSKVFQAQD---LHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 460 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d---~~tg~~vAvKii~~~~~---~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~l 460 (689)
+.||+|+||.||++++ ..+|+.||+|++..... .......|+++++.+ .|+||+++++++...+..|+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~~l 75 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV------NHPFIVKLHYAFQTEGKLYL 75 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC------CCCCcccEEEEEEcCCEEEE
Confidence 5799999999999986 35789999999986431 223455677777766 47899999999999999999
Q ss_pred EEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccc
Q 005590 461 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539 (689)
Q Consensus 461 VmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 539 (689)
||||+. ++|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++..
T Consensus 76 v~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~kL~Dfg~~~~ 147 (318)
T cd05582 76 ILDFLRGGDLFTRLSKE------VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDE--EGHIKLTDFGLSKE 147 (318)
T ss_pred EEcCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECC--CCcEEEeeccCCcc
Confidence 999997 4676665432 23889999999999999999999999999999999999984 78899999999876
Q ss_pred ccCC---ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhh
Q 005590 540 QTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 616 (689)
Q Consensus 540 ~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~ 616 (689)
.... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.+..+....
T Consensus 148 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~------------- 214 (318)
T cd05582 148 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK------------- 214 (318)
T ss_pred cCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 4332 233578999999999999889999999999999999999999998876666555443111
Q ss_pred hhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcC-----HHHHHcCCCCCC
Q 005590 617 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPWLQH 687 (689)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT-----a~ElL~hpwf~~ 687 (689)
..+|. ..+..+.+||++||+.||++||| +.++++||||+.
T Consensus 215 ----------------------~~~p~---------~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 215 ----------------------LGMPQ---------FLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred ----------------------CCCCC---------CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 01111 13456889999999999999999 788999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=350.70 Aligned_cols=292 Identities=22% Similarity=0.272 Sum_probs=206.2
Q ss_pred eCceecCcEEEEEEeccCCCCceEEEEECCC-CcEEEE------------------EEeecchhhhHhHHHHHHHHHHhc
Q 005590 375 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHT-GVDVCL------------------KIIKNDKDFFDQSLDEIKLLKLVN 435 (689)
Q Consensus 375 ~~~~l~~rY~i~~~LG~G~fG~Vyla~d~~t-g~~vAv------------------Kii~~~~~~~~~~~~Ei~iL~~l~ 435 (689)
.+..+.++|++++.||+|+||+||++..+.. +...++ |.+.........+.+|+.+++.++
T Consensus 142 ~~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~ 221 (501)
T PHA03210 142 HDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN 221 (501)
T ss_pred cchhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC
Confidence 3445668999999999999999999875332 222222 222222233456678888888774
Q ss_pred ccCCCCCCceeEEEEEEEeCCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 005590 436 KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLK 515 (689)
Q Consensus 436 ~~~~~~h~~Iv~l~~~f~~~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLK 515 (689)
|+||+++++++...+..++|++++.+++.+++....... ........++.|+.||+.||.|||++||+|||||
T Consensus 222 ------HpnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~-~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLK 294 (501)
T PHA03210 222 ------HENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW-KDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIK 294 (501)
T ss_pred ------CCCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccc-cccccHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 789999999999999999999999988888765332211 1224467788999999999999999999999999
Q ss_pred CCcEEEeccCCCeEEEEecCCcccccCC----ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCC-CCC-
Q 005590 516 PENILIKSYQRCEIKIIDLGSSCFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVL-FPN- 589 (689)
Q Consensus 516 p~NILl~~~~~~~vkL~DFGls~~~~~~----~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~P-F~~- 589 (689)
|+|||++. ++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..+ |..
T Consensus 295 P~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~ 372 (501)
T PHA03210 295 LENIFLNC--DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDG 372 (501)
T ss_pred HHHEEECC--CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCC
Confidence 99999984 788999999999765432 2235789999999999999999999999999999999998754 432
Q ss_pred -ChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhccc
Q 005590 590 -DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEI 668 (689)
Q Consensus 590 -~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~ 668 (689)
......+.+++..++....+.........+++.... . ......++ .+... ...+..+.++|.+||++
T Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~-~-------~~~~~~~~---~~~~~-~~~~~~~~~li~kmL~~ 440 (501)
T PHA03210 373 GGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAE-I-------DHAGHSVP---PLIRN-LGLPADFEYPLVKMLTF 440 (501)
T ss_pred CCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhh-c-------ccCccchh---hHHHh-cCCChHHHHHHHHHhcc
Confidence 234455555555554433322111112222221100 0 00000011 11111 12346688999999999
Q ss_pred CCCCCcCHHHHHcCCCCCC
Q 005590 669 NPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 669 dP~kRpTa~ElL~hpwf~~ 687 (689)
||.+|||+.|+|+||||+.
T Consensus 441 DP~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 441 DWHLRPGAAELLALPLFSA 459 (501)
T ss_pred CcccCcCHHHHhhChhhhc
Confidence 9999999999999999975
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.40 Aligned_cols=249 Identities=28% Similarity=0.478 Sum_probs=208.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|++.+.||+|+||.||++.+..+++.+|+|++.... .....+.+|+++++.+. |+||+++++++....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~ 74 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR------HPFLVNLYGSFQDDS 74 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC------CCCccceeeEEEcCC
Confidence 47999999999999999999999999999999987532 23455667788777664 789999999999999
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
..++||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+|+||+|+||+|+. ++.+||+|||
T Consensus 75 ~~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~--~~~~kl~dfg 146 (290)
T cd05580 75 NLYLVMEYVPGGELFSHLRKSG------RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDS--DGYIKITDFG 146 (290)
T ss_pred eEEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECC--CCCEEEeeCC
Confidence 9999999995 67877765432 2889999999999999999999999999999999999984 7889999999
Q ss_pred CcccccCCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 005590 536 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615 (689)
Q Consensus 536 ls~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~ 615 (689)
++...........+++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+...
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------- 213 (290)
T cd05580 147 FAKRVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG------------- 213 (290)
T ss_pred CccccCCCCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-------------
Confidence 9887665555567899999999999888999999999999999999999999877654444443211
Q ss_pred hhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCc-----CHHHHHcCCCCCC
Q 005590 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQH 687 (689)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRp-----Ta~ElL~hpwf~~ 687 (689)
...+|. ..+..++++|++||+.||.+|+ +++|+++||||+.
T Consensus 214 ----------------------~~~~~~---------~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 214 ----------------------KVRFPS---------FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred ----------------------CccCCc---------cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccccc
Confidence 001111 1245688999999999999999 9999999999974
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=329.49 Aligned_cols=245 Identities=22% Similarity=0.346 Sum_probs=194.3
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEE
Q 005590 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 462 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVm 462 (689)
+.||+|+||+||++++..+++.||+|+++... .....+.+|+.++..+. .|++|+++++++...+++++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~-----~~~~i~~~~~~~~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQAS-----SNPFLVGLHSCFQTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhc-----CCCCEeeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999998642 22345667777777664 3789999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccc-
Q 005590 463 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ- 540 (689)
Q Consensus 463 Ey~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~- 540 (689)
||+.+ +|..++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++...
T Consensus 76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~--~~~~kl~Dfg~~~~~~ 147 (327)
T cd05617 76 EYVNGGDLMFHMQRQR------KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDA--DGHIKLTDYGMCKEGL 147 (327)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeC--CCCEEEeccccceecc
Confidence 99985 5655554322 2899999999999999999999999999999999999985 788999999998642
Q ss_pred --cCCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChH------HHHHHHHHhhcCCCcHHHHh
Q 005590 541 --TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV------VMILARIIGMLGPIDLEMLM 612 (689)
Q Consensus 541 --~~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~------~~~l~~i~~~~g~~~~e~~~ 612 (689)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||..... .+.+..++
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~------------ 215 (327)
T cd05617 148 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI------------ 215 (327)
T ss_pred CCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH------------
Confidence 2223446799999999999999999999999999999999999999953211 11111110
Q ss_pred hhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcC------HHHHHcCCCCC
Q 005590 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT------AREALDHPWLQ 686 (689)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT------a~ElL~hpwf~ 686 (689)
......+|. ..+..+.++|.+||+.||++|++ ..++++||||+
T Consensus 216 ----------------------~~~~~~~p~---------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~ 264 (327)
T cd05617 216 ----------------------LEKPIRIPR---------FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFR 264 (327)
T ss_pred ----------------------HhCCCCCCC---------CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCC
Confidence 000111221 23456789999999999999998 57999999997
Q ss_pred C
Q 005590 687 H 687 (689)
Q Consensus 687 ~ 687 (689)
.
T Consensus 265 ~ 265 (327)
T cd05617 265 S 265 (327)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=347.26 Aligned_cols=255 Identities=24% Similarity=0.328 Sum_probs=204.3
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
..++|++.+.||+|+||+||+|++..+|+.||||++.... .......+|+.++..+ .|++|++++..+...
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~------~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC------DFFSIVKCHEDFAKK 103 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC------CCCcEEEeecceecc
Confidence 3579999999999999999999999999999999987542 2334455666666544 478999998877643
Q ss_pred C--------eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCC
Q 005590 456 E--------HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 526 (689)
Q Consensus 456 ~--------~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~ 526 (689)
. .+++||||+. |+|.+++..... ....+++..+..++.||+.||.|||+.||+||||||+|||++. +
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~--~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~--~ 179 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAK--TNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCS--N 179 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeC--C
Confidence 2 4789999998 578777654332 2234899999999999999999999999999999999999985 7
Q ss_pred CeEEEEecCCcccccCC-----ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHh
Q 005590 527 CEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 601 (689)
Q Consensus 527 ~~vkL~DFGls~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~ 601 (689)
+.+||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~ 259 (496)
T PTZ00283 180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA 259 (496)
T ss_pred CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 88999999998764322 2346789999999999999999999999999999999999999988776655544421
Q ss_pred hcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 602 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 602 ~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
.. ...+| ...++.+.+||.+||+.||.+||++.++|+
T Consensus 260 ~~----------------------------------~~~~~---------~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 260 GR----------------------------------YDPLP---------PSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred CC----------------------------------CCCCC---------CCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 00 00011 123466889999999999999999999999
Q ss_pred CCCCC
Q 005590 682 HPWLQ 686 (689)
Q Consensus 682 hpwf~ 686 (689)
|||++
T Consensus 297 ~p~~~ 301 (496)
T PTZ00283 297 MPICK 301 (496)
T ss_pred CHHHH
Confidence 99975
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=329.67 Aligned_cols=255 Identities=20% Similarity=0.315 Sum_probs=200.2
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|++.++||+|+||.||++++..+++.+|+|++.+.. .....+..|+.++..+ .|++|+++++++....
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~~~~~~~ 74 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG------DNQWITTLHYAFQDEN 74 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC------CCCCEeeEEEEEecCC
Confidence 47999999999999999999999999999999986532 1122344555555544 5789999999999999
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
++++||||+. |+|.+++..... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~--~~~~kL~DfG 147 (332)
T cd05623 75 NLYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM--NGHIRLADFG 147 (332)
T ss_pred EEEEEEeccCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECC--CCCEEEeecc
Confidence 9999999997 577777754221 2888999999999999999999999999999999999984 7889999999
Q ss_pred CcccccCC----ccccccCccccChhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 005590 536 SSCFQTDN----LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 606 (689)
Q Consensus 536 ls~~~~~~----~~~~~gt~~Y~APE~l~-----~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~ 606 (689)
++...... ....+||+.|+|||++. ...++.++|||||||++|+|++|+.||...+..+.+..+.....
T Consensus 148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-- 225 (332)
T cd05623 148 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-- 225 (332)
T ss_pred hheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc--
Confidence 98653221 12357899999999986 34588999999999999999999999988776666655531100
Q ss_pred cHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCC--CcCHHHHHcCCC
Q 005590 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR--RPTAREALDHPW 684 (689)
Q Consensus 607 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~k--RpTa~ElL~hpw 684 (689)
...+|.. ....+..+++||++||..++.+ |+++.|+++|||
T Consensus 226 -------------------------------~~~~p~~------~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~ 268 (332)
T cd05623 226 -------------------------------RFQFPAQ------VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPF 268 (332)
T ss_pred -------------------------------cccCCCc------cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCC
Confidence 0111111 1123567899999999765555 789999999999
Q ss_pred CCC
Q 005590 685 LQH 687 (689)
Q Consensus 685 f~~ 687 (689)
|++
T Consensus 269 f~~ 271 (332)
T cd05623 269 FTG 271 (332)
T ss_pred cCC
Confidence 985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.44 Aligned_cols=279 Identities=30% Similarity=0.493 Sum_probs=218.9
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
++|++.+.||+|+||.||+|.+..+++.||+|+++.. ......+.+|+++++.+. |+||+++++++...+.
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~ 74 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR------HENIVNLKEAFRRKGR 74 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcC------CCCeeehhheEEECCE
Confidence 4799999999999999999999999999999998653 233467778888888875 6799999999999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 458 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 458 l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
.++||||+.++++..+.... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++. ++.++|+|||++
T Consensus 75 ~~iv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~--~~~~kl~d~g~~ 147 (288)
T cd07833 75 LYLVFEYVERTLLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSE--SGVLKLCDFGFA 147 (288)
T ss_pred EEEEEecCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC--CCCEEEEeeecc
Confidence 99999999988776554322 12789999999999999999999999999999999999984 888999999998
Q ss_pred ccccCC----ccccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 005590 538 CFQTDN----LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 612 (689)
Q Consensus 538 ~~~~~~----~~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~ 612 (689)
...... .....++..|+|||++.+. .++.++|+||||+++|+|++|++||.+....+.+..+...++..+..+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07833 148 RALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQE 227 (288)
T ss_pred cccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhh
Confidence 765432 2235678899999999888 78999999999999999999999999887777777777777776665443
Q ss_pred hhhhhhhhhhccccchhhhhccccccccCCccchhhhh-ccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHH-LQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~-~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
.......+.. .... ........... ....+..+++||++||..+|++|||++++++||||
T Consensus 228 ~~~~~~~~~~------------~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 228 LFSSNPRFAG------------VAFP-EPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred hcccCccccc------------cccC-CCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 2211100000 0000 00000111111 11235778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=334.13 Aligned_cols=245 Identities=25% Similarity=0.377 Sum_probs=193.5
Q ss_pred eccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEEEc
Q 005590 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 464 (689)
Q Consensus 389 LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmEy 464 (689)
||+|+||+||+|++..+++.||+|++..... .......|..++..+. ...||+|+++++++....+.++||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~---~~~~p~i~~~~~~~~~~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTL---LDESPFIVGLKFSFQTDSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhc---cCCCCcCcceEEEEecCCeEEEEEcC
Confidence 7999999999999999999999999875321 1223334555554443 12589999999999999999999999
Q ss_pred ccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccC-
Q 005590 465 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD- 542 (689)
Q Consensus 465 ~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~- 542 (689)
+.+ +|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.++|+|||++.....
T Consensus 78 ~~~g~L~~~l~~~------~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~--~~~~kl~Dfg~a~~~~~~ 149 (330)
T cd05586 78 MSGGELFWHLQKE------GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDA--TGHIALCDFGLSKANLTD 149 (330)
T ss_pred CCCChHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC--CCCEEEecCCcCcCCCCC
Confidence 985 666655432 22889999999999999999999999999999999999984 78899999999865322
Q ss_pred --CccccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhh
Q 005590 543 --NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYK 619 (689)
Q Consensus 543 --~~~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~ 619 (689)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~----------------- 212 (330)
T cd05586 150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG----------------- 212 (330)
T ss_pred CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 23346789999999999765 4889999999999999999999999887665555444210
Q ss_pred hhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCc----CHHHHHcCCCCCC
Q 005590 620 YFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP----TAREALDHPWLQH 687 (689)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRp----Ta~ElL~hpwf~~ 687 (689)
...+|. ...+..+.+||++||+.||.+|| ++.++++||||..
T Consensus 213 ------------------~~~~~~--------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 213 ------------------KVRFPK--------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred ------------------CCCCCC--------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence 011111 11345678999999999999998 7999999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=332.13 Aligned_cols=244 Identities=27% Similarity=0.395 Sum_probs=193.0
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEE
Q 005590 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 462 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVm 462 (689)
+.||+|+||+||+|++..+|+.+|+|++..... ....+..|..++.. ...||||+++++++...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~-----~~~hp~iv~~~~~~~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLK-----NVKHPFLVGLHYSFQTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHH-----hCCCCCCccEEEEEecCCEEEEEE
Confidence 368999999999999999999999999975421 12233333332211 235899999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccccc
Q 005590 463 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 541 (689)
Q Consensus 463 Ey~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~ 541 (689)
||+.+ +|...+... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++....
T Consensus 76 e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~--~~~~kL~DfG~~~~~~ 147 (325)
T cd05604 76 DFVNGGELFFHLQRE------RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDS--QGHVVLTDFGLCKEGI 147 (325)
T ss_pred cCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC--CCCEEEeecCCcccCC
Confidence 99986 555554322 23889999999999999999999999999999999999984 7889999999986532
Q ss_pred ---CCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhh
Q 005590 542 ---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 618 (689)
Q Consensus 542 ---~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~ 618 (689)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~---------------- 211 (325)
T cd05604 148 AQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK---------------- 211 (325)
T ss_pred CCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC----------------
Confidence 2233467899999999999999999999999999999999999999887666555444310
Q ss_pred hhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCH----HHHHcCCCCCC
Q 005590 619 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA----REALDHPWLQH 687 (689)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa----~ElL~hpwf~~ 687 (689)
...++. ..+..+.++|++||+.||.+||++ .++++||||+.
T Consensus 212 -------------------~~~~~~---------~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 212 -------------------PLVLRP---------GASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred -------------------CccCCC---------CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 000010 123567899999999999999987 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=329.62 Aligned_cols=255 Identities=20% Similarity=0.295 Sum_probs=200.8
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|++.+.||+|+||+||++++..+++.||+|++.+.. .....+.+|..++..+ .|++|+++++++...+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~l~~~~~~~~ 74 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG------DCQWITTLHYAFQDEN 74 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC------CCCCEeeEEEEEEcCC
Confidence 47999999999999999999999999999999987532 1223344556665544 5789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
+.++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~Ey~~gg~L~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~--~~~~kl~DfG 147 (331)
T cd05624 75 YLYLVMDYYVGGDLLTLLSKFE-----DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDM--NGHIRLADFG 147 (331)
T ss_pred EEEEEEeCCCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcC--CCCEEEEecc
Confidence 99999999974 6777765422 12889999999999999999999999999999999999984 7889999999
Q ss_pred CcccccCCc----cccccCccccChhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 005590 536 SSCFQTDNL----CLYVQSRSYRAPEVIIG-----LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 606 (689)
Q Consensus 536 ls~~~~~~~----~~~~gt~~Y~APE~l~~-----~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~ 606 (689)
++....... ....||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+..+.+..+.....
T Consensus 148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-- 225 (331)
T cd05624 148 SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEE-- 225 (331)
T ss_pred ceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCC--
Confidence 987654321 23568999999999875 4678899999999999999999999988766665555431100
Q ss_pred cHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCC--CcCHHHHHcCCC
Q 005590 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR--RPTAREALDHPW 684 (689)
Q Consensus 607 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~k--RpTa~ElL~hpw 684 (689)
...+|.. ....+..+++||.+||..++++ |++++++++|||
T Consensus 226 -------------------------------~~~~p~~------~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~ 268 (331)
T cd05624 226 -------------------------------RFQFPSH------ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAF 268 (331)
T ss_pred -------------------------------cccCCCc------cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCC
Confidence 0111111 1123467889999999976655 579999999999
Q ss_pred CCC
Q 005590 685 LQH 687 (689)
Q Consensus 685 f~~ 687 (689)
|+.
T Consensus 269 f~~ 271 (331)
T cd05624 269 FEG 271 (331)
T ss_pred cCC
Confidence 975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=328.42 Aligned_cols=280 Identities=31% Similarity=0.527 Sum_probs=218.4
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
+..+|++.+.||+|+||+||++++..+++.||||.+... ........+|+.+++.++ |+||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~ni~~~~~~~~~~ 76 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLD------HENVIAIKDIMPPP 76 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcC------CCCccchHHheecc
Confidence 457899999999999999999999999999999998642 222345667888887764 67999999988644
Q ss_pred -----CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEE
Q 005590 456 -----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 530 (689)
Q Consensus 456 -----~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vk 530 (689)
.+.++||||+.++|.+++.... .+++..+..++.||+.||.|||+.+++||||||+||+++. ++.+|
T Consensus 77 ~~~~~~~~~lv~e~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~--~~~~k 148 (337)
T cd07858 77 HREAFNDVYIVYELMDTDLHQIIRSSQ------TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA--NCDLK 148 (337)
T ss_pred cccccCcEEEEEeCCCCCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--CCCEE
Confidence 3589999999988887765322 2899999999999999999999999999999999999985 77899
Q ss_pred EEecCCcccccCC---ccccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 005590 531 IIDLGSSCFQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 606 (689)
Q Consensus 531 L~DFGls~~~~~~---~~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~ 606 (689)
|+|||++...... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+....+..+...++++
T Consensus 149 L~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 228 (337)
T cd07858 149 ICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSP 228 (337)
T ss_pred ECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999998765432 223467889999999875 468999999999999999999999999988888888888888877
Q ss_pred cHHHHhhhh--hhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCC
Q 005590 607 DLEMLMQGQ--EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 684 (689)
Q Consensus 607 ~~e~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpw 684 (689)
+.+.+.... ...++.. ... ..............+..+++||++||+.+|++|||+.++|+|||
T Consensus 229 ~~~~~~~~~~~~~~~~~~-------------~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~ 293 (337)
T cd07858 229 SEEDLGFIRNEKARRYIR-------------SLP--YTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY 293 (337)
T ss_pred ChHHhhhcCchhhhHHHH-------------hcC--cccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcc
Confidence 766542111 0111110 000 00000111112234567899999999999999999999999999
Q ss_pred CCC
Q 005590 685 LQH 687 (689)
Q Consensus 685 f~~ 687 (689)
|..
T Consensus 294 ~~~ 296 (337)
T cd07858 294 LAS 296 (337)
T ss_pred hhh
Confidence 975
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=320.61 Aligned_cols=254 Identities=26% Similarity=0.343 Sum_probs=199.5
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
.|++.+.||+|+||.||++.+..+++.||+|.+.... ........|+.+++.++ |++|+++++.+...++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~------~~~i~~~~~~~~~~~~ 74 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN------SRFVVSLAYAYETKDA 74 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC------CCCeeeeeEEEecCCE
Confidence 3788899999999999999999999999999986532 12234567888887774 6799999999999999
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 458 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 458 l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
.++||||+.+ +|.+++..... ..+++..+..++.|++.||.|||+.||+||||||+||+++. ++.++|+|||+
T Consensus 75 ~~lv~e~~~g~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~--~~~~~l~Dfg~ 148 (285)
T cd05630 75 LCLVLTLMNGGDLKFHIYHMGE----AGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDD--HGHIRISDLGL 148 (285)
T ss_pred EEEEEEecCCCcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECC--CCCEEEeeccc
Confidence 9999999985 66666543221 23889999999999999999999999999999999999984 77899999999
Q ss_pred cccccCC--ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 537 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 537 s~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
+...... .....|++.|+|||++.+..++.++|+||+||++|+|++|..||...............
T Consensus 149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~------------ 216 (285)
T cd05630 149 AVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL------------ 216 (285)
T ss_pred eeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhh------------
Confidence 8764332 22357899999999999999999999999999999999999999764221111110000
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcC-----HHHHHcCCCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPWLQH 687 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT-----a~ElL~hpwf~~ 687 (689)
.. ......+ ...++.+++||++||+.||++||| ++|+++||||..
T Consensus 217 ------~~-------------~~~~~~~---------~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 217 ------VK-------------EVQEEYS---------EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred ------hh-------------hhhhhcC---------ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 00 0000011 123456889999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=343.09 Aligned_cols=253 Identities=25% Similarity=0.291 Sum_probs=205.1
Q ss_pred CcEEEEEEeccCCCCceEEEEECCC-CcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHT-GVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~t-g~~vAvKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
..|.+.+.||+|++|.||+|.+..+ ++.||+|.+..+. .....+.+|+.+++.+ +||||+++++++...+++
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l------~Hpniv~~~~~~~~~~~~ 140 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC------DHFGIVKHFDDFKSDDKL 140 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhC------CCCCEeEEEEEEEECCEE
Confidence 4599999999999999999998777 7889999775433 2334556688777766 478999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
+|||||+.+ +|.+.+.... .....+++..+..++.||+.||.|||+.||+||||||+||||+. ++.+||+|||++
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~--~~~~kL~DFgla 216 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRL--KEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMP--TGIIKLGDFGFS 216 (478)
T ss_pred EEEEECCCCCCHHHHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECC--CCcEEEEeCcCc
Confidence 999999974 6776654322 12234889999999999999999999999999999999999985 788999999999
Q ss_pred ccccCC-----ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 005590 538 CFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 612 (689)
Q Consensus 538 ~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~ 612 (689)
...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~-------- 288 (478)
T PTZ00267 217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY-------- 288 (478)
T ss_pred eecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------
Confidence 765432 2345789999999999999999999999999999999999999988766665554431000
Q ss_pred hhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCC
Q 005590 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686 (689)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~ 686 (689)
..+| ...+..+.+||.+||..||++||++.++|.|||++
T Consensus 289 --------------------------~~~~---------~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~ 327 (478)
T PTZ00267 289 --------------------------DPFP---------CPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327 (478)
T ss_pred --------------------------CCCC---------ccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHH
Confidence 0011 11235688999999999999999999999999985
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=320.11 Aligned_cols=255 Identities=26% Similarity=0.430 Sum_probs=198.8
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
++|++.++||+|+||.||+|++..+++.||+|++..+. .....+.+|+.+++.+ +||||+++++.+...+..
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~~ 74 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC------DSPYIIGFYGAFFVENRI 74 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC------CCCCeeeEEEEEEECCEE
Confidence 36889999999999999999999999999999987542 2334566788777766 478999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcc
Q 005590 459 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 459 ~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 538 (689)
++||||+.++.++... .+++..+..++.||+.||.|||+.||+|+||||+|||++. ++.++|+|||++.
T Consensus 75 ~lv~e~~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~--~~~~~l~dfg~~~ 143 (279)
T cd06619 75 SICTEFMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNT--RGQVKLCDFGVST 143 (279)
T ss_pred EEEEecCCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECC--CCCEEEeeCCcce
Confidence 9999999976554321 1678889999999999999999999999999999999985 7889999999987
Q ss_pred cccCC-ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhh
Q 005590 539 FQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 617 (689)
Q Consensus 539 ~~~~~-~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~ 617 (689)
..... .....++..|+|||++.+..++.++|+|||||++|+|++|..||.......... .+...
T Consensus 144 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~--------~~~~~------- 208 (279)
T cd06619 144 QLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL--------MPLQL------- 208 (279)
T ss_pred ecccccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc--------chHHH-------
Confidence 65432 334578999999999999899999999999999999999999996522111000 00000
Q ss_pred hhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 618 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
....... .....+ ....++.+++||.+||+.||.+||+++|+++||||+.
T Consensus 209 ~~~~~~~------------~~~~~~--------~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~ 258 (279)
T cd06619 209 LQCIVDE------------DPPVLP--------VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ 258 (279)
T ss_pred HHHHhcc------------CCCCCC--------CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccc
Confidence 0000000 000000 0113466899999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=330.31 Aligned_cols=245 Identities=29% Similarity=0.415 Sum_probs=198.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcE-EEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVD-VCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~-vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
....+.+.||+|+||+||++.+ .|.. ||+|++.... .....+.+|+.+|..++ |||||++++++....
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~------HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLR------HPNIVQFYGACTSPP 112 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCC------CCCeeeEEEEEcCCC
Confidence 4455666699999999999986 4555 9999997632 22558889999999875 789999999999887
Q ss_pred -eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCcEEEeccCCC-eEEEE
Q 005590 457 -HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG-IIHCDLKPENILIKSYQRC-EIKII 532 (689)
Q Consensus 457 -~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~g-IvHrDLKp~NILl~~~~~~-~vkL~ 532 (689)
.++|||||+.+ +|..++... ....++...+..|+.||++||.|||+++ ||||||||+||||+. +. ++||+
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~----~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~--~~~~~KI~ 186 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKK----RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDL--KGKTLKIA 186 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhc----ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcC--CCCEEEEC
Confidence 79999999995 666666543 2233999999999999999999999999 999999999999995 65 99999
Q ss_pred ecCCcccccC---CccccccCccccChhhhc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCc
Q 005590 533 DLGSSCFQTD---NLCLYVQSRSYRAPEVII--GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 607 (689)
Q Consensus 533 DFGls~~~~~---~~~~~~gt~~Y~APE~l~--~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~ 607 (689)
|||+++.... ..+...||+.|||||++. ...|+.++||||+|+++|||+||+.||.+.........+...
T Consensus 187 DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~----- 261 (362)
T KOG0192|consen 187 DFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVG----- 261 (362)
T ss_pred CCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-----
Confidence 9999987654 333368999999999999 568999999999999999999999999987775555444311
Q ss_pred HHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 608 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 608 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
..+..+|.. .++.+..||..||..||.+||+..+++.
T Consensus 262 ----------------------------~~Rp~~p~~---------~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 262 ----------------------------GLRPPIPKE---------CPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred ----------------------------CCCCCCCcc---------CCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 112222221 3456889999999999999999999874
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=328.98 Aligned_cols=243 Identities=24% Similarity=0.374 Sum_probs=192.6
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecchhh----hHhHHHHHHH-HHHhcccCCCCCCceeEEEEEEEeCCeEEEE
Q 005590 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF----FDQSLDEIKL-LKLVNKNDPADEHHILRLYDYFYHLEHLFIV 461 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~----~~~~~~Ei~i-L~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lV 461 (689)
+.||+|+||+||+|++..+++.||+|++...... ......|... ++ ...|+||+++++++...+..++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~------~~~h~~Iv~~~~~~~~~~~~~lv 74 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLK------NVKHPFLVGLHFSFQTADKLYFV 74 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHH------hCCCCCCCceeEEEEcCCeEEEE
Confidence 3689999999999999999999999999754211 1122223222 22 24688999999999999999999
Q ss_pred EEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccc
Q 005590 462 CELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 540 (689)
Q Consensus 462 mEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~ 540 (689)
|||+.+ +|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++...
T Consensus 75 ~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~--~~~~kl~DfG~a~~~ 146 (325)
T cd05602 75 LDYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS--QGHIVLTDFGLCKEN 146 (325)
T ss_pred EeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC--CCCEEEccCCCCccc
Confidence 999986 5666554322 2788899999999999999999999999999999999984 788999999998653
Q ss_pred c---CCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhh
Q 005590 541 T---DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 617 (689)
Q Consensus 541 ~---~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~ 617 (689)
. ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-------------- 212 (325)
T cd05602 147 IEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-------------- 212 (325)
T ss_pred ccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--------------
Confidence 2 22334679999999999999999999999999999999999999998877666555443100
Q ss_pred hhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHH----HHHcCCCCCC
Q 005590 618 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR----EALDHPWLQH 687 (689)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~----ElL~hpwf~~ 687 (689)
..++ ...+..+.+||.+||+.||.+|+++. ++++|+||..
T Consensus 213 ---------------------~~~~---------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 213 ---------------------LQLK---------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred ---------------------cCCC---------CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 0000 11245688999999999999999876 8999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=326.44 Aligned_cols=279 Identities=31% Similarity=0.552 Sum_probs=219.2
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
+.++|++.+.||+|+||.||++.+..+++.||||++... ......+.+|+.+++.++ |+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~ 86 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK------HENVIGLLDVFTPD 86 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcC------CCCccceeeeecCC
Confidence 468899999999999999999999999999999998643 222345667888888774 67999999998755
Q ss_pred C------eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeE
Q 005590 456 E------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 529 (689)
Q Consensus 456 ~------~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~v 529 (689)
. ..++||||+++++.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~l~~~~~~-------~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~--~~~~ 157 (343)
T cd07880 87 LSLDRFHDFYLVMPFMGTDLGKLMKH-------EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNE--DCEL 157 (343)
T ss_pred ccccccceEEEEEecCCCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCE
Confidence 3 4689999997777766542 12889999999999999999999999999999999999984 7889
Q ss_pred EEEecCCcccccCCccccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcH
Q 005590 530 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 608 (689)
Q Consensus 530 kL~DFGls~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~ 608 (689)
+|+|||++...........+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||........+..++...+..+.
T Consensus 158 kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 158 KILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred EEeecccccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99999999876655555677899999999876 45889999999999999999999999988877778888777776665
Q ss_pred HHHhhhhhhh--hhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCC
Q 005590 609 EMLMQGQEIY--KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686 (689)
Q Consensus 609 e~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~ 686 (689)
+++....... .+.. .+... ....+.......+..+.++|.+||+.||++|||+.++++||||+
T Consensus 238 ~~~~~~~~~~~~~~~~-------------~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~ 302 (343)
T cd07880 238 EFVQKLQSEDAKNYVK-------------KLPRF--RKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302 (343)
T ss_pred HHHHhhcchhHHHHHH-------------hcccc--CcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHh
Confidence 5443322110 0000 00000 00111122233456789999999999999999999999999997
Q ss_pred C
Q 005590 687 H 687 (689)
Q Consensus 687 ~ 687 (689)
.
T Consensus 303 ~ 303 (343)
T cd07880 303 E 303 (343)
T ss_pred h
Confidence 5
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=329.19 Aligned_cols=280 Identities=34% Similarity=0.597 Sum_probs=222.2
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
+.++|++.+.||+|++|.||+|++..+++.||+|++... ........+|+.+++.+. |+||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~ 86 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMD------HENVIGLLDVFTPA 86 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhcc------CCCHHHHHHHhhcc
Confidence 467899999999999999999999999999999998643 223345667888887764 67999999888765
Q ss_pred Ce------EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeE
Q 005590 456 EH------LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 529 (689)
Q Consensus 456 ~~------l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~v 529 (689)
.. .++|+||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~L~~~~~~-------~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~--~~~~ 157 (343)
T cd07851 87 SSLEDFQDVYLVTHLMGADLNNIVKC-------QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE--DCEL 157 (343)
T ss_pred ccccccccEEEEEecCCCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC--CCCE
Confidence 54 899999998888887753 12899999999999999999999999999999999999985 7889
Q ss_pred EEEecCCcccccCCccccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcH
Q 005590 530 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 608 (689)
Q Consensus 530 kL~DFGls~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~ 608 (689)
+|+|||++...........++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+......+..+....+.++.
T Consensus 158 kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 237 (343)
T cd07851 158 KILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237 (343)
T ss_pred EEccccccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence 99999999876655555678899999999875 36789999999999999999999999988888888888888877776
Q ss_pred HHHhhhhhh--hhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCC
Q 005590 609 EMLMQGQEI--YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686 (689)
Q Consensus 609 e~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~ 686 (689)
.++.+.... ..+.. .+ ...............+..+.+||++||+.||++|||+.||++||||+
T Consensus 238 ~~~~~~~~~~~~~~~~-------------~~--~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~ 302 (343)
T cd07851 238 ELLQKISSESARNYIQ-------------SL--PQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA 302 (343)
T ss_pred HHHhhccchhHHHHHH-------------hc--cccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcc
Confidence 655433211 00000 00 00000111111122356799999999999999999999999999998
Q ss_pred CC
Q 005590 687 HP 688 (689)
Q Consensus 687 ~~ 688 (689)
+.
T Consensus 303 ~~ 304 (343)
T cd07851 303 EY 304 (343)
T ss_pred cc
Confidence 63
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=316.22 Aligned_cols=276 Identities=29% Similarity=0.458 Sum_probs=217.5
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEE
Q 005590 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 459 (689)
Q Consensus 383 Y~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~ 459 (689)
|++.+.||.|++|.||+|.++.+|..||+|++..+. .....+.+|+.+++.++ |+||+++++++......+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~------~~~iv~~~~~~~~~~~~~ 74 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN------HPNIVRLLDVVHSENKLY 74 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcC------CCCccCHhheeccCCeEE
Confidence 678899999999999999999999999999987543 22345677888888775 679999999999999999
Q ss_pred EEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccc
Q 005590 460 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539 (689)
Q Consensus 460 lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 539 (689)
+||||++++|.+++..... ..+++..+..++.||+.||.|||+.+++|+||+|+||+++. ++.++|+|||.+..
T Consensus 75 iv~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~--~~~~~l~df~~~~~ 148 (283)
T cd07835 75 LVFEFLDLDLKKYMDSSPL----TGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDR--EGALKLADFGLARA 148 (283)
T ss_pred EEEeccCcCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcC--CCcEEEeecccccc
Confidence 9999998888887754331 23889999999999999999999999999999999999985 78899999999875
Q ss_pred ccCCc---cccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 005590 540 QTDNL---CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615 (689)
Q Consensus 540 ~~~~~---~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~ 615 (689)
..... ....++..|+|||++.+. .++.++|+|||||++|+|++|++||...+....+.++....+.+....|....
T Consensus 149 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07835 149 FGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVT 228 (283)
T ss_pred cCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhh
Confidence 43221 223457889999988764 57899999999999999999999999888777777777777777766655443
Q ss_pred hhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
....+...- ... .. ..........+..+.+||.+||+.||.+|||+.|+++||||
T Consensus 229 ~~~~~~~~~----------~~~--~~---~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 229 SLPDYKPTF----------PKW--AR---QDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hchhhhhhc----------ccc--cc---cchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 332221100 000 00 00111122345678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=327.18 Aligned_cols=279 Identities=31% Similarity=0.557 Sum_probs=216.3
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC-
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL- 455 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~- 455 (689)
.++|.+.+.||+|+||.||+|++..+|+.||+|++... ......+.+|+.+++.++ |+||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~~~ 87 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ------HENVIGLLDVFTSAV 87 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcC------CCCccchhheecccc
Confidence 57899999999999999999999999999999998653 222345667888877764 67999999998754
Q ss_pred -----CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEE
Q 005590 456 -----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 530 (689)
Q Consensus 456 -----~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vk 530 (689)
...++||||+..++..... ..+++..+..++.|++.||.|||+.||+||||||+||+++. ++.++
T Consensus 88 ~~~~~~~~~lv~e~~~~~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~--~~~~k 157 (342)
T cd07879 88 SGDEFQDFYLVMPYMQTDLQKIMG--------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNE--DCELK 157 (342)
T ss_pred cCCCCceEEEEecccccCHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEE
Confidence 3569999999876654431 12888999999999999999999999999999999999985 78899
Q ss_pred EEecCCcccccCCccccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHH
Q 005590 531 IIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 609 (689)
Q Consensus 531 L~DFGls~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e 609 (689)
|+|||++...........+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+....+..+....+.+..+
T Consensus 158 L~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07879 158 ILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE 237 (342)
T ss_pred EeeCCCCcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9999998766544445577889999999876 458899999999999999999999999988888888888877776665
Q ss_pred HHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
.+.........- +.. .. ..++ ...+.......+..+++||++||+.||.+|||+.++|.||||+.
T Consensus 238 ~~~~~~~~~~~~-------~~~----~~-~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~ 302 (342)
T cd07879 238 FVQKLEDKAAKS-------YIK----SL-PKYP-RKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS 302 (342)
T ss_pred HHHHhcccchHH-------HHh----hc-CCcc-cchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhh
Confidence 544332211000 000 00 0011 11111111224567889999999999999999999999999975
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=327.33 Aligned_cols=243 Identities=27% Similarity=0.396 Sum_probs=191.9
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHH-HHHHhcccCCCCCCceeEEEEEEEeCCeEEEE
Q 005590 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIK-LLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 461 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~----~~~~~~~Ei~-iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lV 461 (689)
+.||+|+||+||+|++..+++.||+|++..... ....+..|.. +++. ..|+||+++++++...+..++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~------~~h~~iv~~~~~~~~~~~~~lv 74 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKN------LKHPFLVGLHYSFQTAEKLYFV 74 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHh------CCCCCccceeeEEEcCCEEEEE
Confidence 368999999999999999999999999975421 1222333333 2332 3588999999999999999999
Q ss_pred EEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccc
Q 005590 462 CELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 540 (689)
Q Consensus 462 mEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~ 540 (689)
|||+.+ +|...+... ..+++..++.++.||+.||.|||+.||+||||||+||||+. ++.+||+|||++...
T Consensus 75 ~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~--~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 75 LDYVNGGELFFHLQRE------RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDS--QGHVVLTDFGLCKEG 146 (321)
T ss_pred EcCCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC--CCCEEEccCCCCccC
Confidence 999986 555444322 22888999999999999999999999999999999999984 788999999998653
Q ss_pred cC---CccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhh
Q 005590 541 TD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 617 (689)
Q Consensus 541 ~~---~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~ 617 (689)
.. .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+...
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--------------- 211 (321)
T cd05603 147 VEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK--------------- 211 (321)
T ss_pred CCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---------------
Confidence 22 223457899999999999989999999999999999999999999887665555444210
Q ss_pred hhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCH----HHHHcCCCCCC
Q 005590 618 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA----REALDHPWLQH 687 (689)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa----~ElL~hpwf~~ 687 (689)
...+|. ..+..+.++|.+||+.||.+|+++ .++++||||+.
T Consensus 212 --------------------~~~~~~---------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 212 --------------------PLQLPG---------GKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred --------------------CCCCCC---------CCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 001111 123557899999999999999976 59999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=315.12 Aligned_cols=276 Identities=29% Similarity=0.484 Sum_probs=218.7
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC--Ce
Q 005590 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--EH 457 (689)
Q Consensus 383 Y~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~--~~ 457 (689)
|++.+.||.|++|.||+|++..+++.+|+|++.... .....+.+|+.+++.+. |+||+++++++... ..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~ 74 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR------HPNIVRLKEIVTSKGKGS 74 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhcc------CCCeeeheeeEecCCCCc
Confidence 678999999999999999999999999999998652 23345677888888775 67999999999988 89
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 458 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 458 l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
.++||||+.+++.+++.... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++. ++.++|+|||++
T Consensus 75 ~~lv~e~~~~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~--~~~~~l~d~g~~ 147 (287)
T cd07840 75 IYMVFEYMDHDLTGLLDSPE-----VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINN--DGVLKLADFGLA 147 (287)
T ss_pred EEEEeccccccHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcC--CCCEEEccccce
Confidence 99999999988877765432 23889999999999999999999999999999999999995 788999999998
Q ss_pred ccccCCc----cccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 005590 538 CFQTDNL----CLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 612 (689)
Q Consensus 538 ~~~~~~~----~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~ 612 (689)
....... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+....+..+....+.++...+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07840 148 RPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227 (287)
T ss_pred eeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcc
Confidence 7654432 23456788999998765 457899999999999999999999999988888888888877777666654
Q ss_pred hhhhhhhhhhccccchhhhhccccccccCCccchhhhhccC-CcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQF-SDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~-~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
........- ......+....+...... .+..+.++|++||+.+|++|||+.++++||||
T Consensus 228 ~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 228 GVSKLPWFE--------------NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccchhhh--------------hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 433221000 000001111111122222 25678999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=316.06 Aligned_cols=260 Identities=29% Similarity=0.431 Sum_probs=206.6
Q ss_pred ecCcEEEEE-EeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe---
Q 005590 379 IAGRYYVTE-YLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--- 454 (689)
Q Consensus 379 l~~rY~i~~-~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~--- 454 (689)
+.++|+|.. +||-|-.|+|..+.++.||+++|+|++... ....+|+++..... .|+|||.++++|..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s-----~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMAS-----GHPHIVSIIDVYENSYQ 129 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhc-----CCCceEEeehhhhhhcc
Confidence 456777764 699999999999999999999999998654 35567777766654 58999999999874
Q ss_pred -CCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec-cCCCeEEE
Q 005590 455 -LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKI 531 (689)
Q Consensus 455 -~~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~-~~~~~vkL 531 (689)
...+.+|||.|+| .|+..+... +...|++.++..|++||..|+.|||+.+|.||||||+|+|.+. ..+..+||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~----g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDR----GDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHc----ccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEe
Confidence 3679999999996 576666543 3345999999999999999999999999999999999999964 34678999
Q ss_pred EecCCccccc--CCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHH
Q 005590 532 IDLGSSCFQT--DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 609 (689)
Q Consensus 532 ~DFGls~~~~--~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e 609 (689)
+|||+|+... ....+.+-||.|.|||++...+|+...|+||+||++|-||+|.+||....-.. ++..
T Consensus 206 tDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-----------ispg 274 (400)
T KOG0604|consen 206 TDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----------ISPG 274 (400)
T ss_pred cccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-----------CChh
Confidence 9999998766 34556788999999999999999999999999999999999999996542211 1111
Q ss_pred HHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
|- .......|.+|.... ...++..+|+|+++|..+|++|+|+.+++.|||+.+
T Consensus 275 Mk--------------------~rI~~gqy~FP~pEW-----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 275 MK--------------------RRIRTGQYEFPEPEW-----SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred HH--------------------hHhhccCccCCChhH-----hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 10 011122344443211 123467899999999999999999999999999975
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=311.41 Aligned_cols=249 Identities=29% Similarity=0.387 Sum_probs=199.3
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh------hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD------FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~------~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
+.|.+.+.||+|++|.||++.+..+++.+|+|.+..... ....+.+|+.+++.+ .|+||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~ 75 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL------QHERIVQYYGCLRD 75 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC------CCCCeeeeEEEEcc
Confidence 468999999999999999999999999999999875321 223556677777766 47899999999999
Q ss_pred CCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEe
Q 005590 455 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 533 (689)
Q Consensus 455 ~~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~D 533 (689)
....++||||+.+ +|.+.+.... .+++..+..++.|++.||.|||+.||+|+||+|+||+++. ++.++|+|
T Consensus 76 ~~~~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~--~~~~~l~d 147 (263)
T cd06625 76 DETLSIFMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDS--AGNVKLGD 147 (263)
T ss_pred CCeEEEEEEECCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEee
Confidence 9999999999985 6766665332 2788999999999999999999999999999999999984 78899999
Q ss_pred cCCcccccCCc------cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCc
Q 005590 534 LGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 607 (689)
Q Consensus 534 FGls~~~~~~~------~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~ 607 (689)
||++....... ....++..|+|||++.+..++.++|+||||+++|+|++|+.||...........+...
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----- 222 (263)
T cd06625 148 FGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ----- 222 (263)
T ss_pred cccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhcc-----
Confidence 99986543211 2345778999999999988999999999999999999999999765443332222100
Q ss_pred HHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 608 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 608 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
.....+| ...+..+.+||++||..+|.+|||+.++|+||||
T Consensus 223 ----------------------------~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 223 ----------------------------PTNPQLP---------SHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred ----------------------------CCCCCCC---------ccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 0001111 1234568899999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=335.74 Aligned_cols=251 Identities=27% Similarity=0.398 Sum_probs=216.3
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
++|.+++++|+|+||.+++++++..+..+++|.+.... ........|+.++.+++ ||||+.+++.|...+.
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~------hP~iv~y~ds~~~~~~ 77 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLL------HPNIVEYKDSFEEDGQ 77 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhcc------CCCeeeeccchhcCCc
Confidence 67999999999999999999999999999999997643 23346678888888765 7899999999998888
Q ss_pred -EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 458 -LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 458 -l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
++|||+|++| ++.+.+...+ ...++++.+..++.||+.||.|||+++|+|||||+.||++++ ++.|+|+|||
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~k----~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk--~~~VkLgDfG 151 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQK----GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTK--DKKVKLGDFG 151 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccc--cCceeecchh
Confidence 9999999996 5666665444 234999999999999999999999999999999999999996 6778999999
Q ss_pred CcccccCC---ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 005590 536 SSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 612 (689)
Q Consensus 536 ls~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~ 612 (689)
+|+..+.. ..+.+||+.|++||++.+.+|..++|||||||++|||++-+++|.+.+...+..+|......
T Consensus 152 laK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~------- 224 (426)
T KOG0589|consen 152 LAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYS------- 224 (426)
T ss_pred hhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCC-------
Confidence 99987654 34578999999999999999999999999999999999999999999999999888744421
Q ss_pred hhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCC
Q 005590 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686 (689)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~ 686 (689)
.+|. ....+++.||..||+.+|+.||++.+||.+|.++
T Consensus 225 ---------------------------Plp~---------~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 225 ---------------------------PLPS---------MYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred ---------------------------CCCc---------cccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 1111 1235688999999999999999999999998775
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=326.40 Aligned_cols=277 Identities=36% Similarity=0.529 Sum_probs=222.7
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC--
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE-- 456 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~-- 456 (689)
||++.+.||.|++|.||+|++..+++.+|||++... ......+.+|+.+++.++ |+||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR------HENIIGLLDILRPPSPE 74 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcC------CcchhhhhhhhcccCcc
Confidence 689999999999999999999889999999998753 233456778888888775 679999999988775
Q ss_pred ---eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEe
Q 005590 457 ---HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 533 (689)
Q Consensus 457 ---~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~D 533 (689)
.+++||||+.++|.+++.... .+++..++.++.||+.||.|||+.||+|+||||+|||++. ++.++|+|
T Consensus 75 ~~~~~~lv~e~~~~~l~~~l~~~~------~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~--~~~~~L~d 146 (330)
T cd07834 75 DFNDVYIVTELMETDLHKVIKSPQ------PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNS--NCDLKICD 146 (330)
T ss_pred cccceEEEecchhhhHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEcc
Confidence 899999999988777765322 3899999999999999999999999999999999999995 68999999
Q ss_pred cCCcccccCC------ccccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 005590 534 LGSSCFQTDN------LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 606 (689)
Q Consensus 534 FGls~~~~~~------~~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~ 606 (689)
||.+...... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||.+.+..+.+..++...+.+
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 226 (330)
T cd07834 147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP 226 (330)
T ss_pred cCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCC
Confidence 9998765443 2234678899999999887 79999999999999999999999999999999999999888887
Q ss_pred cHHHHhhhh--hhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCC
Q 005590 607 DLEMLMQGQ--EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 684 (689)
Q Consensus 607 ~~e~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpw 684 (689)
+.+.+.... ....+... . .......+.......+..+.+||.+||+++|.+|||+.++++|||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~-------------~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 291 (330)
T cd07834 227 SEEDLKFITSEKARNYLKS-------------L--PKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY 291 (330)
T ss_pred ChhHhhhccccchhhHHhh-------------c--ccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCcc
Confidence 776654211 11111110 0 000011111122234567899999999999999999999999999
Q ss_pred CCC
Q 005590 685 LQH 687 (689)
Q Consensus 685 f~~ 687 (689)
|++
T Consensus 292 ~~~ 294 (330)
T cd07834 292 LAQ 294 (330)
T ss_pred HHh
Confidence 975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=314.12 Aligned_cols=253 Identities=26% Similarity=0.419 Sum_probs=199.7
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC----
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL---- 455 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~---- 455 (689)
.++|++.+.||+|+||.||+|++..+++.+|+|++.........+..|+.+++.+. .|+||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~-----~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS-----HHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhc-----CCCCeeeEeeEEeecCCCC
Confidence 46799999999999999999999999999999999876555567778888888774 378999999998753
Q ss_pred --CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEE
Q 005590 456 --EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 532 (689)
Q Consensus 456 --~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~ 532 (689)
...++||||+.+ +|.+++.... ...+++..+..++.|++.||.|||+.+|+|+||||+||+++. ++.++|+
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~--~~~~~l~ 153 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTK----GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTE--NAEVKLV 153 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECC--CCCEEEc
Confidence 468999999985 6777665422 123889999999999999999999999999999999999984 7789999
Q ss_pred ecCCcccccCC---ccccccCccccChhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 005590 533 DLGSSCFQTDN---LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 604 (689)
Q Consensus 533 DFGls~~~~~~---~~~~~gt~~Y~APE~l~-----~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g 604 (689)
|||++...... .....+++.|+|||++. +..++.++|+||+||++|+|++|..||...........+..
T Consensus 154 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~--- 230 (272)
T cd06637 154 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR--- 230 (272)
T ss_pred cCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc---
Confidence 99998754322 23356889999999986 34588899999999999999999999965433222111100
Q ss_pred CCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCC
Q 005590 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 684 (689)
Q Consensus 605 ~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpw 684 (689)
.......+ ...+..+.+||.+||..||.+|||+.++++|||
T Consensus 231 ------------------------------~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 271 (272)
T cd06637 231 ------------------------------NPAPRLKS---------KKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271 (272)
T ss_pred ------------------------------CCCCCCCC---------CCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCC
Confidence 00000000 012356889999999999999999999999999
Q ss_pred C
Q 005590 685 L 685 (689)
Q Consensus 685 f 685 (689)
|
T Consensus 272 ~ 272 (272)
T cd06637 272 I 272 (272)
T ss_pred C
Confidence 7
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=324.79 Aligned_cols=288 Identities=22% Similarity=0.280 Sum_probs=197.9
Q ss_pred EEEEeccC--CCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEE
Q 005590 385 VTEYLGSA--AFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 459 (689)
Q Consensus 385 i~~~LG~G--~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~ 459 (689)
++++||+| +|++||++.+..+|+.||+|++..+. .....+.+|+.+++.++ ||||+++++++...+..+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~------hpniv~~~~~~~~~~~~~ 75 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFN------HPNIVPYRATFIADNELW 75 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcC------CCCeeeEEEEEEECCEEE
Confidence 46789999 67899999999999999999997542 23345666777777664 789999999999999999
Q ss_pred EEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcc
Q 005590 460 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 460 lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 538 (689)
+||||+.+ ++.+++...... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.++++||+...
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~--~~~~~l~~~~~~~ 149 (327)
T cd08227 76 VVTSFMAYGSAKDLICTHFMD----GMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISV--DGKVYLSGLRSNL 149 (327)
T ss_pred EEEeccCCCcHHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEec--CCcEEEcccchhh
Confidence 99999984 677776543221 2889999999999999999999999999999999999985 7789999998643
Q ss_pred cccC----------CccccccCccccChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 005590 539 FQTD----------NLCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 606 (689)
Q Consensus 539 ~~~~----------~~~~~~gt~~Y~APE~l~~--~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~ 606 (689)
.... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||.............. +..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~ 227 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTV 227 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCc
Confidence 3211 1122356778999999976 4689999999999999999999999986554443333221 111
Q ss_pred cHHHHh---hhhhhhhhhhccccchhhhhccccccccCCcc--chhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 607 DLEMLM---QGQEIYKYFTKEYDLYYINEETNQLEYIIPEE--SSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 607 ~~e~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~--~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
+...-. ..+................. ........+.. ..........++.+.+||++||+.||++|||++|||+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 228 PCLLDTTTIPAEELTMKPSRSGANSGLGE-STTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccccccchhhhhcccCCcccCCcCCCCc-ccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 100000 00000000000000000000 00000000000 0000111234567999999999999999999999999
Q ss_pred CCCCCC
Q 005590 682 HPWLQH 687 (689)
Q Consensus 682 hpwf~~ 687 (689)
||||++
T Consensus 307 ~p~f~~ 312 (327)
T cd08227 307 HSFFKQ 312 (327)
T ss_pred Chhhhh
Confidence 999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=316.71 Aligned_cols=254 Identities=24% Similarity=0.305 Sum_probs=201.9
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
.|++.+.||+|+||+||++.+..+++.+|+|++.... .......+|+.+++.++ |++|+++++.+...+.
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~------~~~i~~~~~~~~~~~~ 74 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN------SQFVVNLAYAYETKDA 74 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC------CcCceeEEEEEecCCE
Confidence 3788899999999999999999999999999987542 12234567888888775 6799999999999999
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 458 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 458 l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
.++||||+.+ +|.+.+.... ...+++..+..++.|++.||.|||+.||+||||||+||+++. ++.++|+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~--~~~~kl~Dfg~ 148 (285)
T cd05632 75 LCLVLTIMNGGDLKFHIYNMG----NPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDD--YGHIRISDLGL 148 (285)
T ss_pred EEEEEEeccCccHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECC--CCCEEEecCCc
Confidence 9999999986 4555443221 123899999999999999999999999999999999999985 67899999998
Q ss_pred cccccC--CccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 537 SCFQTD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 537 s~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
+..... ......+++.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+.......
T Consensus 149 ~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~-------- 220 (285)
T cd05632 149 AVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET-------- 220 (285)
T ss_pred ceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc--------
Confidence 865432 2233578999999999999899999999999999999999999998765443333322111000
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcC-----HHHHHcCCCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPWLQH 687 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT-----a~ElL~hpwf~~ 687 (689)
...++ ...+..+.+||.+||+.||++||| +.++++||||+.
T Consensus 221 -----------------------~~~~~---------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05632 221 -----------------------EEVYS---------AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN 266 (285)
T ss_pred -----------------------ccccC---------ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhc
Confidence 00011 112356789999999999999999 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=318.83 Aligned_cols=279 Identities=27% Similarity=0.418 Sum_probs=215.5
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC-
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL- 455 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~---~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~- 455 (689)
.++|++.++||.|+||.||+|++..+++.+|+|++..... ......+|+++++.++ |+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~ 80 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK------HPNVVPLIDMAVERP 80 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcC------CCCccchhhheeccc
Confidence 5899999999999999999999999999999999865321 1234567888888774 67999999987543
Q ss_pred -------CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCe
Q 005590 456 -------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 528 (689)
Q Consensus 456 -------~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~ 528 (689)
..+++||||+.+++...+.... ..+++..++.++.||+.||.|||+.||+|+||||+||+++. ++.
T Consensus 81 ~~~~~~~~~~~lv~~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~--~~~ 153 (311)
T cd07866 81 DKSKRKRGSVYMVTPYMDHDLSGLLENPS-----VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDN--QGI 153 (311)
T ss_pred ccccccCceEEEEEecCCcCHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC--CCC
Confidence 3579999999988777665322 23899999999999999999999999999999999999985 788
Q ss_pred EEEEecCCcccccCCc--------------cccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHH
Q 005590 529 IKIIDLGSSCFQTDNL--------------CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVV 593 (689)
Q Consensus 529 vkL~DFGls~~~~~~~--------------~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~~ 593 (689)
++|+|||++....... ....+++.|+|||.+.+. .++.++|+|||||++|+|++|.+||.+.+..
T Consensus 154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~ 233 (311)
T cd07866 154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233 (311)
T ss_pred EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999886543211 123557889999998754 5889999999999999999999999998888
Q ss_pred HHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCC
Q 005590 594 MILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 673 (689)
Q Consensus 594 ~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kR 673 (689)
.....+....+.++...+..+......... ......+ ..+........+.+.+||++||+.||.+|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 299 (311)
T cd07866 234 DQLHLIFKLCGTPTEETWPGWRSLPGCEGV------------HSFTNYP--RTLEERFGKLGPEGLDLLSKLLSLDPYKR 299 (311)
T ss_pred HHHHHHHHHhCCCChhhchhhhhccccccc------------ccCCCCC--ccHHHHcccCChhHHHHHHHHcccCcccC
Confidence 888888877776666555443322211100 0000011 11222223344678999999999999999
Q ss_pred cCHHHHHcCCCC
Q 005590 674 PTAREALDHPWL 685 (689)
Q Consensus 674 pTa~ElL~hpwf 685 (689)
||+.|++.||||
T Consensus 300 ~t~~ell~~~~f 311 (311)
T cd07866 300 LTASDALEHPYF 311 (311)
T ss_pred cCHHHHhcCCCC
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=315.55 Aligned_cols=248 Identities=24% Similarity=0.307 Sum_probs=191.6
Q ss_pred eccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEEEc
Q 005590 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 464 (689)
Q Consensus 389 LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmEy 464 (689)
||+|+||.||++++..+|+.||+|++..... .......|+.+++.++ ||||+++++++....+.++||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~------hp~i~~~~~~~~~~~~~~lv~e~ 74 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN------SPFIVNLAYAFESKTHLCLVMSL 74 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC------CCcEEEEEEEEecCCeEEEEEec
Confidence 7999999999999999999999999864321 1234455777777664 78999999999999999999999
Q ss_pred ccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccCC
Q 005590 465 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 543 (689)
Q Consensus 465 ~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~ 543 (689)
+.+ +|...+..... ..+++..+..++.||+.||.|||+.||+||||||+||+++. ++.++|+|||++......
T Consensus 75 ~~g~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~--~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 75 MNGGDLKYHIYNVGE----RGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDD--QGNCRLSDLGLAVELKDG 148 (277)
T ss_pred CCCCCHHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcC--CCCEEEeeceeeeecCCC
Confidence 985 56555543221 22788889999999999999999999999999999999984 778999999998765432
Q ss_pred --ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhh
Q 005590 544 --LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYF 621 (689)
Q Consensus 544 --~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~ 621 (689)
.....+++.|+|||++.+..++.++|+|||||++|+|++|..||...........+...
T Consensus 149 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~------------------- 209 (277)
T cd05607 149 KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRR------------------- 209 (277)
T ss_pred ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHH-------------------
Confidence 22356889999999999988999999999999999999999999754221111111000
Q ss_pred hccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCH----HHHHcCCCCCC
Q 005590 622 TKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA----REALDHPWLQH 687 (689)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa----~ElL~hpwf~~ 687 (689)
.....++. .....+.++++||++||+.||++||++ +++++||||+.
T Consensus 210 --------------~~~~~~~~------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 210 --------------TLEDEVKF------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred --------------hhcccccc------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence 00000000 001235668999999999999999999 77889999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=315.46 Aligned_cols=279 Identities=27% Similarity=0.457 Sum_probs=211.4
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
++|++.++||+|+||.||+|.+..+++.||+|++.... .....+.+|+++++.++ |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~ 74 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR------HENLVNLIEVFRRKKR 74 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcC------CcchhhHHHhcccCCe
Confidence 47999999999999999999998899999999876432 12345667888777764 6799999999999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 458 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 458 l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
.++||||+.++++..+.... ..+++..+..++.||+.||.|||+.||+|+||+|+||+++. ++.++|+|||++
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~--~~~~~l~dfg~~ 147 (286)
T cd07846 75 LYLVFEFVDHTVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ--SGVVKLCDFGFA 147 (286)
T ss_pred EEEEEecCCccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC--CCcEEEEeeeee
Confidence 99999999986655443221 12789999999999999999999999999999999999984 788999999998
Q ss_pred ccccCC---ccccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 005590 538 CFQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 538 ~~~~~~---~~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
...... .....++..|+|||++.+ ..++.++|+|||||++|+|++|++||......+.+..+....+.........
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07846 148 RTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI 227 (286)
T ss_pred eeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHH
Confidence 754322 223467889999999875 3478899999999999999999999998887777777776666544321110
Q ss_pred hhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
... ...+.. ......+............+..+.+||.+||+.+|++|||+.++++||||
T Consensus 228 ~~~-~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 228 FQK-NPLFAG------------MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hcc-chHhhc------------cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000 000000 00000111111112222345779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=316.08 Aligned_cols=253 Identities=26% Similarity=0.420 Sum_probs=201.0
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe-----
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH----- 454 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~----- 454 (689)
.++|++.+.||.|+||.||+|++..+++.+|+|++.........+..|+.+++.+. +|+||+++++++..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~-----~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYS-----HHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhc-----CCCcEEEEeeehhcccccC
Confidence 47899999999999999999999999999999999876555566778888888774 47899999999863
Q ss_pred -CCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEE
Q 005590 455 -LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 532 (689)
Q Consensus 455 -~~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~ 532 (689)
....++||||+.+ +|.+++..... ..+++..++.++.||+.||.|||+.||+|+||+|+||+++. ++.++|+
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~--~~~~~l~ 163 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKG----NALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTE--NAEVKLV 163 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEEe
Confidence 4678999999985 67776654321 23778889999999999999999999999999999999984 7789999
Q ss_pred ecCCcccccC---CccccccCccccChhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 005590 533 DLGSSCFQTD---NLCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 604 (689)
Q Consensus 533 DFGls~~~~~---~~~~~~gt~~Y~APE~l~-----~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g 604 (689)
|||++..... ......+++.|+|||.+. +..++.++|+|||||++|+|++|..||........+..+....
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~- 242 (282)
T cd06636 164 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP- 242 (282)
T ss_pred eCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC-
Confidence 9999865432 223456889999999986 3468889999999999999999999996544332222111000
Q ss_pred CCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCC
Q 005590 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 684 (689)
Q Consensus 605 ~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpw 684 (689)
.+. . .....+..+.+||++||+.||.+|||+.|+|+|||
T Consensus 243 ------------------------------------~~~---~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~ 281 (282)
T cd06636 243 ------------------------------------PPK---L--KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF 281 (282)
T ss_pred ------------------------------------CCC---C--cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCC
Confidence 000 0 00123467899999999999999999999999999
Q ss_pred C
Q 005590 685 L 685 (689)
Q Consensus 685 f 685 (689)
|
T Consensus 282 ~ 282 (282)
T cd06636 282 I 282 (282)
T ss_pred C
Confidence 7
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=321.22 Aligned_cols=279 Identities=34% Similarity=0.563 Sum_probs=220.8
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe-
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH- 454 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~- 454 (689)
+.++|++.+.||.|+||.||+|.+..+++.||+|++... ......+.+|+.+++.++ ||||++++++|..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~~~ 81 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR------HENIISLSDIFISP 81 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcC------CCCeeeEeeeEecC
Confidence 568899999999999999999999999999999987642 222355667888888774 6899999999876
Q ss_pred CCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEec
Q 005590 455 LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 534 (689)
Q Consensus 455 ~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DF 534 (689)
....++||||++++|..++... .+++..+..++.||+.||.|||+.||+|+||+|+||+++. ++.++|+||
T Consensus 82 ~~~~~lv~e~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~--~~~~~l~df 152 (328)
T cd07856 82 LEDIYFVTELLGTDLHRLLTSR-------PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINE--NCDLKICDF 152 (328)
T ss_pred CCcEEEEeehhccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECC--CCCEEeCcc
Confidence 5678999999988877665421 2778888999999999999999999999999999999984 788999999
Q ss_pred CCcccccCCccccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 005590 535 GSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 535 Gls~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
|.+...........+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+...++.++.++...
T Consensus 153 g~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 153 GLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccccccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 998766554445567889999999866 5689999999999999999999999998888777888888888888766543
Q ss_pred hhhh--hhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 614 GQEI--YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 614 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
.... .+++. .+. ..............+..+.++|++||+.+|++|||+.+++.||||+.
T Consensus 233 ~~~~~~~~~~~-------------~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~ 293 (328)
T cd07856 233 ICSENTLRFVQ-------------SLP--KREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293 (328)
T ss_pred ccchhhHHHHh-------------hcc--ccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccc
Confidence 2111 00000 000 00011111222234567899999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=340.31 Aligned_cols=254 Identities=30% Similarity=0.477 Sum_probs=213.1
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeec-chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN-DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 459 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~-~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~ 459 (689)
+-|.|+.-||-|+||+||+|.++.++-..|.|++.. .......++.|+.||..+ +||+|+++++.|+..+.++
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~C------dHP~ivkLl~ayy~enkLw 105 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAEC------DHPVIVKLLSAYYFENKLW 105 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcC------CChHHHHHHHHHhccCceE
Confidence 458888999999999999999998888889998864 345567888899998766 5889999999999999999
Q ss_pred EEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccc
Q 005590 460 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539 (689)
Q Consensus 460 lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 539 (689)
|+.|||+|+-.+.+..... ..+++..++.+++|++.||.|||+++|||||||..|||++- +|.|+|+|||.+..
T Consensus 106 iliEFC~GGAVDaimlEL~----r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tl--dGdirLADFGVSAK 179 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLELG----RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTL--DGDIRLADFGVSAK 179 (1187)
T ss_pred EEEeecCCchHhHHHHHhc----cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEe--cCcEeeeccccccc
Confidence 9999999987776654432 23999999999999999999999999999999999999994 88999999998765
Q ss_pred ccC---CccccccCccccChhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 005590 540 QTD---NLCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 611 (689)
Q Consensus 540 ~~~---~~~~~~gt~~Y~APE~l~-----~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~ 611 (689)
... ..-.+.|||+|||||++. ..+|+.++||||||++|.+|..+.+|-...++..++.+|.+--+|.
T Consensus 180 n~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPT----- 254 (1187)
T KOG0579|consen 180 NKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT----- 254 (1187)
T ss_pred chhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCc-----
Confidence 432 234589999999999974 6789999999999999999999999998888888777765322110
Q ss_pred hhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
..-|..+ +..|.|||.+||..||+.||++.++|+|||+++
T Consensus 255 ---------------------------LlqPS~W---------s~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 255 ---------------------------LLQPSHW---------SRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred ---------------------------ccCcchh---------hhHHHHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence 0011111 245889999999999999999999999999985
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=326.57 Aligned_cols=279 Identities=30% Similarity=0.532 Sum_probs=218.5
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-- 454 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~-- 454 (689)
..+|.+.+.||+|++|.||++.+..+|+.||+|++.... .....+.+|+.+++.++ |+||+++++++..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~ 77 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK------HDNIIAIRDILRPPG 77 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcC------CCCccCHHHhccccC
Confidence 478999999999999999999999999999999987532 23345667888888774 6799999998763
Q ss_pred --CCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEE
Q 005590 455 --LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 532 (689)
Q Consensus 455 --~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~ 532 (689)
...+++||||+.++|..++... ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+
T Consensus 78 ~~~~~~~lv~e~~~~~l~~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~--~~~~kl~ 149 (334)
T cd07855 78 ADFKDVYVVMDLMESDLHHIIHSD------QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNE--DCELRIG 149 (334)
T ss_pred CCCceEEEEEehhhhhHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCcEEec
Confidence 3578999999998877766432 22899999999999999999999999999999999999984 7889999
Q ss_pred ecCCcccccCC-------ccccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 005590 533 DLGSSCFQTDN-------LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 604 (689)
Q Consensus 533 DFGls~~~~~~-------~~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g 604 (689)
|||++...... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+....+..+....|
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g 229 (334)
T cd07855 150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG 229 (334)
T ss_pred ccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhC
Confidence 99998654321 123467889999999866 4588999999999999999999999999888888888888888
Q ss_pred CCcHHHHhhhhh--hhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 605 PIDLEMLMQGQE--IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 605 ~~~~e~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
.++.+.+..... ...++. ..... ............+..+.+||++||+.+|++|||+.++++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~-------------~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 230 SPSEEVLNRIGSDRVRKYIQ-------------NLPRK--QPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred CChhHhhhhhchhhHHHHHh-------------hcccC--CCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 777666543221 111110 00000 0001111122346779999999999999999999999999
Q ss_pred CCCCC
Q 005590 683 PWLQH 687 (689)
Q Consensus 683 pwf~~ 687 (689)
|||++
T Consensus 295 ~~~~~ 299 (334)
T cd07855 295 PFLAQ 299 (334)
T ss_pred hhhhh
Confidence 99964
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=324.63 Aligned_cols=280 Identities=26% Similarity=0.427 Sum_probs=210.6
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC---
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--- 455 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~--- 455 (689)
.++|++.+.||.|+||.||+|.+..+|+.||+|++.... .......+|+.+++.++ |+||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~------h~~i~~~~~~~~~~~~~ 77 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLD------HDNIVKVYEVLGPSGSD 77 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcC------CCcchhhHhhhcccccc
Confidence 579999999999999999999999999999999986543 23456777888888774 67999998776543
Q ss_pred -----------CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecc
Q 005590 456 -----------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY 524 (689)
Q Consensus 456 -----------~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~ 524 (689)
...++||||++++|.+++... .+++..++.++.||+.||.|||+.||+||||||+||+++.
T Consensus 78 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~- 149 (342)
T cd07854 78 LTEDVGSLTELNSVYIVQEYMETDLANVLEQG-------PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT- 149 (342)
T ss_pred cccccccccccceEEEEeecccccHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC-
Confidence 368999999998877666421 2889999999999999999999999999999999999975
Q ss_pred CCCeEEEEecCCcccccCC------ccccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHH
Q 005590 525 QRCEIKIIDLGSSCFQTDN------LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILA 597 (689)
Q Consensus 525 ~~~~vkL~DFGls~~~~~~------~~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~ 597 (689)
.++.++|+|||.+...... .....++..|+|||.+.. ..++.++|||||||++|+|++|+.||......+...
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~ 229 (342)
T cd07854 150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229 (342)
T ss_pred CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 4567999999998754321 122356888999998764 568889999999999999999999998877776666
Q ss_pred HHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHH
Q 005590 598 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 677 (689)
Q Consensus 598 ~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ 677 (689)
.+....+....+............ ... ....+ ...........+.++++||++||+.||.+|||+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~------------~~~-~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 295 (342)
T cd07854 230 LILESVPVVREEDRNELLNVIPSF------------VRN-DGGEP-RRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAE 295 (342)
T ss_pred HHHHhcCCCChHHhhhhhhhhhhh------------hhh-ccccc-CCCHHHHccCCCHHHHHHHHHHhCCCchhccCHH
Confidence 665554433332222111000000 000 00001 1111222234567789999999999999999999
Q ss_pred HHHcCCCCCC
Q 005590 678 EALDHPWLQH 687 (689)
Q Consensus 678 ElL~hpwf~~ 687 (689)
|+|+||||+.
T Consensus 296 ell~h~~~~~ 305 (342)
T cd07854 296 EALMHPYMSC 305 (342)
T ss_pred HHhCCCcccc
Confidence 9999999973
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=323.06 Aligned_cols=279 Identities=31% Similarity=0.563 Sum_probs=217.6
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
+.++|.+.+.||+|+||.||++.+..+++.||+|++.... .......+|+.+++.++ |+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~------h~~iv~~~~~~~~~ 88 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK------HENVIGLLDVFTPA 88 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcC------CCcccceeeeeeec
Confidence 4588999999999999999999999999999999987532 12345667777777764 78999999988643
Q ss_pred ------CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeE
Q 005590 456 ------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 529 (689)
Q Consensus 456 ------~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~v 529 (689)
...++++++++++|.+++... .+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+
T Consensus 89 ~~~~~~~~~~lv~~~~~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~--~~~~ 159 (345)
T cd07877 89 RSLEEFNDVYLVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DCEL 159 (345)
T ss_pred ccccccccEEEEehhcccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcC--CCCE
Confidence 357899999988887765421 2889999999999999999999999999999999999985 7789
Q ss_pred EEEecCCcccccCCccccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcH
Q 005590 530 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 608 (689)
Q Consensus 530 kL~DFGls~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~ 608 (689)
+|+|||++...........+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+....+..+....+..+.
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T cd07877 160 KILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 239 (345)
T ss_pred EEecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999998876555555678899999999876 46889999999999999999999999988877777788777776665
Q ss_pred HHHhhhhhh--hhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCC
Q 005590 609 EMLMQGQEI--YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686 (689)
Q Consensus 609 e~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~ 686 (689)
..+...... ..++. .+ ..+|.. .........++.+++||.+||+.||.+|||+.++|+||||+
T Consensus 240 ~~~~~~~~~~~~~~~~-------------~~-~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~ 304 (345)
T cd07877 240 ELLKKISSESARNYIQ-------------SL-TQMPKM-NFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 304 (345)
T ss_pred HHHhhcccHhHHHHHH-------------Hh-cccCCc-chhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhh
Confidence 554332211 00000 00 001110 01111112356789999999999999999999999999998
Q ss_pred C
Q 005590 687 H 687 (689)
Q Consensus 687 ~ 687 (689)
+
T Consensus 305 ~ 305 (345)
T cd07877 305 Q 305 (345)
T ss_pred h
Confidence 5
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=318.31 Aligned_cols=252 Identities=26% Similarity=0.376 Sum_probs=212.8
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~----~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
-.++|..+++||+|.||+|.+++.+.+|+.+|||+++++ ++.....+.|-++|+..+ ||++..+...|+.
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~------HPFLt~LKYsFQt 239 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR------HPFLTSLKYSFQT 239 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc------CcHHHHhhhhhcc
Confidence 346788999999999999999999999999999999875 344556666777777664 7899999999999
Q ss_pred CCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEec
Q 005590 455 LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 534 (689)
Q Consensus 455 ~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DF 534 (689)
.+++|+||||..|+-+-+.... ...+++.+.+.+-..|+.||.|||+.+||+||||.+|+|++. +|+|||+||
T Consensus 240 ~drlCFVMeyanGGeLf~HLsr-----er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDk--DGHIKitDF 312 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDK--DGHIKITDF 312 (516)
T ss_pred CceEEEEEEEccCceEeeehhh-----hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheecc--CCceEeeec
Confidence 9999999999997532222111 233999999999999999999999999999999999999995 999999999
Q ss_pred CCccc---ccCCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 005590 535 GSSCF---QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 611 (689)
Q Consensus 535 Gls~~---~~~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~ 611 (689)
|+++. .++...++||||.|+|||++....|+.++|+|.+||++|||++|++||.+.+...+...|...
T Consensus 313 GLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e--------- 383 (516)
T KOG0690|consen 313 GLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME--------- 383 (516)
T ss_pred ccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh---------
Confidence 99864 455667799999999999999999999999999999999999999999998887777766411
Q ss_pred hhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcC-----HHHHHcCCCCC
Q 005590 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPWLQ 686 (689)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT-----a~ElL~hpwf~ 686 (689)
...+|. ..+++++.|+..+|..||.+|.. |.|+.+|+||.
T Consensus 384 --------------------------d~kFPr---------~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~ 428 (516)
T KOG0690|consen 384 --------------------------DLKFPR---------TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFA 428 (516)
T ss_pred --------------------------hccCCc---------cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhc
Confidence 122332 23467889999999999999985 89999999997
Q ss_pred C
Q 005590 687 H 687 (689)
Q Consensus 687 ~ 687 (689)
.
T Consensus 429 ~ 429 (516)
T KOG0690|consen 429 S 429 (516)
T ss_pred c
Confidence 5
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=354.46 Aligned_cols=261 Identities=26% Similarity=0.367 Sum_probs=204.5
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005590 376 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 452 (689)
Q Consensus 376 ~~~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f 452 (689)
++...++|++++.||+|+||+||+|++..+++.+|+|++... ......+..|+.+++.+. ||||++++++|
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~------HPNIVrl~d~f 81 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK------HKNIVRYIDRF 81 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcC------CCCcCeEEEEE
Confidence 456678999999999999999999999999999999998753 233456778888888875 68999999998
Q ss_pred EeC--CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC-------CceeccCCCCcEEEe
Q 005590 453 YHL--EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-------GIIHCDLKPENILIK 522 (689)
Q Consensus 453 ~~~--~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~-------gIvHrDLKp~NILl~ 522 (689)
... ..+||||||+.+ +|.+++...... ...+++..++.|+.||+.||.|||+. +||||||||+||||+
T Consensus 82 ~de~~~~lyIVMEY~~gGSL~~lL~k~~~~--~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~ 159 (1021)
T PTZ00266 82 LNKANQKLYILMEFCDAGDLSRNIQKCYKM--FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS 159 (1021)
T ss_pred EecCCCEEEEEEeCCCCCcHHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence 654 579999999984 787777543221 12389999999999999999999985 499999999999996
Q ss_pred cc---------------CCCeEEEEecCCcccccCC--ccccccCccccChhhhcC--CCCCchhhHHHHHHHHHHHHhC
Q 005590 523 SY---------------QRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTG 583 (689)
Q Consensus 523 ~~---------------~~~~vkL~DFGls~~~~~~--~~~~~gt~~Y~APE~l~~--~~~s~~~DIwSLGvil~eLltG 583 (689)
.. ....+||+|||++...... .....+|+.|+|||++.+ ..++.++||||||||||+|++|
T Consensus 160 s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG 239 (1021)
T PTZ00266 160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239 (1021)
T ss_pred cCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence 41 2345899999998765432 234578999999999965 4588999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHH
Q 005590 584 EVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVR 663 (689)
Q Consensus 584 ~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~ 663 (689)
..||........+...+.... .+|. ...+..+.+||.
T Consensus 240 k~PF~~~~~~~qli~~lk~~p-----------------------------------~lpi--------~~~S~eL~dLI~ 276 (1021)
T PTZ00266 240 KTPFHKANNFSQLISELKRGP-----------------------------------DLPI--------KGKSKELNILIK 276 (1021)
T ss_pred CCCCCcCCcHHHHHHHHhcCC-----------------------------------CCCc--------CCCCHHHHHHHH
Confidence 999976543332222110000 0010 112456889999
Q ss_pred HhcccCCCCCcCHHHHHcCCCCCC
Q 005590 664 TLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 664 ~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
.||+.+|.+|||+.|+|.||||+.
T Consensus 277 ~~L~~dPeeRPSa~QlL~h~~ik~ 300 (1021)
T PTZ00266 277 NLLNLSAKERPSALQCLGYQIIKN 300 (1021)
T ss_pred HHhcCChhHCcCHHHHhccHHHhh
Confidence 999999999999999999999964
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=305.56 Aligned_cols=249 Identities=25% Similarity=0.363 Sum_probs=203.1
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
+|.+.+.||+|++|.||++.+..+++.|++|.+... ......+.+|+++++.++ |+||+++++++...+..
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~ 74 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD------SSYIIRYYESFLDKGKL 74 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcC------CCCeehheeeeccCCEE
Confidence 488999999999999999999999999999998753 234456667777777664 78999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
++||||+.+ +|.+++.... ...++...+..++.||+.||.|||+.|++|+||||+||+++. ++.++|+|||++
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~--~~~~~l~df~~~ 148 (256)
T cd08529 75 NIVMEYAENGDLHKLLKMQR----GRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDA--YDNVKIGDLGVA 148 (256)
T ss_pred EEEEEeCCCCcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeC--CCCEEEcccccc
Confidence 999999974 7777766432 123888999999999999999999999999999999999985 788999999988
Q ss_pred ccccCCc---cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 538 CFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 538 ~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
....... ....+++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----------- 217 (256)
T cd08529 149 KLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV----------- 217 (256)
T ss_pred eeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 7654322 22467889999999999889999999999999999999999998776554444332100
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
...++ ...+..+.++|++||+.+|++||++.++++|||+
T Consensus 218 -----------------------~~~~~---------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 218 -----------------------FPPVS---------QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred -----------------------CCCCc---------cccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 00011 0124568899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=318.97 Aligned_cols=287 Identities=26% Similarity=0.322 Sum_probs=206.7
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
++|++.+.||+|+||.||++++..++..+|+|.+..+ .....++.+|+++++.++ ||||+++++++...+++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECN------SPYIVGFYGAFYSDGEI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCC------CCCCCeEEEEEeeCCEE
Confidence 4699999999999999999999999999999998754 223456778888888774 68999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~-~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
++||||+.+ +|.+++... ..+++..+..++.||+.||.|||+ .+++|+||||+|||++. ++.++|+|||+
T Consensus 75 ~lv~ey~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~--~~~~~l~dfg~ 146 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKA------GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNS--RGEIKLCDFGV 146 (308)
T ss_pred EEEeeccCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEec--CCcEEEccCCC
Confidence 999999985 677776543 227899999999999999999997 59999999999999984 77899999998
Q ss_pred cccccCC-ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 005590 537 SCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615 (689)
Q Consensus 537 s~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~ 615 (689)
+...... .....+++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+.......+..... .
T Consensus 147 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 224 (308)
T cd06615 147 SGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH--R 224 (308)
T ss_pred cccccccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCc--c
Confidence 8654332 334578899999999988889999999999999999999999997665443332221111100000000 0
Q ss_pred hhhhhhhccccchhhhhccc-cccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCCC
Q 005590 616 EIYKYFTKEYDLYYINEETN-QLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~-~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~~ 688 (689)
.................... ......|. .. ....+..+++||.+||..||++|||+.++++||||++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 225 PVSGHPPDSPRPMAIFELLDYIVNEPPPK---LP--SGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cccCCCCCccchhhHHHHHHHHhcCCCcc---Cc--CcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 00000000000000000000 00000010 00 01135678999999999999999999999999999763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=320.43 Aligned_cols=279 Identities=34% Similarity=0.538 Sum_probs=217.1
Q ss_pred cEEEEEEeccCCCCceEEEEECCC--CcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC-
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHT--GVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL- 455 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~t--g~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~- 455 (689)
+|++.+.||+|+||.||++++..+ +..||+|++... ........+|+.+++.+. +|+||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~~~~~~~~ 75 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFR-----GHKNITCLYDMDIVFP 75 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhc-----CCCChheeeeeeeecc
Confidence 589999999999999999999887 899999998743 222346677888888874 378999999875432
Q ss_pred ---CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEE
Q 005590 456 ---EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 532 (689)
Q Consensus 456 ---~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~ 532 (689)
...+++|+|++++|.+.+.... .+++..++.++.||+.||.|||+.||+||||||+||+++. ++.++|+
T Consensus 76 ~~~~~~~~~~e~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~--~~~~kl~ 147 (332)
T cd07857 76 GNFNELYLYEELMEADLHQIIRSGQ------PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNA--DCELKIC 147 (332)
T ss_pred ccCCcEEEEEecccCCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcC--CCCEEeC
Confidence 4689999999988887775322 3889999999999999999999999999999999999985 7789999
Q ss_pred ecCCcccccCC-------ccccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 005590 533 DLGSSCFQTDN-------LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 604 (689)
Q Consensus 533 DFGls~~~~~~-------~~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g 604 (689)
|||++...... .....+++.|+|||.+.+ ..++.++|+||+||++|+|++|.+||...+....+..++..+|
T Consensus 148 Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 227 (332)
T cd07857 148 DFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG 227 (332)
T ss_pred cCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC
Confidence 99998754321 123468899999998876 4689999999999999999999999999988899999999999
Q ss_pred CCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCC
Q 005590 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 684 (689)
Q Consensus 605 ~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpw 684 (689)
.++.+.+........... .. .. ...+ ...+.......+..+.+||.+||+.||++|||+.+++.|||
T Consensus 228 ~~~~~~~~~~~~~~~~~~-------~~----~~-~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~ 294 (332)
T cd07857 228 TPDEETLSRIGSPKAQNY-------IR----SL-PNIP-KKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294 (332)
T ss_pred CCCHHHHHhhhhhhHHHH-------HH----hc-cccC-CcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 888766544322110000 00 00 0000 00111111223567899999999999999999999999999
Q ss_pred CC
Q 005590 685 LQ 686 (689)
Q Consensus 685 f~ 686 (689)
|+
T Consensus 295 ~~ 296 (332)
T cd07857 295 LA 296 (332)
T ss_pred hh
Confidence 96
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=328.50 Aligned_cols=254 Identities=29% Similarity=0.420 Sum_probs=200.4
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEee---cchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~---~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
+..|+++++||+||.++||++... ..+.||+|.+. .+....+-+..|+.+|.+|+. |..|+++|+|-...+
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg-----~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKG-----HDKIIQLYDYEVTDG 433 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcC-----CceEEEEeeeeccCc
Confidence 356999999999999999999853 34556666544 345567888999999999985 468999999999999
Q ss_pred eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 457 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 457 ~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
.+|+||||=+.+|...+...... .+...++.+.+||+.|+.++|+.||||.||||.|+|+. .|.+||||||.
T Consensus 434 ~lYmvmE~Gd~DL~kiL~k~~~~-----~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV---kG~LKLIDFGI 505 (677)
T KOG0596|consen 434 YLYMVMECGDIDLNKILKKKKSI-----DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV---KGRLKLIDFGI 505 (677)
T ss_pred eEEEEeecccccHHHHHHhccCC-----CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE---eeeEEeeeech
Confidence 99999999888888877654432 44458899999999999999999999999999999998 79999999999
Q ss_pred cccccCCcc-----ccccCccccChhhhcCC-----------CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHH
Q 005590 537 SCFQTDNLC-----LYVQSRSYRAPEVIIGL-----------PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 600 (689)
Q Consensus 537 s~~~~~~~~-----~~~gt~~Y~APE~l~~~-----------~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~ 600 (689)
|.......+ .-+||+.||+||.+... +.+.++||||||||||+|+.|+.||.... ..++++.
T Consensus 506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~ 583 (677)
T KOG0596|consen 506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLH 583 (677)
T ss_pred hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHH
Confidence 876554322 35899999999998632 26689999999999999999999996432 2333332
Q ss_pred hhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHH
Q 005590 601 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 680 (689)
Q Consensus 601 ~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL 680 (689)
.+..| ..+..+|..... -+++++++.||.+||.+|||..|||
T Consensus 584 aI~~P------------------------------~~~Iefp~~~~~--------~~li~~mK~CL~rdPkkR~si~eLL 625 (677)
T KOG0596|consen 584 AITDP------------------------------NHEIEFPDIPEN--------DELIDVMKCCLARDPKKRWSIPELL 625 (677)
T ss_pred hhcCC------------------------------CccccccCCCCc--------hHHHHHHHHHHhcCcccCCCcHHHh
Confidence 22111 112223332221 1278999999999999999999999
Q ss_pred cCCCCCC
Q 005590 681 DHPWLQH 687 (689)
Q Consensus 681 ~hpwf~~ 687 (689)
+|||++-
T Consensus 626 qhpFl~~ 632 (677)
T KOG0596|consen 626 QHPFLQI 632 (677)
T ss_pred cCccccc
Confidence 9999985
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=316.11 Aligned_cols=283 Identities=27% Similarity=0.466 Sum_probs=216.9
Q ss_pred CceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005590 376 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 452 (689)
Q Consensus 376 ~~~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f 452 (689)
+++..++|++.+.||+|+||.||+|.++.+|+.||+|+++... .......+|+.+++.++ ||||+++++++
T Consensus 2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~------h~~i~~~~~~~ 75 (302)
T cd07864 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLN------HRNIVNLKEIV 75 (302)
T ss_pred chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCC------CCCeeeeehee
Confidence 3455688999999999999999999999999999999987532 22245567788777764 68999999998
Q ss_pred EeCC----------eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEe
Q 005590 453 YHLE----------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIK 522 (689)
Q Consensus 453 ~~~~----------~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~ 522 (689)
.... ++++||||+++++..++.... ..+++..++.++.||+.||.|||+.||+|+||||+||+++
T Consensus 76 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~ 150 (302)
T cd07864 76 TDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-----VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN 150 (302)
T ss_pred cCcchhhhccccCCcEEEEEcccCccHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 7654 899999999998777665321 2388999999999999999999999999999999999998
Q ss_pred ccCCCeEEEEecCCcccccCCc----cccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHH
Q 005590 523 SYQRCEIKIIDLGSSCFQTDNL----CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILA 597 (689)
Q Consensus 523 ~~~~~~vkL~DFGls~~~~~~~----~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~ 597 (689)
. ++.+||+|||++....... ....++..|+|||.+.+. .++.++|||||||++|+|++|++||......+.+.
T Consensus 151 ~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~ 228 (302)
T cd07864 151 N--KGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLE 228 (302)
T ss_pred C--CCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 4 7889999999987654322 123457789999988653 57889999999999999999999999888888888
Q ss_pred HHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHH
Q 005590 598 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 677 (689)
Q Consensus 598 ~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ 677 (689)
.+....+.++...+........+.+.... .. . ...........+..+.+||.+||+.||++|||+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~----~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~ 294 (302)
T cd07864 229 LISRLCGSPCPAVWPDVIKLPYFNTMKPK--------KQ----Y--RRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAE 294 (302)
T ss_pred HHHHHhCCCChhhcccccccccccccccc--------cc----c--ccchhhhcCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 88877776665555433222111000000 00 0 0011111122356789999999999999999999
Q ss_pred HHHcCCCC
Q 005590 678 EALDHPWL 685 (689)
Q Consensus 678 ElL~hpwf 685 (689)
++++||||
T Consensus 295 ~il~~~~~ 302 (302)
T cd07864 295 EALNSPWL 302 (302)
T ss_pred HHhcCCCC
Confidence 99999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=312.57 Aligned_cols=274 Identities=33% Similarity=0.546 Sum_probs=219.3
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEE
Q 005590 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 459 (689)
Q Consensus 383 Y~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~---~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~ 459 (689)
|++.+.||.|++|.||++++..+++.+++|.+..... ......+|+.+++.++ |+||+++++++......+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~ 74 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN------HPNIIKLLDVFRHKGDLY 74 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhc------CCCcchHHHhhccCCCEE
Confidence 5678899999999999999988999999999875422 3456777888888775 679999999999999999
Q ss_pred EEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccc
Q 005590 460 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539 (689)
Q Consensus 460 lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 539 (689)
+||||+.+++...+.... ..+++..+..++.||+.||.|||+.+|+|+||||+||+++. ++.++|+|||.+..
T Consensus 75 ~v~e~~~~~l~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~--~~~~~l~df~~~~~ 147 (283)
T cd05118 75 LVFEFMDTDLYKLIKDRQ-----RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINT--EGVLKLADFGLARS 147 (283)
T ss_pred EEEeccCCCHHHHHHhhc-----ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECC--CCcEEEeeeeeeEe
Confidence 999999998887766432 23889999999999999999999999999999999999984 78899999998876
Q ss_pred ccCCc---cccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 005590 540 QTDNL---CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615 (689)
Q Consensus 540 ~~~~~---~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~ 615 (689)
..... ....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+.+..+...++.+....+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd05118 148 FGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFT 227 (283)
T ss_pred cCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccch
Confidence 54432 224577889999999876 78999999999999999999999999988888888888777776666555443
Q ss_pred hhhhhhhccccchhhhhccccccccCCc--cchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 616 EIYKYFTKEYDLYYINEETNQLEYIIPE--ESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
....... ..++. ...........+..+.+||.+||+.||.+||++.+++.||||
T Consensus 228 ~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 228 SLARNYK----------------FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhh----------------hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 3211110 00010 001111122346778999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.32 Aligned_cols=255 Identities=29% Similarity=0.453 Sum_probs=213.1
Q ss_pred cCcEEEE--EEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005590 380 AGRYYVT--EYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 380 ~~rY~i~--~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
..-|+|. ++||+|-||+||-|++..+|+.||||++.+. .....++.+|+.||+.+. ||.|+.+--.|+.
T Consensus 561 stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~------HPGiV~le~M~ET 634 (888)
T KOG4236|consen 561 STVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLH------HPGIVNLECMFET 634 (888)
T ss_pred HHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcC------CCCeeEEEEeecC
Confidence 3446665 6899999999999999999999999998753 234578889999999885 6799999999999
Q ss_pred CCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccC-CCeEEEEe
Q 005590 455 LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RCEIKIID 533 (689)
Q Consensus 455 ~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~-~~~vkL~D 533 (689)
.+..++|||.+.|++++.+...... .+++...+.++.||+.||.|||.++|+|+||||+|||+.+.. -.++||+|
T Consensus 635 ~ervFVVMEKl~GDMLEMILSsEkg----RL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCD 710 (888)
T KOG4236|consen 635 PERVFVVMEKLHGDMLEMILSSEKG----RLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCD 710 (888)
T ss_pred CceEEEEehhhcchHHHHHHHhhcc----cchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeecc
Confidence 9999999999999999887654332 389999999999999999999999999999999999997532 35899999
Q ss_pred cCCcccccCC--ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-hHHHHHHHHHhhcCCCcHHH
Q 005590 534 LGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND-AVVMILARIIGMLGPIDLEM 610 (689)
Q Consensus 534 FGls~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~-~~~~~l~~i~~~~g~~~~e~ 610 (689)
||+|++.++. ....+|||.|+|||++.++.|....|+||+|||+|.-|+|..||..+ +..++++.-.-+.++.| |
T Consensus 711 FGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~P--W 788 (888)
T KOG4236|consen 711 FGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNP--W 788 (888)
T ss_pred ccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCc--h
Confidence 9999998765 34579999999999999999999999999999999999999999643 33333333221111111 0
Q ss_pred HhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
...+++++|||..+|+..-++|.|.++.|.|||+|+
T Consensus 789 -----------------------------------------~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 789 -----------------------------------------SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred -----------------------------------------hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence 123466889999999999999999999999999986
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=304.56 Aligned_cols=249 Identities=23% Similarity=0.355 Sum_probs=199.0
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe-CCe
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-LEH 457 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~-~~~ 457 (689)
+|++.+.||+|++|.||++++..+++.+|+|.+..+. .......+|+.+++.++ |+|++++++.+.. ...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLK------HPNIVAYRESWEGEDGL 74 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCC------CCCeeeeeeeecCCCCE
Confidence 5899999999999999999999999999999987532 22345666777777664 6799999998764 446
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 458 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 458 l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
+++||||+.+ +|.+.+.... ...+++..++.++.|++.||.+||+.||+|+||||+||+++. ++.++|+|||+
T Consensus 75 ~~lv~e~~~~~~l~~~l~~~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~--~~~~~l~df~~ 148 (257)
T cd08223 75 LYIVMGFCEGGDLYHKLKEQK----GKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTR--TNIIKVGDLGI 148 (257)
T ss_pred EEEEecccCCCcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEec--CCcEEEecccc
Confidence 8999999985 6766665321 123889999999999999999999999999999999999984 78899999999
Q ss_pred cccccCC---ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 005590 537 SCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 537 s~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
+...... .....+++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+.....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~--------- 219 (257)
T cd08223 149 ARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL--------- 219 (257)
T ss_pred eEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC---------
Confidence 8755322 2335678899999999999999999999999999999999999987655444333321100
Q ss_pred hhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
...+ ...+..+.+||.+||+.||++|||+.++++||||
T Consensus 220 -------------------------~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 220 -------------------------PPMP---------KDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -------------------------CCCc---------cccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0001 1134568899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=312.19 Aligned_cols=256 Identities=28% Similarity=0.396 Sum_probs=198.8
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
++|++.+.||+|+||.||++++..+|+.||+|+++... ........|+.++.+. .+|+||+++++++......
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~-----~~~~~iv~~~~~~~~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRS-----VDCPYTVTFYGALFREGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHH-----cCCCCeeeeeEEEecCCcE
Confidence 46999999999999999999999999999999987642 2223444555543322 3588999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~-gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
++||||++++|.+++...... ...+++..++.++.||+.||.|||+. +++||||||+||+++. ++.+||+|||++
T Consensus 76 ~lv~e~~~~~l~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~--~~~~kl~dfg~~ 151 (283)
T cd06617 76 WICMEVMDTSLDKFYKKVYDK--GLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINR--NGQVKLCDFGIS 151 (283)
T ss_pred EEEhhhhcccHHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECC--CCCEEEeecccc
Confidence 999999999888777543222 23489999999999999999999997 9999999999999984 788999999998
Q ss_pred ccccCCc--cccccCccccChhhhcC----CCCCchhhHHHHHHHHHHHHhCCCCCCCC-hHHHHHHHHHhhcCCCcHHH
Q 005590 538 CFQTDNL--CLYVQSRSYRAPEVIIG----LPYDQKIDLWSLGCILAELWTGEVLFPND-AVVMILARIIGMLGPIDLEM 610 (689)
Q Consensus 538 ~~~~~~~--~~~~gt~~Y~APE~l~~----~~~s~~~DIwSLGvil~eLltG~~PF~~~-~~~~~l~~i~~~~g~~~~e~ 610 (689)
....... ....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||... ...+.+..+...
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------- 223 (283)
T cd06617 152 GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE-------- 223 (283)
T ss_pred cccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc--------
Confidence 7654322 23467889999999865 45788999999999999999999999642 111111111100
Q ss_pred HhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
....+|. ...+..+.+||.+||..+|.+|||+.++++||||++
T Consensus 224 --------------------------~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 266 (283)
T cd06617 224 --------------------------PSPQLPA--------EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266 (283)
T ss_pred --------------------------CCCCCCc--------cccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence 0001110 012456889999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=322.88 Aligned_cols=255 Identities=22% Similarity=0.311 Sum_probs=194.1
Q ss_pred eecCcEEEEEEeccCCCCceEEEEE-----CCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005590 378 VIAGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 450 (689)
Q Consensus 378 ~l~~rY~i~~~LG~G~fG~Vyla~d-----~~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~ 450 (689)
+-.++|++.+.||+|+||.||+|.+ ..+++.||||+++... .....+.+|+.++..+. .||||+++++
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~niv~~~~ 78 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIG-----NHLNVVNLLG 78 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhc-----cCcceeeEEe
Confidence 3357899999999999999999975 2456789999987532 23456778999888884 3789999999
Q ss_pred EEEeC-CeEEEEEEccc-cchHHHHhhhhccC------------------------------------------------
Q 005590 451 YFYHL-EHLFIVCELLR-ANLYEFQKFNQESG------------------------------------------------ 480 (689)
Q Consensus 451 ~f~~~-~~l~lVmEy~~-g~L~~l~~~~~~~~------------------------------------------------ 480 (689)
++... ..+++||||+. |+|.+++.......
T Consensus 79 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (338)
T cd05102 79 ACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTN 158 (338)
T ss_pred EecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccc
Confidence 88764 46899999998 47777765432100
Q ss_pred --------CCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccCCc-----ccc
Q 005590 481 --------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLY 547 (689)
Q Consensus 481 --------~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~~-----~~~ 547 (689)
....+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++...... ...
T Consensus 159 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~--~~~~kl~DfG~a~~~~~~~~~~~~~~~ 236 (338)
T cd05102 159 PPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSE--NNVVKICDFGLARDIYKDPDYVRKGSA 236 (338)
T ss_pred cchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcC--CCcEEEeecccccccccCcchhcccCC
Confidence 0123778889999999999999999999999999999999984 7789999999987543221 123
Q ss_pred ccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhcccc
Q 005590 548 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYD 626 (689)
Q Consensus 548 ~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~ 626 (689)
.+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+......
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~------------------------ 292 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD------------------------ 292 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc------------------------
Confidence 44678999999999999999999999999999997 99999875432222111100
Q ss_pred chhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 627 LYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 627 ~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
......| ...++.+.+||.+||+.||.+|||+.|+++
T Consensus 293 ---------~~~~~~~---------~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 293 ---------GTRMRAP---------ENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred ---------CCCCCCC---------CCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0000111 122456889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=309.81 Aligned_cols=277 Identities=30% Similarity=0.460 Sum_probs=213.2
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe--
Q 005590 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH-- 457 (689)
Q Consensus 383 Y~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~---~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~-- 457 (689)
|++.+.||+|+||.||++++..+++.||+|+++.... ......+|+.+++.+.. ..|+||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~h~~i~~~~~~~~~~~~~~ 77 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLES---FEHPNIVRLLDVCHGPRTDR 77 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhc---cCCCCcceEEEEEeeccCCC
Confidence 6789999999999999999988899999999975322 22345567778877753 358999999999998776
Q ss_pred ---EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEec
Q 005590 458 ---LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 534 (689)
Q Consensus 458 ---l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DF 534 (689)
.+++|||+.+++.+++..... ..+++..++.++.||+.||.|||+.+++|+||+|+||+++. ++.++|+||
T Consensus 78 ~~~~~l~~e~~~~~l~~~l~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~--~~~~~l~df 151 (287)
T cd07838 78 ELKLTLVFEHVDQDLATYLSKCPK----PGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTS--DGQVKIADF 151 (287)
T ss_pred CceeEEEehhcccCHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEcc--CCCEEEecc
Confidence 999999999888877654322 13889999999999999999999999999999999999995 688999999
Q ss_pred CCcccccCC--ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 005590 535 GSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 612 (689)
Q Consensus 535 Gls~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~ 612 (689)
|.+...... .....++..|+|||.+.+..++.++|+|||||++|+|++|.+||......+.+.++...........+.
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 152 GLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred CcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcC
Confidence 998765432 223457888999999999899999999999999999999999999988888887777555443322221
Q ss_pred hhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
....... .......+. ............+.+||.+||+.||++||++.++++||||
T Consensus 232 ~~~~~~~---------------~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 232 RNVSLPR---------------SSFPSYTPR--SFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred CCcccch---------------hhccccccc--chhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 1110000 000000000 0011111234668899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.34 Aligned_cols=254 Identities=26% Similarity=0.369 Sum_probs=204.6
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|++.+.||+|++|.||+|.+..+++.+|+|.+..... ....+..|+++++.+. |+||+++++.+....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~ 74 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD------HPFLPTLYASFQTET 74 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC------CCCchhheeeeecCC
Confidence 479999999999999999999999999999999876432 3345667777777664 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
..++||||+.+ +|.+++.... ...+++..++.++.||+.||.|||+.|++|+||||+||+++. ++.++|+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~~l~dfg 148 (316)
T cd05574 75 YLCLVMDYCPGGELFRLLQRQP----GKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHE--SGHIMLSDFD 148 (316)
T ss_pred EEEEEEEecCCCCHHHHHHhCC----CCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcC--CCCEEEeecc
Confidence 99999999985 6777665321 223889999999999999999999999999999999999985 7789999999
Q ss_pred CcccccCC--------------------------------ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhC
Q 005590 536 SSCFQTDN--------------------------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 583 (689)
Q Consensus 536 ls~~~~~~--------------------------------~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG 583 (689)
++...... .....|+..|+|||++.+..++.++||||||+++|+|++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g 228 (316)
T cd05574 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228 (316)
T ss_pred hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence 87543211 1123678889999999998899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHH
Q 005590 584 EVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVR 663 (689)
Q Consensus 584 ~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~ 663 (689)
..||.+.+....+..+.... ...+.. ...+..+.+||.
T Consensus 229 ~~pf~~~~~~~~~~~~~~~~-----------------------------------~~~~~~-------~~~~~~~~~li~ 266 (316)
T cd05574 229 TTPFKGSNRDETFSNILKKE-----------------------------------VTFPGS-------PPVSSSARDLIR 266 (316)
T ss_pred CCCCCCCchHHHHHHHhcCC-----------------------------------ccCCCc-------cccCHHHHHHHH
Confidence 99998776555444432100 001110 013467899999
Q ss_pred HhcccCCCCCcC----HHHHHcCCCCCCC
Q 005590 664 TLLEINPQRRPT----AREALDHPWLQHP 688 (689)
Q Consensus 664 ~mL~~dP~kRpT----a~ElL~hpwf~~~ 688 (689)
+||..||++||| +.|+|+||||++.
T Consensus 267 ~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 267 KLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred HHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 999999999999 9999999999863
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=308.13 Aligned_cols=256 Identities=27% Similarity=0.408 Sum_probs=203.0
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC---
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE--- 456 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~--- 456 (689)
.++|++.+.||+|++|.||+|++..+++.+++|++.........+.+|+.+++.+. .|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~-----~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS-----NHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhc-----CCCChheEEEEEEecCCCC
Confidence 47899999999999999999999989999999999876655677888999888874 3789999999997644
Q ss_pred ---eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEE
Q 005590 457 ---HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 532 (689)
Q Consensus 457 ---~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~ 532 (689)
..++||||+.+ +|.+++..... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++. ++.++|+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~--~~~~~l~ 155 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRK--KGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTK--NAEVKLV 155 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEcc--CCeEEEC
Confidence 58999999986 67666654321 1233889999999999999999999999999999999999984 7889999
Q ss_pred ecCCcccccCC---ccccccCccccChhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 005590 533 DLGSSCFQTDN---LCLYVQSRSYRAPEVIIG-----LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 604 (689)
Q Consensus 533 DFGls~~~~~~---~~~~~gt~~Y~APE~l~~-----~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g 604 (689)
|||++...... .....++..|+|||++.. ..++.++|+|||||++|+|++|..||........+..+.....
T Consensus 156 d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 235 (275)
T cd06608 156 DFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP 235 (275)
T ss_pred CCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCC
Confidence 99988654322 233567889999999854 3477899999999999999999999976544333333221000
Q ss_pred CCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCC
Q 005590 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 684 (689)
Q Consensus 605 ~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpw 684 (689)
..+.. ....+..+++||++||..||++|||+.++++|||
T Consensus 236 ----------------------------------~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~ 274 (275)
T cd06608 236 ----------------------------------PTLKS-------PENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274 (275)
T ss_pred ----------------------------------CCCCc-------hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCC
Confidence 00000 0012356889999999999999999999999999
Q ss_pred C
Q 005590 685 L 685 (689)
Q Consensus 685 f 685 (689)
+
T Consensus 275 ~ 275 (275)
T cd06608 275 I 275 (275)
T ss_pred C
Confidence 7
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=322.07 Aligned_cols=252 Identities=25% Similarity=0.433 Sum_probs=210.7
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 461 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lV 461 (689)
-|.|+++||+|+||.||+|.++.+|+.+|||.++.+.+ ...+..|+.|++++.. +++|++|+.|.....++||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD-LQEIIKEISIMQQC~S------~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD-LQEIIKEISIMQQCKS------KYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch-HHHHHHHHHHHHHcCC------chhhhhhhhhccCCceEee
Confidence 36788899999999999999999999999999988764 4677889999988864 5899999999999999999
Q ss_pred EEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccc
Q 005590 462 CELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 540 (689)
Q Consensus 462 mEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~ 540 (689)
||||+ |++.+.++..+.. +++.++..+++..+.||+|||...-||||||..|||++. +|..||+|||.+...
T Consensus 107 MEYCGAGSiSDI~R~R~K~-----L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT--~G~AKLADFGVAGQL 179 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKP-----LSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNT--DGIAKLADFGVAGQL 179 (502)
T ss_pred hhhcCCCcHHHHHHHhcCC-----ccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcc--cchhhhhhccccchh
Confidence 99999 6788887765543 999999999999999999999999999999999999995 899999999999887
Q ss_pred cCC---ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhh
Q 005590 541 TDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 617 (689)
Q Consensus 541 ~~~---~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~ 617 (689)
++. ..+..|||.|||||++..-.|+.++||||||++..||..|++||..-.+..-+. +++.-|++.+
T Consensus 180 TDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF----MIPT~PPPTF------ 249 (502)
T KOG0574|consen 180 TDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF----MIPTKPPPTF------ 249 (502)
T ss_pred hhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE----eccCCCCCCC------
Confidence 764 456789999999999999999999999999999999999999997643322111 1111111111
Q ss_pred hhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCCC
Q 005590 618 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~~ 688 (689)
..|+.+ +.+|.|||++||..+|++|.||.+|++|||++++
T Consensus 250 ----------------------~KPE~W---------S~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 250 ----------------------KKPEEW---------SSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred ----------------------CChHhh---------hhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 111111 2458899999999999999999999999999864
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=313.12 Aligned_cols=254 Identities=31% Similarity=0.476 Sum_probs=200.2
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
++.|++++.||+|+||.||++++..+++.+++|++.... .....+.+|+.+++.+ .|+||+++++.+......
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~ 84 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC------NHPYIVKLLGAFYWDGKL 84 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhC------CCCcEeeeEEEEEeCCeE
Confidence 467999999999999999999999999999999987543 3345566777777766 478999999999999999
Q ss_pred EEEEEccccchHH-HHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRANLYE-FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g~L~~-l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
++||||+.++.+. ++.... ..+++..+..++.||+.||.|||+.|++||||||+||+++. ++.++|+|||++
T Consensus 85 ~lv~e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~kl~dfg~~ 157 (292)
T cd06644 85 WIMIEFCPGGAVDAIMLELD-----RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTL--DGDIKLADFGVS 157 (292)
T ss_pred EEEEecCCCCcHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcC--CCCEEEccCccc
Confidence 9999999976443 332211 12889999999999999999999999999999999999984 788999999987
Q ss_pred ccccCC---ccccccCccccChhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHH
Q 005590 538 CFQTDN---LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 609 (689)
Q Consensus 538 ~~~~~~---~~~~~gt~~Y~APE~l~-----~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e 609 (689)
...... .....+++.|+|||++. ...++.++|+|||||++|+|++|..||...+......++.....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---- 233 (292)
T cd06644 158 AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP---- 233 (292)
T ss_pred eeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCc----
Confidence 654322 22346788999999985 345788999999999999999999999776544433333211000
Q ss_pred HHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
..+. ....+..+.+||.+||..||++||++.++++||||+.
T Consensus 234 ------------------------------~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 234 ------------------------------TLSQ-------PSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred ------------------------------cCCC-------CcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 0000 0112345789999999999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=310.79 Aligned_cols=275 Identities=33% Similarity=0.510 Sum_probs=222.2
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEE
Q 005590 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 459 (689)
Q Consensus 383 Y~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~ 459 (689)
|++.+.||+|++|.||+|++..+++.+|+|++... .........|+.+++.++ |++|+++++++......+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~~~~ 74 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK------HPNIVKLLDVIHTERKLY 74 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcC------CCCHHHHHhhhhcCCceE
Confidence 57788999999999999999999999999999864 233455667888888774 689999999999999999
Q ss_pred EEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccc
Q 005590 460 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539 (689)
Q Consensus 460 lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 539 (689)
+||||+.++|.+++.... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++. ++.++|+|||.+..
T Consensus 75 ~v~e~~~~~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~--~~~~~l~d~g~~~~ 147 (282)
T cd07829 75 LVFEYCDMDLKKYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINR--DGVLKLADFGLARA 147 (282)
T ss_pred EEecCcCcCHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcC--CCCEEEecCCcccc
Confidence 999999999888876542 23889999999999999999999999999999999999985 78899999999876
Q ss_pred ccCCc---cccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 005590 540 QTDNL---CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615 (689)
Q Consensus 540 ~~~~~---~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~ 615 (689)
..... ....++..|+|||.+.+. .++.++|+|||||++|+|++|.+||.+....+.+.++...++.++..+|....
T Consensus 148 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07829 148 FGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVT 227 (282)
T ss_pred cCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhc
Confidence 54322 223457789999999876 78999999999999999999999999999888999999888888877776654
Q ss_pred hhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
... ++...... .+ ...........+..+.++|++||+.||++||++.+++.||||
T Consensus 228 ~~~-~~~~~~~~-------------~~-~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 228 KLP-DYKPTFPK-------------FP-PKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccc-cccccccc-------------cC-ccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 443 11110000 00 000111122235678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=311.51 Aligned_cols=276 Identities=32% Similarity=0.538 Sum_probs=219.0
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEE
Q 005590 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 460 (689)
Q Consensus 383 Y~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~l 460 (689)
|++.+.||+|++|+||+|++..+++.|+||.+..... ......+|+..++.+. .|++|+++++++...+..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-----~h~~i~~~~~~~~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN-----EHPNIVKLKEVFRENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhcc-----CCCCchhHHHHhhcCCcEEE
Confidence 6788999999999999999988999999999875422 1223345666665553 27899999999999999999
Q ss_pred EEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccc
Q 005590 461 VCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 540 (689)
Q Consensus 461 VmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~ 540 (689)
||||+.+++.+.+.... ...+++..+..++.||+.+|.|||++|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 76 v~e~~~~~l~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~--~~~~~l~d~~~~~~~ 149 (283)
T cd07830 76 VFEYMEGNLYQLMKDRK----GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSG--PEVVKIADFGLAREI 149 (283)
T ss_pred EEecCCCCHHHHHHhcc----cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcC--CCCEEEeecccceec
Confidence 99999888888776433 123889999999999999999999999999999999999985 788999999998765
Q ss_pred cCC--ccccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhh
Q 005590 541 TDN--LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 617 (689)
Q Consensus 541 ~~~--~~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~ 617 (689)
... .....++..|+|||++.. ..++.++|+||||+++++|++|++||+.....+.+..+...+++++.+.|..+...
T Consensus 150 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 150 RSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred cCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 432 233567889999998854 45789999999999999999999999999888888899889998888777665444
Q ss_pred hhhhhccccchhhhhccccccccCCccc--hhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 618 YKYFTKEYDLYYINEETNQLEYIIPEES--SLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~--~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
...+. ..++... .+.......+..+++||++||+.||++|||+.|++.||||
T Consensus 230 ~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 230 ASKLG----------------FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred hcccc----------------ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 32221 1111100 0111111224678999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=309.71 Aligned_cols=258 Identities=25% Similarity=0.362 Sum_probs=201.6
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC---
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--- 455 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~--- 455 (689)
..++|.+.+.||+|+||.||++.+..+++.+|+|++...........+|+.+++.+. +|+||+++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~-----~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLP-----NHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhc-----CCCCeEEEEEEEEecccc
Confidence 357899999999999999999999999999999999765444456677888887774 478999999998754
Q ss_pred --CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEE
Q 005590 456 --EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 532 (689)
Q Consensus 456 --~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~ 532 (689)
...++||||+.+ +|.+++..... ....+++..++.++.|++.||.|||+.|++|+||||+||+++. ++.++|+
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~--~~~~kl~ 170 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLI--CGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTT--EGGVKLV 170 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcC--CCCEEEe
Confidence 368999999975 67776653221 1223889999999999999999999999999999999999985 7789999
Q ss_pred ecCCcccccCC---ccccccCccccChhhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 005590 533 DLGSSCFQTDN---LCLYVQSRSYRAPEVIIGL-----PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 604 (689)
Q Consensus 533 DFGls~~~~~~---~~~~~gt~~Y~APE~l~~~-----~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g 604 (689)
|||++...... .....++..|+|||++... .++.++|+|||||++|+|++|+.||........+..+.....
T Consensus 171 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~ 250 (291)
T cd06639 171 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP 250 (291)
T ss_pred ecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC
Confidence 99998754322 2234678899999998643 368899999999999999999999976554433333211000
Q ss_pred CCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCC
Q 005590 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 684 (689)
Q Consensus 605 ~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpw 684 (689)
+ ....+ ......+.+||.+||+.+|++||++.|+++|||
T Consensus 251 --~------------------------------~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~ 289 (291)
T cd06639 251 --P------------------------------TLLHP---------EKWCRSFNHFISQCLIKDFEARPSVTHLLEHPF 289 (291)
T ss_pred --C------------------------------CCCcc---------cccCHHHHHHHHHHhhcChhhCcCHHHHhcCcc
Confidence 0 00000 011245889999999999999999999999999
Q ss_pred CC
Q 005590 685 LQ 686 (689)
Q Consensus 685 f~ 686 (689)
|+
T Consensus 290 ~~ 291 (291)
T cd06639 290 IK 291 (291)
T ss_pred cC
Confidence 96
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=305.17 Aligned_cols=250 Identities=29% Similarity=0.463 Sum_probs=203.5
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 460 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~l 460 (689)
++|++.+.||.|+||.||++++..+++.+++|.+..... ...+.+|+++++.+ .|+||+++++.+....+.++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l------~~~~i~~~~~~~~~~~~~~l 75 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQC------DSPYIVKYYGSYFKNTDLWI 75 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhC------CCCcEeeeeeeeecCCcEEE
Confidence 579999999999999999999988899999999987644 56788888888877 47899999999999999999
Q ss_pred EEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccc
Q 005590 461 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539 (689)
Q Consensus 461 VmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 539 (689)
++||+.+ +|.+++.... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++. ++.++|+|||++..
T Consensus 76 ~~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~--~~~~~l~dfg~~~~ 148 (256)
T cd06612 76 VMEYCGAGSVSDIMKITN-----KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNE--EGQAKLADFGVSGQ 148 (256)
T ss_pred EEecCCCCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECC--CCcEEEcccccchh
Confidence 9999985 6766664322 23889999999999999999999999999999999999985 77899999999876
Q ss_pred ccCCc---cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhh
Q 005590 540 QTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 616 (689)
Q Consensus 540 ~~~~~---~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~ 616 (689)
..... ....++..|+|||++.+..++.++||||+|+++|+|++|+.||...........+...
T Consensus 149 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------- 214 (256)
T cd06612 149 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK-------------- 214 (256)
T ss_pred cccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC--------------
Confidence 54332 2345788999999999999999999999999999999999999765443322111100
Q ss_pred hhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 617 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
....... ....+..+.+||.+||+.||++|||+.|+|+||||
T Consensus 215 --------------------~~~~~~~-------~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 215 --------------------PPPTLSD-------PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred --------------------CCCCCCc-------hhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 0000000 01123568899999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=309.79 Aligned_cols=257 Identities=26% Similarity=0.397 Sum_probs=200.2
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE-----
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY----- 453 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~----- 453 (689)
..++|++.+.||+|+||.||++++..+++.+|+|++.........+.+|+.+++.+. +|+||+++++++.
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS-----DHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHh-----cCCCeeeeeeeeeecccC
Confidence 457899999999999999999999999999999998764444456778888888875 3789999999884
Q ss_pred eCCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEE
Q 005590 454 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 532 (689)
Q Consensus 454 ~~~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~ 532 (689)
.....++||||+.+ +|.+++..... ....+++..++.++.|++.||.|||+.+|+||||||+||+++. ++.++|+
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~--~~~~kl~ 166 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLK--RGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTT--EGGVKLV 166 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhc--cCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECC--CCCEEEc
Confidence 34579999999985 66666543221 1234888999999999999999999999999999999999985 6779999
Q ss_pred ecCCcccccCC---ccccccCccccChhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 005590 533 DLGSSCFQTDN---LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 604 (689)
Q Consensus 533 DFGls~~~~~~---~~~~~gt~~Y~APE~l~-----~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g 604 (689)
|||++...... .....+++.|+|||++. +..++.++|+||+||++|+|++|+.||........+..+....
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~- 245 (286)
T cd06638 167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP- 245 (286)
T ss_pred cCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC-
Confidence 99998764432 22346889999999985 3457889999999999999999999997654333222111000
Q ss_pred CCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCC
Q 005590 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 684 (689)
Q Consensus 605 ~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpw 684 (689)
......| ...+..+.+||.+||+.||++|||+.|+|+|+|
T Consensus 246 -------------------------------~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 246 -------------------------------PPTLHQP---------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred -------------------------------CCcccCC---------CCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 0000001 012356889999999999999999999999999
Q ss_pred C
Q 005590 685 L 685 (689)
Q Consensus 685 f 685 (689)
|
T Consensus 286 ~ 286 (286)
T cd06638 286 I 286 (286)
T ss_pred C
Confidence 7
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=326.69 Aligned_cols=242 Identities=25% Similarity=0.379 Sum_probs=203.4
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEE
Q 005590 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 462 (689)
Q Consensus 383 Y~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVm 462 (689)
++.++.||+|-||.||++.+.. ...||+|.++........+.+|+++|+.|+ |++||++++++...+.++|||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~------H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLR------HEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCc------ccCeEEEEEEEecCCceEEEE
Confidence 4455679999999999999743 358999999886666678889999999997 568999999999988999999
Q ss_pred Eccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccccc
Q 005590 463 ELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 541 (689)
Q Consensus 463 Ey~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~ 541 (689)
|||. |+|+++++.. ....+...++..++.||++|++||+++++|||||...||||+. +..+||+|||+|+...
T Consensus 281 E~m~~GsLl~yLr~~----~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~--~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTR----EGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDE--DLVVKISDFGLARLIG 354 (468)
T ss_pred EecccCcHHHHhhhc----CCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeecc--CceEEEcccccccccC
Confidence 9998 7899998862 2234889999999999999999999999999999999999994 7899999999999665
Q ss_pred CCccc-ccc---CccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhh
Q 005590 542 DNLCL-YVQ---SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 616 (689)
Q Consensus 542 ~~~~~-~~g---t~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~ 616 (689)
+.... ..+ ...|.|||.+....++.++|||||||+||||+| |+.||++-+..+++..+.+.
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G-------------- 420 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG-------------- 420 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc--------------
Confidence 54432 222 456999999999999999999999999999999 99999999999988887522
Q ss_pred hhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHH
Q 005590 617 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 680 (689)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL 680 (689)
+.+|.... .+.++.+++..||..+|++|||.+.+.
T Consensus 421 ----------------------yRlp~P~~-------CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 421 ----------------------YRLPRPEG-------CPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ----------------------CcCCCCCC-------CCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 22222222 345677999999999999999988765
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=341.69 Aligned_cols=246 Identities=28% Similarity=0.458 Sum_probs=201.8
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEee-cchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE-EEe---
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY-FYH--- 454 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~-~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~-f~~--- 454 (689)
..+++|.++|.+|||+.||+|++...|..||+|++- .+........+|+.+|+.|. +|+|||.+++. ...
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~-----gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLS-----GHKNIVSYIDSSAINRSS 110 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhc-----CCCceeeEeccccccccC
Confidence 468999999999999999999998888999999764 46677788999999999997 47899999993 321
Q ss_pred ---CCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEeccCCCe
Q 005590 455 ---LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCE 528 (689)
Q Consensus 455 ---~~~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~g--IvHrDLKp~NILl~~~~~~~ 528 (689)
.-+.+|.||||. |+|.+++....... |++.++++|++|+++|+.+||.+. |||||||-+||||.. ++.
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~----lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~--~g~ 184 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTR----LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSA--DGN 184 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhcc----CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcC--CCC
Confidence 135889999999 69999987554332 999999999999999999999998 999999999999994 789
Q ss_pred EEEEecCCcccccCCcc------------ccccCccccChhhh---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHH
Q 005590 529 IKIIDLGSSCFQTDNLC------------LYVQSRSYRAPEVI---IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVV 593 (689)
Q Consensus 529 vkL~DFGls~~~~~~~~------------~~~gt~~Y~APE~l---~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~ 593 (689)
+||||||.++....... ...-|+.|+|||++ .+.+++.|+|||+|||+||.||....||......
T Consensus 185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l 264 (738)
T KOG1989|consen 185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL 264 (738)
T ss_pred EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce
Confidence 99999999865332221 13458999999997 4778999999999999999999999999754221
Q ss_pred HHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCC
Q 005590 594 MILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 673 (689)
Q Consensus 594 ~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kR 673 (689)
.+ ....|.+|..... ...|++||+.||+.||.+|
T Consensus 265 aI---------------------------------------lng~Y~~P~~p~y-------s~~l~~LI~~mL~~nP~~R 298 (738)
T KOG1989|consen 265 AI---------------------------------------LNGNYSFPPFPNY-------SDRLKDLIRTMLQPNPDER 298 (738)
T ss_pred eE---------------------------------------EeccccCCCCccH-------HHHHHHHHHHHhccCcccC
Confidence 11 1235566654332 3458899999999999999
Q ss_pred cCHHHHHcC
Q 005590 674 PTAREALDH 682 (689)
Q Consensus 674 pTa~ElL~h 682 (689)
|++-+++.+
T Consensus 299 PnI~Qv~~~ 307 (738)
T KOG1989|consen 299 PNIYQVLEE 307 (738)
T ss_pred CCHHHHHHH
Confidence 999998864
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.13 Aligned_cols=252 Identities=30% Similarity=0.483 Sum_probs=200.7
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
.++|++.+.||+|+||.||++++..+++.||+|.+.... .....+.+|+.+++.+ +|+||+++++++....+.
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~------~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN------KNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC------CCCCEeeEEEEEecCCEE
Confidence 478999999999999999999999999999999987532 2234556777777765 478999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
++||||+.+ +|.+++... .+++..+..++.|++.||.|||+.||+||||||+|||++. ++.++|+|||++
T Consensus 92 ~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~--~~~~~l~Dfg~~ 162 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFC 162 (297)
T ss_pred EEeecccCCCCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEECcCccc
Confidence 999999985 566655321 2788899999999999999999999999999999999984 788999999988
Q ss_pred ccccCC---ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 538 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 538 ~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
...... .....+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+....+..+.. .+
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~---------- 231 (297)
T cd06656 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NG---------- 231 (297)
T ss_pred eEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CC----------
Confidence 654332 2234678899999999998899999999999999999999999976543221111100 00
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
.|.. ......+..+++||.+||..||++|||+.++++||||+.
T Consensus 232 --------------------------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 274 (297)
T cd06656 232 --------------------------TPEL----QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKL 274 (297)
T ss_pred --------------------------CCCC----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcc
Confidence 0000 001123456889999999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.56 Aligned_cols=251 Identities=29% Similarity=0.425 Sum_probs=205.3
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
++|++.+.||.|++|.||+|++..+++.+|+|++..+. .....+.+|+.+++.++ |+||+++++++......
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR------SPYITKYYGSFLKGSKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcC------CCCeeeeeEEEEECCeE
Confidence 47899999999999999999999999999999987643 23345677888888774 67999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
++|+||+.+ +|.+++... .+++..+..++.|++.||.|||+.+++|+||+|+||+++. ++.++|+|||++
T Consensus 75 ~~v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~--~~~~~l~d~g~~ 145 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG-------KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSE--EGDVKLADFGVS 145 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC--CCCEEEcccccc
Confidence 999999985 677766532 3889999999999999999999999999999999999995 788999999998
Q ss_pred ccccCC---ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 538 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 538 ~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
...... .....+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+....
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----------- 214 (274)
T cd06609 146 GQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN----------- 214 (274)
T ss_pred eeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC-----------
Confidence 765432 234567888999999999889999999999999999999999997665443333222110
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~~ 688 (689)
...++.. ..+..+.++|.+||..+|++|||++++++||||++.
T Consensus 215 -----------------------~~~~~~~--------~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 215 -----------------------PPSLEGN--------KFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred -----------------------CCCCccc--------ccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 0001100 024568899999999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=302.88 Aligned_cols=249 Identities=22% Similarity=0.369 Sum_probs=202.7
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
+|++.+.||+|+||.||++++..+|+.||+|.+... ......+.+|+.+++.++ |+||+++++++...++.
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK------HPNIVQYQESFEENGNL 74 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCC------CCCeeeeEeeecCCCeE
Confidence 689999999999999999999999999999998743 223346677888877764 67999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
++||||+.+ +|.+.+..... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++. ++.++|+|||++
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~--~~~~~l~d~~~~ 148 (256)
T cd08218 75 YIVMDYCEGGDLYKKINAQRG----VLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK--DGTIKLGDFGIA 148 (256)
T ss_pred EEEEecCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--CCCEEEeeccce
Confidence 999999975 67776653221 22788899999999999999999999999999999999984 778999999998
Q ss_pred ccccCCc---cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 538 CFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 538 ~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
....... ....+++.|+|||++.+..++.++|+|||||++|+|++|..||......+....+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~----------- 217 (256)
T cd08218 149 RVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS----------- 217 (256)
T ss_pred eecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC-----------
Confidence 7654322 23457888999999998889999999999999999999999998766555444432100
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
....+ ...+..+.++|.+||+.+|.+||++.++|+||||
T Consensus 218 -----------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 218 -----------------------YPPVS---------SHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred -----------------------CCCCc---------ccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 00001 1224568899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=311.33 Aligned_cols=252 Identities=28% Similarity=0.456 Sum_probs=202.0
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
..+|++.+.||+|++|.||++++..+++.+|+|.+.... .....+.+|+.+++.+ .|+||+++++.+....+.
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~------~h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN------KNPNIVNYLDSYLVGDEL 92 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhC------CCCCEeeEEEEEEeCCEE
Confidence 368999999999999999999999999999999987543 2235566788877766 478999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
++||||+.+ +|.+++... .++...+..++.|++.||.|||+.||+|+||||+||+++. ++.++|+|||++
T Consensus 93 ~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~--~~~~kl~dfg~~ 163 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFC 163 (296)
T ss_pred EEeecccCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC--CCCEEECccccc
Confidence 999999985 676665321 2788899999999999999999999999999999999984 778999999988
Q ss_pred ccccCC---ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 538 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 538 ~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
...... .....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||........+..+... +.
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~--------- 233 (296)
T cd06654 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GT--------- 233 (296)
T ss_pred hhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CC---------
Confidence 654322 22346888999999999888999999999999999999999999766543322221100 00
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
...+. .......+.+||.+||..+|++|||+.++++||||..
T Consensus 234 ------------------------~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 234 ------------------------PELQN-------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred ------------------------CCCCC-------ccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence 00000 0112356889999999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=310.60 Aligned_cols=254 Identities=31% Similarity=0.463 Sum_probs=203.2
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 459 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~ 459 (689)
++|++++.||.|+||.||++++..++..+|+|++.... .....+.+|+.+++.++ |+||+++++.+......+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~ 78 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECK------HPNIVGLYEAYFYENKLW 78 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCC------CCceeEEEEEEecCCeEE
Confidence 57999999999999999999998899999999987543 33456778888888774 679999999999999999
Q ss_pred EEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcc
Q 005590 460 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 460 lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 538 (689)
+||||+.+ +|.+++.... ..+++..++.++.|++.||.|||+.||+|+||||+||+++. ++.++|+|||++.
T Consensus 79 lv~e~~~~~~L~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~--~~~~~l~d~g~~~ 151 (280)
T cd06611 79 ILIEFCDGGALDSIMLELE-----RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTL--DGDVKLADFGVSA 151 (280)
T ss_pred EEeeccCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECC--CCCEEEccCccch
Confidence 99999986 5655554322 23899999999999999999999999999999999999984 7889999999876
Q ss_pred cccCC---ccccccCccccChhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 005590 539 FQTDN---LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 610 (689)
Q Consensus 539 ~~~~~---~~~~~gt~~Y~APE~l~-----~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~ 610 (689)
..... .....+++.|+|||.+. ...++.++|+|||||++|+|++|..||........+..+.....+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----- 226 (280)
T cd06611 152 KNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPP----- 226 (280)
T ss_pred hhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCC-----
Confidence 54322 23356889999999985 345788999999999999999999999876554444333211000
Q ss_pred HhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCCC
Q 005590 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~~ 688 (689)
....| ...+..+.+||.+||+.+|.+||++.++|+||||.+.
T Consensus 227 ---------------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 227 ---------------------------TLDQP---------SKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred ---------------------------CcCCc---------ccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 00001 1123467899999999999999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=310.09 Aligned_cols=251 Identities=32% Similarity=0.458 Sum_probs=199.3
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc-hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEE
Q 005590 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 461 (689)
Q Consensus 383 Y~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~-~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lV 461 (689)
|++.+.||+|+||.||++++..++..+++|.+... ......+.+|+++++.+ +|+||+++++++......++|
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l------~h~~ii~~~~~~~~~~~~~~v 80 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC------DHPNIVKLLDAFYYENNLWIL 80 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHC------CCCCeeeEEEEEeeCCEEEEE
Confidence 67889999999999999999999999999998653 23345667788887776 478999999999999999999
Q ss_pred EEccccchH-HHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccc
Q 005590 462 CELLRANLY-EFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 540 (689)
Q Consensus 462 mEy~~g~L~-~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~ 540 (689)
|||+.++.+ .++... ...+++..+..++.||+.||.|||+.||+||||||+||+++. ++.++|+|||++...
T Consensus 81 ~e~~~~~~l~~~~~~~-----~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~--~~~~kl~dfg~~~~~ 153 (282)
T cd06643 81 IEFCAGGAVDAVMLEL-----ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTL--DGDIKLADFGVSAKN 153 (282)
T ss_pred EEecCCCcHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcc--CCCEEEccccccccc
Confidence 999987544 433321 123889999999999999999999999999999999999985 778999999998654
Q ss_pred cCC---ccccccCccccChhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 005590 541 TDN---LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 612 (689)
Q Consensus 541 ~~~---~~~~~gt~~Y~APE~l~-----~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~ 612 (689)
... .....+++.|+|||++. +..++.++|+||+||++|+|++|++||...+.......+.....+
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~------- 226 (282)
T cd06643 154 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP------- 226 (282)
T ss_pred cccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC-------
Confidence 322 22356789999999984 445788999999999999999999999876655544443211100
Q ss_pred hhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
.++. ....+..+.+||.+||+.||.+|||+.++++||||..
T Consensus 227 ---------------------------~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 227 ---------------------------TLAQ-------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred ---------------------------CCCC-------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 0000 0112356889999999999999999999999999974
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=309.06 Aligned_cols=252 Identities=25% Similarity=0.405 Sum_probs=197.9
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
.++|++.+.||+|+||.||+|++..+++.||+|+++... .......+|+.+++.+ +|+||+++++.+...+..
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l------~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC------KHSNIVAYFGSYLRRDKL 81 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhC------CCCCeeeEEEEEEeCCEE
Confidence 357889999999999999999999999999999987643 2234456677777766 478999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
++||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.||+|+||||+||+++. ++.++|+|||++
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~--~~~~~l~dfg~~ 153 (267)
T cd06645 82 WICMEFCGGGSLQDIYHVTG------PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTD--NGHVKLADFGVS 153 (267)
T ss_pred EEEEeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEECcceee
Confidence 999999985 6777665332 2889999999999999999999999999999999999984 778999999998
Q ss_pred ccccCC---ccccccCccccChhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 005590 538 CFQTDN---LCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 611 (689)
Q Consensus 538 ~~~~~~---~~~~~gt~~Y~APE~l~---~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~ 611 (689)
...... .....+++.|+|||++. ...++.++|+|||||++|+|++|..||........+..+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~--------- 224 (267)
T cd06645 154 AQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS--------- 224 (267)
T ss_pred eEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc---------
Confidence 654432 23357899999999985 456889999999999999999999999654432222211100
Q ss_pred hhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCC
Q 005590 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 684 (689)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpw 684 (689)
....+.. . .....+..+.+||.+||..+|++|||++++++|||
T Consensus 225 --------------------------~~~~~~~---~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 225 --------------------------NFQPPKL---K-DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred --------------------------CCCCCcc---c-ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 0000000 0 00012356889999999999999999999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=302.45 Aligned_cols=256 Identities=27% Similarity=0.400 Sum_probs=202.9
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
++|++.+.||.|+||+||+|.+..++..+|+|++.... .....+.+|+.+++.+. |+||+++++.+...+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCN------HPNVVKYYTSFVVGDEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcC------CCCEEEEEEEEeeCCEE
Confidence 47999999999999999999998899999999987542 23466778888777664 67999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
++|||++.+ +|.+++..... ...+++..++.++.||+.||.|||+.||+|+||+|+||+++. ++.++|+|||++
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~--~~~~~l~df~~~ 149 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYP---RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGE--DGSVKIADFGVS 149 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcC--CCCEEEcccchH
Confidence 999999985 67666653321 123889999999999999999999999999999999999985 678999999988
Q ss_pred ccccCCc-------cccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHH
Q 005590 538 CFQTDNL-------CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 609 (689)
Q Consensus 538 ~~~~~~~-------~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e 609 (689)
....... ....++..|+|||++... .++.++|+|||||++|+|++|..||...+....+....... +
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~---~-- 224 (267)
T cd06610 150 ASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND---P-- 224 (267)
T ss_pred HHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC---C--
Confidence 6544321 234678899999998876 78999999999999999999999997665544333322110 0
Q ss_pred HHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
..++... .....+..+++||.+||..||++|||+.++++||||
T Consensus 225 -----------------------------~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 225 -----------------------------PSLETGA----DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred -----------------------------CCcCCcc----ccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0000000 011234668899999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=305.08 Aligned_cols=247 Identities=31% Similarity=0.455 Sum_probs=197.8
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh----------hhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----------FFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 451 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~----------~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~ 451 (689)
+|.+.+.||+|++|.||+|.+..+++.+|+|.+..... ....+.+|+.+++.++ |+||++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~ 74 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ------HENIVQYLGS 74 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC------CCCeeeEEEE
Confidence 57888999999999999999988999999998864321 2245666777777764 7899999999
Q ss_pred EEeCCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEE
Q 005590 452 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 530 (689)
Q Consensus 452 f~~~~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vk 530 (689)
+......++||||+.+ +|.+++.... .+++..++.++.|++.||.|||+.|++||||+|+||+++. ++.++
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~--~~~~~ 146 (267)
T cd06628 75 SLDADHLNIFLEYVPGGSVAALLNNYG------AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDN--KGGIK 146 (267)
T ss_pred EEeCCccEEEEEecCCCCHHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcC--CCCEE
Confidence 9999999999999975 6766665322 2788899999999999999999999999999999999984 78899
Q ss_pred EEecCCcccccCC---------ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHh
Q 005590 531 IIDLGSSCFQTDN---------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 601 (689)
Q Consensus 531 L~DFGls~~~~~~---------~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~ 601 (689)
|+|||.+...... .....++..|+|||.+.+..++.++|+|||||++|+|++|+.||........+..+..
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 226 (267)
T cd06628 147 ISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE 226 (267)
T ss_pred ecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc
Confidence 9999988755421 1123578889999999988899999999999999999999999986544332222210
Q ss_pred hcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 602 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 602 ~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
. ....+| ...+..+.+||++||+.||.+||++.|+++
T Consensus 227 ~----------------------------------~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 N----------------------------------ASPEIP---------SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred c----------------------------------CCCcCC---------cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0 000111 113456889999999999999999999999
Q ss_pred CCCC
Q 005590 682 HPWL 685 (689)
Q Consensus 682 hpwf 685 (689)
||||
T Consensus 264 ~~~~ 267 (267)
T cd06628 264 HPFL 267 (267)
T ss_pred CCCC
Confidence 9997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=300.10 Aligned_cols=249 Identities=28% Similarity=0.415 Sum_probs=205.8
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
+|++++.||.|+||.||.+++..+++.+++|.+... ......+.+|+.+++.++ |+||+++++++...+.+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~------h~~i~~~~~~~~~~~~~ 74 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ------HPNIIAYYNHFMDDNTL 74 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCC------CCCeeEEEeEEecCCeE
Confidence 699999999999999999999999999999987643 333456778888888774 67999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
++||||+.+ +|.+++.... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++. ++.+||+|||++
T Consensus 75 ~~~~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~--~~~~kl~d~~~~ 148 (256)
T cd08221 75 LIEMEYANGGTLYDKIVRQK----GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTK--AGLIKLGDFGIS 148 (256)
T ss_pred EEEEEecCCCcHHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeC--CCCEEECcCcce
Confidence 999999985 7777765432 223889999999999999999999999999999999999984 778999999998
Q ss_pred ccccCCc---cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 538 CFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 538 ~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
....... ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+....+... ..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~------- 219 (256)
T cd08221 149 KILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYT------- 219 (256)
T ss_pred EEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCC-------
Confidence 7654332 3356889999999999888999999999999999999999999877666655554310 000
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
..+ ...+..+.++|.+||..+|.+|||+.++|+||||
T Consensus 220 -------------------------~~~---------~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 220 -------------------------PVV---------SVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred -------------------------CCc---------cccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 000 1224568899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=306.60 Aligned_cols=252 Identities=27% Similarity=0.397 Sum_probs=196.9
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
.++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+|+.+++.+ +|+||+++++++...+..
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~------~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC------KHCNIVAYFGSYLSREKL 81 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc------CCCCeeeeeEEEEeCCEE
Confidence 467999999999999999999999999999999987542 2334566778777766 478999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
++||||+.+ +|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||+++. ++.++|+|||++
T Consensus 82 ~iv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~--~~~~~l~dfg~~ 153 (267)
T cd06646 82 WICMEYCGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTD--NGDVKLADFGVA 153 (267)
T ss_pred EEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC--CCCEEECcCccc
Confidence 999999985 6666654321 2789999999999999999999999999999999999984 778999999998
Q ss_pred ccccCC---ccccccCccccChhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 005590 538 CFQTDN---LCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 611 (689)
Q Consensus 538 ~~~~~~---~~~~~gt~~Y~APE~l~---~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~ 611 (689)
...... .....+++.|+|||.+. ...++.++|+||+||++|+|++|..||...........+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~--------- 224 (267)
T cd06646 154 AKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS--------- 224 (267)
T ss_pred eeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC---------
Confidence 765332 22356788999999985 345788999999999999999999998654322211111000
Q ss_pred hhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCC
Q 005590 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 684 (689)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpw 684 (689)
....+... .....+..+.+||++||+.+|++|||++++|+|+|
T Consensus 225 --------------------------~~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 225 --------------------------NFQPPKLK----DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred --------------------------CCCCCCCc----cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 00000000 00122457899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=310.32 Aligned_cols=251 Identities=31% Similarity=0.493 Sum_probs=202.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 459 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~ 459 (689)
.+|++.+.||.|++|.||++.+..+++.||+|.+.... .....+.+|+.+++.++ |+||+++++.+......+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~~~ 92 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELK------NPNIVNFLDSFLVGDELF 92 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcC------CCceeeeeeeEecCceEE
Confidence 57999999999999999999999999999999886532 23355667777777664 789999999999999999
Q ss_pred EEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcc
Q 005590 460 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 460 lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 538 (689)
+|+||+.+ +|..++.. ..+++..+..++.|++.||.|||+.|++|+||||+||+++. ++.++|+|||++.
T Consensus 93 lv~e~~~~~~L~~~~~~-------~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~--~~~~kl~dfg~~~ 163 (296)
T cd06655 93 VVMEYLAGGSLTDVVTE-------TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGM--DGSVKLTDFGFCA 163 (296)
T ss_pred EEEEecCCCcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEEccCccch
Confidence 99999986 45554432 12789999999999999999999999999999999999984 7889999999876
Q ss_pred cccCC---ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 005590 539 FQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615 (689)
Q Consensus 539 ~~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~ 615 (689)
..... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+... +. +
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~-~-------- 233 (296)
T cd06655 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GT-P-------- 233 (296)
T ss_pred hcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CC-c--------
Confidence 54332 22346788999999999888999999999999999999999999876554433322100 00 0
Q ss_pred hhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
....+ ...+..+.+||++||..||++|||+.++++||||+.
T Consensus 234 ----------------------~~~~~---------~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 234 ----------------------ELQNP---------EKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred ----------------------ccCCc---------ccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 00000 123456889999999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=318.91 Aligned_cols=282 Identities=32% Similarity=0.527 Sum_probs=218.0
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005590 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 378 ~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
.+.++|++.+.||+|+||.||+|.+..+++.+|+|.+... ........+|+.+++.+. +|+||+++++++..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~ni~~~~~~~~~ 78 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG-----DHPNIVKLLNVIKA 78 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhc-----CCCCccceeeeecc
Confidence 4568899999999999999999999889999999987542 223345667888888772 36899999999875
Q ss_pred C--CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEE
Q 005590 455 L--EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 532 (689)
Q Consensus 455 ~--~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~ 532 (689)
. ...++||||+.++|.+++... .+.+..++.++.||+.||.|||+.||+|+||||+||+++. ++.+||+
T Consensus 79 ~~~~~~~lv~e~~~~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~--~~~~kl~ 149 (337)
T cd07852 79 ENDKDIYLVFEYMETDLHAVIRAN-------ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNS--DCRVKLA 149 (337)
T ss_pred CCCceEEEEecccccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCcEEEe
Confidence 4 468999999998887776532 2778888999999999999999999999999999999984 8899999
Q ss_pred ecCCcccccC--------CccccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhc
Q 005590 533 DLGSSCFQTD--------NLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 603 (689)
Q Consensus 533 DFGls~~~~~--------~~~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~ 603 (689)
|||.+..... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+....+...++....
T Consensus 150 d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~ 229 (337)
T cd07852 150 DFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVI 229 (337)
T ss_pred eccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 9998865432 1223567889999998865 457889999999999999999999999988888888888887
Q ss_pred CCCcHHHHhhhhhhhh-hhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 604 GPIDLEMLMQGQEIYK-YFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 604 g~~~~e~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
+..+...+........ .+-. ....+............+..+.+||.+||+.||++|||+.++++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 230 GPPSAEDIESIKSPFAATMLD--------------SLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CCCCHHHHHHHHhhhHHHhhh--------------hcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 7766655443321100 0000 000000011111222245678999999999999999999999999
Q ss_pred CCCCC
Q 005590 683 PWLQH 687 (689)
Q Consensus 683 pwf~~ 687 (689)
|||++
T Consensus 296 ~~~~~ 300 (337)
T cd07852 296 PYVAQ 300 (337)
T ss_pred hhhhh
Confidence 99975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=311.81 Aligned_cols=256 Identities=27% Similarity=0.417 Sum_probs=200.6
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
++|++++.||+|+||.||++++..+++.||+|.++.. ......+.+|+.+++.++ |+||+++++.+...+..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAV------SPYIVDFYGAFFIEGAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcC------CCcHHhhhhheecCCeE
Confidence 3689999999999999999999989999999988753 233456778888887764 67999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~-~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
++||||+.+ +|..++.... ....+++..+..++.||+.||.|||+ .||+|+||||+||+++. ++.++|+|||.
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~--~~~~~l~dfg~ 149 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGV---ATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNG--NGQVKLCDFGV 149 (286)
T ss_pred EEEEeecCCCCHHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECC--CCCEEEeecCC
Confidence 999999986 5555544321 12248999999999999999999997 59999999999999985 78899999999
Q ss_pred cccccCC-ccccccCccccChhhhcCC------CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHH
Q 005590 537 SCFQTDN-LCLYVQSRSYRAPEVIIGL------PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 609 (689)
Q Consensus 537 s~~~~~~-~~~~~gt~~Y~APE~l~~~------~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e 609 (689)
+...... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...........+.......
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--- 226 (286)
T cd06622 150 SGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD--- 226 (286)
T ss_pred cccccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC---
Confidence 8765332 3335678899999998654 35789999999999999999999997654433333222111000
Q ss_pred HHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
...+|. ..+..+.+||.+||+.+|++||++.++++||||..
T Consensus 227 ----------------------------~~~~~~---------~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~ 267 (286)
T cd06622 227 ----------------------------PPTLPS---------GYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVK 267 (286)
T ss_pred ----------------------------CCCCCc---------ccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhh
Confidence 000111 13466889999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=300.07 Aligned_cols=250 Identities=26% Similarity=0.385 Sum_probs=203.1
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
+|++.+.||+|+||.||++.+..+++.+|+|.+.... .....+.+|+.+++.++ |++|+++++.+...+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~~~ 74 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS------HPNIIEYYENFLEDKAL 74 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCC------CCchhheeeeEecCCEE
Confidence 5899999999999999999999999999999987532 23456677888888774 67999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
++||||+.+ +|.+++.... ...+++..+..++.|++.||.|||++|++|+||+|+||+++. .+..++|+|||.+
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~-~~~~~~l~d~~~~ 149 (256)
T cd08220 75 MIVMEYAPGGTLAEYIQKRC----NSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDK-HKMVVKIGDFGIS 149 (256)
T ss_pred EEEEecCCCCCHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-CCCEEEEccCCCc
Confidence 999999985 6777765432 123788999999999999999999999999999999999974 3557899999998
Q ss_pred ccccCCc--cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 005590 538 CFQTDNL--CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615 (689)
Q Consensus 538 ~~~~~~~--~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~ 615 (689)
....... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+....
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~------------ 217 (256)
T cd08220 150 KILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT------------ 217 (256)
T ss_pred eecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcC------------
Confidence 7654332 23567889999999998889999999999999999999999998765544443332000
Q ss_pred hhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
...++. ..+..+.+||.+||..+|++|||+.|+|+||||
T Consensus 218 ----------------------~~~~~~---------~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 218 ----------------------FAPISD---------RYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ----------------------CCCCCC---------CcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 000111 124568899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.99 Aligned_cols=253 Identities=27% Similarity=0.432 Sum_probs=198.8
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~-------~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
+|++.+.||+|++|.||++.+..+++.+|+|++.... .....+.+|+++++.++ |+||+++++++..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~ 74 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN------HPHIIRMLGATCE 74 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC------CCceehhhceecc
Confidence 4788899999999999999999999999999987532 12356677888888774 6799999999999
Q ss_pred CCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEe
Q 005590 455 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 533 (689)
Q Consensus 455 ~~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~D 533 (689)
.++.++||||+.+ +|.+++.... .+++..+..++.||+.||.|||+.|++|+||+|+||+++. ....++|+|
T Consensus 75 ~~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~-~~~~~~l~d 147 (268)
T cd06630 75 DSHFNLFVEWMAGGSVSHLLSKYG------AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS-TGQRLRIAD 147 (268)
T ss_pred CCeEEEEEeccCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-CCCEEEEcc
Confidence 9999999999986 5666654322 3788999999999999999999999999999999999974 234699999
Q ss_pred cCCcccccCC-------ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 005590 534 LGSSCFQTDN-------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 606 (689)
Q Consensus 534 FGls~~~~~~-------~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~ 606 (689)
||.+...... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+.....
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-- 225 (268)
T cd06630 148 FGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS-- 225 (268)
T ss_pred cccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhc--
Confidence 9998765432 1224678899999999988899999999999999999999999965432222111110000
Q ss_pred cHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCC
Q 005590 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686 (689)
Q Consensus 607 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~ 686 (689)
......+| ...++.+.++|.+||+.+|.+|||+.++++||||+
T Consensus 226 ----------------------------~~~~~~~~---------~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 226 ----------------------------ATTAPSIP---------EHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ----------------------------cCCCCCCc---------hhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 00000011 12346688999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=302.92 Aligned_cols=248 Identities=25% Similarity=0.346 Sum_probs=196.2
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~-------~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
+|++.+.||+|+||+||+|.+ .+++.+|+|++.... .....+.+|+.+++.++ |+||+++++++..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~ 73 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK------HVNIVQYLGTCLD 73 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC------CCCEeeEeeEeec
Confidence 588899999999999999986 578999999887532 12345666777777664 6799999999999
Q ss_pred CCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEe
Q 005590 455 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 533 (689)
Q Consensus 455 ~~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~D 533 (689)
....++||||+.+ +|.+++.... .+++..++.++.||+.||.|||+.+|+|+||+|+||+++. ++.++|+|
T Consensus 74 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~--~~~~~l~d 145 (265)
T cd06631 74 DNTISIFMEFVPGGSISSILNRFG------PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMP--NGIIKLID 145 (265)
T ss_pred CCeEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECC--CCeEEecc
Confidence 9999999999985 6766664322 2788999999999999999999999999999999999984 78899999
Q ss_pred cCCcccccC---------CccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 005590 534 LGSSCFQTD---------NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 604 (689)
Q Consensus 534 FGls~~~~~---------~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g 604 (689)
||++..... ......++..|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+....+
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~ 225 (265)
T cd06631 146 FGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG 225 (265)
T ss_pred chhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccC
Confidence 998765321 12234678899999999998899999999999999999999999976543332222211000
Q ss_pred CCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCC
Q 005590 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 684 (689)
Q Consensus 605 ~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpw 684 (689)
. ...++ ...+..+.+||++||+.+|.+|||+.++|+|||
T Consensus 226 ~--------------------------------~~~~~---------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~ 264 (265)
T cd06631 226 L--------------------------------MPRLP---------DSFSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264 (265)
T ss_pred C--------------------------------CCCCC---------CCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence 0 00011 123466889999999999999999999999999
Q ss_pred C
Q 005590 685 L 685 (689)
Q Consensus 685 f 685 (689)
|
T Consensus 265 ~ 265 (265)
T cd06631 265 L 265 (265)
T ss_pred C
Confidence 7
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=304.90 Aligned_cols=260 Identities=30% Similarity=0.432 Sum_probs=200.2
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC--C
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--E 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~--~ 456 (689)
++|.+.+.||.|++|.||++.+..+++.+|+|++.... .....+.+|+++++.+ +|+||++++++|... .
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~~ 74 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC------KSPYIVKYYGAFLDESSS 74 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC------CCCCeeeeeeEEEccCCC
Confidence 47999999999999999999999999999999987543 2445677888877766 478999999998653 4
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
.+++||||+.+ +|.+++..... ....+++..+..++.||+.||.|||+.|++|+||+|+||+++. ++.++|+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~--~~~~~l~dfg 150 (287)
T cd06621 75 SIGIAMEYCEGGSLDSIYKKVKK--RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTR--KGQVKLCDFG 150 (287)
T ss_pred eEEEEEEecCCCCHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEec--CCeEEEeecc
Confidence 78999999985 67666543222 2233888999999999999999999999999999999999984 7789999999
Q ss_pred CcccccCC-ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChH-----HHHHHHHHhhcCCCcHH
Q 005590 536 SSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV-----VMILARIIGMLGPIDLE 609 (689)
Q Consensus 536 ls~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~-----~~~l~~i~~~~g~~~~e 609 (689)
++...... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||..... .+....+.....
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----- 225 (287)
T cd06621 151 VSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN----- 225 (287)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc-----
Confidence 98654332 2234578899999999998999999999999999999999999975421 111111110000
Q ss_pred HHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
..+....+.. ...++.+.+||.+||..||++|||+.|+++||||++
T Consensus 226 -------------------------~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 226 -------------------------PELKDEPGNG-------IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred -------------------------hhhccCCCCC-------CchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence 0000000000 012356889999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=311.13 Aligned_cols=255 Identities=24% Similarity=0.360 Sum_probs=204.0
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005590 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 453 (689)
Q Consensus 378 ~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~ 453 (689)
....+|++.+.||+|+||+||+|++..+++.||+|++.... .....+.+|+.+++.++ |+||+++++++.
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~------h~niv~~~~~~~ 85 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR------HPNTIEYKGCYL 85 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC------CCCEEEEEEEEE
Confidence 34467999999999999999999998899999999986431 22345667777777664 789999999999
Q ss_pred eCCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEe
Q 005590 454 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 533 (689)
Q Consensus 454 ~~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~D 533 (689)
..+..++||||+.+++.+++..... .+++..+..++.||+.||.|||+.||+|+||+|+||+++. ++.++|+|
T Consensus 86 ~~~~~~lv~e~~~g~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~--~~~~kL~d 158 (307)
T cd06607 86 REHTAWLVMEYCLGSASDILEVHKK-----PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTE--PGTVKLAD 158 (307)
T ss_pred eCCeEEEEHHhhCCCHHHHHHHccc-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECC--CCCEEEee
Confidence 9999999999999988877654322 2889999999999999999999999999999999999984 78899999
Q ss_pred cCCcccccCCccccccCccccChhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 005590 534 LGSSCFQTDNLCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 610 (689)
Q Consensus 534 FGls~~~~~~~~~~~gt~~Y~APE~l~---~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~ 610 (689)
||++...... ....+++.|+|||++. ...++.++||||||+++|+|++|..||.+.+.......+.....
T Consensus 159 fg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~------ 231 (307)
T cd06607 159 FGSASLVSPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS------ 231 (307)
T ss_pred cCcceecCCC-CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC------
Confidence 9998665433 3356788999999985 35688899999999999999999999977654443333210000
Q ss_pred HhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCCC
Q 005590 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~~ 688 (689)
..++. ...+..+.+||.+||..||++||++.+++.||||+..
T Consensus 232 ----------------------------~~~~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 232 ----------------------------PTLSS--------NDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred ----------------------------CCCCc--------hhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 00000 0123458899999999999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=306.22 Aligned_cols=271 Identities=28% Similarity=0.413 Sum_probs=204.9
Q ss_pred CcEEEE-EEeccCCCCceEEEEECCCCcEEEEEEeecchh-hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 381 GRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 381 ~rY~i~-~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~-~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
+-|++. +.||+|+|+.|--++...+|..||||++.+... ...+..+|++++...+ +|+||++++++|++...+
T Consensus 77 d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cq-----gh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 77 DMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQ-----GHKNILQLIEFFEDDTRF 151 (463)
T ss_pred HHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhc-----CCccHHHHHHHhcccceE
Confidence 335544 479999999999999999999999999987543 4567889999998886 588999999999999999
Q ss_pred EEEEEccccc-hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec-cCCCeEEEEecCC
Q 005590 459 FIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGS 536 (689)
Q Consensus 459 ~lVmEy~~g~-L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~-~~~~~vkL~DFGl 536 (689)
|+|||-|.|+ |+.-+.... .|++.++.++++.|+.||.|||.+||.||||||+|||... +.-.-|||+||.+
T Consensus 152 YLVfEKm~GGplLshI~~~~------~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRK------HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred EEEEecccCchHHHHHHHhh------hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccc
Confidence 9999999964 555554332 3999999999999999999999999999999999999864 2345699999987
Q ss_pred cccc----------cCCccccccCccccChhhhc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHh
Q 005590 537 SCFQ----------TDNLCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 601 (689)
Q Consensus 537 s~~~----------~~~~~~~~gt~~Y~APE~l~-----~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~ 601 (689)
+... ++...+.+|+..|||||++. ...|+.+.|+||||||+|-||+|.+||.+....+
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d------- 298 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD------- 298 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc-------
Confidence 6431 12344568888999999974 2358999999999999999999999997642211
Q ss_pred hcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 602 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 602 ~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
-.|.+++.-...-. .+-+......|.+|+... ...+.+.+|||+.+|..|+..|.++.++++
T Consensus 299 -------CGWdrGe~Cr~CQ~------~LFesIQEGkYeFPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 299 -------CGWDRGEVCRVCQN------KLFESIQEGKYEFPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred -------CCccCCCccHHHHH------HHHHHHhccCCcCChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 01111111000000 000011233445554221 123567889999999999999999999999
Q ss_pred CCCCCC
Q 005590 682 HPWLQH 687 (689)
Q Consensus 682 hpwf~~ 687 (689)
|||++.
T Consensus 361 hPw~~~ 366 (463)
T KOG0607|consen 361 HPWVQR 366 (463)
T ss_pred Cccccc
Confidence 999985
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.60 Aligned_cols=252 Identities=26% Similarity=0.375 Sum_probs=200.8
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|++++.||+|+||.||++.+..+++.|++|.+.... .....+.+|+.+++.+ .|+||+++++.+...+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~~~~~~~ 74 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA------ENPFVVSMFCSFETKR 74 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC------CCCCeeeeEEEEecCC
Confidence 36899999999999999999999999999999987542 2234555677777765 4689999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
+.++||||+.| +|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++. ++.++|+|||
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~--~~~~~l~dfg 146 (305)
T cd05609 75 HLCMVMEYVEGGDCATLLKNIG------ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITS--MGHIKLTDFG 146 (305)
T ss_pred EEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECC--CCCEEEeeCC
Confidence 99999999986 6666664322 2888999999999999999999999999999999999984 7889999999
Q ss_pred CcccccCC------------------ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHH
Q 005590 536 SSCFQTDN------------------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILA 597 (689)
Q Consensus 536 ls~~~~~~------------------~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~ 597 (689)
++...... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||.+....+.+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~ 226 (305)
T cd05609 147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 226 (305)
T ss_pred CccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 87531100 011356778999999998889999999999999999999999998776655554
Q ss_pred HHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcC--
Q 005590 598 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-- 675 (689)
Q Consensus 598 ~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT-- 675 (689)
.+.....+ .|... ...+..+.+||.+||+.||++||+
T Consensus 227 ~~~~~~~~-----------------------------------~~~~~------~~~~~~~~~li~~~l~~~P~~R~~~~ 265 (305)
T cd05609 227 QVISDDIE-----------------------------------WPEGD------EALPADAQDLISRLLRQNPLERLGTG 265 (305)
T ss_pred HHHhcccC-----------------------------------CCCcc------ccCCHHHHHHHHHHhccChhhccCcc
Confidence 43211000 00000 013456889999999999999998
Q ss_pred -HHHHHcCCCCCC
Q 005590 676 -AREALDHPWLQH 687 (689)
Q Consensus 676 -a~ElL~hpwf~~ 687 (689)
+.++|+||||..
T Consensus 266 ~~~~ll~~~~~~~ 278 (305)
T cd05609 266 GAFEVKQHRFFLG 278 (305)
T ss_pred CHHHHHhCccccC
Confidence 899999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=298.66 Aligned_cols=251 Identities=26% Similarity=0.407 Sum_probs=201.1
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--CC
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH--LE 456 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~--~~ 456 (689)
+|++++.||.|+||.||++.+..+++.+|+|++... ......+..|+.+++.++ |+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK------HPNIVRYYDRIIDRSNQ 74 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcC------CCccceeeeeeecCCCC
Confidence 589999999999999999999999999999998653 233455667788777774 6799999998764 45
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHH-----HCCceeccCCCCcEEEeccCCCeEE
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH-----SLGIIHCDLKPENILIKSYQRCEIK 530 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH-----~~gIvHrDLKp~NILl~~~~~~~vk 530 (689)
..+++|||+.+ +|.+++..... ....+++..++.++.||+.||.||| +.+++|+||+|+||+++. ++.++
T Consensus 75 ~~~~~~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~--~~~~k 150 (265)
T cd08217 75 TLYIVMEYCEGGDLAQLIQKCKK--ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDA--NNNVK 150 (265)
T ss_pred EEEEEehhccCCCHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEec--CCCEE
Confidence 68999999985 67777654322 2234889999999999999999999 889999999999999984 78999
Q ss_pred EEecCCcccccCCc---cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCc
Q 005590 531 IIDLGSSCFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 607 (689)
Q Consensus 531 L~DFGls~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~ 607 (689)
|+|||++....... ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+....
T Consensus 151 l~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---- 226 (265)
T cd08217 151 LGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK---- 226 (265)
T ss_pred EecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC----
Confidence 99999987654332 23568899999999998889999999999999999999999998766444333322100
Q ss_pred HHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 608 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 608 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
...+|. ..+..+.+||.+||+.+|++|||+.++|+|||+
T Consensus 227 ------------------------------~~~~~~---------~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 227 ------------------------------FRRIPY---------RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ------------------------------CCCCcc---------ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 000111 123568899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.82 Aligned_cols=252 Identities=29% Similarity=0.450 Sum_probs=201.1
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 459 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~ 459 (689)
++|++.+.||.|+||.||+|++..+++.+++|++.... .....+.+|+.+++.+ +|+||+++++++.....++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~------~h~~i~~~~~~~~~~~~~~ 76 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC------RHPNIVAYFGSYLRRDKLW 76 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhC------CCCChhceEEEEEeCCEEE
Confidence 68999999999999999999999899999999988643 2345677788877776 4789999999999999999
Q ss_pred EEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcc
Q 005590 460 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 460 lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 538 (689)
++|||+.+ +|.+++.... ..+++..++.++.|++.||.|||+.||+|+||+|+||+++. ++.++|+|||++.
T Consensus 77 l~~e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~--~~~~~l~d~g~~~ 149 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTR-----GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTE--DGDVKLADFGVSA 149 (262)
T ss_pred EEEeCCCCCcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECC--CCCEEECccccch
Confidence 99999996 5665554331 23889999999999999999999999999999999999994 7789999999987
Q ss_pred cccCC---ccccccCccccChhhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 005590 539 FQTDN---LCLYVQSRSYRAPEVIIGL---PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 612 (689)
Q Consensus 539 ~~~~~---~~~~~gt~~Y~APE~l~~~---~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~ 612 (689)
..... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+....-.
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~------- 222 (262)
T cd06613 150 QLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP------- 222 (262)
T ss_pred hhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-------
Confidence 64432 2335678899999999877 7899999999999999999999999876544433322110000
Q ss_pred hhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCC
Q 005590 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 684 (689)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpw 684 (689)
.+. ... ....+..+.+||++||..+|.+|||+.+++.|||
T Consensus 223 ----------------------------~~~---~~~-~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 223 ----------------------------PPK---LKD-KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ----------------------------Ccc---ccc-hhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 000 000 0011345889999999999999999999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=321.22 Aligned_cols=266 Identities=27% Similarity=0.378 Sum_probs=206.2
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHH--HHHHHHhcccCCCCCCceeEEEEEEE-
Q 005590 377 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDE--IKLLKLVNKNDPADEHHILRLYDYFY- 453 (689)
Q Consensus 377 ~~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~E--i~iL~~l~~~~~~~h~~Iv~l~~~f~- 453 (689)
..+++||.++.+||+|||+.||+|.|....+.||+|+-...+.|.+..... ...++..+....++||.||++|++|.
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 467899999999999999999999999999999999987665554332211 11333333334457889999999998
Q ss_pred eCCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCcEEEecc-CCCeEE
Q 005590 454 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL--GIIHCDLKPENILIKSY-QRCEIK 530 (689)
Q Consensus 454 ~~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~--gIvHrDLKp~NILl~~~-~~~~vk 530 (689)
+.+.+|-|+|||+|+-+++...... .+++++++.|+.||+.||.||... -|||-||||.|||+..+ .-|.||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeE
Confidence 5567899999999987776654333 299999999999999999999987 49999999999998643 347899
Q ss_pred EEecCCcccccCCcc----------ccccCccccChhhhcCC----CCCchhhHHHHHHHHHHHHhCCCCCCCChHHH-H
Q 005590 531 IIDLGSSCFQTDNLC----------LYVQSRSYRAPEVIIGL----PYDQKIDLWSLGCILAELWTGEVLFPNDAVVM-I 595 (689)
Q Consensus 531 L~DFGls~~~~~~~~----------~~~gt~~Y~APE~l~~~----~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~-~ 595 (689)
|+|||++..+.+... ...||.||+|||++.-. .++.++||||+|||+|.++.|+.||..+.... +
T Consensus 614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI 693 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI 693 (775)
T ss_pred eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH
Confidence 999999988654322 25789999999998633 48899999999999999999999998764332 2
Q ss_pred HHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcC
Q 005590 596 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 675 (689)
Q Consensus 596 l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT 675 (689)
+..- ......+..+|..+. .+.++++||++||++.-+.|+.
T Consensus 694 LqeN--------------------------------TIlkAtEVqFP~KPv-------VsseAkaFIRRCLaYRKeDR~D 734 (775)
T KOG1151|consen 694 LQEN--------------------------------TILKATEVQFPPKPV-------VSSEAKAFIRRCLAYRKEDRID 734 (775)
T ss_pred Hhhh--------------------------------chhcceeccCCCCCc-------cCHHHHHHHHHHHHhhhhhhhh
Confidence 2210 001112333444332 3467889999999999999999
Q ss_pred HHHHHcCCCCC
Q 005590 676 AREALDHPWLQ 686 (689)
Q Consensus 676 a~ElL~hpwf~ 686 (689)
..+|..||+|.
T Consensus 735 V~qLA~dpyll 745 (775)
T KOG1151|consen 735 VQQLACDPYLL 745 (775)
T ss_pred HHHHccCcccc
Confidence 99999999984
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=304.88 Aligned_cols=252 Identities=32% Similarity=0.440 Sum_probs=201.8
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
++|++.+.||.|++|.||++.+..+++.+|+|++.... .....+.+|+.+++.+. |+||+++++.+......
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~~~ 74 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCN------SPYIVGFYGAFYNNGDI 74 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCC------CCchhhhheeeecCCEE
Confidence 36788899999999999999999999999999987652 33456677777777664 78999999999999999
Q ss_pred EEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 459 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 459 ~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~-~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
++|+||+. ++|.+++.... ..+++..+..++.||+.||.|||+ .|++|+||||+||+++. ++.++|+|||.
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~--~~~~~l~d~g~ 147 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQ-----GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNS--RGQIKLCDFGV 147 (265)
T ss_pred EEEEEecCCCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECC--CCCEEEeeccc
Confidence 99999999 57777765432 238899999999999999999999 99999999999999995 77899999998
Q ss_pred cccccCC-ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCh-----HHHHHHHHHhhcCCCcHHH
Q 005590 537 SCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA-----VVMILARIIGMLGPIDLEM 610 (689)
Q Consensus 537 s~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~-----~~~~l~~i~~~~g~~~~e~ 610 (689)
+...... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||.... ..+.+..+...
T Consensus 148 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 219 (265)
T cd06605 148 SGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE-------- 219 (265)
T ss_pred chhhHHHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC--------
Confidence 8654322 122678889999999999999999999999999999999999996542 11111111100
Q ss_pred HhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
.....+. . ..+..+++||.+||..||++|||+.+++.||||++
T Consensus 220 --------------------------~~~~~~~------~--~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 220 --------------------------PPPRLPS------G--KFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred --------------------------CCCCCCh------h--hcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 0000110 0 03466889999999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=308.38 Aligned_cols=261 Identities=26% Similarity=0.369 Sum_probs=199.5
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
++|...+.||+|+||.||++.+..+++.+|+|.+.... .....+.+|+.++..+. +|+||+++++++......
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~-----~~~~iv~~~~~~~~~~~~ 78 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS-----DCPYIVKFYGALFREGDC 78 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhc-----CCCCEeeeeeEEecCCcE
Confidence 35667788999999999999999999999999987532 33455667777777664 378999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~-gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
+++|||+..++.++....... ....+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.++|+|||++
T Consensus 79 ~~~~e~~~~~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~--~~~~kl~dfg~~ 155 (288)
T cd06616 79 WICMELMDISLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDR--NGNIKLCDFGIS 155 (288)
T ss_pred EEEEecccCCHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEcc--CCcEEEeecchh
Confidence 999999988766654332111 113389999999999999999999975 9999999999999985 778999999998
Q ss_pred ccccCC--ccccccCccccChhhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 005590 538 CFQTDN--LCLYVQSRSYRAPEVIIGL---PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 612 (689)
Q Consensus 538 ~~~~~~--~~~~~gt~~Y~APE~l~~~---~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~ 612 (689)
...... .....+++.|+|||++.+. .++.++|+||+||++|+|++|+.||.... .....+.......+
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~----- 228 (288)
T cd06616 156 GQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDP----- 228 (288)
T ss_pred HHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCC-----
Confidence 654332 2234678899999999876 68999999999999999999999997543 11111111100000
Q ss_pred hhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
..++.. .....+..+.+||.+||+.||++|||+.++++||||+.
T Consensus 229 --------------------------~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 229 --------------------------PILSNS-----EEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred --------------------------CcCCCc-----CCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 000000 00123567899999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=298.09 Aligned_cols=248 Identities=29% Similarity=0.401 Sum_probs=198.8
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~------~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
+|++.+.||+|++|+||+|.+..+++.|++|.+.... .....+.+|+.+++.++ |++|+++++++...
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~------h~~i~~~~~~~~~~ 74 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ------HPNIVQYLGTEREE 74 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC------CCCchheeeeEecC
Confidence 5788899999999999999998899999999986532 23456677887777664 67999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEec
Q 005590 456 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 534 (689)
Q Consensus 456 ~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DF 534 (689)
...++||||+.+ +|.+++.... .+++..+..++.||+.||.|||+.||+|+||+|+||+++. ++.+||+||
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~--~~~~kl~d~ 146 (258)
T cd06632 75 DNLYIFLELVPGGSLAKLLKKYG------SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDT--NGVVKLADF 146 (258)
T ss_pred CeEEEEEEecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEEccC
Confidence 999999999985 6777665321 2788899999999999999999999999999999999984 788999999
Q ss_pred CCcccccCC--ccccccCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 005590 535 GSSCFQTDN--LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 611 (689)
Q Consensus 535 Gls~~~~~~--~~~~~gt~~Y~APE~l~~~~-~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~ 611 (689)
|++...... .....++..|+|||.+.... ++.++|+|||||++|+|++|+.||...........+....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-------- 218 (258)
T cd06632 147 GMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-------- 218 (258)
T ss_pred ccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc--------
Confidence 988654332 23456788999999998776 8999999999999999999999997654333222221000
Q ss_pred hhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
....++ ...++.+.+||++||+.+|.+|||+.++|+||||
T Consensus 219 -------------------------~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 219 -------------------------ELPPIP---------DHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred -------------------------cCCCcC---------CCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 000011 1234668899999999999999999999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=305.57 Aligned_cols=282 Identities=25% Similarity=0.459 Sum_probs=224.4
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeec---chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-- 454 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~---~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~-- 454 (689)
.+.|.-+.+||+|.||.||+|+...+|+.||+|++-. ...+....++|+++|..+. |+|++.++..+..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lk------Henv~nliEic~tk~ 89 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLK------HENVVNLIEICRTKA 89 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhc------chhHHHHHHHHhhcc
Confidence 4678888899999999999999999999999997643 2344567789999999886 4567776666542
Q ss_pred ------CCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCe
Q 005590 455 ------LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 528 (689)
Q Consensus 455 ------~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~ 528 (689)
...+|+||.+|+.+|.-++.... ..++...++.++.++++||.|+|...|+|||+|+.|+||+. ++.
T Consensus 90 Tp~~r~r~t~ylVf~~cehDLaGlLsn~~-----vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~--dgi 162 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCEHDLAGLLSNRK-----VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITK--DGI 162 (376)
T ss_pred CCcccccceeeeeHHHhhhhHHHHhcCcc-----ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcC--Cce
Confidence 23589999999998887765332 23999999999999999999999999999999999999994 899
Q ss_pred EEEEecCCcccccC-------CccccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHH
Q 005590 529 IKIIDLGSSCFQTD-------NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 600 (689)
Q Consensus 529 vkL~DFGls~~~~~-------~~~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~ 600 (689)
+||+|||+++.... ..+..+-|.+|++||.++|. .|+.+.|||..|||+.+|+++.+.|++++....+..|.
T Consensus 163 lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is 242 (376)
T KOG0669|consen 163 LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS 242 (376)
T ss_pred EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence 99999999865332 12234669999999999875 59999999999999999999999999999999999999
Q ss_pred hhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCcc--chhhh--hccCCcHHHHHHHHHhcccCCCCCcCH
Q 005590 601 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEE--SSLEH--HLQFSDAFFIDFVRTLLEINPQRRPTA 676 (689)
Q Consensus 601 ~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~--~~l~~--~~~~~~~~l~dLI~~mL~~dP~kRpTa 676 (689)
...|.+..+.|+...++.-|-.-+.. .+|+. ..+.. .....+.+..+|+.+||..||.+|+++
T Consensus 243 ~LcGs~tkevWP~~d~lpL~~sie~e-------------Pl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~a 309 (376)
T KOG0669|consen 243 QLCGSITKEVWPNVDNLPLYQSIELE-------------PLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDA 309 (376)
T ss_pred HHhccCCcccCCCcccchHHHhccCC-------------CCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcch
Confidence 99999999999876654322211000 01110 00000 112346778999999999999999999
Q ss_pred HHHHcCCCCCC
Q 005590 677 REALDHPWLQH 687 (689)
Q Consensus 677 ~ElL~hpwf~~ 687 (689)
+++|.|.||-+
T Consensus 310 d~alnh~~F~k 320 (376)
T KOG0669|consen 310 DQALNHDFFWK 320 (376)
T ss_pred Hhhhchhhhhc
Confidence 99999999954
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=307.56 Aligned_cols=258 Identities=21% Similarity=0.270 Sum_probs=194.6
Q ss_pred cCcEEEEEEeccCCCCceEEEEECC----------------CCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCC
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLH----------------TGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPAD 441 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~----------------tg~~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~ 441 (689)
.++|++.+.||+|+||.||+|.+.. ++..||+|++... ......+.+|+++++.++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------ 77 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLK------ 77 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcC------
Confidence 5789999999999999999997532 3457999998764 233456778888887764
Q ss_pred CCceeEEEEEEEeCCeEEEEEEcccc-chHHHHhhhhcc-------------CCCcccCHHHHHHHHHHHHHHHHHHHHC
Q 005590 442 EHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQES-------------GGEAYFTLGRLQVITRQCLEALEYLHSL 507 (689)
Q Consensus 442 h~~Iv~l~~~f~~~~~l~lVmEy~~g-~L~~l~~~~~~~-------------~~~~~ls~~~i~~i~~QIl~aL~yLH~~ 507 (689)
|+||+++++++...+..++||||+.+ +|.+++...... .....+++..+..++.||+.||.|||+.
T Consensus 78 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 157 (304)
T cd05096 78 DPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157 (304)
T ss_pred CCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 68999999999999999999999974 777776543211 1112367788999999999999999999
Q ss_pred CceeccCCCCcEEEeccCCCeEEEEecCCcccccCCc-----cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh
Q 005590 508 GIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT 582 (689)
Q Consensus 508 gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt 582 (689)
||+||||||+|||++. ++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++
T Consensus 158 ~ivH~dlkp~Nill~~--~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 158 NFVHRDLATRNCLVGE--NLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred CccccCcchhheEEcC--CccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence 9999999999999984 7889999999987543221 12344778999999998899999999999999999987
Q ss_pred --CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHH
Q 005590 583 --GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFID 660 (689)
Q Consensus 583 --G~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~d 660 (689)
+..||...+..+.+..+...+.. . ........| ...+..+.+
T Consensus 236 ~~~~~p~~~~~~~~~~~~~~~~~~~------------------~---------~~~~~~~~~---------~~~~~~~~~ 279 (304)
T cd05096 236 LCKEQPYGELTDEQVIENAGEFFRD------------------Q---------GRQVYLFRP---------PPCPQGLYE 279 (304)
T ss_pred ccCCCCCCcCCHHHHHHHHHHHhhh------------------c---------cccccccCC---------CCCCHHHHH
Confidence 66888776555544433211000 0 000000001 112356889
Q ss_pred HHHHhcccCCCCCcCHHHHHc
Q 005590 661 FVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 661 LI~~mL~~dP~kRpTa~ElL~ 681 (689)
||.+||+.||.+|||+.++.+
T Consensus 280 li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 280 LMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred HHHHHccCCchhCcCHHHHHH
Confidence 999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=300.32 Aligned_cols=247 Identities=26% Similarity=0.412 Sum_probs=192.5
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecchhh----hHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEE
Q 005590 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF----FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 462 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~----~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVm 462 (689)
+.||.|+||.||+|.+..+++.||+|+++..... ......|..++.. ..+|+||+++++++...+..++||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~-----~~~~~~i~~~~~~~~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMI-----QGESPYVAKLYYSFQSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhh-----cCCCCCeeeeeeeEEcCCeEEEEE
Confidence 5689999999999999999999999998754211 1122223222221 236899999999999999999999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccccc
Q 005590 463 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 541 (689)
Q Consensus 463 Ey~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~ 541 (689)
||+.+ +|.+++.... .+++..+..++.||+.||.|||+.+++|+||+|+||+++. ++.++|+|||++....
T Consensus 77 e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~--~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 77 EYLNGGDCASLIKTLG------GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQ--TGHLKLTDFGLSRNGL 148 (260)
T ss_pred eccCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC--CCcEEEeecccceecc
Confidence 99985 6766664322 2889999999999999999999999999999999999984 7789999999886543
Q ss_pred CCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhh
Q 005590 542 DNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYF 621 (689)
Q Consensus 542 ~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~ 621 (689)
. .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+......
T Consensus 149 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 211 (260)
T cd05611 149 E-NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN---------------- 211 (260)
T ss_pred c-cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC----------------
Confidence 3 23346788999999999888999999999999999999999999876665554443211000
Q ss_pred hccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcC---HHHHHcCCCCCC
Q 005590 622 TKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT---AREALDHPWLQH 687 (689)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT---a~ElL~hpwf~~ 687 (689)
.+. . .....+..+.++|.+||+.||++||| +.|+|.||||++
T Consensus 212 -------------------~~~--~---~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 212 -------------------WPE--E---VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred -------------------CCC--c---ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhc
Confidence 000 0 00123466889999999999999995 579999999976
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=302.41 Aligned_cols=246 Identities=27% Similarity=0.415 Sum_probs=200.1
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
+|++.+.||.|+||.||++.+..+++.||+|++.... .....+.+|+++++.+ +||||+++++.+....+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~ 74 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL------NHPFLVNLWYSFQDEEN 74 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC------CCCChHHHHHhhcCCCe
Confidence 5899999999999999999999999999999997542 2345667777777766 47899999999999999
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 458 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 458 l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
.++||||+.+ +|.+.+... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++. ++.++|+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~--~~~~~l~d~~~ 146 (258)
T cd05578 75 MYLVVDLLLGGDLRYHLSQK------VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDE--QGHVHITDFNI 146 (258)
T ss_pred EEEEEeCCCCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcC--CCCEEEeeccc
Confidence 9999999986 566665433 23889999999999999999999999999999999999984 78899999998
Q ss_pred cccccCC--ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChH---HHHHHHHHhhcCCCcHHHH
Q 005590 537 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV---VMILARIIGMLGPIDLEML 611 (689)
Q Consensus 537 s~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~---~~~l~~i~~~~g~~~~e~~ 611 (689)
+...... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+. ........
T Consensus 147 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------- 215 (258)
T cd05578 147 ATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE----------- 215 (258)
T ss_pred ccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc-----------
Confidence 8765433 2335678899999999988899999999999999999999999986543 11111110
Q ss_pred hhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCH--HHHHcCCCC
Q 005590 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA--REALDHPWL 685 (689)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa--~ElL~hpwf 685 (689)
......|. ..+..+.++|++||+.||.+||++ +|+++||||
T Consensus 216 ------------------------~~~~~~~~---------~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 216 ------------------------TADVLYPA---------TWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ------------------------cccccCcc---------cCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 00111111 123568899999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=299.18 Aligned_cols=249 Identities=20% Similarity=0.299 Sum_probs=201.7
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
....|.+.+.||+|+||.||+|.+..+++.||+|++..+......+.+|+++++.+. |+||+++++++......
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK------HPNLVQLLGVCTREPPF 77 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCC------CCChhheEEEEcCCCCc
Confidence 346799999999999999999999999999999999876555567788888888774 67999999999999999
Q ss_pred EEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
++||||+. ++|.+++.... ...+++..++.++.|++.||.|||+.|++||||||+||+++. ++.+||+|||++
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~--~~~~kl~df~~~ 151 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECN----RQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLS 151 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcC--CCcEEeCCCccc
Confidence 99999997 56777765332 123788899999999999999999999999999999999984 788999999998
Q ss_pred ccccCCccc----cccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 005590 538 CFQTDNLCL----YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLM 612 (689)
Q Consensus 538 ~~~~~~~~~----~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~~ 612 (689)
......... ...+..|+|||.+.+..++.++|||||||++|+|++ |..||++....+....+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--------- 222 (263)
T cd05052 152 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY--------- 222 (263)
T ss_pred cccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC---------
Confidence 765433211 223567999999999999999999999999999998 999998776655544432110
Q ss_pred hhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
....| ...+..+.+||.+||+.||++|||+.++++.
T Consensus 223 -------------------------~~~~~---------~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 223 -------------------------RMERP---------EGCPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred -------------------------CCCCC---------CCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 00111 1124568899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=302.66 Aligned_cols=248 Identities=27% Similarity=0.367 Sum_probs=193.0
Q ss_pred CcEEEEEEe--ccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 381 GRYYVTEYL--GSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 381 ~rY~i~~~L--G~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
++|.+.+.+ |+|+||.||+++++.+++.+|+|++...... . .|+.+...+. +|+||+++++.|...+..
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~--~--~e~~~~~~~~-----~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN--A--IEPMVHQLMK-----DNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc--h--hhHHHHHHhh-----cCCCEEEEEEEEecCCee
Confidence 456666665 9999999999999999999999998754211 1 1232222222 488999999999999999
Q ss_pred EEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCC-eEEEEecCC
Q 005590 459 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC-EIKIIDLGS 536 (689)
Q Consensus 459 ~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~-~vkL~DFGl 536 (689)
++||||+. ++|.+++.... .+++..++.++.||+.||.|||+.|++||||||+||+++. ++ .++|+|||+
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~--~~~~~~l~dfg~ 156 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEG------KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDR--AKDRIYLCDYGL 156 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeC--CCCeEEEecCcc
Confidence 99999997 57888776432 3899999999999999999999999999999999999985 44 899999999
Q ss_pred cccccCCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHH-HHHHHhhcCCCcHHHHhhhh
Q 005590 537 SCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI-LARIIGMLGPIDLEMLMQGQ 615 (689)
Q Consensus 537 s~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~-l~~i~~~~g~~~~e~~~~~~ 615 (689)
+...... ....++..|+|||++.+..++.++|+||+||++|+|++|..||........ ...+..
T Consensus 157 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------- 221 (267)
T PHA03390 157 CKIIGTP-SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLK-------------- 221 (267)
T ss_pred ceecCCC-ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHH--------------
Confidence 8765433 234688999999999998999999999999999999999999975432221 111100
Q ss_pred hhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcC-HHHHHcCCCCCC
Q 005590 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-AREALDHPWLQH 687 (689)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT-a~ElL~hpwf~~ 687 (689)
......+ .....++.+.+||.+||+.+|.+||+ .+|+|+||||.+
T Consensus 222 --------------------~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 222 --------------------RQQKKLP-------FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred --------------------hhcccCC-------cccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 0000000 01124567899999999999999996 599999999974
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=297.36 Aligned_cols=250 Identities=25% Similarity=0.397 Sum_probs=201.0
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
+|.+.+.||+|+||.||++.++.+|..+|+|.+.... ...+.+.+|+.+++.++ |+||+++++.+......
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~------h~~i~~~~~~~~~~~~~ 74 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK------HPNIVTFFASFQENGRL 74 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCC------CCChhhhhheeccCCeE
Confidence 5899999999999999999999999999999987542 23456678888888774 67999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
++|+||+.+ +|.+++..... ..+++..+..++.||+.||.|||+.+++|+||||+||+++. ....++|+|||.+
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~-~~~~~~l~d~~~~ 149 (257)
T cd08225 75 FIVMEYCDGGDLMKRINRQRG----VLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSK-NGMVAKLGDFGIA 149 (257)
T ss_pred EEEEecCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcC-CCCeEEecccccc
Confidence 999999975 67776653221 23788999999999999999999999999999999999985 2345799999988
Q ss_pred ccccCCc---cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 538 CFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 538 ~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
....... ....+++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------ 217 (257)
T cd08225 150 RQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG------------ 217 (257)
T ss_pred hhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc------------
Confidence 7654322 2245788999999998888999999999999999999999999876554443332200
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
.... ++ ...+..+.++|.+||..+|++|||+.++++||||
T Consensus 218 ---------------------~~~~-~~---------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 218 ---------------------YFAP-IS---------PNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ---------------------cCCC-CC---------CCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 0000 00 1123568899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=300.46 Aligned_cols=252 Identities=29% Similarity=0.459 Sum_probs=196.0
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh-----------hhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-----------FFDQSLDEIKLLKLVNKNDPADEHHILRLYD 450 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~-----------~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~ 450 (689)
+|.+.+.||.|+||.||+|.+..+|+.+|+|.++.... ..+.+.+|+.+++.+ +|+||+++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~ 75 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL------DHLNIVQYLG 75 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc------CCCCcceEEE
Confidence 58899999999999999999988999999998864211 123455666666666 4789999999
Q ss_pred EEEeCCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeE
Q 005590 451 YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 529 (689)
Q Consensus 451 ~f~~~~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~v 529 (689)
++...+..++||||+.+ +|.+++... ..++...+..++.||+.||.|||+.+++|+||+|+||+++. ++.+
T Consensus 76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~--~~~~ 147 (272)
T cd06629 76 FETTEEYLSIFLEYVPGGSIGSCLRTY------GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDA--DGIC 147 (272)
T ss_pred EeccCCceEEEEecCCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcC--CCeE
Confidence 99999999999999975 676666533 23888899999999999999999999999999999999984 7889
Q ss_pred EEEecCCcccccCC-----ccccccCccccChhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhh
Q 005590 530 KIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 602 (689)
Q Consensus 530 kL~DFGls~~~~~~-----~~~~~gt~~Y~APE~l~~~~--~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~ 602 (689)
+|+|||++...... .....++..|+|||.+.... ++.++|+||||+++|++++|..||........+..+...
T Consensus 148 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 227 (272)
T cd06629 148 KISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK 227 (272)
T ss_pred EEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcc
Confidence 99999998754322 12245788999999987654 889999999999999999999999754433322221100
Q ss_pred cCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 603 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 603 ~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
.....++.. .....+..+.+||.+||..+|++|||+.++|+|
T Consensus 228 ---------------------------------~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 228 ---------------------------------RSAPPIPPD-----VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ---------------------------------ccCCcCCcc-----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000011110 011234678999999999999999999999999
Q ss_pred CCC
Q 005590 683 PWL 685 (689)
Q Consensus 683 pwf 685 (689)
|||
T Consensus 270 ~~~ 272 (272)
T cd06629 270 PFI 272 (272)
T ss_pred CCC
Confidence 997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=301.36 Aligned_cols=249 Identities=28% Similarity=0.394 Sum_probs=195.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~------~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
..|++.+.||+|+||.||+|.+..++..||+|++.... .....+.+|+.+++.++ |+||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~ 75 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ------HERIVQYYGCLRD 75 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC------CCCeeeEEEEEEc
Confidence 36889999999999999999999999999999986431 22345667888877774 6799999999875
Q ss_pred --CCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEE
Q 005590 455 --LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 531 (689)
Q Consensus 455 --~~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL 531 (689)
...++++|||+.+ +|.+.+.... .+++..++.++.||+.||.|||+.+|+|+||||+||+++. ++.++|
T Consensus 76 ~~~~~~~l~~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~--~~~~~l 147 (266)
T cd06651 76 RAEKTLTIFMEYMPGGSVKDQLKAYG------ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDS--AGNVKL 147 (266)
T ss_pred CCCCEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC--CCCEEE
Confidence 3678999999985 6777665322 2788889999999999999999999999999999999984 778999
Q ss_pred EecCCcccccCC------ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 005590 532 IDLGSSCFQTDN------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 605 (689)
Q Consensus 532 ~DFGls~~~~~~------~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~ 605 (689)
+|||++...... .....++..|+|||.+.+..++.++|+||+||++|+|++|+.||...........+....
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~-- 225 (266)
T cd06651 148 GDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP-- 225 (266)
T ss_pred ccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC--
Confidence 999998654321 122457889999999999889999999999999999999999997654333332221000
Q ss_pred CcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 606 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 606 ~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
....+| ...++.+.+|| .||..+|++|||++|+++||||
T Consensus 226 -------------------------------~~~~~~---------~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~ 264 (266)
T cd06651 226 -------------------------------TNPQLP---------SHISEHARDFL-GCIFVEARHRPSAEELLRHPFA 264 (266)
T ss_pred -------------------------------CCCCCc---------hhcCHHHHHHH-HHhcCChhhCcCHHHHhcCccc
Confidence 000111 12345677888 5777899999999999999999
Q ss_pred C
Q 005590 686 Q 686 (689)
Q Consensus 686 ~ 686 (689)
+
T Consensus 265 ~ 265 (266)
T cd06651 265 Q 265 (266)
T ss_pred c
Confidence 7
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=299.28 Aligned_cols=243 Identities=28% Similarity=0.441 Sum_probs=196.7
Q ss_pred eccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEEEc
Q 005590 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 464 (689)
Q Consensus 389 LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmEy 464 (689)
||.|++|.||++++..+++.+|+|++.... .....+.+|+.+++.++ |+||+++++.+......++||||
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~ 74 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN------HPFIVKLYRTFKDKKYIYMLMEY 74 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC------CCCEeeeeeeEEcCCccEEEEec
Confidence 699999999999999999999999987532 23456677777777664 78999999999999999999999
Q ss_pred cc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccCC
Q 005590 465 LR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 543 (689)
Q Consensus 465 ~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~ 543 (689)
+. ++|.+++.... .+++..+..++.||+.||.|||+.|++|+||+|+||+++. ++.++|+|||++......
T Consensus 75 ~~~~~L~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~--~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 75 CLGGELWTILRDRG------LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDS--NGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred CCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcC--CCCEEEeeCCcccccCcc
Confidence 97 47777765432 2788999999999999999999999999999999999985 788999999998765443
Q ss_pred --ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCh--HHHHHHHHHhhcCCCcHHHHhhhhhhhh
Q 005590 544 --LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA--VVMILARIIGMLGPIDLEMLMQGQEIYK 619 (689)
Q Consensus 544 --~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~--~~~~l~~i~~~~g~~~~e~~~~~~~~~~ 619 (689)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.... .......+...
T Consensus 147 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------- 209 (262)
T cd05572 147 QKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKG----------------- 209 (262)
T ss_pred cccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhcc-----------------
Confidence 233567889999999988889999999999999999999999997654 33333332200
Q ss_pred hhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcC-----HHHHHcCCCCCC
Q 005590 620 YFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPWLQH 687 (689)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT-----a~ElL~hpwf~~ 687 (689)
.....+|. ..+..+.+||.+||+.||++||+ +.|+++||||+.
T Consensus 210 ----------------~~~~~~~~---------~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 210 ----------------NGKLEFPN---------YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred ----------------CCCCCCCc---------ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence 00011111 11456889999999999999999 999999999974
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=302.90 Aligned_cols=248 Identities=30% Similarity=0.482 Sum_probs=202.9
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|.+.+.||+|+||.||++++..+++.||+|++.... .....+.+|..+++.+. .|+||+++++++...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~-----~~~~i~~~~~~~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN-----GHPGIIKLYYTFQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcc-----cCCCchhHHHHhcCCc
Confidence 47999999999999999999999999999999987532 22345667777777664 3789999999999999
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
..++||||+. ++|.+++.... .+++..++.++.||+.||.+||+.|++|+||+|+||+++. ++.++|+|||
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~--~~~~~l~df~ 147 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYG------SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDK--DMHIKITDFG 147 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC--CCCEEecCCc
Confidence 9999999995 67877775432 3899999999999999999999999999999999999984 7789999999
Q ss_pred CcccccCCc-----------------------cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChH
Q 005590 536 SSCFQTDNL-----------------------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV 592 (689)
Q Consensus 536 ls~~~~~~~-----------------------~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~ 592 (689)
++....... ....++..|+|||++.+..++.++|+||||++++++++|+.||.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (280)
T cd05581 148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227 (280)
T ss_pred cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 886543321 123567889999999988899999999999999999999999987765
Q ss_pred HHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCC
Q 005590 593 VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 672 (689)
Q Consensus 593 ~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~k 672 (689)
...+..+... ...+|. ..++.+.+||++||+.+|++
T Consensus 228 ~~~~~~~~~~-----------------------------------~~~~~~---------~~~~~~~~li~~~l~~~p~~ 263 (280)
T cd05581 228 YLTFQKILKL-----------------------------------EYSFPP---------NFPPDAKDLIEKLLVLDPQD 263 (280)
T ss_pred HHHHHHHHhc-----------------------------------CCCCCC---------ccCHHHHHHHHHHhcCCHhh
Confidence 4444333211 111111 11456889999999999999
Q ss_pred CcCH----HHHHcCCCC
Q 005590 673 RPTA----REALDHPWL 685 (689)
Q Consensus 673 RpTa----~ElL~hpwf 685 (689)
|||+ .++++||||
T Consensus 264 R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 264 RLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCcccCHHHHhcCCCC
Confidence 9999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=296.54 Aligned_cols=246 Identities=25% Similarity=0.416 Sum_probs=198.9
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 459 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~ 459 (689)
+|++.+.||.|+||.||++++..+++.+|+|.++.. ....+...+|+.+++.+ +|+||+++++.+...++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM------KHPNIVAFKESFEADGHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC------CCCCcceEEEEEEECCEEE
Confidence 589999999999999999999999999999998643 23345666787777766 4789999999999999999
Q ss_pred EEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcc
Q 005590 460 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 460 lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 538 (689)
+||||+.+ ++.+++.... ...+++..+..++.||+.||.|||+.||+|+||||+||+++. ++.++|+|||.+.
T Consensus 75 lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~--~~~~~l~dfg~~~ 148 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQR----GKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQ--NGKVKLGDFGSAR 148 (255)
T ss_pred EEEeeCCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECC--CCcEEEcccCcce
Confidence 99999985 6777665322 123788999999999999999999999999999999999984 7789999999987
Q ss_pred cccCC---ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 005590 539 FQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615 (689)
Q Consensus 539 ~~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~ 615 (689)
..... .....+++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 216 (255)
T cd08219 149 LLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS------------ 216 (255)
T ss_pred eecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCC------------
Confidence 65432 223568889999999999889999999999999999999999998766555444332100
Q ss_pred hhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
...+|. ..+..+.+||.+||+.||++|||+.+++.-
T Consensus 217 ----------------------~~~~~~---------~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 217 ----------------------YKPLPS---------HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ----------------------CCCCCc---------ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 000111 123457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=302.68 Aligned_cols=246 Identities=24% Similarity=0.378 Sum_probs=189.3
Q ss_pred EeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEEE
Q 005590 388 YLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 463 (689)
Q Consensus 388 ~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmE 463 (689)
.||+|+||.||++.+..+++.+|+|++..... ......++..+++.+.. ..|++|+.+++++...+..++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~i~~~~~~~~~~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST---GDCPFIVCMTYAFHTPDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhh---CCCCcEeEEEEEEecCCeEEEEEe
Confidence 38999999999999999999999999875421 11233444545554432 358999999999999999999999
Q ss_pred cccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccC
Q 005590 464 LLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 542 (689)
Q Consensus 464 y~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~ 542 (689)
|+.+ +|.+++.... .+++..+..++.||+.||.|||+.+|+|+||||+|||++. ++.++|+|||++.....
T Consensus 78 ~~~~~~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~--~~~~~l~dfg~~~~~~~ 149 (279)
T cd05633 78 LMNGGDLHYHLSQHG------VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDE--HGHVRISDLGLACDFSK 149 (279)
T ss_pred cCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECC--CCCEEEccCCcceeccc
Confidence 9986 5655554322 3899999999999999999999999999999999999984 77899999999865433
Q ss_pred C-ccccccCccccChhhhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHH--HHHHHHhhcCCCcHHHHhhhhhhh
Q 005590 543 N-LCLYVQSRSYRAPEVII-GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVM--ILARIIGMLGPIDLEMLMQGQEIY 618 (689)
Q Consensus 543 ~-~~~~~gt~~Y~APE~l~-~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~--~l~~i~~~~g~~~~e~~~~~~~~~ 618 (689)
. .....+++.|+|||.+. +..++.++|+||+||++|+|++|..||....... .+..+.
T Consensus 150 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~------------------ 211 (279)
T cd05633 150 KKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT------------------ 211 (279)
T ss_pred cCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh------------------
Confidence 2 23356899999999986 4568999999999999999999999996532111 111110
Q ss_pred hhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCc-----CHHHHHcCCCCCC
Q 005590 619 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQH 687 (689)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRp-----Ta~ElL~hpwf~~ 687 (689)
......+|. ..+..+.+||++||..||.+|+ |++|+++||||+.
T Consensus 212 ----------------~~~~~~~~~---------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 212 ----------------LTVNVELPD---------SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred ----------------hcCCcCCcc---------ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 000011111 1245688999999999999999 6999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.86 Aligned_cols=249 Identities=28% Similarity=0.413 Sum_probs=199.4
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
..|++++.||.|+||.||+|.+..++..+|+|++.... .....+.+|+.+++.+ .|++|+++++++......
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~ 77 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC------DSPYVTKYYGSYLKGTKL 77 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC------CCCCEeeEEEEEEECCEE
Confidence 46888899999999999999999999999999987542 3345566777777766 478999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
++||||+.+ +|.+++... .+++..+..++.|++.||.|||+.+++|+||+|+||+++. ++.++|+|||++
T Consensus 78 ~lv~e~~~~~~L~~~i~~~-------~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~--~~~~~l~dfg~~ 148 (277)
T cd06640 78 WIIMEYLGGGSALDLLRAG-------PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSE--QGDVKLADFGVA 148 (277)
T ss_pred EEEEecCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcC--CCCEEEcccccc
Confidence 999999986 666665421 2788889999999999999999999999999999999984 778999999998
Q ss_pred ccccCC---ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 538 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 538 ~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
...... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+...
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~------------ 216 (277)
T cd06640 149 GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN------------ 216 (277)
T ss_pred eeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC------------
Confidence 654332 22245788899999999888999999999999999999999999765443322221100
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
....++ ...+..+.+||.+||+.+|++||++.++++||||..
T Consensus 217 ----------------------~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06640 217 ----------------------NPPTLT---------GEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVK 258 (277)
T ss_pred ----------------------CCCCCc---------hhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhh
Confidence 000000 012345789999999999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=298.38 Aligned_cols=249 Identities=27% Similarity=0.418 Sum_probs=195.7
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~------~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
.+|++.+.||+|+||.||++++..+++.||||++..+. .....+.+|+.+++.+. |+||+++++++..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~ 75 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL------HERIVQYYGCLRD 75 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC------CCCeeeEEeEecc
Confidence 47999999999999999999999999999999886431 22345667888887774 7899999999876
Q ss_pred C--CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEE
Q 005590 455 L--EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 531 (689)
Q Consensus 455 ~--~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL 531 (689)
. ..+++||||+.+ +|.+++.... .+++..+..++.|++.||.|||+.+|+|+||||+||+++. ++.++|
T Consensus 76 ~~~~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~--~~~~~l 147 (265)
T cd06652 76 PMERTLSIFMEHMPGGSIKDQLKSYG------ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDS--VGNVKL 147 (265)
T ss_pred CCCceEEEEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecC--CCCEEE
Confidence 4 568899999985 6777665322 2778889999999999999999999999999999999984 788999
Q ss_pred EecCCcccccC------CccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 005590 532 IDLGSSCFQTD------NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 605 (689)
Q Consensus 532 ~DFGls~~~~~------~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~ 605 (689)
+|||++..... ......++..|+|||++.+..++.++|+|||||++|+|++|+.||........+.++... +
T Consensus 148 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~ 225 (265)
T cd06652 148 GDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ--P 225 (265)
T ss_pred CcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcC--C
Confidence 99998865432 122346788999999999888999999999999999999999999765433333222100 0
Q ss_pred CcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 606 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 606 ~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
....+|. ..+..+.++|++|| .+|++||+++|+++|||+
T Consensus 226 -------------------------------~~~~~~~---------~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~~~~ 264 (265)
T cd06652 226 -------------------------------TNPVLPP---------HVSDHCRDFLKRIF-VEAKLRPSADELLRHTFV 264 (265)
T ss_pred -------------------------------CCCCCch---------hhCHHHHHHHHHHh-cChhhCCCHHHHhcCccc
Confidence 0000111 12345789999999 499999999999999998
Q ss_pred C
Q 005590 686 Q 686 (689)
Q Consensus 686 ~ 686 (689)
.
T Consensus 265 ~ 265 (265)
T cd06652 265 H 265 (265)
T ss_pred C
Confidence 4
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=299.14 Aligned_cols=246 Identities=17% Similarity=0.220 Sum_probs=192.9
Q ss_pred cCcEEEEEEeccCCCCceEEEEEC---CCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~---~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
..+|++.+.||+|+||.||+|.+. ..+..||+|+++... .....+.+|+.+++.+ +||||+++++++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~ 77 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF------DHSNIVRLEGVITR 77 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC------CCCCcCeEEEEEec
Confidence 467999999999999999999764 456789999988643 2234566677777655 47899999999999
Q ss_pred CCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEe
Q 005590 455 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 533 (689)
Q Consensus 455 ~~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~D 533 (689)
.++.++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+.|++||||||+|||++. ++.++|+|
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~--~~~~~l~d 150 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHE-----GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNS--DLVCKISG 150 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcC--CCcEEECC
Confidence 9999999999986 4555554321 23889999999999999999999999999999999999984 78899999
Q ss_pred cCCcccccCCc--c--ccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcH
Q 005590 534 LGSSCFQTDNL--C--LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDL 608 (689)
Q Consensus 534 FGls~~~~~~~--~--~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~ 608 (689)
||.+....... . ...++..|+|||.+.+..++.++|||||||++|++++ |..||.+.+..+.+..+.....
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~---- 226 (266)
T cd05064 151 FRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR---- 226 (266)
T ss_pred CcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC----
Confidence 99875532221 1 1234568999999999999999999999999999875 9999988766655544421100
Q ss_pred HHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 609 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 609 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
...| ...+..+.+++.+||+.+|.+|||++++++
T Consensus 227 ------------------------------~~~~---------~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 227 ------------------------------LPAP---------RNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ------------------------------CCCC---------CCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 0011 112355789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=300.83 Aligned_cols=253 Identities=28% Similarity=0.453 Sum_probs=202.6
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 459 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~ 459 (689)
.|++.+.||+|+||.||+|.+..+++.+|+|++... ......+.+|+.+++.+.. ..|++++++++++......+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~---~~~~~vi~~~~~~~~~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQ---SQPPNITKYYGSYLKGPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhcc---CCCCCeeeEeeeeeeCCEEE
Confidence 478889999999999999999999999999998653 3344567789999998865 35899999999999999999
Q ss_pred EEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcc
Q 005590 460 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 460 lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 538 (689)
+||||+.+ +|.+++... .+++..+..++.||+.||.|||+.||+|+||+|+||+++. .+.++|+|||++.
T Consensus 79 lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~--~~~~~l~dfg~~~ 149 (277)
T cd06917 79 IIMEYAEGGSVRTLMKAG-------PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTN--TGNVKLCDFGVAA 149 (277)
T ss_pred EEEecCCCCcHHHHHHcc-------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcC--CCCEEEccCCcee
Confidence 99999986 566655421 3889999999999999999999999999999999999995 7889999999987
Q ss_pred cccCC---ccccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 539 FQTDN---LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 539 ~~~~~---~~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
..... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.........+...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~------------ 217 (277)
T cd06917 150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS------------ 217 (277)
T ss_pred ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC------------
Confidence 65432 223468889999999875 45789999999999999999999999765433222111000
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~~ 688 (689)
....++. ......+.+||++||+.||++|||+.++++||||++.
T Consensus 218 ----------------------~~~~~~~--------~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 218 ----------------------KPPRLED--------NGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred ----------------------CCCCCCc--------ccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence 0000000 0123568899999999999999999999999999764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=296.45 Aligned_cols=251 Identities=31% Similarity=0.471 Sum_probs=203.9
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
++|++.+.||.|++|.||+|++..+++.|++|++.... .....+.+|+.++..++ |+||+++++++......
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE------SPYVVKCYGAFYKEGEI 74 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcC------CCCeeeEEEEEccCCeE
Confidence 36899999999999999999999999999999987653 23456777888777775 77999999999999999
Q ss_pred EEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 459 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 459 ~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~-~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
++||||+. ++|.+++... ..+++..+..++.||+.||.|||+ .|++|+||+|+||+++. ++.++|+|||.
T Consensus 75 ~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~--~~~~~l~df~~ 146 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKV------GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINS--KGEVKIADFGI 146 (264)
T ss_pred EEEEEecCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECC--CCCEEEccCcc
Confidence 99999999 5777776543 238999999999999999999999 99999999999999985 78899999998
Q ss_pred cccccCCc---cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCh---HHHHHHHHHhhcCCCcHHH
Q 005590 537 SCFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA---VVMILARIIGMLGPIDLEM 610 (689)
Q Consensus 537 s~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~---~~~~l~~i~~~~g~~~~e~ 610 (689)
+....... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ..+....+...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-------- 218 (264)
T cd06623 147 SKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG-------- 218 (264)
T ss_pred ceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC--------
Confidence 87654322 13467889999999999889999999999999999999999997653 22222222100
Q ss_pred HhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
.....+. ...+..+.++|++||..+|++|||+.++++||||+.
T Consensus 219 --------------------------~~~~~~~--------~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 219 --------------------------PPPSLPA--------EEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred --------------------------CCCCCCc--------ccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 0000000 003456889999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=295.80 Aligned_cols=249 Identities=32% Similarity=0.501 Sum_probs=199.2
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh---hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~---~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
||++.+.||+|+||.||++.+..+++.+|+|+++.... ....+.+|+.+++.++ |+||+++++.+...+..
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~------~~~i~~~~~~~~~~~~~ 74 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK------HPNLVKYYGVEVHREKV 74 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCC------CCChhheeeeEecCCEE
Confidence 69999999999999999999988999999999886533 4567778888888774 67999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
++|+||+.+ +|.+++... ..+++..++.++.|++.||.|||+.||+|+||+|+||+++. ++.+||+|||++
T Consensus 75 ~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~--~~~~kl~d~g~~ 146 (264)
T cd06626 75 YIFMEYCSGGTLEELLEHG------RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDH--NGVIKLGDFGCA 146 (264)
T ss_pred EEEEecCCCCcHHHHHhhc------CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC--CCCEEEcccccc
Confidence 999999985 676665432 12788899999999999999999999999999999999985 788999999998
Q ss_pred ccccCCcc-------ccccCccccChhhhcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCChH-HHHHHHHHhhcCCC
Q 005590 538 CFQTDNLC-------LYVQSRSYRAPEVIIGLP---YDQKIDLWSLGCILAELWTGEVLFPNDAV-VMILARIIGMLGPI 606 (689)
Q Consensus 538 ~~~~~~~~-------~~~gt~~Y~APE~l~~~~---~s~~~DIwSLGvil~eLltG~~PF~~~~~-~~~l~~i~~~~g~~ 606 (689)
........ ...+++.|+|||++.+.. ++.++|+||+|+++|+|++|+.||..... ......+.. +
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~--~-- 222 (264)
T cd06626 147 VKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA--G-- 222 (264)
T ss_pred cccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc--C--
Confidence 76543211 245688999999998766 88999999999999999999999975422 222111110 0
Q ss_pred cHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 607 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
....+|.. ...+..+.+||.+||+.+|++|||+.+++.||||
T Consensus 223 ------------------------------~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 223 ------------------------------HKPPIPDS-------LQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ------------------------------CCCCCCcc-------cccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 01111111 1124567899999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=301.64 Aligned_cols=288 Identities=32% Similarity=0.542 Sum_probs=233.9
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005590 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 378 ~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
++..||.-+..+|.|+- .|..|.|.-+++.||+|..... .....+..+|+.++..++ |+||++++.+|.-
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~------~~nii~l~n~ftP 86 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVN------HKNIISLLNVFTP 86 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhc------ccceeeeeeccCc
Confidence 45578999999999999 8999999999999999986542 233467778999888886 5689999999974
Q ss_pred C------CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCe
Q 005590 455 L------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 528 (689)
Q Consensus 455 ~------~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~ 528 (689)
. ...|+|||+|..+|...+... +.-..+..|++|+++|++|||+.||+||||||+||++.. ++.
T Consensus 87 ~~~l~~~~e~y~v~e~m~~nl~~vi~~e--------lDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~--~~~ 156 (369)
T KOG0665|consen 87 QKTLEEFQEVYLVMELMDANLCQVILME--------LDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNS--DCT 156 (369)
T ss_pred cccHHHHHhHHHHHHhhhhHHHHHHHHh--------cchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecc--hhh
Confidence 4 358999999999998887722 667889999999999999999999999999999999995 899
Q ss_pred EEEEecCCcccccCC--ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 005590 529 IKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 606 (689)
Q Consensus 529 vkL~DFGls~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~ 606 (689)
+||.|||+++..... .+.++.|+.|+|||++.+..|...+||||+||++.||++|+..|++.+..+...+++..+|.+
T Consensus 157 lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtp 236 (369)
T KOG0665|consen 157 LKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTP 236 (369)
T ss_pred eeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCC
Confidence 999999999765443 445788999999999999999999999999999999999999999999999999999999999
Q ss_pred cHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhh--hhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCC
Q 005590 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLE--HHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 684 (689)
Q Consensus 607 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~--~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpw 684 (689)
+.....+-+.....+-.+.+.+.. ......+|...-.. +........+++|+.+||..||++|.+++++|+|||
T Consensus 237 d~~F~~qL~~~~r~yv~~~~~y~~----~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY 312 (369)
T KOG0665|consen 237 DPSFMKQLQPTVRNYVENRPQYQA----ISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPY 312 (369)
T ss_pred CHHHHHHhhHHHHHHhhcChHhhc----cchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCe
Confidence 999888877765544433222211 11222233211110 111122356899999999999999999999999999
Q ss_pred CC
Q 005590 685 LQ 686 (689)
Q Consensus 685 f~ 686 (689)
++
T Consensus 313 ~~ 314 (369)
T KOG0665|consen 313 IK 314 (369)
T ss_pred ee
Confidence 96
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=303.16 Aligned_cols=237 Identities=20% Similarity=0.254 Sum_probs=191.4
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe----CCeE
Q 005590 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH----LEHL 458 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~----~~~l 458 (689)
..||+|+++.||+|.. +|+.||||+++.... ..+.+.+|+.+++.++ ||||+++++++.+ ...+
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv~~~g~~~~~~~~~~~~ 97 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID------SNNILKIYGFIIDIVDDLPRL 97 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC------CCCEEEEeeeEEecccCCCce
Confidence 3589999999999986 789999999876432 2356668898888875 6799999999877 3578
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~-gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
++||||+.+ +|.+++.... .+++.....++.|++.||.|||+. +++||||||+|||++. ++.+||+|||+
T Consensus 98 ~lv~Ey~~~g~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~--~~~~kl~dfg~ 169 (283)
T PHA02988 98 SLILEYCTRGYLREVLDKEK------DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTE--NYKLKIICHGL 169 (283)
T ss_pred EEEEEeCCCCcHHHHHhhCC------CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECC--CCcEEEcccch
Confidence 999999996 5777765332 278888999999999999999984 9999999999999995 78899999999
Q ss_pred cccccCCccccccCccccChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 537 SCFQTDNLCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 537 s~~~~~~~~~~~gt~~Y~APE~l~~--~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
+...........+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...-.
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~---------- 239 (283)
T PHA02988 170 EKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNN---------- 239 (283)
T ss_pred HhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC----------
Confidence 8876555555678999999999976 6799999999999999999999999988766655544421100
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
...+|. ..+..+.+||.+||+.||++|||+.|+++
T Consensus 240 -----------------------~~~~~~---------~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 240 -----------------------SLKLPL---------DCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred -----------------------CCCCCC---------cCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 001110 12456889999999999999999999985
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.95 Aligned_cols=264 Identities=24% Similarity=0.327 Sum_probs=201.5
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
..+|++++.||+|+||+||++++..+|+.||+|++... ......+.+|+++++.++ |+||+++++++.....
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~ 77 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECR------SPYIVSFYGAFLNENN 77 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcC------CCCcceEeeeEecCCE
Confidence 36789999999999999999999999999999988654 233456778888887764 6899999999999999
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 458 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 458 l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~-~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
.++||||+.+ +|.+++.... .+++..++.++.|++.||.|||+ .+++|+||||+||+++. ++.++|+|||
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~--~~~~~l~d~g 149 (284)
T cd06620 78 ICMCMEFMDCGSLDRIYKKGG------PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS--RGQIKLCDFG 149 (284)
T ss_pred EEEEEecCCCCCHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECC--CCcEEEccCC
Confidence 9999999986 5555544321 38899999999999999999997 59999999999999984 7889999999
Q ss_pred CcccccC-CccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 536 SSCFQTD-NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 536 ls~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
++..... ......++..|+|||++.+..++.++|+|||||++|+|++|..||............ +....
T Consensus 150 l~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~-------~~~~~--- 219 (284)
T cd06620 150 VSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD-------PMGIL--- 219 (284)
T ss_pred cccchhhhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhh-------hhHHH---
Confidence 8765432 223357899999999998888999999999999999999999999765432110000 00000
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~~ 688 (689)
....... ......++. ...+..+.+||.+||+.||.+|||+.|+++||||.+.
T Consensus 220 -~~~~~~~------------~~~~~~~~~--------~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 220 -DLLQQIV------------QEPPPRLPS--------SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred -HHHHHHh------------hccCCCCCc--------hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 0000000 000000110 0123568899999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=316.24 Aligned_cols=255 Identities=22% Similarity=0.349 Sum_probs=195.9
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCC-----cEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005590 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHTG-----VDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 450 (689)
Q Consensus 378 ~l~~rY~i~~~LG~G~fG~Vyla~d~~tg-----~~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~ 450 (689)
.-.++|++.+.||+|+||.||+|++...| ..||+|+++.. ......+.+|+.+++.+. .|+||+++++
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-----~h~nIv~~~~ 109 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLG-----QHKNIVNLLG 109 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhc-----cCCceeeEee
Confidence 34568999999999999999999865443 57999999753 223456778888888773 3789999999
Q ss_pred EEEeCCeEEEEEEccc-cchHHHHhhhhc---------------------------------------------------
Q 005590 451 YFYHLEHLFIVCELLR-ANLYEFQKFNQE--------------------------------------------------- 478 (689)
Q Consensus 451 ~f~~~~~l~lVmEy~~-g~L~~l~~~~~~--------------------------------------------------- 478 (689)
++......++||||+. |+|.+++.....
T Consensus 110 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 110 ACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred EecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 9999999999999998 477777643221
Q ss_pred -------------cCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccCCcc
Q 005590 479 -------------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 545 (689)
Q Consensus 479 -------------~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~~~ 545 (689)
......+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++........
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~--~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTD--GRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeC--CCeEEEeeceeeeeccCCcc
Confidence 011124788889999999999999999999999999999999984 78899999999875432211
Q ss_pred -----ccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhh
Q 005590 546 -----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYK 619 (689)
Q Consensus 546 -----~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~ 619 (689)
...+++.|+|||++.+..++.++|||||||++|+|++ |..||........+..+...
T Consensus 268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~----------------- 330 (374)
T cd05106 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKR----------------- 330 (374)
T ss_pred eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHc-----------------
Confidence 1224567999999998899999999999999999997 99999765433322222100
Q ss_pred hhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 620 YFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
......|. ..++++.++|.+||+.||.+|||+.++++
T Consensus 331 ----------------~~~~~~~~---------~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 331 ----------------GYQMSRPD---------FAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred ----------------ccCccCCC---------CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00001111 12466899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=294.43 Aligned_cols=244 Identities=23% Similarity=0.349 Sum_probs=196.8
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 460 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~l 460 (689)
++|++.+.||+|+||.||++... .+..+|+|.+.........+.+|+.+++.++ ||||+++++++......++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~i 76 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLS------HPKLVQLYGVCTQQKPLYI 76 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCC------CCCceeEEEEEccCCCEEE
Confidence 56899999999999999999864 4568999998765544567788999998874 6799999999999999999
Q ss_pred EEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccc
Q 005590 461 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539 (689)
Q Consensus 461 VmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 539 (689)
||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.||+|+||||+||+++. ++.++|+|||.+..
T Consensus 77 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~--~~~~kl~d~g~~~~ 149 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQ-----GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSS--TGVVKVSDFGMTRY 149 (256)
T ss_pred EEEcCCCCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcC--CCeEEECCCCCccc
Confidence 999998 56777665322 12788999999999999999999999999999999999984 78899999998875
Q ss_pred ccCCcc----ccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 540 QTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 540 ~~~~~~----~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
...... ...++..|+|||++.+..++.++|+||||+++|+|++ |+.||...+..+.+..+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~---------- 219 (256)
T cd05114 150 VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR---------- 219 (256)
T ss_pred cCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC----------
Confidence 432211 1234567999999998889999999999999999999 9999988766665555431100
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
...|. ..+..+.+||.+||+.+|++|||+.++++
T Consensus 220 ------------------------~~~~~---------~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 220 ------------------------LYRPK---------LASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred ------------------------CCCCC---------CCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00111 12346789999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=290.79 Aligned_cols=286 Identities=27% Similarity=0.453 Sum_probs=220.2
Q ss_pred CCcceeeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEE
Q 005590 369 KDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 448 (689)
Q Consensus 369 ~~~pi~~~~~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l 448 (689)
..+.+.++. .++|+|.+++|+|-|+.|+.|.+..+.++++||+++.-+ ...+.+|++||+.|. ++|||+++
T Consensus 28 E~~~i~wg~--~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~-----gg~NIi~L 98 (338)
T KOG0668|consen 28 ESLVIDWGN--QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLR-----GGPNIIKL 98 (338)
T ss_pred hheeeeccc--cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhcc-----CCCCeeeh
Confidence 334444443 478999999999999999999999999999999998643 368899999999987 47899999
Q ss_pred EEEEEeCC--eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCC
Q 005590 449 YDYFYHLE--HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 526 (689)
Q Consensus 449 ~~~f~~~~--~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~ 526 (689)
+++..+.. ...+|+||++..-. ....+. ++...++.++.|++.||.|+|++||+|||+||.|++|+. ..
T Consensus 99 ~DiV~Dp~SktpaLiFE~v~n~Df--k~ly~t------l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh-~~ 169 (338)
T KOG0668|consen 99 LDIVKDPESKTPSLIFEYVNNTDF--KQLYPT------LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDH-EL 169 (338)
T ss_pred hhhhcCccccCchhHhhhhccccH--HHHhhh------hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeech-hh
Confidence 99998664 57899999986422 222221 778889999999999999999999999999999999996 56
Q ss_pred CeEEEEecCCcccccCCc--cccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC-CCChHHHHHHHHHhh
Q 005590 527 CEIKIIDLGSSCFQTDNL--CLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLF-PNDAVVMILARIIGM 602 (689)
Q Consensus 527 ~~vkL~DFGls~~~~~~~--~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG~~PF-~~~~~~~~l~~i~~~ 602 (689)
-.++|+|||+|.+..... ...+.+..|.-||.+.. +.|+...|+|||||+|..|+..+-|| .+.+..+++-+|.++
T Consensus 170 rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV 249 (338)
T KOG0668|consen 170 RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV 249 (338)
T ss_pred ceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH
Confidence 689999999999876543 33567888999999875 45899999999999999999988776 678889999999999
Q ss_pred cCCCcHHHHhhhhhhhhhhhcc-------ccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcC
Q 005590 603 LGPIDLEMLMQGQEIYKYFTKE-------YDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 675 (689)
Q Consensus 603 ~g~~~~e~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT 675 (689)
+|.... ..|+.+. .......-....|..-++. .......+++.|||.++|..|.++|+|
T Consensus 250 LGt~el---------~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~-----~n~hl~~peaiDlldklLrYDHqeRlT 315 (338)
T KOG0668|consen 250 LGTDEL---------YAYLNKYQIDLDPQFEDILGRHSRKPWSRFINS-----ENQHLVSPEAIDLLDKLLRYDHQERLT 315 (338)
T ss_pred hChHHH---------HHHHHHHccCCChhHhhHhhccccccHHHhCCc-----cccccCChHHHHHHHHHHhhccccccc
Confidence 985332 2222211 1000000111111111111 111123578999999999999999999
Q ss_pred HHHHHcCCCCC
Q 005590 676 AREALDHPWLQ 686 (689)
Q Consensus 676 a~ElL~hpwf~ 686 (689)
|.|++.||||.
T Consensus 316 akEam~HpyF~ 326 (338)
T KOG0668|consen 316 AKEAMAHPYFA 326 (338)
T ss_pred hHHHhcCchHH
Confidence 99999999996
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=291.81 Aligned_cols=251 Identities=29% Similarity=0.439 Sum_probs=205.5
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
+|.+.+.||.|+||.||++.+..+++.+++|++.... .....+.+|+++++.++ |+|++++++.+......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~~~~~~~~~~~~~~~ 74 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN------HPNIIKYYESFEEKGKL 74 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcC------CCChhheEEEEecCCEE
Confidence 5899999999999999999999899999999987642 34456777888887775 67999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
++|+||+++ +|.+.+..... ....+++..+..++.||+.||.+||+.|++|+||+|+||+++. ++.++|+|||.+
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~--~~~~~l~d~~~~ 150 (258)
T cd08215 75 CIVMEYADGGDLSQKIKKQKK--EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTS--NGLVKLGDFGIS 150 (258)
T ss_pred EEEEEecCCCcHHHHHHHhhc--cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcC--CCcEEECCccce
Confidence 999999985 67776654321 1234899999999999999999999999999999999999984 788999999998
Q ss_pred ccccCC---ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 538 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 538 ~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
...... .....+++.|+|||.+.+..++.++|+||+|+++++|++|..||...........+.....
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~---------- 220 (258)
T cd08215 151 KVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY---------- 220 (258)
T ss_pred eecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC----------
Confidence 765443 2234678899999999988899999999999999999999999987665544444321100
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
..+|. ..+..+.++|++||..+|++|||+.++|+||||
T Consensus 221 ------------------------~~~~~---------~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 221 ------------------------PPIPS---------QYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred ------------------------CCCCC---------CCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 00111 123568899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=307.13 Aligned_cols=251 Identities=27% Similarity=0.446 Sum_probs=199.2
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 459 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~ 459 (689)
+.|.....||+|+||.||++.+..++..||||.+.... .....+.+|+.+++.+ .|+||+++++.+...++.+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l------~h~~ii~~~~~~~~~~~~~ 95 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY------HHENVVDMYNSYLVGDELW 95 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhC------CCCcHHHHHHheecCCeEE
Confidence 44555677999999999999999999999999986532 2334566777777766 4789999999999999999
Q ss_pred EEEEccccc-hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcc
Q 005590 460 IVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 460 lVmEy~~g~-L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 538 (689)
+||||+.++ |.+++. .. .+++..+..++.||+.||.|||+.||+||||||+||+++. ++.++|+|||++.
T Consensus 96 lv~e~~~~~~L~~~~~-~~------~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~--~~~~kL~dfg~~~ 166 (292)
T cd06658 96 VVMEFLEGGALTDIVT-HT------RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTS--DGRIKLSDFGFCA 166 (292)
T ss_pred EEEeCCCCCcHHHHHh-cC------CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC--CCCEEEccCcchh
Confidence 999999864 555442 11 2788999999999999999999999999999999999984 6789999999886
Q ss_pred cccCC---ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 005590 539 FQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615 (689)
Q Consensus 539 ~~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~ 615 (689)
..... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+....+..+...+.+
T Consensus 167 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~---------- 236 (292)
T cd06658 167 QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP---------- 236 (292)
T ss_pred hcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------
Confidence 54322 22356889999999999888999999999999999999999999876554443333211100
Q ss_pred hhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
.++. ....+..+.+||.+||..||.+|||+.++++||||..
T Consensus 237 ------------------------~~~~-------~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~ 277 (292)
T cd06658 237 ------------------------RVKD-------SHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKL 277 (292)
T ss_pred ------------------------cccc-------ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhc
Confidence 0000 0112456889999999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=299.61 Aligned_cols=260 Identities=20% Similarity=0.289 Sum_probs=199.3
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECC-----CCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005590 377 TVIAGRYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLY 449 (689)
Q Consensus 377 ~~l~~rY~i~~~LG~G~fG~Vyla~d~~-----tg~~vAvKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~ 449 (689)
++..++|++.+.||+|+||.||+|.++. .+..||+|.+..... ....+.+|+.+++.+ +|+||++++
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~ 75 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF------TCHHVVRLL 75 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC------CCCCeeeEE
Confidence 3456899999999999999999997542 355899998865432 223445666666655 478999999
Q ss_pred EEEEeCCeEEEEEEccc-cchHHHHhhhhcc----CCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecc
Q 005590 450 DYFYHLEHLFIVCELLR-ANLYEFQKFNQES----GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY 524 (689)
Q Consensus 450 ~~f~~~~~l~lVmEy~~-g~L~~l~~~~~~~----~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~ 524 (689)
+++......++||||+. ++|.+++...... .....++...+..++.||+.||.|||+.+|+||||||+||+++.
T Consensus 76 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~- 154 (288)
T cd05061 76 GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH- 154 (288)
T ss_pred EEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcC-
Confidence 99999999999999997 5788887643221 11233567788999999999999999999999999999999984
Q ss_pred CCCeEEEEecCCcccccCCc-----cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHH
Q 005590 525 QRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILAR 598 (689)
Q Consensus 525 ~~~~vkL~DFGls~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~ 598 (689)
++.++|+|||+++...... ....++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+....+....
T Consensus 155 -~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~ 233 (288)
T cd05061 155 -DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF 233 (288)
T ss_pred -CCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 7889999999987543211 11234667999999998899999999999999999998 7899987665554443
Q ss_pred HHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHH
Q 005590 599 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTARE 678 (689)
Q Consensus 599 i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~E 678 (689)
+.... ....+. ..++.+.++|++||+.||++|||+.+
T Consensus 234 ~~~~~----------------------------------~~~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~~ 270 (288)
T cd05061 234 VMDGG----------------------------------YLDQPD---------NCPERVTDLMRMCWQFNPKMRPTFLE 270 (288)
T ss_pred HHcCC----------------------------------CCCCCC---------CCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 32100 000010 12356889999999999999999999
Q ss_pred HHc------CCCCCC
Q 005590 679 ALD------HPWLQH 687 (689)
Q Consensus 679 lL~------hpwf~~ 687 (689)
+++ ||||+.
T Consensus 271 ll~~l~~~~~~~~~~ 285 (288)
T cd05061 271 IVNLLKDDLHPSFPE 285 (288)
T ss_pred HHHHHHhhcCCCCCC
Confidence 987 999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=300.53 Aligned_cols=245 Identities=24% Similarity=0.380 Sum_probs=190.0
Q ss_pred EeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEEE
Q 005590 388 YLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 463 (689)
Q Consensus 388 ~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmE 463 (689)
.||+|+||.||+|++..+++.||+|++..... .......|..+++.++. ..|++|+++++++...+..++|||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~i~~~~~~~~~~~~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST---GDCPFIVCMSYAFHTPDKLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHh---CCCCcEeeeeeeeecCCEEEEEEe
Confidence 37999999999999999999999999875321 11223445555555543 368999999999999999999999
Q ss_pred cccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccC
Q 005590 464 LLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 542 (689)
Q Consensus 464 y~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~ 542 (689)
|+.| +|..++... ..+++..++.++.|++.||.|||+.+|+||||||+||+++. ++.++|+|||++.....
T Consensus 78 ~~~g~~L~~~l~~~------~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~--~~~~kl~dfg~~~~~~~ 149 (278)
T cd05606 78 LMNGGDLHYHLSQH------GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE--HGHVRISDLGLACDFSK 149 (278)
T ss_pred cCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECC--CCCEEEccCcCccccCc
Confidence 9986 455544322 23899999999999999999999999999999999999985 77899999999865432
Q ss_pred -CccccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHH---HHHHHHHhhcCCCcHHHHhhhhhh
Q 005590 543 -NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVV---MILARIIGMLGPIDLEMLMQGQEI 617 (689)
Q Consensus 543 -~~~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~~---~~l~~i~~~~g~~~~e~~~~~~~~ 617 (689)
......++..|+|||++.+. .++.++|+||+||++|+|++|+.||...... .....+.
T Consensus 150 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------------- 212 (278)
T cd05606 150 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----------------- 212 (278)
T ss_pred cCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh-----------------
Confidence 23345789999999999754 6899999999999999999999999764211 1111000
Q ss_pred hhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCc-----CHHHHHcCCCCCC
Q 005590 618 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQH 687 (689)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRp-----Ta~ElL~hpwf~~ 687 (689)
.....+|. ..+..+.++|.+||..+|.+|| ++.++++||||..
T Consensus 213 ------------------~~~~~~~~---------~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~ 260 (278)
T cd05606 213 ------------------TMAVELPD---------SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260 (278)
T ss_pred ------------------ccCCCCCC---------cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccC
Confidence 00111111 1245688999999999999999 9999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=288.97 Aligned_cols=249 Identities=33% Similarity=0.527 Sum_probs=203.0
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh-hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 460 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~-~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~l 460 (689)
+|.+.+.||+|++|.||++.+..+++.+++|++..... ....+.+|+.+++.++ |++|+++++.+......++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~l 74 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCK------HPNIVKYYGSYLKKDELWI 74 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCC------CCCEeEEEEEEecCCeEEE
Confidence 48889999999999999999988999999999976543 4567778888887775 6799999999999999999
Q ss_pred EEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccc
Q 005590 461 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539 (689)
Q Consensus 461 VmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 539 (689)
++||+. ++|.+++.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++. ++.++|+|||.+..
T Consensus 75 ~~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~--~~~~~l~d~~~~~~ 147 (253)
T cd05122 75 VMEFCSGGSLKDLLKSTN-----QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTS--DGEVKLIDFGLSAQ 147 (253)
T ss_pred EEecCCCCcHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEcc--CCeEEEeecccccc
Confidence 999999 56776665432 23899999999999999999999999999999999999985 78899999999877
Q ss_pred ccCCc--cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhh
Q 005590 540 QTDNL--CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 617 (689)
Q Consensus 540 ~~~~~--~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~ 617 (689)
..... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+...
T Consensus 148 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------------- 212 (253)
T cd05122 148 LSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN--------------- 212 (253)
T ss_pred ccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc---------------
Confidence 65443 4567888999999999888999999999999999999999999776433333222100
Q ss_pred hhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCC
Q 005590 618 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 684 (689)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpw 684 (689)
.....+.. ...+..+.++|.+||+.||++|||+.++|+|||
T Consensus 213 -------------------~~~~~~~~-------~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 213 -------------------GPPGLRNP-------EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred -------------------CCCCcCcc-------cccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 00000000 011356889999999999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=306.21 Aligned_cols=250 Identities=26% Similarity=0.449 Sum_probs=197.3
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEE
Q 005590 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 461 (689)
Q Consensus 383 Y~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lV 461 (689)
|.....||+|+||.||++.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++.+...+..++|
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l------~hp~i~~~~~~~~~~~~~~iv 96 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY------QHQNVVEMYKSYLVGEELWVL 96 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC------CCCchhhhhhheeeCCeEEEE
Confidence 334457999999999999999899999999986532 2234566677766655 478999999999999999999
Q ss_pred EEccccc-hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccc
Q 005590 462 CELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 540 (689)
Q Consensus 462 mEy~~g~-L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~ 540 (689)
|||+.++ |..++.. ..+++..++.++.||+.||.|||+.|++|+||||+||+++. ++.++|+|||++...
T Consensus 97 ~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~--~~~~kL~dfg~~~~~ 167 (297)
T cd06659 97 MEFLQGGALTDIVSQ-------TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTL--DGRVKLSDFGFCAQI 167 (297)
T ss_pred EecCCCCCHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEcc--CCcEEEeechhHhhc
Confidence 9999864 5444321 12789999999999999999999999999999999999984 788999999988654
Q ss_pred cCC---ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhh
Q 005590 541 TDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 617 (689)
Q Consensus 541 ~~~---~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~ 617 (689)
... .....++..|+|||++.+..++.++|+|||||++|+|++|..||......+.+..+.....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------------- 234 (297)
T cd06659 168 SKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP------------- 234 (297)
T ss_pred ccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-------------
Confidence 322 2235688999999999988899999999999999999999999977655544433321000
Q ss_pred hhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCCC
Q 005590 618 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~~ 688 (689)
+. .......+..+.++|++||+.+|.+||++.++++||||.+.
T Consensus 235 ------------------------~~----~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 235 ------------------------PK----LKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred ------------------------CC----ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 00 00001224568899999999999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=344.06 Aligned_cols=254 Identities=24% Similarity=0.371 Sum_probs=212.9
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~----~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
-.++|.|+++||+|+||.|.+++++.+++.||+|++.+- ......+..|-.+|..-+ .+-|++++..|++
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n------s~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN------SEWIVQLHYAFQD 146 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC------cHHHHHHHHHhcC
Confidence 357899999999999999999999999999999999762 233456667777776654 3589999999999
Q ss_pred CCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEe
Q 005590 455 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 533 (689)
Q Consensus 455 ~~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~D 533 (689)
..++|+||||+.| +|+.++.... .+++..++.++..|+-||.-||+.|+|||||||+||||+. .|+|||+|
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~------~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~--~GHikLAD 218 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD------RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDK--SGHIKLAD 218 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC------CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecc--cCcEeecc
Confidence 9999999999985 6888776543 2899999999999999999999999999999999999995 89999999
Q ss_pred cCCcccccCC----ccccccCccccChhhhc----C-CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 005590 534 LGSSCFQTDN----LCLYVQSRSYRAPEVII----G-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 604 (689)
Q Consensus 534 FGls~~~~~~----~~~~~gt~~Y~APE~l~----~-~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g 604 (689)
||.+...... ....+|||.|.+||++. + +.|+...|+|||||++|||+.|..||..++..+.+.+|+..
T Consensus 219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h-- 296 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH-- 296 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch--
Confidence 9988665532 23468999999999996 2 45899999999999999999999999999999999998722
Q ss_pred CCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcC---HHHHHc
Q 005590 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT---AREALD 681 (689)
Q Consensus 605 ~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT---a~ElL~ 681 (689)
+-...+|... ..++++++||++++ -+|+.|.. ++++-.
T Consensus 297 -------------------------------k~~l~FP~~~-------~VSeeakdLI~~ll-~~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 297 -------------------------------KESLSFPDET-------DVSEEAKDLIEALL-CDREVRLGRNGIEDIKN 337 (1317)
T ss_pred -------------------------------hhhcCCCccc-------ccCHHHHHHHHHHh-cChhhhcccccHHHHHh
Confidence 1123344221 14567899999988 47889999 999999
Q ss_pred CCCCCC
Q 005590 682 HPWLQH 687 (689)
Q Consensus 682 hpwf~~ 687 (689)
||||.+
T Consensus 338 HpFF~g 343 (1317)
T KOG0612|consen 338 HPFFEG 343 (1317)
T ss_pred CccccC
Confidence 999975
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=323.22 Aligned_cols=248 Identities=29% Similarity=0.419 Sum_probs=205.5
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
+.+.|.+...+|.|+|+.|..+.+..+++..++|++.+.. ....+|+.++.... +|+||+++.+++.+..+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~-----~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVR-----DHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhc-----CCCcceeecceecCCcee
Confidence 4577999999999999999999999999999999998763 34556777777665 478999999999999999
Q ss_pred EEEEEccccc-hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g~-L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
|+|||++.|. +++-+.... .....+..|+.||+.|+.|||.+|++||||||+|||+. +..++++|+|||.+
T Consensus 392 ~~v~e~l~g~ell~ri~~~~-------~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~-~~~g~lrltyFG~a 463 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKP-------EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD-GSAGHLRLTYFGFW 463 (612)
T ss_pred eeeehhccccHHHHHHHhcc-------hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec-CCCCcEEEEEechh
Confidence 9999999975 444333222 22267788999999999999999999999999999996 35889999999999
Q ss_pred ccccCCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHH-HHHHHHHhhcCCCcHHHHhhhhh
Q 005590 538 CFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVV-MILARIIGMLGPIDLEMLMQGQE 616 (689)
Q Consensus 538 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~-~~l~~i~~~~g~~~~e~~~~~~~ 616 (689)
+.......+.+-|..|.|||++....|+.++||||||++||+||+|+.||...... ++..+| +.++..
T Consensus 464 ~~~~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s------- 532 (612)
T KOG0603|consen 464 SELERSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFS------- 532 (612)
T ss_pred hhCchhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCccc-------
Confidence 98887766667889999999999999999999999999999999999999765444 332222 221110
Q ss_pred hhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC-CCC
Q 005590 617 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL-QHP 688 (689)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf-~~~ 688 (689)
...+..+++||+.||+.||.+|+++.+++.|||| +++
T Consensus 533 -----------------------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~~ 570 (612)
T KOG0603|consen 533 -----------------------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLSHP 570 (612)
T ss_pred -----------------------------------cccCHHHHHHHHHhccCChhhCcChhhhccCcchhcCC
Confidence 2345678999999999999999999999999999 554
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=300.45 Aligned_cols=247 Identities=27% Similarity=0.346 Sum_probs=193.2
Q ss_pred eccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEEEc
Q 005590 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 464 (689)
Q Consensus 389 LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmEy 464 (689)
||+|+||+||+|.+..+|+.||+|++.... .....+..|+++++.++ |+||+++++++...+..++||||
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~lv~e~ 74 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS------SRFIVSLAYAFETKDDLCLVMTL 74 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC------CCCEeeeeeEEecCCeEEEEEec
Confidence 699999999999999999999999987532 22334567888887774 68999999999999999999999
Q ss_pred ccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccCC
Q 005590 465 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 543 (689)
Q Consensus 465 ~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~ 543 (689)
+.+ +|.+++..... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++. ++.++|+|||.+......
T Consensus 75 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~--~~~~~l~dfg~~~~~~~~ 148 (277)
T cd05577 75 MNGGDLKYHIYNVGE----PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDD--HGNVRISDLGLAVELKGG 148 (277)
T ss_pred CCCCcHHHHHHHcCc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC--CCCEEEccCcchhhhccC
Confidence 985 67666653322 23889999999999999999999999999999999999984 778999999988754322
Q ss_pred --ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhh
Q 005590 544 --LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYF 621 (689)
Q Consensus 544 --~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~ 621 (689)
.....++..|+|||++.+..++.++|+|||||++|+|++|+.||...........+....
T Consensus 149 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------------ 210 (277)
T cd05577 149 KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT------------------ 210 (277)
T ss_pred CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc------------------
Confidence 223456788999999998889999999999999999999999997653311111111000
Q ss_pred hccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCc-----CHHHHHcCCCCCC
Q 005590 622 TKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQH 687 (689)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRp-----Ta~ElL~hpwf~~ 687 (689)
.......+ ...++.+.+||++||+.||.+|| ++.++++||||..
T Consensus 211 -------------~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 211 -------------LEMAVEYP---------DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred -------------ccccccCC---------ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence 00000111 11246688999999999999999 9999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=322.37 Aligned_cols=244 Identities=28% Similarity=0.432 Sum_probs=196.0
Q ss_pred EeccCCCCceEEEEECCCCcEEEEEEeecc-hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEEEccc
Q 005590 388 YLGSAAFSKVFQAQDLHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR 466 (689)
Q Consensus 388 ~LG~G~fG~Vyla~d~~tg~~vAvKii~~~-~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmEy~~ 466 (689)
+||+|.||+||-|+|..+....|||-++.. .....-+..|+.+.+.|+ |.|||++++.+...+++-|.||-+.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~Lr------HkNIVrYLGs~senGf~kIFMEqVP 655 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLR------HKNIVRYLGSVSENGFFKIFMEQVP 655 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHh------hHhHHHHhhccCCCCeEEEEeecCC
Confidence 599999999999999999999999988753 334455667888888886 4589999999999999999999998
Q ss_pred c-chHHHHhhhhccCCCccc--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccccc--
Q 005590 467 A-NLYEFQKFNQESGGEAYF--TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT-- 541 (689)
Q Consensus 467 g-~L~~l~~~~~~~~~~~~l--s~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~-- 541 (689)
| +|.++++.. . .++ .+..+..+.+||++||.|||++.|||||||-+||||+. -.|.+||+|||.++...
T Consensus 656 GGSLSsLLrsk-W----GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT-ySGvlKISDFGTsKRLAgi 729 (1226)
T KOG4279|consen 656 GGSLSSLLRSK-W----GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT-YSGVLKISDFGTSKRLAGI 729 (1226)
T ss_pred CCcHHHHHHhc-c----CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee-ccceEEecccccchhhccC
Confidence 6 555555422 1 124 77889999999999999999999999999999999986 46899999999987654
Q ss_pred -CCccccccCccccChhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCC-hHHHHH--HHHHhhcCCCcHHHHhhhh
Q 005590 542 -DNLCLYVQSRSYRAPEVIIGL--PYDQKIDLWSLGCILAELWTGEVLFPND-AVVMIL--ARIIGMLGPIDLEMLMQGQ 615 (689)
Q Consensus 542 -~~~~~~~gt~~Y~APE~l~~~--~~s~~~DIwSLGvil~eLltG~~PF~~~-~~~~~l--~~i~~~~g~~~~e~~~~~~ 615 (689)
+...++.||..|||||++-.+ +|+.++|||||||++.||.||++||..- ++..-+ --|.++-+|
T Consensus 730 nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~---------- 799 (1226)
T KOG4279|consen 730 NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPP---------- 799 (1226)
T ss_pred CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCC----------
Confidence 334458899999999999754 4999999999999999999999999532 111111 112222222
Q ss_pred hhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
+|.. .+.+++.||.+|+.+||.+||+|.++|+.||++.
T Consensus 800 -------------------------iPee---------lsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~ 837 (1226)
T KOG4279|consen 800 -------------------------IPEE---------LSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQH 837 (1226)
T ss_pred -------------------------CcHH---------HHHHHHHHHHHHcCCCcccCccHHHhccCccccc
Confidence 2221 2356789999999999999999999999999985
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=314.15 Aligned_cols=254 Identities=22% Similarity=0.345 Sum_probs=195.4
Q ss_pred cCcEEEEEEeccCCCCceEEEEE-----CCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 452 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d-----~~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f 452 (689)
.++|++.+.||+|+||.||+|++ ..++..||||+++... .....+.+|+.+++.+. .||||+++++++
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~-----~HpnIv~l~~~~ 108 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG-----NHINIVNLLGAC 108 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhc-----CCcceeeeeeee
Confidence 46899999999999999999974 3457789999987532 23456778999988874 378999999999
Q ss_pred EeCCeEEEEEEccc-cchHHHHhhhhcc----------------------------------------------------
Q 005590 453 YHLEHLFIVCELLR-ANLYEFQKFNQES---------------------------------------------------- 479 (689)
Q Consensus 453 ~~~~~l~lVmEy~~-g~L~~l~~~~~~~---------------------------------------------------- 479 (689)
......++||||+. |+|.+++......
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 99999999999998 4777776532210
Q ss_pred -----------------CCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccC
Q 005590 480 -----------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 542 (689)
Q Consensus 480 -----------------~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~ 542 (689)
.....+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++.....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~--~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTH--GRITKICDFGLARDIRN 266 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEEC--CCcEEEecCccceeccC
Confidence 01124778889999999999999999999999999999999984 77899999999876543
Q ss_pred Ccc-----ccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhh
Q 005590 543 NLC-----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 616 (689)
Q Consensus 543 ~~~-----~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~ 616 (689)
... ...++..|+|||++.+..++.++|||||||++|+|++ |..||........+.+++
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~---------------- 330 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI---------------- 330 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHH----------------
Confidence 221 1234567999999999999999999999999999998 899997643322221111
Q ss_pred hhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 617 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
.. ......| ...+.++.+||.+||+.||++|||+.|+++.
T Consensus 331 -----~~------------~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 331 -----KE------------GYRMLSP---------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred -----Hh------------CccCCCC---------CCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 00 0000111 1124568899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=293.83 Aligned_cols=247 Identities=23% Similarity=0.334 Sum_probs=198.2
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
-.++|++.++||+|+||.||+|.+. .+..||+|.+.........+.+|+.+++.++ |+||+++++.+...+..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQ------HDKLVRLYAVVTKEEPI 76 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCC------CCCeeeEEEEEcCCCCc
Confidence 3478999999999999999999864 5678999998765555567788888888774 67999999999999999
Q ss_pred EEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
++||||+. ++|.+++.... ...+++..+..++.||+.||.|||+.+++|+||||+||+++. ++.++|+|||++
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~--~~~~~l~dfg~~ 150 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDE----GGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSE--SLMCKIADFGLA 150 (261)
T ss_pred EEEEecCCCCcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecC--CCcEEECCCccc
Confidence 99999997 57877765432 123788899999999999999999999999999999999984 788999999998
Q ss_pred ccccCCcc----ccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 005590 538 CFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLM 612 (689)
Q Consensus 538 ~~~~~~~~----~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~~ 612 (689)
........ ...++..|+|||.+.+..++.++|+|||||++|+|++ |..||...........+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~--------- 221 (261)
T cd05072 151 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY--------- 221 (261)
T ss_pred eecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC---------
Confidence 76543221 1234567999999998889999999999999999998 999998766555444432110
Q ss_pred hhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
..|.. ...+..+.+||.+||..+|++|||++++++
T Consensus 222 ---------------------------~~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 222 ---------------------------RMPRM-------ENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred ---------------------------CCCCC-------CCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00100 112356889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=299.34 Aligned_cols=250 Identities=22% Similarity=0.252 Sum_probs=198.3
Q ss_pred CcEEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 453 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~-----~tg~~vAvKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~ 453 (689)
++|.+.+.||+|+||.||+|.+. .+++.||+|+++.... ....+.+|+++++.+. |+||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~ 78 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ------HENIVKFYGVCT 78 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcC------CCCchheeeEEe
Confidence 57899999999999999999874 3467899999876432 3467788888888774 679999999999
Q ss_pred eCCeEEEEEEcccc-chHHHHhhhhc--------cCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecc
Q 005590 454 HLEHLFIVCELLRA-NLYEFQKFNQE--------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY 524 (689)
Q Consensus 454 ~~~~l~lVmEy~~g-~L~~l~~~~~~--------~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~ 524 (689)
.....++||||+.+ +|.+++..... ......+++..+..++.||+.||.|||+.|++||||||+||+++.
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~- 157 (280)
T cd05049 79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY- 157 (280)
T ss_pred cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC-
Confidence 99999999999985 67777654321 122334788999999999999999999999999999999999985
Q ss_pred CCCeEEEEecCCcccccCC-----ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHH
Q 005590 525 QRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILAR 598 (689)
Q Consensus 525 ~~~~vkL~DFGls~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~ 598 (689)
++.++|+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||......+....
T Consensus 158 -~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05049 158 -DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236 (280)
T ss_pred -CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 789999999998653221 122345678999999999999999999999999999998 9999977665554444
Q ss_pred HHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHH
Q 005590 599 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTARE 678 (689)
Q Consensus 599 i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~E 678 (689)
+.....+ ..+ ...+..+.+||++||+.||++|||+.|
T Consensus 237 ~~~~~~~----------------------------------~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~e 273 (280)
T cd05049 237 ITQGRLL----------------------------------QRP---------RTCPSEVYDIMLGCWKRDPQQRINIKD 273 (280)
T ss_pred HHcCCcC----------------------------------CCC---------CCCCHHHHHHHHHHcCCCcccCCCHHH
Confidence 3210000 001 112356889999999999999999999
Q ss_pred HHc
Q 005590 679 ALD 681 (689)
Q Consensus 679 lL~ 681 (689)
+++
T Consensus 274 il~ 276 (280)
T cd05049 274 IHE 276 (280)
T ss_pred HHH
Confidence 985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=301.53 Aligned_cols=255 Identities=28% Similarity=0.391 Sum_probs=198.2
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
.++|++.+.||+|++|.||+|.+..+++.||||+++... ........|+.++.... +|+||+++++++.....
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~-----~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSH-----DCPYIVKCYGYFITDSD 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhcc-----CCCchHhhheeeecCCe
Confidence 367999999999999999999998889999999997532 22234455555554432 58899999999999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 458 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 458 l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~-~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
.++||||+.+.+.+++..... .+++..+..++.||+.||.|||+ .||+||||+|+||+++. ++.++|+|||+
T Consensus 89 ~~~v~e~~~~~l~~l~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~--~~~~kL~dfg~ 161 (296)
T cd06618 89 VFICMELMSTCLDKLLKRIQG-----PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDA--SGNVKLCDFGI 161 (296)
T ss_pred EEEEeeccCcCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcC--CCCEEECcccc
Confidence 999999998877776654322 38889999999999999999997 59999999999999984 78899999999
Q ss_pred cccccCC--ccccccCccccChhhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCChH-HHHHHHHHhhcCCCcHH
Q 005590 537 SCFQTDN--LCLYVQSRSYRAPEVIIGLP----YDQKIDLWSLGCILAELWTGEVLFPNDAV-VMILARIIGMLGPIDLE 609 (689)
Q Consensus 537 s~~~~~~--~~~~~gt~~Y~APE~l~~~~----~s~~~DIwSLGvil~eLltG~~PF~~~~~-~~~l~~i~~~~g~~~~e 609 (689)
+...... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||..... .+.+..+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------ 235 (296)
T cd06618 162 SGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE------ 235 (296)
T ss_pred chhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC------
Confidence 8764332 22235678899999987653 78899999999999999999999975322 22222221000
Q ss_pred HHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
....+.. ...+..+.+||.+||..||++|||+.++++||||+.
T Consensus 236 ----------------------------~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 236 ----------------------------PPSLPPN-------EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred ----------------------------CCCCCCC-------CCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 0001100 023456889999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=293.71 Aligned_cols=250 Identities=26% Similarity=0.355 Sum_probs=197.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~----~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|++.+.||+|+||.||+|++..+++.||||.+... ......+.+|+.+++.++ ||||+++++++...+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~ 75 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN------HPNVIKYLDSFIEDN 75 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC------CcceeeeeeeEEECC
Confidence 5799999999999999999999999999999987542 233345677888888774 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
..++||||+.+ +|.+++..... ....+++..+..++.||+.||.|||+.|++|+||||+||+++. ++.++|+|||
T Consensus 76 ~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~--~~~~~l~d~g 151 (267)
T cd08228 76 ELNIVLELADAGDLSQMIKYFKK--QKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITA--TGVVKLGDLG 151 (267)
T ss_pred eEEEEEEecCCCcHHHHHHHhhh--ccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcC--CCCEEECccc
Confidence 99999999995 67766654322 1233788999999999999999999999999999999999985 7789999999
Q ss_pred CcccccCCc---cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChH--HHHHHHHHhhcCCCcHHH
Q 005590 536 SSCFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV--VMILARIIGMLGPIDLEM 610 (689)
Q Consensus 536 ls~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~--~~~l~~i~~~~g~~~~e~ 610 (689)
++....... ....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||..... ......+. ..+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~-~~~~----- 225 (267)
T cd08228 152 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIE-QCDY----- 225 (267)
T ss_pred cceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHh-cCCC-----
Confidence 887654322 234678899999999988899999999999999999999999965422 22222211 0000
Q ss_pred HhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
|... ....+..+.+||.+||+.+|++|||+.++++.
T Consensus 226 -------------------------------~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 226 -------------------------------PPLP-----TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred -------------------------------CCCC-----hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 0000 00123568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=288.86 Aligned_cols=253 Identities=26% Similarity=0.386 Sum_probs=197.9
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC---
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--- 455 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~--- 455 (689)
++||+|.+.||.|||+-|+++++..+++.||+|.+.... ...+..++|++..++++ ||||++++++....
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~------s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFN------SPNVLRLVDHQLREEKD 93 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhC------CcchHHHHHHHHHhhcc
Confidence 479999999999999999999999999999999887643 55677778888887775 57899988876533
Q ss_pred --CeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEeccCCCeEE
Q 005590 456 --EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCEIK 530 (689)
Q Consensus 456 --~~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~g--IvHrDLKp~NILl~~~~~~~vk 530 (689)
...||+++|.. |+|.+.+......+. .+++.++..|+.+|++||++||+.. ++||||||.|||+.. .+.++
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~--~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~--~~~~v 169 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGN--FVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD--SGLPV 169 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCC--ccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC--CCceE
Confidence 35899999987 679998876655433 4999999999999999999999998 999999999999984 78999
Q ss_pred EEecCCcccccCCcc------------ccccCccccChhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHH
Q 005590 531 IIDLGSSCFQTDNLC------------LYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI 595 (689)
Q Consensus 531 L~DFGls~~~~~~~~------------~~~gt~~Y~APE~l~---~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~ 595 (689)
|+|||.++...-... ...-|..|+|||.+. +...+.++|||||||+||.|+.|..||..
T Consensus 170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~------ 243 (302)
T KOG2345|consen 170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER------ 243 (302)
T ss_pred EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH------
Confidence 999999865322111 123478899999985 45578999999999999999999999942
Q ss_pred HHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcC
Q 005590 596 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 675 (689)
Q Consensus 596 l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT 675 (689)
+.. ++....- ......+.+|.... .++.+.+||..||+.||.+||+
T Consensus 244 ---~~~-----------~GgSlaL-------------Av~n~q~s~P~~~~-------yse~l~~lik~mlqvdP~qRP~ 289 (302)
T KOG2345|consen 244 ---IYQ-----------QGGSLAL-------------AVQNAQISIPNSSR-------YSEALHQLIKSMLQVDPNQRPT 289 (302)
T ss_pred ---Hhh-----------cCCeEEE-------------eeeccccccCCCCC-------ccHHHHHHHHHHhcCCcccCCC
Confidence 111 1111100 00112334444333 3567899999999999999999
Q ss_pred HHHHHcC
Q 005590 676 AREALDH 682 (689)
Q Consensus 676 a~ElL~h 682 (689)
+.+++.+
T Consensus 290 i~~ll~~ 296 (302)
T KOG2345|consen 290 IPELLSK 296 (302)
T ss_pred HHHHHHH
Confidence 9999864
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=296.62 Aligned_cols=255 Identities=18% Similarity=0.263 Sum_probs=196.3
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECC-----CCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005590 377 TVIAGRYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 449 (689)
Q Consensus 377 ~~l~~rY~i~~~LG~G~fG~Vyla~d~~-----tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~ 449 (689)
++..++|++.+.||+|+||+||+|.+.. ++..||+|++.... .....+.+|+.+++.+ +|+||++++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l------~~~~iv~~~ 75 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF------NCHHVVRLL 75 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC------CCCCeeeEE
Confidence 4567899999999999999999998642 45679999986432 2234566777777765 478999999
Q ss_pred EEEEeCCeEEEEEEcccc-chHHHHhhhhccC----CCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecc
Q 005590 450 DYFYHLEHLFIVCELLRA-NLYEFQKFNQESG----GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY 524 (689)
Q Consensus 450 ~~f~~~~~l~lVmEy~~g-~L~~l~~~~~~~~----~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~ 524 (689)
+++......++||||+.+ +|.+++....... ....++...+..++.|++.||.|||+.|++|+||||+||+++.
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~- 154 (277)
T cd05062 76 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE- 154 (277)
T ss_pred EEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcC-
Confidence 999999999999999984 6777765322110 1223677888999999999999999999999999999999994
Q ss_pred CCCeEEEEecCCcccccCCc-----cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHH
Q 005590 525 QRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILAR 598 (689)
Q Consensus 525 ~~~~vkL~DFGls~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~ 598 (689)
++.++|+|||++....... ....+++.|+|||.+.+..++.++|+|||||++|+|++ |..||.+....+.+..
T Consensus 155 -~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~ 233 (277)
T cd05062 155 -DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF 233 (277)
T ss_pred -CCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 7889999999986543221 12244678999999999899999999999999999999 7899987766554443
Q ss_pred HHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHH
Q 005590 599 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTARE 678 (689)
Q Consensus 599 i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~E 678 (689)
+..... ..++ ...+..+.+||.+||+.||++|||+.|
T Consensus 234 ~~~~~~----------------------------------~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~e 270 (277)
T cd05062 234 VMEGGL----------------------------------LDKP---------DNCPDMLFELMRMCWQYNPKMRPSFLE 270 (277)
T ss_pred HHcCCc----------------------------------CCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 321000 0011 112356889999999999999999999
Q ss_pred HHcC
Q 005590 679 ALDH 682 (689)
Q Consensus 679 lL~h 682 (689)
++++
T Consensus 271 ~l~~ 274 (277)
T cd05062 271 IISS 274 (277)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=298.00 Aligned_cols=249 Identities=29% Similarity=0.404 Sum_probs=198.8
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 459 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~ 459 (689)
-|++.+.||.|+||.||++.+..+++.+|||++.... .....+.+|+.+++.+ .|+||+++++++......+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~~~ 78 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC------DSPYVTKYYGSYLKDTKLW 78 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc------CCCCEeEEEEEEEeCCeEE
Confidence 3778899999999999999998899999999976432 2334566677777766 4789999999999999999
Q ss_pred EEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcc
Q 005590 460 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 460 lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 538 (689)
+||||+.+ +|..++.. ..++...+..++.|++.||.+||+.|++|+||+|+||+++. ++.++|+|||++.
T Consensus 79 lv~e~~~~~~l~~~i~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~--~~~~~l~dfg~~~ 149 (277)
T cd06641 79 IIMEYLGGGSALDLLEP-------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE--HGEVKLADFGVAG 149 (277)
T ss_pred EEEEeCCCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECC--CCCEEEeecccce
Confidence 99999986 56655532 12789999999999999999999999999999999999984 7789999999886
Q ss_pred cccCC---ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 005590 539 FQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615 (689)
Q Consensus 539 ~~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~ 615 (689)
..... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------- 216 (277)
T cd06641 150 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN------------- 216 (277)
T ss_pred ecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-------------
Confidence 54332 12246788899999998888999999999999999999999999765443333222100
Q ss_pred hhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCCC
Q 005590 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~~ 688 (689)
....++ ...+..+.++|.+||+.+|.+||++.++++||||.+.
T Consensus 217 ---------------------~~~~~~---------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 217 ---------------------NPPTLE---------GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ---------------------CCCCCC---------cccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 000000 1234568899999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=302.01 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=200.1
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
+.|...+.||+|+||+||+|++..+++.|++|++.... .....+.+|+.+++.++ |+|++++++++....
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~ 94 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK------HPNTIEYKGCYLKEH 94 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC------CCCCccEEEEEEeCC
Confidence 34777788999999999999999999999999986432 22345667777777664 789999999999999
Q ss_pred eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 457 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 457 ~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
..++||||+.+++.+++.... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++. ++.++|+|||+
T Consensus 95 ~~~lv~e~~~~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~--~~~~kL~dfg~ 167 (313)
T cd06633 95 TAWLVMEYCLGSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE--PGQVKLADFGS 167 (313)
T ss_pred EEEEEEecCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECC--CCCEEEeecCC
Confidence 999999999998887765432 12788999999999999999999999999999999999984 77899999998
Q ss_pred cccccCCccccccCccccChhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 005590 537 SCFQTDNLCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 537 s~~~~~~~~~~~gt~~Y~APE~l~---~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
+..... .....++..|+|||++. ...++.++|+|||||++|+|++|..||...........+....
T Consensus 168 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~---------- 236 (313)
T cd06633 168 ASKSSP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND---------- 236 (313)
T ss_pred CcccCC-CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC----------
Confidence 865432 23457888999999984 3568889999999999999999999997765444443332100
Q ss_pred hhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
.|... ....+..+++||.+||+.+|.+||++.++++||||+.
T Consensus 237 ---------------------------~~~~~-----~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 237 ---------------------------SPTLQ-----SNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred ---------------------------CCCCC-----ccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 00000 0011245789999999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=308.94 Aligned_cols=289 Identities=19% Similarity=0.238 Sum_probs=193.3
Q ss_pred EEeccC--CCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEE
Q 005590 387 EYLGSA--AFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 461 (689)
Q Consensus 387 ~~LG~G--~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lV 461 (689)
..||+| +||+||++++..+|+.||+|++.... ...+.+.+|+.+++.+ +|+||++++++|...+..++|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l------~h~niv~~~~~~~~~~~~~~v 77 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF------RHPNIMTSWTVFTTGSWLWVI 77 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC------CCCCcceEeeeEecCCceEEE
Confidence 346666 99999999999999999999987532 2234556666666555 478999999999999999999
Q ss_pred EEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccc
Q 005590 462 CELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 540 (689)
Q Consensus 462 mEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~ 540 (689)
|||+.+ ++.+++..... ..+++..+..++.||+.||.|||+.||+||||||+|||++. ++.++++||+.....
T Consensus 78 ~e~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~--~~~~~~~~~~~~~~~ 151 (328)
T cd08226 78 SPFMAYGSANSLLKTYFP----EGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISG--DGLVSLSGLSHLYSL 151 (328)
T ss_pred EecccCCCHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeC--CCcEEEechHHHhhh
Confidence 999985 67766654321 12888999999999999999999999999999999999985 778999999854321
Q ss_pred cC---C-------ccccccCccccChhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcH
Q 005590 541 TD---N-------LCLYVQSRSYRAPEVIIGL--PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 608 (689)
Q Consensus 541 ~~---~-------~~~~~gt~~Y~APE~l~~~--~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~ 608 (689)
.. . .....++..|+|||++.+. .++.++|||||||++|+|++|..||........+..+.......+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd08226 152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPL 231 (328)
T ss_pred hccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCc
Confidence 11 0 1112345679999999764 4789999999999999999999999876655544444332221111
Q ss_pred HHHhhhhhhhhhhhccccchhhhhccc---cccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 609 EMLMQGQEIYKYFTKEYDLYYINEETN---QLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 609 e~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
........................... ...................+..+++||++||+.||++|||+.|+|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~ 311 (328)
T cd08226 232 DITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF 311 (328)
T ss_pred cccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHH
Confidence 100000000000000000000000000 00000000000000011234568999999999999999999999999999
Q ss_pred CC
Q 005590 686 QH 687 (689)
Q Consensus 686 ~~ 687 (689)
.+
T Consensus 312 ~~ 313 (328)
T cd08226 312 KQ 313 (328)
T ss_pred HH
Confidence 64
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=295.96 Aligned_cols=254 Identities=20% Similarity=0.277 Sum_probs=198.4
Q ss_pred cCcEEEEEEeccCCCCceEEEEECC-----CCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 452 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~-----tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f 452 (689)
.++|++.+.||+|++|.||+|.+.. ++..||+|.+.... .....+.+|+.+++.++ |+||+++++++
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~ 78 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFN------HQNIVRLIGVS 78 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC------CCCEeeEEEEE
Confidence 4679999999999999999999877 77889999887542 22345677777777664 68999999999
Q ss_pred EeCCeEEEEEEccc-cchHHHHhhhhcc-CCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccC-CCeE
Q 005590 453 YHLEHLFIVCELLR-ANLYEFQKFNQES-GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RCEI 529 (689)
Q Consensus 453 ~~~~~l~lVmEy~~-g~L~~l~~~~~~~-~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~-~~~v 529 (689)
......++||||+. ++|.+++...... .....+++..+..++.||+.||.|||+.+++|+||||+||+++..+ ...+
T Consensus 79 ~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 79 FERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred ccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcce
Confidence 99999999999997 5788777654321 1123488999999999999999999999999999999999998532 3468
Q ss_pred EEEecCCcccccCCcc-----ccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhc
Q 005590 530 KIIDLGSSCFQTDNLC-----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGML 603 (689)
Q Consensus 530 kL~DFGls~~~~~~~~-----~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~ 603 (689)
||+|||++........ ....+..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~ 238 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG 238 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999876532211 1223467999999998899999999999999999997 999998876655444332110
Q ss_pred CCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 604 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 604 g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
....| ...+..+.+||.+||+.+|++|||+.++|+|
T Consensus 239 ----------------------------------~~~~~---------~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 239 ----------------------------------RLDPP---------KGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred ----------------------------------cCCCC---------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00001 1123568899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=298.21 Aligned_cols=251 Identities=21% Similarity=0.257 Sum_probs=198.6
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCC-----cEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTG-----VDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 453 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg-----~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~ 453 (689)
++|++.+.||+|+||.||+|.+...+ ..+|+|.+.... .....+.+|+.+++.++ |+||+++++++.
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~------h~~i~~~~~~~~ 78 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ------HPNIVCLLGVCT 78 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcC------CcccceEEEEEc
Confidence 57899999999999999999876555 679999987532 23455678888887764 689999999999
Q ss_pred eCCeEEEEEEccc-cchHHHHhhhhccC----------CCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEe
Q 005590 454 HLEHLFIVCELLR-ANLYEFQKFNQESG----------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIK 522 (689)
Q Consensus 454 ~~~~l~lVmEy~~-g~L~~l~~~~~~~~----------~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~ 522 (689)
.....+++|||+. ++|.+++....... ....+++..+..++.||+.||.|||+.|++|+||||+||+++
T Consensus 79 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 79 KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG 158 (283)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence 9899999999998 47877776432211 113488899999999999999999999999999999999998
Q ss_pred ccCCCeEEEEecCCcccccCC-----ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHH
Q 005590 523 SYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMIL 596 (689)
Q Consensus 523 ~~~~~~vkL~DFGls~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l 596 (689)
. ++.++|+|||++...... .....+++.|+|||.+.+..++.++|+|||||++|+|++ |..||.+....+..
T Consensus 159 ~--~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05048 159 E--GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI 236 (283)
T ss_pred C--CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 4 778999999998754321 122355788999999998899999999999999999998 99999877665554
Q ss_pred HHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCH
Q 005590 597 ARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 676 (689)
Q Consensus 597 ~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa 676 (689)
..+..... ...| ...+.++.+|+.+||+.||.+|||+
T Consensus 237 ~~i~~~~~----------------------------------~~~~---------~~~~~~~~~l~~~c~~~~p~~Rp~~ 273 (283)
T cd05048 237 EMIRSRQL----------------------------------LPCP---------EDCPARVYALMIECWNEIPARRPRF 273 (283)
T ss_pred HHHHcCCc----------------------------------CCCc---------ccCCHHHHHHHHHHccCChhhCcCH
Confidence 44321000 0001 1234668899999999999999999
Q ss_pred HHHHcC
Q 005590 677 REALDH 682 (689)
Q Consensus 677 ~ElL~h 682 (689)
.|++++
T Consensus 274 ~~i~~~ 279 (283)
T cd05048 274 KDIHTR 279 (283)
T ss_pred HHHHHH
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=303.18 Aligned_cols=253 Identities=28% Similarity=0.457 Sum_probs=201.0
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc-hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~-~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
.++|.+.+.||+|+||.||++.+..+++.||+|.+... ......+.+|+.+++.+ .||||+++++++...+..
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l------~hp~i~~~~~~~~~~~~~ 91 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN------KHPNIVNYLDSYLVGDEL 91 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhc------CCCCeeehhheeeeCCcE
Confidence 47899999999999999999999889999999998643 22334566777777665 478999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
++|+||+.+ +|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++. ++.++|+|||++
T Consensus 92 ~lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~--~~~~kL~dfg~~ 162 (293)
T cd06647 92 WVVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFC 162 (293)
T ss_pred EEEEecCCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcC--CCCEEEccCcce
Confidence 999999985 676665422 2788899999999999999999999999999999999984 778999999987
Q ss_pred ccccCC---ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 538 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 538 ~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
...... .....+++.|+|||.+....++.++|+|||||++|++++|..||...+....+..+.. +.
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~--~~--------- 231 (293)
T cd06647 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--NG--------- 231 (293)
T ss_pred ecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc--CC---------
Confidence 654322 2234678889999999988899999999999999999999999976544332211100 00
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~~ 688 (689)
...++. ....+..+++||++||..+|++||++.+++.||||+..
T Consensus 232 -----------------------~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 232 -----------------------TPELQN-------PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred -----------------------CCCCCC-------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence 000000 01124568899999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=288.29 Aligned_cols=248 Identities=32% Similarity=0.433 Sum_probs=202.2
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC--C
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--E 456 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~--~ 456 (689)
+|++.+.||+|++|.||+|.+..+++.+++|++.... .....+.+|+.+++.++ |++|+++++.+... .
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ------HPNIVRYYGSERDEEKN 74 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcC------CCCEeeEEEEEecCCCC
Confidence 5888999999999999999999899999999987654 34567778888888775 67999999999988 8
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
..++|+||+. ++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++. ++.++|+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~--~~~~~l~d~~ 146 (260)
T cd06606 75 TLNIFLEYVSGGSLSSLLKKFG------KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDS--DGVVKLADFG 146 (260)
T ss_pred eEEEEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcC--CCCEEEcccc
Confidence 9999999996 57777765432 3899999999999999999999999999999999999995 7889999999
Q ss_pred CcccccCC-----ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCh-HHHHHHHHHhhcCCCcHH
Q 005590 536 SSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA-VVMILARIIGMLGPIDLE 609 (689)
Q Consensus 536 ls~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~-~~~~l~~i~~~~g~~~~e 609 (689)
.+...... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.... .......+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------- 218 (260)
T cd06606 147 CAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS-------- 218 (260)
T ss_pred cEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc--------
Confidence 98765443 233567889999999998889999999999999999999999997654 1111111100
Q ss_pred HHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
......+|. ..+..+.+||.+||+.||++||++.++++||||
T Consensus 219 -------------------------~~~~~~~~~---------~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 219 -------------------------SGEPPEIPE---------HLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred -------------------------cCCCcCCCc---------ccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 000011111 124568899999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=292.84 Aligned_cols=245 Identities=20% Similarity=0.328 Sum_probs=195.1
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 460 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~l 460 (689)
++|++.+.||+|+||+||++.+.. +..+|+|.+.........+.+|+.+++.+ +||||+++++++......++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKL------SHEKLVQLYGVCTKQRPIYI 76 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcC------CCCCeeeEEEEEccCCCcEE
Confidence 579999999999999999998643 45699999876544446677888888766 47899999999998889999
Q ss_pred EEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccc
Q 005590 461 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539 (689)
Q Consensus 461 VmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 539 (689)
||||+.+ +|.+++..... .+++..+..++.||+.||.|||+.|++|+||||+||+++. ++.+||+|||.+..
T Consensus 77 v~e~~~~~~l~~~i~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~--~~~~kl~d~g~~~~ 149 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGK-----RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD--QGCVKVSDFGLSRY 149 (256)
T ss_pred EEEcCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC--CCCEEECCCcccee
Confidence 9999975 67776653221 3889999999999999999999999999999999999984 77899999998875
Q ss_pred ccCCcc-c---cccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 540 QTDNLC-L---YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 540 ~~~~~~-~---~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
...... . ..++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+....+.....+
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------- 220 (256)
T cd05113 150 VLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL--------- 220 (256)
T ss_pred cCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC---------
Confidence 433221 1 234567999999998889999999999999999999 99999876655544444311100
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
..+. ..+..+++++.+||+.||.+|||+.+++++
T Consensus 221 -------------------------~~~~---------~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 221 -------------------------YRPH---------LASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred -------------------------CCCC---------CCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 0011 123568899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=293.37 Aligned_cols=247 Identities=23% Similarity=0.326 Sum_probs=195.0
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 378 ~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
+..++|++.++||+|+||.||+|++..+ ..||+|+++........+.+|+.+++.++ |+||+++++.+. ...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~------~~~i~~~~~~~~-~~~ 74 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR------HEKLVQLYAVVS-EEP 74 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCC------CCCcceEEEEEC-CCC
Confidence 3457899999999999999999998655 46999999865544466788888888774 679999998874 456
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 458 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 458 l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
.++||||+.+ +|.+++.... ...+++..+..++.|++.||.|||+.+|+|+||||+||+++. ++.++|+|||.
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~--~~~~~L~dfg~ 148 (262)
T cd05071 75 IYIVTEYMSKGSLLDFLKGEM----GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE--NLVCKVADFGL 148 (262)
T ss_pred cEEEEEcCCCCcHHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcC--CCcEEeccCCc
Confidence 8999999985 7777775321 123788899999999999999999999999999999999984 78899999999
Q ss_pred cccccCCcc----ccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 005590 537 SCFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEML 611 (689)
Q Consensus 537 s~~~~~~~~----~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~ 611 (689)
+........ ...++..|+|||++.+..++.++|+|||||++|+|++ |..||.+.........+.....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~------- 221 (262)
T cd05071 149 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------- 221 (262)
T ss_pred eeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC-------
Confidence 876543322 1234567999999998889999999999999999999 8999987765554444321100
Q ss_pred hhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
...+ ...+..+.+||.+||+.||++|||+.++++
T Consensus 222 ---------------------------~~~~---------~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 222 ---------------------------MPCP---------PECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ---------------------------CCCc---------cccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0000 112356889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=288.29 Aligned_cols=247 Identities=30% Similarity=0.457 Sum_probs=201.7
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
+|++.+.||+|++|.||++++..+++.|++|.+.... .....+.+|+++++.++ |++++++++++......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK------HPNIVKYIGSIETSDSL 74 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCC------CCCccEEEEEEEeCCEE
Confidence 5889999999999999999999999999999997654 34556777888777764 67999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
++||||+.+ +|.+++... ..+++..+..++.|++.||.+||+.||+|+||+|+||+++. ++.++|+|||.+
T Consensus 75 ~~v~e~~~~~~L~~~~~~~------~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~--~~~~~l~d~~~~ 146 (254)
T cd06627 75 YIILEYAENGSLRQIIKKF------GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK--DGVVKLADFGVA 146 (254)
T ss_pred EEEEecCCCCcHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECC--CCCEEEeccccc
Confidence 999999986 676666533 23889999999999999999999999999999999999985 788999999998
Q ss_pred ccccCCc---cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 538 CFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 538 ~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
....... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~------------- 213 (254)
T cd06627 147 TKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ------------- 213 (254)
T ss_pred eecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-------------
Confidence 7655432 235678899999999888889999999999999999999999976543332222110
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
.....++ ...+..+.++|.+||..+|++|||+.+++.||||
T Consensus 214 ---------------------~~~~~~~---------~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 214 ---------------------DDHPPLP---------EGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ---------------------cCCCCCC---------CCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 0000111 1124568899999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=305.18 Aligned_cols=248 Identities=30% Similarity=0.416 Sum_probs=196.9
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
..|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +|+||+++++++......
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~ 77 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC------DSPYITRYYGSYLKGTKL 77 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC------CCCccHhhhcccccCCce
Confidence 35667788999999999999999999999999987432 2334566777777765 478999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
++||||+.+ +|.+++.. ..+++..++.++.||+.||.|||+.|++|+||+|+||+++. ++.++|+|||++
T Consensus 78 ~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~--~~~~~l~dfg~~ 148 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP-------GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSE--QGDVKLADFGVA 148 (277)
T ss_pred EEEEEccCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeC--CCCEEEcccccc
Confidence 999999986 56555432 12788999999999999999999999999999999999984 788999999998
Q ss_pred ccccCCc---cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 538 CFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 538 ~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
....... ....++..|+|||++.+..++.++|+|||||++|+|++|..||...........+...
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~------------ 216 (277)
T cd06642 149 GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN------------ 216 (277)
T ss_pred ccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC------------
Confidence 7654322 2245788999999999988999999999999999999999999754333222111000
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~ 686 (689)
....++ ...+..+.+||.+||+.+|++|||+.++++||||.
T Consensus 217 ----------------------~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 257 (277)
T cd06642 217 ----------------------SPPTLE---------GQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFIT 257 (277)
T ss_pred ----------------------CCCCCC---------cccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHH
Confidence 000000 01235578999999999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=297.47 Aligned_cols=251 Identities=27% Similarity=0.436 Sum_probs=200.4
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 460 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~l 460 (689)
+|...+.||+|++|.||++.+..+++.+++|++.... .....+.+|+.+++.+ +|+||+++++++...++.++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~------~h~~vv~~~~~~~~~~~~~~ 93 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY------QHPNIVEMYSSYLVGDELWV 93 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHc------CCCChheEEEEEEcCCeEEE
Confidence 4556679999999999999998999999999886432 2234566777777766 47899999999999999999
Q ss_pred EEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccc
Q 005590 461 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539 (689)
Q Consensus 461 VmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 539 (689)
|+||+.+ +|.+++.. ..++...+..++.||+.||.|||+.||+||||+|+||+++. ++.++|+|||.+..
T Consensus 94 v~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~~l~d~g~~~~ 164 (285)
T cd06648 94 VMEFLEGGALTDIVTH-------TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTS--DGRVKLSDFGFCAQ 164 (285)
T ss_pred EEeccCCCCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcC--CCcEEEcccccchh
Confidence 9999975 66665543 12788999999999999999999999999999999999984 78899999998764
Q ss_pred ccCC---ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhh
Q 005590 540 QTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 616 (689)
Q Consensus 540 ~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~ 616 (689)
.... .....+++.|+|||.+.+..++.++|+||+||++|+|++|+.||...+.......+.....+
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~----------- 233 (285)
T cd06648 165 VSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPP----------- 233 (285)
T ss_pred hccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCC-----------
Confidence 3321 22346888999999999888999999999999999999999999876655444443211000
Q ss_pred hhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCCC
Q 005590 617 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~~ 688 (689)
.+.. ....+..+.+||++||+.+|++|||+.++++||||++.
T Consensus 234 -----------------------~~~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 234 -----------------------KLKN-------LHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKA 275 (285)
T ss_pred -----------------------CCcc-------cccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccC
Confidence 0000 01124568899999999999999999999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=291.56 Aligned_cols=248 Identities=21% Similarity=0.302 Sum_probs=199.1
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 378 ~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
+..++|++.+.||+|++|.||+|.+. .++.||+|.++........+.+|+.+++.++ |+||+++++++...+.
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~ 75 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLR------HPKLIQLYAVCTLEEP 75 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCC------CCCccceeEEEecCCC
Confidence 34578999999999999999999974 4578999999876544567788888888875 6799999999999999
Q ss_pred EEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 458 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 458 l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
.++||||+. ++|.+++.... ...+++..+..++.|++.||.+||+.||+|+||||+||+++. ++.++|+|||+
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~--~~~~~l~dfg~ 149 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQGGA----GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGE--NNICKVADFGL 149 (261)
T ss_pred eeeeeecccCCcHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcC--CCCEEECCcce
Confidence 999999995 67888775432 223889999999999999999999999999999999999985 77899999999
Q ss_pred cccccCCcc-ccc---cCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 005590 537 SCFQTDNLC-LYV---QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEML 611 (689)
Q Consensus 537 s~~~~~~~~-~~~---gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~ 611 (689)
+........ ... .+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+......+..+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------- 222 (261)
T cd05068 150 ARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR------- 222 (261)
T ss_pred EEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------
Confidence 876543221 112 2357999999999899999999999999999999 9999988766555544421100
Q ss_pred hhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
...+ ...+..+.++|.+||+.+|++||++.++++
T Consensus 223 ---------------------------~~~~---------~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 223 ---------------------------MPCP---------PGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ---------------------------CCCC---------CcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 0000 012356889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=296.60 Aligned_cols=250 Identities=26% Similarity=0.411 Sum_probs=195.9
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc------hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~------~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
||.+.+.||+|+||.||++++...+..+++|+++.. .........|+.+++.+ .||||+++++++...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~ 74 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL------DHPAIVKFHASFLER 74 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC------CCCcHHHHHHHHhcC
Confidence 689999999999999999999888877888876542 11223444566666655 478999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEec
Q 005590 456 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 534 (689)
Q Consensus 456 ~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DF 534 (689)
...++||||+.+ +|.+++...... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++ .+.++|+||
T Consensus 75 ~~~~lv~e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~---~~~~~l~d~ 149 (260)
T cd08222 75 DAFCIITEYCEGRDLDCKLEELKHT--GKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK---NNLLKIGDF 149 (260)
T ss_pred CceEEEEEeCCCCCHHHHHHHHhhc--ccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee---cCCEeeccc
Confidence 999999999985 666655432221 23389999999999999999999999999999999999997 456999999
Q ss_pred CCcccccCC---ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 005590 535 GSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 611 (689)
Q Consensus 535 Gls~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~ 611 (689)
|.+...... .....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...........+... +.+
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~~~---- 223 (260)
T cd08222 150 GVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--PTP---- 223 (260)
T ss_pred CceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--CCC----
Confidence 988765332 22345788999999998888999999999999999999999999766554444333210 000
Q ss_pred hhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
..+ ...+.++.++|.+||+.+|++||++.|+++||||
T Consensus 224 ----------------------------~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 224 ----------------------------SLP---------ETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ----------------------------CCc---------chhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 001 1123568899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=317.89 Aligned_cols=251 Identities=29% Similarity=0.507 Sum_probs=211.7
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
.+.|.+.++||+|.|++|.+|++..++..||||++.+.. .......+|+++|+.++ ||||++++.+.....
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~------HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLN------HPNIVKLFSVIETEA 128 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcC------Ccceeeeeeeeeecc
Confidence 467999999999999999999999999999999998642 23345678888888875 789999999999999
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
.+|+||||+. |.+.+++..+.. ..+..++.++.|++.|++|||+++|+|||||.+||||+ .+..+||+|||
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr------~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~--~~mnikIaDfg 200 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGR------MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLD--ENMNIKIADFG 200 (596)
T ss_pred eeEEEEEeccCchhHHHHHhccc------chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccc--cccceeeeccc
Confidence 9999999998 468888876654 66788999999999999999999999999999999999 47779999999
Q ss_pred CcccccC--CccccccCccccChhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 005590 536 SSCFQTD--NLCLYVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 612 (689)
Q Consensus 536 ls~~~~~--~~~~~~gt~~Y~APE~l~~~~~s-~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~ 612 (689)
++.+... ...+++|++.|.|||++.+..|. ..+|+||+|+++|-|+.|.+||.+.+..++-.+.+
T Consensus 201 fS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl------------ 268 (596)
T KOG0586|consen 201 FSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVL------------ 268 (596)
T ss_pred cceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhe------------
Confidence 9987653 45678999999999999998865 78999999999999999999998765444332221
Q ss_pred hhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCCC
Q 005590 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~~ 688 (689)
-..+.+|. .+..++.+||++||..+|.+|++.+++..|.|+...
T Consensus 269 -----------------------~gk~rIp~---------~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 269 -----------------------RGKYRIPF---------YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred -----------------------eeeecccc---------eeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 11233332 234567899999999999999999999999998753
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=315.87 Aligned_cols=251 Identities=25% Similarity=0.393 Sum_probs=205.6
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~----~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
.|.=++-||.|+||.||.|+|..+.+.||||.+.-. ..--..++.|+++|+.++ |||++.+.++|.....
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~------HPntieYkgCyLre~T 100 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR------HPNTIEYKGCYLREHT 100 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc------CCCcccccceeeccch
Confidence 355556799999999999999999999999998643 122245677888888775 7899999999998889
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 458 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 458 l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
.++|||||-|+-.+++...... +-+.++..|+.+.+.||.|||+.+.||||||..|||++ +.|.|||+|||.+
T Consensus 101 aWLVMEYClGSAsDlleVhkKp-----lqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs--e~g~VKLaDFGSA 173 (948)
T KOG0577|consen 101 AWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS--EPGLVKLADFGSA 173 (948)
T ss_pred HHHHHHHHhccHHHHHHHHhcc-----chHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec--CCCeeeeccccch
Confidence 9999999999877877766543 88999999999999999999999999999999999999 5999999999998
Q ss_pred ccccCCccccccCccccChhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 538 CFQTDNLCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 538 ~~~~~~~~~~~gt~~Y~APE~l~---~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
.... +...++|||.|||||+++ .+.|+-++||||||++..||...++|+-+-+...-+-.|...-.
T Consensus 174 si~~-PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes---------- 242 (948)
T KOG0577|consen 174 SIMA-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES---------- 242 (948)
T ss_pred hhcC-chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC----------
Confidence 6544 456689999999999997 45699999999999999999999999866555544444431111
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~~ 688 (689)
|... ...-+..|++||..||+.-|.+|||++++|+|+|+..+
T Consensus 243 ---------------------------PtLq-----s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 243 ---------------------------PTLQ-----SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred ---------------------------CCCC-----CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 1000 00113468999999999999999999999999998763
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=292.30 Aligned_cols=248 Identities=27% Similarity=0.387 Sum_probs=190.2
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEEEcc
Q 005590 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELL 465 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmEy~ 465 (689)
..||+|+||.||++++..++..||+|.+.... .....+.+|+.+++.++ |+||+++++++...+..++||||+
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~~~lv~e~~ 87 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLK------HRNIVQYLGSDSENGFFKIFMEQV 87 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcC------CCCeeeeeeeeccCCEEEEEEecC
Confidence 47999999999999999999999999887543 33456778888887764 789999999999999999999999
Q ss_pred cc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccCC-
Q 005590 466 RA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN- 543 (689)
Q Consensus 466 ~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~- 543 (689)
.+ +|.+++...... ...++..+..++.||+.||.|||+.||+||||||+||+++. ..+.++|+|||.+......
T Consensus 88 ~~~~L~~~l~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~-~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 88 PGGSLSALLRSKWGP---LKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred CCCCHHHHHHHhccc---CCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC-CCCeEEEecchhheecccCC
Confidence 85 677666532211 11277888899999999999999999999999999999974 3568999999988654321
Q ss_pred --ccccccCccccChhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhh
Q 005590 544 --LCLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYK 619 (689)
Q Consensus 544 --~~~~~gt~~Y~APE~l~~~~--~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~ 619 (689)
.....+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||...............
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~----------------- 226 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM----------------- 226 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhh-----------------
Confidence 22245788999999987643 788999999999999999999999643211100000000
Q ss_pred hhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 620 YFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
......+| ...++.+++||++||+.+|++|||+.|++.||||
T Consensus 227 ---------------~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 227 ---------------FKIHPEIP---------ESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred ---------------hccCCCCC---------cccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 00000111 1234668899999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=291.75 Aligned_cols=248 Identities=23% Similarity=0.333 Sum_probs=198.0
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 377 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 377 ~~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++..++|++.++||+|+||.||+|.+ .+++.||+|.+.........+.+|+.+++.++ |+||+++++++. .+
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~-~~ 73 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQ------HPRLVRLYAVVT-QE 73 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhcC------CcCeeeEEEEEc-cC
Confidence 35568899999999999999999985 45788999999876555567888988888774 679999999864 56
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
..++||||+. ++|.+++.... ...++...+..++.|++.||.|||+.|++|+||||+||+++. ++.++|+|||
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~--~~~~~l~dfg 147 (260)
T cd05067 74 PIYIITEYMENGSLVDFLKTPE----GIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSE--TLCCKIADFG 147 (260)
T ss_pred CcEEEEEcCCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcC--CCCEEEccCc
Confidence 7899999997 47777765322 223888999999999999999999999999999999999985 7789999999
Q ss_pred CcccccCCc----cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 005590 536 SSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEM 610 (689)
Q Consensus 536 ls~~~~~~~----~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~ 610 (689)
++....... ....++..|+|||++.+..++.++|+||||+++|+|++ |++||.+.+..+....+.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------ 221 (260)
T cd05067 148 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR------ 221 (260)
T ss_pred ceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC------
Confidence 987654221 12234668999999998889999999999999999999 9999987765555444321100
Q ss_pred HhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
...+ ...+.++.+||.+||..+|++|||++++++
T Consensus 222 ----------------------------~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 222 ----------------------------MPRP---------DNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred ----------------------------CCCC---------CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0011 112356889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=290.23 Aligned_cols=253 Identities=27% Similarity=0.387 Sum_probs=203.1
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 459 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~ 459 (689)
+.+++..||.|..|+||++..+.+|...|||.+.... ....+++..+.++...+ +.|+||+++++|......+
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~-----dcpyIV~c~GyFi~n~dV~ 167 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSH-----DCPYIVQCFGYFITNTDVF 167 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhcc-----CCCeeeeeeeEEeeCchHH
Confidence 4566778999999999999999999999999998643 33345555555544433 5789999999999999999
Q ss_pred EEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEeccCCCeEEEEecCCcc
Q 005590 460 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 460 lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~-gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 538 (689)
|.||.|..-...+++..+. ++++..+-.+...++.||.||.++ ||+|||+||+|||++ +.|.|||||||.+.
T Consensus 168 IcMelMs~C~ekLlkrik~-----piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlD--e~GniKlCDFGIsG 240 (391)
T KOG0983|consen 168 ICMELMSTCAEKLLKRIKG-----PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD--ERGNIKLCDFGISG 240 (391)
T ss_pred HHHHHHHHHHHHHHHHhcC-----CchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEc--cCCCEEeecccccc
Confidence 9999998665555554332 288989999999999999999975 899999999999999 58999999999998
Q ss_pred cccCCc--cccccCccccChhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHHhhcCCCcHHHHh
Q 005590 539 FQTDNL--CLYVQSRSYRAPEVIIG---LPYDQKIDLWSLGCILAELWTGEVLFPN-DAVVMILARIIGMLGPIDLEMLM 612 (689)
Q Consensus 539 ~~~~~~--~~~~gt~~Y~APE~l~~---~~~s~~~DIwSLGvil~eLltG~~PF~~-~~~~~~l~~i~~~~g~~~~e~~~ 612 (689)
+..+.. +...|.+.|||||.+.- ..|+.++|+||||+.++||.||+.||.+ ....+.+.++....+
T Consensus 241 rlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-------- 312 (391)
T KOG0983|consen 241 RLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-------- 312 (391)
T ss_pred eeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC--------
Confidence 776543 44688999999999964 3599999999999999999999999987 455566666542111
Q ss_pred hhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
+.+..+-. .++.|++|+..||+.|+++||...+||+|||+..
T Consensus 313 --------------------------------P~L~~~~g-FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 313 --------------------------------PLLPGHMG-FSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred --------------------------------CCCCcccC-cCHHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence 11111111 4577999999999999999999999999999853
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.14 Aligned_cols=252 Identities=19% Similarity=0.251 Sum_probs=196.2
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCc--EEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGV--DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~--~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|++.+.||+|+||.||+|.+..++. .+++|.++.. ......+.+|+.++.++. .||||+++++++....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~iv~~~~~~~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG-----HHPNIINLLGACENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhc-----CCCchhheEEEEccCC
Confidence 579999999999999999999877665 4688887642 233456777888887774 3789999999999999
Q ss_pred eEEEEEEccc-cchHHHHhhhhccC----------CCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccC
Q 005590 457 HLFIVCELLR-ANLYEFQKFNQESG----------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 525 (689)
Q Consensus 457 ~l~lVmEy~~-g~L~~l~~~~~~~~----------~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~ 525 (689)
..++||||+. ++|.+++....... ....+++..++.++.||+.||.|||+.||+||||||+|||++.
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~-- 154 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGE-- 154 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECC--
Confidence 9999999997 57888775433111 1124888999999999999999999999999999999999984
Q ss_pred CCeEEEEecCCcccccCCcccc--ccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhh
Q 005590 526 RCEIKIIDLGSSCFQTDNLCLY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGM 602 (689)
Q Consensus 526 ~~~vkL~DFGls~~~~~~~~~~--~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~ 602 (689)
++.+||+|||++.......... ..+..|+|||++.+..++.++|||||||++|+|++ |..||......+....+...
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~ 234 (297)
T cd05089 155 NLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 234 (297)
T ss_pred CCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence 7889999999986433221211 22456999999998899999999999999999997 99999876655544433211
Q ss_pred cCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 603 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 603 ~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
. ....| ...+..+.+||.+||+.+|.+|||++++++.
T Consensus 235 ~----------------------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 235 Y----------------------------------RMEKP---------RNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred C----------------------------------CCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 00111 1134568899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=293.19 Aligned_cols=249 Identities=19% Similarity=0.271 Sum_probs=192.5
Q ss_pred EEEEEEeccCCCCceEEEEECC---CCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 383 YYVTEYLGSAAFSKVFQAQDLH---TGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 383 Y~i~~~LG~G~fG~Vyla~d~~---tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
|++.+.||+|+||.||+|.+.. ++..||+|+++.+. .....+.+|+.+++.++ |+||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD------HPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCC------CCCeeeEEeeeccCC
Confidence 5678899999999999998754 34789999987542 23456677887777664 789999999886554
Q ss_pred e------EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeE
Q 005590 457 H------LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 529 (689)
Q Consensus 457 ~------l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~v 529 (689)
. .++||||+.+ +|..++...........+++..+..++.||+.||.|||+.+|+||||||+||+++. ++.+
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~--~~~~ 152 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRE--DMTV 152 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECC--CCeE
Confidence 3 7999999985 66666644332223345899999999999999999999999999999999999984 7889
Q ss_pred EEEecCCcccccCCc-----cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhc
Q 005590 530 KIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGML 603 (689)
Q Consensus 530 kL~DFGls~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~ 603 (689)
||+|||+++...... .....+..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+.+..+....
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 232 (273)
T cd05035 153 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN 232 (273)
T ss_pred EECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999987643321 11234567999999988889999999999999999999 999998766555443332100
Q ss_pred CCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 604 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 604 g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
....|. ..+..+.++|.+||+.||++|||+.|++++
T Consensus 233 ----------------------------------~~~~~~---------~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 233 ----------------------------------RLKQPE---------DCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ----------------------------------CCCCCc---------CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000111 124568899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=291.68 Aligned_cols=247 Identities=23% Similarity=0.331 Sum_probs=196.0
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 378 ~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
+..++|++.+.||+|+||.||+|.+. .+..+|+|.+.........+.+|+.+++.++ |++|+++++++. ...
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~------~~~i~~~~~~~~-~~~ 74 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLR------HDKLVQLYAVVS-EEP 74 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcC------CCceEEEEeEEC-CCC
Confidence 45678999999999999999999865 5677999999875555567788998888775 678999999875 456
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 458 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 458 l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
.++||||+.+ +|.+++.... ...+++..++.++.|++.||.|||+.||+|+||||+||+++. ++.++|+|||.
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~--~~~~~l~dfg~ 148 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGE----GRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGD--GLVCKIADFGL 148 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeC--CceEEeCCcee
Confidence 8999999985 7777765321 223789999999999999999999999999999999999984 78899999999
Q ss_pred cccccCCcc----ccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 005590 537 SCFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEML 611 (689)
Q Consensus 537 s~~~~~~~~----~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~ 611 (689)
+........ ...++..|+|||.+.+..++.++|+||||+++|+|++ |.+||.+....+....+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-------- 220 (260)
T cd05070 149 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY-------- 220 (260)
T ss_pred eeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------
Confidence 876543221 1234567999999988889999999999999999999 899998766555554432110
Q ss_pred hhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
....+ ...+..+.+||.+||..+|++|||+.++++
T Consensus 221 --------------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 221 --------------------------RMPCP---------QDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred --------------------------CCCCC---------CcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 00011 112356889999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=297.12 Aligned_cols=256 Identities=29% Similarity=0.440 Sum_probs=207.8
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
..+.|++.+.||+|++|.||++.+..++..+++|++.........+.+|+.+++.++ |+||+++++.+......
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 90 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCK------HPNIVDYYDSYLVGDEL 90 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCC------CCCeeEEEEEEEECCEE
Confidence 346789999999999999999999888999999999865444566778888887774 67999999999999999
Q ss_pred EEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
++|+||+. ++|.+++.... ..++...+..++.||+.||.|||+.||+|+||+|+||+++. ++.++|+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~--~~~~~l~d~~~~ 163 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNF-----VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSK--DGSVKLADFGFA 163 (286)
T ss_pred EEEEeccCCCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcC--CCCEEECccchh
Confidence 99999999 57888776543 23889999999999999999999999999999999999984 778999999987
Q ss_pred ccccCC---ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 538 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 538 ~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
...... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+... +.
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~--------- 233 (286)
T cd06614 164 AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GI--------- 233 (286)
T ss_pred hhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CC---------
Confidence 654332 12345788999999999888999999999999999999999999876554433332200 00
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~~ 688 (689)
...+. ....+..+.+||++||+.+|.+|||+.++|+||||.+.
T Consensus 234 ------------------------~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 234 ------------------------PPLKN-------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred ------------------------CCCcc-------hhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 00000 01123568899999999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=292.28 Aligned_cols=244 Identities=32% Similarity=0.470 Sum_probs=197.2
Q ss_pred eccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEEEc
Q 005590 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 464 (689)
Q Consensus 389 LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmEy 464 (689)
||.|+||.||++++..+|+.+++|++..+. .....+.+|+++++.++ |+||+++++.+......++||||
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~------h~~i~~~~~~~~~~~~~~lv~e~ 74 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ------SPYVVKLYYSFQGKKNLYLVMEY 74 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC------CcchhHHHHheecCcEEEEEEec
Confidence 689999999999999899999999987643 23455666777776664 78999999999999999999999
Q ss_pred ccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccCC
Q 005590 465 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 543 (689)
Q Consensus 465 ~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~ 543 (689)
+.+ +|.+++.... .+++..+..++.||+.||.|||+.|++|+||+|+||+++. ++.++|+|||++......
T Consensus 75 ~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~--~~~~~l~dfg~~~~~~~~ 146 (265)
T cd05579 75 LPGGDLASLLENVG------SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDS--NGHLKLTDFGLSKVGLVR 146 (265)
T ss_pred CCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcC--CCCEEEEecccchhcccC
Confidence 975 7777765322 3889999999999999999999999999999999999985 778999999987653222
Q ss_pred -----------ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHh
Q 005590 544 -----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 612 (689)
Q Consensus 544 -----------~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~ 612 (689)
.....++..|+|||.+....++.++|+||||+++|+|++|..||......+....+...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~---------- 216 (265)
T cd05579 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG---------- 216 (265)
T ss_pred cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC----------
Confidence 12346788899999999888999999999999999999999999877665555443210
Q ss_pred hhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCH---HHHHcCCCCCCC
Q 005590 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA---REALDHPWLQHP 688 (689)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa---~ElL~hpwf~~~ 688 (689)
....|... ..+..+.+||++||+.+|.+|||+ .++|+||||++.
T Consensus 217 -------------------------~~~~~~~~-------~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 217 -------------------------KIEWPEDV-------EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred -------------------------CcCCCccc-------cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 00011100 024568899999999999999999 999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=289.63 Aligned_cols=239 Identities=24% Similarity=0.359 Sum_probs=187.8
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEEEc
Q 005590 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 464 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmEy 464 (689)
+.||+|+||.||+|++..+++.+|+|.+... ......+.+|+++++.+ +|+||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY------SHPNIVRLIGVCTQKQPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC------CCCCcceEEEEEcCCCCeEEEEee
Confidence 3689999999999999999999999987643 33445677888888776 478999999999999999999999
Q ss_pred ccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccCC
Q 005590 465 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 543 (689)
Q Consensus 465 ~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~ 543 (689)
+.+ +|.+++.... ..+++..++.++.|++.||.|||+.||+|+||||+||+++. ++.+||+|||++......
T Consensus 75 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~--~~~~kl~dfg~~~~~~~~ 147 (252)
T cd05084 75 VQGGDFLTFLRTEG-----PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTE--KNVLKISDFGMSREEEDG 147 (252)
T ss_pred ccCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcC--CCcEEECccccCcccccc
Confidence 975 6766664321 23788999999999999999999999999999999999984 778999999998654332
Q ss_pred ccc-----cccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhh
Q 005590 544 LCL-----YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 617 (689)
Q Consensus 544 ~~~-----~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~ 617 (689)
... ...+..|+|||.+.+..++.++|+|||||++|+|++ |..||...........+...
T Consensus 148 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~--------------- 212 (252)
T cd05084 148 VYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG--------------- 212 (252)
T ss_pred cccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC---------------
Confidence 111 122456999999998889999999999999999998 99999765444333322110
Q ss_pred hhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 618 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
.....+. ..+..+.+||.+||+.+|++|||+.++++
T Consensus 213 -------------------~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 213 -------------------VRLPCPE---------LCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -------------------CCCCCcc---------cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0001111 12356889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=291.54 Aligned_cols=245 Identities=21% Similarity=0.340 Sum_probs=195.7
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 460 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~l 460 (689)
.+|++.+.||+|+||.||++.+. ++..+|+|++.........+.+|+.+++.++ |+||+++++++......++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~l 76 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLS------HPNLVQLYGVCTKQRPIFI 76 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCC------CCCEEEEEEEEcCCCceEE
Confidence 46889999999999999999875 4678999998764444456778888888764 7899999999999999999
Q ss_pred EEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccc
Q 005590 461 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539 (689)
Q Consensus 461 VmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 539 (689)
||||+.+ +|.+++..... .+++..+..++.||+.||.|||+.||+||||||+||+++. ++.+||+|||++..
T Consensus 77 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~--~~~~kl~dfg~~~~ 149 (256)
T cd05059 77 VTEYMANGCLLNYLRERKG-----KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGE--DNVVKVSDFGLARY 149 (256)
T ss_pred EEecCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECC--CCcEEECCccccee
Confidence 9999975 67777653321 3889999999999999999999999999999999999984 78899999999876
Q ss_pred ccCCccc----cccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 540 QTDNLCL----YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 540 ~~~~~~~----~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
....... ..++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+....+....
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~----------- 218 (256)
T cd05059 150 VLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY----------- 218 (256)
T ss_pred cccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 5432211 122357999999999899999999999999999999 899998765555444332110
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
....| ...+..+.+++.+||..+|++|||+.|+++.
T Consensus 219 -----------------------~~~~~---------~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 219 -----------------------RLYRP---------KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred -----------------------cCCCC---------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 00111 1134568899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=288.90 Aligned_cols=248 Identities=24% Similarity=0.316 Sum_probs=200.2
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 378 ~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
+..++|++.+.||+|+||.||+|.+. .++.+|||.+..+......+.+|+.+++.++ |+||+++++++.....
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~ 75 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLR------HDKLVQLYAVCSEEEP 75 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCC------CCCEeeeeeeeecCCc
Confidence 45678999999999999999999975 5578999999876555567888988888774 6799999999998899
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 458 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 458 l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
.++||||+.+ +|.+++.... ...+++..+..++.||+.||.|||++|++|+||||+||+++. ++.++|+|||.
T Consensus 76 ~~~v~e~~~~~~L~~~i~~~~----~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~--~~~~~l~d~g~ 149 (261)
T cd05034 76 IYIVTEYMSKGSLLDFLKSGE----GKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGE--NLVCKIADFGL 149 (261)
T ss_pred eEEEEeccCCCCHHHHHhccc----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcC--CCCEEECcccc
Confidence 9999999985 6777765422 123889999999999999999999999999999999999985 78899999999
Q ss_pred cccccCCcc----ccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 005590 537 SCFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEML 611 (689)
Q Consensus 537 s~~~~~~~~----~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~ 611 (689)
+........ ....+..|+|||.+.+..++.++|+|||||++|+|++ |+.||.+.+....+..+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~------- 222 (261)
T cd05034 150 ARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR------- 222 (261)
T ss_pred ceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------
Confidence 876543211 1223567999999999889999999999999999998 9999987766655555431110
Q ss_pred hhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
...+. ..+..+.++|.+||+.+|++||++.++++
T Consensus 223 ---------------------------~~~~~---------~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 223 ---------------------------MPRPP---------NCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ---------------------------CCCCC---------CCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 00010 11356889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=292.46 Aligned_cols=248 Identities=19% Similarity=0.258 Sum_probs=190.6
Q ss_pred EEEEEeccCCCCceEEEEECCCCc--EEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC---
Q 005590 384 YVTEYLGSAAFSKVFQAQDLHTGV--DVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--- 455 (689)
Q Consensus 384 ~i~~~LG~G~fG~Vyla~d~~tg~--~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~--- 455 (689)
.+.+.||+|+||.||+|++..++. .+|+|.++.. ......+.+|+.+++.++ |+||+++++++...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~ 75 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD------HPNVMRLIGVCLQTVES 75 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCC------CCCcceEEEEEccCCcc
Confidence 467889999999999999877765 6899988653 333456677888877764 78999999976532
Q ss_pred ---CeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEE
Q 005590 456 ---EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 531 (689)
Q Consensus 456 ---~~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL 531 (689)
...++||||+. ++|.+++...........+++..+..++.||+.||.|||+.||+||||||+|||++. ++.++|
T Consensus 76 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~kl 153 (272)
T cd05075 76 EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNE--NMNVCV 153 (272)
T ss_pred cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcC--CCCEEE
Confidence 25789999998 567776654433223344889999999999999999999999999999999999984 788999
Q ss_pred EecCCcccccCCc-----cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCC
Q 005590 532 IDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGP 605 (689)
Q Consensus 532 ~DFGls~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~ 605 (689)
+|||++....... ....+++.|+|||.+.+..++.++|+|||||++|+|++ |+.||.+.........+...-
T Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-- 231 (272)
T cd05075 154 ADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN-- 231 (272)
T ss_pred CCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--
Confidence 9999987654321 12245678999999999999999999999999999999 899998765554443332100
Q ss_pred CcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 606 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 606 ~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
....+ ......+.++|.+||+.||++|||+.+++++
T Consensus 232 --------------------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 232 --------------------------------RLKQP---------PDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred --------------------------------CCCCC---------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00000 0123457899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=297.16 Aligned_cols=263 Identities=20% Similarity=0.231 Sum_probs=187.4
Q ss_pred eCceecCcEEEEEEeccCCCCceEEEEECCC---CcEEEEEEeecchhhh--H----hHHHHHHHHHHhcccCCCCCCce
Q 005590 375 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKNDKDFF--D----QSLDEIKLLKLVNKNDPADEHHI 445 (689)
Q Consensus 375 ~~~~l~~rY~i~~~LG~G~fG~Vyla~d~~t---g~~vAvKii~~~~~~~--~----~~~~Ei~iL~~l~~~~~~~h~~I 445 (689)
+.++..++|++.++||+|+||+||+|++..+ +..+|+|+........ + ....+......+.......|++|
T Consensus 6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i 85 (294)
T PHA02882 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI 85 (294)
T ss_pred eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence 4556778999999999999999999998777 6778888754332110 0 00011112222222334678999
Q ss_pred eEEEEEEEeCC----eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 005590 446 LRLYDYFYHLE----HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI 521 (689)
Q Consensus 446 v~l~~~f~~~~----~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl 521 (689)
+++++++.... ..+++++++..++.+.+..... .++..++.++.||+.||.|||+.+|+||||||+|||+
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill 159 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKC------KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV 159 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehhccCHHHHHHhhcc------CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 99998766443 4578899887777666543221 5677889999999999999999999999999999999
Q ss_pred eccCCCeEEEEecCCcccccC----------CccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCh
Q 005590 522 KSYQRCEIKIIDLGSSCFQTD----------NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA 591 (689)
Q Consensus 522 ~~~~~~~vkL~DFGls~~~~~----------~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~ 591 (689)
+. ++.++|+|||+++.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 160 ~~--~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 160 DG--NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred cC--CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 84 67899999999875421 1123468999999999999999999999999999999999999998753
Q ss_pred HHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCC
Q 005590 592 VVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQ 671 (689)
Q Consensus 592 ~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~ 671 (689)
....+...... + ..+.+. .....+ ...+..+.++++.|+..+|+
T Consensus 238 ~~~~~~~~~~~------~-------~~~~~~-------------~~~~~~----------~~~~~~~~~~~~~~~~~~~~ 281 (294)
T PHA02882 238 HNGNLIHAAKC------D-------FIKRLH-------------EGKIKI----------KNANKFIYDFIECVTKLSYE 281 (294)
T ss_pred cchHHHHHhHH------H-------HHHHhh-------------hhhhcc----------CCCCHHHHHHHHHHHhCCCC
Confidence 22211111100 0 000000 000001 11245688999999999999
Q ss_pred CCcCHHHHHc
Q 005590 672 RRPTAREALD 681 (689)
Q Consensus 672 kRpTa~ElL~ 681 (689)
+||+.+++++
T Consensus 282 ~rp~~~~l~~ 291 (294)
T PHA02882 282 EKPDYDALIK 291 (294)
T ss_pred CCCCHHHHHH
Confidence 9999999975
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=293.56 Aligned_cols=251 Identities=21% Similarity=0.273 Sum_probs=195.5
Q ss_pred CcEEEEEEeccCCCCceEEEEE----CCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQD----LHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d----~~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
.+|++.+.||+|+||+||+|.+ ...++.+|+|.+.... .....+.+|+.+++.++ |+||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~ 78 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH------HPNIVCLLGVVTQ 78 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC------CCCeeeEEEEEec
Confidence 5789999999999999999985 3456789999987532 22345677888888774 6899999999999
Q ss_pred CCeEEEEEEcccc-chHHHHhhhhcc-----------CCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEe
Q 005590 455 LEHLFIVCELLRA-NLYEFQKFNQES-----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIK 522 (689)
Q Consensus 455 ~~~l~lVmEy~~g-~L~~l~~~~~~~-----------~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~ 522 (689)
....++||||+.+ +|.+++...... .....+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~ 158 (283)
T cd05090 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG 158 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence 9999999999984 777776432210 0122378888999999999999999999999999999999998
Q ss_pred ccCCCeEEEEecCCcccccCC-----ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHH
Q 005590 523 SYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMIL 596 (689)
Q Consensus 523 ~~~~~~vkL~DFGls~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l 596 (689)
. ++.+||+|||++...... .....++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.......
T Consensus 159 ~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05090 159 E--QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236 (283)
T ss_pred C--CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 5 678999999998754322 122344667999999998889999999999999999998 99999876655444
Q ss_pred HHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCH
Q 005590 597 ARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 676 (689)
Q Consensus 597 ~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa 676 (689)
..+.... ....+ ...+..+.++|.+||+.||.+||++
T Consensus 237 ~~~~~~~----------------------------------~~~~~---------~~~~~~~~~li~~cl~~~p~~Rp~~ 273 (283)
T cd05090 237 EMVRKRQ----------------------------------LLPCS---------EDCPPRMYSLMTECWQEGPSRRPRF 273 (283)
T ss_pred HHHHcCC----------------------------------cCCCC---------CCCCHHHHHHHHHHcccCcccCcCH
Confidence 4332100 00011 1124568899999999999999999
Q ss_pred HHHHcC
Q 005590 677 REALDH 682 (689)
Q Consensus 677 ~ElL~h 682 (689)
.+++++
T Consensus 274 ~~i~~~ 279 (283)
T cd05090 274 KDIHTR 279 (283)
T ss_pred HHHHHH
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=297.77 Aligned_cols=256 Identities=22% Similarity=0.335 Sum_probs=198.8
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECC-------CCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeE
Q 005590 377 TVIAGRYYVTEYLGSAAFSKVFQAQDLH-------TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILR 447 (689)
Q Consensus 377 ~~l~~rY~i~~~LG~G~fG~Vyla~d~~-------tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~ 447 (689)
++..++|.+.+.||+|+||.||++++.. ++..+|+|++..+. .....+..|+.+++.+. .|+||++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~ 88 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-----KHKNIIN 88 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhc-----CCCCEee
Confidence 3445789999999999999999998643 23569999997542 23456777888888774 3789999
Q ss_pred EEEEEEeCCeEEEEEEccc-cchHHHHhhhhcc----------CCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 005590 448 LYDYFYHLEHLFIVCELLR-ANLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 516 (689)
Q Consensus 448 l~~~f~~~~~l~lVmEy~~-g~L~~l~~~~~~~----------~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp 516 (689)
+++++......++||||+. ++|.+++...... .....++...+..++.||+.||.|||+.|++||||||
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp 168 (307)
T cd05098 89 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAA 168 (307)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccH
Confidence 9999999999999999998 4788887654321 1223488899999999999999999999999999999
Q ss_pred CcEEEeccCCCeEEEEecCCcccccCCc-----cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 005590 517 ENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPND 590 (689)
Q Consensus 517 ~NILl~~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~ 590 (689)
+||+++. ++.++|+|||.+....... ....+++.|+|||++.+..++.++|+|||||++|+|++ |..||...
T Consensus 169 ~Nill~~--~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 169 RNVLVTE--DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred HheEEcC--CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 9999984 7889999999986543211 11123467999999999889999999999999999998 89999876
Q ss_pred hHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCC
Q 005590 591 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINP 670 (689)
Q Consensus 591 ~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP 670 (689)
+..+....+... .....|. ..+..+.+||.+||..+|
T Consensus 247 ~~~~~~~~~~~~----------------------------------~~~~~~~---------~~~~~~~~li~~~l~~~p 283 (307)
T cd05098 247 PVEELFKLLKEG----------------------------------HRMDKPS---------NCTNELYMMMRDCWHAVP 283 (307)
T ss_pred CHHHHHHHHHcC----------------------------------CCCCCCC---------cCCHHHHHHHHHHcccCh
Confidence 655544433210 0000111 123568899999999999
Q ss_pred CCCcCHHHHHcC
Q 005590 671 QRRPTAREALDH 682 (689)
Q Consensus 671 ~kRpTa~ElL~h 682 (689)
++|||+.+++++
T Consensus 284 ~~Rps~~evl~~ 295 (307)
T cd05098 284 SQRPTFKQLVED 295 (307)
T ss_pred hhCcCHHHHHHH
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=292.85 Aligned_cols=246 Identities=23% Similarity=0.349 Sum_probs=198.8
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh-hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~-~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
..+|++.++||.|+||.||+|.+.. ++.+|+|++..... ....+.+|+.+++.++ |+||+++++++......
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 77 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLR------HKHLISLFAVCSVGEPV 77 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCC------CcchhheeeeEecCCCe
Confidence 3579999999999999999999877 89999999886543 3456777888877664 68999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
++||||+.+ +|.+++.... ...+++..+..++.||+.||.|||+.||+|+||||+||+++. ++.+||+|||.+
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~--~~~~kl~d~g~~ 151 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPE----GQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGE--DLVCKVADFGLA 151 (261)
T ss_pred EEEEeecccCCHHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcC--CceEEEccccch
Confidence 999999985 7887775422 123788999999999999999999999999999999999984 788999999998
Q ss_pred ccccCCcc---ccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 005590 538 CFQTDNLC---LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 538 ~~~~~~~~---~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
........ ...++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+.+..+.....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------- 222 (261)
T cd05148 152 RLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR--------- 222 (261)
T ss_pred hhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc---------
Confidence 76543221 2234567999999998899999999999999999998 8999987766555554431100
Q ss_pred hhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
...+ ...++.+.++|.+||+.||++|||+.++++
T Consensus 223 -------------------------~~~~---------~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 223 -------------------------MPCP---------AKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred -------------------------CCCC---------CCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0011 112356889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=288.20 Aligned_cols=245 Identities=20% Similarity=0.344 Sum_probs=199.6
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEE
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 459 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~ 459 (689)
.++|++.+.||.|+||.||+|.. .|+.||+|.+........++.+|+.+++.++ |+||+++++++......+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLR------HPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcC------CcceeeeEEEEcCCCCeE
Confidence 46789999999999999999985 4899999999876555567888888888774 679999999999999999
Q ss_pred EEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcc
Q 005590 460 IVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 460 lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 538 (689)
+||||+. ++|.+++..... ..+++..+..++.|++.||.|||+.|++|+||||+||+++. ++.++|+|||.+.
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~--~~~~~l~d~g~~~ 150 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGR----AVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSE--DLVAKVSDFGLAK 150 (256)
T ss_pred EEEEecCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeC--CCCEEEccccccc
Confidence 9999998 478777754321 23889999999999999999999999999999999999984 7889999999987
Q ss_pred cccCCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhh
Q 005590 539 FQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 617 (689)
Q Consensus 539 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~ 617 (689)
...........+..|+|||.+....++.++|+||||+++|+|++ |..||...+..+....+....
T Consensus 151 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-------------- 216 (256)
T cd05039 151 EASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY-------------- 216 (256)
T ss_pred ccccccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC--------------
Confidence 76544333345667999999988889999999999999999997 999998766555443332100
Q ss_pred hhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 618 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
....| ...++.+.+||.+||..+|++|||+.++++
T Consensus 217 --------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 217 --------------------RMEAP---------EGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred --------------------CCCCc---------cCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 00011 112456889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=306.59 Aligned_cols=257 Identities=26% Similarity=0.329 Sum_probs=206.9
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~----~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
.+.|+.-++||+||||.|+-++...||+.||+|.+.+. +......++|..||.+++. ++||.+-..|.++
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s------~FiVslaYAfeTk 257 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSS------PFIVSLAYAFETK 257 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhcc------CcEEEEeeeecCC
Confidence 45688889999999999999999999999999987543 2234566788889998875 4899999999999
Q ss_pred CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 456 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 456 ~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
+.+|+||..|+|+-+.+..++... ..|++++++.++.+|++||.+||..+||+|||||+|||++ +.|+|+|+|+|
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLD--d~GhvRISDLG 332 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLD--DHGHVRISDLG 332 (591)
T ss_pred CceEEEEEeecCCceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeec--cCCCeEeeccc
Confidence 999999999998765555544332 3499999999999999999999999999999999999999 59999999999
Q ss_pred CcccccC--CccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 005590 536 SSCFQTD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 536 ls~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
+|..... .....+||.+|||||++.+..|+...|+|||||+||+|+.|+.||...-...--.++-+.
T Consensus 333 LAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr----------- 401 (591)
T KOG0986|consen 333 LAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRR----------- 401 (591)
T ss_pred eEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHH-----------
Confidence 9987643 445569999999999999999999999999999999999999999643221111111000
Q ss_pred hhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcC-----HHHHHcCCCCCC
Q 005590 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPWLQH 687 (689)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT-----a~ElL~hpwf~~ 687 (689)
........| ...++++++|.+.+|+.||.+|.. ++++-+||||+.
T Consensus 402 --------------------~~~~~~ey~---------~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 402 --------------------TLEDPEEYS---------DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred --------------------Hhcchhhcc---------cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 001111112 123567899999999999999974 779999999975
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=287.31 Aligned_cols=251 Identities=27% Similarity=0.379 Sum_probs=201.6
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
+|++.+.||.|+||.||++++..+++.+|+|.+.... .......+|+++++.++ |+||+++++++......
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~ 74 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN------HPNIISYKEAFLDGNKL 74 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCC------CCCchhhhhhhccCCEE
Confidence 5899999999999999999999999999999987532 22345556777777664 67999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
++||||+.+ +|.+++..... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++. ++.+||+|||++
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~--~~~~kl~d~g~~ 150 (256)
T cd08530 75 CIVMEYAPFGDLSKAISKRKK--KRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVA--NDLVKIGDLGIS 150 (256)
T ss_pred EEEehhcCCCCHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEec--CCcEEEeeccch
Confidence 999999975 67776654322 2234889999999999999999999999999999999999995 778999999998
Q ss_pred ccccCC-ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhh
Q 005590 538 CFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 616 (689)
Q Consensus 538 ~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~ 616 (689)
...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-------------- 216 (256)
T cd08530 151 KVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG-------------- 216 (256)
T ss_pred hhhccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--------------
Confidence 765443 22245788999999999989999999999999999999999999876654443332210
Q ss_pred hhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 617 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
..+... ...+..++++|.+||..+|.+|||+.++++||++
T Consensus 217 -----------------------~~~~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 217 -----------------------KYPPIP------PIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred -----------------------CCCCCc------hhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 000000 0123568899999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=294.79 Aligned_cols=250 Identities=23% Similarity=0.289 Sum_probs=196.5
Q ss_pred CcEEEEEEeccCCCCceEEEEE-----CCCCcEEEEEEeecc-hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d-----~~tg~~vAvKii~~~-~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
.+|.+.+.||+|+||+||++.+ ..++..+|+|.+... ......+.+|+.+++.+. |+||+++++++..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~ 78 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ------HEHIVKFYGVCVE 78 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCC------CCCcceEEEEEec
Confidence 5799999999999999999985 234567999988753 233456778888888774 6799999999999
Q ss_pred CCeEEEEEEccc-cchHHHHhhhhc-------cCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCC
Q 005590 455 LEHLFIVCELLR-ANLYEFQKFNQE-------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 526 (689)
Q Consensus 455 ~~~l~lVmEy~~-g~L~~l~~~~~~-------~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~ 526 (689)
.+..++||||+. ++|.+++..... ......+++..+..++.||+.||.|||+.|++||||||+|||++. +
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~--~ 156 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE--N 156 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc--C
Confidence 999999999998 467777653321 111224899999999999999999999999999999999999984 7
Q ss_pred CeEEEEecCCcccccCCc-----cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHH
Q 005590 527 CEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARII 600 (689)
Q Consensus 527 ~~vkL~DFGls~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~ 600 (689)
+.++|+|||++....... ....++..|+|||++.+..++.++|+|||||++|+|++ |.+||......+.+..+.
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~ 236 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 889999999987543221 12234678999999999899999999999999999998 999998776655554443
Q ss_pred hhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHH
Q 005590 601 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 680 (689)
Q Consensus 601 ~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL 680 (689)
... ....+ ...+..+.+||.+||+.||.+|||+.+++
T Consensus 237 ~~~----------------------------------~~~~~---------~~~~~~l~~li~~~l~~~p~~Rpt~~~v~ 273 (288)
T cd05093 237 QGR----------------------------------VLQRP---------RTCPKEVYDLMLGCWQREPHMRLNIKEIH 273 (288)
T ss_pred cCC----------------------------------cCCCC---------CCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 110 00001 11235688999999999999999999986
Q ss_pred c
Q 005590 681 D 681 (689)
Q Consensus 681 ~ 681 (689)
+
T Consensus 274 ~ 274 (288)
T cd05093 274 S 274 (288)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=288.84 Aligned_cols=247 Identities=24% Similarity=0.356 Sum_probs=195.1
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 378 ~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
+..++|.+.+.||+|++|.||++.+..+ ..+|+|++..+......+.+|+++++.+. |++++++++++. .+.
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~-~~~ 74 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLR------HDKLVPLYAVVS-EEP 74 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCC------CCCeeeEEEEEc-CCC
Confidence 3457899999999999999999987654 46999998765545566778888888774 679999998875 466
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 458 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 458 l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
.++||||+.+ +|.+++.... ...+++..+..++.||+.||.|||+.|++|+||||+||+++. ++.++|+|||+
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~--~~~~~l~dfg~ 148 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGD----GKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGD--NLVCKIADFGL 148 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcC--CCeEEECCCcc
Confidence 8999999985 7887775422 123788899999999999999999999999999999999984 78899999999
Q ss_pred cccccCCcc----ccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 005590 537 SCFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEML 611 (689)
Q Consensus 537 s~~~~~~~~----~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~ 611 (689)
+........ ...++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+....+....+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-------- 220 (260)
T cd05069 149 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-------- 220 (260)
T ss_pred ceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------
Confidence 876543221 1234667999999998889999999999999999999 999998766555444332110
Q ss_pred hhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
....+ ...+..+.+||++||..||++||+++++++
T Consensus 221 --------------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 221 --------------------------RMPCP---------QGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred --------------------------CCCCC---------cccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00011 112356889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=298.91 Aligned_cols=252 Identities=21% Similarity=0.265 Sum_probs=195.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcE--EEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVD--VCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~--vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|++.+.||+|+||.||+|.+..++.. +++|.++.. ......+.+|+.++..+. +|+||+++++++...+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~-----~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-----HHPNIINLLGACEHRG 81 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhc-----CCCCcceEEEEECCCC
Confidence 5799999999999999999998777764 577766532 233456777888888773 3789999999999999
Q ss_pred eEEEEEEccc-cchHHHHhhhhcc----------CCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccC
Q 005590 457 HLFIVCELLR-ANLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 525 (689)
Q Consensus 457 ~l~lVmEy~~-g~L~~l~~~~~~~----------~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~ 525 (689)
..++||||+. ++|.+++...... .....+++..++.++.||+.||+|||+.||+||||||+|||++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~-- 159 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE-- 159 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC--
Confidence 9999999997 5788777644321 11234889999999999999999999999999999999999984
Q ss_pred CCeEEEEecCCcccccCCccc--cccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhh
Q 005590 526 RCEIKIIDLGSSCFQTDNLCL--YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGM 602 (689)
Q Consensus 526 ~~~vkL~DFGls~~~~~~~~~--~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~ 602 (689)
++.+||+|||++......... ...+..|+|||.+.+..++.++|||||||++|+|+| |..||...+..+....+...
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 239 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239 (303)
T ss_pred CCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 778999999998643221111 223567999999988889999999999999999998 99999776554443332100
Q ss_pred cCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 603 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 603 ~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
.....+ ...+..+.+||.+||+.+|++||+++++|++
T Consensus 240 ----------------------------------~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 240 ----------------------------------YRLEKP---------LNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred ----------------------------------CcCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000001 0124568899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=299.04 Aligned_cols=251 Identities=25% Similarity=0.401 Sum_probs=200.1
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
..|.+.+.||+|+||.||++++..++..+|+|++.... .....+.+|+.+++.+ .|+|++++++++....
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~ 98 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI------KHPNSIEYKGCYLREH 98 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC------CCCCEEEEEEEEeeCC
Confidence 45788899999999999999999999999999987532 2234566677777766 4679999999999999
Q ss_pred eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 457 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 457 ~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
..++||||+.+++.+.+..... .+++..+..++.||+.||.|||+.||+||||+|+||+++. ++.++|+|||+
T Consensus 99 ~~~lv~e~~~g~l~~~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~--~~~~kl~dfg~ 171 (317)
T cd06635 99 TAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE--PGQVKLADFGS 171 (317)
T ss_pred eEEEEEeCCCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECC--CCCEEEecCCC
Confidence 9999999999988777654322 2788999999999999999999999999999999999984 78899999998
Q ss_pred cccccCCccccccCccccChhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 005590 537 SCFQTDNLCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 537 s~~~~~~~~~~~gt~~Y~APE~l~---~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
+..... .....+++.|+|||.+. ...++.++|+|||||++|+|++|..||........+..+.....+
T Consensus 172 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-------- 242 (317)
T cd06635 172 ASIASP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP-------- 242 (317)
T ss_pred ccccCC-cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC--------
Confidence 765433 23356888999999984 456889999999999999999999999766544444433211000
Q ss_pred hhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
..+ ....+..+++||.+||+.+|.+||++.++++|+|+-.
T Consensus 243 --------------------------~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 243 --------------------------TLQ--------SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred --------------------------CCC--------CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 000 0012345789999999999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=294.30 Aligned_cols=253 Identities=26% Similarity=0.413 Sum_probs=196.6
Q ss_pred cEEEEEEeccCCCCceEEEEEC---CCCcEEEEEEeecch-----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 453 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~---~tg~~vAvKii~~~~-----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~ 453 (689)
.|++.+.||.|+||.||++++. .+|+.||+|+++... .......+|+++++.+. +|++|+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~~i~~~~~~~~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-----QSPFLVTLHYAFQ 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcc-----cCCChhceeeEee
Confidence 4889999999999999999874 478999999987532 22345667888888775 3679999999999
Q ss_pred eCCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEE
Q 005590 454 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 532 (689)
Q Consensus 454 ~~~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~ 532 (689)
.....++||||+.+ +|.+++.... .+++..+..++.||+.||.|||+.|++||||+|+|||++. ++.++|+
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~--~~~~kl~ 147 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQRE------RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDS--NGHVVLT 147 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECC--CCCEEEe
Confidence 99999999999985 6777665322 2788999999999999999999999999999999999984 7889999
Q ss_pred ecCCcccccCC----ccccccCccccChhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 005590 533 DLGSSCFQTDN----LCLYVQSRSYRAPEVIIGL--PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 606 (689)
Q Consensus 533 DFGls~~~~~~----~~~~~gt~~Y~APE~l~~~--~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~ 606 (689)
|||++...... .....++..|+|||.+... .++.++|+||||+++|+|++|..||...........+...+
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--- 224 (290)
T cd05613 148 DFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI--- 224 (290)
T ss_pred eCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh---
Confidence 99998764332 1234678899999998753 46789999999999999999999996432211111111000
Q ss_pred cHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCc-----CHHHHHc
Q 005590 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALD 681 (689)
Q Consensus 607 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRp-----Ta~ElL~ 681 (689)
. .....+| ...++.+.+||++||+.||.+|| ++++++.
T Consensus 225 ---------------~-------------~~~~~~~---------~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 225 ---------------L-------------KSEPPYP---------QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ---------------h-------------ccCCCCC---------ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0 0000011 11346688999999999999997 8999999
Q ss_pred CCCCCC
Q 005590 682 HPWLQH 687 (689)
Q Consensus 682 hpwf~~ 687 (689)
||||+.
T Consensus 268 ~~~~~~ 273 (290)
T cd05613 268 HPFFQK 273 (290)
T ss_pred Cccccc
Confidence 999985
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=296.85 Aligned_cols=247 Identities=25% Similarity=0.401 Sum_probs=196.6
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEEEc
Q 005590 386 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 464 (689)
Q Consensus 386 ~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmEy 464 (689)
..+||+|+||.||++.+..+++.||+|.+.... .....+.+|+.+++.++ |+||+++++.+...++.++||||
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ------HENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcC------CcchhheeeEEEeCCEEEEEEec
Confidence 357999999999999999999999999886432 23345677887777664 67999999999999999999999
Q ss_pred cccc-hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccCC
Q 005590 465 LRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 543 (689)
Q Consensus 465 ~~g~-L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~ 543 (689)
+.++ |.+++. .. .+++..+..++.|++.||.|||+.|++|+||+|+||+++. ++.++|+|||++......
T Consensus 99 ~~~~~L~~~~~-~~------~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~--~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 99 LEGGALTDIVT-HT------RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTH--DGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred CCCCcHHHHHh-cC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC--CCCEEEcccccceecccc
Confidence 9864 554432 11 2788999999999999999999999999999999999985 678999999987654322
Q ss_pred ---ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhh
Q 005590 544 ---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKY 620 (689)
Q Consensus 544 ---~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~ 620 (689)
.....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.........+...+.
T Consensus 170 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~---------------- 233 (292)
T cd06657 170 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP---------------- 233 (292)
T ss_pred cccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC----------------
Confidence 2234678899999999888899999999999999999999999987655544433321100
Q ss_pred hhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCCC
Q 005590 621 FTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~~ 688 (689)
..++ .....+..+.++|.+||+.+|.+||++.++|+||||.+.
T Consensus 234 ------------------~~~~-------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~ 276 (292)
T cd06657 234 ------------------PKLK-------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 276 (292)
T ss_pred ------------------cccC-------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhcc
Confidence 0000 011234567899999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=291.57 Aligned_cols=254 Identities=21% Similarity=0.292 Sum_probs=197.3
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCC-----CcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005590 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHT-----GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 450 (689)
Q Consensus 378 ~l~~rY~i~~~LG~G~fG~Vyla~d~~t-----g~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~ 450 (689)
+..++|++.+.||+|+||.||++.+... +..||+|.+.... .....+.+|+.+++.+ .|+||+++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~ 76 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF------NCHHVVRLLG 76 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC------CCCceeEEEE
Confidence 3457899999999999999999987643 4789999986542 2234556677777665 4789999999
Q ss_pred EEEeCCeEEEEEEccc-cchHHHHhhhhcc----CCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccC
Q 005590 451 YFYHLEHLFIVCELLR-ANLYEFQKFNQES----GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 525 (689)
Q Consensus 451 ~f~~~~~l~lVmEy~~-g~L~~l~~~~~~~----~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~ 525 (689)
++......++||||+. ++|.+++...... .....+++..+..++.||+.||.|||+.+|+||||||+||+++.
T Consensus 77 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~-- 154 (277)
T cd05032 77 VVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAE-- 154 (277)
T ss_pred EEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcC--
Confidence 9999999999999997 5777776543211 11223778899999999999999999999999999999999985
Q ss_pred CCeEEEEecCCcccccCC-----ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHH
Q 005590 526 RCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARI 599 (689)
Q Consensus 526 ~~~vkL~DFGls~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i 599 (689)
++.+||+|||+++..... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 234 (277)
T cd05032 155 DLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV 234 (277)
T ss_pred CCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH
Confidence 788999999998654322 122345778999999998889999999999999999998 99999876665544433
Q ss_pred HhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHH
Q 005590 600 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA 679 (689)
Q Consensus 600 ~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~El 679 (689)
... .....|. ..+..+.+||.+||+.+|++|||+.++
T Consensus 235 ~~~----------------------------------~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rpt~~~l 271 (277)
T cd05032 235 IDG----------------------------------GHLDLPE---------NCPDKLLELMRMCWQYNPKMRPTFLEI 271 (277)
T ss_pred hcC----------------------------------CCCCCCC---------CCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 200 0001111 113568899999999999999999999
Q ss_pred HcC
Q 005590 680 LDH 682 (689)
Q Consensus 680 L~h 682 (689)
++.
T Consensus 272 ~~~ 274 (277)
T cd05032 272 VSS 274 (277)
T ss_pred HHH
Confidence 863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=293.92 Aligned_cols=255 Identities=23% Similarity=0.349 Sum_probs=198.4
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCC-----CcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005590 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHT-----GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 450 (689)
Q Consensus 378 ~l~~rY~i~~~LG~G~fG~Vyla~d~~t-----g~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~ 450 (689)
+-.++|++.+.||+|+||.||++.+... ...+|+|++.... .....+.+|+.+++.+. .|+||+++++
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~i~~~~~ 83 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-----KHKNIINLLG 83 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhc-----CCCCeeeEEE
Confidence 3357899999999999999999987643 3789999987542 23345677888888773 3789999999
Q ss_pred EEEeCCeEEEEEEccc-cchHHHHhhhhc----------cCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 005590 451 YFYHLEHLFIVCELLR-ANLYEFQKFNQE----------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENI 519 (689)
Q Consensus 451 ~f~~~~~l~lVmEy~~-g~L~~l~~~~~~----------~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NI 519 (689)
++......++||||+. ++|..++..... ......+++..+..++.||+.||.|||+.||+||||||+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 9999999999999997 477777653210 02233488999999999999999999999999999999999
Q ss_pred EEeccCCCeEEEEecCCcccccCCc-----cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHH
Q 005590 520 LIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVV 593 (689)
Q Consensus 520 Ll~~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~ 593 (689)
+++. ++.+||+|||++....... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....
T Consensus 164 l~~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 164 LVTE--DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred EEcC--CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 9984 7889999999987654321 11234567999999998899999999999999999998 99999876655
Q ss_pred HHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCC
Q 005590 594 MILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 673 (689)
Q Consensus 594 ~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kR 673 (689)
+....+.... ....| ......+.+||.+||..||++|
T Consensus 242 ~~~~~~~~~~----------------------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~R 278 (293)
T cd05053 242 ELFKLLKEGY----------------------------------RMEKP---------QNCTQELYHLMRDCWHEVPSQR 278 (293)
T ss_pred HHHHHHHcCC----------------------------------cCCCC---------CCCCHHHHHHHHHHcccCcccC
Confidence 5444332100 00011 1123568899999999999999
Q ss_pred cCHHHHHcC
Q 005590 674 PTAREALDH 682 (689)
Q Consensus 674 pTa~ElL~h 682 (689)
||+.|++++
T Consensus 279 ps~~eil~~ 287 (293)
T cd05053 279 PTFKQLVED 287 (293)
T ss_pred cCHHHHHHH
Confidence 999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=299.74 Aligned_cols=251 Identities=24% Similarity=0.376 Sum_probs=199.4
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~----~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
.+|.+.+.||+|+||.||+|++..+++.+|+|.+... ......+.+|+++++.++ |+|++++++++....
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~ 88 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR------HPNTIQYRGCYLREH 88 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC------CCCcccEEEEEEcCC
Confidence 4577888999999999999999999999999998642 122345667777777764 679999999999999
Q ss_pred eEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 457 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 457 ~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
..++||||+.+++.+++.... ..+++..+..++.|++.||.|||+.+++||||+|+||+++. ++.++|+|||+
T Consensus 89 ~~~lv~e~~~~~l~~~~~~~~-----~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~--~~~~kl~dfg~ 161 (308)
T cd06634 89 TAWLVMEYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE--PGLVKLGDFGS 161 (308)
T ss_pred eeEEEEEccCCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECC--CCcEEECCccc
Confidence 999999999988877665332 22788999999999999999999999999999999999984 78899999999
Q ss_pred cccccCCccccccCccccChhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 005590 537 SCFQTDNLCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 537 s~~~~~~~~~~~gt~~Y~APE~l~---~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
+...... ....+++.|+|||.+. ...++.++|||||||++|+|++|..||......+....+...
T Consensus 162 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----------- 229 (308)
T cd06634 162 ASIMAPA-NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----------- 229 (308)
T ss_pred ceeecCc-ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhc-----------
Confidence 8765432 3356788999999985 345788999999999999999999999765443333222100
Q ss_pred hhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
..|... ....+..+.+||++||+.+|++||++.++++|||+..
T Consensus 230 --------------------------~~~~~~-----~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 230 --------------------------ESPALQ-----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred --------------------------CCCCcC-----cccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 000000 0112356889999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=299.60 Aligned_cols=246 Identities=21% Similarity=0.282 Sum_probs=190.7
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcE----EEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVD----VCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 453 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~----vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~ 453 (689)
..+|++.+.||+|+||+||+|++..+++. ||+|+++... .....+.+|+.+++.+ .|+||+++++++.
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~g~~~ 79 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV------DNPHVCRLLGICL 79 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC------CCCCCCeEEEEEc
Confidence 36799999999999999999998666654 8999986432 2345666777777766 4789999999987
Q ss_pred eCCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEE
Q 005590 454 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 532 (689)
Q Consensus 454 ~~~~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~ 532 (689)
.. ..++|+||+. |+|.+++..... .++...+..++.||+.||.|||+.||+||||||+|||++. ++.+||+
T Consensus 80 ~~-~~~~v~e~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~--~~~~kl~ 151 (316)
T cd05108 80 TS-TVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKT--PQHVKIT 151 (316)
T ss_pred CC-CceeeeecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecC--CCcEEEc
Confidence 64 5678999987 567777764321 2788889999999999999999999999999999999984 7789999
Q ss_pred ecCCcccccCCcc-----ccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCC
Q 005590 533 DLGSSCFQTDNLC-----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 606 (689)
Q Consensus 533 DFGls~~~~~~~~-----~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~ 606 (689)
|||++........ ....+..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 152 DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~---- 227 (316)
T cd05108 152 DFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG---- 227 (316)
T ss_pred cccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCC----
Confidence 9999976543221 1223567999999999999999999999999999998 99999876554433222100
Q ss_pred cHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 607 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
...|.. ...+..+.++|.+||..||.+|||+.+++.+
T Consensus 228 --------------------------------~~~~~~-------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 228 --------------------------------ERLPQP-------PICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred --------------------------------CCCCCC-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 000100 0123457899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=287.18 Aligned_cols=243 Identities=21% Similarity=0.332 Sum_probs=194.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE-eCCeEE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY-HLEHLF 459 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~-~~~~l~ 459 (689)
.+|++.+.||+|+||.||++.. .|..+|+|.+..+.. ...+.+|+.+++.++ |++++++++++. .....+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~-~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDAT-AQAFLAEASVMTQLR------HSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCch-HHHHHHHHHHHHhCC------CCCeeeEEEEEEcCCCceE
Confidence 5799999999999999999975 488899999876543 356778888888774 679999999765 456789
Q ss_pred EEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcc
Q 005590 460 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 460 lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 538 (689)
+||||+.+ +|.+++..... ..+++..+..++.||+.||+|||+.|++||||||+||+++. ++.+||+|||++.
T Consensus 77 lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~--~~~~kl~dfg~~~ 150 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSE--DNVAKVSDFGLTK 150 (256)
T ss_pred EEEECCCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcC--CCcEEecCCccce
Confidence 99999984 78777654322 23788999999999999999999999999999999999984 7889999999987
Q ss_pred cccCCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhh
Q 005590 539 FQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 617 (689)
Q Consensus 539 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~ 617 (689)
...........+..|+|||++.+..++.++|||||||++|+|++ |+.||...........+....
T Consensus 151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-------------- 216 (256)
T cd05082 151 EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-------------- 216 (256)
T ss_pred eccccCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--------------
Confidence 65443334445678999999998889999999999999999998 999998765555444332100
Q ss_pred hhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 618 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
....+ ...++.+.++|.+||+.+|++|||+.++++
T Consensus 217 --------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 217 --------------------KMDAP---------DGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred --------------------CCCCC---------CCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00001 122456889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=305.41 Aligned_cols=255 Identities=24% Similarity=0.332 Sum_probs=193.2
Q ss_pred ecCcEEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 451 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~-----~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~ 451 (689)
-.++|++.+.||+|+||.||+|.+. .+++.||+|+++... .....+.+|+.+++.+. +|+||++++++
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~-----~h~niv~~~~~ 79 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIG-----HHLNVVNLLGA 79 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhc-----cCcchhheeee
Confidence 3468999999999999999999743 345789999987532 23355677888888773 37899999998
Q ss_pred EEeC-CeEEEEEEcccc-chHHHHhhhhcc--------------------------------------------------
Q 005590 452 FYHL-EHLFIVCELLRA-NLYEFQKFNQES-------------------------------------------------- 479 (689)
Q Consensus 452 f~~~-~~l~lVmEy~~g-~L~~l~~~~~~~-------------------------------------------------- 479 (689)
+... ..+++||||+.+ +|.+++......
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 8754 578999999985 677666432210
Q ss_pred -----CCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccCCc-----ccccc
Q 005590 480 -----GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQ 549 (689)
Q Consensus 480 -----~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~~-----~~~~g 549 (689)
.....+++..+..++.||+.||.|||+.||+||||||+|||++. ++.++|+|||++....... ....+
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~--~~~vkL~DfG~a~~~~~~~~~~~~~~~~~ 237 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSE--NNVVKICDFGLARDIYKDPDYVRKGDARL 237 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeC--CCcEEEeccccchhcccCcchhhccCCCC
Confidence 00124788899999999999999999999999999999999984 7789999999987643221 12344
Q ss_pred CccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccch
Q 005590 550 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLY 628 (689)
Q Consensus 550 t~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~ 628 (689)
+..|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+...+..
T Consensus 238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~-------------------------- 291 (337)
T cd05054 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE-------------------------- 291 (337)
T ss_pred CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhc--------------------------
Confidence 678999999999999999999999999999998 99999764332222211100
Q ss_pred hhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 629 YINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 629 ~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
......|. ...+.+.+++.+||+.+|++||++.|+++|
T Consensus 292 -------~~~~~~~~---------~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 292 -------GTRMRAPE---------YATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred -------cCCCCCCc---------cCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00001111 123568899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=286.81 Aligned_cols=245 Identities=24% Similarity=0.366 Sum_probs=196.5
Q ss_pred EEeccCCCCceEEEEECCC---CcEEEEEEeecchhh--hHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEE
Q 005590 387 EYLGSAAFSKVFQAQDLHT---GVDVCLKIIKNDKDF--FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 461 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~t---g~~vAvKii~~~~~~--~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lV 461 (689)
+.||+|+||.||+|.+... +..+++|++...... ...+.+|+++++.++ |+||+++++++......++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG------HPNVVRLLGVCTEEEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcC------CCChheeeeeecCCCceEEE
Confidence 3689999999999998765 899999999875432 466777888887774 67999999999999999999
Q ss_pred EEccc-cchHHHHhhhhcc---CCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 462 CELLR-ANLYEFQKFNQES---GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 462 mEy~~-g~L~~l~~~~~~~---~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
|||+. ++|.+++...... .....+++..++.++.||+.||.|||+.|++|+||||+||+++. ++.++|+|||.+
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~--~~~~~l~dfg~~ 152 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGE--DLVVKISDFGLS 152 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECC--CCcEEEcccccc
Confidence 99995 6788776643211 01233899999999999999999999999999999999999995 688999999998
Q ss_pred ccccCC-----ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 005590 538 CFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEML 611 (689)
Q Consensus 538 ~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~ 611 (689)
...... .....++..|+|||.+....++.++|+|||||++|+|++ |..||......+....+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--------- 223 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG--------- 223 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---------
Confidence 765432 223456788999999998889999999999999999999 69999887665555444310
Q ss_pred hhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
.....|. ..+.++.++|.+||+.||++|||+.|++++
T Consensus 224 -------------------------~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 224 -------------------------YRLPKPE---------YCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred -------------------------CCCCCCc---------cCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0001111 124568899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=286.60 Aligned_cols=239 Identities=32% Similarity=0.503 Sum_probs=196.9
Q ss_pred eccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEEEc
Q 005590 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 464 (689)
Q Consensus 389 LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmEy 464 (689)
||.|+||.||++.+..+++.+|+|++..... ....+..|+.+++.++ |++|+++++.+......++||||
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~~v~e~ 74 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN------HPFIVKLHYAFQTEEKLYLVLEY 74 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC------CCcHHHHHHHeecCCeeEEEEec
Confidence 6999999999999988999999999876432 3456777888887775 67999999999999999999999
Q ss_pred cc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccCC
Q 005590 465 LR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 543 (689)
Q Consensus 465 ~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~ 543 (689)
+. ++|.+++.... .+++..+..++.||+.||.|||+.+++|+||+|+||+++. ++.++|+|||.+......
T Consensus 75 ~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~--~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 75 APGGELFSHLSKEG------RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDA--DGHIKLTDFGLAKELSSE 146 (250)
T ss_pred CCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcC--CCcEEEeecCcceecccC
Confidence 95 67877775432 2889999999999999999999999999999999999985 778999999998765432
Q ss_pred ---ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhh
Q 005590 544 ---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKY 620 (689)
Q Consensus 544 ---~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~ 620 (689)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+...
T Consensus 147 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~------------------ 208 (250)
T cd05123 147 GSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD------------------ 208 (250)
T ss_pred CCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC------------------
Confidence 33456788999999999888999999999999999999999999776654444433210
Q ss_pred hhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCH---HHHHcCCCC
Q 005590 621 FTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA---REALDHPWL 685 (689)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa---~ElL~hpwf 685 (689)
...+|. ..+..+.+||++||..||++|||+ .++++||||
T Consensus 209 -----------------~~~~~~---------~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 209 -----------------PLRFPE---------FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred -----------------CCCCCC---------CCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 011111 114567899999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=327.48 Aligned_cols=252 Identities=24% Similarity=0.341 Sum_probs=194.1
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|++.++||+|+||.||+|++..+|+.||+|++..+. ....++.+|+++++.++ ||||+++++++...+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~------HPNIVkl~~v~~d~~ 75 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI------HPGIVPVYSICSDGD 75 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC------CcCcCeEEEEEeeCC
Confidence 68999999999999999999999999999999987532 23456777888887774 789999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhcc-----CCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEE
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQES-----GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 530 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~l~~~~~~~-----~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vk 530 (689)
..++||||+.| +|.+++...... .....++...+..++.||+.||.|||+.||+||||||+|||++. ++.++
T Consensus 76 ~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~--dg~vK 153 (932)
T PRK13184 76 PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGL--FGEVV 153 (932)
T ss_pred EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcC--CCCEE
Confidence 99999999985 677766432110 11123566778899999999999999999999999999999984 78899
Q ss_pred EEecCCcccccC---------------------CccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005590 531 IIDLGSSCFQTD---------------------NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 589 (689)
Q Consensus 531 L~DFGls~~~~~---------------------~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~ 589 (689)
|+|||++..... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 999999875411 01124689999999999999999999999999999999999999976
Q ss_pred ChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccC
Q 005590 590 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 669 (689)
Q Consensus 590 ~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~d 669 (689)
........... .. .|.. . ......++.+.+++.+||+.|
T Consensus 234 ~~~~ki~~~~~--i~------------------------------------~P~~--~-~p~~~iP~~L~~LI~rcL~~D 272 (932)
T PRK13184 234 KKGRKISYRDV--IL------------------------------------SPIE--V-APYREIPPFLSQIAMKALAVD 272 (932)
T ss_pred cchhhhhhhhh--cc------------------------------------Chhh--c-cccccCCHHHHHHHHHHccCC
Confidence 43322211100 00 0000 0 001123456889999999999
Q ss_pred CCCCcCHHHHHc
Q 005590 670 PQRRPTAREALD 681 (689)
Q Consensus 670 P~kRpTa~ElL~ 681 (689)
|++|++..+.|.
T Consensus 273 P~kR~ss~eeLl 284 (932)
T PRK13184 273 PAERYSSVQELK 284 (932)
T ss_pred hhhCcCHHHHHH
Confidence 999988766553
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=290.84 Aligned_cols=249 Identities=27% Similarity=0.381 Sum_probs=195.9
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~----~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|++.+.||+|+||.||++++..+++.+|||.+... ......+.+|+.+++.+. |+||+++++++...+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~------h~~i~~~~~~~~~~~ 75 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN------HPNVIKYYASFIEDN 75 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc------CCchhhhhheeEeCC
Confidence 4688999999999999999999999999999987642 223356667888877764 679999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
..++||||+.+ +|.+++..... ....+++..++.++.||+.||.|||+.|++|+||||+||+++. ++.++|+|||
T Consensus 76 ~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~--~~~~~l~dfg 151 (267)
T cd08229 76 ELNIVLELADAGDLSRMIKHFKK--QKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA--TGVVKLGDLG 151 (267)
T ss_pred eEEEEEEecCCCCHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC--CCCEEECcch
Confidence 99999999985 67776654322 2234889999999999999999999999999999999999984 7789999999
Q ss_pred CcccccCCc---cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHH--HHHHHHHhhcCCCcHHH
Q 005590 536 SSCFQTDNL---CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVV--MILARIIGMLGPIDLEM 610 (689)
Q Consensus 536 ls~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~--~~l~~i~~~~g~~~~e~ 610 (689)
++....... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.... .....+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------- 223 (267)
T cd08229 152 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-------- 223 (267)
T ss_pred hhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC--------
Confidence 887654322 2346888999999999888999999999999999999999999654321 111111100
Q ss_pred HhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
..+... ....+..+.+||.+||+.||++|||+.++++
T Consensus 224 -----------------------------~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 224 -----------------------------DYPPLP-----SDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred -----------------------------CCCCCC-----cccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 000000 0123457899999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=287.53 Aligned_cols=248 Identities=27% Similarity=0.400 Sum_probs=196.3
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc------hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~------~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
.+|++.+.||+|+||.||++++..+++.+|+|++..+ ......+.+|+.+++.++ |+||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~------h~~i~~~~~~~~~ 75 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR------HDRIVQYYGCLRD 75 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC------CCCcceEEEEEEc
Confidence 4799999999999999999999999999999987542 123346677888888774 6799999999876
Q ss_pred C--CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEE
Q 005590 455 L--EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 531 (689)
Q Consensus 455 ~--~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL 531 (689)
. ..+++||||+.+ +|.+.+.... .+++..+..++.||+.||.|||+.|++|+||||+||+++. ++.++|
T Consensus 76 ~~~~~~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~--~~~~~l 147 (264)
T cd06653 76 PEEKKLSIFVEYMPGGSIKDQLKAYG------ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDS--AGNVKL 147 (264)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--CCCEEE
Confidence 4 468999999975 6766664321 2788889999999999999999999999999999999984 778999
Q ss_pred EecCCcccccC------CccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 005590 532 IDLGSSCFQTD------NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 605 (689)
Q Consensus 532 ~DFGls~~~~~------~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~ 605 (689)
+|||++..... ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||...........+. ..
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~ 224 (264)
T cd06653 148 GDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---TQ 224 (264)
T ss_pred CccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH---cC
Confidence 99999875432 1123467889999999999889999999999999999999999997654443332221 00
Q ss_pred CcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 606 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 606 ~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
.....+| ......+.++|++||+ +|.+|||+.+++.|||.
T Consensus 225 ------------------------------~~~~~~p---------~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 225 ------------------------------PTKPMLP---------DGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred ------------------------------CCCCCCC---------cccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 0001111 1234568899999999 57999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=294.64 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=196.3
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEE-----CCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005590 377 TVIAGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 449 (689)
Q Consensus 377 ~~l~~rY~i~~~LG~G~fG~Vyla~d-----~~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~ 449 (689)
.+..++|.+.+.||+|+||.||++.+ ..++..+|+|+++... .....+.+|+.+++.+. +|+||++++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~ 105 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG-----NHENIVNLL 105 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhcc-----CCCCcceEE
Confidence 34557899999999999999999975 3345689999987542 23456778888888773 378999999
Q ss_pred EEEEeCCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCe
Q 005590 450 DYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 528 (689)
Q Consensus 450 ~~f~~~~~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~ 528 (689)
+++...+..++||||+. ++|.+++..... ..+++..+..++.||+.||.|||+.+|+|+||||+|||++ .++.
T Consensus 106 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~--~~~~ 179 (302)
T cd05055 106 GACTIGGPILVITEYCCYGDLLNFLRRKRE----SFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT--HGKI 179 (302)
T ss_pred EEEecCCceEEEEEcCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEc--CCCe
Confidence 99999999999999998 577777653221 2278999999999999999999999999999999999998 4778
Q ss_pred EEEEecCCcccccCCcc-----ccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhh
Q 005590 529 IKIIDLGSSCFQTDNLC-----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGM 602 (689)
Q Consensus 529 vkL~DFGls~~~~~~~~-----~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~ 602 (689)
++|+|||++........ ...++..|+|||.+.+..++.++||||+||++|+|++ |..||......+.+.++...
T Consensus 180 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~ 259 (302)
T cd05055 180 VKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE 259 (302)
T ss_pred EEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc
Confidence 99999999875432211 1234678999999999899999999999999999998 99999765443332222100
Q ss_pred cCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 603 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 603 ~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
......+ ...+..+.+||.+||..+|++|||+.|+++
T Consensus 260 ---------------------------------~~~~~~~---------~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 260 ---------------------------------GYRMAQP---------EHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred ---------------------------------CCcCCCC---------CCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0000001 112456889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=296.32 Aligned_cols=274 Identities=23% Similarity=0.270 Sum_probs=190.0
Q ss_pred CCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEEEcccc-c
Q 005590 393 AFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA-N 468 (689)
Q Consensus 393 ~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmEy~~g-~ 468 (689)
+++.||++++..+++.||||++... ......+.+|+.+++.++ |+||+++++++...+..+++|||+.+ +
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~------h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQ------HPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcC------CcchhhhhheeecCCeEEEEEeccCCCC
Confidence 5567788887789999999998754 334467778888888774 68999999999999999999999985 5
Q ss_pred hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccCC-----
Q 005590 469 LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN----- 543 (689)
Q Consensus 469 L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~----- 543 (689)
+.+++...... .+++..+..++.||+.||.|||+.+|+||||||+||+++. ++.++|+|||.+......
T Consensus 86 l~~~l~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~--~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 86 CEDLLKTHFPE----GLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSG--DGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred HHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEec--CCceEEecCccceeecccccccc
Confidence 66666533211 2788999999999999999999999999999999999984 788999999987543211
Q ss_pred -----ccccccCccccChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhh
Q 005590 544 -----LCLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 616 (689)
Q Consensus 544 -----~~~~~gt~~Y~APE~l~~--~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~ 616 (689)
.....++..|+|||++.. ..++.++|+||+||++|+|++|..||........+.... .+..+.. +.....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~--~~~~~~~-~~~~~~ 236 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKV--RGTVPCL-LDKSTY 236 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hccCccc-cccCch
Confidence 122356778999999876 358899999999999999999999998754443322211 1111100 000000
Q ss_pred hhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCCC
Q 005590 617 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~~ 688 (689)
... ....... . ....................+..+.+||++||++||++|||+.++|+||||+.-
T Consensus 237 ~~~----~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 237 PLY----EDSMSQS--R-SSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred hhh----cCCcCcc--c-ccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 000 0000000 0 000000000000000111224568899999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=284.09 Aligned_cols=245 Identities=20% Similarity=0.339 Sum_probs=195.8
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 460 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~l 460 (689)
.+|++.+.||.|+||.||++.+. .+..+|+|++.........+.+|+++++.+. |++|+++++++......++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLS------HPKLVQLYGVCTERSPICL 76 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCC------CCCeeeEEEEEccCCceEE
Confidence 47899999999999999999875 4778999998765544567888999888874 6799999999999999999
Q ss_pred EEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccc
Q 005590 461 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539 (689)
Q Consensus 461 VmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 539 (689)
||||+.+ +|.+++.... ..+++..++.++.|++.||.|||+.+++|+||||+||+++. ++.++|+|||.+..
T Consensus 77 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~--~~~~~l~d~g~~~~ 149 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQR-----GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGE--NQVVKVSDFGMTRF 149 (256)
T ss_pred EEEcCCCCcHHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcC--CCeEEECCCcceee
Confidence 9999986 5655554322 12788899999999999999999999999999999999984 77899999999875
Q ss_pred ccCCcc----ccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 540 QTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 540 ~~~~~~----~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
...... ...++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----------- 218 (256)
T cd05112 150 VLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF----------- 218 (256)
T ss_pred cccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC-----------
Confidence 433211 1234568999999998889999999999999999998 999998766555444432110
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
....|. ..+..+.+|+.+||+.+|++|||+.+++++
T Consensus 219 -----------------------~~~~~~---------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 219 -----------------------RLYKPR---------LASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred -----------------------CCCCCC---------CCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 000111 123568899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=287.96 Aligned_cols=246 Identities=21% Similarity=0.288 Sum_probs=194.9
Q ss_pred CcEEEEEEeccCCCCceEEEEECCC---CcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~t---g~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
++|++.+.||+|+||+||+|.+... ...||+|+++... .....+.+|+.+++.++ |+||+++++.+...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~ 77 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD------HPNIIRLEGVVTKS 77 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCC------CCCcceEeEEEecC
Confidence 5799999999999999999988644 4579999987542 23345677888877764 67999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEec
Q 005590 456 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 534 (689)
Q Consensus 456 ~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DF 534 (689)
+..++||||+.+ +|.+++..... .+++..+..++.|++.||.|||+.+|+|+||||+||+++. ++.++|+||
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~--~~~~~l~df 150 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLRENDG-----KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNS--NLVCKVSDF 150 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC--CCCEEECcc
Confidence 999999999985 67777654321 3889999999999999999999999999999999999984 788999999
Q ss_pred CCcccccCCc---c--ccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcH
Q 005590 535 GSSCFQTDNL---C--LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDL 608 (689)
Q Consensus 535 Gls~~~~~~~---~--~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~ 608 (689)
|++....... . ...++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+.....
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~---- 226 (266)
T cd05033 151 GLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR---- 226 (266)
T ss_pred chhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC----
Confidence 9987654211 1 1233567999999998899999999999999999998 9999976655554444321100
Q ss_pred HHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 609 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 609 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
...+ ...+..+.+|+.+||+.+|++||++.|++++
T Consensus 227 ------------------------------~~~~---------~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 227 ------------------------------LPPP---------MDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ------------------------------CCCC---------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0001 1123568899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=284.27 Aligned_cols=249 Identities=28% Similarity=0.372 Sum_probs=196.3
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~----~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|++.+.||+|+||.||+|.+..+|+.||+|.++.. ......+.+|+++++.++ |++|+++++++...+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~------~~~i~~~~~~~~~~~ 75 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD------HPNVIKYLASFIENN 75 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC------CCCeeeeeeeeecCC
Confidence 5899999999999999999999989999999988642 223456778888888774 679999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
..++||||+.+ +|.+++..... ....+++..+..++.||+.||.|||+.||+|+||+|+||+++. ++.++|+|||
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~--~~~~~l~d~~ 151 (267)
T cd08224 76 ELNIVLELADAGDLSRMIKHFKK--QKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITA--TGVVKLGDLG 151 (267)
T ss_pred eEEEEEecCCCCCHHHHHHHhcc--cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECC--CCcEEEeccc
Confidence 99999999985 77777654322 2233889999999999999999999999999999999999984 7789999999
Q ss_pred CcccccCC---ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChH--HHHHHHHHhhcCCCcHHH
Q 005590 536 SSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV--VMILARIIGMLGPIDLEM 610 (689)
Q Consensus 536 ls~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~--~~~l~~i~~~~g~~~~e~ 610 (689)
++...... .....+++.|+|||.+.+..++.++|+|||||++|+|++|..||..... ......+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 222 (267)
T cd08224 152 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK--------- 222 (267)
T ss_pred eeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc---------
Confidence 98654332 2234678899999999998899999999999999999999999965421 111111110
Q ss_pred HhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
......|. ...+..+.++|.+||..+|++|||+.++++
T Consensus 223 -------------------------~~~~~~~~--------~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 223 -------------------------CDYPPLPA--------DHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred -------------------------CCCCCCCh--------hhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00000110 012356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=293.82 Aligned_cols=253 Identities=23% Similarity=0.349 Sum_probs=196.9
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECC-------CCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLH-------TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 449 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~-------tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~ 449 (689)
-.++|.+.++||+|+||.||++++.. ....+|+|++.... .....+..|+.+++.+. .|+||++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~ 84 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG-----KHKNIINLL 84 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhcc-----CCCCeeeEE
Confidence 34789999999999999999998632 34579999987532 23456677888887763 378999999
Q ss_pred EEEEeCCeEEEEEEccc-cchHHHHhhhhc----------cCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 005590 450 DYFYHLEHLFIVCELLR-ANLYEFQKFNQE----------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPEN 518 (689)
Q Consensus 450 ~~f~~~~~l~lVmEy~~-g~L~~l~~~~~~----------~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~N 518 (689)
+++......++||||+. ++|.+++..... ......++...+..++.||+.||.|||+.||+||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 99999999999999998 478777754321 1122348889999999999999999999999999999999
Q ss_pred EEEeccCCCeEEEEecCCcccccCCc-----cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChH
Q 005590 519 ILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAV 592 (689)
Q Consensus 519 ILl~~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~ 592 (689)
||++. ++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 165 ill~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 165 VLVTE--DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred EEEcC--CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 99984 7789999999987543221 11223457999999999889999999999999999999 8999987766
Q ss_pred HHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCC
Q 005590 593 VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 672 (689)
Q Consensus 593 ~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~k 672 (689)
.+....+.... ....+ ...+..+++||.+||..||++
T Consensus 243 ~~~~~~~~~~~----------------------------------~~~~~---------~~~~~~l~~li~~cl~~~p~~ 279 (314)
T cd05099 243 EELFKLLREGH----------------------------------RMDKP---------SNCTHELYMLMRECWHAVPTQ 279 (314)
T ss_pred HHHHHHHHcCC----------------------------------CCCCC---------CCCCHHHHHHHHHHcCCCccc
Confidence 65554432100 00011 012346889999999999999
Q ss_pred CcCHHHHHc
Q 005590 673 RPTAREALD 681 (689)
Q Consensus 673 RpTa~ElL~ 681 (689)
|||+.++++
T Consensus 280 Rps~~~ll~ 288 (314)
T cd05099 280 RPTFKQLVE 288 (314)
T ss_pred CcCHHHHHH
Confidence 999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=285.17 Aligned_cols=248 Identities=22% Similarity=0.321 Sum_probs=196.5
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 377 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 377 ~~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++..++|++.+.||+|+||.||++.+. .+..+|+|.+.........+.+|+.+++.++ |+||+++++.+.. .
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~-~ 73 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQ------HDKLVKLHAVVTK-E 73 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcC------CCCcceEEEEEcC-C
Confidence 456789999999999999999999854 4567999998876555567788988888775 6789999999887 7
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
..++||||+. ++|.+++.... ...++...+..++.||+.||.|||+.|++|+||||+||+++. .+.++|+|||
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~--~~~~~l~d~~ 147 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKSDE----GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA--SLVCKIADFG 147 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHhCC----ccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcC--CCcEEECCCc
Confidence 8899999997 57877775422 223778889999999999999999999999999999999984 7889999999
Q ss_pred CcccccCCcc----ccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 005590 536 SSCFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEM 610 (689)
Q Consensus 536 ls~~~~~~~~----~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~ 610 (689)
.+........ ...++..|+|||++....++.++|+|||||++|+|++ |..||.+.+.......+....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~------- 220 (260)
T cd05073 148 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY------- 220 (260)
T ss_pred ceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC-------
Confidence 8865433211 1234567999999998889999999999999999999 999998765554443332100
Q ss_pred HhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
..+.. ...+..+.+++.+||+.+|++||++.++++
T Consensus 221 -----------------------------~~~~~-------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 221 -----------------------------RMPRP-------ENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred -----------------------------CCCCc-------ccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 00000 122356889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=297.56 Aligned_cols=256 Identities=23% Similarity=0.335 Sum_probs=198.9
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCC-------CcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeE
Q 005590 377 TVIAGRYYVTEYLGSAAFSKVFQAQDLHT-------GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILR 447 (689)
Q Consensus 377 ~~l~~rY~i~~~LG~G~fG~Vyla~d~~t-------g~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~ 447 (689)
++...+|++.+.||+|+||.||+|++... +..+|+|+++... .....+.+|+.+++.+. .|+||++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~ 82 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG-----KHKNIIN 82 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhc-----CCCCeee
Confidence 44557899999999999999999986432 2368999887532 23457778888888774 3689999
Q ss_pred EEEEEEeCCeEEEEEEcccc-chHHHHhhhhc----------cCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 005590 448 LYDYFYHLEHLFIVCELLRA-NLYEFQKFNQE----------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 516 (689)
Q Consensus 448 l~~~f~~~~~l~lVmEy~~g-~L~~l~~~~~~----------~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp 516 (689)
+++++...+..++||||+.+ +|.+++..... ......++...+..++.||+.||.|||+.||+||||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp 162 (334)
T cd05100 83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA 162 (334)
T ss_pred eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 99999999999999999975 78877764321 11233478888999999999999999999999999999
Q ss_pred CcEEEeccCCCeEEEEecCCcccccCCc-----cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 005590 517 ENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPND 590 (689)
Q Consensus 517 ~NILl~~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~ 590 (689)
+|||++. ++.+||+|||+++...... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 163 ~Nill~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 163 RNVLVTE--DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred ceEEEcC--CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 9999984 7789999999987544321 11223467999999999999999999999999999998 89999877
Q ss_pred hHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCC
Q 005590 591 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINP 670 (689)
Q Consensus 591 ~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP 670 (689)
+..+....+.... ....+. .....+.+||.+||+.+|
T Consensus 241 ~~~~~~~~~~~~~----------------------------------~~~~~~---------~~~~~l~~li~~cl~~~p 277 (334)
T cd05100 241 PVEELFKLLKEGH----------------------------------RMDKPA---------NCTHELYMIMRECWHAVP 277 (334)
T ss_pred CHHHHHHHHHcCC----------------------------------CCCCCC---------CCCHHHHHHHHHHcccCh
Confidence 6655544432100 000111 123468899999999999
Q ss_pred CCCcCHHHHHcC
Q 005590 671 QRRPTAREALDH 682 (689)
Q Consensus 671 ~kRpTa~ElL~h 682 (689)
.+|||+.|++++
T Consensus 278 ~~Rps~~ell~~ 289 (334)
T cd05100 278 SQRPTFKQLVED 289 (334)
T ss_pred hhCcCHHHHHHH
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=308.91 Aligned_cols=234 Identities=29% Similarity=0.413 Sum_probs=190.6
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEEEcc
Q 005590 386 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELL 465 (689)
Q Consensus 386 ~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmEy~ 465 (689)
++-||.|+.|.||+++ -.++.||||.++.-+ ..+|+-|++| +|+||+.+.+++...-.+|||||||
T Consensus 129 LeWlGSGaQGAVF~Gr--l~netVAVKKV~elk------ETdIKHLRkL------kH~NII~FkGVCtqsPcyCIiMEfC 194 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGR--LHNETVAVKKVRELK------ETDIKHLRKL------KHPNIITFKGVCTQSPCYCIIMEFC 194 (904)
T ss_pred hhhhccCcccceeeee--ccCceehhHHHhhhh------hhhHHHHHhc------cCcceeeEeeeecCCceeEEeeecc
Confidence 4559999999999998 468999999886322 2455556655 5789999999999999999999999
Q ss_pred c-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccCCc
Q 005590 466 R-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL 544 (689)
Q Consensus 466 ~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~~ 544 (689)
. |-|++.++..+. ++...+..+..+|+.|+.|||...|||||||.-||||.. +..|||+|||.++...+..
T Consensus 195 a~GqL~~VLka~~~------itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~--~d~VKIsDFGTS~e~~~~S 266 (904)
T KOG4721|consen 195 AQGQLYEVLKAGRP------ITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISY--DDVVKISDFGTSKELSDKS 266 (904)
T ss_pred ccccHHHHHhccCc------cCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeec--cceEEeccccchHhhhhhh
Confidence 8 568887765443 888899999999999999999999999999999999995 6679999999998776653
Q ss_pred c--ccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhh
Q 005590 545 C--LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFT 622 (689)
Q Consensus 545 ~--~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~ 622 (689)
+ .++||..|||||++.+.+.+.++|||||||+|||||||..||.+-+...++
T Consensus 267 TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII-------------------------- 320 (904)
T KOG4721|consen 267 TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII-------------------------- 320 (904)
T ss_pred hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE--------------------------
Confidence 3 479999999999999999999999999999999999999999765433221
Q ss_pred ccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCC
Q 005590 623 KEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHP 683 (689)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hp 683 (689)
+......+....|.. .+.-|+=||+.||+..|..||+..++|.|-
T Consensus 321 -------wGVGsNsL~LpvPst---------cP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 321 -------WGVGSNSLHLPVPST---------CPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred -------EeccCCcccccCccc---------CchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 011122333333321 224478899999999999999999999983
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=288.18 Aligned_cols=245 Identities=22% Similarity=0.272 Sum_probs=189.1
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCc----EEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGV----DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 453 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~----~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~ 453 (689)
..+|+++++||+|+||+||+|++..+++ .||+|+++.. ......+.+|+.+++.+ .|+||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~~~~ 79 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV------GSPYVCRLLGICL 79 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc------CCCCCceEEEEEc
Confidence 4689999999999999999999877766 4899998753 22334566677666655 4789999999887
Q ss_pred eCCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEE
Q 005590 454 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 532 (689)
Q Consensus 454 ~~~~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~ 532 (689)
. ...+++|||+. |+|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+
T Consensus 80 ~-~~~~l~~~~~~~g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~--~~~~kL~ 151 (279)
T cd05109 80 T-STVQLVTQLMPYGCLLDYVRENK-----DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKS--PNHVKIT 151 (279)
T ss_pred C-CCcEEEEEcCCCCCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC--CCcEEEC
Confidence 5 45778999998 57777765322 23889999999999999999999999999999999999974 6789999
Q ss_pred ecCCcccccCCccc-----cccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCC
Q 005590 533 DLGSSCFQTDNLCL-----YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 606 (689)
Q Consensus 533 DFGls~~~~~~~~~-----~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~ 606 (689)
|||++......... ..+++.|+|||.+.+..++.++|||||||++|+|++ |..||...........+....
T Consensus 152 dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~--- 228 (279)
T cd05109 152 DFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE--- 228 (279)
T ss_pred CCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC---
Confidence 99998765432211 123567999999999899999999999999999998 999997655444333221100
Q ss_pred cHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 607 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
....+ ...+..+.++|.+||..||++||++.++++
T Consensus 229 -------------------------------~~~~~---------~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 229 -------------------------------RLPQP---------PICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred -------------------------------cCCCC---------ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00000 012356789999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=310.54 Aligned_cols=253 Identities=23% Similarity=0.341 Sum_probs=200.8
Q ss_pred eeeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005590 373 IILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLY 449 (689)
Q Consensus 373 i~~~~~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~ 449 (689)
...+++..+...+.+.||+|.||+||+|++.. .||||+++.+ ....+.+++|+.++++-+ |.||+-+.
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTR------H~NIlLFM 454 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTR------HENILLFM 454 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcc------hhhheeee
Confidence 35667777888999999999999999999754 4999999864 446678889999999886 56899999
Q ss_pred EEEEeCCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCe
Q 005590 450 DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 528 (689)
Q Consensus 450 ~~f~~~~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~ 528 (689)
+++..... .||+-+|+| +|+..+..... .|.....+.|++||++|+.|||.++|||||||..||++.. +++
T Consensus 455 G~~~~p~~-AIiTqwCeGsSLY~hlHv~et-----kfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~--~~k 526 (678)
T KOG0193|consen 455 GACMNPPL-AIITQWCEGSSLYTHLHVQET-----KFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHE--DLK 526 (678)
T ss_pred hhhcCCce-eeeehhccCchhhhhccchhh-----hhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEcc--CCc
Confidence 99988887 999999998 57777664432 2889999999999999999999999999999999999994 699
Q ss_pred EEEEecCCcccccC-----CccccccCccccChhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHH
Q 005590 529 IKIIDLGSSCFQTD-----NLCLYVQSRSYRAPEVIIG---LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 600 (689)
Q Consensus 529 vkL~DFGls~~~~~-----~~~~~~gt~~Y~APE~l~~---~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~ 600 (689)
|||+|||++..... +.....|...|||||++.. .+|+..+||||+||++|||++|..||...+...++-.+-
T Consensus 527 VkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVG 606 (678)
T KOG0193|consen 527 VKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVG 606 (678)
T ss_pred EEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEec
Confidence 99999999865332 2334566778999999974 479999999999999999999999998554444332221
Q ss_pred hhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHH
Q 005590 601 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 680 (689)
Q Consensus 601 ~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL 680 (689)
+ .|..|. +.........++++|+..||..++++||+..+||
T Consensus 607 r------------------------------------G~l~pd---~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il 647 (678)
T KOG0193|consen 607 R------------------------------------GYLMPD---LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLL 647 (678)
T ss_pred c------------------------------------cccCcc---chhhhccCHHHHHHHHHHHHhcCcccCccHHHHH
Confidence 0 011111 1111122345799999999999999999999988
Q ss_pred c
Q 005590 681 D 681 (689)
Q Consensus 681 ~ 681 (689)
.
T Consensus 648 ~ 648 (678)
T KOG0193|consen 648 S 648 (678)
T ss_pred H
Confidence 6
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=292.85 Aligned_cols=251 Identities=20% Similarity=0.250 Sum_probs=194.2
Q ss_pred CcEEEEEEeccCCCCceEEEEECCC-----CcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHT-----GVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 453 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~t-----g~~vAvKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~ 453 (689)
.+|++.+.||+|+||.||+|.+..+ ++.||||++..... ....+.+|+.++..+ .|+||+++++++.
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l------~h~~iv~~~~~~~ 78 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL------QHPNIVCLLGVVT 78 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC------CCCCcCeEEEEEc
Confidence 4678889999999999999987543 57899999975432 234556677666655 4789999999999
Q ss_pred eCCeEEEEEEcccc-chHHHHhhhhc----------cCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEe
Q 005590 454 HLEHLFIVCELLRA-NLYEFQKFNQE----------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIK 522 (689)
Q Consensus 454 ~~~~l~lVmEy~~g-~L~~l~~~~~~----------~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~ 522 (689)
.....++++||+.+ +|.+++..... ......+++..+..++.|++.||.|||+.||+||||||+||+++
T Consensus 79 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 79 KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF 158 (283)
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec
Confidence 99999999999984 67666642211 11123478888999999999999999999999999999999998
Q ss_pred ccCCCeEEEEecCCcccccCCc-----cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHH
Q 005590 523 SYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMIL 596 (689)
Q Consensus 523 ~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l 596 (689)
. ++.+||+|||+++...... ....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+....+.+
T Consensus 159 ~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05091 159 D--KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236 (283)
T ss_pred C--CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 4 7789999999887543221 12345678999999998889999999999999999998 88999887666655
Q ss_pred HHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCH
Q 005590 597 ARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 676 (689)
Q Consensus 597 ~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa 676 (689)
..+..... ..+| ...+..+.+|+.+||+.+|.+||++
T Consensus 237 ~~i~~~~~----------------------------------~~~~---------~~~~~~~~~li~~cl~~~p~~RP~~ 273 (283)
T cd05091 237 EMIRNRQV----------------------------------LPCP---------DDCPAWVYTLMLECWNEFPSRRPRF 273 (283)
T ss_pred HHHHcCCc----------------------------------CCCC---------CCCCHHHHHHHHHHhCCCcccCCCH
Confidence 55431100 0011 1124567899999999999999999
Q ss_pred HHHHcC
Q 005590 677 REALDH 682 (689)
Q Consensus 677 ~ElL~h 682 (689)
+++++.
T Consensus 274 ~~i~~~ 279 (283)
T cd05091 274 KDIHSR 279 (283)
T ss_pred HHHHHH
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=290.99 Aligned_cols=258 Identities=21% Similarity=0.249 Sum_probs=197.2
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCC----------------cEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCC
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTG----------------VDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPAD 441 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg----------------~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~ 441 (689)
.++|++.+.||+|+||.||+|.+..++ ..||+|++..+. .....+.+|+++++.++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~------ 77 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLS------ 77 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcC------
Confidence 368999999999999999999876544 558999987643 34456778888888774
Q ss_pred CCceeEEEEEEEeCCeEEEEEEcccc-chHHHHhhhhcc-----CCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 005590 442 EHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQES-----GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLK 515 (689)
Q Consensus 442 h~~Iv~l~~~f~~~~~l~lVmEy~~g-~L~~l~~~~~~~-----~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLK 515 (689)
|+||+++++++......++||||+.+ +|.+++...... .....+++..++.++.|++.||.|||+.||+|+|||
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk 157 (296)
T cd05051 78 DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157 (296)
T ss_pred CCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence 67999999999999999999999985 677766543210 111248899999999999999999999999999999
Q ss_pred CCcEEEeccCCCeEEEEecCCcccccCC-----ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh--CCCCCC
Q 005590 516 PENILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT--GEVLFP 588 (689)
Q Consensus 516 p~NILl~~~~~~~vkL~DFGls~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt--G~~PF~ 588 (689)
|+||+++. ++.++|+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ +..||.
T Consensus 158 p~Nili~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 158 TRNCLVGK--NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred hhceeecC--CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 99999985 688999999998754322 122345678999999998889999999999999999998 788887
Q ss_pred CChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhccc
Q 005590 589 NDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEI 668 (689)
Q Consensus 589 ~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~ 668 (689)
.....+.+..+....... ......+.. ...+.++.+||.+||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~-------~~~~~~l~~li~~cl~~ 279 (296)
T cd05051 236 HLTDQQVIENAGHFFRDD-----------------------------GRQIYLPRP-------PNCPKDIYELMLECWRR 279 (296)
T ss_pred CcChHHHHHHHHhccccc-----------------------------cccccCCCc-------cCCCHHHHHHHHHHhcc
Confidence 665555444432111000 000000100 11235689999999999
Q ss_pred CCCCCcCHHHHHc
Q 005590 669 NPQRRPTAREALD 681 (689)
Q Consensus 669 dP~kRpTa~ElL~ 681 (689)
||++|||+.|+++
T Consensus 280 ~p~~Rpt~~el~~ 292 (296)
T cd05051 280 DEEDRPTFREIHL 292 (296)
T ss_pred ChhcCCCHHHHHH
Confidence 9999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=313.41 Aligned_cols=250 Identities=27% Similarity=0.479 Sum_probs=206.2
Q ss_pred CcEEE-EEEeccCCCCceEEEEECCCCcEEEEEEee-----cchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005590 381 GRYYV-TEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-----NDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 381 ~rY~i-~~~LG~G~fG~Vyla~d~~tg~~vAvKii~-----~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
+||-. .+.||+|+|-+||+|.|..+|..||--.++ +......++..|+.+|+.|+ |+||+++|+++.+
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~------H~NIirfy~SW~d 112 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK------HPNIIRFYDSWVD 112 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC------CCceeeeeeheec
Confidence 45533 357999999999999999999988733322 33445578889999999875 6799999999997
Q ss_pred CCe--EEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEeccCCCeE
Q 005590 455 LEH--LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCEI 529 (689)
Q Consensus 455 ~~~--l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~g--IvHrDLKp~NILl~~~~~~~v 529 (689)
... +.+|+|.+. |+|..|.+..+. +..+.++.|++||++||.|||++. |||||||-+||+|+. ..|.|
T Consensus 113 ~~n~~in~iTEL~TSGtLr~Y~kk~~~------vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG-~~G~V 185 (632)
T KOG0584|consen 113 TDNKTINFITELFTSGTLREYRKKHRR------VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNG-NLGEV 185 (632)
T ss_pred CCCceeeeeeecccCCcHHHHHHHhcc------CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcC-CcCce
Confidence 654 889999998 788888876655 778899999999999999999985 999999999999986 68999
Q ss_pred EEEecCCcccccCCccc-cccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHHhhcCCCc
Q 005590 530 KIIDLGSSCFQTDNLCL-YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN-DAVVMILARIIGMLGPID 607 (689)
Q Consensus 530 kL~DFGls~~~~~~~~~-~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~-~~~~~~l~~i~~~~g~~~ 607 (689)
||+|+|+|......... .+|||.|||||++. ..|...+||||||+.|.||.|+..||.. .++..++.+++..+.|
T Consensus 186 KIGDLGLAtl~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP-- 262 (632)
T KOG0584|consen 186 KIGDLGLATLLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKP-- 262 (632)
T ss_pred eecchhHHHHhhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCH--
Confidence 99999999887765443 68999999999998 6799999999999999999999999965 4555555555422221
Q ss_pred HHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 608 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 608 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
. ...+..+++.++||.+||.. .+.|+|+.|||+||||+.
T Consensus 263 -----------------------------------~-----sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 263 -----------------------------------A-----ALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred -----------------------------------H-----HhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 1 11234468899999999999 999999999999999975
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=290.01 Aligned_cols=249 Identities=23% Similarity=0.348 Sum_probs=193.0
Q ss_pred cEEEEEEeccCCCCceEEEEECC-----CCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~-----tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
+|++.+.||+|+||.||+|++.. ....+++|.+.... .....+.+|+.+++.+ .||||+++++.+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~ 74 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV------NHPHVIKLYGACSQ 74 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC------CCCCEeeEEEEEec
Confidence 47889999999999999998743 23568999887543 2335677788888766 47899999999999
Q ss_pred CCeEEEEEEccc-cchHHHHhhhhcc------------------CCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 005590 455 LEHLFIVCELLR-ANLYEFQKFNQES------------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLK 515 (689)
Q Consensus 455 ~~~l~lVmEy~~-g~L~~l~~~~~~~------------------~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLK 515 (689)
.+..++||||+. ++|.+++...... .....+++..+..++.|++.||.|||+.||+|||||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik 154 (290)
T cd05045 75 DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA 154 (290)
T ss_pred CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence 999999999998 5677766532211 112347888999999999999999999999999999
Q ss_pred CCcEEEeccCCCeEEEEecCCcccccCCc-----cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 005590 516 PENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589 (689)
Q Consensus 516 p~NILl~~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~ 589 (689)
|+|||++. ++.++|+|||++....... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+
T Consensus 155 p~nill~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 155 ARNVLVAE--GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hheEEEcC--CCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 99999984 7789999999987543221 12244678999999998889999999999999999998 9999987
Q ss_pred ChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccC
Q 005590 590 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 669 (689)
Q Consensus 590 ~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~d 669 (689)
.....+...+... .....| ...+..+.+||.+||+.+
T Consensus 233 ~~~~~~~~~~~~~----------------------------------~~~~~~---------~~~~~~~~~~i~~cl~~~ 269 (290)
T cd05045 233 IAPERLFNLLKTG----------------------------------YRMERP---------ENCSEEMYNLMLTCWKQE 269 (290)
T ss_pred CCHHHHHHHHhCC----------------------------------CCCCCC---------CCCCHHHHHHHHHHccCC
Confidence 6555444332110 000011 122356889999999999
Q ss_pred CCCCcCHHHHHc
Q 005590 670 PQRRPTAREALD 681 (689)
Q Consensus 670 P~kRpTa~ElL~ 681 (689)
|++||++.|+++
T Consensus 270 P~~Rp~~~~i~~ 281 (290)
T cd05045 270 PDKRPTFADISK 281 (290)
T ss_pred cccCCCHHHHHH
Confidence 999999999985
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=290.04 Aligned_cols=250 Identities=23% Similarity=0.286 Sum_probs=194.9
Q ss_pred CcEEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEeecchh-hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~-----~tg~~vAvKii~~~~~-~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
.+|.+.+.||+|+||.||++++. .++..+++|.+..... ....+.+|+.+++.+ .|+||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~ 78 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL------QHEHIVKFYGVCGD 78 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcC------CCCCcceEEEEEcc
Confidence 57999999999999999999853 3456689998875432 234566777777766 46899999999999
Q ss_pred CCeEEEEEEccc-cchHHHHhhhhc----------cCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec
Q 005590 455 LEHLFIVCELLR-ANLYEFQKFNQE----------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 523 (689)
Q Consensus 455 ~~~l~lVmEy~~-g~L~~l~~~~~~----------~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~ 523 (689)
....++||||+. ++|.+++..... ......+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 158 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 999999999997 578777754321 011234888999999999999999999999999999999999985
Q ss_pred cCCCeEEEEecCCcccccCCc-----cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHH
Q 005590 524 YQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILA 597 (689)
Q Consensus 524 ~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~ 597 (689)
++.++|+|||++....... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+.+.
T Consensus 159 --~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 159 --NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred --CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 7889999999987543321 22345778999999999999999999999999999999 999997766555443
Q ss_pred HHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHH
Q 005590 598 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 677 (689)
Q Consensus 598 ~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ 677 (689)
.+..... ...+ ...+..+.+||.+||+.||++|||+.
T Consensus 237 ~~~~~~~----------------------------------~~~~---------~~~~~~~~~li~~~l~~~P~~Rpt~~ 273 (291)
T cd05094 237 CITQGRV----------------------------------LERP---------RVCPKEVYDIMLGCWQREPQQRLNIK 273 (291)
T ss_pred HHhCCCC----------------------------------CCCC---------ccCCHHHHHHHHHHcccChhhCcCHH
Confidence 3321000 0000 11235688999999999999999999
Q ss_pred HHHc
Q 005590 678 EALD 681 (689)
Q Consensus 678 ElL~ 681 (689)
++++
T Consensus 274 ~v~~ 277 (291)
T cd05094 274 EIYK 277 (291)
T ss_pred HHHH
Confidence 9975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=305.66 Aligned_cols=253 Identities=22% Similarity=0.305 Sum_probs=193.5
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCC-----CcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHT-----GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 452 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~t-----g~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f 452 (689)
.++|++.++||+|+||.||+|.+... +..||||+++... .....+.+|+.+++.+. .||||+++++++
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~-----~HpnIv~l~~~~ 110 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLG-----PHLNIVNLLGAC 110 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-----CCCCeeeEEEEE
Confidence 46899999999999999999987433 3479999997532 23456778999888774 378999999999
Q ss_pred EeCCeEEEEEEccc-cchHHHHhhhhcc----------------------------------------------------
Q 005590 453 YHLEHLFIVCELLR-ANLYEFQKFNQES---------------------------------------------------- 479 (689)
Q Consensus 453 ~~~~~l~lVmEy~~-g~L~~l~~~~~~~---------------------------------------------------- 479 (689)
......++||||+. |+|.+++......
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 99999999999998 5777766543210
Q ss_pred --------------------------------------CCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 005590 480 --------------------------------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI 521 (689)
Q Consensus 480 --------------------------------------~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl 521 (689)
.....+++..+..++.||+.||.|||+.+|+||||||+|||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill 270 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence 001237788889999999999999999999999999999999
Q ss_pred eccCCCeEEEEecCCcccccCCc-----cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHH
Q 005590 522 KSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMI 595 (689)
Q Consensus 522 ~~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~ 595 (689)
+. ++.+||+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus 271 ~~--~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 271 AQ--GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred eC--CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 85 7789999999987543221 12345678999999999899999999999999999997 9999976432222
Q ss_pred HHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcC
Q 005590 596 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 675 (689)
Q Consensus 596 l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT 675 (689)
+...+.. ......+ ...+..+.+||.+||+.||++|||
T Consensus 349 ~~~~~~~---------------------------------~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPt 386 (400)
T cd05105 349 FYNKIKS---------------------------------GYRMAKP---------DHATQEVYDIMVKCWNSEPEKRPS 386 (400)
T ss_pred HHHHHhc---------------------------------CCCCCCC---------ccCCHHHHHHHHHHCccCHhHCcC
Confidence 2111100 0000011 112456889999999999999999
Q ss_pred HHHHHc
Q 005590 676 AREALD 681 (689)
Q Consensus 676 a~ElL~ 681 (689)
+.++.+
T Consensus 387 ~~~l~~ 392 (400)
T cd05105 387 FLHLSD 392 (400)
T ss_pred HHHHHH
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=291.71 Aligned_cols=256 Identities=23% Similarity=0.358 Sum_probs=199.5
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEEC-------CCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeE
Q 005590 377 TVIAGRYYVTEYLGSAAFSKVFQAQDL-------HTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILR 447 (689)
Q Consensus 377 ~~l~~rY~i~~~LG~G~fG~Vyla~d~-------~tg~~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~ 447 (689)
.+..++|.+.+.||+|+||.||+|++. ..+..+|+|++... ......+.+|+.+++.+. .|+||++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~i~~ 85 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-----KHKNIIN 85 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhc-----cCCCchh
Confidence 345688999999999999999999752 23457999998753 233456778888888774 3789999
Q ss_pred EEEEEEeCCeEEEEEEcccc-chHHHHhhhhccC----------CCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 005590 448 LYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESG----------GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 516 (689)
Q Consensus 448 l~~~f~~~~~l~lVmEy~~g-~L~~l~~~~~~~~----------~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp 516 (689)
+++++......++||||+.+ +|.+++....... ....++...+..++.||+.||.|||+.||+||||||
T Consensus 86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp 165 (304)
T cd05101 86 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA 165 (304)
T ss_pred eeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 99999999999999999985 7777776432211 123478888999999999999999999999999999
Q ss_pred CcEEEeccCCCeEEEEecCCcccccCCc-----cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 005590 517 ENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPND 590 (689)
Q Consensus 517 ~NILl~~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~ 590 (689)
+||+++. ++.+||+|||++....... ....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus 166 ~Nili~~--~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 166 RNVLVTE--NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred ceEEEcC--CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 9999984 7889999999987654321 11234567999999998889999999999999999998 88999877
Q ss_pred hHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCC
Q 005590 591 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINP 670 (689)
Q Consensus 591 ~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP 670 (689)
+..+....+.... ....+ ...+..+++||.+||..+|
T Consensus 244 ~~~~~~~~~~~~~----------------------------------~~~~~---------~~~~~~~~~li~~cl~~~p 280 (304)
T cd05101 244 PVEELFKLLKEGH----------------------------------RMDKP---------ANCTNELYMMMRDCWHAIP 280 (304)
T ss_pred CHHHHHHHHHcCC----------------------------------cCCCC---------CCCCHHHHHHHHHHcccCh
Confidence 6655554432100 00001 1124568899999999999
Q ss_pred CCCcCHHHHHcC
Q 005590 671 QRRPTAREALDH 682 (689)
Q Consensus 671 ~kRpTa~ElL~h 682 (689)
++|||+.|+++.
T Consensus 281 ~~Rps~~e~l~~ 292 (304)
T cd05101 281 SHRPTFKQLVED 292 (304)
T ss_pred hhCCCHHHHHHH
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=323.00 Aligned_cols=144 Identities=27% Similarity=0.430 Sum_probs=123.7
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|+++++||+|+||+||+|++..+++.||||+++... .....+.+|+.+++.+ .|+||++++.++....
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l------~hp~Iv~~~~~~~~~~ 77 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS------KSPFIVHLYYSLQSAN 77 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc------CCCCcCeEEEEEEECC
Confidence 68999999999999999999999999999999997532 2234566677777665 4789999999999999
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
+.|+||||+. ++|.+++.... .+++..++.|+.||+.||.|||..||+||||||+||||+. ++.+||+|||
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~------~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~--~g~vkL~DFG 149 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYG------YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISN--EGHIKLTDFG 149 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcC--CCCEEEEeCC
Confidence 9999999996 47777765332 2788899999999999999999999999999999999984 7889999999
Q ss_pred Ccc
Q 005590 536 SSC 538 (689)
Q Consensus 536 ls~ 538 (689)
+++
T Consensus 150 ls~ 152 (669)
T cd05610 150 LSK 152 (669)
T ss_pred CCc
Confidence 764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=284.48 Aligned_cols=246 Identities=21% Similarity=0.304 Sum_probs=192.5
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCc---EEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGV---DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~---~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
.++|+..+.||+|+||.||+|.+..++. .+|+|.+... ......+..|+++++.+ .|+||+++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~ 77 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF------SHHNIIRLEGVVTK 77 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC------CCCCeeEEEEEEcc
Confidence 4678999999999999999999876654 6999998754 22344566777777666 47899999999999
Q ss_pred CCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEe
Q 005590 455 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 533 (689)
Q Consensus 455 ~~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~D 533 (689)
.+..++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+||+++. ++.++|+|
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~--~~~~kl~d 150 (268)
T cd05063 78 FKPAMIITEYMENGALDKYLRDHD-----GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNS--NLECKVSD 150 (268)
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcC--CCcEEECC
Confidence 9999999999986 5666654321 23888999999999999999999999999999999999984 77899999
Q ss_pred cCCcccccCCccc------cccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCC
Q 005590 534 LGSSCFQTDNLCL------YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 606 (689)
Q Consensus 534 FGls~~~~~~~~~------~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~ 606 (689)
||++......... ...+..|+|||++.+..++.++|+|||||++|+|++ |..||......+....+....
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~--- 227 (268)
T cd05063 151 FGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF--- 227 (268)
T ss_pred CccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC---
Confidence 9998755332111 112456999999998889999999999999999997 999997766555444442110
Q ss_pred cHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 607 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
..|.. ...+..+.+|+.+||+.+|++||++.++++
T Consensus 228 ---------------------------------~~~~~-------~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 228 ---------------------------------RLPAP-------MDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred ---------------------------------CCCCC-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 00100 012356789999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=283.92 Aligned_cols=242 Identities=24% Similarity=0.375 Sum_probs=192.8
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 460 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~l 460 (689)
++|++.+.||+|+||.||++. .+++.+|+|+++.+.. ...+.+|+.+++.++ |+||+++++++... ..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~-~~~~~~e~~~l~~~~------~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVT-AQAFLEETAVMTKLH------HKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcch-HHHHHHHHHHHHhCC------CCCcCeEEEEEcCC-CcEE
Confidence 679999999999999999986 5788999999876532 356778888887664 67999999998754 5799
Q ss_pred EEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccc
Q 005590 461 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539 (689)
Q Consensus 461 VmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 539 (689)
||||+. ++|.+++..... ..+++..+..++.|++.||.|||+.|++||||||+||+++. ++.++|+|||++..
T Consensus 76 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~--~~~~kl~Dfg~~~~ 149 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGR----ALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSE--DGVAKVSDFGLARV 149 (254)
T ss_pred EEECCCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC--CCcEEECCCcccee
Confidence 999998 478777754321 23788899999999999999999999999999999999984 77899999999876
Q ss_pred ccCCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhh
Q 005590 540 QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 618 (689)
Q Consensus 540 ~~~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~ 618 (689)
..........+..|+|||.+.+..++.++|+|||||++|+|++ |..||......+....+....
T Consensus 150 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------------- 214 (254)
T cd05083 150 GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY--------------- 214 (254)
T ss_pred ccccCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC---------------
Confidence 5443333344678999999998889999999999999999998 999998766554433322100
Q ss_pred hhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 619 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
....+ ...+..+.+||++||+.+|.+||++.++++
T Consensus 215 -------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 215 -------------------RMEPP---------EGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred -------------------CCCCC---------CcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00001 112456889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=289.16 Aligned_cols=254 Identities=28% Similarity=0.396 Sum_probs=194.3
Q ss_pred cEEEEEEeccCCCCceEEEEEC---CCCcEEEEEEeecch-----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 453 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~---~tg~~vAvKii~~~~-----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~ 453 (689)
+|++.+.||+|++|.||++++. .+++.||||+++... .....+.+|+.++..+. +|++|+++++.+.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~-----~~~~i~~~~~~~~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVR-----RCPFLVTLHYAFQ 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhcc-----CCcchhhhheeee
Confidence 4889999999999999999864 467889999987532 12345667888888775 3689999999999
Q ss_pred eCCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEE
Q 005590 454 HLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 532 (689)
Q Consensus 454 ~~~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~ 532 (689)
.....++||||+.+ +|.+.+... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++. ++.++|+
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~--~~~~~l~ 147 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQR------EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDS--EGHVVLT 147 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhhc------CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC--CCCEEEE
Confidence 99999999999985 666665432 12788999999999999999999999999999999999985 6789999
Q ss_pred ecCCcccccCC----ccccccCccccChhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 005590 533 DLGSSCFQTDN----LCLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 606 (689)
Q Consensus 533 DFGls~~~~~~----~~~~~gt~~Y~APE~l~~~~--~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~ 606 (689)
|||++...... .....++..|+|||.+.+.. .+.++|+||||+++|+|++|..||...........+.
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~------ 221 (288)
T cd05583 148 DFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEIS------ 221 (288)
T ss_pred ECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHH------
Confidence 99988654322 12245788999999987655 7889999999999999999999996432111111110
Q ss_pred cHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcC---HHHHHcCC
Q 005590 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT---AREALDHP 683 (689)
Q Consensus 607 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT---a~ElL~hp 683 (689)
+... ......| ...+..+.+||.+||+.||++||| +.++|+||
T Consensus 222 ------------~~~~-------------~~~~~~~---------~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 222 ------------RRIL-------------KSKPPFP---------KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ------------HHHH-------------ccCCCCC---------cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0000 0000111 113456889999999999999998 57789999
Q ss_pred CCCCC
Q 005590 684 WLQHP 688 (689)
Q Consensus 684 wf~~~ 688 (689)
||+..
T Consensus 268 ~~~~~ 272 (288)
T cd05583 268 FFQGI 272 (288)
T ss_pred ccccC
Confidence 99863
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=283.60 Aligned_cols=236 Identities=22% Similarity=0.273 Sum_probs=185.2
Q ss_pred EeccCCCCceEEEEE--CCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEE
Q 005590 388 YLGSAAFSKVFQAQD--LHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVC 462 (689)
Q Consensus 388 ~LG~G~fG~Vyla~d--~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVm 462 (689)
.||+|+||.||+|.+ ..++..+|+|+++... .....+.+|+.+++.+ +|+||+++++++. .+..++||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~-~~~~~lv~ 74 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL------DNPYIVRMIGICE-AESWMLVM 74 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC------CCCCcceEEEEEc-CCCcEEEE
Confidence 589999999999964 4678899999987542 2345667777777766 4789999999875 45678999
Q ss_pred Ecccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccccc
Q 005590 463 ELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 541 (689)
Q Consensus 463 Ey~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~ 541 (689)
||+.+ +|.+++.... .+++..+..++.||+.||.|||+.||+||||||.||+++. ++.++|+|||++....
T Consensus 75 e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~--~~~~kl~Dfg~~~~~~ 146 (257)
T cd05116 75 ELAELGPLNKFLQKNK------HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVT--QHYAKISDFGLSKALG 146 (257)
T ss_pred ecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcC--CCeEEECCCccccccC
Confidence 99985 5777664322 2889999999999999999999999999999999999985 7789999999987654
Q ss_pred CCcc------ccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 542 DNLC------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 542 ~~~~------~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
.... ...++..|+|||.+....++.++|+|||||++|+|++ |..||......+....+...
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~------------ 214 (257)
T cd05116 147 ADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG------------ 214 (257)
T ss_pred CCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC------------
Confidence 3221 1233578999999988889999999999999999998 99999877665554443210
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
....+|. ..++.+.+||++||+.||++||+++++.+
T Consensus 215 ----------------------~~~~~~~---------~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 215 ----------------------ERMECPQ---------RCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred ----------------------CCCCCCC---------CCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 0011111 13456889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=319.07 Aligned_cols=250 Identities=24% Similarity=0.315 Sum_probs=206.2
Q ss_pred cCcEEEEEEeccCCCCceEEEEECC-----CCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 452 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~-----tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f 452 (689)
..+.+..+.||+|+||+||+|+-.. ....||||.++... ....++.+|++++..++ |||||++++++
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~------H~nIVrLlGVC 558 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQ------HPNIVRLLGVC 558 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhcc------CCCeEEEEEEE
Confidence 3556777889999999999997432 34579999998653 34678899999999885 68999999999
Q ss_pred EeCCeEEEEEEccc-cchHHHHhhhhccCC--------CcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec
Q 005590 453 YHLEHLFIVCELLR-ANLYEFQKFNQESGG--------EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 523 (689)
Q Consensus 453 ~~~~~l~lVmEy~~-g~L~~l~~~~~~~~~--------~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~ 523 (689)
..++.+++|+|||. |+|.++++....... ..+++..+...|+.||+.|+.||-++.+|||||-.+|+||.
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg- 637 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG- 637 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec-
Confidence 99999999999998 789999875543211 22388899999999999999999999999999999999999
Q ss_pred cCCCeEEEEecCCcccccCCcccc-----ccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHH
Q 005590 524 YQRCEIKIIDLGSSCFQTDNLCLY-----VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILA 597 (689)
Q Consensus 524 ~~~~~vkL~DFGls~~~~~~~~~~-----~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~ 597 (689)
++..|||+|||+++..-...... .-..+|||||.|.+.+++.++||||+||+|||+++ |..||.+.+..+++.
T Consensus 638 -e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe 716 (774)
T KOG1026|consen 638 -ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE 716 (774)
T ss_pred -cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH
Confidence 48899999999998654333322 33678999999999999999999999999999999 999999999999888
Q ss_pred HHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHH
Q 005590 598 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 677 (689)
Q Consensus 598 ~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ 677 (689)
.|... ++ ...|+ ..+.++.+||..||+.+|++||+..
T Consensus 717 ~i~~g---------------------------------~l-L~~Pe---------~CP~~vY~LM~~CW~~~P~~RPsF~ 753 (774)
T KOG1026|consen 717 CIRAG---------------------------------QL-LSCPE---------NCPTEVYSLMLECWNENPKRRPSFK 753 (774)
T ss_pred HHHcC---------------------------------Cc-ccCCC---------CCCHHHHHHHHHHhhcCcccCCCHH
Confidence 77411 11 12222 2346688999999999999999999
Q ss_pred HHH
Q 005590 678 EAL 680 (689)
Q Consensus 678 ElL 680 (689)
|+-
T Consensus 754 eI~ 756 (774)
T KOG1026|consen 754 EIH 756 (774)
T ss_pred HHH
Confidence 863
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=288.64 Aligned_cols=251 Identities=20% Similarity=0.238 Sum_probs=195.3
Q ss_pred cCcEEEEEEeccCCCCceEEEEECC-----CCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 452 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~-----tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f 452 (689)
.++|++.+.||+|+||.||+|.+.. ++..+|+|++.... .....+.+|+.+++.+. |+||+++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~------h~~iv~~~~~~ 77 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD------HPNIVKLLGVC 77 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcC------CCchheEEEEE
Confidence 3679999999999999999998743 67889999987542 23456777888888774 78999999999
Q ss_pred EeCCeEEEEEEcccc-chHHHHhhhhc----------------cCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 005590 453 YHLEHLFIVCELLRA-NLYEFQKFNQE----------------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLK 515 (689)
Q Consensus 453 ~~~~~l~lVmEy~~g-~L~~l~~~~~~----------------~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLK 515 (689)
......++||||+.+ +|.+++..... ......+++..+..++.||+.||.|||+.+++|||||
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~ 157 (288)
T cd05050 78 AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA 157 (288)
T ss_pred cCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 999999999999985 78777753321 0111237888899999999999999999999999999
Q ss_pred CCcEEEeccCCCeEEEEecCCcccccCC-----ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 005590 516 PENILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589 (689)
Q Consensus 516 p~NILl~~~~~~~vkL~DFGls~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~ 589 (689)
|+||+++. ++.++|+|||++...... ......+..|+|||.+.+..++.++|+|||||++|+|++ |..||.+
T Consensus 158 p~nil~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 158 TRNCLVGE--NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred HhheEecC--CCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999984 788999999998654322 112234567999999998899999999999999999998 8889976
Q ss_pred ChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccC
Q 005590 590 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 669 (689)
Q Consensus 590 ~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~d 669 (689)
....+....+.... ....|. ..+..+.+||.+||+.+
T Consensus 236 ~~~~~~~~~~~~~~----------------------------------~~~~~~---------~~~~~l~~li~~~l~~~ 272 (288)
T cd05050 236 MAHEEVIYYVRDGN----------------------------------VLSCPD---------NCPLELYNLMRLCWSKL 272 (288)
T ss_pred CCHHHHHHHHhcCC----------------------------------CCCCCC---------CCCHHHHHHHHHHcccC
Confidence 65555443332000 000011 12356889999999999
Q ss_pred CCCCcCHHHHHc
Q 005590 670 PQRRPTAREALD 681 (689)
Q Consensus 670 P~kRpTa~ElL~ 681 (689)
|++|||+.|+++
T Consensus 273 p~~Rpt~~el~~ 284 (288)
T cd05050 273 PSDRPSFASINR 284 (288)
T ss_pred cccCCCHHHHHH
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=284.45 Aligned_cols=246 Identities=22% Similarity=0.287 Sum_probs=193.4
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCc---EEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGV---DVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~---~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
..+|++.+.||+|+||.||+|++..++. .+|+|.++... .....+.+|+.+++.+ +||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~ 76 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF------DHPNIIHLEGVVTK 76 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC------CCCCcceEEEEEec
Confidence 3689999999999999999998865443 79999886532 2335667777777766 47899999999999
Q ss_pred CCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEe
Q 005590 455 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 533 (689)
Q Consensus 455 ~~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~D 533 (689)
.+..++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+|||++. ++.++|+|
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~--~~~~~l~d 149 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHD-----GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNS--NLVCKVSD 149 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECC--CCeEEeCC
Confidence 9999999999985 6776665322 23788999999999999999999999999999999999984 78899999
Q ss_pred cCCcccccCCcc------ccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCC
Q 005590 534 LGSSCFQTDNLC------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 606 (689)
Q Consensus 534 FGls~~~~~~~~------~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~ 606 (689)
||++........ ....+..|+|||.+.+..++.++|+|||||++|++++ |..||......+....+.....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-- 227 (267)
T cd05066 150 FGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR-- 227 (267)
T ss_pred CCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc--
Confidence 999876543221 1122457999999998889999999999999999887 9999987665554444321100
Q ss_pred cHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 607 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
.|.. ...++.+.+++.+||+.+|.+||++.++++
T Consensus 228 ----------------------------------~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 228 ----------------------------------LPAP-------MDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ----------------------------------CCCC-------CCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 0110 112356889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=286.72 Aligned_cols=243 Identities=28% Similarity=0.422 Sum_probs=189.1
Q ss_pred EEEEEeccCCCCceEEEEEC----CCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 384 YVTEYLGSAAFSKVFQAQDL----HTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 384 ~i~~~LG~G~fG~Vyla~d~----~tg~~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
.+.+.||.|.||.||+|... ..+..|+||+++.. ......+.+|+++++.++ ||||+++++++...+.
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~------h~ni~~~~g~~~~~~~ 75 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLR------HPNIVKLYGFCIENEP 75 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHS------BTTBE-EEEEEESSSS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccc------cccccccccccccccc
Confidence 46789999999999999976 45678999999653 233577888888888774 6799999999998888
Q ss_pred EEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 458 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 458 l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
.++||||+. |+|.+++.... ...++...+..|+.||+.||.|||+.+++|++|+++||+++. ++.+||+|||+
T Consensus 76 ~~lv~e~~~~g~L~~~L~~~~----~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~--~~~~Kl~~f~~ 149 (259)
T PF07714_consen 76 LFLVMEYCPGGSLDDYLKSKN----KEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDS--NGQVKLSDFGL 149 (259)
T ss_dssp EEEEEE--TTEBHHHHHHHTC----TTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEET--TTEEEEESTTT
T ss_pred ccccccccccccccccccccc----cccccccccccccccccccccccccccccccccccccccccc--ccccccccccc
Confidence 999999998 67888877651 122889999999999999999999999999999999999995 78999999999
Q ss_pred cccccCCc-----cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 005590 537 SCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEM 610 (689)
Q Consensus 537 s~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~ 610 (689)
+....... ........|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~------- 222 (259)
T PF07714_consen 150 SRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ------- 222 (259)
T ss_dssp GEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------
Confidence 87663211 12345678999999998889999999999999999999 789998877766665543110
Q ss_pred HhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
....+ ...+..+.++|..||..||++|||+.++++
T Consensus 223 ---------------------------~~~~~---------~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 223 ---------------------------RLPIP---------DNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ---------------------------ETTSB---------TTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ---------------------------cceec---------cchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 00111 112456889999999999999999999985
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=290.49 Aligned_cols=272 Identities=30% Similarity=0.490 Sum_probs=213.4
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC-----CeE
Q 005590 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL-----EHL 458 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~-----~~l 458 (689)
+-||.|+||.||.+.|..+|+.||+|.+.+- -.......+|+++|...+ |.|++..++..+-. +.+
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFk------HdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFR------HDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhc------cccHHHHHHhcCCCCchHHHHH
Confidence 4589999999999999999999999988642 233467778888888776 45788777776533 357
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcc
Q 005590 459 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 459 ~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~ 538 (689)
|+|+|.|..+|...+-..+ .++...++.+++||++||+|||+.+|.||||||.|+|+++ ++.+||+|||+++
T Consensus 133 YV~TELmQSDLHKIIVSPQ------~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNS--NCvLKICDFGLAR 204 (449)
T KOG0664|consen 133 YVLTELMQSDLHKIIVSPQ------ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNS--NCILKICDFGLAR 204 (449)
T ss_pred HHHHHHHHhhhhheeccCC------CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEecc--CceEEeccccccc
Confidence 8889998877776655333 3888899999999999999999999999999999999996 9999999999998
Q ss_pred cccCCc----cccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 005590 539 FQTDNL----CLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 539 ~~~~~~----~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
...... +..+-|..|+|||++.|. .|+.++||||+|||+.||+..+..|+..++.+.+..|...+|.+..+....
T Consensus 205 vee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 205 TWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred ccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 755432 224568899999999986 499999999999999999999999999999999999999999998887654
Q ss_pred hhhhhhhhhccccchhhhhccccccccCCccchhhhhccC-----CcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQF-----SDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~-----~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
.-+=.+.. + ++ ..+..+++...+.. ...+..+++.+||..||++|++..+++.|+++.+
T Consensus 285 ACEGAk~H-----~---------LR-~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 285 ACEGAKNH-----V---------LR-AGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred HhhhhHHH-----h---------hc-cCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 32211100 0 00 01111122211111 2246789999999999999999999999999864
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=290.78 Aligned_cols=258 Identities=21% Similarity=0.260 Sum_probs=194.1
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCC--------------cEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCC
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTG--------------VDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEH 443 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg--------------~~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~ 443 (689)
..+|++.+.||+|+||.||++++..++ ..||+|++... ......+.+|+++++.++ |+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~------h~ 77 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLK------NP 77 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC------CC
Confidence 368999999999999999999875432 35899998764 223456778888888774 67
Q ss_pred ceeEEEEEEEeCCeEEEEEEcccc-chHHHHhhhhcc------CCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 005590 444 HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQES------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 516 (689)
Q Consensus 444 ~Iv~l~~~f~~~~~l~lVmEy~~g-~L~~l~~~~~~~------~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp 516 (689)
||+++++++......++||||+.+ +|.+++...... .....+++..+..++.||+.||.|||+.|++|+||||
T Consensus 78 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp 157 (295)
T cd05097 78 NIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLAT 157 (295)
T ss_pred CcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccCh
Confidence 999999999999999999999985 677766432110 0112367888999999999999999999999999999
Q ss_pred CcEEEeccCCCeEEEEecCCcccccCCc-----cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh--CCCCCCC
Q 005590 517 ENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT--GEVLFPN 589 (689)
Q Consensus 517 ~NILl~~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt--G~~PF~~ 589 (689)
+||+++. ++.+||+|||++....... ....++..|+|||++.+..++.++|+|||||++|+|++ +..||..
T Consensus 158 ~Nill~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 158 RNCLVGN--HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hhEEEcC--CCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 9999984 7789999999986543221 11234668999999998889999999999999999998 6788877
Q ss_pred ChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccC
Q 005590 590 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 669 (689)
Q Consensus 590 ~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~d 669 (689)
.+..+.+..+....... ........+ ...+..+.+||.+||+.|
T Consensus 236 ~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~---------~~~~~~l~~li~~~l~~~ 279 (295)
T cd05097 236 LSDEQVIENTGEFFRNQ---------------------------GRQIYLSQT---------PLCPSPVFKLMMRCWSRD 279 (295)
T ss_pred cChHHHHHHHHHhhhhc---------------------------cccccCCCC---------CCCCHHHHHHHHHHcCCC
Confidence 66555544432111000 000000000 112456899999999999
Q ss_pred CCCCcCHHHHHc
Q 005590 670 PQRRPTAREALD 681 (689)
Q Consensus 670 P~kRpTa~ElL~ 681 (689)
|++|||++++++
T Consensus 280 p~~RPs~~~i~~ 291 (295)
T cd05097 280 IKDRPTFNKIHH 291 (295)
T ss_pred chhCcCHHHHHH
Confidence 999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=299.20 Aligned_cols=255 Identities=23% Similarity=0.325 Sum_probs=193.0
Q ss_pred ecCcEEEEEEeccCCCCceEEEEE-----CCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 451 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d-----~~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~ 451 (689)
-.++|++.+.||+|+||.||+|++ ..+++.||||+++.+. .....+.+|+.++..+. .|+||++++++
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~niv~~~~~ 79 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-----HHLNVVNLLGA 79 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhcc-----CCccHhhhcce
Confidence 357899999999999999999984 3567899999997532 23456778999888885 36899999998
Q ss_pred EEeC-CeEEEEEEcccc-chHHHHhhhhcc--------------------------------------------------
Q 005590 452 FYHL-EHLFIVCELLRA-NLYEFQKFNQES-------------------------------------------------- 479 (689)
Q Consensus 452 f~~~-~~l~lVmEy~~g-~L~~l~~~~~~~-------------------------------------------------- 479 (689)
+... ...++||||+.+ +|.+++......
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 7654 568999999984 777776532110
Q ss_pred -----------CCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccCCc----
Q 005590 480 -----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL---- 544 (689)
Q Consensus 480 -----------~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~~---- 544 (689)
.....+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~--~~~~kl~dfg~~~~~~~~~~~~~ 237 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE--NNVVKICDFGLARDIYKDPDYVR 237 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcC--CCcEEEEecccccccccCcchhh
Confidence 00123678888999999999999999999999999999999984 7789999999987643221
Q ss_pred -cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhh
Q 005590 545 -CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFT 622 (689)
Q Consensus 545 -~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~ 622 (689)
....++..|+|||.+.+..++.++|+|||||++|+|++ |..||........+.....
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------------------- 296 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK--------------------- 296 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHh---------------------
Confidence 11234567999999999899999999999999999997 9999976432221111100
Q ss_pred ccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 623 KEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
.......|. ..++.+.+++..||+.||++|||+.|+++|
T Consensus 297 ------------~~~~~~~~~---------~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 297 ------------EGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ------------ccCCCCCCC---------CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 000011111 134568899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=284.76 Aligned_cols=246 Identities=21% Similarity=0.302 Sum_probs=193.4
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCc---EEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGV---DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~---~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
++|++.+.||+|+||.||+|.+..+++ .||||++... ......+..|+.+++.+. ||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~------h~ni~~~~~~~~~~ 77 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD------HPNIIHLEGVVTKS 77 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC------CcCcceEEEEECCC
Confidence 569999999999999999999877665 5999998753 333456777888887664 78999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEec
Q 005590 456 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 534 (689)
Q Consensus 456 ~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DF 534 (689)
...++||||+.+ +|.+++.... ..+++..++.++.|++.||.|||+.|++|+||||+||+++. ++.++|+||
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~--~~~~kl~df 150 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNS--NLVCKVSDF 150 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcC--CCcEEECCC
Confidence 999999999986 5666654322 23888999999999999999999999999999999999984 778999999
Q ss_pred CCcccccCCcc--c---cc---cCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCC
Q 005590 535 GSSCFQTDNLC--L---YV---QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGP 605 (689)
Q Consensus 535 Gls~~~~~~~~--~---~~---gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~ 605 (689)
|++........ . .. .+..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+....+....
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~-- 228 (269)
T cd05065 151 GLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY-- 228 (269)
T ss_pred ccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC--
Confidence 98865433211 1 11 1347999999998899999999999999999986 999998766555444432110
Q ss_pred CcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 606 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 606 ~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
..|.. ...+..+.+++.+||+.+|++||++.+++..
T Consensus 229 ----------------------------------~~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 229 ----------------------------------RLPPP-------MDCPTALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred ----------------------------------cCCCc-------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00100 0123557899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=289.19 Aligned_cols=258 Identities=21% Similarity=0.311 Sum_probs=194.2
Q ss_pred cCcEEEEEEeccCCCCceEEEEECC----------------CCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCC
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLH----------------TGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPAD 441 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~----------------tg~~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~ 441 (689)
.++|++.+.||+|+||.||++.+.. ++..+|+|++... ......+.+|+.+++.++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~------ 77 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLK------ 77 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC------
Confidence 4689999999999999999986432 3456899998754 233456778888888775
Q ss_pred CCceeEEEEEEEeCCeEEEEEEccc-cchHHHHhhhhccC-----CCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 005590 442 EHHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESG-----GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLK 515 (689)
Q Consensus 442 h~~Iv~l~~~f~~~~~l~lVmEy~~-g~L~~l~~~~~~~~-----~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLK 515 (689)
|+||+++++++......++||||+. ++|.+++....... ....+++..+..++.||+.||.|||+.||+|+|||
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlk 157 (296)
T cd05095 78 DPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLA 157 (296)
T ss_pred CCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence 6799999999999999999999997 47777765432211 11347788999999999999999999999999999
Q ss_pred CCcEEEeccCCCeEEEEecCCcccccCCc-----cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh--CCCCCC
Q 005590 516 PENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT--GEVLFP 588 (689)
Q Consensus 516 p~NILl~~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt--G~~PF~ 588 (689)
|+|||++. ++.++|+|||++....... .....+..|+|||+..+..++.++|+|||||++|+|++ |..||.
T Consensus 158 p~Nili~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 158 TRNCLVGK--NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred hheEEEcC--CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 99999984 7889999999987543221 11233568999999988889999999999999999998 788997
Q ss_pred CChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhccc
Q 005590 589 NDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEI 668 (689)
Q Consensus 589 ~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~ 668 (689)
..+..+....... ++... .....+|.. ...+..+.+||..||+.
T Consensus 236 ~~~~~~~~~~~~~------------------~~~~~-----------~~~~~~~~~-------~~~~~~~~~li~~cl~~ 279 (296)
T cd05095 236 QLSDEQVIENTGE------------------FFRDQ-----------GRQVYLPKP-------ALCPDSLYKLMLSCWRR 279 (296)
T ss_pred ccChHHHHHHHHH------------------HHhhc-----------cccccCCCC-------CCCCHHHHHHHHHHcCC
Confidence 6655444332210 00000 000001111 11235688999999999
Q ss_pred CCCCCcCHHHHHc
Q 005590 669 NPQRRPTAREALD 681 (689)
Q Consensus 669 dP~kRpTa~ElL~ 681 (689)
||++|||+.++++
T Consensus 280 ~p~~Rp~~~~i~~ 292 (296)
T cd05095 280 NAKERPSFQEIHA 292 (296)
T ss_pred CcccCCCHHHHHH
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=284.70 Aligned_cols=245 Identities=22% Similarity=0.285 Sum_probs=189.4
Q ss_pred EeccCCCCceEEEEECCCCc--EEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEEE
Q 005590 388 YLGSAAFSKVFQAQDLHTGV--DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 463 (689)
Q Consensus 388 ~LG~G~fG~Vyla~d~~tg~--~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmE 463 (689)
.||+|+||.||+|++..++. .+++|.++.. ......+.+|+.++..+. .||||+++++++......++|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~~~~~~~~~~~lv~e 76 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-----HHPNIINLLGACEHRGYLYLAIE 76 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhc-----cCCCeeeEEEEEecCCCceEEEE
Confidence 58999999999999887776 4688887642 334456778888888875 37899999999999999999999
Q ss_pred ccc-cchHHHHhhhhcc----------CCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEE
Q 005590 464 LLR-ANLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 532 (689)
Q Consensus 464 y~~-g~L~~l~~~~~~~----------~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~ 532 (689)
|+. ++|.+++...... .....+++..+..++.|++.||+|||+.|++||||||+||+++. ++.+||+
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~--~~~~kl~ 154 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE--NYVAKIA 154 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcC--CCeEEEC
Confidence 997 5788877643311 11224788999999999999999999999999999999999984 7889999
Q ss_pred ecCCcccccCCcc--ccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHH
Q 005590 533 DLGSSCFQTDNLC--LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLE 609 (689)
Q Consensus 533 DFGls~~~~~~~~--~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e 609 (689)
|||++........ ....+..|+|||++....++.++|+|||||++|+|++ |..||.+.+..+....+...
T Consensus 155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~------- 227 (270)
T cd05047 155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG------- 227 (270)
T ss_pred CCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC-------
Confidence 9999853322111 1223567999999988889999999999999999997 99999766544443332100
Q ss_pred HHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
.....+ ...+..+.+|+.+||..||.+|||+.++++.
T Consensus 228 ---------------------------~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (270)
T cd05047 228 ---------------------------YRLEKP---------LNCDDEVYDLMRQCWREKPYERPSFAQILVS 264 (270)
T ss_pred ---------------------------CCCCCC---------CcCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 000011 0123568899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=280.05 Aligned_cols=243 Identities=26% Similarity=0.381 Sum_probs=195.2
Q ss_pred EEEEEeccCCCCceEEEEECCCC----cEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 384 YVTEYLGSAAFSKVFQAQDLHTG----VDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 384 ~i~~~LG~G~fG~Vyla~d~~tg----~~vAvKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
++.+.||.|+||.||++++...+ ..+|+|++..... ....+..|+.+++.++ |+||+++++++...+.
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~ 75 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLD------HPNIVKLLGVCTEEEP 75 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcC------CCchheEEEEEcCCCe
Confidence 56788999999999999987766 8999999976543 4567778888888773 6799999999999999
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 458 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 458 l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
.+++|||+.+ +|.+++...... .+++..+..++.||+.||.+||+.|++|+||||+||+++. ++.++|+|||+
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~--~~~~~l~dfg~ 149 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPK----ELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGE--NLVVKISDFGL 149 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhc----cCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEcc--CCeEEEcccCC
Confidence 9999999985 677776543221 1789999999999999999999999999999999999985 77899999999
Q ss_pred cccccCCccc----cccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 005590 537 SCFQTDNLCL----YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEML 611 (689)
Q Consensus 537 s~~~~~~~~~----~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~ 611 (689)
+......... ..+++.|+|||.+.+..++.++|+|||||++|+|++ |.+||...+.......+....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-------- 221 (258)
T smart00219 150 SRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY-------- 221 (258)
T ss_pred ceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--------
Confidence 8765433111 225678999999988889999999999999999998 899998766555554432110
Q ss_pred hhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
....+. ..+..+.++|.+||..||++|||+.|+++
T Consensus 222 --------------------------~~~~~~---------~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 222 --------------------------RLPKPE---------NCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred --------------------------CCCCCC---------cCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 000111 13456889999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=287.45 Aligned_cols=259 Identities=22% Similarity=0.231 Sum_probs=188.7
Q ss_pred cCcE-EEEEEeccCCCCceEEEE----ECCCCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005590 380 AGRY-YVTEYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 452 (689)
Q Consensus 380 ~~rY-~i~~~LG~G~fG~Vyla~----d~~tg~~vAvKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f 452 (689)
.+|| ++++.||+|+||+||++. ...+++.||+|+++.... ....+.+|+++++.+. |+||+++++++
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~ 75 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY------HENIVKYKGCC 75 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCC------CCCEeeEEEEE
Confidence 3566 999999999999998864 345688999999976432 3456678888888774 68999999987
Q ss_pred EeC--CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeE
Q 005590 453 YHL--EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 529 (689)
Q Consensus 453 ~~~--~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~v 529 (689)
... ...++||||+.+ +|.+++... .+++..++.++.|++.||.|||+.||+||||||+|||++. ++.+
T Consensus 76 ~~~~~~~~~lv~e~~~~~~l~~~~~~~-------~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~--~~~~ 146 (283)
T cd05080 76 SEQGGKGLQLIMEYVPLGSLRDYLPKH-------KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDN--DRLV 146 (283)
T ss_pred ecCCCceEEEEecCCCCCCHHHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcC--CCcE
Confidence 753 468999999985 566665422 2889999999999999999999999999999999999985 6789
Q ss_pred EEEecCCcccccCCcc------ccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhc
Q 005590 530 KIIDLGSSCFQTDNLC------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 603 (689)
Q Consensus 530 kL~DFGls~~~~~~~~------~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~ 603 (689)
+|+|||++........ ...++..|+|||.+.+..++.++|||||||++|+|++|..||....... ...+....
T Consensus 147 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~ 225 (283)
T cd05080 147 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQ 225 (283)
T ss_pred EEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccc
Confidence 9999999876543211 1234567999999998889999999999999999999999986543211 00000000
Q ss_pred CCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 604 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 604 g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
+...... ..+.. ........| ...+..+.+|+.+||+.+|++|||++++++
T Consensus 226 ~~~~~~~------~~~~~------------~~~~~~~~~---------~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 226 GQMTVVR------LIELL------------ERGMRLPCP---------KNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cccchhh------hhhhh------------hcCCCCCCC---------CCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000000 00000 000000011 123467899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=281.95 Aligned_cols=237 Identities=24% Similarity=0.304 Sum_probs=185.5
Q ss_pred EEeccCCCCceEEEEECCCC---cEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEE
Q 005590 387 EYLGSAAFSKVFQAQDLHTG---VDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 461 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~tg---~~vAvKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lV 461 (689)
++||+|+||.||+|++..++ ..+|+|.+..... ....+.+|+.+++.+ +|+||+++++++. ....++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~-~~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL------DHPCIVRLIGVCK-GEPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc------CCCCeeeEEEEEc-CCceEEE
Confidence 36899999999999875554 7899999886543 445677788887766 4789999999875 4568999
Q ss_pred EEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccc
Q 005590 462 CELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 540 (689)
Q Consensus 462 mEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~ 540 (689)
|||+. ++|.+++.... .+++..+..++.|++.||.|||..+++|+||||+|||++. ++.+||+|||++...
T Consensus 74 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~--~~~~kl~df~~~~~~ 145 (257)
T cd05060 74 MELAPLGPLLKYLKKRR------EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVN--RHQAKISDFGMSRAL 145 (257)
T ss_pred EEeCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcC--CCcEEecccccccee
Confidence 99997 47877775433 3889999999999999999999999999999999999984 788999999998765
Q ss_pred cCCcccc------ccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 005590 541 TDNLCLY------VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 541 ~~~~~~~------~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
....... .++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+....+....
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~---------- 215 (257)
T cd05060 146 GAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE---------- 215 (257)
T ss_pred ecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC----------
Confidence 4322211 12357999999998899999999999999999998 999997765544433332100
Q ss_pred hhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
....| ...+..++++|.+||..+|++|||+.++++
T Consensus 216 ------------------------~~~~~---------~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 216 ------------------------RLPRP---------EECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ------------------------cCCCC---------CCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00011 112356889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=283.69 Aligned_cols=228 Identities=25% Similarity=0.287 Sum_probs=181.1
Q ss_pred CCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEEEcccc-chH
Q 005590 392 AAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLY 470 (689)
Q Consensus 392 G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmEy~~g-~L~ 470 (689)
|.+|+||++++..+++.||+|.++.... ..+|...+.. ..||||+++++++...+..++||||+.+ +|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~------~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIP------HCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHh------cCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence 8899999999999999999999976532 1223222221 2478999999999999999999999985 677
Q ss_pred HHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccCCccccccC
Q 005590 471 EFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQS 550 (689)
Q Consensus 471 ~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~~~~~~gt 550 (689)
+++.... .+++..+..++.||+.||.|||+.||+||||||+||+++. ++.++|+|||.+...........++
T Consensus 74 ~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~ 145 (237)
T cd05576 74 SHISKFL------NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDD--RGHIQLTYFSRWSEVEDSCDGEAVE 145 (237)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcC--CCCEEEecccchhccccccccCCcC
Confidence 7765332 2889999999999999999999999999999999999985 7789999999876665554445667
Q ss_pred ccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhh
Q 005590 551 RSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYI 630 (689)
Q Consensus 551 ~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~ 630 (689)
..|+|||.+.+..++.++|+||+||++|+|++|..||...... +.
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~------------------------------ 190 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----IN------------------------------ 190 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cc------------------------------
Confidence 7899999998888999999999999999999999887432100 00
Q ss_pred hhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCH-----HHHHcCCCC
Q 005590 631 NEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA-----REALDHPWL 685 (689)
Q Consensus 631 ~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa-----~ElL~hpwf 685 (689)
......+|. ..+..+.+||.+||+.||++|||+ +++++||||
T Consensus 191 ----~~~~~~~~~---------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 191 ----THTTLNIPE---------WVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ----cccccCCcc---------cCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 000011221 134568899999999999999996 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=285.73 Aligned_cols=244 Identities=20% Similarity=0.241 Sum_probs=185.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCc----EEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGV----DVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~----~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
++|++.+.||+|+||+||+|.+..+++ .+++|.+.... .....+..|+.++. ...|+||+++++++.
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~------~l~h~~iv~~~~~~~- 79 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMG------SLDHAYIVRLLGICP- 79 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHh------cCCCCCcceEEEEEC-
Confidence 578999999999999999999877776 46777765322 12233444444443 346889999999875
Q ss_pred CCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEe
Q 005590 455 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 533 (689)
Q Consensus 455 ~~~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~D 533 (689)
....++|+||+. ++|.+++..... .+++..+..++.||+.||.|||+.|++||||||+|||++. ++.+||+|
T Consensus 80 ~~~~~~i~e~~~~gsL~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~--~~~~kl~D 152 (279)
T cd05111 80 GASLQLVTQLSPLGSLLDHVRQHRD-----SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKS--DSIVQIAD 152 (279)
T ss_pred CCccEEEEEeCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcC--CCcEEEcC
Confidence 456788999987 678877754322 3889999999999999999999999999999999999984 78899999
Q ss_pred cCCcccccCCc-----cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCc
Q 005590 534 LGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPID 607 (689)
Q Consensus 534 FGls~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~ 607 (689)
||+++...... ....++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.........+...
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~----- 227 (279)
T cd05111 153 FGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG----- 227 (279)
T ss_pred CccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-----
Confidence 99987643221 12345678999999998899999999999999999998 99999876544332222100
Q ss_pred HHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 608 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 608 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
.....+. .....+.+++.+||..||.+|||+.|+++
T Consensus 228 -----------------------------~~~~~~~---------~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 228 -----------------------------ERLAQPQ---------ICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred -----------------------------CcCCCCC---------CCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0000010 12345778999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=286.01 Aligned_cols=251 Identities=24% Similarity=0.308 Sum_probs=194.1
Q ss_pred cCcEEEEEEeccCCCCceEEEEE-----CCCCcEEEEEEeecc-hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 453 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d-----~~tg~~vAvKii~~~-~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~ 453 (689)
..+|++.++||+|+||.||+++. ..++..+|+|.+... ......+.+|+++++.+. |+||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~ 77 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQ------HQHIVRFYGVCT 77 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCC------CCCCceEEEEEe
Confidence 45788999999999999999974 235678999987643 233456777888887664 679999999999
Q ss_pred eCCeEEEEEEccc-cchHHHHhhhhc---------cCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec
Q 005590 454 HLEHLFIVCELLR-ANLYEFQKFNQE---------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 523 (689)
Q Consensus 454 ~~~~l~lVmEy~~-g~L~~l~~~~~~---------~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~ 523 (689)
.....++||||+. ++|.+++..... ......+++..+..++.||+.||.|||+.|++||||||+|||++.
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~ 157 (280)
T cd05092 78 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ 157 (280)
T ss_pred cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcC
Confidence 9999999999998 477777654321 011124788999999999999999999999999999999999984
Q ss_pred cCCCeEEEEecCCcccccCCc-----cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHH
Q 005590 524 YQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILA 597 (689)
Q Consensus 524 ~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~ 597 (689)
++.++|+|||++....... ....+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......+...
T Consensus 158 --~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05092 158 --GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE 235 (280)
T ss_pred --CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence 7889999999986543221 12334678999999999999999999999999999998 999997665554443
Q ss_pred HHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHH
Q 005590 598 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 677 (689)
Q Consensus 598 ~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ 677 (689)
.+.... ....+ ...++.+.+||.+||+.||.+||++.
T Consensus 236 ~~~~~~----------------------------------~~~~~---------~~~~~~~~~li~~cl~~~P~~Rp~~~ 272 (280)
T cd05092 236 CITQGR----------------------------------ELERP---------RTCPPEVYAIMQGCWQREPQQRMVIK 272 (280)
T ss_pred HHHcCc----------------------------------cCCCC---------CCCCHHHHHHHHHHccCChhhCCCHH
Confidence 332100 00011 11235678999999999999999999
Q ss_pred HHHc
Q 005590 678 EALD 681 (689)
Q Consensus 678 ElL~ 681 (689)
++++
T Consensus 273 ~l~~ 276 (280)
T cd05092 273 DIHS 276 (280)
T ss_pred HHHH
Confidence 9985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=277.97 Aligned_cols=238 Identities=24% Similarity=0.366 Sum_probs=187.4
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEEEc
Q 005590 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 464 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmEy 464 (689)
++||+|+||.||++.+.. ++.||+|++..... ....+.+|+++++.+ +|+||+++++++......++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQY------DHPNIVKLIGVCVQKQPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhC------CCCCeEEEEEEEecCCCeEEEEEc
Confidence 368999999999999877 99999999875432 345667788877766 478999999999999999999999
Q ss_pred ccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccCC
Q 005590 465 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 543 (689)
Q Consensus 465 ~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~ 543 (689)
+.+ +|.+++.... ..++...+..++.|++.||.|||+++++||||||+||+++. ++.++|+|||++......
T Consensus 74 ~~~~~l~~~l~~~~-----~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~--~~~~~l~d~g~~~~~~~~ 146 (251)
T cd05041 74 VPGGSLLTFLRKKK-----NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGE--NNVLKISDFGMSREEEGG 146 (251)
T ss_pred CCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcC--CCcEEEeeccccccccCC
Confidence 975 6766664322 13788899999999999999999999999999999999984 788999999998755422
Q ss_pred cc-----ccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhh
Q 005590 544 LC-----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 617 (689)
Q Consensus 544 ~~-----~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~ 617 (689)
.. ....+..|+|||.+.+..++.++|+|||||++|+|++ |..||...........+....
T Consensus 147 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-------------- 212 (251)
T cd05041 147 IYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-------------- 212 (251)
T ss_pred cceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC--------------
Confidence 11 1223556999999998889999999999999999999 899997765444333321100
Q ss_pred hhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 618 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
....| ...+..+.+||.+||..+|++|||+.|+++
T Consensus 213 --------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 213 --------------------RMPAP---------QLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred --------------------CCCCC---------ccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 00011 112456889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=300.29 Aligned_cols=256 Identities=21% Similarity=0.294 Sum_probs=196.9
Q ss_pred eecCcEEEEEEeccCCCCceEEEEEC-----CCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005590 378 VIAGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 450 (689)
Q Consensus 378 ~l~~rY~i~~~LG~G~fG~Vyla~d~-----~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~ 450 (689)
+-.++|.+.++||+|+||.||+|++. .+++.||+|+++... .....+.+|++++..+. .|+||+++++
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-----~H~niv~~~~ 108 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLG-----PHLNIVNLLG 108 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcC-----CCCCeEEEEE
Confidence 33467899999999999999999853 345689999997542 22346778888888774 2789999999
Q ss_pred EEEeCCeEEEEEEccc-cchHHHHhhhhcc--------------------------------------------------
Q 005590 451 YFYHLEHLFIVCELLR-ANLYEFQKFNQES-------------------------------------------------- 479 (689)
Q Consensus 451 ~f~~~~~l~lVmEy~~-g~L~~l~~~~~~~-------------------------------------------------- 479 (689)
++....+.++||||+. |+|.+++......
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 9999999999999998 5788877543210
Q ss_pred ------------------------------------------CCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 005590 480 ------------------------------------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPE 517 (689)
Q Consensus 480 ------------------------------------------~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~ 517 (689)
.....+++..++.++.||+.||.|||+.+|+||||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~ 268 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence 01123677788999999999999999999999999999
Q ss_pred cEEEeccCCCeEEEEecCCcccccCC-----ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCh
Q 005590 518 NILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDA 591 (689)
Q Consensus 518 NILl~~~~~~~vkL~DFGls~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~ 591 (689)
|||++. .+.+||+|||++...... .....+++.|+|||.+.+..++.++|+|||||++|+|++ |..||....
T Consensus 269 NiLl~~--~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 269 NVLICE--GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred eEEEeC--CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999984 778999999998754321 122356788999999998889999999999999999998 899997654
Q ss_pred HHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCC
Q 005590 592 VVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQ 671 (689)
Q Consensus 592 ~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~ 671 (689)
..+.+...+.. ......|. ..+..+.+||.+||..+|.
T Consensus 347 ~~~~~~~~~~~---------------------------------~~~~~~p~---------~~~~~l~~li~~cl~~~P~ 384 (401)
T cd05107 347 MNEQFYNAIKR---------------------------------GYRMAKPA---------HASDEIYEIMQKCWEEKFE 384 (401)
T ss_pred chHHHHHHHHc---------------------------------CCCCCCCC---------CCCHHHHHHHHHHcCCChh
Confidence 33332222100 00001111 1245688999999999999
Q ss_pred CCcCHHHHHcC
Q 005590 672 RRPTAREALDH 682 (689)
Q Consensus 672 kRpTa~ElL~h 682 (689)
+||+++++++.
T Consensus 385 ~RPs~~ell~~ 395 (401)
T cd05107 385 IRPDFSQLVHL 395 (401)
T ss_pred HCcCHHHHHHH
Confidence 99999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=279.02 Aligned_cols=240 Identities=25% Similarity=0.317 Sum_probs=189.2
Q ss_pred EEeccCCCCceEEEEECC-CCc--EEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEE
Q 005590 387 EYLGSAAFSKVFQAQDLH-TGV--DVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 461 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~-tg~--~vAvKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lV 461 (689)
+.||+|++|.||+|.+.. .++ .+|||.+..+.. ....+.+|+.+++.++ |+||+++++.+.. ...++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~-~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD------HENLIRLYGVVLT-HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcC------CCCccceeEEEcC-CeEEEE
Confidence 368999999999999755 333 689999986543 3456677888777664 6899999999988 899999
Q ss_pred EEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccc
Q 005590 462 CELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 540 (689)
Q Consensus 462 mEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~ 540 (689)
|||+. ++|.+.+..... ..+++..++.++.||+.||.|||+.|++|+||||+||+++. ++.+||+|||++...
T Consensus 74 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~--~~~~kl~dfg~~~~~ 147 (257)
T cd05040 74 TELAPLGSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLAS--DDKVKIGDFGLMRAL 147 (257)
T ss_pred EEecCCCcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEec--CCEEEeccccccccc
Confidence 99997 577777654321 23889999999999999999999999999999999999995 688999999998765
Q ss_pred cCCc------cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 005590 541 TDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 541 ~~~~------~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
.... ....++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+....+.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------- 218 (257)
T cd05040 148 PQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE--------- 218 (257)
T ss_pred cccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---------
Confidence 4321 12345678999999999899999999999999999998 9999977666555444421000
Q ss_pred hhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
....+ ...+..+.++|.+||+.+|++|||+.++++
T Consensus 219 ------------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 219 ------------------------RLERP---------EACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ------------------------cCCCC---------ccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 00001 112356889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=280.77 Aligned_cols=247 Identities=22% Similarity=0.310 Sum_probs=192.5
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCC---CcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 453 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~t---g~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~ 453 (689)
-..+|.+.+.||+|+||.||+|.+... ...+|+|...... .....+.+|+.+++.+ +|+||+++++++.
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~------~h~~i~~~~~~~~ 77 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF------DHPHIVKLIGVIT 77 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC------CCCchhceeEEEc
Confidence 346799999999999999999987543 3568999887543 3445677788887777 4689999999886
Q ss_pred eCCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEE
Q 005590 454 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 532 (689)
Q Consensus 454 ~~~~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~ 532 (689)
. ...++||||+. ++|.+++..... .+++..+..++.||+.||.|||+.|++|+||||+||+++. .+.++|+
T Consensus 78 ~-~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~--~~~~~l~ 149 (270)
T cd05056 78 E-NPVWIVMELAPLGELRSYLQVNKY-----SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSS--PDCVKLG 149 (270)
T ss_pred C-CCcEEEEEcCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEec--CCCeEEc
Confidence 5 55789999998 478777754321 2789999999999999999999999999999999999985 7789999
Q ss_pred ecCCcccccCCcc----ccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCc
Q 005590 533 DLGSSCFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPID 607 (689)
Q Consensus 533 DFGls~~~~~~~~----~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~ 607 (689)
|||++........ ...++..|+|||.+....++.++|+|||||++|+|++ |..||......+....+....
T Consensus 150 d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~---- 225 (270)
T cd05056 150 DFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE---- 225 (270)
T ss_pred cCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC----
Confidence 9999876443211 1223467999999988889999999999999999996 999998776555444332100
Q ss_pred HHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 608 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 608 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
....| ...+..+.+||.+||..+|++|||+.+++..
T Consensus 226 ------------------------------~~~~~---------~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 226 ------------------------------RLPMP---------PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred ------------------------------cCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00011 1124568899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=312.96 Aligned_cols=274 Identities=20% Similarity=0.223 Sum_probs=176.1
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCC----CcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE----
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHT----GVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY---- 451 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~t----g~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~---- 451 (689)
.++|.+.+.||+|+||.||+|.+..+ +..||+|.+..... .|..+...+.+.. +.++..++..
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~------~e~~~~e~l~~~~---~~~~~~~~~~~~~~ 201 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA------VEIWMNERVRRAC---PNSCADFVYGFLEP 201 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch------hHHHHHHHHHhhc---hhhHHHHHHhhhcc
Confidence 36899999999999999999999888 99999998764321 1222222222111 1111111111
Q ss_pred --EEeCCeEEEEEEcccc-chHHHHhhhhcc--------------CCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 005590 452 --FYHLEHLFIVCELLRA-NLYEFQKFNQES--------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDL 514 (689)
Q Consensus 452 --f~~~~~l~lVmEy~~g-~L~~l~~~~~~~--------------~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDL 514 (689)
.......++||||+.+ +|.+++...... ..........+..++.||+.||.|||+.+|+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 2345679999999985 577766532110 00011223456789999999999999999999999
Q ss_pred CCCcEEEeccCCCeEEEEecCCcccccC----CccccccCccccChhhhcCC----------------------CCCchh
Q 005590 515 KPENILIKSYQRCEIKIIDLGSSCFQTD----NLCLYVQSRSYRAPEVIIGL----------------------PYDQKI 568 (689)
Q Consensus 515 Kp~NILl~~~~~~~vkL~DFGls~~~~~----~~~~~~gt~~Y~APE~l~~~----------------------~~s~~~ 568 (689)
||+|||++. .++.+||+|||++..... ......+++.|+|||.+... .+..++
T Consensus 282 KP~NILl~~-~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSE-GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeC-CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999984 357899999999975432 22346789999999976432 233456
Q ss_pred hHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhh
Q 005590 569 DLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLE 648 (689)
Q Consensus 569 DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~ 648 (689)
|||||||+||+|+++..|+. .....+.+++...+... ..|.. . .... ..+......
T Consensus 361 DVwSlGviL~el~~~~~~~~--~~~~~~~~~l~~~~~~~-~~~~~---~---~~~~---------------~~~~~~~~~ 416 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYDL-VAWRK---L---VEPR---------------ASPDLRRGF 416 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCcH-HHHHH---h---hccc---------------cchhhhhhh
Confidence 99999999999999776643 22333333332222111 11110 0 0000 000000000
Q ss_pred hhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 649 HHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 649 ~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
...........+||.+||+.||++|||+.|+|+||||++
T Consensus 417 ~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~ 455 (566)
T PLN03225 417 EVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDR 455 (566)
T ss_pred hhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCC
Confidence 111122345679999999999999999999999999986
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=280.14 Aligned_cols=250 Identities=27% Similarity=0.421 Sum_probs=193.3
Q ss_pred cEEEEEEeccCCCCceEEEEECC-CCcEEEEEEeecch-----------hhhHhHHHHHHHHHHhcccCCCCCCceeEEE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLH-TGVDVCLKIIKNDK-----------DFFDQSLDEIKLLKLVNKNDPADEHHILRLY 449 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~-tg~~vAvKii~~~~-----------~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~ 449 (689)
.|++.+.||+|+||.||++++.. +++.+|+|.+.... ........|+.++... .+|+||++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~h~~i~~~~ 75 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ-----LRHPNIVRYY 75 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhc-----CCCCCeeeEE
Confidence 47889999999999999999877 78899999876321 1123344455544432 3588999999
Q ss_pred EEEEeCCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEeccCCC
Q 005590 450 DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRC 527 (689)
Q Consensus 450 ~~f~~~~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~-~gIvHrDLKp~NILl~~~~~~ 527 (689)
+++...++.++||||+.+ +|.+++...... ...+++..++.++.|++.||.|||+ .+++|+||+|+||+++. ++
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~--~~ 151 (269)
T cd08528 76 KTFLENDRLYIVMDLIEGAPLGEHFNSLKEK--KQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGE--DD 151 (269)
T ss_pred eeEccCCeEEEEEecCCCCcHHHHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECC--CC
Confidence 999999999999999985 676666432211 2238899999999999999999996 78999999999999985 77
Q ss_pred eEEEEecCCcccccCC--ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 005590 528 EIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 605 (689)
Q Consensus 528 ~vkL~DFGls~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~ 605 (689)
.++|+|||.+...... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+......
T Consensus 152 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (269)
T cd08528 152 KVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE 231 (269)
T ss_pred cEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC
Confidence 8999999998765443 23356788999999999888999999999999999999999999776555444433211000
Q ss_pred CcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 606 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 606 ~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
..+. ...++.+.+||.+||+.||++||++.|+..+
T Consensus 232 ----------------------------------~~~~--------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 232 ----------------------------------PLPE--------GMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ----------------------------------cCCc--------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 0000 1123568899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=334.05 Aligned_cols=251 Identities=31% Similarity=0.433 Sum_probs=203.5
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
.-||+-..+||.|.||.||.|.+..+|+..|+|-++.. ....+.+.+|..++..++ |||++++|++-.+.+
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~ln------HpNlV~YyGVEvHRe 1307 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLN------HPNLVRYYGVEVHRE 1307 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhcc------CccccccCceeecHH
Confidence 45788889999999999999999999999999977643 344567788888888886 679999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
..+|.||||.+ +|.++...... ..+...+.+..|++.||.|||+.|||||||||.||+++. +|.||++|||
T Consensus 1308 kv~IFMEyC~~GsLa~ll~~gri------~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~--~g~iK~~DFG 1379 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHGRI------EDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDF--NGLIKYGDFG 1379 (1509)
T ss_pred HHHHHHHHhccCcHHHHHHhcch------hhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeec--CCcEEeeccc
Confidence 99999999995 67666654432 567778899999999999999999999999999999995 7899999999
Q ss_pred CcccccCC-------ccccccCccccChhhhcCC---CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 005590 536 SSCFQTDN-------LCLYVQSRSYRAPEVIIGL---PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 605 (689)
Q Consensus 536 ls~~~~~~-------~~~~~gt~~Y~APE~l~~~---~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~ 605 (689)
.|...... ....+||+.|||||++.+. +...+.|||||||++.||+||+.||...+.+-.+...++
T Consensus 1380 sa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~---- 1455 (1509)
T KOG4645|consen 1380 SAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA---- 1455 (1509)
T ss_pred ceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh----
Confidence 99765443 2346899999999999764 466799999999999999999999976443322221111
Q ss_pred CcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 606 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 606 ~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
.+-..++|+. .+++.++||.+||+.||++|+++.|+|+|-|-
T Consensus 1456 -----------------------------~gh~Pq~P~~---------ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~ 1497 (1509)
T KOG4645|consen 1456 -----------------------------AGHKPQIPER---------LSSEGRDFLEHCLEQDPKMRWTASQLLEHAFG 1497 (1509)
T ss_pred -----------------------------ccCCCCCchh---------hhHhHHHHHHHHHhcCchhhhHHHHHHHhhcc
Confidence 1112233332 34567899999999999999999999999875
Q ss_pred C
Q 005590 686 Q 686 (689)
Q Consensus 686 ~ 686 (689)
.
T Consensus 1498 ~ 1498 (1509)
T KOG4645|consen 1498 K 1498 (1509)
T ss_pred c
Confidence 4
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=282.18 Aligned_cols=245 Identities=21% Similarity=0.317 Sum_probs=188.2
Q ss_pred EeccCCCCceEEEEECCCC------cEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEE
Q 005590 388 YLGSAAFSKVFQAQDLHTG------VDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 459 (689)
Q Consensus 388 ~LG~G~fG~Vyla~d~~tg------~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~ 459 (689)
.||+|+||.||++++.... +.+|+|.+.... .....+.+|+.+++.+ +|+||+++++++......+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~ 75 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF------NHPNIVKLLGVCLLNEPQY 75 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc------CCCCeeeEeeeecCCCCeE
Confidence 5899999999999876443 689999886543 3345667777777766 4789999999999999999
Q ss_pred EEEEccc-cchHHHHhhhhccC-CCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccC---CCeEEEEec
Q 005590 460 IVCELLR-ANLYEFQKFNQESG-GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ---RCEIKIIDL 534 (689)
Q Consensus 460 lVmEy~~-g~L~~l~~~~~~~~-~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~---~~~vkL~DF 534 (689)
+||||+. ++|.+++....... ....+++..+..++.||+.||.|||+.+++|+||||+||+++.+. ...++|+||
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCc
Confidence 9999998 47777775432211 233478899999999999999999999999999999999998522 127999999
Q ss_pred CCcccccCC-----ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcH
Q 005590 535 GSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDL 608 (689)
Q Consensus 535 Gls~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~ 608 (689)
|++...... ......+..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+...
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~------ 229 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG------ 229 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC------
Confidence 998654321 112344678999999999899999999999999999998 99999876555444333100
Q ss_pred HHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 609 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 609 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
.....+ ...+..+.+||.+||..+|.+||+++++++
T Consensus 230 ----------------------------~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 230 ----------------------------GRLQKP---------ENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ----------------------------CccCCc---------ccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 000011 112356789999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=281.64 Aligned_cols=252 Identities=21% Similarity=0.313 Sum_probs=196.1
Q ss_pred CcEEEEEEeccCCCCceEEEEECC-----CCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 453 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~-----tg~~vAvKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~ 453 (689)
.+|++++.||+|+||+||+|+.+. ..+.+++|.+..... ....+.+|+++++.++ |+||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~ 78 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS------HKNVVRLLGLCR 78 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcC------CcceeeeEEEEC
Confidence 679999999999999999999653 356799998865432 3466788999988875 679999999999
Q ss_pred eCCeEEEEEEccc-cchHHHHhhhhccC---CCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeE
Q 005590 454 HLEHLFIVCELLR-ANLYEFQKFNQESG---GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 529 (689)
Q Consensus 454 ~~~~l~lVmEy~~-g~L~~l~~~~~~~~---~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~v 529 (689)
.....++||||+. ++|.+++....... ....+++..+..++.||+.||.|||+.+|+||||||+||+++. ++.+
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~--~~~~ 156 (275)
T cd05046 79 EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSS--QREV 156 (275)
T ss_pred CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeC--CCcE
Confidence 8899999999998 57777775443111 1124899999999999999999999999999999999999985 7789
Q ss_pred EEEecCCcccccCC----ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcC
Q 005590 530 KIIDLGSSCFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLG 604 (689)
Q Consensus 530 kL~DFGls~~~~~~----~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g 604 (689)
+|+|||++...... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||........+..+...
T Consensus 157 ~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~-- 234 (275)
T cd05046 157 KVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG-- 234 (275)
T ss_pred EEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--
Confidence 99999987643221 122345677999999988889999999999999999999 88999765444433332100
Q ss_pred CCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 605 ~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
......+ ...+..+.++|.+||+.+|++|||+.|+++.
T Consensus 235 -------------------------------~~~~~~~---------~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 235 -------------------------------KLELPVP---------EGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred -------------------------------CcCCCCC---------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 0000001 1223568899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-32 Score=278.36 Aligned_cols=238 Identities=20% Similarity=0.262 Sum_probs=184.1
Q ss_pred EeccCCCCceEEEEEC--CCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEEE
Q 005590 388 YLGSAAFSKVFQAQDL--HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 463 (689)
Q Consensus 388 ~LG~G~fG~Vyla~d~--~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmE 463 (689)
.||+|+||.||+|.+. ..+..||+|++.... .....+.+|+.+++.++ |+||+++++++. ....++|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~------h~~ii~~~~~~~-~~~~~lv~e 74 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLD------NPYIVRMIGVCE-AEALMLVME 74 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcC------CCCeEEEEEEEc-CCCeEEEEE
Confidence 3899999999999764 445679999987643 23456778888888774 689999999875 457899999
Q ss_pred cccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccC
Q 005590 464 LLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 542 (689)
Q Consensus 464 y~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~ 542 (689)
|+.+ +|.+++.... ..+++..++.++.||+.||.|||++|++||||||+|||++. ++.+||+|||++.....
T Consensus 75 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~--~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 75 MASGGPLNKFLSGKK-----DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVN--QHYAKISDFGLSKALGA 147 (257)
T ss_pred eCCCCCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcC--CCcEEeccCCccccccC
Confidence 9985 6666654322 23889999999999999999999999999999999999984 77899999999875433
Q ss_pred Ccc----c--cccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 005590 543 NLC----L--YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615 (689)
Q Consensus 543 ~~~----~--~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~ 615 (689)
... . ..++..|+|||.+.+..++.++|+|||||++|+|++ |..||......+....+....
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------------ 215 (257)
T cd05115 148 DDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK------------ 215 (257)
T ss_pred CccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC------------
Confidence 211 1 122467999999998889999999999999999996 999998765555443332110
Q ss_pred hhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
...+|. ..++++.++|.+||..+|++||++.++++.
T Consensus 216 ----------------------~~~~~~---------~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~ 251 (257)
T cd05115 216 ----------------------RLDCPA---------ECPPEMYALMKDCWIYKWEDRPNFAKVEER 251 (257)
T ss_pred ----------------------CCCCCC---------CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001111 124678899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=280.57 Aligned_cols=240 Identities=19% Similarity=0.234 Sum_probs=176.8
Q ss_pred EEeccCCCCceEEEEECC------------CCcEEEEEEeecchh-hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005590 387 EYLGSAAFSKVFQAQDLH------------TGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 453 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~------------tg~~vAvKii~~~~~-~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~ 453 (689)
+.||+|+||.||+++... ....+++|++..... ....+..|+.+++.+ .||||+++++++.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l------~hp~iv~~~~~~~ 74 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV------SHKHIVLLYGVCV 74 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC------CCCCEeeEEEEEe
Confidence 368999999999998432 233588898765432 223455566666655 4789999999999
Q ss_pred eCCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCC-----Ce
Q 005590 454 HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-----CE 528 (689)
Q Consensus 454 ~~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~-----~~ 528 (689)
.....++||||+.++.++.+..... ..+++..+..++.||+.||.|||+.||+||||||+|||++.+.. ..
T Consensus 75 ~~~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~ 150 (262)
T cd05077 75 RDVENIMVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPF 150 (262)
T ss_pred cCCCCEEEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCce
Confidence 9899999999999755444432211 23888999999999999999999999999999999999974221 24
Q ss_pred EEEEecCCcccccCCccccccCccccChhhhc-CCCCCchhhHHHHHHHHHHHH-hCCCCCCCChHHHHHHHHHhhcCCC
Q 005590 529 IKIIDLGSSCFQTDNLCLYVQSRSYRAPEVII-GLPYDQKIDLWSLGCILAELW-TGEVLFPNDAVVMILARIIGMLGPI 606 (689)
Q Consensus 529 vkL~DFGls~~~~~~~~~~~gt~~Y~APE~l~-~~~~s~~~DIwSLGvil~eLl-tG~~PF~~~~~~~~l~~i~~~~g~~ 606 (689)
++++|||++...... ....++..|+|||++. +..++.++|||||||++|+|+ +|..||......+......
T Consensus 151 ~~l~d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~------ 223 (262)
T cd05077 151 IKLSDPGIPITVLSR-QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYE------ 223 (262)
T ss_pred eEeCCCCCCccccCc-ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHh------
Confidence 899999998654322 2345788899999987 466899999999999999998 5888887643322211000
Q ss_pred cHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 607 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
. ... .. .....++.+||.+||+.||++||++.++|++
T Consensus 224 ----------------~------------~~~--~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 224 ----------------G------------QCM--LV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ----------------c------------Ccc--CC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 0 000 00 0112457899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=278.87 Aligned_cols=237 Identities=22% Similarity=0.281 Sum_probs=181.0
Q ss_pred EEeccCCCCceEEEEECCCC----------cEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 387 EYLGSAAFSKVFQAQDLHTG----------VDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~tg----------~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
+.||+|+||.||+|.+..++ ..+++|++.........+.+|+.+++.+ .|+||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~-~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQL------SHKHLVKLYGVCVR-D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcC------CCcchhheeeEEec-C
Confidence 36899999999999987766 3588888776543345666777777665 47899999999888 7
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCC-----CeEE
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-----CEIK 530 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~-----~~vk 530 (689)
..++||||+.+ +|.+++..... .++...+..++.||+.||.|||+.||+||||||+|||++.+.. ..++
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~k 148 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREKN-----NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIK 148 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEE
Confidence 78999999985 56666554321 3888999999999999999999999999999999999985321 1799
Q ss_pred EEecCCcccccCCccccccCccccChhhhcCC--CCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCc
Q 005590 531 IIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL--PYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPID 607 (689)
Q Consensus 531 L~DFGls~~~~~~~~~~~gt~~Y~APE~l~~~--~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~ 607 (689)
|+|||++..... .....++..|+|||++.+. .++.++|+|||||++|+|++ |..||.............
T Consensus 149 l~Dfg~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~------- 220 (259)
T cd05037 149 LSDPGIPITVLS-REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ------- 220 (259)
T ss_pred eCCCCccccccc-ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-------
Confidence 999999876544 2234567789999999876 78999999999999999999 578886543222111100
Q ss_pred HHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 608 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 608 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
.....+.. ....+.+||.+||..+|++|||+.++++
T Consensus 221 -----------------------------~~~~~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 221 -----------------------------DQHRLPMP---------DCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -----------------------------cCCCCCCC---------CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00001100 0145789999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=280.29 Aligned_cols=245 Identities=22% Similarity=0.301 Sum_probs=192.7
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCc----EEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGV----DVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 453 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~----~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~ 453 (689)
..+|++.+.||+|+||+||+|.+..+|+ .+|+|.+.... .....+.+|+.+++.+ .|+||+++++++.
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~ 79 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV------DHPHVVRLLGICL 79 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC------CCCCcceEEEEEe
Confidence 4689999999999999999999876665 58999887653 2345666788888776 4789999999988
Q ss_pred eCCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEE
Q 005590 454 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 532 (689)
Q Consensus 454 ~~~~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~ 532 (689)
. ...++||||+. ++|.+++..... .+++..+..++.||+.||.|||+.||+|+||||+||+++. ++.+||+
T Consensus 80 ~-~~~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~--~~~~kL~ 151 (279)
T cd05057 80 S-SQVQLITQLMPLGCLLDYVRNHKD-----NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKT--PQHVKIT 151 (279)
T ss_pred c-CceEEEEecCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcC--CCeEEEC
Confidence 7 78999999997 467776653321 2889999999999999999999999999999999999984 7789999
Q ss_pred ecCCcccccCCccc-----cccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCC
Q 005590 533 DLGSSCFQTDNLCL-----YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 606 (689)
Q Consensus 533 DFGls~~~~~~~~~-----~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~ 606 (689)
|||.+......... ..++..|+|||.+....++.++|+|||||++|++++ |..||......+....+....
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--- 228 (279)
T cd05057 152 DFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE--- 228 (279)
T ss_pred CCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC---
Confidence 99998765432211 122467999999988889999999999999999998 999998776555444332100
Q ss_pred cHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 607 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
....|. ..+..+.+++.+||..||.+|||+.++++
T Consensus 229 -------------------------------~~~~~~---------~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 229 -------------------------------RLPQPP---------ICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred -------------------------------CCCCCC---------CCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000111 12345789999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-32 Score=280.73 Aligned_cols=252 Identities=19% Similarity=0.246 Sum_probs=194.5
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECC----CCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLH----TGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 452 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~----tg~~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f 452 (689)
-.++|++.+.||+|+||.||+|.+.. ++..|++|++... ......+.+|+.+++.+ .|+||+++++++
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l------~h~ni~~~~~~~ 77 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL------SHQNILPILHVC 77 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC------CCCCCCeEEEEE
Confidence 35789999999999999999999865 3688999988753 23345566777777766 478999999987
Q ss_pred Ee-CCeEEEEEEccc-cchHHHHhhhhccC--CCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCe
Q 005590 453 YH-LEHLFIVCELLR-ANLYEFQKFNQESG--GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 528 (689)
Q Consensus 453 ~~-~~~l~lVmEy~~-g~L~~l~~~~~~~~--~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~ 528 (689)
.. ....+++++|+. ++|.+++....... ....+++..+..++.||+.||.|||+.+++|+||||+||+++. ++.
T Consensus 78 ~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~--~~~ 155 (280)
T cd05043 78 IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDE--ELQ 155 (280)
T ss_pred ecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcC--CCc
Confidence 65 467899999997 57777765432211 1134889999999999999999999999999999999999984 788
Q ss_pred EEEEecCCcccccCCc-----cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhh
Q 005590 529 IKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGM 602 (689)
Q Consensus 529 vkL~DFGls~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~ 602 (689)
+||+|||+++...... ....++..|+|||++.+..++.++|||||||++|++++ |+.||...+..+....+...
T Consensus 156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 235 (280)
T cd05043 156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG 235 (280)
T ss_pred EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC
Confidence 9999999987543221 11234667999999999899999999999999999999 99999876555443332210
Q ss_pred cCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 603 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 603 ~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
. .++.. ...+..+.++|.+||..||++|||+.++++
T Consensus 236 ~------------------------------------~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 236 Y------------------------------------RLAQP-------INCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred C------------------------------------CCCCC-------CcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 00000 012356889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=283.40 Aligned_cols=239 Identities=19% Similarity=0.300 Sum_probs=180.1
Q ss_pred EEeccCCCCceEEEEECCCCc-------EEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 387 EYLGSAAFSKVFQAQDLHTGV-------DVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~tg~-------~vAvKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
+.||+|+||+||+|.+...+. .+|+|++.... ...+.+..|..+++.+ +|+||+++++++......
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~------~h~~iv~~~~~~~~~~~~ 74 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL------SHKHLVLNYGVCVCGDES 74 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC------CCCChhheeeEEEeCCCc
Confidence 368999999999998765544 38888876543 2334556677776655 478999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCC------CeEEE
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR------CEIKI 531 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~------~~vkL 531 (689)
++||||+.+ +|..++..... .+++..+..++.||+.||.|||+.||+||||||+||+++.+.. +.+++
T Consensus 75 ~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l 149 (258)
T cd05078 75 IMVQEYVKFGSLDTYLKKNKN-----LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKL 149 (258)
T ss_pred EEEEecCCCCcHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEe
Confidence 999999986 56666653322 3788889999999999999999999999999999999985322 24899
Q ss_pred EecCCcccccCCccccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhC-CCCCCCChHHHHHHHHHhhcCCCcHH
Q 005590 532 IDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTG-EVLFPNDAVVMILARIIGMLGPIDLE 609 (689)
Q Consensus 532 ~DFGls~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG-~~PF~~~~~~~~l~~i~~~~g~~~~e 609 (689)
+|||.+..... .....+++.|+|||++.+ ..++.++|+|||||++|+|++| .+||.............
T Consensus 150 ~d~g~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~--------- 219 (258)
T cd05078 150 SDPGISITVLP-KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE--------- 219 (258)
T ss_pred cccccccccCC-chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH---------
Confidence 99998865433 223567889999999986 4588999999999999999998 56665443322211110
Q ss_pred HHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
....+|. .....+.+||.+||+.||++|||++++++.
T Consensus 220 ---------------------------~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 220 ---------------------------DRHQLPA---------PKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred ---------------------------ccccCCC---------CCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 0011111 112457899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=274.29 Aligned_cols=239 Identities=24% Similarity=0.345 Sum_probs=186.3
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEEEc
Q 005590 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 464 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmEy 464 (689)
++||+|+||.||++.. .++..+|+|++.... .....+.+|+.+++.+ +|+||+++++++......++||||
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQY------DHPNIVKLIGVCTQRQPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC------CCCCcCeEEEEEecCCccEEEEEC
Confidence 3689999999999985 468899999987542 2233566777777766 478999999999999999999999
Q ss_pred ccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccCC
Q 005590 465 LRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 543 (689)
Q Consensus 465 ~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~ 543 (689)
+.+ +|.+++.... ..+.+..+..++.|++.||.|||+.|++|+||||+||+++. ++.++|+|||++......
T Consensus 74 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~--~~~~~l~d~g~~~~~~~~ 146 (250)
T cd05085 74 VPGGDFLSFLRKKK-----DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGE--NNVLKISDFGMSRQEDDG 146 (250)
T ss_pred CCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcC--CCeEEECCCccceecccc
Confidence 985 6666654221 12788999999999999999999999999999999999984 778999999998654332
Q ss_pred cc----ccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhh
Q 005590 544 LC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIY 618 (689)
Q Consensus 544 ~~----~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~ 618 (689)
.. ...++..|+|||++.+..++.++|+||||+++|+|++ |..||...........+....
T Consensus 147 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~--------------- 211 (250)
T cd05085 147 IYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY--------------- 211 (250)
T ss_pred ccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC---------------
Confidence 21 1233567999999998889999999999999999998 999998765544433332100
Q ss_pred hhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 619 KYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
....+ ...+..+.+|+.+||..+|++|||+.|+++.
T Consensus 212 -------------------~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 212 -------------------RMSCP---------QKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred -------------------CCCCC---------CCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 00011 1123568899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=279.91 Aligned_cols=262 Identities=21% Similarity=0.282 Sum_probs=189.2
Q ss_pred CcEEEEEEeccCCCCceEEEE----ECCCCcEEEEEEeecch-hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQ----DLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~----d~~tg~~vAvKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
.+|++++.||+|+||.||++. +..+++.||+|.+.... .....+.+|+++++.++ |+||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~~~~ 77 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQ------HDNIVKYKGVCYSA 77 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCC------CCCeeEEEEEEccC
Confidence 579999999999999999997 45678999999987543 33456678888888764 78999999987543
Q ss_pred --CeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEE
Q 005590 456 --EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 532 (689)
Q Consensus 456 --~~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~ 532 (689)
..+++||||+. ++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+||+++. ++.++|+
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~--~~~~~l~ 150 (284)
T cd05081 78 GRRNLRLVMEYLPYGSLRDYLQKHR-----ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVES--ENRVKIG 150 (284)
T ss_pred CCCceEEEEEecCCCCHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECC--CCeEEEC
Confidence 46899999997 57877765332 12788999999999999999999999999999999999984 7789999
Q ss_pred ecCCcccccCCccc------cccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 005590 533 DLGSSCFQTDNLCL------YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 606 (689)
Q Consensus 533 DFGls~~~~~~~~~------~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~ 606 (689)
|||++......... ..++..|+|||++.+..++.++|+|||||++|+|++|..|+..... .....+ +..
T Consensus 151 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~----~~~ 225 (284)
T cd05081 151 DFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMM----GND 225 (284)
T ss_pred CCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhc----ccc
Confidence 99998765432211 1233459999999988899999999999999999999887654322 111111 110
Q ss_pred cHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 607 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
..... ....+..... . ....+.. ...+..+.+||.+||..+|++|||+.|+++.
T Consensus 226 ~~~~~-~~~~~~~~~~------------~--~~~~~~~-------~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 226 KQGQM-IVYHLIELLK------------N--NGRLPAP-------PGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred ccccc-chHHHHHHHh------------c--CCcCCCC-------CCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 00000 0000000000 0 0011110 1224568899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=278.20 Aligned_cols=247 Identities=20% Similarity=0.256 Sum_probs=180.6
Q ss_pred EeccCCCCceEEEEECC--CCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEEE
Q 005590 388 YLGSAAFSKVFQAQDLH--TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 463 (689)
Q Consensus 388 ~LG~G~fG~Vyla~d~~--tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmE 463 (689)
.||+|+||+||+|.... ....+|+|.+.... .....+.+|+.+++.+ +|+||+++++.+......++|||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l------~h~nii~~~~~~~~~~~~~lv~e 75 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL------NHPNVLQCLGQCIESIPYLLVLE 75 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC------CCCCcceEEEEECCCCceEEEEE
Confidence 58999999999996432 44578888776432 2234556777777655 47899999999999999999999
Q ss_pred cccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccC
Q 005590 464 LLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 542 (689)
Q Consensus 464 y~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~ 542 (689)
|+.+ +|.+++...... .....++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 76 ~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~--~~~~kl~dfg~~~~~~~ 152 (269)
T cd05042 76 FCPLGDLKNYLRSNRGM-VAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTA--DLSVKIGDYGLALEQYP 152 (269)
T ss_pred eCCCCcHHHHHHhcccc-ccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecC--CCcEEEecccccccccc
Confidence 9985 777776544321 1222567788899999999999999999999999999999985 78899999999864322
Q ss_pred C-----ccccccCccccChhhhcC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHH
Q 005590 543 N-----LCLYVQSRSYRAPEVIIG-------LPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLE 609 (689)
Q Consensus 543 ~-----~~~~~gt~~Y~APE~l~~-------~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e 609 (689)
. .....+++.|+|||++.. ..++.++|||||||++|+|++ |..||......+.+..+.....
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~----- 227 (269)
T cd05042 153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD----- 227 (269)
T ss_pred chheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccC-----
Confidence 1 112345677999999743 357889999999999999999 8899987665554444321110
Q ss_pred HHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
..++... .....+..+.+++..|+ .||++|||++++++-
T Consensus 228 -----------------------------~~~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 228 -----------------------------IKLPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred -----------------------------ccCCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 0000000 00123355778899888 599999999999863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=278.88 Aligned_cols=249 Identities=19% Similarity=0.247 Sum_probs=188.9
Q ss_pred EEEEEEeccCCCCceEEEEEC---CCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 383 YYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 383 Y~i~~~LG~G~fG~Vyla~d~---~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
|++.+.||+|+||.||+|.+. .+++.+|||++..+. ...+++.+|+++++.++ ||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD------HPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCC------CCCcceEEEEEccCC
Confidence 567889999999999999864 357899999987642 23455667887777664 789999999886542
Q ss_pred ------eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeE
Q 005590 457 ------HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 529 (689)
Q Consensus 457 ------~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~v 529 (689)
..++++||+. +++.+++...........++...++.++.||+.||.|||+.||+||||||+||+++. ++.+
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~--~~~~ 152 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNE--NMTV 152 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcC--CCCE
Confidence 2478899997 466655543222222234788899999999999999999999999999999999984 7789
Q ss_pred EEEecCCcccccCCc-----cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhc
Q 005590 530 KIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGML 603 (689)
Q Consensus 530 kL~DFGls~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~ 603 (689)
||+|||++....... ....+++.|++||.+.+..++.++|||||||++|+|++ |.+||......+....+....
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 232 (273)
T cd05074 153 CVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN 232 (273)
T ss_pred EECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999987643221 22334568999999998889999999999999999999 899998766554443332100
Q ss_pred CCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 604 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 604 g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
....+ ......+.+++.+||+.+|++|||+.+++++
T Consensus 233 ----------------------------------~~~~~---------~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 233 ----------------------------------RLKQP---------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred ----------------------------------cCCCC---------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00000 0123568899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=282.77 Aligned_cols=260 Identities=22% Similarity=0.278 Sum_probs=190.1
Q ss_pred cEEEEEEeccCCCCceEEEEE----CCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC
Q 005590 382 RYYVTEYLGSAAFSKVFQAQD----LHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d----~~tg~~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
-|++++.||+|+||.||+++. ..+++.||+|.++.. ......+.+|+.+++.+. |+||+++++++...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~ 78 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY------HENIVKYKGICTED 78 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCC------CCCeeeeeeEEecC
Confidence 478999999999999999974 457889999998754 233456778888888774 67999999998865
Q ss_pred --CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEE
Q 005590 456 --EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 532 (689)
Q Consensus 456 --~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~ 532 (689)
...++||||+.+ +|.+++.... ..+++..+..++.||+.||.|||+.|++||||||+||+++. ++.++|+
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~--~~~~~l~ 151 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRNK-----NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES--EHQVKIG 151 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcC--CCCEEEC
Confidence 578999999974 6776664322 12788999999999999999999999999999999999984 7789999
Q ss_pred ecCCcccccCCc------cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCC
Q 005590 533 DLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 606 (689)
Q Consensus 533 DFGls~~~~~~~------~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~ 606 (689)
|||++....... ....++..|+|||.+.+..++.++|||||||++|+|+++..|+.... ....+..++.
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~-----~~~~~~~~~~ 226 (284)
T cd05079 152 DFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPM-----TLFLKMIGPT 226 (284)
T ss_pred CCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCcccc-----chhhhhcccc
Confidence 999987543321 12345667999999998889999999999999999999887654321 1111222222
Q ss_pred cHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 607 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
..+..... ...... ... ..+.. ...+..+.+||.+||+.||++|||+.+++++
T Consensus 227 ~~~~~~~~--~~~~~~------------~~~--~~~~~-------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 227 HGQMTVTR--LVRVLE------------EGK--RLPRP-------PNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred cccccHHH--HHHHHH------------cCc--cCCCC-------CCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 21110000 000000 000 01100 1134668999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=280.28 Aligned_cols=238 Identities=20% Similarity=0.246 Sum_probs=175.7
Q ss_pred EeccCCCCceEEEEECCC------------------------CcEEEEEEeecchh-hhHhHHHHHHHHHHhcccCCCCC
Q 005590 388 YLGSAAFSKVFQAQDLHT------------------------GVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADE 442 (689)
Q Consensus 388 ~LG~G~fG~Vyla~d~~t------------------------g~~vAvKii~~~~~-~~~~~~~Ei~iL~~l~~~~~~~h 442 (689)
.||+|+||.||+|....+ ...|++|++..... ....+.+|+.+++.+ .|
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l------~h 75 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV------SH 75 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC------CC
Confidence 589999999999974321 24588888865432 223445555555544 57
Q ss_pred CceeEEEEEEEeCCeEEEEEEccccc-hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 005590 443 HHILRLYDYFYHLEHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI 521 (689)
Q Consensus 443 ~~Iv~l~~~f~~~~~l~lVmEy~~g~-L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl 521 (689)
+||+++++++......++||||+.++ |..++.... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 76 ~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill 150 (274)
T cd05076 76 IHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-----GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILL 150 (274)
T ss_pred CCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEE
Confidence 89999999999999999999999965 444443211 237888999999999999999999999999999999999
Q ss_pred eccC-----CCeEEEEecCCcccccCCccccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHH-hCCCCCCCChHHH
Q 005590 522 KSYQ-----RCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELW-TGEVLFPNDAVVM 594 (689)
Q Consensus 522 ~~~~-----~~~vkL~DFGls~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLl-tG~~PF~~~~~~~ 594 (689)
+... ...++|+|||.+...... ....++..|+|||.+.+ ..++.++|+|||||++|+|+ +|..||......+
T Consensus 151 ~~~~~~~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 151 ARLGLAEGTSPFIKLSDPGVSFTALSR-EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred eccCcccCccceeeecCCccccccccc-cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 7522 235899999987544322 22356788999999875 56899999999999999995 6999997654433
Q ss_pred HHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCc
Q 005590 595 ILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP 674 (689)
Q Consensus 595 ~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRp 674 (689)
....+. ....+|.. ..+.+.+||.+||+.+|++||
T Consensus 230 ~~~~~~------------------------------------~~~~~~~~---------~~~~~~~li~~cl~~~p~~Rp 264 (274)
T cd05076 230 KERFYE------------------------------------KKHRLPEP---------SCKELATLISQCLTYEPTQRP 264 (274)
T ss_pred HHHHHH------------------------------------hccCCCCC---------CChHHHHHHHHHcccChhhCc
Confidence 221110 00011110 124578999999999999999
Q ss_pred CHHHHHcC
Q 005590 675 TAREALDH 682 (689)
Q Consensus 675 Ta~ElL~h 682 (689)
|+.++|++
T Consensus 265 s~~~il~~ 272 (274)
T cd05076 265 SFRTILRD 272 (274)
T ss_pred CHHHHHHh
Confidence 99999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=319.02 Aligned_cols=253 Identities=30% Similarity=0.419 Sum_probs=187.4
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe--
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-- 454 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~-- 454 (689)
...+|+.++.||+||||.||+++++-+|+.||||.++.. ......+.+|+++|.+|+ |||||+++..+..
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLn------HpNVVRYysAWVEs~ 550 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLN------HPNVVRYYSAWVEST 550 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcC------CcceeeeehhhhccC
Confidence 346788899999999999999999999999999999865 445567888999998886 5677777655400
Q ss_pred --------------------------------------------------------------------------------
Q 005590 455 -------------------------------------------------------------------------------- 454 (689)
Q Consensus 455 -------------------------------------------------------------------------------- 454 (689)
T Consensus 551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~ 630 (1351)
T KOG1035|consen 551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL 630 (1351)
T ss_pred CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence
Q ss_pred -----------------------------C--------CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHH
Q 005590 455 -----------------------------L--------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 497 (689)
Q Consensus 455 -----------------------------~--------~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QI 497 (689)
. ..+||-||||+..++..+....... --...++++++||
T Consensus 631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreI 706 (1351)
T KOG1035|consen 631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREI 706 (1351)
T ss_pred ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHH
Confidence 0 1368899999976555444332210 1356799999999
Q ss_pred HHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccccc--------------------C-CccccccCccccCh
Q 005590 498 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT--------------------D-NLCLYVQSRSYRAP 556 (689)
Q Consensus 498 l~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~--------------------~-~~~~~~gt~~Y~AP 556 (689)
++||.|+|++|||||||||.||+++. ++.|||+|||+++... + ..+..+||--|+||
T Consensus 707 lEGLaYIH~~giIHRDLKP~NIFLd~--~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP 784 (1351)
T KOG1035|consen 707 LEGLAYIHDQGIIHRDLKPRNIFLDS--RNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP 784 (1351)
T ss_pred HHHHHHHHhCceeeccCCcceeEEcC--CCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence 99999999999999999999999994 8889999999987511 0 12346889999999
Q ss_pred hhhcCCC---CCchhhHHHHHHHHHHHHhCCCCCCCChHH-HHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhh
Q 005590 557 EVIIGLP---YDQKIDLWSLGCILAELWTGEVLFPNDAVV-MILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINE 632 (689)
Q Consensus 557 E~l~~~~---~s~~~DIwSLGvil~eLltG~~PF~~~~~~-~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~ 632 (689)
|++.+.. |+.++||||||+|||||+. ||...-.. ..+..+. -|.+|
T Consensus 785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR--~g~iP------------------------- 834 (1351)
T KOG1035|consen 785 ELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR--KGSIP------------------------- 834 (1351)
T ss_pred HHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc--cCCCC-------------------------
Confidence 9997654 9999999999999999984 57543222 1222221 11111
Q ss_pred ccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCC
Q 005590 633 ETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686 (689)
Q Consensus 633 ~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~ 686 (689)
....+. ...-+.-..+|+.||+.||.+||||.|||++.||.
T Consensus 835 ----------~~~~f~---~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 835 ----------EPADFF---DPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred ----------CCcccc---cccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 110000 00012235899999999999999999999999986
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=302.03 Aligned_cols=251 Identities=25% Similarity=0.387 Sum_probs=213.0
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeec----chhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN----DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~----~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
.+.+++..||-|+||.|-++........+|+|++++ +......+..|.+||..++. ++|+++|..|.+..
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s------~fIvrLYrTfrd~k 493 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRS------DFIVRLYRTFRDSK 493 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCc------hHHHHHHHHhccch
Confidence 567888899999999999998665555689999876 34456777888899988863 69999999999999
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
++|++||-|- |.++..++..+ .|....++.++..+++|+.|||.+|||+|||||+|+|++. +|-+||.|||
T Consensus 494 yvYmLmEaClGGElWTiLrdRg------~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~--~Gy~KLVDFG 565 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDRG------SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDN--RGYLKLVDFG 565 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhcC------CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeecc--CCceEEeehh
Confidence 9999999986 46777766443 2888999999999999999999999999999999999994 8999999999
Q ss_pred CcccccCC--ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhh
Q 005590 536 SSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 536 ls~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
+|+..... .-++||||.|.|||+++++..+.++|.||||+++||||+|.+||.+.++...+..|.+.+..+
T Consensus 566 FAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i------- 638 (732)
T KOG0614|consen 566 FAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI------- 638 (732)
T ss_pred hHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh-------
Confidence 99987654 345899999999999999999999999999999999999999999999998888887443211
Q ss_pred hhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcC-----HHHHHcCCCCCC
Q 005590 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPWLQH 687 (689)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT-----a~ElL~hpwf~~ 687 (689)
.+|. .......+||+++...+|.+|.. +.++-+|.||.+
T Consensus 639 --------------------------~~Pr---------~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 639 --------------------------EFPR---------RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred --------------------------hccc---------ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 1121 12234679999999999999997 899999999964
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-31 Score=276.65 Aligned_cols=246 Identities=20% Similarity=0.217 Sum_probs=181.7
Q ss_pred EeccCCCCceEEEEEC--CCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEEE
Q 005590 388 YLGSAAFSKVFQAQDL--HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 463 (689)
Q Consensus 388 ~LG~G~fG~Vyla~d~--~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmE 463 (689)
.||+|+||.||+|.+. .++..+|+|.++... .....+.+|+.+++.+ +||||+++++++......++|||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~~~lv~e 75 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL------QHSNLLQCLGQCTEVTPYLLVME 75 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhC------CCCCEeeEEEEEcCCCCcEEEEE
Confidence 5899999999999754 456789999887543 2234566777777766 47899999999999999999999
Q ss_pred ccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccC
Q 005590 464 LLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 542 (689)
Q Consensus 464 y~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~ 542 (689)
|+. ++|.+++..... ......+...++.++.|++.||.|||+.+++|+||||+||+++. ++.++|+|||.+.....
T Consensus 76 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~--~~~~kL~dfg~~~~~~~ 152 (269)
T cd05087 76 FCPLGDLKGYLRSCRK-AELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTA--DLTVKIGDYGLSHNKYK 152 (269)
T ss_pred CCCCCcHHHHHHHhhh-cccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcC--CCcEEECCccccccccC
Confidence 998 567777654322 11223567788899999999999999999999999999999985 77899999999865432
Q ss_pred Cc-----cccccCccccChhhhcCC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHH
Q 005590 543 NL-----CLYVQSRSYRAPEVIIGL-------PYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLE 609 (689)
Q Consensus 543 ~~-----~~~~gt~~Y~APE~l~~~-------~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e 609 (689)
.. ....++..|+|||++.+. .++.++|+|||||++|+|++ |..||......+.........
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------ 226 (269)
T cd05087 153 EDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQ------ 226 (269)
T ss_pred cceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcc------
Confidence 21 123567789999998642 35789999999999999996 999997765444332221000
Q ss_pred HHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
......|.. .......+.++|+.|+ .+|++|||++||++
T Consensus 227 --------------------------~~~~~~~~~------~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 227 --------------------------QLKLPKPRL------KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred --------------------------cCCCCCCcc------CCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 000000110 0112345789999998 68999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-31 Score=282.30 Aligned_cols=246 Identities=21% Similarity=0.254 Sum_probs=187.8
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCc----EEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGV----DVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 453 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~----~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~ 453 (689)
..+|++.+.||+|+||.||++.+..+|+ .+|+|++.... .....+.+|+.+++.+ .|+||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l------~h~niv~~~~~~~ 79 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM------DHPHLVRLLGVCL 79 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC------CCCCcccEEEEEc
Confidence 3678999999999999999999877776 57888887542 2223456677776665 4789999999886
Q ss_pred eCCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEE
Q 005590 454 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 532 (689)
Q Consensus 454 ~~~~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~ 532 (689)
.. ..++|+||+. |+|.+++..... .+++..+..++.||+.||.|||+.||+|+||||+||+++. ++.+||+
T Consensus 80 ~~-~~~~v~e~~~~g~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~--~~~~kL~ 151 (303)
T cd05110 80 SP-TIQLVTQLMPHGCLLDYVHEHKD-----NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKS--PNHVKIT 151 (303)
T ss_pred CC-CceeeehhcCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecC--CCceEEc
Confidence 54 4678999998 567777654321 2788899999999999999999999999999999999984 6789999
Q ss_pred ecCCcccccCCc-----cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCC
Q 005590 533 DLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 606 (689)
Q Consensus 533 DFGls~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~ 606 (689)
|||++....... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.........+...
T Consensus 152 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~---- 227 (303)
T cd05110 152 DFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG---- 227 (303)
T ss_pred cccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC----
Confidence 999987643221 11234678999999999999999999999999999997 99999775443332222100
Q ss_pred cHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 607 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
...+.. ...+..+.++|.+||..+|++||++.++++.
T Consensus 228 --------------------------------~~~~~~-------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 228 --------------------------------ERLPQP-------PICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred --------------------------------CCCCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000000 0123457899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=274.76 Aligned_cols=240 Identities=20% Similarity=0.285 Sum_probs=178.8
Q ss_pred EEeccCCCCceEEEEECC---CCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEE-eCCeEEE
Q 005590 387 EYLGSAAFSKVFQAQDLH---TGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY-HLEHLFI 460 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~---tg~~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~-~~~~l~l 460 (689)
+.||+|+||.||+|.+.. .+..+|+|.+... ......+.+|+.+++.+ +||||+++++++. .....++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~~~~l 74 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF------SHPNVLSLLGICLPSEGSPLV 74 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC------CCCCcceEEEEeecCCCCcEE
Confidence 358999999999998643 3457999988542 22344566677666554 5789999999765 4556899
Q ss_pred EEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccc
Q 005590 461 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539 (689)
Q Consensus 461 VmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 539 (689)
||||+. ++|.+++..... .++...+..++.||+.||.|||+.+++||||||+|||++. ++.+||+|||++..
T Consensus 75 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~--~~~~kl~dfg~~~~ 147 (262)
T cd05058 75 VLPYMKHGDLRNFIRSETH-----NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDE--SFTVKVADFGLARD 147 (262)
T ss_pred EEecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcC--CCcEEECCcccccc
Confidence 999998 467777653221 1567778889999999999999999999999999999984 77899999999875
Q ss_pred ccCC-------ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 005590 540 QTDN-------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEML 611 (689)
Q Consensus 540 ~~~~-------~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~ 611 (689)
.... .....++..|+|||.+.+..++.++|||||||++|+|++ |.+||......+....+...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--------- 218 (262)
T cd05058 148 IYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--------- 218 (262)
T ss_pred ccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC---------
Confidence 4321 112345678999999998899999999999999999999 56777765544433322100
Q ss_pred hhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
.....+ ...+..+.+++.+||..+|++||++.++++.
T Consensus 219 -------------------------~~~~~~---------~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 219 -------------------------RRLLQP---------EYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred -------------------------CCCCCC---------CcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 000001 1123468899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-33 Score=307.46 Aligned_cols=273 Identities=25% Similarity=0.328 Sum_probs=202.4
Q ss_pred eeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005590 374 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 451 (689)
Q Consensus 374 ~~~~~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~ 451 (689)
.+...-+.-|...+.||+|+||.||+++++.+|+.||||.++.. ....+.+.+|+++|++++ |+|||++.++
T Consensus 6 ~l~~~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLn------h~NIVk~f~i 79 (732)
T KOG4250|consen 6 VLTSGENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLN------HPNIVKLFDI 79 (732)
T ss_pred ccccCCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcC------chhhhhhccc
Confidence 33334456788889999999999999999999999999999863 345678899999999996 5799999988
Q ss_pred EEeC------CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecc
Q 005590 452 FYHL------EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY 524 (689)
Q Consensus 452 f~~~------~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~ 524 (689)
-... ....+|||||.| +|...+...... .-+++.++..++..+..||.|||++||+||||||.||++-.+
T Consensus 80 ee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~---~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~G 156 (732)
T KOG4250|consen 80 EETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENA---YGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIG 156 (732)
T ss_pred CCccccCcccccceEEEeecCCCcHHHHhcCcccc---cCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeec
Confidence 6543 367899999985 676666543322 239999999999999999999999999999999999998765
Q ss_pred CCC--eEEEEecCCcccccCC--ccccccCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCh----HHHH
Q 005590 525 QRC--EIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDA----VVMI 595 (689)
Q Consensus 525 ~~~--~vkL~DFGls~~~~~~--~~~~~gt~~Y~APE~l~~-~~~s~~~DIwSLGvil~eLltG~~PF~~~~----~~~~ 595 (689)
.+| ..||+|||.|+-..+. ....+||+.|.+||++.. +.|+..+|+||+||++|++.||..||-... ..+.
T Consensus 157 edgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~ 236 (732)
T KOG4250|consen 157 EDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEI 236 (732)
T ss_pred CCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchh
Confidence 544 4699999999987654 456899999999999994 789999999999999999999999995432 2222
Q ss_pred HHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCc
Q 005590 596 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP 674 (689)
Q Consensus 596 l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRp 674 (689)
...+.. .+ |.......+ ........+...+|....+.... ...+-.++..||.++|++|.
T Consensus 237 ~~~~~t--kk-p~~v~i~~~-------------~~eNgpv~~s~~lP~p~~Ls~~l---~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 237 MWHIIT--KK-PSGVAIGAQ-------------EEENGPVEWSSTLPQPNHLSRGL---ATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred hhhhhc--cC-CCceeEeee-------------cccCCceeeeccCCCcccccHHH---HhhhhHHHHHHHhhhHHHhC
Confidence 222210 01 100000000 00111223445555544433222 23466789999999999999
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=294.06 Aligned_cols=197 Identities=22% Similarity=0.351 Sum_probs=166.3
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhh-hHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC-eE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF-FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE-HL 458 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~-~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~-~l 458 (689)
+.|.-...||+|+||.||+|.- ..|..||||.+...... ..++.+|+.++..++ |+||+++++||.+.+ +.
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~------H~Nlv~LlGyC~e~~~~~ 147 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRLR------HPNLVKLLGYCLEGGEHR 147 (361)
T ss_pred hCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcCC------CcCcccEEEEEecCCceE
Confidence 5667777899999999999985 45589999988765543 456889999988875 679999999999888 59
Q ss_pred EEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCcEEEeccCCCeEEEEec
Q 005590 459 FIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG---IIHCDLKPENILIKSYQRCEIKIIDL 534 (689)
Q Consensus 459 ~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~g---IvHrDLKp~NILl~~~~~~~vkL~DF 534 (689)
+||+|||. |+|.+.+...... .+++..+..|+.++++||.|||... |||||||++|||++ .+...||+||
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD--~~~~aKlsDF 221 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD--EDFNAKLSDF 221 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC--CCCCEEccCc
Confidence 99999998 5777766543221 5899999999999999999999854 99999999999999 4889999999
Q ss_pred CCcccccC-Cccc--c-ccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 005590 535 GSSCFQTD-NLCL--Y-VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 590 (689)
Q Consensus 535 Gls~~~~~-~~~~--~-~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~ 590 (689)
|+|+.... .... . .||.+|+|||.+..+..+.++||||+|++|.||+||+.|....
T Consensus 222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred cCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 99976543 2222 2 7999999999999888999999999999999999999887643
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=303.53 Aligned_cols=256 Identities=25% Similarity=0.393 Sum_probs=210.8
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe-----
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH----- 454 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~----- 454 (689)
.+.|.|.+.||.|.+|+||+++++.+++..|+||...+.+....+..|.+||+.+. .|||++.+|++|.-
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~-----~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYS-----HHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhcc-----CCCCcceEEEEEEEecCCC
Confidence 46799999999999999999999999999999999988777788888889998876 48999999999973
Q ss_pred CCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEe
Q 005590 455 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 533 (689)
Q Consensus 455 ~~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~D 533 (689)
.+.++||||||+| +..++++... ...+.+..+..|++.++.||.+||...++|||||-.|||++. ++.|||+|
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~----g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~--e~~VKLvD 166 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTK----GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTE--NAEVKLVD 166 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhc----ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEec--cCcEEEee
Confidence 4689999999995 6777776544 233899999999999999999999999999999999999994 89999999
Q ss_pred cCCcccccC---CccccccCccccChhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 005590 534 LGSSCFQTD---NLCLYVQSRSYRAPEVIIG-----LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 605 (689)
Q Consensus 534 FGls~~~~~---~~~~~~gt~~Y~APE~l~~-----~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~ 605 (689)
||.+...+. ...+.+|||.|||||++.- ..|+..+|+||||++..||.-|.+|+-.-.+..-+..| ...
T Consensus 167 FGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I---pRN 243 (953)
T KOG0587|consen 167 FGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRN 243 (953)
T ss_pred eeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---CCC
Confidence 999887654 3556899999999999963 34888999999999999999999999654433332222 222
Q ss_pred CcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 606 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 606 ~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
+|+. +.++. .-..+|.+||..||..|-.+||+..++|+|||+
T Consensus 244 PPPk-Lkrp~-------------------------------------kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi 285 (953)
T KOG0587|consen 244 PPPK-LKRPK-------------------------------------KWSKKFNDFISTCLVKDYEQRPSTEELLKHPFI 285 (953)
T ss_pred CCcc-ccchh-------------------------------------hHHHHHHHHHHHHHhhccccCcchhhhccCCcc
Confidence 2211 11111 112458899999999999999999999999998
Q ss_pred CC
Q 005590 686 QH 687 (689)
Q Consensus 686 ~~ 687 (689)
..
T Consensus 286 ~e 287 (953)
T KOG0587|consen 286 TE 287 (953)
T ss_pred cc
Confidence 74
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=295.73 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=204.1
Q ss_pred eCceecCcEEEEEEeccCCCCceEEEEECCCCc---E-EEEEEeec----chhhhHhHHHHHHHHHHhcccCCCCCCcee
Q 005590 375 LNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGV---D-VCLKIIKN----DKDFFDQSLDEIKLLKLVNKNDPADEHHIL 446 (689)
Q Consensus 375 ~~~~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~---~-vAvKii~~----~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv 446 (689)
.+.+..++-.+.++||+|+||.||+|..+..+. . ||+|..+. .+.....+++|.++++.++ |+||+
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~------H~NVV 224 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN------HPNVV 224 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC------CCCEE
Confidence 345556667777999999999999998755422 3 89999874 2456678889999999875 78999
Q ss_pred EEEEEEEeCCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccC
Q 005590 447 RLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 525 (689)
Q Consensus 447 ~l~~~f~~~~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~ 525 (689)
++|++......++||||+|.| +|.++++.... .++..+...++.+.++||+|||++++|||||-.+|+|++.
T Consensus 225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-----~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~-- 297 (474)
T KOG0194|consen 225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-----SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSK-- 297 (474)
T ss_pred EEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecC--
Confidence 999999999999999999995 78888876553 2889999999999999999999999999999999999994
Q ss_pred CCeEEEEecCCcccccCCc--c-ccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHh
Q 005590 526 RCEIKIIDLGSSCFQTDNL--C-LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIG 601 (689)
Q Consensus 526 ~~~vkL~DFGls~~~~~~~--~-~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~ 601 (689)
+..+||+|||+++...... . ...-...|+|||.+....|+.++||||+||++||+++ |..||++....++.+.|..
T Consensus 298 ~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~ 377 (474)
T KOG0194|consen 298 KGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK 377 (474)
T ss_pred CCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh
Confidence 6668999999987654211 1 1124568999999999999999999999999999999 8899999988888877741
Q ss_pred hcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 602 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 602 ~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
. ..+...|. ..+..+..++..|+..||++|||+.++.+
T Consensus 378 ~---------------------------------~~r~~~~~---------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 378 N---------------------------------GYRMPIPS---------KTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred c---------------------------------CccCCCCC---------CCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 1 11111121 22356778999999999999999998864
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=276.65 Aligned_cols=253 Identities=22% Similarity=0.354 Sum_probs=203.0
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~----~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
-++|.++.+||+|+|++|.+++.+.|.+.||+|+++++ ....+-...|..+..... .||+++-+..+|+..
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~as-----n~pflvglhscfqte 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-----NNPFLVGLHSCFQTE 323 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhcc-----CCCeEEehhhhhccc
Confidence 46899999999999999999999999999999999864 222333445555655544 478999999999999
Q ss_pred CeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 456 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 456 ~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
..+++|.||++|+-+-+....++. ++++.++.+...|+.||.|||+.|||+||||.+|||++. .|++||+|+|
T Consensus 324 srlffvieyv~ggdlmfhmqrqrk-----lpeeharfys~ei~lal~flh~rgiiyrdlkldnvllda--eghikltdyg 396 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRK-----LPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDA--EGHIKLTDYG 396 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhc-----CcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEcc--CCceeecccc
Confidence 999999999997643333333322 999999999999999999999999999999999999995 8999999999
Q ss_pred Cccc---ccCCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-------ChHHHHHHHHHhhcCC
Q 005590 536 SSCF---QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN-------DAVVMILARIIGMLGP 605 (689)
Q Consensus 536 ls~~---~~~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~-------~~~~~~l~~i~~~~g~ 605 (689)
+.+. .++...+++|||.|.|||++.+..|...+|+|+|||+++||+.|+.||.- .+.++++.+++
T Consensus 397 mcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi----- 471 (593)
T KOG0695|consen 397 MCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI----- 471 (593)
T ss_pred hhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH-----
Confidence 9864 34556779999999999999999999999999999999999999999941 23334444332
Q ss_pred CcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcC------HHHH
Q 005590 606 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT------AREA 679 (689)
Q Consensus 606 ~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT------a~El 679 (689)
..-+..+|...+.. +-.+++..|..||.+|.. ..++
T Consensus 472 -----------------------------lekqiriprslsvk---------as~vlkgflnkdp~erlgc~~~~g~~di 513 (593)
T KOG0695|consen 472 -----------------------------LEKQIRIPRSLSVK---------ASHVLKGFLNKDPKERLGCRPQTGFSDI 513 (593)
T ss_pred -----------------------------hhhcccccceeehh---------hHHHHHHhhcCCcHHhcCCCcccchhhh
Confidence 01123345433322 347899999999999974 7889
Q ss_pred HcCCCCCC
Q 005590 680 LDHPWLQH 687 (689)
Q Consensus 680 L~hpwf~~ 687 (689)
-.|+||+.
T Consensus 514 k~h~ffr~ 521 (593)
T KOG0695|consen 514 KSHAFFRS 521 (593)
T ss_pred hcchhhhh
Confidence 99999974
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=293.77 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=197.4
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
.-|..++.||-|+||+|.++....|...||+|.+++.. ......+.|-.||.+.. .+-||+||..|++++
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD------n~WVVrLyySFQDkd 702 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD------NEWVVRLYYSFQDKD 702 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC------CcceEEEEEEeccCC
Confidence 45899999999999999999998999999999987642 33445566777776654 458999999999999
Q ss_pred eEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
.+|+||+|+.| ++..++..... |.+..++.++..+.+|+.+.|++|+|||||||+||||+. +|+|||+|||
T Consensus 703 nLYFVMdYIPGGDmMSLLIrmgI------FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDr--dGHIKLTDFG 774 (1034)
T KOG0608|consen 703 NLYFVMDYIPGGDMMSLLIRMGI------FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR--DGHIKLTDFG 774 (1034)
T ss_pred ceEEEEeccCCccHHHHHHHhcc------CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEcc--CCceeeeecc
Confidence 99999999985 66666654332 889999999999999999999999999999999999995 9999999999
Q ss_pred Cccc---------ccC------------------C------------------ccccccCccccChhhhcCCCCCchhhH
Q 005590 536 SSCF---------QTD------------------N------------------LCLYVQSRSYRAPEVIIGLPYDQKIDL 570 (689)
Q Consensus 536 ls~~---------~~~------------------~------------------~~~~~gt~~Y~APE~l~~~~~s~~~DI 570 (689)
++.- +.. . ....+||+.|+|||++....|....|+
T Consensus 775 LCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdw 854 (1034)
T KOG0608|consen 775 LCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDW 854 (1034)
T ss_pred ccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchh
Confidence 8621 000 0 001478999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhh
Q 005590 571 WSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHH 650 (689)
Q Consensus 571 wSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~ 650 (689)
||.|||||||+.|++||..+.+-+...+++ .|+.. ..+|....
T Consensus 855 ws~gvil~em~~g~~pf~~~tp~~tq~kv~------------nw~~~---------------------l~~~~~~~---- 897 (1034)
T KOG0608|consen 855 WSVGVILYEMLVGQPPFLADTPGETQYKVI------------NWRNF---------------------LHIPYQGN---- 897 (1034)
T ss_pred hHhhHHHHHHhhCCCCccCCCCCcceeeee------------ehhhc---------------------cccccccc----
Confidence 999999999999999997765444333332 11111 12232222
Q ss_pred ccCCcHHHHHHHHHhcccCCCCCcC---HHHHHcCCCCCC
Q 005590 651 LQFSDAFFIDFVRTLLEINPQRRPT---AREALDHPWLQH 687 (689)
Q Consensus 651 ~~~~~~~l~dLI~~mL~~dP~kRpT---a~ElL~hpwf~~ 687 (689)
.+.++.+||.++. -+++.|+. ++++-.||||+.
T Consensus 898 ---ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 898 ---LSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred ---cCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccc
Confidence 3466889998765 46777764 778999999975
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=276.62 Aligned_cols=260 Identities=22% Similarity=0.305 Sum_probs=192.2
Q ss_pred CcEEEEEEeccCCCCceEEEEEC----CCCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDL----HTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~----~tg~~vAvKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
..|++.+.||+|+||.||+++.. .+++.+|+|++..... ....+.+|+++++.+. |+||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~------~~~i~~~~~~~~~ 77 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD------HENIVKYKGVCEK 77 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCC------CCChheEEeeeec
Confidence 46888999999999999999854 3488999999986544 3567778888887764 6799999999887
Q ss_pred --CCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEE
Q 005590 455 --LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 531 (689)
Q Consensus 455 --~~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL 531 (689)
....++||||+.+ +|.+++..... .+++..+..++.||+.||.|||+.||+|+||||+||+++. ++.++|
T Consensus 78 ~~~~~~~lv~e~~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~--~~~~~l 150 (284)
T cd05038 78 PGGRSLRLIMEYLPSGSLRDYLQRHRD-----QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVES--EDLVKI 150 (284)
T ss_pred CCCCceEEEEecCCCCCHHHHHHhCcc-----ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcC--CCCEEE
Confidence 5689999999974 77777754332 2888999999999999999999999999999999999985 688999
Q ss_pred EecCCcccccCCcc------ccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCC
Q 005590 532 IDLGSSCFQTDNLC------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 605 (689)
Q Consensus 532 ~DFGls~~~~~~~~------~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~ 605 (689)
+|||.+........ ...++..|+|||.+.+..++.++|+|||||++|+|++|..||....... ....++
T Consensus 151 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----~~~~~~ 225 (284)
T cd05038 151 SDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF-----LRMIGI 225 (284)
T ss_pred cccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchh-----cccccc
Confidence 99999876553211 1233556999999998899999999999999999999999986532211 111111
Q ss_pred CcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 606 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 606 ~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
...... ......... .. ...+.. ...+..+.+|+.+||+.+|++|||+.|+++
T Consensus 226 ~~~~~~--~~~~~~~~~------------~~--~~~~~~-------~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 226 AQGQMI--VTRLLELLK------------EG--ERLPRP-------PSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cccccc--HHHHHHHHH------------cC--CcCCCC-------ccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 100000 000000000 00 001110 112356889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=271.69 Aligned_cols=245 Identities=17% Similarity=0.194 Sum_probs=178.4
Q ss_pred EeccCCCCceEEEEECCC--CcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEEE
Q 005590 388 YLGSAAFSKVFQAQDLHT--GVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 463 (689)
Q Consensus 388 ~LG~G~fG~Vyla~d~~t--g~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmE 463 (689)
.||+|+||+||+++.... ...+++|.+.... .....+.+|+.+++.+ .||||+++++.+......++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l------~h~~iv~~~~~~~~~~~~~lv~e 75 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL------QHPNILQCLGQCVEAIPYLLVFE 75 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc------CCcchhheEEEecCCCccEEEEe
Confidence 589999999999975332 3356677765432 2334566666666654 57899999999999999999999
Q ss_pred cccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccC
Q 005590 464 LLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 542 (689)
Q Consensus 464 y~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~ 542 (689)
|+.+ +|.+++...... ...+++..++.++.||+.||.|||+.+++||||||+|||++. ++.++|+|||++.....
T Consensus 76 ~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~--~~~~~l~Dfg~~~~~~~ 151 (268)
T cd05086 76 YCELGDLKSYLSQEQWH--RRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTS--DLTVKVGDYGIGPSRYK 151 (268)
T ss_pred cCCCCcHHHHHHhhhcc--cccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcC--CccEEecccccccccCc
Confidence 9984 777777543221 123667788899999999999999999999999999999984 78899999998754221
Q ss_pred -----CccccccCccccChhhhcC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHH
Q 005590 543 -----NLCLYVQSRSYRAPEVIIG-------LPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLE 609 (689)
Q Consensus 543 -----~~~~~~gt~~Y~APE~l~~-------~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e 609 (689)
......++..|+|||++.. ..++.++|||||||++|+|++ |..||......+.+..+......
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~---- 227 (268)
T cd05086 152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQV---- 227 (268)
T ss_pred chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccc----
Confidence 1123467889999999753 245789999999999999997 57889776655555443211000
Q ss_pred HHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
......++ ...++.+.++|..|| .+|++||+++++++
T Consensus 228 -------------------------~~~~~~~~---------~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 228 -------------------------KLFKPQLE---------LPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred -------------------------ccCCCccC---------CCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 00000001 112356788999999 78999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-33 Score=275.70 Aligned_cols=264 Identities=24% Similarity=0.347 Sum_probs=204.1
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005590 377 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 377 ~~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
+.-.++.+-+..||.|+||+|++..++.+|+..|||.++... ....+++.|.....+-. ..|+||++|+....
T Consensus 60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~-----~cp~IVkfyGa~F~ 134 (361)
T KOG1006|consen 60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSS-----NCPNIVKFYGALFS 134 (361)
T ss_pred ccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhc-----CCcHHHHHhhhhhc
Confidence 333455666678999999999999999999999999997543 23445556665544433 47899999999999
Q ss_pred CCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEeccCCCeEEEEe
Q 005590 455 LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIID 533 (689)
Q Consensus 455 ~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~-~gIvHrDLKp~NILl~~~~~~~vkL~D 533 (689)
.+-.+|.||+|+-++..+.+.-.... ...+++..+-.|....+.||.||.. ..||||||||+|||+++ .|.|||||
T Consensus 135 EGdcWiCMELMd~SlDklYk~vy~vq-~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr--~G~vKLCD 211 (361)
T KOG1006|consen 135 EGDCWICMELMDISLDKLYKRVYSVQ-KSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDR--HGDVKLCD 211 (361)
T ss_pred CCceeeeHHHHhhhHHHHHHHHHHHH-hccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEec--CCCEeeec
Confidence 99999999999988766655433222 2238899999999999999999996 48999999999999995 88999999
Q ss_pred cCCcccccCCc--cccccCccccChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCC-hHHHHHHHHHhhcCCCcH
Q 005590 534 LGSSCFQTDNL--CLYVQSRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVLFPND-AVVMILARIIGMLGPIDL 608 (689)
Q Consensus 534 FGls~~~~~~~--~~~~gt~~Y~APE~l~~--~~~s~~~DIwSLGvil~eLltG~~PF~~~-~~~~~l~~i~~~~g~~~~ 608 (689)
||.+....+.. +.-.|...|||||.+.. ..|+.++|+||||++|||+.||+.||..- +..+++..++ .|.+|.
T Consensus 212 FGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv--~gdpp~ 289 (361)
T KOG1006|consen 212 FGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV--IGDPPI 289 (361)
T ss_pred ccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH--cCCCCe
Confidence 99987765543 33578889999999964 45999999999999999999999999874 4445554443 122221
Q ss_pred HHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCC
Q 005590 609 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686 (689)
Q Consensus 609 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~ 686 (689)
......-...+..|+.||.-||..|-+.||...+|+++||+.
T Consensus 290 ------------------------------------l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr 331 (361)
T KOG1006|consen 290 ------------------------------------LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYR 331 (361)
T ss_pred ------------------------------------ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhh
Confidence 000111112345689999999999999999999999999975
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=306.07 Aligned_cols=251 Identities=20% Similarity=0.336 Sum_probs=200.7
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCC-C----cEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHT-G----VDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 452 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~t-g----~~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f 452 (689)
...-+..+.||+|+||.||.|..... | ..||||.++.. ......+++|..+|..+ +||||+++++++
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f------~HpNiv~liGv~ 764 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF------DHPNIVSLIGVC 764 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC------CCcceeeEEEee
Confidence 45678888999999999999986433 2 34899998865 34456677777777766 578999999999
Q ss_pred EeCCeEEEEEEccc-cchHHHHhhhhccC-CCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEE
Q 005590 453 YHLEHLFIVCELLR-ANLYEFQKFNQESG-GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 530 (689)
Q Consensus 453 ~~~~~l~lVmEy~~-g~L~~l~~~~~~~~-~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vk 530 (689)
......+|++|||. |+|+.+++..+... ....++..++..++.||++|+.||+++++|||||..+|+||+. ...||
T Consensus 765 l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~--~r~VK 842 (1025)
T KOG1095|consen 765 LDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDE--RRVVK 842 (1025)
T ss_pred cCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecc--cCcEE
Confidence 99999999999999 58999988663222 2344999999999999999999999999999999999999995 68899
Q ss_pred EEecCCcccccCCcccc-----ccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcC
Q 005590 531 IIDLGSSCFQTDNLCLY-----VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLG 604 (689)
Q Consensus 531 L~DFGls~~~~~~~~~~-----~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g 604 (689)
|+|||+|+...+..... .-...|||||.+....++.++|||||||++||++| |..||++.+..+++......
T Consensus 843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~g-- 920 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG-- 920 (1025)
T ss_pred EcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC--
Confidence 99999998543332221 23467999999999999999999999999999999 99999998888877644311
Q ss_pred CCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 605 ~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
.+...|. ..+..+.++|..||+.+|++||+...+++
T Consensus 921 --------------------------------gRL~~P~---------~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 921 --------------------------------GRLDPPS---------YCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred --------------------------------CccCCCC---------CCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 1111111 12344669999999999999999999986
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=282.37 Aligned_cols=293 Identities=27% Similarity=0.404 Sum_probs=214.8
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECC---CCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005590 378 VIAGRYYVTEYLGSAAFSKVFQAQDLH---TGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 378 ~l~~rY~i~~~LG~G~fG~Vyla~d~~---tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
.+.+.|.++++||.|.|++||++.+.. ..+.||+|.+.... ...++.+|+++|..+... .||+++.+++..
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~-----~ni~~~~~~~rn 106 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGS-----DNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccc-----hhhhcchhhhcc
Confidence 345679999999999999999999876 78899999887543 246788999999999754 599999999999
Q ss_pred CCeEEEEEEccccc-hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEe
Q 005590 455 LEHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 533 (689)
Q Consensus 455 ~~~l~lVmEy~~g~-L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~D 533 (689)
.++..+||||++.. ..++... ++...++.+++.++.||.++|.+|||||||||+|+|.+. ..+.-.|+|
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~---------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~-~t~rg~LvD 176 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS---------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNR-RTQRGVLVD 176 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc---------CCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccc-ccCCceEEe
Confidence 99999999999964 3333321 778899999999999999999999999999999999986 577789999
Q ss_pred cCCcccc-----------------cC----------------C--------------ccccccCccccChhhhcCCC-CC
Q 005590 534 LGSSCFQ-----------------TD----------------N--------------LCLYVQSRSYRAPEVIIGLP-YD 565 (689)
Q Consensus 534 FGls~~~-----------------~~----------------~--------------~~~~~gt~~Y~APE~l~~~~-~s 565 (689)
||++... .. . .....||++|+|||++...+ .+
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt 256 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT 256 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence 9987510 00 0 00137899999999997654 77
Q ss_pred chhhHHHHHHHHHHHHhCCCCC-CCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhcccccccc----
Q 005590 566 QKIDLWSLGCILAELWTGEVLF-PNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYI---- 640 (689)
Q Consensus 566 ~~~DIwSLGvil~eLltG~~PF-~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 640 (689)
.++||||.|||+.-++++..|| ...+..+.+.+|+-.+|.-...-........-.+.+ .......+....++..
T Consensus 257 taiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~k-sn~~~~~e~~~~f~s~~~~~ 335 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQK-SNIPTIPELRVNFETLHIES 335 (418)
T ss_pred CccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeecc-ccccccHHHHhchhccChhh
Confidence 8999999999999999999998 455666777888888886444332211111001110 0000000000000000
Q ss_pred CCc----cchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 641 IPE----ESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 641 ~p~----~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
+.. ....+.-....+..+.+|+.+||..||.+|+||+++|+||||..
T Consensus 336 ~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 336 IYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred cccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 000 01112223344567899999999999999999999999999974
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=300.57 Aligned_cols=246 Identities=30% Similarity=0.406 Sum_probs=190.9
Q ss_pred EEeccCCCC-ceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEEEcc
Q 005590 387 EYLGSAAFS-KVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELL 465 (689)
Q Consensus 387 ~~LG~G~fG-~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmEy~ 465 (689)
+.+|.|+.| .||+|. ..|+.||||.+-.+ ..+-..+|+..|+.-. .||||+++++.-.+.+++||..|.|
T Consensus 515 eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e--~~~~A~rEi~lL~eSD-----~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGV--YEGREVAVKRLLEE--FFDFAQREIQLLQESD-----EHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHcccCCCCcEEEEEe--eCCceehHHHHhhH--hHHHHHHHHHHHHhcc-----CCCceEEEEeeccCCceEEEEehHh
Confidence 358999998 568887 67899999988654 3456778999988775 5899999999999999999999999
Q ss_pred ccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec---cCCCeEEEEecCCcccccC
Q 005590 466 RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS---YQRCEIKIIDLGSSCFQTD 542 (689)
Q Consensus 466 ~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~---~~~~~vkL~DFGls~~~~~ 542 (689)
..+|.+++...... .........+.++.|++.||++||+.+||||||||.||||.. .....++|+|||+++....
T Consensus 586 ~~sL~dlie~~~~d--~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 586 ACSLQDLIESSGLD--VEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhhHHHHHhccccc--hhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 99999999864111 000111456788999999999999999999999999999986 3456899999999987654
Q ss_pred C------ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCChHHHHHHHHHhhcCCCcHHHHhhhh
Q 005590 543 N------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG-EVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615 (689)
Q Consensus 543 ~------~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG-~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~ 615 (689)
. .....||-+|+|||++....-..++|||||||++|+.++| .+||...-..+ +.|.
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl--------------- 726 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANIL--------------- 726 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhh---------------
Confidence 3 2335789999999999998888899999999999999995 99997642221 2221
Q ss_pred hhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCC
Q 005590 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686 (689)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~ 686 (689)
+.++.. . .++ ...+.++.+||.+||.++|..||+|.++|.||+|=
T Consensus 727 ------~~~~~L----------~-------~L~---~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 727 ------TGNYTL----------V-------HLE---PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred ------cCccce----------e-------eec---cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 000000 0 000 01112678999999999999999999999999983
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=282.28 Aligned_cols=249 Identities=21% Similarity=0.312 Sum_probs=211.5
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 377 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 377 ~~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++-..+..+.++||-|-||.||.+.++.-.-.||||.++.+......++.|..+|+.++ |||+|+++++|...-
T Consensus 263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeik------HpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK------HPNLVQLLGVCTHEP 336 (1157)
T ss_pred hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhc------CccHHHHhhhhccCC
Confidence 34445567778999999999999999988899999999999888899999999999996 679999999999999
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
.+|||+|||. |+|+++++.+.+.. ++.-.+..++.||..|+.||..+++|||||...|+||. ++..||++|||
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~e----v~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg--EnhiVKvADFG 410 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSE----VPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG--ENHIVKVADFG 410 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhh----cchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc--ccceEEeeccc
Confidence 9999999997 89999998876654 77778889999999999999999999999999999998 58889999999
Q ss_pred CcccccCCccc-ccc---CccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 005590 536 SSCFQTDNLCL-YVQ---SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEM 610 (689)
Q Consensus 536 ls~~~~~~~~~-~~g---t~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~ 610 (689)
+++++.....+ ..| ..-|.|||.+....++.++|+|+|||+||||.| |-.||++-+...++..+.+..
T Consensus 411 LsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy------- 483 (1157)
T KOG4278|consen 411 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY------- 483 (1157)
T ss_pred hhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc-------
Confidence 99987655433 334 456999999999999999999999999999999 999999987777766553211
Q ss_pred HhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHH
Q 005590 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 680 (689)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL 680 (689)
+...|+ -.++...+|++.||+|+|.+||+..|+-
T Consensus 484 ---------------------------RM~~Pe---------GCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 484 ---------------------------RMDGPE---------GCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred ---------------------------cccCCC---------CCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 111111 1234467999999999999999998864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=257.59 Aligned_cols=238 Identities=39% Similarity=0.609 Sum_probs=191.7
Q ss_pred CCCceEEEEECCCCcEEEEEEeecchhh--hHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEEEcccc-ch
Q 005590 393 AFSKVFQAQDLHTGVDVCLKIIKNDKDF--FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NL 469 (689)
Q Consensus 393 ~fG~Vyla~d~~tg~~vAvKii~~~~~~--~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmEy~~g-~L 469 (689)
+||.||++++..+++.+|+|++...... ...+.+|++.++.+ .|++|+++++.+......++|+||+.+ +|
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l------~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL------KHPNIVRLYDVFEDEDKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC------CCCcHHHHHhheeeCCEEEEEEeCCCCCCH
Confidence 5899999999888999999999764322 46777888888777 467999999999999999999999997 77
Q ss_pred HHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccCC--cccc
Q 005590 470 YEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN--LCLY 547 (689)
Q Consensus 470 ~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~--~~~~ 547 (689)
.+++..... ++...+..++.+++.+|.+||+.+++|+||+|+||+++. ++.++|+|||.+...... ....
T Consensus 75 ~~~~~~~~~------~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~--~~~~~l~d~~~~~~~~~~~~~~~~ 146 (244)
T smart00220 75 FDLLKKRGR------LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDE--DGHVKLADFGLARQLDPGGLLTTF 146 (244)
T ss_pred HHHHHhccC------CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECC--CCcEEEccccceeeeccccccccc
Confidence 777653321 788899999999999999999999999999999999985 688999999998776542 3445
Q ss_pred ccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhcccc
Q 005590 548 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN-DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYD 626 (689)
Q Consensus 548 ~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~-~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~ 626 (689)
.++..|+|||.+.+..++.++|+||||+++++|++|..||.. .........+........
T Consensus 147 ~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~------------------- 207 (244)
T smart00220 147 VGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP------------------- 207 (244)
T ss_pred cCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc-------------------
Confidence 678899999999988899999999999999999999999977 333333332211100000
Q ss_pred chhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCC
Q 005590 627 LYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 627 ~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf 685 (689)
+. ....+..+.+++.+||..+|++||++.++++||||
T Consensus 208 ---------------~~-------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 208 ---------------PP-------EWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ---------------cc-------cccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 00 00023568899999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=287.66 Aligned_cols=276 Identities=19% Similarity=0.275 Sum_probs=183.7
Q ss_pred cCcEEEEEEeccCCCCceEEEEEC----------------CCCcEEEEEEeecchhh---------------hHhHHHHH
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDL----------------HTGVDVCLKIIKNDKDF---------------FDQSLDEI 428 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~----------------~tg~~vAvKii~~~~~~---------------~~~~~~Ei 428 (689)
.++|.+.++||+|+||+||+|.+. ..++.||||.+..+... .+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 468999999999999999999752 24567999998754211 12233456
Q ss_pred HHHHHhcccCCCCCCceeEEEEEEEe--------CCeEEEEEEcccc-chHHHHhhhhcc------------------CC
Q 005590 429 KLLKLVNKNDPADEHHILRLYDYFYH--------LEHLFIVCELLRA-NLYEFQKFNQES------------------GG 481 (689)
Q Consensus 429 ~iL~~l~~~~~~~h~~Iv~l~~~f~~--------~~~l~lVmEy~~g-~L~~l~~~~~~~------------------~~ 481 (689)
.++.++++.+ ..+.++++++++|.. .+..++||||+.+ +|.+++...... ..
T Consensus 224 ~~l~~l~~~~-l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 224 YMCAKIKRNP-IAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHhhccc-chhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 6666665532 334566777777653 3568999999984 677766432100 01
Q ss_pred CcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccCCc--cc--cccCccccChh
Q 005590 482 EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL--CL--YVQSRSYRAPE 557 (689)
Q Consensus 482 ~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~~--~~--~~gt~~Y~APE 557 (689)
...+.+..++.++.|++.||.|||+.+|+||||||+|||++. ++.+||+|||++....... .. ...++.|+|||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV--DGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECC--CCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 112466778899999999999999999999999999999985 6789999999986543221 11 23478999999
Q ss_pred hhcCCC--------------------CC--chhhHHHHHHHHHHHHhCCC-CCCCChHHHHHHHHHhhcCCCcHHHHhhh
Q 005590 558 VIIGLP--------------------YD--QKIDLWSLGCILAELWTGEV-LFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 558 ~l~~~~--------------------~s--~~~DIwSLGvil~eLltG~~-PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
.+.... |+ ...|+||+|||+|+|++|.. ||.+...... ++. ... .....|
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~--~~~-~~~----~~~~~~ 453 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT--ELR-QYD----NDLNRW 453 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh--HHh-hcc----chHHHH
Confidence 986432 11 24699999999999999875 7753211110 000 000 000000
Q ss_pred hhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCC---CCCcCHHHHHcCCCCCCCC
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINP---QRRPTAREALDHPWLQHPY 689 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP---~kRpTa~ElL~hpwf~~~~ 689 (689)
. . .....+.++. +...++..+|||.+||..+| .+|+|+.|+|+||||...|
T Consensus 454 r---~--------------~~~~~~~~~~-------~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~~ 507 (507)
T PLN03224 454 R---M--------------YKGQKYDFSL-------LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPEF 507 (507)
T ss_pred H---h--------------hcccCCCccc-------ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCCC
Confidence 0 0 0001111111 22345678999999999766 7899999999999998754
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-30 Score=277.46 Aligned_cols=241 Identities=24% Similarity=0.363 Sum_probs=193.1
Q ss_pred EEEEEEeccCCCCceEEEEECC--CC--cEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 383 YYVTEYLGSAAFSKVFQAQDLH--TG--VDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 383 Y~i~~~LG~G~fG~Vyla~d~~--tg--~~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
....++||.|-||.||.|.... .| -.||||..+.+ .+..+.++.|.-+++.+ +||||+++++++.. .
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf------dHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF------DHPHIIKLIGVCVE-Q 463 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC------CCcchhheeeeeec-c
Confidence 3444579999999999997532 23 35899999874 34467788888888876 58899999999864 6
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
..+||||++. |.|..++..+... ++...+..+++||+.||.|||+.++|||||...|||+.+ ..-|||+|||
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~s-----L~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsS--p~CVKLaDFG 536 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKDS-----LPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSS--PQCVKLADFG 536 (974)
T ss_pred ceeEEEecccchhHHHHHHhcccc-----chHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecC--cceeeecccc
Confidence 7899999998 7888888766654 888999999999999999999999999999999999996 4459999999
Q ss_pred CcccccCCcccc----ccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHHH
Q 005590 536 SSCFQTDNLCLY----VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEM 610 (689)
Q Consensus 536 ls~~~~~~~~~~----~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~ 610 (689)
+++...+..... .-..-|||||.+.-..++.++|+|.|||.+||++. |..||.+-...+++..|..
T Consensus 537 LSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn--------- 607 (974)
T KOG4257|consen 537 LSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN--------- 607 (974)
T ss_pred hhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC---------
Confidence 999987764432 22456999999999999999999999999999988 9999988766665544421
Q ss_pred HhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHH
Q 005590 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 680 (689)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL 680 (689)
+-+...|. ..++.+..|+.+||.++|.+||+..|+.
T Consensus 608 -------------------------GeRlP~P~---------nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 608 -------------------------GERLPCPP---------NCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred -------------------------CCCCCCCC---------CCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 11122221 2235577999999999999999988864
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=273.44 Aligned_cols=253 Identities=20% Similarity=0.255 Sum_probs=200.1
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
.++..+.++||+|-||.|.+++- ..+.+||+|+++.+. .....+.+|+++|.+|+ ||||+++++++...+.
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLk------hPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLK------HPNIVELLGVCVQDDP 609 (807)
T ss_pred hhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccC------CCCeeEEEeeeecCCc
Confidence 46788999999999999999984 446999999998753 34568889999998884 7899999999999999
Q ss_pred EEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 458 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 458 l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
+++|+||++ |+|.+++..+.... +.-....+|+.||+.||+||.+.++|||||.+.|+|++ ++.++||+|||+
T Consensus 610 icmI~EYmEnGDLnqFl~aheapt----~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~--~e~~iKiadfgm 683 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELPT----AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVD--GEFTIKIADFGM 683 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCcc----cccchhHHHHHHHHHHHHHHHhhchhhccccccceeec--CcccEEecCccc
Confidence 999999999 67888877654322 33445667999999999999999999999999999999 589999999999
Q ss_pred cccccCCccc-----cccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh--CCCCCCCChHHHHHHHHHhhcCCCcHH
Q 005590 537 SCFQTDNLCL-----YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT--GEVLFPNDAVVMILARIIGMLGPIDLE 609 (689)
Q Consensus 537 s~~~~~~~~~-----~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt--G~~PF~~~~~~~~l~~i~~~~g~~~~e 609 (689)
++..-..... .+-...|||+|.+..++++.++|+|++|+++||+++ .+.||.....+++....-.++...+
T Consensus 684 sR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~-- 761 (807)
T KOG1094|consen 684 SRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQG-- 761 (807)
T ss_pred ccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCC--
Confidence 9854333222 344678999999999999999999999999999876 7899987776666655443322111
Q ss_pred HHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
.+.-...|. ..+..+.+||.+||..+-++|||.+++-.
T Consensus 762 -------------------------~~~~l~~P~---------~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 762 -------------------------RQVVLSRPP---------ACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred -------------------------cceeccCCC---------cCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 011111111 22345679999999999999999999854
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=278.37 Aligned_cols=246 Identities=25% Similarity=0.373 Sum_probs=200.7
Q ss_pred CcEEEEEEeccCCCCceEEEEECCC-C--cEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHT-G--VDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~t-g--~~vAvKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
++.++.++||+|.||.|++|.+... | ..||||+++.+.. ..+.+++|+.+|..|+ |+|++++|++..+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~------H~hliRLyGvVl~- 182 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQ------HPHLIRLYGVVLD- 182 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhcc------CcceeEEeeeecc-
Confidence 4567778999999999999988643 3 3589999987643 4678888998888775 7899999999887
Q ss_pred CeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEec
Q 005590 456 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 534 (689)
Q Consensus 456 ~~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DF 534 (689)
..+.+|||++. |+|++-+... ....|....+..++.||+.||.||..+++|||||-..|||+-+ .-.|||+||
T Consensus 183 qp~mMV~ELaplGSLldrLrka----~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllas--prtVKI~DF 256 (1039)
T KOG0199|consen 183 QPAMMVFELAPLGSLLDRLRKA----KKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLAS--PRTVKICDF 256 (1039)
T ss_pred chhhHHhhhcccchHHHHHhhc----cccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecc--cceeeeecc
Confidence 77889999998 6788777652 2233888999999999999999999999999999999999986 667999999
Q ss_pred CCcccccCCcccccc------CccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCc
Q 005590 535 GSSCFQTDNLCLYVQ------SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPID 607 (689)
Q Consensus 535 Gls~~~~~~~~~~~g------t~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~ 607 (689)
|+.+-++.....++- ...|.|||.+....++.++|+|++||+||||+| |+-||.+-....++.+|.+
T Consensus 257 GLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~------ 330 (1039)
T KOG0199|consen 257 GLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA------ 330 (1039)
T ss_pred cceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc------
Confidence 999877655443322 346999999999999999999999999999999 8999999988888877631
Q ss_pred HHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 608 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 608 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
...+|.. +..++.+.+++..||..+|.+|||...|.+.
T Consensus 331 ------------------------------~erLpRP-------k~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 331 ------------------------------GERLPRP-------KYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ------------------------------cccCCCC-------CCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 1112221 1234567899999999999999999888643
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=274.02 Aligned_cols=198 Identities=29% Similarity=0.524 Sum_probs=175.4
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHH---------HHHHHHHHhcccCCCCCCceeEEEEE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL---------DEIKLLKLVNKNDPADEHHILRLYDY 451 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~---------~Ei~iL~~l~~~~~~~h~~Iv~l~~~ 451 (689)
..|..++.||.|+||+|++|.++.+...|+||.+.+++-..+.+. .|+.||..++.+ .|+||++++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~---sH~NIlKlLdf 637 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKH---SHENILKLLDF 637 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhc---Cccchhhhhhe
Confidence 359999999999999999999999999999999988765544444 499999999865 59999999999
Q ss_pred EEeCCeEEEEEEcccc--chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeE
Q 005590 452 FYHLEHLFIVCELLRA--NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 529 (689)
Q Consensus 452 f~~~~~l~lVmEy~~g--~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~v 529 (689)
|++.++.||+||-.+. +|.+++.+... +++.++..|++|++.|+++||+.||||||||-+||++++ +|-+
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~kp~------m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~--~g~~ 709 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFKPR------MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDS--NGFV 709 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhccCc------cchHHHHHHHHHHHhccccccccCceecccccccEEEec--CCeE
Confidence 9999999999999874 67887776543 899999999999999999999999999999999999995 8999
Q ss_pred EEEecCCccccc-CCccccccCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q 005590 530 KIIDLGSSCFQT-DNLCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPN 589 (689)
Q Consensus 530 kL~DFGls~~~~-~~~~~~~gt~~Y~APE~l~~~~~-s~~~DIwSLGvil~eLltG~~PF~~ 589 (689)
||+|||.+.... .+.-.++||..|.|||++.|.+| +...|||+||++||.++....||.+
T Consensus 710 klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 710 KLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred EEeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999999987654 45667899999999999999876 4678999999999999999999854
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=278.05 Aligned_cols=247 Identities=21% Similarity=0.311 Sum_probs=202.9
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCc---EEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEe
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGV---DVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~---~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
.....|.++||.|.||.|++++.+..|+ .||||.++..- .....++.|..|| .+.+||||++|.++...
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIM------GQFdHPNIIrLEGVVTk 701 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIM------GQFDHPNIIRLEGVVTK 701 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhc------ccCCCCcEEEEEEEEec
Confidence 4568899999999999999999877664 59999998642 3334555555555 45679999999999999
Q ss_pred CCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEe
Q 005590 455 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 533 (689)
Q Consensus 455 ~~~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~D 533 (689)
.....||.|||+ |.|..+++.+.. .|+..++.-+++.|+.|++||-++++|||||...||||++ +...|++|
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~DG-----qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNs--nLvCKVsD 774 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQNDG-----QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNS--NLVCKVSD 774 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcCC-----ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeecc--ceEEEecc
Confidence 999999999999 567777765542 2888899999999999999999999999999999999996 88899999
Q ss_pred cCCcccccCCccc---ccc---CccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCC
Q 005590 534 LGSSCFQTDNLCL---YVQ---SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 606 (689)
Q Consensus 534 FGls~~~~~~~~~---~~g---t~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~ 606 (689)
||+++...+..-. ..| ..+|.|||.+...+++.++|+||+|++|||.++ |..||.+-+..+++..|....+
T Consensus 775 FGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyR-- 852 (996)
T KOG0196|consen 775 FGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYR-- 852 (996)
T ss_pred ccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccC--
Confidence 9999987654321 122 467999999999999999999999999999887 9999999999999988864433
Q ss_pred cHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcC
Q 005590 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 607 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~h 682 (689)
+|.... .+..+.+|+..||++|-.+||+..|++.+
T Consensus 853 ----------------------------------LPpPmD-------CP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 853 ----------------------------------LPPPMD-------CPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred ----------------------------------CCCCCC-------CcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 222111 23457899999999999999999998753
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=239.35 Aligned_cols=213 Identities=26% Similarity=0.394 Sum_probs=174.1
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
+....+..||+|++|.|-+.++..+|...|+|.++..-. ...+.++|+.+... ..++|+++++|+.+......
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r-----~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMR-----TVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhcc-----CCCCCeEEEeehhhhccccE
Confidence 444555679999999999999999999999999876432 23344444444332 35789999999999999999
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL-GIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~-gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
+|.||.|..+|..+.+.--..+. .+++..+-+|+..++.||.|||++ .++|||+||+||||+. .|+|||||||.+
T Consensus 121 wIcME~M~tSldkfy~~v~~~g~--~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~--~GqVKiCDFGIs 196 (282)
T KOG0984|consen 121 WICMELMDTSLDKFYRKVLKKGG--TIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINY--DGQVKICDFGIS 196 (282)
T ss_pred EEeHHHhhhhHHHHHHHHHhcCC--cCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEcc--CCcEEEcccccc
Confidence 99999999888777665443333 389999999999999999999976 8999999999999995 899999999999
Q ss_pred ccccCCccc--cccCccccChhhhcC----CCCCchhhHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHHhh
Q 005590 538 CFQTDNLCL--YVQSRSYRAPEVIIG----LPYDQKIDLWSLGCILAELWTGEVLFPN-DAVVMILARIIGM 602 (689)
Q Consensus 538 ~~~~~~~~~--~~gt~~Y~APE~l~~----~~~s~~~DIwSLGvil~eLltG~~PF~~-~~~~~~l~~i~~~ 602 (689)
..+.+.... -.|...|||||.+.. ..|+-++||||||+.++||.+++.||.. .++.+++.+++..
T Consensus 197 G~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 197 GYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred eeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 887765443 467788999999853 3699999999999999999999999976 5777777777643
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=257.80 Aligned_cols=259 Identities=22% Similarity=0.315 Sum_probs=195.6
Q ss_pred CCCCcceeeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCcee
Q 005590 367 ENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 446 (689)
Q Consensus 367 ~~~~~pi~~~~~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv 446 (689)
.+..+|+.....++.+.++.+.||+|.||.||+|.+ .|+.||||++.... ...+.+|.+|.+.+- +.|+||+
T Consensus 197 SGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd--E~SWfrEtEIYqTvm----LRHENIL 268 (513)
T KOG2052|consen 197 SGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD--ERSWFRETEIYQTVM----LRHENIL 268 (513)
T ss_pred CCCCchhHhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccc--hhhhhhHHHHHHHHH----hccchhh
Confidence 346788888899999999999999999999999985 68999999997643 357788888887653 3588999
Q ss_pred EEEEEEEeC----CeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC--------Cceecc
Q 005590 447 RLYDYFYHL----EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL--------GIIHCD 513 (689)
Q Consensus 447 ~l~~~f~~~----~~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~--------gIvHrD 513 (689)
.+++.=... .+++||.+|.+ |+|+|++..+. ++.....+++..+++||++||.. .|.|||
T Consensus 269 gFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~t-------v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRD 341 (513)
T KOG2052|consen 269 GFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNT-------VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRD 341 (513)
T ss_pred hhhhccccCCCceEEEEEeeecccCCcHHHHHhhcc-------CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccc
Confidence 998875433 37999999998 79999987533 88899999999999999999942 499999
Q ss_pred CCCCcEEEeccCCCeEEEEecCCcccccC-------CccccccCccccChhhhcCCC------CCchhhHHHHHHHHHHH
Q 005590 514 LKPENILIKSYQRCEIKIIDLGSSCFQTD-------NLCLYVQSRSYRAPEVIIGLP------YDQKIDLWSLGCILAEL 580 (689)
Q Consensus 514 LKp~NILl~~~~~~~vkL~DFGls~~~~~-------~~~~~~gt~~Y~APE~l~~~~------~s~~~DIwSLGvil~eL 580 (689)
||..||||.+ ++...|+|+|+|-.... .....+||.+|||||++...- --..+||||||+++||+
T Consensus 342 lKSKNILVKk--n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEi 419 (513)
T KOG2052|consen 342 LKSKNILVKK--NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEI 419 (513)
T ss_pred cccccEEEcc--CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHH
Confidence 9999999995 88899999999865332 344579999999999986531 12468999999999999
Q ss_pred HhC----------CCCCCCC----hHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccch
Q 005590 581 WTG----------EVLFPND----AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESS 646 (689)
Q Consensus 581 ltG----------~~PF~~~----~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 646 (689)
+-. ++||.+- ...+.+.+++ =..+++..+|..+.
T Consensus 420 arRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVV--------------------------------Cv~~~RP~ipnrW~ 467 (513)
T KOG2052|consen 420 ARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVV--------------------------------CVQKLRPNIPNRWK 467 (513)
T ss_pred HHHhhcCCEehhhcCCcccCCCCCCCHHHHhcce--------------------------------eecccCCCCCcccc
Confidence 852 5666431 1111111111 01233444444332
Q ss_pred hhhhccCCcHHHHHHHHHhcccCCCCCcCHHH
Q 005590 647 LEHHLQFSDAFFIDFVRTLLEINPQRRPTARE 678 (689)
Q Consensus 647 l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~E 678 (689)
....+ ..+..+|+.||..||.-|.||--
T Consensus 468 s~~~l----~~m~klMkeCW~~Np~aRltALr 495 (513)
T KOG2052|consen 468 SDPAL----RVMAKLMKECWYANPAARLTALR 495 (513)
T ss_pred cCHHH----HHHHHHHHHhhcCCchhhhHHHH
Confidence 22111 23668999999999999999754
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=261.56 Aligned_cols=261 Identities=21% Similarity=0.235 Sum_probs=188.8
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC----
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE---- 456 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~---- 456 (689)
...+.+++||+|+||.||+|+ -+++.||||+++... ...+..|..|.... ...|+||++++..-....
T Consensus 210 ~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~~~--kqs~~~Ek~Iy~lp----~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPEQE--KQSFQNEKNIYSLP----GMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CchhhHHHhhcCccceeehhh--ccCceeEEEecCHHH--HHHHHhHHHHHhcc----CccchhHHHhhchhccCCcccc
Confidence 345677889999999999998 467999999998643 35677787777766 356999999999876555
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH---------CCceeccCCCCcEEEeccCC
Q 005590 457 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS---------LGIIHCDLKPENILIKSYQR 526 (689)
Q Consensus 457 ~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~---------~gIvHrDLKp~NILl~~~~~ 526 (689)
.++||++|.. |+|.++++.+- +++....+|+..|++||+|||+ ..|+|||||..||||.. +
T Consensus 282 eywLVt~fh~kGsL~dyL~~nt-------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~--D 352 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKANT-------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN--D 352 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhcc-------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc--C
Confidence 7899999998 78999988654 8999999999999999999996 35999999999999995 8
Q ss_pred CeEEEEecCCcccccCC-----ccccccCccccChhhhcCCC-CC-----chhhHHHHHHHHHHHHhCCCCCCCChHHHH
Q 005590 527 CEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLP-YD-----QKIDLWSLGCILAELWTGEVLFPNDAVVMI 595 (689)
Q Consensus 527 ~~vkL~DFGls~~~~~~-----~~~~~gt~~Y~APE~l~~~~-~s-----~~~DIwSLGvil~eLltG~~PF~~~~~~~~ 595 (689)
++..|+|||+|...... ....+||.+|||||++.+.- +. .+.||||+|.+||||++...-+....+.++
T Consensus 353 lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Y 432 (534)
T KOG3653|consen 353 LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEY 432 (534)
T ss_pred CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcc
Confidence 88999999999765432 22368999999999997642 22 368999999999999997554421211222
Q ss_pred HHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcC
Q 005590 596 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 675 (689)
Q Consensus 596 l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT 675 (689)
..-....+|.-|.-. +++..+- ..+.+..+|.. +... ..-..+.+.+..||+.||+-|+|
T Consensus 433 qlpfe~evG~hPt~e-----~mq~~VV-----------~kK~RP~~p~~---W~~h-~~~~~l~et~EeCWDhDaeARLT 492 (534)
T KOG3653|consen 433 QLPFEAEVGNHPTLE-----EMQELVV-----------RKKQRPKIPDA---WRKH-AGMAVLCETIEECWDHDAEARLT 492 (534)
T ss_pred cCchhHHhcCCCCHH-----HHHHHHH-----------hhccCCCChhh---hhcC-ccHHHHHHHHHHHcCCchhhhhh
Confidence 111222333322211 1111111 12223333332 2111 12245889999999999999999
Q ss_pred HHH
Q 005590 676 ARE 678 (689)
Q Consensus 676 a~E 678 (689)
|.=
T Consensus 493 A~C 495 (534)
T KOG3653|consen 493 AGC 495 (534)
T ss_pred hHH
Confidence 863
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=295.33 Aligned_cols=186 Identities=21% Similarity=0.291 Sum_probs=151.4
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 460 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~l 460 (689)
..+...+.||+|+||.||+|++..+++.||+|.+..... ....|+++++.+ +||||+++++++......++
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l------~HpnIv~~~~~~~~~~~~~l 760 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKL------QHPNIVKLIGLCRSEKGAYL 760 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhC------CCCCcceEEEEEEcCCCCEE
Confidence 456777889999999999999989999999999865332 223455666555 58999999999999999999
Q ss_pred EEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHH---HCCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 461 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH---SLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 461 VmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH---~~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
||||+. |+|.+++.. +++..+..|+.||+.||+||| +.+|+||||||+||+++. ++..++. ||.
T Consensus 761 v~Ey~~~g~L~~~l~~---------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~--~~~~~~~-~~~ 828 (968)
T PLN00113 761 IHEYIEGKNLSEVLRN---------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG--KDEPHLR-LSL 828 (968)
T ss_pred EEeCCCCCcHHHHHhc---------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECC--CCceEEE-ecc
Confidence 999998 567776641 778889999999999999999 669999999999999985 4444443 554
Q ss_pred cccccCCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005590 537 SCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP 588 (689)
Q Consensus 537 s~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~ 588 (689)
+..... .....+|+.|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus 829 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~ 879 (968)
T PLN00113 829 PGLLCT-DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879 (968)
T ss_pred cccccc-CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence 433221 122367899999999999999999999999999999999999994
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-29 Score=246.90 Aligned_cols=259 Identities=20% Similarity=0.276 Sum_probs=195.7
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE-EEeCCe
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY-FYHLEH 457 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~-f~~~~~ 457 (689)
+.+.|.|.+.||.|.||++.+++++.+...+++|.++........+.+|..---.|. .|.||+.-|++ |+..+.
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls-----~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLS-----PHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeec-----cchhhhHHHHHHhhcCce
Confidence 457899999999999999999999999999999999877665666666654333332 47799987765 677889
Q ss_pred EEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 458 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 458 l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
.+++|||+. |+|...+.-.+ +-+.....++.|+++||.|||++++||||||.+||||-..+...|||||||.
T Consensus 97 YvF~qE~aP~gdL~snv~~~G-------igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAAG-------IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred EEEeeccCccchhhhhcCccc-------ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccc
Confidence 999999998 67766554322 7788899999999999999999999999999999999776777999999999
Q ss_pred cccccCCccccccCccccChhhhcCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 005590 537 SCFQTDNLCLYVQSRSYRAPEVIIGL-----PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 611 (689)
Q Consensus 537 s~~~~~~~~~~~gt~~Y~APE~l~~~-----~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~ 611 (689)
++..+........+..|.+||.+... .....+|+|.||+|+|.+|||.+||+.....+. +--.|
T Consensus 170 t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~-----------~Y~~~ 238 (378)
T KOG1345|consen 170 TRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK-----------PYWEW 238 (378)
T ss_pred ccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc-----------hHHHH
Confidence 98776655555567789999987533 255789999999999999999999974321110 00001
Q ss_pred hhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCC---cCHHHHHcCCCC
Q 005590 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR---PTAREALDHPWL 685 (689)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kR---pTa~ElL~hpwf 685 (689)
.+|+. .....+...+...++.+..+.++-|..+|++| .++.......|.
T Consensus 239 ~~w~~-------------------------rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 239 EQWLK-------------------------RKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred HHHhc-------------------------ccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 11110 01112334455566778899999999999999 666555544443
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-27 Score=270.12 Aligned_cols=255 Identities=24% Similarity=0.377 Sum_probs=199.3
Q ss_pred ceecCcEEEEEEeccCCCCceEEEEEC----C---CCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeE
Q 005590 377 TVIAGRYYVTEYLGSAAFSKVFQAQDL----H---TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILR 447 (689)
Q Consensus 377 ~~l~~rY~i~~~LG~G~fG~Vyla~d~----~---tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~ 447 (689)
++-..+..+.+.||+|+||+|++|.-. . ....||||.++... .....+..|+++|+.+. .|+||+.
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g-----~H~niv~ 366 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELG-----KHPNIVN 366 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhc-----CCcchhh
Confidence 344455567779999999999999632 1 14579999987543 44678889999999986 4889999
Q ss_pred EEEEEEeCCeEEEEEEccc-cchHHHHhhhh---ccCCC-------cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 005590 448 LYDYFYHLEHLFIVCELLR-ANLYEFQKFNQ---ESGGE-------AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 516 (689)
Q Consensus 448 l~~~f~~~~~l~lVmEy~~-g~L~~l~~~~~---~~~~~-------~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp 516 (689)
+++++...+.+++|+||+. |+|+++++..+ ..... ..++...+..++.||+.|++||++.+++||||-.
T Consensus 367 llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAa 446 (609)
T KOG0200|consen 367 LLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAA 446 (609)
T ss_pred heeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhh
Confidence 9999999999999999998 78999988776 11111 2388999999999999999999999999999999
Q ss_pred CcEEEeccCCCeEEEEecCCcccccCCcccc----cc--CccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 005590 517 ENILIKSYQRCEIKIIDLGSSCFQTDNLCLY----VQ--SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589 (689)
Q Consensus 517 ~NILl~~~~~~~vkL~DFGls~~~~~~~~~~----~g--t~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~ 589 (689)
.||||.. +..+||+|||+++......... .+ ...|||||.+....|+.++|+||+|++||||+| |..||++
T Consensus 447 RNVLi~~--~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 447 RNVLITK--NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hhEEecC--CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 9999995 6789999999998654432221 11 345999999999999999999999999999999 8999987
Q ss_pred Ch-HHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhccc
Q 005590 590 DA-VVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEI 668 (689)
Q Consensus 590 ~~-~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~ 668 (689)
-. ..+++..+. . +.+...|. ....++.++++.||..
T Consensus 525 ~~~~~~l~~~l~------------~----------------------G~r~~~P~---------~c~~eiY~iM~~CW~~ 561 (609)
T KOG0200|consen 525 IPPTEELLEFLK------------E----------------------GNRMEQPE---------HCSDEIYDLMKSCWNA 561 (609)
T ss_pred CCcHHHHHHHHh------------c----------------------CCCCCCCC---------CCCHHHHHHHHHHhCC
Confidence 43 334333221 1 11111121 2246678999999999
Q ss_pred CCCCCcCHHHHHc
Q 005590 669 NPQRRPTAREALD 681 (689)
Q Consensus 669 dP~kRpTa~ElL~ 681 (689)
+|++||+..++.+
T Consensus 562 ~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 562 DPEDRPTFSECVE 574 (609)
T ss_pred CcccCCCHHHHHH
Confidence 9999999998764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-26 Score=221.97 Aligned_cols=208 Identities=42% Similarity=0.683 Sum_probs=178.5
Q ss_pred eccCCCCceEEEEECCCCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEEEccc
Q 005590 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR 466 (689)
Q Consensus 389 LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmEy~~ 466 (689)
||.|.+|.||++.+..+++.+++|++..... ....+.+|+++++.+.+ ++|+++++++......+++||++.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~------~~i~~~~~~~~~~~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH------PNIVKLYGVFEDENHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCC------CCeeeEeeeeecCCeEEEEEecCC
Confidence 6899999999999988899999999987643 24678888888888854 689999999999999999999999
Q ss_pred -cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccCC--
Q 005590 467 -ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN-- 543 (689)
Q Consensus 467 -g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~-- 543 (689)
++|.+++.... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++.. .+.++|+|||.+......
T Consensus 75 ~~~l~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~-~~~~~l~d~~~~~~~~~~~~ 148 (215)
T cd00180 75 GGSLKDLLKENE-----GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSD-NGKVKLADFGLSKLLTSDKS 148 (215)
T ss_pred CCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCC-CCcEEEecCCceEEccCCcc
Confidence 57777765432 227889999999999999999999999999999999999841 578999999998766544
Q ss_pred -ccccccCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhh
Q 005590 544 -LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYF 621 (689)
Q Consensus 544 -~~~~~gt~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~ 621 (689)
.....+...|++||.+... .++.+.|+|++|+++++|
T Consensus 149 ~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------- 187 (215)
T cd00180 149 LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------- 187 (215)
T ss_pred hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------
Confidence 3345678889999999887 788999999999999999
Q ss_pred hccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCC
Q 005590 622 TKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHP 683 (689)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hp 683 (689)
..+.++|.+||+.||++||++.++++|+
T Consensus 188 ----------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1255899999999999999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-28 Score=268.45 Aligned_cols=256 Identities=26% Similarity=0.411 Sum_probs=202.9
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh-hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~-~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
.++|..+..+|.|.||.||+|+|+.+++..|+|+++.+.. ...-+..|+.+++..+ |+||+.+++.|...+.+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~------h~nivay~gsylr~dkl 87 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCR------HPNIVAYFGSYLRRDKL 87 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCC------CcChHHHHhhhhhhcCc
Confidence 3679999999999999999999999999999999997643 3455667777777664 78999999999999999
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
+|+||||+| +|.+..... .++++.++..+.+..+++|.|||++|-+|||||-.|||++ +.|.+|+.|||.+
T Consensus 88 wicMEycgggslQdiy~~T------gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt--d~gDvklaDfgvs 159 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHVT------GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT--DEGDVKLADFGVS 159 (829)
T ss_pred EEEEEecCCCcccceeeec------ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec--ccCceeecccCch
Confidence 999999996 455443322 2389999999999999999999999999999999999999 4888999999998
Q ss_pred ccccCC---ccccccCccccChhhhc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 005590 538 CFQTDN---LCLYVQSRSYRAPEVII---GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 611 (689)
Q Consensus 538 ~~~~~~---~~~~~gt~~Y~APE~l~---~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~ 611 (689)
..++.. ...+.||+.|||||+-. ...|....|+|++|+...|+-.-++|.-...+...+..|.+-.-.
T Consensus 160 aqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~q------ 233 (829)
T KOG0576|consen 160 AQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQ------ 233 (829)
T ss_pred hhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCC------
Confidence 776643 44589999999999963 456899999999999999998878775444443333333211110
Q ss_pred hhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCCC
Q 005590 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~~ 688 (689)
.|. +... ..-.+.|.+|++.+|..+|++|||++.+|+|||.+.+
T Consensus 234 -----------------------------pp~---lkDk-~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 234 -----------------------------PPT---LKDK-TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred -----------------------------CCc---ccCC-ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 010 0000 0113558899999999999999999999999998753
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.9e-27 Score=259.91 Aligned_cols=242 Identities=23% Similarity=0.277 Sum_probs=190.4
Q ss_pred EEEEEEeccCCCCceEEEEECCCCc----EEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC
Q 005590 383 YYVTEYLGSAAFSKVFQAQDLHTGV----DVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 383 Y~i~~~LG~G~fG~Vyla~d~~tg~----~vAvKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
.+..++||+|+||+||+|.+...|+ +||||++..... ....+++|.-+|.. ++|||++++++++....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~mas------ldHpnl~RLLgvc~~s~ 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMAS------LDHPNLLRLLGVCMLST 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhc------CCCchHHHHhhhcccch
Confidence 3445689999999999999876665 578888875432 23455555555554 46899999999998766
Q ss_pred eEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecC
Q 005590 457 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFG 535 (689)
+.||++|+. |.|+++++.++.. +-.+....|..||++||.|||.++++||||-..||||.+ ...+||+|||
T Consensus 772 -~qlvtq~mP~G~LlDyvr~hr~~-----igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVks--P~hvkitdfg 843 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVREHRDN-----IGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKS--PNHVKITDFG 843 (1177)
T ss_pred -HHHHHHhcccchHHHHHHHhhcc-----ccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecC--CCeEEEEecc
Confidence 889999998 6899999886654 778889999999999999999999999999999999995 6789999999
Q ss_pred CcccccCCcccc-----ccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhcCCCcHH
Q 005590 536 SSCFQTDNLCLY-----VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLE 609 (689)
Q Consensus 536 ls~~~~~~~~~~-----~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~~~e 609 (689)
+++........+ .-.+-|||-|.+....|+.++||||+||++||++| |..|+.+....++-..+.+
T Consensus 844 la~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~-------- 915 (1177)
T KOG1025|consen 844 LAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK-------- 915 (1177)
T ss_pred hhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc--------
Confidence 998765443221 22456999999999999999999999999999999 9999998877665544321
Q ss_pred HHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
..+..-|. ..+....-++.+||-.|+..||+++++..
T Consensus 916 --------------------------geRLsqPp---------iCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 916 --------------------------GERLSQPP---------ICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred --------------------------cccCCCCC---------CccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 11111111 12234567899999999999999999764
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=9e-27 Score=278.53 Aligned_cols=194 Identities=19% Similarity=0.219 Sum_probs=143.1
Q ss_pred ceeEEEEEE-------EeCCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 005590 444 HILRLYDYF-------YHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 516 (689)
Q Consensus 444 ~Iv~l~~~f-------~~~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp 516 (689)
||.+++++| .....++++||+++++|.+++.... ..+++..++.+++||+.||.|||++||+||||||
T Consensus 34 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP 108 (793)
T PLN00181 34 YVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPD-----RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRP 108 (793)
T ss_pred HHHHhhcccCCccccccccchhhhhhccCCccHHHHHhccc-----ccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCc
Confidence 666677766 2334678899999999998886321 2389999999999999999999999999999999
Q ss_pred CcEEEec-----------------cCCCeEEEEecCCcccccC-------------------CccccccCccccChhhhc
Q 005590 517 ENILIKS-----------------YQRCEIKIIDLGSSCFQTD-------------------NLCLYVQSRSYRAPEVII 560 (689)
Q Consensus 517 ~NILl~~-----------------~~~~~vkL~DFGls~~~~~-------------------~~~~~~gt~~Y~APE~l~ 560 (689)
+||||+. +.++.+||+|||+++.... .....++|+.|+|||++.
T Consensus 109 ~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 188 (793)
T PLN00181 109 SCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN 188 (793)
T ss_pred hhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhc
Confidence 9999963 2355677888887753211 001245788999999999
Q ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhcccccccc
Q 005590 561 GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYI 640 (689)
Q Consensus 561 ~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (689)
+..|+.++|||||||+||||++|.+|+.... ..+..+....
T Consensus 189 ~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~------------------------------------- 229 (793)
T PLN00181 189 GSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV------------------------------------- 229 (793)
T ss_pred cCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-------------------------------------
Confidence 9999999999999999999999988864321 1111111000
Q ss_pred CCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCC
Q 005590 641 IPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 641 ~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~ 687 (689)
.|... . ...+...+++.+||+.||.+|||+.|+|+||||..
T Consensus 230 ~~~~~-~-----~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 230 LPPQI-L-----LNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred cChhh-h-----hcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 00000 0 00123468899999999999999999999999975
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-25 Score=219.51 Aligned_cols=205 Identities=37% Similarity=0.565 Sum_probs=171.8
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEE
Q 005590 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 460 (689)
Q Consensus 383 Y~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~l 460 (689)
|.+.+.||.|++|.||++.+..+++.+|+|.+..... ....+.+|+..++.+ .|+|++++++.+......++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~------~~~~i~~~~~~~~~~~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL------KHPNIVKLYGVFEDPEPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC------CCCChhhheeeeecCCceEE
Confidence 5678899999999999999988899999999986543 356777788888777 36799999999998899999
Q ss_pred EEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccc
Q 005590 461 VCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539 (689)
Q Consensus 461 VmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 539 (689)
++||+.+ +|.+++...... +++..+..++.|++.+|.+||+.+++|+||+|.||+++. ++.++|+|||.+..
T Consensus 75 v~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~--~~~~~l~d~g~~~~ 147 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGGK-----LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGM--DGLVKLADFGLARF 147 (225)
T ss_pred EEeccCCCCHHHHHHhcccC-----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--CCCEEEeeCceeeE
Confidence 9999997 777776543211 678899999999999999999999999999999999985 58899999999877
Q ss_pred ccCCc----cccccCccccChhhh-cCCCCCchhhHHHHHHHHHHHHhCCCCCCC--ChHHHHHHHHH
Q 005590 540 QTDNL----CLYVQSRSYRAPEVI-IGLPYDQKIDLWSLGCILAELWTGEVLFPN--DAVVMILARII 600 (689)
Q Consensus 540 ~~~~~----~~~~gt~~Y~APE~l-~~~~~s~~~DIwSLGvil~eLltG~~PF~~--~~~~~~l~~i~ 600 (689)
..... ....++..|++||.+ ....++.++|+|+||+++++|++|+.||.. .+...+...+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 215 (225)
T smart00221 148 IHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS 215 (225)
T ss_pred ecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence 65432 445678889999999 667788899999999999999999999977 44445555554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.7e-25 Score=216.35 Aligned_cols=227 Identities=21% Similarity=0.342 Sum_probs=191.5
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 378 ~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
++.++|+++++||+|+||.+|+|.....|+.||||+-..... ..++..|.++.+.|+.. ..|+.+..++....+
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-hpqL~yEskvY~iL~~g-----~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-HPQLLYESKVYRILQGG-----VGIPHIRHYGTEKDY 85 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-CcchhHHHHHHHHhccC-----CCCchhhhhcccccc
Confidence 456899999999999999999999999999999999876533 46788899999999864 478888889999999
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCC-CeEEEEecCC
Q 005590 458 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLGS 536 (689)
Q Consensus 458 l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~-~~vkL~DFGl 536 (689)
-.+||+.++.+|.+++..+.+. ++.+.+..++-|++.-++|+|..++|||||||+|+|+.-+.. ..+.|||||+
T Consensus 86 nvlVMdLLGPsLEdLfnfC~R~-----ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 86 NVLVMDLLGPSLEDLFNFCSRR-----FTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred ceeeeeccCccHHHHHHHHhhh-----hhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccc
Confidence 9999999999999999887765 999999999999999999999999999999999999864333 3689999999
Q ss_pred cccccCC----------ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---hHHHHHHHHHhhc
Q 005590 537 SCFQTDN----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND---AVVMILARIIGML 603 (689)
Q Consensus 537 s~~~~~~----------~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~---~~~~~l~~i~~~~ 603 (689)
|+...+. .....||..|.+-..+.+...+.+.|+-|+|.+|..+.-|.+||++- +...-..+|.+..
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK 240 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK 240 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence 9765443 22357899999999988888899999999999999999999999874 3334455666666
Q ss_pred CCCcHHHHhhhh
Q 005590 604 GPIDLEMLMQGQ 615 (689)
Q Consensus 604 g~~~~e~~~~~~ 615 (689)
-..+.+.+.++-
T Consensus 241 ~s~~ie~LC~G~ 252 (341)
T KOG1163|consen 241 MSTPIEVLCKGF 252 (341)
T ss_pred cCCCHHHHhCCC
Confidence 666666666543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=222.39 Aligned_cols=226 Identities=22% Similarity=0.318 Sum_probs=196.9
Q ss_pred eecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 378 ~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
++.-.|+|.++||+|+||.++.+++..+++.||||.-+.. ....++..|.+..+.|... ++|++.|.+.....+
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-S~APQLrdEYr~YKlL~g~-----~GIP~vYYFGqeG~~ 98 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-SEAPQLRDEYRTYKLLGGT-----EGIPQVYYFGQEGKY 98 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEecccc-CCcchHHHHHHHHHHHcCC-----CCCCceeeeccccch
Confidence 5567899999999999999999999999999999987653 3347888999999999754 689999998888899
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEecc---CCCeEEEEec
Q 005590 458 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY---QRCEIKIIDL 534 (689)
Q Consensus 458 l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~---~~~~vkL~DF 534 (689)
-.+|||+++.+|.+++..+.+. |+.+.+..++.||+.-++|+|++.+|.|||||+|+||... ....|.|+||
T Consensus 99 NiLVidLLGPSLEDLFD~CgR~-----FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDF 173 (449)
T KOG1165|consen 99 NILVIDLLGPSLEDLFDLCGRR-----FSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDF 173 (449)
T ss_pred hhhhhhhhCcCHHHHHHHhcCc-----ccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEec
Confidence 9999999999999999988765 9999999999999999999999999999999999999752 2346899999
Q ss_pred CCcccccCCcc----------ccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC---ChHHHHHHHHHh
Q 005590 535 GSSCFQTDNLC----------LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN---DAVVMILARIIG 601 (689)
Q Consensus 535 Gls~~~~~~~~----------~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~---~~~~~~l~~i~~ 601 (689)
|+|+.+.++.+ ...||..||+-...++...|.+.|+-|||-+++.+|-|.+||++ .+..+-..+|-.
T Consensus 174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence 99988765433 35789999999999999999999999999999999999999986 566677777777
Q ss_pred hcCCCcHHHHhhh
Q 005590 602 MLGPIDLEMLMQG 614 (689)
Q Consensus 602 ~~g~~~~e~~~~~ 614 (689)
.....|.+.+..+
T Consensus 254 ~Kr~T~i~~Lc~g 266 (449)
T KOG1165|consen 254 TKRSTPIEVLCEG 266 (449)
T ss_pred ccccCCHHHHHhc
Confidence 7777777776654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-23 Score=220.58 Aligned_cols=204 Identities=28% Similarity=0.343 Sum_probs=170.4
Q ss_pred cEEEEEEeccCCCCceEEEEECCCC-cEEEEEEeecchhh-hHhHHHHHHHHHHhcccCCCCCCceeEEEEEE-EeCCeE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTG-VDVCLKIIKNDKDF-FDQSLDEIKLLKLVNKNDPADEHHILRLYDYF-YHLEHL 458 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg-~~vAvKii~~~~~~-~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f-~~~~~l 458 (689)
+|++.++||+|+||.||++.+..++ ..+|+|+....... ...+..|..++..+.. ...-.|+..+++.+ ......
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~--~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEK--KNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhh--hcCCCCCCEEEEeccCCCcee
Confidence 8999999999999999999987774 68999988764322 2267889999999985 12235899999999 477889
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccC-C--CeEEEEecC
Q 005590 459 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-R--CEIKIIDLG 535 (689)
Q Consensus 459 ~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~-~--~~vkL~DFG 535 (689)
++||+.++.+|.++..... ...++...+..|+.|++.+|.+||+.|++||||||.|+++.... . ..+.|+|||
T Consensus 97 ~iVM~l~G~sL~dl~~~~~----~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 97 FIVMSLLGPSLEDLRKRNP----PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEEEeccCccHHHHHHhCC----CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 9999999999999876443 23399999999999999999999999999999999999998532 1 579999999
Q ss_pred Ccc--ccc-C---------C-ccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCh
Q 005590 536 SSC--FQT-D---------N-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA 591 (689)
Q Consensus 536 ls~--~~~-~---------~-~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~ 591 (689)
+++ ... . . ...+.||..|.++.+..+...+.+.|+||++.++.+++.|..||.+..
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 998 311 1 1 223569999999999999999999999999999999999999997654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=220.51 Aligned_cols=252 Identities=19% Similarity=0.226 Sum_probs=191.1
Q ss_pred ecCcEEEEEEeccCCCCceEEEEECCC-----CcEEEEEEeecchh--hhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHT-----GVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 451 (689)
Q Consensus 379 l~~rY~i~~~LG~G~fG~Vyla~d~~t-----g~~vAvKii~~~~~--~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~ 451 (689)
-..|++..-++-+|.||.||.|++... .+.|.+|.++.... +...++.|..++.. ..|||++.+.++
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~------~sH~nll~V~~V 355 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYG------ASHPNLLSVLGV 355 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhc------CcCCCccceeEE
Confidence 356788888899999999999976543 23456676655432 23334444444433 358899999998
Q ss_pred EEeC-CeEEEEEEccc-cchHHHHhhhhccCCC--cccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCC
Q 005590 452 FYHL-EHLFIVCELLR-ANLYEFQKFNQESGGE--AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC 527 (689)
Q Consensus 452 f~~~-~~l~lVmEy~~-g~L~~l~~~~~~~~~~--~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~ 527 (689)
.... ...++++++++ |+|..++..++..... ..++..++..++.|++.|+.|||+.|+||.||...|++|+ +..
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvId--d~L 433 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVID--DQL 433 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceeh--hhe
Confidence 8744 56788899998 7898888755533322 3466777888999999999999999999999999999999 478
Q ss_pred eEEEEecCCcccccCCcccccc-----CccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHh
Q 005590 528 EIKIIDLGSSCFQTDNLCLYVQ-----SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIG 601 (689)
Q Consensus 528 ~vkL~DFGls~~~~~~~~~~~g-----t~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~ 601 (689)
+|||+|=.+++..-+......| ...||+||.+.+..|+.++|+|||||+||||+| |+.||..-++.++...+..
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd 513 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD 513 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc
Confidence 9999999999865544443333 456999999999999999999999999999999 9999988887776655531
Q ss_pred hcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHc
Q 005590 602 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 602 ~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~ 681 (689)
. +.+.+. ...+.++..++.-||...|++||+.+|+..
T Consensus 514 G------------------------------------yRlaQP-------~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 514 G------------------------------------YRLAQP-------FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred c------------------------------------ceecCC-------CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 1 111111 122355779999999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-24 Score=208.08 Aligned_cols=168 Identities=28% Similarity=0.326 Sum_probs=123.5
Q ss_pred cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccccCCccc
Q 005590 467 ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL 546 (689)
Q Consensus 467 g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~~~~~~~ 546 (689)
|+|.+++.... ..+++..++.|+.||+.||.|||+.+ ||+|||++. ++.+++ ||++.......
T Consensus 1 GsL~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~--~~~~~~--fG~~~~~~~~~-- 63 (176)
T smart00750 1 VSLADILEVRG-----RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTW--DGLLKL--DGSVAFKTPEQ-- 63 (176)
T ss_pred CcHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcC--ccceee--ccceEeecccc--
Confidence 46777765432 23899999999999999999999999 999999984 778888 99987655432
Q ss_pred cccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChH-HHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccc
Q 005590 547 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV-VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEY 625 (689)
Q Consensus 547 ~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~-~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~ 625 (689)
..+|+.|+|||++.+..++.++|||||||++|+|++|+.||..... ...+..+.....+...
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------------- 126 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDP----------------- 126 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCc-----------------
Confidence 2689999999999999999999999999999999999999965432 1222222111000000
Q ss_pred cchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCC
Q 005590 626 DLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686 (689)
Q Consensus 626 ~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~ 686 (689)
...+....... ...+.+||.+||..||.+|||+.|+++|+|+.
T Consensus 127 -------------~~~~~~~~~~~-----~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 127 -------------RDRSNLESVSA-----ARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred -------------cccccHHHHHh-----hhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 00000000000 02588999999999999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.1e-24 Score=243.24 Aligned_cols=263 Identities=22% Similarity=0.272 Sum_probs=189.3
Q ss_pred CcE-EEEEEeccCCCCceEEEEECCCCcEEEEEEeecc--hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 381 GRY-YVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 381 ~rY-~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
..| .-.+++|.|++|.|+.+......+.++.|.++.. ...... .....+..++-....+.|++++..+..+.....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~-~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~ 395 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESER-KYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG 395 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHH-HHhhhhhhheeecccccCCchhhhHHHHhhccc
Confidence 334 3456789999999999988777776666655421 111111 111125555655667789999887777776665
Q ss_pred EEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 458 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 458 l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
..-+||||.++|..++.... .++..++..++.|++.||+|||+.||.|||||++|+++.. .|.+||+|||.+
T Consensus 396 ~~~~mE~~~~Dlf~~~~~~~------~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~--~g~lki~Dfg~~ 467 (601)
T KOG0590|consen 396 ILQSMEYCPYDLFSLVMSNG------KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTE--NGILKIIDFGAA 467 (601)
T ss_pred chhhhhcccHHHHHHHhccc------ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEec--CCceEEeecCcc
Confidence 55669999998887776542 2888899999999999999999999999999999999995 789999999987
Q ss_pred ccccC-------CccccccCccccChhhhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCChHHHHHH-HHHhhcCCCcH
Q 005590 538 CFQTD-------NLCLYVQSRSYRAPEVIIGLPYDQ-KIDLWSLGCILAELWTGEVLFPNDAVVMILA-RIIGMLGPIDL 608 (689)
Q Consensus 538 ~~~~~-------~~~~~~gt~~Y~APE~l~~~~~s~-~~DIwSLGvil~eLltG~~PF~~~~~~~~l~-~i~~~~g~~~~ 608 (689)
....- .....+|+..|+|||++.+..|+. .+||||.|++++.|.+|+.||......+... .+.
T Consensus 468 ~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~-------- 539 (601)
T KOG0590|consen 468 SVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN-------- 539 (601)
T ss_pred eeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc--------
Confidence 54321 123468899999999999999885 6899999999999999999996543222110 000
Q ss_pred HHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCCCCCC
Q 005590 609 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 609 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpwf~~~ 688 (689)
. ........ .............+.+|.+||++||.+|+|+++|++.+||+..
T Consensus 540 ---------------~----------~~~~~~~~---~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 540 ---------------Y----------SDQRNIFE---GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred ---------------c----------cccccccc---ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 0 00000000 1111122234567899999999999999999999999999864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-20 Score=194.97 Aligned_cols=257 Identities=32% Similarity=0.489 Sum_probs=193.2
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 383 Y~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~----~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
|.+.+.||.|+|+.||++.+. ..+++|.+..... ....+.+|+.++..+.+. ++|+++++.+......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~-----~~i~~~~~~~~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP-----PNIVKLYDFFQDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCC-----cceeeEEEEEecCCEE
Confidence 788999999999999999976 8889999876432 355677888888877643 2799999999877888
Q ss_pred EEEEEccccc-hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCC-eEEEEecCC
Q 005590 459 FIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC-EIKIIDLGS 536 (689)
Q Consensus 459 ~lVmEy~~g~-L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~-~vkL~DFGl 536 (689)
+++++++.+. +.+++...... ..+.......++.|++.+|.|+|..+++||||||+||+++. .+ .++++|||.
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~--~~~~~~l~dfg~ 148 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDR--DGRVVKLIDFGL 148 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecC--CCCeEEEeccCc
Confidence 9999999964 54343322211 23889999999999999999999999999999999999995 44 799999999
Q ss_pred cccccCC---------ccccccCccccChhhhcC---CCCCchhhHHHHHHHHHHHHhCCCCCCCChH----HHHHHHHH
Q 005590 537 SCFQTDN---------LCLYVQSRSYRAPEVIIG---LPYDQKIDLWSLGCILAELWTGEVLFPNDAV----VMILARII 600 (689)
Q Consensus 537 s~~~~~~---------~~~~~gt~~Y~APE~l~~---~~~s~~~DIwSLGvil~eLltG~~PF~~~~~----~~~l~~i~ 600 (689)
+...... .....++..|+|||.+.+ ..++...|+||+|++++++++|..||..... ......+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 228 (384)
T COG0515 149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL 228 (384)
T ss_pred ceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHH
Confidence 8754332 345688999999999988 5788999999999999999999999876653 22222222
Q ss_pred hhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHH
Q 005590 601 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 680 (689)
Q Consensus 601 ~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL 680 (689)
....+ ........... ......+.+++.+++..+|..|.+..+..
T Consensus 229 ~~~~~------------------------------~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~ 273 (384)
T COG0515 229 ELPTP------------------------------SLASPLSPSNP-----ELISKAASDLLKKLLAKDPKNRLSSSSDL 273 (384)
T ss_pred hcCCc------------------------------ccccccCcccc-----chhhHHHHHHHHHHHhcCchhcCCHHHHh
Confidence 11111 00000000000 11124577999999999999999999998
Q ss_pred cCCCCCC
Q 005590 681 DHPWLQH 687 (689)
Q Consensus 681 ~hpwf~~ 687 (689)
.++|...
T Consensus 274 ~~~~~~~ 280 (384)
T COG0515 274 SHDLLAH 280 (384)
T ss_pred hchHhhC
Confidence 8866543
|
|
| >cd08677 C2A_Synaptotagmin-13 C2 domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-22 Score=184.14 Aligned_cols=93 Identities=14% Similarity=0.045 Sum_probs=83.6
Q ss_pred cccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcc-ccccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 308 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V~ 308 (689)
+++.|+|+|++| ||+ + .|.+|||||++|+|+.++ +|+||+++|+|+||+|||+|.|. ++.+++ +++|.++||
T Consensus 12 ~~~~L~V~vikA~~L~-~--~g~sDPYVKv~L~~~~k~-~k~kT~v~rktlnPvfnE~f~F~--v~~~~l~~~tL~~~V~ 85 (118)
T cd08677 12 QKAELHVNILEAENIS-V--DAGCECYISGCVSVSEGQ-KEAQTALKKLALHTQWEEELVFP--LPEEESLDGTLTLTLR 85 (118)
T ss_pred cCCEEEEEEEEecCCC-C--CCCCCeEEEEEEcCCcCc-cEEEcceecCCCCCccccEEEEe--CCHHHhCCcEEEEEEE
Confidence 568999999999 998 4 477999999999998664 57799999999999999999999 888888 777999999
Q ss_pred cCCCCCCCccccccccccccc
Q 005590 309 DNSDTRDGEVNGALHEGKADA 329 (689)
Q Consensus 309 D~d~~~~~d~~G~v~~~~~~~ 329 (689)
|+|++++|++||++..+..+.
T Consensus 86 d~Drfs~~d~IG~v~l~l~~~ 106 (118)
T cd08677 86 CCDRFSRHSTLGELRLKLADV 106 (118)
T ss_pred eCCCCCCCceEEEEEEccccc
Confidence 999999999999999987665
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 13, a member of class 6 synaptotagmins, is located in the brain. It functions are unknown. It, like synaptotagmins 8 and 12, does not have any consensus Ca2+ binding sites. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling step of synaptic vesicles. C2 domain |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.1e-21 Score=207.16 Aligned_cols=166 Identities=20% Similarity=0.179 Sum_probs=126.1
Q ss_pred ceeeCceecCcEEEEEEeccCCCCceEEEEECC-CCcEEEEEEeecc------hhhhHhHHHHHHHHHHhcccCCCCCCc
Q 005590 372 PIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLH-TGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKNDPADEHH 444 (689)
Q Consensus 372 pi~~~~~l~~rY~i~~~LG~G~fG~Vyla~d~~-tg~~vAvKii~~~------~~~~~~~~~Ei~iL~~l~~~~~~~h~~ 444 (689)
|-.....+.++|.+.+.||+|+||+||+|++.. +++.+|||++... ......+.+|+++|+.+++ ++
T Consensus 9 ~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h------~~ 82 (365)
T PRK09188 9 PGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRG------IG 82 (365)
T ss_pred cccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccC------CC
Confidence 334456778999999999999999999998876 6788899986532 2234567899999998864 56
Q ss_pred ee-EEEEEEEeCCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCcEEEe
Q 005590 445 IL-RLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDL-KPENILIK 522 (689)
Q Consensus 445 Iv-~l~~~f~~~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDL-Kp~NILl~ 522 (689)
++ ++++. +..++||||+.|..+.... . .. ...++.|++.||.|||+.||+|||| ||+|||++
T Consensus 83 iv~~l~~~----~~~~LVmE~~~G~~L~~~~---~------~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~ 146 (365)
T PRK09188 83 VVPQLLAT----GKDGLVRGWTEGVPLHLAR---P------HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMG 146 (365)
T ss_pred CCcEEEEc----CCcEEEEEccCCCCHHHhC---c------cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEc
Confidence 66 45442 4689999999875443221 0 11 1467899999999999999999999 99999997
Q ss_pred ccCCCeEEEEecCCcccccCCc-----------cccccCccccChhhhcC
Q 005590 523 SYQRCEIKIIDLGSSCFQTDNL-----------CLYVQSRSYRAPEVIIG 561 (689)
Q Consensus 523 ~~~~~~vkL~DFGls~~~~~~~-----------~~~~gt~~Y~APE~l~~ 561 (689)
. ++.+||+|||+++...... +...+++.|+|||.+..
T Consensus 147 ~--~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 147 P--DGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred C--CCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 4 6789999999987544321 33567888999999853
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.6e-20 Score=193.06 Aligned_cols=206 Identities=22% Similarity=0.337 Sum_probs=131.5
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHhHHHHHHHHHHhcc-cCC---CCCCceeEEEEEEEe
Q 005590 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQSLDEIKLLKLVNK-NDP---ADEHHILRLYDYFYH 454 (689)
Q Consensus 383 Y~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~----~~~~~~~Ei~iL~~l~~-~~~---~~h~~Iv~l~~~f~~ 454 (689)
....+.||.|+++.||.+.|..||+.+|+|++..... ..+++.+|.-....+.. .++ ..|-.++..++....
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 4566789999999999999999999999999864321 22333333322222111 000 001123333333221
Q ss_pred ---------C---C-----eEEEEEEccccchHHHHhhhhccCC-CcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 005590 455 ---------L---E-----HLFIVCELLRANLYEFQKFNQESGG-EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 516 (689)
Q Consensus 455 ---------~---~-----~l~lVmEy~~g~L~~l~~~~~~~~~-~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp 516 (689)
. . ..+++|+-+.++|.+++..-..... +..+.......+..|+++.+++||..|++|+||+|
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~ 173 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKP 173 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SG
T ss_pred cCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccce
Confidence 1 1 3478999999998888664322211 22244445566779999999999999999999999
Q ss_pred CcEEEeccCCCeEEEEecCCcccccCCccccccCccccChhhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005590 517 ENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIG--------LPYDQKIDLWSLGCILAELWTGEVLFP 588 (689)
Q Consensus 517 ~NILl~~~~~~~vkL~DFGls~~~~~~~~~~~gt~~Y~APE~l~~--------~~~s~~~DIwSLGvil~eLltG~~PF~ 588 (689)
+|++++. +|.++|+||+.....+........+..|.|||.... ..++.+.|.|+||+++|.|++|..||.
T Consensus 174 ~nfll~~--~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~ 251 (288)
T PF14531_consen 174 ENFLLDQ--DGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFG 251 (288)
T ss_dssp GGEEE-T--TS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STC
T ss_pred eeEEEcC--CCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCC
Confidence 9999995 899999999987665554333445678999998743 247889999999999999999999996
Q ss_pred CC
Q 005590 589 ND 590 (689)
Q Consensus 589 ~~ 590 (689)
..
T Consensus 252 ~~ 253 (288)
T PF14531_consen 252 LS 253 (288)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.4e-21 Score=222.63 Aligned_cols=244 Identities=26% Similarity=0.396 Sum_probs=174.2
Q ss_pred cEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch--hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEE
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 459 (689)
Q Consensus 382 rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~ 459 (689)
.|...+.||++.|=+|.+|++ ..|. |+||++.+.. .....+.++++-++.. ...+||.+++.-+-......|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~-~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~----l~~~pn~lPfqk~~~t~kAAy 97 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKD-REGL-VVVKVFVKQDPTISLRPFKQRLEEIKFA----LMKAPNCLPFQKVLVTDKAAY 97 (1431)
T ss_pred ceeeecccCchhhhhhhhccC-CCce-EEEEEEeccCCCCCchHHHHHHHHHHHH----hhcCCcccchHHHHHhhHHHH
Confidence 678889999999999999996 4455 9999987643 1223333333333321 224789998877766777889
Q ss_pred EEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccc
Q 005590 460 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539 (689)
Q Consensus 460 lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 539 (689)
+|-+|...+|+|.+..+. .+.+-+.+.|+.||+.||.-+|..||+|||||.+||||++ ..-+.|+||..-+.
T Consensus 98 lvRqyvkhnLyDRlSTRP------FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTS--WNW~~LtDFAsFKP 169 (1431)
T KOG1240|consen 98 LVRQYVKHNLYDRLSTRP------FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITS--WNWLYLTDFASFKP 169 (1431)
T ss_pred HHHHHHhhhhhhhhccch------HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEee--echhhhhcccccCC
Confidence 999999999998776443 3778889999999999999999999999999999999997 44578999986432
Q ss_pred ---ccCCc---cccccC----ccccChhhhcCC----------C-CCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHH
Q 005590 540 ---QTDNL---CLYVQS----RSYRAPEVIIGL----------P-YDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILA 597 (689)
Q Consensus 540 ---~~~~~---~~~~gt----~~Y~APE~l~~~----------~-~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~ 597 (689)
..+++ ..+..| ..|.|||.+... + ..++.||||+||+++||++ |++||.-.+...+-.
T Consensus 170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~ 249 (1431)
T KOG1240|consen 170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRS 249 (1431)
T ss_pred ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhc
Confidence 12222 223444 359999998542 2 5678999999999999998 799995322111100
Q ss_pred HHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHH
Q 005590 598 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 677 (689)
Q Consensus 598 ~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ 677 (689)
. +.... .++-..+ .+..++.||..|++.||++|.+|+
T Consensus 250 ~-----~~~~~--------------------------e~~Le~I------------ed~~~Rnlil~Mi~rdPs~RlSAe 286 (1431)
T KOG1240|consen 250 G-----NADDP--------------------------EQLLEKI------------EDVSLRNLILSMIQRDPSKRLSAE 286 (1431)
T ss_pred c-----CccCH--------------------------HHHHHhC------------cCccHHHHHHHHHccCchhccCHH
Confidence 0 00000 0111111 134578999999999999999999
Q ss_pred HHHcC
Q 005590 678 EALDH 682 (689)
Q Consensus 678 ElL~h 682 (689)
+.|+-
T Consensus 287 dyL~~ 291 (1431)
T KOG1240|consen 287 DYLQK 291 (1431)
T ss_pred HHHHh
Confidence 99974
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.1e-21 Score=214.23 Aligned_cols=236 Identities=27% Similarity=0.346 Sum_probs=183.5
Q ss_pred EeccCCCCceEEEEE---CCCCcEEEEEEeecchhh---hHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEE
Q 005590 388 YLGSAAFSKVFQAQD---LHTGVDVCLKIIKNDKDF---FDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIV 461 (689)
Q Consensus 388 ~LG~G~fG~Vyla~d---~~tg~~vAvKii~~~~~~---~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lV 461 (689)
.+|+|.||.|+++.. ...|..+|+|+.++.... ......|..++..++ .||+++++...|+....++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~-----~~~f~v~lhyafqt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVH-----NTPFLVKLHYAFQTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhcc-----CCCceeeeeeeeccccchhHh
Confidence 379999999998853 345677999988753211 113334555665554 368999999999999999999
Q ss_pred EEccccc-hHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCcccc
Q 005590 462 CELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 540 (689)
Q Consensus 462 mEy~~g~-L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~~ 540 (689)
++++.|+ +..-.. ....+.+...+.+...++-|+.++|+.+|+|||+|++||+++. +|++++.|||+++..
T Consensus 76 ld~~rgg~lft~l~------~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~--~Ghi~~tdfglske~ 147 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLS------KEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLL--EGHIKLTDFGLSKEA 147 (612)
T ss_pred hhhcccchhhhccc------cCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecc--cCccccCCchhhhHh
Confidence 9999874 433222 2223778888899999999999999999999999999999994 899999999999875
Q ss_pred cCCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhh
Q 005590 541 TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKY 620 (689)
Q Consensus 541 ~~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~ 620 (689)
-+.... |||..|||||++. ....++|+||+|+++|+|++|..||.. +...+|.+.--+.|.
T Consensus 148 v~~~~~-cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~------------ 208 (612)
T KOG0603|consen 148 VKEKIA-CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR------------ 208 (612)
T ss_pred Hhhhhc-ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch------------
Confidence 443333 9999999999998 567899999999999999999999987 444444432222222
Q ss_pred hhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCH-----HHHHcCCCCCC
Q 005590 621 FTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA-----REALDHPWLQH 687 (689)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa-----~ElL~hpwf~~ 687 (689)
....++++++..|+..+|.+|.-+ .|+.+|++|+.
T Consensus 209 --------------------------------~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~ 248 (612)
T KOG0603|consen 209 --------------------------------ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQS 248 (612)
T ss_pred --------------------------------hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchhee
Confidence 223557799999999999999875 78999999985
|
|
| >cd08692 C2B_Tac2-N C2 domain second repeat found in Tac2-N (Tandem C2 protein in Nucleus) | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.4e-21 Score=178.64 Aligned_cols=107 Identities=12% Similarity=0.021 Sum_probs=95.1
Q ss_pred cccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCC-CcccccccccccccccCccccccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGS-SIDWIEGFKGSSDLHFKGAEKDLMPAEI 308 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tl-nP~~ne~f~~~~~~~~~~~~~~L~~~V~ 308 (689)
++++|+|+|++| ||++|+..+..|||||+.|++++++.+|+||+++|+|+ ||+|||+|.|+ ++.+..+.+|.++||
T Consensus 12 ~~~rLtV~VikarnL~~~~~~~~~dpYVKV~L~~~~k~~~KkKT~v~k~t~~~P~fNEsF~Fd--v~~~~~~v~l~v~v~ 89 (135)
T cd08692 12 VNSRIQLQILEAQNLPSSSTPLTLSFFVKVGMFSTGGLLYKKKTRLVKSSNGQVKWGETMIFP--VTQQEHGIQFLIKLY 89 (135)
T ss_pred cCCeEEEEEEEccCCCcccCCCCCCcEEEEEEEECCCcceeecCccEECCCCCceecceEEEe--CCchhheeEEEEEEE
Confidence 678899999999 99999777788999999999999999999999999996 58999999999 777666767999999
Q ss_pred cCCCCCCCcccccccccccccccccCCCccc
Q 005590 309 DNSDTRDGEVNGALHEGKADAEEHGVATPDL 339 (689)
Q Consensus 309 D~d~~~~~d~~G~v~~~~~~~~~e~~~~~~~ 339 (689)
|+|++++|++||.+.++..+..+++...|.+
T Consensus 90 d~~~~~~n~~IG~v~lG~~~~~~~~~~hW~~ 120 (135)
T cd08692 90 SRSSVRRKHFLGQVWISSDSSSSEAVEQWKD 120 (135)
T ss_pred eCCCCcCCceEEEEEECCccCCchhhhhHHH
Confidence 9999999999999999987666666666554
|
Tac2-N contains two C2 domains and a short C-terminus including a WHXL motif, which are key in stabilizing transport vesicles to the plasma membrane by binding to a plasma membrane. However unlike the usual carboxyl-terminal-type (C-type) tandem C2 proteins, it lacks a transmembrane domain, a Slp-homology domain, and a Munc13-1-interacting domain. Homology search analysis indicate that no known protein motifs are located in its N-terminus, making Tac2-N a novel class of Ca2+-independent, C-type tandem C2 proteins. The C2 domain was first identified in PKC. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polypho |
| >cd08407 C2B_Synaptotagmin-13 C2 domain second repeat present in Synaptotagmin 13 | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.3e-21 Score=180.89 Aligned_cols=104 Identities=13% Similarity=-0.022 Sum_probs=91.6
Q ss_pred cccceEEEEecc-CCcccCCC--CCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcc-ccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHN--VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPA 306 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~--g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~ 306 (689)
.+++|+|+|++| ||.+||.+ +.+|||||++|+|+.++.+|+||+++++++||+|||+|.|+ ++.+.+ +.+|.++
T Consensus 13 ~~~~L~V~V~karnL~~~d~~~~~~~DpYVKv~l~~~~~k~~kkkT~v~k~t~nPvfNE~f~F~--v~~~~L~~~~L~~~ 90 (138)
T cd08407 13 AANRLLVVVIKAKNLHSDQLKLLLGIDVSVKVTLKHQNAKLKKKQTKRAKHKINPVWNEMIMFE--LPSELLAASSVELE 90 (138)
T ss_pred CCCeEEEEEEEecCCCccccCCCCCCCeEEEEEEEcCCcccceeccceeeCCCCCccccEEEEE--CCHHHhCccEEEEE
Confidence 567899999999 99999954 55899999999999988899999999999999999999999 888888 6669999
Q ss_pred cccCCCCCCCcccccccccccccccccCCCc
Q 005590 307 EIDNSDTRDGEVNGALHEGKADAEEHGVATP 337 (689)
Q Consensus 307 V~D~d~~~~~d~~G~v~~~~~~~~~e~~~~~ 337 (689)
|||+|++++++++|++.++... .++....|
T Consensus 91 V~d~d~~~~~d~iG~v~lg~~~-~g~~~~hW 120 (138)
T cd08407 91 VLNQDSPGQSLPLGRCSLGLHT-SGTERQHW 120 (138)
T ss_pred EEeCCCCcCcceeceEEecCcC-CCcHHHHH
Confidence 9999999999999999998754 44444443
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 13, a member of class 6 synaptotagmins, is located in the brain. It functions are unknown. It, like synaptotagmins 8 and 12, does not have any consensus Ca2+ binding sites. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recy |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.7e-20 Score=214.06 Aligned_cols=218 Identities=29% Similarity=0.391 Sum_probs=160.8
Q ss_pred cCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEE
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 459 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~ 459 (689)
..+|..+++|..|+||.||+++|+.+.+.+|+|+-++.- |++ ||+.+- +..+
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-----------ilR-----------nilt~a------~npf 133 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-----------ILR-----------NILTFA------GNPF 133 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccch-----------hhh-----------cccccc------CCcc
Confidence 468999999999999999999999999999996543321 111 111111 1112
Q ss_pred EEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCccc
Q 005590 460 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539 (689)
Q Consensus 460 lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 539 (689)
.| |+-..+++.... ++. +++.+++|||+.||+|||+||+|.+|+. -|++|++|||+++.
T Consensus 134 vv-----gDc~tllk~~g~------lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~--mGhiKlTDfgLsk~ 192 (1205)
T KOG0606|consen 134 VV-----GDCATLLKNIGP------LPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITS--MGHIKLTDFGLSKK 192 (1205)
T ss_pred ee-----chhhhhcccCCC------Ccc--------hhhHHhHhhccCCeecCCCCCCcceeee--cccccccchhhhhh
Confidence 22 433333332211 222 2266999999999999999999999995 89999999998754
Q ss_pred ccC------------------CccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHh
Q 005590 540 QTD------------------NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 601 (689)
Q Consensus 540 ~~~------------------~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~ 601 (689)
... .....+|||.|+|||++..+.|+..+|+|++|+|+|+.+-|..||.++.+++++...+.
T Consensus 193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis 272 (1205)
T KOG0606|consen 193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 272 (1205)
T ss_pred hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh
Confidence 211 12235899999999999999999999999999999999999999999999999888763
Q ss_pred hcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcC---HHH
Q 005590 602 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT---ARE 678 (689)
Q Consensus 602 ~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpT---a~E 678 (689)
.....|+++ ....++++++|..+|+.+|..|.- +-+
T Consensus 273 d~i~wpE~d-----------------------------------------ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~e 311 (1205)
T KOG0606|consen 273 DDIEWPEED-----------------------------------------EALPPEAQDLIEQLLRQNPLCRLGTGGALE 311 (1205)
T ss_pred hhccccccC-----------------------------------------cCCCHHHHHHHHHHHHhChHhhcccchhhh
Confidence 322211110 112356889999999999999964 566
Q ss_pred HHcCCCCCC
Q 005590 679 ALDHPWLQH 687 (689)
Q Consensus 679 lL~hpwf~~ 687 (689)
+-+|+||+.
T Consensus 312 vk~h~ff~~ 320 (1205)
T KOG0606|consen 312 VKQHGFFQL 320 (1205)
T ss_pred hhhccceee
Confidence 779999974
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.7e-20 Score=186.82 Aligned_cols=177 Identities=15% Similarity=0.203 Sum_probs=131.3
Q ss_pred cceeeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh----hhHh------HHHHHHHHHHhcccCCC
Q 005590 371 LPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD----FFDQ------SLDEIKLLKLVNKNDPA 440 (689)
Q Consensus 371 ~pi~~~~~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~----~~~~------~~~Ei~iL~~l~~~~~~ 440 (689)
+....+.++.++|+++++||.|+||.||++.+ ++..+|||++..... .... +.+|++.+.++.
T Consensus 21 ~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~----- 93 (232)
T PRK10359 21 YKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR----- 93 (232)
T ss_pred HHHHHHHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-----
Confidence 45566788899999999999999999999764 477899999974321 1112 467777888886
Q ss_pred CCCceeEEEEEEEeC--------CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCcee
Q 005590 441 DEHHILRLYDYFYHL--------EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIH 511 (689)
Q Consensus 441 ~h~~Iv~l~~~f~~~--------~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvH 511 (689)
|++|..+.+++... ...++||||++| +|.+... +++ ....+++.+|..||..|++|
T Consensus 94 -~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH~~gi~H 158 (232)
T PRK10359 94 -SEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLHQHGMVS 158 (232)
T ss_pred -HCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHHHcCCcc
Confidence 45788777776643 358999999998 4544321 222 24569999999999999999
Q ss_pred ccCCCCcEEEeccCCCeEEEEecCCcccccCCccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHH
Q 005590 512 CDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELW 581 (689)
Q Consensus 512 rDLKp~NILl~~~~~~~vkL~DFGls~~~~~~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLl 581 (689)
|||||+||+++. ++ ++|+|||........... ...++...|..++|+|+||+++..+.
T Consensus 159 ~Dikp~Nili~~--~g-i~liDfg~~~~~~e~~a~---------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 159 GDPHKGNFIVSK--NG-LRIIDLSGKRCTAQRKAK---------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCChHHEEEeC--CC-EEEEECCCcccccchhhH---------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999999985 55 999999987554322111 11444556778999999999987654
|
|
| >cd08680 C2_Kibra C2 domain found in Human protein Kibra | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-20 Score=172.80 Aligned_cols=99 Identities=14% Similarity=0.054 Sum_probs=90.5
Q ss_pred cccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCc-ceeeeeccccCCCcccccccccccccccCcc-cccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTE-KSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 307 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~-~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V 307 (689)
..++|+|+|++| ||+++|.+|.+|||||++|+|+.++. +++||+++++++||+|||+|.|. ++.+++ +++|.++|
T Consensus 12 ~~~~L~V~V~~arnL~~~~~~~~~dpyVKv~Llp~~~~~~~~~kT~v~~~t~nPvfnE~F~f~--v~~~~L~~~~L~~~V 89 (124)
T cd08680 12 GDSSLVISVEQLRNLSALSIPENSKVYVRVALLPCSSSTSCLFRTKALEDQDKPVFNEVFRVP--ISSTKLYQKTLQVDV 89 (124)
T ss_pred CCCEEEEEEeEecCCcccccCCCCCeEEEEEEccCCCCCCceEEcCccCCCCCCccccEEEEE--CCHHHhhcCEEEEEE
Confidence 457899999999 99999999999999999999999874 68899999999999999999999 888888 67799999
Q ss_pred ccCCCCCCCccccccccccccccc
Q 005590 308 IDNSDTRDGEVNGALHEGKADAEE 331 (689)
Q Consensus 308 ~D~d~~~~~d~~G~v~~~~~~~~~ 331 (689)
||++++++++++|+++++..+.+-
T Consensus 90 ~~~~~~~~~~~lG~~~i~L~~~~~ 113 (124)
T cd08680 90 CSVGPDQQEECLGGAQISLADFES 113 (124)
T ss_pred EeCCCCCceeEEEEEEEEhhhccC
Confidence 999999999999999998776644
|
Kibra is thought to be a regulator of the Salvador (Sav)/Warts (Wts)/Hippo (Hpo) (SWH) signaling network, which limits tissue growth by inhibiting cell proliferation and promoting apoptosis. The core of the pathway consists of a MST and LATS family kinase cascade that ultimately phosphorylates and inactivates the YAP/Yorkie (Yki) transcription coactivator. The FERM domain proteins Merlin (Mer) and Expanded (Ex) are part of the upstream regulation controlling pathway mechanism. Kibra colocalizes and associates with Mer and Ex and is thought to transduce an extracellular signal via the SWH network. The apical scaffold machinery that contains Hpo, Wts, and Ex recruits Yki to the apical membrane facilitating its inhibitory phosphorlyation by Wts. Since Kibra associates with Ex and is apically located it is hypothesized that KIBRA is part of the scaffold, helps in the Hpo/Wts complex, and helps recruit Yki for inactivation that prom |
| >cd08406 C2B_Synaptotagmin-12 C2 domain second repeat present in Synaptotagmin 12 | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-20 Score=175.80 Aligned_cols=103 Identities=12% Similarity=0.020 Sum_probs=91.7
Q ss_pred cccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcc-ccccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 308 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V~ 308 (689)
..++|+|.|++| ||+++|.+|.+|||||++|+|++++.+|+||+++|+|+||+|||+|.|. ++.+.+ +.+|.++||
T Consensus 13 ~~~~L~V~Vi~A~nL~~~~~~g~~DpyVkv~l~~~~~~~~k~kT~v~k~t~nP~~nE~f~F~--v~~~~l~~~~l~~~V~ 90 (136)
T cd08406 13 TAERLTVVVVKARNLVWDNGKTTADPFVKVYLLQDGRKISKKKTSVKRDDTNPIFNEAMIFS--VPAIVLQDLSLRVTVA 90 (136)
T ss_pred CCCEEEEEEEEeeCCCCccCCCCCCeEEEEEEEeCCccccccCCccccCCCCCeeceeEEEE--CCHHHhCCcEEEEEEE
Confidence 457899999999 9999999999999999999999988888999999999999999999999 888777 666999999
Q ss_pred cCCCCCCCcccccccccccccccccCCC
Q 005590 309 DNSDTRDGEVNGALHEGKADAEEHGVAT 336 (689)
Q Consensus 309 D~d~~~~~d~~G~v~~~~~~~~~e~~~~ 336 (689)
|+|++++++++|.+.++... .+++...
T Consensus 91 ~~d~~~~~~~iG~v~lg~~~-~g~~~~h 117 (136)
T cd08406 91 ESTEDGKTPNVGHVIIGPAA-SGMGLSH 117 (136)
T ss_pred eCCCCCCCCeeEEEEECCCC-CChhHHH
Confidence 99999999999999997653 3444443
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 12, a member of class 6 synaptotagmins, is located in the brain. It functions are unknown. It, like synaptotagmins 8 and 13, do not have any consensus Ca2+ binding sites. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycl |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.5e-19 Score=176.13 Aligned_cols=139 Identities=17% Similarity=0.214 Sum_probs=102.8
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEeecchhh---------------------------hHhHHHHHHHHHHhcccC
Q 005590 386 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF---------------------------FDQSLDEIKLLKLVNKND 438 (689)
Q Consensus 386 ~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~---------------------------~~~~~~Ei~iL~~l~~~~ 438 (689)
...||+|+||.||+|.+. +|+.||||+++.+... ......|.+++..+....
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 457999999999999986 8999999999764210 012234888899887542
Q ss_pred CCCCCceeEEEEEEEeCCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCC
Q 005590 439 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL-HSLGIIHCDLKPE 517 (689)
Q Consensus 439 ~~~h~~Iv~l~~~f~~~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yL-H~~gIvHrDLKp~ 517 (689)
. .+|+++. ... .+|||||++|+.+....... ..+++..+..++.|++.+|.+| |+.||+||||||+
T Consensus 81 v-~~p~~~~------~~~-~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~ 147 (190)
T cd05147 81 I-PCPEPIL------LKS-HVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQDCRLVHADLSEY 147 (190)
T ss_pred C-CCCcEEE------ecC-CEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence 1 2333321 122 37999999975432221111 2388899999999999999999 7999999999999
Q ss_pred cEEEeccCCCeEEEEecCCccccc
Q 005590 518 NILIKSYQRCEIKIIDLGSSCFQT 541 (689)
Q Consensus 518 NILl~~~~~~~vkL~DFGls~~~~ 541 (689)
|||++ ++.++|+|||++....
T Consensus 148 NIli~---~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 148 NLLYH---DGKLYIIDVSQSVEHD 168 (190)
T ss_pred HEEEE---CCcEEEEEccccccCC
Confidence 99998 4679999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.5e-19 Score=207.29 Aligned_cols=203 Identities=20% Similarity=0.291 Sum_probs=162.2
Q ss_pred cceeeCceecCcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEE
Q 005590 371 LPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 450 (689)
Q Consensus 371 ~pi~~~~~l~~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~ 450 (689)
.|.....+-+..|.|.+.||+|+||+||+|.+.. |+.||||+-+....|. +.-..+++.+|+.. --+-|..+..
T Consensus 688 ~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE--fYI~~q~~~RLk~~---~~~~~~~~~~ 761 (974)
T KOG1166|consen 688 NPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE--FYICLQVMERLKPQ---MLPSIMHISS 761 (974)
T ss_pred CccceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee--eeehHHHHHhhchh---hhcchHHHHH
Confidence 3444556667889999999999999999999766 9999999988765442 22233444455411 1235777777
Q ss_pred EEEeCCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEec-----c
Q 005590 451 YFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-----Y 524 (689)
Q Consensus 451 ~f~~~~~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~-----~ 524 (689)
.+...+.-++|+||.. |+|++++. ..+.+.+..+..++.||+..+..||..+|||+||||+|+||.. .
T Consensus 762 a~~~~~~S~lv~ey~~~Gtlld~~N------~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~ 835 (974)
T KOG1166|consen 762 AHVFQNASVLVSEYSPYGTLLDLIN------TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADS 835 (974)
T ss_pred HHccCCcceeeeeccccccHHHhhc------cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCC
Confidence 7777888899999999 78999887 3344889999999999999999999999999999999999963 2
Q ss_pred CCCeEEEEecCCccccc---C--CccccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Q 005590 525 QRCEIKIIDLGSSCFQT---D--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 585 (689)
Q Consensus 525 ~~~~vkL~DFGls~~~~---~--~~~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLltG~~ 585 (689)
+...++|||||.+..+. + .....++|-.+-.+|+..|.+|+..+|.|.|+.+++-||.|+.
T Consensus 836 ~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 836 DSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 24469999999886432 2 2344688999999999999999999999999999999999863
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.4e-18 Score=168.29 Aligned_cols=140 Identities=18% Similarity=0.211 Sum_probs=102.7
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEeecchhh---------------------------hHhHHHHHHHHHHhcccC
Q 005590 386 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF---------------------------FDQSLDEIKLLKLVNKND 438 (689)
Q Consensus 386 ~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~---------------------------~~~~~~Ei~iL~~l~~~~ 438 (689)
.+.||+|++|+||+|.+. +|+.||||+++..... .....+|.+.+..+.+.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~- 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA- 79 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC-
Confidence 567999999999999987 8999999998864210 11224677778777654
Q ss_pred CCCCCceeEEEEEEEeCCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCC
Q 005590 439 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPE 517 (689)
Q Consensus 439 ~~~h~~Iv~l~~~f~~~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~-~gIvHrDLKp~ 517 (689)
++.....+... ..++||||++|.......... ..++...+..++.|++.+|.+||+ .||+||||||+
T Consensus 80 -----~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~ 147 (190)
T cd05145 80 -----GVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEY 147 (190)
T ss_pred -----CCCCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChh
Confidence 33222222222 248999999975222111111 126788899999999999999999 99999999999
Q ss_pred cEEEeccCCCeEEEEecCCcccccC
Q 005590 518 NILIKSYQRCEIKIIDLGSSCFQTD 542 (689)
Q Consensus 518 NILl~~~~~~~vkL~DFGls~~~~~ 542 (689)
|||++ ++.++|+|||++.....
T Consensus 148 NIll~---~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 148 NILYH---DGKPYIIDVSQAVELDH 169 (190)
T ss_pred hEEEE---CCCEEEEEcccceecCC
Confidence 99998 57899999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd04028 C2B_RIM1alpha C2 domain second repeat contained in Rab3-interacting molecule (RIM) proteins | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.4e-19 Score=168.50 Aligned_cols=95 Identities=9% Similarity=-0.037 Sum_probs=85.8
Q ss_pred ccceEEEEecc-CCcccC-CCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCccccccccccc-
Q 005590 232 NDYGYLSSKEA-DLIDLQ-HNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI- 308 (689)
Q Consensus 232 ~~~l~v~i~e~-~L~~~d-~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~~~~L~~~V~- 308 (689)
.+.|+|.|++| ||.++| .+|.+|||||++|+|++++..|+||+++|+|+||+|||+|.|. +. ..+++|.++||
T Consensus 28 ~~~L~V~Vi~ArnL~~~~~~~g~sDPYVKv~Llp~~~~~~k~KT~v~kktlnPvfNE~F~f~--v~--l~~~~L~v~V~~ 103 (146)
T cd04028 28 KGQLEVEVIRARGLVQKPGSKVLPAPYVKVYLLEGKKCIAKKKTKIARKTLDPLYQQQLVFD--VS--PTGKTLQVIVWG 103 (146)
T ss_pred CCEEEEEEEEeeCCCcccCCCCCcCCeEEEEEECCCccccceeceecCCCCCCccCCeEEEE--Ec--CCCCEEEEEEEe
Confidence 46899999999 999985 6789999999999999998889999999999999999999999 65 34777999999
Q ss_pred cCCCCCCCcccccccccccccc
Q 005590 309 DNSDTRDGEVNGALHEGKADAE 330 (689)
Q Consensus 309 D~d~~~~~d~~G~v~~~~~~~~ 330 (689)
|++++++++++|++.+.....+
T Consensus 104 d~~~~~~~~~iG~~~i~L~~l~ 125 (146)
T cd04028 104 DYGRMDKKVFMGVAQILLDDLD 125 (146)
T ss_pred CCCCCCCCceEEEEEEEccccc
Confidence 7999999999999999887764
|
RIMs are believed to organize specialized sites of the plasma membrane called active zones. They also play a role in controlling neurotransmitter release, plasticity processes, as well as memory and learning. RIM contains an N-terminal zinc finger domain, a PDZ domain, and two C-terminal C2 domains (C2A, C2B). C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as |
| >cd08392 C2A_SLP-3 C2 domain first repeat present in Synaptotagmin-like protein 3 | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.3e-19 Score=165.68 Aligned_cols=100 Identities=11% Similarity=-0.011 Sum_probs=90.9
Q ss_pred cccceEEEEecc-CCcccCCC-CCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcc-cccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHN-VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 307 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~-g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V 307 (689)
..+.|+|.|++| ||+++|.+ |.+|||||++|+|+.++..|+||+++++++||+|||+|.|. ++.+.+ +++|.+.|
T Consensus 13 ~~~~L~V~V~~a~nL~~~d~~~g~~dpYVkv~llp~~~~~~k~kT~v~~~t~nPvfNE~F~f~--v~~~~l~~~~L~v~V 90 (128)
T cd08392 13 RTSCLEITIKACRNLAYGDEKKKKCHPYVKVCLLPDKSHNSKRKTAVKKGTVNPVFNETLKYV--VEADLLSSRQLQVSV 90 (128)
T ss_pred CCCEEEEEEEecCCCCccCCCCCCCCeEEEEEEEeCCcccceeecccccCCCCCccceEEEEE--cCHHHhCCcEEEEEE
Confidence 567999999999 99999986 99999999999999988889999999999999999999999 887777 56799999
Q ss_pred ccCCCCCCCcccccccccccccccc
Q 005590 308 IDNSDTRDGEVNGALHEGKADAEEH 332 (689)
Q Consensus 308 ~D~d~~~~~d~~G~v~~~~~~~~~e 332 (689)
||++++++++++|++.+...+.+-.
T Consensus 91 ~~~~~~~~~~~lG~~~i~L~~~~~~ 115 (128)
T cd08392 91 WHSRTLKRRVFLGEVLIPLADWDFE 115 (128)
T ss_pred EeCCCCcCcceEEEEEEEcCCcccC
Confidence 9999999999999999988766443
|
All Slp members basically share an N-terminal Slp homology domain (SHD) and C-terminal tandem C2 domains (named the C2A domain and the C2B domain) with the SHD and C2 domains being separated by a linker sequence of various length. SHD of Slp (except for the Slp4-SHD) function as a specific Rab27A/B-binding domain. In addition to Slp, rabphilin, Noc2, and Munc13-4 also function as Rab27-binding proteins. Little is known about the expression or localization of Slp3. The C2A domain of Slp3 is Ca2+ dependent. It has been demonstrated that Slp3 promotes dense-core vesicle exocytosis. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.6e-17 Score=165.38 Aligned_cols=182 Identities=17% Similarity=0.118 Sum_probs=136.9
Q ss_pred EEEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhH-----hHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 384 YVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFD-----QSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 384 ~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~-----~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
.+...|++|+||+|+++.. .+.+++.+.+.....+.. .+.+|+++|+.+.+ +++|++++++ ...
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~-----~~~vP~ll~~----~~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDG-----LPRTPRLLHW----DGR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCC-----CCCCCEEEEE----cCE
Confidence 3567899999999998873 788888887776654433 57789999999965 3578888775 446
Q ss_pred EEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDL-KPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDL-Kp~NILl~~~~~~~vkL~DFGls 537 (689)
+++|||+.|..+... .... ...++.|++.+|.++|+.||+|||| ||+|||++. ++.++|+|||++
T Consensus 74 ~lvmeyI~G~~L~~~-----------~~~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~--~g~i~LIDFG~A 139 (218)
T PRK12274 74 HLDRSYLAGAAMYQR-----------PPRG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQE--DGSPAVIDFQLA 139 (218)
T ss_pred EEEEeeecCccHHhh-----------hhhh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcC--CCCEEEEECCCc
Confidence 999999998643211 0011 1347889999999999999999999 799999984 678999999999
Q ss_pred ccccCCcc----------------ccccCccccChhhhcCC-CCC-chhhHHHHHHHHHHHHhCCCCCCCC
Q 005590 538 CFQTDNLC----------------LYVQSRSYRAPEVIIGL-PYD-QKIDLWSLGCILAELWTGEVLFPND 590 (689)
Q Consensus 538 ~~~~~~~~----------------~~~gt~~Y~APE~l~~~-~~s-~~~DIwSLGvil~eLltG~~PF~~~ 590 (689)
........ ....++.|+.|+...-. ..+ ...++++.|+.+|.++|+..|+-++
T Consensus 140 ~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 140 VRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred eecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 75443221 02347788888875432 344 5778999999999999999887543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.5e-18 Score=178.79 Aligned_cols=191 Identities=24% Similarity=0.326 Sum_probs=137.1
Q ss_pred CCCCceeEEEEEEEe---------------------------CCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHH
Q 005590 440 ADEHHILRLYDYFYH---------------------------LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 492 (689)
Q Consensus 440 ~~h~~Iv~l~~~f~~---------------------------~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~ 492 (689)
..||||+++...|.+ ...+|+||.....+|..++.... .+....+.
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~-------~s~r~~~~ 345 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH-------RSYRTGRV 345 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC-------CchHHHHH
Confidence 479999999988853 23589999999999999887554 56677888
Q ss_pred HHHHHHHHHHHHHHCCceeccCCCCcEEEecc--CCCeEEEEecCCccccc---------CCccccccCccccChhhhcC
Q 005590 493 ITRQCLEALEYLHSLGIIHCDLKPENILIKSY--QRCEIKIIDLGSSCFQT---------DNLCLYVQSRSYRAPEVIIG 561 (689)
Q Consensus 493 i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~--~~~~vkL~DFGls~~~~---------~~~~~~~gt~~Y~APE~l~~ 561 (689)
|+.|+++|+.|||++||.|||+|.+||||.-+ +-..++|+|||.+.--. ......-|.-.-||||+...
T Consensus 346 ~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 346 ILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 99999999999999999999999999998543 34578999999652111 11112345566899999864
Q ss_pred CC------CCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccc
Q 005590 562 LP------YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETN 635 (689)
Q Consensus 562 ~~------~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (689)
.+ --.++|.|+.|.+.||+++...||....... -....
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-----------------L~~r~------------------- 469 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-----------------LDTRT------------------- 469 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-----------------echhh-------------------
Confidence 32 2248999999999999999999996521100 00000
Q ss_pred cccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHH
Q 005590 636 QLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA 679 (689)
Q Consensus 636 ~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~El 679 (689)
-.+.++|. ......+.+++||..+|+.||++|+++.=+
T Consensus 470 Yqe~qLPa------lp~~vpp~~rqlV~~lL~r~pskRvsp~iA 507 (598)
T KOG4158|consen 470 YQESQLPA------LPSRVPPVARQLVFDLLKRDPSKRVSPNIA 507 (598)
T ss_pred hhhhhCCC------CcccCChHHHHHHHHHhcCCccccCCccHH
Confidence 00111221 112234668899999999999999997644
|
|
| >cd08381 C2B_PI3K_class_II C2 domain second repeat present in class II phosphatidylinositol 3-kinases (PI3Ks) | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.8e-19 Score=162.72 Aligned_cols=97 Identities=12% Similarity=0.054 Sum_probs=88.1
Q ss_pred ccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCccccccccccccc-ccCcc-ccccccccc
Q 005590 232 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDL-HFKGA-EKDLMPAEI 308 (689)
Q Consensus 232 ~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~-~~~~~-~~~L~~~V~ 308 (689)
.+.|+|.|++| ||+++| +|.+|||||++|+|+.++..++||+++++++||+|||+|.|. + +.+.+ +.+|.++||
T Consensus 12 ~~~L~V~Vi~A~~L~~~~-~~~~DpyVkv~l~~~~~~~~~~kT~v~~~~~nP~wnE~F~f~--~~~~~~l~~~~L~~~V~ 88 (122)
T cd08381 12 NGTLFVMVMHAKNLPLLD-GSDPDPYVKTYLLPDPQKTTKRKTKVVRKTRNPTFNEMLVYD--GLPVEDLQQRVLQVSVW 88 (122)
T ss_pred CCEEEEEEEEeeCCCCCC-CCCCCCEEEEEEeeCCccCCceeCCccCCCCCCCcccEEEEe--cCChHHhCCCEEEEEEE
Confidence 57899999999 999999 999999999999999988889999999999999999999998 5 55555 567999999
Q ss_pred cCCCCCCCccccccccccccccc
Q 005590 309 DNSDTRDGEVNGALHEGKADAEE 331 (689)
Q Consensus 309 D~d~~~~~d~~G~v~~~~~~~~~ 331 (689)
|+|++++++++|++.+...+...
T Consensus 89 d~d~~~~~~~lG~~~i~l~~l~~ 111 (122)
T cd08381 89 SHDSLVENEFLGGVCIPLKKLDL 111 (122)
T ss_pred eCCCCcCCcEEEEEEEecccccc
Confidence 99999999999999998877664
|
There are 3 classes of PI3Ks based on structure, regulation, and specificity. All classes contain a N-terminal C2 domain, a PIK domain, and a kinase catalytic domain. Unlike class I and class III, class II PI3Ks have additionally a PX domain and a C-terminal C2 domain containing a nuclear localization signal both of which bind phospholipids though in a slightly different fashion. PI3Ks (AKA phosphatidylinositol (PtdIns) 3-kinases) regulate cell processes such as cell growth, differentiation, proliferation, and motility. PI3Ks work on phosphorylation of phosphatidylinositol, phosphatidylinositide (4)P (PtdIns (4)P),2 or PtdIns(4,5)P2. Specifically they phosphorylate the D3 hydroxyl group of phosphoinositol lipids on the inositol ring. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permut |
| >cd08685 C2_RGS-like C2 domain of the Regulator Of G-Protein Signaling (RGS) family | Back alignment and domain information |
|---|
Probab=99.74 E-value=9e-19 Score=160.71 Aligned_cols=98 Identities=15% Similarity=0.096 Sum_probs=88.6
Q ss_pred cccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcccccccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 309 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~~~~L~~~V~D 309 (689)
.+++|+|.|++| ||.+|| +|.+|||||++|+|+.++..++||+++++|+||+|||+|.|. ++.+..++.|.++|||
T Consensus 10 ~~~~L~V~Vi~ar~L~~~~-~g~~dpYVkv~l~p~~~~~~~~kT~v~~~t~~P~~nE~F~f~--v~~~~~~~~l~v~V~~ 86 (119)
T cd08685 10 QNRKLTLHVLEAKGLRSTN-SGTCNSYVKISLSPDKEVRFRQKTSTVPDSANPLFHETFSFD--VNERDYQKRLLVTVWN 86 (119)
T ss_pred cCCEEEEEEEEEECCCCCC-CCCCCeeEEEEEEeCCCCcceEeCccccCCCCCccccEEEEE--cChHHhCCEEEEEEEC
Confidence 457899999999 999999 889999999999999988889999999999999999999998 7777676679999999
Q ss_pred CCCCCC-Cccccccccccccccc
Q 005590 310 NSDTRD-GEVNGALHEGKADAEE 331 (689)
Q Consensus 310 ~d~~~~-~d~~G~v~~~~~~~~~ 331 (689)
++...+ ++++|+++++..+...
T Consensus 87 ~~~~~~~~~~lG~~~i~l~~~~~ 109 (119)
T cd08685 87 KLSKSRDSGLLGCMSFGVKSIVN 109 (119)
T ss_pred CCCCcCCCEEEEEEEecHHHhcc
Confidence 999874 7999999999877753
|
This CD contains members of the regulator of G-protein signaling (RGS) family. RGS is a GTPase activating protein which inhibits G-protein mediated signal transduction. The protein is largely cytosolic, but G-protein activation leads to translocation of this protein to the plasma membrane. A nuclear form of this protein has also been described, but its sequence has not been identified. There are multiple alternatively spliced transcript variants in this family with some members having additional domains (ex. PDZ and RGS) downstream of the C2 domain. The C2 domain was first identified in PKC. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind pho |
| >cd08393 C2A_SLP-1_2 C2 domain first repeat present in Synaptotagmin-like proteins 1 and 2 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-18 Score=161.71 Aligned_cols=100 Identities=10% Similarity=-0.006 Sum_probs=89.9
Q ss_pred cccceEEEEecc-CCcccCCC-CCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcc-cccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHN-VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 307 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~-g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V 307 (689)
..+.|+|.|++| ||+++|.+ |.+|||||++|+|+.++..++||+++++|+||+|||+|.|. ++.+.+ +++|.++|
T Consensus 13 ~~~~L~V~vi~a~~L~~~d~~~g~~dpyVkv~l~p~~~~~~~~kT~v~~~t~nP~~nE~f~f~--v~~~~l~~~~L~~~V 90 (125)
T cd08393 13 KLRELHVHVIQCQDLAAADPKKQRSDPYVKTYLLPDKSNRGKRKTSVKKKTLNPVFNETLRYK--VEREELPTRVLNLSV 90 (125)
T ss_pred CCCEEEEEEEEeCCCCCcCCCCCCCCcEEEEEEEcCCCccccccCccCcCCCCCccCceEEEE--CCHHHhCCCEEEEEE
Confidence 456899999999 99999986 89999999999999988778899999999999999999999 887766 56799999
Q ss_pred ccCCCCCCCcccccccccccccccc
Q 005590 308 IDNSDTRDGEVNGALHEGKADAEEH 332 (689)
Q Consensus 308 ~D~d~~~~~d~~G~v~~~~~~~~~e 332 (689)
||+|++++++++|++.+...+.+-.
T Consensus 91 ~d~~~~~~~~~iG~~~i~L~~~~~~ 115 (125)
T cd08393 91 WHRDSLGRNSFLGEVEVDLGSWDWS 115 (125)
T ss_pred EeCCCCCCCcEeEEEEEecCccccC
Confidence 9999999999999999987766443
|
All Slp members basically share an N-terminal Slp homology domain (SHD) and C-terminal tandem C2 domains (named the C2A domain and the C2B domain) with the SHD and C2 domains being separated by a linker sequence of various length. Slp1/JFC1 and Slp2/exophilin 4 promote granule docking to the plasma membrane. Additionally, their C2A domains are both Ca2+ independent, unlike Slp3 and Slp4/granuphilin which are Ca2+ dependent. It is thought that SHD (except for the Slp4-SHD) functions as a specific Rab27A/B-binding domain. In addition to Slps, rabphilin, Noc2, and Munc13-4 also function as Rab27-binding proteins. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety |
| >cd08408 C2B_Synaptotagmin-14_16 C2 domain second repeat present in Synaptotagmins 14 and 16 | Back alignment and domain information |
|---|
Probab=99.73 E-value=9.6e-19 Score=164.69 Aligned_cols=98 Identities=15% Similarity=0.098 Sum_probs=87.6
Q ss_pred cccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCC-cceeeeeccccCCCcccccccccccccccCcc-cccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGT-EKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 307 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~-~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V 307 (689)
..++|+|+|++| ||+++|.+|..|||||++|+|+.++ ..|+||+++++++||+|||+|.|. ++.+++ +++|.++|
T Consensus 13 ~~~~L~V~VikarnL~~~~~~~~~dpyVkv~llp~~~~~~~~~kT~v~~~t~nPvfnEtF~f~--i~~~~l~~~~L~~~V 90 (138)
T cd08408 13 LTGRLSVEVIKGSNFKNLAMNKAPDTYVKLTLLNSDGQEISKSKTSIRRGQPDPEFKETFVFQ--VALFQLSEVTLMFSV 90 (138)
T ss_pred CCCeEEEEEEEecCCCccccCCCCCeeEEEEEEeCCCcceeeccceeecCCCCCcEeeeEEEE--CCHHHhCccEEEEEE
Confidence 568999999999 9999999999999999999997654 467899999999999999999999 888777 67799999
Q ss_pred ccCCCCCCCcccccccccccccc
Q 005590 308 IDNSDTRDGEVNGALHEGKADAE 330 (689)
Q Consensus 308 ~D~d~~~~~d~~G~v~~~~~~~~ 330 (689)
||++++++++++|.+.++.....
T Consensus 91 ~~~~~~~~~~~iG~v~l~~~~~~ 113 (138)
T cd08408 91 YNKRKMKRKEMIGWFSLGLNSSG 113 (138)
T ss_pred EECCCCCCCcEEEEEEECCcCCC
Confidence 99999999999999988765433
|
Synaptotagmin 14 and 16 are membrane-trafficking proteins in specific tissues outside the brain. Both of these contain C-terminal tandem C2 repeats, but only Synaptotagmin 14 has an N-terminal transmembrane domain and a putative fatty-acylation site. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium and this is indeed the case here. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling step of synaptic vesicle |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.6e-17 Score=162.79 Aligned_cols=139 Identities=21% Similarity=0.261 Sum_probs=106.9
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEeecc-hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCC---eEE-E
Q 005590 386 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE---HLF-I 460 (689)
Q Consensus 386 ~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~-~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~---~l~-l 460 (689)
.+.||+|+||.||. +..++.. +||++... ....+...+|+++++.+.+. ..+||||+++++++.+.. ..+ +
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~-~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRR-LIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhcc-CCCCcccceeeEEEEeCCCCeEEEEE
Confidence 35799999999995 6667666 79988754 22446789999999999763 467999999999999873 434 7
Q ss_pred EEEccc---cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHH-HHHHHCCceeccCCCCcEEEecc--CCCeEEEEec
Q 005590 461 VCELLR---ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL-EYLHSLGIIHCDLKPENILIKSY--QRCEIKIIDL 534 (689)
Q Consensus 461 VmEy~~---g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL-~yLH~~gIvHrDLKp~NILl~~~--~~~~vkL~DF 534 (689)
||||.+ ++|.+++.... +++. ..++.|++.++ .|||+.+|+||||||+|||++.. ....++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~~~-------~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQCR-------YEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHccc-------ccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 899955 58888875321 4444 35678888788 89999999999999999999753 2347999995
Q ss_pred CCc
Q 005590 535 GSS 537 (689)
Q Consensus 535 Gls 537 (689)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 443
|
|
| >cd04029 C2A_SLP-4_5 C2 domain first repeat present in Synaptotagmin-like proteins 4 and 5 | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.7e-18 Score=157.38 Aligned_cols=100 Identities=11% Similarity=0.018 Sum_probs=89.2
Q ss_pred cccceEEEEecc-CCcccCC-CCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcc-cccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQH-NVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 307 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~-~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V 307 (689)
..+.|+|.|++| ||.++|. +|.+|||||++++|+.++..++||+++++++||+|||+|.|. ++.+.+ ++.|.++|
T Consensus 13 ~~~~L~V~Vi~a~~L~~~~~~~~~~DpyVkv~l~p~~~~~~~~kT~v~~~t~nP~wnE~f~f~--i~~~~l~~~~L~~~V 90 (125)
T cd04029 13 KTQSLNVHVKECRNLAYGDEAKKRSNPYVKTYLLPDKSRQSKRKTSIKRNTTNPVYNETLKYS--ISHSQLETRTLQLSV 90 (125)
T ss_pred CCCeEEEEEEEecCCCccCCCCCCCCcEEEEEEEcCCccccceEeeeeeCCCCCcccceEEEE--CCHHHhCCCEEEEEE
Confidence 567899999999 9999986 588999999999999987788899999999999999999999 877766 56699999
Q ss_pred ccCCCCCCCcccccccccccccccc
Q 005590 308 IDNSDTRDGEVNGALHEGKADAEEH 332 (689)
Q Consensus 308 ~D~d~~~~~d~~G~v~~~~~~~~~e 332 (689)
||+|.+++++++|++.++....+-.
T Consensus 91 ~d~~~~~~~~~lG~~~i~l~~~~~~ 115 (125)
T cd04029 91 WHYDRFGRNTFLGEVEIPLDSWNFD 115 (125)
T ss_pred EECCCCCCCcEEEEEEEeCCccccc
Confidence 9999999999999999988766554
|
All Slp members basically share an N-terminal Slp homology domain (SHD) and C-terminal tandem C2 domains (named the C2A domain and the C2B domain) with the SHD and C2 domains being separated by a linker sequence of various length. SHD of Slp (except for the Slp4-SHD) function as a specific Rab27A/B-binding domain. In addition to Slp, rabphilin, Noc2, and Munc13-4 also function as Rab27-binding proteins. It has been demonstrated that Slp4/granuphilin promotes dense-core vesicle exocytosis. The C2A domain of Slp4 is Ca2+ dependent. Slp5 mRNA has been shown to be restricted to human placenta and liver suggesting a role in Rab27A-dependent membrane trafficking in specific tissues. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2 |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.5e-17 Score=165.30 Aligned_cols=144 Identities=16% Similarity=0.158 Sum_probs=108.2
Q ss_pred EEEEEEeccCCCCceEEEE-ECCCCcEEEEEEeecchh-------------------------hhHhHHHHHHHHHHhcc
Q 005590 383 YYVTEYLGSAAFSKVFQAQ-DLHTGVDVCLKIIKNDKD-------------------------FFDQSLDEIKLLKLVNK 436 (689)
Q Consensus 383 Y~i~~~LG~G~fG~Vyla~-d~~tg~~vAvKii~~~~~-------------------------~~~~~~~Ei~iL~~l~~ 436 (689)
|.+.+.||+|++|.||+|. +..+|+.||+|+++.... ......+|..+++.+..
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 8889999999999999999 678999999999875321 01224578999999864
Q ss_pred cCCCCCCceeEEEEEEEeCCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCC-ceeccCC
Q 005590 437 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG-IIHCDLK 515 (689)
Q Consensus 437 ~~~~~h~~Iv~l~~~f~~~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~g-IvHrDLK 515 (689)
. ...+++++.. ...++||||++|..+....... ..+....+..++.||+.+|.+||+.| |+|||||
T Consensus 110 ~----~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dik 176 (237)
T smart00090 110 A----GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLS 176 (237)
T ss_pred c----CCCCCeeeEe----cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCC
Confidence 2 1234444442 2348999999985432221111 12556677899999999999999999 9999999
Q ss_pred CCcEEEeccCCCeEEEEecCCcccccC
Q 005590 516 PENILIKSYQRCEIKIIDLGSSCFQTD 542 (689)
Q Consensus 516 p~NILl~~~~~~~vkL~DFGls~~~~~ 542 (689)
|+||+++ ++.++|+|||.+.....
T Consensus 177 p~NIli~---~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 177 EYNILVH---DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hhhEEEE---CCCEEEEEChhhhccCC
Confidence 9999998 56899999999865443
|
|
| >cd08395 C2C_Munc13 C2 domain third repeat in Munc13 (mammalian uncoordinated) proteins | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.8e-17 Score=151.90 Aligned_cols=97 Identities=16% Similarity=0.045 Sum_probs=81.3
Q ss_pred ceEEEEecc-CCcccCCCCCCCcceeeecCC--CCCCcceeeeeccccCCCcccccccccccccccC-cc-ccccccccc
Q 005590 234 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAP--HPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFK-GA-EKDLMPAEI 308 (689)
Q Consensus 234 ~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~p--d~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~-~~-~~~L~~~V~ 308 (689)
+|+|+|++| ||+++| .|.+|||||++|+- .+.+++|+||+++++|+||+|||+|.|. ++.+ .+ ..+|.+.||
T Consensus 1 kL~V~Vi~A~~L~~~d-~g~~DPYVkV~l~g~~~~~k~~k~kTkv~~~tlnPvwNE~f~F~--v~~~~~~~~~~L~~~V~ 77 (120)
T cd08395 1 KVTVKVVAANDLKWQT-TGMFRPFVEVNLIGPHLSDKKRKFATKSKNNNWSPKYNETFQFI--LGNEDDPESYELHICVK 77 (120)
T ss_pred CEEEEEEECcCCCccc-CCCCCCEEEEEEecCCCcccccEeeeEEecCCCCCccCcEEEEE--eeCcCCCceeEEEEEEE
Confidence 589999999 999999 59999999999962 3344557788888999999999999999 6644 44 456999999
Q ss_pred cCCCCCCCccccccccccccccccc
Q 005590 309 DNSDTRDGEVNGALHEGKADAEEHG 333 (689)
Q Consensus 309 D~d~~~~~d~~G~v~~~~~~~~~e~ 333 (689)
|+|.+++++++|.+.++.......+
T Consensus 78 D~d~~~~dd~IG~~~l~l~~~~~~~ 102 (120)
T cd08395 78 DYCFARDDRLVGVTVLQLRDIAQAG 102 (120)
T ss_pred EecccCCCCEEEEEEEEHHHCcCCC
Confidence 9998888999999998876666544
|
C2-like domains are thought to be involved in phospholipid binding in a Ca2+ independent manner in both Unc13 and Munc13. Caenorabditis elegans Unc13 has a central domain with sequence similarity to PKC, which includes C1 and C2-related domains. Unc13 binds phorbol esters and DAG with high affinity in a phospholipid manner. Mutations in Unc13 results in abnormal neuronal connections and impairment in cholinergic neurotransmission in the nematode. Munc13 is the mammalian homolog which are expressed in the brain. There are 3 isoforms (Munc13-1, -2, -3) and are thought to play a role in neurotransmitter release and are hypothesized to be high-affinity receptors for phorbol esters. Unc13 and Munc13 contain both C1 and C2 domains. There are two C2 related domains present, one central and one at the carboxyl end. Munc13-1 contains a third C2-like domain. Munc13 interacts with syntaxin, synaptobrevi |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.8e-17 Score=165.86 Aligned_cols=242 Identities=19% Similarity=0.249 Sum_probs=176.9
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecch---hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
+...++.+|.....|..|++++. |..++.|++.... .....+..|.-.|+ ...||||+.+++.+....+
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lr------ifshpnilpvlgacnsppn 261 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALR------IFSHPNILPVLGACNSPPN 261 (448)
T ss_pred hhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCccee------eecCCchhhhhhhccCCCC
Confidence 34455667888999999999964 5667778876432 12223333443333 3468999999999999999
Q ss_pred EEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEEEeccCCCeEEEEec
Q 005590 458 LFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCEIKIIDL 534 (689)
Q Consensus 458 l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~g--IvHrDLKp~NILl~~~~~~~vkL~DF 534 (689)
+.++..||. |+|++++... ........++.+++..|++|++|||+.. |.---|....|+|+.+-+..+-.+|-
T Consensus 262 lv~isq~mp~gslynvlhe~----t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~ 337 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQ----TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADT 337 (448)
T ss_pred ceEeeeeccchHHHHHHhcC----ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccc
Confidence 999999998 7888887643 3344777889999999999999999974 44556888999999644445555554
Q ss_pred CCcccccCCccccccCccccChhhhcCCCCC---chhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcCCCcHHHH
Q 005590 535 GSSCFQTDNLCLYVQSRSYRAPEVIIGLPYD---QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 611 (689)
Q Consensus 535 Gls~~~~~~~~~~~gt~~Y~APE~l~~~~~s---~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~ 611 (689)
-++.+.. ...-.|.|++||.+..++-+ .+.|+||+++++|||-|...||..-++.+.-.+|.
T Consensus 338 kfsfqe~----gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia----------- 402 (448)
T KOG0195|consen 338 KFSFQEV----GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA----------- 402 (448)
T ss_pred eeeeecc----ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-----------
Confidence 4433221 12457899999999877644 57899999999999999999998877666544432
Q ss_pred hhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHH
Q 005590 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 680 (689)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL 680 (689)
..+++..+|...+ ..+..|+.-|+..||.+||..+.++
T Consensus 403 ----------------------leglrv~ippgis---------~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 403 ----------------------LEGLRVHIPPGIS---------RHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ----------------------hccccccCCCCcc---------HHHHHHHHHHhcCCCCcCCCcceeh
Confidence 1345555665332 4577999999999999999987654
|
|
| >cd08409 C2B_Synaptotagmin-15 C2 domain second repeat present in Synaptotagmin 15 | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.9e-17 Score=155.74 Aligned_cols=106 Identities=13% Similarity=0.058 Sum_probs=90.1
Q ss_pred cccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcc-ccccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 308 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V~ 308 (689)
..++|+|.|++| ||+++| .|.+|||||+.|+|+.++.+++||+++++++||+|||+|.|. ++.+.+ +.+|.++||
T Consensus 13 ~~~~L~V~V~~a~nL~~~~-~~~~d~yVkv~l~~~~~~~~~~kT~v~~~~~nP~fnE~F~f~--i~~~~l~~~~L~~~V~ 89 (137)
T cd08409 13 TLNRLTVVVLRARGLRQLD-HAHTSVYVKVSLMIHNKVVKTKKTEVVDGAASPSFNESFSFK--VTSRQLDTASLSLSVM 89 (137)
T ss_pred CCCeEEEEEEEecCCCccc-CCCCCeEEEEEEEECCEEeeeeecccEeCCCCCcccceEEEE--CCHHHhCccEEEEEEE
Confidence 467899999999 999999 788999999999999877778899999999999999999999 888878 467999999
Q ss_pred cCCCCCCCcccccccccccc-cccccCCCccc
Q 005590 309 DNSDTRDGEVNGALHEGKAD-AEEHGVATPDL 339 (689)
Q Consensus 309 D~d~~~~~d~~G~v~~~~~~-~~~e~~~~~~~ 339 (689)
|.+.+++++++|++.++... ..+.....|.+
T Consensus 90 ~~~~~~~~~~lG~v~ig~~~~~~~~~~~hW~~ 121 (137)
T cd08409 90 QSGGVRKSKLLGRVVLGPFMYARGKELEHWND 121 (137)
T ss_pred eCCCCCCcceEEEEEECCcccCCChHHHHHHH
Confidence 99999999999999988532 22334444333
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. It is thought to be involved in the trafficking and exocytosis of secretory vesicles in non-neuronal tissues and is Ca2+ independent. Human synaptotagmin 15 has 2 alternatively spliced forms that encode proteins with different C-termini. The larger, SYT15a, contains a N-terminal TM region, a putative fatty-acylation site, and 2 tandem C terminal C2 domains. The smaller, SYT15b, lacks the C-terminal portion of the second C2 domain. Unlike most other synaptotagmins it is nearly absent in the brain and rather is found in the heart, lungs, skeletal muscle, and testis. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 id |
| >cd08410 C2B_Synaptotagmin-17 C2 domain second repeat present in Synaptotagmin 17 | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.6e-17 Score=152.77 Aligned_cols=95 Identities=12% Similarity=0.019 Sum_probs=85.2
Q ss_pred cccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcc-ccccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 308 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V~ 308 (689)
+.+.|+|.|++| ||+++|..|.+|||||+.+.++.+..+++||+++++|+||+|||+|.|. ++.+.+ +..|.++||
T Consensus 12 ~~~~L~V~vi~a~~L~~~d~~g~~DPyV~v~l~~~~~~~~~~kT~v~~~t~nP~wnE~F~f~--i~~~~l~~~~l~~~V~ 89 (135)
T cd08410 12 SAGRLNVDIIRAKQLLQTDMSQGSDPFVKIQLVHGLKLIKTKKTSCMRGTIDPFYNESFSFK--VPQEELENVSLVFTVY 89 (135)
T ss_pred CCCeEEEEEEEecCCCcccCCCCCCeEEEEEEEcCCcccceEcCccccCCCCCccceeEEEe--CCHHHhCCCEEEEEEE
Confidence 557899999999 9999999999999999999888777778889999999999999999999 877777 456999999
Q ss_pred cCCCCCCCccccccccccc
Q 005590 309 DNSDTRDGEVNGALHEGKA 327 (689)
Q Consensus 309 D~d~~~~~d~~G~v~~~~~ 327 (689)
|+|..++++++|.+.++..
T Consensus 90 d~d~~~~~~~iG~~~l~~~ 108 (135)
T cd08410 90 GHNVKSSNDFIGRIVIGQY 108 (135)
T ss_pred eCCCCCCCcEEEEEEEcCc
Confidence 9999999999999976653
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 17 is located in the brain, kidney, and prostate and is thought to be a peripheral membrane protein. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling step of synaptic vesicles. C2 domains fold into an 8-standed beta- |
| >cd08384 C2B_Rabphilin_Doc2 C2 domain second repeat present in Rabphilin and Double C2 domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.8e-17 Score=150.27 Aligned_cols=96 Identities=16% Similarity=0.147 Sum_probs=87.4
Q ss_pred cccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcc-ccccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 308 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V~ 308 (689)
..+.|+|.|++| ||+++|..|.+|||||+.+.++..+..+.||+++++|+||+|||+|.|. ++...+ ++.|.+.||
T Consensus 11 ~~~~L~V~Vi~a~~L~~~d~~~~~DpyV~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--~~~~~l~~~~l~~~V~ 88 (133)
T cd08384 11 QRRGLIVGIIRCVNLAAMDANGYSDPFVKLYLKPDAGKKSKHKTQVKKKTLNPEFNEEFFYD--IKHSDLAKKTLEITVW 88 (133)
T ss_pred CCCEEEEEEEEEcCCCCcCCCCCCCcEEEEEEEcCCCccCCceeeeEeccCCCCcccEEEEE--CCHHHhCCCEEEEEEE
Confidence 467899999999 9999999999999999999998877788899999999999999999999 776666 567999999
Q ss_pred cCCCCCCCcccccccccccc
Q 005590 309 DNSDTRDGEVNGALHEGKAD 328 (689)
Q Consensus 309 D~d~~~~~d~~G~v~~~~~~ 328 (689)
|+|.+++++++|++.++...
T Consensus 89 d~d~~~~~~~lG~~~i~l~~ 108 (133)
T cd08384 89 DKDIGKSNDYIGGLQLGINA 108 (133)
T ss_pred eCCCCCCccEEEEEEEecCC
Confidence 99999999999999998753
|
Rabphilin is found neurons and in neuroendrocrine cells, while Doc2 is found not only in the brain but in tissues, including mast cells, chromaffin cells, and osteoblasts. Rabphilin and Doc2s share highly homologous tandem C2 domains, although their N-terminal structures are completely different: rabphilin contains an N-terminal Rab-binding domain (RBD),7 whereas Doc2 contains an N-terminal Munc13-1-interacting domain (MID). C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domai |
| >KOG1028 consensus Ca2+-dependent phospholipid-binding protein Synaptotagmin, required for synaptic vesicle and secretory granule exocytosis [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.9e-17 Score=176.97 Aligned_cols=97 Identities=11% Similarity=0.055 Sum_probs=86.6
Q ss_pred cccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcc-ccccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 308 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V~ 308 (689)
..+.|+|.|++| +|++||.+|.+|||||++|+||+ +.|.||+++|+|+||+|||+|.|. |+.+++ .++|.++||
T Consensus 165 ~~~~L~V~V~qa~~Lp~~d~~g~sdpyVK~~llPdk--~~k~kT~v~r~tlnP~fnEtf~f~--v~~~~l~~~~L~l~V~ 240 (421)
T KOG1028|consen 165 ELNLLTVRVIQAHDLPAKDRGGTSDPYVKVYLLPDK--KGKFKTRVHRKTLNPVFNETFRFE--VPYEELSNRVLHLSVY 240 (421)
T ss_pred cCCEEEEEEEEecCCCcccCCCCCCCeeEEEEcCCC--CCcceeeeeecCcCCccccceEee--cCHHHhccCEEEEEEE
Confidence 567899999999 99999988899999999999998 558888889999999999999999 777766 888999999
Q ss_pred cCCCCCCCccccccccccccccc
Q 005590 309 DNSDTRDGEVNGALHEGKADAEE 331 (689)
Q Consensus 309 D~d~~~~~d~~G~v~~~~~~~~~ 331 (689)
|+|+|++++++|++......++.
T Consensus 241 ~~drfsr~~~iGev~~~l~~~~~ 263 (421)
T KOG1028|consen 241 DFDRFSRHDFIGEVILPLGEVDL 263 (421)
T ss_pred ecCCcccccEEEEEEecCccccc
Confidence 99999999999999886444433
|
|
| >cd08404 C2B_Synaptotagmin-4 C2 domain second repeat present in Synaptotagmin 4 | Back alignment and domain information |
|---|
Probab=99.63 E-value=9e-17 Score=150.91 Aligned_cols=102 Identities=14% Similarity=0.044 Sum_probs=89.2
Q ss_pred cccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcc-ccccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 308 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V~ 308 (689)
..+.|+|.|++| ||+++|..|.+|||||+++.+++++..++||.++++|+||.|||+|.|. ++.... ..+|.++||
T Consensus 13 ~~~~L~V~vi~a~~L~~~d~~g~~Dpyv~v~l~~~~~~~~~~kT~v~k~t~nP~w~e~F~f~--v~~~~~~~~~l~~~v~ 90 (136)
T cd08404 13 TTNRLTVVVLKARHLPKMDVSGLADPYVKVNLYYGKKRISKKKTHVKKCTLNPVFNESFVFD--IPSEELEDISVEFLVL 90 (136)
T ss_pred CCCeEEEEEEEeeCCCccccCCCCCeEEEEEEEcCCceeeeEcCccccCCCCCccCceEEEE--CCHHHhCCCEEEEEEE
Confidence 457899999999 9999999999999999999998776678899999999999999999999 776666 556999999
Q ss_pred cCCCCCCCcccccccccccccccccCC
Q 005590 309 DNSDTRDGEVNGALHEGKADAEEHGVA 335 (689)
Q Consensus 309 D~d~~~~~d~~G~v~~~~~~~~~e~~~ 335 (689)
|+|.+++++++|++.++... .++...
T Consensus 91 d~d~~~~~~~iG~~~~~~~~-~~~~~~ 116 (136)
T cd08404 91 DSDRVTKNEVIGRLVLGPKA-SGSGGH 116 (136)
T ss_pred ECCCCCCCccEEEEEECCcC-CCchHH
Confidence 99999999999999998876 344433
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 4, a member of class 4 synaptotagmins, is located in the brain. It functions are unknown. It, like synaptotagmin-11, has an Asp to Ser substitution in its C2A domain. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling s |
| >cd04020 C2B_SLP_1-2-3-4 C2 domain second repeat present in Synaptotagmin-like proteins 1-4 | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.5e-16 Score=152.28 Aligned_cols=118 Identities=18% Similarity=0.175 Sum_probs=97.4
Q ss_pred ccccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcc-cccccccc
Q 005590 230 INNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 307 (689)
Q Consensus 230 ~~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V 307 (689)
.+.+.|+|.|.+| ||+++|..|.+|||||++++++..+..++||+++++|+||.|||+|.|.. ++.+++ +..|.++|
T Consensus 24 ~~~g~L~V~Vi~A~nL~~~d~~g~~DPYVkv~l~~~~~~~~~~kT~vi~~t~nP~WnE~f~f~~-~~~~~l~~~~L~i~V 102 (162)
T cd04020 24 PSTGELHVWVKEAKNLPALKSGGTSDSFVKCYLLPDKSKKSKQKTPVVKKSVNPVWNHTFVYDG-VSPEDLSQACLELTV 102 (162)
T ss_pred CCCceEEEEEEeeeCCCCCCCCCCCCCEEEEEEEcCCCCCcceeCCccCCCCCCCCCCEEEEec-CCHHHhCCCEEEEEE
Confidence 3667899999999 99999999999999999999998888899999999999999999999983 344444 56699999
Q ss_pred ccCCCCCCCcccccccccccccccccCCCccchhchhhhhhhhe
Q 005590 308 IDNSDTRDGEVNGALHEGKADAEEHGVATPDLLMFDNLEEECEI 351 (689)
Q Consensus 308 ~D~d~~~~~d~~G~v~~~~~~~~~e~~~~~~~l~~~~l~ee~~~ 351 (689)
||+|.+++++++|++.+...+....+. ...|++...++..+
T Consensus 103 ~d~d~~~~d~~lG~v~i~l~~~~~~~~---~~~w~~~~~~~~~~ 143 (162)
T cd04020 103 WDHDKLSSNDFLGGVRLGLGTGKSYGQ---AVDWMDSTGEEILL 143 (162)
T ss_pred EeCCCCCCCceEEEEEEeCCccccCCC---ccccccCChHHHHH
Confidence 999999999999999998877665442 23366555555443
|
All Slp members basically share an N-terminal Slp homology domain (SHD) and C-terminal tandem C2 domains (named the C2A domain and the C2B domain) with the SHD and C2 domains being separated by a linker sequence of various length. Slp1/JFC1 and Slp2/exophilin 4 promote granule docking to the plasma membrane. Additionally, their C2A domains are both Ca2+ independent, unlike the case in Slp3 and Slp4/granuphilin in which their C2A domains are Ca2+ dependent. It is thought that SHD (except for the Slp4-SHD) functions as a specific Rab27A/B-binding domain. In addition to Slps, rabphilin, Noc2, and Munc13-4 also function as Rab27-binding proteins. It has been demonstrated that Slp3 and Slp4/granuphilin promote dense-core vesicle exocytosis. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involvin |
| >cd08389 C2A_Synaptotagmin-14_16 C2A domain first repeat present in Synaptotagmins 14 and 16 | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.4e-16 Score=144.69 Aligned_cols=98 Identities=10% Similarity=-0.031 Sum_probs=85.2
Q ss_pred cccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcc-ccccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 308 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V~ 308 (689)
....|+|+|++| ||+++|.+|.+|||||+.++|++++ ++||+++++ +||+|||+|.|.. ++.+.+ +++|.+.||
T Consensus 14 ~~~~L~V~Vi~a~nL~~~~~~~~~d~yVk~~llp~~~~--~~kTkv~~~-~nP~fnE~F~f~~-i~~~~l~~~~L~~~V~ 89 (124)
T cd08389 14 SARKLTVTVIRAQDIPTKDRGGASSWQVHLVLLPSKKQ--RAKTKVQRG-PNPVFNETFTFSR-VEPEELNNMALRFRLY 89 (124)
T ss_pred CCCEEEEEEEEecCCCchhcCCCCCcEEEEEEccCCcc--eeecccccC-CCCcccCEEEECC-CCHHHhccCEEEEEEE
Confidence 457899999999 9999999999999999999998654 667887777 9999999999973 666666 777999999
Q ss_pred cCCCCCCCcccccccccccccccc
Q 005590 309 DNSDTRDGEVNGALHEGKADAEEH 332 (689)
Q Consensus 309 D~d~~~~~d~~G~v~~~~~~~~~e 332 (689)
|++++++++++|++.++..+....
T Consensus 90 ~~~~~~~~~~lG~~~i~L~~l~~~ 113 (124)
T cd08389 90 GVERMRKERLIGEKVVPLSQLNLE 113 (124)
T ss_pred ECCCcccCceEEEEEEeccccCCC
Confidence 999999999999999988776443
|
Synaptotagmin 14 and 16 are membrane-trafficking proteins in specific tissues outside the brain. Both of these contain C-terminal tandem C2 repeats, but only Synaptotagmin 14 has an N-terminal transmembrane domain and a putative fatty-acylation site. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium and this is indeed the case here. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling step of synaptic vesicle |
| >cd08521 C2A_SLP C2 domain first repeat present in Synaptotagmin-like proteins | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.7e-16 Score=143.07 Aligned_cols=98 Identities=11% Similarity=0.033 Sum_probs=87.9
Q ss_pred cccceEEEEecc-CCcccC-CCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcc-cccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQ-HNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 307 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d-~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V 307 (689)
..+.|+|.|.+| ||+++| ..|.+|||||++++|+..+..++||+++++++||+|||+|.|. ++...+ .+.|.+.|
T Consensus 12 ~~~~L~V~v~~a~~L~~~~~~~~~~dpyv~v~l~~~~~~~~~~kT~v~~~t~~P~wne~f~f~--i~~~~l~~~~l~i~v 89 (123)
T cd08521 12 KTGSLEVHIKECRNLAYADEKKKRSNPYVKVYLLPDKSKQSKRKTSVKKNTTNPVFNETLKYH--ISKSQLETRTLQLSV 89 (123)
T ss_pred CCCEEEEEEEEecCCCCcCCCCCCCCcEEEEEEecCCCcCceeeccccCCCCCCcccceEEEe--CCHHHhCCCEEEEEE
Confidence 567899999999 999999 8889999999999998876678899999999999999999999 877666 56699999
Q ss_pred ccCCCCCCCcccccccccccccc
Q 005590 308 IDNSDTRDGEVNGALHEGKADAE 330 (689)
Q Consensus 308 ~D~d~~~~~d~~G~v~~~~~~~~ 330 (689)
||++.+++++++|++..+..+..
T Consensus 90 ~d~~~~~~~~~iG~~~i~l~~l~ 112 (123)
T cd08521 90 WHHDRFGRNTFLGEVEIPLDSWD 112 (123)
T ss_pred EeCCCCcCCceeeEEEEeccccc
Confidence 99999999999999998876664
|
All Slp members basically share an N-terminal Slp homology domain (SHD) and C-terminal tandem C2 domains (named the C2A domain and the C2B domain) with the SHD and C2 domains being separated by a linker sequence of various length. Slp1/JFC1 and Slp2/exophilin 4 promote granule docking to the plasma membrane. Additionally, their C2A domains are both Ca2+ independent, unlike the case in Slp3 and Slp4/granuphilin in which their C2A domains are Ca2+ dependent. It is thought that SHD (except for the Slp4-SHD) functions as a specific Rab27A/B-binding domain. In addition to Slps, rabphilin, Noc2, and Munc13-4 also function as Rab27-binding proteins. It has been demonstrated that Slp3 and Slp4/granuphilin promote dense-core vesicle exocytosis. Slp5 mRNA has been shown to be restricted to human placenta and liver suggesting a role in Rab27A-dependent membrane trafficking in specific tissues. C2 domains fold into |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=8.8e-15 Score=146.80 Aligned_cols=133 Identities=22% Similarity=0.314 Sum_probs=103.5
Q ss_pred EEeccCCCCceEEEEECCCCcEEEEEEeecch---------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCe
Q 005590 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 387 ~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---------~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
+.||+|++|.||+|.+ .|..+++|+..... .......+|+.++..+.+ ++|+....++.....
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~------~~i~~p~~~~~~~~~ 73 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARK------AGVNVPAVYFVDPEN 73 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHH------CCCCCCeEEEEeCCC
Confidence 5789999999999986 77889999865321 112356678888888864 345555555666778
Q ss_pred EEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCC
Q 005590 458 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 458 l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGl 536 (689)
.++||||++| +|.+++... .. ....++.+|+.+|.+||+.|++|+|++|.|||++ .+.++|+|||.
T Consensus 74 ~~lv~e~~~G~~L~~~~~~~---------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~---~~~~~liDf~~ 140 (211)
T PRK14879 74 FIIVMEYIEGEPLKDLINSN---------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS---GGKIYLIDFGL 140 (211)
T ss_pred CEEEEEEeCCcCHHHHHHhc---------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE---CCCEEEEECCc
Confidence 8999999986 565554321 11 6788999999999999999999999999999998 57799999999
Q ss_pred cccc
Q 005590 537 SCFQ 540 (689)
Q Consensus 537 s~~~ 540 (689)
+...
T Consensus 141 a~~~ 144 (211)
T PRK14879 141 AEFS 144 (211)
T ss_pred ccCC
Confidence 8653
|
|
| >cd08403 C2B_Synaptotagmin-3-5-6-9-10 C2 domain second repeat present in Synaptotagmins 3, 5, 6, 9, and 10 | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.6e-16 Score=147.41 Aligned_cols=95 Identities=16% Similarity=0.091 Sum_probs=85.8
Q ss_pred cccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCccc-cccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAE-KDLMPAEI 308 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~~-~~L~~~V~ 308 (689)
..++|+|.|.+| +|+++|..|.+|||||++|.+++++.+++||+++++++||.|||+|.|. ++.+.++ ..|.++||
T Consensus 12 ~~~~L~V~v~~A~~L~~~d~~g~~dpyvkv~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--i~~~~~~~~~l~~~v~ 89 (134)
T cd08403 12 TAGRLTLTIIKARNLKAMDITGFSDPYVKVSLMCEGRRLKKKKTSVKKNTLNPTYNEALVFD--VPPENVDNVSLIIAVV 89 (134)
T ss_pred CCCEEEEEEEEeeCCCccccCCCCCceEEEEEEeCCcccceecCCcccCCCCCcccceEEEE--CCHHHhCCCEEEEEEE
Confidence 467899999999 9999999999999999999988877788899988999999999999998 7766664 45999999
Q ss_pred cCCCCCCCccccccccccc
Q 005590 309 DNSDTRDGEVNGALHEGKA 327 (689)
Q Consensus 309 D~d~~~~~d~~G~v~~~~~ 327 (689)
|++++++++++|++.++..
T Consensus 90 d~~~~~~~~~IG~~~l~~~ 108 (134)
T cd08403 90 DYDRVGHNELIGVCRVGPN 108 (134)
T ss_pred ECCCCCCCceeEEEEECCC
Confidence 9999999999999999764
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 3, a member of class 3 synaptotagmins, is located in the brain and localized to the active zone and plasma membrane. It functions as a Ca2+ sensor for fast exocytosis. It, along with synaptotagmins 5,6, and 10, has disulfide bonds at its N-terminus. Synaptotagmin 9, a class 5 synaptotagmins, is located in the brain and localized to the synaptic vesicles. It is thought to be a Ca2+-sensor for dense-core vesicle exocytosis. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind |
| >cd08402 C2B_Synaptotagmin-1 C2 domain second repeat present in Synaptotagmin 1 | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.5e-16 Score=147.83 Aligned_cols=96 Identities=16% Similarity=0.112 Sum_probs=86.5
Q ss_pred cccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcc-ccccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 308 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V~ 308 (689)
+.+.|+|.|.+| ||+++|.+|.+||||++++.++.++.++++|+++++++||+|||+|.|. ++.+.+ +..|.++||
T Consensus 13 ~~~~l~V~Vi~a~~L~~~d~~g~~dpyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--i~~~~l~~~~l~~~v~ 90 (136)
T cd08402 13 TAGKLTVVILEAKNLKKMDVGGLSDPYVKIHLMQNGKRLKKKKTTIKKRTLNPYYNESFSFE--VPFEQIQKVHLIVTVL 90 (136)
T ss_pred CCCeEEEEEEEeeCCCcccCCCCCCCeEEEEEEECCcccceeeccceeCCCCCcccceEEEE--CCHHHhCCCEEEEEEE
Confidence 567899999999 9999999999999999999988777778889999999999999999999 776666 446999999
Q ss_pred cCCCCCCCcccccccccccc
Q 005590 309 DNSDTRDGEVNGALHEGKAD 328 (689)
Q Consensus 309 D~d~~~~~d~~G~v~~~~~~ 328 (689)
|++++++++++|.+.++...
T Consensus 91 d~~~~~~~~~iG~~~i~~~~ 110 (136)
T cd08402 91 DYDRIGKNDPIGKVVLGCNA 110 (136)
T ss_pred eCCCCCCCceeEEEEECCcc
Confidence 99999999999999998754
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 1, a member of the class 1 synaptotagmins, is located in the brain and endocranium and localized to the synaptic vesicles and secretory granules. It functions as a Ca2+ sensor for fast exocytosis. It, like synaptotagmin-2, has an N-glycosylated N-terminus. Synaptotagmin 4, a member of class 4 synaptotagmins, is located in the brain. It functions are unknown. It, like synaptotagmin-11, has an Asp to Ser substitution in its C2A domain. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.9e-16 Score=168.47 Aligned_cols=178 Identities=32% Similarity=0.416 Sum_probs=129.7
Q ss_pred CCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEe
Q 005590 455 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 533 (689)
Q Consensus 455 ~~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~D 533 (689)
..++||.|++|.. +|.+.+...... .. .+....+.++.|++.|+.| +|.+|+|+||.||+... ++.+||.|
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~-e~--~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~--d~q~kIgD 399 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTG-EE--RSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSD--DDQLKIGD 399 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCcc-cc--cchhHHHHHHHhhccchhh---ccchhhhcccccccccc--chhhhhhh
Confidence 3468999999984 666666533322 22 6677889999999999999 99999999999999984 67899999
Q ss_pred cCCcccccCCc---------cccccCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHHhhc
Q 005590 534 LGSSCFQTDNL---------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGML 603 (689)
Q Consensus 534 FGls~~~~~~~---------~~~~gt~~Y~APE~l~~~~~s~~~DIwSLGvil~eLlt-G~~PF~~~~~~~~l~~i~~~~ 603 (689)
||+........ +.-+||.+||+||.+.++.|+.++||||||+||+|++. =..+| +..+.+.
T Consensus 400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~------er~~t~~--- 470 (516)
T KOG1033|consen 400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF------ERIATLT--- 470 (516)
T ss_pred hhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH------HHHHhhh---
Confidence 99876544322 33588999999999999999999999999999999997 22222 1111110
Q ss_pred CCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCC
Q 005590 604 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHP 683 (689)
Q Consensus 604 g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hp 683 (689)
.+. .-.+|+.. ....+.-.+|+..||...|.+||++.+..-|+
T Consensus 471 ------d~r-------------------------~g~ip~~~------~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~ 513 (516)
T KOG1033|consen 471 ------DIR-------------------------DGIIPPEF------LQDYPEEYTLLQQLLSPSPEERPSAIEVALHE 513 (516)
T ss_pred ------hhh-------------------------cCCCChHH------hhcCcHHHHHHHHhcCCCcccCchHHHHhhhh
Confidence 000 01111100 01112235899999999999999999999999
Q ss_pred CCC
Q 005590 684 WLQ 686 (689)
Q Consensus 684 wf~ 686 (689)
|++
T Consensus 514 ~~~ 516 (516)
T KOG1033|consen 514 FLQ 516 (516)
T ss_pred hcC
Confidence 875
|
|
| >cd08388 C2A_Synaptotagmin-4-11 C2A domain first repeat present in Synaptotagmins 4 and 11 | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.9e-16 Score=144.47 Aligned_cols=97 Identities=14% Similarity=0.103 Sum_probs=82.8
Q ss_pred cccceEEEEecc-CCcccCCC-CCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcc-cccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHN-VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 307 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~-g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V 307 (689)
....|+|.|.+| ||+++|.. |.+||||++.|+|+.++ +.||+++++|+||+|||+|.|. .++.+++ +..|.+.|
T Consensus 14 ~~~~L~V~Vi~a~~L~~~~~~~~~~DpyV~v~l~~~~~~--~~kT~v~~~t~nP~wnE~F~f~-~~~~~~~~~~~L~~~V 90 (128)
T cd08388 14 EKKALLVNIIECRDLPAMDEQSGTSDPYVKLQLLPEKEH--KVKTRVLRKTRNPVYDETFTFY-GIPYNQLQDLSLHFAV 90 (128)
T ss_pred CCCEEEEEEEEeECCCCCCCCCCCcCCEEEEEEeCCcCc--eeeccEEcCCCCCceeeEEEEc-ccCHHHhCCCEEEEEE
Confidence 457899999999 99999986 89999999999987543 5678888999999999999993 1666665 56699999
Q ss_pred ccCCCCCCCcccccccccccccc
Q 005590 308 IDNSDTRDGEVNGALHEGKADAE 330 (689)
Q Consensus 308 ~D~d~~~~~d~~G~v~~~~~~~~ 330 (689)
||+|++++++++|++.+...+.+
T Consensus 91 ~d~d~~~~d~~lG~~~i~L~~l~ 113 (128)
T cd08388 91 LSFDRYSRDDVIGEVVCPLAGAD 113 (128)
T ss_pred EEcCCCCCCceeEEEEEeccccC
Confidence 99999999999999988776553
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmins 4 and 11, class 4 synaptotagmins, are located in the brain. Their functions are unknown. They are distinguished from the other synaptotagmins by having and Asp to Ser substitution in their C2A domains. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence |
| >cd04030 C2C_KIAA1228 C2 domain third repeat present in uncharacterized human KIAA1228-like proteins | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.7e-16 Score=143.40 Aligned_cols=99 Identities=13% Similarity=0.101 Sum_probs=88.6
Q ss_pred cccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcc-ccccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 308 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V~ 308 (689)
..+.|+|.|++| ||+++|..|.+|||||+++++++++..++||+++++++||+|||+|.|. ++...+ +..|.+.||
T Consensus 14 ~~~~L~V~vi~a~~L~~~~~~~~~dpyv~v~l~~~~~~~~~~kT~v~~~~~nP~wne~f~f~--i~~~~l~~~~l~i~v~ 91 (127)
T cd04030 14 QRQKLIVTVHKCRNLPPCDSSDIPDPYVRLYLLPDKSKSTRRKTSVKKDNLNPVFDETFEFP--VSLEELKRRTLDVAVK 91 (127)
T ss_pred CCCEEEEEEEEEECCCCccCCCCCCceEEEEEEcCCCCCceEecccccCCCCCEECeEEEEe--cCHHHhcCCEEEEEEE
Confidence 357899999999 9999999999999999999999887889999999999999999999999 777666 566999999
Q ss_pred cCCCC--CCCccccccccccccccc
Q 005590 309 DNSDT--RDGEVNGALHEGKADAEE 331 (689)
Q Consensus 309 D~d~~--~~~d~~G~v~~~~~~~~~ 331 (689)
|.+.+ ++++++|.+..+..+...
T Consensus 92 ~~~~~~~~~~~~iG~~~i~l~~l~~ 116 (127)
T cd04030 92 NSKSFLSREKKLLGQVLIDLSDLDL 116 (127)
T ss_pred ECCcccCCCCceEEEEEEecccccc
Confidence 99986 679999999998877644
|
KIAA proteins are uncharacterized human proteins. They were compiled by the Kazusa mammalian cDNA project which identified more than 2000 human genes. They are identified by 4 digit codes that precede the KIAA designation. Many KIAA genes are still functionally uncharacterized including KIAA1228. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1 |
| >cd08387 C2A_Synaptotagmin-8 C2A domain first repeat present in Synaptotagmin 8 | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.8e-16 Score=142.93 Aligned_cols=98 Identities=13% Similarity=0.069 Sum_probs=86.6
Q ss_pred cccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcc-ccccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 308 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V~ 308 (689)
..+.|+|.|.+| ||+++|.+|.+||||++++.|+.++ ++||+++++++||+|||+|.|. ++...+ +.+|.+.||
T Consensus 14 ~~~~L~V~v~~a~~L~~~d~~g~~dpyv~v~l~~~~~~--~~kT~v~~~t~~P~wne~f~f~--v~~~~l~~~~l~i~V~ 89 (124)
T cd08387 14 DMGILNVKLIQARNLQPRDFSGTADPYCKVRLLPDRSN--TKQSKIHKKTLNPEFDESFVFE--VPPQELPKRTLEVLLY 89 (124)
T ss_pred CCCEEEEEEEEeeCCCCCCCCCCCCCeEEEEEecCCCC--cEeCceEcCCCCCCcccEEEEe--CCHHHhCCCEEEEEEE
Confidence 457899999999 9999999999999999999887654 5678888999999999999998 877666 567999999
Q ss_pred cCCCCCCCcccccccccccccccc
Q 005590 309 DNSDTRDGEVNGALHEGKADAEEH 332 (689)
Q Consensus 309 D~d~~~~~d~~G~v~~~~~~~~~e 332 (689)
|++.+++++++|.+.++..+....
T Consensus 90 d~~~~~~~~~iG~~~i~l~~~~~~ 113 (124)
T cd08387 90 DFDQFSRDECIGVVELPLAEVDLS 113 (124)
T ss_pred ECCCCCCCceeEEEEEecccccCC
Confidence 999999999999999988777643
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling step of synaptic vesicles. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involv |
| >cd04010 C2B_RasA3 C2 domain second repeat present in RAS p21 protein activator 3 (RasA3) | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.3e-16 Score=146.55 Aligned_cols=97 Identities=13% Similarity=0.009 Sum_probs=83.1
Q ss_pred ceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccc-----------cccCcc-c
Q 005590 234 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSD-----------LHFKGA-E 300 (689)
Q Consensus 234 ~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~-----------~~~~~~-~ 300 (689)
+|+|.|++| ||.+ .+|.+||||++++.++.++..++||+++++|+||+|||+|.|... ++.+++ .
T Consensus 1 kL~V~Vi~ArnL~~--~~g~sDPYV~V~l~~~~~k~~~~kT~v~~~t~nP~wNE~F~F~v~~~~~~~~~~~~~~~~~~~~ 78 (148)
T cd04010 1 KLSVRVIECSDLAL--KNGTCDPYASVTLIYSNKKQDTKRTKVKKKTNNPQFDEAFYFDVTIDSSPEKKQFEMPEEDAEK 78 (148)
T ss_pred CEEEEEEeCcCCCC--CCCCCCceEEEEEeCCcccCcccCCccEeCCCCCccceEEEEEEecccccccccccCCcccccE
Confidence 589999999 9998 689999999999999887777889999999999999999999931 134454 3
Q ss_pred cccccccccCCCCCCCcccccccccccccccc
Q 005590 301 KDLMPAEIDNSDTRDGEVNGALHEGKADAEEH 332 (689)
Q Consensus 301 ~~L~~~V~D~d~~~~~d~~G~v~~~~~~~~~e 332 (689)
..|.+.|||.+.+++++++|++.+....+...
T Consensus 79 ~~L~i~V~d~~~~~~ddfLG~v~i~l~~l~~~ 110 (148)
T cd04010 79 LELRVDLWHASMGGGDVFLGEVRIPLRGLDLQ 110 (148)
T ss_pred EEEEEEEEcCCCCCCCceeEEEEEeccccccc
Confidence 56999999999999999999999987766654
|
RasA3 are members of GTPase activating protein 1 (GAP1), a Ras-specific GAP, which suppresses Ras function by enhancing the GTPase activity of Ras proteins resulting in the inactive GDP-bound form of Ras. In this way it can control cellular proliferation and differentiation. RasA3 contains an N-terminal C2 domain, a Ras-GAP domain, a plextrin homology (PH)-like domain, and a Bruton's Tyrosine Kinase (BTK) zinc binding domain. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain |
| >cd04031 C2A_RIM1alpha C2 domain first repeat contained in Rab3-interacting molecule (RIM) proteins | Back alignment and domain information |
|---|
Probab=99.59 E-value=1e-15 Score=141.22 Aligned_cols=97 Identities=15% Similarity=0.167 Sum_probs=85.4
Q ss_pred cccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcc-ccccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 308 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V~ 308 (689)
..+.|+|.|++| ||+++|.+|.+||||++++.++.+...++||+++++|+||+|||+|.|.. ++.+.+ +..|.++||
T Consensus 14 ~~~~L~V~vi~a~~L~~~~~~~~~dpyv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~~-~~~~~l~~~~l~~~V~ 92 (125)
T cd04031 14 VTSQLIVTVLQARDLPPRDDGSLRNPYVKVYLLPDRSEKSKRRTKTVKKTLNPEWNQTFEYSN-VRRETLKERTLEVTVW 92 (125)
T ss_pred CCCEEEEEEEEecCCCCcCCCCCCCCEEEEEEccCCCccccccccccCCCCCCccccEEEEcc-cCHHHhCCCEEEEEEE
Confidence 457899999999 99999999999999999999987777788999999999999999999982 343444 566999999
Q ss_pred cCCCCCCCcccccccccccc
Q 005590 309 DNSDTRDGEVNGALHEGKAD 328 (689)
Q Consensus 309 D~d~~~~~d~~G~v~~~~~~ 328 (689)
|++.+++++++|.+.....+
T Consensus 93 d~~~~~~~~~iG~~~i~l~~ 112 (125)
T cd04031 93 DYDRDGENDFLGEVVIDLAD 112 (125)
T ss_pred eCCCCCCCcEeeEEEEeccc
Confidence 99999999999999998766
|
RIMs are believed to organize specialized sites of the plasma membrane called active zones. They also play a role in controlling neurotransmitter release, plasticity processes, as well as memory and learning. RIM contains an N-terminal zinc finger domain, a PDZ domain, and two C-terminal C2 domains (C2A, C2B). C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as |
| >cd08405 C2B_Synaptotagmin-7 C2 domain second repeat present in Synaptotagmin 7 | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.6e-16 Score=145.49 Aligned_cols=97 Identities=14% Similarity=0.091 Sum_probs=86.7
Q ss_pred cccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcc-ccccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 308 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V~ 308 (689)
..+.|+|.|.+| ||+++|..|.+|||||+.+.+..++..++||+++++++||+|||+|.|. ++.+.+ +..|.++||
T Consensus 13 ~~~~L~v~vi~a~~L~~~~~~g~~dpyV~v~l~~~~~~~~~~kT~v~~~t~~P~wne~F~f~--i~~~~~~~~~l~~~v~ 90 (136)
T cd08405 13 TANRITVNIIKARNLKAMDINGTSDPYVKVWLMYKDKRVEKKKTVIKKRTLNPVFNESFIFN--IPLERLRETTLIITVM 90 (136)
T ss_pred CCCeEEEEEEEeeCCCccccCCCCCceEEEEEEeCCCccccccCcceeCCCCCcccceEEEe--CCHHHhCCCEEEEEEE
Confidence 457899999999 9999999999999999999987766668899999999999999999999 776666 566999999
Q ss_pred cCCCCCCCccccccccccccc
Q 005590 309 DNSDTRDGEVNGALHEGKADA 329 (689)
Q Consensus 309 D~d~~~~~d~~G~v~~~~~~~ 329 (689)
|++.+++++++|.+.++..+.
T Consensus 91 d~~~~~~~~~lG~~~i~~~~~ 111 (136)
T cd08405 91 DKDRLSRNDLIGKIYLGWKSG 111 (136)
T ss_pred ECCCCCCCcEeEEEEECCccC
Confidence 999999999999999887654
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 7, a member of class 2 synaptotagmins, is located in presynaptic plasma membranes in neurons, dense-core vesicles in endocrine cells, and lysosomes in fibroblasts. It has been shown to play a role in regulation of Ca2+-dependent lysosomal exocytosis in fibroblasts and may also function as a vesicular Ca2+-sensor. It is distinguished from the other synaptotagmins by having over 12 splice forms. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic ves |
| >cd08385 C2A_Synaptotagmin-1-5-6-9-10 C2A domain first repeat present in Synaptotagmins 1, 5, 6, 9, and 10 | Back alignment and domain information |
|---|
Probab=99.58 E-value=1e-15 Score=141.27 Aligned_cols=97 Identities=12% Similarity=0.078 Sum_probs=85.4
Q ss_pred cccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcc-ccccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 308 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V~ 308 (689)
..+.|+|.|.+| ||+++|.+|.+||||++++.|+.++ ++||+++++++||+|||+|.|. ++...+ +..|.+.||
T Consensus 14 ~~~~L~V~v~~a~~L~~~d~~~~~dpyv~v~l~~~~~~--~~kT~v~~~t~nP~wne~f~f~--i~~~~l~~~~l~~~V~ 89 (124)
T cd08385 14 QSNQLTVGIIQAADLPAMDMGGTSDPYVKVYLLPDKKK--KFETKVHRKTLNPVFNETFTFK--VPYSELGNKTLVFSVY 89 (124)
T ss_pred CCCEEEEEEEEeeCCCCccCCCCCCCEEEEEEEcCCCC--ceecccCcCCCCCceeeeEEEe--CCHHHhCCCEEEEEEE
Confidence 557899999999 9999999999999999999987653 6788888999999999999999 776555 566999999
Q ss_pred cCCCCCCCccccccccccccccc
Q 005590 309 DNSDTRDGEVNGALHEGKADAEE 331 (689)
Q Consensus 309 D~d~~~~~d~~G~v~~~~~~~~~ 331 (689)
|+|++++++++|++.+...+...
T Consensus 90 d~d~~~~~~~lG~~~i~l~~~~~ 112 (124)
T cd08385 90 DFDRFSKHDLIGEVRVPLLTVDL 112 (124)
T ss_pred eCCCCCCCceeEEEEEecCcccC
Confidence 99999999999999998876644
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 1, a member of class 1 synaptotagmins, is located in the brain and endocranium and localized to the synaptic vesicles and secretory granules. It functions as a Ca2+ sensor for fast exocytosis as do synaptotagmins 5, 6, and 10. It is distinguished from the other synaptotagmins by having an N-glycosylated N-terminus. Synaptotagmins 5, 6, and 10, members of class 3 synaptotagmins, are located primarily in the brain and localized to the active zone and plasma membrane. They is distinguished from the other synaptotagmins by having disulfide bonds at its N-terminus. Synaptotagmin 6 also regulates the acrosome reaction, a unique Ca2+-regulated exocytosis, in sperm. Synaptotagmin 9, a class 5 synaptotagmins, is located in the brain and |
| >KOG1028 consensus Ca2+-dependent phospholipid-binding protein Synaptotagmin, required for synaptic vesicle and secretory granule exocytosis [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.58 E-value=6.2e-16 Score=170.66 Aligned_cols=96 Identities=13% Similarity=0.018 Sum_probs=90.0
Q ss_pred cccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCccccc-cccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKD-LMPAEI 308 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~~~~-L~~~V~ 308 (689)
.+++|+|+|++| ||++||.+|.+|||||++++++.++.+|+||.++|+++||+|||+|.|. ++.+.++++ |.++||
T Consensus 296 ~~g~ltv~v~kar~L~~~~~~~~~d~~Vk~~l~~~~~~~~kkkT~~~~~~~npv~nesf~F~--vp~~~l~~~~l~l~V~ 373 (421)
T KOG1028|consen 296 TAGRLTVVVIKARNLKSMDVGGLSDPYVKVTLLDGDKRLSKKKTSVKKKTLNPVFNETFVFD--VPPEQLAEVSLELTVW 373 (421)
T ss_pred CCCeEEEEEEEecCCCcccCCCCCCccEEEEEecCCceeeeeeeecccCCCCCcccccEEEe--CCHHHhheeEEEEEEE
Confidence 679999999999 9999999999999999999999999999999999999999999999998 999998655 999999
Q ss_pred cCCCCCCCcccccccccccc
Q 005590 309 DNSDTRDGEVNGALHEGKAD 328 (689)
Q Consensus 309 D~d~~~~~d~~G~v~~~~~~ 328 (689)
|+|++++|+++|.+..+...
T Consensus 374 d~d~~~~~~~iG~~~lG~~~ 393 (421)
T KOG1028|consen 374 DHDTLGSNDLIGRCILGSDS 393 (421)
T ss_pred EcccccccceeeEEEecCCC
Confidence 99999999999998877644
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.7e-14 Score=143.83 Aligned_cols=138 Identities=22% Similarity=0.201 Sum_probs=102.2
Q ss_pred EEEEEEeccCCCCceEEEEECCCCcEEEEEEeecchh-----------------------hhHhHHHHHHHHHHhcccCC
Q 005590 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-----------------------FFDQSLDEIKLLKLVNKNDP 439 (689)
Q Consensus 383 Y~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~-----------------------~~~~~~~Ei~iL~~l~~~~~ 439 (689)
|.+.+.||+|+||.||++.+. +|+.||||+++.+.. .......|..++..+.+..
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~- 94 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG- 94 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC-
Confidence 778899999999999999864 799999999765321 0112456777888776532
Q ss_pred CCCCceeEEEEEEEeCCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 005590 440 ADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENI 519 (689)
Q Consensus 440 ~~h~~Iv~l~~~f~~~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NI 519 (689)
..++..++ ....++||||+.|..+..+.. ......++.+|+.++.++|+.||+||||||+||
T Consensus 95 ---i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-----------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Ni 156 (198)
T cd05144 95 ---FPVPKPID----WNRHAVVMEYIDGVELYRVRV-----------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNI 156 (198)
T ss_pred ---CCCCceee----cCCceEEEEEeCCcchhhccc-----------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccE
Confidence 13444443 234589999999753322210 134567889999999999999999999999999
Q ss_pred EEeccCCCeEEEEecCCcccccC
Q 005590 520 LIKSYQRCEIKIIDLGSSCFQTD 542 (689)
Q Consensus 520 Ll~~~~~~~vkL~DFGls~~~~~ 542 (689)
+++. ++.++|+|||.+.....
T Consensus 157 ll~~--~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 157 LVDD--DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EEcC--CCcEEEEECCccccCCC
Confidence 9984 78999999999855443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.7e-14 Score=141.07 Aligned_cols=129 Identities=19% Similarity=0.256 Sum_probs=96.9
Q ss_pred EeccCCCCceEEEEECCCCcEEEEEEeecch---------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeE
Q 005590 388 YLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 388 ~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~---------~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
.||+|+||.||++. ..|..+++|+..... ....+..+|+++++.+.+. ++.....++......
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~------~i~~p~~~~~~~~~~ 72 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKA------GVNTPVVYDVDPDNK 72 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHC------CCCCCEEEEEECCCC
Confidence 37999999999998 467889999865321 1124566799999888753 233223333455667
Q ss_pred EEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEEEEecCCc
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vkL~DFGls 537 (689)
++||||+.| ++.+++.... . .++.|++.+|.+||+.|++|+|++|.||+++ ++.++|+|||++
T Consensus 73 ~lv~e~~~g~~l~~~~~~~~------------~-~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~---~~~~~liDfg~a 136 (199)
T TIGR03724 73 TIVMEYIEGKPLKDVIEEGN------------D-ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR---DDKLYLIDFGLG 136 (199)
T ss_pred EEEEEEECCccHHHHHhhcH------------H-HHHHHHHHHHHHHHHCCeecCCCCcceEEEE---CCcEEEEECCCC
Confidence 899999986 4555432110 0 7899999999999999999999999999998 578999999998
Q ss_pred ccc
Q 005590 538 CFQ 540 (689)
Q Consensus 538 ~~~ 540 (689)
...
T Consensus 137 ~~~ 139 (199)
T TIGR03724 137 KYS 139 (199)
T ss_pred cCC
Confidence 653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd04041 C2A_fungal C2 domain first repeat; fungal group | Back alignment and domain information |
|---|
Probab=99.56 E-value=3e-15 Score=135.55 Aligned_cols=96 Identities=13% Similarity=0.018 Sum_probs=81.3
Q ss_pred cceEEEEecc-CCcccCCC-CCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcc--ccccccccc
Q 005590 233 DYGYLSSKEA-DLIDLQHN-VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA--EKDLMPAEI 308 (689)
Q Consensus 233 ~~l~v~i~e~-~L~~~d~~-g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~--~~~L~~~V~ 308 (689)
+.|+|+|.+| ||+++|.. |.+||||++++.++++ .+.||+++++|+||+|||+|.|. +...++ +..|.++||
T Consensus 1 G~L~V~v~~a~~L~~~d~~~~~~Dpyv~v~~~~~~~--~~~kT~v~~~t~nP~Wne~f~f~--~~~~~~~~~~~l~~~V~ 76 (111)
T cd04041 1 GVLVVTIHRATDLPKADFGTGSSDPYVTASFAKFGK--PLYSTRIIRKDLNPVWEETWFVL--VTPDEVKAGERLSCRLW 76 (111)
T ss_pred CEEEEEEEEeeCCCcccCCCCCCCccEEEEEccCCC--ccEeeeeECCCCCCccceeEEEE--eCchhccCCCEEEEEEE
Confidence 4689999999 99999998 9999999999987653 35678888999999999999997 443332 456999999
Q ss_pred cCCCCCCCcccccccccccccccc
Q 005590 309 DNSDTRDGEVNGALHEGKADAEEH 332 (689)
Q Consensus 309 D~d~~~~~d~~G~v~~~~~~~~~e 332 (689)
|+|++++++++|.+.+...+..+.
T Consensus 77 d~d~~~~dd~lG~~~i~l~~l~~~ 100 (111)
T cd04041 77 DSDRFTADDRLGRVEIDLKELIED 100 (111)
T ss_pred eCCCCCCCCcceEEEEEHHHHhcC
Confidence 999999999999999987766643
|
C2 domains were first identified in Protein Kinase C (PKC). C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1. However, there are a few exceptions to this including RIM isoforms and some splice variants of piccolo/aczonin and intersectin which only have a single C2 domain. C2 domains with a calcium binding region have negatively charged residues, primarily aspartates, that serve as ligan |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.4e-14 Score=140.86 Aligned_cols=139 Identities=22% Similarity=0.293 Sum_probs=96.3
Q ss_pred EEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHh-------------------------HHHHHHHHHHhcccCCC
Q 005590 386 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ-------------------------SLDEIKLLKLVNKNDPA 440 (689)
Q Consensus 386 ~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~-------------------------~~~Ei~iL~~l~~~~~~ 440 (689)
.+.||+|+||+||+|.+. +|+.||||+++........ ...|...+..+....
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-- 78 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAG-- 78 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcC--
Confidence 467999999999999976 8999999998764221111 124455555554321
Q ss_pred CCCceeEEEEEEEeCCeEEEEEEccccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcE
Q 005590 441 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENI 519 (689)
Q Consensus 441 ~h~~Iv~l~~~f~~~~~l~lVmEy~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~-~gIvHrDLKp~NI 519 (689)
-.+++++.+ ...++||||+.++........... . ...++.++.+++.++.++|. .||+|+||||+||
T Consensus 79 --~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Ni 146 (187)
T cd05119 79 --VPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNI 146 (187)
T ss_pred --CCCCceEec----CCCEEEEEEeCCCCccChhhhhhh-----h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhE
Confidence 124444443 346899999997321111111100 1 15678899999999999999 9999999999999
Q ss_pred EEeccCCCeEEEEecCCcccccC
Q 005590 520 LIKSYQRCEIKIIDLGSSCFQTD 542 (689)
Q Consensus 520 Ll~~~~~~~vkL~DFGls~~~~~ 542 (689)
+++ ++.++|+|||.+.....
T Consensus 147 li~---~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 147 LVD---DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred EEE---CCcEEEEECcccccccC
Confidence 998 67899999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd04039 C2_PSD C2 domain present in Phosphatidylserine decarboxylase (PSD) | Back alignment and domain information |
|---|
Probab=99.53 E-value=7.8e-15 Score=132.24 Aligned_cols=92 Identities=10% Similarity=-0.049 Sum_probs=77.0
Q ss_pred cceEEEEecc-CCcccCCC----CCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcccccccccc
Q 005590 233 DYGYLSSKEA-DLIDLQHN----VVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAE 307 (689)
Q Consensus 233 ~~l~v~i~e~-~L~~~d~~----g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~~~~L~~~V 307 (689)
+.|.|.|++| ||+++|.. +.+||||++.+ ..+++||+++++++||+|||+|.|. +.....+..|.+.|
T Consensus 1 g~l~v~v~~A~~L~~~~~~~~~~~~~DPYv~v~~-----~~~~~kT~v~~~t~nPvWne~f~f~--v~~~~~~~~L~~~V 73 (108)
T cd04039 1 GVVFMEIKSITDLPPLKNMTRTGFDMDPFVIISF-----GRRVFRTSWRRHTLNPVFNERLAFE--VYPHEKNFDIQFKV 73 (108)
T ss_pred CEEEEEEEeeeCCCCccccCCCCCccCceEEEEE-----CCEeEeeeeecCCCCCcccceEEEE--EeCccCCCEEEEEE
Confidence 4688999999 99998842 34799999998 2346689999999999999999998 65544556799999
Q ss_pred ccCCCCCCCccccccccccccccc
Q 005590 308 IDNSDTRDGEVNGALHEGKADAEE 331 (689)
Q Consensus 308 ~D~d~~~~~d~~G~v~~~~~~~~~ 331 (689)
||+|++++++++|.+.+...+...
T Consensus 74 ~D~d~~~~dd~IG~~~l~L~~l~~ 97 (108)
T cd04039 74 LDKDKFSFNDYVATGSLSVQELLN 97 (108)
T ss_pred EECCCCCCCcceEEEEEEHHHHHh
Confidence 999999999999999998776655
|
PSD is involved in the biosynthesis of aminophospholipid by converting phosphatidylserine (PtdSer) to phosphatidylethanolamine (PtdEtn). There is a single C2 domain present and it is thought to confer PtdSer binding motif that is common to PKC and synaptotagmin. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1. However, there are a few exceptions to this including RIM |
| >cd08682 C2_Rab11-FIP_classI C2 domain found in Rab11-family interacting proteins (FIP) class I | Back alignment and domain information |
|---|
Probab=99.52 E-value=6.1e-15 Score=136.60 Aligned_cols=89 Identities=15% Similarity=0.047 Sum_probs=76.9
Q ss_pred eEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCccccccccccccccc---Ccc-cccccccccc
Q 005590 235 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHF---KGA-EKDLMPAEID 309 (689)
Q Consensus 235 l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~---~~~-~~~L~~~V~D 309 (689)
++|.|.+| ||.++|.+|.+||||++.+. ..+.||+++++|+||+|||+|.|. ++. +.. ...|.+.|||
T Consensus 1 ~~V~V~~A~~L~~~d~~g~~dpYv~v~l~-----~~~~kT~v~~~t~nP~Wne~f~F~--v~~~~~~~~~~~~l~~~v~d 73 (126)
T cd08682 1 VQVTVLQARGLLCKGKSGTNDAYVIIQLG-----KEKYSTSVKEKTTSPVWKEECSFE--LPGLLSGNGNRATLQLTVMH 73 (126)
T ss_pred CEEEEEECcCCcCCCCCcCCCceEEEEEC-----CeeeeeeeecCCCCCEeCceEEEE--ecCcccCCCcCCEEEEEEEE
Confidence 47999999 99999999999999999993 346788888999999999999998 665 233 5569999999
Q ss_pred CCCCCCCcccccccccccccc
Q 005590 310 NSDTRDGEVNGALHEGKADAE 330 (689)
Q Consensus 310 ~d~~~~~d~~G~v~~~~~~~~ 330 (689)
++++++++++|.+.+...+..
T Consensus 74 ~~~~~~d~~iG~~~i~l~~l~ 94 (126)
T cd08682 74 RNLLGLDKFLGQVSIPLNDLD 94 (126)
T ss_pred ccccCCCceeEEEEEEHHHhh
Confidence 999999999999998876654
|
Rab GTPases recruit various effector proteins to organelles and vesicles. Rab11-family interacting proteins (FIPs) are involved in mediating the role of Rab11. FIPs can be divided into three classes: class I FIPs (Rip11a, Rip11b, RCP, and FIP2) which contain a C2 domain after N-terminus of the protein, class II FIPs (FIP3 and FIP4) which contain two EF-hands and a proline rich region, and class III FIPs (FIP1) which exhibits no homology to known protein domains. All FIP proteins contain a highly conserved, 20-amino acid motif at the C-terminus of the protein, known as Rab11/25 binding domain (RBD). Class I FIPs are thought to bind to endocytic membranes via their C2 domain, which interacts directly with phospholipids. Class II FIPs do not have any membrane binding domains leaving much to speculate about the mechanism involving FIP3 and FIP4 interactions with endocytic membranes. The member |
| >cd08386 C2A_Synaptotagmin-7 C2A domain first repeat present in Synaptotagmin 7 | Back alignment and domain information |
|---|
Probab=99.52 E-value=8.7e-15 Score=135.15 Aligned_cols=98 Identities=12% Similarity=0.097 Sum_probs=84.3
Q ss_pred cccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcc-ccccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 308 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V~ 308 (689)
....|+|.|.+| ||+++|.+|.+||||+++++|+.++ +.+|+++++++||+|||+|.|.. ++.+.+ ++.|.++||
T Consensus 14 ~~~~L~v~v~~a~~L~~~d~~~~~dpyv~v~~~~~~~~--~~kT~v~~~t~~P~Wne~f~f~~-~~~~~l~~~~l~~~v~ 90 (125)
T cd08386 14 QESTLTLKILKAVELPAKDFSGTSDPFVKIYLLPDKKH--KLETKVKRKNLNPHWNETFLFEG-FPYEKLQQRVLYLQVL 90 (125)
T ss_pred CCCEEEEEEEEecCCCCccCCCCCCceEEEEECCCCCc--ceeeeeecCCCCCccceeEEEcc-cCHHHhCCCEEEEEEE
Confidence 456899999999 9999999999999999999987654 56888889999999999999973 344444 567999999
Q ss_pred cCCCCCCCccccccccccccccc
Q 005590 309 DNSDTRDGEVNGALHEGKADAEE 331 (689)
Q Consensus 309 D~d~~~~~d~~G~v~~~~~~~~~ 331 (689)
|+|++++++++|++++...+...
T Consensus 91 d~d~~~~~~~iG~~~i~l~~l~~ 113 (125)
T cd08386 91 DYDRFSRNDPIGEVSLPLNKVDL 113 (125)
T ss_pred eCCCCcCCcEeeEEEEecccccC
Confidence 99999999999999998877654
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Synaptotagmin 7, a member of class 2 synaptotagmins, is located in presynaptic plasma membranes in neurons, dense-core vesicles in endocrine cells, and lysosomes in fibroblasts. It has been shown to play a role in regulation of Ca2+-dependent lysosomal exocytosis in fibroblasts and may also function as a vesicular Ca2+-sensor. It is distinguished from the other synaptotagmins by having over 12 splice forms. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic ves |
| >cd04009 C2B_Munc13-like C2 domain second repeat in Munc13 (mammalian uncoordinated)-like proteins | Back alignment and domain information |
|---|
Probab=99.52 E-value=8.7e-15 Score=136.97 Aligned_cols=99 Identities=14% Similarity=0.045 Sum_probs=84.9
Q ss_pred cccceEEEEecc-CCcccCCCCCCCcceeeecCCCCC--CcceeeeeccccCCCcccccccccccccccCc---cccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPG--TEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKG---AEKDLM 304 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~--~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~---~~~~L~ 304 (689)
..+.|+|.|.+| +|+++|..|.+||||++++.++.+ +..++||+++++|+||+|||+|.|. +.... .+..|.
T Consensus 14 ~~~~L~V~Vi~A~~L~~~~~~g~~dPyv~v~l~~~~~~~~~~~~kT~v~~~t~nP~wnE~f~f~--i~~~~~~~~~~~l~ 91 (133)
T cd04009 14 SEQSLRVEILNARNLLPLDSNGSSDPFVKVELLPRHLFPDVPTPKTQVKKKTLFPLFDESFEFN--VPPEQCSVEGALLL 91 (133)
T ss_pred CCCEEEEEEEEeeCCCCcCCCCCCCCEEEEEEECCCcCccccccccccCcCCCCCccCCEEEEE--echhhcccCCCEEE
Confidence 346899999999 999999999999999999998765 3568899999999999999999999 55432 255699
Q ss_pred cccccCCCCCCCccccccccccccccc
Q 005590 305 PAEIDNSDTRDGEVNGALHEGKADAEE 331 (689)
Q Consensus 305 ~~V~D~d~~~~~d~~G~v~~~~~~~~~ 331 (689)
++|||++++++++++|++++...+..+
T Consensus 92 ~~V~d~d~~~~d~~iG~~~i~l~~l~~ 118 (133)
T cd04009 92 FTVKDYDLLGSNDFEGEAFLPLNDIPG 118 (133)
T ss_pred EEEEecCCCCCCcEeEEEEEeHHHCCc
Confidence 999999999999999999987766654
|
C2-like domains are thought to be involved in phospholipid binding in a Ca2+ independent manner in both Unc13 and Munc13. Caenorabditis elegans Unc13 has a central domain with sequence similarity to PKC, which includes C1 and C2-related domains. Unc13 binds phorbol esters and DAG with high affinity in a phospholipid manner. Mutations in Unc13 results in abnormal neuronal connections and impairment in cholinergic neurotransmission in the nematode. Munc13 is the mammalian homolog which are expressed in the brain. There are 3 isoforms (Munc13-1, -2, -3) and are thought to play a role in neurotransmitter release and are hypothesized to be high-affinity receptors for phorbol esters. Unc13 and Munc13 contain both C1 and C2 domains. There are two C2 related domains present, one central and one at the carboxyl end. Munc13-1 contains a third C2-like domain. Munc13 interacts with syntaxin, s |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.51 E-value=9.7e-14 Score=159.28 Aligned_cols=135 Identities=21% Similarity=0.269 Sum_probs=102.4
Q ss_pred CcEEEEEEeccCCCCceEEEEECCCCcEEEEEEeecc----h-----hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEE
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----K-----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 451 (689)
Q Consensus 381 ~rY~i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~----~-----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~ 451 (689)
..|...+.||+|+||+||++.+. +..+++|+.... . .......+|+++++.+++ ++++....+
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~------~~i~~p~~~ 404 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARR------AGVPTPVIY 404 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcc------cCCCeeEEE
Confidence 44566789999999999999864 344555543211 1 123456788888888864 467776666
Q ss_pred EEeCCeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCCCeEE
Q 005590 452 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 530 (689)
Q Consensus 452 f~~~~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~~~vk 530 (689)
.......++||||++| +|.+++. ....++.|++.+|.+||+.||+||||||+|||++ ++.++
T Consensus 405 ~~~~~~~~lv~E~~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~---~~~~~ 467 (535)
T PRK09605 405 DVDPEEKTIVMEYIGGKDLKDVLE--------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR---DDRLY 467 (535)
T ss_pred EEeCCCCEEEEEecCCCcHHHHHH--------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE---CCcEE
Confidence 6677778999999986 5555443 2467899999999999999999999999999994 67899
Q ss_pred EEecCCcccc
Q 005590 531 IIDLGSSCFQ 540 (689)
Q Consensus 531 L~DFGls~~~ 540 (689)
|+|||+++..
T Consensus 468 liDFGla~~~ 477 (535)
T PRK09605 468 LIDFGLGKYS 477 (535)
T ss_pred EEeCcccccC
Confidence 9999998653
|
|
| >cd08688 C2_KIAA0528-like C2 domain found in the Human KIAA0528 cDNA clone | Back alignment and domain information |
|---|
Probab=99.51 E-value=9.3e-15 Score=132.15 Aligned_cols=91 Identities=12% Similarity=0.081 Sum_probs=79.9
Q ss_pred eEEEEecc-CCcccCC-CCCCCcceeeecCCCCCCcceeeeeccccCCCccc-ccccccccccccCcc-ccccccccccC
Q 005590 235 GYLSSKEA-DLIDLQH-NVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDW-IEGFKGSSDLHFKGA-EKDLMPAEIDN 310 (689)
Q Consensus 235 l~v~i~e~-~L~~~d~-~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~-ne~f~~~~~~~~~~~-~~~L~~~V~D~ 310 (689)
|+|.|.+| ||++||. +|.+||||++++.. .+.||+++++++||.| ||+|.|. ++...+ +..|.++|||+
T Consensus 1 l~V~v~~a~~L~~~d~~~~~~Dpyv~v~~~~-----~~~kT~v~~~~~nP~W~ne~f~f~--i~~~~l~~~~l~i~V~d~ 73 (110)
T cd08688 1 LKVRVVAARDLPVMDRSSDLTDAFVEVKFGS-----TTYKTDVVKKSLNPVWNSEWFRFE--VDDEELQDEPLQIRVMDH 73 (110)
T ss_pred CEEEEEEEECCCccccCCCCCCceEEEEECC-----eeEecceecCCCCCcccCcEEEEE--cChHHcCCCeEEEEEEeC
Confidence 67999999 9999994 78999999999943 6778888899999999 9999999 776655 56799999999
Q ss_pred CCCCCCcccccccccccccccc
Q 005590 311 SDTRDGEVNGALHEGKADAEEH 332 (689)
Q Consensus 311 d~~~~~d~~G~v~~~~~~~~~e 332 (689)
+.+++++++|++.....+....
T Consensus 74 d~~~~~~~iG~~~~~l~~l~~~ 95 (110)
T cd08688 74 DTYSANDAIGKVYIDLNPLLLK 95 (110)
T ss_pred CCCCCCCceEEEEEeHHHhccc
Confidence 9999999999999988777663
|
The members of this CD are named after the Human KIAA0528 cDNA clone. All members here contain a single C2 repeat. No other information on this protein is currently known. The C2 domain was first identified in PKC. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1. However, there are a few exceptions to this including RIM isoforms and some splice variants of piccolo/a |
| >cd08401 C2A_RasA2_RasA3 C2 domain first repeat present in RasA2 and RasA3 | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.9e-14 Score=132.54 Aligned_cols=89 Identities=18% Similarity=0.068 Sum_probs=75.1
Q ss_pred eEEEEecc-CCcccC-CCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCccccccccccccCCC
Q 005590 235 GYLSSKEA-DLIDLQ-HNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSD 312 (689)
Q Consensus 235 l~v~i~e~-~L~~~d-~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~~~~L~~~V~D~d~ 312 (689)
|+|.|.+| ||++++ .+|.+||||++++ ++.++.||+++++|+||+|||+|.|. ++.. .++|.+.|||+++
T Consensus 2 l~v~v~~a~~L~~~~~~~g~sDpYv~v~l----~~~~~~kT~v~~kt~~P~WnE~F~f~--v~~~--~~~l~~~v~d~~~ 73 (121)
T cd08401 2 LKIKIGEAKNLPPRSGPNKMRDCYCTVNL----DQEEVFRTKTVEKSLCPFFGEDFYFE--IPRT--FRHLSFYIYDRDV 73 (121)
T ss_pred eEEEEEEccCCCCCCCCCCCcCcEEEEEE----CCccEEEeeEEECCCCCccCCeEEEE--cCCC--CCEEEEEEEECCC
Confidence 68999999 999985 5789999999999 23346778888999999999999999 7643 3579999999999
Q ss_pred CCCCccccccccccccccc
Q 005590 313 TRDGEVNGALHEGKADAEE 331 (689)
Q Consensus 313 ~~~~d~~G~v~~~~~~~~~ 331 (689)
+++++++|.+.+...+...
T Consensus 74 ~~~~~~iG~~~i~l~~l~~ 92 (121)
T cd08401 74 LRRDSVIGKVAIKKEDLHK 92 (121)
T ss_pred CCCCceEEEEEEEHHHccC
Confidence 9999999999887665553
|
RasA2 and RasA3 are GAP1s (GTPase activating protein 1s ), Ras-specific GAP members, which suppresses Ras function by enhancing the GTPase activity of Ras proteins resulting in the inactive GDP-bound form of Ras. In this way it can control cellular proliferation and differentiation. RasA2 and RasA3 are both inositol 1,3,4,5-tetrakisphosphate-binding proteins and contain an N-terminal C2 domain, a Ras-GAP domain, a pleckstrin-homology (PH) domain which localizes it to the plasma membrane, and Bruton's Tyrosine Kinase (BTK) a zinc binding domain. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular p |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.8e-13 Score=127.62 Aligned_cols=134 Identities=20% Similarity=0.233 Sum_probs=108.1
Q ss_pred EEEEeccCCCCceEEEEECCCCcEEEEEEeecchhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeCCeEEEEEEc
Q 005590 385 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL 464 (689)
Q Consensus 385 i~~~LG~G~fG~Vyla~d~~tg~~vAvKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmEy 464 (689)
+.+.||.|.++.||++... +..+++|+...... ...+.+|..+++.+++. ..++++++.++...+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~----~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-GADREREVAILQLLARK----GLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-hhHHHHHHHHHHHHHHc----CCCCCeEEEEcCCCCccEEEEEe
Confidence 4577999999999999964 37899999876543 45788899999999764 24678888888777889999999
Q ss_pred cccchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCcEEEeccCCCeEEEEecCCccc
Q 005590 465 LRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL---GIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539 (689)
Q Consensus 465 ~~g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~---gIvHrDLKp~NILl~~~~~~~vkL~DFGls~~ 539 (689)
+.+..... ++......++.+++.+|..||.. +++|+|++|.||+++. .+.++++|||.+..
T Consensus 75 ~~g~~~~~------------~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~--~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDE------------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD--GKILGIIDWEYAGY 138 (155)
T ss_pred cCCeeccc------------CCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC--CcEEEEEecccccC
Confidence 98653221 13455677899999999999985 7999999999999985 67899999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1e-13 Score=153.63 Aligned_cols=197 Identities=21% Similarity=0.254 Sum_probs=144.4
Q ss_pred CCCCceeEEEEEEEeCCeEEEEEEccc-cchHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCc-eeccCCCC
Q 005590 440 ADEHHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGI-IHCDLKPE 517 (689)
Q Consensus 440 ~~h~~Iv~l~~~f~~~~~l~lVmEy~~-g~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gI-vHrDLKp~ 517 (689)
+.|.|+.++++...+....++|.+||. |+|.+.+..... .+.......+++.|+.||.|||..-| .|+.++..
T Consensus 4 l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~-----~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 4 LDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI-----KLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred cchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc-----CccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 468899999999999999999999998 788888765322 26667788899999999999998866 99999999
Q ss_pred cEEEeccCCCeEEEEecCCcccccCCc-----cccccCccccChhhhcCCC-------CCchhhHHHHHHHHHHHHhCCC
Q 005590 518 NILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLP-------YDQKIDLWSLGCILAELWTGEV 585 (689)
Q Consensus 518 NILl~~~~~~~vkL~DFGls~~~~~~~-----~~~~gt~~Y~APE~l~~~~-------~s~~~DIwSLGvil~eLltG~~ 585 (689)
|++++. ...+||+|||+........ .......-|.|||.+.+.. .+.+.|+||+|++++|+++...
T Consensus 79 nClvd~--~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 79 NCLVDS--RWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cceeee--eEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999995 8899999999987664311 1112234599999997642 4667999999999999999999
Q ss_pred CCCCChH----HHHHHHHHhhcCCCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHH
Q 005590 586 LFPNDAV----VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDF 661 (689)
Q Consensus 586 PF~~~~~----~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dL 661 (689)
||..... .+++.++.+ .+ .....|...... ...+++..+
T Consensus 157 ~~~~~~~~~~~~eii~~~~~-~~--------------------------------~~~~rP~i~~~~----e~~~~l~~l 199 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK-GG--------------------------------SNPFRPSIELLN----ELPPELLLL 199 (484)
T ss_pred ccccccccCChHHHHHHHHh-cC--------------------------------CCCcCcchhhhh----hcchHHHHH
Confidence 9975322 223322221 00 000111111110 122367899
Q ss_pred HHHhcccCCCCCcCHHHHH
Q 005590 662 VRTLLEINPQRRPTAREAL 680 (689)
Q Consensus 662 I~~mL~~dP~kRpTa~ElL 680 (689)
++.||..+|.+||+++++-
T Consensus 200 ~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 200 VARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred HHHhcccChhhCccHHHHH
Confidence 9999999999999998864
|
|
| >cd08390 C2A_Synaptotagmin-15-17 C2A domain first repeat present in Synaptotagmins 15 and 17 | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.9e-14 Score=131.23 Aligned_cols=98 Identities=15% Similarity=0.054 Sum_probs=84.9
Q ss_pred cccceEEEEecc-CCcccC-CCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcc-cccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQ-HNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 307 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d-~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V 307 (689)
.++.|+|.|.+| ||+++| ..|.+||||+++++|+.++ +.+|+++++++||+|||+|.|. ++...+ .+.|.+.|
T Consensus 12 ~~~~L~V~v~~a~~L~~~~~~~~~~dpyV~v~l~~~~~~--~~~T~v~~~~~~P~wne~f~f~--i~~~~l~~~~l~i~v 87 (123)
T cd08390 12 EEEQLTVSLIKARNLPPRTKDVAHCDPFVKVCLLPDERR--SLQSKVKRKTQNPNFDETFVFQ--VSFKELQRRTLRLSV 87 (123)
T ss_pred CCCEEEEEEEEecCCCCccCCCCCCCcEEEEEEeeCCCC--ceEeeeEcCCCCCccceEEEEE--cCHHHhcccEEEEEE
Confidence 457899999999 999999 6889999999999988754 4578888999999999999999 877666 45699999
Q ss_pred ccCCCCCCCcccccccccccccccc
Q 005590 308 IDNSDTRDGEVNGALHEGKADAEEH 332 (689)
Q Consensus 308 ~D~d~~~~~d~~G~v~~~~~~~~~e 332 (689)
||++.+++++++|.+.+...+....
T Consensus 88 ~d~~~~~~~~~iG~~~i~L~~l~~~ 112 (123)
T cd08390 88 YDVDRFSRHCIIGHVLFPLKDLDLV 112 (123)
T ss_pred EECCcCCCCcEEEEEEEeccceecC
Confidence 9999999999999998877665553
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. It is thought to be involved in the trafficking and exocytosis of secretory vesicles in non-neuronal tissues and is Ca2+ independent. Human synaptotagmin 15 has 2 alternatively spliced forms that encode proteins with different C-termini. The larger, SYT15a, contains a N-terminal TM region, a putative fatty-acylation site, and 2 tandem C terminal C2 domains. The smaller, SYT15b, lacks the C-terminal portion of the second C2 domain. Unlike most other synaptotagmins it is nearly absent in the brain and rather is found in the heart, lungs, skeletal muscle, and testis. Synaptotagmin 17 is located in the brain, kidney, and prostate and is thought to be a peripheral membrane protein. Previously all synaptotagmins were thought to be calcium sensors in the regulat |
| >cd04032 C2_Perforin C2 domain of Perforin | Back alignment and domain information |
|---|
Probab=99.47 E-value=5.6e-14 Score=130.15 Aligned_cols=90 Identities=10% Similarity=-0.052 Sum_probs=74.4
Q ss_pred cccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcccccccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 309 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~~~~L~~~V~D 309 (689)
..++|+|+|.+| ||+ +|..|.+|||||+++. .++.||+++++++||+|||+|.|. .........|.++|||
T Consensus 26 ~~~~L~V~V~~A~~L~-~d~~g~~DPYVkV~~~-----~~~~kT~vi~~t~nPvWNE~F~f~--~~~~~~~~~L~v~V~D 97 (127)
T cd04032 26 GLATLTVTVLRATGLW-GDYFTSTDGYVKVFFG-----GQEKRTEVIWNNNNPRWNATFDFG--SVELSPGGKLRFEVWD 97 (127)
T ss_pred CcEEEEEEEEECCCCC-cCcCCCCCeEEEEEEC-----CccccCceecCCCCCcCCCEEEEe--cccCCCCCEEEEEEEe
Confidence 457899999999 997 5888899999999982 227788888999999999999986 2221234569999999
Q ss_pred CCCCCCCcccccccccccc
Q 005590 310 NSDTRDGEVNGALHEGKAD 328 (689)
Q Consensus 310 ~d~~~~~d~~G~v~~~~~~ 328 (689)
+|.+++++++|.+.+....
T Consensus 98 ~d~~s~dd~IG~~~i~l~~ 116 (127)
T cd04032 98 RDNGWDDDLLGTCSVVPEA 116 (127)
T ss_pred CCCCCCCCeeEEEEEEecC
Confidence 9999999999999887653
|
Perforin contains a single copy of a C2 domain in its C-terminus and plays a role in lymphocyte-mediated cytotoxicity. Mutations in perforin leads to familial hemophagocytic lymphohistiocytosis type 2. The function of perforin is calcium dependent and the C2 domain is thought to confer this binding to target cell membranes. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1. However, there are a few |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=6.4e-15 Score=169.65 Aligned_cols=258 Identities=21% Similarity=0.255 Sum_probs=184.8
Q ss_pred cCcEEEEEEeccCCCCceEEEEECC-CCcEEEEEEeecc---hhhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEEEeC
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLH-TGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 380 ~~rY~i~~~LG~G~fG~Vyla~d~~-tg~~vAvKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
...|.+.+.||+|+|+.|-++.... ....+|+|.+... ......+..|..+-+.+.. |.|++++++...+.
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~-----h~n~~~~~~~~~~~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSK-----HSNTVHMIEPSSSP 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccc-----cccccccCCccCCC
Confidence 3568888889999999999998643 3445666665543 2233344445555444432 88999999999999
Q ss_pred CeEEEEEEcccc-chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCcEEEeccCCC-eEEEE
Q 005590 456 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH-SLGIIHCDLKPENILIKSYQRC-EIKII 532 (689)
Q Consensus 456 ~~l~lVmEy~~g-~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH-~~gIvHrDLKp~NILl~~~~~~-~vkL~ 532 (689)
+..+++++|..| .+.+.+.. ......+...+..++.|+..+|.|+| ..++.|+||||+|.+++. .+ .+++.
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~----~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~--s~~~l~~~ 167 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISH----PDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDE--SGSALKIA 167 (601)
T ss_pred cccccccCccccccccccccc----CCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhcc--CCCcccCC
Confidence 999999999775 34443311 11112667788899999999999999 999999999999999985 55 89999
Q ss_pred ecCCcccccC-C-----cccccc-CccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCChHHHHHHHHHhhcC
Q 005590 533 DLGSSCFQTD-N-----LCLYVQ-SRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 604 (689)
Q Consensus 533 DFGls~~~~~-~-----~~~~~g-t~~Y~APE~l~~~-~~s~~~DIwSLGvil~eLltG~~PF~~~~~~~~l~~i~~~~g 604 (689)
|||+|..... . ....+| ++.|+|||...+. ......|+||+|+++.-+++|..||.........
T Consensus 168 df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-------- 239 (601)
T KOG0590|consen 168 DFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-------- 239 (601)
T ss_pred CchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc--------
Confidence 9999876544 1 223578 9999999999884 4567899999999999999999999654322200
Q ss_pred CCcHHHHhhhhhhhhhhhccccchhhhhccccccccCCccchhhhhccCCcHHHHHHHHHhcccCCCCCcCHHHHHcCCC
Q 005590 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 684 (689)
Q Consensus 605 ~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ElL~hpw 684 (689)
...+.. . ....... ..........+++.++|..+|..|.+.+++-.+||
T Consensus 240 ------------~~~~~~-~-----------~~~~~~~-------~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~ 288 (601)
T KOG0590|consen 240 ------------YSSWKS-N-----------KGRFTQL-------PWNSISDQAHDLLHKILKENPSNRLSIEELKLDNW 288 (601)
T ss_pred ------------ceeecc-c-----------ccccccC-------ccccCChhhhhcccccccCCchhcccccccccccc
Confidence 000000 0 0000000 11122344678999999999999999999999999
Q ss_pred CCC
Q 005590 685 LQH 687 (689)
Q Consensus 685 f~~ 687 (689)
+..
T Consensus 289 ~~~ 291 (601)
T KOG0590|consen 289 LSS 291 (601)
T ss_pred ccc
Confidence 975
|
|
| >cd08376 C2B_MCTP_PRT C2 domain second repeat found in Multiple C2 domain and Transmembrane region Proteins (MCTP) | Back alignment and domain information |
|---|
Probab=99.45 E-value=6.4e-14 Score=127.63 Aligned_cols=89 Identities=15% Similarity=0.127 Sum_probs=76.4
Q ss_pred eEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCccccccccccccCCCC
Q 005590 235 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDT 313 (689)
Q Consensus 235 l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~~~~L~~~V~D~d~~ 313 (689)
++|.|.+| ||+++|.+|.+||||++++ +..+.||+++++|+||.|||+|.|. +... .+..|.++|||++.+
T Consensus 2 ~~V~v~~a~~L~~~~~~~~~dPyv~v~~-----~~~~~kT~v~~~t~nP~Wne~f~f~--~~~~-~~~~l~v~v~d~~~~ 73 (116)
T cd08376 2 VTIVLVEGKNLPPMDDNGLSDPYVKFRL-----GNEKYKSKVCSKTLNPQWLEQFDLH--LFDD-QSQILEIEVWDKDTG 73 (116)
T ss_pred EEEEEEEEECCCCCCCCCCCCcEEEEEE-----CCEeEecccccCCCCCceeEEEEEE--ecCC-CCCEEEEEEEECCCC
Confidence 68999999 9999999999999999998 2356788888999999999999998 5433 255699999999999
Q ss_pred CCCccccccccccccccc
Q 005590 314 RDGEVNGALHEGKADAEE 331 (689)
Q Consensus 314 ~~~d~~G~v~~~~~~~~~ 331 (689)
++++++|.+.....+...
T Consensus 74 ~~~~~iG~~~~~l~~l~~ 91 (116)
T cd08376 74 KKDEFIGRCEIDLSALPR 91 (116)
T ss_pred CCCCeEEEEEEeHHHCCC
Confidence 999999999987765543
|
MCTPs are involved in Ca2+ signaling at the membrane. MCTP is composed of a variable N-terminal sequence, three C2 domains, two transmembrane regions (TMRs), and a short C-terminal sequence. It is one of four protein classes that are anchored to membranes via a transmembrane region; the others being synaptotagmins, extended synaptotagmins, and ferlins. MCTPs are the only membrane-bound C2 domain proteins that contain two functional TMRs. MCTPs are unique in that they bind Ca2+ but not phospholipids. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular protei |
| >cd04018 C2C_Ferlin C2 domain third repeat in Ferlin | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.2e-14 Score=134.19 Aligned_cols=94 Identities=15% Similarity=0.106 Sum_probs=78.3
Q ss_pred ceEEEEecc-CCcccCCCC--------------CCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCc
Q 005590 234 YGYLSSKEA-DLIDLQHNV--------------VGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKG 298 (689)
Q Consensus 234 ~l~v~i~e~-~L~~~d~~g--------------~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~ 298 (689)
.|+|+|.+| +|++||..+ .+||||++.+.. ++.||+++++++||+|||+|.|. +....
T Consensus 1 ~~~V~V~~A~dLp~~d~~~~~~~~~~~~~~~~~~~DPYV~V~~~g-----~~~kT~v~~~t~nPvWNE~f~f~--v~~p~ 73 (151)
T cd04018 1 RFIFKIYRAEDLPQMDSGIMANVKKAFLGEKKELVDPYVEVSFAG-----QKVKTSVKKNSYNPEWNEQIVFP--EMFPP 73 (151)
T ss_pred CeEEEEEEeCCCCccChhhhccceeccccCCCCCcCcEEEEEECC-----EeeecceEcCCCCCCcceEEEEE--eeCCC
Confidence 478999999 999999665 689999999842 35578888999999999999998 54444
Q ss_pred cccccccccccCCCCCCCcccccccccccccccccC
Q 005590 299 AEKDLMPAEIDNSDTRDGEVNGALHEGKADAEEHGV 334 (689)
Q Consensus 299 ~~~~L~~~V~D~d~~~~~d~~G~v~~~~~~~~~e~~ 334 (689)
.+..|.++|||+|.+++++++|.+.+...++...+.
T Consensus 74 ~~~~l~~~v~D~d~~~~dd~iG~~~l~l~~l~~~~~ 109 (151)
T cd04018 74 LCERIKIQIRDWDRVGNDDVIGTHFIDLSKISNSGD 109 (151)
T ss_pred cCCEEEEEEEECCCCCCCCEEEEEEEeHHHhccCCc
Confidence 556799999999999999999999998776655543
|
Ferlins are involved in vesicle fusion events. Ferlins and other proteins, such as Synaptotagmins, are implicated in facilitating the fusion process when cell membranes fuse together. There are six known human Ferlins: Dysferlin (Fer1L1), Otoferlin (Fer1L2), Myoferlin (Fer1L3), Fer1L4, Fer1L5, and Fer1L6. Defects in these genes can lead to a wide range of diseases including muscular dystrophy (dysferlin), deafness (otoferlin), and infertility (fer-1, fertilization factor-1). Structurally they have 6 tandem C2 domains, designated as (C2A-C2F) and a single C-terminal transmembrane domain, though there is a new study that disputes this and claims that there are actually 7 tandem C2 domains with another C2 domain inserted between C2D and C2E. In a subset of them (Dysferlin, Myoferlin, and Fer1) there is an additional conserved domain called DysF. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangemen |
| >cd08690 C2_Freud-1 C2 domain found in 5' repressor element under dual repression binding protein-1 (Freud-1) | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.3e-13 Score=131.58 Aligned_cols=96 Identities=14% Similarity=-0.018 Sum_probs=76.5
Q ss_pred ceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccC------cc-cccccc
Q 005590 234 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFK------GA-EKDLMP 305 (689)
Q Consensus 234 ~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~------~~-~~~L~~ 305 (689)
.++|....+ +|++.+.+|.+|||||++|+....+..+.||+++|+|+||+|||+|.|. ++.. .+ .+.|.+
T Consensus 5 el~i~~~~~~~l~~~~~~~~~DpYVk~~l~~p~~~~~k~KT~v~k~TlnPvfNE~f~f~--I~~~~~~~~R~l~~~~L~~ 82 (155)
T cd08690 5 ELTIVRCIGIPLPSGWNPKDLDTYVKFEFPYPNEEPQSGKTSTIKDTNSPEYNESFKLN--INRKHRSFQRVFKRHGLKF 82 (155)
T ss_pred EEEEEEeeccccCCCcCCCCCCeEEEEEEecCCCCCceeecCcccCCCCCcccceEEEE--eccccchhhhhccCCcEEE
Confidence 344444444 5889999999999999998544567789999999999999999999999 6655 23 455999
Q ss_pred ccccCCCCC-CCccccccccccccccc
Q 005590 306 AEIDNSDTR-DGEVNGALHEGKADAEE 331 (689)
Q Consensus 306 ~V~D~d~~~-~~d~~G~v~~~~~~~~~ 331 (689)
+|||++.+. +++++|.+.......+.
T Consensus 83 ~V~d~~~f~~~D~~iG~~~i~L~~l~~ 109 (155)
T cd08690 83 EVYHKGGFLRSDKLLGTAQVKLEPLET 109 (155)
T ss_pred EEEeCCCcccCCCeeEEEEEEcccccc
Confidence 999999985 69999999886655544
|
Freud-1 is a novel calcium-regulated repressor that negatively regulates basal 5-HT1A receptor expression in neurons. It may also play a role in the altered regulation of 5-HT1A receptors associated with anxiety or major depression. Freud-1 contains two DM-14 basic repeats, a helix-loop-helix DNA binding domain, and a C2 domain. The Freud-1 C2 domain is thought to be calcium insensitive and it lacks several acidic residues that mediate calcium binding of the PKC C2 domain. In addition, it contains a poly-basic insert that is not present in calcium-dependent C2 domains and may function as a nuclear localization signal. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules tha |
| >cd04036 C2_cPLA2 C2 domain present in cytosolic PhosphoLipase A2 (cPLA2) | Back alignment and domain information |
|---|
Probab=99.44 E-value=7.7e-14 Score=127.85 Aligned_cols=91 Identities=11% Similarity=0.036 Sum_probs=76.7
Q ss_pred eEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCccccccccccccCCCC
Q 005590 235 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDT 313 (689)
Q Consensus 235 l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~~~~L~~~V~D~d~~ 313 (689)
|+|.|++| ||++.|..|.+||||++.+...+ ..++||+++++++||+|||+|.|. +... ....|.++|||+|.+
T Consensus 2 L~V~vi~a~~L~~~~~~~~~Dpyv~v~~~~~~--~~~~kT~vv~~t~nP~Wne~f~f~--i~~~-~~~~l~v~v~d~d~~ 76 (119)
T cd04036 2 LTVRVLRATNITKGDLLSTPDCYVELWLPTAS--DEKKRTKTIKNSINPVWNETFEFR--IQSQ-VKNVLELTVMDEDYV 76 (119)
T ss_pred eEEEEEEeeCCCccCCCCCCCcEEEEEEcCCC--CccCccceecCCCCCccceEEEEE--eCcc-cCCEEEEEEEECCCC
Confidence 78999999 99999999999999999996543 346778888999999999999998 6554 344599999999999
Q ss_pred CCCccccccccccccccc
Q 005590 314 RDGEVNGALHEGKADAEE 331 (689)
Q Consensus 314 ~~~d~~G~v~~~~~~~~~ 331 (689)
+++++|.+.+.......
T Consensus 77 -~~~~iG~~~~~l~~l~~ 93 (119)
T cd04036 77 -MDDHLGTVLFDVSKLKL 93 (119)
T ss_pred -CCcccEEEEEEHHHCCC
Confidence 89999999887765543
|
A single copy of the C2 domain is present in cPLA2 which releases arachidonic acid from membranes initiating the biosynthesis of potent inflammatory mediators such as prostaglandins, leukotrienes, and platelet-activating factor. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1. However, there are a few exceptions to this including RIM isoforms and some splice variants o |
| >cd04016 C2_Tollip C2 domain present in Toll-interacting protein (Tollip) | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.4e-13 Score=126.41 Aligned_cols=86 Identities=8% Similarity=-0.040 Sum_probs=72.3
Q ss_pred cceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeecccc-CCCcccccccccccccccCccccccccccccC
Q 005590 233 DYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKR-GSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 310 (689)
Q Consensus 233 ~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~-tlnP~~ne~f~~~~~~~~~~~~~~L~~~V~D~ 310 (689)
+.|+|.|++| +|+.++ -|.+||||++.+ +..+.||+++++ ++||+|||+|.|. +... ...|.++|||.
T Consensus 2 g~L~v~v~~Ak~l~~~~-~g~sDPYv~i~l-----g~~~~kT~v~~~~~~nP~WNe~F~f~--v~~~--~~~l~~~V~d~ 71 (121)
T cd04016 2 GRLSITVVQAKLVKNYG-LTRMDPYCRIRV-----GHAVYETPTAYNGAKNPRWNKTIQCT--LPEG--VDSIYIEIFDE 71 (121)
T ss_pred cEEEEEEEEccCCCcCC-CCCCCceEEEEE-----CCEEEEeEEccCCCCCCccCeEEEEE--ecCC--CcEEEEEEEeC
Confidence 5799999999 988887 689999999999 334668887654 8999999999998 6543 24599999999
Q ss_pred CCCCCCcccccccccccc
Q 005590 311 SDTRDGEVNGALHEGKAD 328 (689)
Q Consensus 311 d~~~~~d~~G~v~~~~~~ 328 (689)
|.+++++++|.+......
T Consensus 72 d~~~~dd~iG~~~i~l~~ 89 (121)
T cd04016 72 RAFTMDERIAWTHITIPE 89 (121)
T ss_pred CCCcCCceEEEEEEECch
Confidence 999999999999887753
|
Tollip is a part of the Interleukin-1 receptor (IL-1R) signaling pathway. Tollip is proposed to link serine/threonine kinase IRAK to IL-1Rs as well as inhibiting phosphorylation of IRAK. There is a single C2 domain present in Tollip. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking proteins which contain at least two C2 domains, such as synaptotagmin 1. However, there are a few exceptions to this including RIM isoforms and some splice varian |
| >cd04025 C2B_RasA1_RasA4 C2 domain second repeat present in RasA1 and RasA4 | Back alignment and domain information |
|---|
Probab=99.43 E-value=1e-13 Score=127.80 Aligned_cols=90 Identities=17% Similarity=0.046 Sum_probs=77.2
Q ss_pred ceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCccccccccccccCCC
Q 005590 234 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSD 312 (689)
Q Consensus 234 ~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~~~~L~~~V~D~d~ 312 (689)
+|+|.|.+| ||.++|.+|.+||||++++ ...+.+|+++++|+||.|||+|.|. +.... ...|.++|||++.
T Consensus 1 ~L~v~vi~a~~L~~~d~~~~~DPyv~v~~-----~~~~~kT~v~~~t~nP~Wne~f~f~--~~~~~-~~~l~~~v~d~~~ 72 (123)
T cd04025 1 RLRCHVLEARDLAPKDRNGTSDPFVRVFY-----NGQTLETSVVKKSCYPRWNEVFEFE--LMEGA-DSPLSVEVWDWDL 72 (123)
T ss_pred CEEEEEEEeeCCCCCCCCCCcCceEEEEE-----CCEEEeceeecCCCCCccCcEEEEE--cCCCC-CCEEEEEEEECCC
Confidence 589999999 9999999999999999998 2345678888999999999999998 55433 4559999999999
Q ss_pred CCCCccccccccccccccc
Q 005590 313 TRDGEVNGALHEGKADAEE 331 (689)
Q Consensus 313 ~~~~d~~G~v~~~~~~~~~ 331 (689)
+++++++|.+.....++..
T Consensus 73 ~~~~~~iG~~~~~l~~l~~ 91 (123)
T cd04025 73 VSKNDFLGKVVFSIQTLQQ 91 (123)
T ss_pred CCCCcEeEEEEEEHHHccc
Confidence 9999999999998766644
|
RasA1 and RasA4 are GAP1s (GTPase activating protein 1s ), Ras-specific GAP members, which suppresses Ras function by enhancing the GTPase activity of Ras proteins resulting in the inactive GDP-bound form of Ras. In this way it can control cellular proliferation and differentiation. Both proteins contain two C2 domains, a Ras-GAP domain, a plextrin homology (PH)-like domain, and a Bruton's Tyrosine Kinase (BTK) zinc binding domain. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such a |
| >cd00276 C2B_Synaptotagmin C2 domain second repeat present in Synaptotagmin | Back alignment and domain information |
|---|
Probab=99.43 E-value=4.8e-14 Score=131.54 Aligned_cols=103 Identities=16% Similarity=0.081 Sum_probs=89.8
Q ss_pred cccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcc-ccccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 308 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V~ 308 (689)
+.+.|+|.|.+| ||+++|..|..||||++.+.++..+..+++|++++++.||.|||+|.|. ++...+ +..|.++||
T Consensus 12 ~~~~L~V~v~~a~~L~~~~~~~~~dpyv~v~l~~~~~~~~~~~T~~~~~~~~P~wne~f~f~--i~~~~l~~~~l~~~v~ 89 (134)
T cd00276 12 TAERLTVVVLKARNLPPSDGKGLSDPYVKVSLLQGGKKLKKKKTSVKKGTLNPVFNEAFSFD--VPAEQLEEVSLVITVV 89 (134)
T ss_pred CCCEEEEEEEEeeCCCCccCCCCCCcEEEEEEEcCCeEeeeecCcceecCCCCeeeeeEEEE--CCHHHhCCcEEEEEEE
Confidence 457899999999 9999999999999999999998877678888888999999999999999 777665 566999999
Q ss_pred cCCCCCCCcccccccccccccccccCCC
Q 005590 309 DNSDTRDGEVNGALHEGKADAEEHGVAT 336 (689)
Q Consensus 309 D~d~~~~~d~~G~v~~~~~~~~~e~~~~ 336 (689)
|.+.+++++++|.+.++..+ .+.+...
T Consensus 90 d~~~~~~~~~lG~~~i~l~~-~~~~~~~ 116 (134)
T cd00276 90 DKDSVGRNEVIGQVVLGPDS-GGEELEH 116 (134)
T ss_pred ecCCCCCCceeEEEEECCCC-CCcHHHH
Confidence 99999999999999998877 4444433
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. There are several classes of Synaptotagmins. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling step of synaptic vesicles. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distin |
| >cd04035 C2A_Rabphilin_Doc2 C2 domain first repeat present in Rabphilin and Double C2 domain | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.1e-13 Score=127.41 Aligned_cols=99 Identities=12% Similarity=0.071 Sum_probs=84.5
Q ss_pred cccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcc-ccccccccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 308 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V~ 308 (689)
.+.+|+|.|.+| +|+++|..|.+|||||++++++..+..+.+|+++++++||+|||+|.|.. +..... +..|.++||
T Consensus 13 ~~~~L~V~v~~a~~L~~~~~~~~~dpyv~v~~~~~~~~~~~~rT~v~~~~~~P~Wne~f~f~~-~~~~~~~~~~l~~~v~ 91 (123)
T cd04035 13 ANSALHCTIIRAKGLKAMDANGLSDPYVKLNLLPGASKATKLRTKTVHKTRNPEFNETLTYYG-ITEEDIQRKTLRLLVL 91 (123)
T ss_pred CCCEEEEEEEEeeCCCCCCCCCCCCceEEEEEecCCCCCCceeeeeecCCCCCCccceEEEcC-CCHHHhCCCEEEEEEE
Confidence 457899999999 99999999999999999999988777788999999999999999999962 443333 456999999
Q ss_pred cCCCCCCCccccccccccccccc
Q 005590 309 DNSDTRDGEVNGALHEGKADAEE 331 (689)
Q Consensus 309 D~d~~~~~d~~G~v~~~~~~~~~ 331 (689)
|++.+ +++++|.+.++..+...
T Consensus 92 d~~~~-~~~~iG~~~i~l~~l~~ 113 (123)
T cd04035 92 DEDRF-GNDFLGETRIPLKKLKP 113 (123)
T ss_pred EcCCc-CCeeEEEEEEEcccCCC
Confidence 99999 88999999887765544
|
Rabphilin is found neurons and in neuroendrocrine cells, while Doc2 is found not only in the brain but in tissues, including mast cells, chromaffin cells, and osteoblasts. Rabphilin and Doc2s share highly homologous tandem C2 domains, although their N-terminal structures are completely different: rabphilin contains an N-terminal Rab-binding domain (RBD),7 whereas Doc2 contains an N-terminal Munc13-1-interacting domain (MID). C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.1e-12 Score=132.96 Aligned_cols=133 Identities=17% Similarity=0.192 Sum_probs=96.6
Q ss_pred Eec-cCCCCceEEEEECCCCcEEEEEEeecch--------------hhhHhHHHHHHHHHHhcccCCCCCCceeEEEEEE
Q 005590 388 YLG-SAAFSKVFQAQDLHTGVDVCLKIIKNDK--------------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 452 (689)
Q Consensus 388 ~LG-~G~fG~Vyla~d~~tg~~vAvKii~~~~--------------~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f 452 (689)
.|| .||.|+||.+.. .+..++||.+.... .......+|+.++..+.+.. ..+++.+++.
T Consensus 38 ~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~g----i~vP~pl~~~ 111 (239)
T PRK01723 38 VVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAG----LPVPRPIAAR 111 (239)
T ss_pred eeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCC----CCCceeEeee
Confidence 477 899999999975 47889999885311 12245678999999997642 2246666654
Q ss_pred EeCC----eEEEEEEcccc--chHHHHhhhhccCCCcccCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEeccCC
Q 005590 453 YHLE----HLFIVCELLRA--NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR 526 (689)
Q Consensus 453 ~~~~----~l~lVmEy~~g--~L~~l~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDLKp~NILl~~~~~ 526 (689)
.... ..++|||++.| +|.+++... .+++. .+.||+.+|.+||+.||+|+||||.|||++. +
T Consensus 112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-------~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~--~ 178 (239)
T PRK01723 112 VVRHGLFYRADILIERIEGARDLVALLQEA-------PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDP--D 178 (239)
T ss_pred eeecCcceeeeEEEEecCCCCCHHHHHhcC-------CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcC--C
Confidence 4322 23599999986 555554321 14433 3678999999999999999999999999985 5
Q ss_pred CeEEEEecCCccc
Q 005590 527 CEIKIIDLGSSCF 539 (689)
Q Consensus 527 ~~vkL~DFGls~~ 539 (689)
+.++|+|||.+..
T Consensus 179 ~~v~LIDfg~~~~ 191 (239)
T PRK01723 179 GKFWLIDFDRGEL 191 (239)
T ss_pred CCEEEEECCCccc
Confidence 6899999998865
|
|
| >cd04042 C2A_MCTP_PRT C2 domain first repeat found in Multiple C2 domain and Transmembrane region Proteins (MCTP) | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.3e-13 Score=126.76 Aligned_cols=90 Identities=12% Similarity=0.054 Sum_probs=76.4
Q ss_pred ceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCccccccccccccCCC
Q 005590 234 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSD 312 (689)
Q Consensus 234 ~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~~~~L~~~V~D~d~ 312 (689)
.|+|.|++| ||+++|.+|.+||||++.+. .++..||+++++|+||+|||+|.|. +.. ....|.++|||++.
T Consensus 1 ~L~v~v~~a~~L~~~d~~g~~Dpyv~v~~~----~~~~~kT~~~~~t~nP~Wne~f~f~--v~~--~~~~l~~~v~D~d~ 72 (121)
T cd04042 1 QLDIHLKEGRNLAARDRGGTSDPYVKFKYG----GKTVYKSKTIYKNLNPVWDEKFTLP--IED--VTQPLYIKVFDYDR 72 (121)
T ss_pred CeEEEEEEeeCCCCcCCCCCCCCeEEEEEC----CEEEEEeeeccCCCCCccceeEEEE--ecC--CCCeEEEEEEeCCC
Confidence 378999999 99999999999999999983 2346778888999999999999998 542 34569999999999
Q ss_pred CCCCccccccccccccccc
Q 005590 313 TRDGEVNGALHEGKADAEE 331 (689)
Q Consensus 313 ~~~~d~~G~v~~~~~~~~~ 331 (689)
+++++++|.+++...+...
T Consensus 73 ~~~~~~iG~~~~~l~~l~~ 91 (121)
T cd04042 73 GLTDDFMGSAFVDLSTLEL 91 (121)
T ss_pred CCCCcceEEEEEEHHHcCC
Confidence 9999999999987765553
|
MCTPs are involved in Ca2+ signaling at the membrane. MCTP is composed of a variable N-terminal sequence, three C2 domains, two transmembrane regions (TMRs), and a short C-terminal sequence. It is one of four protein classes that are anchored to membranes via a transmembrane region; the others being synaptotagmins, extended synaptotagmins, and ferlins. MCTPs are the only membrane-bound C2 domain proteins that contain two functional TMRs. MCTPs are unique in that they bind Ca2+ but not phospholipids. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular protein |
| >cd08686 C2_ABR C2 domain in the Active BCR (Breakpoint cluster region) Related protein | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.2e-13 Score=125.05 Aligned_cols=80 Identities=10% Similarity=0.058 Sum_probs=68.1
Q ss_pred eEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCccccccccccccC---
Q 005590 235 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN--- 310 (689)
Q Consensus 235 l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~~~~L~~~V~D~--- 310 (689)
|+|+|++| ||+ |.+||||++.+.+.++...+.||+++++|+||+|||+|.|. ++ ..++|.+.|||+
T Consensus 1 L~V~V~~A~~L~-----~~sDPYV~l~v~~~~~~~~~~KTk~i~~TlnPvWnE~F~i~--l~---~s~~L~~~v~d~~~~ 70 (118)
T cd08686 1 LNVIVHSAQGFK-----QSANLYCTLEVDSFGYFVKKAKTRVCRDTTEPNWNEEFEIE--LE---GSQTLRILCYEKCYS 70 (118)
T ss_pred CEEEEEeCCCCC-----CCCCCEEEEEEcCccccceeeeeeeecCCCCCccceEEEEE--eC---CCCEEEEEEEEcccc
Confidence 68999999 995 67999999999998766678999999999999999999998 64 255799999998
Q ss_pred ----CCCCCCcccccccc
Q 005590 311 ----SDTRDGEVNGALHE 324 (689)
Q Consensus 311 ----d~~~~~d~~G~v~~ 324 (689)
|.++.++.+|.-..
T Consensus 71 ~~~~d~~~~d~~~G~g~i 88 (118)
T cd08686 71 KVKLDGEGTDAIMGKGQI 88 (118)
T ss_pred cccccccCcccEEEEEEE
Confidence 57777888866544
|
The ABR protein is similar to the breakpoint cluster region protein. It has homology to guanine nucleotide exchange proteins and GTPase-activating proteins (GAPs). ABR is expressed primarily in the brain, but also includes non-neuronal tissues such as the heart. It has been associated with human diseases such as Miller-Dieker syndrome in which mental retardation and malformations of the heart are present. ABR contains a RhoGEF domain and a PH-like domain upstream of its C2 domain and a RhoGAP domain downstream of this domain. A few members also contain a Bcr-Abl oncoprotein oligomerization domain at the very N-terminal end. Splice variants of ABR have been identified. ABR is found in a wide variety of organisms including chimpanzee, dog, mouse, rat, fruit fly, and mosquito. The C2 domain was first identified in PKC. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arr |
| >cd04022 C2A_MCTP_PRT_plant C2 domain first repeat found in Multiple C2 domain and Transmembrane region Proteins (MCTP); plant subset | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.3e-13 Score=127.95 Aligned_cols=90 Identities=9% Similarity=0.011 Sum_probs=77.1
Q ss_pred ceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCccccccccccccccc-Ccc-ccccccccccC
Q 005590 234 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHF-KGA-EKDLMPAEIDN 310 (689)
Q Consensus 234 ~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~-~~~-~~~L~~~V~D~ 310 (689)
+|+|.|++| ||.++|.+|.+||||++++.. .++||+++++++||+|||+|.|. +.. ... +..|.++|||.
T Consensus 1 ~L~V~vi~A~~L~~~d~~g~~dpyv~v~~~~-----~~~rT~v~~~t~nP~Wne~f~f~--~~~~~~~~~~~l~~~V~d~ 73 (127)
T cd04022 1 KLVVEVVDAQDLMPKDGQGSSSAYVELDFDG-----QKKRTRTKPKDLNPVWNEKLVFN--VSDPSRLSNLVLEVYVYND 73 (127)
T ss_pred CeEEEEEEeeCCCCCCCCCCcCcEEEEEECC-----EEecceeEcCCCCCccceEEEEE--ccCHHHccCCeEEEEEeeC
Confidence 589999999 999999999999999999854 35678888999999999999999 543 333 45699999999
Q ss_pred CCCC-CCcccccccccccccc
Q 005590 311 SDTR-DGEVNGALHEGKADAE 330 (689)
Q Consensus 311 d~~~-~~d~~G~v~~~~~~~~ 330 (689)
++++ +++++|.+.+...+..
T Consensus 74 ~~~~~~d~~lG~v~i~l~~l~ 94 (127)
T cd04022 74 RRSGRRRSFLGRVRISGTSFV 94 (127)
T ss_pred CCCcCCCCeeeEEEEcHHHcC
Confidence 9997 7999999999876665
|
MCTPs are involved in Ca2+ signaling at the membrane. Plant-MCTPs are composed of a variable N-terminal sequence, four C2 domains, two transmembrane regions (TMRs), and a short C-terminal sequence. It is one of four protein classes that are anchored to membranes via a transmembrane region; the others being synaptotagmins, extended synaptotagmins, and ferlins. MCTPs are the only membrane-bound C2 domain proteins that contain two functional TMRs. MCTPs are unique in that they bind Ca2+ but not phospholipids. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates |
| >cd08379 C2D_MCTP_PRT_plant C2 domain fourth repeat found in Multiple C2 domain and Transmembrane region Proteins (MCTP); plant subset | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.3e-13 Score=127.48 Aligned_cols=87 Identities=15% Similarity=0.033 Sum_probs=73.1
Q ss_pred eEEEEecc-C---CcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCccccccccccccC
Q 005590 235 GYLSSKEA-D---LIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 310 (689)
Q Consensus 235 l~v~i~e~-~---L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~~~~L~~~V~D~ 310 (689)
|+|.|++| | |.++|..|.+||||++.+ ..++.+|+++++++||+|||+|.|. +.. ....|.++|||+
T Consensus 2 L~v~v~~A~~~~~l~~~d~~g~sDPYv~i~~-----g~~~~rTk~~~~~~nP~WnE~f~f~--v~~--~~~~l~v~V~d~ 72 (126)
T cd08379 2 LEVGILGAQGLDVLRAKDGRGSTDAYCVAKY-----GPKWVRTRTVEDSSNPRWNEQYTWP--VYD--PCTVLTVGVFDN 72 (126)
T ss_pred eEEEEEEeECCccccccccCCCCCeeEEEEE-----CCEEeEcCcccCCCCCcceeEEEEE--ecC--CCCEEEEEEEEC
Confidence 78999999 9 999999999999999998 3346688888999999999999998 532 223699999999
Q ss_pred CCCC------CCcccccccccccccc
Q 005590 311 SDTR------DGEVNGALHEGKADAE 330 (689)
Q Consensus 311 d~~~------~~d~~G~v~~~~~~~~ 330 (689)
+.++ .++++|++.+......
T Consensus 73 d~~~~~~~~~~dd~lG~~~i~l~~l~ 98 (126)
T cd08379 73 SQSHWKEAVQPDVLIGKVRIRLSTLE 98 (126)
T ss_pred CCccccccCCCCceEEEEEEEHHHcc
Confidence 9984 7999999988654443
|
MCTPs are involved in Ca2+ signaling at the membrane. Plant-MCTPs are composed of a variable N-terminal sequence, four C2 domains, two transmembrane regions (TMRs), and a short C-terminal sequence. It is one of four protein classes that are anchored to membranes via a transmembrane region; the others being synaptotagmins, extended synaptotagmins, and ferlins. MCTPs are the only membrane-bound C2 domain proteins that contain two functional TMRs. MCTPs are unique in that they bind Ca2+ but not phospholipids. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphate |
| >cd08375 C2_Intersectin C2 domain present in Intersectin | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.7e-13 Score=127.35 Aligned_cols=94 Identities=12% Similarity=0.005 Sum_probs=80.4
Q ss_pred ccccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCccccccccccc
Q 005590 230 INNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI 308 (689)
Q Consensus 230 ~~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~~~~L~~~V~ 308 (689)
..-+.|+|.|++| ||+++|..|.+||||++.+ ...+.||+++++|+||.|||+|.|. +... ....|.++||
T Consensus 12 ~~~G~L~V~Vi~A~~L~~~d~~g~~DPYv~v~~-----~~~~~kT~vi~~t~nP~Wne~f~f~--v~~~-~~~~l~i~V~ 83 (136)
T cd08375 12 SGIGRLMVVIVEGRDLKPCNSNGKSDPYCEVSM-----GSQEHKTKVVSDTLNPKWNSSMQFF--VKDL-EQDVLCITVF 83 (136)
T ss_pred CCcEEEEEEEEEeeCCCCCCCCCCcCcEEEEEE-----CCEeeeccccCCCCCCccCceEEEE--ecCc-cCCEEEEEEE
Confidence 4568899999999 9999999999999999998 2346788888999999999999998 5432 2456999999
Q ss_pred cCCCCCCCccccccccccccccc
Q 005590 309 DNSDTRDGEVNGALHEGKADAEE 331 (689)
Q Consensus 309 D~d~~~~~d~~G~v~~~~~~~~~ 331 (689)
|+|.+++++++|.+.....+...
T Consensus 84 D~d~~~~d~~lG~~~i~l~~l~~ 106 (136)
T cd08375 84 DRDFFSPDDFLGRTEIRVADILK 106 (136)
T ss_pred ECCCCCCCCeeEEEEEEHHHhcc
Confidence 99999999999999988766655
|
A single instance of the C2 domain is located C terminally in the intersectin protein. Intersectin functions as a scaffolding protein, providing a link between the actin cytoskeleton and the components of endocytosis and plays a role in signal transduction. In addition to C2, intersectin contains several additional domains including: Eps15 homology domains, SH3 domains, a RhoGEF domain, and a PH domain. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transduction enzymes that contain a single C2 domain, such as protein kinase C, or membrane trafficking pro |
| >cd04026 C2_PKC_alpha_gamma C2 domain in Protein Kinase C (PKC) alpha and gamma | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.8e-13 Score=126.27 Aligned_cols=112 Identities=21% Similarity=0.246 Sum_probs=93.1
Q ss_pred cceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCccccccccccccCC
Q 005590 233 DYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNS 311 (689)
Q Consensus 233 ~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~~~~L~~~V~D~d 311 (689)
+.|+|.|.+| ||++.|..|..||||++.+.+++++..+.+|++.++++||.|||+|.|. +.....+..|.+.|||++
T Consensus 13 ~~l~v~i~~a~nL~~~~~~~~~dpyv~v~~~~~~~~~~~~rT~v~~~~~~P~wne~f~~~--~~~~~~~~~l~v~v~d~~ 90 (131)
T cd04026 13 NKLTVEVREAKNLIPMDPNGLSDPYVKLKLIPDPKNETKQKTKTIKKTLNPVWNETFTFD--LKPADKDRRLSIEVWDWD 90 (131)
T ss_pred CEEEEEEEEeeCCCCcCCCCCCCCcEEEEEEcCCCCCceecceeecCCCCCCccceEEEe--CCchhcCCEEEEEEEECC
Confidence 6789999999 9999999999999999999988777778889988999999999999998 665445667999999999
Q ss_pred CCCCCcccccccccccccccccCCCccchhchhhhhhhh
Q 005590 312 DTRDGEVNGALHEGKADAEEHGVATPDLLMFDNLEEECE 350 (689)
Q Consensus 312 ~~~~~d~~G~v~~~~~~~~~e~~~~~~~l~~~~l~ee~~ 350 (689)
.+++++++|.++....+........ |+....+...
T Consensus 91 ~~~~~~~iG~~~~~l~~l~~~~~~~----w~~L~~~~~~ 125 (131)
T cd04026 91 RTTRNDFMGSLSFGVSELIKMPVDG----WYKLLNQEEG 125 (131)
T ss_pred CCCCcceeEEEEEeHHHhCcCccCc----eEECcCcccc
Confidence 9999999999999877776543333 5555544443
|
A single C2 domain is found in PKC alpha and gamma. The PKC family of serine/threonine kinases regulates apoptosis, proliferation, migration, motility, chemo-resistance, and differentiation. There are 3 groups: group 1(alpha, betaI, beta II, gamma) which require phospholipids and calcium, group 2 (delta, epsilon, theta, eta) which do not require calcium for activation, and group 3 (xi, iota/lambda) which are atypical and can be activated in the absence of diacylglycerol and calcium. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. Most C2 domain proteins are either signal transd |
| >cd08676 C2A_Munc13-like C2 domain first repeat in Munc13 (mammalian uncoordinated)-like proteins | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.5e-13 Score=129.77 Aligned_cols=99 Identities=14% Similarity=0.087 Sum_probs=80.3
Q ss_pred cccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCc------------------------ceeeeeccccCCCcccc
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTE------------------------KSSSYSSSKRGSSIDWI 285 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~------------------------~k~kt~~~k~tlnP~~n 285 (689)
+...|+|.|.+| ||.++|.+|.+||||++.+.+..++. ..++|.++++|+||.||
T Consensus 26 ~~~~L~V~vi~a~~L~~~d~~g~~DPyv~v~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kT~v~~~tlnP~Wn 105 (153)
T cd08676 26 PIFVLKVTVIEAKGLLAKDVNGFSDPYCMLGIVPASRERNSEKSKKRKSHRKKAVLKDTVPAKSIKVTEVKPQTLNPVWN 105 (153)
T ss_pred CeEEEEEEEEeccCCcccCCCCCCCceEEEEEcccccccccccccccccccccccccccccccccEecceecCCCCCccc
Confidence 456899999999 99999999999999999998764331 23678888999999999
Q ss_pred cccccccccccCccccccccccccCCCCCCCcccccccccccccccccCCC
Q 005590 286 EGFKGSSDLHFKGAEKDLMPAEIDNSDTRDGEVNGALHEGKADAEEHGVAT 336 (689)
Q Consensus 286 e~f~~~~~~~~~~~~~~L~~~V~D~d~~~~~d~~G~v~~~~~~~~~e~~~~ 336 (689)
|+|.|. +... .+..|.++|||++ ++++|.+.+...++...+...
T Consensus 106 E~F~f~--v~~~-~~~~L~i~V~D~d----d~~IG~v~i~l~~l~~~~~d~ 149 (153)
T cd08676 106 ETFRFE--VEDV-SNDQLHLDIWDHD----DDFLGCVNIPLKDLPSCGLDS 149 (153)
T ss_pred cEEEEE--eccC-CCCEEEEEEEecC----CCeEEEEEEEHHHhCCCCCCC
Confidence 999998 5432 2456999999998 889999999887776444433
|
C2-like domains are thought to be involved in phospholipid binding in a Ca2+ independent manner in both Unc13 and Munc13. Caenorabditis elegans Unc13 has a central domain with sequence similarity to PKC, which includes C1 and C2-related domains. Unc13 binds phorbol esters and DAG with high affinity in a phospholipid manner. Mutations in Unc13 results in abnormal neuronal connections and impairment in cholinergic neurotransmission in the nematode. Munc13 is the mammalian homolog which are expressed in the brain. There are 3 isoforms (Munc13-1, -2, -3) and are thought to play a role in neurotransmitter release and are hypothesized to be high-affinity receptors for phorbol esters. Unc13 and Munc13 contain both C1 and C2 domains. There are two C2 related domains present, one central and one at the carboxyl end. Munc13-1 contains a third C2-like domain. Munc13 interacts with syntaxin, sy |
| >KOG1030 consensus Predicted Ca2+-dependent phospholipid-binding protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.8e-13 Score=127.87 Aligned_cols=86 Identities=12% Similarity=0.045 Sum_probs=76.1
Q ss_pred ccceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCccccccccccccC
Q 005590 232 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 310 (689)
Q Consensus 232 ~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~~~~L~~~V~D~ 310 (689)
.+-|+|.|+.+ ||...|+.|+|||||-+.+ +..|.||++.++++||+|||.|+|. + .+....|.++|||+
T Consensus 5 vGLL~v~v~~g~~L~~rD~~~sSDPyVVl~l-----g~q~lkT~~v~~n~NPeWNe~ltf~--v--~d~~~~lkv~VyD~ 75 (168)
T KOG1030|consen 5 VGLLRVRVKRGKNLAIRDFLGSSDPYVVLEL-----GNQKLKTRVVYKNLNPEWNEELTFT--V--KDPNTPLKVTVYDK 75 (168)
T ss_pred ceEEEEEEEeecCeeeeccccCCCCeEEEEE-----CCeeeeeeeecCCCCCcccceEEEE--e--cCCCceEEEEEEeC
Confidence 35789999999 9999999899999999999 5668888899999999999999987 3 34456699999999
Q ss_pred CCCCCCcccccccccc
Q 005590 311 SDTRDGEVNGALHEGK 326 (689)
Q Consensus 311 d~~~~~d~~G~v~~~~ 326 (689)
|.++..|++|+..+..
T Consensus 76 D~fs~dD~mG~A~I~l 91 (168)
T KOG1030|consen 76 DTFSSDDFMGEATIPL 91 (168)
T ss_pred CCCCcccccceeeecc
Confidence 9999999999997754
|
|
| >cd08374 C2F_Ferlin C2 domain sixth repeat in Ferlin | Back alignment and domain information |
|---|
Probab=99.39 E-value=2e-13 Score=126.86 Aligned_cols=91 Identities=12% Similarity=-0.008 Sum_probs=77.1
Q ss_pred eEEEEecc-CCcc--cCCCCC--CCcceeeecCCCCCCcceeeeeccccCCC--ccccccccccccccc-----------
Q 005590 235 GYLSSKEA-DLID--LQHNVV--GDSSTDCDLAPHPGTEKSSSYSSSKRGSS--IDWIEGFKGSSDLHF----------- 296 (689)
Q Consensus 235 l~v~i~e~-~L~~--~d~~g~--sDpyvk~~l~pd~~~~~k~kt~~~k~tln--P~~ne~f~~~~~~~~----------- 296 (689)
|||+|-+| |++. ++.+|. +|||||++|.+. +.+|+||.++++++| |.||+.|.|. ++.
T Consensus 2 LRViIw~~~~v~~~~~~~~g~~~sD~yVK~~L~~~--~~~kqkTDVHyrslnG~~~FNwRfvF~--~~~~~~~~~~~~~~ 77 (133)
T cd08374 2 LRVIVWNTRDVLNDDTNITGEKMSDIYVKGWLDGL--EEDKQKTDVHYRSLDGEGNFNWRFVFP--FDYLPAEKKIVVIK 77 (133)
T ss_pred EEEEEEECcCCcccccccCCccccCeEEEEEEccC--cccccccceEEecCCCCcEEeEEEEEe--eecCCccceeEEEe
Confidence 79999999 9554 455784 999999999997 567889999999999 9999999998 554
Q ss_pred ----------Ccc-ccccccccccCCCCCCCccccccccccccc
Q 005590 297 ----------KGA-EKDLMPAEIDNSDTRDGEVNGALHEGKADA 329 (689)
Q Consensus 297 ----------~~~-~~~L~~~V~D~d~~~~~d~~G~v~~~~~~~ 329 (689)
+.+ ..+|.++|||.|++++++++|++.++....
T Consensus 78 ~~~~~~~~~~e~~~~~~L~lqvwD~D~~s~dd~iG~~~l~l~~l 121 (133)
T cd08374 78 KEHFWSLDETEYKIPPKLTLQVWDNDKFSPDDFLGSLELDLSIL 121 (133)
T ss_pred eccccccCcceEecCcEEEEEEEECcccCCCCcceEEEEEhhhc
Confidence 455 566999999999999999999998866433
|
Ferlins are involved in vesicle fusion events. Ferlins and other proteins, such as Synaptotagmins, are implicated in facilitating the fusion process when cell membranes fuse together. There are six known human Ferlins: Dysferlin (Fer1L1), Otoferlin (Fer1L2), Myoferlin (Fer1L3), Fer1L4, Fer1L5, and Fer1L6. Defects in these genes can lead to a wide range of diseases including muscular dystrophy (dysferlin), deafness (otoferlin), and infertility (fer-1, fertilization factor-1). Structurally they have 6 tandem C2 domains, designated as (C2A-C2F) and a single C-terminal transmembrane domain, though there is a new study that disputes this and claims that there are actually 7 tandem C2 domains with another C2 domain inserted between C2D and C2E. In a subset of them (Dysferlin, Myoferlin, and Fer1) there is an additional conserved domain called DysF. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangemen |
| >cd04019 C2C_MCTP_PRT_plant C2 domain third repeat found in Multiple C2 domain and Transmembrane region Proteins (MCTP); plant subset | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.7e-13 Score=128.49 Aligned_cols=90 Identities=20% Similarity=0.146 Sum_probs=75.3
Q ss_pred ceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeecccc-CCCcccccccccccccccCccccccccccccCC
Q 005590 234 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKR-GSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNS 311 (689)
Q Consensus 234 ~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~-tlnP~~ne~f~~~~~~~~~~~~~~L~~~V~D~d 311 (689)
+|+|.|.+| ||+++|.+|.+||||++.+.. ++.||++.++ |+||+|||+|.|. ++.. ....|.+.|||++
T Consensus 1 ~L~V~Vi~A~~L~~~d~~g~sDPYV~v~l~~-----~~~kTk~~~~~t~nP~WNE~F~f~--v~~~-~~~~l~v~V~d~~ 72 (150)
T cd04019 1 YLRVTVIEAQDLVPSDKNRVPEVFVKAQLGN-----QVLRTRPSQTRNGNPSWNEELMFV--AAEP-FEDHLILSVEDRV 72 (150)
T ss_pred CEEEEEEEeECCCCCCCCCCCCeEEEEEECC-----EEeeeEeccCCCCCCcccCcEEEE--ecCc-cCCeEEEEEEEec
Confidence 689999999 999999999999999999943 4666765554 7999999999998 6432 2346899999999
Q ss_pred CCCCCccccccccccccccc
Q 005590 312 DTRDGEVNGALHEGKADAEE 331 (689)
Q Consensus 312 ~~~~~d~~G~v~~~~~~~~~ 331 (689)
..++++++|.+.+...+...
T Consensus 73 ~~~~dd~lG~v~i~L~~l~~ 92 (150)
T cd04019 73 GPNKDEPLGRAVIPLNDIER 92 (150)
T ss_pred CCCCCCeEEEEEEEHHHCcc
Confidence 99999999999998876643
|
MCTPs are involved in Ca2+ signaling at the membrane. Plant-MCTPs are composed of a variable N-terminal sequence, four C2 domains, two transmembrane regions (TMRs), and a short C-terminal sequence. It is one of four protein classes that are anchored to membranes via a transmembrane region; the others being synaptotagmins, extended synaptotagmins, and ferlins. MCTPs are the only membrane-bound C2 domain proteins that contain two functional TMRs. MCTPs are unique in that they bind Ca2+ but not phospholipids. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates |
| >cd04033 C2_NEDD4_NEDD4L C2 domain present in the Human neural precursor cell-expressed, developmentally down-regulated 4 (NEDD4) and NEDD4-like (NEDD4L/NEDD42) | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.2e-13 Score=126.07 Aligned_cols=95 Identities=15% Similarity=0.097 Sum_probs=79.7
Q ss_pred ceEEEEecc-CCcccCCCCCCCcceeeecCCC--CCCcceeeeeccccCCCcccccccccccccccCccccccccccccC
Q 005590 234 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPH--PGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 310 (689)
Q Consensus 234 ~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd--~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~~~~L~~~V~D~ 310 (689)
.|+|.|.+| ||+++|..|.+||||++.+... .++..+.+|+++++|+||.|||+|.|. ++.. +..|.+.|||+
T Consensus 1 ~L~v~Vi~a~~L~~~d~~~~~Dpyv~v~~~~~~~~~~~~~~kT~v~~~t~nP~Wne~f~f~--~~~~--~~~l~~~v~d~ 76 (133)
T cd04033 1 ILRVKVLAGIDLAKKDIFGASDPYVKISLYDPDGNGEIDSVQTKTIKKTLNPKWNEEFFFR--VNPR--EHRLLFEVFDE 76 (133)
T ss_pred CEEEEEEEeECCCcccCCCCcCcEEEEEEECCCCCCcccceeeeEEcCCCCCcEeeEEEEE--EcCC--CCEEEEEEEEC
Confidence 478999999 9999999999999999999865 223346688888999999999999998 5543 34589999999
Q ss_pred CCCCCCcccccccccccccccc
Q 005590 311 SDTRDGEVNGALHEGKADAEEH 332 (689)
Q Consensus 311 d~~~~~d~~G~v~~~~~~~~~e 332 (689)
+.+++++++|.+.....+....
T Consensus 77 ~~~~~~~~iG~~~i~l~~l~~~ 98 (133)
T cd04033 77 NRLTRDDFLGQVEVPLNNLPTE 98 (133)
T ss_pred CCCCCCCeeEEEEEEHHHCCCc
Confidence 9999999999999877666543
|
Nedd4 and Nedd4-2 are two of the nine members of the Human Nedd4 family. All vertebrates appear to have both Nedd4 and Nedd4-2 genes. They are thought to participate in the regulation of epithelial Na+ channel (ENaC) activity. They also have identical specificity for ubiquitin conjugating enzymes (E2). Nedd4 and Nedd4-2 are composed of a C2 domain, 2-4 WW domains, and a ubiquitin ligase Hect domain. Their WW domains can bind PPxY (PY) or LPSY motifs, and in vitro studies suggest that WW3 and WW4 of both proteins bind PY motifs in the key substrates, with WW3 generally exhibiting higher affinity. Most Nedd4 family members, especially Nedd4-2, also have multiple splice variants, which might play different roles in regulating their substrates. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangemen |
| >cd04024 C2A_Synaptotagmin-like C2 domain first repeat present in Synaptotagmin-like proteins | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.2e-13 Score=123.09 Aligned_cols=90 Identities=10% Similarity=-0.033 Sum_probs=77.3
Q ss_pred cceEEEEecc-CCcccCC--CCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcccccccccccc
Q 005590 233 DYGYLSSKEA-DLIDLQH--NVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 309 (689)
Q Consensus 233 ~~l~v~i~e~-~L~~~d~--~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~~~~L~~~V~D 309 (689)
+.|+|.|.+| ||+++|. .|.+||||++++ +..+.+|+++++|+||.|||+|.|. +.. .....|.++|||
T Consensus 1 g~l~v~v~~a~~L~~~~~~~~~~~dPyv~v~~-----~~~~~kT~~~~~t~~P~Wne~f~~~--~~~-~~~~~l~i~v~d 72 (128)
T cd04024 1 GVLRVHVVEAKDLAAKDRSGKGKSDPYAILSV-----GAQRFKTQTIPNTLNPKWNYWCEFP--IFS-AQNQLLKLILWD 72 (128)
T ss_pred CEEEEEEEEeeCCCcccCCCCCCcCCeEEEEE-----CCEEEecceecCCcCCccCCcEEEE--ecC-CCCCEEEEEEEE
Confidence 4688999999 9999999 899999999998 2356788888999999999999998 554 234569999999
Q ss_pred CCCCCCCcccccccccccccc
Q 005590 310 NSDTRDGEVNGALHEGKADAE 330 (689)
Q Consensus 310 ~d~~~~~d~~G~v~~~~~~~~ 330 (689)
++.+++++++|.+.+...+..
T Consensus 73 ~~~~~~~~~lG~~~i~l~~~~ 93 (128)
T cd04024 73 KDRFAGKDYLGEFDIALEEVF 93 (128)
T ss_pred CCCCCCCCcceEEEEEHHHhh
Confidence 999999999999999876665
|
Synaptotagmin is a membrane-trafficking protein characterized by a N-terminal transmembrane region, a linker, and 2 C-terminal C2 domains. Previously all synaptotagmins were thought to be calcium sensors in the regulation of neurotransmitter release and hormone secretion, but it has been shown that not all of them bind calcium. Of the 17 identified synaptotagmins only 8 bind calcium (1-3, 5-7, 9, 10). The function of the two C2 domains that bind calcium are: regulating the fusion step of synaptic vesicle exocytosis (C2A) and binding to phosphatidyl-inositol-3,4,5-triphosphate (PIP3) in the absence of calcium ions and to phosphatidylinositol bisphosphate (PIP2) in their presence (C2B). C2B also regulates also the recycling step of synaptic vesicles. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permu |
| >cd04037 C2E_Ferlin C2 domain fifth repeat in Ferlin | Back alignment and domain information |
|---|
Probab=99.36 E-value=5.3e-13 Score=123.40 Aligned_cols=89 Identities=11% Similarity=-0.031 Sum_probs=73.0
Q ss_pred eEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCccccccccccccCCCC
Q 005590 235 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDT 313 (689)
Q Consensus 235 l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~~~~L~~~V~D~d~~ 313 (689)
++|.|++| ||+++|..|.+||||++.+... ..++||.++++|+||+|||+|.|. +... ....|.++|||+|.+
T Consensus 2 lrV~Vi~a~~L~~~d~~g~~DPYv~v~~~~~---~~~~kT~~v~~t~nP~Wne~f~f~--~~~~-~~~~L~~~V~d~d~~ 75 (124)
T cd04037 2 VRVYVVRARNLQPKDPNGKSDPYLKIKLGKK---KINDRDNYIPNTLNPVFGKMFELE--ATLP-GNSILKISVMDYDLL 75 (124)
T ss_pred EEEEEEECcCCCCCCCCCCCCcEEEEEECCe---eccceeeEEECCCCCccceEEEEE--ecCC-CCCEEEEEEEECCCC
Confidence 78999999 9999999999999999999432 234566667889999999999997 4322 134599999999999
Q ss_pred CCCccccccccccccc
Q 005590 314 RDGEVNGALHEGKADA 329 (689)
Q Consensus 314 ~~~d~~G~v~~~~~~~ 329 (689)
++++++|.+.....+.
T Consensus 76 ~~dd~iG~~~i~l~~~ 91 (124)
T cd04037 76 GSDDLIGETVIDLEDR 91 (124)
T ss_pred CCCceeEEEEEeeccc
Confidence 9999999998866433
|
Ferlins are involved in vesicle fusion events. Ferlins and other proteins, such as Synaptotagmins, are implicated in facilitating the fusion process when cell membranes fuse together. There are six known human Ferlins: Dysferlin (Fer1L1), Otoferlin (Fer1L2), Myoferlin (Fer1L3), Fer1L4, Fer1L5, and Fer1L6. Defects in these genes can lead to a wide range of diseases including muscular dystrophy (dysferlin), deafness (otoferlin), and infertility (fer-1, fertilization factor-1). Structurally they have 6 tandem C2 domains, designated as (C2A-C2F) and a single C-terminal transmembrane domain, though there is a new study that disputes this and claims that there are actually 7 tandem C2 domains with another C2 domain inserted between C2D and C2E. In a subset of them (Dysferlin, Myoferlin, and Fer1) there is an additional conserved domain called DysF. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangemen |
| >cd04043 C2_Munc13_fungal C2 domain in Munc13 (mammalian uncoordinated) proteins; fungal group | Back alignment and domain information |
|---|
Probab=99.35 E-value=9.1e-13 Score=121.82 Aligned_cols=91 Identities=11% Similarity=-0.038 Sum_probs=76.5
Q ss_pred ceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCccccccccccccCCC
Q 005590 234 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSD 312 (689)
Q Consensus 234 ~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~~~~L~~~V~D~d~ 312 (689)
.++|.|.+| ||+++|.+|.+||||++++... +.++.||+++++++||.|||+|.|. ++.. ....|.++|||++.
T Consensus 2 ~~~V~v~~a~~L~~~~~~~~~Dpyv~v~~~~~--~~~~~kT~~~~~t~~P~Wne~f~f~--i~~~-~~~~L~i~v~d~d~ 76 (126)
T cd04043 2 LFTIRIVRAENLKADSSNGLSDPYVTLVDTNG--KRRIAKTRTIYDTLNPRWDEEFELE--VPAG-EPLWISATVWDRSF 76 (126)
T ss_pred EEEEEEEEeECCCCCCCCCCCCceEEEEECCC--CeeeecccEecCCCCCcccceEEEE--cCCC-CCCEEEEEEEECCC
Confidence 578999999 9999999999999999987543 2345688888999999999999998 6554 34569999999999
Q ss_pred CCCCccccccccccccc
Q 005590 313 TRDGEVNGALHEGKADA 329 (689)
Q Consensus 313 ~~~~d~~G~v~~~~~~~ 329 (689)
+++++++|.+.+.....
T Consensus 77 ~~~~~~iG~~~i~l~~~ 93 (126)
T cd04043 77 VGKHDLCGRASLKLDPK 93 (126)
T ss_pred CCCCceEEEEEEecCHH
Confidence 99999999998876543
|
C2-like domains are thought to be involved in phospholipid binding in a Ca2+ independent manner in both Unc13 and Munc13. Caenorabditis elegans Unc13 has a central domain with sequence similarity to PKC, which includes C1 and C2-related domains. Unc13 binds phorbol esters and DAG with high affinity in a phospholipid manner. Mutations in Unc13 results in abnormal neuronal connections and impairment in cholinergic neurotransmission in the nematode. Munc13 is the mammalian homolog which are expressed in the brain. There are 3 isoforms (Munc13-1, -2, -3) and are thought to play a role in neurotransmitter release and are hypothesized to be high-affinity receptors for phorbol esters. Unc13 and Munc13 contain both C1 and C2 domains. There are two C2 related domains present, one central and one at the carboxyl end. Munc13-1 contains a third C2-like domain. Munc13 interacts with syntaxin, synap |
| >cd04054 C2A_Rasal1_RasA4 C2 domain first repeat present in RasA1 and RasA4 | Back alignment and domain information |
|---|
Probab=99.34 E-value=8.9e-13 Score=121.32 Aligned_cols=87 Identities=13% Similarity=0.029 Sum_probs=73.5
Q ss_pred eEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCccccccccccccCCCC
Q 005590 235 GYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDT 313 (689)
Q Consensus 235 l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~~~~L~~~V~D~d~~ 313 (689)
|+|.|.+| ||+++|.+|.+||||++.+- ..+..||+++++|+||+|||.|.|. ++.. .+.|.+.|||++.+
T Consensus 2 l~v~vi~a~~L~~~d~~g~~DPYv~v~~~----~~~~~kT~v~~~t~nP~Wne~f~~~--~~~~--~~~l~v~v~d~~~~ 73 (121)
T cd04054 2 LYIRIVEGKNLPAKDITGSSDPYCIVKVD----NEVIIRTATVWKTLNPFWGEEYTVH--LPPG--FHTVSFYVLDEDTL 73 (121)
T ss_pred EEEEEEEeeCCcCCCCCCCCCceEEEEEC----CEeeeeeeeEcCCCCCcccceEEEe--eCCC--CCEEEEEEEECCCC
Confidence 78999999 99999999999999999982 2234678888999999999999998 5432 35699999999999
Q ss_pred CCCccccccccccccc
Q 005590 314 RDGEVNGALHEGKADA 329 (689)
Q Consensus 314 ~~~d~~G~v~~~~~~~ 329 (689)
++++++|.+..+....
T Consensus 74 ~~d~~iG~~~~~~~~~ 89 (121)
T cd04054 74 SRDDVIGKVSLTREVI 89 (121)
T ss_pred CCCCEEEEEEEcHHHh
Confidence 9999999998875443
|
Rasal1 and RasA4 are both members of GAP1 (GTPase activating protein 1). Rasal1 responds to repetitive Ca2+ signals by associating with the plasma membrane and deactivating Ras. RasA4 suppresses Ras function by enhancing the GTPase activity of Ras proteins resulting in the inactive GDP-bound form of Ras. In this way it can control cellular proliferation and differentiation. Both of these proteins contains two C2 domains, a Ras-GAP domain, a plextrin homology (PH)-like domain, and a Bruton's Tyrosine Kinase (BTK) zinc binding domain. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangements: Type I and Type II, distinguished by a circular permutation involving their N- and C-terminal beta strands. Many C2 domains are Ca2+-dependent membrane-targeting modules that bind a wide variety of substances including bind phospholipids, inositol polyphosphates, and intracellular proteins. |
| >cd04011 C2B_Ferlin C2 domain second repeat in Ferlin | Back alignment and domain information |
|---|
Probab=99.34 E-value=8.1e-13 Score=119.57 Aligned_cols=89 Identities=13% Similarity=0.012 Sum_probs=73.8
Q ss_pred ceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccccccCcc-ccccccccccCC
Q 005590 234 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEIDNS 311 (689)
Q Consensus 234 ~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V~D~d 311 (689)
.++|.|.+| ||. +|..||||++.+.. +++||+++++++||.|||+|.|....+...+ +..|.++|||++
T Consensus 5 ~l~V~v~~a~~L~----~~~~dpyv~v~~~~-----~~~kT~~~~~t~nP~wne~f~f~~~~~~~~l~~~~l~i~V~d~~ 75 (111)
T cd04011 5 QVRVRVIEARQLV----GGNIDPVVKVEVGG-----QKKYTSVKKGTNCPFYNEYFFFNFHESPDELFDKIIKISVYDSR 75 (111)
T ss_pred EEEEEEEEcccCC----CCCCCCEEEEEECC-----EeeeeeEEeccCCCccccEEEEecCCCHHHHhcCeEEEEEEcCc
Confidence 578999999 998 68899999999962 3557888899999999999999833344444 556999999999
Q ss_pred CCCCCccccccccccccccc
Q 005590 312 DTRDGEVNGALHEGKADAEE 331 (689)
Q Consensus 312 ~~~~~d~~G~v~~~~~~~~~ 331 (689)
.+++++++|++.+.......
T Consensus 76 ~~~~~~~iG~~~i~l~~v~~ 95 (111)
T cd04011 76 SLRSDTLIGSFKLDVGTVYD 95 (111)
T ss_pred ccccCCccEEEEECCccccC
Confidence 99999999999998766644
|
Ferlins are involved in vesicle fusion events. Ferlins and other proteins, such as Synaptotagmins, are implicated in facilitating the fusion process when cell membranes fuse together. There are six known human Ferlins: Dysferlin (Fer1L1), Otoferlin (Fer1L2), Myoferlin (Fer1L3), Fer1L4, Fer1L5, and Fer1L6. Defects in these genes can lead to a wide range of diseases including muscular dystrophy (dysferlin), deafness (otoferlin), and infertility (fer-1, fertilization factor-1). Structurally they have 6 tandem C2 domains, designated as (C2A-C2F) and a single C-terminal transmembrane domain, though there is a new study that disputes this and claims that there are actually 7 tandem C2 domains with another C2 domain inserted between C2D and C2E. In a subset of them (Dysferlin, Myoferlin, and Fer1) there is an additional conserved domain called DysF. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangeme |
| >cd08681 C2_fungal_Inn1p-like C2 domain found in fungal Ingression 1 (Inn1) proteins | Back alignment and domain information |
|---|
Probab=99.34 E-value=8.2e-13 Score=120.69 Aligned_cols=90 Identities=12% Similarity=0.089 Sum_probs=73.6
Q ss_pred cceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeecc-ccCCCcccccccccccccccCccccccccccccC
Q 005590 233 DYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSS-KRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 310 (689)
Q Consensus 233 ~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~-k~tlnP~~ne~f~~~~~~~~~~~~~~L~~~V~D~ 310 (689)
+.|+|.|.+| ||+++|..|.+||||++.+.. .++||++. +.++||+|||+|.|. ++.. ....|.++|||+
T Consensus 1 g~L~V~v~~A~~L~~~~~~~~~dpyv~v~~~~-----~~~kT~~~~~~~~nP~Wne~f~f~--v~~~-~~~~l~i~v~d~ 72 (118)
T cd08681 1 GTLVVVVLKARNLPNKRKLDKQDPYCVLRIGG-----VTKKTKTDFRGGQHPEWDEELRFE--ITED-KKPILKVAVFDD 72 (118)
T ss_pred CEEEEEEEEccCCCCCCcCCCCCceEEEEECC-----CccccccccCCCCCCccCceEEEE--ecCC-CCCEEEEEEEeC
Confidence 4789999999 999999999999999999843 34556654 568999999999998 6654 345599999999
Q ss_pred CCCCCCccccccccccccccc
Q 005590 311 SDTRDGEVNGALHEGKADAEE 331 (689)
Q Consensus 311 d~~~~~d~~G~v~~~~~~~~~ 331 (689)
+..+ ++++|++.+...+...
T Consensus 73 ~~~~-~~~iG~~~~~l~~~~~ 92 (118)
T cd08681 73 DKRK-PDLIGDTEVDLSPALK 92 (118)
T ss_pred CCCC-CcceEEEEEecHHHhh
Confidence 9887 8999999987765543
|
Saccharomyces cerevisiae Inn1 associates with the contractile actomyosin ring at the end of mitosis and is needed for cytokinesis. The C2 domain of Inn1, located at the N-terminus, is required for ingression of the plasma membrane. The C-terminus is relatively unstructured and contains eight PXXP motifs that are thought to mediate interaction of Inn1 with other proteins with SH3 domains in the cytokinesis proteins Hof1 (an F-BAR protein) and Cyk3 (whose overexpression can restore primary septum formation in Inn1Delta cells) as well as recruiting Inn1 to the bud-neck by binding to Cyk3. Inn1 and Cyk3 appear to cooperate in activating chitin synthase Chs2 for primary septum formation, which allows coordination of actomyosin ring contraction with ingression of the cleavage furrow. It is thought that the C2 domain of Inn1 helps to preserve the link between the actomyosin ring and the plasma membrane, contr |
| >cd04017 C2D_Ferlin C2 domain fourth repeat in Ferlin | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.3e-12 Score=122.57 Aligned_cols=86 Identities=14% Similarity=0.038 Sum_probs=71.1
Q ss_pred ceEEEEecc-CCcccCCCCCCCcceeeecCCCCCCcceeeeeccccCCCcccccccccccc-cc--cCcc---ccccccc
Q 005590 234 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSD-LH--FKGA---EKDLMPA 306 (689)
Q Consensus 234 ~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~-~~--~~~~---~~~L~~~ 306 (689)
+|+|.|.+| +|+++|.+|.+|||||+.+. ..++||+++++|+||+|||+|.|... +. .+.. ...|.++
T Consensus 2 ~l~v~V~~a~~L~~~d~~g~~dpyv~v~~~-----~~~~kT~v~~~t~nP~Wne~~~f~~~~~~~~~~~~~~~~~~l~v~ 76 (135)
T cd04017 2 QLRAYIYQARDLLAADKSGLSDPFARVSFL-----NQSQETEVIKETLSPTWDQTLIFDEVELYGSPEEIAQNPPLVVVE 76 (135)
T ss_pred EEEEEEEEeecCcCCCCCCCCCCEEEEEEC-----CeeeEeeeEcCCCCCccCcEEEEeeeeccCChHHhhcCCCEEEEE
Confidence 578999999 99999999999999999984 24677888899999999999999721 11 1111 2458999
Q ss_pred cccCCCCCCCcccccccc
Q 005590 307 EIDNSDTRDGEVNGALHE 324 (689)
Q Consensus 307 V~D~d~~~~~d~~G~v~~ 324 (689)
|||+|.+++++++|++..
T Consensus 77 V~d~d~~~~d~~iG~~~i 94 (135)
T cd04017 77 LFDQDSVGKDEFLGRSVA 94 (135)
T ss_pred EEeCcCCCCCccceEEEe
Confidence 999999999999999975
|
Ferlins are involved in vesicle fusion events. Ferlins and other proteins, such as Synaptotagmins, are implicated in facilitating the fusion process when cell membranes fuse together. There are six known human Ferlins: Dysferlin (Fer1L1), Otoferlin (Fer1L2), Myoferlin (Fer1L3), Fer1L4, Fer1L5, and Fer1L6. Defects in these genes can lead to a wide range of diseases including muscular dystrophy (dysferlin), deafness (otoferlin), and infertility (fer-1, fertilization factor-1). Structurally they have 6 tandem C2 domains, designated as (C2A-C2F) and a single C-terminal transmembrane domain, though there is a new study that disputes this and claims that there are actually 7 tandem C2 domains with another C2 domain inserted between C2D and C2E. In a subset of them (Dysferlin, Myoferlin, and Fer1) there is an additional conserved domain called DysF. C2 domains fold into an 8-standed beta-sandwich that can adopt 2 structural arrangeme |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 689 | ||||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-48 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-48 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-48 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 7e-43 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-42 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-42 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-39 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-39 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 7e-39 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-38 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-35 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 1e-34 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 2e-34 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 4e-34 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-32 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-32 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-32 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-30 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-29 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-29 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-27 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-27 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-27 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-27 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-27 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-27 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-27 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-27 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-27 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-27 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-27 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-27 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-27 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-27 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-27 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-27 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-27 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-27 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-27 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-27 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-27 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-27 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-27 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-27 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-27 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-27 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-27 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-27 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-27 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-27 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-27 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-27 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-27 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-27 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-27 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-27 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-27 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-27 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-27 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-26 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-26 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-26 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-26 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-26 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-26 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-26 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-26 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-26 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-26 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-26 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-26 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-26 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-26 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-26 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-26 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-26 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-26 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-26 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-26 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-26 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-26 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-26 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-26 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-26 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-26 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-26 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-26 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-26 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-26 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-26 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-25 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-25 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-25 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-25 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-25 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-25 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-25 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-25 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-25 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-25 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-25 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-25 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-25 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-25 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-25 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-25 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-25 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-25 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-25 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-25 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-25 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-25 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-25 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-25 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-25 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-25 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-25 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-25 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-25 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-25 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-25 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-25 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-25 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-25 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-25 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-25 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-25 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-24 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-24 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-24 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-24 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-24 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-24 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-24 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-24 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-24 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-24 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-24 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-24 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-24 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-24 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-24 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 8e-24 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-24 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-23 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-23 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-23 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-23 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-23 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-23 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-23 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-23 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-23 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-23 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-23 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-23 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-22 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-22 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-22 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-22 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-22 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-22 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-22 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-22 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-22 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-22 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-22 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-22 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-22 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-22 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-22 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-22 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-22 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-22 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-22 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-22 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-22 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-22 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-22 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-22 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-22 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-22 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-22 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-22 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-22 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-22 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-22 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-22 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-22 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-22 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-22 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-22 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-22 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-22 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-22 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-22 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-22 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-22 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-22 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-22 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-22 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-22 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-22 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-22 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-22 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-21 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-21 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-21 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-21 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-21 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-21 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-21 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-21 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-21 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-21 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-21 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-21 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-21 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-21 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-20 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-20 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-20 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-20 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-20 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-19 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-19 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-19 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-19 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-19 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-19 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-19 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-19 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-19 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-19 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-19 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-18 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-18 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-18 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-18 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-18 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-18 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-18 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-18 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-18 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-17 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-17 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-17 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-17 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-17 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-17 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-17 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-17 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-17 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-17 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-17 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-17 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-17 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-16 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-16 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-16 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-16 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-16 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-16 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-16 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-16 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-16 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-16 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-16 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-16 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-16 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-16 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-16 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-16 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-16 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-16 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-16 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-16 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-16 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-16 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-16 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-16 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-16 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-16 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-16 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 6e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-16 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 6e-16 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-16 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-16 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-16 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-16 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-16 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-16 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-16 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-16 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-16 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-15 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-15 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-15 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-15 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-15 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-15 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-15 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-15 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-15 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-15 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-15 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-15 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-15 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-15 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-15 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-15 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-15 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-15 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-15 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-15 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-15 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-15 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-15 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-15 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-15 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 7e-15 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-15 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 8e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-15 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 8e-15 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 8e-15 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 8e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-15 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-15 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 8e-15 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 9e-15 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-15 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-15 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-14 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-14 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-14 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-14 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-14 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-14 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-14 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-14 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-14 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-14 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-14 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-14 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-14 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-14 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-14 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-14 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-14 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-14 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-14 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-14 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-14 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-14 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-14 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-14 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-14 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-14 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-14 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-14 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 8e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-14 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 9e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-14 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-13 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-13 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-13 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-13 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-13 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-13 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-13 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-13 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-13 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-13 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-13 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-13 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-13 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-13 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-13 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-13 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-13 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-13 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-13 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-13 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-13 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-13 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-13 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-13 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-13 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-13 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-13 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-13 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-13 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-13 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-13 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-13 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-13 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-13 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-13 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-13 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-13 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-13 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-12 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-12 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-12 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-11 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-11 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 9e-11 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 9e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-10 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 9e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-08 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-08 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-08 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 9e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-07 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-07 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 6e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 6e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 7e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 7e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-06 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-06 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-06 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-06 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-06 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-05 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-04 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-04 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-04 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-04 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-04 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-04 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-04 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-04 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-04 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-04 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-04 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-04 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-04 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 5e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-04 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 5e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-04 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-04 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-04 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-04 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-04 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-04 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-04 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-04 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-04 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-04 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-04 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-04 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-04 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-04 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-04 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-04 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-04 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-04 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-04 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-04 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-04 |
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 689 | |||
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 1e-140 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-139 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 1e-135 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 1e-130 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 1e-129 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-124 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 7e-75 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 2e-54 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 5e-54 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 6e-53 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 6e-53 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 1e-52 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-52 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 3e-52 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 6e-52 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-51 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 6e-51 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 8e-51 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 8e-51 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 2e-50 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 8e-50 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-49 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 3e-49 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 5e-49 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 8e-48 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-47 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 3e-47 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 6e-47 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 4e-46 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 4e-46 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 5e-46 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 8e-46 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 1e-45 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 1e-44 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-44 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 2e-44 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-44 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 4e-44 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 5e-44 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 6e-44 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-43 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-43 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 5e-43 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 6e-43 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 7e-43 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 1e-42 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-42 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-42 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 3e-42 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 4e-42 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 5e-42 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 5e-42 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 6e-42 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-41 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-41 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-41 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-41 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 2e-41 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-41 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-41 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 3e-41 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 7e-41 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 8e-41 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 8e-41 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 9e-41 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 9e-41 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-40 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 1e-40 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-40 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 4e-40 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 4e-40 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 5e-40 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 7e-40 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 9e-40 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 9e-40 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 1e-39 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-39 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 1e-38 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-38 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-38 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-38 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 7e-38 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 1e-37 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-37 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 3e-37 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-36 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 4e-07 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 2e-36 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 5e-36 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 8e-36 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 1e-35 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-35 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-35 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 3e-35 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 4e-35 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 4e-35 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-34 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 5e-34 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-06 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 5e-34 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 2e-06 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 7e-34 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 8e-34 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 4e-07 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 9e-34 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 3e-06 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-33 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 1e-33 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-33 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 1e-33 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-33 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 6e-07 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 4e-33 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-06 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 4e-33 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 4e-33 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 4e-33 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 9e-33 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-32 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 1e-32 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-06 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 2e-32 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-06 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-32 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 5e-07 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 8e-32 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-06 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 8e-32 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 9e-32 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 7e-07 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-31 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 6e-07 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-31 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 1e-06 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 6e-31 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-06 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 7e-31 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 9e-07 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 8e-31 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 7e-07 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 9e-31 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 8e-07 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-30 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 4e-30 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 4e-07 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-29 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-06 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 4e-29 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 2e-28 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-28 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-26 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 4e-26 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-25 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 3e-25 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 8e-25 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-04 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-24 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 3e-24 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 4e-24 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 4e-24 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 7e-24 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 6e-23 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-22 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 7e-22 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 1e-21 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 2e-21 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 2e-21 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 3e-21 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 8e-21 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 1e-20 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 3e-20 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 1e-19 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-19 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 3e-19 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 5e-19 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 8e-19 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-18 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 1e-18 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-18 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 3e-18 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 3e-18 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 4e-18 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 5e-18 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 5e-18 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 6e-18 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 7e-18 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-17 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 1e-17 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-17 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-17 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-16 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-16 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 3e-16 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 7e-16 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-15 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 6e-15 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 1e-14 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-14 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-14 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 4e-14 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 4e-14 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 5e-14 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 6e-14 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-13 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-13 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 2e-13 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-13 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-13 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-13 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-13 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 3e-13 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 3e-13 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 7e-13 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 8e-13 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 8e-13 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-12 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-11 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-11 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 2e-11 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 6e-11 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 2e-10 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-10 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 4e-10 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 4e-10 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 5e-10 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 8e-10 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-09 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-09 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 4e-09 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 4e-09 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 8e-09 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 1e-08 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-08 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-08 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-08 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 3e-08 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 6e-08 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 7e-08 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 7e-08 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 8e-08 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 1e-07 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 2e-07 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 3e-07 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 3e-07 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 8e-07 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 9e-07 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-04 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-06 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 3e-06 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 4e-06 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 6e-06 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 6e-06 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 9e-06 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-05 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 5e-05 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-04 |
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 416 bits (1071), Expect = e-140
Identities = 116/343 (33%), Positives = 178/343 (51%), Gaps = 20/343 (5%)
Query: 360 KNRTGF-EENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK 418
N G+ ++ + + +A RY V + +G +F +V +A D V LK+++N+K
Sbjct: 75 PNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK 134
Query: 419 DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQE 478
F Q+ +EI++L+ + K D + +++ + + F H+ + ELL NLYE K N+
Sbjct: 135 RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKF 194
Query: 479 SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538
G F+L ++ L+ L+ LH IIHCDLKPENIL+K R IK+ID GSSC
Sbjct: 195 QG----FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250
Query: 539 FQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILAR 598
++ + Y+QSR YRAPEVI+G Y ID+WSLGCILAEL TG L P + LA
Sbjct: 251 YEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLAC 310
Query: 599 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYI-NEETNQLEYIIPEESSLEHHLQF---- 653
+I +LG ++L + + + + Y + ++ S L+
Sbjct: 311 MIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPES 370
Query: 654 ----------SDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686
D F+DF++ LE +P R T +AL HPWL+
Sbjct: 371 REWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 411 bits (1058), Expect = e-139
Identities = 119/362 (32%), Positives = 181/362 (50%), Gaps = 31/362 (8%)
Query: 352 FHLRIIHRKNRTGF-----EENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTG 406
F H+K R + ++N D + RY + +G +F +V +A D
Sbjct: 20 FQSMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQ 79
Query: 407 VDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR 466
V +KIIKN K F +Q+ E++LL+L+NK+D +++I+ L +F HL +V E+L
Sbjct: 80 EWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS 139
Query: 467 ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS--LGIIHCDLKPENILIKSY 524
NLY+ + G +L + +Q AL +L + L IIHCDLKPENIL+ +
Sbjct: 140 YNLYDLLRNTNFRG----VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP 195
Query: 525 QRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGE 584
+R IKI+D GSSC + Y+QSR YR+PEV++G+PYD ID+WSLGCIL E+ TGE
Sbjct: 196 KRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
Query: 585 VLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYY--INEETNQLEYIIP 642
LF V + +I+ +LG +L Q + K+F K D + + + EY P
Sbjct: 256 PLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPP 315
Query: 643 EESSLEHHLQFSDAF------------------FIDFVRTLLEINPQRRPTAREALDHPW 684
L + L F D + +L+ +P+ R AL H +
Sbjct: 316 GTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSF 375
Query: 685 LQ 686
+
Sbjct: 376 FK 377
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 401 bits (1033), Expect = e-135
Identities = 95/364 (26%), Positives = 164/364 (45%), Gaps = 35/364 (9%)
Query: 353 HLRIIHRKNRTGF-----EENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGV 407
H H R +E ++ + V +G F +V Q +
Sbjct: 2 HHHHHHSSGRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKK 61
Query: 408 DVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA 467
+K+++N K + + E +LK + +D + ++I++ + F + +H+ ++ E L
Sbjct: 62 YYAVKVVRNIKKYTRSAKIEADILKKIQNDDI-NNNNIVKYHGKFMYYDHMCLIFEPLGP 120
Query: 468 NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS---- 523
+LYE N +G F + +++ + L+AL YL + + H DLKPENIL+
Sbjct: 121 SLYEIITRNNYNG----FHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFE 176
Query: 524 -------------------YQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPY 564
+ IK+ID G + F++D + +R YRAPEVI+ L +
Sbjct: 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGW 236
Query: 565 DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ--EIYKYFT 622
D D+WS GC+LAEL+TG +LF + LA + ++ PI ML + KY
Sbjct: 237 DVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVN 296
Query: 623 KEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682
K+ E + + I + L + F DF+ ++L+I+P RP+ E L H
Sbjct: 297 KDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH 356
Query: 683 PWLQ 686
+L+
Sbjct: 357 KFLE 360
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 388 bits (998), Expect = e-130
Identities = 102/339 (30%), Positives = 170/339 (50%), Gaps = 28/339 (8%)
Query: 368 NKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTG-VDVCLKIIKNDKDFFDQSLD 426
+ L V++ RY + + LG AF KV + D G V +KI+KN + + +
Sbjct: 1 SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS 60
Query: 427 EIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFT 486
EI++L+ +N DP +++ ++F H H+ IV ELL + Y+F K N F
Sbjct: 61 EIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLP----FR 116
Query: 487 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI-----------------KSYQRCEI 529
L ++ + Q +++ +LHS + H DLKPENIL ++ +I
Sbjct: 117 LDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 530 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 589
K++D GS+ + ++ V +R YRAPEVI+ L + Q D+WS+GCIL E + G +FP
Sbjct: 177 KVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236
Query: 590 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEH 649
LA + +LGP+ M+ + ++ KYF + + +E ++ Y+ L+
Sbjct: 237 HDSKEHLAMMERILGPLPKHMIQKTRK-RKYFHHDRLDW--DEHSSAGRYVSRACKPLKE 293
Query: 650 HLQFSDAF---FIDFVRTLLEINPQRRPTAREALDHPWL 685
+ D D ++ +LE +P +R T REAL HP+
Sbjct: 294 FMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 385 bits (991), Expect = e-129
Identities = 102/343 (29%), Positives = 155/343 (45%), Gaps = 26/343 (7%)
Query: 367 ENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTG-VDVCLKIIKNDKDFFDQSL 425
+ L + + RY + LG F KV + D G V LKII+N + + +
Sbjct: 5 KEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAAR 64
Query: 426 DEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF 485
EI +LK + + D ++ + + D+F H+ I ELL N +EF K N +
Sbjct: 65 LEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQP----Y 120
Query: 486 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI-----------------KSYQRCE 528
L ++ + Q AL +LH + H DLKPENIL KS +
Sbjct: 121 PLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 529 IKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP 588
I++ D GS+ F ++ V +R YR PEVI+ L + Q D+WS+GCIL E + G LF
Sbjct: 181 IRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ 240
Query: 589 NDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQL--EYIIPEESS 646
L + +LGPI M+ + ++ KYF K ++ N + E P +S
Sbjct: 241 THENREHLVMMEKILGPIPSHMIHRTRK-QKYFYKGGLVWDENSSDGRYVKENCKPLKSY 299
Query: 647 LEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHPY 689
+ D +R +LE +P +R T EAL HP+
Sbjct: 300 MLQDSLE-HVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 373 bits (959), Expect = e-124
Identities = 107/330 (32%), Positives = 172/330 (52%), Gaps = 28/330 (8%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 438
RY + LG FS V+ A+D+ V +KI++ DK + + + DEIKLL+ VN D
Sbjct: 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDAD 76
Query: 439 PADE-----HHILRLYDYFYH----LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGR 489
E +HIL+L D+F H H+ +V E+L NL K + G L
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG----IPLIY 132
Query: 490 LQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCE----IKIIDLGSSCFQTDNL 544
++ I++Q L L+Y+H GIIH D+KPEN+L++ E IKI DLG++C+ ++
Sbjct: 133 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192
Query: 545 CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI------LAR 598
+Q+R YR+PEV++G P+ D+WS C++ EL TG+ LF D +A+
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252
Query: 599 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQ-LEYIIPEESSLEHHLQFSDAF 657
II +LG + +L G+ +F L I++ LE ++ E+
Sbjct: 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD---EAKE 309
Query: 658 FIDFVRTLLEINPQRRPTAREALDHPWLQH 687
DF+ +L+++P++R A ++HPWL+
Sbjct: 310 ISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 7e-75
Identities = 107/378 (28%), Positives = 179/378 (47%), Gaps = 72/378 (19%)
Query: 371 LPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKL 430
+ + + GRY+V LG FS V+ + D+ V +K++K+ + + + +LDEI+L
Sbjct: 27 HLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRL 86
Query: 431 LKLVNKNDPADE--HHILRLYDYFYHL----EHLFIVCELLRANLYEFQKFNQESGGEAY 484
LK V +DP D +++L D F H+ +V E+L +L ++ + G
Sbjct: 87 LKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQG---- 142
Query: 485 FTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILI---------------------- 521
L ++ I +Q L+ L+YLH+ IIH D+KPENIL+
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 202
Query: 522 -------------------------KSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAP 556
K+ ++ ++KI DLG++C+ + +Q+R YR+
Sbjct: 203 PPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSL 262
Query: 557 EVIIGLPYDQKIDLWSLGCILAELWTGEVLFP------NDAVVMILARIIGMLGPIDLEM 610
EV+IG Y+ D+WS C+ EL TG+ LF +A II +LG + ++
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322
Query: 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSD---AFFIDFVRTLLE 667
++ G+ ++FTK+ DL +I + L ++S A F DF+ +LE
Sbjct: 323 IVAGKYSKEFFTKKGDLKHITKLKP-----WGLFEVLVEKYEWSQEEAAGFTDFLLPMLE 377
Query: 668 INPQRRPTAREALDHPWL 685
+ P++R TA E L HPWL
Sbjct: 378 LIPEKRATAAECLRHPWL 395
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-54
Identities = 84/316 (26%), Positives = 140/316 (44%), Gaps = 40/316 (12%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 441
Y T+ +G+ +F V+QA+ +G V +K + DK F E+++++ ++
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLD------ 105
Query: 442 EH-HILRLYDYFYHLE------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVIT 494
H +I+RL +FY +L +V + + +Y + + + +++
Sbjct: 106 -HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT--LPVIYVKLYM 162
Query: 495 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS--SCFQTDNLCLYVQSRS 552
Q +L Y+HS GI H D+KP+N+L+ +K+ D GS + + Y+ SR
Sbjct: 163 YQLFRSLAYIHSFGICHRDIKPQNLLLDP-DTAVLKLCDFGSAKQLVRGEPNVSYICSRY 221
Query: 553 YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 611
YRAPE+I G Y ID+WS GC+LAEL G+ +FP D+ V L II +LG E
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE-- 279
Query: 612 MQGQEIYKYFTKEYDLYYINEETNQLEY-IIPEESSLEHHLQFSDAFFIDFVRTLLEINP 670
+ +N + ++ I + + I LLE P
Sbjct: 280 --------------QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 325
Query: 671 QRRPTAREALDHPWLQ 686
R T EA H +
Sbjct: 326 TARLTPLEACAHSFFD 341
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 5e-54
Identities = 94/324 (29%), Positives = 151/324 (46%), Gaps = 45/324 (13%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLVN 435
RY + +GS A V A D +V +K + F E+ L+K VN
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR---PFQNQTHAKRAYRELVLMKCVN 82
Query: 436 -KNDPADEHHILRLYDYFY------HLEHLFIVCELLRANLYEF--QKFNQESGGEAYFT 486
KN I+ L + F + ++IV EL+ ANL + + + E
Sbjct: 83 HKN-------IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE-------- 127
Query: 487 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--SSCFQTDNL 544
R+ + Q L +++LHS GIIH DLKP NI++KS C +KI+D G + + +
Sbjct: 128 --RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTSFMM 183
Query: 545 CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 604
YV +R YRAPEVI+G+ Y + +D+WS+GCI+ E+ G VLFP + ++I LG
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 243
Query: 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPE--ESSLEHHLQFSDAFFIDFV 662
E + + Q + + + Y E + P+ + H + + D +
Sbjct: 244 TPCPEFMKKLQPTVRTYVENRPKY----AGYSFEKLFPDVLFPADSEHNKLKASQARDLL 299
Query: 663 RTLLEINPQRRPTAREALDHPWLQ 686
+L I+ +R + EAL HP++
Sbjct: 300 SKMLVIDASKRISVDEALQHPYIN 323
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 6e-53
Identities = 89/322 (27%), Positives = 148/322 (45%), Gaps = 41/322 (12%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLVN 435
RY + +GS A V A D +V +K + F E+ L+K VN
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR---PFQNQTHAKRAYRELVLMKCVN 119
Query: 436 -KNDPADEHHILRLYDYFY------HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLG 488
KN I+ L + F + +++V EL+ ANL + +
Sbjct: 120 HKN-------IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--------MELDHE 164
Query: 489 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL-- 546
R+ + Q L +++LHS GIIH DLKP NI++KS C +KI+D G + + +
Sbjct: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTSFMMTP 222
Query: 547 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 606
YV +R YRAPEVI+G+ Y + +D+WS+GCI+ E+ ++LFP + ++I LG
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 282
Query: 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIP--EESSLEHHLQFSDAFFIDFVRT 664
E + + Q + + + Y + P + H + + D +
Sbjct: 283 CPEFMKKLQPTVRNYVENRPKY----AGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 338
Query: 665 LLEINPQRRPTAREALDHPWLQ 686
+L I+P +R + +AL HP++
Sbjct: 339 MLVIDPAKRISVDDALQHPYIN 360
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 6e-53
Identities = 89/322 (27%), Positives = 145/322 (45%), Gaps = 46/322 (14%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 432
+ RY +GS A+ V A D TG+ V +K + F + E++LLK
Sbjct: 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR---PFQSIIHAKRTYRELRLLK 83
Query: 433 LVN-KNDPADEHHILRLYDYFY------HLEHLFIVCELLRANLYEFQKFNQESGGEAYF 485
+ +N ++ L D F +++V L+ A+L K +
Sbjct: 84 HMKHEN-------VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-------L 129
Query: 486 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 545
T +Q + Q L L+Y+HS IIH DLKP N+ + CE+KI+D G + D +
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DCELKILDFGLARHTADEMT 187
Query: 546 LYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 604
YV +R YRAPE+++ Y+Q +D+WS+GCI+AEL TG LFP + L I+ ++G
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247
Query: 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 664
E+L ++I + Y + + L +D +
Sbjct: 248 TPGAELL---KKISSESARNYIQSLTQMPKMNFANVFIGANPLA----------VDLLEK 294
Query: 665 LLEINPQRRPTAREALDHPWLQ 686
+L ++ +R TA +AL H +
Sbjct: 295 MLVLDSDKRITAAQALAHAYFA 316
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-52
Identities = 85/324 (26%), Positives = 146/324 (45%), Gaps = 51/324 (15%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 432
+ Y ++GS A+ V A D +G V +K + F + E+ LLK
Sbjct: 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR---PFQSEIFAKRAYRELLLLK 78
Query: 433 LVN-KNDPADEHHILRLYDYFY------HLEHLFIVCELLRANLYEF--QKFNQESGGEA 483
+ +N ++ L D F + ++V ++ +L + KF++E
Sbjct: 79 HMQHEN-------VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEE----- 126
Query: 484 YFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 543
++Q + Q L+ L+Y+HS G++H DLKP N+ + CE+KI+D G +
Sbjct: 127 -----KIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE--DCELKILDFGLARHADAE 179
Query: 544 LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 602
+ YV +R YRAPEVI+ Y+Q +D+WS+GCI+AE+ TG+ LF + L +I+ +
Sbjct: 180 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 239
Query: 603 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFV 662
G E + + + YI L + D +
Sbjct: 240 TGVPGTEFV-------QKLNDKAAKSYI----QSLPQT--PRKDFTQLFPRASPQAADLL 286
Query: 663 RTLLEINPQRRPTAREALDHPWLQ 686
+LE++ +R TA +AL HP+ +
Sbjct: 287 EKMLELDVDKRLTAAQALTHPFFE 310
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-52
Identities = 85/318 (26%), Positives = 136/318 (42%), Gaps = 37/318 (11%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 441
R+ V G F V ++ TG+ V +K + D F ++ L ++ L ++
Sbjct: 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL------- 76
Query: 442 EHH--ILRLYDYFYHLEH-------LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 492
HH I++L YFY L L +V E + L+ + ++V
Sbjct: 77 -HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVA--PPPILIKV 133
Query: 493 ITRQCLEALEYLH--SLGIIHCDLKPENILIKSYQRCEIKIIDLGS--SCFQTDNLCLYV 548
Q + ++ LH S+ + H D+KP N+L+ + +K+ D GS ++ Y+
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV-NEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 549 QSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 607
SR YRAPE+I G Y +D+WS+GCI AE+ GE +F D L I+ +LG
Sbjct: 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252
Query: 608 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLE 667
E+L + + + DLY IP + H D + LL+
Sbjct: 253 REVLRKLNPSH----TDVDLYNSKG--------IPWSNVFSDHSLKDAKEAYDLLSALLQ 300
Query: 668 INPQRRPTAREALDHPWL 685
P+ R EAL HP+
Sbjct: 301 YLPEERMKPYEALCHPYF 318
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 3e-52
Identities = 77/342 (22%), Positives = 135/342 (39%), Gaps = 50/342 (14%)
Query: 361 NRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLK-IIKNDKD 419
N GF+ + RY + LG VF A D V +K I+ D
Sbjct: 3 NIHGFD------------LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ 50
Query: 420 FFDQSLDEIKLLKLVN-KN-------DPADEHHILRLYDYFYHLEHLFIVCELLRANLYE 471
+L EIK+++ ++ N + L ++IV E + +L
Sbjct: 51 SVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLAN 110
Query: 472 FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 531
+ ++ Q L L+Y+HS ++H DLKP N+ I + + +KI
Sbjct: 111 VLEQGP-------LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT-EDLVLKI 162
Query: 532 IDLG------SSCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGE 584
D G +L + ++ YR+P +++ Y + ID+W+ GCI AE+ TG+
Sbjct: 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
Query: 585 VLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEE 644
LF + + I+ + + E + + + + + E L ++P
Sbjct: 223 TLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRN----DMTEPHKPLTQLLPGI 278
Query: 645 SSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686
S +DF+ +L +P R TA EAL HP++
Sbjct: 279 SREA----------VDFLEQILTFSPMDRLTAEEALSHPYMS 310
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 6e-52
Identities = 90/322 (27%), Positives = 143/322 (44%), Gaps = 46/322 (14%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 432
+ Y + +GS A+ V A D TG V +K + F L E++LLK
Sbjct: 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR---PFQSELFAKRAYRELRLLK 79
Query: 433 LVN-KNDPADEHHILRLYDYFY------HLEHLFIVCELLRANLYEFQKFNQESGGEAYF 485
+ +N ++ L D F ++V + +L + K +
Sbjct: 80 HMRHEN-------VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-------L 125
Query: 486 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 545
R+Q + Q L+ L Y+H+ GIIH DLKP N+ + CE+KI+D G + +
Sbjct: 126 GEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE--DCELKILDFGLARQADSEMT 183
Query: 546 LYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 604
YV +R YRAPEVI+ Y Q +D+WS+GCI+AE+ TG+ LF + L I+ + G
Sbjct: 184 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 243
Query: 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 664
E + Q + K Y E I+ S L ++ +
Sbjct: 244 TPPAEFV---QRLQSDEAKNYMKGLPELEKKDFASILTNASPLA----------VNLLEK 290
Query: 665 LLEINPQRRPTAREALDHPWLQ 686
+L ++ ++R TA EAL HP+ +
Sbjct: 291 MLVLDAEQRVTAGEALAHPYFE 312
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-51
Identities = 78/313 (24%), Positives = 130/313 (41%), Gaps = 35/313 (11%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKND 438
+Y +G ++ VF+ ++ TG V +K +D +L EI++LK +
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK--- 60
Query: 439 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 497
H +++ L + F L +V E + Q ++ IT Q
Sbjct: 61 ----HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRG-----VPEHLVKSITWQT 111
Query: 498 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYR 554
L+A+ + H IH D+KPENILI IK+ D G +D V +R YR
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILITK--HSVIKLCDFGFARLLTGPSDYYDDEVATRWYR 169
Query: 555 APEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613
+PE+++G Y +D+W++GC+ AEL +G L+P + V L I LG + Q
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLI-PRHQQ 228
Query: 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 673
+YF+ + E LE + ++ L ++P R
Sbjct: 229 VFSTNQYFSG----------VKIPDPEDME--PLELKFPNISYPALGLLKGCLHMDPTER 276
Query: 674 PTAREALDHPWLQ 686
T + L HP+ +
Sbjct: 277 LTCEQLLHHPYFE 289
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 6e-51
Identities = 81/329 (24%), Positives = 135/329 (41%), Gaps = 48/329 (14%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDF------FDQSLD------ 426
+ Y V ++ S ++ V D G+ V +K + N S
Sbjct: 20 MQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 427 EIKLLKLVN-KNDPADEHHILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESG 480
EI+LL + N IL L D F + L++V EL+R +L + +
Sbjct: 79 EIRLLNHFHHPN-------ILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIV- 130
Query: 481 GEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--SSC 538
+ +Q L L LH G++H DL P NIL+ +I I D
Sbjct: 131 ----ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD--NNDITICDFNLARED 184
Query: 539 FQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILA 597
N YV R YRAPE+++ + + +D+WS GC++AE++ + LF L
Sbjct: 185 TADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244
Query: 598 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAF 657
+I+ ++G +E + F+ Y+ N L + + + +D
Sbjct: 245 KIVEVVGTPKIEDV-------VMFSSPSARDYLR---NSLSNV--PARAWTAVVPTADPV 292
Query: 658 FIDFVRTLLEINPQRRPTAREALDHPWLQ 686
+D + +LE NPQRR + +AL HP+ +
Sbjct: 293 ALDLIAKMLEFNPQRRISTEQALRHPYFE 321
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 8e-51
Identities = 82/312 (26%), Positives = 141/312 (45%), Gaps = 31/312 (9%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 441
Y + LG +S+VF+A ++ V +KI+K K + EIK+L+ + + P
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENL-RGGP-- 91
Query: 442 EHHILRLYDYFY---HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
+I+ L D + + + + + T ++ + L
Sbjct: 92 --NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEIL 140
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQSRSYRAP 556
+AL+Y HS+GI+H D+KP N++I + ++++ID G + F V SR ++ P
Sbjct: 141 KALDYCHSMGIMHRDVKPHNVMIDH-EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 199
Query: 557 EVIIGLP-YDQKIDLWSLGCILAELWTG-EVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614
E+++ YD +D+WSLGC+LA + E F L RI +LG DL +
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259
Query: 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP 674
I ++ + E + E+ HL +A +DF+ LL + Q R
Sbjct: 260 YNIEL--DPRFNDILGRHSRKRWERFVHSEN---QHLVSPEA--LDFLDKLLRYDHQSRL 312
Query: 675 TAREALDHPWLQ 686
TAREA++HP+
Sbjct: 313 TAREAMEHPYFY 324
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 8e-51
Identities = 86/316 (27%), Positives = 143/316 (45%), Gaps = 41/316 (12%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 441
Y + +G+ +F VFQA+ + + +V +K + DK F E++++++V
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRF---KNRELQIMRIVK------ 90
Query: 442 EH-HILRLYDYFYHLEH------LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVIT 494
H +++ L +FY L +V E + +Y + + + +++
Sbjct: 91 -HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQT--MPMLLIKLYM 147
Query: 495 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS--SCFQTDNLCLYVQSRS 552
Q L +L Y+HS+GI H D+KP+N+L+ +K+ID GS + Y+ SR
Sbjct: 148 YQLLRSLAYIHSIGICHRDIKPQNLLLDP-PSGVLKLIDFGSAKILIAGEPNVSYICSRY 206
Query: 553 YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 611
YRAPE+I G Y ID+WS GC++AEL G+ LFP ++ + L II +LG E
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE-- 264
Query: 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFS-DAFFIDFVRTLLEINP 670
+ +N + ++ + ID + LLE P
Sbjct: 265 --------------QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTP 310
Query: 671 QRRPTAREALDHPWLQ 686
R TA EAL HP+
Sbjct: 311 SARLTAIEALCHPFFD 326
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 2e-50
Identities = 89/327 (27%), Positives = 141/327 (43%), Gaps = 52/327 (15%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 432
+ RY Y+G A+ V A D V V +K I F+ EIK+L
Sbjct: 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP----FEHQTYCQRTLREIKILL 80
Query: 433 LVN-KNDPADEHHILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFT 486
+N I+ + D ++ ++IV +L+ +LY+ K +
Sbjct: 81 RFRHEN-------IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH-------LS 126
Query: 487 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG------SSCFQ 540
+ Q L L+Y+HS ++H DLKP N+L+ + C++KI D G
Sbjct: 127 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDHDH 184
Query: 541 TDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 599
T L YV +R YRAPE+++ Y + ID+WS+GCILAE+ + +FP + L I
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244
Query: 600 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFI 659
+G+LG E L I + Y L ++ + P S +
Sbjct: 245 LGILGSPSQEDL---NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA----------L 291
Query: 660 DFVRTLLEINPQRRPTAREALDHPWLQ 686
D + +L NP +R +AL HP+L+
Sbjct: 292 DLLDKMLTFNPHKRIEVEQALAHPYLE 318
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 8e-50
Identities = 94/339 (27%), Positives = 149/339 (43%), Gaps = 68/339 (20%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 432
I+ + + LG A+ V A TG V +K I+ FD+ L EIK+LK
Sbjct: 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP----FDKPLFALRTLREIKILK 64
Query: 433 LVN-KNDPADEHHILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFT 486
+N I+ +++ + ++I+ EL++ +L+ +
Sbjct: 65 HFKHEN-------IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM-------LS 110
Query: 487 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG----------- 535
+Q Q L A++ LH +IH DLKP N+LI S C++K+ D G
Sbjct: 111 DDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS--NCDLKVCDFGLARIIDESAAD 168
Query: 536 --SSCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAV 592
Q + +V +R YRAPEV++ Y + +D+WS GCILAEL+ +FP
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228
Query: 593 VMILARIIGMLG-PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYI----IPEESSL 647
L I G++G P + DL I + EYI + + L
Sbjct: 229 RHQLLLIFGIIGTP----------------HSDNDLRCIESPRAR-EYIKSLPMYPAAPL 271
Query: 648 EHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686
E + ID ++ +L +P +R TA+EAL+HP+LQ
Sbjct: 272 EKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-49
Identities = 75/334 (22%), Positives = 127/334 (38%), Gaps = 84/334 (25%)
Query: 377 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKL 433
+V Y + + +GS SKVFQ + + +K + + D D +EI L
Sbjct: 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNK 82
Query: 434 VNKNDPADEHHILRLYDYFYHLEHLFIVCEL----LRANLYEFQKFNQESGGEAYFTLGR 489
+ ++ I+RLYDY +++++V E L + L + + +
Sbjct: 83 LQQHSD----KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPW----------E 128
Query: 490 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYV 548
+ + LEA+ +H GI+H DLKP N LI +K+ID G ++ Q D +
Sbjct: 129 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVK 185
Query: 549 QSR----SYRAPEVIIGLP-----------YDQKIDLWSLGCILAELWTGEVLFPNDAVV 593
S+ +Y PE I + K D+WSLGCIL + G+ F
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245
Query: 594 M-ILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQ 652
+ L II I+ P+ +
Sbjct: 246 ISKLHAIIDPNHEIE---------------------------------FPDIPEKD---- 268
Query: 653 FSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686
D ++ L+ +P++R + E L HP++Q
Sbjct: 269 -----LQDVLKCCLKRDPKQRISIPELLAHPYVQ 297
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-49
Identities = 77/314 (24%), Positives = 132/314 (42%), Gaps = 37/314 (11%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKND 438
+Y +G ++ V + ++ TG V +K D ++ EIKLLK +
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR--- 82
Query: 439 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 497
H +++ L + + ++V E + + + + +Q Q
Sbjct: 83 ----HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG-----LDYQVVQKYLFQI 133
Query: 498 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG---SSCFQTDNLCLYVQSRSYR 554
+ + + HS IIH D+KPENIL+ +K+ D G + + V +R YR
Sbjct: 134 INGIGFCHSHNIIHRDIKPENILVSQ--SGVVKLCDFGFARTLAAPGEVYDDEVATRWYR 191
Query: 555 APEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613
APE+++G Y + +D+W++GC++ E++ GE LFP D+ + L I+ LG +
Sbjct: 192 APELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLI------ 245
Query: 614 GQEIYKYFTKEYDLYYINEETNQLEY-IIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 672
+ F K N + I E LE ID + L I+P +
Sbjct: 246 -PRHQELFNK-------NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDK 297
Query: 673 RPTAREALDHPWLQ 686
RP E L H + Q
Sbjct: 298 RPFCAELLHHDFFQ 311
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 5e-49
Identities = 82/351 (23%), Positives = 146/351 (41%), Gaps = 72/351 (20%)
Query: 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKN 437
+ +Y + + LG+ +F V + D+ +G LK + D + E+ ++K+++
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLD-- 58
Query: 438 DPADEH-HILRLYDYFYHLEH--------------------------------------L 458
H +I++L DYFY L
Sbjct: 59 -----HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 459 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPEN 518
++ E + L++ K SG + + + Q A+ ++HSLGI H D+KP+N
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRS--IPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQN 171
Query: 519 ILIKSYQRCEIKIIDLGS--SCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGC 575
+L+ S + +K+ D GS ++ Y+ SR YRAPE+++G Y IDLWS+GC
Sbjct: 172 LLVNS-KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230
Query: 576 ILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETN 635
+ EL G+ LF + + L RII ++G E + +N
Sbjct: 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKE----------------QMIRMNPHYT 274
Query: 636 QLEYIIPEESSLEHHL-QFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685
++ + + L + + + ID + +L P R EA+ HP+
Sbjct: 275 EVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 8e-48
Identities = 75/334 (22%), Positives = 127/334 (38%), Gaps = 84/334 (25%)
Query: 377 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKL 433
+V Y + + +GS SKVFQ + + +K + + D D +EI L
Sbjct: 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNK 63
Query: 434 VNKNDPADEHHILRLYDYFYHLEHLFIVCEL----LRANLYEFQKFNQESGGEAYFTLGR 489
+ ++ I+RLYDY +++++V E L + L + + +
Sbjct: 64 LQQHSD----KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPW----------E 109
Query: 490 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYV 548
+ + LEA+ +H GI+H DLKP N LI +K+ID G ++ Q D +
Sbjct: 110 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVK 166
Query: 549 QSR----SYRAPEVIIGLP-----------YDQKIDLWSLGCILAELWTGEVLFPNDAVV 593
S+ +Y PE I + K D+WSLGCIL + G+ F
Sbjct: 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 226
Query: 594 M-ILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQ 652
+ L II I+ P+ +
Sbjct: 227 ISKLHAIIDPNHEIE---------------------------------FPDIPEKD---- 249
Query: 653 FSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686
D ++ L+ +P++R + E L HP++Q
Sbjct: 250 -----LQDVLKCCLKRDPKQRISIPELLAHPYVQ 278
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-47
Identities = 42/335 (12%), Positives = 87/335 (25%), Gaps = 65/335 (19%)
Query: 381 GRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKII----KNDKDFFDQSLDEIKLLKLVN 435
R E L S VF +D+ D LK+ +N + ++ + +
Sbjct: 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLL 120
Query: 436 KNDPADEHHILRLYDYF--------------------YHLEHLFIVCELLRANLYEFQK- 474
P + RL Y + + ++ +L
Sbjct: 121 GESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFST 180
Query: 475 FNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 534
+ + L ++T Q + L S G++H P+N+ I + + D+
Sbjct: 181 LDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM--PDGRLMLGDV 238
Query: 535 GSSCFQTDNLCLYVQSRSYRAPEVI--IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV 592
+ +Y E + + ++ W LG + +W + F
Sbjct: 239 SALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298
Query: 593 VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQ 652
+ + L + +
Sbjct: 299 GIKGSWKRPSLRVPG----------------------------------TDSLAFGSCTP 324
Query: 653 FSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687
D + L + +RR EA++ P
Sbjct: 325 LPDF-VKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 3e-47
Identities = 74/336 (22%), Positives = 126/336 (37%), Gaps = 88/336 (26%)
Query: 377 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS-----LDEIKLL 431
+V Y + + +GS SKVFQ + +K + + + D +EI L
Sbjct: 52 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYV--NLEEADNQTLDSYRNEIAYL 108
Query: 432 KLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL----LRANLYEFQKFNQESGGEAYFTL 487
+ ++ I+RLYDY +++++V E L + L + + +
Sbjct: 109 NKLQQHSD----KIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPW--------- 155
Query: 488 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCL 546
+ + LEA+ +H GI+H DLKP N LI +K+ID G ++ Q D +
Sbjct: 156 -ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSV 211
Query: 547 YVQSR----SYRAPEVIIGLP-----------YDQKIDLWSLGCILAELWTGEVLFPNDA 591
S+ +Y PE I + K D+WSLGCIL + G+ F
Sbjct: 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271
Query: 592 VVM-ILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHH 650
+ L II I+ P+ +
Sbjct: 272 NQISKLHAIIDPNHEIE---------------------------------FPDIPEKD-- 296
Query: 651 LQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686
D ++ L+ +P++R + E L HP++Q
Sbjct: 297 -------LQDVLKCCLKRDPKQRISIPELLAHPYVQ 325
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 6e-47
Identities = 58/334 (17%), Positives = 111/334 (33%), Gaps = 55/334 (16%)
Query: 377 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD----EIKLLK 432
+ + +++ LG A + VF+ + TG +K+ + F + +D E ++LK
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVF--NNISFLRPVDVQMREFEVLK 62
Query: 433 LVNKNDPADEH-HILRLYDYF--YHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAY 484
+N H +I++L+ H ++ E L L E E
Sbjct: 63 KLN-------HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF- 114
Query: 485 FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ--RCEIKIIDLGSSCFQTD 542
++ R + + +L GI+H ++KP NI+ + + K+ D G++ D
Sbjct: 115 ------LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168
Query: 543 NLCLYVQ--SRSYRAPEVIIGL--------PYDQKIDLWSLGCILAELWTGEVLFPNDAV 592
+ + Y P++ Y +DLWS+G TG + F
Sbjct: 169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF----- 223
Query: 593 VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQ 652
GP + +M K + +P SL LQ
Sbjct: 224 -------RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQ 276
Query: 653 FSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686
+ +LE + ++ +
Sbjct: 277 ---VLLTPVLANILEADQEKCWGFDQFFAETSDI 307
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 4e-46
Identities = 68/335 (20%), Positives = 115/335 (34%), Gaps = 74/335 (22%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 438
+ + LG + V Q G V +K + DF D +L EIKLL
Sbjct: 13 LKNLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRM--LIDFCDIALMEIKLLTES---- 65
Query: 439 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEF-QKFNQESGGEAYFTLGRLQVITRQ 496
D+H +++R Y L+I EL NL + + N + RQ
Sbjct: 66 --DDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 497 CLEALEYLHSLGIIHCDLKPENILIKS-----------YQRCEIKIIDLGSSCFQTDNLC 545
+ +LHSL IIH DLKP+NIL+ + + I I D G
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 546 LYVQSRS-------YRAPEVIIGL-------PYDQKIDLWSLGCILAELWTGEVLFPNDA 591
+ + + +RAPE++ + ID++S+GC+ + + D
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD- 242
Query: 592 VVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHL 651
+ + L ++++ + E
Sbjct: 243 ---------------------KYSRESNIIRGIFSL-------DEMKCLHDRSLIAE--- 271
Query: 652 QFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686
D + +++ +P +RPTA + L HP
Sbjct: 272 ------ATDLISQMIDHDPLKRPTAMKVLRHPLFW 300
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 4e-46
Identities = 88/347 (25%), Positives = 153/347 (44%), Gaps = 59/347 (17%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 432
+ +Y + + LG A+ V+++ D TG V +K I + F S D EI +L
Sbjct: 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD---AFQNSTDAQRTFREIMILT 63
Query: 433 LVNKNDPADEHHILRLYDYFY--HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRL 490
++ ++ +I+ L + + +++V + + +L+ + N
Sbjct: 64 ELSGHE-----NIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANI-------LEPVHK 111
Query: 491 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG--------------- 535
Q + Q ++ ++YLHS G++H D+KP NIL+ + C +K+ D G
Sbjct: 112 QYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNA--ECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 536 ---------SSCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEV 585
+ L YV +R YRAPE+++G Y + ID+WSLGCIL E+ G+
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229
Query: 586 LFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEY--DLYYINEETNQLEYIIPE 643
+FP + + L RIIG++ E + + I F K L E + I
Sbjct: 230 IFPGSSTMNQLERIIGVIDFPSNEDV---ESIQSPFAKTMIESLKEKVEIRQSNKRDIFT 286
Query: 644 ESSLEHHLQFSDAFF----IDFVRTLLEINPQRRPTAREALDHPWLQ 686
+ A +D + LL+ NP +R +A +AL HP++
Sbjct: 287 KWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVS 333
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 5e-46
Identities = 69/337 (20%), Positives = 124/337 (36%), Gaps = 73/337 (21%)
Query: 367 ENKDLPIILNTVIAG--RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS 424
E D + VI G + + LG A + + + DV +K I + F +
Sbjct: 8 EQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRI--LPECFSFA 64
Query: 425 LDEIKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEF--QKFNQESGG 481
E++LL+ DEH +++R + + +I EL A L E+ QK G
Sbjct: 65 DREVQLLRES------DEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGL 118
Query: 482 EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS---YQRCEIKIIDLGSSC 538
E + +Q L +LHSL I+H DLKP NILI + + + I D G
Sbjct: 119 EP-------ITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171
Query: 539 FQTDNLCLYVQ------SRSYRAPEVIIGLP---YDQKIDLWSLGCILAELWTGEVLFPN 589
+ + + + APE++ +D++S GC+ + +
Sbjct: 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231
Query: 590 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEH 649
++ ++G L+ + PE+
Sbjct: 232 KSLQRQANILLG--------------------------------ACSLDCLHPEKH---- 255
Query: 650 HLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686
D + + ++ ++PQ+RP+A+ L HP+
Sbjct: 256 ----EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFW 288
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 8e-46
Identities = 68/331 (20%), Positives = 123/331 (37%), Gaps = 75/331 (22%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII-KNDKDFFDQSLDEIKLLKLVNKNDPA 440
Y + LG FS V + LH G LK I +++ +++ E + +L N
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFN----- 84
Query: 441 DEH-HILRLYDYFYHLE----HLFIVCEL-LRANLYEFQKFNQESGGEAYFTLGRLQVIT 494
H +ILRL Y +++ R L+ + ++ G + T ++ +
Sbjct: 85 --HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN--FLTEDQILWLL 140
Query: 495 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR--- 551
LE +H+ G H DLKP NIL+ + ++DLGS ++ Q+
Sbjct: 141 LGICRGLEAIHAKGYAHRDLKPTNILL--GDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198
Query: 552 ---------SYRAPEVIIGLPY---DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 599
SYRAPE+ + D++ D+WSLGC+L + GE +
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY------------ 246
Query: 600 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFI 659
+ ++ + + + + S+ + S A
Sbjct: 247 ----------------------------DMVFQKGDSVALAVQNQLSIPQSPRHSSA-LW 277
Query: 660 DFVRTLLEINPQRRPTAREALDHPW-LQHPY 689
+ +++ ++P +RP L LQ P
Sbjct: 278 QLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 1e-45
Identities = 88/314 (28%), Positives = 149/314 (47%), Gaps = 30/314 (9%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDP 439
++ E LG+ ++ V++ + TGV V LK +K D + ++ EI L+K +
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK---- 61
Query: 440 ADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
H +I+RLYD + L +V E + +L ++ L ++ Q L
Sbjct: 62 ---HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYRA 555
+ L + H I+H DLKP+N+LI R ++K+ D G + + + V + YRA
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINK--RGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRA 176
Query: 556 PEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614
P+V++G Y ID+WS GCILAE+ TG+ LFP L I ++G +
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN------- 229
Query: 615 QEIYKYFTK--EYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 672
+ ++ TK +Y+ L ++ + + D +DF+ LL++NP
Sbjct: 230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTK-----EPLDGNLMDFLHGLLQLNPDM 284
Query: 673 RPTAREALDHPWLQ 686
R +A++AL HPW
Sbjct: 285 RLSAKQALHHPWFA 298
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-44
Identities = 68/334 (20%), Positives = 118/334 (35%), Gaps = 82/334 (24%)
Query: 372 PIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDE 427
++++ RY +LG F+K F+ D T KI+ ++ E
Sbjct: 6 EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 65
Query: 428 IKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFT 486
I + + + H H++ + +F + +F+V EL
Sbjct: 66 ISIHRSLA-------HQHVVGFHGFFEDNDFVFVVLELC-------------RRRSLLEL 105
Query: 487 L---GRLQ-----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SS 537
L RQ + +YLH +IH DLK N+ + E+KI D G ++
Sbjct: 106 HKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE--DLEVKIGDFGLAT 163
Query: 538 CFQTDNLCLYVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI 595
+ D V + +Y APEV+ + ++D+WS+GCI+ L G+ F +
Sbjct: 164 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 223
Query: 596 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSD 655
RI + EY IP+ +
Sbjct: 224 YLRI-----------------------------------KKNEYSIPKHIN-------PV 241
Query: 656 AFFIDFVRTLLEINPQRRPTAREALDHPWLQHPY 689
A ++ +L+ +P RPT E L+ + Y
Sbjct: 242 A--ASLIQKMLQTDPTARPTINELLNDEFFTSGY 273
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-44
Identities = 68/334 (20%), Positives = 119/334 (35%), Gaps = 82/334 (24%)
Query: 372 PIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDE 427
++++ RY +LG F+K F+ D T KI+ ++ E
Sbjct: 32 EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 91
Query: 428 IKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFT 486
I + + + H H++ + +F + +F+V EL
Sbjct: 92 ISIHRSLA-------HQHVVGFHGFFEDNDFVFVVLELC-------------RRRSLLEL 131
Query: 487 L---GRL-----QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SS 537
L + RQ + +YLH +IH DLK N+ + E+KI D G ++
Sbjct: 132 HKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE--DLEVKIGDFGLAT 189
Query: 538 CFQTDNLCLYVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI 595
+ D V + +Y APEV+ + ++D+WS+GCI+ L G+ F +
Sbjct: 190 KVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 249
Query: 596 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSD 655
RI + EY IP+ +
Sbjct: 250 YLRI-----------------------------------KKNEYSIPKHIN-------PV 267
Query: 656 AFFIDFVRTLLEINPQRRPTAREALDHPWLQHPY 689
A ++ +L+ +P RPT E L+ + Y
Sbjct: 268 A--ASLIQKMLQTDPTARPTINELLNDEFFTSGY 299
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-44
Identities = 77/351 (21%), Positives = 123/351 (35%), Gaps = 97/351 (27%)
Query: 376 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVN 435
+ A + LG AF +V +A++ +K I++ ++ L E+ LL +N
Sbjct: 1 SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLN 60
Query: 436 KNDPADEH-HILRLYDYFYHLEH-------------LFIVCEL-----LRANLYEFQKFN 476
H +++R Y + + LFI E L ++
Sbjct: 61 -------HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQ 113
Query: 477 QESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536
Q + RQ LEAL Y+HS GIIH DLKP NI I +KI D G
Sbjct: 114 QRD---------EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE--SRNVKIGDFGL 162
Query: 537 SCFQTDNLCLYVQSRS-----------------YRAPEVIIGLP-YDQKIDLWSLGCILA 578
+ +L + Y A EV+ G Y++KID++SLG I
Sbjct: 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFF 222
Query: 579 ELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLE 638
E+ V IL ++ + + F ++D +
Sbjct: 223 EMIYP--FSTGMERVNILKKL---------------RSVSIEFPPDFDDNKMKV------ 259
Query: 639 YIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHPY 689
+R L++ +P +RP AR L+ WL +
Sbjct: 260 -------------------EKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 4e-44
Identities = 65/314 (20%), Positives = 105/314 (33%), Gaps = 67/314 (21%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 437
+ LG ++ +VF+ + G +K KD + L E+ + V ++
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR-ARKLAEVGSHEKVGQH 116
Query: 438 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEF-QKFNQESGGEAYFTLGRLQVITRQ 496
+RL + L++ EL +L + + + ++ R
Sbjct: 117 P-----CCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGA------SLPEAQVWGYLRD 165
Query: 497 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ--SRSYR 554
L AL +LHS G++H D+KP NI + R K+ D G VQ Y
Sbjct: 166 TLLALAHLHSQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTAGAGEVQEGDPRYM 223
Query: 555 APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614
APE++ G Y D++SLG + E+ L + L QG
Sbjct: 224 APELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---------------GWQQLRQG 267
Query: 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP 674
L S E + +LE +P+ R
Sbjct: 268 ---------------------YLPPEFTAGLSSE---------LRSVLVMMLEPDPKLRA 297
Query: 675 TAREALDHPWLQHP 688
TA L P L+ P
Sbjct: 298 TAEALLALPVLRQP 311
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-44
Identities = 75/319 (23%), Positives = 135/319 (42%), Gaps = 41/319 (12%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQ----SLDEIKLLKLVN 435
RY +G A+ V++A+D H+G V LK ++ N ++ E+ LL+ +
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 436 KNDPADEH-HILRLYDYFYHLEH-----LFIVCELLRANLYEFQKFNQESGGEAYFTLGR 489
+ H +++RL D + +V E + +L + +
Sbjct: 70 AFE----HPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYL----DKAPPPGLPAET 121
Query: 490 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--Y 547
++ + RQ L L++LH+ I+H DLKPENIL+ S +K+ D G + + + L
Sbjct: 122 IKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS--GGTVKLADFGLARIYSYQMALTPV 179
Query: 548 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 607
V + YRAPEV++ Y +D+WS+GCI AE++ + LF ++ L +I ++G
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239
Query: 608 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLE 667
E + ++ + + + +L
Sbjct: 240 -EDDWPRDVSLPRGA----------------FPPRGPRPVQSVVPEMEESGAQLLLEMLT 282
Query: 668 INPQRRPTAREALDHPWLQ 686
NP +R +A AL H +L
Sbjct: 283 FNPHKRISAFRALQHSYLH 301
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 6e-44
Identities = 80/310 (25%), Positives = 136/310 (43%), Gaps = 35/310 (11%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD--FFDQSLDEIKLLKLVNKNDP 439
Y + LG ++ V++ + T V LK I+ + + ++ E+ LLK +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK---- 58
Query: 440 ADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
H +I+ L+D + + L +V E L +L ++ + +++ Q L
Sbjct: 59 ---HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGN-----IINMHNVKLFLFQLL 110
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYRA 555
L Y H ++H DLKP+N+LI R E+K+ D G + ++ Y V + YR
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINE--RGELKLADFGLARAKSIPTKTYDNEVVTLWYRP 168
Query: 556 PEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614
P++++G Y +ID+W +GCI E+ TG LFP V L I +LG
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPT------- 221
Query: 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP 674
+E + NEE Y +L H D+ D + LL+ + R
Sbjct: 222 EETWPGILS-------NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRI 274
Query: 675 TAREALDHPW 684
+A +A+ HP+
Sbjct: 275 SAEDAMKHPF 284
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 71/318 (22%), Positives = 142/318 (44%), Gaps = 42/318 (13%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQ-SLDEIKLLKLVNKND 438
RY LG + +V++A D T V +K I+ ++++ ++ E+ LLK +
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ--- 91
Query: 439 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 497
H +I+ L +H L ++ E +L ++ N + ++ ++ Q
Sbjct: 92 ----HRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPD------VSMRVIKSFLYQL 141
Query: 498 LEALEYLHSLGIIHCDLKPENILI---KSYQRCEIKIIDLGSSCFQTDNLCLY---VQSR 551
+ + + HS +H DLKP+N+L+ + + +KI D G + + + + +
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITL 201
Query: 552 SYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 610
YR PE+++G Y +D+WS+ CI AE+ LFP D+ + L +I +LG D
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPD--- 258
Query: 611 LMQGQEIYKYFTK--EYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEI 668
+ T ++ + L+ ++ + +D + +LE+
Sbjct: 259 ----DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLD-------DEG--LDLLTAMLEM 305
Query: 669 NPQRRPTAREALDHPWLQ 686
+P +R +A+ AL+HP+
Sbjct: 306 DPVKRISAKNALEHPYFS 323
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 4e-43
Identities = 87/323 (26%), Positives = 135/323 (41%), Gaps = 75/323 (23%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLV 434
+ RY LG +F +V +D TG + +K+I K + L E++LLK +
Sbjct: 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 435 NKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFT 486
D +I++LY++F + ++V E+ +GGE F+
Sbjct: 84 ------DHPNIMKLYEFFEDKGYFYLVGEVY-------------TGGELFDEIISRKRFS 124
Query: 487 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGSSCF--QTDN 543
I RQ L + Y+H I+H DLKPEN+L++S + I+IID G S +
Sbjct: 125 EVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184
Query: 544 LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 603
+ + + Y APEV+ G YD+K D+WS G IL L +G F IL ++
Sbjct: 185 MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV--EK 241
Query: 604 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVR 663
G E + K + E + D +R
Sbjct: 242 GKYTFE--------LPQWKK-----------------VSESA-------------KDLIR 263
Query: 664 TLLEINPQRRPTAREALDHPWLQ 686
+L P R +AR+ALDH W+Q
Sbjct: 264 KMLTYVPSMRISARDALDHEWIQ 286
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 5e-43
Identities = 84/323 (26%), Positives = 137/323 (42%), Gaps = 76/323 (23%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKLVN 435
++ Y + LGS A+ +V +D T V+ +KII + L+E+ +LKL++
Sbjct: 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94
Query: 436 KNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFT 486
H +I++LYD+F + ++V E GGE F
Sbjct: 95 -------HPNIMKLYDFFEDKRNYYLVMECY-------------KGGELFDEIIHRMKFN 134
Query: 487 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGSSCF--QTDN 543
VI +Q L + YLH I+H DLKPEN+L++S + IKI+D G S
Sbjct: 135 EVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194
Query: 544 LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 603
+ + + Y APEV+ YD+K D+WS+G IL L G F IL ++
Sbjct: 195 MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV--EK 251
Query: 604 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVR 663
G + + + E + D ++
Sbjct: 252 GKYTFD--------SPEWKN-----------------VSEGA-------------KDLIK 273
Query: 664 TLLEINPQRRPTAREALDHPWLQ 686
+L+ + QRR +A++AL+HPW++
Sbjct: 274 QMLQFDSQRRISAQQALEHPWIK 296
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 6e-43
Identities = 82/375 (21%), Positives = 139/375 (37%), Gaps = 99/375 (26%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 432
+ Y + +G ++ V+ A D +T +V +K + F+ +D EI +L
Sbjct: 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR---MFEDLIDCKRILREITILN 80
Query: 433 LVNKNDPADEH-HILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFT 486
+ +I+RLYD + L+IV E+ ++L + K + T
Sbjct: 81 RLK-------SDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPI------FLT 127
Query: 487 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG----------- 535
++ I L ++H GIIH DLKP N L+ C +K+ D G
Sbjct: 128 EEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQ--DCSVKVCDFGLARTINSEKDT 185
Query: 536 --------------SSCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAEL 580
+ L +V +R YRAPE+I+ Y + ID+WS GCI AE
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAE- 244
Query: 581 WTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEE-TNQLEY 639
++ + P + L G + + +QL
Sbjct: 245 -------------LLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNI 291
Query: 640 II-----PEESSLEH-----------------HLQFSDAF------FIDFVRTLLEINPQ 671
I P E L++ + + I+ + ++L+ NP
Sbjct: 292 IFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPN 351
Query: 672 RRPTAREALDHPWLQ 686
+R T +ALDHP+L+
Sbjct: 352 KRITIDQALDHPYLK 366
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 7e-43
Identities = 46/343 (13%), Positives = 94/343 (27%), Gaps = 88/343 (25%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIK--------LLKL 433
LG +A D TG + + + ++ ++K L +
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 434 VNKNDPADEHHILRLYDYFYHLEHLFIVCELLRAN---------LYEFQKFNQESGGEAY 484
N+ + +D + ++ L LY + N ++ GE
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 485 FTLGRLQ---------VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535
+ +T Q + L LH G++H L+P +I++ R + +
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQ--RGGVFLTGFE 251
Query: 536 SSCFQTDNLCLYVQSRSYRAPEVII-----------GLPYDQKIDLWSLGCILAELWTGE 584
+ + SR + PE+ D W+LG ++ +W +
Sbjct: 252 HLV-RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 585 VLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEE 644
+ DA + I F + IP+
Sbjct: 311 LPITKDAALGGSEWI---------------------FRSCKN--------------IPQP 335
Query: 645 SSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687
+ L + R +A++ P +
Sbjct: 336 VR-------------ALLEGFLRYPKEDRLLPLQAMETPEYEQ 365
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-42
Identities = 77/323 (23%), Positives = 123/323 (38%), Gaps = 86/323 (26%)
Query: 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNK 436
+ + LG F V+ A++ + + LK++ + Q E+++ +
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 67
Query: 437 NDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRL-- 490
H +ILRLY YF+ ++++ E G Y L +
Sbjct: 68 ------HPNILRLYGYFHDATRVYLILEYA-------------PLGTVYRELQKLSKFDE 108
Query: 491 ---QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---- 543
+ AL Y HS +IH D+KPEN+L+ S E+KI D G S +
Sbjct: 109 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVHAPSSRRTD 166
Query: 544 LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 603
LC + Y PE+I G +D+K+DLWSLG + E G+ F + RI
Sbjct: 167 LC---GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--- 220
Query: 604 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVR 663
++E+ P+ + A D +
Sbjct: 221 --------------------------------RVEFTFPDFVT-------EGA--RDLIS 239
Query: 664 TLLEINPQRRPTAREALDHPWLQ 686
LL+ NP +RP RE L+HPW+
Sbjct: 240 RLLKHNPSQRPMLREVLEHPWIT 262
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 82/315 (26%), Positives = 143/315 (45%), Gaps = 42/315 (13%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQS-LDEIKLLKLVNKND 438
+Y+ E +G + V++AQ+ + G LK I+ + + + + EI +LK +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELK--- 58
Query: 439 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 497
H +I++LYD + + L +V E L +L + + + Q
Sbjct: 59 ----HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-----LESVTAKSFLLQL 109
Query: 498 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYR 554
L + Y H ++H DLKP+N+LI E+KI D G + + Y + + YR
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINR--EGELKIADFGLARAFGIPVRKYTHEIVTLWYR 167
Query: 555 APEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613
AP+V++G Y ID+WS+GCI AE+ G LFP + L RI +LG +
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN------ 221
Query: 614 GQEIYKYFTK--EYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQ 671
+ + T+ +YD + E E + ID + +L+++P
Sbjct: 222 -SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLD--------ESG--IDLLSKMLKLDPN 270
Query: 672 RRPTAREALDHPWLQ 686
+R TA++AL+H + +
Sbjct: 271 QRITAKQALEHAYFK 285
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-42
Identities = 58/330 (17%), Positives = 109/330 (33%), Gaps = 51/330 (15%)
Query: 377 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLV 434
+ + +++ LG A + VF+ + TG +K+ N D + E ++LK +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 435 NKNDPADEH-HILRLYDYFYHL--EHLFIVCEL-----LRANLYEFQKFNQESGGEAYFT 486
N H +I++L+ H ++ E L L E E
Sbjct: 65 N-------HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF--- 114
Query: 487 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ--RCEIKIIDLGSSCFQTDNL 544
++ R + + +L GI+H ++KP NI+ + + K+ D G++ D+
Sbjct: 115 ----LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
Query: 545 CL--YVQSRSYRAPEVIIGL--------PYDQKIDLWSLGCILAELWTGEVLFPNDAVVM 594
+ Y P++ Y +DLWS+G TG + F
Sbjct: 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF------- 223
Query: 595 ILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFS 654
GP + +M K + +P SL LQ
Sbjct: 224 -----RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQ-- 276
Query: 655 DAFFIDFVRTLLEINPQRRPTAREALDHPW 684
+ +LE + ++ +
Sbjct: 277 -VLLTPVLANILEADQEKCWGFDQFFAETS 305
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-42
Identities = 78/334 (23%), Positives = 135/334 (40%), Gaps = 87/334 (26%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--------------NDKDFFDQS 424
I Y+ LGS A+ +V ++ + + +K+IK N + F ++
Sbjct: 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 425 LDEIKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE- 482
+EI LLK ++ H +I++L+D F ++ ++V E GGE
Sbjct: 94 YNEISLLKSLD-------HPNIIKLFDVFEDKKYFYLVTEFY-------------EGGEL 133
Query: 483 -------AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDL 534
F I +Q L + YLH I+H D+KPENIL+++ IKI+D
Sbjct: 134 FEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193
Query: 535 GSSCFQTDNLCLY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV 592
G S F + + L + + Y APEV+ Y++K D+WS G I+ L G F
Sbjct: 194 GLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND 252
Query: 593 VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQ 652
I+ ++ G + + + I +E+
Sbjct: 253 QDIIKKV--EKGKYYFD--------FNDWKN-----------------ISDEA------- 278
Query: 653 FSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686
+ ++ +L + +R TA EAL+ W++
Sbjct: 279 ------KELIKLMLTYDYNKRCTAEEALNSRWIK 306
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-42
Identities = 79/332 (23%), Positives = 112/332 (33%), Gaps = 84/332 (25%)
Query: 376 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-------EI 428
Y + LG F VF L + V +K+I ++ L E+
Sbjct: 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEV 85
Query: 429 KLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--AYF 485
LL V H ++RL D+F E +V E + Y
Sbjct: 86 ALLWKVGA---GGGHPGVIRLLDWFETQEGFMLVLER------------PLPAQDLFDYI 130
Query: 486 TL-GRLQ-----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539
T G L Q + A+++ HS G++H D+K ENILI +R K+ID GS
Sbjct: 131 TEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL-RRGCAKLIDFGSGAL 189
Query: 540 QTDNLCL-YVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILA 597
D + +R Y PE I Y +WSLG +L ++ G++ F D
Sbjct: 190 LHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------- 242
Query: 598 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAF 657
QEI + E P S D
Sbjct: 243 -----------------QEILEA-----------------ELHFPAHVS-------PDC- 260
Query: 658 FIDFVRTLLEINPQRRPTAREALDHPWLQHPY 689
+R L P RP+ E L PW+Q P
Sbjct: 261 -CALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-42
Identities = 90/316 (28%), Positives = 145/316 (45%), Gaps = 42/316 (13%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFD-QSLDEIKLLKLVNKND 438
+Y E +G + VF+A++ T V LK ++ +D + +L EI LLK +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--- 59
Query: 439 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 497
H +I+RL+D + + L +V E +L ++ ++ Q
Sbjct: 60 ----HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD-----LDPEIVKSFLFQL 110
Query: 498 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYR 554
L+ L + HS ++H DLKP+N+LI E+K+ + G + + Y V + YR
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINR--NGELKLANFGLARAFGIPVRCYSAEVVTLWYR 168
Query: 555 APEVIIGLP-YDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLM 612
P+V+ G Y ID+WS GCI AEL G LFP + V L RI +LG
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT----- 223
Query: 613 QGQEIYKYFTK--EYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINP 670
+E + TK +Y Y + T L ++P+ + + D ++ LL+ NP
Sbjct: 224 --EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLN--------ATG--RDLLQNLLKCNP 271
Query: 671 QRRPTAREALDHPWLQ 686
+R +A EAL HP+
Sbjct: 272 VQRISAEEALQHPYFS 287
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 5e-42
Identities = 80/313 (25%), Positives = 143/313 (45%), Gaps = 37/313 (11%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFD-QSLDEIKLLKLVNKND 438
+Y E +G + V++A+D G V LK I+ + + ++ EI LLK ++
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELH--- 77
Query: 439 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 497
H +I+ L D + L +V E + +L + N+ ++++ Q
Sbjct: 78 ----HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTG-----LQDSQIKIYLYQL 128
Query: 498 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSRSYR 554
L + + H I+H DLKP+N+LI S +K+ D G + + Y V + YR
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINS--DGALKLADFGLARAFGIPVRSYTHEVVTLWYR 186
Query: 555 APEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613
AP+V++G Y +D+WS+GCI AE+ TG+ LFP L +I +LG +
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN------ 240
Query: 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 673
+ + L+ Q + + E+ + ID + +L +P +R
Sbjct: 241 -PREWPQVQE-LPLW------KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKR 292
Query: 674 PTAREALDHPWLQ 686
+AR+A++HP+ +
Sbjct: 293 ISARDAMNHPYFK 305
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 6e-42
Identities = 62/319 (19%), Positives = 102/319 (31%), Gaps = 83/319 (26%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEH-HI 445
+G +F +V + +D TG +K + ++E+ ++ I
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLS-------SPRI 112
Query: 446 LRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG------EAY--FTLGRLQVITRQC 497
+ LY + I ELL GG + R Q
Sbjct: 113 VPLYGAVREGPWVNIFMELL-------------EGGSLGQLIKQMGCLPEDRALYYLGQA 159
Query: 498 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSRS---- 552
LE LEYLH+ I+H D+K +N+L+ S + D G + C Q D L + +
Sbjct: 160 LEGLEYLHTRRILHGDVKADNVLL-SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 553 ---YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 609
+ APEV++G P D K+D+WS C++ + G + + + I P E
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK-IASEPPPIRE 277
Query: 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 669
IP + ++ L
Sbjct: 278 -------------------------------IPPSCAPL---------TAQAIQEGLRKE 297
Query: 670 PQRRPTAREALDHPWLQHP 688
P R +A E
Sbjct: 298 PVHRASAMELRRKVGKALQ 316
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 69/332 (20%), Positives = 123/332 (37%), Gaps = 85/332 (25%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII-KNDKDFFDQSLDEIKLLKLVNKNDPA 440
R V L F+ V++AQD+ +G + LK + N+++ + E+ +K ++ +
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHP-- 86
Query: 441 DEHHILRLYDYFYHLEH--------LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 492
+I++ + ++ EL + L EF K + G + +
Sbjct: 87 ---NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG---PLSCDTVLK 140
Query: 493 ITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQS 550
I Q A++++H IIH DLK EN+L+ + IK+ D GS+ + +
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLL--SNQGTIKLCDFGSATTISHYPDYSWSA 198
Query: 551 R---------------SYRAPEVI---IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV 592
+ YR PE+I P +K D+W+LGCIL L + F + A
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258
Query: 593 VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQ 652
+ I+ +Y IP H
Sbjct: 259 LRIV---------------------------------------NGKYSIPP------HDT 273
Query: 653 FSDAFFIDFVRTLLEINPQRRPTAREALDHPW 684
F +R +L++NP+ R + E +
Sbjct: 274 QYTV-FHSLIRAMLQVNPEERLSIAEVVHQLQ 304
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-41
Identities = 89/344 (25%), Positives = 139/344 (40%), Gaps = 80/344 (23%)
Query: 358 HRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII--- 414
H + + EN + A RY + LG +F +V + +D T + +K+I
Sbjct: 3 HHHHHSSGREN----LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKA 58
Query: 415 KNDKDFFDQSLDEIKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQ 473
L E++LLK ++ H +I++L++ +IV EL
Sbjct: 59 SAKNKDTSTILREVELLKKLD-------HPNIMKLFEILEDSSSFYIVGELY-------- 103
Query: 474 KFNQESGGE--------AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-Y 524
+GGE F+ I +Q + Y+H I+H DLKPENIL++S
Sbjct: 104 -----TGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE 158
Query: 525 QRCEIKIIDLGSSCFQTDNLCLY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT 582
+ C+IKIID G S N + + + Y APEV+ G YD+K D+WS G IL L +
Sbjct: 159 KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLS 217
Query: 583 GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIP 642
G F IL R+ G + + I
Sbjct: 218 GTPPFYGKNEYDILKRV--ETGKYAFD--------LPQWRT-----------------IS 250
Query: 643 EESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686
+++ D +R +L +P R TA + L+HPW+Q
Sbjct: 251 DDA-------------KDLIRKMLTFHPSLRITATQCLEHPWIQ 281
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-41
Identities = 60/333 (18%), Positives = 111/333 (33%), Gaps = 84/333 (25%)
Query: 374 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKL 433
++ + E +GS F +VF+A+ G +K +K + + ++ E+K L
Sbjct: 4 TVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE---KAEREVKALAK 60
Query: 434 VNKNDPADEH-HILRLYDYFYHLEH----------------LFIVCELL-RANLYEFQKF 475
++ H +I+ + ++ LFI E + L ++ +
Sbjct: 61 LD-------HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113
Query: 476 NQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535
+ + Q + ++Y+HS +I+ DLKP NI + + ++KI D G
Sbjct: 114 RRGE----KLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK--QVKIGDFG 167
Query: 536 SSCF--QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVV 593
+ Y +PE I Y +++DL++LG ILAEL +
Sbjct: 168 LVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF 227
Query: 594 MILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQF 653
R + II + F
Sbjct: 228 FTDLR---------------------------------------DGIISD--------IF 240
Query: 654 SDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686
++ LL P+ RP E L +
Sbjct: 241 DKK-EKTLLQKLLSKKPEDRPNTSEILRTLTVW 272
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-41
Identities = 72/317 (22%), Positives = 125/317 (39%), Gaps = 65/317 (20%)
Query: 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNK 436
+ V LG +F+ V++A+ +HTG++V +K+I + +E+K+ +
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK- 69
Query: 437 NDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 495
H IL LY+YF ++++V E+ E ++ + F+ +
Sbjct: 70 ------HPSILELYNYFEDSNYVYLVLEMCHNG--EMNRYLKNRVK--PFSENEARHFMH 119
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQ--SRS 552
Q + + YLHS GI+H DL N+L+ IKI D G ++ + + Y + +
Sbjct: 120 QIITGMLYLHSHGILHRDLTLSNLLLTR--NMNIKIADFGLATQLKMPHEKHYTLCGTPN 177
Query: 553 YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 612
Y +PE+ + + D+WSLGC+ L G F D V L ++
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV------------- 224
Query: 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 672
+Y +P S +A D + LL NP
Sbjct: 225 ----------------------VLADYEMPSFLS-------IEA--KDLIHQLLRRNPAD 253
Query: 673 RPTAREALDHPWLQHPY 689
R + LDHP++
Sbjct: 254 RLSLSSVLDHPFMSRNS 270
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 78/325 (24%), Positives = 125/325 (38%), Gaps = 81/325 (24%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADE 442
+ LG +FS + + +KII K + EI LKL +
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQKEITALKLC------EG 64
Query: 443 H-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRLQVI 493
H +I++L++ F+ H F+V ELL GGE +F+ I
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLN-------------GGELFERIKKKKHFSETEASYI 111
Query: 494 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLG-SSCFQTDNLCLY--VQ 549
R+ + A+ ++H +G++H DLKPEN+L EIKIID G + DN L
Sbjct: 112 MRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF 171
Query: 550 SRSYRAPEVIIGLPYDQKIDLWSLGCILAEL-------WTGEVLFPNDAVVMILARIIGM 602
+ Y APE++ YD+ DLWSLG IL + + + + V I+ +I
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI--K 229
Query: 603 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFV 662
G E + + +++E L +
Sbjct: 230 KGDFSFE------------GEAWK--NVSQEAKDL------------------------I 251
Query: 663 RTLLEINPQRRPTAREALDHPWLQH 687
+ LL ++P +R + WLQ
Sbjct: 252 QGLLTVDPNKRLKMSGLRYNEWLQD 276
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-41
Identities = 63/322 (19%), Positives = 116/322 (36%), Gaps = 41/322 (12%)
Query: 377 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLV 434
T G + + E LG+ F V + TG V +K + + ++ EI+++K +
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 435 NKNDPADEH-HILRLYDYFYHLEHL------FIVCELLRANLYEFQKFNQESGGEAYFTL 487
N H +++ + L+ L + E + +K+ +
Sbjct: 70 N-------HPNVVSAREVPDGLQKLAPNDLPLLAMEY--CEGGDLRKYLNQFENCCGLKE 120
Query: 488 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGSSCFQTDNLCL 546
G ++ + AL YLH IIH DLKPENI+++ QR KIIDLG +
Sbjct: 121 GPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC 180
Query: 547 --YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 604
+V + Y APE++ Y +D WS G + E TG F + + +
Sbjct: 181 TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV---- 236
Query: 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 664
+ E + + ++ + ++
Sbjct: 237 ------REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERW----------LQC 280
Query: 665 LLEINPQRRPTAREALDHPWLQ 686
+L + ++R T + + Q
Sbjct: 281 MLMWHQRQRGTDPQNPNVGCFQ 302
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 2e-41
Identities = 85/371 (22%), Positives = 141/371 (38%), Gaps = 83/371 (22%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLK 432
I RY + +G+ ++ V +A D V +K I F+ +D EI +L
Sbjct: 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV---FEDLIDCKRILREIAILN 107
Query: 433 LVNKNDPADEH-HILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFT 486
+N H H++++ D + L++V E+ ++ + + Y T
Sbjct: 108 RLN-------HDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV------YLT 154
Query: 487 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG----------- 535
++ + L ++Y+HS GI+H DLKP N L+ C +K+ D G
Sbjct: 155 ELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQ--DCSVKVCDFGLARTVDYPENG 212
Query: 536 -------------------SSCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGC 575
+ L +V +R YRAPE+I+ Y + ID+WS+GC
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGC 272
Query: 576 ILAEL-----------WTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFT-- 622
I AEL LFP + + + Q + F
Sbjct: 273 IFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQ-LNVIFNIL 331
Query: 623 ---KEYDLYYINEETNQLEYI----IPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 675
E D+ + +E + YI E + L S A I ++ +L NP +R T
Sbjct: 332 GTPSEEDIEALEKE-DAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRIT 390
Query: 676 AREALDHPWLQ 686
E L HP+ +
Sbjct: 391 INECLAHPFFK 401
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 3e-41
Identities = 81/317 (25%), Positives = 141/317 (44%), Gaps = 39/317 (12%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDL-HTGVDVCLKIIK--NDKDFFD-QSLDEIKLLKLVNKN 437
+Y +G A+ KVF+A+DL + G V LK ++ ++ ++ E+ +L+ +
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 438 DPADEH-HILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQ 491
+ H +++RL+D L +V E + +L + + E ++
Sbjct: 72 E----HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL----DKVPEPGVPTETIK 123
Query: 492 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQ 549
+ Q L L++LHS ++H DLKP+NIL+ S +IK+ D G + + + L V
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQIKLADFGLARIYSFQMALTSVVV 181
Query: 550 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 609
+ YRAPEV++ Y +DLWS+GCI AE++ + LF + V L +I+ ++G E
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG-E 240
Query: 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 669
+ +E + D D + L N
Sbjct: 241 EDWPRDVALPRQA----------------FHSKSAQPIEKFVTDIDELGKDLLLKCLTFN 284
Query: 670 PQRRPTAREALDHPWLQ 686
P +R +A AL HP+ Q
Sbjct: 285 PAKRISAYSALSHPYFQ 301
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 7e-41
Identities = 77/328 (23%), Positives = 124/328 (37%), Gaps = 84/328 (25%)
Query: 376 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-------EI 428
+ +Y V LGS F V+ + + V +K ++ D+ L E+
Sbjct: 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 97
Query: 429 KLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--AYFT 486
LLK V+ ++RL D+F + ++ E E + + T
Sbjct: 98 VLLKKVSSGFS----GVIRLLDWFERPDSFVLILERP------------EPVQDLFDFIT 141
Query: 487 L-GRLQ-----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQ 540
G LQ Q LEA+ + H+ G++H D+K ENILI R E+K+ID GS
Sbjct: 142 ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI-DLNRGELKLIDFGSGALL 200
Query: 541 TDNLCL-YVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILAR 598
D + + +R Y PE I Y + +WSLG +L ++ G++ F +D
Sbjct: 201 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-------- 252
Query: 599 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFF 658
+EI + + + S S+
Sbjct: 253 ----------------EEIIRG-----------------QVFFRQRVS-------SEC-- 270
Query: 659 IDFVRTLLEINPQRRPTAREALDHPWLQ 686
+R L + P RPT E +HPW+Q
Sbjct: 271 QHLIRWCLALRPSDRPTFEEIQNHPWMQ 298
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 8e-41
Identities = 87/323 (26%), Positives = 135/323 (41%), Gaps = 59/323 (18%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQ------SLDEIKLLKLVN 435
RY ++LG F+ V++A+D +T V +K IK + +L EIKLL+ ++
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 436 KNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVIT 494
H +I+ L D F H ++ +V + + +L K N T ++
Sbjct: 71 -------HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV-----LTPSHIKAYM 118
Query: 495 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY---VQSR 551
L+ LEYLH I+H DLKP N+L+ +K+ D G + Y V +R
Sbjct: 119 LMTLQGLEYLHQHWILHRDLKPNNLLLDE--NGVLKLADFGLAKSFGSPNRAYTHQVVTR 176
Query: 552 SYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG-PIDLE 609
YRAPE++ G Y +D+W++GCILAEL P D+ + L RI LG P
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP---- 232
Query: 610 MLMQGQEIYKYFTKEYDLYYINEET--------NQLEYIIPEESSLEHHLQFSDAFFIDF 661
EE + + + L H + +D
Sbjct: 233 ---------------------TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDL 271
Query: 662 VRTLLEINPQRRPTAREALDHPW 684
++ L NP R TA +AL +
Sbjct: 272 IQGLFLFNPCARITATQALKMKY 294
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 8e-41
Identities = 69/323 (21%), Positives = 119/323 (36%), Gaps = 86/323 (26%)
Query: 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNK 436
+ + LG F V+ A++ + LK++ + Q EI++ +
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR- 72
Query: 437 NDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRLQ- 491
H +ILR+Y+YF+ + ++++ E GE Y L GR
Sbjct: 73 ------HPNILRMYNYFHDRKRIYLMLEFA-------------PRGELYKELQKHGRFDE 113
Query: 492 ----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---- 543
+ +AL Y H +IH D+KPEN+L+ + E+KI D G S
Sbjct: 114 QRSATFMEELADALHYCHERKVIHRDIKPENLLMGY--KGELKIADFGWSVHAPSLRRRT 171
Query: 544 LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 603
+C + Y PE+I G +D+K+DLW G + E G F + + RI+
Sbjct: 172 MC---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV--- 225
Query: 604 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVR 663
++ P S + D +
Sbjct: 226 --------------------------------NVDLKFPPFLS-------DGS--KDLIS 244
Query: 664 TLLEINPQRRPTAREALDHPWLQ 686
LL +P +R + ++HPW++
Sbjct: 245 KLLRYHPPQRLPLKGVMEHPWVK 267
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 9e-41
Identities = 72/342 (21%), Positives = 127/342 (37%), Gaps = 66/342 (19%)
Query: 353 HLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLK 412
H H R I + LGS AF V ++ +G++ +K
Sbjct: 2 HHHHHHSSGRENLYFQGT--------IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIK 53
Query: 413 IIKNDKDFFDQS--LDEIKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANL 469
I D+ EI++LK ++ H +I+++++ F +++IV E
Sbjct: 54 TINKDRSQVPMEQIEAEIEVLKSLD-------HPNIIKIFEVFEDYHNMYIVMETCEGG- 105
Query: 470 YE-FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRC 527
E ++ + G + + +Q + AL Y HS ++H DLKPENIL +
Sbjct: 106 -ELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHS 164
Query: 528 EIKIIDLGSSCFQTDNLCLY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEV 585
IKIID G + + + Y APEV K D+WS G ++ L TG +
Sbjct: 165 PIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCL 223
Query: 586 LFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEES 645
F ++ + + + + E + +
Sbjct: 224 PFTGTSLEEVQQKA--TYKEPN-------------YAVECR--PLTPQA----------- 255
Query: 646 SLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687
+D ++ +L +P+RRP+A + L H W +
Sbjct: 256 -------------VDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 9e-41
Identities = 80/327 (24%), Positives = 132/327 (40%), Gaps = 81/327 (24%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 438
Y V E +G ++S + T ++ +KII K +EI++L +
Sbjct: 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQ-- 74
Query: 439 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGR 489
H +I+ L D + +++++V EL++ GGE +F+
Sbjct: 75 ----HPNIITLKDVYDDGKYVYVVTELMK-------------GGELLDKILRQKFFSERE 117
Query: 490 LQVITRQCLEALEYLHSLGIIHCDLKPENILI--KSYQRCEIKIIDLG-SSCFQTDNLCL 546
+ + +EYLH+ G++H DLKP NIL +S I+I D G + + +N L
Sbjct: 118 ASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 547 Y--VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLF---PNDAVVMILARIIG 601
+ ++ APEV+ YD D+WSLG +L + TG F P+D ILARI
Sbjct: 178 MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI-- 235
Query: 602 MLGPIDLEMLMQGQEIYKYFTKEY-DLYYINEETNQLEYIIPEESSLEHHLQFSDAFFID 660
G + Y + +++ L
Sbjct: 236 GSGKFS-------------LSGGYWN--SVSDTAKDL----------------------- 257
Query: 661 FVRTLLEINPQRRPTAREALDHPWLQH 687
V +L ++P +R TA L HPW+ H
Sbjct: 258 -VSKMLHVDPHQRLTAALVLRHPWIVH 283
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 75/320 (23%), Positives = 123/320 (38%), Gaps = 64/320 (20%)
Query: 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNK 436
+ + + +G FS+V++A L GV V LK ++ D + EI LLK +N
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN- 90
Query: 437 NDPADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVIT 494
H ++++ Y F L IV EL A +L K ++ +
Sbjct: 91 ------HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR--LIPERTVWKYF 142
Query: 495 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSR 551
Q ALE++HS ++H D+KP N+ I + +K+ DLG F + V +
Sbjct: 143 VQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSLVGTP 200
Query: 552 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV-VMILARIIGMLGPIDLEM 610
Y +PE I Y+ K D+WSLGC+L E+ + F D + + L + I
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI---------- 250
Query: 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYI-IPEESSLEHHLQFSDAFFIDFVRTLLEIN 669
Q +Y +P + +S+ V + +
Sbjct: 251 ------------------------EQCDYPPLPSD-------HYSEE-LRQLVNMCINPD 278
Query: 670 PQRRPTAREALDHPWLQHPY 689
P++RP D H
Sbjct: 279 PEKRPDVTYVYDVAKRMHAC 298
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 77/353 (21%), Positives = 122/353 (34%), Gaps = 85/353 (24%)
Query: 357 IHRKNRTGFEENKDLPIILNTVIAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIK 415
H + +G E P + Y ++ + LG KV + TG LK++
Sbjct: 4 HHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY 63
Query: 416 NDKDFFDQSLDEIKLLKLVNKNDPADEH-HILRLYDYF----YHLEHLFIVCELLRANLY 470
+ E+ + HI+ + D + + L I+ E +
Sbjct: 64 DSPKARQ----EVDHHWQASG------GPHIVCILDVYENMHHGKRCLLIIMECME---- 109
Query: 471 EFQKFNQESGGE----------AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENIL 520
GGE FT I R A+++LHS I H D+KPEN+L
Sbjct: 110 ---------GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 160
Query: 521 IKS-YQRCEIKIIDLG-SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILA 578
S + +K+ D G + + L + Y APEV+ YD+ D+WSLG I+
Sbjct: 161 YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 220
Query: 579 ELWTGEVLF----PNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEET 634
L G F + RI LG E+ ++E+
Sbjct: 221 ILLCGFPPFYSNTGQAISPGMKRRI--RLGQYGFP------------NPEWS--EVSEDA 264
Query: 635 NQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687
QL +R LL+ +P R T + ++HPW+
Sbjct: 265 KQL------------------------IRLLLKTDPTERLTITQFMNHPWINQ 293
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 61/327 (18%), Positives = 111/327 (33%), Gaps = 76/327 (23%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKND 438
++ E +GS F VF+ G +K K +L E+ ++ ++
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 439 PADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQC 497
H++R + + +H+ I E +L + N YF L+ + Q
Sbjct: 72 -----HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMS--YFKEAELKDLLLQV 124
Query: 498 LEALEYLHSLGIIHCDLKPENILI-----------------KSYQRCEIKIIDLGSSCFQ 540
L Y+HS+ ++H D+KP NI I + + KI DLG +
Sbjct: 125 GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT-R 183
Query: 541 TDNLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 599
+ + + A EV+ + K D+++L + E L N + +
Sbjct: 184 ISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQ- 242
Query: 600 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFI 659
G L IP+ S E F
Sbjct: 243 -GRLPR-----------------------------------IPQVLSQE---------FT 257
Query: 660 DFVRTLLEINPQRRPTAREALDHPWLQ 686
+ ++ ++ +P+RRP+A + H L
Sbjct: 258 ELLKVMIHPDPERRPSAMALVKHSVLL 284
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-40
Identities = 62/315 (19%), Positives = 121/315 (38%), Gaps = 68/315 (21%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 437
+Y + +G +F K + G +K I + K+ ++S E+ +L +
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER-EESRREVAVLANMK-- 81
Query: 438 DPADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR 495
H +I++ + F L+IV + +L F++ N + G F ++
Sbjct: 82 -----HPNIVQYRESFEENGSLYIVMDYCEGGDL--FKRINAQKGV--LFQEDQILDWFV 132
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQSRS 552
Q AL+++H I+H D+K +NI + +++ D G + + + +
Sbjct: 133 QICLALKHVHDRKILHRDIKSQNIFLTKDGT--VQLGDFGIARVLNSTVELARACIGTPY 190
Query: 553 YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII-GMLGPIDLEML 611
Y +PE+ PY+ K D+W+LGC+L EL T + F ++ ++ +II G P
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP------ 244
Query: 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQ 671
+ +S V L + NP+
Sbjct: 245 -----------------------------VSL--------HYSYD-LRSLVSQLFKRNPR 266
Query: 672 RRPTAREALDHPWLQ 686
RP+ L+ ++
Sbjct: 267 DRPSVNSILEKGFIA 281
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-40
Identities = 88/332 (26%), Positives = 139/332 (41%), Gaps = 84/332 (25%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD---------EIK 429
+ Y +++ LGS A +V A + T V ++II K + + EI+
Sbjct: 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 192
Query: 430 LLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE------ 482
+LK +N H I+++ + F+ E +IV EL+ GGE
Sbjct: 193 ILKKLN-------HPCIIKIKN-FFDAEDYYIVLELM-------------EGGELFDKVV 231
Query: 483 --AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGSSCF 539
++ Q L A++YLH GIIH DLKPEN+L+ S + C IKI D G S
Sbjct: 232 GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291
Query: 540 QTDNLCLY--VQSRSYRAPEVIIGL---PYDQKIDLWSLGCILAELWTGEVLFPNDAVVM 594
+ + + +Y APEV++ + Y++ +D WSLG IL +G F +
Sbjct: 292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 351
Query: 595 ILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFS 654
L I G+ Y + + + ++E+
Sbjct: 352 SLKDQI-----------TSGK--YNFIPEVWA--EVSEKA-------------------- 376
Query: 655 DAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686
+D V+ LL ++P+ R T EAL HPWLQ
Sbjct: 377 ----LDLVKKLLVVDPKARFTTEEALRHPWLQ 404
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-40
Identities = 74/331 (22%), Positives = 137/331 (41%), Gaps = 44/331 (13%)
Query: 384 YVTEYLGSAAFSKVFQAQDLH--TGVDVCLKIIKNDKDFFDQSLDEIKLLK-LVNKNDPA 440
Y +G + V++A+ D LK I+ + EI LL+ L + N
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACREIALLRELKHPN--- 79
Query: 441 DEHHILRLYDYFYH--LEHLFIVCELLRANLY---EFQKFNQESGGEAYFTLGRLQVITR 495
++ L F ++++ + +L+ +F + ++ + G ++ +
Sbjct: 80 ----VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSY--QRCEIKIIDLGSSCFQTDNLCLYVQSRS- 552
Q L+ + YLH+ ++H DLKP NIL+ +R +KI D+G + L
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 553 -----YRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMI---------LA 597
YRAPE+++G Y + ID+W++GCI AEL T E +F + L
Sbjct: 196 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255
Query: 598 RIIGMLGPIDLEMLMQGQEIYKYFTK--EYDLYYINEETNQLEYIIPEESSLEHHLQFSD 655
RI ++G + ++ K E+ + N +E H D
Sbjct: 256 RIFNVMGFPA-------DKDWEDIKKMPEHSTLMKDFRRNTYTN-CSLIKYMEKHKVKPD 307
Query: 656 AFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686
+ ++ LL ++P +R T+ +A+ P+
Sbjct: 308 SKAFHLLQKLLTMDPIKRITSEQAMQDPYFL 338
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 7e-40
Identities = 61/322 (18%), Positives = 112/322 (34%), Gaps = 73/322 (22%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 437
Y V +G+ ++ + + + G + K + + + + E+ LL+ +
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELK-- 63
Query: 438 DPADEH-HILRLYDYFYHLE--HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVI 493
H +I+R YD L+IV E +L + Y + +
Sbjct: 64 -----HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER--QYLDEEFVLRV 116
Query: 494 TRQCLEALEYLHSLG-----IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL-- 546
Q AL+ H ++H DLKP N+ + Q +K+ D G + +
Sbjct: 117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLARILNHDTSFAK 174
Query: 547 -YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII-GMLG 604
+V + Y +PE + + Y++K D+WSLGC+L EL F + + +I G
Sbjct: 175 TFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 234
Query: 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 664
IP S E + +
Sbjct: 235 R-----------------------------------IPYRYSDE---------LNEIITR 250
Query: 665 LLEINPQRRPTAREALDHPWLQ 686
+L + RP+ E L++P +
Sbjct: 251 MLNLKDYHRPSVEEILENPLIL 272
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 9e-40
Identities = 83/325 (25%), Positives = 145/325 (44%), Gaps = 50/325 (15%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQ-SLDEIKLLKLVNKND 438
+Y +G F +VF+A+ TG V LK + N+K+ F +L EIK+L+L+
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK--- 74
Query: 439 PADEH-HILRLYD--------YFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGR 489
H +++ L + Y +++V + +L + FTL
Sbjct: 75 ----HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL----SNVLVK-FTLSE 125
Query: 490 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG----SSCFQTDNLC 545
++ + + L L Y+H I+H D+K N+LI +K+ D G S +
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR--DGVLKLADFGLARAFSLAKNSQPN 183
Query: 546 LY---VQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 601
Y V + YR PE+++G Y IDLW GCI+AE+WT + + LA I
Sbjct: 184 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243
Query: 602 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQ--FSDAFFI 659
+ G I E++ Y+LY +LE + ++ ++ L+ D + +
Sbjct: 244 LCGSIT-------PEVWPNVDN-YELY------EKLELVKGQKRKVKDRLKAYVRDPYAL 289
Query: 660 DFVRTLLEINPQRRPTAREALDHPW 684
D + LL ++P +R + +AL+H +
Sbjct: 290 DLIDKLLVLDPAQRIDSDDALNHDF 314
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 9e-40
Identities = 71/374 (18%), Positives = 120/374 (32%), Gaps = 84/374 (22%)
Query: 358 HRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND 417
H + + EN + +Y++ +G ++ V A + T +KI+ +
Sbjct: 3 HHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKN 62
Query: 418 KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELL------------ 465
K D ++ V +I RLY+ + +++ +V EL
Sbjct: 63 KIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVF 122
Query: 466 -----------------------RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 502
+ + I RQ AL
Sbjct: 123 IDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182
Query: 503 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF-------QTDNLCLYVQSRSYRA 555
YLH+ GI H D+KPEN L + + EIK++D G S + + + + A
Sbjct: 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242
Query: 556 PEVIIGL--PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613
PEV+ Y K D WS G +L L G V FP ++++ +
Sbjct: 243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQV------------LN 290
Query: 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 673
+ + Y++ + + D + LL N R
Sbjct: 291 KK--LCFENPNYNV-------------LSPLA-------------RDLLSNLLNRNVDER 322
Query: 674 PTAREALDHPWLQH 687
A AL HPW+
Sbjct: 323 FDAMRALQHPWISQ 336
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 80/326 (24%), Positives = 139/326 (42%), Gaps = 85/326 (26%)
Query: 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-----EIKLLKLVN 435
G Y + + +G F+KV A+ + TG +V +KII DK + + E++++K++N
Sbjct: 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILN 72
Query: 436 KNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRLQ 491
H +I++L++ + L+++ E SGGE + L GR++
Sbjct: 73 -------HPNIVKLFEVIETEKTLYLIMEYA-------------SGGEVFDYLVAHGRMK 112
Query: 492 -----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN--L 544
RQ + A++Y H I+H DLK EN+L+ + IKI D G S T L
Sbjct: 113 EKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDA--DMNIKIADFGFSNEFTVGGKL 170
Query: 545 CLYVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 603
+ + Y APE+ G YD ++D+WSLG IL L +G + F + + R+
Sbjct: 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV---- 226
Query: 604 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVR 663
++G +Y IP S + + ++
Sbjct: 227 --------LRG-----------------------KYRIPFYMSTDC---------ENLLK 246
Query: 664 TLLEINPQRRPTAREALDHPWLQHPY 689
L +NP +R T + + W+ +
Sbjct: 247 RFLVLNPIKRGTLEQIMKDRWINAGH 272
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-39
Identities = 82/335 (24%), Positives = 123/335 (36%), Gaps = 86/335 (25%)
Query: 376 NTVIAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLV 434
I Y VT + LG KV Q + T LK++++ E++L
Sbjct: 56 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRA 111
Query: 435 NKNDPADEH-HILRLYDYF----YHLEHLFIVCELLRANLYEFQKFNQESGGE------- 482
++ HI+R+ D + + L IV E L GGE
Sbjct: 112 SQ------CPHIVRIVDVYENLYAGRKCLLIVMECLD-------------GGELFSRIQD 152
Query: 483 ---AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGSSC 538
FT I + EA++YLHS+ I H D+KPEN+L S +K+ D G +
Sbjct: 153 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212
Query: 539 FQTDNLCLY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLF----PNDAV 592
T + L + Y APEV+ YD+ D+WSLG I+ L G F
Sbjct: 213 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS 272
Query: 593 VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQ 652
+ RI +G + E+ ++EE L
Sbjct: 273 PGMKTRI--RMGQYEFP------------NPEWS--EVSEEVKML--------------- 301
Query: 653 FSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687
+R LL+ P +R T E ++HPW+
Sbjct: 302 ---------IRNLLKTEPTQRMTITEFMNHPWIMQ 327
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 82/330 (24%), Positives = 122/330 (36%), Gaps = 92/330 (27%)
Query: 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD---------EIKLL 431
+Y LGS AF V+ A D +V +K IK +K D ++ EI +L
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 432 KLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--AYFTL- 487
V H +I+++ D F + +V E SG + A+
Sbjct: 84 SRVE-------HANIIKVLDIFENQGFFQLVMEK------------HGSGLDLFAFIDRH 124
Query: 488 GRLQ-----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 542
RL I RQ + A+ YL IIH D+K ENI+I IK+ID GS+ +
Sbjct: 125 PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAE--DFTIKLIDFGSAAYLER 182
Query: 543 NLCLYVQ--SRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 599
Y + Y APEV++G PY ++++WSLG L L E F
Sbjct: 183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC----------- 231
Query: 600 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFI 659
+LE ++ P S + +
Sbjct: 232 -------ELEETVEA-----------------------AIHPPYLVS-------KEL--M 252
Query: 660 DFVRTLLEINPQRRPTAREALDHPWLQHPY 689
V LL+ P+RR T + + PW+ P
Sbjct: 253 SLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-38
Identities = 75/339 (22%), Positives = 128/339 (37%), Gaps = 68/339 (20%)
Query: 362 RTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDF 420
R+ E + + ++ LG + V+ +DL V + +K I D +
Sbjct: 3 RSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY 62
Query: 421 FDQSLDEIKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLR----ANLYEFQKF 475
+EI L K + H +I++ F + I E + + L K+
Sbjct: 63 SQPLHEEIALHKHLK-------HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLR-SKW 114
Query: 476 NQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535
E + T+Q LE L+YLH I+H D+K +N+LI +Y +KI D G
Sbjct: 115 GPLKDNEQT-----IGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV-LKISDFG 168
Query: 536 SSCFQTDNLCLYVQSRS----YRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVLFPN 589
+S + + ++ + Y APE+I P Y + D+WSLGC + E+ TG+ F
Sbjct: 169 TSK-RLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227
Query: 590 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEH 649
L + Q ++ + ++ IPE S E
Sbjct: 228 ---------------------LGEPQAA---------MFKV--GMFKVHPEIPESMSAE- 254
Query: 650 HLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688
F+ E +P +R A + L +L+
Sbjct: 255 --------AKAFILKCFEPDPDKRACANDLLVDEFLKVS 285
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-38
Identities = 46/356 (12%), Positives = 96/356 (26%), Gaps = 88/356 (24%)
Query: 370 DLPIILNTVIAGRYYVT---EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD 426
P + + + R LG +A D TG + + + ++
Sbjct: 64 GQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIK 123
Query: 427 EIK--------LLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRAN---------L 469
++K L + N+ + +D + ++ L L
Sbjct: 124 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 183
Query: 470 YEFQKFNQESGGEAYFTLGRLQV---------ITRQCLEALEYLHSLGIIHCDLKPENIL 520
Y + N ++ GE + +T Q + L LH G++H L+P +I+
Sbjct: 184 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIV 243
Query: 521 IKSYQRCEIKIIDLGSSCFQTDNLC----LYVQSRSYRAPEVIIGLP-----YDQKIDLW 571
+ QR + + + A ++ D W
Sbjct: 244 LD--QRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301
Query: 572 SLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYIN 631
+LG + +W ++ +DA + I F +
Sbjct: 302 TLGLAIYWIWCADLPNTDDAALGGSEWI---------------------FRSCKN----- 335
Query: 632 EETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687
IP+ + L + R +A++ P +
Sbjct: 336 ---------IPQPVR-------------ALLEGFLRYPKEDRLLPLQAMETPEYEQ 369
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 69/347 (19%), Positives = 126/347 (36%), Gaps = 77/347 (22%)
Query: 358 HRKNRTGFEENKDLPIILNTVIAGRYY-VTEYLGSAAFSKVFQAQDLHTGVDVCLKII-- 414
+N+ + + + GR+ +G +F V++ D T V+V +
Sbjct: 2 EERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQD 61
Query: 415 -KNDKDFFDQSLDEIKLLK-LVNKNDPADEHHILRLYDYFYHL----EHLFIVCEL---- 464
K K + +E ++LK L + N I+R YD + + + +V EL
Sbjct: 62 RKLTKSERQRFKEEAEMLKGLQHPN-------IVRFYDSWESTVKGKKCIVLVTELMTSG 114
Query: 465 -LRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILI 521
L+ L F+ + L+ RQ L+ L++LH+ IIH DLK +NI I
Sbjct: 115 TLKTYLKRFKVMK----------IKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI 164
Query: 522 KSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY-RAPEVIIGLPYDQKIDLWSLGCILAEL 580
+KI DLG + + + V APE+ YD+ +D+++ G + E+
Sbjct: 165 TGPT-GSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEM 222
Query: 581 WTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYI 640
T E + + + Q IY+ T
Sbjct: 223 ATSEYPYS------------------ECQNAAQ---IYRRVTSG-----------VKPAS 250
Query: 641 IPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687
+ + E + + + N R + ++ L+H + Q
Sbjct: 251 FDKVAIPE---------VKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 7e-38
Identities = 74/309 (23%), Positives = 121/309 (39%), Gaps = 31/309 (10%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 446
LG+ VF+ +G+ + K+I +Q + E+++L + +I+
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH------ECNSPYIV 94
Query: 447 RLYDYFYHLEHLFIVCELLRA----NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 502
Y FY + I E + + + E L ++ ++ L
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ---------ILGKVSIAVIKGLT 145
Query: 503 YLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC-LYVQSRSYRAPEVII 560
YL I+H D+KP NIL+ S R EIK+ D G S D++ +V +RSY +PE +
Sbjct: 146 YLREKHKIMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ 203
Query: 561 GLPYDQKIDLWSLGCILAELWTGEVLFP---NDAVVMILARIIGMLGPIDLEMLMQGQEI 617
G Y + D+WS+G L E+ G +P DA + L + G
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGR--YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261
Query: 618 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 677
D L+YI+ E FS F DFV L NP R +
Sbjct: 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLE-FQDFVNKCLIKNPAERADLK 320
Query: 678 EALDHPWLQ 686
+ + H +++
Sbjct: 321 QLMVHAFIK 329
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 83/325 (25%), Positives = 130/325 (40%), Gaps = 82/325 (25%)
Query: 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNK 436
G Y + + LG F KV + TG V +KI+ K D + EI+ LKL
Sbjct: 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR- 69
Query: 437 NDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRLQ- 491
H HI++LY F+V E + SGGE + + GR++
Sbjct: 70 ------HPHIIKLYQVISTPTDFFMVMEYV-------------SGGELFDYICKHGRVEE 110
Query: 492 ----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 547
+ +Q L A++Y H ++H DLKPEN+L+ ++ KI D G S +D L
Sbjct: 111 MEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFLR 168
Query: 548 VQ--SRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 604
S +Y APEVI G Y ++D+WS G IL L G + F ++ V + +I
Sbjct: 169 TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI----- 223
Query: 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 664
G + IPE + +
Sbjct: 224 -------RGG-----------------------VFYIPEYLN-------RSV--ATLLMH 244
Query: 665 LLEINPQRRPTAREALDHPWLQHPY 689
+L+++P +R T ++ +H W +
Sbjct: 245 MLQVDPLKRATIKDIREHEWFKQDL 269
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 69/336 (20%), Positives = 117/336 (34%), Gaps = 88/336 (26%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDP 439
+ + LG F VF+A++ + +K I+ N + ++ + E+K L +
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE---- 61
Query: 440 ADEH-HILRLYDYF------------YHLEHLFIVCELL-RANLYEFQKFNQESGGEAYF 485
H I+R ++ + +L+I +L + NL ++
Sbjct: 62 ---HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN---GRCTIEER 115
Query: 486 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF------ 539
I Q EA+E+LHS G++H DLKP NI +K+ D G
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD--VVKVGDFGLVTAMDQDEE 173
Query: 540 ---------QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 590
V ++ Y +PE I G Y K+D++SLG IL EL L+P
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL-----LYPFS 228
Query: 591 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHH 650
M L + + F + Y P E +
Sbjct: 229 T---------QMERVRTLTDVRNLK-----FPPLFTQKY------------PCEYVM--- 259
Query: 651 LQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686
V+ +L +P RP A +++ +
Sbjct: 260 -----------VQDMLSPSPMERPEAINIIENAVFE 284
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 70/211 (33%), Positives = 100/211 (47%), Gaps = 32/211 (15%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL-DEIKLLKLVNKN 437
I + E LGS AFS+VF + TG LK IK F D SL +EI +LK +
Sbjct: 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK-- 64
Query: 438 DPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLG 488
H +I+ L D + H ++V +L+ SGGE +T
Sbjct: 65 -----HENIVTLEDIYESTTHYYLVMQLV-------------SGGELFDRILERGVYTEK 106
Query: 489 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLG-SSCFQTDNLCL 546
++ +Q L A++YLH GI+H DLKPEN+L + + +I I D G S Q +
Sbjct: 107 DASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST 166
Query: 547 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 577
+ Y APEV+ PY + +D WS+G I
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 4e-07
Identities = 13/27 (48%), Positives = 17/27 (62%)
Query: 660 DFVRTLLEINPQRRPTAREALDHPWLQ 686
DF+ LLE +P R T +AL HPW+
Sbjct: 240 DFICHLLEKDPNERYTCEKALSHPWID 266
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 77/329 (23%), Positives = 130/329 (39%), Gaps = 82/329 (24%)
Query: 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-----EIKLLKLVN 435
G+Y + + LG ++ KV + D T +KI+K K + + EI+LL+ +
Sbjct: 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR 64
Query: 436 KNDPADEH-HILRLYDYFYHLE--HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV 492
H ++++L D Y+ E +++V E + E + R V
Sbjct: 65 -------HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEM--LD-------SVPEKRFPV 108
Query: 493 IT-----RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS----CFQTDN 543
Q ++ LEYLHS GI+H D+KP N+L+ + +KI LG + F D+
Sbjct: 109 CQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT--LKISALGVAEALHPFAADD 166
Query: 544 LCLYVQ-SRSYRAPEVIIGL-PYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 600
C Q S +++ PE+ GL + K+D+WS G L + TG F D + + I
Sbjct: 167 TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI- 225
Query: 601 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFID 660
+G Y IP + D
Sbjct: 226 -----------GKG-----------------------SYAIPGDCG-------PPL--SD 242
Query: 661 FVRTLLEINPQRRPTAREALDHPWLQHPY 689
++ +LE P +R + R+ H W + +
Sbjct: 243 LLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-36
Identities = 76/330 (23%), Positives = 126/330 (38%), Gaps = 76/330 (23%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKII-KNDKDFFDQSLDEIKLLKLVNKNDPADEH-H 444
+ LG A ++V +L T + +KII K + E+++L H +
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ------GHRN 72
Query: 445 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRLQVITRQ 496
+L L ++F + ++V E +R GG +F V+ +
Sbjct: 73 VLELIEFFEEEDRFYLVFEKMR-------------GGSILSHIHKRRHFNELEASVVVQD 119
Query: 497 CLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLG-SSCFQTDNLCLYVQSRS-- 552
AL++LH+ GI H DLKPENIL + Q +KI D S + + C + +
Sbjct: 120 VASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 553 -------YRAPEVIIGL-----PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 600
Y APEV+ YD++ DLWSLG IL L +G F
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG 239
Query: 601 GMLGPIDLEML---MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAF 657
+ +G+ Y++ K++ +I+ L
Sbjct: 240 EACPACQNMLFESIQEGK--YEFPDKDWA--HISCAAKDL-------------------- 275
Query: 658 FIDFVRTLLEINPQRRPTAREALDHPWLQH 687
+ LL + ++R +A + L HPW+Q
Sbjct: 276 ----ISKLLVRDAKQRLSAAQVLQHPWVQG 301
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 8e-36
Identities = 69/321 (21%), Positives = 107/321 (33%), Gaps = 70/321 (21%)
Query: 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA 440
RY + +GS F +D T V +K I+ + EI + +
Sbjct: 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLR----- 74
Query: 441 DEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRLQVIT-- 494
H +I+R + HL I+ E SGGE Y + GR
Sbjct: 75 --HPNIVRFKEVILTPTHLAIIMEYA-------------SGGELYERICNAGRFSEDEAR 119
Query: 495 ---RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--YVQ 549
+Q L + Y HS+ I H DLK EN L+ +KI D G S + V
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 550 SRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 608
+ +Y APEV++ YD + D+WS G L + G F D R +
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRKT-------I 231
Query: 609 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEI 668
+ ++ + Y IP++ + + +
Sbjct: 232 QRILSVK-----------------------YSIPDDIRISPECC-------HLISRIFVA 261
Query: 669 NPQRRPTAREALDHPWLQHPY 689
+P R + E H W
Sbjct: 262 DPATRISIPEIKTHSWFLKNL 282
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 81/327 (24%), Positives = 123/327 (37%), Gaps = 87/327 (26%)
Query: 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIKLLKLV 434
G Y + E LG +F KV A T V LK I + +S EI LKL+
Sbjct: 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFI--SRQLLKKSDMHMRVEREISYLKLL 66
Query: 435 NKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRL 490
H HI++LYD + +V E +GGE + + R+
Sbjct: 67 R-------HPHIIKLYDVITTPTDIVMVIEY--------------AGGELFDYIVEKKRM 105
Query: 491 Q-----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC 545
+Q + A+EY H I+H DLKPEN+L+ +KI D G S TD
Sbjct: 106 TEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDGNF 163
Query: 546 LYVQ--SRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 602
L S +Y APEVI G Y ++D+WS G +L + G + F ++ + + ++
Sbjct: 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--- 220
Query: 603 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFV 662
Y++P+ S A +
Sbjct: 221 ---------NSC-----------------------VYVMPDFLS-------PGA--QSLI 239
Query: 663 RTLLEINPQRRPTAREALDHPWLQHPY 689
R ++ +P +R T +E PW
Sbjct: 240 RRMIVADPMQRITIQEIRRDPWFNVNL 266
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 84/329 (25%), Positives = 123/329 (37%), Gaps = 70/329 (21%)
Query: 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKN 437
Y + E +GS A + V A V +K I +K D+ L EI+ + +
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH-- 71
Query: 438 DPADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQ--VI 493
H +I+ Y F + L++V +LL ++ + K G L I
Sbjct: 72 -----HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 494 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY 553
R+ LE LEYLH G IH D+K NIL+ ++I D G S F +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGE--DGSVQIADFGVSAFLATGGDITRNKV-- 182
Query: 554 R----------APEVII-GLPYDQKIDLWSLGCILAELWTGE----VLFPNDAVVMILAR 598
R APEV+ YD K D+WS G EL TG P +++ L
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242
Query: 599 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFF 658
P LE +Q +E+ K + K F
Sbjct: 243 -----DPPSLETGVQDKEMLKKYGKS---------------------------------F 264
Query: 659 IDFVRTLLEINPQRRPTAREALDHPWLQH 687
+ L+ +P++RPTA E L H + Q
Sbjct: 265 RKMISLCLQKDPEKRPTAAELLRHKFFQK 293
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 61/336 (18%), Positives = 116/336 (34%), Gaps = 69/336 (20%)
Query: 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK------------------NDKDFFD 422
Y + L F+K+ + LK + + K +D
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 423 QSLDEIKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEF--QKFNQE 478
+E++++ + + + L + + ++I+ E + ++ +F F +
Sbjct: 89 DFKNELQIITDIK-------NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLD 141
Query: 479 SGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537
+ + ++ I + L + Y+H+ I H D+KP NIL+ +K+ D G S
Sbjct: 142 KNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK--NGRVKLSDFGES 199
Query: 538 CFQTDNL----CLYVQSRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVLFPNDA 591
+ D + + PE K+D+WSLG L ++ V F
Sbjct: 200 EYMVDKKIKGSR---GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256
Query: 592 VVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHL 651
++ L I + N Y + + S +
Sbjct: 257 SLVELFNNI-----------RTKN------------IEYPLDRNHFLYPLTNKKSTCSNN 293
Query: 652 QFS-DAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686
S + IDF++ L NP R T+ +AL H WL
Sbjct: 294 FLSNED--IDFLKLFLRKNPAERITSEDALKHEWLA 327
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 3e-35
Identities = 48/253 (18%), Positives = 93/253 (36%), Gaps = 36/253 (14%)
Query: 365 FEENKDLPIILN----TVIAGRYYVTEYLGSAAFSKVFQA-----QDLHTGVDVCLKIIK 415
FE LP I + + YV LG AF++V++A D LK+ K
Sbjct: 45 FEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK 104
Query: 416 NDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA----NLYE 471
+ + +L+ + P+ +H ++ Y +V EL N
Sbjct: 105 PANPW-----EFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAIN 159
Query: 472 FQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--- 528
K E G + + L +E +H IIH D+KP+N ++ + +
Sbjct: 160 LYKNTPEKV----MPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215
Query: 529 ------IKIIDLGSSCF-----QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 577
+ +IDLG S + ++ ++ E++ P++ +ID + + +
Sbjct: 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATV 275
Query: 578 AELWTGEVLFPND 590
+ G + +
Sbjct: 276 YCMLFGTYMKVKN 288
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 74/316 (23%), Positives = 125/316 (39%), Gaps = 64/316 (20%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPA 440
+GS +V++ + TG + +K ++ +K+ + L ++ ++ +
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH----- 81
Query: 441 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 500
D +I++ + F +FI EL+ + +K Q E L +T ++A
Sbjct: 82 DCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERI-----LGKMTVAIVKA 136
Query: 501 LEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL--CLYVQSRSYRAPE 557
L YL G+IH D+KP NIL+ R +IK+ D G S D+ +Y APE
Sbjct: 137 LYYLKEKHGVIHRDVKPSNILLDE--RGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPE 194
Query: 558 VI-----IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 612
I YD + D+WSLG L EL TG+ FP +
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQ--FPYK----------NCKTDFE----- 237
Query: 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEES-SLEHHLQFSDAFFIDFVRTLLEINPQ 671
L ++ EE L H+ FS F FV+ L + +
Sbjct: 238 -----------------------VLTKVLQEEPPLLPGHMGFSGD-FQSFVKDCLTKDHR 273
Query: 672 RRPTAREALDHPWLQH 687
+RP + L+H +++
Sbjct: 274 KRPKYNKLLEHSFIKR 289
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-35
Identities = 83/325 (25%), Positives = 130/325 (40%), Gaps = 82/325 (25%)
Query: 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNK 436
G Y + + LG F KV + TG V +KI+ K D + EI+ LKL
Sbjct: 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR- 74
Query: 437 NDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRLQ- 491
H HI++LY +F+V E + SGGE + + GRL
Sbjct: 75 ------HPHIIKLYQVISTPSDIFMVMEYV-------------SGGELFDYICKNGRLDE 115
Query: 492 ----VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 547
+ +Q L ++Y H ++H DLKPEN+L+ ++ KI D G S +D L
Sbjct: 116 KESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFLR 173
Query: 548 VQ--SRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 604
S +Y APEVI G Y ++D+WS G IL L G + F +D V + +I G
Sbjct: 174 TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD--G 231
Query: 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 664
+ P+ + I ++
Sbjct: 232 ---------------------------------IFYTPQYLN-------PSV--ISLLKH 249
Query: 665 LLEINPQRRPTAREALDHPWLQHPY 689
+L+++P +R T ++ +H W +
Sbjct: 250 MLQVDPMKRATIKDIREHEWFKQDL 274
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 60/328 (18%), Positives = 111/328 (33%), Gaps = 84/328 (25%)
Query: 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKND 438
+ + + LG A+ +V A + T V +KI+ + D + EI + K++N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--- 63
Query: 439 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRLQVIT 494
H ++++ Y + ++ E SGGE + + +
Sbjct: 64 ----HENVVKFYGHRREGNIQYLFLEYC-------------SGGELFDRIEPDIGMPEPD 106
Query: 495 -----RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN-----L 544
Q + + YLH +GI H D+KPEN+L+ +KI D G + N L
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLL 164
Query: 545 CLYVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLF--PNDAVVMILARIIG 601
+ Y APE++ + + +D+WS G +L + GE+ + P+D+
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK 224
Query: 602 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDF 661
+ + ++
Sbjct: 225 ------------------------------------KTYLNPWKKIDSAPL-------AL 241
Query: 662 VRTLLEINPQRRPTAREALDHPWLQHPY 689
+ +L NP R T + W P
Sbjct: 242 LHKILVENPSARITIPDIKKDRWYNKPL 269
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-34
Identities = 53/211 (25%), Positives = 87/211 (41%), Gaps = 32/211 (15%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKN 437
I Y + +G ++ +V A T + K I + D+ EI+++K +
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL--- 63
Query: 438 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGR 489
D +I+RLY+ F +++V EL +GGE F
Sbjct: 64 ---DHPNIIRLYETFEDNTDIYLVMELC-------------TGGELFERVVHKRVFRESD 107
Query: 490 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGSSCFQTDNLCLY- 547
I + L A+ Y H L + H DLKPEN L + +K+ID G + +
Sbjct: 108 AARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167
Query: 548 -VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 577
V + Y +P+V+ G Y + D WS G ++
Sbjct: 168 KVGTPYYVSPQVLEG-LYGPECDEWSAGVMM 197
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 10/27 (37%), Positives = 18/27 (66%)
Query: 660 DFVRTLLEINPQRRPTAREALDHPWLQ 686
+R LL +P++R T+ +AL+H W +
Sbjct: 240 SLIRRLLTKSPKQRITSLQALEHEWFE 266
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 35/214 (16%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD---EIKLLKLVN 435
+ Y V E LG AFS V + TG++ KII K E ++ + +
Sbjct: 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 63
Query: 436 KNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFT 486
H +I+RL+D ++V +L+ +GGE +++
Sbjct: 64 -------HPNIVRLHDSIQEESFHYLVFDLV-------------TGGELFEDIVAREFYS 103
Query: 487 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLGSSCFQTDNLC 545
+Q LE++ Y HS GI+H +LKPEN+L+ S + +K+ D G + D+
Sbjct: 104 EADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163
Query: 546 LY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 577
+ + Y +PEV+ PY + +D+W+ G IL
Sbjct: 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 10/27 (37%), Positives = 18/27 (66%)
Query: 660 DFVRTLLEINPQRRPTAREALDHPWLQ 686
+ ++L +NP++R TA +AL PW+
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWIC 266
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 74/312 (23%), Positives = 122/312 (39%), Gaps = 65/312 (20%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG A+ V + + + +G + +K I+ + + L ++ +
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP-----F 67
Query: 445 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG---EAYFTLGRLQVITRQCLEAL 501
+ Y + ++I EL+ +L +F K + G E L I ++AL
Sbjct: 68 TVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDI-----LGKIAVSIVKAL 122
Query: 502 EYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL--CLYVQSRSYRAPEV 558
E+LHS L +IH D+KP N+LI + ++K+ D G S + D++ + + Y APE
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINA--LGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPER 180
Query: 559 IIG----LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614
I Y K D+WSLG + EL FP D+ P
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILR--FPYDS----------WGTPFQ------- 221
Query: 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP 674
QL+ ++ E S +FS F+DF L+ N + RP
Sbjct: 222 ---------------------QLKQVVEEPSPQLPADKFSAE-FVDFTSQCLKKNSKERP 259
Query: 675 TAREALDHPWLQ 686
T E + HP+
Sbjct: 260 TYPELMQHPFFT 271
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-34
Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 31/210 (14%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 438
++ + V LG A S V++ + T LK++K D EI +L +
Sbjct: 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-KIVRTEIGVLLRL---- 105
Query: 439 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRL 490
+I++L + F + +V EL+ +GGE Y++
Sbjct: 106 --SHPNIIKLKEIFETPTEISLVLELV-------------TGGELFDRIVEKGYYSERDA 150
Query: 491 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLGSSCFQTDNLCLY-- 547
+Q LEA+ YLH GI+H DLKPEN+L + +KI D G S + +
Sbjct: 151 ADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV 210
Query: 548 VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 577
+ Y APE++ G Y ++D+WS+G I
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 12/27 (44%), Positives = 19/27 (70%)
Query: 660 DFVRTLLEINPQRRPTAREALDHPWLQ 686
D VR L+ ++P++R T +AL HPW+
Sbjct: 284 DLVRKLIVLDPKKRLTTFQALQHPWVT 310
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-34
Identities = 67/223 (30%), Positives = 102/223 (45%), Gaps = 45/223 (20%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---------NDKDFFDQSLDEIK 429
+ Y +++ LGS A +V A + T V +KII + D EI+
Sbjct: 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 430 LLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE------ 482
+LK +N H I+++ + F+ E +IV EL+ GGE
Sbjct: 68 ILKKLN-------HPCIIKIKN-FFDAEDYYIVLELM-------------EGGELFDKVV 106
Query: 483 --AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGSSCF 539
++ Q L A++YLH GIIH DLKPEN+L+ S + C IKI D G S
Sbjct: 107 GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166
Query: 540 QTDNLCLY--VQSRSYRAPEVIIGL---PYDQKIDLWSLGCIL 577
+ + + +Y APEV++ + Y++ +D WSLG IL
Sbjct: 167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 15/27 (55%), Positives = 19/27 (70%)
Query: 660 DFVRTLLEINPQRRPTAREALDHPWLQ 686
D V+ LL ++P+ R T EAL HPWLQ
Sbjct: 253 DLVKKLLVVDPKARFTTEEALRHPWLQ 279
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 79/328 (24%), Positives = 135/328 (41%), Gaps = 95/328 (28%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPA 440
+Y E +G A V+ A D+ TG +V ++ + + + ++EI +++
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR-------- 72
Query: 441 DEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG-------EAYFTLGRLQ 491
+ + I+ D + + L++V E L +GG E G++
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYL-------------AGGSLTDVVTETCMDEGQIA 119
Query: 492 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 551
+ R+CL+ALE+LHS +IH D+K +NIL+ +K+ D G C Q +
Sbjct: 120 AVCRECLQALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFG-FCAQITP------EQ 170
Query: 552 SYR----------APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 601
S R APEV+ Y K+D+WSLG + E+ GE P
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE---P------------- 214
Query: 602 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEES--SLEHHLQFSDAFFI 659
P Y+NE + Y+I L++ + S F
Sbjct: 215 ---P-----------------------YLNENPLRALYLIATNGTPELQNPEKLSAI-FR 247
Query: 660 DFVRTLLEINPQRRPTAREALDHPWLQH 687
DF+ LE++ ++R +A+E L H +L+
Sbjct: 248 DFLNRCLEMDVEKRGSAKELLQHQFLKI 275
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 79/329 (24%), Positives = 121/329 (36%), Gaps = 95/329 (28%)
Query: 376 NTVIAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLV 434
I Y VT + LG KV Q + T LK++++ E++L
Sbjct: 12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA----RREVELHWRA 67
Query: 435 NKNDPADEH-HILRLYDYF----YHLEHLFIVCELLRANLYEFQKFNQESGGE------- 482
++ HI+R+ D + + L IV E L GGE
Sbjct: 68 SQ------CPHIVRIVDVYENLYAGRKCLLIVMECL-------------DGGELFSRIQD 108
Query: 483 ---AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLGSSC 538
FT I + EA++YLHS+ I H D+KPEN+L S + +K+ D G
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--- 165
Query: 539 FQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILAR 598
A E G YD+ D+WSLG I+ L G F ++ + I
Sbjct: 166 ---------------FAKET-TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 209
Query: 599 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFF 658
+ + GQ Y++ E+ ++EE L
Sbjct: 210 M--------KTRIRMGQ--YEFPNPEWS--EVSEEVKML--------------------- 236
Query: 659 IDFVRTLLEINPQRRPTAREALDHPWLQH 687
+R LL+ P +R T E ++HPW+
Sbjct: 237 ---IRNLLKTEPTQRMTITEFMNHPWIMQ 262
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 66/374 (17%), Positives = 117/374 (31%), Gaps = 119/374 (31%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPA 440
+ + +G F VF+A++ + +K I+ N + ++ + E+K L +
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 441 DEHH---------------------------------------------------ILRLY 449
+ +
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 450 DYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG 508
+L+I +L + NL ++ G I Q EA+E+LHS G
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMN---RRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 509 IIHCDLKPENILIKSYQRCEIKIIDLG---------------SSCFQTDNLCLYVQSRSY 553
++H DLKP NI +K+ D G + V ++ Y
Sbjct: 185 LMHRDLKPSNIFFTM--DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 554 RAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613
+PE I G Y K+D++SLG IL EL F M RI + +
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYS---FSTQ---MERVRI--------ITDVRN 288
Query: 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 673
+ F + Y P+E + V+ +L +P R
Sbjct: 289 LK-----FPLLFTQKY------------PQEHMM--------------VQDMLSPSPTER 317
Query: 674 PTAREALDHPWLQH 687
P A + +++ ++
Sbjct: 318 PEATDIIENAIFEN 331
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 70/328 (21%), Positives = 123/328 (37%), Gaps = 95/328 (28%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPA 440
+G + V A++ H+G V +K++ + + +E+ +++
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMR-------- 97
Query: 441 DEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGG-------EAYFTLGRLQ 491
D H ++ +Y + E L+++ E L GG + ++
Sbjct: 98 DYQHFNVVEMYKSYLVGEELWVLMEFL-------------QGGALTDIVSQVRLNEEQIA 144
Query: 492 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 551
+ L+AL YLH+ G+IH D+K ++IL+ +K+ D G C Q
Sbjct: 145 TVCEAVLQALAYLHAQGVIHRDIKSDSILLTL--DGRVKLSDFG-FCAQISK------DV 195
Query: 552 SYR----------APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 601
R APEVI Y ++D+WSLG ++ E+ GE P
Sbjct: 196 PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE---P------------- 239
Query: 602 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEES--SLEHHLQFSDAFFI 659
P Y ++ Q + + L++ + S
Sbjct: 240 ---P-----------------------YFSDSPVQAMKRLRDSPPPKLKNSHKVSPV-LR 272
Query: 660 DFVRTLLEINPQRRPTAREALDHPWLQH 687
DF+ +L +PQ R TA+E LDHP+L
Sbjct: 273 DFLERMLVRDPQERATAQELLDHPFLLQ 300
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 68/235 (28%), Positives = 103/235 (43%), Gaps = 44/235 (18%)
Query: 358 HRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII--- 414
H R A RY + LG +F +V + +D T + +K+I
Sbjct: 7 HSSGRENLYFQGT--------FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKA 58
Query: 415 KNDKDFFDQSLDEIKLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQ 473
L E++LLK ++ H +I++L++ +IV EL
Sbjct: 59 SAKNKDTSTILREVELLKKLD-------HPNIMKLFEILEDSSSFYIVGELY-------- 103
Query: 474 KFNQESGGE--------AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 525
+GGE F+ I +Q + Y+H I+H DLKPENIL++S +
Sbjct: 104 -----TGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE 158
Query: 526 R-CEIKIIDLGSSCFQTDNLCLY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 577
+ C+IKIID G S N + + + Y APEV+ G YD+K D+WS G IL
Sbjct: 159 KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVIL 212
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 6e-07
Identities = 12/28 (42%), Positives = 18/28 (64%)
Query: 660 DFVRTLLEINPQRRPTAREALDHPWLQH 687
D +R +L +P R TA + L+HPW+Q
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQK 282
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-33
Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 35/214 (16%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKLVN 435
+ Y V E LG AFS V + TG++ KII K F + E ++ + +
Sbjct: 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 86
Query: 436 KNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFT 486
H +I+RL+D ++V +L+ +GGE +++
Sbjct: 87 -------HPNIVRLHDSIQEESFHYLVFDLV-------------TGGELFEDIVAREFYS 126
Query: 487 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLGSSCFQTDNLC 545
+Q LE++ Y HS GI+H +LKPEN+L+ S + +K+ D G + D+
Sbjct: 127 EADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186
Query: 546 LY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 577
+ + Y +PEV+ PY + +D+W+ G IL
Sbjct: 187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 10/27 (37%), Positives = 18/27 (66%)
Query: 660 DFVRTLLEINPQRRPTAREALDHPWLQ 686
+ ++L +NP++R TA +AL PW+
Sbjct: 263 SLIDSMLTVNPKKRITADQALKVPWIC 289
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 60/328 (18%), Positives = 111/328 (33%), Gaps = 84/328 (25%)
Query: 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKND 438
+ + + LG A+ +V A + T V +KI+ + D + EI + K++N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--- 63
Query: 439 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTL---GRLQVIT 494
H ++++ Y + ++ E SGGE + + +
Sbjct: 64 ----HENVVKFYGHRREGNIQYLFLEYC-------------SGGELFDRIEPDIGMPEPD 106
Query: 495 -----RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN-----L 544
Q + + YLH +GI H D+KPEN+L+ +KI D G + N L
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLL 164
Query: 545 CLYVQSRSYRAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLF--PNDAVVMILARIIG 601
+ Y APE++ + + +D+WS G +L + GE+ + P+D+
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK 224
Query: 602 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDF 661
+ + ++
Sbjct: 225 ------------------------------------KTYLNPWKKIDSAPL-------AL 241
Query: 662 VRTLLEINPQRRPTAREALDHPWLQHPY 689
+ +L NP R T + W P
Sbjct: 242 LHKILVENPSARITIPDIKKDRWYNKPL 269
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-33
Identities = 63/319 (19%), Positives = 111/319 (34%), Gaps = 36/319 (11%)
Query: 390 GSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKLVNKNDPADEH-HI 445
G V A+ TG V ++ I + E+ + KL N H +I
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN-------HPNI 88
Query: 446 LRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYL 504
+ F L++V + + + + G + I + L+AL+Y+
Sbjct: 89 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG----MNELAIAYILQGVLKALDYI 144
Query: 505 HSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR---------- 554
H +G +H +K +ILI ++ + L S+ + +
Sbjct: 145 HHMGYVHRSVKASHILISV--DGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202
Query: 555 APEVI--IGLPYDQKIDLWSLGCILAELWTGEV----LFPNDAVVMILARIIGMLGPIDL 608
+PEV+ YD K D++S+G EL G V + ++ L + L
Sbjct: 203 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262
Query: 609 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEI 668
+ L + T+ + S +H FS F FV L+
Sbjct: 263 IPAEELTMSPSRSVANSGLSD-SLTTSTPRPSNGDSPSHPYHRTFSPH-FHHFVEQCLQR 320
Query: 669 NPQRRPTAREALDHPWLQH 687
NP RP+A L+H + +
Sbjct: 321 NPDARPSASTLLNHSFFKQ 339
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-33
Identities = 62/349 (17%), Positives = 122/349 (34%), Gaps = 107/349 (30%)
Query: 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII-------------------------- 414
+Y + + +G ++ V A + + +K++
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 415 -KNDKDFFDQSLDEIKLLKLVNKNDPADEH-HILRLYDYFYHLE--HLFIVCELLRANLY 470
+ +Q EI +LK ++ H ++++L + HL++V EL+
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLD-------HPNVVKLVEVLDDPNEDHLYMVFELV----- 120
Query: 471 EFQKFNQESGGE--AYFTLGRLQVIT-----RQCLEALEYLHSLGIIHCDLKPENILIKS 523
+ G TL L + ++ +EYLH IIH D+KP N+L+
Sbjct: 121 --------NQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGE 172
Query: 524 YQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPEVIIGL--PYD-QKIDLWSLGCIL 577
IKI D G S + L V + ++ APE + + + +D+W++G L
Sbjct: 173 DGH--IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
Query: 578 AELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQL 637
G+ F ++ ++ + ++I
Sbjct: 231 YCFVFGQCPFMDERIMCLHSKI------------KSQ----------------------- 255
Query: 638 EYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQ 686
P++ + L+ D + +L+ NP+ R E HPW+
Sbjct: 256 ALEFPDQPDIAEDLK-------DLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 76/313 (24%), Positives = 120/313 (38%), Gaps = 63/313 (20%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIK-LLKLVNKNDPADEH 443
+G A+ V + +G + +K I+ D+ Q L ++ +++ D
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS------DCP 81
Query: 444 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 503
+I++ Y + +I EL+ + +F K+ + L IT ++AL +
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDV-IPEEILGKITLATVKALNH 140
Query: 504 LHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL--CLYVQSRSYRAPEVI- 559
L L IIH D+KP NIL+ IK+ D G S D++ R Y APE I
Sbjct: 141 LKENLKIIHRDIKPSNILLDR--SGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 198
Query: 560 ---IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 616
YD + D+WSLG L EL TG FP D
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGR--FPYPK----------WNSVFD--------- 237
Query: 617 IYKYFTKEYDLYYINEETNQLEYIIPEES---SLEHHLQFSDAFFIDFVRTLLEINPQRR 673
QL ++ + S +FS + FI+FV L + +R
Sbjct: 238 -------------------QLTQVVKGDPPQLSNSEEREFSPS-FINFVNLCLTKDESKR 277
Query: 674 PTAREALDHPWLQ 686
P +E L HP++
Sbjct: 278 PKYKELLKHPFIL 290
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 59/226 (26%), Positives = 89/226 (39%), Gaps = 48/226 (21%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----------NDKDFFDQSLDEI 428
Y E LG S V + T + +KII ++ + +L E+
Sbjct: 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 74
Query: 429 KLLKLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE----- 482
+L+ V H +I++L D + F+V +L+ GE
Sbjct: 75 DILRKV------SGHPNIIQLKDTYETNTFFFLVFDLM-------------KKGELFDYL 115
Query: 483 ---AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539
+ + I R LE + LH L I+H DLKPENIL+ IK+ D G SC
Sbjct: 116 TEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD--DMNIKLTDFGFSCQ 173
Query: 540 QTDNLCLY--VQSRSYRAPEVIIGL------PYDQKIDLWSLGCIL 577
L + SY APE+I Y +++D+WS G I+
Sbjct: 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 14/28 (50%), Positives = 17/28 (60%)
Query: 660 DFVRTLLEINPQRRPTAREALDHPWLQH 687
D V L + PQ+R TA EAL HP+ Q
Sbjct: 262 DLVSRFLVVQPQKRYTAEEALAHPFFQQ 289
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 50/224 (22%), Positives = 86/224 (38%), Gaps = 41/224 (18%)
Query: 376 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD------EIK 429
+ + Y + E +G FS V + + TG +KI+ K L E
Sbjct: 19 DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS 78
Query: 430 LLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE------- 482
+ ++ HI+ L + + L++V E + G +
Sbjct: 79 ICHML------KHPHIVELLETYSSDGMLYMVFEFM-------------DGADLCFEIVK 119
Query: 483 -----AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLGS 536
++ RQ LEAL Y H IIH D+KP +L+ S + +K+ G
Sbjct: 120 RADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179
Query: 537 SCFQTDNLCLY---VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 577
+ ++ + V + + APEV+ PY + +D+W G IL
Sbjct: 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 14/27 (51%), Positives = 19/27 (70%)
Query: 660 DFVRTLLEINPQRRPTAREALDHPWLQ 686
D VR +L ++P R T EAL+HPWL+
Sbjct: 265 DLVRRMLMLDPAERITVYEALNHPWLK 291
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 50/211 (23%), Positives = 83/211 (39%), Gaps = 32/211 (15%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 438
+ +Y + E LG F V + + + K +K EI +L +
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR--- 59
Query: 439 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE---------AYFTLG 488
H +IL L++ F +E L ++ E + SG +
Sbjct: 60 ----HRNILHLHESFESMEELVMIFEFI-------------SGLDIFERINTSAFELNER 102
Query: 489 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYV 548
+ Q EAL++LHS I H D++PENI+ ++ + IKII+ G + +
Sbjct: 103 EIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162
Query: 549 Q--SRSYRAPEVIIGLPYDQKIDLWSLGCIL 577
+ Y APEV D+WSLG ++
Sbjct: 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 5e-07
Identities = 15/29 (51%), Positives = 17/29 (58%)
Query: 660 DFVRTLLEINPQRRPTAREALDHPWLQHP 688
DFV LL + R TA EAL HPWL+
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWLKQK 264
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-32
Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII-KNDKDFFDQS--LDEIKLLKLVN 435
Y + E LG AFS V + + G + II D E ++ +L+
Sbjct: 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK 68
Query: 436 KNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFT 486
H +I+RL+D H +++ +L+ +GGE Y++
Sbjct: 69 -------HPNIVRLHDSISEEGHHYLIFDLV-------------TGGELFEDIVAREYYS 108
Query: 487 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR-CEIKIIDLG-SSCFQTDNL 544
+Q LEA+ + H +G++H +LKPEN+L+ S + +K+ D G + + +
Sbjct: 109 EADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168
Query: 545 CLY--VQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 577
+ + Y +PEV+ PY + +DLW+ G IL
Sbjct: 169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 15/28 (53%), Positives = 19/28 (67%)
Query: 660 DFVRTLLEINPQRRPTAREALDHPWLQH 687
D + +L INP +R TA EAL HPW+ H
Sbjct: 246 DLINKMLTINPSKRITAAEALKHPWISH 273
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-32
Identities = 73/313 (23%), Positives = 130/313 (41%), Gaps = 63/313 (20%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 441
+ V E LG ++ V++A TG V +K + + D + + EI +++ D
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-QEIIKEISIMQ------QCD 82
Query: 442 EHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 500
H+++ Y ++ L+IV E A ++ + + ++ E + I + L+
Sbjct: 83 SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE-----IATILQSTLKG 137
Query: 501 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRSYRAPE 557
LEYLH + IH D+K NIL+ + K+ D G + TD + + + + APE
Sbjct: 138 LEYLHFMRKIHRDIKAGNILLNT--EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPE 195
Query: 558 VIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 617
VI + Y+ D+WSLG E+ G+ P P
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGK---P----------------P------------ 224
Query: 618 YKYFTKEYDLYYINEETNQLEYIIPEES--SLEHHLQFSDAFFIDFVRTLLEINPQRRPT 675
Y + + ++IP + +SD F DFV+ L +P++R T
Sbjct: 225 -----------YADIHPMRAIFMIPTNPPPTFRKPELWSDN-FTDFVKQCLVKSPEQRAT 272
Query: 676 AREALDHPWLQHP 688
A + L HP+++
Sbjct: 273 ATQLLQHPFVRSA 285
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 40/216 (18%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-------EIKLLKLV 434
Y + E LGS F+ V + ++ TG++ K IK + + E+ +L+ V
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 435 NKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYF 485
H +++ L+D + + + ++ EL+ SGGE
Sbjct: 73 L-------HHNVITLHDVYENRTDVVLILELV-------------SGGELFDFLAQKESL 112
Query: 486 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI--KSYQRCEIKIIDLGSSCFQTDN 543
+ +Q L+ + YLH+ I H DLKPENI++ K+ IK+ID G + D
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 544 LCLYVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCIL 577
+ + + APE++ P + D+WS+G I
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 7e-07
Identities = 13/27 (48%), Positives = 18/27 (66%)
Query: 660 DFVRTLLEINPQRRPTAREALDHPWLQ 686
DF+R LL ++R T +EAL HPW+
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWIT 277
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 56/216 (25%), Positives = 90/216 (41%), Gaps = 40/216 (18%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-------EIKLLKLV 434
Y + E LGS F+ V + + TG + K IK + + E+ +L+ +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 435 NKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYF 485
H +I+ L+D F + + ++ EL+ SGGE
Sbjct: 66 R-------HPNIITLHDIFENKTDVVLILELV-------------SGGELFDFLAEKESL 105
Query: 486 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI--KSYQRCEIKIIDLGSSCFQTDN 543
T +Q L+ + YLHS I H DLKPENI++ K+ IK+ID G +
Sbjct: 106 TEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG 165
Query: 544 LCLYVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCIL 577
+ + APE++ P + D+WS+G I
Sbjct: 166 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 6e-07
Identities = 12/27 (44%), Positives = 20/27 (74%)
Query: 660 DFVRTLLEINPQRRPTAREALDHPWLQ 686
DF+R LL +P+RR T ++L+H W++
Sbjct: 244 DFIRRLLVKDPKRRMTIAQSLEHSWIK 270
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-31
Identities = 50/215 (23%), Positives = 90/215 (41%), Gaps = 39/215 (18%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLV 434
+ Y + E LG+ AF V + + TG + K + +DK+ + EI+ + ++
Sbjct: 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EIQTMSVL 211
Query: 435 NKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE---------AY 484
H ++ L+D F + ++ E + SGGE
Sbjct: 212 R-------HPTLVNLHDAFEDDNEMVMIYEFM-------------SGGELFEKVADEHNK 251
Query: 485 FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF--QTD 542
+ RQ + L ++H +H DLKPENI+ + + E+K+ID G +
Sbjct: 252 MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311
Query: 543 NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCIL 577
++ + + + APEV G P D+WS+G +
Sbjct: 312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 16/47 (34%), Positives = 21/47 (44%), Gaps = 7/47 (14%)
Query: 647 LEHHLQFSDAFF-------IDFVRTLLEINPQRRPTAREALDHPWLQ 686
D+ F DF+R LL +P R T +AL+HPWL
Sbjct: 369 KSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 415
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 6e-31
Identities = 55/224 (24%), Positives = 91/224 (40%), Gaps = 45/224 (20%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---------DFFDQSLDEIK 429
+Y + +G S V + TG + +KI++ + + + E
Sbjct: 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETH 151
Query: 430 LLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE------- 482
+L+ V A HI+ L D + +F+V +L+ GE
Sbjct: 152 ILRQV-----AGHPHIITLIDSYESSSFMFLVFDLM-------------RKGELFDYLTE 193
Query: 483 -AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 541
+ + I R LEA+ +LH+ I+H DLKPENIL+ +I++ D G SC
Sbjct: 194 KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDD--NMQIRLSDFGFSCHLE 251
Query: 542 DNLCLY--VQSRSYRAPEVIIGL------PYDQKIDLWSLGCIL 577
L + Y APE++ Y +++DLW+ G IL
Sbjct: 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 11/27 (40%), Positives = 19/27 (70%)
Query: 660 DFVRTLLEINPQRRPTAREALDHPWLQ 686
D + LL+++P+ R TA +AL HP+ +
Sbjct: 338 DLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-31
Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 38/218 (17%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD-------EIKLL 431
+ Y E LGS F+ V + ++ TG+ K IK + + E+ +L
Sbjct: 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 432 KLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------A 483
K + +++ L++ + + + ++ EL+ +GGE
Sbjct: 69 KEI------QHPNVITLHEVYENKTDVILILELV-------------AGGELFDFLAEKE 109
Query: 484 YFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI--KSYQRCEIKIIDLGSSCFQT 541
T +Q L + YLHSL I H DLKPENI++ ++ + IKIID G +
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 542 DNLCLYVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCIL 577
+ + APE++ P + D+WS+G I
Sbjct: 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 9e-07
Identities = 12/27 (44%), Positives = 21/27 (77%)
Query: 660 DFVRTLLEINPQRRPTAREALDHPWLQ 686
DF+R LL +P++R T +++L HPW++
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 8e-31
Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 33/209 (15%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL-DEIKLLKLVNKNDPA 440
Y + E LGS AF V + + TG K I ++ +EI ++ ++
Sbjct: 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH----- 106
Query: 441 DEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE---------AYFTLGRL 490
H ++ L+D F + ++ E L SGGE + +
Sbjct: 107 --HPKLINLHDAFEDKYEMVLILEFL-------------SGGELFDRIAAEDYKMSEAEV 151
Query: 491 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ- 549
RQ E L+++H I+H D+KPENI+ ++ + +KIID G + + + V
Sbjct: 152 INYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT 211
Query: 550 -SRSYRAPEVIIGLPYDQKIDLWSLGCIL 577
+ + APE++ P D+W++G +
Sbjct: 212 ATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 13/28 (46%), Positives = 21/28 (75%)
Query: 660 DFVRTLLEINPQRRPTAREALDHPWLQH 687
DF++ LL+ P++R T +AL+HPWL+
Sbjct: 283 DFIKNLLQKEPRKRLTVHDALEHPWLKG 310
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-31
Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 40/216 (18%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-------NDKDFFDQSLDEIKLLKLV 434
Y + E LGS F+ V + ++ TG++ K IK ++ E+ +L+ V
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 435 NKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYF 485
H +I+ L+D + + + ++ EL+ SGGE
Sbjct: 73 L-------HPNIITLHDVYENRTDVVLILELV-------------SGGELFDFLAQKESL 112
Query: 486 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILI--KSYQRCEIKIIDLGSSCFQTDN 543
+ +Q L+ + YLH+ I H DLKPENI++ K+ IK+ID G + D
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 544 LCLYVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCIL 577
+ + + APE++ P + D+WS+G I
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 13/27 (48%), Positives = 18/27 (66%)
Query: 660 DFVRTLLEINPQRRPTAREALDHPWLQ 686
DF+R LL ++R T +EAL HPW+
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWIT 277
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 65/316 (20%), Positives = 120/316 (37%), Gaps = 67/316 (21%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII----KNDKDFFDQSLDEIKLLKLVNKN 437
+ +G +F V+ A+D+ V +K + K + + + E++ L+
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ----- 109
Query: 438 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 497
+ ++ + ++V E + + + +++ E + +T
Sbjct: 110 -KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE-----IAAVTHGA 163
Query: 498 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPE 557
L+ L YLHS +IH D+K NIL+ + +K+ D GS+ +V + + APE
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLS--EPGLVKLGDFGSAS-IMAPANSFVGTPYWMAPE 220
Query: 558 VIIGL---PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614
VI+ + YD K+D+WSLG EL + P P
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERK---P----------------P--------- 252
Query: 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEES--SLEHHLQFSDAFFIDFVRTLLEINPQR 672
N Y I + +L+ +S+ F +FV + L+ PQ
Sbjct: 253 --------------LFNMNAMSALYHIAQNESPALQSG-HWSEY-FRNFVDSCLQKIPQD 296
Query: 673 RPTAREALDHPWLQHP 688
RPT+ L H ++
Sbjct: 297 RPTSEVLLKHRFVLRE 312
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 55/241 (22%), Positives = 96/241 (39%), Gaps = 41/241 (17%)
Query: 358 HRKNRTGFEENKDLPIILNTV--IAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKII 414
H + + + + ++ Y +T + LG F+ V Q TG + K +
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFL 62
Query: 415 KNDKDFFDQSLD---EIKLLKLVNKNDPADEHH--ILRLYDYFYHLEHLFIVCELLRANL 469
K + D + EI +L+L ++ L++ + + + ++ E
Sbjct: 63 KKRRRGQDCRAEILHEIAVLELAK-------SCPRVINLHEVYENTSEIILILEYA---- 111
Query: 470 YEFQKFNQESGGE----------AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENI 519
+GGE + + + +Q LE + YLH I+H DLKP+NI
Sbjct: 112 ---------AGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNI 162
Query: 520 LIKS-YQRCEIKIIDLGSSCFQTDNLCLYVQ--SRSYRAPEVIIGLPYDQKIDLWSLGCI 576
L+ S Y +IKI+D G S L + Y APE++ P D+W++G I
Sbjct: 163 LLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGII 222
Query: 577 L 577
Sbjct: 223 A 223
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 15/27 (55%), Positives = 20/27 (74%)
Query: 660 DFVRTLLEINPQRRPTAREALDHPWLQ 686
DF+++LL NP++RPTA L H WLQ
Sbjct: 266 DFIQSLLVKNPEKRPTAEICLSHSWLQ 292
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 39/208 (18%)
Query: 386 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKNDPAD 441
TE LG F +V + ++ TG+ + KIIK DK+ +EI ++ ++
Sbjct: 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEV---KNEISVMNQLD------ 144
Query: 442 EH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE---------AYFTLGRLQ 491
H ++++LYD F + +V E + GGE T
Sbjct: 145 -HANLIQLYDAFESKNDIVLVMEYV-------------DGGELFDRIIDESYNLTELDTI 190
Query: 492 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ-- 549
+ +Q E + ++H + I+H DLKPENIL + +IKIID G + L V
Sbjct: 191 LFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFG 250
Query: 550 SRSYRAPEVIIGLPYDQKIDLWSLGCIL 577
+ + APEV+ D+WS+G I
Sbjct: 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 12/27 (44%), Positives = 15/27 (55%)
Query: 660 DFVRTLLEINPQRRPTAREALDHPWLQ 686
+F+ LL R +A EAL HPWL
Sbjct: 321 EFISKLLIKEKSWRISASEALKHPWLS 347
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 385 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEH- 443
V E +G AF V +A+ DV +K I+++ + + E++ L VN H
Sbjct: 12 VEEVVGRGAFGVVCKAK--WRAKDVAIKQIESESER-KAFIVELRQLSRVN-------HP 61
Query: 444 HILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 502
+I++LY L + +V E +LY + Y+T QC + +
Sbjct: 62 NIVKLYGA--CLNPVCLVMEYAEGGSLY---NVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 503 YLHSL---GIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVI 559
YLHS+ +IH DLKP N+L+ + +KI D G++C ++ S ++ APEV
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTV-LKICDFGTACDIQTHMTNNKGSAAWMAPEVF 175
Query: 560 IGLPYDQKIDLWSLGCILAELWTGEVLFPN 589
G Y +K D++S G IL E+ T F
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDE 205
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 79/328 (24%), Positives = 118/328 (35%), Gaps = 92/328 (28%)
Query: 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII--KNDKDFFDQSLDEIKLLKLVNKN 437
+ E +G +F +VF+ D T V +KII + +D + EI +L
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC--- 77
Query: 438 DPADEHHILRLYDYFYHLEHLFIVCELLRA----NLYEFQKFNQESGGEAYFTLGRLQVI 493
D ++ + Y + L+I+ E L +L E + E + I
Sbjct: 78 ---DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD-----ETQ-----IATI 124
Query: 494 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY 553
R+ L+ L+YLHS IH D+K N+L+ E+K+ D G + TD
Sbjct: 125 LREILKGLDYLHSEKKIHRDIKAANVLLSE--HGEVKLADFGVAGQLTDTQ-------IK 175
Query: 554 R----------APEVIIGLPYDQKIDLWSLGCILAELWTGE----VLFPNDAVVMILARI 599
R APEVI YD K D+WSLG EL GE L P + +I
Sbjct: 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN- 234
Query: 600 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFI 659
P LE ++K + F+
Sbjct: 235 ----NPPTLE---------GNYSKP----------------------------LKE--FV 251
Query: 660 DFVRTLLEINPQRRPTAREALDHPWLQH 687
+ L P RPTA+E L H ++
Sbjct: 252 EAC---LNKEPSFRPTAKELLKHKFILR 276
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 48/223 (21%), Positives = 87/223 (39%), Gaps = 34/223 (15%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKN-DKDFFDQSLDEIKLLKLVNKNDPADEH-H 444
E LG F + + TG + +K + D++ L E+K+++ + H +
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE-------HPN 68
Query: 445 ILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 503
+L+ Y + L + E + L K ++ + + + + Y
Sbjct: 69 VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM-----DSQYPWSQRVSFAKDIASGMAY 123
Query: 504 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR--------- 554
LHS+ IIH DL N L++ + + D G + D RS +
Sbjct: 124 LHSMNIIHRDLNSHNCLVRENKNV--VVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 555 --------APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 589
APE+I G YD+K+D++S G +L E+ P+
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-26
Identities = 58/237 (24%), Positives = 101/237 (42%), Gaps = 52/237 (21%)
Query: 377 TVIAGRYYVTEYLGSAAFSKVFQAQDLH-TGVDVCLKIIKN--DKDFFDQSLDEIKLLKL 433
++AG+Y V + ++ A D + G V LK + + D + ++ E + L
Sbjct: 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAE 135
Query: 434 VNKNDPADEH-HILRLYDYFYHLEH-----LFIVCELLRANLYEFQKFNQESGGEAYFTL 487
V H I++++++ H + +IV E + GG+ +L
Sbjct: 136 VV-------HPSIVQIFNFVEHTDRHGDPVGYIVMEYV--------------GGQ---SL 171
Query: 488 -----GRLQV-----ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-- 535
+L V + L AL YLHS+G+++ DLKPENI++ Q +K+IDLG
Sbjct: 172 KRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ---LKLIDLGAV 228
Query: 536 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV 592
S L + ++APE++ P D++++G LA L V
Sbjct: 229 SRINSFGYL---YGTPGFQAPEIVRTGPTVAT-DIYTVGRTLAALTLDLPTRNGRYV 281
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 42/222 (18%), Positives = 78/222 (35%), Gaps = 31/222 (13%)
Query: 385 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD--------EIKLLKLVNK 436
+ +G F V + + + V +K + + + E+ ++ +N
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN- 81
Query: 437 NDPADEH-HILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVIT 494
H +I++LY +V E + +LY +
Sbjct: 82 ------HPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHP-----IKWSVKLRLM 128
Query: 495 RQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCE---IKIIDLGSSCFQTDNLCLYVQ 549
+EY+ + I+H DL+ NI ++S K+ D G S ++ +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLG 188
Query: 550 SRSYRAPEVIIG--LPYDQKIDLWSLGCILAELWTGEVLFPN 589
+ + APE I Y +K D +S IL + TGE F
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 24/213 (11%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEH 443
E +G+ +F V +A+ G DV +KI+ + ++ L E+ ++K + H
Sbjct: 43 EKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR-------H 93
Query: 444 -HILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 501
+I+ +L IV E L R +LY + +SG R + + +
Sbjct: 94 PNIVLFMGAVTQPPNLSIVTEYLSRGSLY---RLLHKSGAREQLDERRRLSMAYDVAKGM 150
Query: 502 EYLHSLG--IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR-SYR--AP 556
YLH+ I+H +LK N+L+ K+ D G S + + + AP
Sbjct: 151 NYLHNRNPPIVHRNLKSPNLLVDKKYTV--KVCDFGLSRLKASTFLSSKSAAGTPEWMAP 208
Query: 557 EVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 589
EV+ P ++K D++S G IL EL T + + N
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 56/243 (23%), Positives = 89/243 (36%), Gaps = 53/243 (21%)
Query: 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDF---FDQSLDEIKLLKL 433
G Y + +G V++A+D V LK++ +D F + L
Sbjct: 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-- 91
Query: 434 VNKNDPADEHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLG 488
E H++ ++D+ L++ L L A L G
Sbjct: 92 -------QEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ---------------G 129
Query: 489 RLQV-----ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-------S 536
L I RQ AL+ H+ G H D+KPENIL+ + ++D G
Sbjct: 130 PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF--AYLVDFGIASATTDE 187
Query: 537 SCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMIL 596
Q N V + Y APE + D+++L C+L E TG + D + ++
Sbjct: 188 KLTQLGNT---VGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG 244
Query: 597 ARI 599
A I
Sbjct: 245 AHI 247
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 32/223 (14%)
Query: 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 439
AG + + E +G+ + +V++ + + TG +K++ D ++ EI +LK
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLK-----KY 77
Query: 440 ADEHHILRLYDYFYHL------EHLFIVCELLRA----NLYEFQKFNQESGGEAYFTLGR 489
+ +I Y F + L++V E A +L + K N E +
Sbjct: 78 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK--EEW----- 130
Query: 490 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL--- 546
+ I R+ L L +LH +IH D+K +N+L+ + E+K++D G S +
Sbjct: 131 IAYICREILRGLSHLHQHKVIHRDIKGQNVLLT--ENAEVKLVDFGVSAQLDRTVGRRNT 188
Query: 547 YVQSRSYRAPEVI-----IGLPYDQKIDLWSLGCILAELWTGE 584
++ + + APEVI YD K DLWSLG E+ G
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 9/36 (25%), Positives = 19/36 (52%), Gaps = 1/36 (2%)
Query: 652 QFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687
++S F F+ + L N +RP + + HP+++
Sbjct: 258 KWSKKF-QSFIESCLVKNHSQRPATEQLMKHPFIRD 292
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 59/223 (26%), Positives = 82/223 (36%), Gaps = 39/223 (17%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-----FFDQSLDEIKLLKLVNKNDPAD 441
E +G F KV++A G +V +K ++D D + E KL ++
Sbjct: 13 EIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK------ 64
Query: 442 EH-HILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 499
H +I+ L +L +V E L + L Q
Sbjct: 65 -HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-------IPPDILVNWAVQIAR 116
Query: 500 ALEYLHSLG---IIHCDLKPENILI------KSYQRCEIKIIDLGSSCFQTDNLCLYVQS 550
+ YLH IIH DLK NILI +KI D G + S
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT---TKMS 173
Query: 551 R--SYR--APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 589
+Y APEVI + + D+WS G +L EL TGEV F
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 54/215 (25%), Positives = 88/215 (40%), Gaps = 44/215 (20%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG +FS V A++L T + +KI++ ++ E ++ ++ H
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD--------H 89
Query: 445 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC----- 497
++LY F E L+ GE + ++ C
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYA-------------KNGELLKYIRKIGSFDETCTRFYT 136
Query: 498 ---LEALEYLHSLGIIHCDLKPENILIKSYQRCEI------KIIDLGSSCFQTDNLCLYV 548
+ ALEYLH GIIH DLKPENIL+ +I K++ S + ++
Sbjct: 137 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196
Query: 549 QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG 583
Q Y +PE++ + DLW+LGCI+ +L G
Sbjct: 197 Q---YVSPELLTEKSACKSSDLWALGCIIYQLVAG 228
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 76/329 (23%), Positives = 131/329 (39%), Gaps = 84/329 (25%)
Query: 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKND 438
+ + LG AF KV++A++ TG K+I+ ++ + + EI++L +
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD--- 74
Query: 439 PADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQ 496
H +I++L +YH L+I+ E + E +QV+ RQ
Sbjct: 75 ----HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-----IQVVCRQ 125
Query: 497 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR-- 554
LEAL +LHS IIH DLK N+L+ +I++ D G S + R
Sbjct: 126 MLEALNFLHSKRIIHRDLKAGNVLMTL--EGDIRLADFGVSAKNLK-------TLQKRDS 176
Query: 555 --------APEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 601
APEV++ PYD K A++W+
Sbjct: 177 FIGTPYWMAPEVVMCETMKDTPYDYK----------ADIWS------------------- 207
Query: 602 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEES--SLEHHLQFSDAFFI 659
LG +EM + + + ++ I + +L ++S F
Sbjct: 208 -LGITLIEMA------------QIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEF-R 253
Query: 660 DFVRTLLEINPQRRPTAREALDHPWLQHP 688
DF++ L+ NP+ RP+A + L+HP++
Sbjct: 254 DFLKIALDKNPETRPSAAQLLEHPFVSSI 282
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 55/236 (23%), Positives = 101/236 (42%), Gaps = 39/236 (16%)
Query: 377 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLL- 431
+I RY + + LG S V+ A+D + V +K I ++ + E+
Sbjct: 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSS 66
Query: 432 KLVNKNDPADEHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFT 486
+L + +I+ + D + ++V E L + +
Sbjct: 67 QL---SHQ----NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES----------HGPLS 109
Query: 487 LGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-------SSCF 539
+ T Q L+ +++ H + I+H D+KP+NILI S + +KI D G +S
Sbjct: 110 VDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETSLT 167
Query: 540 QTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI 595
QT+++ + + Y +PE G D+ D++S+G +L E+ GE F + V I
Sbjct: 168 QTNHV---LGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI 220
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 49/241 (20%), Positives = 91/241 (37%), Gaps = 46/241 (19%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD---EIKLLKLVNKNDPADEH 443
E +G F +V+ + H +V +++I ++D DQ E+ +
Sbjct: 39 ELIGKGRFGQVYHGR-WHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQT--------R 87
Query: 444 H--ILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 500
H ++ HL I+ L LY + + + + + I ++ ++
Sbjct: 88 HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR-----DAKIVLDVNKTRQIAQEIVKG 142
Query: 501 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR--------S 552
+ YLH+ GI+H DLK +N+ + + + I D G + +
Sbjct: 143 MGYLHAKGILHKDLKSKNVFYDNGK---VVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199
Query: 553 YRAPEVI---------IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGML 603
+ APE+I LP+ + D+++LG I EL E F II +
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT----QPAEAIIWQM 255
Query: 604 G 604
G
Sbjct: 256 G 256
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 6e-23
Identities = 55/217 (25%), Positives = 90/217 (41%), Gaps = 33/217 (15%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVNKNDPADEH 443
+ +GS +F V++ H DV +K++ +E+ +L+
Sbjct: 30 QRIGSGSFGTVYKG-KWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT--------R 78
Query: 444 H--ILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 500
H IL Y L IV + ++LY E F + +L I RQ
Sbjct: 79 HVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLH-----ASETKFEMKKLIDIARQTARG 132
Query: 501 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-----YRA 555
++YLH+ IIH DLK NI + KI D G + ++ + + + A
Sbjct: 133 MDYLHAKSIIHRDLKSNNIFLHEDNTV--KIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 556 PEVIIG---LPYDQKIDLWSLGCILAELWTGEVLFPN 589
PEVI PY + D+++ G +L EL TG++ + N
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 65/261 (24%), Positives = 104/261 (39%), Gaps = 72/261 (27%)
Query: 376 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDF---FDQ----- 423
+ ++ RY + E LG S+V A+DL DV +K+++ D F F +
Sbjct: 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNA 66
Query: 424 -SLDEIKLLKLVNKNDPADEHHILRLYDY----FYHLEHLFIVCEL-----LRANLYEFQ 473
+L N P I+ +YD +IV E LR ++
Sbjct: 67 AAL-----------NHP----AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE- 110
Query: 474 KFNQESGGEAYFTLGRLQV-----ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 528
G + + +AL + H GIIH D+KP NI+I +
Sbjct: 111 --------------GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA-- 154
Query: 529 IKIIDLG---------SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAE 579
+K++D G +S QT + + + Y +PE G D + D++SLGC+L E
Sbjct: 155 VKVMDFGIARAIADSGNSVTQTAAV---IGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 211
Query: 580 LWTGEVLFPND-AVVMILARI 599
+ TGE F D V + +
Sbjct: 212 VLTGEPPFTGDSPVSVAYQHV 232
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 50/223 (22%), Positives = 87/223 (39%), Gaps = 28/223 (12%)
Query: 376 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVN 435
N V+ Y V +G +F +F+ +L V +K D Q DE + KL+
Sbjct: 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-PQLRDEYRTYKLLA 63
Query: 436 KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 495
I +Y + H +V +LL +L + F++ + + +
Sbjct: 64 GC-----TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK-----FSVKTVAMAAK 113
Query: 496 QCLEALEYLHSLGIIHCDLKPENILI---KSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 552
Q L ++ +H +++ D+KP+N LI S I ++D G F D + Q
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT--KQHIP 171
Query: 553 YRAPEVIIG----------LPYDQ--KIDLWSLGCILAELWTG 583
YR + + G L +Q + DL +LG + G
Sbjct: 172 YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 214
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 97.4 bits (242), Expect = 2e-21
Identities = 46/220 (20%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKN 437
+ ++ + +GS +F +++ ++ T +V +K+ Q L E K+ +++
Sbjct: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQLLYESKIYRILQG- 61
Query: 438 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYE-FQKFNQESGGEAYFTLGRLQVITRQ 496
I + + ++ +V +LL +L + F +++ +L + ++ Q
Sbjct: 62 ----GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK------LSLKTVLMLADQ 111
Query: 497 CLEALEYLHSLGIIHCDLKPENILIKSYQRC-EIKIIDLGSSCFQTDNLCLYVQSRSYRA 555
+ +E++HS +H D+KP+N L+ +R ++ IID G + D Q YR
Sbjct: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH--QHIPYRE 169
Query: 556 PEVIIG----------LPYDQ--KIDLWSLGCILAELWTG 583
+ + G L +Q + DL SLG +L G
Sbjct: 170 NKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRG 209
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 47/234 (20%), Positives = 87/234 (37%), Gaps = 50/234 (21%)
Query: 376 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVN 435
++ + V + +G F ++ ++L+T V +K+ Q E + K +
Sbjct: 4 VLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-PQLHLEYRFYKQLG 62
Query: 436 KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 495
I ++Y + ++ +V ELL +L + + F+L + +I
Sbjct: 63 SG-----DGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRT-----FSLKTVLMIAI 112
Query: 496 QCLEALEYLHSLGIIHCDLKPENILI---KSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 552
Q + +EY+HS +I+ D+KPEN LI + + I IID ++
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL-------------AKE 159
Query: 553 YRAPEVIIGLPYDQKI-----------------------DLWSLGCILAELWTG 583
Y PE +PY + DL +LG + G
Sbjct: 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRG 213
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 59/236 (25%), Positives = 103/236 (43%), Gaps = 57/236 (24%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG+ +F +V + +G +KI+ + +L+E ++L+ VN
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN--------F 100
Query: 445 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR------- 495
+++L F +L++V E + +GGE + L R+ +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYV-------------AGGEMFSHLRRIGRFSEPHARFYA 147
Query: 496 -QCLEALEYLHSLGIIHCDLKPENILIKS--YQRCEIKIIDLGSSCFQTDNLCLYVQSRS 552
Q + EYLHSL +I+ DLKPEN+LI Y I++ D G V+ R+
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY----IQVTDFG--------FAKRVKGRT 195
Query: 553 --------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 600
APE+I+ Y++ +D W+LG ++ E+ G F D + I +I+
Sbjct: 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 8e-21
Identities = 32/226 (14%), Positives = 62/226 (27%), Gaps = 45/226 (19%)
Query: 377 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLK 432
+ GRY + + G + +QA D V L + D ++L L
Sbjct: 27 RIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLS 86
Query: 433 LVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQ 491
++ P + R+ D + +V E +R +L E ++ +
Sbjct: 87 RID--KP----GVARVLDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGAIR--- 133
Query: 492 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 551
+ A + H G+ P + + + +
Sbjct: 134 -AMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD--VVLAYPA---------------- 174
Query: 552 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILA 597
+ + D+ +G L L P V LA
Sbjct: 175 -TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA 212
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 52/219 (23%), Positives = 90/219 (41%), Gaps = 26/219 (11%)
Query: 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKN 437
+ RY + +GS +F ++ D+ G +V +K+ Q E K+ K++
Sbjct: 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-QLHIESKIYKMMQGG 64
Query: 438 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 497
I + ++ +V ELL +L + F F+L + ++ Q
Sbjct: 65 -----VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK-----FSLKTVLLLADQM 114
Query: 498 LEALEYLHSLGIIHCDLKPENILIKSYQRC-EIKIIDLGSSCFQTDNLCLYVQSRSYRAP 556
+ +EY+HS IH D+KP+N L+ ++ + IID G + D Q YR
Sbjct: 115 ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH--QHIPYREN 172
Query: 557 EVIIG----------LPYDQ--KIDLWSLGCILAELWTG 583
+ + G L +Q + DL SLG +L G
Sbjct: 173 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLG 211
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 38/219 (17%), Positives = 72/219 (32%), Gaps = 33/219 (15%)
Query: 385 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLD---EIKLLKLVNKNDPAD 441
L ++++ G D+ +K++K +S D E L++ +
Sbjct: 14 FLTKLNENHSGELWKG--RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS------ 65
Query: 442 EH-HILRLYDYFYH--LEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQC 497
H ++L + H ++ + +LY G +
Sbjct: 66 -HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH----EGTNFVVDQSQAVKFALDM 120
Query: 498 LEALEYLHSLG--IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR- 554
+ +LH+L I L +++I +I +Y +
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDEDMTA--RISMADVKFSFQSPGRMY----APAW 174
Query: 555 -APEVIIGLPYD---QKIDLWSLGCILAELWTGEVLFPN 589
APE + P D + D+WS +L EL T EV F +
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 42/310 (13%), Positives = 88/310 (28%), Gaps = 65/310 (20%)
Query: 359 RKNRTGFEENKDLP--IILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN 416
+ ++ P +L+ + ++ + + +GS F ++ A + ++K
Sbjct: 13 LGTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKV 72
Query: 417 DKDFFDQSLDEIKLLKLVNKNDPADEHH---------ILRLYDYFYHL----EHLFIVCE 463
+ E+K + V K D + I Y + F+V E
Sbjct: 73 EYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVME 132
Query: 464 LLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 523
L +L + N F + + + L+ LEY+H +H D+K N+L+
Sbjct: 133 RLGIDLQKISGQNGT------FKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGY 186
Query: 524 YQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKI--------------- 568
++ + D G S Y + +
Sbjct: 187 KNPDQVYLADYGL-------------SYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHK 233
Query: 569 --------DLWSLGCILAEL------WTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614
D+ LG + W + P + + +
Sbjct: 234 GVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGS 293
Query: 615 --QEIYKYFT 622
EI ++
Sbjct: 294 SCCEIAQFLV 303
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 88.7 bits (221), Expect = 2e-19
Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 57/219 (26%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG+ +F +V + H G +K++K + + + DE +L +V H
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT--------H 65
Query: 445 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV----ITR--- 495
I+R++ F + +F++ + + GGE + L + Q + +
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYI-------------EGGELFSLLRKSQRFPNPVAKFYA 112
Query: 496 -QCLEALEYLHSLGIIHCDLKPENILIKS--YQRCEIKIIDLGSSCFQTDNLCLYVQSRS 552
+ ALEYLHS II+ DLKPENIL+ + IKI D G YV +
Sbjct: 113 AEVCLALEYLHSKDIIYRDLKPENILLDKNGH----IKITDFG--------FAKYVPDVT 160
Query: 553 --------YRAPEVIIGLPYDQKIDLWSLGCILAELWTG 583
Y APEV+ PY++ ID WS G ++ E+ G
Sbjct: 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 45/228 (19%), Positives = 85/228 (37%), Gaps = 49/228 (21%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEH- 443
E +G + +V++ G +V +KI ++K +F ++ E+ ++ H
Sbjct: 14 ECVGKGRYGEVWRGS--WQGENVAVKIFSSRDEKSWFRET--ELYNTVMLR-------HE 62
Query: 444 HILRLY----DYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
+IL + L+++ +LY++ + I
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-------LDTVSCLRIVLSIA 115
Query: 499 EALEYLHSL--------GIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQS 550
L +LH I H DLK +NIL+K +C I DLG + + +
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQC--CIADLGLAVMHSQSTNQLDVG 173
Query: 551 RS-------YRAPEVIIGLP------YDQKIDLWSLGCILAELWTGEV 585
+ Y APEV+ +++D+W+ G +L E+ V
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMV 221
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 5e-19
Identities = 57/215 (26%), Positives = 89/215 (41%), Gaps = 31/215 (14%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG F +V Q TG K ++ + +L+E ++L+ VN
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN--------S 243
Query: 445 --ILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 501
++ L + + L +V L+ +L KF+ G+A F R + L
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDL----KFHIYHMGQAGFPEARAVFYAAEICCGL 299
Query: 502 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------YRA 555
E LH I++ DLKPENIL+ + I+I DLG + + + Y A
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEG----QTIKGRVGTVGYMA 353
Query: 556 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 590
PEV+ Y D W+LGC+L E+ G+ F
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 8e-19
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 42/214 (19%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
+G F +V+ + TG +K + K +L+E +L LV+ D
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-----C 251
Query: 445 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR------- 495
I+ + F+ + L + +L+ +GG+ ++ L + V +
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLM-------------NGGDLHYHLSQHGVFSEADMRFYA 298
Query: 496 -QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF----QTDNLCLYVQS 550
+ + LE++H+ +++ DLKP NIL+ + ++I DLG +C +
Sbjct: 299 AEIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKKKPHASVGTHG- 355
Query: 551 RSYRAPEVII-GLPYDQKIDLWSLGCILAELWTG 583
Y APEV+ G+ YD D +SLGC+L +L G
Sbjct: 356 --YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 62/321 (19%), Positives = 107/321 (33%), Gaps = 88/321 (27%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
+G +F KV Q T +K + ++ E+++++ + H
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE--------H 74
Query: 445 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR------- 495
++ L+ F E +F+V +LL GG+ + L +
Sbjct: 75 PFLVNLWYSFQDEEDMFMVVDLL-------------LGGDLRYHLQQNVHFKEETVKLFI 121
Query: 496 -QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-- 552
+ + AL+YL + IIH D+KP+NIL+ + I D + + + +
Sbjct: 122 CELVMALDYLQNQRIIHRDMKPDNILLDE--HGHVHITDFNIAAMLPRETQIT--TMAGT 177
Query: 553 --YRAPEVI---IGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 607
Y APE+ G Y +D WSLG EL G P
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRG-------------------RRPYH 218
Query: 608 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLE 667
+ +EI F P S E + ++ LLE
Sbjct: 219 IRSSTSSKEIVHTFETT-------------VVTYPSAWSQE---------MVSLLKKLLE 256
Query: 668 INPQRR-PTAREALDHPWLQH 687
NP +R + + P++
Sbjct: 257 PNPDQRFSQLSDVQNFPYMND 277
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 50/224 (22%), Positives = 87/224 (38%), Gaps = 49/224 (21%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
+G +++KV + T +K++K + + D E + + + H
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN-------H 69
Query: 445 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRLQVIT 494
++ L+ F LF V E + +GG+ + +
Sbjct: 70 PFLVGLHSCFQTESRLFFVIEYV-------------NGGDLMFHMQRQRKLPEEHARFYS 116
Query: 495 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLCLYVQSRS 552
+ AL YLH GII+ DLK +N+L+ S E IK+ D G + L + +
Sbjct: 117 AEISLALNYLHERGIIYRDLKLDNVLLDS----EGHIKLTDYGMC---KEGLRPGDTTST 169
Query: 553 ------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 590
Y APE++ G Y +D W+LG ++ E+ G F
Sbjct: 170 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 213
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 49/245 (20%), Positives = 89/245 (36%), Gaps = 45/245 (18%)
Query: 370 DLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIK 429
LP+++ IA + + + +G + +V+ + G V +K+ ++ EI
Sbjct: 26 GLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGK--WRGEKVAVKVFFTTEEASWFRETEIY 83
Query: 430 LLKLVNKNDPADEH-HILRLY----DYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEA 483
L+ H +IL L+++ + +LY++ K
Sbjct: 84 QTVLMR-------HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT------ 130
Query: 484 YFTLGRLQVITRQCLEALEYLHSL--------GIIHCDLKPENILIKSYQRCEIKIIDLG 535
+ + + L +LH+ I H DLK +NIL+K C I DLG
Sbjct: 131 -LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC--CIADLG 187
Query: 536 SSC-FQTDNLCLYVQSRS------YRAPEVIIG------LPYDQKIDLWSLGCILAELWT 582
+ F +D + + + Y PEV+ D++S G IL E+
Sbjct: 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR 247
Query: 583 GEVLF 587
V
Sbjct: 248 RCVSG 252
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 59/229 (25%), Positives = 94/229 (41%), Gaps = 60/229 (26%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG F KV ++ TG +KI++ + KD ++ E ++L+ H
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR--------H 64
Query: 445 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR------- 495
+ L F + L V E +GGE +F L R +V T
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYA-------------NGGELFFHLSRERVFTEERARFYG 111
Query: 496 -QCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLC---LYVQ 549
+ + ALEYLHS +++ D+K EN+++ + IKI D G LC +
Sbjct: 112 AEIVSALEYLHSRDVVYRDIKLENLMLDK----DGHIKITDFG--------LCKEGISDG 159
Query: 550 SRS--------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 590
+ Y APEV+ Y + +D W LG ++ E+ G + F N
Sbjct: 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 4e-18
Identities = 57/227 (25%), Positives = 97/227 (42%), Gaps = 55/227 (24%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG +F KVF A+ T +K +K D D + ++ E ++L L ++ P
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH-P----F 79
Query: 445 ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR--------Q 496
+ ++ F E+LF V E L +GG+ + + +
Sbjct: 80 LTHMFCTFQTKENLFFVMEYL-------------NGGDLMYHIQSCHKFDLSRATFYAAE 126
Query: 497 CLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLC---LYVQSR 551
+ L++LHS GI++ DLK +NIL+ + IKI D G +C + ++
Sbjct: 127 IILGLQFLHSKGIVYRDLKLDNILLDK----DGHIKIADFG--------MCKENMLGDAK 174
Query: 552 --------SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 590
Y APE+++G Y+ +D WS G +L E+ G+ F
Sbjct: 175 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 5e-18
Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 30/216 (13%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG F +VF Q TG K + + + ++ E K+L V+
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH--------S 244
Query: 445 --ILRLYDYFYHLEHLFIVCELLRAN--LYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 500
I+ L F L +V ++ Y ++++ G F R T Q +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG---FQEPRAIFYTAQIVSG 301
Query: 501 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------YR 554
LE+LH II+ DLKPEN+L+ ++I DLG + + +++ +
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGN--VRISDLGLAV---ELKAGQTKTKGYAGTPGFM 356
Query: 555 APEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 590
APE+++G YD +D ++LG L E+ F
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 45/222 (20%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG +F KV A+ TG +K++K D D + ++ E ++L L H
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN-------H 83
Query: 445 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRLQVIT 494
+ +L+ F + LF V E + +GG+ F R +
Sbjct: 84 PFLTQLFCCFQTPDRLFFVMEFV-------------NGGDLMFHIQKSRRFDEARARFYA 130
Query: 495 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS-- 552
+ + AL +LH GII+ DLK +N+L+ K+ D G + +C V + +
Sbjct: 131 AEIISALMFLHDKGIIYRDLKLDNVLLDH--EGHCKLADFGMC---KEGICNGVTTATFC 185
Query: 553 ----YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 590
Y APE++ + Y +D W++G +L E+ G F +
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE 227
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 47/242 (19%), Positives = 91/242 (37%), Gaps = 49/242 (20%)
Query: 371 LPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEI 428
LP+++ IA + E +G F +V++ + G +V +KI ++ +F ++ EI
Sbjct: 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREA--EI 87
Query: 429 KLLKLVNKNDPADEH-HILRLY----DYFYHLEHLFIVCELL-RANLYEFQKFNQESGGE 482
++ H +IL L++V + +L+++
Sbjct: 88 YQTVMLR-------HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----- 135
Query: 483 AYFTLGRLQVITRQCLEALEYLHS--------LGIIHCDLKPENILIKSYQRCEIKIIDL 534
T+ + + L +LH I H DLK +NIL+K C I DL
Sbjct: 136 --VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC--CIADL 191
Query: 535 GSSCFQTDNLCLYVQSRS-------YRAPEVIIG------LPYDQKIDLWSLGCILAELW 581
G + + + Y APEV+ ++ D++++G + E+
Sbjct: 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
Query: 582 TG 583
Sbjct: 252 RR 253
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 7e-18
Identities = 51/224 (22%), Positives = 88/224 (39%), Gaps = 49/224 (21%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKNDPADEHH 444
+G +++KV + T ++++K ND + D E + + + H
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN-------H 112
Query: 445 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRLQVIT 494
++ L+ F LF V E + +GG+ + +
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYV-------------NGGDLMFHMQRQRKLPEEHARFYS 159
Query: 495 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLCLYVQSRS 552
+ AL YLH GII+ DLK +N+L+ S E IK+ D G + L + +
Sbjct: 160 AEISLALNYLHERGIIYRDLKLDNVLLDS----EGHIKLTDYGMC---KEGLRPGDTTST 212
Query: 553 ------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 590
Y APE++ G Y +D W+LG ++ E+ G F
Sbjct: 213 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 86.2 bits (213), Expect = 1e-17
Identities = 54/221 (24%), Positives = 97/221 (43%), Gaps = 43/221 (19%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG +F KV ++ T +KI+K D D + ++ E ++L L K
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK------PP 402
Query: 445 -ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR-------- 495
+ +L+ F ++ L+ V E + +GG+ + + ++
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYV-------------NGGDLMYHIQQVGRFKEPHAVFYAA 449
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS--- 552
+ L +L S GII+ DLK +N+++ S IKI D G +N+ V +++
Sbjct: 450 EIAIGLFFLQSKGIIYRDLKLDNVMLDS--EGHIKIADFGMC---KENIWDGVTTKTFCG 504
Query: 553 ---YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 590
Y APE+I PY + +D W+ G +L E+ G+ F +
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 545
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 53/226 (23%), Positives = 95/226 (42%), Gaps = 53/226 (23%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG +F KV ++ T +KI+K D D + ++ E ++L L K
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK------PP 81
Query: 445 -ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR-------- 495
+ +L+ F ++ L+ V E + +GG+ + + ++
Sbjct: 82 FLTQLHSCFQTMDRLYFVMEYV-------------NGGDLMYHIQQVGRFKEPHAVFYAA 128
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSRS 552
+ L +L S GII+ DLK +N+++ S IKI D G +C ++ +
Sbjct: 129 EIAIGLFFLQSKGIIYRDLKLDNVMLDS--EGHIKIADFG--------MCKENIWDGVTT 178
Query: 553 --------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 590
Y APE+I PY + +D W+ G +L E+ G+ F +
Sbjct: 179 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 66/326 (20%), Positives = 121/326 (37%), Gaps = 71/326 (21%)
Query: 312 DTRDGEVNGALHEGKADAEEHGVATPDLL-MFDNLEEECEIFHLRIIHRKNRTGFEENKD 370
+ R ++ + +G A + LL + L +EC LR KN + E
Sbjct: 3 EVRLRQLEQFILDGPAQTNGQCFSVETLLDILICLYDECNNSPLRRE--KNILEYLEWAK 60
Query: 371 LPIILNTVIAGRYYVTEY-----LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL 425
+ V R + ++ +G AF +V + + +KI+ K
Sbjct: 61 P--FTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN--KW------ 110
Query: 426 DEIKLLKLVNKNDPA---DEHHILRLYDYFYHLEHLFIVCELLRANL-YEFQKFNQ---- 477
+++ + + A +E +L + + +I L Y FQ N
Sbjct: 111 ------EMLKRAETACFREERDVLV------NGDSKWIT------TLHYAFQDDNNLYLV 152
Query: 478 ---ESGGEAYFTLGRLQVI---------TRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 525
GG+ L + + + + A++ +H L +H D+KP+NIL+
Sbjct: 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG 212
Query: 526 RCEIKIIDLGSSCFQTDNLCLYVQSRS------YRAPEVIIGLP-----YDQKIDLWSLG 574
I++ D GS VQS Y +PE++ + Y + D WSLG
Sbjct: 213 --HIRLADFGSC--LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLG 268
Query: 575 CILAELWTGEVLFPNDAVVMILARII 600
+ E+ GE F +++V +I+
Sbjct: 269 VCMYEMLYGETPFYAESLVETYGKIM 294
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 60/227 (26%), Positives = 93/227 (40%), Gaps = 55/227 (24%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG F KV ++ TG +KI+K + KD +L E ++L+ H
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-------HP 208
Query: 445 -ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR-------- 495
+ L F + L V E +GGE +F L R +V +
Sbjct: 209 FLTALKYSFQTHDRLCFVMEYA-------------NGGELFFHLSRERVFSEDRARFYGA 255
Query: 496 QCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC---LYVQSR 551
+ + AL+YLHS +++ DLK EN+++ IKI D G LC + +
Sbjct: 256 EIVSALDYLHSEKNVVYRDLKLENLMLDK--DGHIKITDFG--------LCKEGIKDGAT 305
Query: 552 S--------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 590
Y APEV+ Y + +D W LG ++ E+ G + F N
Sbjct: 306 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 2e-16
Identities = 60/236 (25%), Positives = 100/236 (42%), Gaps = 70/236 (29%)
Query: 389 LGSAAFSKVFQAQDL---HTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHI 445
LG + KVFQ + + +TG +K++K K ++ + K E +I
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLK--KAMIVRNAKDTAHTK--------AERNI 74
Query: 446 LRLYDYFYHLEHLFIVCELLRANL-YEFQKFNQE---------SGGEAYFTLGRLQVITR 495
L ++H FIV +L Y FQ SGGE + L R +
Sbjct: 75 LE------EVKHPFIV------DLIYAFQ--TGGKLYLILEYLSGGELFMQLEREGIFME 120
Query: 496 --------QCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLC 545
+ AL +LH GII+ DLKPENI++ + +K+ D G LC
Sbjct: 121 DTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNH----QGHVKLTDFG--------LC 168
Query: 546 ---LYVQSRS--------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 590
++ + + Y APE+++ +++ +D WSLG ++ ++ TG F +
Sbjct: 169 KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE 224
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 50/240 (20%), Positives = 90/240 (37%), Gaps = 53/240 (22%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
+G AFS+V + TG +KI+ + +E +L +
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD--------R 120
Query: 445 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI--------- 493
I +L+ F +L++V E GG+ L +
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYY-------------VGGDLLTLLSKFGERIPAEMARFY 167
Query: 494 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS- 552
+ + A++ +H LG +H D+KP+NIL+ I++ D GS V+S
Sbjct: 168 LAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG--HIRLADFGSC--LKLRADGTVRSLVA 223
Query: 553 -----YRAPEVIIGL-------PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 600
Y +PE++ + Y + D W+LG E++ G+ F D+ +I+
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 61/236 (25%), Positives = 97/236 (41%), Gaps = 73/236 (30%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA---DEHHI 445
+G +F KV A+ V +K+++ K ++ K + E ++
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQ--KKA------------ILKKKEEKHIMSERNV 91
Query: 446 LRLYDYFYHLEHLFIVCELLRANL-YEFQKFNQE---------SGGEAYFTLGRLQVITR 495
L +++H F+V L + FQ + +GGE ++ L R +
Sbjct: 92 LLK-----NVKHPFLV------GLHFSFQ--TADKLYFVLDYINGGELFYHLQRERCFLE 138
Query: 496 --------QCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLC 545
+ AL YLHSL I++ DLKPENIL+ S + I + D G LC
Sbjct: 139 PRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS----QGHIVLTDFG--------LC 186
Query: 546 ---LYVQSRS--------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 590
+ S + Y APEV+ PYD+ +D W LG +L E+ G F +
Sbjct: 187 KENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 242
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 7e-16
Identities = 46/214 (21%), Positives = 83/214 (38%), Gaps = 32/214 (14%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEH- 443
LG + +V++ + V +K +K D ++F L E ++K + H
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF----LKEAAVMKEIK-------HP 276
Query: 444 HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 502
++++L +I+ E + NL ++ + + L + Q A+E
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLR----ECNRQEVSAVVLLYMATQISSAME 332
Query: 503 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------AP 556
YL IH +L N L+ K+ D G S T + Y + AP
Sbjct: 333 YLEKKNFIHRNLAARNCLVGENHLV--KVADFGLSRLMTGD--TYTAHAGAKFPIKWTAP 388
Query: 557 EVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589
E + + K D+W+ G +L E+ T G +P
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 422
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 49/235 (20%), Positives = 96/235 (40%), Gaps = 48/235 (20%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
+G AF +V + T +K++ + +E ++ N
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN--------S 128
Query: 445 --ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQV---ITR---- 495
+++L+ F +L++V E + GG+ + V R
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYM-------------PGGDLVNLMSNYDVPEKWARFYTA 175
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS--- 552
+ + AL+ +HS+G IH D+KP+N+L+ + +K+ D G+ V+ +
Sbjct: 176 EVVLALDAIHSMGFIHRDVKPDNMLLD--KSGHLKLADFGTCMKMNKE--GMVRCDTAVG 231
Query: 553 ---YRAPEVIIG----LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 600
Y +PEV+ Y ++ D WS+G L E+ G+ F D++V ++I+
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 60/233 (25%), Positives = 93/233 (39%), Gaps = 66/233 (28%)
Query: 389 LGSAAFSKVFQAQ---DLHTGVDVCLKIIKNDKDFFDQ-----SLDEIKLLKLVNKNDPA 440
LG +F KVF + +K++K K + E +L VN
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLK--KATLKVRDRVRTKMERDILVEVN----- 84
Query: 441 DEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGRL 490
H I++L+ F L+++ + L GG+ FT +
Sbjct: 85 ---HPFIVKLHYAFQTEGKLYLILDFL-------------RGGDLFTRLSKEVMFTEEDV 128
Query: 491 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLC--- 545
+ + AL++LHSLGII+ DLKPENIL+ E IK+ D G L
Sbjct: 129 KFYLAELALALDHLHSLGIIYRDLKPENILLDE----EGHIKLTDFG--------LSKES 176
Query: 546 LYVQSRS--------YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND 590
+ + ++ Y APEV+ + Q D WS G ++ E+ TG + F
Sbjct: 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 32/215 (14%), Positives = 76/215 (35%), Gaps = 39/215 (18%)
Query: 374 ILNTVIAGRYYVTEYLGSAAFSKVFQA-----QDLHTGVDVCLKIIKNDKDFFDQSLDEI 428
I+ + A + V +G F ++ A + + + +K+ +D E+
Sbjct: 28 IITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG---PLFTEL 84
Query: 429 KLLKLVNKNDPADEHH---------ILRLYDYFYH----LEHLFIVCELLRANLYEFQKF 475
K + K + + + + + H + F++ + ++L + +
Sbjct: 85 KFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA 144
Query: 476 NQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535
N + F+ + ++ + L+ LEY+H +H D+K N+L+ ++ ++D G
Sbjct: 145 NAKR-----FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYG 199
Query: 536 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDL 570
+ Y V D K
Sbjct: 200 L-------------AYRYCPEGVHKAYAADPKRCH 221
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 55/250 (22%), Positives = 98/250 (39%), Gaps = 41/250 (16%)
Query: 389 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND-----KDFFDQSLDEIKLLKLVNKNDP 439
LG F V +TG V +K +++ +DF EI++LK +
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF----EREIEILKSLQ---- 69
Query: 440 ADEH-HILRLYD--YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR 495
H +I++ Y +L ++ E L +L ++ + ++E +L T
Sbjct: 70 ---HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTS 121
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR- 554
Q + +EYL + IH DL NIL+++ R KI D G + + +
Sbjct: 122 QICKGMEYLGTKRYIHRDLATRNILVENENRV--KIGDFGLTKVLPQDKEFFKVKEPGES 179
Query: 555 -----APEVIIGLPYDQKIDLWSLGCILAELWT--GEVLFPNDAVVMILARI--IGMLGP 605
APE + + D+WS G +L EL+T + P + ++ M+
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239
Query: 606 IDLEMLMQGQ 615
+E+L
Sbjct: 240 HLIELLKNNG 249
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 24/211 (11%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 446
LG F +V+ + V +K +K + L E +++K + ++
Sbjct: 273 VKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL------RHEKLV 325
Query: 447 RLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH 505
+LY E ++IV E + +L +F K Y L +L + Q + Y+
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLK----GETGKYLRLPQLVDMAAQIASGMAYVE 380
Query: 506 SLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APEVI 559
+ +H DL+ NIL+ C K+ D G + DN Y + + APE
Sbjct: 381 RMNYVHRDLRAANILVGENLVC--KVADFGLARLIEDN--EYTARQGAKFPIKWTAPEAA 436
Query: 560 IGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589
+ + K D+WS G +L EL T G V +P
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGRVPYPG 467
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 48/224 (21%), Positives = 78/224 (34%), Gaps = 46/224 (20%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK-NDKDFFDQSLDEIKLLKLVNKNDPADEH-H 444
E F V++AQ V +KI DK + E+ L + +H +
Sbjct: 30 EVKARGRFGCVWKAQ--LLNEYVAVKIFPIQDKQSWQNEY-EVYSLPGM-------KHEN 79
Query: 445 ILRLYDY----FYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 499
IL+ L+++ + +L +F K N + L I
Sbjct: 80 ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-------VSWNELCHIAETMAR 132
Query: 500 ALEYLHS----------LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ 549
L YLH I H D+K +N+L+K+ I D G +
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA--CIADFGLALKFEAGKSAGDT 190
Query: 550 SRS-----YRAPEVIIG-----LPYDQKIDLWSLGCILAELWTG 583
Y APEV+ G +ID++++G +L EL +
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 24/211 (11%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHIL 446
LG F +V+ + V +K +K + L E +++K + ++
Sbjct: 190 VKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL------RHEKLV 242
Query: 447 RLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH 505
+LY E ++IV E + +L +F K Y L +L + Q + Y+
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLK----GETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 506 SLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APEVI 559
+ +H DL+ NIL+ C K+ D G + DN Y + + APE
Sbjct: 298 RMNYVHRDLRAANILVGENLVC--KVADFGLARLIEDN--EYTARQGAKFPIKWTAPEAA 353
Query: 560 IGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589
+ + K D+WS G +L EL T G V +P
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVPYPG 384
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 55/249 (22%), Positives = 97/249 (38%), Gaps = 39/249 (15%)
Query: 389 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND-----KDFFDQSLDEIKLLKLVNKNDP 439
LG F V +TG V +K +++ +DF EI++LK +
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF----EREIEILKSL----- 99
Query: 440 ADEHHILRLYD--YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQ 496
+I++ Y +L ++ E L +L ++ + ++E +L T Q
Sbjct: 100 -QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQ 153
Query: 497 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR-- 554
+ +EYL + IH DL NIL+++ R KI D G + + Y
Sbjct: 154 ICKGMEYLGTKRYIHRDLATRNILVENENRV--KIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 555 ----APEVIIGLPYDQKIDLWSLGCILAELWT--GEVLFPNDAVVMILARI--IGMLGPI 606
APE + + D+WS G +L EL+T + P + ++ M+
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271
Query: 607 DLEMLMQGQ 615
+E+L
Sbjct: 272 LIELLKNNG 280
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 448
LG+ F +V+ A + V +K +K + L E ++K + +++L
Sbjct: 196 LGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL------QHDKLVKL 248
Query: 449 YDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSL 507
+ E ++I+ E + +L +F K S + L +L + Q E + ++
Sbjct: 249 HAVVTK-EPIYIITEFMAKGSLLDFLK----SDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303
Query: 508 GIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APEVIIG 561
IH DL+ NIL+ + C KI D G + DN Y + APE I
Sbjct: 304 NYIHRDLRAANILVSASLVC--KIADFGLARVIEDN--EYTAREGAKFPIKWTAPEAINF 359
Query: 562 LPYDQKIDLWSLGCILAELWT-GEVLFPN 589
+ K D+WS G +L E+ T G + +P
Sbjct: 360 GSFTIKSDVWSFGILLMEIVTYGRIPYPG 388
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 50/219 (22%), Positives = 87/219 (39%), Gaps = 32/219 (14%)
Query: 387 EYLGSAAFSKVFQAQDLHTG---VDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 437
+ +G+ F +V + + V +K +K +DF L E ++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF----LGEASIMGQF--- 103
Query: 438 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 497
D +I+RL + + IV E + F ++ + FT+ +L + R
Sbjct: 104 ---DHPNIIRLEGVVTKSKPVMIVTEYME--NGSLDSFLRKHDAQ--FTVIQLVGMLRGI 156
Query: 498 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR--- 554
++YL +G +H DL NILI S C K+ D G D+ +R +
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSNLVC--KVSDFGLGRVLEDDPEAAYTTRGGKIPI 214
Query: 555 ---APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589
+PE I + D+WS G +L E+ + GE +
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 59/248 (23%), Positives = 100/248 (40%), Gaps = 38/248 (15%)
Query: 389 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND-----KDFFDQSLDEIKLLKLVNKNDP 439
LG F V +TG V +K +++ +DF EI++LK +
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDF----QREIQILKAL----- 81
Query: 440 ADEHHILRLYD--YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQ 496
I++ Y + L +V E L + L +F + ++ RL + + Q
Sbjct: 82 -HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-----LDASRLLLYSSQ 135
Query: 497 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR-- 554
+ +EYL S +H DL NIL++S KI D G + + YV +
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAHV--KIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 555 ----APEVIIGLPYDQKIDLWSLGCILAELWT-GEV--LFPNDAVVMILARIIGMLGPID 607
APE + + ++ D+WS G +L EL+T + + + M+
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253
Query: 608 LEMLMQGQ 615
LE+L +GQ
Sbjct: 254 LELLEEGQ 261
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 49/221 (22%), Positives = 87/221 (39%), Gaps = 35/221 (15%)
Query: 387 EYLGSAAFSKVFQA----QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNK 436
+ +G+ F +V++ V V +K +K DF L E ++
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF----LGEAGIMGQF-- 103
Query: 437 NDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR 495
H+I+RL + + I+ E + L +F + F++ +L + R
Sbjct: 104 ----SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-----FSVLQLVGMLR 154
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR- 554
++YL ++ +H DL NIL+ S C K+ D G S D+ + +
Sbjct: 155 GIAAGMKYLANMNYVHRDLAARNILVNSNLVC--KVSDFGLSRVLEDDPEATYTTSGGKI 212
Query: 555 -----APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589
APE I + D+WS G ++ E+ T GE +
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 45/215 (20%), Positives = 83/215 (38%), Gaps = 32/215 (14%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADE 442
+ LGS F V + DV +K+IK +F E + + +
Sbjct: 14 KELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEF----FQEAQTMMKL------SH 62
Query: 443 HHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 501
+++ Y ++IV E + L + + + + +L + E +
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG-----LEPSQLLEMCYDVCEGM 117
Query: 502 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------A 555
+L S IH DL N L+ K+ D G + + D+ YV S + A
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRDLCV--KVSDFGMTRYVLDD--QYVSSVGTKFPVKWSA 173
Query: 556 PEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589
PEV Y K D+W+ G ++ E+++ G++ +
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL 208
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 53/220 (24%), Positives = 85/220 (38%), Gaps = 34/220 (15%)
Query: 387 EYLGSAAFSKVFQAQDLHTG---VDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 437
+ +GS +V + G V V +K +K +DF L E ++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF----LSEASIMGQF--- 107
Query: 438 DPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQ 496
D +I+RL IV E + +L F + + FT+ +L + R
Sbjct: 108 ---DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-----FTIMQLVGMLRG 159
Query: 497 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR-- 554
+ YL LG +H DL N+L+ S C K+ D G S D+ + +
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVDSNLVC--KVSDFGLSRVLEDDPDAAYTTTGGKIP 217
Query: 555 ----APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589
APE I + D+WS G ++ E+ GE + N
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN 257
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 49/243 (20%), Positives = 84/243 (34%), Gaps = 57/243 (23%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEH- 443
E +G + V++ V +K+ N ++F ++ I + L+ EH
Sbjct: 19 ELIGRGRYGAVYKGS--LDERPVAVKVFSFANRQNFINEK--NIYRVPLM-------EHD 67
Query: 444 HILRLY-----DYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQC 497
+I R +V E +L ++ + +
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-------SDWVSSCRLAHSV 120
Query: 498 LEALEYLHS---------LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYV 548
L YLH+ I H DL N+L+K+ C I D G S T N +
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC--VISDFGLSMRLTGNRLVRP 178
Query: 549 QSRS-----------YRAPEVIIGL-------PYDQKIDLWSLGCILAELWTG-EVLFPN 589
Y APEV+ G +++D+++LG I E++ LFP
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238
Query: 590 DAV 592
++V
Sbjct: 239 ESV 241
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 46/213 (21%), Positives = 82/213 (38%), Gaps = 30/213 (14%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG + +V++ + V +K +K D ++F L E ++K + +
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF----LKEAAVMKEI------KHPN 70
Query: 445 ILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 503
+++L +I+ E + NL ++ + + L + Q A+EY
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLR----ECNRQEVSAVVLLYMATQISSAMEY 126
Query: 504 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APE 557
L IH DL N L+ K+ D G S T + Y + APE
Sbjct: 127 LEKKNFIHRDLAARNCLVGENHLV--KVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPE 182
Query: 558 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589
+ + K D+W+ G +L E+ T G +P
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-13
Identities = 52/216 (24%), Positives = 81/216 (37%), Gaps = 34/216 (15%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKNDPADE 442
+G F +VF + V +K + F L E ++LK
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKF----LQEARILKQY------SH 171
Query: 443 HHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 501
+I+RL + ++IV EL++ + F + + L + +
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-----LRVKTLLQMVGDAAAGM 226
Query: 502 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------- 554
EYL S IH DL N L+ KI D G S + D +Y S R
Sbjct: 227 EYLESKCCIHRDLAARNCLVTEKNVL--KISDFGMSREEADG--VYAASGGLRQVPVKWT 282
Query: 555 APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589
APE + Y + D+WS G +L E ++ G +PN
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFSLGASPYPN 318
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 68/230 (29%)
Query: 389 LGSAAFSKVFQAQDL---HTGVDVCLKIIK------NDKDFFDQSLDEIKLLKLVNKNDP 439
LG+ A+ KVF + + TG +K++K K + + E ++L+ +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT-EHTRTERQVLEHIR---- 116
Query: 440 ADEHH--ILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGE--------AYFTLGR 489
++ L+ F L ++ + + +GGE FT
Sbjct: 117 ---QSPFLVTLHYAFQTETKLHLILDYI-------------NGGELFTHLSQRERFTEHE 160
Query: 490 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE--IKIIDLGSSCFQTDNLC-L 546
+Q+ + + ALE+LH LGII+ D+K ENIL+ S + + D G L
Sbjct: 161 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS----NGHVVLTDFG--------LSKE 208
Query: 547 YVQSRS-----------YRAPEVIIGLP--YDQKIDLWSLGCILAELWTG 583
+V + Y AP+++ G +D+ +D WSLG ++ EL TG
Sbjct: 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 49/218 (22%), Positives = 85/218 (38%), Gaps = 46/218 (21%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEH-H 444
+G F V + G V +K IKND + F L E ++ + H +
Sbjct: 201 IGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQAF----LAEASVMTQLR-------HSN 247
Query: 445 ILRLY-----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
+++L + L+IV E + +L ++ + S G + L +
Sbjct: 248 LVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLR----SRGRSVLGGDCLLKFSLDVC 299
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR---- 554
EA+EYL +H DL N+L+ K+ D G + + +
Sbjct: 300 EAMEYLEGNNFVHRDLAARNVLVSEDNVA--KVSDFGLTKE------ASSTQDTGKLPVK 351
Query: 555 --APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589
APE + + K D+WS G +L E+++ G V +P
Sbjct: 352 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 389
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 25/179 (13%), Positives = 59/179 (32%), Gaps = 24/179 (13%)
Query: 374 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGV--------DVCLKIIKNDKDFFDQSL 425
+L ++ + + +++A T LK+ D F++
Sbjct: 35 VLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQN 94
Query: 426 --------DEIKLLKLVNKNDPADEHHILRLYDYFYHL-EHLFIVCELLRANLYEFQKFN 476
++ K + I + H ++ F+V L +L +
Sbjct: 95 FFQRAAKPLQVNKWKKLYSTP---LLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSA--LD 149
Query: 477 QESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535
+ + + + L+ALE+LH +H ++ ENI + + ++ + G
Sbjct: 150 VSPKHV--LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYG 206
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 8e-13
Identities = 47/214 (21%), Positives = 86/214 (40%), Gaps = 34/214 (15%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEH- 443
+GS F V V +K I+ +DF ++E +++ ++ H
Sbjct: 16 IGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDF----IEEAEVMMKLS-------HP 63
Query: 444 HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 502
+++LY + +V E + L ++ + + F L + E +
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL-----FAAETLLGMCLDVCEGMA 118
Query: 503 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------AP 556
YL +IH DL N L+ Q K+ D G + F D+ Y S + +P
Sbjct: 119 YLEEACVIHRDLAARNCLVGENQVI--KVSDFGMTRFVLDD--QYTSSTGTKFPVKWASP 174
Query: 557 EVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589
EV Y K D+WS G ++ E+++ G++ + N
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 208
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 52/250 (20%), Positives = 93/250 (37%), Gaps = 41/250 (16%)
Query: 389 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKND 438
LG F KV + +TG V +K +K + D EI++L+ +
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADL----KKEIEILRNLY--- 81
Query: 439 PADEH-HILRLYD--YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVIT 494
H +I++ + ++ E L + +L E+ N+ L +
Sbjct: 82 ----HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-----INLKQQLKYA 132
Query: 495 RQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR 554
Q + ++YL S +H DL N+L++S + KI D G + + Y
Sbjct: 133 VQICKGMDYLGSRQYVHRDLAARNVLVESEHQV--KIGDFGLTKAIETDKEYYTVKDDRD 190
Query: 555 ------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARI--IGMLGP 605
APE ++ + D+WS G L EL T + A+ + + M
Sbjct: 191 SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250
Query: 606 IDLEMLMQGQ 615
+ L +G+
Sbjct: 251 RLVNTLKEGK 260
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 32/213 (15%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG+ F +V+ + V +K +K F L E L+K +
Sbjct: 21 LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAF----LAEANLMKQL------QHQR 69
Query: 445 ILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 503
++RLY E ++I+ E + +L +F K + T+ +L + Q E + +
Sbjct: 70 LVRLYAVVTQ-EPIYIITEYMENGSLVDFLK----TPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 504 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APE 557
+ IH DL+ NIL+ C KI D G + DN Y + APE
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSC--KIADFGLARLIEDN--EYTAREGAKFPIKWTAPE 180
Query: 558 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589
I + K D+WS G +L E+ T G + +P
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 47/213 (22%), Positives = 89/213 (41%), Gaps = 32/213 (15%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG+ F V + DV +K+IK +F ++E K++ +
Sbjct: 32 LGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEF----IEEAKVMMNL------SHEK 80
Query: 445 ILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 503
+++LY +FI+ E + L + + + F +L + + EA+EY
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-----FQTQQLLEMCKDVCEAMEY 135
Query: 504 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APE 557
L S +H DL N L+ K+ D G S + D+ Y S + PE
Sbjct: 136 LESKQFLHRDLAARNCLVNDQGVV--KVSDFGLSRYVLDD--EYTSSVGSKFPVRWSPPE 191
Query: 558 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589
V++ + K D+W+ G ++ E+++ G++ +
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 224
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 48/213 (22%), Positives = 84/213 (39%), Gaps = 36/213 (16%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHI 445
+G F V + G V +K IKND + F L E ++ + ++
Sbjct: 29 IGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQAF----LAEASVMTQL------RHSNL 76
Query: 446 LRLYDY-FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 503
++L L+IV E + +L ++ + S G + L + EA+EY
Sbjct: 77 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR----SRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 504 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APE 557
L +H DL N+L+ K+ D G + + + + APE
Sbjct: 133 LEGNNFVHRDLAARNVLVSEDNVA--KVSDFGLT---KE---ASSTQDTGKLPVKWTAPE 184
Query: 558 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589
+ + K D+WS G +L E+++ G V +P
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 217
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 55/249 (22%), Positives = 89/249 (35%), Gaps = 41/249 (16%)
Query: 389 LGSAAFSKVFQAQ----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKND 438
LG F KV + TG V +K +K D + EI +L+ +
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGW----KQEIDILRTL---- 90
Query: 439 PADEHHILRLYD--YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR 495
HI++ L +V E + +L ++ + L +L + +
Sbjct: 91 --YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQ 141
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR- 554
Q E + YLH+ IH DL N+L+ + + KI D G + + Y
Sbjct: 142 QICEGMAYLHAQHYIHRDLAARNVLLDNDRLV--KIGDFGLAKAVPEGHEYYRVREDGDS 199
Query: 555 -----APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARI--IGMLGPI 606
APE + + D+WS G L EL T + + L I M
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259
Query: 607 DLEMLMQGQ 615
E+L +G+
Sbjct: 260 LTELLERGE 268
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 53/225 (23%), Positives = 82/225 (36%), Gaps = 47/225 (20%)
Query: 389 LGSAAFSKVFQA---QDLHTGVDVCLKIIKND--------KDFFDQSLDEIKLLKLVNKN 437
LG +F V + V V +K +K D DF + E+ + ++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDF----IREVNAMHSLD-- 79
Query: 438 DPADEH-HILRLY----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQ 491
H +++RLY + +V EL +L + + +Q F LG L
Sbjct: 80 -----HRNLIRLYGVVLT-----PPMKMVTELAPLGSLLDRLRKHQGH-----FLLGTLS 124
Query: 492 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 551
Q E + YL S IH DL N+L+ + KI D G N YV
Sbjct: 125 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLV--KIGDFGLMRALPQNDDHYVMQE 182
Query: 552 SYR------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589
+ APE + + D W G L E++T G+ +
Sbjct: 183 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 227
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 47/218 (21%), Positives = 83/218 (38%), Gaps = 36/218 (16%)
Query: 389 LGSAAFSKVFQA--QDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEH 443
LGS F V + Q V +KI+KN+ D+ L E +++ + D
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL------DNP 78
Query: 444 HILRLY----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
+I+R+ E +V E+ L ++ + N+ + + Q
Sbjct: 79 YIVRMIGICEA-----ESWMLVMEMAELGPLNKYLQQNRH------VKDKNIIELVHQVS 127
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR---- 554
++YL +H DL N+L+ + KI D G S + Y +
Sbjct: 128 MGMKYLEESNFVHRDLAARNVLLVTQHYA--KISDFGLSKALRADENYYKAQTHGKWPVK 185
Query: 555 --APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589
APE I + K D+WS G ++ E ++ G+ +
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 223
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 53/259 (20%), Positives = 96/259 (37%), Gaps = 62/259 (23%)
Query: 389 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKND 438
LGS F V + + + VC+K+I++ + D + + +
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAV----TDHMLAIGSL---- 72
Query: 439 PADEHHILRLY----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVI 493
D HI+RL L +V + L +L + + ++ + L
Sbjct: 73 --DHAHIVRLLGLCPG-----SSLQLVTQYLPLGSLLDHVRQHRGA-----LGPQLLLNW 120
Query: 494 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSRS 552
Q + + YL G++H +L N+L+KS + ++ D G + D+ +
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQV--QVADFGVADLLPPDD--KQLLYSE 176
Query: 553 YR------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGML-- 603
+ A E I Y + D+WS G + EL T G + + LA + +L
Sbjct: 177 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAG----LRLAEVPDLLEK 232
Query: 604 G---------PIDLEMLMQ 613
G ID+ M+M
Sbjct: 233 GERLAQPQICTIDVYMVMV 251
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 52/260 (20%), Positives = 99/260 (38%), Gaps = 64/260 (24%)
Query: 389 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKND 438
LGS AF V++ + + V +K ++ K+ LDE ++ V+
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI----LDEAYVMASVD--- 75
Query: 439 PADEH-HILRLY----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQV 492
+ H+ RL + ++ +L+ L ++ + ++++ L
Sbjct: 76 ----NPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDN-----IGSQYLLN 121
Query: 493 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSR 551
Q + + YL ++H DL N+L+K+ Q KI D G + + +
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV--KITDFGLAKLLGAEE--KEYHAE 177
Query: 552 SYR------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGML- 603
+ A E I+ Y + D+WS G + EL T G + + + I +L
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG----IPASEISSILE 233
Query: 604 -G---------PIDLEMLMQ 613
G ID+ M+M+
Sbjct: 234 KGERLPQPPICTIDVYMIMR 253
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 46/213 (21%), Positives = 80/213 (37%), Gaps = 26/213 (12%)
Query: 389 LGSAAFSKVFQAQDLHTG---VDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPADEH 443
LG F V Q +DV +K++K + D + E +++ + D
Sbjct: 344 LGCGNFGSVRQGV-YRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL------DNP 396
Query: 444 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 503
+I+RL E L +V E+ A KF E + + + Q ++Y
Sbjct: 397 YIVRLIGVCQA-EALMLVMEM--AGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKY 451
Query: 504 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR------APE 557
L +H +L N+L+ + KI D G S + Y + + APE
Sbjct: 452 LEEKNFVHRNLAARNVLLVNRHYA--KISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 509
Query: 558 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589
I + + D+WS G + E + G+ +
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 542
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 8e-10
Identities = 41/231 (17%), Positives = 81/231 (35%), Gaps = 51/231 (22%)
Query: 387 EYLGSAAFSKVFQAQDLHTG-------VDVCLKIIKND-----KDFFDQSLDEIKLLKLV 434
E LG F+K+F+ G +V LK++ + F + ++ +
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF----FEAASMMSKL 69
Query: 435 NKNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVI 493
H++ Y + +V E ++ +L + K N+ + +
Sbjct: 70 ------SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC-----INILWKLEV 118
Query: 494 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE------IKIIDLGSSCFQTDNLCLY 547
+Q A+ +L +IH ++ +NIL+ + + IK+ D G + +
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG--------ISIT 170
Query: 548 VQSRSYR-------APEVII-GLPYDQKIDLWSLGCILAELWT-GEVLFPN 589
V + PE I + D WS G L E+ + G+
Sbjct: 171 VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 45/221 (20%), Positives = 81/221 (36%), Gaps = 42/221 (19%)
Query: 389 LGSAAFSKVFQAQ--DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKNDPA 440
LG F V Q +DV +K++K ++ + E +++ ++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM----MREAQIMHQLD----- 68
Query: 441 DEH-HILRLY----DYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 495
+ +I+RL E L +V E+ A KF E + + +
Sbjct: 69 --NPYIVRLIGVCQA-----EALMLVMEM--AGGGPLHKFLVGKREE--IPVSNVAELLH 117
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYR- 554
Q ++YL +H DL N+L+ + KI D G S + Y + +
Sbjct: 118 QVSMGMKYLEEKNFVHRDLAARNVLLVNRHYA--KISDFGLSKALGADDSYYTARSAGKW 175
Query: 555 -----APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589
APE I + + D+WS G + E + G+ +
Sbjct: 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 216
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 52/223 (23%), Positives = 81/223 (36%), Gaps = 40/223 (17%)
Query: 389 LGSAAFSKVFQA-----QDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPAD 441
LG+ AF KV +A + V +K++K ++ + E+K+L +
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN----- 85
Query: 442 EH-HILRLYDYFYHLEHLFIVCEL---------LRAN----LYEFQKFNQESGGEAYFTL 487
H +I+ L ++ E LR + E L
Sbjct: 86 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 488 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLC 545
L + Q + + +L S IH DL NIL+ + KI D G + N
Sbjct: 145 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT--KICDFGLARDIKNDSN-- 200
Query: 546 LYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 582
YV + R APE I Y + D+WS G L EL++
Sbjct: 201 -YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 47/219 (21%), Positives = 88/219 (40%), Gaps = 36/219 (16%)
Query: 389 LGSAAFSKVFQAQDLHTG-----VDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPAD 441
LG+ AF KV +A G + V +K++K+ ++ + E+K++ + +
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ----- 108
Query: 442 EH-HILRLYDYFYHLEHLFIVCEL---------LRANLYEFQKFNQESGGEAYFTLGRLQ 491
H +I+ L H + ++ E LR + + + + L
Sbjct: 109 -HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 492 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQ 549
+ Q + + +L S IH D+ N+L+ + KI D G + N Y+
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA--KIGDFGLARDIMNDSN---YIV 222
Query: 550 SRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 582
+ R APE I Y + D+WS G +L E+++
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 50/223 (22%), Positives = 79/223 (35%), Gaps = 43/223 (19%)
Query: 387 EYLGSAAFSKVFQAQDLHTG---VDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 437
+G F V Q + + V +K KN + F L E ++
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKF----LQEALTMRQF--- 448
Query: 438 DPADEHHILRLY----DYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI 493
D HI++L + ++I+ EL E + F Q L L +
Sbjct: 449 ---DHPHIVKLIGVITE-----NPVWIIMELCTLG--ELRSFLQVRKFS--LDLASLILY 496
Query: 494 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSY 553
Q AL YL S +H D+ N+L+ S K+ D G S + D+ Y ++
Sbjct: 497 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV--KLGDFGLSRYMEDS--TYYKASKG 552
Query: 554 R------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589
+ APE I + D+W G + E+ G F
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 52/260 (20%), Positives = 98/260 (37%), Gaps = 64/260 (24%)
Query: 389 LGSAAFSKVFQA----QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKND 438
LGS AF V++ + + V +K ++ K+ LDE ++ V+
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI----LDEAYVMASVD--- 75
Query: 439 PADEH-HILRLY----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQV 492
+ H+ RL + ++ +L+ L ++ + ++++ L
Sbjct: 76 ----NPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDN-----IGSQYLLN 121
Query: 493 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSR 551
Q + + YL ++H DL N+L+K+ Q KI D G + + +
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV--KITDFGLAKLLGAEE--KEYHAE 177
Query: 552 SYR------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGML- 603
+ A E I+ Y + D+WS G + EL T G + + + I +L
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG----IPASEISSILE 233
Query: 604 -G---------PIDLEMLMQ 613
G ID+ M+M
Sbjct: 234 KGERLPQPPICTIDVYMIMV 253
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 1e-08
Identities = 44/251 (17%), Positives = 74/251 (29%), Gaps = 59/251 (23%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---------FFDQSLDEIKLLK 432
+ E +G F +VFQ HT V +KII + F++ L EI + K
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 433 LVNKNDPADEHHILRLYDYFYHLEHLFIV-----CELLRANLYEFQKFNQESGGEAYF-- 485
++ + + F L + V LL+A + + +F
Sbjct: 79 ELSLLSGEVCNRT----EGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 486 ------------------------TLGRLQVITRQCLEALEYLH-SLGIIHCDLKPENIL 520
+L + I Q +L SL H DL N+L
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVL 194
Query: 521 IKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAEL 580
+K ++ G S + S + + Y + ++
Sbjct: 195 LKKTSLKKLHYTLNGKS--------STIPSCGLQVSII----DYTLSRLERDGIVVFCDV 242
Query: 581 WTGEVLFPNDA 591
E LF D
Sbjct: 243 SMDEDLFTGDG 253
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 43/218 (19%), Positives = 80/218 (36%), Gaps = 39/218 (17%)
Query: 389 LGSAAFSKVFQA---QDLHTGVDVCLKIIKND-------KDFFDQSLDEIKLLKLVNKND 438
LG F V + Q+ T + V +K +K D ++F L E +K
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEF----LSEAACMKDF---- 93
Query: 439 PADEHHILRLY-----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQV 492
+++RL + ++ ++ +L+ + +++ G + L L
Sbjct: 94 --SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151
Query: 493 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQS 550
+EYL + +H DL N +++ + D G S + D Y Q
Sbjct: 152 FMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTV--CVADFGLSKKIYSGD---YYRQG 206
Query: 551 RSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 582
R + A E + Y K D+W+ G + E+ T
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 53/227 (23%), Positives = 87/227 (38%), Gaps = 48/227 (21%)
Query: 389 LGSAAFSKVFQA-------QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVN 435
LG AF +V A + V +K++K+D D + E++++K++
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL----ISEMEMMKMIG 132
Query: 436 KNDPADEH-HILRLYDYFYHLEHLFIVCEL---------LRAN--LYEFQKFNQESGGEA 483
K H +I+ L L+++ E L+A +N E
Sbjct: 133 K------HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 484 YFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQT 541
+ L Q +EYL S IH DL N+L+ KI D G +
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM--KIADFGLARDIHHI 244
Query: 542 DNLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 582
D Y ++ + R APE + Y + D+WS G +L E++T
Sbjct: 245 DY---YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 50/224 (22%), Positives = 80/224 (35%), Gaps = 45/224 (20%)
Query: 387 EYLGSAAFSKVFQAQDLHTG---VDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 437
+G F V Q + + V +K KN + F L E ++
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKF----LQEALTMRQF--- 73
Query: 438 DPADEHHILRLY----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQV 492
D HI++L + ++I+ EL L F + + S L L +
Sbjct: 74 ---DHPHIVKLIGVITE-----NPVWIIMELCTLGELRSFLQVRKYS-----LDLASLIL 120
Query: 493 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 552
Q AL YL S +H D+ N+L+ S K+ D G S + D+ Y ++
Sbjct: 121 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV--KLGDFGLSRYMEDS--TYYKASK 176
Query: 553 YR------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589
+ APE I + D+W G + E+ G F
Sbjct: 177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 220
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 46/219 (21%), Positives = 79/219 (36%), Gaps = 40/219 (18%)
Query: 389 LGSAAFSKVFQA---QDLHTGVDVCLKIIKND-------KDFFDQSLDEIKLLKLVNKND 438
LG F V +A Q+ + V V +K++K D ++F L E +K
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEF----LREAACMKEF---- 82
Query: 439 PADEHHILRLY------DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQ 491
D H+ +L L ++ ++ +L+ F ++ L L
Sbjct: 83 --DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLV 140
Query: 492 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQ 549
+EYL S IH DL N ++ + + + D G S + D Y Q
Sbjct: 141 RFMVDIACGMEYLSSRNFIHRDLAARNCML-AEDMT-VCVADFGLSRKIYSGD---YYRQ 195
Query: 550 SRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 582
+ + A E + Y D+W+ G + E+ T
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 6e-08
Identities = 49/224 (21%), Positives = 89/224 (39%), Gaps = 45/224 (20%)
Query: 387 EYLGSAAFSKVFQA---QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 437
LG F +V++ ++V +K K D + F + E ++K +
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKF----MSEAVIMKNL--- 70
Query: 438 DPADEHHILRLY----DYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQV 492
D HI++L + E +I+ EL L + + N+ S + L +
Sbjct: 71 ---DHPHIVKLIGIIEE-----EPTWIIMELYPYGELGHYLERNKNS-----LKVLTLVL 117
Query: 493 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS 552
+ Q +A+ YL S+ +H D+ NIL+ S + K+ D G S + D Y ++
Sbjct: 118 YSLQICKAMAYLESINCVHRDIAVRNILVASPECV--KLGDFGLSRYIEDE--DYYKASV 173
Query: 553 YR------APEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589
R +PE I + D+W + E+ + G+ F
Sbjct: 174 TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 7e-08
Identities = 55/223 (24%), Positives = 89/223 (39%), Gaps = 40/223 (17%)
Query: 389 LGSAAFSKVFQA-------QDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKND 438
LG AF +V A V V +K++K +KD D + E++++K++ K+
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL-VSEMEMMKMIGKHK 101
Query: 439 PADEHHILRLYDYFYHLEHLFIVCEL---------LRAN--LYEFQKFNQESGGEAYFTL 487
+I+ L L+++ E LRA ++ E T
Sbjct: 102 -----NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 488 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLC 545
L T Q +EYL S IH DL N+L+ KI D G + D
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVM--KIADFGLARDINNIDY-- 212
Query: 546 LYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 582
Y ++ + R APE + Y + D+WS G ++ E++T
Sbjct: 213 -YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 7e-08
Identities = 47/219 (21%), Positives = 80/219 (36%), Gaps = 40/219 (18%)
Query: 389 LGSAAFSKVFQAQ--DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKNDPA 440
+G F +V +A+ +D +K +K +DF E+++L + +
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF----AGELEVLCKLGHHP-- 86
Query: 441 DEHHILRLYDYFYHLEHLFIVCEL---------LRAN--LYEFQKFNQESGGEAYFTLGR 489
+I+ L H +L++ E LR + L F + + + +
Sbjct: 87 ---NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 490 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ 549
L ++YL IH DL NIL+ KI D G S + YV+
Sbjct: 144 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLS-RGQEV---YVK 197
Query: 550 SRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 582
R A E + Y D+WS G +L E+ +
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 8e-08
Identities = 53/226 (23%), Positives = 87/226 (38%), Gaps = 46/226 (20%)
Query: 389 LGSAAFSKVFQA-------QDLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVN 435
LG F +V A V V +K++K+D D + E++++K++
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL----VSEMEMMKMIG 144
Query: 436 KNDPADEHHILRLYDYFYHLEHLFIVCEL---------LRAN--LYEFQKFNQESGGEAY 484
K+ +I+ L L+++ E LRA ++ E
Sbjct: 145 KHK-----NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 485 FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTD 542
T L T Q +EYL S IH DL N+L+ KI D G + D
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVM--KIADFGLARDINNID 257
Query: 543 NLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 582
Y ++ + R APE + Y + D+WS G ++ E++T
Sbjct: 258 Y---YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 52/231 (22%), Positives = 87/231 (37%), Gaps = 51/231 (22%)
Query: 389 LGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 437
LGS AF KV A + V +K++K + + E+K++ + +
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREAL----MSELKMMTQLGSH 108
Query: 438 DPADEHHILRLYDYFYHLEHLFIVCEL---------LRAN---------LYEFQKFNQES 479
+ +I+ L ++++ E LR+ YE QK +E
Sbjct: 109 E-----NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 480 GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS-- 537
T L Q + +E+L +H DL N+L+ + KI D G +
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVV--KICDFGLARD 221
Query: 538 CFQTDNLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 582
N YV + R APE + Y K D+WS G +L E+++
Sbjct: 222 IMSDSN---YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 57/228 (25%), Positives = 84/228 (36%), Gaps = 54/228 (23%)
Query: 389 LGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND-----KDFFDQSLDEIKLLKLVNKND 438
LG AF KVF A+ + V +K +K+ KDF E +LL +
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF----QREAELLTNL---- 74
Query: 439 PADEHHILRLYDYFYHLEHLFIVCEL---------LRAN--LYEFQKFNQESGGEAYFTL 487
HI++ Y + L +V E LRA+ Q + L
Sbjct: 75 --QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 488 GRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY 547
++ I Q + YL S +H DL N L+ + +KI D G +
Sbjct: 133 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA--NLLVKIGDFG--------MSRD 182
Query: 548 VQSRSY-----------R--APEVIIGLPYDQKIDLWSLGCILAELWT 582
V S Y R PE I+ + + D+WS G IL E++T
Sbjct: 183 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 52/225 (23%), Positives = 88/225 (39%), Gaps = 45/225 (20%)
Query: 389 LGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 437
LG AF +V +A T V +K++K + + E+K+L + +
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL----MSELKILIHIGHH 90
Query: 438 DPADEHHILRLYDY-FYHLEHLFIVCEL---------LRAN--LYEFQKFNQESGGEAYF 485
+++ L L ++ E LR+ + K E + +
Sbjct: 91 L-----NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 486 TLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDN 543
TL L + Q + +E+L S IH DL NIL+ KI D G + ++ +
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV--KICDFGLARDIYKDPD 203
Query: 544 LCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 582
YV+ R APE I Y + D+WS G +L E+++
Sbjct: 204 ---YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 39/210 (18%), Positives = 71/210 (33%), Gaps = 27/210 (12%)
Query: 387 EYLGSAAFSKVFQA---QDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPAD 441
E +G F V+ + + +K + D + S L E ++K
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF------S 148
Query: 442 EHHILRLYDYFYHLEH-LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 499
++L L E +V ++ +L F + + T+ L Q +
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQVAK 203
Query: 500 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG-SSCFQTDNLCLYVQSRSYR---- 554
+++L S +H DL N ++ K+ D G + +
Sbjct: 204 GMKFLASKKFVHRDLAARNCMLDEKFTV--KVADFGLARDMYDKEFDSVHNKTGAKLPVK 261
Query: 555 --APEVIIGLPYDQKIDLWSLGCILAELWT 582
A E + + K D+WS G +L EL T
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 8e-07
Identities = 42/214 (19%), Positives = 83/214 (38%), Gaps = 31/214 (14%)
Query: 389 LGSAAFSKVFQAQ-----DLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPAD 441
LG +F V++ V +K + ++ L+E ++K N
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC----- 87
Query: 442 EHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 496
HH++RL + ++ EL L++ L + + A +L ++ + +
Sbjct: 88 -HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 497 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQSRSYR 554
+ + YL++ +H DL N ++ KI D G + ++TD Y +
Sbjct: 147 IADGMAYLNANKFVHRDLAARNCMVAEDFTV--KIGDFGMTRDIYETDY---YRKGGKGL 201
Query: 555 ------APEVIIGLPYDQKIDLWSLGCILAELWT 582
+PE + + D+WS G +L E+ T
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 9e-07
Identities = 62/448 (13%), Positives = 125/448 (27%), Gaps = 132/448 (29%)
Query: 290 GSSDLHFKGAEKDLMPAEIDNSDTRDGEVNGALHEGKADAE-EHGVATPD-----LLMFD 343
G +K A +DN D +D V + E +H + + D L +F
Sbjct: 12 GEHQYQYKDILSVFEDAFVDNFDCKD--VQDMPKSILSKEEIDHIIMSKDAVSGTLRLFW 69
Query: 344 NLEEECEIFHLRIIHRKNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDL 403
L K ++ + V+ Y ++L S + +
Sbjct: 70 TLL------------SKQEEMVQK------FVEEVLRINY---KFLMSP-----IKTEQR 103
Query: 404 HTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCE 463
+ + + D +L N N ++++ R ++
Sbjct: 104 QPSMM---------TRMYIEQRD-----RLYNDNQVFAKYNVSR--------LQPYLK-- 139
Query: 464 LLRANLYEFQKFNQESGGEAYFTL------GRLQVITRQCLEALEYLHSLGII------- 510
LR L E + + G + + AL+ S +
Sbjct: 140 -LRQALLELRP-------AKNVLIDGVLGSG------KTWV-ALDVCLSYKVQCKMDFKI 184
Query: 511 ------HCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPY 564
+C+ PE +L + + S + N+ L + S ++ PY
Sbjct: 185 FWLNLKNCN-SPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY 243
Query: 565 DQKIDLWSLGCILAELWTGEVL--FPNDAVVMILAR---IIGMLGP-----IDLEMLMQG 614
+ L +L + + F +++ R + L I L+
Sbjct: 244 EN-----CL-LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMT 297
Query: 615 QEIYKYFTKEY--DLY--YINEETNQLEYIIPEESSLEHHLQFS--DAFFIDFVRT---L 665
T + L Y++ L P E + + S D + T
Sbjct: 298 ------LTPDEVKSLLLKYLDCRPQDL----PREVLTTNPRRLSIIAESIRDGLATWDNW 347
Query: 666 LEINPQRRPTAREA----LDHPWLQHPY 689
+N + T E+ L+ + +
Sbjct: 348 KHVNCDKLTTIIESSLNVLEPAEYRKMF 375
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 3e-04
Identities = 98/667 (14%), Positives = 184/667 (27%), Gaps = 233/667 (34%)
Query: 4 VSSSDVETVIEFLRKNGFKEAESALKEDMMEKIRDLGS---FD---------YEKFLFPV 51
V + D + V + + + + E + +M K G+ F +KF+ V
Sbjct: 30 VDNFDCKDVQDMPK-SILSKEE--IDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEV 86
Query: 52 LPP------VKIPASLRQTEVD----EGGADRSSRSSSASSSDD----DEFVSLASSTSD 97
L I RQ + DR + + + ++ L + +
Sbjct: 87 LRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLE 146
Query: 98 LCSSEFTNPYGLRSTSHGNSEASSESLSQFDTARDYDLQNDF----YWHDEKDEGYFMTP 153
L ++ G+ + G + ++ D Y +Q +W +
Sbjct: 147 LRPAKNVLIDGVLGS--GKT-----WVAL-DVCLSYKVQCKMDFKIFW---------LN- 188
Query: 154 SYGGSDFFGCPSEDKFIMTSEAD---RLFENPLAVYDQSEGLHSETNQPEAGGIKEKLKD 210
+ + ++ ++ N + D S + + I+ +L+
Sbjct: 189 -------LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS-----IQAELRR 236
Query: 211 CAAYGCSEPLCKCCAGEGKINNDYGYLSSKEADLIDLQHNVVGDSSTDCDLAPHPGTEKS 270
S+P C L+ L + V ++
Sbjct: 237 ---LLKSKPYENC--------------------LLVLLN--VQNAKA------------- 258
Query: 271 SSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSDTRDGEVN---GALHEGKA 327
F S K L+ TR +V A
Sbjct: 259 --------------WNAFNLSC--------KILLT-------TRFKQVTDFLSAATTTHI 289
Query: 328 DAEEHGVA-TPD----LLM------FDNL-EEECEI--FHLRIIHRKNRTGFEENKDLPI 373
+ H + TPD LL+ +L E L II R G +
Sbjct: 290 SLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKH 349
Query: 374 I----LNTVIAGRYYVTEYLGSAAFSKVFQA-----QDLHTGVDVCLKIIKNDKDFFD-- 422
+ L T+I L A + K+F H + L +I D D
Sbjct: 350 VNCDKLTTIIESSL---NVLEPAEYRKMFDRLSVFPPSAHIPTIL-LSLIWFDVIKSDVM 405
Query: 423 QSLDEIKLLKLVNKN-------------------DPADEHH--------ILRLYD----- 450
++++ LV K + H I + +D
Sbjct: 406 VVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLI 465
Query: 451 ------YFY-HLE-HLFIV-----CELLRANLY---EF--QK-----FNQESGGEAYFTL 487
YFY H+ HL + L R ++ F QK + G TL
Sbjct: 466 PPYLDQYFYSHIGHHLKNIEHPERMTLFR-MVFLDFRFLEQKIRHDSTAWNASGSILNTL 524
Query: 488 GRLQV----ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN 543
+L+ I + +++ I+ K E LI S ++I ++
Sbjct: 525 QQLKFYKPYICDNDPKYERLVNA--ILDFLPKIEENLICSKYTDLLRIA------LMAED 576
Query: 544 LCLYVQS 550
++ ++
Sbjct: 577 EAIFEEA 583
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 56/233 (24%), Positives = 90/233 (38%), Gaps = 55/233 (23%)
Query: 389 LGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVNKN 437
LG F KV +A V +K++K + +D L E +LK VN
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDL----LSEFNVLKQVN-- 84
Query: 438 DPADEH-HILRLYDYFYHLEHLFIVCEL---------LRAN----------LYEFQKFNQ 477
H H+++LY L ++ E LR + +
Sbjct: 85 -----HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 478 ESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537
+ E T+G L Q + ++YL + ++H DL NIL+ ++ KI D G S
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKM--KISDFGLS 197
Query: 538 --CFQTDNLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 582
++ D+ YV+ R A E + Y + D+WS G +L E+ T
Sbjct: 198 RDVYEEDS---YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 57/228 (25%), Positives = 84/228 (36%), Gaps = 55/228 (24%)
Query: 389 LGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND-----KDFFDQSLDEIKLLKLVNKND 438
LG AF KVF A+ + V +K +K +DF E +LL ++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDF----QREAELLTML---- 100
Query: 439 PADEHHILRLYDYFYHLEHLFIVCEL---------LRAN-LYEFQKFNQESGGEAYFTLG 488
HI+R + L +V E LR++ E LG
Sbjct: 101 --QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 158
Query: 489 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCL 546
+L + Q + YL L +H DL N L+ +KI D G S + TD
Sbjct: 159 QLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ--GLVVKIGDFGMSRDIYSTD---- 212
Query: 547 YVQSRSYR------------APEVIIGLPYDQKIDLWSLGCILAELWT 582
Y YR PE I+ + + D+WS G +L E++T
Sbjct: 213 Y-----YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 43/231 (18%), Positives = 77/231 (33%), Gaps = 55/231 (23%)
Query: 387 EYLGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVN 435
E LG F KV++ V +K +K+ ++F E L +
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEF----RHEAMLRARL- 69
Query: 436 KNDPADEHHILRLYDYFYHLEHLFIVCEL---------LRAN--LYEFQKFNQESGGEAY 484
+++ L + L ++ L + + + ++
Sbjct: 70 -----QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 485 FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNL 544
+ Q +EYL S ++H DL N+L+ KI DLG L
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNV--KISDLG--------L 174
Query: 545 CLYVQSRS-YR------------APEVIIGLPYDQKIDLWSLGCILAELWT 582
V + Y+ APE I+ + D+WS G +L E+++
Sbjct: 175 FREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 44/223 (19%), Positives = 75/223 (33%), Gaps = 45/223 (20%)
Query: 387 EYLGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVN 435
LG AF +V++ Q + + + V +K + DF L E ++ N
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF----LMEALIISKFN 132
Query: 436 KNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEF-QKFNQESGGEAYFTLGRLQVI 493
+I+R FI+ EL+ +L F ++ + + L +
Sbjct: 133 ------HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 494 TRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGSSCFQTDNLCLYVQSRS 552
R +YL IH D+ N L+ KI D G + +
Sbjct: 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG--------MARDIYRAG 238
Query: 553 YR-------------APEVIIGLPYDQKIDLWSLGCILAELWT 582
Y PE + + K D WS G +L E+++
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 6e-06
Identities = 41/213 (19%), Positives = 73/213 (34%), Gaps = 33/213 (15%)
Query: 387 EYLGSAAFSKVFQA---QDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPAD 441
E +G F V+ + + +K + D + S L E ++K
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF------S 84
Query: 442 EHHILRLYDYFYHLEH-LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 499
++L L E +V ++ +L F + + T+ L Q +
Sbjct: 85 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQVAK 139
Query: 500 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQSRSYR--- 554
++YL S +H DL N ++ K+ D G + + + Y
Sbjct: 140 GMKYLASKKFVHRDLAARNCMLDEKFTV--KVADFGLARDMYDKE---YYSVHNKTGAKL 194
Query: 555 -----APEVIIGLPYDQKIDLWSLGCILAELWT 582
A E + + K D+WS G +L EL T
Sbjct: 195 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 44/223 (19%), Positives = 76/223 (34%), Gaps = 45/223 (20%)
Query: 387 EYLGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVN 435
LG AF +V++ Q + + + V +K + DF L E ++
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF----LMEALIISKF- 90
Query: 436 KNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEF-QKFNQESGGEAYFTLGRLQVI 493
+ +I+R FI+ EL+ +L F ++ + + L +
Sbjct: 91 -----NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 494 TRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGSSCFQTDNLCLYVQSRS 552
R +YL IH D+ N L+ KI D G + + S
Sbjct: 146 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG--------MARDIYRAS 197
Query: 553 YR-------------APEVIIGLPYDQKIDLWSLGCILAELWT 582
Y PE + + K D WS G +L E+++
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 39/212 (18%), Positives = 74/212 (34%), Gaps = 35/212 (16%)
Query: 389 LGSAAFSKVFQAQDLHTG---VDVCLKIIKNDKDFFDQS--LDEIKLLKLVNKNDPADEH 443
+G F V+ + + + +K + + L E L++ + +
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL------NHP 82
Query: 444 HILRLYDYFYHLE-HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 501
++L L E ++ + +L +F + Q + T+ L Q +
Sbjct: 83 NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN-----PTVKDLISFGLQVARGM 137
Query: 502 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTDNLCLYVQSRSYR----- 554
EYL +H DL N ++ K+ D G + + Y + +R
Sbjct: 138 EYLAEQKFVHRDLAARNCMLDESFTV--KVADFGLARDILDRE----YYSVQQHRHARLP 191
Query: 555 ----APEVIIGLPYDQKIDLWSLGCILAELWT 582
A E + + K D+WS G +L EL T
Sbjct: 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 32/106 (30%), Positives = 48/106 (45%), Gaps = 13/106 (12%)
Query: 485 FTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS--CFQTD 542
TL L + Q + +E+L S IH DL NIL+ KI D G + ++
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV--KICDFGLARDIYKDP 247
Query: 543 NLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 582
+ YV+ R APE I Y + D+WS G +L E+++
Sbjct: 248 D---YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 48/234 (20%), Positives = 78/234 (33%), Gaps = 53/234 (22%)
Query: 387 EYLGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND------KDFFDQSLDEIKLLKLVN 435
+G AF +VFQA+ V +K++K + DF E L+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF----QREAALMAEF- 107
Query: 436 KNDPADEHHILRLYDYFYHLEHLFIVCEL---------LRAN----------LYEFQKFN 476
D +I++L + + ++ E LR+ +
Sbjct: 108 -----DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 477 QESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536
S G + I RQ + YL +H DL N L+ KI D G
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVV--KIADFGL 220
Query: 537 S--CFQTDNLCLYVQSRSYR------APEVIIGLPYDQKIDLWSLGCILAELWT 582
S + D Y + PE I Y + D+W+ G +L E+++
Sbjct: 221 SRNIYSADY---YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 689 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-60 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-58 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-56 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-56 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-53 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-53 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-53 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-52 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-52 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-52 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-51 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-50 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-49 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-49 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-48 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-48 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-48 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-47 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-47 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-46 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-46 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-38 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-37 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-37 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-36 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-35 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-34 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-34 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-34 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-32 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-32 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-31 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-31 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-31 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-30 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-30 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-30 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-30 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-29 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-29 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-29 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-28 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-27 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-27 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-18 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 5e-60
Identities = 74/311 (23%), Positives = 120/311 (38%), Gaps = 21/311 (6%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDP 439
+ LG+ VF+ +G+ + K+I +Q + E+++L N
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN---- 62
Query: 440 ADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
+I+ Y FY + I E + + L ++ +
Sbjct: 63 ---SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVI 114
Query: 499 EALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL-YVQSRSYRAP 556
+ L YL I+H D+KP NIL+ S R EIK+ D G S D++ +V +RSY +P
Sbjct: 115 KGLTYLREKHKIMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMANSFVGTRSYMSP 172
Query: 557 EVIIGLPYDQKIDLWSLGCILAELWTGEVLF-PNDAVVMILARIIGMLGPIDLEMLMQGQ 615
E + G Y + D+WS+G L E+ G P DA + L + G
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 675
+ D L+YI+ E FS F DFV L NP R
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLE-FQDFVNKCLIKNPAERAD 291
Query: 676 AREALDHPWLQ 686
++ + H +++
Sbjct: 292 LKQLMVHAFIK 302
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 197 bits (502), Expect = 7e-58
Identities = 102/335 (30%), Positives = 166/335 (49%), Gaps = 25/335 (7%)
Query: 372 PIILNTVIA-GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKL 430
P RY + LG FS V+ A+D+ V +KI++ DK + + + DEIKL
Sbjct: 3 PAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKL 62
Query: 431 LKLVN-----KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYF 485
L+ VN K D +HIL+L D+F H + ++ L E +
Sbjct: 63 LQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI 122
Query: 486 TLGRLQVITRQCLEALEYL-HSLGIIHCDLKPENILIKS----YQRCEIKIIDLGSSCFQ 540
L ++ I++Q L L+Y+ GIIH D+KPEN+L++ +IKI DLG++C+
Sbjct: 123 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 182
Query: 541 TDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV------VM 594
++ +Q+R YR+PEV++G P+ D+WS C++ EL TG+ LF D
Sbjct: 183 DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242
Query: 595 ILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFS 654
+A+II +LG + +L G+ +F L I++ P E L +FS
Sbjct: 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLK-----FWPLEDVLTEKYKFS 297
Query: 655 DAF---FIDFVRTLLEINPQRRPTAREALDHPWLQ 686
DF+ +L+++P++R A ++HPWL+
Sbjct: 298 KDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK 332
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 3e-56
Identities = 79/311 (25%), Positives = 138/311 (44%), Gaps = 27/311 (8%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHT-GVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA 440
+Y +G A+ KVF+A+DL G V LK ++ L I+ + ++ +
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 441 DEHHILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 495
+ +++RL+D L +V E + +L + E G ++ +
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG----VPTETIKDMMF 123
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRA 555
Q L L++LHS ++H DLKP+NIL+ S + ++ L L V + YRA
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 183
Query: 556 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615
PEV++ Y +DLWS+GCI AE++ + LF + V L +I+ ++G + G+
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG-------LPGE 236
Query: 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 675
E + + ++ +E + + L D + L NP +R +
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDEL----------GKDLLLKCLTFNPAKRIS 286
Query: 676 AREALDHPWLQ 686
A AL HP+ Q
Sbjct: 287 AYSALSHPYFQ 297
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 192 bits (488), Expect = 6e-56
Identities = 69/317 (21%), Positives = 120/317 (37%), Gaps = 55/317 (17%)
Query: 374 ILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL-DEIKLLK 432
I + + Y + E LG+ AF V + + TG + K + + +++ EI+ +
Sbjct: 19 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMS 78
Query: 433 LVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQ 491
++ H ++ L+D F + ++ E + F+K E +
Sbjct: 79 VLR-------HPTLVNLHDAFEDDNEMVMIYEFMSGGEL-FEKVADEHNK---MSEDEAV 127
Query: 492 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQ 549
RQ + L ++H +H DLKPENI+ + + E+K+ID G + + +
Sbjct: 128 EYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG 187
Query: 550 SRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 609
+ + APEV G P D+WS+G + L +G F + L + +D
Sbjct: 188 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS 247
Query: 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 669
I E+ DF+R LL +
Sbjct: 248 AFSG---------------------------ISED-------------GKDFIRKLLLAD 267
Query: 670 PQRRPTAREALDHPWLQ 686
P R T +AL+HPWL
Sbjct: 268 PNTRMTIHQALEHPWLT 284
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 9e-56
Identities = 72/310 (23%), Positives = 117/310 (37%), Gaps = 62/310 (20%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 437
+ + LG F V+ A++ + + LK++ Q E+++ +
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH- 65
Query: 438 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 497
+ILRLY YF+ ++++ E + F R +
Sbjct: 66 -----PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITEL 115
Query: 498 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF-QTDNLCLYVQSRSYRAP 556
AL Y HS +IH D+KPEN+L+ S E+KI D G S + + Y P
Sbjct: 116 ANALSYCHSKRVIHRDIKPENLLLGS--AGELKIADFGWSVHAPSSRRTTLCGTLDYLPP 173
Query: 557 EVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 616
E+I G +D+K+DLWSLG + E G+ F + RI
Sbjct: 174 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS---------------- 217
Query: 617 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 676
++E+ P+ + D + LL+ NP +RP
Sbjct: 218 -------------------RVEFTFPDFVTEG---------ARDLISRLLKHNPSQRPML 249
Query: 677 REALDHPWLQ 686
RE L+HPW+
Sbjct: 250 REVLEHPWIT 259
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 2e-53
Identities = 84/314 (26%), Positives = 138/314 (43%), Gaps = 36/314 (11%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 441
Y T+ +G+ +F V+QA+ +G V +K + DK F ++ E+++++ ++
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLD------ 71
Query: 442 EHHILRLYDYFYH------LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 495
+I+RL +FY +L +V + + +Y + + + +++
Sbjct: 72 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT--LPVIYVKLYMY 129
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSY 553
Q +L Y+HS GI H D+KP+N+L+ +K+ D GS+ Y+ SR Y
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV-LKLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 554 RAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 612
RAPE+I G Y ID+WS GC+LAEL G+ +FP D+ V L II +LG E +
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 672
+ Y F I + + I LLE P
Sbjct: 249 EMNPNYTEFKFPQ---------------IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 293
Query: 673 RPTAREALDHPWLQ 686
R T EA H +
Sbjct: 294 RLTPLEACAHSFFD 307
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 3e-53
Identities = 83/312 (26%), Positives = 137/312 (43%), Gaps = 34/312 (10%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKND 438
+ E +G + V++A++ TG V LK I+ + ++ EI LLK +N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH-- 60
Query: 439 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
+I++L D + L++V E L +L +F + +G L ++ Q L
Sbjct: 61 ----PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG----IPLPLIKSYLFQLL 112
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQSRSYRA 555
+ L + HS ++H DLKP+N+LI + IK+ D G + V + YRA
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 170
Query: 556 PEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614
PE+++G Y +D+WSLGCI AE+ T LFP D+ + L RI LG D +
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230
Query: 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP 674
+ Y + + + D + +L +P +R
Sbjct: 231 TSMPDY---------------KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI 275
Query: 675 TAREALDHPWLQ 686
+A+ AL HP+ Q
Sbjct: 276 SAKAALAHPFFQ 287
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 184 bits (469), Expect = 3e-53
Identities = 65/313 (20%), Positives = 122/313 (38%), Gaps = 57/313 (18%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSL-DEIKLLKLVNKN 437
+ Y + E LGS AF V + + TG K I ++ +EI ++ ++
Sbjct: 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH-- 84
Query: 438 DPADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITR 495
H ++ L+D F + ++ E L L++ + + R
Sbjct: 85 -----HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-----MSEAEVINYMR 134
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSY 553
Q E L+++H I+H D+KPENI+ ++ + +KIID G + + + + + +
Sbjct: 135 QACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEF 194
Query: 554 RAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613
APE++ P D+W++G + L +G F + + L + D +
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 254
Query: 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 673
+ E DF++ LL+ P++R
Sbjct: 255 ---------------------------VSPE-------------AKDFIKNLLQKEPRKR 274
Query: 674 PTAREALDHPWLQ 686
T +AL+HPWL+
Sbjct: 275 LTVHDALEHPWLK 287
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 4e-53
Identities = 75/311 (24%), Positives = 120/311 (38%), Gaps = 54/311 (17%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 438
+ +Y + E LG F V + + + K +K EI +L +
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR--- 59
Query: 439 PADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQC 497
+IL L++ F +E L ++ E + +++E + + Q
Sbjct: 60 ---HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-----LNEREIVSYVHQV 111
Query: 498 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF--QTDNLCLYVQSRSYRA 555
EAL++LHS I H D++PENI+ ++ + IKII+ G + DN L + Y A
Sbjct: 112 CEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171
Query: 556 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615
PEV D+WSLG ++ L +G F + I+ I+ D +
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD-------E 224
Query: 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 675
E +K + E +DFV LL + R T
Sbjct: 225 EAFKEISIE---------------------------------AMDFVDRLLVKERKSRMT 251
Query: 676 AREALDHPWLQ 686
A EAL HPWL+
Sbjct: 252 ASEALQHPWLK 262
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 5e-53
Identities = 88/325 (27%), Positives = 145/325 (44%), Gaps = 42/325 (12%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNK 436
+ RY Y+G A+ V A D V V +K I + + ++L EIK+L
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR- 64
Query: 437 NDPADEHHILRLYDYFY-----HLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQ 491
+I+ + D ++ +++V L+ A+LY+ K + +
Sbjct: 65 -----HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-------LSNDHIC 112
Query: 492 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN------LC 545
Q L L+Y+HS ++H DLKP N+L+ + C++KI D G + + L
Sbjct: 113 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDHDHTGFLT 170
Query: 546 LYVQSRSYRAPEVII-GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 604
YV +R YRAPE+++ Y + ID+WS+GCILAE+ + +FP + L I+G+LG
Sbjct: 171 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230
Query: 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 664
E L I + Y L ++ + P S +D +
Sbjct: 231 SPSQEDL---NCIINLKARNYLLSLPHKNKVPWNRLFPNADSK----------ALDLLDK 277
Query: 665 LLEINPQRRPTAREALDHPWLQHPY 689
+L NP +R +AL HP+L+ Y
Sbjct: 278 MLTFNPHKRIEVEQALAHPYLEQYY 302
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-52
Identities = 71/311 (22%), Positives = 127/311 (40%), Gaps = 61/311 (19%)
Query: 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII-KNDKDFFDQSLDEIKLLKLVNKNDP 439
+Y E +G A V+ A D+ TG +V ++ + + + ++EI +++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK---- 75
Query: 440 ADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
+ +I+ D + + L++V E L G++ + R+CL
Sbjct: 76 ---NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECL 126
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQSRSYRA 555
+ALE+LHS +IH D+K +NIL+ +K+ D G + V + + A
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184
Query: 556 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615
PEV+ Y K+D+WSLG + E+ GE + N+ + L I P
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP---------- 234
Query: 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 675
E PE+ S F DF+ L+++ ++R +
Sbjct: 235 ----------------------ELQNPEKLSAI---------FRDFLNRCLDMDVEKRGS 263
Query: 676 AREALDHPWLQ 686
A+E L H +L+
Sbjct: 264 AKELLQHQFLK 274
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 3e-52
Identities = 80/314 (25%), Positives = 126/314 (40%), Gaps = 62/314 (19%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII-KNDKDFFDQSLDEIKLLKLVNKNDPA 440
+ + LG AF KV++AQ+ T V K+I ++ + + EI +L +
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH---- 68
Query: 441 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 500
+I++L D FY+ +L+I+ E + E T ++QV+ +Q L+A
Sbjct: 69 --PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP----LTESQIQVVCKQTLDA 122
Query: 501 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPE 557
L YLH IIH DLK NIL +IK+ D G S T + ++ + + APE
Sbjct: 123 LNYLHDNKIIHRDLKAGNILFTL--DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 180
Query: 558 VIIGL-----PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 612
V++ PYD K D+WSLG L E+ E + +L +I
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA------------ 228
Query: 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 672
++ P S F DF++ LE N
Sbjct: 229 --------------------KSEPPTLAQPSRWSSN---------FKDFLKKCLEKNVDA 259
Query: 673 RPTAREALDHPWLQ 686
R T + L HP++
Sbjct: 260 RWTTSQLLQHPFVT 273
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 4e-52
Identities = 82/311 (26%), Positives = 130/311 (41%), Gaps = 39/311 (12%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK------NDKDFFDQSLDEIKLLKLVNKNDPA 440
++LG F+ V++A+D +T V +K IK +L EIKLL+ ++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH---- 59
Query: 441 DEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 500
+I+ L D F H ++ +V + + +L K N + ++ L+
Sbjct: 60 --PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPS-----HIKAYMLMTLQG 112
Query: 501 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YVQSRSYRAPE 557
LEYLH I+H DLKP N+L+ +K+ D G + V +R YRAPE
Sbjct: 113 LEYLHQHWILHRDLKPNNLLLDE--NGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPE 170
Query: 558 VIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 616
++ G Y +D+W++GCILAEL P D+ + L RI LG E
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230
Query: 617 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 676
+ Y T + L H + +D ++ L NP R TA
Sbjct: 231 LPDYVTFKS----------------FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA 274
Query: 677 REALDHPWLQH 687
+AL + +
Sbjct: 275 TQALKMKYFSN 285
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 7e-52
Identities = 77/320 (24%), Positives = 135/320 (42%), Gaps = 32/320 (10%)
Query: 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD---FFDQSLDEIKLLKLVNKN 437
+Y +G F +VF+A+ TG V LK + + + F +L EIK+L+L+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 438 DPADEHHILRLYDYFYHLE--HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 495
+ + I R Y+ +++V + +L FTL ++ + +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-----FTLSEIKRVMQ 124
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS-------CFQTDNLCLYV 548
L L Y+H I+H D+K N+LI + +K+ D G + Q + V
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLIT--RDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 549 QSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 607
+ YR PE+++G Y IDLW GCI+AE+WT + + LA I + G I
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 608 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLE 667
E+ Y E + ++L+ + D + +D + LL
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYV------------RDPYALDLIDKLLV 290
Query: 668 INPQRRPTAREALDHPWLQH 687
++P +R + +AL+H +
Sbjct: 291 LDPAQRIDSDDALNHDFFWS 310
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 3e-51
Identities = 83/314 (26%), Positives = 146/314 (46%), Gaps = 13/314 (4%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVN 435
+ RY + +GS A V A D +V +K + ++ ++ E+ L+K VN
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 436 KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 495
+ ++ + +++V EL+ ANL + + R+ +
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--------LDHERMSYLLY 126
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRA 555
Q L +++LHS GIIH DLKP NI++KS +I L + + + YV +R YRA
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186
Query: 556 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615
PEVI+G+ Y + +D+WS+GCI+ E+ ++LFP + ++I LG E + + Q
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246
Query: 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 675
+ + + Y + S + L+ S A D + +L I+P +R +
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQA--RDLLSKMLVIDPAKRIS 304
Query: 676 AREALDHPWLQHPY 689
+AL HP++ Y
Sbjct: 305 VDDALQHPYINVWY 318
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 175 bits (444), Expect = 2e-50
Identities = 84/312 (26%), Positives = 141/312 (45%), Gaps = 36/312 (11%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII---KNDKDFFDQSLDEIKLLKLVNKND 438
+Y+ E +G + V++AQ+ + G LK I K D+ ++ EI +LK +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELK--- 58
Query: 439 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
+I++LYD + + L +V E L +L + + + Q L
Sbjct: 59 ---HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-----LESVTAKSFLLQLL 110
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN---LCLYVQSRSYRA 555
+ Y H ++H DLKP+N+LI E+KI D G + + + YRA
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINR--EGELKIADFGLARAFGIPVRKYTHEIVTLWYRA 168
Query: 556 PEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614
P+V++G Y ID+WS+GCI AE+ G LFP + L RI +LG + +
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP 674
E+ KY + + E E L+ D ID + +L+++P +R
Sbjct: 229 TELPKY---------------DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI 273
Query: 675 TAREALDHPWLQ 686
TA++AL+H + +
Sbjct: 274 TAKQALEHAYFK 285
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 4e-50
Identities = 81/318 (25%), Positives = 128/318 (40%), Gaps = 58/318 (18%)
Query: 378 VIAGRYYVT-EYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNK 436
I Y VT + LG KV Q + T LK++++ E++L ++
Sbjct: 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA----RREVELHWRASQ 63
Query: 437 NDPADEHHILRLYDYFYHL----EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQ 491
HI+R+ D + +L + L IV E L L+ + G+ FT
Sbjct: 64 CP-----HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREAS 114
Query: 492 VITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGSSCFQTDN--LCLYV 548
I + EA++YLHS+ I H D+KPEN+L S +K+ D G + T + L
Sbjct: 115 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 174
Query: 549 QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 608
+ Y APEV+ YD+ D+WSLG I+ L G F ++ + I +
Sbjct: 175 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--------- 225
Query: 609 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEI 668
Q E+ PE S + ++ +R LL+
Sbjct: 226 --------------------KTRIRMGQYEFPNPEWSEVSEEVK-------MLIRNLLKT 258
Query: 669 NPQRRPTAREALDHPWLQ 686
P +R T E ++HPW+
Sbjct: 259 EPTQRMTITEFMNHPWIM 276
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (436), Expect = 5e-49
Identities = 62/313 (19%), Positives = 115/313 (36%), Gaps = 65/313 (20%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 437
+ +G +F V+ A+D+ V +K + + + + E++ L+ +
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-- 73
Query: 438 DPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 496
H + ++ + ++V E + + + +++ + +T
Sbjct: 74 -----HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAVTHG 123
Query: 497 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAP 556
L+ L YLHS +IH D+K NIL+ +K+ D GS+ +V + + AP
Sbjct: 124 ALQGLAYLHSHNMIHRDVKAGNILLSE--PGLVKLGDFGSASIMAPA-NSFVGTPYWMAP 180
Query: 557 EVIIGL---PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613
EVI+ + YD K+D+WSLG EL + N + L I
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA------------- 227
Query: 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 673
N+ + S F +FV + L+ PQ R
Sbjct: 228 --------------------QNESPALQSGHWSEY---------FRNFVDSCLQKIPQDR 258
Query: 674 PTAREALDHPWLQ 686
PT+ L H ++
Sbjct: 259 PTSEVLLKHRFVL 271
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 6e-49
Identities = 89/318 (27%), Positives = 147/318 (46%), Gaps = 38/318 (11%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVN 435
+ Y + +GS A+ V A D TG V +K + + F ++ E++LLK +
Sbjct: 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 75
Query: 436 KNDPADEHHILRLYDYFYHLE------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGR 489
+++ L D F E ++V + +L + K + R
Sbjct: 76 ------HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-------LGEDR 122
Query: 490 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ 549
+Q + Q L+ L Y+H+ GIIH DLKP N+ + + CE+KI+D G + + YV
Sbjct: 123 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN--EDCELKILDFGLARQADSEMTGYVV 180
Query: 550 SRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 608
+R YRAPEVI+ + Y Q +D+WS+GCI+AE+ TG+ LF + L I+ + G
Sbjct: 181 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240
Query: 609 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEI 668
E + Q + K Y E I+ S L ++ + +L +
Sbjct: 241 EFV---QRLQSDEAKNYMKGLPELEKKDFASILTNASPL----------AVNLLEKMLVL 287
Query: 669 NPQRRPTAREALDHPWLQ 686
+ ++R TA EAL HP+ +
Sbjct: 288 DAEQRVTAGEALAHPYFE 305
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 3e-48
Identities = 82/312 (26%), Positives = 138/312 (44%), Gaps = 26/312 (8%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLKLVN 435
+ RY +GS A+ V A D TG+ V +K + ++ E++LLK +
Sbjct: 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 436 KNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 495
+ + +++V L+ A+L K + T +Q +
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-------LTDDHVQFLIY 128
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRA 555
Q L L+Y+HS IIH DLKP N+ + KI+D G + D + YV +R YRA
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCEL--KILDFGLARHTDDEMTGYVATRWYRA 186
Query: 556 PEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614
PE+++ + Y+Q +D+WS+GCI+AEL TG LFP + L I+ ++G E+L
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL--- 243
Query: 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP 674
++I + Y + + L +D + +L ++ +R
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPL----------AVDLLEKMLVLDSDKRI 293
Query: 675 TAREALDHPWLQ 686
TA +AL H +
Sbjct: 294 TAAQALAHAYFA 305
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 3e-48
Identities = 60/317 (18%), Positives = 112/317 (35%), Gaps = 62/317 (19%)
Query: 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKII--KNDKDFFDQSLDEIKLLKLVNKND 438
+ + + LG A+ +V A + T V +KI+ K D + EI + K++N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN--- 61
Query: 439 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
++++ Y + ++ E F + + G Q Q +
Sbjct: 62 ---HENVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIG----MPEPDAQRFFHQLM 113
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF-----QTDNLCLYVQSRSY 553
+ YLH +GI H D+KPEN+L+ R +KI D G + + L + Y
Sbjct: 114 AGVVYLHGIGITHRDIKPENLLLDE--RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171
Query: 554 RAPEVIIGLPYD-QKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 612
APE++ + + +D+WS G +L + GE+ +
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP---------------------- 209
Query: 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 672
++ Q E+ + + + D+ + + +L NP
Sbjct: 210 -------------------SDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSA 250
Query: 673 RPTAREALDHPWLQHPY 689
R T + W P
Sbjct: 251 RITIPDIKKDRWYNKPL 267
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 4e-48
Identities = 72/317 (22%), Positives = 118/317 (37%), Gaps = 68/317 (21%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-------DFFDQSLDEIKLL 431
+ +Y V LGS F V+ + + V +K ++ D+ + E+ LL
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 432 KLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQ 491
K V+ ++RL D+F + ++ E F + +
Sbjct: 62 KKVSSGFS----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA----LQEELAR 113
Query: 492 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL-YVQS 550
Q LEA+ + H+ G++H D+K ENILI R E+K+ID GS D + + +
Sbjct: 114 SFFWQVLEAVRHCHNCGVLHRDIKDENILI-DLNRGELKLIDFGSGALLKDTVYTDFDGT 172
Query: 551 RSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 609
R Y PE I Y + +WSLG +L ++ G++ F +D
Sbjct: 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------------------- 213
Query: 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 669
EE + + + S E +R L +
Sbjct: 214 ----------------------EEIIRGQVFFRQRVSSE---------CQHLIRWCLALR 242
Query: 670 PQRRPTAREALDHPWLQ 686
P RPT E +HPW+Q
Sbjct: 243 PSDRPTFEEIQNHPWMQ 259
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 4e-48
Identities = 84/313 (26%), Positives = 135/313 (43%), Gaps = 36/313 (11%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKND 438
+Y E +G + VF+A++ T V LK ++ +D+ +L EI LLK +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK--- 59
Query: 439 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
+I+RL+D + + L +V E +L ++ ++ Q L
Sbjct: 60 ---HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE-----IVKSFLFQLL 111
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQSRSYRA 555
+ L + HS ++H DLKP+N+LI K+ + G + V + YR
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRNGEL--KLANFGLARAFGIPVRCYSAEVVTLWYRP 169
Query: 556 PEVIIGLP-YDQKIDLWSLGCILAELWTGEV-LFPNDAVVMILARIIGMLGPIDLEMLMQ 613
P+V+ G Y ID+WS GCI AEL LFP + V L RI +LG E
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229
Query: 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 673
++ Y + P +SL + + +A D ++ LL+ NP +R
Sbjct: 230 MTKLPDYKPYP---------------MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQR 274
Query: 674 PTAREALDHPWLQ 686
+A EAL HP+
Sbjct: 275 ISAEEALQHPYFS 287
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 8e-48
Identities = 72/319 (22%), Positives = 118/319 (36%), Gaps = 69/319 (21%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 437
+ + LG +FS V A++L T + +KI++ ++ E ++ ++
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-- 66
Query: 438 DPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 496
H ++LY F E L+ + S F + T +
Sbjct: 67 -----HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAE 116
Query: 497 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSR 551
+ ALEYLH GIIH DLKPENIL+ I+I D G++ + +V +
Sbjct: 117 IVSALEYLHGKGIIHRDLKPENILLNE--DMHIQITDFGTAKVLSPESKQARANSFVGTA 174
Query: 552 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 611
Y +PE++ + DLW+LGCI+ +L G F +I +II
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----------- 223
Query: 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQ 671
+LEY PE+ + D V LL ++
Sbjct: 224 ------------------------KLEYDFPEKFFPK---------ARDLVEKLLVLDAT 250
Query: 672 RRPTAREALDHPW-LQHPY 689
+R E + HP+
Sbjct: 251 KRLGCEEMEGYGPLKAHPF 269
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 167 bits (424), Expect = 1e-47
Identities = 78/324 (24%), Positives = 127/324 (39%), Gaps = 72/324 (22%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----------NDKDFFDQSLDEIKLL 431
Y E LG S V + T + +KII ++ + +L E+ +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 432 KLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRL 490
+ V+ +I++L D + F+V +L++ L+++ +
Sbjct: 64 RKVS-----GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV------TLSEKET 112
Query: 491 QVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF--QTDNLCLYV 548
+ I R LE + LH L I+H DLKPENIL+ IK+ D G SC + L
Sbjct: 113 RKIMRALLEVICALHKLNIVHRDLKPENILLDD--DMNIKLTDFGFSCQLDPGEKLREVC 170
Query: 549 QSRSYRAPEVIIG------LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGM 602
+ SY APE+I Y +++D+WS G I+ L G F + +++L I+
Sbjct: 171 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM-- 228
Query: 603 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFV 662
+ ++ PE ++ D V
Sbjct: 229 -------------------------------SGNYQFGSPEWDDYSDTVK-------DLV 250
Query: 663 RTLLEINPQRRPTAREALDHPWLQ 686
L + PQ+R TA EAL HP+ Q
Sbjct: 251 SRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (424), Expect = 2e-47
Identities = 81/315 (25%), Positives = 129/315 (40%), Gaps = 60/315 (19%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLVNK 436
I Y + LG+ AFS+V A+D T V +K I + +EI +L +
Sbjct: 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK- 65
Query: 437 NDPADEH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVIT 494
H +I+ L D + HL+++ +L+ L++ ++T +
Sbjct: 66 ------HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG------FYTERDASRLI 113
Query: 495 RQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKIIDLGSSCFQTDN--LCLYVQSR 551
Q L+A++YLH LGI+H DLKPEN+L S + +I I D G S + L +
Sbjct: 114 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTP 173
Query: 552 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 611
Y APEV+ PY + +D WS+G I L G F ++ + +I+ D
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW 233
Query: 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQ 671
I + DF+R L+E +P+
Sbjct: 234 DD---------------------------ISDS-------------AKDFIRHLMEKDPE 253
Query: 672 RRPTAREALDHPWLQ 686
+R T +AL HPW+
Sbjct: 254 KRFTCEQALQHPWIA 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 5e-47
Identities = 58/321 (18%), Positives = 118/321 (36%), Gaps = 65/321 (20%)
Query: 377 TVIAGRYY-VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKN---DKDFFDQSLDEIKLLK 432
GR+ +G +F V++ D T V+V +++ K + +E ++LK
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK 63
Query: 433 LVNKNDPADEHHILRLYDYFYHL----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLG 488
+ +I+R YD + + + +V EL+ + + + +
Sbjct: 64 GLQ------HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-----MKIK 112
Query: 489 RLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLC- 545
L+ RQ L+ L++LH+ IIH DLK +NI I +KI DLG + + +
Sbjct: 113 VLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATLKRASFAK 171
Query: 546 LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 605
+ + + APE+ YD+ +D+++ G + E+ T E + + R +
Sbjct: 172 AVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV----- 225
Query: 606 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTL 665
+ + + E + +
Sbjct: 226 ---------------------------TSGVKPASFDKVAIPE---------VKEIIEGC 249
Query: 666 LEINPQRRPTAREALDHPWLQ 686
+ N R + ++ L+H + Q
Sbjct: 250 IRQNKDERYSIKDLLNHAFFQ 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 3e-46
Identities = 56/317 (17%), Positives = 111/317 (35%), Gaps = 67/317 (21%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKNDP 439
Y V +G+ ++ + + + G + K + + + E+ LL+ +
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK---- 61
Query: 440 ADEHHILRLYDYFYHLE--HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQ 496
+I+R YD L+IV E +L + Y + + Q
Sbjct: 62 --HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ--YLDEEFVLRVMTQ 117
Query: 497 CLEALEYLHSLG-----IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCL---YV 548
AL+ H ++H DLKP N+ + + +K+ D G + + +V
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDG--KQNVKLGDFGLARILNHDTSFAKAFV 175
Query: 549 QSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 608
+ Y +PE + + Y++K D+WSLGC+L EL F + + +I
Sbjct: 176 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI--------- 226
Query: 609 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEI 668
+ ++ Y +E + + +L +
Sbjct: 227 ---------------------REGKFRRIPYRYSDE-------------LNEIITRMLNL 252
Query: 669 NPQRRPTAREALDHPWL 685
RP+ E L++P +
Sbjct: 253 KDYHRPSVEEILENPLI 269
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 164 bits (416), Expect = 4e-46
Identities = 82/309 (26%), Positives = 137/309 (44%), Gaps = 25/309 (8%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 441
Y + LG +S+VF+A ++ V +KI+K K + EIK+L+ +
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGP--- 90
Query: 442 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 501
+I+ L D N +F++ Q T ++ + L+AL
Sbjct: 91 --NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKAL 142
Query: 502 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVI 559
+Y HS+GI+H D+KP N++I + ++++ID G + F + V SR ++ PE++
Sbjct: 143 DYCHSMGIMHRDVKPHNVMIDH-EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 201
Query: 560 IGLP-YDQKIDLWSLGCILAELWTGEV-LFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 617
+ YD +D+WSLGC+LA + + F L RI +LG DL + I
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 618 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 677
E D + + E+ S +DF+ LL + Q R TAR
Sbjct: 262 ------ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEA-LDFLDKLLRYDHQSRLTAR 314
Query: 678 EALDHPWLQ 686
EA++HP+
Sbjct: 315 EAMEHPYFY 323
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 6e-45
Identities = 72/320 (22%), Positives = 124/320 (38%), Gaps = 64/320 (20%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQS-------LDEIKLL 431
+ Y E LGS F+ V + ++ TG+ K IK + + E+ +L
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 432 KLVNKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRL 490
K + H +++ L++ + + + ++ EL+ +ES E
Sbjct: 68 KEIQ-------HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE-----A 115
Query: 491 QVITRQCLEALEYLHSLGIIHCDLKPENILI--KSYQRCEIKIIDLGSSCF--QTDNLCL 546
+Q L + YLHSL I H DLKPENI++ ++ + IKIID G + +
Sbjct: 116 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 547 YVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 606
+ + APE++ P + D+WS+G I L +G F D LA + +
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235
Query: 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLL 666
+ E DF+R LL
Sbjct: 236 EDEYFSN---------------------------TSAL-------------AKDFIRRLL 255
Query: 667 EINPQRRPTAREALDHPWLQ 686
+P++R T +++L HPW++
Sbjct: 256 VKDPKKRMTIQDSLQHPWIK 275
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (394), Expect = 2e-43
Identities = 54/325 (16%), Positives = 108/325 (33%), Gaps = 61/325 (18%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 438
+ RY + +GS +F ++ D+ G +V +K+ Q E K+ K++
Sbjct: 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-PQLHIESKIYKMMQ--- 60
Query: 439 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
I + ++ +V ELL +L + F F+L + ++ Q +
Sbjct: 61 --GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK-----FSLKTVLLLADQMI 113
Query: 499 EALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGSSCFQTDN----------LCLY 547
+EY+HS IH D+KP+N L+ + + IID G + D
Sbjct: 114 SRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173
Query: 548 VQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 607
+ Y + +G+ ++ DL SLG +L G + + +
Sbjct: 174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-------- 225
Query: 608 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLE 667
+ ++ L P E F ++
Sbjct: 226 ---------------ERISEKKMSTPIEVLCKGYPSE-------------FATYLNFCRS 257
Query: 668 INPQRRPTA---REALDHPWLQHPY 689
+ +P R+ + + + +
Sbjct: 258 LRFDDKPDYSYLRQLFRNLFHRQGF 282
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 155 bits (392), Expect = 6e-43
Identities = 65/314 (20%), Positives = 114/314 (36%), Gaps = 68/314 (21%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKND 438
+ + LG+ +F +V + H G +K++K + + DE +L +V
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT--- 62
Query: 439 PADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 497
H I+R++ F + +F++ + + + F + +
Sbjct: 63 ----HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEV 113
Query: 498 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPE 557
ALEYLHS II+ DLKPENIL+ IKI D G + + D + Y APE
Sbjct: 114 CLALEYLHSKDIIYRDLKPENILLDK--NGHIKITDFGFAKYVPDVTYTLCGTPDYIAPE 171
Query: 558 VIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 617
V+ PY++ ID WS G ++ E+ G F + + +I+
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL----------------- 214
Query: 618 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR---- 673
E P + + D + L+ + +R
Sbjct: 215 ------------------NAELRFPPFFNED---------VKDLLSRLITRDLSQRLGNL 247
Query: 674 -PTAREALDHPWLQ 686
+ +HPW +
Sbjct: 248 QNGTEDVKNHPWFK 261
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 154 bits (390), Expect = 4e-42
Identities = 68/316 (21%), Positives = 120/316 (37%), Gaps = 62/316 (19%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKN 437
+ V +G F +V+ + TG +K + K +L+E +L LV+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 438 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 497
D I+ + F+ + L + +L+ + EA ++ +
Sbjct: 65 D---CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEI 116
Query: 498 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC-FQTDNLCLYVQSRSYRAP 556
+ LE++H+ +++ DLKP NIL+ + ++I DLG +C F V + Y AP
Sbjct: 117 ILGLEHMHNRFVVYRDLKPANILLDEH--GHVRISDLGLACDFSKKKPHASVGTHGYMAP 174
Query: 557 EVII-GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615
EV+ G+ YD D +SLGC+L +L G F
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH------------------------- 209
Query: 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 675
K D + I+ T + +P+ S E + LL+ + RR
Sbjct: 210 -------KTKDKHEIDRMTLTMAVELPDSFSPE---------LRSLLEGLLQRDVNRRLG 253
Query: 676 -----AREALDHPWLQ 686
A+E + P+ +
Sbjct: 254 CLGRGAQEVKESPFFR 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 151 bits (381), Expect = 1e-41
Identities = 66/322 (20%), Positives = 114/322 (35%), Gaps = 63/322 (19%)
Query: 377 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLK 432
+ ++ RY + E LG S+V A+DL DV +K+++ D F+ + E +
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62
Query: 433 LVNKNDPADEHHILRLYDYFYHLEH----LFIVCELLRANLYEFQKFNQESGGEAYFTLG 488
+N I+ +YD +IV E + + T
Sbjct: 63 ALN------HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPK 111
Query: 489 RLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN----L 544
R + +AL + H GIIH D+KP NI+I + ++ + + + N
Sbjct: 112 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 171
Query: 545 CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 604
+ + Y +PE G D + D++SLGC+L E+ TGE F D+ V + + +
Sbjct: 172 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV---- 227
Query: 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRT 664
+ + I P H S V
Sbjct: 228 -------------------------------REDPIPPS----ARHEGLSAD-LDAVVLK 251
Query: 665 LLEINPQRRPTAREALDHPWLQ 686
L NP+ R + ++
Sbjct: 252 ALAKNPENRYQTAAEMRADLVR 273
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 150 bits (379), Expect = 3e-41
Identities = 53/264 (20%), Positives = 94/264 (35%), Gaps = 29/264 (10%)
Query: 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKN 437
V+ Y V +G +F +F+ +L V +K D Q DE + KL+
Sbjct: 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-PQLRDEYRTYKLLAGC 60
Query: 438 DPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQC 497
I +Y + H +V +LL +L + F++ + + +Q
Sbjct: 61 -----TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR-----KFSVKTVAMAAKQM 110
Query: 498 LEALEYLHSLGIIHCDLKPENILIKSYQRCE---IKIIDLGSSCFQTDNLC--------- 545
L ++ +H +++ D+KP+N LI I ++D G F D +
Sbjct: 111 LARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170
Query: 546 -LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFP---NDAVVMILARIIG 601
+ Y + +G ++ DL +LG + G + + RI
Sbjct: 171 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 230
Query: 602 MLGPIDLEMLMQG--QEIYKYFTK 623
L L G +E YKY
Sbjct: 231 KKQSTPLRELCAGFPEEFYKYMHY 254
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 8e-41
Identities = 66/314 (21%), Positives = 111/314 (35%), Gaps = 66/314 (21%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKN 437
+ + + LG +F KVF A+ T +K +K D D + ++ E ++L L ++
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 438 DPADEHHILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQ 496
+ ++ F E+LF V E L +L + + F L R +
Sbjct: 63 P-----FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK------FDLSRATFYAAE 111
Query: 497 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF---QTDNLCLYVQSRSY 553
+ L++LHS GI++ DLK +NIL+ KI D G + + Y
Sbjct: 112 IILGLQFLHSKGIVYRDLKLDNILLDKDGHI--KIADFGMCKENMLGDAKTNTFCGTPDY 169
Query: 554 RAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613
APE+++G Y+ +D WS G +L E+ G+ F + I
Sbjct: 170 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR------------- 216
Query: 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 673
P E D + L P++R
Sbjct: 217 ----------------------MDNPFYPRWLEKE---------AKDLLVKLFVREPEKR 245
Query: 674 PTAR-EALDHPWLQ 686
R + HP +
Sbjct: 246 LGVRGDIRQHPLFR 259
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 9e-38
Identities = 64/316 (20%), Positives = 111/316 (35%), Gaps = 69/316 (21%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKND 438
+ + LG F KV ++ TG +KI++ + KD ++ E ++L+
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR--- 63
Query: 439 PADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
+ L F + L V E F + FT R + + +
Sbjct: 64 ---HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIV 115
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS---CFQTDNLCLYVQSRSYRA 555
ALEYLHS +++ D+K EN+++ IKI D G + + + Y A
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLA 173
Query: 556 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615
PEV+ Y + +D W LG ++ E+ G + F N + I+
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL--------------- 218
Query: 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP- 674
E P S E + LL+ +P++R
Sbjct: 219 --------------------MEEIRFPRTLSPE---------AKSLLAGLLKKDPKQRLG 249
Query: 675 ----TAREALDHPWLQ 686
A+E ++H +
Sbjct: 250 GGPSDAKEVMEHRFFL 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 1e-37
Identities = 54/310 (17%), Positives = 107/310 (34%), Gaps = 65/310 (20%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 441
+ + +G F V + G V +K IKND L E ++ +
Sbjct: 8 ELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATA-QAFLAEASVMTQLR------ 58
Query: 442 EH-HILRLYDYFYHLE-HLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCL 498
H ++++L + L+IV E + + +L ++ + S G + L +
Sbjct: 59 -HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR----SRGRSVLGGDCLLKFSLDVC 113
Query: 499 EALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEV 558
EA+EYL +H DL N+L+ K+ D G + + + APE
Sbjct: 114 EAMEYLEGNNFVHRDLAARNVLVSE--DNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEA 171
Query: 559 IIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQEI 617
+ + K D+WS G +L E+++ G V +P + ++ R+
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV------------------ 213
Query: 618 YKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 677
+ P+ + ++ ++ RP+
Sbjct: 214 ----------------EKGYKMDAPDGCPPA---------VYEVMKNCWHLDAAMRPSFL 248
Query: 678 EALDHPWLQH 687
+ + L+H
Sbjct: 249 QLREQ--LEH 256
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 140 bits (354), Expect = 2e-37
Identities = 68/336 (20%), Positives = 125/336 (37%), Gaps = 67/336 (19%)
Query: 360 KNRTGFEENKDLPIILNTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK- 418
K + F + + P NT ++ + LG+ +F +V + +G +KI+ K
Sbjct: 21 KAKEDFLKKWETPS-QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 419 ---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKF 475
+ +L+E ++L+ VN +++L F +L++V E +
Sbjct: 80 VKLKQIEHTLNEKRILQAVNF------PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133
Query: 476 NQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535
F+ + Q + EYLHSL +I+ DLKPEN+LI Q+ I++ D G
Sbjct: 134 RIG-----RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI--DQQGYIQVTDFG 186
Query: 536 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMI 595
+ + APE+I+ Y++ +D W+LG ++ E+ G F D + I
Sbjct: 187 FAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 596 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSD 655
+I + P S +
Sbjct: 247 YEKI-----------------------------------VSGKVRFPSHFSSD------- 264
Query: 656 AFFIDFVRTLLEINPQRR-----PTAREALDHPWLQ 686
D +R LL+++ +R + +H W
Sbjct: 265 --LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 7e-37
Identities = 65/313 (20%), Positives = 111/313 (35%), Gaps = 65/313 (20%)
Query: 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDV-CLKIIKNDKDFFDQSLDEIKLLKLVNKNDP 439
G+ V + +GS +F V++ + H V V L + +E+ +L+
Sbjct: 8 GQITVGQRIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR---- 62
Query: 440 ADEH-HILRLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQC 497
H +IL Y L IV + ++LY + F + +L I RQ
Sbjct: 63 ---HVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQT 113
Query: 498 LEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF-----QTDNLCLYVQSRS 552
+ ++YLH+ IIH DLK NI + +KI D G + + S
Sbjct: 114 AQGMDYLHAKSIIHRDLKSNNIFLHE--DLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 553 YRAPEVIIGL---PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLE 609
+ APEVI PY + D+++ G +L EL TG++ + N + ++G
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR------- 224
Query: 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 669
Y+ P+ S + + + L+
Sbjct: 225 ----------------------------GYLSPDLSKVRSNC---PKAMKRLMAECLKKK 253
Query: 670 PQRRPTAREALDH 682
RP + L
Sbjct: 254 RDERPLFPQILAS 266
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 4e-36
Identities = 56/314 (17%), Positives = 95/314 (30%), Gaps = 63/314 (20%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 441
+ LG F +V+ T V +K +K + L E +++K +
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLR------ 70
Query: 442 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 501
+++LY E ++IV E + + Y L +L + Q +
Sbjct: 71 HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGM 126
Query: 502 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN----LCLYVQSRSYRAPE 557
Y+ + +H DL+ NIL+ K+ D G + DN + APE
Sbjct: 127 AYVERMNYVHRDLRAANILVGE--NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 184
Query: 558 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 616
+ + K D+WS G +L EL T G V +P +L ++
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---------------- 228
Query: 617 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 676
P E D + P+ RPT
Sbjct: 229 ------------------RGYRMPCPPECPES---------LHDLMCQCWRKEPEERPTF 261
Query: 677 REALD--HPWLQHP 688
+
Sbjct: 262 EYLQAFLEDYFTST 275
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 7e-35
Identities = 59/313 (18%), Positives = 101/313 (32%), Gaps = 63/313 (20%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 441
+ E LG+ F +V+ + V +K +K D L E L+K +
Sbjct: 14 TLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ------ 66
Query: 442 EHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEAL 501
++RLY E ++I+ E + T+ +L + Q E +
Sbjct: 67 HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAEGM 122
Query: 502 EYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS----YRAPE 557
++ IH DL+ NIL+ C KI D G + DN + + APE
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSC--KIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 558 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 616
I + K D+WS G +L E+ T G + +P ++ +
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----------------- 223
Query: 617 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 676
+ P+ E +R + P+ RPT
Sbjct: 224 -----------------ERGYRMVRPDNCPEE---------LYQLMRLCWKERPEDRPTF 257
Query: 677 REALDHPWLQHPY 689
L+ +
Sbjct: 258 DYLRS--VLEDFF 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 3e-34
Identities = 54/307 (17%), Positives = 106/307 (34%), Gaps = 65/307 (21%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADE 442
+ LG+ F V + DV +K+IK D+ ++E K++ ++
Sbjct: 6 LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS------- 57
Query: 443 H-HILRLYDYFYHLEHLFIVCELL-RANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 500
H +++LY +FI+ E + L + + + F +L + + EA
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-----FQTQQLLEMCKDVCEA 112
Query: 501 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN----LCLYVQSRSYRAP 556
+EYL S +H DL N L+ + +K+ D G S + D+ + P
Sbjct: 113 MEYLESKQFLHRDLAARNCLVND--QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170
Query: 557 EVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615
EV++ + K D+W+ G ++ E+++ G++ + I
Sbjct: 171 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA--------------- 215
Query: 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 675
L P +S + + + RPT
Sbjct: 216 -------------------QGLRLYRPHLASEK---------VYTIMYSCWHEKADERPT 247
Query: 676 AREALDH 682
+ L +
Sbjct: 248 FKILLSN 254
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (326), Expect = 4e-34
Identities = 53/314 (16%), Positives = 99/314 (31%), Gaps = 61/314 (19%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 441
+ LG + +V++ + V +K +K D ++ L E ++K +
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK------ 71
Query: 442 EH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEA 500
H ++++L +I+ E + + L + Q A
Sbjct: 72 -HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSA 127
Query: 501 LEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN----LCLYVQSRSYRAP 556
+EYL IH DL N L+ +K+ D G S T + + AP
Sbjct: 128 MEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185
Query: 557 EVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 616
E + + K D+W+ G +L E+ T + + +
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG---------------------IDLSQ 224
Query: 617 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 676
+Y+ K+Y + PE + + +R + NP RP+
Sbjct: 225 VYELLEKDYRMER------------PEGCPEK---------VYELMRACWQWNPSDRPSF 263
Query: 677 REALD--HPWLQHP 688
E Q
Sbjct: 264 AEIHQAFETMFQES 277
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 5e-34
Identities = 70/324 (21%), Positives = 125/324 (38%), Gaps = 71/324 (21%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLH---TGVDVCLKIIK-----NDKDFFDQSLDEIKLLKL 433
+ + + LG+ A+ KVF + + TG +K++K + + E ++L+
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 434 VNKNDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI 493
+ ++ L+ F L ++ + + +E FT +Q+
Sbjct: 85 IR-----QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-----FTEHEVQIY 134
Query: 494 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF----QTDNLCLYVQ 549
+ + ALE+LH LGII+ D+K ENIL+ S + + D G S +T+ +
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDS--NGHVVLTDFGLSKEFVADETERAYDFCG 192
Query: 550 SRSYRAPEVIIGLP--YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 607
+ Y AP+++ G +D+ +D WSLG ++ EL TG F D A I
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS------- 245
Query: 608 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLE 667
+ E P+E S D ++ LL
Sbjct: 246 ------------------------RRILKSEPPYPQEMSAL---------AKDLIQRLLM 272
Query: 668 INPQRRP-----TAREALDHPWLQ 686
+P++R A E +H + Q
Sbjct: 273 KDPKKRLGCGPRDADEIKEHLFFQ 296
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 7e-34
Identities = 50/307 (16%), Positives = 98/307 (31%), Gaps = 63/307 (20%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPAD 441
+ +GS F V L V +K I+ + ++E +++ ++
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS------ 58
Query: 442 EH-HILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLE 499
H +++LY + +V E + L ++ + + L + E
Sbjct: 59 -HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE-----TLLGMCLDVCE 112
Query: 500 ALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN----LCLYVQSRSYRA 555
+ YL +IH DL N L+ + IK+ D G + F D+ + +
Sbjct: 113 GMAYLEEACVIHRDLAARNCLVG--ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS 170
Query: 556 PEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615
PEV Y K D+WS G ++ E+++ + +
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN---------------------RSNS 209
Query: 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT 675
E+ + + + LY P +S + + P+ RP
Sbjct: 210 EVVEDISTGFRLY------------KPRLASTH---------VYQIMNHCWKERPEDRPA 248
Query: 676 AREALDH 682
L
Sbjct: 249 FSRLLRQ 255
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-32
Identities = 56/332 (16%), Positives = 105/332 (31%), Gaps = 80/332 (24%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTG-----VDVCLKIIKNDKD--FFDQSLDEIKLLKLV 434
+ LGS AF KV A + V +K++K D + + E+K++ +
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 435 NKNDPADEHHILRLYDYFYHLEHLFIVCELL------------------RANLYEFQKFN 476
++ +I+ L ++++ E YE QK
Sbjct: 98 GSHE-----NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 477 QESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536
+E T L Q + +E+L +H DL N+L+ +KI D G
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH--GKVVKICDFGL 210
Query: 537 SCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPND 590
+ + + APE + Y K D+WS G +L E+++ G +P
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270
Query: 591 AVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHH 650
V ++I N + P ++ E
Sbjct: 271 PVDANFYKLI---------------------------------QNGFKMDQPFYATEE-- 295
Query: 651 LQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682
+++ + ++RP+
Sbjct: 296 -------IYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 3e-32
Identities = 60/316 (18%), Positives = 98/316 (31%), Gaps = 71/316 (22%)
Query: 382 RYYVTEYLGSAAFSKVFQAQ---DLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLV 434
+ E LG +F V + + V V +K +K + + D + E+ + +
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 435 NKNDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVI 493
+ H +++RLY + +L + + +Q F LG L
Sbjct: 69 D-------HRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGH-----FLLGTLSRY 116
Query: 494 TRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS- 552
Q E + YL S IH DL N+L+ R +KI D G N YV
Sbjct: 117 AVQVAEGMGYLESKRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174
Query: 553 -----YRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 606
+ APE + + D W G L E++T G+ + IL +I
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------ 228
Query: 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLL 666
PE+ + + +
Sbjct: 229 ---------------------------KEGERLPRPEDCPQD---------IYNVMVQCW 252
Query: 667 EINPQRRPTAREALDH 682
P+ RPT D
Sbjct: 253 AHKPEDRPTFVALRDF 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 3e-31
Identities = 56/313 (17%), Positives = 98/313 (31%), Gaps = 71/313 (22%)
Query: 389 LGSAAFSKVFQA--QDLHTGVDVCLKIIK---NDKDFFDQSLDEIKLLKLVNKNDPADEH 443
LGS F V + Q V +KI+K ND D+ L E +++ ++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN------P 68
Query: 444 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 503
+I+R+ E +V E+ + + + Q ++Y
Sbjct: 69 YIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKY 122
Query: 504 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------YRAPE 557
L +H DL N+L+ + + KI D G S + Y + APE
Sbjct: 123 LEESNFVHRDLAARNVLLVT--QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 558 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 616
I + K D+WS G ++ E ++ G+ + M+G E
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG----------------------MKGSE 218
Query: 617 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 676
+ K + P E D + + + RP
Sbjct: 219 VTAMLEKGERMG------------CPAGCPRE---------MYDLMNLCWTYDVENRPGF 257
Query: 677 REALDHPWLQHPY 689
L++ Y
Sbjct: 258 AAVELR--LRNYY 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 121 bits (304), Expect = 4e-31
Identities = 50/323 (15%), Positives = 106/323 (32%), Gaps = 71/323 (21%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTG---VDVCLKIIKND--KDFFDQSLDEIKLLKLVNK 436
+ + +G+ F +V G + V +K +K+ + L E ++ +
Sbjct: 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD- 85
Query: 437 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 496
+++ L + I+ E + + + FT+ +L + R
Sbjct: 86 -----HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG----QFTVIQLVGMLRG 136
Query: 497 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS---- 552
++YL + +H DL NIL+ S K+ D G S F D+ + +
Sbjct: 137 IAAGMKYLADMNYVHRDLAARNILVNS--NLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 194
Query: 553 ----YRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPID 607
+ APE I + D+WS G ++ E+ + GE + +
Sbjct: 195 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD------------------ 236
Query: 608 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLE 667
M Q++ ++Y L P + + +
Sbjct: 237 ----MTNQDVINAIEQDYRLP------------PPMDCPSA---------LHQLMLDCWQ 271
Query: 668 INPQRRPTAREALDH--PWLQHP 688
+ RP + ++ +++P
Sbjct: 272 KDRNHRPKFGQIVNTLDKMIRNP 294
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 4e-31
Identities = 55/311 (17%), Positives = 101/311 (32%), Gaps = 66/311 (21%)
Query: 383 YYVTEYLGSAAFSKVFQAQDLHTG----VDVCLKIIK--NDKDFFDQSLDEIKLLKLVNK 436
+ + LGS AF V++ + G + V +K ++ + LDE ++ V+
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 437 NDPADEHHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQ 496
H+ RL I + L ++ + ++++ G Y L Q
Sbjct: 71 ------PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQY-----LLNWCVQ 119
Query: 497 CLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF-----QTDNLCLYVQSR 551
+ + YL ++H DL N+L+K+ +KI D G + + +
Sbjct: 120 IAKGMNYLEDRRLVHRDLAARNVLVKT--PQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 552 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 611
+ A E I+ Y + D+WS G + EL T +
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------------- 216
Query: 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQ 671
+ EI K L P +++ + I+
Sbjct: 217 IPASEISSILEKGERL------------PQPPICTID---------VYMIMVKCWMIDAD 255
Query: 672 RRPTAREALDH 682
RP RE +
Sbjct: 256 SRPKFRELIIE 266
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-30
Identities = 55/322 (17%), Positives = 102/322 (31%), Gaps = 51/322 (15%)
Query: 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKND 438
IA + E +G F +V++ + G +V +KI + ++ E ++ + V
Sbjct: 1 IARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREE--RSWFREAEIYQTVMLRH 56
Query: 439 PADEHHILRLYDYFYH----LEHLFIVCELLRA-NLYEF-QKFNQESGGEAYFTLGRLQV 492
+IL L++V + +L+++ ++ G L
Sbjct: 57 E----NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASG 112
Query: 493 ITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLY----- 547
+ +E + I H DLK +NIL+K I DLG +
Sbjct: 113 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKK--NGTCCIADLGLAVRHDSATDTIDIAPN 170
Query: 548 --VQSRSYRAPEVIIG------LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 599
V ++ Y APEV+ ++ D++++G + E+ + +
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230
Query: 600 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFI 659
+ P EM E +L IP L+
Sbjct: 231 LVPSDPSVEEMRKVVCE------------------QKLRPNIPNRWQSCEALR----VMA 268
Query: 660 DFVRTLLEINPQRRPTAREALD 681
+R N R TA
Sbjct: 269 KIMRECWYANGAARLTALRIKK 290
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 1e-30
Identities = 56/313 (17%), Positives = 102/313 (32%), Gaps = 71/313 (22%)
Query: 389 LGSAAFSKVFQAQDLHT--GVDVCLKIIK--NDKDFFDQSLDEIKLLKLVNKNDPADEHH 444
LG F V Q +DV +K++K +K ++ + E +++ + D +
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL------DNPY 70
Query: 445 ILRLYDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEY 503
I+RL E L +V E+ L++F G + + + Q ++Y
Sbjct: 71 IVRLIGVCQA-EALMLVMEMAGGGPLHKFLV-----GKREEIPVSNVAELLHQVSMGMKY 124
Query: 504 LHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS------YRAPE 557
L +H DL N+L+ + R KI D G S + Y + + APE
Sbjct: 125 LEEKNFVHRDLAARNVLLVN--RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 182
Query: 558 VIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 616
I + + D+WS G + E + G+ + M+G E
Sbjct: 183 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK----------------------MKGPE 220
Query: 617 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 676
+ + + + P E E + + RP
Sbjct: 221 VMAFIEQGKRME------------CPPECPPE---------LYALMSDCWIYKWEDRPDF 259
Query: 677 REALDHPWLQHPY 689
++ Y
Sbjct: 260 LTVEQR--MRACY 270
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-30
Identities = 51/311 (16%), Positives = 90/311 (28%), Gaps = 62/311 (19%)
Query: 387 EYLGSAAFSKVFQAQDLHTGVDVCLKIIK----NDKDFFDQSLDEIKLLKLVNKNDPADE 442
+ +G F +V +A+ G+ + I + KD E+++L + +
Sbjct: 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP---- 71
Query: 443 HHILRLYDYFYHLEHLFIVCELL-----------RANLYEFQKFNQESGGEAYFTLGRLQ 491
+I+ L H +L++ E L F + + + +L
Sbjct: 72 -NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 492 VITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSR 551
++YL IH DL NIL+ +I L +
Sbjct: 131 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 190
Query: 552 SYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 611
+ A E + Y D+WS G +L E+ +
Sbjct: 191 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG--------------------- 229
Query: 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQ 671
M E+Y+ + Y L P E D +R P
Sbjct: 230 MTCAELYEKLPQGYRLE------------KPLNCDDE---------VYDLMRQCWREKPY 268
Query: 672 RRPTAREALDH 682
RP+ + L
Sbjct: 269 ERPSFAQILVS 279
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 2e-30
Identities = 60/325 (18%), Positives = 108/325 (33%), Gaps = 75/325 (23%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDKDFFDQS--LDEIKLLKLV 434
R + LG+ AF KV +A + V +K++K ++ + E+K+L +
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 435 NKNDPADEHHILRLYDYFYHLEHLFIVCELL-------------RANLYEFQKFNQESGG 481
+ +I+ L ++ E + +
Sbjct: 84 -----GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 482 EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 541
E L L + Q + + +L S IH DL NIL+ KI D G +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL--THGRITKICDFGLARDIK 196
Query: 542 DNLCLYVQSRS-----YRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMI 595
++ V+ + + APE I Y + D+WS G L EL++ G +P V
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 596 LARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSD 655
++I + PE + E
Sbjct: 257 FYKMI---------------------------------KEGFRMLSPEHAPAE------- 276
Query: 656 AFFIDFVRTLLEINPQRRPTAREAL 680
D ++T + +P +RPT ++ +
Sbjct: 277 --MYDIMKTCWDADPLKRPTFKQIV 299
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 3e-29
Identities = 54/333 (16%), Positives = 100/333 (30%), Gaps = 73/333 (21%)
Query: 368 NKDLPIILNTVIAGRYYVT----EYLGSAAFSKVFQAQDLH---TGVDVCLKIIK--NDK 418
N +L + V+ G + E +G F V+ L + +K + D
Sbjct: 10 NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI 69
Query: 419 DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE-HLFIVCELLRA-NLYEFQKFN 476
Q L E ++K + ++L L E +V ++ +L F +
Sbjct: 70 GEVSQFLTEGIIMKDFSH------PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 123
Query: 477 QESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536
+ T+ L Q + +++L S +H DL N ++ + +K+ D G
Sbjct: 124 THN-----PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE--KFTVKVADFGL 176
Query: 537 SCFQTDN-------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPN 589
+ D + A E + + K D+WS G +L EL T
Sbjct: 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236
Query: 590 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEH 649
D + +I Y + L + PE
Sbjct: 237 D---------------------VNTFDITVYLLQGRRL------------LQPEYCPDP- 262
Query: 650 HLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682
+ + + RP+ E +
Sbjct: 263 --------LYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 3e-29
Identities = 59/324 (18%), Positives = 107/324 (33%), Gaps = 70/324 (21%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHTGVD-------VCLKIIKND--KDFFDQSLDEIKLLK 432
R + + LG AF +V A+ + D V +K++K+D + + E++++K
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 433 LVNKNDPADEHHILRLYDYFYHLEHLFIVCELL-RANLYEF----------QKFNQESGG 481
++ K+ +I+ L L+++ E + NL E+ +N
Sbjct: 74 MIGKH-----KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 482 EAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQT 541
E + L Q +EYL S IH DL N+L+ +I L
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 542 D---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILAR 598
D + APE + Y + D+WS G +L E++T V L +
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248
Query: 599 IIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFF 658
++ P + E
Sbjct: 249 LL---------------------------------KEGHRMDKPSNCTNE---------L 266
Query: 659 IDFVRTLLEINPQRRPTAREALDH 682
+R P +RPT ++ ++
Sbjct: 267 YMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 4e-29
Identities = 48/314 (15%), Positives = 98/314 (31%), Gaps = 68/314 (21%)
Query: 389 LGSAAFSKVFQAQDLHTG----VDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADE 442
+G+ F +V++ + V V +K +K + L E ++ +
Sbjct: 15 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH------ 68
Query: 443 HHILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALE 502
H+I+RL + + I+ E + + ++ F++ +L + R ++
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMK 124
Query: 503 YLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDN------LCLYVQSRSYRAP 556
YL ++ +H DL NIL+ S K+ D G S D+ + AP
Sbjct: 125 YLANMNYVHRDLAARNILVNS--NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 557 EVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQE 616
E I + D+WS G ++ E+ T + + + I
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI---------------- 226
Query: 617 IYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTA 676
+ P + + + RRP
Sbjct: 227 -----------------NDGFRLPTPMDCPSA---------IYQLMMQCWQQERARRPKF 260
Query: 677 REALD--HPWLQHP 688
+ + ++ P
Sbjct: 261 ADIVSILDKLIRAP 274
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 113 bits (284), Expect = 2e-28
Identities = 56/338 (16%), Positives = 97/338 (28%), Gaps = 85/338 (25%)
Query: 382 RYYVTEYLGSAAFSKVFQAQ-----DLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLV 434
+G AF +VFQA+ V +K++K + D E L+
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 435 NKNDPADEHHILRLYDYFYHLEHLFIVCELL-RANLYEF------------------QKF 475
+ +I++L + + ++ E + +L EF +
Sbjct: 74 DN------PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127
Query: 476 NQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535
S G + I RQ + YL +H DL N L+ +KI D G
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGE--NMVVKIADFG 185
Query: 536 SSCFQTDNLCLYVQSRS-----YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVL-FPN 589
S + PE I Y + D+W+ G +L E+++ + +
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245
Query: 590 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEH 649
A ++ + + PE LE
Sbjct: 246 MAHEEVIYYVR----------------------------------DGNILACPENCPLE- 270
Query: 650 HLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687
+ +R P RP+ LQ
Sbjct: 271 --------LYNLMRLCWSKLPADRPSFCSIHR--ILQR 298
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 1e-27
Identities = 56/312 (17%), Positives = 90/312 (28%), Gaps = 68/312 (21%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKN--DKDFFDQSLDEIKLLKLVNK 436
R + +G F V Q + + V +K KN ++ L E ++ +
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD- 66
Query: 437 NDPADEH-HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITR 495
H HI++L I+ L F + + S L L +
Sbjct: 67 ------HPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAY 115
Query: 496 QCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRS--- 552
Q AL YL S +H D+ N+L+ S +K+ D G S + D+
Sbjct: 116 QLSTALAYLESKRFVHRDIAARNVLVSSN--DCVKLGDFGLSRYMEDSTYYKASKGKLPI 173
Query: 553 -YRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEM 610
+ APE I + D+W G + E+ G F ++ RI
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE---------- 223
Query: 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINP 670
N +P + +P
Sbjct: 224 ------------------------NGERLPMPPNCPPT---------LYSLMTKCWAYDP 250
Query: 671 QRRPTAREALDH 682
RRP E
Sbjct: 251 SRRPRFTELKAQ 262
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 4e-27
Identities = 59/326 (18%), Positives = 107/326 (32%), Gaps = 74/326 (22%)
Query: 382 RYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKND--KDFFDQSLDEIKLLKLV 434
R + + LG AF +V +A T V +K++K + E+K+L +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 435 NKNDPADEHHILRLYDYFYHL-EHLFIVCELL-----------RANLYEFQKFNQESGGE 482
+++ L L ++ E + N + K E +
Sbjct: 74 G-----HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 483 AYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTD 542
+ TL L + Q + +E+L S IH DL NIL+ + +KI D G +
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE--KNVVKICDFGLARDIYK 186
Query: 543 NLCLYVQSRS-----YRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVL-FPNDAVVMIL 596
+ + + + APE I Y + D+WS G +L E+++ +P +
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246
Query: 597 ARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDA 656
R + P+ ++ E
Sbjct: 247 CRRL---------------------------------KEGTRMRAPDYTTPE-------- 265
Query: 657 FFIDFVRTLLEINPQRRPTAREALDH 682
+ P +RPT E ++H
Sbjct: 266 -MYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 3e-26
Identities = 51/331 (15%), Positives = 110/331 (33%), Gaps = 75/331 (22%)
Query: 382 RYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDKDFFDQS--LDEIKLLKLV 434
+ ++ LG +F V++ V +K + ++ L+E ++K
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 435 NKNDPADEHHILRLYDYFYHLEHLFIVCEL-----LRANLYEFQKFNQESGGEAYFTLGR 489
N HH++RL + ++ EL L++ L + + A +L +
Sbjct: 81 N------CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 490 LQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQ 549
+ + + + + YL++ +H DL N ++ +KI D G + +
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE--DFTVKIGDFGMTRDIYETDYYRKG 192
Query: 550 SRS-----YRAPEVIIGLPYDQKIDLWSLGCILAELWTG-EVLFPNDAVVMILARIIGML 603
+ + +PE + + D+WS G +L E+ T E + + +L ++
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM--- 249
Query: 604 GPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVR 663
E L+ P+ + +R
Sbjct: 250 -----------------------------EGGLLD--KPDNCPDM---------LFELMR 269
Query: 664 TLLEINPQRRPTAREALD------HPWLQHP 688
+ NP+ RP+ E + P +
Sbjct: 270 MCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 81.4 bits (200), Expect = 3e-18
Identities = 30/191 (15%), Positives = 53/191 (27%), Gaps = 7/191 (3%)
Query: 389 LGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL 448
+G S VF + +K K F + ++ L
Sbjct: 8 MGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSV--LAIRSARNE 64
Query: 449 YDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG 508
+ L+ L + + +V+ LE + + G
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVL-DMILEEVAKFYHRG 123
Query: 509 IIHCDLKPENILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKI 568
I+H DL N+L+ I IID S + + R R Y +
Sbjct: 124 IVHGDLSQYNVLV---SEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTYRTEK 180
Query: 569 DLWSLGCILAE 579
D+ S + +
Sbjct: 181 DINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 689 | |||
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1a25a_ | 132 | C2 domain from protein kinase c (beta) {Rat (Rattu | 99.69 | |
| d1dqva2 | 145 | Synaptotagmin III {Rat (Rattus norvegicus) [TaxId: | 99.63 | |
| d1dqva1 | 130 | Synaptotagmin III {Rat (Rattus norvegicus) [TaxId: | 99.63 | |
| d2bwqa1 | 125 | Regulating synaptic membrane exocytosis protein, r | 99.61 | |
| d1w15a_ | 138 | Synaptotagmin IV {Rat (Rattus norvegicus) [TaxId: | 99.59 | |
| d1rsya_ | 143 | Synaptogamin I {Rat (Rattus norvegicus) [TaxId: 10 | 99.59 | |
| d1uowa_ | 157 | Synaptogamin I {Rat (Rattus norvegicus) [TaxId: 10 | 99.59 | |
| d2cm5a1 | 137 | C2b-domain of rabphilin {Rat (Rattus norvegicus) [ | 99.57 | |
| d1ugka_ | 138 | Synaptotagmin IV {Human (Homo sapiens) [TaxId: 960 | 99.54 | |
| d1rh8a_ | 142 | Piccolo {Rat (Rattus norvegicus) [TaxId: 10116]} | 99.54 | |
| d1wfma_ | 138 | Synaptotagmin XIII {Human (Homo sapiens) [TaxId: 9 | 99.51 | |
| d2ep6a1 | 126 | Multiple C2 and transmembrane domain-containing pr | 99.48 | |
| d1qasa2 | 131 | PI-specific phospholipase C isozyme D1 (PLC-D1), C | 99.37 | |
| d1wfja_ | 136 | C2 domain protein At1g63220 {Thale cress (Arabidop | 99.34 | |
| d1rlwa_ | 126 | Domain from cytosolic phospholipase A2 {Human (Hom | 99.32 | |
| d1gmia_ | 136 | Domain from protein kinase C epsilon {Rat (Rattus | 99.26 | |
| d2nq3a1 | 133 | E3 ubiquitin-protein ligase Itchy {Human (Homo sap | 99.17 | |
| d1bdya_ | 123 | Domain from protein kinase C delta {Rat (Rattus no | 98.98 | |
| d2cjta1 | 128 | Unc-13 homolog A {Rat (Rattus norvegicus) [TaxId: | 98.92 | |
| d2zkmx2 | 122 | Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI | 98.76 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.64 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.14 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.96 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.69 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.64 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.94 | |
| d1e7ua2 | 174 | Phoshoinositide 3-kinase (PI3K) {Pig (Sus scrofa) | 80.38 |
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=388.50 Aligned_cols=259 Identities=25% Similarity=0.365 Sum_probs=219.4
Q ss_pred ECCCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCH-HHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEECCE
Q ss_conf 2375899999325888753999988789379999960541-346759999999999601699998722587789984784
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 379 i~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
+.++|++.+.||+|+||.||+|+++.+|+.||+|++.... .....+.+|+.+++.++ ||||+++++++.+.++
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~------HpnIv~~~~~~~~~~~ 97 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR------HPTLVNLHDAFEDDNE 97 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTC------CTTBCCEEEEEEETTE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCC------CCCCCCEEEEEEECCE
T ss_conf 8657589889840768199999988999899999984524316999999999998679------9799929999998999
Q ss_pred EEEEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEECCC
Q ss_conf 9999971421-438898632026997555988999999977999999998895303589995798025787099983688
Q 005590 458 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 458 l~lVmEy~~g-~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~DFGl 536 (689)
+++||||+.| +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+..+.++.+||+|||+
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~ 172 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL 172 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCTT-----SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEECCCCCCHHHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEEEEECHHHEEECCCCCCEEEEEECCH
T ss_conf 999998579988999997623-----789999999999999999999975697600015467364168898699954521
Q ss_pred CCCCCCC--CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCHHHHHHH
Q ss_conf 4213688--64223676545703231899991256999999999999399999998399999999841199867887332
Q 005590 537 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 537 s~~~~~~--~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
+...... .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+.+..+......++.
T Consensus 173 a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~------ 246 (350)
T d1koaa2 173 TAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD------ 246 (350)
T ss_dssp CEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC------
T ss_pred HEECCCCCCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCC------
T ss_conf 04425654320006862421889975899872676554659999998598998997999999999847889894------
Q ss_pred HHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 23544320011100000000100014775430112014791999999998130098999389999809898889
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~Hpwf~~~ 688 (689)
......++.+++||.+||+.||++|||+.|+|+||||+..
T Consensus 247 ----------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 247 ----------------------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp ----------------------------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred ----------------------------------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf ----------------------------------2235899999999999756896679089998629132889
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=398.71 Aligned_cols=292 Identities=24% Similarity=0.320 Sum_probs=213.0
Q ss_pred EECCCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECC--HHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEEC
Q ss_conf 3237589999932588875399998878937999996054--13467599999999996016999987225877899847
Q 005590 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 378 ~i~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
+..++|++.+.||+|+||+||+|+++.+|+.||+|+++.+ .....++.+|+.+|+.+ .||||++++++|.+.
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l------~HpnIv~l~~~~~~~ 76 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC------NSPYIVGFYGAFYSD 76 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC------CCTTBCCEEEEEECS
T ss_pred CCCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHC------CCCCCCCEEEEEEEC
T ss_conf 87568889789712778099999998999699999987540978999999999999867------999999499999989
Q ss_pred CEEEEEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCEECCCCCCCEEEECCCCCEEEEEE
Q ss_conf 849999971421-438898632026997555988999999977999999998-895303589995798025787099983
Q 005590 456 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPENILIKSYQRCEIKIID 533 (689)
Q Consensus 456 ~~l~lVmEy~~g-~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~-~gIvHrDIKp~NILi~~~~~~~ikL~D 533 (689)
.++++||||+.| +|.+++..... +++..++.++.||+.||.|||+ .||+||||||+|||++. ++.+||+|
T Consensus 77 ~~~~iVmEy~~gg~L~~~l~~~~~------l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~--~~~vkl~D 148 (322)
T d1s9ja_ 77 GEISICMEHMDGGSLDQVLKKAGR------IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS--RGEIKLCD 148 (322)
T ss_dssp SEEEEEEECCTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECT--TCCEEECC
T ss_pred CEEEEEEECCCCCCHHHHHHHCCC------CCHHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECC--CCCEEEEE
T ss_conf 999999976799868998742499------9999999999999999999998599971445779946878--99899954
Q ss_pred CCCCCCCCC-CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHH-HHHHHCCCCCHHH-
Q ss_conf 688421368-8642236765457032318999912569999999999993999999983999999-9984119986788-
Q 005590 534 LGSSCFQTD-NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILA-RIIGMLGPIDLEM- 610 (689)
Q Consensus 534 FGls~~~~~-~~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~-~i~~~~g~~~~e~- 610 (689)
||+|....+ .....+||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+.+...... .+....+......
T Consensus 149 FGla~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (322)
T d1s9ja_ 149 FGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228 (322)
T ss_dssp CCCCHHHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
T ss_conf 87762567886211137714119468758998948889989999999998889989988789999998875177545774
Q ss_pred --HHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf --73322354432001110000000010001477543011201479199999999813009899938999980989888
Q 005590 611 --LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 611 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~Hpwf~~ 687 (689)
...............................+.. + .....+.++++||.+||+.||++||||+|+|+||||++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPK--L--PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp -----------------CCCCHHHHHHHHHTSCCCC--C--CBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCC--C--CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCC
T ss_conf 212333221111222354134778876650268766--7--64448999999999986899467908999960986476
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=387.64 Aligned_cols=259 Identities=24% Similarity=0.373 Sum_probs=217.6
Q ss_pred ECCCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCH-HHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEECCE
Q ss_conf 2375899999325888753999988789379999960541-346759999999999601699998722587789984784
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 379 i~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
+.++|++.+.||+|+||+||+|+++.+|+.||+|++.... .....+.+|+.+++.+ .||||++++++|.+.++
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l------~HpnIv~~~~~~~~~~~ 100 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL------HHPKLINLHDAFEDKYE 100 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC------CSTTBCCEEEEEECSSE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHC------CCCCCCCEEEEEEECCE
T ss_conf 540359989993177829999999899979999998872646799999999999867------99798919999998999
Q ss_pred EEEEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEECCC
Q ss_conf 9999971421-438898632026997555988999999977999999998895303589995798025787099983688
Q 005590 458 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 458 l~lVmEy~~g-~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~DFGl 536 (689)
+|+||||+.| +|.+.+.... ..+++..++.++.||+.||.|||+.||+||||||+|||++....+.+||+|||+
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGl 175 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL 175 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred EEEEEECCCCCHHHHHHHHCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCCCCCCCEEEEEECCC
T ss_conf 999998289980888898638-----998999999999999999999997792651314455311346788489952563
Q ss_pred CCCCCCC--CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCHHHHHHH
Q ss_conf 4213688--64223676545703231899991256999999999999399999998399999999841199867887332
Q 005590 537 SCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 537 s~~~~~~--~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
+...... .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+.+..+......++.
T Consensus 176 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~------ 249 (352)
T d1koba_ 176 ATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE------ 249 (352)
T ss_dssp CEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS------
T ss_pred CEECCCCCCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCC------
T ss_conf 03437887201004764534899974799897633389899999999688998997999999999847889893------
Q ss_pred HHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 23544320011100000000100014775430112014791999999998130098999389999809898889
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~Hpwf~~~ 688 (689)
......++.+++||.+||+.||++|||+.|+|+||||+..
T Consensus 250 ----------------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 250 ----------------------------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp ----------------------------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ----------------------------------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf ----------------------------------0024799999999999756996689189999609734888
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=383.76 Aligned_cols=252 Identities=29% Similarity=0.465 Sum_probs=211.8
Q ss_pred CCCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCH-HHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEECCEE
Q ss_conf 375899999325888753999988789379999960541-3467599999999996016999987225877899847849
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 380 ~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
.++|++.+.||+|+||+||+|+++.+|+.||+|++.... ...+.+.+|+.+++.++ ||||++++++|...++.
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~------HpnIv~~~~~~~~~~~~ 92 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK------NPNIVNYLDSYLVGDEL 92 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCC------CTTBCCEEEEEEETTEE
T ss_pred CCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCC------CCCEEEEEEEEEECCEE
T ss_conf 105388789812858299999998999899999984301727999999999998679------99880585779889998
Q ss_pred EEEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEECCCC
Q ss_conf 999971421-4388986320269975559889999999779999999988953035899957980257870999836884
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g-~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~DFGls 537 (689)
++||||+.| +|.+++.. + .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 93 ~ivmEy~~gg~L~~~~~~-~------~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~--~~~vkl~DFG~a 163 (293)
T d1yhwa1 93 WVVMEYLAGGSLTDVVTE-T------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFC 163 (293)
T ss_dssp EEEEECCTTCBHHHHHHH-S------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCCTTC
T ss_pred EEEEEECCCCCHHHHHHC-C------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECC--CCCEEECCCHHH
T ss_conf 999970379808988641-5------9999999999999999999999879722677688868878--996864251564
Q ss_pred CCCCCC---CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCHHHHHHH
Q ss_conf 213688---64223676545703231899991256999999999999399999998399999999841199867887332
Q 005590 538 CFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 538 ~~~~~~---~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
...... ....+||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+.+....+..+.....+
T Consensus 164 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~--------- 234 (293)
T d1yhwa1 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP--------- 234 (293)
T ss_dssp EECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC---------
T ss_pred EEECCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC---------
T ss_conf 13213666444444477736826644799880120313729999980488998997999999999857999---------
Q ss_pred HHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 2354432001110000000010001477543011201479199999999813009899938999980989888
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~Hpwf~~ 687 (689)
....| ...++.+++||.+||+.||++|||+.|+|+||||+.
T Consensus 235 -----------------------~~~~~---------~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 235 -----------------------ELQNP---------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp -----------------------CCSSG---------GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred -----------------------CCCCC---------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf -----------------------88885---------537999999999986699668909999964996577
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=383.93 Aligned_cols=259 Identities=31% Similarity=0.469 Sum_probs=217.0
Q ss_pred CEECCCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCH--HHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEE
Q ss_conf 132375899999325888753999988789379999960541--346759999999999601699998722587789984
Q 005590 377 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 377 ~~i~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
+.+.++|++.+.||+|+||+||+|+++.+++.||+|++.... .....+.+|+.+++.++ ||||+++++++.+
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~------HpnIv~l~~~~~~ 78 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK------HPNIVALDDIYES 78 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCC------CTTBCCEEEEEEC
T ss_pred CCCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCC------CCCCCCEEEEEEE
T ss_conf 8776666998899406583999999999998999999815773128999999999998679------9899919899998
Q ss_pred CCEEEEEEECCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEEC-CCCCEEEEE
Q ss_conf 784999997142-143889863202699755598899999997799999999889530358999579802-578709998
Q 005590 455 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS-YQRCEIKII 532 (689)
Q Consensus 455 ~~~l~lVmEy~~-g~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~-~~~~~ikL~ 532 (689)
.+.+|+||||+. |+|.+++.... .+++..++.++.||+.||.|||+.+|+||||||+|||+.. +.++.+||+
T Consensus 79 ~~~~~lvmE~~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~ 152 (307)
T d1a06a_ 79 GGHLYLIMQLVSGGELFDRIVEKG------FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMIS 152 (307)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCS------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred CCEEEEEEECCCCCCHHHHHHCCC------CCCHHHHHHHHHHHHHHHHHHHHCEEEEEEECCCCEEECCCCCCCEEEEE
T ss_conf 998889885268984888653036------78878999999999999875241305568704630011046888249983
Q ss_pred ECCCCCCCCCC--CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCHHH
Q ss_conf 36884213688--6422367654570323189999125699999999999939999999839999999984119986788
Q 005590 533 DLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 610 (689)
Q Consensus 533 DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~~~g~~~~e~ 610 (689)
|||++...... ....+||+.|+|||++.+..|+.++||||+||++|+|++|++||.+....+....+......++
T Consensus 153 DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~--- 229 (307)
T d1a06a_ 153 DFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD--- 229 (307)
T ss_dssp CC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC---
T ss_pred CCCEEEECCCCCEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCC---
T ss_conf 15435872589704400328422591887379998078734515999999859799999899999999861687778---
Q ss_pred HHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 73322354432001110000000010001477543011201479199999999813009899938999980989888
Q 005590 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~Hpwf~~ 687 (689)
.+. ....++.+++||.+||+.||++|||+.|+|+||||++
T Consensus 230 ------------------------------~~~-------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 230 ------------------------------SPY-------WDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp ------------------------------TTT-------TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred ------------------------------CCC-------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf ------------------------------766-------6678999999999976089757918999862984479
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=385.11 Aligned_cols=249 Identities=30% Similarity=0.501 Sum_probs=214.3
Q ss_pred CCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCH----HHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEECC
Q ss_conf 75899999325888753999988789379999960541----34675999999999960169999872258778998478
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|++.+.||+|+||+||+|+++.+++.||+|++.+.. .....+.+|+.+++.++ ||||+++++++.+.+
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~------hpnIv~~~~~~~~~~ 79 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR------HPNILRLYGYFHDAT 79 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC------CTTBCCEEEEEECSS
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCC------CCCCCEEEEEEEECC
T ss_conf 37699889851778589999998999499999981688567689999999999998568------888885999999899
Q ss_pred EEEEEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEECC
Q ss_conf 49999971421-43889863202699755598899999997799999999889530358999579802578709998368
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~DFG 535 (689)
..++||||+.+ +|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~~~~------l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~--~~~~kl~DFG 151 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQKLSK------FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGS--AGELKIADFG 151 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCEEECCCC
T ss_pred EEEEEEEECCCCCHHHHHHHCCC------CCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCCEECC--CCCEEECCCC
T ss_conf 98999850479858988750489------999999999999999999999889465220234414668--9987115556
Q ss_pred CCCCCCCC-CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCHHHHHHH
Q ss_conf 84213688-64223676545703231899991256999999999999399999998399999999841199867887332
Q 005590 536 SSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 536 ls~~~~~~-~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
++...... .....||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+.+..+.+..+...
T Consensus 152 ~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~------------ 219 (263)
T d2j4za1 152 WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------ 219 (263)
T ss_dssp SCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT------------
T ss_pred EEEECCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC------------
T ss_conf 33544888523557887634999975899893144046759999983299998889999999999718------------
Q ss_pred HHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 2354432001110000000010001477543011201479199999999813009899938999980989888
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~Hpwf~~ 687 (689)
...+|. ..++.+++||.+||+.||++|||+.|+|+||||++
T Consensus 220 -----------------------~~~~p~---------~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 220 -----------------------EFTFPD---------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -----------------------CCCCCT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -----------------------CCCCCC---------CCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf -----------------------999986---------68999999999976479768909999971907078
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=378.17 Aligned_cols=289 Identities=30% Similarity=0.495 Sum_probs=235.9
Q ss_pred CCEEECCE---ECCCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECC---HHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 55462813---237589999932588875399998878937999996054---134675999999999960169999872
Q 005590 371 LPIILNTV---IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHH 444 (689)
Q Consensus 371 ~pi~~~~~---i~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~ 444 (689)
++..++.+ +.++|++++.||+|+||+||+|.++.+|+.||||+++.. ........+|+++|+.++ |||
T Consensus 5 ~~~~~~~~~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~------hpn 78 (346)
T d1cm8a_ 5 YRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR------HEN 78 (346)
T ss_dssp CCEECSSSEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC------BTT
T ss_pred EEEECCCCEEECCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCC------CCC
T ss_conf 78853673334477189988980177819999999999989999998522259699999999999998668------987
Q ss_pred EEEEEEEEEECC------EEEEEEECCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCC
Q ss_conf 258778998478------49999971421438898632026997555988999999977999999998895303589995
Q 005590 445 ILRLYDYFYHLE------HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPEN 518 (689)
Q Consensus 445 Iv~l~~~f~~~~------~l~lVmEy~~g~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~N 518 (689)
|++++++|...+ ++++||||++.++..+.... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 79 iv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~N 151 (346)
T d1cm8a_ 79 VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGN 151 (346)
T ss_dssp BCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred EEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCH
T ss_conf 54799986357655554159999840552189998740-------22699999999999999999873787645668511
Q ss_pred EEEECCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHH
Q ss_conf 79802578709998368842136886422367654570323189-99912569999999999993999999983999999
Q 005590 519 ILIKSYQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILA 597 (689)
Q Consensus 519 ILi~~~~~~~ikL~DFGls~~~~~~~~~~~gt~~y~APE~l~~~-~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~ 597 (689)
||++. ++.+||+|||++.......+...+|+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+....+.
T Consensus 152 IL~~~--~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~ 229 (346)
T d1cm8a_ 152 LAVNE--DCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK 229 (346)
T ss_dssp EEECT--TCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred HHCCC--CCCCCCCCCCCEECCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHH
T ss_conf 11210--0122113431022068763102455333588998178789965010300389999997869988897689999
Q ss_pred HHHHHCCCCCHHHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHH
Q ss_conf 99841199867887332235443200111000000001000147754301120147919999999981300989993899
Q 005590 598 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 677 (689)
Q Consensus 598 ~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ 677 (689)
.+....+.++.+.+............ ..+. ......+.......++.+++||++||+.||++|||+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~--~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ 296 (346)
T d1cm8a_ 230 EIMKVTGTPPAEFVQRLQSDEAKNYM-----------KGLP--ELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296 (346)
T ss_dssp HHHHHHCCCCHHHHHTCSCHHHHHHH-----------HHSC--CCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred HHHHCCCCCCHHHHHHHCCHHHHHHH-----------CCCC--CCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHH
T ss_conf 99850378848888653000344331-----------1578--6665566775568999999999997729955792999
Q ss_pred HHHCCCCCCC
Q ss_conf 9980989888
Q 005590 678 EALDHPWLQH 687 (689)
Q Consensus 678 elL~Hpwf~~ 687 (689)
|+|+||||+.
T Consensus 297 eiL~Hp~f~~ 306 (346)
T d1cm8a_ 297 EALAHPYFES 306 (346)
T ss_dssp HHHHSGGGTT
T ss_pred HHHCCHHHCC
T ss_conf 9963962375
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=384.59 Aligned_cols=255 Identities=22% Similarity=0.325 Sum_probs=207.7
Q ss_pred CCCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCH--HHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEECCE
Q ss_conf 375899999325888753999988789379999960541--346759999999999601699998722587789984784
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 380 ~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
.++|++.+.||+|+||+||+|+++.+++.||+|++.... .....+.+|+.+++.++ ||||+++++++.+.+.
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~------HpnIv~~~~~~~~~~~ 77 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN------HENVVKFYGHRREGNI 77 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCC------CTTBCCEEEEEEETTE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCC------CCCEEEEEEEECCCCE
T ss_conf 7460899897217480999999999997999999845664127999999999998579------9888469654046743
Q ss_pred EEEEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEECCC
Q ss_conf 9999971421-438898632026997555988999999977999999998895303589995798025787099983688
Q 005590 458 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 458 l~lVmEy~~g-~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~DFGl 536 (689)
.++||||+.+ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 78 ~~ivmEy~~gg~L~~~l~~~~------~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~--~~~~KL~DFG~ 149 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE--RDNLKISDFGL 149 (271)
T ss_dssp EEEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT--TCCEEECCCTT
T ss_pred EEEEEECCCCCCHHHHHHCCC------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECC--CCCEEECCCHH
T ss_conf 679886458980899975379------9999999999999999999999759835754689978878--99879832314
Q ss_pred CCCCCC-----CCCCCCCCCCCCCHHHHCCCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCHHH
Q ss_conf 421368-----8642236765457032318999-9125699999999999939999999839999999984119986788
Q 005590 537 SCFQTD-----NLCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 610 (689)
Q Consensus 537 s~~~~~-----~~~~~~gt~~y~APE~l~~~~~-s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~~~g~~~~e~ 610 (689)
+..... .....+||+.|+|||++.+..+ +.++||||+||++|+|++|++||.................
T Consensus 150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~------ 223 (271)
T d1nvra_ 150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK------ 223 (271)
T ss_dssp CEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC------
T ss_pred HEEECCCCCCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCC------
T ss_conf 22404688653111325574742872861899999710161737999999829978888985999999986388------
Q ss_pred HHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf 7332235443200111000000001000147754301120147919999999981300989993899998098988899
Q 005590 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHPY 689 (689)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~Hpwf~~~~ 689 (689)
...+. ....++.+++||.+||+.||++|||+.|+|+||||+++.
T Consensus 224 ----------------------------~~~~~-------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 224 ----------------------------TYLNP-------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp ----------------------------TTSTT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred ----------------------------CCCCC-------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf ----------------------------87886-------446999999999997679966890999996198458598
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=378.80 Aligned_cols=250 Identities=24% Similarity=0.424 Sum_probs=215.1
Q ss_pred CCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCH----HHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEECC
Q ss_conf 75899999325888753999988789379999960541----34675999999999960169999872258778998478
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|++++.||+|+||+||+|+++.+|+.||+|++.+.. .....+.+|+++|+.+ .||||+++++++....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l------~hpnIv~~~~~~~~~~ 114 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV------NFPFLVKLEFSFKDNS 114 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC------CCTTBCCEEEEEECSS
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHC------CCCCEEECCCCCCCCC
T ss_conf 3708988961176808999999899989999998267745889999999999999974------8772740344443222
Q ss_pred EEEEEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEECC
Q ss_conf 49999971421-43889863202699755598899999997799999999889530358999579802578709998368
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~DFG 535 (689)
..++||||+.+ ++...+..... +++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||
T Consensus 115 ~~~~v~e~~~~g~l~~~l~~~~~------l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~--~g~ikL~DFG 186 (350)
T d1rdqe_ 115 NLYMVMEYVAGGEMFSHLRRIGR------FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ--QGYIQVTDFG 186 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCT
T ss_pred CCCCCCCCCCCCCHHHHHHHCCC------CCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHCCCCC--CCCEEEEECE
T ss_conf 22322223346622666751589------899999999999999899998599861767999936077--8978861010
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCHHHHHHHH
Q ss_conf 84213688642236765457032318999912569999999999993999999983999999998411998678873322
Q 005590 536 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615 (689)
Q Consensus 536 ls~~~~~~~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~ 615 (689)
+++..........||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 187 ~a~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~----------- 255 (350)
T d1rdqe_ 187 FAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV----------- 255 (350)
T ss_dssp TCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------
T ss_pred EEEECCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC-----------
T ss_conf 333225666433676356788997179988533114500789999758899899599999999861798-----------
Q ss_pred HHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCC-----CHHHHHCCCCCCCC
Q ss_conf 35443200111000000001000147754301120147919999999981300989993-----89999809898889
Q 005590 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQHP 688 (689)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRp-----Ta~elL~Hpwf~~~ 688 (689)
.+|. ..++.+.+||++||+.||.+|+ |++++++||||+..
T Consensus 256 ------------------------~~p~---------~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 256 ------------------------RFPS---------HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp ------------------------CCCT---------TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred ------------------------CCCC---------CCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCCCCCCCC
T ss_conf ------------------------8976---------68999999999983409986065534549999719051589
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=379.72 Aligned_cols=259 Identities=27% Similarity=0.400 Sum_probs=222.1
Q ss_pred ECCCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEECCEE
Q ss_conf 23758999993258887539999887893799999605413467599999999996016999987225877899847849
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 379 i~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
+-++|++.+.||+|+||+||+|+++.+++.||+|+++........+.+|+.+|+.++ ||||++++++|.+.+++
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~------HpnIv~~~~~~~~~~~~ 76 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR------HRNILHLHESFESMEEL 76 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSC------CTTBCCEEEEEEETTEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHCC------CCCCCEEEEEEEECCEE
T ss_conf 701058878983177839999999899969999997578665999999999998579------97989098999889988
Q ss_pred EEEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEECCCC
Q ss_conf 999971421-4388986320269975559889999999779999999988953035899957980257870999836884
Q 005590 459 FIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 459 ~lVmEy~~g-~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~DFGls 537 (689)
|+||||+.| +|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++...+||+|||++
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~-----~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~ 151 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred EEEEECCCCCCHHHHHHHCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHH
T ss_conf 99995389980889987538-----9999999999999999999999876997513554443443788518997644111
Q ss_pred CCCCCC--CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCHHHHHHHH
Q ss_conf 213688--642236765457032318999912569999999999993999999983999999998411998678873322
Q 005590 538 CFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615 (689)
Q Consensus 538 ~~~~~~--~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~ 615 (689)
...... .....+++.|+|||.+.+..|+.++||||+||++|+|++|..||.+.+..+.+..|......++.+.+
T Consensus 152 ~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~---- 227 (321)
T d1tkia_ 152 RQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF---- 227 (321)
T ss_dssp EECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH----
T ss_pred HCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHC----
T ss_conf 0034677532122332223402104877784011302799999998289999998999999999838999880223----
Q ss_pred HHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 3544320011100000000100014775430112014791999999998130098999389999809898889
Q 005590 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~Hpwf~~~ 688 (689)
...++.+++||.+||+.||++|||+.|+|+||||++.
T Consensus 228 ------------------------------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 228 ------------------------------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ------------------------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ------------------------------------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf ------------------------------------6789999999999866996689099999639965667
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=378.18 Aligned_cols=249 Identities=27% Similarity=0.500 Sum_probs=214.2
Q ss_pred CCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCH----HHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEECC
Q ss_conf 75899999325888753999988789379999960541----34675999999999960169999872258778998478
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|++.+.||+|+||+||+|+++.+|+.||+|+++++. .....+.+|+.+++.++ ||||+++++++.+.+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~------HpnIv~~~~~~~~~~ 77 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT------HPFIIRMWGTFQDAQ 77 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC------BTTBCCEEEEEECSS
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCC------CCCHHHEEEEEEECC
T ss_conf 47088889720768089999998999799999984577548899999999999998636------967533035685288
Q ss_pred EEEEEEECCCCC-HHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEECC
Q ss_conf 499999714214-3889863202699755598899999997799999999889530358999579802578709998368
Q 005590 457 HLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~g~-L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~DFG 535 (689)
++|+||||+.|+ +..++.... . +++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 78 ~~~ivmE~~~gg~l~~~~~~~~-~-----~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~--~g~vkL~DFG 149 (316)
T d1fota_ 78 QIFMIMDYIEGGELFSLLRKSQ-R-----FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDK--NGHIKITDFG 149 (316)
T ss_dssp EEEEEECCCCSCBHHHHHHHTS-S-----CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT--TSCEEECCCS
T ss_pred EEEEEEEECCCCCCCCCCCCCC-C-----CCCCHHHHHHHHHHHHHHHHCCCCEECCCCCCHHEEECC--CCCEEEECCC
T ss_conf 0056765037863223432222-1-----110079999999987655412476770556810503868--9988983175
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCHHHHHHHH
Q ss_conf 84213688642236765457032318999912569999999999993999999983999999998411998678873322
Q 005590 536 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQGQ 615 (689)
Q Consensus 536 ls~~~~~~~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~~ 615 (689)
++..........+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+...++...
T Consensus 150 ~a~~~~~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~------------- 216 (316)
T d1fota_ 150 FAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA------------- 216 (316)
T ss_dssp SCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-------------
T ss_pred CCEEECCCCCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHCC-------------
T ss_conf 2167124564345763435999983899980430465333689997598999996999999999708-------------
Q ss_pred HHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCC-----CHHHHHCCCCCCC
Q ss_conf 35443200111000000001000147754301120147919999999981300989993-----8999980989888
Q 005590 616 EIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQH 687 (689)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRp-----Ta~elL~Hpwf~~ 687 (689)
...+|. ..++.+.++|.+||..||.+|+ |++++++||||++
T Consensus 217 ----------------------~~~~p~---------~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 217 ----------------------ELRFPP---------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp ----------------------CCCCCT---------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred ----------------------CCCCCC---------CCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCCCCCCC
T ss_conf ----------------------988997---------7899999999999544997666431021999981935146
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.74 Aligned_cols=282 Identities=28% Similarity=0.438 Sum_probs=226.9
Q ss_pred CCCEEEEEEECCCCCCCEEEEEECCC-CCEEEEEEEECCH---HHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEE-
Q ss_conf 37589999932588875399998878-9379999960541---346759999999999601699998722587789984-
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHT-GVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH- 454 (689)
Q Consensus 380 ~~~Y~i~~~LG~G~fG~Vy~a~d~~t-g~~vAIKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~- 454 (689)
.++|++++.||+|+||+||+|++..+ ++.||||+++.+. .......+|+.+++.+... .||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~---~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF---EHPNVVRLFDVCTVS 82 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHT---CCTTBCCEEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHC---CCCCCCEEEEEECCC
T ss_conf 58979888992155869999999888998999999802324516799999999999987425---898802366322146
Q ss_pred ----CCEEEEEEECCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEE
Q ss_conf ----7849999971421438898632026997555988999999977999999998895303589995798025787099
Q 005590 455 ----LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 530 (689)
Q Consensus 455 ----~~~l~lVmEy~~g~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ik 530 (689)
..+.+++|||+.++++.+...... ..+++..++.++.|++.||.|||+++|+||||||+|||++. .+.+|
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~--~~~~k 156 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQIK 156 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCEE
T ss_pred CCCCCCEEEEEEEECCCCCHHHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEECC--CCCEE
T ss_conf 6666746999997405871444443037----89998999999999999999997588983579862789858--99754
Q ss_pred EEECCCCCCCCC--CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCH
Q ss_conf 983688421368--864223676545703231899991256999999999999399999998399999999841199867
Q 005590 531 IIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 608 (689)
Q Consensus 531 L~DFGls~~~~~--~~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~~~g~~~~ 608 (689)
|+|||++..... ......||+.|+|||++.+.+|+.++||||+||++|+|++|++||.+.+..+.+..+....+.+..
T Consensus 157 l~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 157 LADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp ECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred ECCHHHHHHHCCCCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCH
T ss_conf 21000101100234577765485114831001798881110003289999998787998998989999999984079961
Q ss_pred HHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 8873322354432001110000000010001477543011201479199999999813009899938999980989888
Q 005590 609 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 609 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~Hpwf~~ 687 (689)
..+........... ........+......++.+++||++||++||++||||.|+|+||||++
T Consensus 237 ~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 237 EDWPRDVALPRQAF-----------------HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp GGSCTTCSSCGGGS-----------------CCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred HCCCCCCCCHHHHH-----------------CCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 10532111103330-----------------223456454404458999999999987489667918999966963407
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.59 Aligned_cols=250 Identities=25% Similarity=0.390 Sum_probs=213.7
Q ss_pred CCCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECC----HHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEEC
Q ss_conf 37589999932588875399998878937999996054----13467599999999996016999987225877899847
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 380 ~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~----~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
-++|++++.||+|+||+||+|+++.+++.||+|++.+. ........+|+.+|+.+ .||||++++++|.+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l------~hp~Iv~l~~~~~~~ 77 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT------RHPFLTALKYAFQTH 77 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC------CCTTBCCEEEEEECS
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHC------CCCCEEEEEEEECCC
T ss_conf 47428988983176849999999899989999998156544979999999999999867------999887787640356
Q ss_pred CEEEEEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEEC
Q ss_conf 849999971421-4388986320269975559889999999779999999988953035899957980257870999836
Q 005590 456 EHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 534 (689)
Q Consensus 456 ~~l~lVmEy~~g-~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~DF 534 (689)
+++|+||||+.| +|..++..... +++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 78 ~~~~iv~ey~~gg~L~~~~~~~~~------~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~--~g~vkl~DF 149 (337)
T d1o6la_ 78 DRLCFVMEYANGGELFFHLSRERV------FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK--DGHIKITDF 149 (337)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECCC
T ss_pred CCCCCCEECCCCCCHHHHHHCCCC------CCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECC--CCCEEEEEC
T ss_conf 421110003579860555532567------759999999999965211343159622464777847658--998888205
Q ss_pred CCCCCCCC---CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCHHHH
Q ss_conf 88421368---864223676545703231899991256999999999999399999998399999999841199867887
Q 005590 535 GSSCFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 611 (689)
Q Consensus 535 Gls~~~~~---~~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~ 611 (689)
|+++.... .....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..++...+...
T Consensus 150 G~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~--------- 220 (337)
T d1o6la_ 150 GLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--------- 220 (337)
T ss_dssp TTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------
T ss_pred CCCCCCCCCCCCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCC---------
T ss_conf 65200356786205510088996666504898883331022306788998789999996999999998528---------
Q ss_pred HHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCC-----CHHHHHCCCCCC
Q ss_conf 332235443200111000000001000147754301120147919999999981300989993-----899998098988
Q 005590 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREALDHPWLQ 686 (689)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRp-----Ta~elL~Hpwf~ 686 (689)
...+|. ..++.+++||++||++||.+|+ ++.++++||||+
T Consensus 221 --------------------------~~~~p~---------~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~ 265 (337)
T d1o6la_ 221 --------------------------EIRFPR---------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265 (337)
T ss_dssp --------------------------CCCCCT---------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred --------------------------CCCCCC---------CCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCCCCCC
T ss_conf --------------------------998986---------689999999986663893442256523499997291503
Q ss_pred C
Q ss_conf 8
Q 005590 687 H 687 (689)
Q Consensus 687 ~ 687 (689)
.
T Consensus 266 ~ 266 (337)
T d1o6la_ 266 S 266 (337)
T ss_dssp T
T ss_pred C
T ss_conf 6
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.30 Aligned_cols=281 Identities=29% Similarity=0.447 Sum_probs=227.3
Q ss_pred CCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCH---HHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEECCE
Q ss_conf 75899999325888753999988789379999960541---346759999999999601699998722587789984784
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 381 ~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
++|++++.||+|+||+||+|+++.+++.||+|+++.+. ....++.+|+++++.+ .||||++++++|.+.++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l------~Hp~Iv~~~~~~~~~~~ 75 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL------NHPNIVKLLDVIHTENK 75 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC------CCTTBCCEEEEEEETTE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHC------CCCCEEEECCCCCCCCC
T ss_conf 997765177237680999999999997999999802225758999999999999867------99838874453322432
Q ss_pred EEEEEECCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEECCCC
Q ss_conf 99999714214388986320269975559889999999779999999988953035899957980257870999836884
Q 005590 458 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 458 l~lVmEy~~g~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~DFGls 537 (689)
+++||||+.+++..+....... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||.+
T Consensus 76 ~~iv~e~~~~~~~~~~~~~~~~----~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~--~~~~kl~DFG~a 149 (298)
T d1gz8a_ 76 LYLVFEFLHQDLKKFMDASALT----GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLA 149 (298)
T ss_dssp EEEEEECCSEEHHHHHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TSCEEECSTTHH
T ss_pred EEEEEEECCCCHHHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCHHEEECC--CCCCEECCCCCC
T ss_conf 0378862377445554420256----8888999999999999999865288992135711401134--676210357861
Q ss_pred CCCCCC---CCCCCCCCCCCCHHHHCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCHHHHHH
Q ss_conf 213688---64223676545703231899-99125699999999999939999999839999999984119986788733
Q 005590 538 CFQTDN---LCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 538 ~~~~~~---~~~~~gt~~y~APE~l~~~~-~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
...... .....||+.|+|||++.... ++.++||||+||++|+|++|+.||.+.+..+.+.++....+.++...+..
T Consensus 150 ~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 229 (298)
T d1gz8a_ 150 RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229 (298)
T ss_dssp HHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred EECCCCCCCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCC
T ss_conf 34368864100103652154112213665777422103333134279668799898899999999998328983331444
Q ss_pred HHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 223544320011100000000100014775430112014791999999998130098999389999809898889
Q 005590 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~Hpwf~~~ 688 (689)
......+... ................++.+++||++||+.||++|||+.|+|+||||++-
T Consensus 230 ~~~~~~~~~~---------------~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 230 VTSMPDYKPS---------------FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp GGGSTTCCTT---------------SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CCCCCCCCCC---------------CCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 2224212434---------------54322220444166789999999999763995579189999678701469
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=380.44 Aligned_cols=274 Identities=31% Similarity=0.458 Sum_probs=223.6
Q ss_pred EEEEECCCCCCCEEEEEECCCCCEEEEEEEECCHH------HHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEECCEE
Q ss_conf 99993258887539999887893799999605413------467599999999996016999987225877899847849
Q 005590 385 VTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD------FFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHL 458 (689)
Q Consensus 385 i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~~------~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l 458 (689)
.+++||+|+||+||+|+++.+|+.||||+++.... ....+.+|+.+++.++ ||||+++++++...+++
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~------hpnIv~~~~~~~~~~~~ 75 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS------HPNIIGLLDAFGHKSNI 75 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC------CTTBCCEEEEECCTTCC
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCC------CCCEEEEEEEECCCCCE
T ss_conf 563851272829999999999969999998420212456799999999999998679------99986898542258740
Q ss_pred EEEEECCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEECCCCC
Q ss_conf 99997142143889863202699755598899999997799999999889530358999579802578709998368842
Q 005590 459 FIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 459 ~lVmEy~~g~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~DFGls~ 538 (689)
++||||+.+++...+.... ..+++..++.+++||+.||.|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 76 ~ivmE~~~~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~--~~~~KL~DFG~a~ 148 (299)
T d1ua2a_ 76 SLVFDFMETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE--NGVLKLADFGLAK 148 (299)
T ss_dssp EEEEECCSEEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCEEECCCGGGS
T ss_pred EEHHHHHCCHHHHHHHHCC-----CCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECC--CCCCCCCCCCCCC
T ss_conf 2204553450776554126-----67789999999999999998863163550357762588537--7841146576100
Q ss_pred CCCCC---CCCCCCCCCCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCHHHHHHH
Q ss_conf 13688---6422367654570323189-9991256999999999999399999998399999999841199867887332
Q 005590 539 FQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 539 ~~~~~---~~~~~gt~~y~APE~l~~~-~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
..... ....+||+.|+|||++.+. .|+.++||||+||++|+|++|.+||.+.+..+.+..|...++.++.+.+...
T Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~ 228 (299)
T d1ua2a_ 149 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 228 (299)
T ss_dssp TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred CCCCCCCCCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCH
T ss_conf 05787554330204733363999726778880564363042899998596999999999999999985189972545210
Q ss_pred HHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 2354432001110000000010001477543011201479199999999813009899938999980989888
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~Hpwf~~ 687 (689)
........ ....+ ...+.......++.+++||.+||+.||++||||.|+|+||||+.
T Consensus 229 ~~~~~~~~---------------~~~~~-~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 229 CSLPDYVT---------------FKSFP-GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp TSSTTCCC---------------CCCCC-CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred HCCCHHHH---------------HCCCC-CCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 00213443---------------03478-98867856568999999999976389456908999967996578
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.82 Aligned_cols=258 Identities=28% Similarity=0.436 Sum_probs=217.9
Q ss_pred EECCCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCH-------HHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEE
Q ss_conf 32375899999325888753999988789379999960541-------34675999999999960169999872258778
Q 005590 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-------DFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 450 (689)
Q Consensus 378 ~i~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~-------~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~ 450 (689)
.+.++|++.+.||+|+||+||+|+++.+|+.||+|++.+.. .....+.+|+.+++.++ ||||+++++
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~------HpnIv~~~~ 80 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ------HPNVITLHE 80 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC------CTTBCCEEE
T ss_pred CCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCC------CCCCCCEEE
T ss_conf 85567798279811789599999999999899999987566321340689999999999998679------989993889
Q ss_pred EEEECCEEEEEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCC--C
Q ss_conf 99847849999971421-43889863202699755598899999997799999999889530358999579802578--7
Q 005590 451 YFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQR--C 527 (689)
Q Consensus 451 ~f~~~~~l~lVmEy~~g-~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~--~ 527 (689)
+|.+.+++++||||+.+ +|.+++..... +++..++.++.||+.||.|||+.+|+||||||+|||++..+. .
T Consensus 81 ~~~~~~~~~iv~E~~~gg~L~~~i~~~~~------l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~ 154 (293)
T d1jksa_ 81 VYENKTDVILILELVAGGELFDFLAEKES------LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKP 154 (293)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSC
T ss_pred EEEECCEEEEEEECCCCCCCCCHHCCCCC------CCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEEECCCCCCC
T ss_conf 99979989999986778643100103564------215578999999999987666254221133301279825898666
Q ss_pred EEEEEECCCCCCCCC--CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 099983688421368--864223676545703231899991256999999999999399999998399999999841199
Q 005590 528 EIKIIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 605 (689)
Q Consensus 528 ~ikL~DFGls~~~~~--~~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~~~g~ 605 (689)
.+||+|||++..... ......+|+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+.+..+......
T Consensus 155 ~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~ 234 (293)
T d1jksa_ 155 RIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234 (293)
T ss_dssp CEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC
T ss_pred CEEECCHHHHHHCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC
T ss_conf 46964334421057776312247777430999981899997665221409999997088998899999999999816888
Q ss_pred CCHHHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCC
Q ss_conf 86788733223544320011100000000100014775430112014791999999998130098999389999809898
Q 005590 606 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 606 ~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~Hpwf 685 (689)
++... ....+..+++||++||+.||++|||+.|+|+||||
T Consensus 235 ~~~~~----------------------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 274 (293)
T d1jksa_ 235 FEDEY----------------------------------------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274 (293)
T ss_dssp CCHHH----------------------------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred CCCHH----------------------------------------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCC
T ss_conf 87010----------------------------------------47889999999999863896689199999619041
Q ss_pred CC
Q ss_conf 88
Q 005590 686 QH 687 (689)
Q Consensus 686 ~~ 687 (689)
+.
T Consensus 275 ~~ 276 (293)
T d1jksa_ 275 KP 276 (293)
T ss_dssp CC
T ss_pred CC
T ss_conf 88
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.71 Aligned_cols=254 Identities=31% Similarity=0.442 Sum_probs=210.7
Q ss_pred CCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECC-HHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEECCEEE
Q ss_conf 7589999932588875399998878937999996054-134675999999999960169999872258778998478499
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND-KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 459 (689)
Q Consensus 381 ~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~-~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~ 459 (689)
+.|++.+.||+|+||+||+|+++.+++.||+|++... ......+.+|+++++.++ ||||+++++++.+.+..+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~------HpnIv~l~~~~~~~~~~~ 85 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD------HPNIVKLLDAFYYENNLW 85 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCC------CTTBCCEEEEEEETTEEE
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCC------CCCCCEEEEEEEECCEEE
T ss_conf 37598479930778199999999999399999987289999999999999998679------999884988980099589
Q ss_pred EEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEECCCCC
Q ss_conf 99971421-43889863202699755598899999997799999999889530358999579802578709998368842
Q 005590 460 IVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSC 538 (689)
Q Consensus 460 lVmEy~~g-~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~DFGls~ 538 (689)
+||||+.+ +|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 86 lvmEy~~~g~L~~~~~~~~~-----~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~--~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLELER-----PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTL--DGDIKLADFGVSA 158 (288)
T ss_dssp EEEECCTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TSCEEECCCTTCE
T ss_pred EEEECCCCCCHHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEEEECCHHHEEECC--CCCEEEEECHHHH
T ss_conf 99962799818899986289-----9999999999999999999999889887140700314878--9998997161230
Q ss_pred CCCCC---CCCCCCCCCCCCHHHHC-----CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCHHH
Q ss_conf 13688---64223676545703231-----89999125699999999999939999999839999999984119986788
Q 005590 539 FQTDN---LCLYVQSRSYRAPEVII-----GLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 610 (689)
Q Consensus 539 ~~~~~---~~~~~gt~~y~APE~l~-----~~~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~~~g~~~~e~ 610 (689)
..... ....+||+.|+|||++. +..|+.++||||+||++|+|++|+.||.+.+..+.+.++.....+
T Consensus 159 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~----- 233 (288)
T d2jfla1 159 KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP----- 233 (288)
T ss_dssp ECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCC-----
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCC-----
T ss_conf 357786410010256264799998320257888880665787899999982088999998999999999707998-----
Q ss_pred HHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 733223544320011100000000100014775430112014791999999998130098999389999809898889
Q 005590 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~Hpwf~~~ 688 (689)
.++.. ...++.+++||.+||+.||++|||+.|+|+||||+..
T Consensus 234 -----------------------------~~~~~-------~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 234 -----------------------------TLAQP-------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp -----------------------------CCSSG-------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred -----------------------------CCCCC-------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf -----------------------------77765-------6699999999999766996689199999629231889
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.22 Aligned_cols=300 Identities=29% Similarity=0.500 Sum_probs=237.4
Q ss_pred CCCCEEECC-E--ECCCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECC---HHHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 885546281-3--237589999932588875399998878937999996054---1346759999999999601699998
Q 005590 369 KDLPIILNT-V--IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADE 442 (689)
Q Consensus 369 ~~~pi~~~~-~--i~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h 442 (689)
..+|+.+++ + +.++|+++++||+|+||+||+|+++.+|+.||||+++.. .....++.+|+.+++.++ |
T Consensus 2 ~~~~~~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~------h 75 (355)
T d2b1pa1 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN------H 75 (355)
T ss_dssp CEEEEEETTEEEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCC------C
T ss_pred CCEEEEECCCCEEECCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCC------C
T ss_conf 9879995894045337759988962175859999999999989999998823369799999999999998648------9
Q ss_pred CCEEEEEEEEEE------CCEEEEEEECCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCC
Q ss_conf 722587789984------78499999714214388986320269975559889999999779999999988953035899
Q 005590 443 HHILRLYDYFYH------LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKP 516 (689)
Q Consensus 443 ~~Iv~l~~~f~~------~~~l~lVmEy~~g~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp 516 (689)
|||++++++|.. ..++|+||||+.++++..... .+++..++.++.||+.||.|||++||+||||||
T Consensus 76 pnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~~--------~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP 147 (355)
T d2b1pa1 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 147 (355)
T ss_dssp TTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred CCEEEEEEEEECCCCCCCCCEEEEEEECCCHHHHHHHHC--------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 876489989702564345762699984144677876503--------899999999999999999886522112456776
Q ss_pred CCEEEECCCCCEEEEEECCCCCCCCCC--CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHH
Q ss_conf 957980257870999836884213688--642236765457032318999912569999999999993999999983999
Q 005590 517 ENILIKSYQRCEIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVM 594 (689)
Q Consensus 517 ~NILi~~~~~~~ikL~DFGls~~~~~~--~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG~~PF~~~~~~~ 594 (689)
+|||++. ++.++++|||++...... ....++|+.|+|||++.+..++.++||||+||++|+|++|++||.+.+...
T Consensus 148 ~Nil~~~--~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~ 225 (355)
T d2b1pa1 148 SNIVVKS--DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225 (355)
T ss_dssp GGEEECT--TCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred CCCCCCC--CCCEEEECHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHH
T ss_conf 3211365--44313201023211466655332214655558133147777877433356625789865989988897788
Q ss_pred HHHHHHHHCCCCCHHHHHHHHHHHHHHHCCCCCHHHHHCCC-CCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 99999841199867887332235443200111000000001-00014775430112014791999999998130098999
Q 005590 595 ILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETN-QLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRR 673 (689)
Q Consensus 595 ~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kR 673 (689)
....+....+.+..+.+.........+.............. ......+... ......++.+++||++||..||++|
T Consensus 226 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~s~~~~dll~~mL~~dP~~R 302 (355)
T d2b1pa1 226 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADS---EHNKLKASQARDLLSKMLVIDPAKR 302 (355)
T ss_dssp HHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSS---HHHHHHHHHHHHHHHHHSCSSTTTS
T ss_pred HHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCC---CCCCCCCHHHHHHHHHHCCCCHHHC
T ss_conf 9999997205898799987656677776417543566642126433354321---0133379999999999876994579
Q ss_pred CCHHHHHCCCCCCC
Q ss_conf 38999980989888
Q 005590 674 PTAREALDHPWLQH 687 (689)
Q Consensus 674 pTa~elL~Hpwf~~ 687 (689)
|||+|+|+||||+.
T Consensus 303 ~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 303 ISVDDALQHPYINV 316 (355)
T ss_dssp CCHHHHHTSTTTGG
T ss_pred CCHHHHHCCCCCCC
T ss_conf 08999966942087
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=376.10 Aligned_cols=252 Identities=24% Similarity=0.374 Sum_probs=209.2
Q ss_pred CCCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCH----HHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEEC
Q ss_conf 375899999325888753999988789379999960541----3467599999999996016999987225877899847
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 380 ~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
..+|++++.||+|+||+||+|+++.+++.||||++.... .....+.+|+.+++.+ .||||+++++++.+.
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l------~HpnIv~~~~~~~~~ 87 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL------RHPNTIQYRGCYLRE 87 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC------CCTTBCCEEEEEEET
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHC------CCCCEEEEEEEEEEC
T ss_conf 78567627970188809999999899939999998444435889999999999999977------899982389999989
Q ss_pred CEEEEEEECCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEECC
Q ss_conf 84999997142143889863202699755598899999997799999999889530358999579802578709998368
Q 005590 456 EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 456 ~~l~lVmEy~~g~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~DFG 535 (689)
++.++||||+.++++........ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 88 ~~~~iv~E~~~~g~l~~~~~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~--~~~~Kl~DFG 160 (309)
T d1u5ra_ 88 HTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE--PGLVKLGDFG 160 (309)
T ss_dssp TEEEEEEECCSEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET--TTEEEECCCT
T ss_pred CEEEEEEEECCCCCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCEEEECC--CCCEEEEECC
T ss_conf 98899998069994578997379-----9999999999999999999998689766678842179879--9978984436
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHCC---CCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCHHHHH
Q ss_conf 84213688642236765457032318---999912569999999999993999999983999999998411998678873
Q 005590 536 SSCFQTDNLCLYVQSRSYRAPEVIIG---LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 612 (689)
Q Consensus 536 ls~~~~~~~~~~~gt~~y~APE~l~~---~~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~ 612 (689)
++...... ...+||+.|+|||++.+ ..|+.++||||+||++|+|++|..||.+.+..+.+.++.....+..
T Consensus 161 ~a~~~~~~-~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~----- 234 (309)
T d1u5ra_ 161 SASIMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL----- 234 (309)
T ss_dssp TCBSSSSB-CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-----
T ss_pred CCCCCCCC-CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC-----
T ss_conf 53346778-731347663688998346788867214545589999999878899999799999999982899988-----
Q ss_pred HHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 322354432001110000000010001477543011201479199999999813009899938999980989888
Q 005590 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~Hpwf~~ 687 (689)
.+ ...++.+++||.+||+.||++|||+.|+|+||||+.
T Consensus 235 ----------------------------~~---------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 235 ----------------------------QS---------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp ----------------------------SC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred ----------------------------CC---------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCC
T ss_conf ----------------------------87---------888999999999977379657918999971997537
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.00 Aligned_cols=249 Identities=28% Similarity=0.452 Sum_probs=213.5
Q ss_pred CCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCH----HHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEECC
Q ss_conf 75899999325888753999988789379999960541----34675999999999960169999872258778998478
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|++.+.||+|+||+||+|+++.+++.||+|++.+.. .....+.+|+.+++.++ ||||++++++|.+.+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~------HpnIv~l~~~~~~~~ 81 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD------HPFFVKLYFTFQDDE 81 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC------STTBCCEEEEEECSS
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCC------CCCEEEEEEEEEECC
T ss_conf 87789889850879099999998999799999986577557778999999999998768------888617999999899
Q ss_pred EEEEEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEECC
Q ss_conf 49999971421-43889863202699755598899999997799999999889530358999579802578709998368
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~DFG 535 (689)
.+|+||||+.| +|.+++...+. +++..++.++.|++.||.|||+.+|+||||||+|||++. ++.+||+|||
T Consensus 82 ~~~ivmEy~~gg~L~~~~~~~~~------l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~--~~~vkl~DFG 153 (288)
T d1uu3a_ 82 KLYFGLSYAKNGELLKYIRKIGS------FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE--DMHIQITDFG 153 (288)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TSCEEECCCT
T ss_pred EEEEEEECCCCCCHHHHHHCCCC------CCHHHHHHHHHHHHHHHHHHCCCCEECCCCCCCCCCCCC--CCEEEECCCC
T ss_conf 88999970489877776531599------999999999999999997621650884767741236688--8538860321
Q ss_pred CCCCCCCC-----CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCHHH
Q ss_conf 84213688-----6422367654570323189999125699999999999939999999839999999984119986788
Q 005590 536 SSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEM 610 (689)
Q Consensus 536 ls~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~~~g~~~~e~ 610 (689)
+++..... ....+||+.|+|||++.+..|+.++||||+||++|+|++|..||.+.+..+++.++...
T Consensus 154 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~-------- 225 (288)
T d1uu3a_ 154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-------- 225 (288)
T ss_dssp TCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT--------
T ss_pred CCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCC--------
T ss_conf 024225677643335556775525844002689896662304569999980388998995999999999718--------
Q ss_pred HHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHH------HHCCCC
Q ss_conf 73322354432001110000000010001477543011201479199999999813009899938999------980989
Q 005590 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTARE------ALDHPW 684 (689)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~e------lL~Hpw 684 (689)
...+|. ..++.+++||.+||+.||++|||++| +++|||
T Consensus 226 ---------------------------~~~~p~---------~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpf 269 (288)
T d1uu3a_ 226 ---------------------------EYDFPE---------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269 (288)
T ss_dssp ---------------------------CCCCCT---------TCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGG
T ss_pred ---------------------------CCCCCC---------CCCHHHHHHHHHHCCCCHHHCCCHHHHCCCHHHHCCCC
T ss_conf ---------------------------999985---------47999999999985579768919789737789876976
Q ss_pred CCC
Q ss_conf 888
Q 005590 685 LQH 687 (689)
Q Consensus 685 f~~ 687 (689)
|+.
T Consensus 270 f~~ 272 (288)
T d1uu3a_ 270 FES 272 (288)
T ss_dssp GTT
T ss_pred CCC
T ss_conf 478
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.82 Aligned_cols=280 Identities=30% Similarity=0.473 Sum_probs=225.1
Q ss_pred CCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEEC-----
Q ss_conf 758999993258887539999887893799999605413467599999999996016999987225877899847-----
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL----- 455 (689)
Q Consensus 381 ~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~----- 455 (689)
-+|++.++||+|+||+||+|+++.+++.||||++..+.. ...+|+.+|+.++ |+||++++++|...
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~------h~niv~~~~~~~~~~~~~~ 90 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLD------HCNIVRLRYFFYSSGEKKD 90 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCC------CTTBCCEEEEEEEC--CCS
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH---HHHHHHHHHHHCC------CCCCCCEEEEEEECCCCCC
T ss_conf 776751698217683999999999997999999881606---8999999998668------9898738789974476577
Q ss_pred -CEEEEEEECCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEEC
Q ss_conf -8499999714214388986320269975559889999999779999999988953035899957980257870999836
Q 005590 456 -EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 534 (689)
Q Consensus 456 -~~l~lVmEy~~g~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~DF 534 (689)
.++++||||+.+++...+....... ..+++..++.+++||+.||.|||++||+||||||+|||++. +...+||+||
T Consensus 91 ~~~~~lv~Ey~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~-~~~~~kl~DF 167 (350)
T d1q5ka_ 91 EVYLNLVLDYVPETVYRVARHYSRAK--QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP-DTAVLKLCDF 167 (350)
T ss_dssp CCEEEEEEECCSEEHHHHHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT-TTCCEEECCC
T ss_pred CEEEEEEEECCCCCCHHHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEEC-CCCCEEEECC
T ss_conf 31899998416886078888631036--89999999999999999999998668764578860378735-8971167336
Q ss_pred CCCCCCCC--CCCCCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCHHHH
Q ss_conf 88421368--8642236765457032318-99991256999999999999399999998399999999841199867887
Q 005590 535 GSSCFQTD--NLCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEML 611 (689)
Q Consensus 535 Gls~~~~~--~~~~~~gt~~y~APE~l~~-~~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~ 611 (689)
|++..... .....+|++.|+|||++.+ ..|+.++||||+||++|+|++|+.||...+..+.+..+.+.+|.+..+.+
T Consensus 168 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 168 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp TTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CCHHHCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHH
T ss_conf 60544047765320025555568277640468882100024652778550287998987999999999997489817765
Q ss_pred HHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 3322354432001110000000010001477543011201479199999999813009899938999980989888
Q 005590 612 MQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~Hpwf~~ 687 (689)
......+.... .. ...............++.+++||.+||+.||++||||.|+|+||||+.
T Consensus 248 ~~~~~~~~~~~--------------~~-~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 248 REMNPNYTEFK--------------FP-QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp HHHCC---CCC--------------CC-CCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred HHHCCCHHHCC--------------CC-CCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 43062101103--------------55-445674444315689999999999976589557929999966984524
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=370.12 Aligned_cols=255 Identities=24% Similarity=0.358 Sum_probs=206.0
Q ss_pred CCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCH----HHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEECC
Q ss_conf 75899999325888753999988789379999960541----34675999999999960169999872258778998478
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|++.+.||+|+||.||+|+++.+|+.||+|++.+.. .......+|..+++.+.. ..||||++++++|...+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~---~~hpnIv~l~~~~~~~~ 80 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST---GDCPFIVCMSYAFHTPD 80 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSS---SCCTTBCCEEEEEECSS
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHC---CCCCCEEEEEEEEEECC
T ss_conf 768510188428890999999999997999999845875426679999999999999850---89985889999999899
Q ss_pred EEEEEEECCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEECC
Q ss_conf 4999997142-143889863202699755598899999997799999999889530358999579802578709998368
Q 005590 457 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~-g~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~DFG 535 (689)
.+|+||||+. |+|.+++..... +++..++.++.||+.||.|||+.+|+||||||+|||++. ++.+||+|||
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~------~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~--~g~iKl~DFG 152 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGV------FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE--HGHVRISDLG 152 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS--SSCEEECCCT
T ss_pred EEEEEEEECCCCCHHHHHHHCCC------CCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCEEEECC--CCCEEEEEEC
T ss_conf 88999991489838999873255------327899999999999999999779622044422167858--8967982201
Q ss_pred CCCCCCCC-CCCCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCHHHHHH
Q ss_conf 84213688-642236765457032318-9999125699999999999939999999839999999984119986788733
Q 005590 536 SSCFQTDN-LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 536 ls~~~~~~-~~~~~gt~~y~APE~l~~-~~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
+++..... ....+||+.|+|||++.. ..|+.++|||||||++|+|++|+.||.+..............
T Consensus 153 la~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~---------- 222 (364)
T d1omwa3 153 LACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---------- 222 (364)
T ss_dssp TCEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS----------
T ss_pred EEEECCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCC----------
T ss_conf 0233378864331134554216876038999844104677899999985999888899899999998604----------
Q ss_pred HHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCC-----HHHHHCCCCCCC
Q ss_conf 22354432001110000000010001477543011201479199999999813009899938-----999980989888
Q 005590 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPT-----AREALDHPWLQH 687 (689)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpT-----a~elL~Hpwf~~ 687 (689)
.....+|. ..++.+++||.+||+.||++||| |+++++||||+.
T Consensus 223 ----------------------~~~~~~~~---------~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 223 ----------------------TMAVELPD---------SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp ----------------------SCCCCCCS---------SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred ----------------------CCCCCCCC---------CCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCCCCCCC
T ss_conf ----------------------68887887---------7899999999998566988808874357999974910237
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.68 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=202.9
Q ss_pred EECCCE-EEEEEECCCCCCCEEEEEECCCCCEEEEEEEECC---HHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEE
Q ss_conf 323758-9999932588875399998878937999996054---134675999999999960169999872258778998
Q 005590 378 VIAGRY-YVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 453 (689)
Q Consensus 378 ~i~~~Y-~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~ 453 (689)
...+|| ++.++||+|+||+||+|+++.+++.||+|++... ......+.+|+++++.+ .||||+++++++.
T Consensus 5 ~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l------~HpnIv~~~~~~~ 78 (270)
T d1t4ha_ 5 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL------QHPNIVRFYDSWE 78 (270)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC------CCTTBCCEEEEEE
T ss_pred CCCCCEEEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHC------CCCCEEEEEEEEE
T ss_conf 7788778851697008284999999999995999999851227989999999999999857------9998506999984
Q ss_pred E----CCEEEEEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CEECCCCCCCEEEECCCC
Q ss_conf 4----7849999971421-43889863202699755598899999997799999999889--530358999579802578
Q 005590 454 H----LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG--IIHCDLKPENILIKSYQR 526 (689)
Q Consensus 454 ~----~~~l~lVmEy~~g-~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~g--IvHrDIKp~NILi~~~~~ 526 (689)
. ...+++||||+.+ +|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||++. .+
T Consensus 79 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~------~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~-~~ 151 (270)
T d1t4ha_ 79 STVKGKKCIVLVTELMTSGTLKTYLKRFKV------MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-PT 151 (270)
T ss_dssp EESSSCEEEEEEEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS-TT
T ss_pred ECCCCCCEEEEEEECCCCCCHHHHHHCCCC------CCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEEC-CC
T ss_conf 033458889999957898948999751355------46999999999999999999978997996876743511667-99
Q ss_pred CEEEEEECCCCCCCCCC-CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCH-HHHHHHHHHHHCC
Q ss_conf 70999836884213688-642236765457032318999912569999999999993999999983-9999999984119
Q 005590 527 CEIKIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA-VVMILARIIGMLG 604 (689)
Q Consensus 527 ~~ikL~DFGls~~~~~~-~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG~~PF~~~~-~~~~l~~i~~~~g 604 (689)
+.+||+|||++...... ....+||+.|+|||++.+ .|+.++||||+||++|+|++|+.||.+.. ...+...+.....
T Consensus 152 ~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~ 230 (270)
T d1t4ha_ 152 GSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 230 (270)
T ss_dssp SCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC
T ss_pred CCEEEEECCCCEECCCCCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC
T ss_conf 988980057654236876677553813008988478-9998671100799999998788999876559999999973899
Q ss_pred CCCHHHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCC
Q ss_conf 98678873322354432001110000000010001477543011201479199999999813009899938999980989
Q 005590 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 684 (689)
Q Consensus 605 ~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~Hpw 684 (689)
+. .. ....++++.+||.+||+.||++|||+.|+|+|||
T Consensus 231 ~~---------------------------------------~~---~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~ 268 (270)
T d1t4ha_ 231 PA---------------------------------------SF---DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268 (270)
T ss_dssp CG---------------------------------------GG---GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CC---------------------------------------CC---CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCC
T ss_conf 86---------------------------------------56---7557899999999976379758929999967754
Q ss_pred CC
Q ss_conf 88
Q 005590 685 LQ 686 (689)
Q Consensus 685 f~ 686 (689)
||
T Consensus 269 fk 270 (270)
T d1t4ha_ 269 FQ 270 (270)
T ss_dssp GC
T ss_pred CC
T ss_conf 09
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.60 Aligned_cols=253 Identities=23% Similarity=0.347 Sum_probs=208.1
Q ss_pred CCCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCH---HHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEE--
Q ss_conf 375899999325888753999988789379999960541---346759999999999601699998722587789984--
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-- 454 (689)
Q Consensus 380 ~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~-- 454 (689)
.++|++.+.||+|+||+||+|+++.+|+.||+|++.... .....+.+|+++++.+ .||||+++++++.+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l------~HpnIv~~~~~~~~~~ 76 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL------KHPNIVRYYDRIIDRT 76 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC------CCTTBCCEEEEEEC--
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHC------CCCCEEEEEEEEEECC
T ss_conf 3337996798308891999999999997999999874657979999999999999977------8999824899999178
Q ss_pred CCEEEEEEECCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CEECCCCCCCEEEECCCCCE
Q ss_conf 784999997142-143889863202699755598899999997799999999889-----53035899957980257870
Q 005590 455 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLG-----IIHCDLKPENILIKSYQRCE 528 (689)
Q Consensus 455 ~~~l~lVmEy~~-g~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~g-----IvHrDIKp~NILi~~~~~~~ 528 (689)
.+.+|+||||+. |+|.+++....... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.
T Consensus 77 ~~~~~ivmEy~~~g~L~~~i~~~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~--~~~ 152 (269)
T d2java1 77 NTTLYIVMEYCEGGDLASVITKGTKER--QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG--KQN 152 (269)
T ss_dssp --CEEEEEECCTTEEHHHHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECT--TSC
T ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCC--CCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCC--CCC
T ss_conf 998999995689993899998515457--8999999999999999999999971677887885867654257478--885
Q ss_pred EEEEECCCCCCCCCC---CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 999836884213688---64223676545703231899991256999999999999399999998399999999841199
Q 005590 529 IKIIDLGSSCFQTDN---LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 605 (689)
Q Consensus 529 ikL~DFGls~~~~~~---~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~~~g~ 605 (689)
+||+|||++...... ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..++...+....
T Consensus 153 vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~-- 230 (269)
T d2java1 153 VKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK-- 230 (269)
T ss_dssp EEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--
T ss_pred EEEEECCCEEECCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHCCC--
T ss_conf 798001000322457775566778823279999839999938988752789999801889989989999999997189--
Q ss_pred CCHHHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCC
Q ss_conf 86788733223544320011100000000100014775430112014791999999998130098999389999809898
Q 005590 606 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWL 685 (689)
Q Consensus 606 ~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~Hpwf 685 (689)
...+|. ..++++.+||++||+.||++|||+.|+|+|||+
T Consensus 231 --------------------------------~~~~~~---------~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 231 --------------------------------FRRIPY---------RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp --------------------------------CCCCCT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --------------------------------CCCCCC---------CCCHHHHHHHHHHCCCCHHHCCCHHHHHHCCCC
T ss_conf --------------------------------988974---------359999999999767995579189999729819
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.84 Aligned_cols=250 Identities=26% Similarity=0.427 Sum_probs=210.5
Q ss_pred CCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCH----HHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEECC
Q ss_conf 75899999325888753999988789379999960541----34675999999999960169999872258778998478
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~----~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|.+.+.||+|+||+||+|+++.+++.||+|+++++. ........|..++... ..||||+++++++.+.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~-----~~hp~Iv~~~~~~~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-----WEHPFLTHMFCTFQTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHH-----TTCTTBCCEEEEEECSS
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHH-----CCCCCEEEEEEEECCCC
T ss_conf 9718865894087828999999999989999998055533848999999999999984-----79996878988970498
Q ss_pred EEEEEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEECC
Q ss_conf 49999971421-43889863202699755598899999997799999999889530358999579802578709998368
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~DFG 535 (689)
++|+||||+.+ +|.+++..... +++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~~------~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~--~~~~kl~DFG 148 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCHK------FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK--DGHIKIADFG 148 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT--TSCEEECCCT
T ss_pred CEEEEEEECCCCCHHHHHHCCCC------CCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECC--CCCEECCCCC
T ss_conf 31677750379808998640478------999999999999999999998689340347654044448--9963015553
Q ss_pred CCCCCCC---CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCHHHHH
Q ss_conf 8421368---8642236765457032318999912569999999999993999999983999999998411998678873
Q 005590 536 SSCFQTD---NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLM 612 (689)
Q Consensus 536 ls~~~~~---~~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~ 612 (689)
++..... ......||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+.+..++...+...
T Consensus 149 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~---------- 218 (320)
T d1xjda_ 149 MCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD---------- 218 (320)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----------
T ss_pred HHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCC----------
T ss_conf 0232356653345457877768999982799883232011227898987388999998999999999718----------
Q ss_pred HHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHH-HHHCCCCCCC
Q ss_conf 32235443200111000000001000147754301120147919999999981300989993899-9980989888
Q 005590 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR-EALDHPWLQH 687 (689)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~-elL~Hpwf~~ 687 (689)
...+|. ..++.+.+||++||+.||++|||+. ++++||||++
T Consensus 219 -------------------------~~~~p~---------~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 219 -------------------------NPFYPR---------WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp -------------------------CCCCCT---------TSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred -------------------------CCCCCC---------CCCHHHHHHHHHHCCCCCCCCCCHHHHHHHCCHHCC
T ss_conf -------------------------998975---------679999999999654489878388999980901315
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=366.64 Aligned_cols=278 Identities=30% Similarity=0.473 Sum_probs=225.9
Q ss_pred CCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCH---HHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEECCE
Q ss_conf 75899999325888753999988789379999960541---346759999999999601699998722587789984784
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 381 ~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
++|+++++||+|+||+||+|+++ +++.||+|++.... ....++.+|+.+++.++ ||||+++++++...++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~------hpnIv~~~~~~~~~~~ 74 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELK------HSNIVKLYDVIHTKKR 74 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC------CTTBCCEEEEEECSSC
T ss_pred CCCEECCEEECCCCCEEEEEEEC-CCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCC------CCCEEEEEEECCCCCC
T ss_conf 99634318722778189999968-9999999998123268589999999999998679------9868766012046773
Q ss_pred EEEEEECCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEECCCC
Q ss_conf 99999714214388986320269975559889999999779999999988953035899957980257870999836884
Q 005590 458 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 458 l~lVmEy~~g~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~DFGls 537 (689)
.+++++++.++++..+..... .+++..++.++.||+.||.|||+.+|+||||||+|||++. ++.+||+|||.+
T Consensus 75 ~~i~~e~~~~~~~~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~--~~~~kl~DfG~a 147 (286)
T d1ob3a_ 75 LVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR--EGELKIADFGLA 147 (286)
T ss_dssp EEEEEECCSEEHHHHHHTSTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TSCEEECCTTHH
T ss_pred EEEEEEEEHHHHHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCEEEECC--CCCEEECCCCCC
T ss_conf 158997400456789986047-----7514456899999999999860574882678775056868--997873236643
Q ss_pred CCCCCC---CCCCCCCCCCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCHHHHHH
Q ss_conf 213688---6422367654570323189-999125699999999999939999999839999999984119986788733
Q 005590 538 CFQTDN---LCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 538 ~~~~~~---~~~~~gt~~y~APE~l~~~-~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
...... .....+++.|+|||.+.+. .++.++||||+||++|+|++|++||.+.+..+.+.++....+.+....+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (286)
T d1ob3a_ 148 RAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (286)
T ss_dssp HHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred EECCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCC
T ss_conf 01146765410102431101378871788888410021117589999779799898898999999998638997110421
Q ss_pred HHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 22354432001110000000010001477543011201479199999999813009899938999980989888
Q 005590 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~Hpwf~~ 687 (689)
......+.. .................++.+++||++||++||++|||++|+|+||||++
T Consensus 228 ~~~~~~~~~---------------~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 228 VTELPKYDP---------------NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp GGGSTTCCT---------------TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHCCC---------------CCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf 233322143---------------33335676466651258999999999986689668909999856922074
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=361.82 Aligned_cols=256 Identities=30% Similarity=0.456 Sum_probs=214.4
Q ss_pred ECCCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCH----------HHHHHHHHHHHHHHHHCCCCCCCCCCEEEE
Q ss_conf 2375899999325888753999988789379999960541----------346759999999999601699998722587
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK----------DFFDQSLDEIKLLKLVNKNDPADEHHILRL 448 (689)
Q Consensus 379 i~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~----------~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l 448 (689)
+.++|++.+.||+|+||+||+|+++.+++.||+|++.+.. ...+.+.+|+.+++.+. .||||+++
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~hpnIv~~ 75 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS-----GHPNIIQL 75 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT-----TCTTBCCE
T ss_pred CCCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHC-----CCCCEEEE
T ss_conf 9663888528841768499999999999899999996244641147888999999999999999850-----79974799
Q ss_pred EEEEEECCEEEEEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCC
Q ss_conf 7899847849999971421-438898632026997555988999999977999999998895303589995798025787
Q 005590 449 YDYFYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC 527 (689)
Q Consensus 449 ~~~f~~~~~l~lVmEy~~g-~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~ 527 (689)
++++.+.++.|+||||+.+ +|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++. ++
T Consensus 76 ~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~------l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~--~~ 147 (277)
T d1phka_ 76 KDTYETNTFFFLVFDLMKKGELFDYLTEKVT------LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD--DM 147 (277)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TC
T ss_pred EEECCCCCCEEEEEECCCCCHHHHHHHHCCC------CCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECC--CC
T ss_conf 7621467605999976898668999986599------999999999999999999998759943234625489868--99
Q ss_pred EEEEEECCCCCCCCCC--CCCCCCCCCCCCHHHHCC------CCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHH
Q ss_conf 0999836884213688--642236765457032318------99991256999999999999399999998399999999
Q 005590 528 EIKIIDLGSSCFQTDN--LCLYVQSRSYRAPEVIIG------LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARI 599 (689)
Q Consensus 528 ~ikL~DFGls~~~~~~--~~~~~gt~~y~APE~l~~------~~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i 599 (689)
.+||+|||++...... ....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+
T Consensus 148 ~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i 227 (277)
T d1phka_ 148 NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 227 (277)
T ss_dssp CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CEEECCCHHEEECCCCCCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHHHHHH
T ss_conf 83871240316726887213452467888988860534456788992331856560231032288898899999999999
Q ss_pred HHHCCCCCHHHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHH
Q ss_conf 84119986788733223544320011100000000100014775430112014791999999998130098999389999
Q 005590 600 IGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA 679 (689)
Q Consensus 600 ~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~el 679 (689)
...-. ....+.. ...++++++||.+||++||++|||+.|+
T Consensus 228 ~~~~~---------------------------------~~~~~~~-------~~~s~~~~~li~~~L~~~p~~R~s~~ei 267 (277)
T d1phka_ 228 MSGNY---------------------------------QFGSPEW-------DDYSDTVKDLVSRFLVVQPQKRYTAEEA 267 (277)
T ss_dssp HHTCC---------------------------------CCCTTTG-------GGSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred HHCCC---------------------------------CCCCCCC-------CCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 81898---------------------------------8898543-------4689999999999765896689199999
Q ss_pred HCCCCCCC
Q ss_conf 80989888
Q 005590 680 LDHPWLQH 687 (689)
Q Consensus 680 L~Hpwf~~ 687 (689)
|+||||++
T Consensus 268 l~h~~~~~ 275 (277)
T d1phka_ 268 LAHPFFQQ 275 (277)
T ss_dssp TTSGGGCT
T ss_pred HCCHHHHH
T ss_conf 73978797
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.37 Aligned_cols=261 Identities=29% Similarity=0.403 Sum_probs=207.9
Q ss_pred EECCCEEEEE-EECCCCCCCEEEEEECCCCCEEEEEEEECCHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEE--
Q ss_conf 3237589999-9325888753999988789379999960541346759999999999601699998722587789984--
Q 005590 378 VIAGRYYVTE-YLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-- 454 (689)
Q Consensus 378 ~i~~~Y~i~~-~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~-- 454 (689)
.+.++|++.+ .||+|+||+||+|+++.+++.||||+++.. ....+|+.++..+. .||||++++++|.+
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~-----~hpnIv~l~~~~~~~~ 78 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRAS-----QCPHIVRIVDVYENLY 78 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHT-----TSTTBCCEEEEEEEEE
T ss_pred CCCCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC----HHHHHHHHHHHHHC-----CCCCCCEEEEEEEECC
T ss_conf 70148798107965454869999998899989999998974----77999999999866-----9999782989995034
Q ss_pred --CCEEEEEEECCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCC-CCEEE
Q ss_conf --784999997142-14388986320269975559889999999779999999988953035899957980257-87099
Q 005590 455 --LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ-RCEIK 530 (689)
Q Consensus 455 --~~~l~lVmEy~~-g~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~-~~~ik 530 (689)
..++|+|||||. |+|.+++.... ...+++..++.++.||+.||.|||+.||+||||||+|||++... .+.+|
T Consensus 79 ~~~~~~~ivmEy~~gg~L~~~i~~~~----~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~K 154 (335)
T d2ozaa1 79 AGRKCLLIVMECLDGGELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 154 (335)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHSCS----CCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEE
T ss_pred CCCCEEEEEEECCCCCCHHHHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 68978999997789984999998627----87757999999999999999999976986444100220113555566311
Q ss_pred EEECCCCCCCCC--CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCH
Q ss_conf 983688421368--864223676545703231899991256999999999999399999998399999999841199867
Q 005590 531 IIDLGSSCFQTD--NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 608 (689)
Q Consensus 531 L~DFGls~~~~~--~~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~~~g~~~~ 608 (689)
|+|||+++.... .....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+.......+...+.
T Consensus 155 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~---- 230 (335)
T d2ozaa1 155 LTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---- 230 (335)
T ss_dssp ECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCC----
T ss_pred CCCCCEEEECCCCCCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHH----
T ss_conf 3545512333688864322677563792777489888888887645167788658899889887788999999985----
Q ss_pred HHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 8873322354432001110000000010001477543011201479199999999813009899938999980989888
Q 005590 609 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 609 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~Hpwf~~ 687 (689)
.....+|... ....++++++||++||+.||++|||+.|+|+||||++
T Consensus 231 ---------------------------~~~~~~~~~~-----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 231 ---------------------------MGQYEFPNPE-----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp ---------------------------SCSSSCCTTH-----HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred ---------------------------CCCCCCCCCC-----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHC
T ss_conf ---------------------------3888889854-----3469999999999975699657909999970987617
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.83 Aligned_cols=282 Identities=30% Similarity=0.525 Sum_probs=224.0
Q ss_pred ECCCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECC--HHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEEC-
Q ss_conf 237589999932588875399998878937999996054--13467599999999996016999987225877899847-
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL- 455 (689)
Q Consensus 379 i~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~- 455 (689)
++.||++++.||+|+||+||+|.++.+|+.||||++... .....++.+|+.+|+.++ |++|+++++++...
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~------hp~iv~~~~~~~~~~ 79 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR------HENIIGINDIIRAPT 79 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCC------CTTBCCCCEEECCSS
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCC------CCCCCCEEEEEEECC
T ss_conf 38985997899406480999999999994999999803109589999999999999768------989885888995056
Q ss_pred ----CEEEEEEECCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEE
Q ss_conf ----8499999714214388986320269975559889999999779999999988953035899957980257870999
Q 005590 456 ----EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 531 (689)
Q Consensus 456 ----~~l~lVmEy~~g~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL 531 (689)
.+.++++++++++|.+++.... +++..++.++.||+.||.|||++||+||||||+|||++. ++.+||
T Consensus 80 ~~~~~~~~l~~~~~~g~L~~~l~~~~-------l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~--~~~~kl 150 (345)
T d1pmea_ 80 IEQMKDVYLVTHLMGADLYKLLKTQH-------LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKI 150 (345)
T ss_dssp TTTCCCEEEEEECCCEEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TCCEEE
T ss_pred CCCCCEEEEEEEECCCCHHHHHHCCC-------CCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECC--CCCEEE
T ss_conf 45541499999625986566440589-------999999999999999999999789867778764378879--997787
Q ss_pred EECCCCCCCCCC------CCCCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCC
Q ss_conf 836884213688------642236765457032318-9999125699999999999939999999839999999984119
Q 005590 532 IDLGSSCFQTDN------LCLYVQSRSYRAPEVIIG-LPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 604 (689)
Q Consensus 532 ~DFGls~~~~~~------~~~~~gt~~y~APE~l~~-~~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~~~g 604 (689)
+|||++...... ....+|++.|+|||++.. ..++.++||||+||++|+|++|+.||.+.+..+....+...++
T Consensus 151 ~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~ 230 (345)
T d1pmea_ 151 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230 (345)
T ss_dssp CCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred CCCCCEEECCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCC
T ss_conf 54570565047776410101102652000387860478887410100467013377669799788888999998765206
Q ss_pred CCCHHHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCC
Q ss_conf 98678873322354432001110000000010001477543011201479199999999813009899938999980989
Q 005590 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPW 684 (689)
Q Consensus 605 ~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~Hpw 684 (689)
.+..+...........- ....................++.+++||.+||+.||.+||||.|+|+|||
T Consensus 231 ~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf 297 (345)
T d1pmea_ 231 SPSQEDLNCIINLKARN-------------YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297 (345)
T ss_dssp SCCHHHHHTCCCHHHHH-------------HHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred CCCHHHHHHHHHHHHHC-------------CCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf 99756642343322220-------------24467755778777837899999999999976489567908999861986
Q ss_pred CCCC
Q ss_conf 8889
Q 005590 685 LQHP 688 (689)
Q Consensus 685 f~~~ 688 (689)
|+.-
T Consensus 298 ~~~~ 301 (345)
T d1pmea_ 298 LEQY 301 (345)
T ss_dssp GTTT
T ss_pred HCCC
T ss_conf 5558
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.05 Aligned_cols=281 Identities=26% Similarity=0.452 Sum_probs=222.7
Q ss_pred CCCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECC---HHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEE--
Q ss_conf 37589999932588875399998878937999996054---1346759999999999601699998722587789984--
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-- 454 (689)
Q Consensus 380 ~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~-- 454 (689)
.++|++++.||+|+||+||+|+++.+|+.||||++..+ .....++.+|+.+|+.++ |+||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~------h~nii~~~~~~~~~~ 82 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK------HENVVNLIEICRTKA 82 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCC------CTTBCCEEEEEEC--
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHC------CCCCCCEEEEEECCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835------999660676540246
Q ss_pred ------CCEEEEEEECCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCE
Q ss_conf ------78499999714214388986320269975559889999999779999999988953035899957980257870
Q 005590 455 ------LEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCE 528 (689)
Q Consensus 455 ------~~~l~lVmEy~~g~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ 528 (689)
.++.++||||+.+++......... .+++..++.+++||+.||.|||+.||+||||||+|||++. ++.
T Consensus 83 ~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~-----~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~--~~~ 155 (318)
T d3blha1 83 SPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR--DGV 155 (318)
T ss_dssp --------CEEEEEECCCEEHHHHHTCTTC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT--TSC
T ss_pred CCCCCCCCEEEEEEECCCCCCCCHHHHCCC-----CCCCHHHHHHHHHHHHHHHHHCCCCEEECCCCCHHEEECC--CCC
T ss_conf 544445763899985357874101222034-----4330899999999999998852299885676722203668--996
Q ss_pred EEEEECCCCCCCCC-------CCCCCCCCCCCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHH
Q ss_conf 99983688421368-------86422367654570323189-99912569999999999993999999983999999998
Q 005590 529 IKIIDLGSSCFQTD-------NLCLYVQSRSYRAPEVIIGL-PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARII 600 (689)
Q Consensus 529 ikL~DFGls~~~~~-------~~~~~~gt~~y~APE~l~~~-~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~ 600 (689)
+||+|||++..... .....+||+.|+|||++.+. .|+.++||||+||++|+|++|++||.+.+....+..+.
T Consensus 156 ~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~ 235 (318)
T d3blha1 156 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 235 (318)
T ss_dssp EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred EEEEECCEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHH
T ss_conf 87631350022355444321135660249787428997079998917870067864661744879989989999999999
Q ss_pred HHCCCCCHHHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHH--HCCCCCHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf 4119986788733223544320011100000000100014775430112--01479199999999813009899938999
Q 005590 601 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEH--HLQFSDAFFIDFVRTLLEINPQRRPTARE 678 (689)
Q Consensus 601 ~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~--~~~~~~~~l~dLI~~mL~~dP~kRpTa~e 678 (689)
...+.++.+.+........+.. ............. .....++.++|||.+||++||++||||.|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~e 301 (318)
T d3blha1 236 QLCGSITPEVWPNVDNYELYEK--------------LELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301 (318)
T ss_dssp HHHCCCCTTTSTTCCCC---------------------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHCCCCCHHHCCCCCHHHHHHH--------------HCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 8418998255344320344433--------------20133445550334044459989999999987389658909999
Q ss_pred HHCCCCCCC
Q ss_conf 980989888
Q 005590 679 ALDHPWLQH 687 (689)
Q Consensus 679 lL~Hpwf~~ 687 (689)
+|+||||+.
T Consensus 302 lL~Hpff~~ 310 (318)
T d3blha1 302 ALNHDFFWS 310 (318)
T ss_dssp HHHSGGGSS
T ss_pred HHCCHHHCC
T ss_conf 974950156
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.17 Aligned_cols=282 Identities=30% Similarity=0.520 Sum_probs=227.2
Q ss_pred ECCCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECC---HHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEEC
Q ss_conf 237589999932588875399998878937999996054---13467599999999996016999987225877899847
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 379 i~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
+.+||++++.||+|+||+||+|+++.+|+.||||++... .....++.+|+.+|+.++ |++|+++++++...
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~------h~~iv~~~~~~~~~ 89 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK------HENVIGLLDVFTPA 89 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCC------CTTBCCCSEEECSC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCC------CCCEEEEEEEEEEC
T ss_conf 898718888983178839999999999979999998820028689999999999998668------98742599999634
Q ss_pred ------CEEEEEEECCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEE
Q ss_conf ------84999997142143889863202699755598899999997799999999889530358999579802578709
Q 005590 456 ------EHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 529 (689)
Q Consensus 456 ------~~l~lVmEy~~g~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~i 529 (689)
.+.++++++.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+
T Consensus 90 ~~~~~~~~~~i~~~~~gg~L~~~~~~~-------~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~--~~~~ 160 (348)
T d2gfsa1 90 RSLEEFNDVYLVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DCEL 160 (348)
T ss_dssp SSTTTCCCCEEEEECCSEEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TCCE
T ss_pred CCCCCCCEEEEEEEECCCCHHHHCCCC-------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCC--CCCC
T ss_conf 645668649999962588623200224-------5309999999999999999997388765166776334554--3220
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCCCHHHHCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCCH
Q ss_conf 9983688421368864223676545703231899-991256999999999999399999998399999999841199867
Q 005590 530 KIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPIDL 608 (689)
Q Consensus 530 kL~DFGls~~~~~~~~~~~gt~~y~APE~l~~~~-~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~~~g~~~~ 608 (689)
|++|||.+...........|++.|+|||++.+.. ++.++||||+||++|+|++|++||.+.+.......+....+.++.
T Consensus 161 kl~dfg~a~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~ 240 (348)
T d2gfsa1 161 KILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240 (348)
T ss_dssp EECCC----CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred CCCCCCHHCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCH
T ss_conf 01321000125754444345435558355337756785512432058999997688997889889999999973079975
Q ss_pred HHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 88733223544320011100000000100014775430112014791999999998130098999389999809898889
Q 005590 609 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 609 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~Hpwf~~~ 688 (689)
+.............. ......+ ...+.......++.+++||++||+.||++||||.|+|+||||++-
T Consensus 241 ~~~~~~~~~~~~~~~------------~~~~~~~-~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 241 ELLKKISSESARNYI------------QSLTQMP-KMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHTTCCCHHHHHHH------------TTSCCCC-CCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHHCCCHHHHHHH------------HHCCCCC-CCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 773200102445444------------3035578-755566267899999999999775883459389998559954879
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=358.09 Aligned_cols=286 Identities=27% Similarity=0.425 Sum_probs=214.7
Q ss_pred CCCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEEC--CE
Q ss_conf 3758999993258887539999887893799999605413467599999999996016999987225877899847--84
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL--EH 457 (689)
Q Consensus 380 ~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~--~~ 457 (689)
.++|+++++||+|+||+||+|+++.+++.||+|+++... ..++.+|+.+|+.+. .|+||++++++|... .+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~-----~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLR-----GGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHT-----TSTTBCCEEEEEECTTTCS
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHHCC-----CCCCCCEEEEEEEECCCCC
T ss_conf 867189789831748199999988999799999988899--999999999998515-----7998767999998168771
Q ss_pred EEEEEECCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEECCCC
Q ss_conf 99999714214388986320269975559889999999779999999988953035899957980257870999836884
Q 005590 458 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 458 l~lVmEy~~g~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~DFGls 537 (689)
+++||||+.++.+..+ .+ .+++..++.+++||+.||.|||++||+||||||+|||++. .+..+||+|||++
T Consensus 107 ~~~v~e~~~~~~L~~~--~~------~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~-~~~~vkl~DFG~a 177 (328)
T d3bqca1 107 PALVFEHVNNTDFKQL--YQ------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH-EHRKLRLIDWGLA 177 (328)
T ss_dssp EEEEEECCCSCBGGGT--TT------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-TTTEEEECCGGGC
T ss_pred EEEEEEECCCCCHHHH--HC------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECC-CCCEEEECCCCCC
T ss_conf 2688863179858997--46------8999999999999999998876433443456441237748-9983664156542
Q ss_pred CCCCC--CCCCCCCCCCCCCHHHHCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCC-CHHHHHHHHHHHHCCCCCHHHHHH
Q ss_conf 21368--864223676545703231899-99125699999999999939999999-839999999984119986788733
Q 005590 538 CFQTD--NLCLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVLFPN-DAVVMILARIIGMLGPIDLEMLMQ 613 (689)
Q Consensus 538 ~~~~~--~~~~~~gt~~y~APE~l~~~~-~s~~sDIwSLGviL~elltG~~PF~~-~~~~~~l~~i~~~~g~~~~e~~~~ 613 (689)
..... ......+|+.|+|||++.+.. ++.++||||+||++|+|++|..||.. .+.......+...++.+....+..
T Consensus 178 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 178 EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp EECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHH
T ss_conf 66468874443224864247610268888884523233545558760488999887601899999999878841555554
Q ss_pred HHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 223544320011100000000100014775430112014791999999998130098999389999809898889
Q 005590 614 GQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~Hpwf~~~ 688 (689)
...... ...... ............. .........++++++||++||+.||++|||++|+|+||||+.-
T Consensus 258 ~~~~~~--~~~~~~-~~~~~~~~~~~~~----~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 258 KYNIEL--DPRFND-ILGRHSRKRWERF----VHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp HTTCCC--CGGGGG-TCCCCCCCCGGGG----CCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred HCCCCC--CCCCCH-HCCCCCCCCHHHC----CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf 225444--743000-0033343311211----5521124489999999999866995689089999649355887
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.01 Aligned_cols=249 Identities=29% Similarity=0.465 Sum_probs=206.0
Q ss_pred ECCCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCHH-------HHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEE
Q ss_conf 23758999993258887539999887893799999605413-------46759999999999601699998722587789
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------FFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 451 (689)
Q Consensus 379 i~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~~-------~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~ 451 (689)
+.++|++.+.||+|+||+||+|+++.+++.||+|++.++.. ...++.+|+.+++.+++ .||||++++++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~----~h~nIv~~~~~ 77 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS----GFSGVIRLLDW 77 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS----SSCSBCCEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCC----CCCCCCEEEEE
T ss_conf 78837996798408783999999999997999999856884433455679999999999997435----89881279999
Q ss_pred EEECCEEEEEEECCCC--CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEE
Q ss_conf 9847849999971421--43889863202699755598899999997799999999889530358999579802578709
Q 005590 452 FYHLEHLFIVCELLRA--NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEI 529 (689)
Q Consensus 452 f~~~~~l~lVmEy~~g--~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~i 529 (689)
+.+.+..++||||+.+ ++.+++..... +++..++.++.||+.||.|||+.+|+||||||+|||++. +++.+
T Consensus 78 ~~~~~~~~lv~e~~~~~~~l~~~~~~~~~------l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~-~~~~v 150 (273)
T d1xwsa_ 78 FERPDSFVLILERPEPVQDLFDFITERGA------LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGEL 150 (273)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET-TTTEE
T ss_pred EEECCEEEEEEEECCCCCHHHHHHHCCCC------CCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEEC-CCCEE
T ss_conf 83099689999833686228999861589------999999999999999999998779755667611147744-78848
Q ss_pred EEEECCCCCCCCCC-CCCCCCCCCCCCHHHHCCCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCCC
Q ss_conf 99836884213688-642236765457032318999-9125699999999999939999999839999999984119986
Q 005590 530 KIIDLGSSCFQTDN-LCLYVQSRSYRAPEVIIGLPY-DQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPID 607 (689)
Q Consensus 530 kL~DFGls~~~~~~-~~~~~gt~~y~APE~l~~~~~-s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~~~g~~~ 607 (689)
||+|||++...... .....||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+... +..
T Consensus 151 kl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~------ 218 (273)
T d1xwsa_ 151 KLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR------ 218 (273)
T ss_dssp EECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH------
T ss_pred EECCCCCCEECCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCHH------HHH------
T ss_conf 97754653532444556656587747999984899788653325540345367568899887367------761------
Q ss_pred HHHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 78873322354432001110000000010001477543011201479199999999813009899938999980989888
Q 005590 608 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 608 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~Hpwf~~ 687 (689)
....++. ..++++++||++||+.||++|||+.|+|+||||++
T Consensus 219 -----------------------------~~~~~~~---------~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 219 -----------------------------GQVFFRQ---------RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp -----------------------------CCCCCSS---------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred -----------------------------CCCCCCC---------CCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf -----------------------------5447787---------79999999999976089758939999853986678
Q ss_pred C
Q ss_conf 9
Q 005590 688 P 688 (689)
Q Consensus 688 ~ 688 (689)
.
T Consensus 261 ~ 261 (273)
T d1xwsa_ 261 V 261 (273)
T ss_dssp C
T ss_pred C
T ss_conf 8
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.79 Aligned_cols=279 Identities=30% Similarity=0.428 Sum_probs=222.2
Q ss_pred CCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCH---HHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEECCE
Q ss_conf 75899999325888753999988789379999960541---346759999999999601699998722587789984784
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK---DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 381 ~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~---~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
+||++++.||+|+||+||+|+++.+++.||||+++.+. ....++.+|+.+++.+ .|+||+++++++....+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l------~h~niv~~~~~~~~~~~ 75 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL------KHKNIVRLHDVLHSDKK 75 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC------CCTTBCCEEEEEECSSE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHC------CCCCEEEECCCCCCCCC
T ss_conf 997862697128681999999999996999999803217868999999999999856------75788821354444431
Q ss_pred EEEEEECCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEECCCC
Q ss_conf 99999714214388986320269975559889999999779999999988953035899957980257870999836884
Q 005590 458 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSS 537 (689)
Q Consensus 458 l~lVmEy~~g~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~DFGls 537 (689)
.++|++++.++.+..+..... .+++..++.++.|++.||.|||+++|+||||||+|||++. ++.+||+|||.+
T Consensus 76 ~~iv~~~~~~~~l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~--~~~~kl~DFG~a 148 (292)
T d1unla_ 76 LTLVFEFCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR--NGELKLANFGLA 148 (292)
T ss_dssp EEEEEECCSEEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT--TCCEEECCCTTC
T ss_pred EEEEEEECCCCCCCCCCCCCC-----CCCHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCCCC--CCCEEEEECCHH
T ss_conf 158863023322211212356-----5403678999999999987743399860014676121133--782665204601
Q ss_pred CCCCCCC---CCCCCCCCCCCHHHHCCCC-CCCHHHHHHHHHHHHHHHHCCCC-CCCCHHHHHHHHHHHHCCCCCHHHHH
Q ss_conf 2136886---4223676545703231899-99125699999999999939999-99983999999998411998678873
Q 005590 538 CFQTDNL---CLYVQSRSYRAPEVIIGLP-YDQKIDLWSLGCILAELWTGEVL-FPNDAVVMILARIIGMLGPIDLEMLM 612 (689)
Q Consensus 538 ~~~~~~~---~~~~gt~~y~APE~l~~~~-~s~~sDIwSLGviL~elltG~~P-F~~~~~~~~l~~i~~~~g~~~~e~~~ 612 (689)
....... ....+++.|+|||++.+.. ++.++||||+||++|+|++|+.| |.+.+..+.+.++....+.+....+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (292)
T d1unla_ 149 RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp EECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCT
T ss_pred HCCCCCCCCCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHH
T ss_conf 10468875100103443101466750698888044402654188998518999988999999999998611899735513
Q ss_pred HHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 322354432001110000000010001477543011201479199999999813009899938999980989888
Q 005590 613 QGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDHPWLQH 687 (689)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~Hpwf~~ 687 (689)
.......+.. ....+............++.+++||++||++||++||||+|+|+||||++
T Consensus 229 ~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 229 SMTKLPDYKP---------------YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TGGGSTTCCC---------------CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred HHHHCCCCCC---------------CCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 4432221133---------------44454431043306568999999999986499668909999964953407
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=353.94 Aligned_cols=310 Identities=33% Similarity=0.552 Sum_probs=240.4
Q ss_pred CCCEEECCEEC-CCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCHHHHHHHHHHHHHHHHHCCCCCC-----CCC
Q ss_conf 85546281323-758999993258887539999887893799999605413467599999999996016999-----987
Q 005590 370 DLPIILNTVIA-GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPA-----DEH 443 (689)
Q Consensus 370 ~~pi~~~~~i~-~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~~~~~~~~~Ei~iL~~l~~~~~~-----~h~ 443 (689)
++|+.+++.+. +||+++++||+|+||+||+|+++.+|+.||||+++++....+...+|+++++.+.+.... .|+
T Consensus 1 ~~p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~ 80 (362)
T d1q8ya_ 1 YHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 80 (362)
T ss_dssp CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred CCCCCCCCCCCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHCCHHHHHHHHCCCC
T ss_conf 97888888844785799899750778189999999999799999983431336899999999998401455555422767
Q ss_pred CEEEEEEEEEEC--CEEEEEEECCC--CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCEECCCCCCC
Q ss_conf 225877899847--84999997142--1438898632026997555988999999977999999998-895303589995
Q 005590 444 HILRLYDYFYHL--EHLFIVCELLR--ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS-LGIIHCDLKPEN 518 (689)
Q Consensus 444 ~Iv~l~~~f~~~--~~l~lVmEy~~--g~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~-~gIvHrDIKp~N 518 (689)
||+++++++... ...++++.++. ++........ ....+++..++.++.||+.||.|||+ .||+||||||+|
T Consensus 81 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~N 156 (362)
T d1q8ya_ 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY----EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN 156 (362)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHT----TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGG
T ss_pred CEEEEEEEEEECCCCCEEEEEEECCCCCCCCCCCCCC----CCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHH
T ss_conf 6478998763125652023432000354200000122----346786899999999999998887640586465677057
Q ss_pred EEEECCCC----CEEEEEECCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCH---
Q ss_conf 79802578----70999836884213688642236765457032318999912569999999999993999999983---
Q 005590 519 ILIKSYQR----CEIKIIDLGSSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDA--- 591 (689)
Q Consensus 519 ILi~~~~~----~~ikL~DFGls~~~~~~~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG~~PF~~~~--- 591 (689)
||++..+. ..++++|||.+..........+||+.|+|||++.+..++.++|+||+||++++|++|+.||....
T Consensus 157 Ill~~~~~~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~ 236 (362)
T d1q8ya_ 157 VLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 236 (362)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred EEEECCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCC
T ss_conf 05630576564430567531442123445422366521057132146677764320123789999987889989875543
Q ss_pred ---HHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHC---CCCCHHHHHHHHHH
Q ss_conf ---999999998411998678873322354432001110000000010001477543011201---47919999999981
Q 005590 592 ---VVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHL---QFSDAFFIDFVRTL 665 (689)
Q Consensus 592 ---~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~---~~~~~~l~dLI~~m 665 (689)
..+.+..++..+|.++.+++........++.............. .+......... ...++.+++||.+|
T Consensus 237 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~dll~~m 311 (362)
T d1q8ya_ 237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKF-----WPLEDVLTEKYKFSKDEAKEISDFLSPM 311 (362)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCB-----CCHHHHHHHTTCCCHHHHHHHHHHHGGG
T ss_pred CCCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCC-----CCHHHHCCCCCCCCCCCCHHHHHHHHHH
T ss_conf 21026899999998379987886245322000132012202432357-----7644421000156743589999999998
Q ss_pred CCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 30098999389999809898889
Q 005590 666 LEINPQRRPTAREALDHPWLQHP 688 (689)
Q Consensus 666 L~~dP~kRpTa~elL~Hpwf~~~ 688 (689)
|++||.+||||+|+|+||||+..
T Consensus 312 L~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 312 LQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp GCSSTTTCBCHHHHHTCGGGTTC
T ss_pred CCCCHHHCCCHHHHHCCCCCCCC
T ss_conf 77994579089999669340789
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=348.15 Aligned_cols=257 Identities=20% Similarity=0.285 Sum_probs=208.7
Q ss_pred CCEECCCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEEC
Q ss_conf 81323758999993258887539999887893799999605413467599999999996016999987225877899847
Q 005590 376 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHL 455 (689)
Q Consensus 376 ~~~i~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~ 455 (689)
+++-.++|++.+.||+|+||+||+|.++.+++.||+|+++.+....+++.+|+.+++.++ ||||+++++++...
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~------HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK------HPNLVQLLGVCTRE 85 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCC------CTTBCCEEEEECSS
T ss_pred CEECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCCHHHHHHHHHHHHHHCC------CCCEECCCCCEEEC
T ss_conf 174579939865982088808999999999969999997776103999999999998679------99882677527457
Q ss_pred CEEEEEEECCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEEC
Q ss_conf 84999997142-14388986320269975559889999999779999999988953035899957980257870999836
Q 005590 456 EHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDL 534 (689)
Q Consensus 456 ~~l~lVmEy~~-g~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~DF 534 (689)
+..++||||+. |++.+++..... ..+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+||
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~----~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~--~~~~Kl~DF 159 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADF 159 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCEEECCC
T ss_pred CEEEEEEECCCCCCHHHHHHHCCC----CCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECC--CCCEEECCC
T ss_conf 854787631467606777530355----41579999999999999788898789305760457689989--992898324
Q ss_pred CCCCCCCCCCC----CCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCC-CCCCHHHHHHHHHHHHCCCCCHH
Q ss_conf 88421368864----22367654570323189999125699999999999939999-99983999999998411998678
Q 005590 535 GSSCFQTDNLC----LYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVL-FPNDAVVMILARIIGMLGPIDLE 609 (689)
Q Consensus 535 Gls~~~~~~~~----~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG~~P-F~~~~~~~~l~~i~~~~g~~~~e 609 (689)
|+++....... ...|++.|+|||++.+..|+.++||||+||++|+|++|..| |.+.+.......+...
T Consensus 160 G~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~------- 232 (287)
T d1opja_ 160 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD------- 232 (287)
T ss_dssp CCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-------
T ss_pred CCEEECCCCCCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCC-------
T ss_conf 4546537887221035566546669278727999810430217899999986799887742599999998558-------
Q ss_pred HHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC--CCCCCC
Q ss_conf 873322354432001110000000010001477543011201479199999999813009899938999980--989888
Q 005590 610 MLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD--HPWLQH 687 (689)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~--Hpwf~~ 687 (689)
....+|. ..++.+.+||.+||+.||++|||+.++++ ..++++
T Consensus 233 ---------------------------~~~~~~~---------~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 233 ---------------------------YRMERPE---------GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp ---------------------------CCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred ---------------------------CCCCCCC---------CCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf ---------------------------8888874---------3309999999997577976893999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.42 Aligned_cols=256 Identities=20% Similarity=0.292 Sum_probs=205.7
Q ss_pred EECCCEEEEEEECCCCCCCEEEEEECCCCC-----EEEEEEEECC--HHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEE
Q ss_conf 323758999993258887539999887893-----7999996054--134675999999999960169999872258778
Q 005590 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGV-----DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 450 (689)
Q Consensus 378 ~i~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~-----~vAIKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~ 450 (689)
+-.++|++.+.||+|+||+||+|++...++ .||+|++... ......+.+|+.++..+. .||||+++++
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~HpnIv~l~~ 108 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG-----SHENIVNLLG 108 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHC-----CCTTBCCEEE
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHC-----CCCCEEEEEE
T ss_conf 77899397019830788199999985788554204999999663358789999999999999715-----8996868778
Q ss_pred EEEECCEEEEEEECCC-CCHHHHHHHHHCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEEC
Q ss_conf 9984784999997142-1438898632026-----------------997555988999999977999999998895303
Q 005590 451 YFYHLEHLFIVCELLR-ANLYEFQKFNQES-----------------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHC 512 (689)
Q Consensus 451 ~f~~~~~l~lVmEy~~-g~L~~~~~~~~~~-----------------~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHr 512 (689)
++...+.+++||||+. |+|.+++...... .....+++..++.++.||+.||.|||+++|+||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR 188 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEEECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEC
T ss_conf 88629958999972799959999986257775102210000122200125778999999999999999999973990505
Q ss_pred CCCCCCEEEECCCCCEEEEEECCCCCCCCCCC-----CCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCC
Q ss_conf 58999579802578709998368842136886-----42236765457032318999912569999999999993-9999
Q 005590 513 DLKPENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVL 586 (689)
Q Consensus 513 DIKp~NILi~~~~~~~ikL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~ellt-G~~P 586 (689)
||||+|||++. ++.+||+|||+++...... ....||+.|+|||++.+..|+.++||||+||++|||++ |.+|
T Consensus 189 DlKp~Nill~~--~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 189 DLAARNVLVTH--GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp TCSGGGEEEET--TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CCCHHCCCCCC--CCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCC
T ss_conf 27032144345--9828985142222045778615623435787657838872799996330300039999998389999
Q ss_pred CCCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHC
Q ss_conf 99983999999998411998678873322354432001110000000010001477543011201479199999999813
Q 005590 587 FPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLL 666 (689)
Q Consensus 587 F~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL 666 (689)
|.+.+....+.+++.. ......|. ..++.+++||.+||
T Consensus 267 f~~~~~~~~~~~~~~~---------------------------------~~~~~~p~---------~~~~~l~~li~~cl 304 (325)
T d1rjba_ 267 YPGIPVDANFYKLIQN---------------------------------GFKMDQPF---------YATEEIYIIMQSCW 304 (325)
T ss_dssp STTCCCSHHHHHHHHT---------------------------------TCCCCCCT---------TCCHHHHHHHHHHT
T ss_pred CCCCCHHHHHHHHHHC---------------------------------CCCCCCCC---------CCCHHHHHHHHHHC
T ss_conf 9998989999999856---------------------------------99899887---------67899999999975
Q ss_pred CCCCCCCCCHHHHHCC
Q ss_conf 0098999389999809
Q 005590 667 EINPQRRPTAREALDH 682 (689)
Q Consensus 667 ~~dP~kRpTa~elL~H 682 (689)
+.||++|||++|+++|
T Consensus 305 ~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 305 AFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred CCCHHHCCCHHHHHHH
T ss_conf 8896689399999999
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=343.19 Aligned_cols=256 Identities=26% Similarity=0.352 Sum_probs=205.4
Q ss_pred CEECCCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECC----HHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEE
Q ss_conf 13237589999932588875399998878937999996054----13467599999999996016999987225877899
Q 005590 377 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 452 (689)
Q Consensus 377 ~~i~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~----~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f 452 (689)
..+.++|++.+.||+|+||+||+|+++.+++.||+|+++.+ ......+.+|+++++.+ .||||+++++++
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~------~hpniv~~~~~~ 76 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL------NHPAIVAVYDTG 76 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC------CCTTBCCEEEEE
T ss_pred CCCCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHC------CCCCCCCCCCEE
T ss_conf 57062069868996089929999999999989999998556646989999999999999856------999887311435
Q ss_pred EECC----EEEEEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCC
Q ss_conf 8478----49999971421-438898632026997555988999999977999999998895303589995798025787
Q 005590 453 YHLE----HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRC 527 (689)
Q Consensus 453 ~~~~----~l~lVmEy~~g-~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~ 527 (689)
...+ ..|+||||+.| +|..++...+. +++..++.++.||+.||.|||+.||+||||||+|||++. ++
T Consensus 77 ~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~------l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~--~~ 148 (277)
T d1o6ya_ 77 EAETPAGPLPYIVMEYVDGVTLRDIVHTEGP------MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA--TN 148 (277)
T ss_dssp EEECSSSEEEEEEEECCCEEEHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TS
T ss_pred EECCCCCCEEEEEEECCCCCEEHHHHCCCCC------CCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCC--CC
T ss_conf 4326887669999977889871011203589------999999999999999999998579527634675566575--43
Q ss_pred EEEEEECCCCCCCCC------CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHH
Q ss_conf 099983688421368------86422367654570323189999125699999999999939999999839999999984
Q 005590 528 EIKIIDLGSSCFQTD------NLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIG 601 (689)
Q Consensus 528 ~ikL~DFGls~~~~~------~~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~ 601 (689)
.++|+|||.+..... .....+||+.|+|||++.+..++.++||||+||++|+|++|++||.+.+..+.+.++..
T Consensus 149 ~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~ 228 (277)
T d1o6ya_ 149 AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 228 (277)
T ss_dssp CEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCEEEHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHH
T ss_conf 20100344432212354433334642576243699998399999663202652899999769799899699999999984
Q ss_pred HCCCCCHHHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 11998678873322354432001110000000010001477543011201479199999999813009899938999980
Q 005590 602 MLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 602 ~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~ 681 (689)
.-..++ .......++.+.+||.+||+.||++||+..+.|.
T Consensus 229 ~~~~~~----------------------------------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~ 268 (277)
T d1o6ya_ 229 EDPIPP----------------------------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 268 (277)
T ss_dssp CCCCCG----------------------------------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CCCCCC----------------------------------------CHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHH
T ss_conf 699997----------------------------------------1003478999999999986679767773999999
Q ss_pred CCCCC
Q ss_conf 98988
Q 005590 682 HPWLQ 686 (689)
Q Consensus 682 Hpwf~ 686 (689)
|+|++
T Consensus 269 ~~l~r 273 (277)
T d1o6ya_ 269 ADLVR 273 (277)
T ss_dssp HHHHH
T ss_pred HHHHH
T ss_conf 99999
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=343.09 Aligned_cols=247 Identities=20% Similarity=0.275 Sum_probs=201.2
Q ss_pred CCCEEEEEEECCCCCCCEEEEEECCCCC---EEEEEEEECC--HHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEE
Q ss_conf 3758999993258887539999887893---7999996054--1346759999999999601699998722587789984
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLHTGV---DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 380 ~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~---~vAIKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
.++|++.+.||+|+||+||+|+++.+++ .||+|.+... ......+.+|+.+|+.+ .||||+++++++..
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~HpnIv~l~g~~~~ 98 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF------DHPNVIHLEGVVTK 98 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC------CCTTBCCEEEEECS
T ss_pred HHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHC------CCCCCCCEEEEEEE
T ss_conf 004278569802788299999995799788999999978445989999999999999857------99888618999962
Q ss_pred CCEEEEEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEE
Q ss_conf 7849999971421-438898632026997555988999999977999999998895303589995798025787099983
Q 005590 455 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 533 (689)
Q Consensus 455 ~~~l~lVmEy~~g-~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~D 533 (689)
.+..++||||+.+ +|.+++..... .+++..+..++.||+.||.|||+.+|+||||||+|||++. ++.+||+|
T Consensus 99 ~~~~~iv~Ey~~~g~L~~~~~~~~~-----~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~--~~~~Kl~D 171 (299)
T d1jpaa_ 99 STPVMIITEFMENGSLDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNS--NLVCKVSD 171 (299)
T ss_dssp SSSCEEEEECCTTEEHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCEEECC
T ss_pred CCEEEEEEEECCCCCCEEEECCCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECC--CCCEEECC
T ss_conf 8877999972279853002104567-----9999999999999999889885279835761504489889--99199888
Q ss_pred CCCCCCCCCCC--------CCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCHHHHHHHHHHHHCC
Q ss_conf 68842136886--------42236765457032318999912569999999999993-9999999839999999984119
Q 005590 534 LGSSCFQTDNL--------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLG 604 (689)
Q Consensus 534 FGls~~~~~~~--------~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~ellt-G~~PF~~~~~~~~l~~i~~~~g 604 (689)
||+++...... ....+|+.|+|||++.+..++.++||||+||++|||+| |++||.+.+..+++..+.....
T Consensus 172 FGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 251 (299)
T d1jpaa_ 172 FGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR 251 (299)
T ss_dssp C-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred CCCCEECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC
T ss_conf 44315756777765365025666883003878883699786121445357899998679999999999999999973788
Q ss_pred CCCHHHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 986788733223544320011100000000100014775430112014791999999998130098999389999809
Q 005590 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 605 ~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~H 682 (689)
...|. ..+..+.+||.+||+.||++|||+.|++++
T Consensus 252 ----------------------------------~~~~~---------~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 252 ----------------------------------LPPPM---------DCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ----------------------------------CCCCT---------TCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ----------------------------------CCCCC---------CCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf ----------------------------------99974---------226999999999758797689299999999
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.05 Aligned_cols=245 Identities=20% Similarity=0.336 Sum_probs=204.9
Q ss_pred CCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEECCEEEE
Q ss_conf 75899999325888753999988789379999960541346759999999999601699998722587789984784999
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 460 (689)
Q Consensus 381 ~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~l 460 (689)
++|++.+.||+|+||.||+|++. ++..||||+++.+....+.+.+|+.+++.++ ||||+++++++...+..++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~------HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS------HPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCC------CTTBCCEEEEECSSSSCEE
T ss_pred HHCEEEEEEEECCCEEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHHCC------CCCCCCCCCEECCCCCEEE
T ss_conf 99588889820888299999988-9999999998788676899999999999668------9975653524315993379
Q ss_pred EEECCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEECCCCCC
Q ss_conf 997142-1438898632026997555988999999977999999998895303589995798025787099983688421
Q 005590 461 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539 (689)
Q Consensus 461 VmEy~~-g~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~DFGls~~ 539 (689)
||||+. |+|.+++..... .+++..+..++.||+.||.|||+.+|+||||||+|||++. ++.+||+|||+++.
T Consensus 78 v~E~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~--~~~~Kl~DFGla~~ 150 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE--NQVIKVSDFGMTRF 150 (263)
T ss_dssp EEECCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECG--GGCEEECSCC----
T ss_pred EEEECCCCCHHHHHHCCCC-----CCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCHHHEEECC--CCCEEECCCCHHEE
T ss_conf 9983699918997520134-----7889999999999999877653164310443153266668--87768655321002
Q ss_pred CCCCC----CCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCHHHHHHHHHHHHCCCCCHHHHHHH
Q ss_conf 36886----42236765457032318999912569999999999993-99999998399999999841199867887332
Q 005590 540 QTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 540 ~~~~~----~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
..... ....||+.|+|||++.+..|+.++||||+||++|||++ |.+||...+..+.+..+....
T Consensus 151 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~----------- 219 (263)
T d1sm2a_ 151 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF----------- 219 (263)
T ss_dssp --------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC-----------
T ss_pred CCCCCCEEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC-----------
T ss_conf 368873350430017666785786079998403321059999999878988877899999999998068-----------
Q ss_pred HHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 23544320011100000000100014775430112014791999999998130098999389999809
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~H 682 (689)
....|. ..++.+.+||.+||+.||++|||++++++|
T Consensus 220 -----------------------~~~~p~---------~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 220 -----------------------RLYKPR---------LASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp -----------------------CCCCCT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------CCCCCC---------CCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf -----------------------889954---------367999999999765797689199999999
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.77 Aligned_cols=254 Identities=24% Similarity=0.342 Sum_probs=206.8
Q ss_pred CEECCCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEECC
Q ss_conf 13237589999932588875399998878937999996054134675999999999960169999872258778998478
Q 005590 377 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 377 ~~i~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++-.++|++.+.||+|+||.||+|+++ ++..||||+++.+....+.+.+|+.++..++ ||||+++++++. .+
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~------HpnIv~~~g~~~-~~ 80 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ------HQRLVRLYAVVT-QE 80 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCC------CTTBCCEEEEEC-SS
T ss_pred ECCHHHEEEEEEEECCCCCEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHHCC------CCCEEEEEEEEC-CC
T ss_conf 038899388679810798289999999-9999999998647688899999999998679------998857873104-59
Q ss_pred EEEEEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEECC
Q ss_conf 49999971421-43889863202699755598899999997799999999889530358999579802578709998368
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~DFG 535 (689)
..++||||+.+ +|.+++...... .+++..+..|+.||+.||.|||+.+|+||||||+|||++. ++.+||+|||
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~----~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~--~~~~Kl~DFG 154 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD--TLSCKIADFG 154 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHH----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT--TSCEEECCCT
T ss_pred CEEEEEEECCCCCHHHHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEEC--CCCEEECCCC
T ss_conf 769999957898288887514789----8878899999999999999997489546756422515620--2440423410
Q ss_pred CCCCCCCCC----CCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCHHHHHHHHHHHHCCCCCHHH
Q ss_conf 842136886----42236765457032318999912569999999999993-9999999839999999984119986788
Q 005590 536 SSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEM 610 (689)
Q Consensus 536 ls~~~~~~~----~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~ 610 (689)
+++...... ....+++.|+|||++.+..++.++||||+||++|||+| |.+||...+..+.+..+....
T Consensus 155 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~------- 227 (272)
T d1qpca_ 155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY------- 227 (272)
T ss_dssp TCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-------
T ss_pred CEEECCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC-------
T ss_conf 1477358864420356774444582898379998245645257999999968988888889999999997068-------
Q ss_pred HHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC--CCCCCC
Q ss_conf 73322354432001110000000010001477543011201479199999999813009899938999980--989888
Q 005590 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD--HPWLQH 687 (689)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~--Hpwf~~ 687 (689)
....|. ..++.+.+||.+||+.||++|||++++++ |+||++
T Consensus 228 ---------------------------~~~~p~---------~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 228 ---------------------------RMVRPD---------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp ---------------------------CCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------------------------CCCCCC---------CCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf ---------------------------888965---------5719999999997588976893999999986113213
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=333.45 Aligned_cols=255 Identities=22% Similarity=0.314 Sum_probs=206.6
Q ss_pred CEECCCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEECC
Q ss_conf 13237589999932588875399998878937999996054134675999999999960169999872258778998478
Q 005590 377 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 377 ~~i~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++-.++|++.+.||+|+||+||+|++..+ ..||||+++.+....+.+.+|+.+++.++ |+||+++++++. .+
T Consensus 13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~------h~nIv~~~g~~~-~~ 84 (285)
T d1fmka3 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR------HEKLVQLYAVVS-EE 84 (285)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCC------CTTBCCEEEEEC-SS
T ss_pred ECCHHHEEEEEEEEECCCEEEEEEEECCC-CEEEEEEECCCCCCHHHHHHHHHHHHHCC------CCCEEEEEEEEE-CC
T ss_conf 74779979846993079809999999999-99999998804488899999999998666------678868999982-39
Q ss_pred EEEEEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEECC
Q ss_conf 49999971421-43889863202699755598899999997799999999889530358999579802578709998368
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~DFG 535 (689)
..++||||+.+ ++..++...... .+++..+..++.||+.||.|||+.+|+||||||+|||++. ++.+||+|||
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~~~~----~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~--~~~~kl~DfG 158 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE--NLVCKVADFG 158 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG--GGCEEECCCC
T ss_pred CEEEEEEECCCCCHHHHHHHCCCC----CCHHHHHHHHHHHHHHHHHHHHHHHEECCCCCCEEEEECC--CCCEEECCCC
T ss_conf 759999944799435420000355----3059999999999999999875411433531230799989--9929984425
Q ss_pred CCCCCCCCC----CCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCCHHHHHHHHHHHHCCCCCHHH
Q ss_conf 842136886----422367654570323189999125699999999999939-999999839999999984119986788
Q 005590 536 SSCFQTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG-EVLFPNDAVVMILARIIGMLGPIDLEM 610 (689)
Q Consensus 536 ls~~~~~~~----~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG-~~PF~~~~~~~~l~~i~~~~g~~~~e~ 610 (689)
+++...... ....+|+.|+|||++....++.++||||+||++|||++| .+||.+....+.+..+....
T Consensus 159 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~------- 231 (285)
T d1fmka3 159 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY------- 231 (285)
T ss_dssp TTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-------
T ss_pred HHHHCCCCCCEEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC-------
T ss_conf 5542568873352454556654580898379989177413235899999868999998888999999998268-------
Q ss_pred HHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC--CCCCCCC
Q ss_conf 73322354432001110000000010001477543011201479199999999813009899938999980--9898889
Q 005590 611 LMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD--HPWLQHP 688 (689)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~--Hpwf~~~ 688 (689)
...++. ..++.+.+||.+||+.||++|||++++++ ++||+..
T Consensus 232 ---------------------------~~~~~~---------~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 232 ---------------------------RMPCPP---------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp ---------------------------CCCCCT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ---------------------------CCCCCC---------CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCC
T ss_conf ---------------------------999983---------23799999999975669758919999999876662389
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=334.64 Aligned_cols=249 Identities=20% Similarity=0.244 Sum_probs=200.4
Q ss_pred CCCEEEEEE-ECCCCCCCEEEEEECC--CCCEEEEEEEECC--HHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEE
Q ss_conf 375899999-3258887539999887--8937999996054--1346759999999999601699998722587789984
Q 005590 380 AGRYYVTEY-LGSAAFSKVFQAQDLH--TGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 380 ~~~Y~i~~~-LG~G~fG~Vy~a~d~~--tg~~vAIKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
.++|.+.+. ||+|+||+||+|.++. ++..||||+++.. ......+.+|+++++.++ ||||+++++++..
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~------HpnIv~l~g~~~~ 80 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD------NPYIVRLIGVCQA 80 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC------CTTBCCEEEEEES
T ss_pred CCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCC------CCCEEEEEEEECC
T ss_conf 4471887848730608099999996089768999999882039789999999999998679------9888068656036
Q ss_pred CCEEEEEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEE
Q ss_conf 7849999971421-438898632026997555988999999977999999998895303589995798025787099983
Q 005590 455 LEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 533 (689)
Q Consensus 455 ~~~l~lVmEy~~g-~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~D 533 (689)
+.+++||||+.+ +|.+++...+ ..+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|
T Consensus 81 -~~~~lvmE~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~--~~~~Kl~D 152 (285)
T d1u59a_ 81 -EALMLVMEMAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN--RHYAKISD 152 (285)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEE--TTEEEECC
T ss_pred -CEEEEEEEECCCCCHHHHHHCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECC--CCCEEECC
T ss_conf -80799998078996899752125-----69999999999999999878998688105767646604546--88542033
Q ss_pred CCCCCCCCCCC------CCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf 68842136886------42236765457032318999912569999999999993-999999983999999998411998
Q 005590 534 LGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPI 606 (689)
Q Consensus 534 FGls~~~~~~~------~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~ 606 (689)
||+++...... ....||+.|+|||++.+..++.++||||+||++|||++ |+.||.+.+..++...+...
T Consensus 153 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~---- 228 (285)
T d1u59a_ 153 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG---- 228 (285)
T ss_dssp CTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT----
T ss_pred CHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC----
T ss_conf 1342115543432113562113743358688727999954123220178999993899999997999999999818----
Q ss_pred CHHHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHH---HCCC
Q ss_conf 6788733223544320011100000000100014775430112014791999999998130098999389999---8098
Q 005590 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA---LDHP 683 (689)
Q Consensus 607 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~el---L~Hp 683 (689)
....+|. ..++.+.+||.+||+.||++|||+.++ |+|+
T Consensus 229 ------------------------------~~~~~p~---------~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 229 ------------------------------KRMECPP---------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp ------------------------------CCCCCCT---------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------------------------------CCCCCCC---------CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf ------------------------------9999997---------6789999999997577976890999999999999
Q ss_pred CC
Q ss_conf 98
Q 005590 684 WL 685 (689)
Q Consensus 684 wf 685 (689)
|+
T Consensus 270 ~~ 271 (285)
T d1u59a_ 270 YY 271 (285)
T ss_dssp HH
T ss_pred HH
T ss_conf 99
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.14 Aligned_cols=245 Identities=21% Similarity=0.336 Sum_probs=206.3
Q ss_pred CCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEECCEEEE
Q ss_conf 75899999325888753999988789379999960541346759999999999601699998722587789984784999
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFI 460 (689)
Q Consensus 381 ~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~l 460 (689)
++|++.++||+|+||+||+++++ +++.||||+++.+....+.+.+|+.++..++ ||||+++++++...+.+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~------HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS------HEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCC------CTTBCCEEEEECCSSSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHHCC------CCCEEEEEEEEEECCCEEE
T ss_conf 99799689820788399999988-9989999998747577899999999999668------9860158899850781699
Q ss_pred EEECCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEECCCCCC
Q ss_conf 997142-1438898632026997555988999999977999999998895303589995798025787099983688421
Q 005590 461 VCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539 (689)
Q Consensus 461 VmEy~~-g~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~DFGls~~ 539 (689)
||||+. |++..++...... +++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++.
T Consensus 77 v~Ey~~~g~l~~~~~~~~~~-----~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~--~~~~kl~DfG~a~~ 149 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRHR-----FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND--QGVVKVSDFGLSRY 149 (258)
T ss_dssp EEECCTTEEHHHHHHSGGGC-----CCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECT--TCCEEECCCSSCCB
T ss_pred EEECCCCCCHHHHHHCCCCC-----CCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEECC--CCCEEECCCHHHEE
T ss_conf 99704899388864102467-----768999999999999999875468434665413588769--98479886144202
Q ss_pred CCCCC----CCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCHHHHHHHHHHHHCCCCCHHHHHHH
Q ss_conf 36886----42236765457032318999912569999999999993-99999998399999999841199867887332
Q 005590 540 QTDNL----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 540 ~~~~~----~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
..... ....+|+.|+|||++.+..++.++||||+|+++|||+| |+.||.+.+..++...+....
T Consensus 150 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~----------- 218 (258)
T d1k2pa_ 150 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL----------- 218 (258)
T ss_dssp CSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC-----------
T ss_pred CCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC-----------
T ss_conf 357872252465788775780786379988521033643246739755999988999999999998079-----------
Q ss_pred HHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 23544320011100000000100014775430112014791999999998130098999389999809
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~H 682 (689)
....|. ..++.+.+||.+||+.||++|||+.++|+|
T Consensus 219 -----------------------~~~~p~---------~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 219 -----------------------RLYRPH---------LASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp -----------------------CCCCCT---------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----------------------CCCCCC---------CCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf -----------------------789965---------465999999999766897689399999987
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.61 Aligned_cols=251 Identities=25% Similarity=0.369 Sum_probs=195.3
Q ss_pred CEECCCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECC---HHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEE
Q ss_conf 13237589999932588875399998878937999996054---134675999999999960169999872258778998
Q 005590 377 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFY 453 (689)
Q Consensus 377 ~~i~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~ 453 (689)
++-.++|++.+.||+|+||+||+|+. +..||||+++.. ......+.+|+.++..+ .||||+++++++.
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l------~HpnIv~~~~~~~ 74 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT------RHVNILLFMGYST 74 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTC------CCTTBCCEEEEEC
T ss_pred CCCCCCEEEEEEEEECCCCEEEEEEE---CCEEEEEEEECCCCCHHHHHHHHHHHHHHHHC------CCCCEEEEEEEEE
T ss_conf 31545189988983078858999999---99899999973469989999999999999847------9987864567971
Q ss_pred ECCEEEEEEECCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEE
Q ss_conf 4784999997142-143889863202699755598899999997799999999889530358999579802578709998
Q 005590 454 HLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKII 532 (689)
Q Consensus 454 ~~~~l~lVmEy~~-g~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~ 532 (689)
...+++||||+. |+|.+++..... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+
T Consensus 75 -~~~~~lv~Ey~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~--~~~~Kl~ 146 (276)
T d1uwha_ 75 -APQLAIVTQWCEGSSLYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHE--DLTVKIG 146 (276)
T ss_dssp -SSSCEEEEECCCEEEHHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET--TSSEEEC
T ss_pred -CCEEEEEEECCCCCCHHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCHHHEEECC--CCCEEEC
T ss_conf -5589999965899888999852357-----8999999999999999988875099951614789979818--9978875
Q ss_pred ECCCCCCCCCC-----CCCCCCCCCCCCHHHHCCC---CCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCC
Q ss_conf 36884213688-----6422367654570323189---999125699999999999939999999839999999984119
Q 005590 533 DLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGL---PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLG 604 (689)
Q Consensus 533 DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~---~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~~~g 604 (689)
|||++...... .....||+.|+|||++.+. .|+.++||||+||++|||++|+.||.+.+....+..+....
T Consensus 147 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~- 225 (276)
T d1uwha_ 147 DFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG- 225 (276)
T ss_dssp CCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHT-
T ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCC-
T ss_conf 0022133355677631256655743179999950568999953151635999999997889989989699999999658-
Q ss_pred CCCHHHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 986788733223544320011100000000100014775430112014791999999998130098999389999809
Q 005590 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 605 ~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~H 682 (689)
...|. +.......++.+.+||.+||+.||++|||+.+++++
T Consensus 226 ----------------------------------~~~p~---~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 226 ----------------------------------YLSPD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp ----------------------------------SCCCC---GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------------CCCCC---CHHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf ----------------------------------88986---000365554999999999758897689299999999
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=334.85 Aligned_cols=254 Identities=27% Similarity=0.403 Sum_probs=205.7
Q ss_pred CCEEEEEEECCCCCCCEEEEEEC---CCCCEEEEEEEECC-----HHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEE
Q ss_conf 75899999325888753999988---78937999996054-----13467599999999996016999987225877899
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDL---HTGVDVCLKIIKND-----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 452 (689)
Q Consensus 381 ~~Y~i~~~LG~G~fG~Vy~a~d~---~tg~~vAIKii~~~-----~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f 452 (689)
++|++.+.||+|+||+||+|++. .+|+.||+|+++.. ......+.+|+.+++.+++ |+||+++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h-----~pnIv~~~~~~ 98 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ-----SPFLVTLHYAF 98 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHT-----CTTBCCEEEEE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCC-----CCEEEEEEEEE
T ss_conf 0259998983287839999998765887948999998367721016899999999999986467-----98399962000
Q ss_pred EECCEEEEEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEE
Q ss_conf 847849999971421-4388986320269975559889999999779999999988953035899957980257870999
Q 005590 453 YHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 531 (689)
Q Consensus 453 ~~~~~l~lVmEy~~g-~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL 531 (689)
.+....++||||+.+ +|.+.+...+. +++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~~------~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~--~~~vkL 170 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRER------FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS--NGHVVL 170 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT--TSCEEE
T ss_pred CCCCCEEEEEECCCCCHHHHHHHHCCC------CCHHHHHHHHHHHHHHHHHHHCCCEEECCCCCCCEEECC--CCCEEE
T ss_conf 248730012312341179999873045------437888888999999998851499896547732012469--998887
Q ss_pred EECCCCCCCCCC----CCCCCCCCCCCCHHHHCCC--CCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 836884213688----6422367654570323189--9991256999999999999399999998399999999841199
Q 005590 532 IDLGSSCFQTDN----LCLYVQSRSYRAPEVIIGL--PYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGP 605 (689)
Q Consensus 532 ~DFGls~~~~~~----~~~~~gt~~y~APE~l~~~--~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~~~g~ 605 (689)
+|||++...... .....|++.|+|||.+.+. .++.++||||+||+||+|++|+.||.+.+.......+....
T Consensus 171 ~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~-- 248 (322)
T d1vzoa_ 171 TDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI-- 248 (322)
T ss_dssp SCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--
T ss_pred EECCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHC--
T ss_conf 413202220344443221222333331068760577688713251777799999976899988887777999999833--
Q ss_pred CCHHHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCC-----CHHHHH
Q ss_conf 867887332235443200111000000001000147754301120147919999999981300989993-----899998
Q 005590 606 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRP-----TAREAL 680 (689)
Q Consensus 606 ~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRp-----Ta~elL 680 (689)
......+| ...++.+++||.+||++||.+|| |++|++
T Consensus 249 -----------------------------~~~~~~~~---------~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil 290 (322)
T d1vzoa_ 249 -----------------------------LKSEPPYP---------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290 (322)
T ss_dssp -----------------------------HHCCCCCC---------TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH
T ss_pred -----------------------------CCCCCCCC---------CCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHH
T ss_conf -----------------------------56899886---------5479999999999744589881999745099997
Q ss_pred CCCCCCC
Q ss_conf 0989888
Q 005590 681 DHPWLQH 687 (689)
Q Consensus 681 ~Hpwf~~ 687 (689)
+||||+.
T Consensus 291 ~Hpff~~ 297 (322)
T d1vzoa_ 291 EHLFFQK 297 (322)
T ss_dssp TSGGGTT
T ss_pred CCHHHCC
T ss_conf 4972348
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.79 Aligned_cols=245 Identities=21% Similarity=0.267 Sum_probs=196.9
Q ss_pred CCEEEEEEECCCCCCCEEEEEECCCCC----EEEEEEEECC--HHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEE
Q ss_conf 758999993258887539999887893----7999996054--1346759999999999601699998722587789984
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGV----DVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 381 ~~Y~i~~~LG~G~fG~Vy~a~d~~tg~----~vAIKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
.+|+++++||+|+||+||+|.+..+|+ +||+|.++.. ......+.+|+.+++.++ ||||+++++++..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------HpnIv~l~g~~~~ 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD------NPHVCRLLGICLT 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCC------CTTBCCEEEEEES
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC------CCCEEEEEEEEEC
T ss_conf 9997831982089929999999589988989999999651349799999999999998679------9888158999961
Q ss_pred CCEEEEEEECCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEE
Q ss_conf 784999997142-1438898632026997555988999999977999999998895303589995798025787099983
Q 005590 455 LEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIID 533 (689)
Q Consensus 455 ~~~l~lVmEy~~-g~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~D 533 (689)
.. .+++++++. ++|.+.+..... .+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|
T Consensus 83 ~~-~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~--~~~~kl~D 154 (317)
T d1xkka_ 83 ST-VQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT--PQHVKITD 154 (317)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHTSS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE--TTEEEECC
T ss_pred CC-EEEEEEECCCCCCCCCCCCCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHCCEECC--CCCEEEEC
T ss_conf 98-3699984268740101113345-----7999999999999999999998769504762120311679--98758602
Q ss_pred CCCCCCCCCCC-----CCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCHHHHHHHHHHHHCCCCC
Q ss_conf 68842136886-----42236765457032318999912569999999999993-9999999839999999984119986
Q 005590 534 LGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPID 607 (689)
Q Consensus 534 FGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~~ 607 (689)
||+++...... ....||+.|+|||++.+..|+.++||||+||++|||+| |.+||.+.+..++...+..-
T Consensus 155 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~----- 229 (317)
T d1xkka_ 155 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG----- 229 (317)
T ss_dssp CSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT-----
T ss_pred CCCCEECCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC-----
T ss_conf 552223354445322365105864467088746999835654407999999997799999999989999999759-----
Q ss_pred HHHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 788733223544320011100000000100014775430112014791999999998130098999389999809
Q 005590 608 LEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 608 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~H 682 (689)
.....|. ..++.+.+||.+||..||++|||+.++++|
T Consensus 230 -----------------------------~~~~~p~---------~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 230 -----------------------------ERLPQPP---------ICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp -----------------------------CCCCCCT---------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------------CCCCCCC---------CCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf -----------------------------9899985---------568999999998478993469199999999
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.78 Aligned_cols=246 Identities=20% Similarity=0.261 Sum_probs=196.4
Q ss_pred EEEE-EEECCCCCCCEEEEEEC--CCCCEEEEEEEECC---HHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEECC
Q ss_conf 8999-99325888753999988--78937999996054---134675999999999960169999872258778998478
Q 005590 383 YYVT-EYLGSAAFSKVFQAQDL--HTGVDVCLKIIKND---KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 383 Y~i~-~~LG~G~fG~Vy~a~d~--~tg~~vAIKii~~~---~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
+.+. ++||+|+||+||+|.+. .+++.||+|+++.+ ....+.+.+|+.+++.++ ||||+++++++.. +
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~------HpnIv~~~g~~~~-~ 80 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD------NPYIVRMIGICEA-E 80 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC------CTTBCCEEEEEES-S
T ss_pred CEECCCCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCC------CCCCCEEEEEECC-C
T ss_conf 70018783458782999999816973859999998801089899999999999998679------9898527777505-9
Q ss_pred EEEEEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEECC
Q ss_conf 49999971421-43889863202699755598899999997799999999889530358999579802578709998368
Q 005590 457 HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~g-~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~DFG 535 (689)
..++||||+.+ +|.+++..... +++..+..++.||+.||.|||+.+|+||||||+|||++. ++.+||+|||
T Consensus 81 ~~~lvmE~~~~g~L~~~l~~~~~------l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~--~~~~kl~DFG 152 (277)
T d1xbba_ 81 SWMLVMEMAELGPLNKYLQQNRH------VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT--QHYAKISDFG 152 (277)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTT------CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE--TTEEEECCCT
T ss_pred CEEEEEECCCCCCHHHHHHHCCC------CCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCCC--CCCCCCCCHH
T ss_conf 77999974788968999752257------899999999999999976687479556777611310235--6751234134
Q ss_pred CCCCCCCCC------CCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCHHHHHHHHHHHHCCCCCH
Q ss_conf 842136886------42236765457032318999912569999999999993-99999998399999999841199867
Q 005590 536 SSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDL 608 (689)
Q Consensus 536 ls~~~~~~~------~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~~~ 608 (689)
+++...... ....||+.|+|||++.+..++.++||||+||++|||++ |++||.+.+..++...+...
T Consensus 153 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~------ 226 (277)
T d1xbba_ 153 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG------ 226 (277)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT------
T ss_pred HHHHCCCCCCCCCCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC------
T ss_conf 53313432344322445677842039166537999843443034031328965899999998999999999828------
Q ss_pred HHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHH---HCCCCC
Q ss_conf 88733223544320011100000000100014775430112014791999999998130098999389999---809898
Q 005590 609 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREA---LDHPWL 685 (689)
Q Consensus 609 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~el---L~Hpwf 685 (689)
....+|. ..++.+.+||.+||+.||++|||+.++ |+|+|+
T Consensus 227 ----------------------------~~~~~p~---------~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 227 ----------------------------ERMGCPA---------GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp ----------------------------CCCCCCT---------TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----------------------------CCCCCCC---------CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHH
T ss_conf ----------------------------9999986---------567999999999758897689098999998528875
Q ss_pred C
Q ss_conf 8
Q 005590 686 Q 686 (689)
Q Consensus 686 ~ 686 (689)
+
T Consensus 270 ~ 270 (277)
T d1xbba_ 270 D 270 (277)
T ss_dssp H
T ss_pred H
T ss_conf 0
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=330.91 Aligned_cols=262 Identities=19% Similarity=0.248 Sum_probs=206.7
Q ss_pred EECCCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEECCE
Q ss_conf 32375899999325888753999988789379999960541346759999999999601699998722587789984784
Q 005590 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 378 ~i~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
.++++|++.+.||+|+||.||+|+++.+++.||||++..... ...+.+|+++++.+++. ++|+.+.+++...+.
T Consensus 4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~-----~~i~~~~~~~~~~~~ 77 (299)
T d1ckia_ 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGG-----VGIPTIRWCGAEGDY 77 (299)
T ss_dssp EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTS-----TTCCCEEEEEEETTE
T ss_pred EECCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC-CHHHHHHHHHHHHCCCC-----CCCCEEEEEEECCCE
T ss_conf 188889996898507880999999988998999999721005-88899999999970389-----960179999951987
Q ss_pred EEEEEECCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECC-CCCEEEEEECCC
Q ss_conf 9999971421438898632026997555988999999977999999998895303589995798025-787099983688
Q 005590 458 LFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY-QRCEIKIIDLGS 536 (689)
Q Consensus 458 l~lVmEy~~g~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~-~~~~ikL~DFGl 536 (689)
.++||||+++++.......... +++..+..++.|++.||.|||++||+||||||+|||++.. .+..++|+|||+
T Consensus 78 ~~ivme~~~~~l~~~~~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~ 152 (299)
T d1ckia_ 78 NVMVMELLGPSLEDLFNFCSRK-----FSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 152 (299)
T ss_dssp EEEEEECCCCBHHHHHHHTTTC-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSS
T ss_pred EEEEEEECCCCHHHHHHHCCCC-----CCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHCCCCCCCCCCEEEEECCCC
T ss_conf 7899987387133324430688-----76899999999999999999979944266787660643357776156504675
Q ss_pred CCCCCCC----------CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf 4213688----------642236765457032318999912569999999999993999999983999999998411998
Q 005590 537 SCFQTDN----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAVVMILARIIGMLGPI 606 (689)
Q Consensus 537 s~~~~~~----------~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG~~PF~~~~~~~~l~~i~~~~g~~ 606 (689)
++..... .....||+.|+|||++.+..++.++||||+||++|+|++|..||...........+.....
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~-- 230 (299)
T d1ckia_ 153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-- 230 (299)
T ss_dssp CEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH--
T ss_pred CEECCCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHC--
T ss_conf 134255445541000135776787353299999189989832188617789999849876655305779999998523--
Q ss_pred CHHHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHH---HHCCC
Q ss_conf 678873322354432001110000000010001477543011201479199999999813009899938999---98098
Q 005590 607 DLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTARE---ALDHP 683 (689)
Q Consensus 607 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~e---lL~Hp 683 (689)
..... ..+......++++.+||..||..||++||++.+ +|+|+
T Consensus 231 ------------------------------~~~~~----~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 231 ------------------------------KKMST----PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp ------------------------------HHHHS----CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred ------------------------------CCCCC----CHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf ------------------------------56789----83575347889999999998439955791999999999999
Q ss_pred CCC
Q ss_conf 988
Q 005590 684 WLQ 686 (689)
Q Consensus 684 wf~ 686 (689)
|.+
T Consensus 277 ~~~ 279 (299)
T d1ckia_ 277 FHR 279 (299)
T ss_dssp HHH
T ss_pred HHH
T ss_conf 997
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=324.39 Aligned_cols=247 Identities=20% Similarity=0.271 Sum_probs=195.8
Q ss_pred ECCCEEEEEEECCCCCCCEEEEEECCCC----CEEEEEEEECCH--HHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEE
Q ss_conf 2375899999325888753999988789----379999960541--3467599999999996016999987225877899
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTG----VDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 452 (689)
Q Consensus 379 i~~~Y~i~~~LG~G~fG~Vy~a~d~~tg----~~vAIKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f 452 (689)
-...|++.++||+|+||+||+|.++.++ ..||||++.... .....+.+|+.+++.++ ||||+++++++
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~------H~nIv~~~g~~ 78 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS------HHNIIRLEGVI 78 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC------CTTBCCEEEEE
T ss_pred CHHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC------CCCEEEEEEEE
T ss_conf 889968615981177909999999689987879999999884459689999999999998568------98783236778
Q ss_pred EECCEEEEEEECCCCC-HHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEE
Q ss_conf 8478499999714214-388986320269975559889999999779999999988953035899957980257870999
Q 005590 453 YHLEHLFIVCELLRAN-LYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 531 (689)
Q Consensus 453 ~~~~~l~lVmEy~~g~-L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL 531 (689)
......++||||+.++ +.+.+..... .+++..+..++.||+.||.|||+.+|+||||||+|||++. ++.+||
T Consensus 79 ~~~~~~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~--~~~~Kl 151 (283)
T d1mqba_ 79 SKYKPMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS--NLVCKV 151 (283)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT--TCCEEE
T ss_pred ECCCCEEEEEEECCCCCCHHHHHCCCC-----CCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECC--CCEEEE
T ss_conf 338803899972135740222102345-----4208999999999998541212123425765644278889--984998
Q ss_pred EECCCCCCCCCC------CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCCHHHHHHHHHHHHCC
Q ss_conf 836884213688------6422367654570323189999125699999999999939-999999839999999984119
Q 005590 532 IDLGSSCFQTDN------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG-EVLFPNDAVVMILARIIGMLG 604 (689)
Q Consensus 532 ~DFGls~~~~~~------~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG-~~PF~~~~~~~~l~~i~~~~g 604 (689)
+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||+++ .+||...+..+.+..+...
T Consensus 152 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-- 229 (283)
T d1mqba_ 152 SDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-- 229 (283)
T ss_dssp CCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT--
T ss_pred CCCCHHHCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC--
T ss_conf 455103003578765267426777734348888704999973556344898999996798865568999999998635--
Q ss_pred CCCHHHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 98678873322354432001110000000010001477543011201479199999999813009899938999980
Q 005590 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 605 ~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~ 681 (689)
.....|. ..+..+.+||.+||+.||++|||+.++++
T Consensus 230 --------------------------------~~~~~~~---------~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 230 --------------------------------FRLPTPM---------DCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp --------------------------------CCCCCCT---------TCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------------------------------CCCCCCH---------HHHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf --------------------------------7899850---------45799999999977679768939999999
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=327.62 Aligned_cols=249 Identities=22% Similarity=0.300 Sum_probs=199.7
Q ss_pred CEECCCEEEEEEECCCCCCCEEEEEECCC---CCEEEEEEEECC--HHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEE
Q ss_conf 13237589999932588875399998878---937999996054--1346759999999999601699998722587789
Q 005590 377 TVIAGRYYVTEYLGSAAFSKVFQAQDLHT---GVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 451 (689)
Q Consensus 377 ~~i~~~Y~i~~~LG~G~fG~Vy~a~d~~t---g~~vAIKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~ 451 (689)
++..++|++.+.||+|+||.||+|++..+ +..||+|.++.. ......+.+|+.+++.++ ||||++++++
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~------HpnIv~l~~~ 76 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD------HPHIVKLIGV 76 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCC------CTTBCCEEEE
T ss_pred CCCHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC------CCCEEEEEEE
T ss_conf 7688996987799307882999999936996449999999365668799999999999998689------9998569889
Q ss_pred EEECCEEEEEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEE
Q ss_conf 9847849999971421-438898632026997555988999999977999999998895303589995798025787099
Q 005590 452 FYHLEHLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIK 530 (689)
Q Consensus 452 f~~~~~l~lVmEy~~g-~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ik 530 (689)
+. .+..++||||+.+ ++.+++..... .+++..+..++.||+.||.|||+.+|+||||||+||+++. ++.+|
T Consensus 77 ~~-~~~~~iv~E~~~~g~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~--~~~~K 148 (273)
T d1mp8a_ 77 IT-ENPVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS--NDCVK 148 (273)
T ss_dssp EC-SSSCEEEEECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE--TTEEE
T ss_pred EE-CCEEEEEEEECCCCCHHHHHHCCCC-----CCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCHHHEEECC--CCCEE
T ss_conf 95-3747999984069807765422478-----9999999999999987752302267441410265532067--89678
Q ss_pred EEECCCCCCCCCC----CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 9836884213688----642236765457032318999912569999999999993-99999998399999999841199
Q 005590 531 IIDLGSSCFQTDN----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGP 605 (689)
Q Consensus 531 L~DFGls~~~~~~----~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~ellt-G~~PF~~~~~~~~l~~i~~~~g~ 605 (689)
|+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||++ |.+||.+.+..+++..+...
T Consensus 149 l~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~--- 225 (273)
T d1mp8a_ 149 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--- 225 (273)
T ss_dssp ECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT---
T ss_pred ECCCHHHEECCCCCCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC---
T ss_conf 76503421336776233054005831032667516998874524442478999982699998889999999999818---
Q ss_pred CCHHHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 86788733223544320011100000000100014775430112014791999999998130098999389999809
Q 005590 606 IDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 606 ~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~H 682 (689)
....+|. ..++.+.+||.+||..||++|||+.|+++|
T Consensus 226 -------------------------------~~~~~~~---------~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 226 -------------------------------ERLPMPP---------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp -------------------------------CCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------------CCCCCCC---------CCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf -------------------------------9998987---------779999999999768797689299999999
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.99 Aligned_cols=256 Identities=22% Similarity=0.328 Sum_probs=199.1
Q ss_pred EECCCEEEEEEECCCCCCCEEEEEECC-----CCCEEEEEEEECC--HHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEE
Q ss_conf 323758999993258887539999887-----8937999996054--134675999999999960169999872258778
Q 005590 378 VIAGRYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYD 450 (689)
Q Consensus 378 ~i~~~Y~i~~~LG~G~fG~Vy~a~d~~-----tg~~vAIKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~ 450 (689)
+-.++|++.+.||+|+||.||+|.+.. +++.||+|+++.. ......+.+|..++..+.+ |++|+.+++
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~-----h~~iv~~~~ 84 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH-----HLNVVNLLG 84 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCC-----CTTBCCEEE
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-----CCEEEEEEE
T ss_conf 167997984498416783999999867775557839999998600171789999999999886149-----984997411
Q ss_pred EEEEC-CEEEEEEECCC-CCHHHHHHHHHCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCC
Q ss_conf 99847-84999997142-1438898632026----------997555988999999977999999998895303589995
Q 005590 451 YFYHL-EHLFIVCELLR-ANLYEFQKFNQES----------GGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPEN 518 (689)
Q Consensus 451 ~f~~~-~~l~lVmEy~~-g~L~~~~~~~~~~----------~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~N 518 (689)
++... ..+++||||+. |+|.+++...... .....+++..+..++.||+.||.|||+++|+||||||+|
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~N 164 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 164 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred EECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCC
T ss_conf 54047975799998458992999998536666653222023321468999999999999999998873797178677310
Q ss_pred EEEECCCCCEEEEEECCCCCCCCCC-----CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCCHH
Q ss_conf 7980257870999836884213688-----6422367654570323189999125699999999999939-999999839
Q 005590 519 ILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG-EVLFPNDAV 592 (689)
Q Consensus 519 ILi~~~~~~~ikL~DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG-~~PF~~~~~ 592 (689)
||++. ++.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||+++ .+||.+...
T Consensus 165 ILl~~--~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 165 ILLSE--KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp EEECG--GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred EEECC--CCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCH
T ss_conf 65779--9828984575200113566522247516672102036864688996632213678999998688999989998
Q ss_pred HHHHHHHHHHCCCCCHHHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf 99999998411998678873322354432001110000000010001477543011201479199999999813009899
Q 005590 593 VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 672 (689)
Q Consensus 593 ~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~k 672 (689)
.+.+..++.. .....+|. ..++.+.+||.+||+.||++
T Consensus 243 ~~~~~~~~~~---------------------------------~~~~~~~~---------~~~~~l~~li~~cl~~dP~~ 280 (299)
T d1ywna1 243 DEEFCRRLKE---------------------------------GTRMRAPD---------YTTPEMYQTMLDCWHGEPSQ 280 (299)
T ss_dssp SHHHHHHHHH---------------------------------TCCCCCCT---------TCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHHHHHC---------------------------------CCCCCCCC---------CCCHHHHHHHHHHCCCCHHH
T ss_conf 9999999963---------------------------------89888886---------57899999999976779667
Q ss_pred CCCHHHHHCC
Q ss_conf 9389999809
Q 005590 673 RPTAREALDH 682 (689)
Q Consensus 673 RpTa~elL~H 682 (689)
|||+.|+++|
T Consensus 281 Rpt~~eil~~ 290 (299)
T d1ywna1 281 RPTFSELVEH 290 (299)
T ss_dssp SCCHHHHHHH
T ss_pred CCCHHHHHHH
T ss_conf 9199999999
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=320.20 Aligned_cols=255 Identities=19% Similarity=0.243 Sum_probs=204.1
Q ss_pred CEECCCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEECC
Q ss_conf 13237589999932588875399998878937999996054134675999999999960169999872258778998478
Q 005590 377 TVIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 377 ~~i~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
+++.++|++.+.||+|+||+||+|+++.+++.||+|++..... ...+.+|+++++.+.+ ++|++.+++++....
T Consensus 1 ~vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~e~~~~~~l~~-----~~~i~~~~~~~~~~~ 74 (293)
T d1csna_ 1 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-APQLRDEYRTYKLLAG-----CTGIPNVYYFGQEGL 74 (293)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-SCCHHHHHHHHHHTTT-----CTTCCCEEEEEEETT
T ss_pred CCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCC-----CCCCCEEEEEEECCC
T ss_conf 9789806997998417882999999988997999999750258-2999999999999648-----999877999960188
Q ss_pred EEEEEEECCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECC---CCCEEEEEE
Q ss_conf 49999971421438898632026997555988999999977999999998895303589995798025---787099983
Q 005590 457 HLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSY---QRCEIKIID 533 (689)
Q Consensus 457 ~l~lVmEy~~g~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~---~~~~ikL~D 533 (689)
+.++||||++++|.+++...... ++...+..++.|++.||.|||+.||+||||||+|||++.. ..+.+||+|
T Consensus 75 ~~~~vme~~~~~l~~~~~~~~~~-----~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~D 149 (293)
T d1csna_ 75 HNVLVIDLLGPSLEDLLDLCGRK-----FSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVD 149 (293)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTC-----CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred CCEEEEEECCCCHHHHHHHHCCC-----HHHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCCCEEECC
T ss_conf 11799996488879999752031-----1068999999999999999997796626677131523475434479568723
Q ss_pred CCCCCCCCCC----------CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHH---HHHHHHHH
Q ss_conf 6884213688----------6422367654570323189999125699999999999939999999839---99999998
Q 005590 534 LGSSCFQTDN----------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPNDAV---VMILARII 600 (689)
Q Consensus 534 FGls~~~~~~----------~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG~~PF~~~~~---~~~l~~i~ 600 (689)
||+++..... ....+||+.|+|||++.+..++.++||||||+++|+|++|..||.+... .....++.
T Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~ 229 (293)
T d1csna_ 150 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229 (293)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred CCEEEECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
T ss_conf 66057714676654111024676277510267989648888869998983199999986987678853021999999997
Q ss_pred HHCCCCCHHHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHH
Q ss_conf 41199867887332235443200111000000001000147754301120147919999999981300989993899998
Q 005590 601 GMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREAL 680 (689)
Q Consensus 601 ~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL 680 (689)
...... .........++++.+++..|+..+|++||+.+.+.
T Consensus 230 ~~~~~~---------------------------------------~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 230 EKKQST---------------------------------------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HHHHHS---------------------------------------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred HCCCCC---------------------------------------CHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHH
T ss_conf 056799---------------------------------------95896579989999999998439930085999999
Q ss_pred C
Q ss_conf 0
Q 005590 681 D 681 (689)
Q Consensus 681 ~ 681 (689)
+
T Consensus 271 ~ 271 (293)
T d1csna_ 271 G 271 (293)
T ss_dssp H
T ss_pred H
T ss_conf 9
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=318.94 Aligned_cols=256 Identities=22% Similarity=0.333 Sum_probs=206.1
Q ss_pred CCEECCCEEEEEEECCCCCCCEEEEEECCCC-------CEEEEEEEECCH--HHHHHHHHHHHHHHHHCCCCCCCCCCEE
Q ss_conf 8132375899999325888753999988789-------379999960541--3467599999999996016999987225
Q 005590 376 NTVIAGRYYVTEYLGSAAFSKVFQAQDLHTG-------VDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHIL 446 (689)
Q Consensus 376 ~~~i~~~Y~i~~~LG~G~fG~Vy~a~d~~tg-------~~vAIKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv 446 (689)
+++-.++|++.+.||+|+||.||+|++..++ ..||+|+++.+. .....+.+|...+..+. .||||+
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~-----~HpnIv 82 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-----KHKNII 82 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHC-----CCTTBC
T ss_pred CCCCHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHC-----CCCEEE
T ss_conf 722589969700985167828999998578755566754999999881128688999999999999813-----999697
Q ss_pred EEEEEEEECCEEEEEEECCC-CCHHHHHHHHHC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCC
Q ss_conf 87789984784999997142-143889863202----------6997555988999999977999999998895303589
Q 005590 447 RLYDYFYHLEHLFIVCELLR-ANLYEFQKFNQE----------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLK 515 (689)
Q Consensus 447 ~l~~~f~~~~~l~lVmEy~~-g~L~~~~~~~~~----------~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIK 515 (689)
++++++...+..++||||+. |++.+++..... ......+++..+..++.||+.||.|||+.+|+|||||
T Consensus 83 ~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiK 162 (299)
T d1fgka_ 83 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 162 (299)
T ss_dssp CEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred ECCCCCCCCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEEC
T ss_conf 34652201886899997369990999998606776432223345743467999999999999999987663797863022
Q ss_pred CCCEEEECCCCCEEEEEECCCCCCCCCC-----CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCC
Q ss_conf 9957980257870999836884213688-----642236765457032318999912569999999999993-9999999
Q 005590 516 PENILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589 (689)
Q Consensus 516 p~NILi~~~~~~~ikL~DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~ellt-G~~PF~~ 589 (689)
|+|||++. ++.+||+|||++...... .....+++.|+|||++.+..|+.++||||+|+++|+|++ |.+||.+
T Consensus 163 p~NiLl~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~ 240 (299)
T d1fgka_ 163 ARNVLVTE--DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 240 (299)
T ss_dssp GGGEEECT--TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCCEEECC--CCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 10224547--8976762211101135555543146678884663266751798882555477588888740179898999
Q ss_pred CHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCC
Q ss_conf 83999999998411998678873322354432001110000000010001477543011201479199999999813009
Q 005590 590 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 669 (689)
Q Consensus 590 ~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~d 669 (689)
.+.......+... .....|. ..++.+.+||.+||+.|
T Consensus 241 ~~~~~~~~~i~~~----------------------------------~~~~~p~---------~~~~~l~~li~~cl~~d 277 (299)
T d1fgka_ 241 VPVEELFKLLKEG----------------------------------HRMDKPS---------NCTNELYMMMRDCWHAV 277 (299)
T ss_dssp CCHHHHHHHHHTT----------------------------------CCCCCCS---------SCCHHHHHHHHHHTCSS
T ss_pred CCHHHHHHHHHCC----------------------------------CCCCCCC---------CCHHHHHHHHHHHCCCC
T ss_conf 9999999999728----------------------------------8889874---------35299999999976679
Q ss_pred CCCCCCHHHHHC
Q ss_conf 899938999980
Q 005590 670 PQRRPTAREALD 681 (689)
Q Consensus 670 P~kRpTa~elL~ 681 (689)
|++|||+.|+++
T Consensus 278 P~~Rps~~eil~ 289 (299)
T d1fgka_ 278 PSQRPTFKQLVE 289 (299)
T ss_dssp GGGSCCHHHHHH
T ss_pred HHHCCCHHHHHH
T ss_conf 767939999999
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=320.95 Aligned_cols=252 Identities=21% Similarity=0.262 Sum_probs=203.0
Q ss_pred CCEEEEEEECCCCCCCEEEEEECCCCCE--EEEEEEECC--HHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEECC
Q ss_conf 7589999932588875399998878937--999996054--134675999999999960169999872258778998478
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVD--VCLKIIKND--KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE 456 (689)
Q Consensus 381 ~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~--vAIKii~~~--~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~ 456 (689)
++|++.+.||+|+||+||+|+++.++.. ||||.+... ......+.+|++++..+. .||||+++++++...+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-----~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-----HHPNIINLLGACEHRG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCC-----CCTTBCCEEEEEEETT
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-----CCCCEEEEEEEEECCC
T ss_conf 99688779820788289999998999699999999782338579999999999998622-----8998836788884187
Q ss_pred EEEEEEECCC-CCHHHHHHHHHC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCC
Q ss_conf 4999997142-143889863202----------69975559889999999779999999988953035899957980257
Q 005590 457 HLFIVCELLR-ANLYEFQKFNQE----------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQ 525 (689)
Q Consensus 457 ~l~lVmEy~~-g~L~~~~~~~~~----------~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~ 525 (689)
.+++||||+. |+|.+++..... ......+++..+..++.||+.||.|||+.+|+||||||+|||++.
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~-- 162 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE-- 162 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG--
T ss_pred EEEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECC--
T ss_conf 369999802898699998640355555123101234578999999999999999987663089545550520489868--
Q ss_pred CCEEEEEECCCCCCCCCCC--CCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCCHHHHHHHHHHHH
Q ss_conf 8709998368842136886--422367654570323189999125699999999999939-9999998399999999841
Q 005590 526 RCEIKIIDLGSSCFQTDNL--CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG-EVLFPNDAVVMILARIIGM 602 (689)
Q Consensus 526 ~~~ikL~DFGls~~~~~~~--~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG-~~PF~~~~~~~~l~~i~~~ 602 (689)
++.+||+|||+++...... ....+|+.|+|||.+.+..++.++||||+||++|||++| .+||.+.+..++...+..-
T Consensus 163 ~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242 (309)
T ss_dssp GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred CCCEEECCCCCCCCCCCCCCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHC
T ss_conf 87638743443224442234553013775555387526999962215313889999983689999999999999999826
Q ss_pred CCCCCHHHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 19986788733223544320011100000000100014775430112014791999999998130098999389999809
Q 005590 603 LGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 603 ~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~H 682 (689)
....+|. ..++.+.+||.+||+.||++|||+.++++|
T Consensus 243 ----------------------------------~~~~~~~---------~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 243 ----------------------------------YRLEKPL---------NCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp ----------------------------------CCCCCCT---------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------------CCCCCCC---------CCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf ----------------------------------8888876---------678999999999767896689499999999
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=319.20 Aligned_cols=252 Identities=20% Similarity=0.236 Sum_probs=203.6
Q ss_pred ECCCEEEEEEECCCCCCCEEEEEEC-----CCCCEEEEEEEECCH--HHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEE
Q ss_conf 2375899999325888753999988-----789379999960541--346759999999999601699998722587789
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDL-----HTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDY 451 (689)
Q Consensus 379 i~~~Y~i~~~LG~G~fG~Vy~a~d~-----~tg~~vAIKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~ 451 (689)
-.++|++.+.||+|+||+||+|+++ .+++.||||+++... .....+.+|+.+++.++ |+||++++++
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~------h~niv~~~~~ 84 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD------NPNIVKLLGV 84 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCC------CTTBCCEEEE
T ss_pred CHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCC------CCCCCCCEEE
T ss_conf 9889388679820788399999988876577882999999882108579999999999999668------9976552466
Q ss_pred EEECCEEEEEEECCC-CCHHHHHHHHHC------------------CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEEC
Q ss_conf 984784999997142-143889863202------------------6997555988999999977999999998895303
Q 005590 452 FYHLEHLFIVCELLR-ANLYEFQKFNQE------------------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHC 512 (689)
Q Consensus 452 f~~~~~l~lVmEy~~-g~L~~~~~~~~~------------------~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHr 512 (689)
+......++||||+. |+|.+++..... ......+++..+..++.|++.||.|||+.+|+||
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHr 164 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 164 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred ECCCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEEE
T ss_conf 60598038999815899299999852755421000011100121034678898999999999999998554135786854
Q ss_pred CCCCCCEEEECCCCCEEEEEECCCCCCCCCC-----CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHC-CCC
Q ss_conf 5899957980257870999836884213688-----6422367654570323189999125699999999999939-999
Q 005590 513 DLKPENILIKSYQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG-EVL 586 (689)
Q Consensus 513 DIKp~NILi~~~~~~~ikL~DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG-~~P 586 (689)
||||+|||++. ++.+||+|||+++..... .....+++.|+|||++.+..|+.++||||+||++|||++| .+|
T Consensus 165 DlKp~NILld~--~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 165 DLATRNCLVGE--NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CCSGGGEEECG--GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred EECCCCEEECC--CCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCC
T ss_conf 88401168989--9928983314421136776411157777676767989972688980563025236299998068999
Q ss_pred CCCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHC
Q ss_conf 99983999999998411998678873322354432001110000000010001477543011201479199999999813
Q 005590 587 FPNDAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLL 666 (689)
Q Consensus 587 F~~~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL 666 (689)
|.+.+..+.+..+.... ...+| ...++.+.+||.+||
T Consensus 243 ~~~~~~~e~~~~v~~~~----------------------------------~~~~p---------~~~~~~~~~li~~cl 279 (301)
T d1lufa_ 243 YYGMAHEEVIYYVRDGN----------------------------------ILACP---------ENCPLELYNLMRLCW 279 (301)
T ss_dssp TTTSCHHHHHHHHHTTC----------------------------------CCCCC---------TTCCHHHHHHHHHHT
T ss_pred CCCCCHHHHHHHHHCCC----------------------------------CCCCC---------CCCHHHHHHHHHHHC
T ss_conf 99989999999997399----------------------------------78887---------325299999999974
Q ss_pred CCCCCCCCCHHHHHC
Q ss_conf 009899938999980
Q 005590 667 EINPQRRPTAREALD 681 (689)
Q Consensus 667 ~~dP~kRpTa~elL~ 681 (689)
+.||++|||+.|+++
T Consensus 280 ~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 280 SKLPADRPSFCSIHR 294 (301)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred CCCHHHCCCHHHHHH
T ss_conf 889657939999999
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.29 Aligned_cols=247 Identities=20% Similarity=0.326 Sum_probs=203.6
Q ss_pred EECCCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEE-CC
Q ss_conf 32375899999325888753999988789379999960541346759999999999601699998722587789984-78
Q 005590 378 VIAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-LE 456 (689)
Q Consensus 378 ~i~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~-~~ 456 (689)
+-.++|++.+.||+|+||.||+|.+ .|..||+|+++.+.. .+.+.+|+.+++.+ .||||+++++++.. .+
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~-~~~~~~E~~~l~~l------~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDAT-AQAFLAEASVMTQL------RHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC---HHHHHTHHHHTTC------CCTTBCCEEEEECCC--
T ss_pred CCHHHEEEEEEEECCCCEEEEEEEE--CCEEEEEEEECCHHH-HHHHHHHHHHHHHC------CCCCEEEEEEEEEECCC
T ss_conf 5789948857982079808999999--990999999885777-99999999999867------89898549878872389
Q ss_pred EEEEEEECCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEECC
Q ss_conf 4999997142-143889863202699755598899999997799999999889530358999579802578709998368
Q 005590 457 HLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLG 535 (689)
Q Consensus 457 ~l~lVmEy~~-g~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~DFG 535 (689)
.+++||||+. |+|.+++...... .+++..+..++.||+.||.|||+.+|+||||||+|||++. ++.+||+|||
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~----~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~--~~~~kl~dfg 148 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE--DNVAKVSDFG 148 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHH----HCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT--TSCEEECCCC
T ss_pred CEEEEEECCCCCCHHHHHHHCCCC----CCCHHHHHHHHHHHHHHCCCCCCCCEECCCCCHHHHEECC--CCCEEECCCC
T ss_conf 289999636999899998745788----8899999999999985232113376553666567601468--9977632456
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCHHHHHHHHHHHHCCCCCHHHHHHH
Q ss_conf 84213688642236765457032318999912569999999999993-99999998399999999841199867887332
Q 005590 536 SSCFQTDNLCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLGPIDLEMLMQG 614 (689)
Q Consensus 536 ls~~~~~~~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~~~e~~~~~ 614 (689)
++...........+++.|+|||++.+..++.++||||+|+++|||++ |.+||...+..+....+..
T Consensus 149 ~s~~~~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~------------- 215 (262)
T d1byga_ 149 LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------- 215 (262)
T ss_dssp C------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-------------
T ss_pred CCEECCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-------------
T ss_conf 0034478776556664677817872798885887775799999999789999999999999999980-------------
Q ss_pred HHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 23544320011100000000100014775430112014791999999998130098999389999809
Q 005590 615 QEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~H 682 (689)
.....+|. ..++.+.+||.+||+.||.+|||+.+++++
T Consensus 216 ---------------------~~~~~~~~---------~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 216 ---------------------GYKMDAPD---------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ---------------------TCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCCCCCC---------CCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf ---------------------89999976---------579999999999756697689399999999
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=316.68 Aligned_cols=246 Identities=25% Similarity=0.306 Sum_probs=198.9
Q ss_pred CCCEEEEEEECCCCCCCEEEEEECC-CC--CEEEEEEEECC----HHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEE
Q ss_conf 3758999993258887539999887-89--37999996054----13467599999999996016999987225877899
Q 005590 380 AGRYYVTEYLGSAAFSKVFQAQDLH-TG--VDVCLKIIKND----KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYF 452 (689)
Q Consensus 380 ~~~Y~i~~~LG~G~fG~Vy~a~d~~-tg--~~vAIKii~~~----~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f 452 (689)
.++|++.+.||+|+||.||+|+... ++ ..||+|++..+ ......+.+|+.+++.++ ||||+++++++
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~------H~nIv~~~g~~ 80 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD------HRNLIRLYGVV 80 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC------CTTBCCEEEEE
T ss_pred HHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCC------CCCEEEEEEEE
T ss_conf 489199789803888399999998899907999999998355579899999999999998689------99987898777
Q ss_pred EECCEEEEEEECCC-CCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEE
Q ss_conf 84784999997142-14388986320269975559889999999779999999988953035899957980257870999
Q 005590 453 YHLEHLFIVCELLR-ANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKI 531 (689)
Q Consensus 453 ~~~~~l~lVmEy~~-g~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL 531 (689)
.+ ...++||||+. +++.+.+...... +++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||
T Consensus 81 ~~-~~~~lv~e~~~~~~l~~~~~~~~~~-----l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~--~~~vkl 152 (273)
T d1u46a_ 81 LT-PPMKMVTELAPLGSLLDRLRKHQGH-----FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT--RDLVKI 152 (273)
T ss_dssp CS-SSCEEEEECCTTCBHHHHHHHHGGG-----SCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE--TTEEEE
T ss_pred EE-CCHHEEEEEECCCCHHHHHHCCCCC-----CCHHHHHHHHHHHHHHHHHHHHCCEEEEEECHHHHCCCC--CCCEEE
T ss_conf 40-1001146542386125444212689-----999999999999999998752178752056688815655--654332
Q ss_pred EECCCCCCCCCCC------CCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCHHHHHHHHHHHHCC
Q ss_conf 8368842136886------42236765457032318999912569999999999993-9999999839999999984119
Q 005590 532 IDLGSSCFQTDNL------CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPNDAVVMILARIIGMLG 604 (689)
Q Consensus 532 ~DFGls~~~~~~~------~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~ellt-G~~PF~~~~~~~~l~~i~~~~g 604 (689)
+|||++....... ....++..|+|||++.+..++.++||||+|+++|||++ |.+||.+.+..+.+..+....
T Consensus 153 ~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~- 231 (273)
T d1u46a_ 153 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG- 231 (273)
T ss_dssp CCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC-
T ss_pred CCCHHHHHCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC-
T ss_conf 5611555303588752654763257310799998379999421566148999999968999999969999999998479-
Q ss_pred CCCHHHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 98678873322354432001110000000010001477543011201479199999999813009899938999980
Q 005590 605 PIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALD 681 (689)
Q Consensus 605 ~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~ 681 (689)
.....+ ...+..+.+||.+||..||++|||+.++++
T Consensus 232 --------------------------------~~~~~~---------~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 232 --------------------------------ERLPRP---------EDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp --------------------------------CCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------------CCCCCC---------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf --------------------------------999985---------445399999999976889667929999999
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=313.66 Aligned_cols=257 Identities=24% Similarity=0.341 Sum_probs=204.3
Q ss_pred CCEECCCEEEEEEECCCCCCCEEEEEE-----CCCCCEEEEEEEECCH--HHHHHHHHHHHHHHHHCCCCCCCCCCEEEE
Q ss_conf 813237589999932588875399998-----8789379999960541--346759999999999601699998722587
Q 005590 376 NTVIAGRYYVTEYLGSAAFSKVFQAQD-----LHTGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRL 448 (689)
Q Consensus 376 ~~~i~~~Y~i~~~LG~G~fG~Vy~a~d-----~~tg~~vAIKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l 448 (689)
+++-.++|++.++||+|+||.||+|++ ..+++.||+|+++... .....+.+|+.++..+. +||||+++
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~-----~HpnIv~~ 92 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG-----NHMNIVNL 92 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCE
T ss_pred CCCCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-----CCCCEEEE
T ss_conf 6377899698549820688299999980664477886999999874248779999999999987626-----99988789
Q ss_pred EEEEEECCEEEEEEECCCC-CHHHHHHHHHC------------CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCC
Q ss_conf 7899847849999971421-43889863202------------6997555988999999977999999998895303589
Q 005590 449 YDYFYHLEHLFIVCELLRA-NLYEFQKFNQE------------SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLK 515 (689)
Q Consensus 449 ~~~f~~~~~l~lVmEy~~g-~L~~~~~~~~~------------~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIK 515 (689)
++++......++||||+.+ ++.+++..... ......+++..+..++.||+.||.|||+++++|||||
T Consensus 93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLK 172 (311)
T d1t46a_ 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 172 (311)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEEECCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCC
T ss_conf 98983199789999737998799999853566544444533222334588999999999999999998875792666241
Q ss_pred CCCEEEECCCCCEEEEEECCCCCCCCCCC-----CCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCC
Q ss_conf 99579802578709998368842136886-----42236765457032318999912569999999999993-9999999
Q 005590 516 PENILIKSYQRCEIKIIDLGSSCFQTDNL-----CLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWT-GEVLFPN 589 (689)
Q Consensus 516 p~NILi~~~~~~~ikL~DFGls~~~~~~~-----~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~ellt-G~~PF~~ 589 (689)
|+||+++. .+.+||+|||.++...... ....||+.|+|||++.+..++.++|||||||++|+|++ |.+||..
T Consensus 173 p~NIl~~~--~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~ 250 (311)
T d1t46a_ 173 ARNILLTH--GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (311)
T ss_dssp GGGEEEET--TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred CCCCCCCC--CCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC
T ss_conf 02100002--5752102340102336788615862013596876778861799997400102589999998589988778
Q ss_pred CHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCC
Q ss_conf 83999999998411998678873322354432001110000000010001477543011201479199999999813009
Q 005590 590 DAVVMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEIN 669 (689)
Q Consensus 590 ~~~~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~d 669 (689)
.+..+.+.+++.. ......|. ..+..+.+||.+||+.|
T Consensus 251 ~~~~~~~~~~i~~---------------------------------~~~~~~~~---------~~~~~l~~Li~~cl~~d 288 (311)
T d1t46a_ 251 MPVDSKFYKMIKE---------------------------------GFRMLSPE---------HAPAEMYDIMKTCWDAD 288 (311)
T ss_dssp CCSSHHHHHHHHH---------------------------------TCCCCCCT---------TSCHHHHHHHHHHTCSS
T ss_pred CCHHHHHHHHHHC---------------------------------CCCCCCCC---------CCCHHHHHHHHHHCCCC
T ss_conf 9989999999866---------------------------------89889854---------36599999999975779
Q ss_pred CCCCCCHHHHHC
Q ss_conf 899938999980
Q 005590 670 PQRRPTAREALD 681 (689)
Q Consensus 670 P~kRpTa~elL~ 681 (689)
|++|||+.++|+
T Consensus 289 P~~RPs~~~il~ 300 (311)
T d1t46a_ 289 PLKRPTFKQIVQ 300 (311)
T ss_dssp GGGSCCHHHHHH
T ss_pred HHHCCCHHHHHH
T ss_conf 657929999999
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=317.42 Aligned_cols=261 Identities=18% Similarity=0.261 Sum_probs=207.3
Q ss_pred CCEECCCEEEEEEECCCCCCCEEEEEECC-----CCCEEEEEEEECCH--HHHHHHHHHHHHHHHHCCCCCCCCCCEEEE
Q ss_conf 81323758999993258887539999887-----89379999960541--346759999999999601699998722587
Q 005590 376 NTVIAGRYYVTEYLGSAAFSKVFQAQDLH-----TGVDVCLKIIKNDK--DFFDQSLDEIKLLKLVNKNDPADEHHILRL 448 (689)
Q Consensus 376 ~~~i~~~Y~i~~~LG~G~fG~Vy~a~d~~-----tg~~vAIKii~~~~--~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l 448 (689)
+++..++|++.+.||+|+||+||+|.+.. ++..||||+++... .....+.+|+.+++.+ .|+||+++
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l------~h~nIv~~ 88 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF------NCHHVVRL 88 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC------CCTTBCCE
T ss_pred EEECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHC------CCCCEEEE
T ss_conf 042689918835982078818999998786447789689999987012868999999999999976------99988412
Q ss_pred EEEEEECCEEEEEEECCC-CCHHHHHHHHHC----CCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEEC
Q ss_conf 789984784999997142-143889863202----699755598899999997799999999889530358999579802
Q 005590 449 YDYFYHLEHLFIVCELLR-ANLYEFQKFNQE----SGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 523 (689)
Q Consensus 449 ~~~f~~~~~l~lVmEy~~-g~L~~~~~~~~~----~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~ 523 (689)
++++......++||||+. |++.+++..... ......++...+..++.|++.||.|||+.+|+||||||+|||++.
T Consensus 89 ~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~ 168 (308)
T d1p4oa_ 89 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 168 (308)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECT
T ss_pred EEEEECCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECEECCCCEEECC
T ss_conf 54784288106777604899889998750332113444688799999999999999999876479654328677540359
Q ss_pred CCCCEEEEEECCCCCCCCCC-----CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCCHHHHHHH
Q ss_conf 57870999836884213688-----6422367654570323189999125699999999999939-99999983999999
Q 005590 524 YQRCEIKIIDLGSSCFQTDN-----LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTG-EVLFPNDAVVMILA 597 (689)
Q Consensus 524 ~~~~~ikL~DFGls~~~~~~-----~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG-~~PF~~~~~~~~l~ 597 (689)
++.+||+|||++...... .....+++.|+|||.+.+..++.++||||+|+++|||++| .+||.+.+..+.+.
T Consensus 169 --~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~ 246 (308)
T d1p4oa_ 169 --DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 246 (308)
T ss_dssp --TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred --CCEEEEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHH
T ss_conf --964999424542023577630313402316323788887369988333444378999999968999999989999999
Q ss_pred HHHHHCCCCCHHHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHH
Q ss_conf 99841199867887332235443200111000000001000147754301120147919999999981300989993899
Q 005590 598 RIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAR 677 (689)
Q Consensus 598 ~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~ 677 (689)
.+.... ...+|. ..++.+.+||.+||+.||++|||+.
T Consensus 247 ~i~~~~----------------------------------~~~~p~---------~~~~~l~~li~~cl~~~P~~RPs~~ 283 (308)
T d1p4oa_ 247 FVMEGG----------------------------------LLDKPD---------NCPDMLFELMRMCWQYNPKMRPSFL 283 (308)
T ss_dssp HHHTTC----------------------------------CCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHCC----------------------------------CCCCCC---------CCHHHHHHHHHHHCCCCHHHCCCHH
T ss_conf 998088----------------------------------888863---------3539999999997577965893999
Q ss_pred HHHC------CCCCCC
Q ss_conf 9980------989888
Q 005590 678 EALD------HPWLQH 687 (689)
Q Consensus 678 elL~------Hpwf~~ 687 (689)
++++ +|+|++
T Consensus 284 ~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 284 EIISSIKEEMEPGFRE 299 (308)
T ss_dssp HHHHHHGGGSCTTHHH
T ss_pred HHHHHHHHHCCCCCCC
T ss_conf 9999978761778757
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-45 Score=305.58 Aligned_cols=243 Identities=19% Similarity=0.254 Sum_probs=189.4
Q ss_pred EEEEEECCCCCCCEEEEEECCCC---CEEEEEEEEC--CHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEE-CCE
Q ss_conf 99999325888753999988789---3799999605--41346759999999999601699998722587789984-784
Q 005590 384 YVTEYLGSAAFSKVFQAQDLHTG---VDVCLKIIKN--DKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH-LEH 457 (689)
Q Consensus 384 ~i~~~LG~G~fG~Vy~a~d~~tg---~~vAIKii~~--~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~-~~~ 457 (689)
...++||+|+||+||+|.+..++ ..||||+++. +......+.+|++++..++ ||||+++++++.. ...
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~------HpnIv~~~g~~~~~~~~ 103 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS------HPNVLSLLGICLRSEGS 103 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCC------CTTBCCCCEEEEETTTE
T ss_pred CCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC------CCCEEEEEEEEEECCCC
T ss_conf 266698136880999999977998799999999884369789999999999998678------99986786789806994
Q ss_pred EEEEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCEEEEEECCC
Q ss_conf 9999971421-438898632026997555988999999977999999998895303589995798025787099983688
Q 005590 458 LFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKSYQRCEIKIIDLGS 536 (689)
Q Consensus 458 l~lVmEy~~g-~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~~~~~~ikL~DFGl 536 (689)
.++||||+.+ ++.+++..... .+++..+..++.|++.||.|||+.+|+||||||+|||++. ++.+||+|||+
T Consensus 104 ~~lv~E~~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~--~~~~kL~DFG~ 176 (311)
T d1r0pa_ 104 PLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE--KFTVKVADFGL 176 (311)
T ss_dssp EEEEEECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT--TCCEEECSSGG
T ss_pred EEEEEEEEECCCHHHHHCCCCC-----CCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHEEECC--CCCEEEECCCC
T ss_conf 3899987406741442101345-----4048999999999887652003367625776687576779--99889910652
Q ss_pred CCCCCCC-------CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC-HHHHHHHHHHHHCCCCCH
Q ss_conf 4213688-------64223676545703231899991256999999999999399999998-399999999841199867
Q 005590 537 SCFQTDN-------LCLYVQSRSYRAPEVIIGLPYDQKIDLWSLGCILAELWTGEVLFPND-AVVMILARIIGMLGPIDL 608 (689)
Q Consensus 537 s~~~~~~-------~~~~~gt~~y~APE~l~~~~~s~~sDIwSLGviL~elltG~~PF~~~-~~~~~l~~i~~~~g~~~~ 608 (689)
++..... .....||+.|+|||.+....++.++||||+|+++|||++|..||... +..+....+..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~------- 249 (311)
T d1r0pa_ 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------- 249 (311)
T ss_dssp GCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT-------
T ss_pred HHHCCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-------
T ss_conf 3225566555310025655564556768874379997457466199999999789999888999999999980-------
Q ss_pred HHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 88733223544320011100000000100014775430112014791999999998130098999389999809
Q 005590 609 EMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQRRPTAREALDH 682 (689)
Q Consensus 609 e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~kRpTa~elL~H 682 (689)
......|. ..+..+.+||.+||+.||++|||+.|+++|
T Consensus 250 ---------------------------g~~~~~p~---------~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 250 ---------------------------GRRLLQPE---------YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp ---------------------------TCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------CCCCCCCC---------CCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf ---------------------------89889964---------475999999999768897689399999999
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-45 Score=306.87 Aligned_cols=265 Identities=20% Similarity=0.196 Sum_probs=185.9
Q ss_pred ECCCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEECC--
Q ss_conf 237589999932588875399998878937999996054134675999999999960169999872258778998478--
Q 005590 379 IAGRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLE-- 456 (689)
Q Consensus 379 i~~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~-- 456 (689)
++.+|.+.+.||+|+||.||+|++ +|+.||||++..+.. ....+|.+++ ......||||+++++++...+
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~--~~~~~e~ei~----~~~~~~HpnIv~~~~~~~~~~~~ 72 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIY----QTVMLRHENILGFIAADNKDNGT 72 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHH----TSTTCCCTTBCCEEEEEEEECSS
T ss_pred CCCEEEEEEEEEECCCEEEEEEEE--CCEEEEEEEECCCCH--HHHHHHHHHH----HHHHCCCCCCCCEEEEEEECCCC
T ss_conf 986899988982078819999999--998999999872004--6799999999----99627998683268899837986
Q ss_pred --EEEEEEECCCC-CHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCEECCCCCCCEEEECCC
Q ss_conf --49999971421-438898632026997555988999999977999999998--------8953035899957980257
Q 005590 457 --HLFIVCELLRA-NLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHS--------LGIIHCDLKPENILIKSYQ 525 (689)
Q Consensus 457 --~l~lVmEy~~g-~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~--------~gIvHrDIKp~NILi~~~~ 525 (689)
.+++||||+.+ +|.+++... .+++..+..++.|++.||.|||. ++|+||||||+|||++.
T Consensus 73 ~~~~~lv~Ey~~~g~L~~~l~~~-------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~-- 143 (303)
T d1vjya_ 73 WTQLWLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-- 143 (303)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECT--
T ss_pred CEEEEEEEECCCCCCHHHHHHCC-------CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECC--
T ss_conf 04899999646698989998658-------999899999999999999998876652046898661531731357868--
Q ss_pred CCEEEEEECCCCCCCCCC-------CCCCCCCCCCCCHHHHCCCC------CCCHHHHHHHHHHHHHHHHCCCCCCCCHH
Q ss_conf 870999836884213688-------64223676545703231899------99125699999999999939999999839
Q 005590 526 RCEIKIIDLGSSCFQTDN-------LCLYVQSRSYRAPEVIIGLP------YDQKIDLWSLGCILAELWTGEVLFPNDAV 592 (689)
Q Consensus 526 ~~~ikL~DFGls~~~~~~-------~~~~~gt~~y~APE~l~~~~------~s~~sDIwSLGviL~elltG~~PF~~~~~ 592 (689)
++.+||+|||++...... .....||+.|+|||++.+.. ++.++||||+||++|||++|..||.....
T Consensus 144 ~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~ 223 (303)
T d1vjya_ 144 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223 (303)
T ss_dssp TSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCC
T ss_pred CCCEEEEECCCCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 87768876386623467776200135525035476782210565454677767501220159999999628998876631
Q ss_pred HHHHHHHHHHCCCCCHHHHHHHHHHHHHHHCCCCCHHHHHCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf 99999998411998678873322354432001110000000010001477543011201479199999999813009899
Q 005590 593 VMILARIIGMLGPIDLEMLMQGQEIYKYFTKEYDLYYINEETNQLEYIIPEESSLEHHLQFSDAFFIDFVRTLLEINPQR 672 (689)
Q Consensus 593 ~~~l~~i~~~~g~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~sl~~~~~~~~~~l~dLI~~mL~~dP~k 672 (689)
....... ........... ... ......+..+|...... .....+.+|+.+||+.||++
T Consensus 224 ~~~~~~~-~~~~~~~~~~~------~~~-----------~~~~~~~p~~~~~~~~~----~~~~~l~~li~~cl~~dp~~ 281 (303)
T d1vjya_ 224 YQLPYYD-LVPSDPSVEEM------RKV-----------VCEQKLRPNIPNRWQSC----EALRVMAKIMRECWYANGAA 281 (303)
T ss_dssp CCCTTTT-TSCSSCCHHHH------HHH-----------HTTSCCCCCCCGGGGGC----HHHHHHHHHHHTTCCSSGGG
T ss_pred CCCCHHH-CCCCCCHHHHH------HHH-----------HHCCCCCCCCCCCCCCH----HHHHHHHHHHHHHCCCCHHH
T ss_conf 1241012-25564309999------998-----------75024688877655776----89999999999976069858
Q ss_pred CCCHHHHHCC
Q ss_conf 9389999809
Q 005590 673 RPTAREALDH 682 (689)
Q Consensus 673 RpTa~elL~H 682 (689)
|||+.|++++
T Consensus 282 Rps~~ei~~~ 291 (303)
T d1vjya_ 282 RLTALRIKKT 291 (303)
T ss_dssp SCCHHHHHHH
T ss_pred CCCHHHHHHH
T ss_conf 9599999999
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=9.4e-23 Score=162.36 Aligned_cols=164 Identities=18% Similarity=0.171 Sum_probs=113.5
Q ss_pred EEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCHH-------------------HHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 8999993258887539999887893799999605413-------------------467599999999996016999987
Q 005590 383 YYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKD-------------------FFDQSLDEIKLLKLVNKNDPADEH 443 (689)
Q Consensus 383 Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~~-------------------~~~~~~~Ei~iL~~l~~~~~~~h~ 443 (689)
+.+.++||+|+||.||+|.+ .+|+.||+|+++.... ......+|...+..+. +.
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------~~ 74 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ------GL 74 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT------TS
T ss_pred CHHCCEEEECCCEEEEEEEC-CCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCC------CC
T ss_conf 02277802485659999997-999999999986044346665565630008889999997789999999816------99
Q ss_pred CEEEEEEEEEECCEEEEEEECCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEEC
Q ss_conf 22587789984784999997142143889863202699755598899999997799999999889530358999579802
Q 005590 444 HILRLYDYFYHLEHLFIVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLHSLGIIHCDLKPENILIKS 523 (689)
Q Consensus 444 ~Iv~l~~~f~~~~~l~lVmEy~~g~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH~~gIvHrDIKp~NILi~~ 523 (689)
+++..+++. ..+++|||+++..... ++...+..++.|++.+|.+||+.||+||||||+|||++.
T Consensus 75 ~v~~~~~~~----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~ 138 (191)
T d1zara2 75 AVPKVYAWE----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE 138 (191)
T ss_dssp SSCCEEEEE----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET
T ss_pred CCCEEEEEC----CCEEEEEEECCCCCCC------------HHHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHEEEEC
T ss_conf 914499862----8889999504565420------------015789999999999999982688898368903611428
Q ss_pred CCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCHH-----HHCCCCCCCHHHHHHHHHHH
Q ss_conf 5787099983688421368864223676545703-----23189999125699999999
Q 005590 524 YQRCEIKIIDLGSSCFQTDNLCLYVQSRSYRAPE-----VIIGLPYDQKIDLWSLGCIL 577 (689)
Q Consensus 524 ~~~~~ikL~DFGls~~~~~~~~~~~gt~~y~APE-----~l~~~~~s~~sDIwSLGviL 577 (689)
..++|+|||.+.....+... .|.... .+..+.|+..+|+||+.--+
T Consensus 139 ---~~~~liDFG~a~~~~~~~~~-----~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 139 ---EGIWIIDFPQSVEVGEEGWR-----EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ---TEEEECCCTTCEETTSTTHH-----HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred ---CCEEEEECCCCCCCCCCCCH-----HHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
T ss_conf ---98999877884308998709-----9998779999999757899844689999987
|
| >d1a25a_ b.7.1.2 (A:) C2 domain from protein kinase c (beta) {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: C2 domain from protein kinase c (beta) species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.69 E-value=4.3e-18 Score=132.09 Aligned_cols=106 Identities=20% Similarity=0.259 Sum_probs=92.7
Q ss_pred CCCCEEEEEECC-CCCCCCCCCCCCCCEEEECCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 563049988226-9731278788996225430789998520231001357896210132236556557666433452235
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 309 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~~~~L~~~V~D 309 (689)
..+.|+|.|.+| ||+++|.+|.+||||+++|+++..+..+.+|+++++|+||+|||+|.|. +.....+..|.+.|||
T Consensus 13 ~~~~L~V~V~~a~~L~~~d~~g~~DpYv~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~f~--v~~~~~~~~L~i~V~d 90 (132)
T d1a25a_ 13 DREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKCSLNPEWNETFRFQ--LKESDKDRRLSVEIWD 90 (132)
T ss_dssp SSSEEEEEEEEEESCCCCSTTSCCCEEEEEEEESCTTCSSCEECCCCSSCSSCEEEEEEEEE--CCSGGGGCEEEEEEEE
T ss_pred CCCEEEEEEEEEECCCCCCCCCCCCEEEEEEECCCCCCCCCCEEEEECCCCCCCCCEEEEEE--EECCCCCCEEEEEEEE
T ss_conf 49999999985549988789989690899998267888664088416588998455499999--5764569787699780
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 88778885345323563320112677863
Q 005590 310 NSDTRDGEVNGALHEGKADAEEHGVATPD 338 (689)
Q Consensus 310 ~d~~~~~~~~G~v~~~~~~~~~e~~~~~~ 338 (689)
+|.+++++++|.+.+....+.......|.
T Consensus 91 ~d~~~~d~~iG~~~i~l~~l~~~~~~~W~ 119 (132)
T d1a25a_ 91 WDLTSRNDFMGSLSFGISELQKAGVDGWF 119 (132)
T ss_dssp CCSSSCCEEEEEEEEEHHHHTTCCEEEEE
T ss_pred CCCCCCCCEEEEEEEEHHHCCCCCCCEEE
T ss_conf 67788896769999968994888788289
|
| >d1dqva2 b.7.1.2 (A:425-569) Synaptotagmin III {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptotagmin III species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.63 E-value=1.1e-16 Score=122.92 Aligned_cols=105 Identities=17% Similarity=0.098 Sum_probs=92.4
Q ss_pred CCCCEEEEEECC-CCCCCCCCCCCCCCEEEECCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCC
Q ss_conf 563049988226-973127878899622543078999852023100135789621013223655655766-643345223
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 308 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V~ 308 (689)
.++.|+|.|++| ||++++.+|.+||||++.|+++.++.++++|+++++|+||.|||+|.|. ++.+.+ ..+|.+.||
T Consensus 18 ~~~~L~V~V~~a~nL~~~~~~~~~dpyv~v~l~~~~~~~~~~kT~~~~~t~~P~wne~f~F~--v~~~~~~~~~l~v~v~ 95 (145)
T d1dqva2 18 TAGLLTVTIIKASNLKAMDLTGFSDPYVKASLISEGRRLKKRKTSIKKNTLNPTYNEALVFD--VAPESVENVGLSIAVV 95 (145)
T ss_dssp TTTEEEEEEEEEESCCCCSSSSCCCEEEEECCCTTCCTTSCEECCCCCSCSSCEEEECCCCC--CCSGGGGSCCCCCEEE
T ss_pred CCCEEEEEEEEEECCCCCCCCCCCCCEEEEEECCCCCCCEEECCEEEECCCCCEECCEEEEE--EEHHHCCCCEEEEEEE
T ss_conf 99999999999867987378999584099999067766356067899488774033069999--8411368778999997
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 58877888534532356332011267786
Q 005590 309 DNSDTRDGEVNGALHEGKADAEEHGVATP 337 (689)
Q Consensus 309 D~d~~~~~~~~G~v~~~~~~~~~e~~~~~ 337 (689)
|++.+++++++|.+.++......++...|
T Consensus 96 d~~~~~~~~~iG~~~i~l~~~~~~~~~~W 124 (145)
T d1dqva2 96 DYDCIGHNEVIGVCRVGPEAADPHGREHW 124 (145)
T ss_dssp ECCSSSCCEEEEECCCSSCTTCHHHHHHH
T ss_pred ECCCCCCCCEEEEEEECCHHCCCHHHHHH
T ss_conf 56999889679999988167195356779
|
| >d1dqva1 b.7.1.2 (A:295-424) Synaptotagmin III {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptotagmin III species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.63 E-value=3.3e-16 Score=119.93 Aligned_cols=92 Identities=15% Similarity=0.078 Sum_probs=82.4
Q ss_pred CCCCEEEEEECC-CCCCCCCCCCCCCCEEEECCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCC
Q ss_conf 563049988226-973127878899622543078999852023100135789621013223655655766-643345223
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 308 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V~ 308 (689)
....|+|.|++| ||++++.+|.+||||++.++++.++ +++|+++++|+||.|||+|.|. ++...+ +.+|.++||
T Consensus 16 ~~~~L~V~V~~a~~L~~~~~~g~~dpyv~v~l~~~~~~--~~kT~v~~~t~~P~wne~f~f~--v~~~~~~~~~L~v~V~ 91 (130)
T d1dqva1 16 GSDQLVVRILQALDLPAKDSNGFSDPYVKIYLLPDRKK--KFQTKVHRKTLNPIFNETFQFS--VPLAELAQRKLHFSVY 91 (130)
T ss_dssp SSCEEEEEEEEEECCCCCSTTSCCCEEEEEECTTSTTS--CEECCCCCSCSSCEEEEEEEEE--CCGGGGSSCCCEEEEE
T ss_pred CCCEEEEEEEEEECCCCCCCCCCCCEEEEEEECCCCCC--EEECEEECCCCCEEEEEEEEEE--ECHHHCCCCEEEEEEE
T ss_conf 99999999986048964168997566789997167875--1866047687770652678898--8457718986999998
Q ss_pred CCCCCCCCCCCCCCCCCC
Q ss_conf 588778885345323563
Q 005590 309 DNSDTRDGEVNGALHEGK 326 (689)
Q Consensus 309 D~d~~~~~~~~G~v~~~~ 326 (689)
|++.+++++++|++.+..
T Consensus 92 d~~~~~~d~~iG~~~i~~ 109 (130)
T d1dqva1 92 DFDRFSRHDLIGQVVLDN 109 (130)
T ss_dssp ECCSSSCCCEEEEEECCC
T ss_pred ECCCCCCCCEEEEEEECC
T ss_conf 768899986689999876
|
| >d2bwqa1 b.7.1.2 (A:729-853) Regulating synaptic membrane exocytosis protein, rim2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Regulating synaptic membrane exocytosis protein, rim2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=1.5e-16 Score=122.12 Aligned_cols=106 Identities=15% Similarity=0.088 Sum_probs=90.0
Q ss_pred CCCCEEEEEECC-CCCCCCCCCCCCCCEEEECCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCC
Q ss_conf 563049988226-973127878899622543078999852023100135789621013223655655766-643345223
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 308 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V~ 308 (689)
...+|+|.|.+| ||++++.+|.+|||||+.|+|+..+..+++|+++++|+||.|||+|.|.. ++...+ +++|.++||
T Consensus 12 ~~~~L~V~V~~a~~L~~~~~~~~~dpyVkv~l~~~~~~~~~~kT~~~~~t~~P~wne~f~f~~-~~~~~l~~~~L~i~v~ 90 (125)
T d2bwqa1 12 VGHQLIVTILGAKDLPSREDGRPRNPYVKIYFLPDRSDKNKRRTKTVKKTLEPKWNQTFIYSP-VHRREFRERMLEITLW 90 (125)
T ss_dssp TTTEEEEEEEEEESCCCCTTSCCBCEEEEEEEESSCSGGGEEECCCCSSBSSCEEEEEEEECS-CCGGGGGGCEEEEEEE
T ss_pred CCCEEEEEEEEEECCCCCCCCCCCCEEEEEEEECCCCCCCCCCCCEECCCCCCEECCEEEEEE-ECHHHCCCCEEEEEEE
T ss_conf 999999999982799886799998978999996778886412167786899989853999960-3866628887999999
Q ss_pred CCCCCC--CCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 588778--88534532356332011267786
Q 005590 309 DNSDTR--DGEVNGALHEGKADAEEHGVATP 337 (689)
Q Consensus 309 D~d~~~--~~~~~G~v~~~~~~~~~e~~~~~ 337 (689)
|.+.++ +++++|++.++..++..+....|
T Consensus 91 d~~~~~~~~~~~iG~~~i~l~~~~~~~~~~W 121 (125)
T d2bwqa1 91 DQARVREEESEFLGEILIELETALLDDEPHW 121 (125)
T ss_dssp EC-------CEEEEEEEEEGGGCCCSSCEEE
T ss_pred ECCCCCCCCCEEEEEEEEECHHCCCCCCCEE
T ss_conf 8888889999069999998055088999998
|
| >d1w15a_ b.7.1.2 (A:) Synaptotagmin IV {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptotagmin IV species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.59 E-value=2.1e-16 Score=121.19 Aligned_cols=96 Identities=15% Similarity=0.041 Sum_probs=87.7
Q ss_pred CCCCEEEEEECC-CCCCCCCCCCCCCCEEEECCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCC
Q ss_conf 563049988226-973127878899622543078999852023100135789621013223655655766-643345223
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 308 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V~ 308 (689)
.++.|.|.|++| ||+++|.+|.+|||||+.|+|+.++..++||++++++.||.|||+|.|. ++...+ +.+|.+.||
T Consensus 13 ~~~~L~V~v~~a~~L~~~~~~~~~dpyvkv~l~~~~~~~~~~kT~~~~~t~~P~wne~f~F~--v~~~~~~~~~l~i~v~ 90 (138)
T d1w15a_ 13 TTNTLTVVVLKARHLPKSDVSGLSDPYVKVNLYHAKKRISKKKTHVKKCTPNAVFNELFVFD--IPCESLEEISVEFLVL 90 (138)
T ss_dssp TTTEEEEEEEEEESCC------CCCEEEEEEEEETTEEEEEEECCCCCSCSSEEEEEEEEEE--CCSSSSTTEEEEEEEE
T ss_pred CCCEEEEEEEEEECCCCCCCCCCCCEEEEEEEECCCCCCCCCCCEEECCCCCCEECCEEEEE--ECHHHHCCCEEEEEEE
T ss_conf 89999999999688999888998578999999577426764355318899997377479998--2379927558999998
Q ss_pred CCCCCCCCCCCCCCCCCCCC
Q ss_conf 58877888534532356332
Q 005590 309 DNSDTRDGEVNGALHEGKAD 328 (689)
Q Consensus 309 D~d~~~~~~~~G~v~~~~~~ 328 (689)
|++.+++++++|++.++...
T Consensus 91 d~~~~~~~~~iG~~~i~l~~ 110 (138)
T d1w15a_ 91 DSERGSRNEVIGRLVLGATA 110 (138)
T ss_dssp ECCTTSCCEEEEEEEESTTC
T ss_pred ECCCCCCCCEEEEEEECCHH
T ss_conf 67998889788999986600
|
| >d1rsya_ b.7.1.2 (A:) Synaptogamin I {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptogamin I species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.59 E-value=2.6e-16 Score=120.57 Aligned_cols=97 Identities=14% Similarity=0.097 Sum_probs=85.1
Q ss_pred CCCCEEEEEECC-CCCCCCCCCCCCCCEEEECCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCC
Q ss_conf 563049988226-973127878899622543078999852023100135789621013223655655766-643345223
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 308 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V~ 308 (689)
....|+|.|++| ||+++|.+|.+|||||+.|+++.++ +.+|+++++|+||.|||+|.|. ++...+ +.+|.+.||
T Consensus 32 ~~~~L~V~V~~a~~L~~~~~~g~~dpyV~v~l~~~~~~--~~kT~~~~~t~~P~wne~f~f~--i~~~~l~~~~L~i~V~ 107 (143)
T d1rsya_ 32 QNNQLLVGIIQAAELPALDMGGTSDPYVKVFLLPDKKK--KFETKVHRKTLNPVFNEQFTFK--VPYSELGGKTLVMAVY 107 (143)
T ss_dssp TTTEEEEEEEEEESCCCCSTTSCCCEEEEEEEETTCCS--CEECCCCTTCSSCEEEEEEEEC--CCHHHHTTCEEEEEEE
T ss_pred CCCEEEEEEEECCCCCCCCCCCCCCEEEEEEECCCCCE--EEEEEEECCCCCCCEEEEEEEE--EEEECCCCCEEEEEEE
T ss_conf 99999999997508998778999780799998589971--6888886566683122316999--9853158846999999
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 58877888534532356332011
Q 005590 309 DNSDTRDGEVNGALHEGKADAEE 331 (689)
Q Consensus 309 D~d~~~~~~~~G~v~~~~~~~~~ 331 (689)
|++.+++++++|.+.+...++..
T Consensus 108 d~d~~~~~~~iG~~~i~L~~~~~ 130 (143)
T d1rsya_ 108 DFDRFSKHDIIGEFKVPMNTVDF 130 (143)
T ss_dssp ECCSSSCCEEEEEEEEEGGGCCC
T ss_pred ECCCCCCCCEEEEEEEECHHCCC
T ss_conf 83898889679999998203349
|
| >d1uowa_ b.7.1.2 (A:) Synaptogamin I {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptogamin I species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.59 E-value=2.6e-16 Score=120.59 Aligned_cols=97 Identities=13% Similarity=0.113 Sum_probs=88.0
Q ss_pred CCCCEEEEEECC-CCCCCCCCCCCCCCEEEECCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCC
Q ss_conf 563049988226-973127878899622543078999852023100135789621013223655655766-643345223
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 308 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V~ 308 (689)
.+++|+|.|++| ||++.+.+|.+|||||++++++.++..++||+++++++||+|||+|.|. ++...+ +..|.+.||
T Consensus 23 ~~~~L~V~V~~a~~L~~~~~~~~~dpyV~v~l~~~~~~~~~~kT~v~~~t~nP~wne~f~F~--v~~~~l~~~~l~i~v~ 100 (157)
T d1uowa_ 23 TAGKLTVVILEAKNLKKMDVGGLSDPYVKIHLMQNGKRLKKKKTTIKKNTLNPYYNESFSFE--VPFEQIQKVQVVVTVL 100 (157)
T ss_dssp TTTEEEEEEEEEESCCCCSTTSCCCEEEEEEEEETTEEEEEEECCCCCSCSSCEEEEEEEEE--CCGGGGGGCEEEEEEE
T ss_pred CCCEEEEEEEEEEECCCCCCCCCCCEEEEEEEECCCCCCCCEECCCCCCCCCCCCCCEEEEE--ECHHHCCCCEEEEEEC
T ss_conf 89999999999797136557999790699999538862345011023688896367769999--6089937638999981
Q ss_pred CCCCCCCCCCCCCCCCCCCCC
Q ss_conf 588778885345323563320
Q 005590 309 DNSDTRDGEVNGALHEGKADA 329 (689)
Q Consensus 309 D~d~~~~~~~~G~v~~~~~~~ 329 (689)
|++.+++++++|++.++....
T Consensus 101 d~~~~~~~~~iG~~~i~l~~~ 121 (157)
T d1uowa_ 101 DYDKIGKNDAIGKVFVGYNST 121 (157)
T ss_dssp ECCSSSCCCEEEEEEEETTCC
T ss_pred CCCCCCCCCEEEEEEEECCCC
T ss_conf 569888884669999806008
|
| >d2cm5a1 b.7.1.2 (A:541-677) C2b-domain of rabphilin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: C2b-domain of rabphilin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.57 E-value=8.2e-16 Score=117.33 Aligned_cols=97 Identities=14% Similarity=0.097 Sum_probs=88.5
Q ss_pred CCCCEEEEEECC-CCCCCCCCCCCCCCEEEECCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCC
Q ss_conf 563049988226-973127878899622543078999852023100135789621013223655655766-643345223
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 308 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V~ 308 (689)
..+.|+|.|.+| ||++++.+|.+|||||+.++++.+..+++||+++++|+||.|||+|.|. ++...+ ..+|.+.||
T Consensus 13 ~~~~L~V~v~~a~nL~~~~~~~~~dpyv~v~l~~~~~~~~~~kT~v~~~t~~P~wne~f~f~--v~~~~l~~~~l~v~v~ 90 (137)
T d2cm5a1 13 QQGGLIVGIIRCVHLAAMDANGYSDPFVKLWLKPDMGKKAKHKTQIKKKTLNPEFNEEFFYD--IKHSDLAKKSLDISVW 90 (137)
T ss_dssp TTTEEEEEEEEEESCCCCSTTSCCCEEEEEEEETC---CCEEECCCCCSCSSCEEEEEEEEE--CCGGGGGGCEEEEEEE
T ss_pred CCCEEEEEEEEEECCCCCCCCCCCCEEEEEEEECCCCCCEEECCEEECCCCCCCCCEEEEEE--EEHHHCCCCEEEEEEE
T ss_conf 99999999999878999777877686999999768866566368757189998566499999--6878856129999766
Q ss_pred CCCCCCCCCCCCCCCCCCCCC
Q ss_conf 588778885345323563320
Q 005590 309 DNSDTRDGEVNGALHEGKADA 329 (689)
Q Consensus 309 D~d~~~~~~~~G~v~~~~~~~ 329 (689)
|++.+++++++|++.++....
T Consensus 91 ~~~~~~~~~~iG~~~i~l~~~ 111 (137)
T d2cm5a1 91 DYDIGKSNDYIGGCQLGISAK 111 (137)
T ss_dssp ECCSSSCCEEEEEEEEETTCC
T ss_pred ECCCCCCCCEEEEEEECCCCC
T ss_conf 179998887999987473004
|
| >d1ugka_ b.7.1.2 (A:) Synaptotagmin IV {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptotagmin IV species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=2.3e-15 Score=114.38 Aligned_cols=97 Identities=12% Similarity=0.087 Sum_probs=83.0
Q ss_pred CCCCEEEEEECC-CCCCCCCCCC-CCCCEEEECCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCC
Q ss_conf 563049988226-9731278788-99622543078999852023100135789621013223655655766-64334522
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVV-GDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAE 307 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~-sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V 307 (689)
....|+|.|.+| ||+.+|..|. +|||||+.|+|+.+. +++|+++++++||.|||+|.|.. ++...+ +.+|.+.|
T Consensus 20 ~~~~L~V~V~~a~~L~~~d~~~~~~dpyV~v~l~~~~~~--~~kT~v~~~t~nP~wne~f~f~~-~~~~~l~~~~L~~~V 96 (138)
T d1ugka_ 20 ERKAFVVNIKEARGLPAMDEQSMTSDPYIKMTILPEKKH--KVKTRVLRKTLDPAFDETFTFYG-IPYTQIQELALHFTI 96 (138)
T ss_dssp GGTEEEEEEEEEESCCCCBTTTTBCEEEEEEEEETTTCS--EEECCCCSSCSSCEEEEEEEEEC-CCSTTGGGCEEEEEE
T ss_pred CCCEEEEEEEEECCCCCCCCCCCCCCEEEEEEECCCCCE--EEECEEEECCCCCCEEEEEEEEE-ECHHHCCCCEEEEEE
T ss_conf 899999999981098988899986533999999289998--67071476778974456899961-288995565589999
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 35887788853453235633201
Q 005590 308 IDNSDTRDGEVNGALHEGKADAE 330 (689)
Q Consensus 308 ~D~d~~~~~~~~G~v~~~~~~~~ 330 (689)
||.|++++++++|++.+...+..
T Consensus 97 ~d~d~~~~~~~iG~~~i~L~~~~ 119 (138)
T d1ugka_ 97 LSFDRFSRDDIIGEVLIPLSGIE 119 (138)
T ss_dssp EEECSSCCCCCCEEEEEECTTCC
T ss_pred EECCCCCCCCEEEEEEEECCCCC
T ss_conf 98999888957899999834165
|
| >d1rh8a_ b.7.1.2 (A:) Piccolo {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Piccolo species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.54 E-value=5.3e-16 Score=118.58 Aligned_cols=101 Identities=13% Similarity=0.103 Sum_probs=85.4
Q ss_pred CCCCEEEEEECC-CCCCCCCCCCCCCCEEEECCCCCCCC---------CEEEEECCCCCCCCCCCCCCCCCCCCCCCCC-
Q ss_conf 563049988226-97312787889962254307899985---------2023100135789621013223655655766-
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTE---------KSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA- 299 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~---------~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~- 299 (689)
..+.|+|.|.+| ||+++|..|.+|||||+.|+++.+.. .+++|+++++|+||.|||+|.|.. ++.+.+
T Consensus 16 ~~~~L~V~V~~A~~L~~~d~~g~~DpyV~v~l~~~~~~~~~~~~~~~~~~~kT~v~~~t~nP~wne~f~f~~-~~~~~~~ 94 (142)
T d1rh8a_ 16 DLGNLIIHILQARNLVPRDNNGYSDPFVKVYLLPGRGQVMVVQNASAEYKRRTKYVQKSLNPEWNQTVIYKS-ISMEQLM 94 (142)
T ss_dssp ETTEEEEEEEEEESCCCCSSSSCSCCEEEEEETTSSCCCEECCCCCHHHHTTTTTTHHHHSCEEEEEEEECS-CCHHHHT
T ss_pred ECCEEEEEEEEEECCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCEEEECCCCCCCCCCEEEEEEEEEE-ECCCCCC
T ss_conf 599999999973899886789997947899994676631000257883504346783888834678998752-2333467
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 643345223588778885345323563320112
Q 005590 300 EKDLMPAEIDNSDTRDGEVNGALHEGKADAEEH 332 (689)
Q Consensus 300 ~~~L~~~V~D~d~~~~~~~~G~v~~~~~~~~~e 332 (689)
+.+|.++|||++.+++++++|++.+........
T Consensus 95 ~~~L~i~V~d~d~~~~~~~lG~~~i~L~~l~~~ 127 (142)
T d1rh8a_ 95 KKTLEVTVWDYDRFSSNDFLGEVLIDLSSTSHL 127 (142)
T ss_dssp TCEEEEEEEEECSSSCEEEEEEEEEETTSCGGG
T ss_pred CCEEEEEEEEECCCCCCEEEEEEEEEHHHCCCC
T ss_conf 787999999705899981468999986775788
|
| >d1wfma_ b.7.1.2 (A:) Synaptotagmin XIII {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: Synaptotagmin XIII species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=4.7e-15 Score=112.43 Aligned_cols=95 Identities=18% Similarity=0.135 Sum_probs=81.7
Q ss_pred CCCCEEEEEECC-CCCCCCCCCCCCCCEEEECCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCC
Q ss_conf 563049988226-973127878899622543078999852023100135789621013223655655766-643345223
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA-EKDLMPAEI 308 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~-~~~L~~~V~ 308 (689)
....|.|.|++| ||+ .+|.+|||||++|+|+.++ .+++|+++++++||+|||+|.|. ++...+ ..+|.++||
T Consensus 24 ~~~~L~V~v~~a~~L~---~~g~~dpyVkv~l~~~~~~-~~~kT~v~~~~~~P~wne~f~f~--v~~~~l~~~~L~~~V~ 97 (138)
T d1wfma_ 24 QKAELFVTRLEAVTSN---HDGGCDCYVQGSVANRTGS-VEAQTALKKRQLHTTWEEGLVLP--LAEEELPTATLTLTLR 97 (138)
T ss_dssp TTTEEEEEEEEEECCC---CSSCCCEEEEEEEEETTEE-EEEECCCCCCCSSEECSSCEEEE--CCTTSSTTCEEEEEEE
T ss_pred CCCEEEEEEEECCCCC---CCCCCCCEEEEEECCCCCC-CCEEEEEECCCCCCEEEEEEEEE--EEEHHCCCEEEEEEEE
T ss_conf 8999999999867989---8998383799998799885-42530387778995381308998--6510166218999874
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 58877888534532356332011
Q 005590 309 DNSDTRDGEVNGALHEGKADAEE 331 (689)
Q Consensus 309 D~d~~~~~~~~G~v~~~~~~~~~ 331 (689)
|++++++++++|++.+...+...
T Consensus 98 d~~~~~~~~~iG~~~i~L~~l~~ 120 (138)
T d1wfma_ 98 TCDRFSRHSVAGELRLGLDGTSV 120 (138)
T ss_dssp ECCSSCTTSCSEEEEEESSSSSS
T ss_pred EECCCCCCEEEEEEEEEHHHCCC
T ss_conf 20556631454599998577348
|
| >d2ep6a1 b.7.1.1 (A:92-217) Multiple C2 and transmembrane domain-containing protein 2, MCTP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: Multiple C2 and transmembrane domain-containing protein 2, MCTP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=9.6e-15 Score=110.39 Aligned_cols=92 Identities=11% Similarity=0.076 Sum_probs=77.7
Q ss_pred CCCCEEEEEECC-CCCCCCCCCCCCCCEEEECCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 563049988226-9731278788996225430789998520231001357896210132236556557666433452235
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 309 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~~~~L~~~V~D 309 (689)
+.++|+|.|++| ||+++|..|.+||||++.+- ..+++|+++++|+||.|||+|.|. ++. ....|.+.|||
T Consensus 4 ~~G~L~V~v~~A~~L~~~d~~g~~Dpyv~v~~~-----~~~~~T~~~~~t~nP~wne~f~f~--v~~--~~~~L~i~V~d 74 (126)
T d2ep6a1 4 DVGILQVKVLKAADLLAADFSGKSDPFCLLELG-----NDRLQTHTVYKNLNPEWNKVFTFP--IKD--IHDVLEVTVFD 74 (126)
T ss_dssp CSEEEEEEEEEEESCCCSSSSSCCCEEEEEEET-----TEEEECCCCSSCSSCCCCEEEEEE--ESC--TTCEEEEEEEE
T ss_pred CCEEEEEEEEEEECCCCCCCCCCCCEEEEEECC-----CEEEEEEEECCCEEEEEEEEEEEE--EEC--CCCEEEEEEEE
T ss_conf 619999999982789887889996959999769-----858877740774057898999999--843--67500899999
Q ss_pred CCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 8877888534532356332011
Q 005590 310 NSDTRDGEVNGALHEGKADAEE 331 (689)
Q Consensus 310 ~d~~~~~~~~G~v~~~~~~~~~ 331 (689)
++.+++++++|.+.+...+...
T Consensus 75 ~~~~~~d~~lG~~~i~l~~l~~ 96 (126)
T d2ep6a1 75 EDGDKPPDFLGKVAIPLLSIRD 96 (126)
T ss_dssp EETTEEEEECCBCEEEGGGCCS
T ss_pred CCCCCCCCEEEEEEEEHHHCCC
T ss_conf 3698476258999999899889
|
| >d1qasa2 b.7.1.1 (A:626-756) PI-specific phospholipase C isozyme D1 (PLC-D1), C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: PI-specific phospholipase C isozyme D1 (PLC-D1), C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.37 E-value=1.7e-13 Score=102.23 Aligned_cols=94 Identities=10% Similarity=-0.008 Sum_probs=76.1
Q ss_pred CCEEEEEECC-CCCC--CCCCCCCCCCEEEECCCCCCCCCEEEEECC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 3049988226-9731--278788996225430789998520231001-35789621013223655655766643345223
Q 005590 233 DYGYLSSKEA-DLID--LQHNVVGDSSTDCDLAPHPGTEKSSSYSSS-KRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI 308 (689)
Q Consensus 233 ~~l~v~i~e~-~L~~--~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~-k~tlnP~~ne~f~~~~~~~~~~~~~~L~~~V~ 308 (689)
..|+|.|++| +|+. ++.+|.+||||++.+........+.+|+++ ++++||.|||+|.|. +..... ..|.++||
T Consensus 4 ~~l~V~Vi~a~~L~~~~~~~~~~~DPyV~v~l~g~~~~~~~~~T~~v~~~~~nP~wne~f~f~--~~~~~~-~~L~~~V~ 80 (131)
T d1qasa2 4 ERLRVRIISGQQLPKVNKNKNSIVDPKVIVEIHGVGRDTGSRQTAVITNNGFNPRWDMEFEFE--VTVPDL-ALVRFMVE 80 (131)
T ss_dssp EEEEEEEEEEESCCCCC-----CCCEEEEEEEESSTTTCEEEECCCCSSCSSSCEEEEEEEEE--ESCGGG-CEEEEEEE
T ss_pred EEEEEEEEEEECCCCCCCCCCCCCCEEEEEEECCCCCCCEEEEEEEEECCCCCCEEEEEEEEE--EECCHH-CEEEEEEE
T ss_conf 799999999229997789889981869999996678885787888896665796597799999--776323-25899999
Q ss_pred CCCCCCCCCCCCCCCCCCCCC
Q ss_conf 588778885345323563320
Q 005590 309 DNSDTRDGEVNGALHEGKADA 329 (689)
Q Consensus 309 D~d~~~~~~~~G~v~~~~~~~ 329 (689)
|+|.+++++++|.+.+....+
T Consensus 81 D~d~~~~d~~iG~~~i~l~~l 101 (131)
T d1qasa2 81 DYDSSSKNDFIGQSTIPWNSL 101 (131)
T ss_dssp ECCTTTCCEEEEEEEEEGGGB
T ss_pred EECCCCCCCEEEEEEEEEECC
T ss_conf 806888986889999997626
|
| >d1wfja_ b.7.1.2 (A:) C2 domain protein At1g63220 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: Synaptotagmin-like (S variant) domain: C2 domain protein At1g63220 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.34 E-value=3.6e-13 Score=100.22 Aligned_cols=92 Identities=12% Similarity=0.035 Sum_probs=74.6
Q ss_pred CCCCEEEEEECC-CCCCCCCCCCCCCCEEEECCCCCCCCCEEEEECC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 563049988226-9731278788996225430789998520231001-35789621013223655655766643345223
Q 005590 231 NNDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSS-KRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEI 308 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~-k~tlnP~~ne~f~~~~~~~~~~~~~~L~~~V~ 308 (689)
+.+.|+|.|++| +|+++|..|.+||||++.+-. .+.+|+++ ++++||.|||+|.|. +.. ....|.+.||
T Consensus 8 p~G~L~V~v~~a~~L~~~d~~g~~Dpyv~v~~~~-----~~~~t~~~~~~~~nP~Wne~f~f~--v~~--~~~~L~v~V~ 78 (136)
T d1wfja_ 8 PHGTLEVVLVSAKGLEDADFLNNMDPYVQLTCRT-----QDQKSNVAEGMGTTPEWNETFIFT--VSE--GTTELKAKIF 78 (136)
T ss_dssp CEEEEEEEEEEEEECSSCCSSCSSCCCEEEESSS-----CEEECCCCTTCCSSCEEEEEEEEE--EES--SCCEEEEEEC
T ss_pred CCEEEEEEEEEEECCCCCCCCCCCCCCEEEEEEE-----EEEEEEEEECCCCCEEEEEEEEEE--ECC--CCCEEEEEEE
T ss_conf 9389999999956898988899979328999945-----537888996688728870699999--738--3115799999
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 58877888534532356332011
Q 005590 309 DNSDTRDGEVNGALHEGKADAEE 331 (689)
Q Consensus 309 D~d~~~~~~~~G~v~~~~~~~~~ 331 (689)
|++.+++++++|.+.+...++..
T Consensus 79 d~d~~~~d~~iG~~~i~L~~l~~ 101 (136)
T d1wfja_ 79 DKDVGTEDDAVGEATIPLEPVFV 101 (136)
T ss_dssp CSSSCTTTCCSEEEEEESHHHHH
T ss_pred EECCCCCCCEEEEEEEEHHHHCC
T ss_conf 95699999889999999387112
|
| >d1rlwa_ b.7.1.1 (A:) Domain from cytosolic phospholipase A2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: Domain from cytosolic phospholipase A2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.32 E-value=4e-13 Score=99.90 Aligned_cols=95 Identities=13% Similarity=0.016 Sum_probs=75.9
Q ss_pred CCCCEEEEEECC-CCCC---CCCCCCCCCCEEEECCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 563049988226-9731---278788996225430789998520231001357896210132236556557666433452
Q 005590 231 NNDYGYLSSKEA-DLID---LQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPA 306 (689)
Q Consensus 231 ~~~~l~v~i~e~-~L~~---~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~~~~L~~~ 306 (689)
|..+|+|.|.+| ||+. .|..|..||||++++.++..+ +++|+++++++||.|||+|.|. +... ....|.+.
T Consensus 1 ss~~l~V~v~~a~~L~~~~~~d~~~~~Dpyv~v~l~~~~~~--~~~T~~~~~t~nP~wne~f~f~--i~~~-~~~~L~v~ 75 (126)
T d1rlwa_ 1 SSHKFTVVVLRATKVTKGAFGDMLDTPDPYVELFISTTPDS--RKRTRHFNNDINPVWNETFEFI--LDPN-QENVLEIT 75 (126)
T ss_dssp CCEEEEEEEEEEESCCSCHHHHHHCCCCEEEEEECTTSTTC--CEECCCCTTCSSCEEEEEEEEE--ECTT-SCCEEEEE
T ss_pred CCCEEEEEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCC--EEEEEECCCCCCCEECEEEEEC--CCCC-CCCCEEEE
T ss_conf 97189999998608988636666889781899999773461--1676404788650101145010--4584-12717999
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 2358877888534532356332011
Q 005590 307 EIDNSDTRDGEVNGALHEGKADAEE 331 (689)
Q Consensus 307 V~D~d~~~~~~~~G~v~~~~~~~~~ 331 (689)
|||++..+ ++++|.+.+...++..
T Consensus 76 V~d~d~~~-d~~lG~~~i~L~~l~~ 99 (126)
T d1rlwa_ 76 LMDANYVM-DETLGTATFTVSSMKV 99 (126)
T ss_dssp EEECCSSC-CEEEEEEEEEGGGSCT
T ss_pred EEECCCCC-CCEEEEEEEEHHHCCC
T ss_conf 99879978-9748999999888659
|
| >d1gmia_ b.7.1.1 (A:) Domain from protein kinase C epsilon {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: Domain from protein kinase C epsilon species: Rat (Rattus rattus) [TaxId: 10117]
Probab=99.26 E-value=1e-12 Score=97.26 Aligned_cols=93 Identities=11% Similarity=0.107 Sum_probs=76.4
Q ss_pred CCCEEEEEECC-CCCCCC-----------CCCCCCCCEEEECCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 63049988226-973127-----------878899622543078999852023100135789621013223655655766
Q 005590 232 NDYGYLSSKEA-DLIDLQ-----------HNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGA 299 (689)
Q Consensus 232 ~~~l~v~i~e~-~L~~~d-----------~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~ 299 (689)
++.|+|.|.+| +|++++ .++.+||||++.+ .+....+|++++++.||.|||+|.|. ++.
T Consensus 5 ~G~L~v~I~~A~~L~~~~~~~~~~~~~~~~~~~~DPYv~v~l----~~~~~~~T~~~~~t~~P~Wne~f~f~--v~~--- 75 (136)
T d1gmia_ 5 NGLLKIKICEAVSLKPTAWSLRDAVGPRPQTFLLDPYIALNV----DDSRIGQTATKQKTNSPAWHDEFVTD--VCN--- 75 (136)
T ss_dssp EEEEEEEEEEEESCCCCHHHHCC-CCSSCCCCCCCEEEEEEE----TTEEEEECCCCSSCSSCEEEEEEEEE--EEE---
T ss_pred EEEEEEEEEEEECCCCCCCCCCCCCCCCCCCCCCCCEEEEEE----CCCCCCEEEEECCCCCCCCCCEEEEE--EEC---
T ss_conf 899999999947998653444333245678887583799991----89867670588498895396379999--932---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 6433452235887788853453235633201126
Q 005590 300 EKDLMPAEIDNSDTRDGEVNGALHEGKADAEEHG 333 (689)
Q Consensus 300 ~~~L~~~V~D~d~~~~~~~~G~v~~~~~~~~~e~ 333 (689)
.+.|.++|||++.+++++++|.+.+...++...+
T Consensus 76 ~~~l~i~V~d~~~~~~d~~iG~~~i~l~~l~~~~ 109 (136)
T d1gmia_ 76 GRKIELAVFHDAPIGYDDFVANCTIQFEELLQNG 109 (136)
T ss_dssp ECEEEEEEEECCSSSSCEEEEEEEEEHHHHTSTT
T ss_pred CCCEEEEEEEECCCCCCEEEEEEEEEHHHHHHCC
T ss_conf 7845999999668987405789999979953168
|
| >d2nq3a1 b.7.1.1 (A:13-145) E3 ubiquitin-protein ligase Itchy {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: E3 ubiquitin-protein ligase Itchy species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.17 E-value=5.5e-12 Score=92.50 Aligned_cols=90 Identities=7% Similarity=-0.034 Sum_probs=74.6
Q ss_pred CCCEEEEEECC-CCCCCCCCCCCCCCEEEECCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 63049988226-97312787889962254307899985202310013578962101322365565576664334522358
Q 005590 232 NDYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDN 310 (689)
Q Consensus 232 ~~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~~~~L~~~V~D~ 310 (689)
...|.|+|++| +++..+..+..||||++.+ ..++.+|+++++|+||.|||.|.|. +... ..|.+.|||+
T Consensus 5 ~~~L~v~v~~A~~~~~~~~~~~~dpyv~v~~-----~~~~~kT~v~~~t~nP~wne~f~f~--~~~~---~~l~~~V~d~ 74 (133)
T d2nq3a1 5 KSQLQITVISAKLKENKKNWFGPSPYVEVTV-----DGQSKKTEKCNNTNSPKWKQPLTVI--VTPV---SKLHFRVWSH 74 (133)
T ss_dssp CEEEEEEEEEEEECCCC--CCCCCEEEEEEE-----TTEEEECCCCSSCSSCEEEEEEEEE--ECTT---CEEEEEEEEC
T ss_pred CEEEEEEEEEEECCCCCCCCCCCCEEEEEEE-----CCEEEEEEEEEECCCEEECCEEEEE--EEEC---CEEEEEEEEC
T ss_conf 5389999999399976778899695999999-----9847843799703627876567999--9802---2069999982
Q ss_pred CCCCCCCCCCCCCCCCCCCCC
Q ss_conf 877888534532356332011
Q 005590 311 SDTRDGEVNGALHEGKADAEE 331 (689)
Q Consensus 311 d~~~~~~~~G~v~~~~~~~~~ 331 (689)
+.+++++++|.+.....++..
T Consensus 75 d~~~~d~~iG~~~i~L~~l~~ 95 (133)
T d2nq3a1 75 QTLKSDVLLGTAALDIYETLK 95 (133)
T ss_dssp CSSSCCEEEEEEEEEHHHHHH
T ss_pred CCCCCCCEEEEEEEEHHHHHH
T ss_conf 688899468999999799341
|
| >d1bdya_ b.7.1.1 (A:) Domain from protein kinase C delta {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: Domain from protein kinase C delta species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.98 E-value=7.4e-11 Score=85.18 Aligned_cols=87 Identities=10% Similarity=0.068 Sum_probs=66.2
Q ss_pred CEEEEEECC-CCCCCCCCCCCCCCEEEECCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 049988226-9731278788996225430789998520231001357896210132236556557666433452235887
Q 005590 234 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNSD 312 (689)
Q Consensus 234 ~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~~~~L~~~V~D~d~ 312 (689)
+.+|.+.++ .++.+ +|.+||||++.+....+..++++|+++|+|+||+|||+|.|. +.. ...|.+.|||+|
T Consensus 6 ~~~~~~~~~~~~~~~--~~~~dPY~~v~l~~~~~~~~~~~t~~~kkT~nP~WnE~F~~~--v~~---~~~l~i~V~d~d- 77 (123)
T d1bdya_ 6 RISFNSYELGSLQAE--DDASQPFCAVKMKEALTTDRGKTLVQKKPTMYPEWKSTFDAH--IYE---GRVIQIVLMRAA- 77 (123)
T ss_dssp EEEEEEEECCTTCCC--CCSCCCEEEEEEEEECCGGGTTBEEECSCCBCCCTTCEEEEE--CCT---TCEEEEEEEEET-
T ss_pred EEEEEEEECCCCCCC--CCCCCCEEEEEECCCCCCCCCEEEEEECCCCCCCCCEEEEEE--ECC---CCEEEEEEEECC-
T ss_conf 999997405668899--988897799997686653344389986797886346699999--744---667999999864-
Q ss_pred CCCCCCCCCCCCCCCCCCC
Q ss_conf 7888534532356332011
Q 005590 313 TRDGEVNGALHEGKADAEE 331 (689)
Q Consensus 313 ~~~~~~~G~v~~~~~~~~~ 331 (689)
++++|...++...+..
T Consensus 78 ---d~~~g~~~i~l~~l~~ 93 (123)
T d1bdya_ 78 ---EDPMSEVTVGVSVLAE 93 (123)
T ss_dssp ---TEEEEEEEEEHHHHHH
T ss_pred ---CCCCCCCEEEHHHEEE
T ss_conf ---3536751775666240
|
| >d2cjta1 b.7.1.1 (A:1-128) Unc-13 homolog A {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: Unc-13 homolog A species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.92 E-value=3e-10 Score=81.24 Aligned_cols=86 Identities=10% Similarity=0.026 Sum_probs=68.9
Q ss_pred CCEEEEEECC-CCCCCCCCCCCCCCEEEECCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 3049988226-973127878899622543078999852023100135789621013223655655766643345223588
Q 005590 233 DYGYLSSKEA-DLIDLQHNVVGDSSTDCDLAPHPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEIDNS 311 (689)
Q Consensus 233 ~~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~pd~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~~~~L~~~V~D~d 311 (689)
..|+|.|.+| +|++.| ..||||++.+ ...+.+|.+.+ +.||.|||+|.|. +.. .+..|.+.|||++
T Consensus 2 ~~L~V~v~~a~~l~~~~---~~dpYv~l~~-----~~~k~~T~~~k-~~nP~Wne~f~f~--v~~--~~~~L~v~V~d~~ 68 (128)
T d2cjta1 2 SLLCVGVKKAKFDGAQE---KFNTYVTLKV-----QNVKSTTIAVR-GSQPSWEQDFMFE--INR--LDLGLTVEVWNKG 68 (128)
T ss_dssp EEEEEEEEEEECSSCGG---GCEEEEEEEE-----TTEEEECCCEE-SSSCEEEEEEEEE--ECC--CSSEEEEEEEECC
T ss_pred EEEEEEEEEEECCCCCC---CCCEEEEEEE-----CCEEEEEEEEC-CCCCEEEEEEEEE--ECC--CCCEEEEEEEECC
T ss_conf 38999999988898988---8680999995-----99989998746-8998389999885--146--6525999999678
Q ss_pred CCCCCCCCCCCCCCCCCCCCC
Q ss_conf 778885345323563320112
Q 005590 312 DTRDGEVNGALHEGKADAEEH 332 (689)
Q Consensus 312 ~~~~~~~~G~v~~~~~~~~~e 332 (689)
..+ ++++|.+.+...++...
T Consensus 69 ~~~-d~~lG~~~I~L~~l~~~ 88 (128)
T d2cjta1 69 LIW-DTMVGTVWIPLRTIRQS 88 (128)
T ss_dssp SSC-EEEEEEEEEEGGGSCBC
T ss_pred CCC-CCCEEEEEEEEHHHCCC
T ss_conf 767-86149999994330147
|
| >d2zkmx2 b.7.1.1 (X:678-799) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: C2 domain-like superfamily: C2 domain (Calcium/lipid-binding domain, CaLB) family: PLC-like (P variant) domain: Phospholipase C-beta-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.76 E-value=2.6e-09 Score=75.16 Aligned_cols=84 Identities=12% Similarity=0.009 Sum_probs=58.6
Q ss_pred CEEEEEECC-CCCCCCCCCCCCCCEEEECCC---CCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 049988226-973127878899622543078---9998520231001357896210132236556557666433452235
Q 005590 234 YGYLSSKEA-DLIDLQHNVVGDSSTDCDLAP---HPGTEKSSSYSSSKRGSSIDWIEGFKGSSDLHFKGAEKDLMPAEID 309 (689)
Q Consensus 234 ~l~v~i~e~-~L~~~d~~g~sDpyvk~~l~p---d~~~~~k~kt~~~k~tlnP~~ne~f~~~~~~~~~~~~~~L~~~V~D 309 (689)
.|+|.|+.| +|+.. ..|||||+.|.. |..++.++++.++++++||.|||.+.+...+...++ ..|.+.|||
T Consensus 2 tl~V~Visaq~L~~~----~~dPyV~V~l~g~~~D~~~~~~t~~~~~~n~~nP~wne~~~~~~~~~~~~l-~~L~f~V~D 76 (122)
T d2zkmx2 2 TLSITVISGQFLSER----SVRTYVEVELFGLPGDPKRRYRTKLSPSTNSINPVWKEEPFVFEKILMPEL-ASLRVAVME 76 (122)
T ss_dssp EEEEEEEEEESCCSS----CCCEEEEEEEECCTTSCCCCEECCCCSSSCCSSCBCCCCCEEEEEESSGGG-CEEEEEEEE
T ss_pred EEEEEEEEEECCCCC----CCCCEEEEEEECCCCCCCCCEEEEEEEECCEECCEECCCEEEEEECCCCCC-CEEEEEEEC
T ss_conf 799999981179999----999689999987678777527978877487364158065869886177741-699999999
Q ss_pred CCCCCCCCCCCCCCCCC
Q ss_conf 88778885345323563
Q 005590 310 NSDTRDGEVNGALHEGK 326 (689)
Q Consensus 310 ~d~~~~~~~~G~v~~~~ 326 (689)
++ ++++|.+....
T Consensus 77 ~d----~~~lG~~~ipl 89 (122)
T d2zkmx2 77 EG----NKFLGHRIIPI 89 (122)
T ss_dssp TT----TEEEEEEEEEG
T ss_pred CC----CCEEEEEEEEC
T ss_conf 99----99999999893
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.64 E-value=7.1e-07 Score=59.37 Aligned_cols=140 Identities=16% Similarity=0.120 Sum_probs=87.5
Q ss_pred CCEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCH-HHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEECCEEE
Q ss_conf 75899999325888753999988789379999960541-34675999999999960169999872258778998478499
Q 005590 381 GRYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDK-DFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLF 459 (689)
Q Consensus 381 ~~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~-~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~ 459 (689)
..|++.+..+.++.+.||+.. ..+..+.+|+..... .......+|..+++.+.... -+++++.+....+..+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~v-----pvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKL-----PVPKVLHFERHDGWSN 86 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTS-----CCCCEEEEEEETTEEE
T ss_pred HCEEEEECCCCCCCCCEEEEE--ECCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCC-----CCCCEEEEEECCCCEE
T ss_conf 352799767899877189999--089869999848876532556999999999876069-----9872899975089649
Q ss_pred EEEECCCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHH----------------------------------
Q ss_conf 9997142143889863202699755598899999997799999999----------------------------------
Q 005590 460 IVCELLRANLYEFQKFNQESGGEAYFTLGRLQVITRQCLEALEYLH---------------------------------- 505 (689)
Q Consensus 460 lVmEy~~g~L~~~~~~~~~~~~~~~ls~~~i~~i~~QIl~aL~yLH---------------------------------- 505 (689)
+||+++.|......... ......++.++...+..||
T Consensus 87 lv~~~l~G~~~~~~~~~----------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEECCSSEEHHHHTTT----------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEECCCCCCCCCCCC----------CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_conf 99986043343543344----------02699999989999999855684214357644656555778998776555543
Q ss_pred -------------------HC------CCEECCCCCCCEEEECCCCCEEEEEECCCCCC
Q ss_conf -------------------88------95303589995798025787099983688421
Q 005590 506 -------------------SL------GIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539 (689)
Q Consensus 506 -------------------~~------gIvHrDIKp~NILi~~~~~~~ikL~DFGls~~ 539 (689)
.. .++|+|+.|.|||++. ...+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~--~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKD--GKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEET--TEEEEECCCTTCEE
T ss_pred CCCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECC--CCEEEEEECHHCCC
T ss_conf 0332320057999999998449867817898600476423649--96599960231441
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.14 E-value=1.5e-05 Score=50.79 Aligned_cols=77 Identities=18% Similarity=0.125 Sum_probs=53.2
Q ss_pred EEEECCCCCCCEEEEEECCCCCEEEEEEEECC--------HHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEECCE
Q ss_conf 99932588875399998878937999996054--------1346759999999999601699998722587789984784
Q 005590 386 TEYLGSAAFSKVFQAQDLHTGVDVCLKIIKND--------KDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEH 457 (689)
Q Consensus 386 ~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~--------~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~ 457 (689)
.+.||.|....||++.+...++.+++|.-... ....++...|..+|+.+.... ...+++++.+ +...
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~---p~~vP~v~~~--d~~~ 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV---PHLVPRVFYS--DTEM 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTC---GGGSCCEEEE--ETTT
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHC---CCCCCEEEEE--CCCC
T ss_conf 9980798527689999579984899961771303467778887789999999999865057---9885528998--5988
Q ss_pred EEEEEECCCC
Q ss_conf 9999971421
Q 005590 458 LFIVCELLRA 467 (689)
Q Consensus 458 l~lVmEy~~g 467 (689)
.++|||++.+
T Consensus 106 ~~lvmE~L~~ 115 (392)
T d2pula1 106 AVTVMEDLSH 115 (392)
T ss_dssp TEEEECCCTT
T ss_pred CEEEEECCCC
T ss_conf 7798713577
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.96 E-value=6.5e-05 Score=46.63 Aligned_cols=143 Identities=11% Similarity=0.034 Sum_probs=82.5
Q ss_pred EECCCCC-CCEEEEEECCCCCEEEEEEEECCHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEECCEEEEEEECCC
Q ss_conf 9325888-753999988789379999960541346759999999999601699998722587789984784999997142
Q 005590 388 YLGSAAF-SKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYHLEHLFIVCELLR 466 (689)
Q Consensus 388 ~LG~G~f-G~Vy~a~d~~tg~~vAIKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~~~~l~lVmEy~~ 466 (689)
.+..|.. +.||+... ..+..+++|...... ...+..|...++.+.... -.+++++.+..+.+..++||+++.
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~g----vpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA--LNELQDEAARLSWLATTG----VPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTT----CCBCCEEEEEECSSCEEEEEECCS
T ss_pred ECCCCCCCCEEEEEEE-CCCCEEEEEECCCCC--HHHHHHHHHHHHHHHHCC----CCCCCEEEECCCCCCEEEEEEEEE
T ss_conf 7678654775899993-898789999589667--768999999999998659----998861322245661599987441
Q ss_pred CCHH-H--------------HHH-HHHCCCCCCC--CCHHHHH----H-H---------------HHHHHHHHHHHHHC-
Q ss_conf 1438-8--------------986-3202699755--5988999----9-9---------------99779999999988-
Q 005590 467 ANLY-E--------------FQK-FNQESGGEAY--FTLGRLQ----V-I---------------TRQCLEALEYLHSL- 507 (689)
Q Consensus 467 g~L~-~--------------~~~-~~~~~~~~~~--ls~~~i~----~-i---------------~~QIl~aL~yLH~~- 507 (689)
|... . .+. .+........ ....... . + .......+..+...
T Consensus 90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (255)
T d1nd4a_ 90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM 169 (255)
T ss_dssp SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHC
T ss_conf 35543221268999999999999873688544887554124688999999875411011340112137999999998718
Q ss_pred ------CCEECCCCCCCEEEECCCCCEEEEEECCCCCC
Q ss_conf ------95303589995798025787099983688421
Q 005590 508 ------GIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539 (689)
Q Consensus 508 ------gIvHrDIKp~NILi~~~~~~~ikL~DFGls~~ 539 (689)
.++|+|+.|.|||++. ...+.|+||+.+..
T Consensus 170 ~~~~~~~liHgD~~~~Nvl~~~--~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 170 PDGEDLVVTHGDACLPNIMVEN--GRFSGFIDCGRLGV 205 (255)
T ss_dssp CSSCCEEEECSSCCGGGEEEET--TEEEEECCCTTCEE
T ss_pred CCCCCCEEEECCCCCCCEEEEC--CCEEEEEECHHCCC
T ss_conf 7657956786788876357737--96589998533265
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.69 E-value=0.00012 Score=44.82 Aligned_cols=140 Identities=16% Similarity=0.159 Sum_probs=77.3
Q ss_pred CCCEEEEEECCCCCEEEEEEEECCHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEE--EEEEEECCEEEEEEECCCCCHH-
Q ss_conf 8753999988789379999960541346759999999999601699998722587--7899847849999971421438-
Q 005590 394 FSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRL--YDYFYHLEHLFIVCELLRANLY- 470 (689)
Q Consensus 394 fG~Vy~a~d~~tg~~vAIKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l--~~~f~~~~~l~lVmEy~~g~L~- 470 (689)
--.||++.. .+|..+++|+.+.......++..|...+..+..... ..+..+.. -..+......+.+++++.|...
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gi-pv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEV-PVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTC-SBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred CCEEEEEEC-CCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCC-CCCCCEECCCCEEEEEEEEEEEEEEECCCCCCC
T ss_conf 202699983-899979999847877889999999999999985599-878752068980566534799998652776889
Q ss_pred ---------------HHHHHHHC--CCCCCCCCHH----------------------HHHHHHHHHHHHHHHHH----HC
Q ss_conf ---------------89863202--6997555988----------------------99999997799999999----88
Q 005590 471 ---------------EFQKFNQE--SGGEAYFTLG----------------------RLQVITRQCLEALEYLH----SL 507 (689)
Q Consensus 471 ---------------~~~~~~~~--~~~~~~ls~~----------------------~i~~i~~QIl~aL~yLH----~~ 507 (689)
.+...... ...+...... .....+.+++..+.-.- ..
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf 99999999989999998863035786556778978876656899987476998898999999999999999845456871
Q ss_pred CCEECCCCCCCEEEECCCCCEEEEEECCCCCC
Q ss_conf 95303589995798025787099983688421
Q 005590 508 GIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539 (689)
Q Consensus 508 gIvHrDIKp~NILi~~~~~~~ikL~DFGls~~ 539 (689)
+++|+|+.+.|||++ ++ ..++||+-++.
T Consensus 193 ~liHgDlh~~NvL~~---~~-~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWR---DG-PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEES---SS-EEECCCTTCCE
T ss_pred EEECCCCCCCCEEEE---CC-CEEEECHHCCC
T ss_conf 202478880428783---89-35886520146
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.64 E-value=0.00027 Score=42.67 Aligned_cols=76 Identities=13% Similarity=0.132 Sum_probs=49.3
Q ss_pred CEEEEEEECCCCCCCEEEEEEC-------CCCCEEEEEEEECCHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEEEEEEE
Q ss_conf 5899999325888753999988-------789379999960541346759999999999601699998722587789984
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDL-------HTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLYDYFYH 454 (689)
Q Consensus 382 ~Y~i~~~LG~G~fG~Vy~a~d~-------~tg~~vAIKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~~~f~~ 454 (689)
..++ +.|+.|-.-.+|++... ...+.|.+++.-..... ....+|..+++.+.... -.+++++++..
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~-idr~~E~~i~~~ls~~g-----l~Pkll~~~~~ 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE-SHLVAESVIFTLLSERH-----LGPKLYGIFSG 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH-HHHHHHHHHHHHHHHTT-----SSSCEEEEETT
T ss_pred CEEE-EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCCCHH-HHHHHHHHHHHHHHHCC-----CCCEEEEECCC
T ss_conf 1699-99178533434899968877544578981799965996116-58999999999997579-----99808998189
Q ss_pred CCEEEEEEECCCCC
Q ss_conf 78499999714214
Q 005590 455 LEHLFIVCELLRAN 468 (689)
Q Consensus 455 ~~~l~lVmEy~~g~ 468 (689)
.+|++|+.|.
T Consensus 117 ----g~I~efi~g~ 126 (395)
T d1nw1a_ 117 ----GRLEEYIPSR 126 (395)
T ss_dssp ----EEEECCCCEE
T ss_pred ----CEEEEEECCC
T ss_conf ----5699973455
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.94 E-value=0.0039 Score=35.11 Aligned_cols=152 Identities=12% Similarity=0.008 Sum_probs=76.7
Q ss_pred CEEEEEEECCCCCCCEEEEEECCCCCEEEEEEEECCHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEE---EEEEECCEE
Q ss_conf 58999993258887539999887893799999605413467599999999996016999987225877---899847849
Q 005590 382 RYYVTEYLGSAAFSKVFQAQDLHTGVDVCLKIIKNDKDFFDQSLDEIKLLKLVNKNDPADEHHILRLY---DYFYHLEHL 458 (689)
Q Consensus 382 ~Y~i~~~LG~G~fG~Vy~a~d~~tg~~vAIKii~~~~~~~~~~~~Ei~iL~~l~~~~~~~h~~Iv~l~---~~f~~~~~l 458 (689)
...-.+.|..|---+.|+... ++..+++|++.... ..+.+..+..++..+..... ..|..+... .........
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t--~~g~yVLri~~~~~-~~~~l~~~~~~l~~L~~~g~-pvp~pi~~~~g~~~~~~~~~~ 94 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHT--TKDPLILTLYEKRV-EKNDLPFFLGLMQHLAAKGL-SCPLPLPRKDGELLGELSGRP 94 (316)
T ss_dssp CEEEEEEECC---EEEEEEEE--SSCCEEEEEECC----CCHHHHHHHHHHHHHHTTC-CCCCBCCBTTCCSCEEETTEE
T ss_pred CCEEEECCCCCCCCCEEEEEE--CCCCEEEEECCCCC-CHHHHHHHHHHHHHHHHCCC-CCCCCCEECCCCCCEEEECCC
T ss_conf 856852378885267389997--89728999807899-98899999999875430255-545564104897621341255
Q ss_pred EEEEECCCCCH---------------HHHHHHH-HCCCCC--CCCC------------------HHHHHHHHHHHHHHHH
Q ss_conf 99997142143---------------8898632-026997--5559------------------8899999997799999
Q 005590 459 FIVCELLRANL---------------YEFQKFN-QESGGE--AYFT------------------LGRLQVITRQCLEALE 502 (689)
Q Consensus 459 ~lVmEy~~g~L---------------~~~~~~~-~~~~~~--~~ls------------------~~~i~~i~~QIl~aL~ 502 (689)
..++.++.+.. ....... ...... .... .......+..+...+.
T Consensus 95 ~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 174 (316)
T d2ppqa1 95 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 174 (316)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred CEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_conf 02453114655333204678888899876454443202453101110120024567777653114127999999987642
Q ss_pred HHHH----CCCEECCCCCCCEEEECCCCCEEEEEECCCCCC
Q ss_conf 9998----895303589995798025787099983688421
Q 005590 503 YLHS----LGIIHCDLKPENILIKSYQRCEIKIIDLGSSCF 539 (689)
Q Consensus 503 yLH~----~gIvHrDIKp~NILi~~~~~~~ikL~DFGls~~ 539 (689)
.... .|+||+|+.++||+++. +...-|+||+.++.
T Consensus 175 ~~~~~~L~~giIHgDl~~dNvl~~~--~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 175 AHWPKDLPAGVIHADLFQDNVFFLG--DELSGLIDFYFACN 213 (316)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEET--TEEEEECCCTTCEE
T ss_pred CCCCCCCCCCCCCCCCCHHHHHCCC--CCCEEEECCCCCCC
T ss_conf 0485545450333786365640204--54126742221236
|